PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Felson, DT; McLaughlin, S; Goggins, J; LaValley, MP; Gale, E; Totterman, S; Li, W; Hill, C; Gale, D				Felson, DT; McLaughlin, S; Goggins, J; LaValley, MP; Gale, E; Totterman, S; Li, W; Hill, C; Gale, D			Bone marrow edema and its relation to progression of knee osteoarthritis	ANNALS OF INTERNAL MEDICINE			English	Article							JOINT SPACE WIDTH; RADIOGRAPHIC FEATURES; CLINICAL-TRIAL; MODIFYING DRUG; SCINTIGRAPHY; ALIGNMENT; PAIN	Background: While factors affecting the course of knee osteoarthritis are mostly unknown, lesions on bone scan and mechanical malalignment increase risk for radiographic deterioration. Bone marrow edema lesions on magnetic resonance imaging correspond to bone scan lesions. Objective: To determine whether edema lesions in the subarticular bone in patients with knee osteoarthritis identify knees at high risk for radiographic progression and whether these lesions are associated with limb malalignment. Design: Natural history study. Setting: A Veterans Administration hospital in Boston, Massachusetts. Patients: Persons 45 years of age and older with symptomatic knee osteoarthritis. Measurements: Baseline assessments included magnetic resonance imaging of the knee and fluoroscopically positioned radiography. During follow-up at 15 and 30 months, patients underwent repeated radiography; at 15 months, long-limb films were obtained to assess mechanical alignment. Progression was defined as an increase over follow-up in medial or lateral joint space narrowing, based on a semi-quantitative grading. Generalized estimating equations were used to evaluate the relation of medial bone marrow edema lesions to medial progression and lateral lesions to lateral progression, before and after adjustment for limb alignment. Results: Of 256 patients, 223 (87.1%) participated in at least one follow-up examination. Medial bone marrow lesions were seen mostly in patients with varus limbs, and lateral lesions were seen mostly in those with valgus limbs. Twenty-seven of 75 knees with medial lesions (36.0%) showed medial progression versus 12 of 148 knees without lesions (8.1%) (odds ratio for progression, 6.5 [95% Cl, 3.0 to 14.0]). Approximately 69% of knees that progressed medially had medial lesions, and lateral lesions conferred a marked risk for lateral progression. These increased risks were attenuated by 37% to 53% after adjustment for limb alignment. Conclusion: Bone marrow edema is a potent risk factor for structural deterioration in knee osteoarthritis, and its relation to progression is explained in part by its association with limb alignment.	Boston Univ, Sch Med, Boston, MA 02118 USA; Vet Affairs Boston Hlth Care Syst, Boston, MA USA; Univ Rochester, Rochester, NY USA	Boston University; University of Rochester	Felson, DT (corresponding author), Boston Univ, Sch Med, 715 Albany St,A203, Boston, MA 02118 USA.		LaValley, Michael/AAA-2030-2020; McLaughlin, Sara/S-3521-2019	Felson, David/0000-0002-2668-2447; LaValley, Michael/0000-0002-8488-5170	NIAMS NIH HHS [AR47785] Funding Source: Medline	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; ALTMAN RD, 1995, OSTEOARTHR CARTILAGE, V3, P3; ANDRIACCHI TP, 1994, ORTHOP CLIN N AM, V25, P395; BERGMAN AG, 1994, SKELETAL RADIOL, V23, P445; Boegard T, 1999, ANN RHEUM DIS, V58, P20, DOI 10.1136/ard.58.1.20; Brandt KD, 2002, J RHEUMATOL, V29, P1308; Buckland-Wright JC, 2003, J RHEUMATOL, V30, P329; BUCKLANDWRIGHT C, 1995, OSTEOARTHR CARTILAGE, V3, P71; BUCKLANDWRIGHT JC, 1995, ANN RHEUM DIS, V54, P263, DOI 10.1136/ard.54.4.263; DIEPPE P, 1993, ANN RHEUM DIS, V52, P557, DOI 10.1136/ard.52.8.557; Felson DT, 2001, ANN INTERN MED, V134, P541, DOI 10.7326/0003-4819-134-7-200104030-00007; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; HUTTON CW, 1986, ANN RHEUM DIS, V45, P622, DOI 10.1136/ard.45.8.622; JOHNSON F, 1980, J BONE JOINT SURG BR, V62, P346, DOI 10.1302/0301-620X.62B3.7410467; Lavalley MP, 2002, ARTHRIT RHEUM-ARTHR, V47, P255, DOI 10.1002/art.10453; Lazzarini KM, 1997, RADIOLOGY, V202, P540, DOI 10.1148/radiology.202.2.9015087; LEDINGHAM J, 1995, ANN RHEUM DIS, V54, P53, DOI 10.1136/ard.54.1.53; MAZZUCA S, 2000, 46 ANN ORTH RES SOC; Mazzuca SA, 1997, OSTEOARTHR CARTILAGE, V5, P217, DOI 10.1016/S1063-4584(97)80017-9; MCALINDON TEM, 1991, ANN RHEUM DIS, V50, P14, DOI 10.1136/ard.50.1.14; MORELAND JR, 1987, J BONE JOINT SURG AM, V69A, P745, DOI 10.2106/00004623-198769050-00016; Rangger C, 1998, ACTA ORTHOP SCAND, V69, P291, DOI 10.3109/17453679809000933; Rothman KJ., 2002, EPIDEMIOLOGY INTRO, P181; SCHOUTEN JSAG, 1992, ANN RHEUM DIS, V51, P932, DOI 10.1136/ard.51.8.932; Sharma L, 2001, JAMA-J AM MED ASSOC, V286, P188, DOI 10.1001/jama.286.2.188; Zanetti M, 2000, RADIOLOGY, V215, P835, DOI 10.1148/radiology.215.3.r00jn05835; Zhang YQ, 1996, J RHEUMATOL, V23, P1130	27	530	554	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 2	2003	139	5	1				330	336		10.7326/0003-4819-139-5_Part_1-200309020-00008	http://dx.doi.org/10.7326/0003-4819-139-5_Part_1-200309020-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	716PL	12965956				2022-12-01	WOS:000185037500003
J	Englund, C; Loren, CE; Grabbe, C; Varshney, GK; Deleuil, F; Hallberg, B; Palmer, RH				Englund, C; Loren, CE; Grabbe, C; Varshney, GK; Deleuil, F; Hallberg, B; Palmer, RH			Jeb signals through the Alk receptor tyrosine kinase to drive visceral muscle fusion	NATURE			English	Article							NON-HODGKINS-LYMPHOMA; DROSOPHILA-MELANOGASTER; GENE; EMBRYOGENESIS	The Drosophila melanogaster gene Anaplastic lymphoma kinase (Alk) is homologous to mammalian Alk, a member of the Alk/Ltk family of receptor tyrosine kinases (RTKs)(1). We have previously shown that the Drosophila Alk RTK is crucial for visceral mesoderm development during early embryogenesis(2). Notably, observed Alk visceral mesoderm defects are highly reminiscent of the phenotype reported for the secreted molecule Jelly belly (Jeb)(3). Here we show that Drosophila Alk is the receptor for Jeb in the developing visceral mesoderm, and that Jeb binding stimulates an Alk-driven, extracellular signal-regulated kinase-mediated signalling pathway, which results in the expression of the downstream gene duf (also known as kirre)(4,5)-needed for muscle fusion. This new signal transduction pathway drives specification of the muscle founder cells, and the regulation of Duf expression by the Drosophila Alk RTK explains the visceral-mesoderm-specific muscle fusion defects observed in both Alk and jeb mutant animals.	Umea Univ, Umea Ctr Mol Pathogenesis, S-90187 Umea, Sweden; Umea Univ, Dept Med Biosci, S-90187 Umea, Sweden	Umea University; Umea University	Palmer, RH (corresponding author), Umea Univ, Umea Ctr Mol Pathogenesis, S-90187 Umea, Sweden.	Ruth.Palmer@ucmp.umu.se	Varshney, Gaurav/L-5261-2014	Varshney, Gaurav K./0000-0002-0429-1904				BATE M, 1990, DEVELOPMENT, V110, P791; Baylies MK, 2001, CURR OPIN GENET DEV, V11, P431, DOI 10.1016/S0959-437X(00)00214-8; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; CARMENA A, 1995, GENE DEV, V9, P2373, DOI 10.1101/gad.9.19.2373; Duyster J, 2001, ONCOGENE, V20, P5623, DOI 10.1038/sj.onc.1204594; Dworak HA, 2002, BIOESSAYS, V24, P591, DOI 10.1002/bies.10115; Fujioka H, 2002, CHEM IMMUNOL, V80, P1; Gabay L, 1997, DEVELOPMENT, V124, P3535; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Klapper R, 2002, MECH DEVELOP, V110, P85, DOI 10.1016/S0925-4773(01)00567-6; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; Loren CE, 2003, EMBO REP, V4, P781, DOI 10.1038/sj.embor.embor897; Loren CE, 2001, GENES CELLS, V6, P531, DOI 10.1046/j.1365-2443.2001.00440.x; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Palmer RH, 1999, J BIOL CHEM, V274, P35621, DOI 10.1074/jbc.274.50.35621; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; San Martin B, 2001, DEVELOPMENT, V128, P3331; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; Weiss JB, 2001, CELL, V107, P387, DOI 10.1016/S0092-8674(01)00540-2	23	120	121	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2003	425	6957					512	516		10.1038/nature01950	http://dx.doi.org/10.1038/nature01950			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727FN	14523447				2022-12-01	WOS:000185648100045
J	Staal, M; Meysman, FJR; Stal, LJ				Staal, M; Meysman, FJR; Stal, LJ			Temperature excludes N-2-fixing heterocystous cyanobacteria in the tropical oceans	NATURE			English	Article							NITROGEN-FIXATION; N-2 FIXATION; BALTIC SEA; PHOTOSYNTHESIS; TRICHODESMIUM; OXYGEN	Whereas the non-heterocystous cyanobacteria Trichodesmium spp. are the dominant N-2-fixing organisms in the tropical oceans(1), heterocystous species dominate N-2 fixation in freshwater lakes and brackish environments such as the Baltic Sea(2). So far no satisfactory explanation for the absence of heterocystous cyanobacteria in the pelagic of the tropical oceans has been given, even though heterocysts would seem to represent an ideal strategy for protecting nitrogenase from being inactivated by O-2, thereby enabling cyanobacteria to fix N-2 and to perform photosynthesis simultaneously. Trichodesmium is capable of N-2 fixation, apparently without needing to differentiate heterocysts(3). Here we show that differences in the temperature dependence of O-2 flux, respiration and N-2 fixation activity explain how Trichodesmium performs better than heterocystous species at higher temperatures. Our results also explain why Trichodesmium is not successful in temperate or cold seas. The absence of heterocystous cyanobacteria in the pelagic zone of temperate and cold seas, however, requires another explanation.	NIOO KNAW, Dept Marine Microbiol, NL-4400 AC Yerseke, Netherlands; NIOO KNAW, Dept Ecosyst Studies, NL-4400 AC Yerseke, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Staal, M (corresponding author), NIOO KNAW, Dept Marine Microbiol, POB 140, NL-4400 AC Yerseke, Netherlands.		Stal, Lucas J/B-3334-2011; Meysman, Filip JR/C-9585-2009	Meysman, Filip JR/0000-0001-5334-7655				Bergman B, 1997, FEMS MICROBIOL REV, V19, P139, DOI 10.1016/S0168-6445(96)00028-9; Berman-Frank I, 2001, LIMNOL OCEANOGR, V46, P1249, DOI 10.4319/lo.2001.46.6.1249; Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Carpenter EJ, 2001, PHYCOLOGIA, V40, P105; Chen YB, 1996, J PHYCOL, V32, P916, DOI 10.1111/j.0022-3646.1996.00916.x; DAVISON IR, 1991, J PHYCOL, V27, P2, DOI 10.1111/j.0022-3646.1991.00002.x; Hoffmann L, 1999, EUR J PHYCOL, V34, P371; KANA TM, 1993, LIMNOL OCEANOGR, V38, P18, DOI 10.4319/lo.1993.38.1.0018; KANGATHARALINGAM N, 1991, J PHYCOL, V27, P680, DOI 10.1111/j.0022-3646.1991.00680.x; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Laamanen MJ, 1997, J PLANKTON RES, V19, P1385, DOI 10.1093/plankt/19.10.1385; MURRY MA, 1989, ARCH MICROBIOL, V151, P469, DOI 10.1007/BF00454860; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; Staal M, 2001, ENVIRON MICROBIOL, V3, P343, DOI 10.1046/j.1462-2920.2001.00201.x; Staal M, 2002, APPL ENVIRON MICROB, V68, P4679, DOI 10.1128/AEM.68.9.4679-4683.2002; Stal LJ, 2000, EUR J PHYCOL, V35, P97, DOI 10.1080/09670260010001735681; TALLING J. F., 1957, NEW PHYTOL, V56, P29, DOI 10.1111/j.1469-8137.1957.tb07447.x; WALSBY A E, 1985, Proceedings of the Royal Society of London Series B Biological Sciences, V226, P345, DOI 10.1098/rspb.1985.0099; Wolk C.P., 1994, MOL BIOL CYANOBACTER, P770	20	123	130	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2003	425	6957					504	507		10.1038/nature01999	http://dx.doi.org/10.1038/nature01999			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727FN	14523445				2022-12-01	WOS:000185648100043
J	Ouyang, Z; Takats, Z; Blake, TA; Gologan, B; Guymon, AJ; Wiseman, JM; Oliver, JC; Davisson, VJ; Cooks, RG				Ouyang, Z; Takats, Z; Blake, TA; Gologan, B; Guymon, AJ; Wiseman, JM; Oliver, JC; Davisson, VJ; Cooks, RG			Preparing protein microarrays by soft-landing of mass-selected ions	SCIENCE			English	Article							POLYATOMIC IONS; FABRICATION; DEPOSITION	Intact, multiply protonated proteins of particular mass and charge were selected from ionized protein mixtures and gently landed at different positions on a surface to form a microarray. An array of cytochrome c, lysozyme, insulin, and apomyoglobin was generated, and the deposited proteins showed electrospray ionization mass spectra that matched those of the authentic compounds. Deposited lysozyme and trypsin retained their biological activity. Multiply charged ions of protein kinase A catalytic subunit and hexokinase were also soft-landed into glycerol-based liquid surfaces. These soft-landed kinases phosphorylated LRRASLG oligopeptide and D-fructose, respectively.	Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Cooks, RG (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	cooks@purdue.edu	Cockshutt, Naomi/AAJ-2721-2020; Cooks, R Graham/G-1051-2015	Cooks, R Graham/0000-0002-9581-9603; Blake, Thomas/0000-0001-8536-9998				Bromann K, 1996, SCIENCE, V274, P956, DOI 10.1126/science.274.5289.956; Feng BB, 1999, J AM CHEM SOC, V121, P8961, DOI 10.1021/ja9923888; FRANCHETTI V, 1977, INT J MASS SPECTROM, V23, P29, DOI 10.1016/0020-7381(77)80004-1; Fuerstenau SD, 2001, ANGEW CHEM INT EDIT, V40, P542, DOI 10.1002/1521-3773(20010202)40:3<541::AID-ANIE541>3.0.CO;2-K; Geiger RJ, 1999, INT J MASS SPECTROM, V182, P415, DOI 10.1016/S1387-3806(98)14262-8; Jones VW, 1998, ANAL CHEM, V70, P1233, DOI 10.1021/ac971125y; Laurell T, 1999, J MICROMECH MICROENG, V9, P369, DOI 10.1088/0960-1317/9/4/314; LEE JC, 1981, J BIOL CHEM, V256, P7193; Luo H, 1998, INT J MASS SPECTROM, V174, P193, DOI 10.1016/S0168-1176(97)00302-9; MacBeath G, 2000, SCIENCE, V289, P1760; Martin BD, 1998, LANGMUIR, V14, P3971, DOI 10.1021/la9713311; Miller SA, 1997, SCIENCE, V275, P1447, DOI 10.1126/science.275.5305.1447; Mooney JF, 1996, P NATL ACAD SCI USA, V93, P12287, DOI 10.1073/pnas.93.22.12287; Morozov VN, 1999, ANAL CHEM, V71, P3110, DOI 10.1021/ac981412h; Pan P, 2003, ANAL CHEM, V75, P1491, DOI 10.1021/ac020637w; Roda A, 2000, BIOTECHNIQUES, V28, P492, DOI 10.2144/00283st07; Rowe CA, 1999, ANAL CHEM, V71, P433, DOI 10.1021/ac980798t; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schwartz JC, 2002, J AM SOC MASS SPECTR, V13, P659, DOI 10.1016/S1044-0305(02)00384-7; Siuzdak G, 1999, J MASS SPECTROM, V34, P1087, DOI 10.1002/(SICI)1096-9888(199910)34:10<1087::AID-JMS872>3.0.CO;2-A; Zhu H, 2003, CURR OPIN CHEM BIOL, V7, P55, DOI 10.1016/S1367-5931(02)00005-4	21	219	226	2	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2003	301	5638					1351	1354		10.1126/science.1088776	http://dx.doi.org/10.1126/science.1088776			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717XQ	12920304				2022-12-01	WOS:000185116400032
J	Diehr, P; Patrick, DL				Diehr, P; Patrick, DL			Trajectories of health for older adults over time: Accounting fully for death	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	8th Regenstrief Conference	SEP 30-OCT 02, 2002	MARSHALL, IN				SELF-RATED HEALTH; PATTERNS; TRIAL; INDEX; LIFE	The process of healthy aging can best be described by plotting the trajectory of health-related variables over time. Unfortunately, graphs including data only from survivors may be misleading because they may confuse patterns of mortality with patterns of change in health. Two approaches for creating graphs that account for death in such situations are 1) to incorporate a category or value for death into the longitudinal health variable and 2) to measure time in years before death or some other event. The first approach has been applied to self-rated health (excellent to poor) and the 36-Item Short-Form Health Survey (SF-36). It allows for flexible and interpretable analyses and may be appropriate for other variables as well. The second approach also accounts fully for death, but the questions it can address are limited. Both approaches are useful and should be used at a minimum for supporting analyses in longitudinal studies in which persons die during observation.	Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Diehr, P (corresponding author), Univ Washington, Dept Biostat, Box 357232, Seattle, WA 98195 USA.	pdiehr@u.washington.edu	Patrick, Donald/Y-2460-2019	Patrick, Donald/0000-0003-0756-0492	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085085, N01HC085083, N01HC085080, N01HC015103, N01HC035129, N01HC085081, N01HC085084, N01HC085079, N01HC085086, N01HC085082] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-85082, N01-HC-85081, N01-HC-85080, N01-HC-85079, N01-HC-35129, N01 HC-15103, N01-HC-85086, N01-HC-85085, N01-HC-85084, N01-HC-85083] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOZZETTE SA, 1995, JAMA-J AM MED ASSOC, V273, P295, DOI 10.1001/jama.273.4.295; DIEHR P, 1995, MED CARE, V33, pAS164; Diehr P, 1998, J CLIN EPIDEMIOL, V51, P343, DOI 10.1016/S0895-4356(97)00298-9; Diehr P, 2002, J CLIN EPIDEMIOL, V55, P269, DOI 10.1016/S0895-4356(01)00462-0; Diehr P, 2001, QUAL LIFE RES, V10, P431, DOI 10.1023/A:1012566130639; Diehr P, 2001, MED CARE, V39, P670, DOI 10.1097/00005650-200107000-00004; Diehr P, 2001, J AM GERIATR SOC, V49, P36, DOI 10.1046/j.1532-5415.2001.49007.x; DIEHR P, 2003, IN PRESS MED CARE; FEENY D, 1995, PHARMACOECONOMICS, V7, P490, DOI 10.2165/00019053-199507060-00004; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; JOHNSON LL, 2002, THESIS U WASHINGTON; KAPLAN RM, 1979, MED CARE, V17, P501, DOI 10.1097/00005650-197905000-00005; LONGSTRETH WT, 1993, NEUROLOGY, V43, P2534, DOI 10.1212/WNL.43.12.2534; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Shock NW., 1984, NORMAL HUMAN AGING B	16	38	38	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 2	2003	139	5	2	S			416	420		10.7326/0003-4819-139-5_Part_2-200309021-00007	http://dx.doi.org/10.7326/0003-4819-139-5_Part_2-200309021-00007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	718FE	12965968				2022-12-01	WOS:000185133800007
J	Trembleau, L; Rebek, J				Trembleau, L; Rebek, J			Helical conformation of alkanes in a hydrophobic cavitand	SCIENCE			English	Article							MOLECULAR RECOGNITION; COMPLEXATION	Alkanes adopt extended conformations in solution that minimize steric interactions and maximize surface area. Folding can reduce the amount of hydrophobic surface exposed to solvent, but sterically unfavorable gauche interactions result. However, we found that the alkyl chains of two common surfactants in aqueous solution adopt helical conformations when bound within a synthetic receptor. The receptor recognizes the helical alkane better than the extended conformation, even though 2 to 3 kilocalories per mole of strain is introduced. The proper filling of space and burial of hydrophobic surface drive the molecular recognition between the receptor and the coiled alkane.	Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Rebek, J (corresponding author), Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jrebek@scripps.edu		Trembleau, Laurent/0000-0001-6376-9077	NIGMS NIH HHS [GM 27932] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027932, R01GM027932] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atwood JL, 2002, J AM CHEM SOC, V124, P10646, DOI 10.1021/ja027191l; Atwood JL, 2003, CHEM COMMUN, P940, DOI 10.1039/b301511d; ATWOOD JL, 1995, SUPRAMOL CHEM, V5, P105, DOI 10.1080/10610279508029481; BLOKZIJL W, 1993, ANGEW CHEM INT EDIT, V32, P1545, DOI 10.1002/anie.199315451; Casnati A, 2003, ACCOUNTS CHEM RES, V36, P246, DOI 10.1021/ar0200798; GOODLING K, 1994, J CHEM EDUC, V71, pA8, DOI 10.1021/ed071pA8; Haino T, 2000, CHEM-EUR J, V6, P3797, DOI 10.1002/1521-3765(20001016)6:20<3797::AID-CHEM3797>3.0.CO;2-1; Hof F, 2003, ANGEW CHEM INT EDIT, V42, P3150, DOI 10.1002/anie.200351174; LEHN JM, 1995, SUPRAMOL CHEM, V5, P97, DOI 10.1080/10610279508029480; MCDONALD DQ, 1992, TETRAHEDRON LETT, V33, P7743, DOI 10.1016/0040-4039(93)88034-G; Mecozzi S, 1998, CHEM-EUR J, V4, P1016, DOI 10.1002/(SICI)1521-3765(19980615)4:6<1016::AID-CHEM1016>3.0.CO;2-B; Meyer EA, 2003, ANGEW CHEM INT EDIT, V42, P1210, DOI 10.1002/anie.200390319; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; NISHIO M, 1998, CH PI INTERACTION; PETERSON BR, 1995, TETRAHEDRON, V51, P401, DOI 10.1016/0040-4020(94)00905-A; Rekharsky MV, 1998, CHEM REV, V98, P1875, DOI 10.1021/cr970015o; Rudkevich DM, 1998, J AM CHEM SOC, V120, P12216, DOI 10.1021/ja982970g; SCHNEIDER HJ, 1987, J ORG CHEM, V52, P1613, DOI 10.1021/jo00384a046; SONCINI P, 1992, J ORG CHEM, V57, P4608, DOI 10.1021/jo00043a015; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; TURRO NJ, 1978, J AM CHEM SOC, V100, P5951, DOI 10.1021/ja00486a062; VANSTAM J, 1994, J CHEM EDUC, V75, P93; [No title captured]	23	191	192	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2003	301	5637					1219	1220		10.1126/science.1086644	http://dx.doi.org/10.1126/science.1086644			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZC	12947192				2022-12-01	WOS:000185003500035
J	Eichinger, S; Minar, E; Bialonczyk, C; Hirschl, M; Quehenberger, P; Schneider, B; Weltermann, A; Wagner, O; Kyrle, PA				Eichinger, S; Minar, E; Bialonczyk, C; Hirschl, M; Quehenberger, P; Schneider, B; Weltermann, A; Wagner, O; Kyrle, PA			D-dimer levels and risk of recurrent venous thromboembolism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ORAL ANTICOAGULANT-THERAPY; DEEP-VEIN THROMBOSIS; FACTOR-V-LEIDEN; PROTHROMBIN GENE; HETEROZYGOUS CARRIERS; FIRST EPISODE; MUTATION; THROMBOPHILIA	Context Widespread screening of patients with venous thromboembolism (VTE) for thrombophilic risk factors has become common clinical practice. Because of the increasing number of risk factors, assessing the risk of recurrence in an individual patient is intricate; therefore, a laboratory method that measures multifactorial thrombophilia is required. Objective To prospectively study the relationship between the risk of recurrent VTE and D-dimer, a global marker of coagulation activation and fibrinolysis. Design, Setting, and Participants Prospective cohort study of 610 patients older than 18 years who were treated with oral anticoagulants for at least 3 months with a first spontaneous VTE, in whom D-dimer levels were measured shortly after discontinuation of oral anticoagulation. The study was conducted at the Department of Internal Medicine I, University Hospital, Vienna, Austria. Patients entered the study at time of discontinuation of oral anticoagulants and were observed at 3-month intervals during the first year and every 6 months thereafter from July 1992 to October 2002. Main Outcome Measure Objectively documented symptomatic recurrent VTE. Results A total of 79 (13%) of 610 patients had recurrent VTE with a mean observation time of 38 months. Patients with recurrence had significantly higher D-dimer levels compared with those without recurrence (553 ng/mL vs 427 ng/mL, P=.01). Compared with patients with D-dimer levels of 750 ng/mL or higher, the relative risk (RR) of recurrence was 0.6 (95% confidence interval [CI], 0.3-1.4),0.6 (95% CI, 0.3-1.2), and 0.3 (95% CI, 0.1-0.6) in patients with D-dimer levels of 500 to 749 ng/mL, 250 to 499 ng/mL, and less than 250 ng/mL, respectively. The cumulative probability of recurrent VTE at 2 years was 3.7% (95% CI, 0.9%-6.5%) among patients with D-dimer levels of less than 250 ng/mL compared with 11.5% (95% CI, 8.0%-15.0%) among patients with higher levels (P=.001). Patients with D-dimer levels of less than 250 ng/mL had a 60% lower RR of recurrence compared with patients with higher levels (RR, 0.4; 95% CI, 0.2-0.8). Conclusion Patients with a first spontaneous VTE and a D-dimer level of less than 250 ng/mL after withdrawal of oral anticoagulation have a low risk of VTE recurrence.	Univ Vienna, Dept Internal Med 1, A-1090 Vienna, Austria; Univ Vienna, Ludwig Boltzmann Inst, A-1090 Vienna, Austria; Univ Vienna, Dept Internal Med 2, A-1090 Vienna, Austria; Univ Vienna, Clin Inst Med & Chem Lab Diagnost, A-1090 Vienna, Austria; Univ Vienna, Inst Med Stat, A-1090 Vienna, Austria; Wilhelminenspital Stadt Wien, Vienna, Austria; Hanuschkrankenhaus, Vienna, Austria	University of Vienna; Ludwig Boltzmann Institute; University of Vienna; University of Vienna; University of Vienna; University of Vienna; Wilhelminenspital; WGKK - Hanusch Hospital	Eichinger, S (corresponding author), Univ Vienna, Dept Internal Med 1, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	sabine.eichinger@akh-wien.ac.at						Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; Andreescu ACM, 2002, THROMB HAEMOSTASIS, V87, P47, DOI 10.1055/s-0037-1612942; Bauer KA, 2001, ANN INTERN MED, V135, P367, DOI 10.7326/0003-4819-135-5-200109040-00013; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Cushman M, 2003, BLOOD, V101, P1243, DOI 10.1182/blood-2002-05-1416; De Stefano V, 1999, NEW ENGL J MED, V341, P801, DOI 10.1056/NEJM199909093411104; De Stefano V, 2001, BRIT J HAEMATOL, V113, P630, DOI 10.1046/j.1365-2141.2001.02827.x; Eichinger S, 1999, THROMB HAEMOSTASIS, V81, P14; Eichinger S, 1998, THROMB HAEMOSTASIS, V80, P566; Eichinger S, 2002, ARCH INTERN MED, V162, P2357, DOI 10.1001/archinte.162.20.2357; Hirsh J, 2002, BLOOD, V99, P3102, DOI 10.1182/blood.V99.9.3102; Kalbfleisch JD., 2002, STAT ANAL FAILURE TI, V2, DOI [10.1002/9781118032985, DOI 10.1016/0197-2456(81)90009-X]; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kelly J, 2002, ARCH INTERN MED, V162, P747, DOI 10.1001/archinte.162.7.747; Kyrle PA, 2000, NEW ENGL J MED, V343, P457, DOI 10.1056/NEJM200008173430702; Lindmarker P, 1999, THROMB HAEMOSTASIS, V81, P684; Mannucci PM, 2002, THROMB HAEMOSTASIS, V88, P1; Margaglione M, 1999, THROMB HAEMOSTASIS, V82, P1583; Martinelli I, 2001, THROMB HAEMOSTASIS, V86, P395; Palareti G, 2002, THROMB HAEMOSTASIS, V87, P7; Pinede L, 2001, CIRCULATION, V103, P2453; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501	24	254	261	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2003	290	8					1071	1074		10.1001/jama.290.8.1071	http://dx.doi.org/10.1001/jama.290.8.1071			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715FA	12941680	Bronze			2022-12-01	WOS:000184958900026
J	Wang, TJ; Massaro, JM; Levy, D; Vasan, RS; Wolf, PA; D'Agostino, RB; Larson, MG; Kannel, WB; Benjamin, EJ				Wang, TJ; Massaro, JM; Levy, D; Vasan, RS; Wolf, PA; D'Agostino, RB; Larson, MG; Kannel, WB; Benjamin, EJ			A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community - The Framingham Heart Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR HYPERTROPHY; ISCHEMIC-STROKE; ANTICOAGULATION; MANAGEMENT; DISEASE; ASPIRIN; THROMBOEMBOLISM; PREVALENCE; VALIDATION; PREVENTION	Context Prior risk stratification schemes for atrial fibrillation (AF) have been based on randomized trial cohorts or Medicare administrative databases, have included patients with established AF, and have focused on stroke as the principal outcome. Objective To derive risk scores for stroke alone and stroke or death in community-based individuals with new-onset AF. Design, Setting, and Participants Prospective, community-based, observational cohort in Framingham, Mass. We identified 868 participants with new-onset AF, 705 of whom were not treated with warfarin at baseline. Risk scores for stroke (ischemic or hemorrhagic) and stroke or death were developed with censoring when warfarin initiation occurred during follow-up. Event rates were examined in low-risk individuals, as defined by the risk score and 4 previously published risk schemes. Main Outcome Measures Stroke and the combination of stroke or death. Results During a mean follow-up of 4.0 years free of warfarin use, stroke alone occurred in 83 participants and stroke or death occurred in 382 participants. A risk score for stroke was derived that included the following risk predictors: advancing age, female sex, increasing systolic blood pressure, prior stroke or transient ischemic attack, and diabetes. With the risk score, 14.3% of the cohort had a predicted 5-year stroke rate less than or equal to7.5% (average annual rate less than or equal to1.5%), and 30.6% of the cohort had a predicted 5-year stroke rate less than or equal to10% (average annual rate less than or equal to2%). Actual stroke rates in these low-risk groups were 1.1 and 1.5 per 100 person-years, respectively. Previous risk schemes classified 6.4% to 17.3% of subjects as low risk, with actual stroke rates of 0.9 to 2.3 per 100 person-years. A risk score for stroke or death is also presented. Conclusion These risk scores can be used to estimate the absolute risk of an adverse event in individuals with AF, which may be helpful in counseling patients and making treatment decisions.	Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Cardiol, Boston, MA 02215 USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Epidemiol, Boston, MA 02215 USA; Boston Univ, Dept Math, Boston, MA 02215 USA; NHLBI, Bethesda, MD 20892 USA; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Med, Div Cardiol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Prevent Med, Boston, MA 02118 USA	Framingham Heart Study; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Boston University	Benjamin, EJ (corresponding author), Framingham Heart Dis Epidemiol Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.	emelia@fram.nhlbi.nih.gov	Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Benjamin, Emelia/E-7103-2011; Ramachandran, Vasan/Y-2527-2019	Levy, Daniel/0000-0003-1843-8724; Benjamin, Emelia/0000-0003-4076-2336; Ramachandran, Vasan/0000-0001-7357-5970; Larson, Martin/0000-0002-9631-1254; Massaro, Joseph/0000-0002-2682-4812; Wolf, Philip/0000-0002-3628-301X	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL074077, K24HL004334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NHLBI NIH HHS [1K24-HL-04334, K23 HL074077-01, N01-HC-25195] Funding Source: Medline; NINDS NIH HHS [5R01-NS-17950] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		*AM HEART ASS, 2002, HEART DIS STROK STAT; Anderson DC, 1998, JAMA-J AM MED ASSOC, V279, P1273; ANDERSON DC, 1992, ANN INTERN MED, V116, P6; [Anonymous], 1994, ARCH INTERN MED, V154, P2254; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Biblo LA, 2001, AM J CARDIOL, V87, P346, DOI 10.1016/S0002-9149(00)01374-6; CABIN HS, 1990, AM J CARDIOL, V65, P1112, DOI 10.1016/0002-9149(90)90323-S; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Evans A, 2001, ARCH INTERN MED, V161, P1443, DOI 10.1001/archinte.161.11.1443; Ezekowitz M, 1998, ARCH INTERN MED, V158, P1316; Feinberg WM, 1999, J GEN INTERN MED, V14, P56, DOI 10.1046/j.1525-1497.1999.00281.x; Feinberg WM, 1999, THROMB HAEMOSTASIS, V82, P100, DOI 10.1055/s-0037-1614636; Fihn SD, 1996, ANN INTERN MED, V124, P970, DOI 10.7326/0003-4819-124-11-199606010-00004; Fuster V, 2001, J AM COLL CARDIOL, V38, P1231, DOI 10.1016/S0735-1097(01)01587-X; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Gerdts E, 2002, HYPERTENSION, V39, P739, DOI 10.1161/hy0302.105683; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hart RG, 1999, STROKE, V30, P1223, DOI 10.1161/01.STR.30.6.1223; Hart RG, 1999, ANN INTERN MED, V131, P688, DOI 10.7326/0003-4819-131-9-199911020-00010; Hart RG, 2000, J AM COLL CARDIOL, V35, P183, DOI 10.1016/S0735-1097(99)00489-1; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Kalra L, 1999, STROKE, V30, P1218, DOI 10.1161/01.STR.30.6.1218; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KANNEL WB, 1969, ANN INTERN MED, V71, P89, DOI 10.7326/0003-4819-71-1-89; Kearon C, 1997, NEW ENGL J MED, V336, P1506, DOI 10.1056/NEJM199705223362107; LAKE FR, 1989, AUST NZ J MED, V19, P321, DOI 10.1111/j.1445-5994.1989.tb00271.x; Laupacis A, 1998, CHEST, V114, p579S, DOI 10.1378/chest.114.5_Supplement.579S; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Nam BH, 2000, THESIS BOSTON U BOST; NOVELLO P, 1993, ITAL J NEUROL SCI, V14, P571, DOI 10.1007/BF02339217; ONUNDARSON PT, 1987, EUR HEART J, V8, P521; Pearce LA, 2000, AM J MED, V109, P45, DOI 10.1016/S0002-9343(00)00440-X; Seidl K, 1998, AM J CARDIOL, V82, P580, DOI 10.1016/S0002-9149(98)00419-6; *STROK PREV ATR FI, 1992, ANN INTERN MED, V116, P71; SULLIVAN LM, IN PRESS STAT MED; van Walraven C, 2003, ARCH INTERN MED, V163, P936, DOI 10.1001/archinte.163.8.936; van Walraven C, 2002, JAMA-J AM MED ASSOC, V288, P2441, DOI 10.1001/jama.288.19.2441; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; WOLF PA, 1978, NEUROLOGY, V28, P973, DOI 10.1212/WNL.28.10.973; Wood KA, 1997, AM J CARDIOL, V79, P1043, DOI 10.1016/S0002-9149(97)00044-1	44	584	613	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2003	290	8					1049	1056		10.1001/jama.290.8.1049	http://dx.doi.org/10.1001/jama.290.8.1049			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715FA	12941677	Bronze			2022-12-01	WOS:000184958900023
J	Gebert, B; Fischer, W; Weiss, E; Hoffmann, R; Haas, R				Gebert, B; Fischer, W; Weiss, E; Hoffmann, R; Haas, R			Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation	SCIENCE			English	Article							GASTRIC EPITHELIAL-CELLS; PROTEIN; ABSENCE; TOXIN; GENE; CAGA; TRANSLOCATION; COLONIZATION; EXPRESSION; INFECTION	Helicobacter pylori (Hp) vacuolating cytotoxin VacA induces cellular vacuolation in epithelial cells. We found that VacA could efficiently block proliferation of T cells by inducing a G(1)/S cell cycle arrest. It interfered with the T cell receptor/interleukin-2 (IL-2) signaling pathway at the level of the Ca2+-calmodulin-dependent phosphatase calcineurin. Nuclear translocation of nuclear factor of activated T cells (NFAT), a transcription factor acting as a global regulator of immune response genes, was abrogated, resulting in downregulation of IL-2 transcription. VacA partially mimicked the activity of the immunosuppressive drug FK506 by possibly inducing a local immune suppression, explaining the extraordinary chronicity of Hp infections.	LMU Munchen, Max Von Pettenkofer Inst Hyg & Med Microbiol, Munich, Germany	University of Munich	Haas, R (corresponding author), LMU Munchen, Max Von Pettenkofer Inst Hyg & Med Microbiol, Munich, Germany.		Hoffmann, Reinhard/I-8748-2018	Hoffmann, Reinhard/0000-0003-1514-1183				ARNIEVA MR, 2003, SCIENCE, V300, P1430; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Blaser MJ, 1996, SCI AM, V274, P104, DOI 10.1038/scientificamerican0296-104; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Ermak TH, 1998, J EXP MED, V188, P2277, DOI 10.1084/jem.188.12.2277; Galmiche A, 2000, EMBO J, V19, P6361, DOI 10.1093/emboj/19.23.6361; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Kehlenbach RH, 1998, J CELL BIOL, V141, P863, DOI 10.1083/jcb.141.4.863; Kim HP, 2002, EMBO J, V21, P3051, DOI 10.1093/emboj/cdf321; KNIPP U, 1994, FEMS IMMUNOL MED MIC, V8, P157, DOI 10.1111/j.1574-695X.1994.tb00438.x; Krauss-Etschmann S, 2003, CLIN DIAGN LAB IMMUN, V10, P22, DOI 10.1128/CDLI.10.1.22-29.2003; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lucas B, 2001, INFECT IMMUN, V69, P1714, DOI 10.1128/IAI.69.3.1714-1721.2001; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; MAI UEH, 1992, J EXP MED, V175, P517, DOI 10.1084/jem.175.2.517; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Molinari M, 1998, J EXP MED, V187, P135, DOI 10.1084/jem.187.1.135; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Odenbreit S, 2001, CELL MICROBIOL, V3, P21, DOI 10.1046/j.1462-5822.2001.00088.x; RYFFEL B, 1995, IMMUNOPHARMACOLOGY, V30, P199, DOI 10.1016/0162-3109(95)00023-M; Salama NR, 2001, INFECT IMMUN, V69, P730, DOI 10.1128/IAI.69.2.730-736.2001; Shirin H, 1999, CANCER RES, V59, P2277; Whitehouse CA, 1998, INFECT IMMUN, V66, P1934, DOI 10.1128/IAI.66.5.1934-1940.1998; Yoshida T, 1999, J IMMUNOL, V163, P3295	25	406	426	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 22	2003	301	5636					1099	1102		10.1126/science.1086871	http://dx.doi.org/10.1126/science.1086871			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713RP	12934009				2022-12-01	WOS:000184872400041
J	Tsuda, M; Shigemoto-Mogami, Y; Koizumi, S; Mizokoshi, A; Kohsaka, S; Salter, MW; Inoue, K				Tsuda, M; Shigemoto-Mogami, Y; Koizumi, S; Mizokoshi, A; Kohsaka, S; Salter, MW; Inoue, K			P2X(4) receptors induced in spinal microglia gate tactile allodynia after nerve injury	NATURE			English	Article							DORSAL HORN NEURONS; ATP P-2X RECEPTORS; SYNAPTIC TRANSMISSION; BRAIN; CORD; RAT; PAIN; INVOLVEMENT; CYTOKINES; RELEASE	Pain after nerve damage is an expression of pathological operation of the nervous system 1,2, one hallmark of which is tactile allodynia-pain hypersensitivity evoked by innocuous stimuli. Effective therapy for this pain is lacking, and the underlying mechanisms are poorly understood. Here we report that pharmacological blockade of spinal P2X(4) receptors (P2X(4)Rs)(3-7), a subtype of ionotropic ATP receptor(8), reversed tactile allodynia caused by peripheral nerve injury without affecting acute pain behaviours in naive animals. After nerve injury, P2X(4)R expression increased strikingly in the ipsilateral spinal cord, and P2X(4)Rs were induced in hyperactive microglia but not in neurons or astrocytes. Intraspinal administration of P2X(4)R antisense oligodeoxynucleotide decreased the induction of P2X(4)Rs and suppressed tactile allodynia after nerve injury. Conversely, intraspinal administration of microglia in which P2X(4)Rs had been induced and stimulated, produced tactile allodynia in naive rats. Taken together, our results demonstrate that activation of P2X(4)Rs in hyperactive microglia is necessary for tactile allodynia after nerve injury and is sufficient to produce tactile allodynia in normal animals. Thus, blocking P2X(4)Rs in microglia might be a new therapeutic strategy for pain induced by nerve injury.	Natl Inst Hlth Sci, Div Biosignaling, Setagaya Ku, Tokyo 1588501, Japan; Hosp Sick Children, Programme Brain & Behav, Toronto, ON M5G 1X8, Canada; Natl Inst Hlth Sci, Div Pharmacol, Setagaya Ku, Tokyo 1588501, Japan; Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol & Syst Pharmacol, Higashi Ku, Fukuoka 8128582, Japan; Natl Inst Neurosci, Dept Neurochem, Tokyo 1878502, Japan	National Institute of Health Sciences - Japan; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); National Institute of Health Sciences - Japan; Kyushu University; National Center for Neurology & Psychiatry - Japan	Inoue, K (corresponding author), Natl Inst Hlth Sci, Div Biosignaling, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.		Koizumi, Schuichi/E-8568-2010; Tsuda, Makoto/AAE-7256-2020	Koizumi, Schuichi/0000-0001-6184-3106; 				Aldskogius H, 1998, PROG NEUROBIOL, V55, P1, DOI 10.1016/S0301-0082(97)00093-2; Bardoni R, 1997, J NEUROSCI, V17, P5297; BO XN, 1995, FEBS LETT, V375, P129, DOI 10.1016/0014-5793(95)01203-Q; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; Carson MJ, 2002, GLIA, V40, P218, DOI 10.1002/glia.10145; Eikelenboom P, 2002, GLIA, V40, P232, DOI 10.1002/glia.10146; Fam SR, 2000, J NEUROSCI, V20, P2800; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Honore P, 2000, NEUROSCIENCE, V98, P585, DOI 10.1016/S0306-4522(00)00110-X; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; Jo YH, 1999, NAT NEUROSCI, V2, P241, DOI 10.1038/6344; Khakh BS, 2001, PHARMACOL REV, V53, P107; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Li P, 1998, J NEUROPHYSIOL, V80, P3356, DOI 10.1152/jn.1998.80.6.3356; NAKAJIMA K, 1993, NEUROSCI RES, V17, P187, DOI 10.1016/0168-0102(93)90047-T; NAKAJIMA K, 1992, J NEUROCHEM, V58, P1401, DOI 10.1111/j.1471-4159.1992.tb11356.x; Nakatsuka T, 2001, J NEUROSCI, V21, P6522, DOI 10.1523/JNEUROSCI.21-17-06522.2001; SAWYNOK J, 1993, BRAIN RES, V610, P32, DOI 10.1016/0006-8993(93)91213-C; Seguela P, 1996, J NEUROSCI, V16, P448; Soto F, 1996, P NATL ACAD SCI USA, V93, P3684, DOI 10.1073/pnas.93.8.3684; Tsuda M, 1999, BRIT J PHARMACOL, V128, P1497, DOI 10.1038/sj.bjp.0702960; Tsuda M, 1999, BRIT J PHARMACOL, V127, P449, DOI 10.1038/sj.bjp.0702582; Virginio C, 1998, MOL PHARMACOL, V53, P969; Vitkovic L, 2000, J NEUROCHEM, V74, P457, DOI 10.1046/j.1471-4159.2000.740457.x; Wang CZ, 1996, BIOCHEM BIOPH RES CO, V220, P196, DOI 10.1006/bbrc.1996.0380; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zheng JH, 2000, NEUROSCI LETT, V278, P41, DOI 10.1016/S0304-3940(99)00896-4	28	1130	1241	4	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 14	2003	424	6950					778	783		10.1038/nature01786	http://dx.doi.org/10.1038/nature01786			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12917686				2022-12-01	WOS:000184733900041
J	Anglana, M; Apiou, F; Bensimon, A; Debatisse, M				Anglana, M; Apiou, F; Bensimon, A; Debatisse, M			Dynamics of DNA replication in mammalian somatic cells: Nucleotide pool modulates origin choice and interorigin spacing	CELL			English	Article							SINGLE-MOLECULE ANALYSIS; CHINESE-HAMSTER; S-PHASE; SACCHAROMYCES-CEREVISIAE; INITIATION SITES; ADENYLATE DEAMINASE; SEQUENCE ELEMENTS; BUDDING YEAST; EGG EXTRACTS; LOCUS	Selection of active origins and regulation of interorigin spacing are poorly understood in mammalian cells. Using tricolor analysis of combed DNA molecules, we studied an amplified locus containing the known origin, oriGNAI3. We visualized replication firing events at this and other discrete regions and established a strict correlation between AT richness and initiation sites. We found that oriGNAI3 is the prominent origin of the domain, the firing of which correlates with silencing of neighboring sites and establishes large interorigin distances. We demonstrate that cells reversibly respond to a reduction in nucleotide availability by slowing the rate of replication fork progression; in addition, the efficiency of initiation at oriGNAI3 is lowered while other normally dormant origins in the region are activated, which results in an overall increase in the density of initiation events. Thus, nucleotide pools are involved in the specification of active origins, which in turn defines their density along chromosomes.	Inst Curie, F-75248 Paris, France; Inst Pasteur, Genomes Stabil Unit, F-75724 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Debatisse, M (corresponding author), Inst Curie, FRE 2584,26 Rue Ulm, F-75248 Paris, France.	michelle.debatisse@curie.fr						Abdurashidova G, 2000, SCIENCE, V287, P2023, DOI 10.1126/science.287.5460.2023; Aladjem MI, 1998, SCIENCE, V281, P1005, DOI 10.1126/science.281.5379.1005; Aladjem MI, 2002, MOL CELL BIOL, V22, P442, DOI 10.1128/MCB.22.2.442-452.2002; Altman AL, 2001, MOL CELL BIOL, V21, P1098, DOI 10.1128/MCB.21.4.1098-1110.2001; Angus SP, 2002, J BIOL CHEM, V277, P44376, DOI 10.1074/jbc.M205911200; ATEN JA, 1992, HISTOCHEM J, V24, P251, DOI 10.1007/BF01046839; Baron B, 1996, MAMM GENOME, V7, P429, DOI 10.1007/s003359900127; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bogan JA, 2000, J CELL PHYSIOL, V184, P139, DOI 10.1002/1097-4652(200008)184:2<139::AID-JCP1>3.0.CO;2-8; BREWER BJ, 1994, P NATL ACAD SCI USA, V91, P3418, DOI 10.1073/pnas.91.8.3418; COLLINS JM, 1978, J BIOL CHEM, V253, P8570; DEBATISSE M, 1988, MOL CELL BIOL, V8, P17, DOI 10.1128/MCB.8.1.17; DEBATISSE M, 1982, MOL CELL BIOL, V2, P1346, DOI 10.1128/MCB.2.11.1346; DePamphilis ML, 2000, J STRUCT BIOL, V129, P186, DOI 10.1006/jsbi.2000.4219; DEPAMPHILLIS M, 1996, DNA REPLICATION EUKA; Devault A, 2002, CURR BIOL, V12, P689, DOI 10.1016/S0960-9822(02)00768-6; DIJKWEL PA, 1991, MOL CELL BIOL, V11, P3850, DOI 10.1128/MCB.11.8.3850; Dijkwel PA, 2002, MOL CELL BIOL, V22, P3053, DOI 10.1128/MCB.22.9.3053-3065.2002; Fernandez MA, 1997, J CELL BIOCHEM, V67, P541, DOI 10.1002/(SICI)1097-4644(19971215)67:4<541::AID-JCB11>3.0.CO;2-C; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; Herrick J, 2000, J MOL BIOL, V300, P1133, DOI 10.1006/jmbi.2000.3930; Herrick J, 2002, J MOL BIOL, V320, P741, DOI 10.1016/S0022-2836(02)00522-3; Herrick J, 1999, BIOCHIMIE, V81, P859, DOI 10.1016/S0300-9084(99)00210-2; HOUSMAN D, 1975, J MOL BIOL, V94, P173, DOI 10.1016/0022-2836(75)90076-5; HYRIEN O, 1988, EMBO J, V7, P407, DOI 10.1002/j.1460-2075.1988.tb02828.x; HYRIEN O, 1995, SCIENCE, V270, P994, DOI 10.1126/science.270.5238.994; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; Kobayashi T, 1998, MOL CELL BIOL, V18, P3266, DOI 10.1128/MCB.18.6.3266; Koc A, 2003, J BIOL CHEM, V278, P9345, DOI 10.1074/jbc.M213013200; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Lengronne A, 2001, NUCLEIC ACIDS RES, V29, P1433, DOI 10.1093/nar/29.7.1433; Li F, 2003, J CELL BIOL, V161, P257, DOI 10.1083/jcb.200211127; Malinsky J, 2001, J CELL SCI, V114, P747; MARAHRENS Y, 1994, EMBO J, V13, P3395, DOI 10.1002/j.1460-2075.1994.tb06642.x; Marheineke K, 2001, J BIOL CHEM, V276, P17092, DOI 10.1074/jbc.M100271200; Mechali M, 2001, NAT REV GENET, V2, P640, DOI 10.1038/35084598; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Norio P, 2001, SCIENCE, V294, P2361, DOI 10.1126/science.1064603; Okuno Y, 2001, EMBO J, V20, P4263, DOI 10.1093/emboj/20.15.4263; Pasero P, 2002, GENE DEV, V16, P2479, DOI 10.1101/gad.232902; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Santocanale C, 1999, GENE DEV, V13, P2360, DOI 10.1101/gad.13.18.2360; Santocanale C, 1996, EMBO J, V15, P6671, DOI 10.1002/j.1460-2075.1996.tb01057.x; Sasaki T, 1999, MOL CELL BIOL, V19, P547; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; SKOOG L, 1971, EUR J BIOCHEM, V19, P81, DOI 10.1111/j.1432-1033.1971.tb01290.x; Stevenson JB, 1999, GENE DEV, V13, P146, DOI 10.1101/gad.13.2.146; Svetlova EY, 2001, J CELL BIOCHEM, P170; Toledo F, 1999, NUCLEIC ACIDS RES, V27, P1600, DOI 10.1093/nar/27.7.1600; Toledo F, 1998, NUCLEIC ACIDS RES, V26, P2313, DOI 10.1093/nar/26.10.2313; Visser AE, 1998, EXP CELL RES, V243, P398, DOI 10.1006/excr.1998.4144; Vujcic M, 1999, MOL CELL BIOL, V19, P6098; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; Wu JR, 1996, SCIENCE, V271, P1270, DOI 10.1126/science.271.5253.1270; ZANNISHADJOPOULOS M, 1980, J CELL BIOL, V85, P777, DOI 10.1083/jcb.85.3.777	55	260	270	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2003	114	3					385	394		10.1016/S0092-8674(03)00569-5	http://dx.doi.org/10.1016/S0092-8674(03)00569-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914702	Bronze			2022-12-01	WOS:000184679200014
J	Zhu, J; Shendure, J; Mitra, RD; Church, GM				Zhu, J; Shendure, J; Mitra, RD; Church, GM			Single molecule profiling of alternative pre-mRNA splicing	SCIENCE			English	Article							EPITHELIAL-CELLS; CD44; DIVERSITY; NONSENSE	Alternative pre-messenger RNA splicing is an important mechanism for generating protein diversity and may explain in part how mammalian complexity arises from a surprisingly small complement of genes. Here, we describe "digital polony exon profiling," a single molecule - based technology for studying complex alternative pre-messenger RNA splicing. This technology allows researchers to monitor the combinatorial diversity of exon inclusion in individual transcripts. A minisequencing strategy provides single nucleotide resolution, and the digital nature of the technology allows quantitation of individual splicing variants. Digital polony exon pro. ling can be used to investigate the physiological and pathological roles of alternately spliced messenger RNAs, as well as the mechanisms by which these messenger RNAs are produced.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Harvard University; Harvard Medical School; Washington University (WUSTL)	Church, GM (corresponding author), Harvard Univ, Sch Med, Dept Genet, 200 Longwood Ave, Boston, MA 02115 USA.			Mitra, Robi/0000-0002-2680-4264; Shendure, Jay/0000-0002-1516-1865; church, george/0000-0001-6232-9969	NIGMS NIH HHS [5U54GM62119] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062119] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bajorath J, 2000, PROTEINS, V39, P103, DOI 10.1002/(SICI)1097-0134(20000501)39:2<103::AID-PROT1>3.3.CO;2-7; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bell MV, 1998, MOL CELL BIOL, V18, P5930, DOI 10.1128/MCB.18.10.5930; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Delacourte Andre, 2000, Current Opinion in Neurology, V13, P371, DOI 10.1097/00019052-200008000-00002; Herrlich P, 2000, ANN NY ACAD SCI, V910, P106; Kan ZY, 2001, GENOME RES, V11, P889, DOI 10.1101/gr.155001; LESLEY J, 1998, FRONT BIOSCI, V3, P616; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Mitra RD, 2003, P NATL ACAD SCI USA, V100, P5926, DOI 10.1073/pnas.0936399100; MITRA RD, IN PRESS ANAL BIOCH; Mitra RD, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e34; Pinkas J, 2002, CANCER RES, V62, P4781; Roca X, 1998, AM J PATHOL, V153, P183, DOI 10.1016/S0002-9440(10)65559-9; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Sergeant N, 2001, HUM MOL GENET, V10, P2143, DOI 10.1093/hmg/10.19.2143; Soukka T, 1997, CANCER RES, V57, P2281; Valentine CR, 1998, MUTAT RES-REV MUTAT, V411, P87, DOI 10.1016/S1383-5742(98)00010-6; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Yeakley JM, 2002, NAT BIOTECHNOL, V20, P353, DOI 10.1038/nbt0402-353	24	83	101	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					836	838		10.1126/science.1085792	http://dx.doi.org/10.1126/science.1085792			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907803	Green Submitted			2022-12-01	WOS:000184615700046
J	Yonekura, K; Maki-Yonekura, S; Namba, K				Yonekura, K; Maki-Yonekura, S; Namba, K			Complete atomic model of the bacterial flagellar filament by electron cryomicroscopy	NATURE			English	Article							SALMONELLA-TYPHIMURIUM; MEMBRANE-PROTEINS; TUBULAR CRYSTALS; ANGSTROM RESOLUTION; MOLECULAR-DYNAMICS; FIBER DIFFRACTION; EXPORT APPARATUS; ESCHERICHIA-COLI; TERMINAL REGIONS; CRYSTALLOGRAPHY	The bacterial flagellar filament is a helical propeller for bacterial locomotion. It is a helical assembly of a single protein, flagellin, and its tubular structure is formed by 11 protofilaments in two distinct conformations, L- and R- type, for supercoiling. The X-ray crystal structure of a flagellin fragment lacking about 100 terminal residues revealed the protofilament structure, but the full filament structure is still essential for understanding the mechanism of supercoiling and polymerization. Here we report a complete atomic model of the R-type filament by electron cryomicroscopy. A density map obtained from image data up to 4Angstrom resolution shows the feature of alpha-helical backbone and some large side chains. The atomic model built on the map reveals intricate molecular packing and an alpha-helical coiled coil formed by the terminal chains in the inner core of the filament, with its intersubunit hydrophobic interactions having an important role in stabilizing the filament.	ERATO, JST, Proton NanoMachine Project, Tokyo, Japan; Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 565, Japan; ICORP, JST, Dynam NanoMachine Project, Kyoto 6190237, Japan	Japan Science & Technology Agency (JST); Osaka University; Japan Science & Technology Agency (JST)	Namba, K (corresponding author), ERATO, JST, Proton NanoMachine Project, Tokyo, Japan.		YONEKURA, Koji/N-5060-2015; Namba, Keiichi/A-9406-2016	Yonekura, Koji/0000-0001-5520-4391				Asakura S, 1970, Adv Biophys, V1, P99; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; Beroukhim R, 1997, ULTRAMICROSCOPY, V70, P57, DOI 10.1016/S0304-3991(97)00070-3; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CALLADINE CR, 1976, J THEOR BIOL, V57, P469, DOI 10.1016/0022-5193(76)90016-3; CALLADINE CR, 1978, J MOL BIOL, V118, P457, DOI 10.1016/0022-2836(78)90285-1; CALLADINE CR, 1975, NATURE, V225, P121; Delahay RM, 2002, MOL MICROBIOL, V45, P905, DOI 10.1046/j.1365-2958.2002.03083.x; DeRosier DJ, 2000, ULTRAMICROSCOPY, V81, P83, DOI 10.1016/S0304-3991(99)00120-5; Drenth J, 1994, PRINCIPLES PROTEIN X; Fan F, 1997, MOL MICROBIOL, V26, P1035, DOI 10.1046/j.1365-2958.1997.6412010.x; Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)90004-1; HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; HOMMA M, 1990, J MOL BIOL, V213, P819, DOI 10.1016/S0022-2836(05)80266-9; HYMAN HC, 1991, J MOL BIOL, V220, P79, DOI 10.1016/0022-2836(91)90382-G; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KANTO S, 1991, J MOL BIOL, V219, P471, DOI 10.1016/0022-2836(91)90187-B; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; KUDO S, 1990, NATURE, V346, P677, DOI 10.1038/346677a0; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; LARSEN SH, 1974, NATURE, V249, P74, DOI 10.1038/249074a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MACNAB RM, 1977, J MOL BIOL, V112, P1, DOI 10.1016/S0022-2836(77)80153-8; Maki S, 1998, J MOL BIOL, V277, P771, DOI 10.1006/jmbi.1998.1663; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MIMORI Y, 1995, J MOL BIOL, V249, P69, DOI 10.1006/jmbi.1995.0281; Mimori-Kiyosue Y, 1998, J MOL BIOL, V284, P521, DOI 10.1006/jmbi.1998.2184; MimoriKiyosue Y, 1997, J MOL BIOL, V270, P222, DOI 10.1006/jmbi.1997.1111; MimoriKiyosue Y, 1996, P NATL ACAD SCI USA, V93, P15108, DOI 10.1073/pnas.93.26.15108; Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999; MORGAN DG, 1995, J MOL BIOL, V249, P88, DOI 10.1006/jmbi.1995.0282; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; OBRIEN EJ, 1972, J MOL BIOL, V70, P133, DOI 10.1016/0022-2836(72)90168-4; Ryu WS, 2000, NATURE, V403, P444, DOI 10.1038/35000233; Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504; SILVERMAN M, 1974, NATURE, V249, P73, DOI 10.1038/249073a0; Toyoshima C, 2000, ULTRAMICROSCOPY, V84, P1, DOI 10.1016/S0304-3991(00)00010-3; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; VONDERVISZT F, 1989, J MOL BIOL, V209, P127, DOI 10.1016/0022-2836(89)90176-9; WANG H, 1993, ACTA CRYSTALLOGR A, V49, P504, DOI 10.1107/S0108767392011255; Yamashita I, 1998, NAT STRUCT BIOL, V5, P125; Yonekura K, 2000, SCIENCE, V290, P2148, DOI 10.1126/science.290.5499.2148; Yonekura K, 2000, ULTRAMICROSCOPY, V84, P29, DOI 10.1016/S0304-3991(00)00008-5	47	542	567	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					643	650		10.1038/nature01830	http://dx.doi.org/10.1038/nature01830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904785				2022-12-01	WOS:000184578800037
J	Bacon, CG; Mittleman, MA; Kawachi, I; Giovannucci, E; Glasser, DB; Rimm, EB				Bacon, CG; Mittleman, MA; Kawachi, I; Giovannucci, E; Glasser, DB; Rimm, EB			Sexual function in men older than 50 years of age: Results from the health professionals follow-up study	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; TIME PHYSICAL-ACTIVITY; ERECTILE DYSFUNCTION; RISK-FACTORS; PROSTATE-CANCER; PREVALENCE; COMMUNITY; QUESTIONNAIRE; EPIDEMIOLOGY; PREDICTORS	Background: Although many studies have provided data on erectile dysfunction in specific settings, few studies have been large enough to precisely examine age-specific prevalence and correlates. Objective: To describe the association between age and several aspects of sexual functioning in men older than 50 years of age. Design: Cross-sectional analysis of data from a prospective cohort study. Setting: U.S. health professionals. Participants: 31 742 men, age 53 to 90 years. Measurements: Questionnaires mailed in 2000 asked about sexual function, physical activity, body weight, smoking, marital status, medical conditions, and medications. Previous biennial questionnaires since 1986 asked about date of birth, alcohol intake, and other health information. Results: When men with prostate cancer were excluded, the age-standardized prevalence of erectile dysfunction in the previous 3 months was 33%. Many aspects of sexual function (including overall function, desire, orgasm, and overall ability) decreased sharply by decade after 50 years of age. Physical activity was associated with lower risk for erectile dysfunction (multivariable relative risk, 0.7 [95% CI, 0.6 to 0.7] for >32.6 metabolic equivalent hours of exercise per week vs. 0 to 2.7 metabolic equivalent hours of exercise per week), and obesity was associated with higher risk (relative risk, 1.3 [CI, 1.2 to 1.4] for body mass index >28.7 kg/m(2) VS. <23.2 kg/m(2)). Smoking, alcohol consumption, and television viewing time were also associated with increased prevalence of erectile dysfunction. Men who had no chronic medical conditions and engaged in healthy behaviors had the lowest prevalence. Conclusions: several modifiable health behaviors were associated with maintenance of good erectile function, even after comorbid conditions were considered. Lifestyle factors most strongly associated with erectile dysfunction were physical activity and leanness.	Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Pfizer Inc, New York, NY USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Pfizer	Bacon, CG (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.			Mittleman, Murray/0000-0001-9788-7274	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER; NCI NIH HHS [CA55075] Funding Source: Medline; NHLBI NIH HHS [HL35464] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ansong KS, 2000, ANN EPIDEMIOL, V10, P293, DOI 10.1016/S1047-2797(00)00050-8; Aytac IA, 2000, SOC SCI MED, V51, P771, DOI 10.1016/S0277-9536(00)00022-8; Bacon CG, 2001, J UROLOGY, V166, P1804, DOI 10.1016/S0022-5347(05)65679-0; Blanker MH, 2001, UROLOGY, V57, P763, DOI 10.1016/S0090-4295(00)01091-8; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Chew KK, 2000, INT J IMPOT RES, V12, P41, DOI 10.1038/sj.ijir.3900457; Derby CA, 2000, UROLOGY, V56, P302, DOI 10.1016/S0090-4295(00)00614-2; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Fung TT, 2000, AM J EPIDEMIOL, V152, P1171, DOI 10.1093/aje/152.12.1171; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; KINSEY AC, 1948, SEXUAL BEHAV HUMAN M, P218; Kongkanand A, 2000, INT J ANDROL, V23, P77, DOI 10.1046/j.1365-2605.2000.00022.x; Kronenberg F, 2000, ATHEROSCLEROSIS, V153, P433, DOI 10.1016/S0021-9150(00)00426-3; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; Leitzmann MF, 1998, ANN INTERN MED, V128, P417, DOI 10.7326/0003-4819-128-6-199803150-00001; Lewis RW, 2001, UROL CLIN N AM, V28, P209, DOI 10.1016/S0094-0143(05)70132-4; Litwin MS, 1998, MED CARE, V36, P1002, DOI 10.1097/00005650-199807000-00007; Litwin MS, 1998, J GEN INTERN MED, V13, P159, DOI 10.1046/j.1525-1497.1998.00050.x; Malmsten UGH, 1997, J UROLOGY, V158, P1733, DOI 10.1016/S0022-5347(01)64113-2; MANNINO DM, 1994, AM J EPIDEMIOL, V140, P1003, DOI 10.1093/oxfordjournals.aje.a117189; Masumori N, 1999, UROLOGY, V54, P335, DOI 10.1016/S0090-4295(99)00108-9; McVary KT, 2001, J UROLOGY, V166, P1624, DOI 10.1016/S0022-5347(05)65641-8; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; PANSER LA, 1995, J AM GERIATR SOC, V43, P1107, DOI 10.1111/j.1532-5415.1995.tb07009.x; Parazzini F, 2000, EUR UROL, V37, P43, DOI 10.1159/000020098; Pinnock CB, 1999, MED J AUSTRALIA, V171, P353, DOI 10.5694/j.1326-5377.1999.tb123691.x; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; SOLSTAD K, 1993, ARCH SEX BEHAV, V22, P51, DOI 10.1007/BF01552912; Sullivan ME, 2001, BJU INT, V87, P838, DOI 10.1046/j.1464-410x.2001.02211.x; Ventegodt S, 1998, ARCH SEX BEHAV, V27, P295, DOI 10.1023/A:1018655219133; WEI M, 1994, AM J EPIDEMIOL, V140, P930, DOI 10.1093/oxfordjournals.aje.a117181	33	498	515	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2003	139	3					161	168		10.7326/0003-4819-139-3-200308050-00005	http://dx.doi.org/10.7326/0003-4819-139-3-200308050-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	707RH	12899583				2022-12-01	WOS:000184523300001
J	Meyerson, M				Meyerson, M			Human genetic variation and disease	LANCET			English	Editorial Material							DNA-SEQUENCES; ASSOCIATION		Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Meyerson, M (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	Matthew_Meyerson@dfci.harvard.edu	Meyerson, Matthew L/E-7123-2012					Britten RJ, 2002, P NATL ACAD SCI USA, V99, P13633, DOI 10.1073/pnas.172510699; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Hallberg P, 2002, J HYPERTENS, V20, P2089, DOI 10.1097/00004872-200210000-00030; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lindblad-Toh K, 2000, NAT BIOTECHNOL, V18, P1001, DOI 10.1038/79269; Reich DE, 2003, NAT GENET, V33, P457, DOI 10.1038/ng1133; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878	11	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					259	260		10.1016/S0140-6736(03)14002-0	http://dx.doi.org/10.1016/S0140-6736(03)14002-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892951				2022-12-01	WOS:000184413400003
J	Drazen, JM				Drazen, JM			SARS - Looking back over the first 100 days	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material													Drazen, Jeffrey M/E-5841-2012	Drazen, Jeffrey/0000-0003-2715-9890				Holmes KV, 2003, NEW ENGL J MED, V348, P1948, DOI 10.1056/NEJMp030078	1	26	27	0	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2003	349	4					319	320		10.1056/NEJMp038118	http://dx.doi.org/10.1056/NEJMp038118			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703ZH	12878735				2022-12-01	WOS:000184312800001
J	Huber, DL; Manginell, RP; Samara, MA; Kim, BI; Bunker, BC				Huber, DL; Manginell, RP; Samara, MA; Kim, BI; Bunker, BC			Programmed adsorption and release of proteins in a microfluidic device	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; SURFACE-PROPERTIES; SILICA; SYSTEMS; SILVER; GOLD	A microfluidic device has been developed that can adsorb proteins from solution, hold them with negligible denaturation, and release them on command. The active element in the device is a 4-nanometer-thick polymer film that can be thermally switched between an antifouling hydrophilic state and a protein-adsorbing state that is more hydrophobic. This active polymer has been integrated into a microfluidic hot plate that can be programmed to adsorb and desorb protein monolayers in less than 1 second. The rapid response characteristics of the device can be manipulated for proteomic functions, including preconcentration and separation of soluble proteins on an integrated fluidics chip.	Sandia Natl Labs, Albuquerque, NM 87185 USA	United States Department of Energy (DOE); Sandia National Laboratories	Bunker, BC (corresponding author), Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA.		Huber, Dale L./A-6006-2008	Huber, Dale L./0000-0001-6872-8469; Kim, Byung/0000-0003-4484-1728				ABBOTT NL, 1995, LANGMUIR, V11, P16, DOI 10.1021/la00001a005; Berne B.J., 2000, DYNAMIC LIGHT SCATTE; Burns MA, 1996, P NATL ACAD SCI USA, V93, P5556, DOI 10.1073/pnas.93.11.5556; Figeys D, 2001, ELECTROPHORESIS, V22, P208, DOI 10.1002/1522-2683(200101)22:2<208::AID-ELPS208>3.0.CO;2-O; Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z; JOYCE SA, 1991, REV SCI INSTRUM, V62, P710, DOI 10.1063/1.1142072; Kanazawa H, 1996, ANAL CHEM, V68, P100, DOI 10.1021/ac950359j; Kidoaki S, 2001, LANGMUIR, V17, P2402, DOI 10.1021/la001522v; Kleijn M, 1995, HETEROGEN CHEM REV, V2, P157; Lahann J, 2003, SCIENCE, V299, P371, DOI 10.1126/science.1078933; Lakhiari H, 1998, BBA-GEN SUBJECTS, V1379, P303, DOI 10.1016/S0304-4165(97)00110-4; Liang L, 1998, MACROMOLECULES, V31, P7845; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Ostuni E, 1999, COLLOID SURFACE B, V15, P3, DOI 10.1016/S0927-7765(99)00004-1; Pelton R, 2000, ADV COLLOID INTERFAC, V85, P1, DOI 10.1016/S0001-8686(99)00023-8; PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164; Revillon A, 1995, REACT FUNCT POLYM, V26, P105, DOI 10.1016/1381-5148(95)00009-5; TAKEI YG, 1994, MACROMOLECULES, V27, P6163, DOI 10.1021/ma00099a035; Whitesides GM, 2001, PHYS TODAY, V54, P42, DOI 10.1063/1.1387591; ZHANG J, 1995, LANGMUIR, V11, P2301	20	477	491	5	181	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					352	354		10.1126/science.1080759	http://dx.doi.org/10.1126/science.1080759			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869757				2022-12-01	WOS:000184207300039
J	King, N; Hittinger, CT; Carroll, SB				King, N; Hittinger, CT; Carroll, SB			Evolution of key cell signaling and adhesion protein families predates animal origins	SCIENCE			English	Article							TYROSINE KINASE; UNICELLULAR RELATIVES; MITOGENIC AGENTS; PHOSPHORYLATION; SEQUENCE	The evolution of animals from a unicellular ancestor involved many innovations. Choanoflagellates, unicellular and colonial protozoa closely related to Metazoa, provide a potential window into early animal evolution. We have found that choanoflagellates express representatives of a surprising number of cell signaling and adhesion protein families that have not previously been isolated from nonmetazoans, including cadherins, C-type lectins, several tyrosine kinases, and tyrosine kinase signaling pathway components. Choanoflagellates have a complex and dynamic tyrosine phosphoprotein pro. le, and cell proliferation is selectively affected by tyrosine kinase inhibitors. The expression in choanoflagellates of proteins involved in cell interactions in Metazoa demonstrates that these proteins evolved before the origin of animals and were later co-opted for development.	Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1525 Linden Dr, Madison, WI 53706 USA.				NIGMS NIH HHS [GM-20734] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Burger G, 2003, P NATL ACAD SCI USA, V100, P892, DOI 10.1073/pnas.0336115100; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; COOPER JA, 1984, MOL CELL BIOL, V4, P30, DOI 10.1128/MCB.4.1.30; Dodd RB, 2001, GLYCOBIOLOGY, V11, p71R, DOI 10.1093/glycob/11.5.71R; HIBBERD DJ, 1975, J CELL SCI, V17, P191; King N, 2001, P NATL ACAD SCI USA, V98, P15032, DOI 10.1073/pnas.261477698; Kumar P, 2001, J BIOL CHEM, V276, P21039, DOI 10.1074/jbc.M009099200; Lang BF, 2002, CURR BIOL, V12, P1773, DOI 10.1016/S0960-9822(02)01187-9; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; MIYAZAWA K, 1992, BLOOD, V80, P1685; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; PASQUALE EB, 1988, J CELL PHYSIOL, V137, P146, DOI 10.1002/jcp.1041370118; Porter AC, 1998, ONCOGENE, V17, P1343, DOI 10.1038/sj.onc.1202171; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Saville Kent W., 1880, MANUAL INFUSORIA; SHAPIRO L, 1995, P NATL ACAD SCI USA, V92, P6793, DOI 10.1073/pnas.92.15.6793; Snell EA, 2001, CURR BIOL, V11, P967, DOI 10.1016/S0960-9822(01)00275-5; WAINRIGHT PO, 1993, SCIENCE, V260, P340, DOI 10.1126/science.8469985; Watkins RF, 1999, J MOL EVOL, V48, P542, DOI 10.1007/PL00006497; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724	23	283	301	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					361	363		10.1126/science.1083853	http://dx.doi.org/10.1126/science.1083853			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869759				2022-12-01	WOS:000184207300042
J	Cahan, SH; Keller, L				Cahan, SH; Keller, L			Complex hybrid origin of genetic caste determination in harvester ants	NATURE			English	Article								Caste differentiation and division of labour are the hallmarks of insect societies(1) and at the root of their ecological success(2). Kin selection predicts that caste determination should result from environmentally induced differences in gene expression(3,4), a prediction largely supported by empirical data(5). However, two exceptional cases of genetically determined caste differentiation have recently been found in harvester ants(6-8). Here we show that genetic caste determination evolved in these populations after complex hybridization events. We identified four distinct genetic lineages, each consisting of unique blends of the genomes of the parental species, presumably Pogonomyrmex barbatus and P. rugosus. Crosses between lineages H1 and H2 and between J1 and J2 give rise to workers, whereas queens develop from within-lineage matings. Although historical gene flow is evident, genetic exchange among lineages and between lineages and the parental species no longer occurs. This unusual system of caste determination seems to be evolutionarily stable.	Univ Lausanne, Inst Ecol, CH-1015 Lausanne, Switzerland	University of Lausanne	Cahan, SH (corresponding author), Univ Lausanne, Inst Ecol, CH-1015 Lausanne, Switzerland.		keller, laurent/AAI-7175-2020	keller, laurent/0000-0002-5046-9953				Bourke AFG, 1997, P ROY SOC B-BIOL SCI, V264, P277, DOI 10.1098/rspb.1997.0039; Buschinger A., 1990, P37; Cahan SH, 2002, P ROY SOC B-BIOL SCI, V269, P1871, DOI 10.1098/rspb.2002.2061; CAVALLISFORZA LL, 1967, EVOLUTION, V21, P550, DOI 10.1111/j.1558-5646.1967.tb03411.x; Cole AC, 1968, POGONOMYRMEX HARVEST; Crozier R.H., 1996, EVOLUTION SOCIAL INS; Foitzik S, 1997, INSECT SOC, V44, P219, DOI 10.1007/s000400050043; JONES TR, 1995, MOL PHYLOGENET EVOL, V4, P194, DOI 10.1006/mpev.1995.1019; Julian GE, 2002, P NATL ACAD SCI USA, V99, P8157, DOI 10.1073/pnas.112222099; OSTER GF, 1975, CASTE ECOLOGY SOCIAL; Parker JD, 2002, EVOLUTION, V56, P2017, DOI 10.1111/j.0014-3820.2002.tb00128.x; SEGER J, 1981, J THEOR BIOL, V91, P191, DOI 10.1016/0022-5193(81)90380-5; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Taber S. W., 1998, WORLD HARVESTER ANTS; Volny VP, 2002, P NATL ACAD SCI USA, V99, P6108, DOI 10.1073/pnas.092066699; Volny VP, 2002, MOL ECOL NOTES, V2, P302, DOI 10.1046/j.1471-8286.2002.00243.x; Welch ME, 2002, EVOLUTION, V56, P2126, DOI 10.1111/j.0014-3820.2002.tb00138.x; WHEELER DE, 1986, AM NAT, V128, P13, DOI 10.1086/284536; Wilson E.O., 1971, INSECT SOC; Xu SZ, 2000, MOL BIOL EVOL, V17, P897, DOI 10.1093/oxfordjournals.molbev.a026370	20	130	133	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					306	309		10.1038/nature01744	http://dx.doi.org/10.1038/nature01744			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867980	Green Published			2022-12-01	WOS:000184183900040
J	Skordalakes, E; Berger, JM				Skordalakes, E; Berger, JM			Structure of the Rho transcription terminator: Mechanism of mRNA recognition and helicase loading	CELL			English	Article							ESCHERICHIA-COLI RHO; RNP1-LIKE SEQUENCE MOTIF; TRP-T' TERMINATOR; DEPENDENT TERMINATION; CRYSTAL-STRUCTURE; BINDING DOMAIN; DNA HELICASE; PROTEIN-RHO; SHOCK PROTEIN; NMR STRUCTURE	In bacteria, one of the major transcriptional termination mechanisms requires a RNA/DNA helicase known as the Rho factor. We have determined two structures of Rho complexed with nucleic acid recognition site mimics in both free and nucleotide bound states to 3.0 Angstrom resolution. Both structures show that Rho forms a hexameric ring in which two RNA binding sites-a primary one responsible for target mRNA recognition and a secondary one required for mRNA translocation and unwinding-point toward the center of the ring. Rather than forming a closed ring, the Rho hexamer is split open, resembling a "lock washer" in its global architecture. The distance between subunits at the opening is sufficiently wide (12 Angstrom) to accommodate single-stranded RNA. This open configuration most likely resembles a state poised to load onto mRNA and suggests how related ring-shaped enzymes may be breached to bind nucleic acids.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Berger, JM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 239 Hildebrand Hall,3206, Berkeley, CA 94720 USA.	jmberger@uclink4.berkeley.edu	Skordalakes, Emmanuel/H-7071-2019	Skordalakes, Emmanuel/0000-0002-7600-2833				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ALIFANO P, 1991, CELL, V64, P553; Allison TJ, 1998, NAT STRUCT BIOL, V5, P352, DOI 10.1038/nsb0598-352; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barcena M, 2001, EMBO J, V20, P1462, DOI 10.1093/emboj/20.6.1462; BEAR DG, 1988, J MOL BIOL, V199, P623, DOI 10.1016/0022-2836(88)90306-3; BEAR DG, 1985, P NATL ACAD SCI USA, V82, P1911, DOI 10.1073/pnas.82.7.1911; Bird LE, 1998, NUCLEIC ACIDS RES, V26, P2686, DOI 10.1093/nar/26.11.2686; Bird LE, 1998, CURR OPIN STRUC BIOL, V8, P14, DOI 10.1016/S0959-440X(98)80004-3; Bogden CE, 1999, MOL CELL, V3, P487, DOI 10.1016/S1097-2765(00)80476-1; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BRENNAN CA, 1990, J BIOL CHEM, V265, P5440; BRENNAN CA, 1987, CELL, V48, P945, DOI 10.1016/0092-8674(87)90703-3; Briercheck DM, 1998, NAT STRUCT BIOL, V5, P393, DOI 10.1038/nsb0598-393; BROWN S, 1981, J BACTERIOL, V146, P422, DOI 10.1128/JB.146.1.422-425.1981; Burgess BR, 2001, J BIOL CHEM, V276, P4182, DOI 10.1074/jbc.M007066200; Burgess BR, 2001, J BIOL CHEM, V276, P17106, DOI 10.1074/jbc.M101856200; CAVARELLI J, 1993, NATURE, V362, P181, DOI 10.1038/362181a0; CHEN CYA, 1986, CELL, V46, P1023, DOI 10.1016/0092-8674(86)90701-4; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P750, DOI 10.1107/S0907444997016247; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Delagoutte E, 2003, Q REV BIOPHYS, V36, P1, DOI 10.1017/S0033583502003864; DOLAN JW, 1990, J BIOL CHEM, V265, P5747; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; ENGEL D, 1984, NUCLEIC ACIDS RES, V12, P7389, DOI 10.1093/nar/12.19.7389; GALLUPPI GR, 1980, J MOL BIOL, V138, P513, DOI 10.1016/S0022-2836(80)80016-7; Gan E, 1999, BIOCHEMISTRY-US, V38, P16882, DOI 10.1021/bi991559i; GEISELMANN J, 1993, P NATL ACAD SCI USA, V90, P7754, DOI 10.1073/pnas.90.16.7754; GEISELMANN J, 1992, PROTEIN SCI, V1, P861, DOI 10.1002/pro.5560010704; GOGOL EP, 1991, J MOL BIOL, V221, P1127, DOI 10.1016/0022-2836(91)80116-C; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim DE, 2001, J BIOL CHEM, V276, P13902, DOI 10.1074/jbc.M011043200; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LOWERYGO.C, 1974, P NATL ACAD SCI USA, V71, P2003, DOI 10.1073/pnas.71.5.2003; LUSKY M, 1993, J BIOL CHEM, V268, P15795; Martinez A, 1996, J MOL BIOL, V257, P895, DOI 10.1006/jmbi.1996.0210; Martinez A, 1996, J MOL BIOL, V257, P909, DOI 10.1006/jmbi.1996.0211; MCSWIGGEN JA, 1988, J MOL BIOL, V199, P609, DOI 10.1016/0022-2836(88)90305-1; MIWA Y, 1995, J MOL BIOL, V254, P815, DOI 10.1006/jmbi.1995.0658; MODRAK D, 1994, BIOCHEMISTRY-US, V33, P8292, DOI 10.1021/bi00193a016; MORGAN WD, 1985, NUCLEIC ACIDS RES, V13, P3739, DOI 10.1093/nar/13.10.3739; MORGAN WD, 1983, J BIOL CHEM, V258, P9553; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; NEWKIRK K, 1994, P NATL ACAD SCI USA, V91, P5114, DOI 10.1073/pnas.91.11.5114; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ODA T, 1972, J MOL BIOL, V71, P799; OPPERMAN T, 1994, J BACTERIOL, V176, P5033, DOI 10.1128/jb.176.16.5033-5043.1994; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PLATT T, 1994, MOL MICROBIOL, V11, P983, DOI 10.1111/j.1365-2958.1994.tb00376.x; RICHARDSON JP, 1982, J BIOL CHEM, V257, P5760; Richardson JP, 2002, BBA-GENE STRUCT EXPR, V1577, P251, DOI 10.1016/S0167-4781(02)00456-6; RICHARDSON JP, 1980, BIOCHEMISTRY-US, V19, P4293, DOI 10.1021/bi00559a022; RICHARDSON JP, 1996, CELLULAR MOL BIOL, P822; RICHARDSON LV, 1992, NUCLEIC ACIDS RES, V20, P5383, DOI 10.1093/nar/20.20.5383; ROBERTS JW, 1969, NATURE, V224, P1168, DOI 10.1038/2241168a0; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; SCHINDELIN H, 1994, P NATL ACAD SCI USA, V91, P5119, DOI 10.1073/pnas.91.11.5119; SEO YS, 1993, P NATL ACAD SCI USA, V90, P2865, DOI 10.1073/pnas.90.7.2865; SHIGESADA K, 1980, NUCLEIC ACIDS RES, V8, P3355, DOI 10.1093/nar/8.15.3355; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; STEINMETZ EJ, 1994, P NATL ACAD SCI USA, V91, P1401, DOI 10.1073/pnas.91.4.1401; Stitt BL, 2001, BIOCHEMISTRY-US, V40, P2276, DOI 10.1021/bi002253a; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; SULLIVAN SL, 1992, CELL, V68, P989, DOI 10.1016/0092-8674(92)90041-A; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; Walstrom KM, 1997, BIOCHEMISTRY-US, V36, P7980, DOI 10.1021/bi963179s; Wei RR, 2001, J MOL BIOL, V314, P1007, DOI 10.1006/jmbi.2000.5207; Wei RR, 2001, J BIOL CHEM, V276, P28380, DOI 10.1074/jbc.M102444200; Weinreich M, 1999, P NATL ACAD SCI USA, V96, P441, DOI 10.1073/pnas.96.2.441; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu H, 2000, BIOCHEMISTRY-US, V39, P12225, DOI 10.1021/bi0008938; Xu Y, 2002, J BIOL CHEM, V277, P30023, DOI 10.1074/jbc.M111009200; Yu X, 2000, J MOL BIOL, V299, P1279, DOI 10.1006/jmbi.2000.3810; Zhu AQ, 1998, BIOCHEMISTRY-US, V37, P11215, DOI 10.1021/bi972912s; Zhu AQ, 1998, BIOCHEMISTRY-US, V37, P11202, DOI 10.1021/bi9729110	81	194	198	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2003	114	1					135	146		10.1016/S0092-8674(03)00512-9	http://dx.doi.org/10.1016/S0092-8674(03)00512-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	702JC	12859904	Bronze			2022-12-01	WOS:000184219900012
J	Tang, XD; Xu, R; Reynolds, MF; Garcia, ML; Heinemann, SH; Hoshi, T				Tang, XD; Xu, R; Reynolds, MF; Garcia, ML; Heinemann, SH; Hoshi, T			Haem can bind to and inhibit mammalian calcium-dependent Slo1 BK channels	NATURE			English	Article							CA2+-ACTIVATED K+ CHANNELS; CRYSTAL-STRUCTURE; MEMBRANE	Haem is essential for living organisms, functioning as a crucial element in the redox-sensitive reaction centre in haemproteins(1). During the biogenesis of these proteins, the haem cofactor is typically incorporated enzymatically into the haem pockets of the apo-haemprotein as the functionally indispensable prosthetic group(2,3). A class of ion channel, the large-conductance calcium-dependent Slo1 BK channels, possesses a conserved haem-binding sequence motif. Here we present electrophysiological and structural evidence showing that haem directly regulates cloned human Slo1 channels and wild-type BK channels in rat brain. Both oxidized and reduced haem binds to the hSlo1 channel protein and profoundly inhibits transmembrane K+ currents by decreasing the frequency of channel opening. This direct regulation of the BK channel identifies a previously unknown role of haem as an acute signalling molecule.	Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; St Josephs Univ, Dept Chem, Philadelphia, PA 19131 USA; Merck Res Labs, Dept Ion Channels, Rahway, NJ 07065 USA; Univ Jena, Fac Med, Res Unit Mol & Cellular Biophys, D-07747 Jena, Germany	University of Pennsylvania; Saint Joseph's University; Merck & Company; Friedrich Schiller University of Jena	Hoshi, T (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.	hoshi@hoshi.org		Heinemann, Stefan H./0000-0002-4144-0251				Blackmon BJ, 2002, ARCH BIOCHEM BIOPHYS, V407, P196, DOI 10.1016/S0003-9861(02)00471-X; BRAUTIGAN DL, 1977, J BIOL CHEM, V252, P574; Daltrop O, 2002, P NATL ACAD SCI USA, V99, P7872, DOI 10.1073/pnas.132259099; Dore S, 2002, FREE RADICAL BIO MED, V32, P1276, DOI 10.1016/S0891-5849(02)00805-5; Granick S, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P33; Gribkoff VK, 2001, NAT MED, V7, P471, DOI 10.1038/86546; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; More C, 1999, BIOSPECTROSCOPY, V5, pS3, DOI 10.1002/(SICI)1520-6343(1999)5:5+<S3::AID-BSPY2>3.0.CO;2-P; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Ricci AJ, 2000, J PHYSIOL-LONDON, V524, P423, DOI 10.1111/j.1469-7793.2000.00423.x; SHAKLAI N, 1985, BIOCHIM BIOPHYS ACTA, V821, P355, DOI 10.1016/0005-2736(85)90106-3; Siemen D, 1999, BIOCHEM BIOPH RES CO, V257, P549, DOI 10.1006/bbrc.1999.0496; Taketani S, 1998, J BIOL CHEM, V273, P31388, DOI 10.1074/jbc.273.47.31388; Tang XD, 2001, J GEN PHYSIOL, V117, P253, DOI 10.1085/jgp.117.3.253; Worthington MT, 2001, AM J PHYSIOL-GASTR L, V280, pG1172, DOI 10.1152/ajpgi.2001.280.6.G1172; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Yermolaieva O, 2001, BIOPHYS J, V80, p237A; ZhuGe R, 2000, J GEN PHYSIOL, V116, P845, DOI 10.1085/jgp.116.6.845	19	224	234	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2003	425	6957					531	535		10.1038/nature02003	http://dx.doi.org/10.1038/nature02003			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727FN	14523450				2022-12-01	WOS:000185648100049
J	Murphy, G				Murphy, G			Lost for words	NATURE			English	News Item							DEVELOPMENTAL DYSLEXIA; CHILDREN; REMEDIATION; DISRUPTION; SYSTEMS; BRAIN		Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Murphy, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.							Eden GF, 2002, NAT NEUROSCI, V5, P1080, DOI 10.1038/nn946; LIVINGSTONE MS, 1991, P NATL ACAD SCI USA, V88, P7943, DOI 10.1073/pnas.88.18.7943; Nicolson RI, 1999, LANCET, V353, P1662, DOI 10.1016/S0140-6736(98)09165-X; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Ramus F, 2003, CURR OPIN NEUROBIOL, V13, P212, DOI 10.1016/S0959-4388(03)00035-7; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Shaywitz SE, 2003, BIOL PSYCHIAT, V54, P25, DOI 10.1016/S0006-3223(02)01836-X; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; Stein J, 2001, Dyslexia, V7, P12, DOI 10.1002/dys.186; STEIN JF, 1982, BRIT J OPHTHALMOL, V66, P332, DOI 10.1136/bjo.66.5.332; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; Temple E, 2003, P NATL ACAD SCI USA, V100, P2860, DOI 10.1073/pnas.0030098100	12	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2003	425	6956					340	342		10.1038/425340a	http://dx.doi.org/10.1038/425340a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	724TG	14508456				2022-12-01	WOS:000185502300012
J	Cool, CD; Rai, PR; Yeager, ME; Hernandez-Saavedra, D; Serls, AE; Bull, TM; Geraci, MW; Brown, KK; Routes, JM; Tuder, RM; Voelkel, NF				Cool, CD; Rai, PR; Yeager, ME; Hernandez-Saavedra, D; Serls, AE; Bull, TM; Geraci, MW; Brown, KK; Routes, JM; Tuder, RM; Voelkel, NF			Expression of human herpesvirus 8 in primary pulmonary hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; ENDOTHELIAL GROWTH-FACTOR; TGF-BETA RECEPTOR; KAPOSIS-SARCOMA; PLEXIFORM LESIONS; DNA-SEQUENCES; GERMLINE MUTATIONS; PROTEIN; GENE; GENOME	BACKGROUND: Severe pulmonary hypertension constitutes a group of diseases characterized by complex, lumen-occluding vascular lesions that develop in genetically susceptible persons. The only viral infection associated with severe pulmonary hypertension has been that due to human immunodeficiency virus type 1, but neither the viral genome nor viral antigens have been demonstrated in pathologic lesions. METHODS: We examined lung-tissue samples from 16 patients with sporadic primary pulmonary hypertension and 14 patients with secondary pulmonary hypertension for evidence of infection with human herpesvirus 8 (HHV-8). HHV-8 infection was ascertained immunohistochemically with use of an antibody directed against latency-associated nuclear antigen 1 (LANA-1), and a polymerase-chain-reaction (PCR) assay was performed on lung DNA to detect the viral cyclin gene of HHV-8. Sequence analysis was also performed. RESULTS: In lung tissue from 10 of 16 patients with primary pulmonary hypertension (62 percent), cells within the plexiform lesions as well as cells outside the lesions were positive for LANA-1 on immunohistochemical analysis. Tissue from the same 10 patients contained viral cyclin on PCR analysis. No LANA-1 was detected in lung tissue from patients with secondary pulmonary hypertension, although one such patient had PCR evidence of viral cyclin. Plexiform lesions from patients with primary pulmonary hypertension had a histologic and immunohistochemical resemblance to cutaneous Kaposi's sarcoma lesions. CONCLUSIONS: The spectrum of trigger factors and molecular mechanisms leading to severe pulmonary hypertension and the formation of plexiform lesions is apparently wide, including both genetic and epigenetic factors. Our data suggest that infection with the vasculotropic virus HHV-8 may have a pathogenetic role in primary pulmonary hypertension.	Univ Colorado, Hlth Sci Ctr, Div Pulm & Crit Care, Pulm Hypertens Ctr, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Pathol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Webb Waring Inst, Denver, CO 80262 USA; Natl Jewish Med & Res Ctr, Denver, CO USA; Johns Hopkins Univ, Dept Pathol, Cardiopulm Div, Baltimore, MD USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health; Johns Hopkins University	Voelkel, NF (corresponding author), Univ Colorado, Hlth Sci Ctr, Div Pulm & Crit Care, Pulm Hypertens Ctr, Box C272,4200 E 9th Ave, Denver, CO 80262 USA.	norbert.voelkel@uchsc.edu	Brown, Kevin/ABF-2544-2020; Hernandez-Saavedra, Daniel/AGO-1286-2022; Routes, john/AAA-4833-2021	Routes, john/0000-0001-8378-3773; Hernandez-Saavedra, Daniel/0000-0003-1449-944X	NHLBI NIH HHS [K08 HL03911, P01 HL66524] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003911] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abenhaim L, 1996, NEW ENGL J MED, V335, P609, DOI 10.1056/NEJM199608293350901; Antman K, 2000, NEW ENGL J MED, V342, P1027, DOI 10.1056/NEJM200004063421407; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Boshoff C, 1998, ADV CANCER RES, V75, P57, DOI 10.1016/S0065-230X(08)60739-3; BULL TM, IN PRESS EUR RESP J; Cesarman E, 1996, J VIROL, V70, P8218, DOI 10.1128/JVI.70.11.8218-8223.1996; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chang Y, 1996, NATURE, V382, P410, DOI 10.1038/382410a0; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Dittmer D, 1998, J VIROL, V72, P8309, DOI 10.1128/JVI.72.10.8309-8315.1998; Dupin N, 1999, P NATL ACAD SCI USA, V96, P4546, DOI 10.1073/pnas.96.8.4546; Eddahibi S, 2000, AM J RESP CRIT CARE, V162, P1493, DOI 10.1164/ajrccm.162.4.2003124; Fakhari FD, 2002, J VIROL, V76, P6213, DOI 10.1128/JVI.76.12.6213-6223.2002; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Geraci MW, 2001, CIRC RES, V88, P555, DOI 10.1161/01.RES.88.6.555; HUMBERT M, 1995, AM J RESP CRIT CARE, V151, P1628, DOI 10.1164/ajrccm.151.5.7735624; Judde JG, 2000, JNCI-J NATL CANCER I, V92, P729, DOI 10.1093/jnci/92.9.729; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Lee SD, 1998, J CLIN INVEST, V101, P927, DOI 10.1172/JCI1910; Lennette ET, 1996, LANCET, V348, P858, DOI 10.1016/S0140-6736(96)03240-0; LOSCALZO J, 1992, NEW ENGL J MED, V327, P117, DOI 10.1056/NEJM199207093270209; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Masood R, 2002, AM J PATHOL, V160, P23, DOI 10.1016/S0002-9440(10)64344-1; Masood R, 1997, P NATL ACAD SCI USA, V94, P979, DOI 10.1073/pnas.94.3.979; Mehta NJ, 2000, CHEST, V118, P1133, DOI 10.1378/chest.118.4.1133; METTE SA, 1992, AM REV RESPIR DIS, V145, P1196, DOI 10.1164/ajrccm/145.5.1196; MOORE PS, 1995, NEW ENGL J MED, V332, P1181, DOI 10.1056/NEJM199505043321801; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; Pan LX, 2001, J MOL DIAGN, V3, P32, DOI 10.1016/S1525-1578(10)60647-2; Sarid R, 1998, J VIROL, V72, P1005, DOI 10.1128/JVI.72.2.1005-1012.1998; SCHULZ TF, 1998, HUMAN TUMOR VIRUSES, P87; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; SPEICH R, 1991, CHEST, V100, P1268, DOI 10.1378/chest.100.5.1268; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Tuder RM, 1998, J LAB CLIN MED, V132, P16, DOI 10.1016/S0022-2143(98)90020-8; Tuder RM, 2001, J PATHOL, V195, P367, DOI 10.1002/path.953; TUDER RM, 1994, AM J PATHOL, V144, P275; Tuder RM, 2001, CLIN CHEST MED, V22, P405, DOI 10.1016/S0272-5231(05)70280-X; Voelkel NF, 2002, CRIT CARE MED, V30, pS251, DOI 10.1097/00003246-200205001-00013; Voelkel NF, 1995, EUR RESPIR J, V8, P2129, DOI 10.1183/09031936.95.08122129; Weiss R A, 1998, J Natl Cancer Inst Monogr, P51; Yeager ME, 1999, CIRCULATION, V100, P587; Zur Hausen H, 2001, ONCOGENE, V20, P7820, DOI 10.1038/sj.onc.1204958; BLAST 2 SEQUENES	44	213	221	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2003	349	12					1113	1122		10.1056/NEJMoa035115	http://dx.doi.org/10.1056/NEJMoa035115			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722HQ	13679525				2022-12-01	WOS:000185369700004
J	Kirwan, CC; Nath, E; Byrne, GJ; McCollum, CN				Kirwan, CC; Nath, E; Byrne, GJ; McCollum, CN			Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey	BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER		Wythenshawe Hosp, Manchester M23 9LT, Lancs, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Byrne, GJ (corresponding author), Wythenshawe Hosp, Educ & Res Bldg, Manchester M23 9LT, Lancs, England.			Byrne, Ged/0000-0002-8194-7540; Kirwan, Cliona/0000-0002-1725-4790				FISHER B, 1989, NEW ENGL J MED, V320, P479, DOI 10.1056/NEJM198902233200802; GOODNOUGH LT, 1984, CANCER-AM CANCER SOC, V54, P1264, DOI 10.1002/1097-0142(19841001)54:7<1264::AID-CNCR2820540706>3.0.CO;2-R; Jilma B, 2003, BRIT MED J, V326, P93, DOI 10.1136/bmj.326.7380.93; Thodiyil PA, 2001, ACTA HAEMATOL-BASEL, V106, P73, DOI 10.1159/000046592; WEISS RB, 1981, CANCER TREAT REP, V65, P677	5	33	33	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 13	2003	327	7415					597	598		10.1136/bmj.327.7415.597	http://dx.doi.org/10.1136/bmj.327.7415.597			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722CW	12969928	Green Published, Bronze			2022-12-01	WOS:000185358700024
J	Bendjennat, M; Boulaire, J; Jascur, T; Brickner, H; Barbier, V; Sarasin, A; Fotedar, A; Fotedar, R				Bendjennat, M; Boulaire, J; Jascur, T; Brickner, H; Barbier, V; Sarasin, A; Fotedar, A; Fotedar, R			UV irradiation triggers ubiquitin-dependent degradation of p21(WAF1) to promote DNA repair	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; CELL-CYCLE ARREST; HUMAN FIBROBLASTS; G(1) ARREST; P53 PROTEIN; IN-VITRO; P21; PCNA; RADIATION; INHIBITION	p53-mediated increase in cyclin-dependent kinase inhibitor p21(WAF1) protein is thought to be the major mediator of cell cycle arrest after DNA damage. Previously p21 protein levels have been reported to increase or to decrease after UV irradiation. We show that p21 protein is degraded after irradiation of a variety of cell types with low but not high doses of UV. Cell cycle arrest occurs despite p21 degradation via Tyr(15) inhibitory phosphorylation of cdk2 and differs from the classical p21-dependent checkpoint elicited by ionizing radiation. In contrast to the basal turnover of p21, degradation of p21 switches to ubiquitin/Skp2-dependent proteasome pathway following UV irradiation. ATR activation after UV irradiation is essential for signaling p21 degradation. Finally, UV-induced p21 degradation is essential for optimal DNA repair. These results provide novel insight into regulation of p21 protein and its role in the cellular response to DNA damage.	Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA; Inst Gustave Roussy, F-94805 Villejuif, France; Inst Biol Struct JP Ebel, F-38027 Grenoble, France	UNICANCER; Gustave Roussy; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Fotedar, A (corresponding author), Sidney Kimmel Canc Ctr, 10835 Altman Rd, San Diego, CA 92121 USA.	afotedar@skcc.org; fotedar@ibs.fr	Boulaire, Jerome/A-5954-2009		NCI NIH HHS [CA74435, CA92321] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA092321, R01CA074435] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABOUSSEKHRA A, 1995, EXP CELL RES, V221, P326, DOI 10.1006/excr.1995.1382; ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Adimoolam S, 2001, J BIOL CHEM, V276, P25813, DOI 10.1074/jbc.M102240200; Allan LA, 1999, ONCOGENE, V18, P5403, DOI 10.1038/sj.onc.1202931; Blagosklonny MV, 1996, BIOCHEM BIOPH RES CO, V227, P564, DOI 10.1006/bbrc.1996.1546; Boulaire J, 2000, PATHOL BIOL, V48, P190; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Butz K, 1998, ONCOGENE, V17, P781, DOI 10.1038/sj.onc.1201995; Cayrol C, 1998, ONCOGENE, V16, P311, DOI 10.1038/sj.onc.1201543; CELIS JE, 1986, FEBS LETT, V209, P277, DOI 10.1016/0014-5793(86)81127-9; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; CLEAVER JE, 1981, DNA REPAIR LABORATOR, P277; Cooper MP, 1999, MOL BIOL CELL, V10, P2119, DOI 10.1091/mbc.10.7.2119; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Fotedar R, 1996, ONCOGENE, V12, P2155; Freedman DA, 1999, CANCER RES, V59, P1; Geyer RK, 2000, CELL GROWTH DIFFER, V11, P149; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HUI Z, 1993, MOL BIOL CELL, V4, P897, DOI 10.1091/mbc.4.9.897; Li R, 1996, CURR BIOL, V6, P189, DOI 10.1016/S0960-9822(02)00452-9; LI R, 1994, NATURE, V371, P534, DOI 10.1038/371534a0; Lu X, 1996, ONCOGENE, V13, P413; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Maki CG, 1997, MOL CELL BIOL, V17, P355, DOI 10.1128/MCB.17.1.355; NICHOLS AF, 1992, NUCLEIC ACIDS RES, V20, P2441, DOI 10.1093/nar/20.10.2441; PAGANO M, 1994, GENE DEV, V8, P1627, DOI 10.1101/gad.8.14.1627; PAN ZQ, 1995, J BIOL CHEM, V270, P22008, DOI 10.1074/jbc.270.37.22008; PODUST VN, 1995, BIOCHEMISTRY-US, V34, P8869, DOI 10.1021/bi00027a039; Poon RYC, 1996, J BIOL CHEM, V271, P13283, DOI 10.1074/jbc.271.22.13283; Rieber M, 2000, INT J CANCER, V86, P462, DOI 10.1002/(SICI)1097-0215(20000515)86:4<462::AID-IJC3>3.0.CO;2-B; Rousseau D, 1999, ONCOGENE, V18, P4313, DOI 10.1038/sj.onc.1202686; Sarkaria JN, 1999, CANCER RES, V59, P4375; Schoenfeld AR, 2000, ONCOGENE, V19, P5851, DOI 10.1038/sj.onc.1203985; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; SHIVJI MKK, 1994, CURR BIOL, V4, P1062, DOI 10.1016/S0960-9822(00)00244-X; SHIVJI MKK, 1992, CELL, V69, P367, DOI 10.1016/0092-8674(92)90416-A; Shivji MKK, 1998, ONCOGENE, V17, P2827, DOI 10.1038/sj.onc.1202352; Smith ML, 2000, MOL CELL BIOL, V20, P3705, DOI 10.1128/MCB.20.10.3705-3714.2000; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; TOSCHI L, 1988, J CELL BIOL, V107, P1623, DOI 10.1083/jcb.107.5.1623; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Wang JA, 1999, INT J RADIAT BIOL, V75, P301, DOI 10.1080/095530099140483; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031	51	220	225	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2003	114	5					599	610		10.1016/S0092-8674(03)00644-5	http://dx.doi.org/10.1016/S0092-8674(03)00644-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	719FN	13678583	Bronze			2022-12-01	WOS:000185193100009
J	Brogan, KV				Brogan, KV			James	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Cornell Univ, Joan & Sanford I Weill Med Coll, New York, NY 10021 USA	Cornell University	Brogan, KV (corresponding author), Cornell Univ, Joan & Sanford I Weill Med Coll, New York, NY 10021 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2003	290	9					1221	1222		10.1001/jama.290.9.1221	http://dx.doi.org/10.1001/jama.290.9.1221			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	717LK	12953010	Bronze			2022-12-01	WOS:000185090400023
J	Sox, CM; Cooper, WO; Koepsell, TD; DiGiuseppe, DL; Christakis, DA				Sox, CM; Cooper, WO; Koepsell, TD; DiGiuseppe, DL; Christakis, DA			Provision of pneumococcal prophylaxis for publicly insured children with sickle cell disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPROVING PRIMARY-CARE; PENICILLIN PROPHYLAXIS; ORAL PENICILLIN; PRESCRIPTION; SERVICES; URBAN	Context It is recommended that children younger than 5 years with sickle cell disease (SCD) take daily prophylactic antibiotics to prevent pneumococcal infections; however, how much prophylactic medication they actually are dispensed is unclear. Objectives To measure the amount of prophylactic antibiotics dispensed to young children with SCD and to investigate factors associated with increased delivery of medication. Design, Setting, and Patients Retrospective longitudinal study conducted January 1995 through December 1999 using Tennessee and Washington State Medicaid administrative claims and encounter data. Children (N=261) who had 1 inpatient or 2 outpatient claims or encounters listing an International Classification of Diseases, Ninth Revision, Clinical Modification code for SCD, were younger than 4 years at study entry (mean age, 1.4 years), and were continuously enrolled in Medicaid for a 1-year period. Main Outcome Measure Number of days during a 365-day period covered by prescription fills for a penicillin or macrolide antibiotic, or for trimethoprimsulfamethoxazole. Results In a 365-day period, patients were dispensed a mean of 148.4 (SD, 121.3; median, 114; interquartile range [IQR], 39-247) days of prophylactic medication. The total amount of medication dispensed varied widely: 10.3% of patients received none and 21.5% received more than 270 days of medication. In a 365-day period, a mean of 12.7 (SD, 10.5; range, 0-40) prophylactic prescriptions were filled per patient. The median prescription duration was 10 days. In a multivariate linear regression model adjusting for state, sex, age at study entry, inclusion year, residence in urban community, outpatient inclusion encounter, required prescription co-payment, and number of outpatient visits for nonpreventive care, each preventive visit was associated with 12.0 (95% confidence interval [CI], 2.3-21.7) additional days of prophylactic antibiotics, and each emergency department visit was associated with 10.0 (95% CI, 1.2-18.8) additional days. Conclusions Publicly insured children with SCD may receive inadequate antibiotic prophylaxis against pneumococcal infections, placing them at increased risk of morbidity and mortality; however, increased numbers of outpatient visits for preventive care are associated with improved provision of prophylactic antibiotics.	Univ Washington, Robert Wood Johnson Clin Scholars Program, Hlth Sci Ctr H220, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Inst Child Hlth, Seattle, WA USA; Vanderbilt Univ, Dept Pediat, Nashville, TN USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Vanderbilt University	Sox, CM (corresponding author), Univ Washington, Robert Wood Johnson Clin Scholars Program, Hlth Sci Ctr H220, Dept Pediat, Box 357183, Seattle, WA 98195 USA.	colinsox@u.washington.edu		Sox, Colin/0000-0002-0249-9656				Abramson JS, 2000, PEDIATRICS, V106, P367, DOI 10.1542/peds.106.2.367; Abramson JS, 2000, PEDIATRICS, V106, P362; Berkovitch M, 1998, BRIT J CLIN PHARMACO, V45, P605, DOI 10.1046/j.1365-2125.1998.00730.x; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; BUCHANAN GR, 1982, PEDIATRICS, V70, P926; Carson JL, 2000, PHARMACOEPIDEM DR S, P307; Christakis DA, 2001, AMBUL PEDIATR, V1, P99, DOI 10.1367/1539-4409(2001)001<0099:CAQOCF>2.0.CO;2; Cooper WO, 2002, AMBUL PEDIATR, V2, P375, DOI 10.1367/1539-4409(2002)002<0375:OCUACI>2.0.CO;2; Cooper WO, 2002, OBSTET GYNECOL, V100, P101, DOI 10.1016/S0029-7844(02)02001-X; Cooper WO, 2001, ARCH PEDIAT ADOL MED, V155, P1111, DOI 10.1001/archpedi.155.10.1111; *COUNC REG NETW GE, 1995, NAT NEWB SCREEN REP; CUMMINS D, 1991, BRIT MED J, V302, P989, DOI 10.1136/bmj.302.6783.989; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; Gindler J. S., 1995, Morbidity and Mortality Weekly Report, V44, P1; GURWITZ JH, 1993, AM J PUBLIC HEALTH, V83, P711, DOI 10.2105/AJPH.83.5.711; Haque A, 2000, J RURAL HEALTH, V16, P43, DOI 10.1111/j.1748-0361.2000.tb00435.x; JOHNSON RE, 1991, J AM GERIATR SOC, V39, P1079, DOI 10.1111/j.1532-5415.1991.tb02872.x; Kuhlthau K, 2001, PEDIATRICS, V108, P906, DOI 10.1542/peds.108.4.906; Lane PA, 2002, PEDIATRICS, V109, P526; Li STT, 2003, ARCH PEDIAT ADOL MED, V157, P475, DOI 10.1001/archpedi.157.5.475; LOZANO P, 1995, JAMA-J AM MED ASSOC, V274, P469, DOI 10.1001/jama.274.6.469; MILNE RIG, 1990, BRIT MED J, V300, P371, DOI 10.1136/bmj.300.6721.371; Morrill R, 1999, URBAN GEOGR, V20, P727, DOI 10.2747/0272-3638.20.8.727; OVERTURF GD, 1977, AM J DIS CHILD, V131, P784, DOI 10.1001/archpedi.1977.02120200066014; PEGELOW CH, 1991, J PEDIATR-US, V118, P736, DOI 10.1016/S0022-3476(05)80036-8; STEINER JF, 1988, MED CARE, V26, P814, DOI 10.1097/00005650-198808000-00007; Teach SJ, 1998, ARCH PEDIAT ADOL MED, V152, P274	28	47	47	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2003	290	8					1057	1061		10.1001/jama.290.8.1057	http://dx.doi.org/10.1001/jama.290.8.1057			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	715FA	12941678	Bronze			2022-12-01	WOS:000184958900024
J	Jansen, VAA; Stollenwerk, N; Jensen, HJ; Ramsay, ME; Edmunds, WJ; Rhodes, CJ				Jansen, VAA; Stollenwerk, N; Jensen, HJ; Ramsay, ME; Edmunds, WJ; Rhodes, CJ			Measles outbreaks in a population with declining vaccine uptake	SCIENCE			English	Article									Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England; Univ London Imperial Coll Sci Technol & Med, Dept Math, London SW7 2BZ, England; Hlth Protect Agcy, CDSC, London NW9 5EQ, England	University of London; Royal Holloway University London; Imperial College London; Health Protection Agency	Jansen, VAA (corresponding author), Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England.	vincent.jansen@rhul.ac.uk	Jansen, Vincent A A/C-8353-2009; Ramsay, Mary Elizabeth/S-8281-2016	Stollenwerk, Nico/0000-0001-9315-5586; Jansen, Vincent A.A./0000-0002-6518-2090; Ramsay, Mary Elizabeth/0000-0002-7156-7640				ANDERSON R M, 1991; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; GAY NJ, 1995, EPIDEMIOL INFECT, V115, P139, DOI 10.1017/S0950268800058209; Rhodes CJ, 1996, NATURE, V381, P600, DOI 10.1038/381600a0	4	248	258	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2003	301	5634					804	804		10.1126/science.1086726	http://dx.doi.org/10.1126/science.1086726			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907792				2022-12-01	WOS:000184615700035
J	Snow, A				Snow, A			Unnatural selection	NATURE			English	Editorial Material									Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA	Ohio State University	Snow, A (corresponding author), Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA.							Lassner M, 2001, CURR OPIN PLANT BIOL, V4, P152, DOI 10.1016/S1369-5266(00)00152-7; Nam YK, 2001, TRANSGENIC RES, V10, P353, DOI 10.1023/A:1016696104185; Nielsen KM, 2003, NAT BIOTECHNOL, V21, P227, DOI 10.1038/nbt0303-227; United States National Research Council, 2002, ENV EFF TRANSG PLANT	4	14	14	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					619	619		10.1038/424619a	http://dx.doi.org/10.1038/424619a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904767	Bronze			2022-12-01	WOS:000184578800021
J	Garry, DJ; Mammen, PPA				Garry, DJ; Mammen, PPA			Neuroprotection and the role of neuroglobin	LANCET			English	Editorial Material							MYOGLOBIN; MICE; BRAIN; MECHANISMS; PROTECTS; MEMBER		Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Garry, DJ (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA.							Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Couture M, 2001, J BIOL CHEM, V276, P36377, DOI 10.1074/jbc.M103907200; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Garry DJ, 2003, TRENDS CARDIOVAS MED, V13, P111, DOI 10.1016/S1050-1738(02)00256-6; Garry DJ, 1998, NATURE, V395, P905, DOI 10.1038/27681; Godecke A, 1999, P NATL ACAD SCI USA, V96, P10495, DOI 10.1073/pnas.96.18.10495; Grange RW, 2001, AM J PHYSIOL-CELL PH, V281, pC1487, DOI 10.1152/ajpcell.2001.281.5.C1487; Mammen PPA, 2002, J HISTOCHEM CYTOCHEM, V50, P1591, DOI 10.1177/002215540205001203; Meeson AP, 2001, CIRC RES, V88, P713, DOI 10.1161/hh0701.089753; Shiva S, 2001, P NATL ACAD SCI USA, V98, P7212, DOI 10.1073/pnas.131128898; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Zhang CG, 2002, BIOCHEM BIOPH RES CO, V290, P1411, DOI 10.1006/bbrc.2002.6360	14	38	44	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 2	2003	362	9381					342	343		10.1016/S0140-6736(03)14055-X	http://dx.doi.org/10.1016/S0140-6736(03)14055-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907003				2022-12-01	WOS:000184498700004
J	Seo, DW; Li, HM; Guedez, L; Wingfield, PT; Diaz, T; Salloum, R; Wei, BY; Stetler-Stevenson, WG				Seo, DW; Li, HM; Guedez, L; Wingfield, PT; Diaz, T; Salloum, R; Wei, BY; Stetler-Stevenson, WG			TIMP-2 mediated inhibition of angiogenesis: An MMP-independent mechanism	CELL			English	Article							ENDOTHELIAL-CELL PROLIFERATION; PROTEIN-TYROSINE-PHOSPHATASE; TISSUE INHIBITOR; METALLOPROTEINASE INHIBITORS; TUMOR-GROWTH; ACTIVATION; CANCER; GENE; ALPHA-3-BETA-1; INVASION	Tissue inhibitors of metalloproteinases (TIMPs) suppress matrix metalloproteinase (MMP) activity critical for extracellular matrix turnover associated with both physiologic and pathologic tissue remodeling. We demonstrate here that TIMP-2 abrogates angiogenic factor-induced endothelial cell proliferation in vitro and angiogenesis in vivo independent of MMP inhibition. These effects require alpha3beta1 integrin-mediated binding of TIMP-2 to endothelial cells. Further,TIMP-2 induces a decrease in total protein tyrosine phosphatase (PTP) activity associated with beta1 integrin subunits as well as dissociation of the phosphatase SHP-1 from beta1. TIMP-2 treatment also results in a concomitant increase in PTP activity associated with tyrosine kinase receptors FGFR-1 and KDR. Our findings establish an unexpected, MMP-independent mechanism for TIMP-2 inhibition of endothelial cell proliferation in vitro and reveal an important component of the antiangiogenic effect of TIMP2 in vivo.	NCI, Canc Res Ctr, Vasc Biol Fac, Extracellular Matrix Pathol Sect, Bethesda, MD 20892 USA; NCI, Canc Res Ctr, Pathol Lab, Extracellular Matrix Pathol Sect, Bethesda, MD 20892 USA; NIAMSD, Prot Express Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Stetler-Stevenson, WG (corresponding author), NCI, Canc Res Ctr, Vasc Biol Fac, Extracellular Matrix Pathol Sect, Bethesda, MD 20892 USA.		Guedez, Liliana/H-4951-2012; Stetler-Stevenson, William/AAE-3501-2020; Stetler-Stevenson, William G/H-6956-2012	Stetler-Stevenson, William/0000-0002-5500-5808; Stetler-Stevenson, William G/0000-0002-5500-5808; Wingfield, Paul/0000-0002-9515-4752; Seo, Dong-Wan/0000-0003-4971-834X	NATIONAL CANCER INSTITUTE [Z01SC009179, ZIASC009179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041115, ZIAAR041115] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Baker AH, 1999, BRIT J CANCER, V79, P1347, DOI 10.1038/sj.bjc.6690217; Barazi HO, 2002, CANCER RES, V62, P1541; Bousquet C, 1998, J BIOL CHEM, V273, P7099, DOI 10.1074/jbc.273.12.7099; BRAUTIGAN DL, 1988, METHOD ENZYMOL, V159, P339; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; EMMERTBUCK MR, 1995, FEBS LETT, V364, P28, DOI 10.1016/0014-5793(95)00345-A; FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Guedez L, 2003, AM J PATHOL, V162, P1431, DOI 10.1016/S0002-9440(10)64276-9; Guedez L, 2001, BLOOD, V97, P1796, DOI 10.1182/blood.V97.6.1796; Guedez L, 1998, J CLIN INVEST, V102, P2002, DOI 10.1172/JCI2881; Guedez L, 2001, AM J PATHOL, V158, P1207, DOI 10.1016/S0002-9440(10)64070-9; Guo DQ, 2000, J BIOL CHEM, V275, P11216, DOI 10.1074/jbc.275.15.11216; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hoegy SE, 2001, J BIOL CHEM, V276, P3203, DOI 10.1074/jbc.M008157200; Imren S, 1996, CANCER RES, V56, P2891; Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291; Jiang YF, 2001, CANCER RES, V61, P2365; Keilhack H, 1998, J BIOL CHEM, V273, P24839, DOI 10.1074/jbc.273.38.24839; LAU KHW, 1989, BIOCHEM J, V257, P23, DOI 10.1042/bj2570023; Maeshima Y, 2002, SCIENCE, V295, P140, DOI 10.1126/science.1065298; MURPHY AN, 1993, J CELL PHYSIOL, V157, P351, DOI 10.1002/jcp.1041570219; Nakagami H, 2002, ARTERIOSCL THROM VAS, V22, P238, DOI 10.1161/hq0202.104001; Perollet C, 1998, BLOOD, V91, P3289, DOI 10.1182/blood.V91.9.3289.3289_3289_3299; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Rehn M, 2001, P NATL ACAD SCI USA, V98, P1024, DOI 10.1073/pnas.031564998; STUPACK DG, 2002, ECM REMODELING REGUL; Sugiura T, 1999, J CELL BIOL, V146, P1375, DOI 10.1083/jcb.146.6.1375; Tartaglia M, 2001, DNA CELL BIOL, V20, P367, DOI 10.1089/10445490152122488; Tarui T, 2001, J BIOL CHEM, V276, P39562, DOI 10.1074/jbc.M101815200; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; Wennerberg K, 2000, MOL CELL BIOL, V20, P5758, DOI 10.1128/MCB.20.15.5758-5765.2000; Wingfield PT, 1999, J BIOL CHEM, V274, P21362, DOI 10.1074/jbc.274.30.21362; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791	39	406	434	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 25	2003	114	2					171	180		10.1016/S0092-8674(03)00551-8	http://dx.doi.org/10.1016/S0092-8674(03)00551-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887919	Bronze			2022-12-01	WOS:000184378700007
J	Zheng, L; Roeder, RG; Luo, Y				Zheng, L; Roeder, RG; Luo, Y			S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component	CELL			English	Article							OCT-1 POU DOMAIN; CELL-CYCLE; GENE-TRANSCRIPTION; DNA-BINDING; PROTEINS; REPLICATION; PHOSPHORYLATION; DEHYDROGENASE; CHAPERONES; EXPRESSION	We have isolated and functionally characterized a multicomponent Oct-1 coactivator, OCA-S which is essential for S phase-dependent histone H2B transcription. The p38 component of OCA-S binds directly to Oct-1, exhibits potent transactivation potential, is selectively recruited to the H2B promoter in S phase, and is essential for S phase-specific H2B transcription in vivo and in vitro. Surprisingly, p38 represents a nuclear form of glyceraldehyde-3-phosphate dehydrogenase, and binding to Oct-1, as well as OCA-S function, is stimulated by NAD(+) but inhibited by NADH. OCA-S also interacts with NPAT, a cyclin E/cdk2 substrate that is broadly involved in histone gene transcription. These studies thus link the H2B transcriptional machinery to cell cycle regulators, and possibly to cellular metabolic state (redox status), and set the stage for studies of the underlying mechanisms and the basis for coordinated histone gene expression and coupling to DNA replication.	Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA	Rockefeller University	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.	roeder@mail.rockefeller.edu; luoy@mail.rockefeller.edu						Babb R, 1997, MOL CELL BIOL, V17, P7295, DOI 10.1128/MCB.17.12.7295; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Ewen ME, 2000, GENE DEV, V14, P2265, DOI 10.1101/gad.842100; Fan WH, 2002, J BIOL CHEM, V277, P8061, DOI 10.1074/jbc.M110225200; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Ford E, 1998, GENE DEV, V12, P3528, DOI 10.1101/gad.12.22.3528; Freije JMP, 1998, BIOCHEM SOC SYMP, P261; Frydman J, 1997, TRENDS BIOCHEM SCI, V22, P87, DOI 10.1016/S0968-0004(97)01005-0; Ge H, 1996, METHOD ENZYMOL, V274, P57; HAN M, 1987, CELL, V48, P589, DOI 10.1016/0092-8674(87)90237-6; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kimmins S, 2000, CELL STRESS CHAPERON, V5, P76, DOI 10.1379/1466-1268(2000)005<0076:MOSRAE>2.0.CO;2; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; LABELLA F, 1988, GENE DEV, V2, P32, DOI 10.1101/gad.2.1.32; LUO Y, 1992, CELL, V71, P231, DOI 10.1016/0092-8674(92)90352-D; LUO Y, 1995, MOL CELL BIOL, V15, P4115; Luo Y, 1999, COLD SPRING HARB SYM, V64, P119, DOI 10.1101/sqb.1999.64.119; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; RONAI Z, 1993, INT J BIOCHEM, V25, P1073, DOI 10.1016/0020-711X(93)90123-V; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; SEGIL N, 1991, SCIENCE, V254, P1814, DOI 10.1126/science.1684878; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Takahashi Y, 2000, GENE DEV, V14, P804; Zhang QH, 2002, SCIENCE, V295, P1895; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zhao JY, 1998, GENE DEV, V12, P456, DOI 10.1101/gad.12.4.456	33	414	447	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2003	114	2					255	266		10.1016/S0092-8674(03)00552-X	http://dx.doi.org/10.1016/S0092-8674(03)00552-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887926	Bronze			2022-12-01	WOS:000184378700014
J	Brook, BW; Sodhi, NS; Ng, PKL				Brook, BW; Sodhi, NS; Ng, PKL			Catastrophic extinctions follow deforestation in Singapore	NATURE			English	Article							CONSERVATION; FOREST; LESSONS; BIRD	The looming mass extinction of biodiversity in the humid tropics is a major concern for the future(1), yet most reports of extinctions in these regions are anecdotal or conjectural, with a scarcity of robust, broad-based empirical data(2-4). Here we report on local extinctions among a wide range of terrestrial and freshwater taxa from Singapore (540 km(2)) in relation to habitat loss exceeding 95% over 183 years(5,6). Substantial rates of documented and inferred extinctions were found, especially for forest specialists, with the greatest proportion of extinct taxa (34-87%) in butterflies, fish, birds and mammals. Observed extinctions were generally fewer, but inferred losses often higher, in vascular plants, phasmids, decapods, amphibians and reptiles (5-80%). Forest reserves comprising only 0.25% of Singapore's area now harbour over 50% of the residual native biodiversity. Extrapolations of the observed and inferred local extinction data, using a calibrated species-area model(7-9), imply that the current unprecedented rate of habitat destruction in Southeast Asia(10) will result in the loss of 13-42% of regional populations over the next century, at least half of which will represent global species extinctions.	Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan; No Terr Univ, Key Ctr Trop Wildlife Management, Darwin, NT 0909, Australia; Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Kyoto University; Charles Darwin University; National University of Singapore	Brook, BW (corresponding author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan.	barry.brook@ntu.edu.au; dbsns@nus.edu.sg	Brook, Barry W./G-2686-2011; Ng, Peter/J-7393-2012	Brook, Barry W./0000-0002-2491-1517; 				Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Araujo MB, 2000, BIOL CONSERV, V96, P331, DOI 10.1016/S0006-3207(00)00074-4; BIERREGAARD RO, 1992, BIOSCIENCE, V42, P859, DOI 10.2307/1312085; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; Brooks TM, 1997, CONSERV BIOL, V11, P382, DOI 10.1046/j.1523-1739.1997.95493.x; Castelletta M, 2000, CONSERV BIOL, V14, P1870, DOI 10.1111/j.1523-1739.2000.99285.x; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Corlett R.T., 2000, P333; CORLETT RT, 1992, J BIOGEOGR, V19, P411, DOI 10.2307/2845569; DIAMOND J M, 1987, Conservation Biology, V1, P77, DOI 10.1111/j.1523-1739.1987.tb00012.x; Droege S, 1998, CONSERV BIOL, V12, P1134, DOI 10.1046/j.1523-1739.1998.96402.x; HEYWOOD VH, 1992, TROPICAL DEFORESTATION AND SPECIES EXTINCTION, P91; HEYWOOD VH, 1994, NATURE, V368, P105, DOI 10.1038/368105a0; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; Lim KS, 1997, BIRDS ILLUSTRATED FI; May RM, 2000, SCIENCE, V290, P2084, DOI 10.1126/science.290.5499.2084; Milner-Gulland EJ, 2001, TRENDS ECOL EVOL, V16, P686, DOI 10.1016/S0169-5347(01)02278-9; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ng P. K., 1994, SINGAPORE RED DATA B; NG PKL, 1992, AQUAT CONSERV, V2, P255, DOI 10.1002/aqc.3270020305; Novacek MJ, 2001, P NATL ACAD SCI USA, V98, P5466, DOI 10.1073/pnas.091093698; Pitman NCA, 2002, SCIENCE, V298, P989, DOI 10.1126/science.298.5595.989; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Ridley H.N., 1900, J STRAITS BRANCH ROY, V33, P27; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Sodhi NS, 2000, CONSERV BIOL, V14, P1211, DOI 10.1046/j.1523-1739.2000.99416.x; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Turner IM, 1996, TRENDS ECOL EVOL, V11, P330, DOI 10.1016/0169-5347(96)10046-X; TURNER IM, 1994, CONSERV BIOL, V8, P705, DOI 10.1046/j.1523-1739.1994.08030705.x; WILLIAMSON M, 1989, PHILOS T ROY SOC B, V325, P457, DOI 10.1098/rstb.1989.0099	30	460	488	1	228	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					420	423		10.1038/nature01795	http://dx.doi.org/10.1038/nature01795			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879068				2022-12-01	WOS:000184318400041
J	Travis, LB; Hill, DA; Dores, GM; Gospodarowicz, M; van Leeuwen, FE; Holowaty, E; Glimelius, B; Andersson, M; Wiklund, T; Lynch, CF; Van't Veer, MB; Glimelius, I; Storm, H; Pukkala, E; Stovall, M; Curtis, R; Boice, JD; Gilbert, E				Travis, LB; Hill, DA; Dores, GM; Gospodarowicz, M; van Leeuwen, FE; Holowaty, E; Glimelius, B; Andersson, M; Wiklund, T; Lynch, CF; Van't Veer, MB; Glimelius, I; Storm, H; Pukkala, E; Stovall, M; Curtis, R; Boice, JD; Gilbert, E			Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HORMONE REPLACEMENT THERAPY; 2ND MALIGNANT NEOPLASMS; MANTLE IRRADIATION; RADIATION-THERAPY; OVARIAN-FUNCTION; RISK; SURVIVORS; MORTALITY; ESTROGEN; COHORT	Context Second cancer is the leading cause of death in long-term survivors of Hodgkin disease (HD), with exceptionally high risks of breast cancer among women treated at a young age. Quantitative associations between radiotherapy dose delivered to the breast and administered chemotherapy have not been reported to date in large series, nor has the influence of ovarian exposures on subsequent risk. Objective To quantify the long-term risk of breast cancer associated with use of radiotherapy and chemotherapy to treat young women with HD. Design, Setting, and Subjects Matched case-control study of breast cancer within a cohort of 3817 female 1-year survivors of HD diagnosed at age 30 years or younger, between January 1, 1965, and December 31, 1994, and within 6 population-based cancer registries. The study was conducted March 1, 1996, through September 30, 1998. Main Outcome Measures Relative risk (RR) of breast cancer associated with radiation dose delivered to site of breast cancer or to ovaries and with cumulative dose of alkylating agents. Results Breast cancer occurred in 105 patients with HD who were matched to 266 patients with HD but without breast cancer. A radiation dose of 4 Gy or more delivered to the breast was associated with a 3.2-fold (95% confidence interval [CI], 1.4-8.2) increased risk, compared with the risk in patients who received lower doses and no alkylating agents. Risk increased to 9-fold (95% CI, 2.6-26.4) with a dose of more than 40 Gy (P<.001 for trend). Radiation risk did not vary appreciably by age at exposure or reproductive history. increased risks persisted for 25 or more years following radiotherapy (RR, 2.3; 95% CI, 0.5-16.5; P=.03 for trend with dose). Treatment with alkylating agents alone resulted in a reduced risk (RR, 0.6; 95% CI, 0.2-2.0) of breast cancer, and combined alkylating agents and radiotherapy in a 1.4-fold (95% CI, 0.6-3.5) increased risk. Risk of breast cancer decreased with increasing number of alkylating agent cycles (P=.003 for trend). Risk also was low (RR, 0.4; 95% CI, 0.1-1.1) among women who received 5 Gy or more delivered to ovaries compared with those who received lower doses. Conclusions Hormonal stimulation appears important for the development of radiation-induced breast cancer, as evidenced by the reduced risk associated with ovarian damage from alkylating agents or radiation. The high radiation-related risk, which did not diminish at the highest doses or the longest follow-up, however, suggests the need for lifetime surveillance and programs of patient and public awareness.	NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada; Netherlands Canc Inst, Amsterdam, Netherlands; Canc Care Ontario, Toronto, ON, Canada; Uppsala Univ, Uppsala, Sweden; Danish Canc Soc, Copenhagen, Denmark; Univ Helsinki, Cent Hosp, Helsinki, Finland; Univ Iowa, Iowa City, IA USA; Dr Daniel den Hoed Canc Ctr, NL-3008 AE Rotterdam, Netherlands; Finnish Canc Registry, FIN-00170 Helsinki, Finland; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA; Int Epidemiol Inst, Rockville, MD USA; Vanderbilt Univ, Med Ctr, Nashville, TN USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Netherlands Cancer Institute; Cancer Care Ontario; Uppsala University; Danish Cancer Society; University of Helsinki; Helsinki University Central Hospital; University of Iowa; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Finnish Cancer Registry; University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University	Travis, LB (corresponding author), NCI, Div Canc Epidemiol & Stat, NIH, Dept Hlth & Human Serv,EPS 7086,MSC 7238, Bethesda, MD 20892 USA.		Glimelius, Ingrid Cecilia/Q-1325-2015; Glimelius, Ingrid/AAJ-4986-2020	Glimelius, Ingrid Cecilia/0000-0001-6158-3041; Glimelius, Ingrid/0000-0001-6158-3041; Wiklund, Tom/0000-0002-9384-9614; Dores, Graca/0000-0002-3985-2935; Storm, Hans/0000-0001-7223-8198	NCI NIH HHS [N01-CP-61121, N01-CP-61122, N01-CP-91024, N02-CP-81005, CP-33013-18, N01-CP-61119, N01-CP-61120] Funding Source: Medline; DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [N01CP061122, N01CP061119, N01CP061121, N01CP061120, N01CP091024] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics)		Aisenberg AC, 1997, CANCER, V79, P1203, DOI 10.1002/(SICI)1097-0142(19970315)79:6<1203::AID-CNCR20>3.0.CO;2-2; Aisenberg AC, 1999, BLOOD, V93, P761, DOI 10.1182/blood.V93.3.761.403a27_761_779; [Anonymous], 2002, SEER CANC STAT REV 1; [Anonymous], 1983, BRIT J RADIOL, V17, P1; ARSENEAU JC, 1972, NEW ENGL J MED, V287, P1119, DOI 10.1056/NEJM197211302872204; Bhatia S, 1996, NEW ENGL J MED, V334, P745, DOI 10.1056/NEJM199603213341201; BOICE JD, 1989, INT J CANCER, V44, P7, DOI 10.1002/ijc.2910440103; Boice JD, 2001, MED PEDIATR ONCOL, V36, P508, DOI 10.1002/mpo.1122; BOICE JD, 1993, J NATL CANCER I, V85, P4, DOI 10.1093/jnci/85.1.4; BOKEMEYER C, 1994, ANN HEMATOL, V68, P105, DOI 10.1007/BF01727413; Breslow NE., 1980, IARC SCI PUBL, P5; Brusamolino E, 2000, HAEMATOLOGICA, V85, P1032; CANELLOS GP, 1992, NEW ENGL J MED, V327, P1478, DOI 10.1056/NEJM199211193272102; Canellos GP, 2002, ANN ONCOL, V13, P153, DOI 10.1093/annonc/mdf653; Chen CL, 2002, JAMA-J AM MED ASSOC, V287, P734, DOI 10.1001/jama.287.6.734; Christie DRH, 1998, INT J RADIAT ONCOL, V41, P223, DOI 10.1016/S0360-3016(97)00902-4; Clemons M, 2000, CANCER TREAT REV, V26, P291, DOI 10.1053/ctrv.2000.0174; Connors J M, 2001, Hematology Am Soc Hematol Educ Program, P178; DARBY SC, 1994, INT J CANCER, V56, P793, DOI 10.1002/ijc.2910560606; DEVITA VT, 1970, ANN INTERN MED, V73, P881, DOI 10.7326/0003-4819-73-6-881; Diller L, 2002, J CLIN ONCOL, V20, P2085, DOI 10.1200/JCO.2002.08.031; Dores GM, 2002, J CLIN ONCOL, V20, P3484, DOI 10.1200/JCO.2002.09.038; HANCOCK SL, 1993, J NATL CANCER I, V85, P25, DOI 10.1093/jnci/85.1.25; Henry-Amar M, 1992, Ann Oncol, V3 Suppl 4, P117; Hoppe RT, 1997, ANN ONCOL, V8, P115, DOI 10.1023/A:1008238908676; HORNING SJ, 1981, NEW ENGL J MED, V304, P1377, DOI 10.1056/NEJM198106043042301; Jolleys JV, 1996, MATURITAS, V23, P47, DOI 10.1016/0378-5122(95)00952-3; Lucraft HH, 2000, CLIN ONCOL-UK, V12, P276, DOI 10.1053/clon.2000.9173; MASHCHAK CA, 1982, AM J OBSTET GYNECOL, V144, P511, DOI 10.1016/0002-9378(82)90218-6; Mauch P, 1999, HODGKINS DIS; Mauch P M, 1995, Cancer J Sci Am, V1, P33; Meirow D, 2001, HUM REPROD UPDATE, V7, P535, DOI 10.1093/humupd/7.6.535; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Ng AK, 1999, SEMIN HEMATOL, V36, P290; PARKIN DM, 1997, CANC INCIDENCE 5 CON, V7; PERSSON I, 1983, ACTA OBSTET GYN SCAN, V62, P289, DOI 10.3109/00016348309156224; PETERS MH, 1995, AM SURGEON, V61, P763; PETERS MV, 1950, AM J ROENTGENOL, V63, P299; *PHIL MED SYST, RAD ONC SYST PINN; Preston DL, 2002, RADIAT RES, V158, P220, DOI 10.1667/0033-7587(2002)158[0220:REOBCR]2.0.CO;2; PRESTON DL, 1991, EPICURE USERS GUIDE; Prosnitz LR, 2002, J CLIN ONCOL, V20, P2225, DOI 10.1200/JCO.2002.20.9.2225; RAY GR, 1970, RADIOLOGY, V96, P175, DOI 10.1148/96.1.175; Schairer C, 1997, INT J CANCER, V70, P150, DOI 10.1002/(SICI)1097-0215(19970117)70:2<150::AID-IJC2>3.0.CO;2-W; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485; SHORE RE, 1980, PREV MED, V9, P815, DOI 10.1016/0091-7435(80)90024-9; STOVALL M, 1995, MED PHYS, V22, P63, DOI 10.1118/1.597525; STOVALL M, 1989, MED PHYS, V16, P726, DOI 10.1118/1.596331; Swerdlow AJ, 2000, J CLIN ONCOL, V18, P498, DOI 10.1200/JCO.2000.18.3.498; Titus-Ernstoff L, 1998, CANCER EPIDEM BIOMAR, V7, P783; Travis LB, 1999, NEW ENGL J MED, V340, P351, DOI 10.1056/NEJM199902043400504; Travis LB, 2002, JNCI-J NATL CANCER I, V94, P182, DOI 10.1093/jnci/94.3.182; TRAVIS LB, 2003, NEW ENGL J MED, V95, P971; TRICHOPOULOS D, 1972, JNCI-J NATL CANCER I, V48, P605; United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), 2000, SOURC EFF LON RAD; van Leeuwen FE, 2000, J CLIN ONCOL, V18, P487, DOI 10.1200/JCO.2000.18.3.487; VANLEEUWEN FE, IN PRESS J NATL CANC; Williams RS, 1999, CANCER, V86, P2138, DOI 10.1002/(SICI)1097-0142(19991115)86:10<2138::AID-CNCR36>3.3.CO;2-M; Wolden SL, 2000, J CLIN ONCOL, V18, P765, DOI 10.1200/JCO.2000.18.4.765; YAHALOM J, 1992, J CLIN ONCOL, V10, P1674, DOI 10.1200/JCO.1992.10.11.1674; ZELLMER DL, 1991, INT J RADIAT ONCOL, V21, P1343, DOI 10.1016/0360-3016(91)90296-G	61	446	453	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2003	290	4					465	475		10.1001/jama.290.4.465	http://dx.doi.org/10.1001/jama.290.4.465			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703JB	12876089	Bronze			2022-12-01	WOS:000184275300018
J	Mariani, R; Chen, D; Schrofelbauer, B; Navarro, F; Konig, R; Bollman, B; Munk, C; Nymark-McMahon, H; Landau, NR				Mariani, R; Chen, D; Schrofelbauer, B; Navarro, F; Konig, R; Bollman, B; Munk, C; Nymark-McMahon, H; Landau, NR			Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif	CELL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; B MESSENGER-RNA; TYPE-1 VIF; EDITING ENZYME; DNA; HYPERMUTATION; PROTEIN; REPLICATION; EXPRESSION; GENE	The HIV-1 accessory protein Vif (virion infectivity factor) is required for the production of infectious virions by CD4(+) lymphocytes. Vif facilitates particle infectivity by blocking the inhibitory activity of APOBEC3G (CEM15), a virion-encapsidated cellular protein that deaminates minus-strand reverse transcript cytosines to uracils. We report that HIV-1 Vif forms a complex with human APOBEC3G that prevents its virion encapsidation. HIV-1 Vif did not efficiently form a complex with mouse APOBEC3G. Vif dramatically reduced the amount of human APOBEC3G encapsidated in HIV-1 virions but did not prevent encapsidation of mouse or AGM APOBEC3G. As a result, these enzymes are potent inhibitors of wild-type HIV-1 replication. The species-specificity of this interaction may play a role in restricting HIV-1 infection to humans. Together these findings suggest that therapeutic intervention that either induced APOBEC3G or blocked its interaction with Vif could be clinically beneficial.	Salk Inst Biol Studies, Infect Dis Lab, La Jolla, CA 92037 USA	Salk Institute	Landau, NR (corresponding author), Salk Inst Biol Studies, Infect Dis Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	landau@salk.edu	König, Renate/AAB-8918-2019	König, Renate/0000-0003-4882-9179	NIDA NIH HHS [DA014494] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014494] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ANANT S, 1995, J BIOL CHEM, V270, P14762, DOI 10.1074/jbc.270.24.14762; BORMAN AM, 1995, VIROLOGY, V208, P601, DOI 10.1006/viro.1995.1191; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Camaur D, 1996, J VIROL, V70, P6106, DOI 10.1128/JVI.70.9.6106-6111.1996; Chowdhury IH, 1996, J VIROL, V70, P5336, DOI 10.1128/JVI.70.8.5336-5345.1996; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Desrosiers RC, 1998, J VIROL, V72, P1431, DOI 10.1128/JVI.72.2.1431-1437.1998; Dettenhofer M, 1999, J VIROL, V73, P1460, DOI 10.1128/JVI.73.2.1460-1467.1999; Emerman M, 1998, SCIENCE, V280, P1880, DOI 10.1126/science.280.5371.1880; FOLEY GE, 1965, CANCER RES, V25, P1254; Fouchier RAM, 1996, J VIROL, V70, P8263, DOI 10.1128/JVI.70.12.8263-8269.1996; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Gaddis NC, 2003, J VIROL, V77, P5810, DOI 10.1128/JVI.77.10.5810-5820.2003; Goncalves J, 1996, J VIROL, V70, P8701, DOI 10.1128/JVI.70.12.8701-8709.1996; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; JUTILA MA, 1994, J IMMUNOL, V153, P3917; Keppler OT, 2002, J EXP MED, V195, P719, DOI 10.1084/jem.20011549; Keppler OT, 2001, J VIROL, V75, P8063, DOI 10.1128/JVI.75.17.8063-8073.2001; Khan MA, 2001, J VIROL, V75, P7252, DOI 10.1128/JVI.75.16.7252-7265.2001; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Lau PP, 2001, J BIOL CHEM, V276, P46445, DOI 10.1074/jbc.M109215200; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; LENBURG ME, 1993, J VIROL, V67, P7238, DOI 10.1128/JVI.67.12.7238-7245.1993; LIU HM, 1995, J VIROL, V69, P7630, DOI 10.1128/JVI.69.12.7630-7638.1995; Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998; MANGEAT B, 2003, IN PRESS NATURE; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Muto T, 2000, GENOMICS, V68, P85, DOI 10.1006/geno.2000.6268; NARA PL, 1988, NATURE, V332, P469, DOI 10.1038/332469a0; OBERSTE MS, 1992, VIRUS GENES, V6, P95, DOI 10.1007/BF01703760; Onishi M, 1996, EXP HEMATOL, V24, P324; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; RALPH P, 1973, J NATL CANCER I, V51, P883, DOI 10.1093/jnci/51.3.883; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987; SIMON JHM, 1995, J VIROL, V69, P4166, DOI 10.1128/JVI.69.7.4166-4172.1995; Simon JHM, 1996, J VIROL, V70, P5297, DOI 10.1128/JVI.70.8.5297-5305.1996; Soares MA, 1997, VIROLOGY, V228, P394, DOI 10.1006/viro.1996.8387; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; TRONO D, 1995, CELL, V82, P189, DOI 10.1016/0092-8674(95)90306-2; VARTANIAN JP, 1994, P NATL ACAD SCI USA, V91, P3092, DOI 10.1073/pnas.91.8.3092; VARTANIAN JP, 1991, J VIROL, V65, P1779, DOI 10.1128/JVI.65.4.1779-1788.1991; Vartanian JP, 2002, J GEN VIROL, V83, P801, DOI 10.1099/0022-1317-83-4-801; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Yang Y, 2000, J BIOL CHEM, V275, P22663, DOI 10.1074/jbc.M910406199; ZHANG H, 2003, IN PRESS NATURE	52	747	796	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2003	114	1					21	31		10.1016/S0092-8674(03)00515-4	http://dx.doi.org/10.1016/S0092-8674(03)00515-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	702JC	12859895	Bronze			2022-12-01	WOS:000184219900003
J	Villunger, A; Michalak, EM; Coultas, L; Mullauer, F; Bock, G; Ausserlechner, MJ; Adams, JM; Strasser, A				Villunger, A; Michalak, EM; Coultas, L; Mullauer, F; Bock, G; Ausserlechner, MJ; Adams, JM; Strasser, A			p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa	SCIENCE			English	Article							COLORECTAL-CANCER CELLS; BCL-2 FAMILY; DNA-DAMAGE; P53; DEATH; GENE; THYMOCYTES; EXPRESSION; INDUCTION; SURVIVAL	Apoptosis provoked by DNA damage requires the p53 tumor suppressor, but which of the many p53-regulated genes are required has remained unknown. Two genes induced by this transcription factor, noxa and puma (bbc3), stand out, because they encode BH3-only proteins, proapoptotic members of the Bcl-2 family required to initiate apoptosis. In mice with either noxa or puma disrupted, we observed decreased DNA damage-induced apoptosis in fibroblasts, although only loss of Puma protected lymphocytes from cell death. Puma deficiency also protected cells against diverse p53-independent cytotoxic insults, including cytokine deprivation and exposure to glucocorticoids, the kinase inhibitor staurosporine, or phorbol ester. Hence, Puma and Noxa are critical mediators of the apoptotic responses induced by p53 and other agents.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Univ Innsbruck, Inst Pathophysiol, A-6020 Innsbruck, Austria	Walter & Eliza Hall Institute; University of Innsbruck	Villunger, A (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	andreas.villunger@uibk.ac.at; strasser@wehi.edu.au	Adams, Jerry M/E-1199-2013; Strasser, Andreas/C-7581-2013	Strasser, Andreas/0000-0002-5020-4891; Michalak, Ewa/0000-0002-5772-2122; Ausserlechner, Michael/0000-0002-1015-2302; Adams, Jerry/0000-0002-4360-8628				Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Chao C, 2000, EMBO J, V19, P4967, DOI 10.1093/emboj/19.18.4967; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Jimenez GS, 2000, NAT GENET, V26, P37, DOI 10.1038/79152; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Schuler M, 2003, CELL DEATH DIFFER, V10, P451, DOI 10.1038/sj.cdd.4401180; SELLINS KS, 1987, J IMMUNOL, V139, P3199; SENTMAN CL, 1991, CELL, V67, P79; SHIBUE T, 2003, GENE DEV, V2, P2; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; VILLUNGER A, UNPUB; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100	24	1029	1064	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2003	302	5647					1036	1038		10.1126/science.1090072	http://dx.doi.org/10.1126/science.1090072			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740HE	14500851				2022-12-01	WOS:000186396300045
J	Webber, LJ; Stubbs, S; Stark, J; Trew, GH; Margara, R; Hardy, K; Franks, S				Webber, LJ; Stubbs, S; Stark, J; Trew, GH; Margara, R; Hardy, K; Franks, S			Formation and early development of follicles in the polycystic ovary	LANCET			English	Article							TERM-FOLLOW-UP; WOMEN; HORMONE; GROWTH; CELLS	Background Polycystic ovary syndrome is the most common cause of anovulatory infertility. It has long-term health implications and is an important risk factor for type 2 diabetes. However, little is known about the cause of polycystic ovaries. We have used detailed morphological analysis to assess the hypothesis that there is an intrinsic ovarian abnormality that affects the earliest stages of follicular development. Methods We took small cortical biopsies during routine laparoscopy from 24 women with normal ovaries and regular cycles and from 32 women with polycystic ovaries, 16 of whom had regular, ovulatory cycles and 16 of whom had oligomenorrhoea. We used computerised image analysis to assess the density and developmental stage of small preantral follicles in serial sections of fixed tissue. Findings Median density of small preantral follicles, including those at primordial and primary stages, was six-fold greater in biopsies from polycystic ovaries in anovulatory women than in normal ovaries (p=0.009). In both ovulatory and anovulatory women with polycystic ovaries, we noted a significant increase in the percentage of early growing (primary) follicles and a reciprocal decrease in the proportion of primordial follicles compared with normal ovaries. Interpretation Our findings indicate that there are fundamental differences between polycystic and normal ovaries in early follicular development, suggesting an intrinsic ovarian abnormality. The increased density of small preantral follicles in polycystic ovaries could result from increased population of the fetal ovary by germ cells, or from decreased rate of loss of oocytes during late gestation, childhood, and puberty.	Hammersmith Hosp, Imperial Coll London, Inst Reprod & Dev Biol, Wolfson & Weston Res Ctr Family Hlth, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Dept Math, London SW7 2AZ, England	Imperial College London; Imperial College London	Franks, S (corresponding author), Hammersmith Hosp, Imperial Coll London, Inst Reprod & Dev Biol, Wolfson & Weston Res Ctr Family Hlth, London W12 0NN, England.	s.franks@imperial.ac.uk	Norman, Robert J/A-1155-2007	Norman, Robert J/0000-0002-3118-3896; Webber, Lisa/0000-0003-3129-9212				Abbott DH, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740001; BAKER TG, 1963, PROC R SOC SER B-BIO, V158, P417, DOI 10.1098/rspb.1963.0055; BALEN AH, 1995, HUM REPROD, V10, P2107, DOI 10.1093/oxfordjournals.humrep.a136243; DAHLGREN E, 1992, FERTIL STERIL, V57, P505; DUNAIF A, 1987, J CLIN ENDOCR METAB, V65, P499, DOI 10.1210/jcem-65-3-499; Durlinger ALL, 2002, ENDOCRINOLOGY, V143, P1076, DOI 10.1210/en.143.3.1076; FARQUHAR CM, 1994, AUST NZ J OBSTET GYN, V34, P67, DOI 10.1111/j.1479-828X.1994.tb01041.x; Franks S, 1997, HUM REPROD, V12, P2641, DOI 10.1093/humrep/12.12.2641; FRANKS S, 1989, CLIN ENDOCRINOL, V31, P87, DOI 10.1111/j.1365-2265.1989.tb00457.x; GillingSmith C, 1997, CLIN ENDOCRINOL, V47, P93, DOI 10.1046/j.1365-2265.1997.2321049.x; GILLINGSMITH C, 1994, J CLIN ENDOCR METAB, V79, P1158, DOI 10.1210/jc.79.4.1158; GOLDZIEHER JW, 1962, J CLIN ENDOCR METAB, V22, P325, DOI 10.1210/jcem-22-3-325; Gougeon A, 1996, ENDOCR REV, V17, P121, DOI 10.1210/er.17.2.121; Hovatta O, 1997, HUM REPROD, V12, P1032; Hughesdon P E, 1982, Obstet Gynecol Surv, V37, P59, DOI 10.1097/00006254-198202000-00001; KURILO LF, 1981, HUM GENET, V57, P86; Lass A, 1997, HUM REPROD, V12, P1028; MELICA F, 1995, INT J FERTIL MENOP S, V40, P79; POLSON DW, 1988, LANCET, V1, P870; ROBINSON S, 1993, CLIN ENDOCRINOL, V39, P351, DOI 10.1111/j.1365-2265.1993.tb02376.x; Teixeira FL, 2002, J CLIN ENDOCR METAB, V87, P1337, DOI 10.1210/jc.87.3.1337; Vendola K, 1999, HUM REPROD, V14, P2328, DOI 10.1093/humrep/14.9.2328; Wild S, 2000, CLIN ENDOCRINOL, V52, P595, DOI 10.1046/j.1365-2265.2000.01000.x; Willis DS, 1998, J CLIN ENDOCR METAB, V83, P3984, DOI 10.1210/jc.83.11.3984; Wright CS, 1999, HUM REPROD, V14, P1555, DOI 10.1093/humrep/14.6.1555; Zawadzki JK, 1992, POLYCYSTIC OVARY SYN, P59	26	309	333	1	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 27	2003	362	9389					1017	1021		10.1016/S0140-6736(03)14410-8	http://dx.doi.org/10.1016/S0140-6736(03)14410-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725WD	14522531				2022-12-01	WOS:000185564600008
J	Caldeira, K; Wickett, ME				Caldeira, K; Wickett, ME			Anthropogenic carbon and ocean pH	NATURE			English	Editorial Material							DIOXIDE; CYCLE; CO2		Lawrence Livermore Natl Lab, Energy & Environm Directorate, Livermore, CA 94550 USA; Lawrence Livermore Natl Lab, Ctr Appl Sci Comp, Livermore, CA 94550 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Caldeira, K (corresponding author), Lawrence Livermore Natl Lab, Energy & Environm Directorate, 7000 East Ave, Livermore, CA 94550 USA.	kenc@llnl.gov	Moe, Kaitlin/P-5316-2019; Caldeira, Ken/E-7914-2011	Caldeira, Ken/0000-0002-4591-643X				Beerling DJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001637; CALDEIRA K, 1993, PALEOCEANOGRAPHY, V8, P515, DOI 10.1029/93PA01163; Caldeira K, 2000, GEOPHYS RES LETT, V27, P225, DOI 10.1029/1999GL002364; Caldeira K, 2000, SCIENCE, V287, P620, DOI 10.1126/science.287.5453.620; Caldeira K., 1999, SCIENCE, V286, P2043, DOI DOI 10.1126/SCIENCE.286.5447.2043A; CROWLEY TJ, 2001, SCIENCE, V292, P780; Houghton JT, 2001, CONTRIBUTION WORKING; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; MARLAND G, 2002, TRENDS COMPENDIUM DA; Pan J., 2001, CLIMATE CHANGE 2001; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; SANYAL A, 1995, NATURE, V373, P234, DOI 10.1038/373234a0; Seibel BA, 2001, SCIENCE, V294, P319, DOI 10.1126/science.1065301	13	2368	2495	25	998	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2003	425	6956					365	365		10.1038/425365a	http://dx.doi.org/10.1038/425365a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	724TG	14508477	Green Published			2022-12-01	WOS:000185502300029
J	Holmes, KC; Angert, I; Kull, FJ; Jahn, W; Schroder, RR				Holmes, KC; Angert, I; Kull, FJ; Jahn, W; Schroder, RR			Electron cryo-microscopy shows how strong binding of myosin to actin releases nucleotide	NATURE			English	Article							RABBIT SKELETAL-MUSCLE; MOTOR DOMAIN; COMPLEX; CONTRACTION; VISUALIZATION; ACTOMYOSIN; MICROSCOPY; MOLSCRIPT; MECHANISM; KINESIN	Muscle contraction involves the cyclic interaction of the myosin cross-bridges with the actin filament, which is coupled to steps in the hydrolysis of ATP(1). While bound to actin each cross-bridge undergoes a conformational change, often referred to as the "power stroke"(2), which moves the actin filament past the myosin filaments; this is associated with the release of the products of ATP hydrolysis and a stronger binding of myosin to actin. The association of a new ATP molecule weakens the binding again, and the attached cross-bridge rapidly dissociates from actin. The nucleotide is then hydrolysed, the conformational change reverses, and the myosin cross-bridge reattaches to actin. X-ray crystallography has determined the structural basis of the power stroke, but it is still not clear why the binding of actin weakens that of the nucleotide and vice versa. Here we describe, by fitting atomic models of actin and the myosin cross-bridge into high-resolution electron cryo-microscopy three-dimensional reconstructions, the molecular basis of this linkage. The closing of the actin-binding cleft when actin binds is structurally coupled to the opening of the nucleotide-binding pocket.	Max Planck Inst Med Res, Dept Biophys, D-69120 Heidelberg, Germany	Max Planck Society	Holmes, KC (corresponding author), Max Planck Inst Med Res, Dept Biophys, Jahnstr 29, D-69120 Heidelberg, Germany.		Schröder, Rasmus R/S-6220-2016	Holmes, Kenneth/0000-0001-8894-9453				Angert I, 2000, ULTRAMICROSCOPY, V81, P203, DOI 10.1016/S0304-3991(99)00190-4; CONIBEAR PB, IN PRESS NATURE STRU; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Geeves M. A., 1995, Biophysical Journal, V68, P194; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; JAHN W, 1995, J MICROSC-OXFORD, V179, P333, DOI 10.1111/j.1365-2818.1995.tb03649.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kull FJ, 1998, J MUSCLE RES CELL M, V19, P877, DOI 10.1023/A:1005489907021; LOBAU V, 1997, THESIS U STUTTGART; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Naber N, 2003, SCIENCE, V300, P798, DOI 10.1126/science.1082374; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; REUBOLD T, IN PRESS NATURE STRU; Sasaki N, 1999, J BIOL CHEM, V274, P37840, DOI 10.1074/jbc.274.53.37840; SCHRODER RR, 1993, NATURE, V364, P171, DOI 10.1038/364171a0; SCHROEDER RR, 2002, P 15 INT C EL MICR, V3, P443; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; SWEENEY HL, 1994, J BIOL CHEM, V269, P1603; Volkmann N, 2003, P NATL ACAD SCI USA, V100, P3227, DOI 10.1073/pnas.0536510100; Volkmann N, 2000, NAT STRUCT BIOL, V7, P1147; YAGLE AE, 1999, DISCRETE TOMOGRAPHY; Yengo CM, 2002, J BIOL CHEM, V277, P24114, DOI 10.1074/jbc.M111253200	31	300	303	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 25	2003	425	6956					423	427		10.1038/nature02005	http://dx.doi.org/10.1038/nature02005			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	724TG	14508495				2022-12-01	WOS:000185502300047
J	Konishi, A; Shimizu, S; Hirota, J; Takao, T; Fan, YH; Matsuoka, Y; Zhang, LL; Yoneda, Y; Fujii, Y; Skouitchi, AI; Tsujimoto, Y				Konishi, A; Shimizu, S; Hirota, J; Takao, T; Fan, YH; Matsuoka, Y; Zhang, LL; Yoneda, Y; Fujii, Y; Skouitchi, AI; Tsujimoto, Y			Involvement of histone H1.2 in apoptosis induced by DNA double-strand breaks	CELL			English	Article							CYTOCHROME-C RELEASE; BCL-2 PROTEIN FAMILY; CELL-DEATH; MITOCHONDRIAL DYSFUNCTION; P53-DEPENDENT APOPTOSIS; IN-VIVO; P53-INDUCED APOPTOSIS; CONFORMATIONAL-CHANGE; BAX; P53	It is poorly understood how apoptotic signals arising from DNA damage are transmitted to mitochondria, which release apoptogenic factors into the cytoplasm that activate downstream destruction programs. Here, we identify histone H1.2 as a cytochrome c-releasing factor that appears in the cytoplasm after exposure to X-ray irradiation. While all nuclear histone H1 forms are released into the cytoplasm in a p53-dependent manner after irradiation, only H1.2, but not other H1 forms, induced cytochrome c release from isolated mitochondria in a Bak-dependent manner. Reducing H1.2 expression enhanced cellular resistance to apoptosis induced by X-ray irradiation or etoposide, but not that induced by other stimuli including TNF-alpha and UV irradiation. H1.2-deficient mice exhibited increased cellular resistance in thymocytes and the small intestine to X-ray-induced apoptosis. These results indicate that histone H1.2 plays an important role in transmitting apoptotic signals from the nucleus to the mitochondria following DNA double-strand breaks.	Osaka Univ, Sch Med, Dept Post Genom & Dis, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, JST, SORST, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, JST, CREST, Suita, Osaka 5650871, Japan; Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Frontier Biosci, Dept Frontier Biosci, Suita, Osaka 5650871, Japan; Nagoya City Univ, Sch Med, Dept Surg 2, Nagoya, Aichi 4678601, Japan; Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi 4678601, Japan; Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Osaka University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Osaka University; Osaka University; Nagoya City University; Nagoya City University; Yeshiva University; Albert Einstein College of Medicine	Tsujimoto, Y (corresponding author), Osaka Univ, Sch Med, Dept Post Genom & Dis, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tsujimot@gene.med.osaka-u.ac.jp	Konishi, Akimitsu/J-4024-2019	Konishi, Akimitsu/0000-0002-3291-0821	NATIONAL CANCER INSTITUTE [R01CA079057] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA079057] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Albig W, 1997, HUM GENET, V101, P284, DOI 10.1007/s004390050630; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Attardi LD, 2000, GENE DEV, V14, P704; Bleher R, 1999, CHROMOSOMA, V108, P308, DOI 10.1007/s004120050382; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chadee DN, 1997, J BIOL CHEM, V272, P8113, DOI 10.1074/jbc.272.13.8113; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Epand RF, 2002, J BIOL CHEM, V277, P32632, DOI 10.1074/jbc.M202396200; Esposti MD, 2001, MOL CELL BIOL, V21, P7268, DOI 10.1128/MCB.21.21.7268-7276.2001; Fan YH, 2001, MOL CELL BIOL, V21, P7933, DOI 10.1128/MCB.21.23.7933-7943.2001; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Franke K, 1998, BBA-GENE STRUCT EXPR, V1398, P232, DOI 10.1016/S0167-4781(98)00062-1; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kratzmeier M, 1999, BIOCHEM J, V337, P319, DOI 10.1042/0264-6021:3370319; LENNOX RW, 1983, J BIOL CHEM, V258, P262; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Majumder PK, 2000, J BIOL CHEM, V275, P21793, DOI 10.1074/jbc.C000048200; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; MATSUOKA Y, 1994, J CELL SCI, V107, P693; MIYASHITA T, 1995, CELL, V80, P293; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; PEPE I, 1990, BIOCHIM BIOPHYS ACTA, V1041, P14, DOI 10.1016/0167-4838(90)90116-W; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Pritchard DM, 1999, ONCOGENE, V18, P7287, DOI 10.1038/sj.onc.1203150; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Shimizu S, 1996, ONCOGENE, V12, P2251; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Tanaka M, 2001, DEVELOPMENT, V128, P655; Tanaka N, 1996, NATURE, V382, P816, DOI 10.1038/382816a0; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Tsujimoto Y, 2000, FEBS LETT, V466, P6, DOI 10.1016/S0014-5793(99)01761-5; Vignali M, 1998, NAT STRUCT BIOL, V5, P1025, DOI 10.1038/4133; Vila R, 2000, PROTEIN SCI, V9, P627; Wang XD, 2001, GENE DEV, V15, P2922; Wang ZF, 1997, J MOL BIOL, V271, P124, DOI 10.1006/jmbi.1997.1166; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Westphal CH, 1997, NAT GENET, V16, P397, DOI 10.1038/ng0897-397; Wolf BB, 2002, CURR BIOL, V12, pR177, DOI 10.1016/S0960-9822(02)00736-4; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yamaguchi H, 2002, J BIOL CHEM, V277, P41604, DOI 10.1074/jbc.M207516200; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	59	253	269	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2003	114	6					673	688		10.1016/S0092-8674(03)00719-0	http://dx.doi.org/10.1016/S0092-8674(03)00719-0			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	724AL	14505568	Bronze			2022-12-01	WOS:000185464000006
J	Xu, L; Wei, Y; Reboul, J; Vaglio, P; Shin, TH; Vidal, M; Elledge, SJ; Harper, JW				Xu, L; Wei, Y; Reboul, J; Vaglio, P; Shin, TH; Vidal, M; Elledge, SJ; Harper, JW			BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3	NATURE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; CYCLIN-E; DEGRADATION; GENE; FAMILY; MEI-1	Programmed destruction of regulatory proteins through the ubiquitin-proteasome system is a widely used mechanism for controlling signalling pathways(1,2). Cullins(3) are proteins that function as scaffolds for modular ubiquitin ligases typified by the SCF (Skp1-Cul1-F-box) complex(4-6). The substrate selectivity of these E3 ligases is dictated by a specificity module that binds cullins. In the SCF complex, this module is composed of Skp1, which binds directly to Cul1, and a member of the F-box family of proteins(4-7). F-box proteins bind Skp1 through the F-box motif(7), and substrates by means of carboxy-terminal protein interaction domains(1,2,5). Similarly, Cul2 and Cul5 interact with BC-box-containing specificity factors through the Skp1-like protein elongin C-2. Cul3 is required for embryonic development in mammals and Caenorhabditis elegans(8-10) but its specificity module is unknown. Here we report the identification of a large family of BTB-domain proteins as substrate-specific adaptors for C. elegans CUL-3. Biochemical studies using the BTB protein MEL-26 and its genetic target MEI-1 (refs 12, 13) indicate that BTB proteins merge the functional properties of Skp1 and F-box proteins into a single polypeptide.	Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Cell & Mol Biol, Houston, TX 77030 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Genet, Boston, MA 02115 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu	Reboul, Jerome/P-9103-2016	Reboul, Jerome/0000-0002-5513-4546; Harper, Jeffrey/0000-0002-6944-7236; Vaglio, Philippe/0000-0003-2900-5596	NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG011085] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aravind L, 1999, J MOL BIOL, V285, P1353, DOI 10.1006/jmbi.1998.2394; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; CLARKMAGUIRE S, 1994, GENETICS, V136, P533; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dow MR, 1998, GENETICS, V150, P119; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Kurz T, 2002, SCIENCE, V295, P1294, DOI 10.1126/science.1067765; Pintard L, 2003, CURR BIOL, V13, P911, DOI 10.1016/S0960-9822(03)00336-1; PINTARD L, 2003, NATURE          0903, DOI DOI 10.1038/NATURE01959; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Srayko M, 2000, GENE DEV, V14, P1072; Uren AG, 1996, TRENDS BIOCHEM SCI, V21, P244, DOI 10.1016/S0968-0004(96)30022-4; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Winston JT, 1999, GENE DEV, V13, P2751, DOI 10.1101/gad.13.21.2751; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	23	378	396	1	35	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 18	2003	425	6955					316	321		10.1038/nature01985	http://dx.doi.org/10.1038/nature01985			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722JA	13679922				2022-12-01	WOS:000185370900050
J	Sharp, D				Sharp, D			Faster, higher, stronger ... and deeper?	LANCET			English	Editorial Material							SCUBA-DIVERS		Lancet, London NW1 7BY, England		Sharp, D (corresponding author), Lancet, 32 Jamestown Rd, London NW1 7BY, England.							*BBC NEWS, TIT BOUGHT NAT; *INT ASS DEV APN, 2002, REG REC REC VERS 5 2; *INT ASS FREE DIV, IAFDS OFF REP A MEST; Nakayama H, 2003, EMERG MED J, V20, P332, DOI 10.1136/emj.20.4.332; Taylor DM, 2003, WILD ENVIRON MED, V14, P83, DOI 10.1580/1080-6032(2003)014[0083:ESDIAA]2.0.CO;2	5	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 13	2003	362	9387					846	846		10.1016/S0140-6736(03)14349-8	http://dx.doi.org/10.1016/S0140-6736(03)14349-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721RH	13678969				2022-12-01	WOS:000185329400006
J	Papineni, P				Papineni, P			Children of bad memories	LANCET			English	Article									UCL, Int Hlth & Med Educ Ctr, London N19 5LW, England	University of London; University College London	Papineni, P (corresponding author), UCL, Int Hlth & Med Educ Ctr, London N19 5LW, England.	p.papineni@ucl.ac.uk		Papineni, Padmasayee/0000-0001-6923-1542				Carpenter RC, 2000, HUM RIGHTS QUART, V22, P428, DOI 10.1353/hrq.2000.0020; *HUM RIGHTS WATCH, 1996, SHATT LIV SEX VIOL R; Lewis M, 1998, SHAME INTERPERSONAL; SANDHER H, 2000, WOMEN VIOLENCE WAR W; Stiglmayer Alexandra, 1994, MASS RAPE WAR WOMEN	5	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 6	2003	362	9386					825	826		10.1016/S0140-6736(03)14277-8	http://dx.doi.org/10.1016/S0140-6736(03)14277-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	719DN	13678880				2022-12-01	WOS:000185188500025
J	Pacala, SW; Bulte, E; List, JA; Levin, SA				Pacala, SW; Bulte, E; List, JA; Levin, SA			False alarm over environmental false alarms	SCIENCE			English	Editorial Material							ECONOMIC-GROWTH; KUZNETS CURVE; AIR-POLLUTION		Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Tilburg Univ, Dept Econ, NL-5000 LE Tilburg, Netherlands; Univ Maryland, Dept Econ, College Pk, MD 20742 USA; Univ Maryland, AREC Dept, Presidents Council Econ Advisers, College Pk, MD 20742 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA	Princeton University; Tilburg University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Bureau of Economic Research	Pacala, SW (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.		Levin, Simon A/J-1218-2014	Levin, Simon A/0000-0002-8216-5639; Bulte, Erwin/0000-0001-9491-5268; List, John/0000-0002-1740-3848				Andreoni J, 2001, J PUBLIC ECON, V80, P269, DOI 10.1016/S0047-2727(00)00110-9; AOROA S, 1998, S EC J, V65, P691; ARROW K, 1995, SCIENCE, V268, P520, DOI 10.1126/science.268.5210.520; GROSSMAN GM, 1995, Q J ECON, V110, P353, DOI 10.2307/2118443; Grubb M, 2002, ANNU REV ENERG ENV, V27, P271, DOI 10.1146/annurev.energy.27.122001.083408; Jaeger W., 1998, THEORETICAL BASIS EN; Kinzig AP, 2003, AMBIO, V32, P330, DOI 10.1639/0044-7447(2003)032[0330:CWUACF]2.0.CO;2; Lesser J. A., 1997, ENV EC POLICY; LOMBORG B, 2001, SKEPTICAL ENV, P168; LUTTER R, 2000, REGULATION, V23; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; SELDEN TM, 1994, J ENVIRON ECON MANAG, V27, P147, DOI 10.1006/jeem.1994.1031; VISCUSI WK, 1993, J ECON LIT, V31, P1912; POLLUTION ABATEMENT	14	18	18	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 29	2003	301	5637					1187	1188		10.1126/science.1086646	http://dx.doi.org/10.1126/science.1086646			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZC	12947184	Green Published			2022-12-01	WOS:000185003500025
J	Takagi, J; Yang, YT; Liu, JH; Wang, JH; Springer, TA				Takagi, J; Yang, YT; Liu, JH; Wang, JH; Springer, TA			Complex between nidogen and laminin fragments reveals a paradigmatic beta-propeller interface	NATURE			English	Article							BASEMENT-MEMBRANE FORMATION; RECEPTOR-RELATED PROTEIN-5; EGF-LIKE MOTIF; GAMMA-1 CHAIN; BINDING-SITE; BONE-DENSITY; MODULE; GENE; PROTEOGLYCAN; LIPOPROTEIN	Basement membranes are fundamental to tissue organization and physiology in all metazoans. The interaction between laminin and nidogen is crucial to the assembly of basement membranes(1-4). The structure of the interacting domains reveals a six-bladed Tyr-Trp-Thr-Asp (YWTD) beta-propeller domain in nidogen bound to laminin epidermal-growth-factor-like (LE) modules III3-5 in laminin (LE3-5). Laminin LE module 4 binds to an amphitheatre-shaped surface on the pseudo-6-fold axis of the beta-propeller, and LE module 3 binds over its rim. A Phe residue that shutters the water-filled central aperture of the beta-propeller, the rigidity of the amphitheatre, and high shape complementarity enable the construction of an evolutionarily conserved binding surface for LE4 of unprecedentedly high affinity for its small size(5). Hypermorphic mutations in the Wnt co-receptor LRP5 (refs 6-9) suggest that a similar YWTD beta-propeller interface is used to bind ligands that function in developmental pathways. A related interface, but shifted off-centre from the pseudo-6-fold axis and lacking the shutter over the central aperture, is used in the low-density lipoprotein receptor for an intramolecular interaction that is regulated by pH in receptor recycling(10).	Ctr Blood Res, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wang, JH (corresponding author), Ctr Blood Res, 800 Huntington Ave, Boston, MA 02115 USA.							Baumgartner R, 1996, J MOL BIOL, V257, P658, DOI 10.1006/jmbi.1996.0192; Bork P, 1996, Q REV BIOPHYS, V29, P119, DOI 10.1017/S0033583500005783; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dong LJ, 2002, LAB INVEST, V82, P1617, DOI 10.1097/01.LAB.0000042240.52093.0F; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Mayer U, 1997, EUR J BIOCHEM, V245, P745, DOI 10.1111/j.1432-1033.1997.t01-1-00745.x; Mayer U, 1998, ANN NY ACAD SCI, V857, P130, DOI 10.1111/j.1749-6632.1998.tb10113.x; MAYER U, 1993, EMBO J, V12, P1879, DOI 10.1002/j.1460-2075.1993.tb05836.x; Murshed M, 2000, MOL CELL BIOL, V20, P7007, DOI 10.1128/MCB.20.18.7007-7012.2000; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POSCHL E, 1994, EMBO J, V13, P3741, DOI 10.1002/j.1460-2075.1994.tb06683.x; Poschl E, 1996, EMBO J, V15, P5154, DOI 10.1002/j.1460-2075.1996.tb00899.x; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schymeinsky J, 2002, MOL CELL BIOL, V22, P6820, DOI 10.1128/MCB.22.19.6820-6830.2002; Springer TA, 1998, J MOL BIOL, V283, P837, DOI 10.1006/jmbi.1998.2115; Stetefeld J, 1996, J MOL BIOL, V257, P644, DOI 10.1006/jmbi.1996.0191; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; TIMPL R, 1999, GUIDEBOOK EXTRACELLU, P455; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Willem M, 2002, DEVELOPMENT, V129, P2711; YNES RO, 2000, J CELL BIOL, V150, pF89	30	116	122	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 21	2003	424	6951					969	974		10.1038/nature01873	http://dx.doi.org/10.1038/nature01873			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713EH	12931195				2022-12-01	WOS:000184843600048
J	Kettenberger, H; Armache, KJ; Cramer, P				Kettenberger, H; Armache, KJ; Cramer, P			Architecture of the RNA polymerase II-TFIIS complex and implications for mRNA cleavage	CELL			English	Article							ELONGATION-FACTOR TFIIS; FACILITATED TRANSCRIPT CLEAVAGE; STRUCTURAL BASIS; EXONUCLEASE ACTIVITY; NASCENT TRANSCRIPT; CRYSTAL-STRUCTURE; SUBUNIT RPB9; ACTIVE-SITE; INITIATION; DOMAIN	The transcription elongation factor TFIIS induces mRNA cleavage by enhancing the intrinsic nuclease activity of RNA polymerase (Pol) II. We have diffused TFIIS into Pol II crystals and derived a model of the Pol II-TFIIS complex from X-ray diffraction data to 3.8 Angstrom resolution. TFIIS extends from the polymerase surface via a pore to the internal active site, spanning a distance of 100 Angstrom. Two essential and invariant acidic residues in a TFIIS loop complement the Pol II active site and could position a metal ion and a water molecule for hydrolytic RNA cleavage. TFIIS also induces extensive structural changes in Pol II that would realign nucleic acids in the active center. Our results support the idea that Pol II contains a single tunable active site for RNA polymerization and cleavage, in contrast to DNA polymerases with two separate active sites for DNA polymerization and cleavage.	Univ Munich, Inst Biochem, Gene Ctr, D-81377 Munich, Germany	University of Munich	Cramer, P (corresponding author), Univ Munich, Inst Biochem, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@LMB.uni-muenchen.de						Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Awrey DE, 1997, J BIOL CHEM, V272, P14747, DOI 10.1074/jbc.272.23.14747; Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Booth V, 2000, J BIOL CHEM, V275, P31266, DOI 10.1074/jbc.M002595200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; CIPRESPALACIN G, 1994, P NATL ACAD SCI USA, V91, P8087, DOI 10.1073/pnas.91.17.8087; Cramer P, 2002, BIOESSAYS, V24, P724, DOI 10.1002/bies.10127; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Davie JK, 2000, MOL CELL BIOL, V20, P5960, DOI 10.1128/MCB.20.16.5960-5973.2000; Ederth J, 2002, J BIOL CHEM, V277, P37456, DOI 10.1074/jbc.M207038200; Erie DA, 2002, BBA-GENE STRUCT EXPR, V1577, P224, DOI 10.1016/S0167-4781(02)00454-2; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gu WG, 1995, J BIOL CHEM, V270, P30441, DOI 10.1074/jbc.270.51.30441; Hausner W, 2000, J BIOL CHEM, V275, P12393, DOI 10.1074/jbc.275.17.12393; Hemming SA, 2000, J BIOL CHEM, V275, P35506, DOI 10.1074/jbc.M004721200; HORIKOSHI M, 1984, J BIOL CHEM, V259, P608; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; IZBAN MG, 1993, J BIOL CHEM, V268, P12874; IZBAN MG, 1993, J BIOL CHEM, V268, P12864; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; JEON CJ, 1994, P NATL ACAD SCI USA, V91, P9106, DOI 10.1073/pnas.91.19.9106; JOHNSON TL, 1994, CELL, V77, P217, DOI 10.1016/0092-8674(94)90314-X; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.biochem.63.1.777; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Koulich D, 1997, J BIOL CHEM, V272, P7201, DOI 10.1074/jbc.272.11.7201; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; Morin PE, 1996, P NATL ACAD SCI USA, V93, P10604, DOI 10.1073/pnas.93.20.10604; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NEDLALKOV YA, 2003, J BIOL CHEM, V278, P18303; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Olmsted VK, 1998, J BIOL CHEM, V273, P22589, DOI 10.1074/jbc.273.35.22589; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Powell W, 1996, J BIOL CHEM, V271, P22301, DOI 10.1074/jbc.271.37.22301; QIAN XQ, 1993, BIOCHEMISTRY-US, V32, P9944, DOI 10.1021/bi00089a010; REINES D, 1992, J BIOL CHEM, V267, P3795; RUDD MD, 1994, P NATL ACAD SCI USA, V91, P8057, DOI 10.1073/pnas.91.17.8057; Rudd MD, 1996, J BIOL CHEM, V271, P21549, DOI 10.1074/jbc.271.35.21549; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SEKIMIZU K, 1976, BIOCHEMISTRY-US, V15, P5064, DOI 10.1021/bi00668a018; Shaw RJ, 2002, J BIOL CHEM, V277, P24420, DOI 10.1074/jbc.M202059200; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Shimasaki NB, 2000, J BIOL CHEM, V275, P36541, DOI 10.1074/jbc.M005834200; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; WANG DG, 1993, P NATL ACAD SCI USA, V90, P843, DOI 10.1073/pnas.90.3.843; Weilbaecher RG, 2003, J BIOL CHEM, V278, P24189, DOI 10.1074/jbc.M211197200; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Wu JS, 1996, P NATL ACAD SCI USA, V93, P11552, DOI 10.1073/pnas.93.21.11552	62	257	276	3	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2003	114	3					347	357		10.1016/S0092-8674(03)00598-1	http://dx.doi.org/10.1016/S0092-8674(03)00598-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914699	Bronze, Green Published			2022-12-01	WOS:000184679200011
J	Passafaro, M; Nakagawa, T; Sala, C; Sheng, M				Passafaro, M; Nakagawa, T; Sala, C; Sheng, M			Induction of dendritic spines by an extracellular domain of AMPA receptor subunit GluR2	NATURE			English	Article							N-TERMINAL DOMAINS; NMDA RECEPTORS; GLUTAMATE RECEPTORS; BINDING-PROTEINS; EXPRESSION; SYNAPSES; NEURONS; DESENSITIZATION; DEPENDENCE; CHANNELS	Synaptic transmission from excitatory nerve cells in the mammalian brain is largely mediated by AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid)-type glutamate receptors located at the surface of dendritic spines. The abundance of postsynaptic AMPA receptors correlates with the size of the synapse and the dimensions of the dendritic spine head(1-4). Moreover, long-term potentiation is associated with the formation of dendritic spines as well as synaptic delivery of AMPA receptors(5-8). The molecular mechanisms that coordinate AMPA receptor delivery and spine morphogenesis are unknown. Here we show that overexpression of the glutamate receptor 2 (GluR2) subunit of AMPA receptors increases spine size and density in hippocampal neurons, and more remarkably, induces spine formation in GABA-releasing interneurons that normally lack spines. The extracellular N-terminal domain (NTD) of GluR2 is responsible for this effect, and heterologous fusion proteins of the NTD of GluR2 inhibit spine morphogenesis. We propose that the NTD of GluR2 functions at the cell surface as part of a receptor-ligand interaction that is important for spine growth and/or stability.	MIT, Howard Hughes Med Inst, RIKEN,Neurosci Res Ctr, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA; Univ Milan, Dept Pharmacol, CNR, Inst Neurosci Cellular & Mol Pharmacol, I-20129 Milan, Italy	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Consiglio Nazionale delle Ricerche (CNR); University of Milan	Sheng, M (corresponding author), MIT, Howard Hughes Med Inst, RIKEN,Neurosci Res Ctr, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA.		Sala, Carlo/A-2493-2009	Sala, Carlo/0000-0003-0662-9523; Sheng, Morgan/0000-0002-8703-5366	Telethon [TCP01014] Funding Source: Medline	Telethon(Fondazione Telethon)		Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; Hayashi T, 1999, NATURE, V397, P72, DOI 10.1038/16269; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; Leuschner WD, 1999, J BIOL CHEM, V274, P16907, DOI 10.1074/jbc.274.24.16907; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Masuko T, 1999, MOL PHARMACOL, V55, P957, DOI 10.1124/mol.55.6.957; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Nusser Z, 2000, CURR OPIN NEUROBIOL, V10, P337, DOI 10.1016/S0959-4388(00)00086-6; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Villarroel A, 1998, NEURON, V20, P329, DOI 10.1016/S0896-6273(00)80460-2; Washburn MS, 1997, J NEUROSCI, V17, P9393	30	249	257	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					677	681		10.1038/nature01781	http://dx.doi.org/10.1038/nature01781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904794				2022-12-01	WOS:000184578800046
J	Straume, T; Rugel, G; Marchetti, AA; Ruhm, W; Korschinek, G; McAninch, JE; Carroll, K; Egbert, S; Faestermann, T; Knie, K; Martinelli, R; Wallner, A; Wallner, C				Straume, T; Rugel, G; Marchetti, AA; Ruhm, W; Korschinek, G; McAninch, JE; Carroll, K; Egbert, S; Faestermann, T; Knie, K; Martinelli, R; Wallner, A; Wallner, C			Measuring fast neutrons in Hiroshima at distances relevant to atomic-bomb survivors	NATURE			English	Article							ACCELERATOR MASS-SPECTROMETRY; DOSIMETRY SYSTEM 1986; NI-63; NAGASAKI; EU-152; CO-60; CL-36; MAGNET; CA-41; IONS	Data from the survivors of the atomic bombs serve as the major basis for risk calculations of radiation-induced cancer in humans(1). A controversy has existed for almost two decades, however, concerning the possibility that neutron doses in Hiroshima may have been much larger than estimated. This controversy was based on measurements of radioisotopes activated by thermal neutrons that suggested much higher fluences at larger distances than expected(2-6). For fast neutrons, which contributed almost all the neutron dose, clear measurement validation has so far proved impossible at the large distances (900 to 1,500 m) most relevant to survivor locations(6). Here, the first results are reported for the detection of Ni-63 produced predominantly by fast neutrons (above about 1 MeV) in copper samples from Hiroshima. This breakthrough was made possible by the development of chemical extraction methods(7,8) and major improvements in the sensitivity of accelerator mass spectrometry for detection of Ni-63 atoms (refs 8-11). When results are compared with Ni-63 activation predicted by neutron doses for Hiroshima survivors(6), good agreement is observed at the distances most relevant to survivor data. These findings provide, for the first time, clear measurement validation of the neutron doses to survivors in Hiroshima.	Univ Utah, Salt Lake City, UT 84108 USA; Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; Tech Univ Munich, D-85747 Garching, Germany; Univ Munich, D-80336 Munich, Germany; Sci Applicat Int Corp, San Diego, CA 92121 USA	Utah System of Higher Education; University of Utah; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Technical University of Munich; University of Munich; Science Applications International Corporation (SAIC)	Straume, T (corresponding author), Univ Utah, 729 Arapeen Dr,Suite 2334, Salt Lake City, UT 84108 USA.		Faestermann, Thomas/ABE-2360-2020; Wallner, Anton/G-1480-2011; Rühm, Werner/C-4302-2011	Faestermann, Thomas/0000-0002-6603-8787; Wallner, Anton/0000-0003-2804-3670; Ruhm, Werner/0000-0002-6354-7359				ARAKATSU B, 1953, COLLECTION INVESTIGA, P34; BARNES IL, 1971, INT J APPL RADIAT IS, V22, P781; *BEIR, 1990, 5 BEIR; Feldman GJ, 1998, PHYS REV D, V57, P3873, DOI 10.1103/PhysRevD.57.3873; GRITZNER ML, 1987, US JAPAN JOINT REASS, V2, P283; HABERSTOCK G, 1986, RADIOCARBON, V28, P204, DOI 10.1017/S0033822200007281; HASHIZUME T, 1967, HEALTH PHYS, V13, P149, DOI 10.1097/00004032-196702000-00004; HOSHI M, 1989, HEALTH PHYS, V57, P831; JOHNSON JO, 1999, USERS MANUAL MASH V; KATO K, 1990, INT J RADIAT BIOL, V58, P661, DOI 10.1080/09553009014552011; Knie K, 1997, NUCL INSTRUM METH B, V123, P128, DOI 10.1016/S0168-583X(96)00753-7; KORSCHINEK G, 1987, NUCL INSTRUM METH B, V29, P67, DOI 10.1016/0168-583X(87)90206-0; Marchetti AA, 1996, APPL RADIAT ISOTOPES, V47, P97, DOI 10.1016/0969-8043(95)00240-5; Marchetti AA, 1997, NUCL INSTRUM METH B, V123, P230, DOI 10.1016/S0168-583X(96)00611-8; McAninch JE, 1997, NUCL INSTRUM METH B, V123, P137, DOI 10.1016/S0168-583X(96)00411-9; NAKANISHI T, 1983, NATURE, V302, P132, DOI 10.1038/302132a0; ROESCH WC, 1987, US JAP JOINT REASS A; ROSE PF, 1991, ENDF B 6 SUMMARY DOC; Rugel G, 2000, NUCL INSTRUM METH B, V172, P934, DOI 10.1016/S0168-583X(00)00108-7; Ruhm W, 2000, HEALTH PHYS, V79, P358, DOI 10.1097/00004032-200010000-00003; RUHM W, 1992, Z PHYS A-HADRON NUCL, V341, P235, DOI 10.1007/BF01298486; Ruhm W, 1998, RADIAT ENVIRON BIOPH, V37, P293, DOI 10.1007/s004110050131; SHIBATA T, 1994, J PHYS SOC JPN, V63, P3546, DOI 10.1143/JPSJ.63.3546; SHIZUMA K, 1993, HEALTH PHYS, V65, P272, DOI 10.1097/00004032-199309000-00004; Shizuma K, 1998, HEALTH PHYS, V75, P278, DOI 10.1097/00004032-199809000-00006; STRANDBERG TE, 1992, CIRCULATION, V86, P63; Straume T, 1996, RADIAT PROT DOSIM, V67, P5, DOI 10.1093/oxfordjournals.rpd.a031797; STRAUME T, 1994, RADIAT RES, V138, P193, DOI 10.2307/3578589; STRAUME T, 1990, NUCL INSTRUM METH B, V52, P552, DOI 10.1016/0168-583X(90)90475-A; YAMASAKI F, 1953, COLLECTION INVESTIGA, P18	30	49	50	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					539	542		10.1038/nature01815	http://dx.doi.org/10.1038/nature01815			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891354				2022-12-01	WOS:000184454700039
J	Grill, SW; Howard, J; Schaffer, E; Stelzer, EHK; Hyman, A				Grill, SW; Howard, J; Schaffer, E; Stelzer, EHK; Hyman, A			The distribution of active force generators controls mitotic spindle position	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS EMBRYOS; C-ELEGANS; CELL-DIVISION; POLARITY; MECHANISMS; DROSOPHILA; GEOMETRY; MITOSIS; PROTEIN; COMPLEX	During unequal cell divisions a mitotic spindle is eccentrically positioned before cell cleavage. To determine the basis of the net force imbalance that causes spindle displacement in one-cell Caenorhabditis elegans embryos, we fragmented centrosomes with an ultraviolet laser. Analysis of the mean and variance of fragment speeds suggests that the force imbalance is due to a larger number of force generators pulling on astral microtubules of the posterior aster relative to the anterior aster. Moreover, activation of heterotrimeric guanine nucleotide-binding protein (G protein) alpha subunits is required to generate these astral forces.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL)	Grill, SW (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	grill@mpi-cbg.de; howard@mpi-cbg.de	Howard, Jonathon/D-4229-2011; Hyman, Anthony A/B-3917-2017; Schäffer, Erik/A-4664-2010; Hyman, Tony/F-1923-2011; Grill, Stephan/D-9427-2012; Stelzer, Ernst H K/A-7648-2011; Howard, Jonathon/J-7492-2016	Howard, Jonathon/0000-0003-0086-1196; Hyman, Anthony A/0000-0003-3664-154X; Schäffer, Erik/0000-0001-7876-085X; Stelzer, Ernst H K/0000-0003-1545-0736; Howard, Jonathon/0000-0003-0086-1196				ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Gonczy P, 2002, TRENDS CELL BIOL, V12, P332, DOI 10.1016/S0962-8924(02)02306-1; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; KEMPHUES KJ, 1997, C ELEGANS, V0002, P00335; Lyczak R, 2002, DEV CELL, V3, P157, DOI 10.1016/S1534-5807(02)00226-5; Mitchison TJ, 2001, NAT CELL BIOL, V3, pE17, DOI 10.1038/35050656; Pellettieri J, 2002, SCIENCE, V298, P1946, DOI 10.1126/science.1072162; Sachs L, 1984, APPL STAT HDB TECHNI; SCHMIDT DMZ, UNPUB; Schuyler SC, 2001, J CELL SCI, V114, P247; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; SIGWORTH FJ, 1977, NATURE, V270, P265, DOI 10.1038/270265a0; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Tsou MFB, 2003, J CELL BIOL, V160, P845, DOI 10.1083/jcb.200209079	26	264	275	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2003	301	5632					518	521		10.1126/science.1086560	http://dx.doi.org/10.1126/science.1086560			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881570				2022-12-01	WOS:000184340500043
J	Caspi, A; Sugden, K; Moffitt, TE; Taylor, A; Craig, IW; Harrington, H; McClay, J; Mill, J; Martin, J; Braithwaite, A; Poulton, R				Caspi, A; Sugden, K; Moffitt, TE; Taylor, A; Craig, IW; Harrington, H; McClay, J; Mill, J; Martin, J; Braithwaite, A; Poulton, R			Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene	SCIENCE			English	Article							MAJOR DEPRESSION; EVENTS; HISTORY; PERSPECTIVES; LIABILITY; GENOMICS; ONSET	In a prospective-longitudinal study of a representative birth cohort, we tested why stressful experiences lead to depression in some people but not in others. A functional polymorphism in the promoter region of the serotonin transporter (5-HTT) gene was found to moderate the influence of stressful life events on depression. Individuals with one or two copies of the short allele of the 5-HTT promoter polymorphism exhibited more depressive symptoms, diagnosable depression, and suicidality in relation to stressful life events than individuals homozygous for the long allele. This epidemiological study thus provides evidence of a gene-by-environment interaction, in which an individual's response to environmental insults is moderated by his or her genetic makeup.	Kings Coll London, Inst Psychiat, PSychiat Res Ctr, MRC Social Genet & Dev Psychiat Res Ctr, London SE5 8AF, England; Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; Univ Otago, Dept Pathol, Dunedin, New Zealand; Univ Otago, Dunedin Sch Med, Dunedin, New Zealand	University of London; King's College London; University of Wisconsin System; University of Wisconsin Madison; University of Otago; University of Otago	Moffitt, TE (corresponding author), Kings Coll London, Inst Psychiat, PSychiat Res Ctr, MRC Social Genet & Dev Psychiat Res Ctr, PO80 De Crespigny Pk, London SE5 8AF, England.	t.moffitt@iop.kcl.ac.uk	Moffitt, Terrie E/D-5295-2011; Sugden, Karen/I-8531-2016; Mill, Jonathan/B-5678-2014; Sugden, Karen/O-6046-2019; caspi, avshalom/AAJ-5874-2020; caspi, avshalom/D-5294-2011; Mill, Jonathan S/B-3276-2010; anand, amit/A-7222-2009; Zhang, Xiao/V-9027-2017; Craig, Ian/AAF-9167-2019; McClay, Joseph/C-9931-2009	Moffitt, Terrie E/0000-0002-8589-6760; Sugden, Karen/0000-0002-4076-5927; Mill, Jonathan/0000-0003-1115-3224; Sugden, Karen/0000-0002-4076-5927; caspi, avshalom/0000-0003-0082-4600; caspi, avshalom/0000-0003-0082-4600; Mill, Jonathan S/0000-0003-1115-3224; Zhang, Xiao/0000-0002-2932-5875; McClay, Joseph/0000-0002-3628-2447; Craig, Ian/0000-0002-4063-1005	Economic and Social Research Council [L330253002] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH049414, R01MH045070, R01MH049414] Funding Source: NIH RePORTER; NIMH NIH HHS [MH49414, MH45070] Funding Source: Medline	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aiken L., 1991, MULTIPLE REGRESSION; APA, 1994, DIAGN STAT MAN MENT; Belli RF, 2001, PUBLIC OPIN QUART, V65, P45, DOI 10.1086/320037; Bennett AJ, 2002, MOL PSYCHIATR, V7, P118, DOI 10.1038/sj/mp/4000949; Brown GW, 1998, SOC PSYCH PSYCH EPID, V33, P363, DOI 10.1007/s001270050067; Caspi A, 1996, INT J METHOD PSYCH, V6, P101, DOI 10.1002/(SICI)1234-988X(199607)6:2<101::AID-MPR156>3.3.CO;2-E; Caspi A, 2002, SCIENCE, V297, P851, DOI 10.1126/science.1072290; Costello EJ, 2002, BIOL PSYCHIAT, V52, P529, DOI 10.1016/S0006-3223(02)01372-0; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Hamer D, 2002, SCIENCE, V298, P71, DOI 10.1126/science.1077582; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hill AVS, 1999, BRIT MED BULL, V55, P401, DOI 10.1258/0007142991902457; Kendler KS, 1997, PSYCHOL MED, V27, P539, DOI 10.1017/S0033291797004716; KENDLER KS, 1995, AM J PSYCHIAT, V152, P833; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Lesch K, 2002, MOL GENETICS HUMAN P, P109; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 2003, BEHAVIORAL GENETICS IN THE POSTGENOMIC ERA, P389, DOI 10.1037/10480-020; MONROE SM, 1991, PSYCHOL BULL, V110, P406, DOI 10.1037/0033-2909.110.3.406; Murphy DL, 2001, BRAIN RES BULL, V56, P487, DOI 10.1016/S0361-9230(01)00622-0; Pine DS, 2002, J AFFECT DISORDERS, V68, P49, DOI 10.1016/S0165-0327(00)00331-1; PLOMIN R, 1991, BEHAV BRAIN SCI, V14, P373, DOI 10.1017/S0140525X00070278; Robins LN, 1995, DIAGNOSTIC INTERVIEW; Salichon N, 2001, J NEUROSCI, V21, P884, DOI 10.1523/JNEUROSCI.21-03-00884.2001; Tamminga CA, 2002, BIOL PSYCHIAT, V52, P589, DOI 10.1016/S0006-3223(02)01470-1; TANG CJ, 1997, LANCET, V349, P1498	29	5375	5535	29	1459	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2003	301	5631					386	389		10.1126/science.1083968	http://dx.doi.org/10.1126/science.1083968			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	702CG	12869766				2022-12-01	WOS:000184207300050
J	Bryant, Z; Stone, MD; Gore, J; Smith, SB; Cozzarelli, NR; Bustamante, C				Bryant, Z; Stone, MD; Gore, J; Smith, SB; Cozzarelli, NR; Bustamante, C			Structural transitions and elasticity from torque measurements on DNA	NATURE			English	Article								Knowledge of the elastic properties of DNA is required to understand the structural dynamics of cellular processes such as replication and transcription. Measurements of force and extension on single molecules of DNA(1-3) have allowed direct determination of the molecule's mechanical properties, provided rigorous tests of theories of polymer elasticity(4), revealed unforeseen structural transitions induced by mechanical stresses(3,5-7), and established an experimental and conceptual framework for mechanical assays of enzymes that act on DNA(8). However, a complete description of DNA mechanics must also consider the effects of torque, a quantity that has hitherto not been directly measured in micromanipulation experiments. We have measured torque as a function of twist for stretched DNA-torsional strain in over- or underwound molecules was used to power the rotation of submicrometre beads serving as calibrated loads. Here we report tests of the linearity of DNA's twist elasticity, direct measurements of the torsional modulus (finding a value similar to40% higher than generally accepted), characterization of torque-induced structural transitions, and the establishment of a framework for future assays of torque and twist generation by DNA-dependent enzymes. We also show that cooperative structural transitions in DNA can be exploited to construct constant-torque wind-up motors and force-torque converters.	Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.			Bustamante, Carlos/0000-0002-2970-0073				Allemand JF, 1998, P NATL ACAD SCI USA, V95, P14152, DOI 10.1073/pnas.95.24.14152; Bouchiat C, 1998, PHYS REV LETT, V80, P1556, DOI 10.1103/PhysRevLett.80.1556; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cluzel P, 1996, SCIENCE, V271, P792, DOI 10.1126/science.271.5250.792; CROTHERS DM, 1992, METHOD ENZYMOL, V212, P3; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; DAVIS MH, 1969, CHEM ENG SCI, V24, P1769, DOI 10.1016/0009-2509(69)87020-X; Harada Y, 2001, NATURE, V409, P113, DOI 10.1038/35051126; Heath PJ, 1996, J MOL BIOL, V260, P718, DOI 10.1006/jmbi.1996.0432; HOROWITZ DS, 1984, J MOL BIOL, V173, P75, DOI 10.1016/0022-2836(84)90404-2; Leger JF, 1999, PHYS REV LETT, V83, P1066, DOI 10.1103/PhysRevLett.83.1066; MILLAR DP, 1980, P NATL ACAD SCI USA, V77, P5593, DOI 10.1073/pnas.77.10.5593; Moroz JD, 1998, MACROMOLECULES, V31, P6333, DOI 10.1021/ma971804a; Sarkar A, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.051903; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; SELVIN PR, 1992, SCIENCE, V255, P82, DOI 10.1126/science.1553534; SHORE D, 1983, J MOL BIOL, V170, P983, DOI 10.1016/S0022-2836(83)80199-5; Smith SB, 2003, METHOD ENZYMOL, V361, P134; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Soong RK, 2000, SCIENCE, V290, P1555, DOI 10.1126/science.290.5496.1555; Strick TR, 1999, GENETICA, V106, P57, DOI 10.1023/A:1003772626927; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Vologodskii AV, 1997, BIOPHYS J, V73, P123, DOI 10.1016/S0006-3495(97)78053-6; Williams MC, 2002, ACCOUNTS CHEM RES, V35, P159, DOI 10.1021/ar010045k; WOBBE CR, 1985, P NATL ACAD SCI USA, V82, P5710, DOI 10.1073/pnas.82.17.5710; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yasuda R, 1996, J MOL BIOL, V263, P227, DOI 10.1006/jmbi.1996.0571	29	437	458	1	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					338	341		10.1038/nature01810	http://dx.doi.org/10.1038/nature01810			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867987				2022-12-01	WOS:000184183900048
J	Alon, U				Alon, U			Biological networks: The tinkerer as an engineer	SCIENCE			English	Editorial Material							TRANSCRIPTIONAL REGULATION; GENE-REGULATION; ROBUSTNESS; MOTIFS; ORGANIZATION; EVOLUTION	This viewpoint comments on recent advances in understanding the design principles of biological networks. It highlights the surprising discovery of "good-engineering" principles in biochemical circuitry that evolved by random tinkering.	Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	urialon@weizmann.ac.il						Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Arkin A, 1997, SCIENCE, V277, P1275, DOI 10.1126/science.277.5330.1275; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BRAY D, 1990, J THEOR BIOL, V143, P215, DOI 10.1016/S0022-5193(05)80268-1; Conant GC, 2003, NAT GENET, V34, P264, DOI 10.1038/ng1181; Csete ME, 2002, SCIENCE, V295, P1664, DOI 10.1126/science.1069981; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Fell D., 1997, UNDERSTANDING CONTRO; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gerhart J, 1997, CELLS EMBRYOS EVOLUT; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; KACSER H, 1973, S SOC EXP BIOL, V32, P65; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lipson H, 2002, EVOLUTION, V56, P1549, DOI 10.1111/j.0014-3820.2002.tb01466.x; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MYERS CR, 2003, CONDMAT0305575; Rao CV, 2001, ANNU REV BIOMED ENG, V3, P391, DOI 10.1146/annurev.bioeng.3.1.391; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Savageau M, 1976, BIOCH SYSTEMS ANAL S; SAVAGEAU MA, 1971, NATURE, V229, P542, DOI 10.1038/229542a0; Setty Y, 2003, P NATL ACAD SCI USA, V100, P7702, DOI 10.1073/pnas.1230759100; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; WAGNER A, 2003, SCI STKE, pPE41; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896	34	410	429	5	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2003	301	5641					1866	1867		10.1126/science.1089072	http://dx.doi.org/10.1126/science.1089072			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725GW	14512615				2022-12-01	WOS:000185536700037
J	Pealer, LN; Marfin, AA; Petersen, LR; Lanciotti, RS; Page, PL; Stramer, SL; Stobierski, MG; Signs, K; Newman, B; Kapoor, H; Goodman, JL; Chamberland, ME				Pealer, LN; Marfin, AA; Petersen, LR; Lanciotti, RS; Page, PL; Stramer, SL; Stobierski, MG; Signs, K; Newman, B; Kapoor, H; Goodman, JL; Chamberland, ME		W Nile Virus Transmission Investig	Transmission of West Nile virus through blood transfusion in the United States in 2002	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEW-YORK-CITY; ENCEPHALITIS; EPIDEMIC; INFECTION; RISK	BACKGROUND: During the 2002 West Nile virus epidemic in the United States, patients were identified whose West Nile virus illness was temporally associated with the receipt of transfused blood and blood components. METHODS: Patients with laboratory evidence of recent West Nile virus infection within four weeks after receipt of a blood component from a donor with viremia were considered to have a confirmed transfusion-related infection. We interviewed the donors of these components, asking them whether they had had symptoms compatible with the presence of a viral illness before or after their donation; blood specimens retained from the time of donation and collected at follow-up were tested for West Nile virus. RESULTS: Twenty-three patients were confirmed to have acquired West Nile virus through transfused leukoreduced and nonleukoreduced red cells, platelets, or fresh-frozen plasma. Of the 23 recipients, 10 (43 percent) were immunocompromised owing to transplantation or cancer and 8 (35 percent) were at least 70 years of age. Immunocompromised recipients tended to have longer incubation periods than nonimmunocompromised recipients and infected persons in mosquito-borne community outbreaks. Sixteen donors with evidence of viremia at donation were linked to the 23 infected recipients; of these donors, 9 reported viral symptoms before or after donation, 5 were asymptomatic, and 2 were lost to follow-up. Fever, new rash, and painful eyes were independently associated with being an implicated donor with viremia rather than a donor without viremia. All 16 donors were negative for West Nile virus-specific IgM antibody at donation. CONCLUSIONS: Transfused red cells, platelets, and fresh-frozen plasma can transmit West Nile virus. Screening of potential donors with the use of nucleic acid-based assays for West Nile virus may reduce this risk.	Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDC, Div Vector Borne Infect Dis, Natl Ctr Infect Dis, Ft Collins, CO USA; Amer Red Cross, Blood Serv, Biomed Headquarters, Washington, DC 20006 USA; Amer Red Cross, Blood Serv, Sci Support Off, Gaithersburg, MD USA; Michigan Dept Community Hlth, Bur Labs, Lansing, MI USA; Amer Red Cross, Blood Serv, Detroit, MI USA; US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; American Red Cross; American Red Cross; MDHHS - Michigan Department of Health & Human Services; American Red Cross; US Food & Drug Administration (FDA)	Pealer, LN (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Appl Publ Hlth Training, Epidemiol Program Off, 1600 Clifton Rd,D-18, Atlanta, GA 30333 USA.			Basile, Alison Jane/0000-0002-5646-1557				[Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P833; [Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P790; Biggerstaff BJ, 2002, TRANSFUSION, V42, P1019, DOI 10.1046/j.1537-2995.2002.00167.x; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; *CDCP, 2003, EP EP W NIL VIR US R; Chamberland ME, 2002, CLIN INFECT DIS, V34, P797, DOI 10.1086/338787; *FOOD DRUG ADM, 2003, GUID IND REV REC ASS; Harrington T, 2003, TRANSFUSION, V43, P1018, DOI 10.1046/j.1537-2995.2003.00481.x; Huang CN, 2002, EMERG INFECT DIS, V8, P1367, DOI 10.3201/eid0812.020532; Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Petersen LR, 2002, ANN INTERN MED, V137, P173, DOI 10.7326/0003-4819-137-3-200208060-00009; Roehrig JT, 2002, CURR TOP MICROBIOL, V267, P223; SOUTHAM CM, 1954, AM J TROP MED HYG, V3, P19, DOI 10.4269/ajtmh.1954.3.19; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; 2003, MMWR MORB MORTAL WKL, V52, P769; 2001, MMWR MORB MORTAL WKL, V50, P37; 2002, MMWR MORB MORTAL WKL, V51, P1129; 2000, MMWR MORB MORTAL WKL, V50, P101; 2002, MMWR MORB MORTAL WKL, V51, P929	23	433	463	0	19	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2003	349	13					1236	1245		10.1056/NEJMoa030969	http://dx.doi.org/10.1056/NEJMoa030969			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724LJ	14500806				2022-12-01	WOS:000185488800006
J	Gaucher, EA; Thomson, JM; Burgan, MF; Benner, SA				Gaucher, EA; Thomson, JM; Burgan, MF; Benner, SA			Inferring the palaeoenvironment of ancient bacteria on the basis of resurrected proteins	NATURE			English	Article							ELONGATION-FACTOR TU; COMMON ANCESTOR; EVOLUTION; THERMOSTABILITY; RIBONUCLEASE; DIVERSITY; SEQUENCES; LIFE	Features of the physical environment surrounding an ancestral organism can be inferred by reconstructing sequences(1-9) of ancient proteins made by those organisms, resurrecting these proteins in the laboratory, and measuring their properties. Here, we resurrect candidate sequences for elongation factors of the Tu family (EF-Tu) found at ancient nodes in the bacterial evolutionary tree, and measure their activities as a function of temperature. The ancient EF-Tu proteins have temperature optima of 55-65degreesC. This value seems to be robust with respect to uncertainties in the ancestral reconstruction. This suggests that the ancient bacteria that hosted these particular genes were thermophiles, and neither hyperthermophiles nor mesophiles. This conclusion can be compared and contrasted with inferences drawn from an analysis of the lengths of branches in trees joining proteins from contemporary bacteria(10), the distribution of thermophily in derived bacterial lineages(11), the inferred G+C content of ancient ribosomal RNA(12), and the geological record combined with assumptions concerning molecular clocks(13). The study illustrates the use of experimental palaeobiochemistry and assumptions about deep phylogenetic relationships between bacteria to explore the character of ancient life.	Univ Florida, NASA, Astrobiol Inst, Gainesville, FL 32611 USA; Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32611 USA; Univ Florida, Dept Chem, Gainesville, FL 32611 USA	National Aeronautics & Space Administration (NASA); State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Gaucher, EA (corresponding author), Univ Florida, NASA, Astrobiol Inst, Gainesville, FL 32611 USA.		Gaucher, Eric/I-7313-2013	Green, Michelle/0000-0002-6055-4342				Adachi J., 1996, COMPUT SCI MONOGR, V28, P1; ADEY NB, 1994, P NATL ACAD SCI USA, V91, P1569, DOI 10.1073/pnas.91.4.1569; ARAI KI, 1972, J BIOL CHEM, V247, P7029; Benner SA, 2002, SCIENCE, V296, P864, DOI 10.1126/science.1069863; Brochier C, 2002, NATURE, V417, P244, DOI 10.1038/417244a; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P7, DOI 10.1099/00207713-52-1-7; Chandrasekharan UM, 1996, SCIENCE, V271, P502, DOI 10.1126/science.271.5248.502; Chang BSW, 2002, MOL BIOL EVOL, V19, P1483, DOI 10.1093/oxfordjournals.molbev.a004211; Dayhoff M., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Galtier N, 1999, SCIENCE, V283, P220, DOI 10.1126/science.283.5399.220; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Gaucher EA, 2001, P NATL ACAD SCI USA, V98, P548, DOI 10.1073/pnas.98.2.548; Golding GB, 1998, MOL BIOL EVOL, V15, P355, DOI 10.1093/oxfordjournals.molbev.a025932; Gromiha MM, 1999, BIOPHYS CHEM, V82, P51, DOI 10.1016/S0301-4622(99)00103-9; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; JERMANN TM, 1995, NATURE, V374, P57, DOI 10.1038/374057a0; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; MALCOLM BA, 1990, NATURE, V345, P86, DOI 10.1038/345086a0; Miyazaki J, 2001, J BIOCHEM-TOKYO, V129, P777, DOI 10.1093/oxfordjournals.jbchem.a002919; NOCK S, 1995, EUR J BIOCHEM, V234, P132, DOI 10.1111/j.1432-1033.1995.00132.x; PAULING L, 1963, ACTA CHEM SCAND, V17, pS9; Sanangelantoni AM, 1996, MICROBIOL-UK, V142, P2525, DOI 10.1099/00221287-142-9-2525; STACKHOUSE J, 1990, FEBS LETT, V262, P104, DOI 10.1016/0014-5793(90)80164-E; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; YANG Z, 1999, COMPUT APPL BIOSCI, V13, P555; YANG ZH, 1995, GENETICS, V141, P1641; Zhang JZ, 2002, P NATL ACAD SCI USA, V99, P5486, DOI 10.1073/pnas.072626199	30	179	187	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 18	2003	425	6955					285	288		10.1038/nature01977	http://dx.doi.org/10.1038/nature01977			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722JA	13679914				2022-12-01	WOS:000185370900042
J	McMahon, BJ; Hennessy, TW; Bensler, JM; Bruden, DL; Parkinson, AJ; Morris, JM; Reasonover, AL; Hurlburt, DA; Bruce, MG; Sacco, F; Butler, JC				McMahon, BJ; Hennessy, TW; Bensler, JM; Bruden, DL; Parkinson, AJ; Morris, JM; Reasonover, AL; Hurlburt, DA; Bruce, MG; Sacco, F; Butler, JC			The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections	ANNALS OF INTERNAL MEDICINE			English	Article							ANTIBIOTIC-RESISTANCE; METRONIDAZOLE RESISTANCE; TRIPLE THERAPIES; HIGH PREVALENCE; UNITED-STATES; RISK-FACTORS; CLARITHROMYCIN; ERADICATION; SUSCEPTIBILITY; POPULATION	Background: The relationship between previous antimicrobial treatments and infection with drug-resistant Helicobacter pylori is unknown. Objectives: To determine whether previous use of antimicrobial agents predicts subsequent antibiotic resistance of H. pylori and whether resistance affects treatment outcome. Design: Retrospective cohort analysis of adults recruited sequentially from a clinical practice. Setting: A referral hospital in Anchorage, Alaska. Patients: 125 adults infected with H. pylori. Measurements: Medical records were reviewed for antimicrobial agents prescribed in the 10 years before diagnosis with H. pylori infection. Antimicrobial susceptibility of H. pylori isolates obtained from endoscopic gastric biopsy was determined by using agar dilution, Cure was determined by using the urea breath test 2 months after antimicrobial treatment. Results: Among the 125 patients, 37 (30%) were found to have H. pylori isolates resistant to clarithromycin and 83 (66%) were found to have H. pylori isolates resistant to metronidazole. Resistance to clarithromycin was associated with previous use of any macrolide antibiotic (P < 0.001), and resistance to metronidazole was associated with previous use of metronidazole (P < 0.001). The odds of isolates being resistant to clarithromycin increased in relation to the number of courses of macrolides received (P < 0.001). Among 53 persons treated with clarithromycin-based regimens, treatment failed in 77% of those carrying clarithromycin-resistant H. pylori (10 of 13) and 13% of those with clarithromycin-susceptible strains (5 of 40) (relative risk, 6.2 [95% Cl, 1.9 to 37.1]; P < 0.001). Conclusions: Previous use of macrolides and metronidazole is associated with H. pylori resistant to these antimicrobial agents. Clarithromycin resistance is associated with a greater risk for failure with clarithromycin-based treatments.	CDCP, Arctic Invest Program, Natl Ctr Infect Dis, Anchorage, AK 99508 USA; Alaska Native Med Ctr, Anchorage, AK USA	Alaska Native Medical Center	McMahon, BJ (corresponding author), CDCP, Arctic Invest Program, Natl Ctr Infect Dis, 4055 Tudor Ctr Dr, Anchorage, AK 99508 USA.	bdm9@cdc.gov						Alarcon T, 1999, INT J ANTIMICROB AG, V12, P19, DOI 10.1016/S0924-8579(99)00051-5; BANATVALA N, 1994, GUT, V35, P1562, DOI 10.1136/gut.35.11.1562; Bardhan PK, 1997, CLIN INFECT DIS, V25, P973, DOI 10.1086/516067; Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; BAYERDORFFER E, 1995, LANCET, V345, P1591, DOI 10.1016/S0140-6736(95)90113-2; Blaser MJ, 1997, J CLIN INVEST, V100, P759, DOI 10.1172/JCI119588; Blecker U, 1997, PEDIATR INFECT DIS J, V16, P391, DOI 10.1097/00006454-199704000-00011; Blum AL, 1998, NEW ENGL J MED, V339, P1875, DOI 10.1056/NEJM199812243392602; CASELLA G, 1986, CAN J STAT, V14, P113, DOI 10.2307/3314658; Centers for Disease Control and Prevention (CDC), 2016, DEV WAT MAN PROGR RE; Dore MP, 2000, DIGEST DIS SCI, V45, P68, DOI 10.1023/A:1005457226341; Dowell SF, 1998, PEDIATRICS, V101, P163; Falk GW, 1997, CLEV CLIN J MED, V64, P187, DOI 10.3949/ccjm.64.4.187; Fraser AG, 1999, AUST NZ J MED, V29, P512, DOI 10.1111/j.1445-5994.1999.tb00752.x; Gonzales R, 2001, ANN INTERN MED, V134, P479, DOI 10.7326/0003-4819-134-6-200103200-00013; GRAHAM DY, 1991, GASTROENTEROLOGY, V100, P1495, DOI 10.1016/0016-5085(91)90644-Z; Greenberg PD, 1999, ARCH INTERN MED, V159, P2283, DOI 10.1001/archinte.159.19.2283; Hoshiya S, 2000, J GASTROENTEROL, V35, P10; Katelaris PH, 2002, GASTROENTEROLOGY, V123, P1763, DOI 10.1053/gast.2002.37051; Laine L, 2001, ANN INTERN MED, V134, P361, DOI 10.7326/0003-4819-134-5-200103060-00008; Lautenbach E, 2001, CLIN INFECT DIS, V32, P1162, DOI 10.1086/319757; Leach AJ, 1997, CLIN INFECT DIS, V24, P356, DOI 10.1093/clinids/24.3.356; Mandell Lionel A., 2000, Clinical Infectious Diseases, V31, P383, DOI 10.1086/313959; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; McColl K, 1998, NEW ENGL J MED, V339, P1869, DOI 10.1056/NEJM199812243392601; Megraud F, 1999, ANTIMICROB AGENTS CH, V43, P2747, DOI 10.1128/AAC.43.11.2747; Meyer JM, 2002, ANN INTERN MED, V136, P13, DOI 10.7326/0003-4819-136-1-200201010-00008; Miehlke S, 2001, Semin Gastrointest Dis, V12, P167; Miyaji H, 1997, ALIMENT PHARM THERAP, V11, P1131, DOI 10.1046/j.1365-2036.1997.00258.x; Moayyedi P, 2000, LANCET, V355, P1665, DOI 10.1016/S0140-6736(00)02236-4; Moayyedi P, 1998, J GASTROENTEROL, V33, P62; MORRIS JG, 1995, ANN INTERN MED, V123, P250, DOI 10.7326/0003-4819-123-4-199508150-00002; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; Osato MS, 1999, INT J ANTIMICROB AG, V12, P341, DOI 10.1016/S0924-8579(99)00079-5; Osato MS, 2001, ARCH INTERN MED, V161, P1217, DOI 10.1001/archinte.161.9.1217; Parkinson AJ, 2000, CLIN DIAGN LAB IMMUN, V7, P885, DOI 10.1128/CDLI.7.6.885-888.2000; PETERSON WL, 1993, AM J GASTROENTEROL, V88, P1860; Pilotto A, 1999, ALIMENT PHARM THER, V13, P667; Pilotto A, 2000, DIGEST LIVER DIS, V32, P763, DOI 10.1016/S1590-8658(00)80352-7; RAUWS EAJ, 1990, LANCET, V335, P1233, DOI 10.1016/0140-6736(90)91301-P; RICHARD P, 1994, J INFECT DIS, V170, P377, DOI 10.1093/infdis/170.2.377; Rozynek E, 1997, EUR J CLIN MICROBIOL, V16, P943, DOI 10.1007/BF01700566; Taylor DE, 1998, CAN J GASTROENTEROL, V12, P295, DOI 10.1155/1998/672746; TYTGAT GNJ, 1990, GASTROENTEROL CLIN N, V19, P183; van der Hulst RWM, 1998, GUT, V42, P166, DOI 10.1136/gut.42.2.166; Wolle K, 1998, EUR J CLIN MICROBIOL, V17, P519, DOI 10.1007/BF01691138; Xia HHX, 1997, AM J GASTROENTEROL, V92, P1780; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65; 2000, PERFORMANCE STANDARD, V20, P1	49	143	151	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2003	139	6					463	469		10.7326/0003-4819-139-6-200309160-00008	http://dx.doi.org/10.7326/0003-4819-139-6-200309160-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721PE	13679322				2022-12-01	WOS:000185324100001
J	Schoofs, MWCJ; van der Klift, M; Hofman, A; de Laet, CEDH; Herings, RMC; Stijnen, T; Pols, HAP; Stricker, BHC				Schoofs, MWCJ; van der Klift, M; Hofman, A; de Laet, CEDH; Herings, RMC; Stijnen, T; Pols, HAP; Stricker, BHC			Thiazide diuretics and the risk for hip fracture	ANNALS OF INTERNAL MEDICINE			English	Article							BONE-MINERAL DENSITY; NORMAL POSTMENOPAUSAL WOMEN; OSTEOPOROTIC FRACTURES; CONTROLLED-TRIAL; LONG-TERM; ROTTERDAM; MEN; HYDROCHLOROTHIAZIDE; QUESTIONNAIRE; EPIDEMIOLOGY	Background: Since most hip fractures are related to osteoporosis, treating accelerated bone loss can be an important strategy to prevent hip fractures. Thiazides have been associated with reduced age-related bone loss by decreasing urinary calcium excretion. Objective: To examine the association between dose and duration of thiazide diuretic use and the risk for hip fracture and to study the consequences of discontinuing use. Design: Prospective population-based cohort study. Setting: The Rotterdam Study. Participants: 7891 individuals 55 years of age and older. Measurements: Hip fractures were reported by the general practitioners and verified by trained research assistants. Details of all dispensed drugs were available on a day-to-day basis. Exposure to thiazides was divided into 7 mutually exclusive categories: never use, current use for 1 to 42 days, current use for 43 to 365 days, current use for more than 365 days, discontinuation of use since 1 to 60 days, discontinuation of use since 61 to 120 days, and discontinuation of use since more than 120 days. Results: 281 hip fractures occurred. Relative to nonuse, current use of thiazides for more than 365 days was statistically significantly associated with a lower risk for hip fracture (hazard ratio, 0.46 [95% Cl, 0.21 to 0.96]). There was no clear dose dependency. This lower risk disappeared approximately 4 months after thiazide use was discontinued. Conclusions: Thiazide diuretics protect against hip fracture, but this protective effect disappears within 4 months after use is discontinued.	Erasmus Univ, Ctr Med, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam	Stricker, BHC (corresponding author), Erasmus Univ, Ctr Med, Dept Epidemiol & Biostat, POB 1738, NL-3000 DR Rotterdam, Netherlands.		Herings, Ron/AAE-4096-2021	Herings, Ron/0000-0002-2561-8734; De Laet, Chris/0000-0002-1951-2079				Adams JS, 1999, ANN INTERN MED, V130, P658, DOI 10.7326/0003-4819-130-8-199904200-00012; ADLANDDAVENPORT P, 1985, AM J OBSTET GYNECOL, V152, P630, DOI 10.1016/S0002-9378(85)80035-1; [Anonymous], 1992, INT STAT CLASS DIS R, V1-3; Arnett TR, 1996, BONE, V18, P277, DOI 10.1016/8756-3282(95)00486-6; Aubin R, 1996, KIDNEY INT, V50, P1476, DOI 10.1038/ki.1996.461; BURGER H, 1994, BONE MINER, V25, P1, DOI 10.1016/S0169-6009(08)80203-6; Burger H, 1998, AM J EPIDEMIOL, V147, P871, DOI 10.1093/oxfordjournals.aje.a009541; CAULEY JA, 1993, ANN INTERN MED, V118, P666, DOI 10.7326/0003-4819-118-9-199305010-00002; COX DR, 1972, J R STAT SOC B, V34, P187; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; DUARTE CG, 1971, NEW ENGL J MED, V284, P828, DOI 10.1056/NEJM197104152841506; FELSON DT, 1991, JAMA-J AM MED ASSOC, V265, P370, DOI 10.1001/jama.265.3.370; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; HALE WE, 1984, NEW ENGL J MED, V310, P926; HEIDRICH FE, 1991, ANN INTERN MED, V115, P1, DOI 10.7326/0003-4819-115-1-1; Herings RMC, 1996, J CLIN EPIDEMIOL, V49, P115, DOI 10.1016/0895-4356(95)00552-8; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; LaCroix AZ, 2000, ANN INTERN MED, V133, P516, DOI 10.7326/0003-4819-133-7-200010030-00010; LACROIX AZ, 1990, NEW ENGL J MED, V322, P286, DOI 10.1056/NEJM199002013220502; Lajeunesse D, 2000, J BONE MINER RES, V15, P894, DOI 10.1359/jbmr.2000.15.5.894; Meijer WT, 1998, ARTERIOSCL THROM VAS, V18, P185, DOI 10.1161/01.ATV.18.2.185; MELTON LJ, 1993, BONE, V14, pS1; MORTON DJ, 1994, AM J EPIDEMIOL, V139, P1107, DOI 10.1093/oxfordjournals.aje.a116954; Moser M, 1998, JAMA-J AM MED ASSOC, V279, P1813, DOI 10.1001/jama.279.22.1813; Onder G, 2001, J HUM HYPERTENS, V15, P291, DOI 10.1038/sj.jhh.1001176; PEH CA, 1993, J AM GERIATR SOC, V41, P513, DOI 10.1111/j.1532-5415.1993.tb01887.x; PINCUS T, 1983, ARTHRITIS RHEUM-US, V26, P1346, DOI 10.1002/art.1780261107; RASHIQ S, 1986, BRIT MED J, V292, P861, DOI 10.1136/bmj.292.6524.861; RAY WA, 1989, LANCET, V1, P687; Reid IR, 2000, AM J MED, V109, P362, DOI 10.1016/S0002-9343(00)00510-6; Savage PJ, 1998, ARCH INTERN MED, V158, P741, DOI 10.1001/archinte.158.7.741; Sigurdsson G, 2001, J INTERN MED, V250, P51, DOI 10.1046/j.1365-2796.2001.00850.x; TRANSBOL I, 1982, METABOLISM, V31, P383, DOI 10.1016/0026-0495(82)90115-9; Twisk J, 2002, J CLIN EPIDEMIOL, V55, P329, DOI 10.1016/S0895-4356(01)00476-0; VANDERKUY A, 2000, FARMACOTHERAPEUTISCH, P523; WASNICH RD, 1986, OBSTET GYNECOL, V67, P457; WASNICH RD, 1983, NEW ENGL J MED, V309, P344, DOI 10.1056/NEJM198308113090605; *WHO COLL CTR DRUG, 1993, AN THER CHEM IND; *WHO COLL CTR DRUG, 1992, AN THER CHEM IND INC; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086	42	146	155	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2003	139	6					476	482		10.7326/0003-4819-139-6-200309160-00010	http://dx.doi.org/10.7326/0003-4819-139-6-200309160-00010			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721PE	13679324	Green Published			2022-12-01	WOS:000185324100003
J	Sjolund, M; Wreiber, K; Andersson, DI; Blaser, MJ; Engstrand, L				Sjolund, M; Wreiber, K; Andersson, DI; Blaser, MJ; Engstrand, L			Long-term persistence of resistant enterococcus species after antibiotics to eradicate Helicobacter pylori	ANNALS OF INTERNAL MEDICINE			English	Article							GROUP-A STREPTOCOCCI; BIOLOGICAL COST; MACROLIDE RESISTANCE; DETERMINANTS; PCR	Background: Antibiotic treatment selects for resistance not only in the pathogen to which it is directed but also in the indigenous microflora. Objective: To determine whether a widely used regimen (clarithromycin, metronidazole, and omeprazole) for Helicobacter pylori eradication affects resistance development in enterococci. Design: Cohort study. Setting: Endoscopy units at 3 community hospitals in Sweden. Patients: 5 consecutive dyspeptic patients who were colonized with H. pylori, had endoscopy-confirmed duodenal ulcer, and received antibiotic treatment, and 5 consecutive controls with dyspepsia but no ulcer who did not receive treatment. Measurements: Fecal samples were obtained from patients and controls before, immediately after, 1 year after, and 3 years after treatment. From each patient and sample, enterococci were isolated and analyzed for DNA fingerprint, clarithromycin susceptibility, and presence of the erm(B) gene. Results: in treated patients, all enterococci isolated immediately after treatment showed high-level clarithromycin resistance due to erm(B). In 3 patients, resistant enterococci persisted for 1 to 3 years after treatment. No resistance developed among controls. Conclusion: A common H. pylori treatment selects for highly resistant enterococci that can persist for at least 3 years without further selection.	Swedish Inst Infect Dis Control, Dept Bacteriol, SE-17182 Solna, Sweden	Swedish Institute for Infectious Disease Control	Engstrand, L (corresponding author), Swedish Inst Infect Dis Control, Dept Bacteriol, SE-17182 Solna, Sweden.	lars.engstrand@smi.ki.se		Andersson, Dan/0000-0001-6640-2174	NIGMS NIH HHS [R01GM63270] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063270] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; Bjorkholm B, 2001, P NATL ACAD SCI USA, V98, P14607, DOI 10.1073/pnas.241517298; Bjorkman J, 1998, P NATL ACAD SCI USA, V95, P3949, DOI 10.1073/pnas.95.7.3949; Cresti S, 2002, ANTIMICROB AGENTS CH, V46, P1816, DOI 10.1128/AAC.46.6.1816-1822.2002; Descheemaeker P, 1997, INT J SYST BACTERIOL, V47, P555, DOI 10.1099/00207713-47-2-555; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; KUIPERS EJ, 1995, ALIMENT PHARM THERAP, V9, P59; Levy SB, 2002, J ANTIMICROB CHEMOTH, V49, P25, DOI 10.1093/jac/49.1.25; Maiden MCJ, 1998, CLIN INFECT DIS, V27, pS12, DOI 10.1086/514917; Martinez JL, 2000, ANTIMICROB AGENTS CH, V44, P1771, DOI 10.1128/AAC.44.7.1771-1777.2000; Megraud F, 2000, GASTROENTEROL CLIN N, V29, P759, DOI 10.1016/S0889-8553(05)70145-X; Murray BE, 1999, P ASSOC AM PHYSICIAN, V111, P328, DOI 10.1046/j.1525-1381.1999.99241.x; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; Nagaev I, 2001, MOL MICROBIOL, V40, P433, DOI 10.1046/j.1365-2958.2001.02389.x; Portillo A, 2000, ANTIMICROB AGENTS CH, V44, P967, DOI 10.1128/AAC.44.4.967-971.2000; Sander P, 2002, ANTIMICROB AGENTS CH, V46, P1204, DOI 10.1128/AAC.46.5.1204-1211.2002; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Shoemaker NB, 2001, APPL ENVIRON MICROB, V67, P561, DOI 10.1128/AEM.67.2.561-568.2001; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P2562, DOI 10.1128/AAC.40.11.2562	20	109	124	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2003	139	6					483	487		10.7326/0003-4819-139-6-200309160-00011	http://dx.doi.org/10.7326/0003-4819-139-6-200309160-00011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721PE	13679325				2022-12-01	WOS:000185324100004
J	Coupland, C; Hippisley-Cox, J; Kendrick, D; Groom, L; Cross, E; Savelyich, B				Coupland, C; Hippisley-Cox, J; Kendrick, D; Groom, L; Cross, E; Savelyich, B			Severe traffic injuries to children, Trent, 1992-7: time trend analysis	BRITISH MEDICAL JOURNAL			English	Article									Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England	University of Nottingham	Coupland, C (corresponding author), Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England.		Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Coupland, Carol/0000-0002-2327-3306; Kendrick, Denise/0000-0003-3603-6542				Cryer PC, 2000, PUBLIC HEALTH, V114, P232; Hippisley-Cox J, 2002, BRIT MED J, V324, P1132, DOI 10.1136/bmj.324.7346.1132; *OFF NAT STAT, 2001, MORT STAT INJ POIS; THOMPSON DC, 1999, COCHRANE LIB; Towner E, 2001, Inj Prev, V7, P161, DOI 10.1136/ip.7.2.161	5	9	10	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 13	2003	327	7415					593	594		10.1136/bmj.327.7415.593	http://dx.doi.org/10.1136/bmj.327.7415.593			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722CW	12969925	Green Published, Bronze			2022-12-01	WOS:000185358700021
J	Clack, JA; Ahlberg, PE; Finney, SM; Alonso, PD; Robinson, J; Ketcham, RA				Clack, JA; Ahlberg, PE; Finney, SM; Alonso, PD; Robinson, J; Ketcham, RA			A uniquely specialized ear in a very early tetrapod	NATURE			English	Article							PHOLIDERPETON-SCUTIGERUM HUXLEY; EARLY EVOLUTION; COAL MEASURES; ACANTHOSTEGA; AMPHIBIANS; STAPES; FOSSIL	The Late Devonian genus Ichthyostega was for many decades the earliest known tetrapod, and the sole representative of a transitional form between a fish and a land vertebrate. However, despite being known since 1932 (ref. 1) from a large collection of specimens, its morphology remained enigmatic and not what was expected of a very primitive tetrapod(2). Its apparent specializations led it to be considered as a "blind offshoot"(3) or "side-branch"(4) off the tetrapod family tree, and recent cladistic analyses have disagreed about its exact phylogenetic position(5-8) within the tetrapod stem group. In particular, its braincase and ear region defied interpretation, such that conventional anatomical terms seemed inapplicable(4). Using new material collected in 1998 (ref. 9), preparation of earlier-collected material, and high-resolution computed tomography scanning, here we identify and interpret these problematic anatomical structures. They can now be seen to form part of a highly specialized ear, probably a hearing device for use in water. This represents a structurally and functionally unique modification of the tetrapod otic region, unlike anything seen in subsequent tetrapod evolution. The presence of deeply grooved gill bars as in its contemporary Acanthostega(10) suggest that Ichthyostega may have been more aquatically adapted than previously believed.	Univ Museum Zool, Cambridge CB2 3EJ, England; Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; Univ Texas, Dept Geol Sci, High Resolut Xray CT Facil, Austin, TX 78712 USA	University of Cambridge; Natural History Museum London; University of Texas System; University of Texas Austin	Clack, JA (corresponding author), Univ Museum Zool, Downing St, Cambridge CB2 3EJ, England.	j.a.clack@zoo.cam.ac.uk	Domínguez Alonso, Patricio/C-2679-2013; Ketcham, Richard/B-5431-2011; Ahlberg, Per/E-8086-2013	Ketcham, Richard/0000-0002-2748-0409; Ahlberg, Per/0000-0001-9054-2900				Ahlberg PE, 1998, T ROY SOC EDIN-EARTH, V89, P11, DOI 10.1017/S0263593300002340; Ahlberg PE, 1996, NATURE, V381, P61, DOI 10.1038/381061a0; BERNACSEK GM, 1981, CAN J EARTH SCI, V18, P150, DOI 10.1139/e81-012; CLACK JA, 1987, PHILOS T ROY SOC B, V318, P1, DOI 10.1098/rstb.1987.0082; Clack JA, 1998, ZOOL J LINN SOC-LOND, V122, P61, DOI 10.1006/zjls.1997.0114; CLACK JA, 1983, ZOOL J LINN SOC-LOND, V79, P121, DOI 10.1111/j.1096-3642.1983.tb01163.x; Clack JA, 2002, J NEUROBIOL, V53, P251, DOI 10.1002/neu.10129; Clack JA, 2002, NATURE, V418, P72, DOI 10.1038/nature00824; Clack JA, 2000, GEOL SOC SPEC PUBL, V180, P557, DOI 10.1144/GSL.SP.2000.180.01.29; COATES MI, 1991, NATURE, V352, P234, DOI 10.1038/352234a0; Dominguez P, 2002, NATURE, V417, P841, DOI 10.1038/nature00805; HETHERINGTON TE, 1982, J EXP BIOL, V98, P49; Jarvik E., 1952, Meddelelser om Gronland, V114, P1; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; Jarvik Erik, 1996, Fossils and Strata, V40, P1; Ketcham RA, 2001, COMPUT GEOSCI-UK, V27, P381, DOI 10.1016/S0098-3004(00)00116-3; Laurin M, 1998, ANN SCI NAT ZOOL, V19, P1, DOI 10.1016/S0003-4339(98)80132-9; Ruta M, 2003, BIOL REV, V78, P251, DOI 10.1017/S1464793102006103; Save-Soderbergh G., 1932, Medd Grenland, V94 T, P1; SMITHSON TR, 1982, ZOOL J LINN SOC-LOND, V74, P93, DOI 10.1111/j.1096-3642.1982.tb01142.x; SMITHSON TR, 1982, ZOOL J LINN SOC-LOND, V76, P29, DOI 10.1111/j.1096-3642.1982.tb01955.x; Yan HY, 2000, J COMP PHYSIOL A, V186, P435, DOI 10.1007/s003590050443	22	80	82	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2003	425	6953					65	69		10.1038/nature01904	http://dx.doi.org/10.1038/nature01904			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717LD	12955140				2022-12-01	WOS:000185089200037
J	Guerin, PJ; Brasher, C; Baron, E; Mic, D; Grimont, F; Ryan, M; Aavitsland, P; Legros, D				Guerin, PJ; Brasher, C; Baron, E; Mic, D; Grimont, F; Ryan, M; Aavitsland, P; Legros, D			Shigella dysenteriae serotype 1 in west Africa: intervention strategy for an outbreak in Sierra Leone	LANCET			English	Article							FLUOROQUINOLONES	In November 1999, a Medecins Sans Frontieres team based in the southeastern part of Sierra Leone reported an increased number of cases of bloody diarrhoea. Shigella dysenteriae serotype 1 (Sd1) was isolated in the early cases. A total of 4218 cases of dysentery were reported in Kenema district from December, 1999, to March, 2000. The overall attack rate was 7-5%. The attack rate was higher among children younger than 5 years than in the rest of the population (11.2% vs 6.8%; relative risk=1.6; 95% CI 1.5-1.8). The case fatality was 3.1%, also higher for children younger than 5 years (6.1% vs 2.1%; relative risk=2.9; 95% CI 2.1-4-1]). Among 583 patients regarded at increased risk of death who were treated with ciprofloxacin in isolation centres, case fatality was 0.9%. A 5-day ciprofloxacin regimen, targeted to the most severe cases of bloody diarrhoea, was highly effective. This is the first time a large outbreak caused by Sd1 has been reported in west Africa.	Epictr, F-75011 Paris, France; Norwegian Inst Publ Hlth, Div Infect Dis Control, Oslo, Norway; Med Sans Frontieres, Paris, France; Inst Pasteur, Ctr Natl Reference Escherichia Coli & Shigella, Paris, France; WHO, Global Alert & Response Team, Dept Surveillance & Response, Communicable Dis Cluster, CH-1211 Geneva, Switzerland; European Programme Intervent Epidemiol Training, Paris, France	Norwegian Institute of Public Health (NIPH); Doctors Without Borders; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; World Health Organization	Guerin, PJ (corresponding author), Epictr, F-75011 Paris, France.		Guerin, Philippe/AAH-8873-2021; Brasher, Chris/Y-4488-2019	Brasher, Chris/0000-0003-1037-3604; Guerin, Philippe/0000-0002-6008-2963				Bethell DB, 1996, ARCH DIS CHILD, V74, P44, DOI 10.1136/adc.74.1.44; Hooper DC, 2000, CLIN INFECT DIS, V31, pS24, DOI 10.1086/314056; KEUSCH GT, 1998, BACTERIAL INFECT HUM, P631; Legros D, 1999, TROP MED INT HEALTH, V4, P428, DOI 10.1046/j.1365-3156.1999.00413.x; RIES AA, 1994, J INFECT DIS, V169, P1035, DOI 10.1093/infdis/169.5.1035	5	35	38	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 30	2003	362	9385					705	706		10.1016/S0140-6736(03)14227-4	http://dx.doi.org/10.1016/S0140-6736(03)14227-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	716NH	12957094				2022-12-01	WOS:000185034800012
J	Shao, F; Golstein, C; Ade, J; Stoutemyer, M; Dixon, JE; Innes, RW				Shao, F; Golstein, C; Ade, J; Stoutemyer, M; Dixon, JE; Innes, RW			Cleavage of Arabidopsis PBS1 by a bacterial type III effector	SCIENCE			English	Article							DISEASE RESISTANCE GENE; RICE BLAST RESISTANCE; PSEUDOMONAS-SYRINGAE; AVIRULENCE GENE; YERSINIA EFFECTOR; PROTEINS; KINASE; RIN4; VIRULENCE; PROTEASE	Plant disease-resistance (R) proteins are thought to function as receptors for ligands produced directly or indirectly by pathogen avirulence (Avr) proteins. The biochemical functions of most Avr proteins are unknown, and the mechanisms by which they activate R proteins have not been determined. In Arabidopsis, resistance to Pseudomonas syringae strains expressing AvrPphB requires RPS5, a member of the class of R proteins that have a predicted nucleotide-binding site and leucine-rich repeats, and PBS1, a protein kinase. AvrPphB was found to proteolytically cleave PBS1, and this cleavage was required for RPS5-mediated resistance, which indicates that AvrPphB is detected indirectly via its enzymatic activity.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	Indiana University System; Indiana University Bloomington; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Innes, RW (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.		Innes, Roger/A-5244-2010		NIDDK NIH HHS [DK18849] Funding Source: Medline; NIGMS NIH HHS [GM46451] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM046451, R01GM046451] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnold DL, 2001, MICROBIOL-SGM, V147, P1171, DOI 10.1099/00221287-147-5-1171; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; FLOR HH, 1955, PHYTOPATHOLOGY, V45, P680; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; Kjemtrup S, 2000, CURR OPIN MICROBIOL, V3, P73, DOI 10.1016/S1369-5274(99)00054-5; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; Orbach MJ, 2000, PLANT CELL, V12, P2019, DOI 10.1105/tpc.12.11.2019; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Puri N, 1997, MOL PLANT MICROBE IN, V10, P247, DOI 10.1094/MPMI.1997.10.2.247; Rossi M, 1998, P NATL ACAD SCI USA, V95, P9750, DOI 10.1073/pnas.95.17.9750; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; SHAO F, UNPUB; Swiderski MR, 2001, PLANT J, V26, P101, DOI 10.1046/j.1365-313x.2001.01014.x; Tampakaki AP, 2002, MOL PLANT MICROBE IN, V15, P292, DOI 10.1094/MPMI.2002.15.3.292; Tornero P, 2002, PLANT CELL, V14, P1005, DOI 10.1105/tpc.001032; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Warren RF, 1998, PLANT CELL, V10, P1439, DOI 10.1105/tpc.10.9.1439; Warren RF, 1999, GENETICS, V152, P401; ZHOU JM, 1995, CELL, V83, P925, DOI 10.1016/0092-8674(95)90208-2	27	421	440	4	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 29	2003	301	5637					1230	1233		10.1126/science.1085671	http://dx.doi.org/10.1126/science.1085671			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZC	12947197				2022-12-01	WOS:000185003500040
J	Canman, JC; Cameron, LA; Maddox, PS; Straight, A; Tirnauer, JS; Mitchison, TJ; Fang, GW; Kapoor, TM; Salmon, ED				Canman, JC; Cameron, LA; Maddox, PS; Straight, A; Tirnauer, JS; Mitchison, TJ; Fang, GW; Kapoor, TM; Salmon, ED			Determining the position of the cell division plane	NATURE			English	Article							SMALL-MOLECULE INHIBITOR; MAMMALIAN-CELLS; CLEAVAGE FURROW; MICROTUBULES; CYTOKINESIS; SPINDLE; ANAPHASE; MECHANISMS; PROTEIN; MAD2	Proper positioning of the cell division plane during mitosis is essential for determining the size and position of the two daughter cells-a critical step during development and cell differentiation(1). A bipolar microtubule array has been proposed to be a minimum requirement for furrow positioning in mammalian cells, with furrows forming at the site of microtubule plus-end overlap between the spindle poles(2-4). Observations in other species have suggested, however, that this may not be true(5,6). Here we show, by inducing mammalian tissue cells with monopolar spindles to enter anaphase(7,8), that furrow formation in cultured mammalian cells does not require a bipolar spindle. Unexpectedly, cytokinesis occurs at high frequency in monopolar cells. Division always occurs at a cortical position distal to the chromosomes. Analysis of microtubules during cytokinesis in cells with monopolar and bipolar spindles shows that a subpopulation of stable microtubules extends past chromosomes and binds to the cell cortex at the site of furrow formation. Our data are consistent with a model in which chromosomes supply microtubules with factors that promote microtubule stability and furrowing.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27699 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA	University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School; Stanford University; Rockefeller University	Salmon, ED (corresponding author), Univ N Carolina, Dept Biol, 607 Fordham Hall,CB 3280, Chapel Hill, NC 27699 USA.		Canman, Julie C/A-3875-2016	Canman, Julie C/0000-0001-8135-2072; Straight, Aaron/0000-0001-5885-7881	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024364] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; ASNES CF, 1979, EXP CELL RES, V122, P327, DOI 10.1016/0014-4827(79)90309-4; Canman JC, 2000, CURR BIOL, V10, P611, DOI 10.1016/S0960-9822(00)00490-5; Canman JC, 2002, CELL MOTIL CYTOSKEL, V52, P61, DOI 10.1002/cm.10032; Canman JC, 2002, J CELL SCI, V115, P3787, DOI 10.1242/jcs.00057; Dechant R, 2003, DEV CELL, V4, P333, DOI 10.1016/S1534-5807(03)00057-1; Foe VE, 2000, DEVELOPMENT, V127, P1767; Gorbsky GJ, 1998, J CELL BIOL, V141, P1193, DOI 10.1083/jcb.141.5.1193; HARRIS AK, 1989, J CELL BIOL, V109, P2215, DOI 10.1083/jcb.109.5.2215; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; KUBAI DF, 1982, J CELL BIOL, V93, P655, DOI 10.1083/jcb.93.3.655; Kurz T, 2002, SCIENCE, V295, P1294, DOI 10.1126/science.1067765; Mackay AM, 1998, J CELL BIOL, V140, P991, DOI 10.1083/jcb.140.5.991; Mandato CA, 2000, CELL MOTIL CYTOSKEL, V45, P87, DOI 10.1002/(SICI)1097-0169(200002)45:2<87::AID-CM1>3.0.CO;2-0; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Murata-Hori M, 2002, J CELL BIOL, V159, P45, DOI 10.1083/jcb.200207014; RADLEY JM, 1980, BLOOD, V56, P996; RAPPAPORT R, 1961, J EXP ZOOL, V148, P81, DOI 10.1002/jez.1401480107; RAPPAPORT R, 1997, CYTOKINESIS ANIMALS; Shannon KB, 2002, MOL BIOL CELL, V13, P3706, DOI 10.1091/mbc.E02-03-0137; Wheatley SP, 2001, EXP CELL RES, V262, P122, DOI 10.1006/excr.2000.5088; WHITE JG, 1983, J THEOR BIOL, V101, P289, DOI 10.1016/0022-5193(83)90342-9; Wittmann T, 2001, J CELL SCI, V114, P3795; WOLF N, 1978, J ULTRA MOL STRUCT R, V63, P155, DOI 10.1016/S0022-5320(78)80071-9	25	180	183	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2003	424	6952					1074	1078		10.1038/nature01860	http://dx.doi.org/10.1038/nature01860			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715QR	12904818				2022-12-01	WOS:000184984200048
J	Yanagisawa, K; Shyr, Y; Xu, BGJ; Massion, PP; Larsen, PH; White, BC; Roberts, JR; Edgerton, M; Gonzalez, A; Nadaf, S; Moore, JH; Caprioli, RM; Carbone, DP				Yanagisawa, K; Shyr, Y; Xu, BGJ; Massion, PP; Larsen, PH; White, BC; Roberts, JR; Edgerton, M; Gonzalez, A; Nadaf, S; Moore, JH; Caprioli, RM; Carbone, DP			Proteomic patterns of tumour subsets in non-small-cell lung cancer	LANCET			English	Article							IMAGING MASS-SPECTROMETRY; GENE-EXPRESSION; PROSTATE-CANCER; MESSENGER-RNA; BREAST-CANCER; PROTEINS; SERUM; SUMO; CLASSIFICATION; ADENOCARCINOMA	Background Proteomics-based approaches complement the genome initiatives and may be the next step in attempts to understand the biology of cancer. We used matrix-assisted laser desorption/ionisation mass spectrometry directly from 1-mm regions of single frozen tissue sections for profiling of protein expression from surgically resected tissues to classify lung tumours. Methods Proteomic spectra were obtained and aligned from 79 lung tumours and 14 normal lung tissues. We built a class-prediction model with the proteomic patterns in a training cohort of 42 lung tumours and eight normal lung samples, and assessed their statistical significance. We then applied this model to a blinded test cohort, including 37 lung tumours; and six normal lung samples, to estimate the misclassification rate. Findings We obtained more than 1600 protein peaks from histologically selected 1 mm diameter regions of single frozen sections from each tissue. Class-prediction models based on differentially expressed peaks enabled us to perfectly classify lung cancer histologies, distinguish primary tumours from metastases to the lung from other sites, and classify nodal involvement with 85% accuracy in the training cohort. This model nearly perfectly classified samples in the independent blinded test cohort. We also obtained a proteomic pattern comprised of 15 distinct mass spectrometry peaks that distinguished between patients with resected non-small-cell lung cancer who had poor prognosis (median survival 6 months, n=25) and those who had good prognosis (median survival 33 months, n=41, p<0.0001). Interpretation Proteomic patterns obtained directly from small amounts of fresh frozen lung-tumour tissue could be used to accurately classify and predict histological groups as well as nodal involvement and survival in resected non-small-cell lung cancer.	Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Div Hematol & Oncol,Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Cardiovasc & Thorac Surg, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Program Human Genet, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Carbone, DP (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Div Hematol & Oncol,Dept Med, 2200 Pierce Ave,685 Preston Res Bldg, Nashville, TN 37232 USA.		Moore, Jason H./AAV-9645-2021; Yanagisawa, Kiyoshi/I-7263-2014	Moore, Jason H./0000-0002-5015-1099; White, Bill/0000-0002-0684-5210	NCI NIH HHS [CA 86243, P50CA70907, 1P50CA90949] Funding Source: Medline; NIGMS NIH HHS [GM 58008] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA090949, R33CA086243, P50CA070907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058008] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adam BL, 2002, CANCER RES, V62, P3609; Alarcon-Vargas D, 2002, CANCER BIOL THER, V1, P237, DOI 10.4161/cbt.74; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Carbone DP, 1997, SEMIN ONCOL, V24, P388; Chaurand P, 2002, CURR OPIN CHEM BIOL, V6, P676, DOI 10.1016/S1367-5931(02)00370-8; Chaurand P, 2001, PROTEOMICS, V1, P1320, DOI 10.1002/1615-9861(200110)1:10<1320::AID-PROT1320>3.0.CO;2-G; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; HALL AK, 1991, INT J CANCER, V48, P672, DOI 10.1002/ijc.2910480507; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Junker K, 2000, J CANCER RES CLIN, V126, P361, DOI 10.1007/PL00008483; Kobayashi T, 2002, AM J PATHOL, V160, P869, DOI 10.1016/S0002-9440(10)64910-3; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; MINNA JD, 2001, HARRISONS PRINCIPLES, P562; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Paciucci R, 1996, FEBS LETT, V385, P72, DOI 10.1016/0014-5793(96)00352-3; Paweletz CP, 2001, DIS MARKERS, V17, P301, DOI 10.1155/2001/674959; Petricoin EF, 2002, J NATL CANCER I, V94, P1576; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; SHYR Y, 2003, TUMOR PROTEOMIC PATT; SHYR Y, 2003, PRACTICAL APPROACH M; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; TUKEY JW, 1993, CONTROL CLIN TRIALS, V14, P266, DOI 10.1016/0197-2456(93)90225-3; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wilkins MR, 1996, ELECTROPHORESIS, V17, P830, DOI 10.1002/elps.1150170504; Xu BGJ, 2002, J AM SOC MASS SPECTR, V13, P1292, DOI 10.1016/S1044-0305(02)00644-X	33	456	512	4	69	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 9	2003	362	9382					433	439		10.1016/S0140-6736(03)14068-8	http://dx.doi.org/10.1016/S0140-6736(03)14068-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	709XD	12927430				2022-12-01	WOS:000184651100010
J	Cutforth, T; Moring, L; Mendelsohn, M; Nemes, A; Shah, NM; Kim, MM; Frisen, J; Axel, R				Cutforth, T; Moring, L; Mendelsohn, M; Nemes, A; Shah, NM; Kim, MM; Frisen, J; Axel, R			Axonal ephrin-as and odorant receptors: Coordinate determination of the olfactory sensory map	CELL			English	Article							EXPRESSION PATTERNS; CRYSTAL-STRUCTURE; BRANCH EXTENSION; TOPOGRAPHIC MAP; MULTIPLE ROLES; MESSENGER-RNAS; MICE DEFICIENT; CELL-ADHESION; SYSTEM; LIGANDS	Olfactory sensory neurons expressing a given odorant receptor (OR) project with precision to specific glomeruli in the olfactory bulb, generating a topographic map. In this study, we demonstrate that neurons expressing different ORs express different levels of ephrin-A protein on their axons. Moreover, alterations in the level of ephrin-A alter the glomerular map. Deletion of the ephrin-A5 and ephrin-A3 genes posteriorizes the glomerular locations for neurons expressing either the P2 or SR1 receptor, whereas overexpression of ephrin-A5 in P2 neurons results in an anterior shift in their glomeruli. Thus the ephrin-As are differentially expressed in distinct subpopulations of neurons and are likely to participate, along with the ORs, as one of a complement of guidance receptors governing the targeting of like axons to precise locations in the olfactory bulb.	Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, Coll Phys & Surg, New York, NY 10032 USA; Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Columbia University; Howard Hughes Medical Institute; Columbia University; Karolinska Institutet	Axel, R (corresponding author), Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA.			Axel, Richard/0000-0002-3141-4076	NATIONAL CANCER INSTITUTE [P01CA023767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004209] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA23767] Funding Source: Medline; NIDCD NIH HHS [R01 DC04209] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Cerretti DP, 1998, GENOMICS, V47, P131, DOI 10.1006/geno.1997.5088; CHEN G, 1994, BIOL CONTROL, V4, P157, DOI 10.1006/bcon.1994.1025; Davy A, 2000, EMBO J, V19, P5396, DOI 10.1093/emboj/19.20.5396; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; Hennecke M, 2001, NUCLEIC ACIDS RES, V29, P3327, DOI 10.1093/nar/29.16.3327; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Huai JS, 2001, J BIOL CHEM, V276, P6689, DOI 10.1074/jbc.M008127200; KILLACKEY HP, 1995, TRENDS NEUROSCI, V18, P402, DOI 10.1016/0166-2236(95)93937-S; Knoll B, 2001, DEVELOPMENT, V128, P895; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lane RP, 2001, P NATL ACAD SCI USA, V98, P7390, DOI 10.1073/pnas.131215398; Mann F, 2002, NEURON, V35, P461, DOI 10.1016/S0896-6273(02)00786-9; McLaughlin T, 2003, DEVELOPMENT, V130, P2407, DOI 10.1242/dev.00467; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 2001, NAT NEUROSCI, V4, P1192, DOI 10.1038/nn751; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; Prakash N, 2000, J NEUROSCI, V20, P5841, DOI 10.1523/JNEUROSCI.20-15-05841.2000; Puche AC, 1996, DEV BIOL, V179, P274, DOI 10.1006/dbio.1996.0257; Renzi MJ, 2000, NEURON, V28, P437, DOI 10.1016/S0896-6273(00)00123-9; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Schaefer ML, 2001, J COMP NEUROL, V436, P351; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schwarting GA, 2000, J NEUROSCI, V20, P7691; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; St John JA, 2002, DEV BRAIN RES, V138, P1, DOI 10.1016/S0165-3806(02)00454-6; St John JA, 2001, DEV BRAIN RES, V126, P43, DOI 10.1016/S0165-3806(00)00136-X; St John JA, 2000, J COMP NEUROL, V416, P540; Tisay KT, 2000, J COMP NEUROL, V428, P656, DOI 10.1002/1096-9861(20001225)428:4<656::AID-CNE6>3.0.CO;2-7; Toth J, 2001, DEV CELL, V1, P83, DOI 10.1016/S1534-5807(01)00002-8; Treloar H, 1997, J NEUROBIOL, V32, P643, DOI 10.1002/(SICI)1097-4695(19970620)32:7<643::AID-NEU1>3.0.CO;2-4; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Walz A, 2002, J NEUROSCI, V22, P4025, DOI 10.1523/JNEUROSCI.22-10-04025.2002; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Zhang JH, 1996, J NEUROSCI, V16, P7182; ZHANG JH, 1990, NEUROSCI LETT, V119, P257, DOI 10.1016/0304-3940(90)90847-3; Zhang JH, 1997, MOL BRAIN RES, V47, P202, DOI 10.1016/S0169-328X(97)00051-X; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	55	175	176	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 8	2003	114	3					311	322		10.1016/S0092-8674(03)00568-3	http://dx.doi.org/10.1016/S0092-8674(03)00568-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914696	Bronze			2022-12-01	WOS:000184679200008
J	Damak, S; Rong, MQ; Yasumatsu, K; Kokrashvili, Z; Varadarajan, V; Zou, SY; Jiang, PH; Ninomiya, Y; Margolskee, RF				Damak, S; Rong, MQ; Yasumatsu, K; Kokrashvili, Z; Varadarajan, V; Zou, SY; Jiang, PH; Ninomiya, Y; Margolskee, RF			Detection of sweet and umami taste in the absence of taste receptor T1r3	SCIENCE			English	Article							SACCHARIN PREFERENCE; GLOSSOPHARYNGEAL NERVES; CHORDA TYMPANI; INBRED STRAINS; MICE; SUBSTANCES; RESPONSES; LOCUS; SAC; IDENTIFICATION	The tastes of sugars ( sweet) and glutamate (umami) are thought to be detected by T1r receptors expressed in taste cells. Molecular genetics and heterologous expression implicate T1r2 plus T1r3 as a sweet-responsive receptor, and T1r1 plus T1r3, as well as a truncated form of the type 4 metabotropic glutamate receptor (taste-mGluR4), as umami-responsive receptors. Here, we show that mice lacking T1r3 showed no preference for artificial sweeteners and had diminished but not abolished behavioral and nerve responses to sugars and umami compounds. These results indicate that T1r3-independent sweet- and umami-responsive receptors and/or pathways exist in taste cells.	CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Howard Hughes Med Inst, New York, NY 10029 USA; Kyushu Univ, Sect Oral Neurosci, Higashi Ku, Fukuoka 8128582, Japan	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Howard Hughes Medical Institute; Icahn School of Medicine at Mount Sinai; Kyushu University	Margolskee, RF (corresponding author), CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, Box 1677,1425 Madison Ave, New York, NY 10029 USA.			Margolskee, Robert/0000-0002-9572-2887				Bachmanov AA, 1997, MAMM GENOME, V8, P545, DOI 10.1007/s003359900500; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; CAPELESS CG, 1995, CHEM SENSES, V20, P291, DOI 10.1093/chemse/20.3.291; CAPRETTA PJ, 1970, PSYCHON SCI, V21, P133; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; FULLER JL, 1974, J HERED, V65, P33, DOI 10.1093/oxfordjournals.jhered.a108452; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; LUSH IE, 1989, GENET RES, V53, P95, DOI 10.1017/S0016672300027968; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Ninomiya Y, 2000, J NUTR, V130, p950S, DOI 10.1093/jn/130.4.950S; NINOMIYA Y, 1993, NEUROSCI LETT, V163, P197, DOI 10.1016/0304-3940(93)90381-T; PELZ WE, 1973, PHYSIOL BEHAV, V10, P263, DOI 10.1016/0031-9384(73)90308-9; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Sako N, 2000, PHYSIOL BEHAV, V71, P193, DOI 10.1016/S0031-9384(00)00342-5; SCHIFFMAN SS, 1995, BRAIN RES BULL, V36, P505, DOI 10.1016/0361-9230(94)00225-P; SHINGAI T, 1985, BRAIN RES, V335, P245, DOI 10.1016/0006-8993(85)90476-7	20	452	497	10	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					850	853		10.1126/science.1087155	http://dx.doi.org/10.1126/science.1087155			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12869700				2022-12-01	WOS:000184615700050
J	Sullivan, NJ; Geisbert, TW; Geisbert, JB; Xu, L; Yang, ZY; Roederer, M; Koup, RA; Jahrling, PB; Nabel, GJ				Sullivan, NJ; Geisbert, TW; Geisbert, JB; Xu, L; Yang, ZY; Roederer, M; Koup, RA; Jahrling, PB; Nabel, GJ			Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates	NATURE			English	Article							PASSIVE TRANSFER; INFECTION; GLYCOPROTEINS; CYTOTOXICITY; INJURY; GENE	Containment of highly lethal Ebola virus outbreaks poses a serious public health challenge. Although an experimental vaccine has successfully protected non-human primates against disease(1), more than six months was required to complete the immunizations, making it impractical to limit an acute epidemic. Here, we report the development of accelerated vaccination against Ebola virus in non-human primates. The antibody response to immunization with an adenoviral (ADV) vector encoding the Ebola glycoprotein (GP) was induced more rapidly than with DNA priming and ADV boosting, but it was of lower magnitude. To determine whether this earlier immune response could nonetheless protect against disease, cynomolgus macaques were challenged with Ebola virus after vaccination with ADV-GP and nucleoprotein (NP) vectors. Protection was highly effective and correlated with the generation of Ebola-specific CD8(+) T-cell and antibody responses. Even when animals were immunized once with ADV-GP/NP and challenged 28 days later, they remained resistant to challenge with either low or high doses of virus. This accelerated vaccine provides an intervention that may help to limit the epidemic spread of Ebola, and is applicable to other viruses.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bldg 40,Room 4502,MSC 3005,40 Convent Dr, Bethesda, MD 20892 USA.	gnabel@nih.gov	Roederer, Mario/G-1887-2011		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005004, Z01AI005073, ZIAAI005073] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aoki K, 1999, MOL MED, V5, P224, DOI 10.1007/BF03402119; Chan SY, 2000, J GEN VIROL, V81, P2155, DOI 10.1099/0022-1317-81-9-2155; Gupta M, 2001, J VIROL, V75, P4649, DOI 10.1128/JVI.75.10.4649-4654.2001; Jahrling PB, 1999, J INFECT DIS, V179, pS224, DOI 10.1086/514310; Jahrling PB, 1996, ARCH VIROL, P135; KSIAZEK TG, 1992, J CLIN MICROBIOL, V30, P947, DOI 10.1128/JCM.30.4.947-950.1992; OHNO T, 1994, SCIENCE, V265, P781, DOI 10.1126/science.8047883; Parren PWHI, 2002, J VIROL, V76, P6408, DOI 10.1128/JVI.76.12.6408-6412.2002; Sanchez A, 1998, J VIROL, V72, P6442, DOI 10.1128/JVI.72.8.6442-6447.1998; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Takada A, 2000, VIROLOGY, V278, P20, DOI 10.1006/viro.2000.0601; Volchkov VE, 2001, SCIENCE, V291, P1965, DOI 10.1126/science.1057269; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; *WHO, 2003, DIS OUTBR EB HAEM FE; Wilson JA, 2001, J VIROL, V75, P2660, DOI 10.1128/JVI.75.6.2660-2664.2001; Xu L, 1998, NAT MED, V4, P37, DOI 10.1038/nm0198-037; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654	17	361	390	0	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2003	424	6949					681	684		10.1038/nature01876	http://dx.doi.org/10.1038/nature01876			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904795	Bronze, Green Published			2022-12-01	WOS:000184578800047
J	Neumann, CA; Krause, DS; Carman, CV; Das, S; Dubey, DP; Abraham, JL; Bronson, RT; Fujiwara, Y; Orkin, SH; Van Etten, RA				Neumann, CA; Krause, DS; Carman, CV; Das, S; Dubey, DP; Abraham, JL; Bronson, RT; Fujiwara, Y; Orkin, SH; Van Etten, RA			Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression	NATURE			English	Article							ABL TYROSINE KINASE; PAG GENE-PRODUCT; PHYSIOLOGICAL INHIBITOR; STRESS; CLONING; RESISTANCE; PROTEIN; FAMILY; CELLS; MICE	Reactive oxygen species are involved in many cellular metabolic and signalling processes(1) and are thought to have a role in disease, particularly in carcinogenesis and ageing(2). We have generated mice with targeted inactivation of Prdx1, a member of the peroxiredoxin family of antioxidant enzymes(3). Here we show that mice lacking Prdx1 are viable and fertile but have a shortened lifespan owing to the development beginning at about 9 months of severe haemolytic anaemia and several malignant cancers, both of which are also observed at increased frequency in heterozygotes. The haemolytic anaemia is characterized by an increase in erythrocyte reactive oxygen species, leading to protein oxidation, haemoglobin instability, Heinz body formation and decreased erythrocyte lifespan. The malignancies include lymphomas, sarcomas and carcinomas, and are frequently associated with loss of Prdx1 expression in heterozygotes, which suggests that this protein functions as a tumour suppressor. Prdx1-deficient fibroblasts show decreased proliferation and increased sensitivity to oxidative DNA damage, whereas Prdx1-null mice have abnormalities in numbers, phenotype and function of natural killer cells. Our results implicate Prdx1 as an important defence against oxidants in ageing mice.	Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Tufts Univ, Sch Vet Med, North Grafton, MA 01536 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Tufts University	Van Etten, RA (corresponding author), Tufts Univ New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA.	rvanetten@tufts-nemc.org	Carman, Christopher V./AAX-8995-2020; Carman, Christopher/L-8108-2016	Carman, Christopher V./0000-0001-7358-2548; Carman, Christopher/0000-0001-7358-2548; Neumann, Carola/0000-0003-2801-9531	NIEHS NIH HHS [F32 ES011586] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES011586] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Butterfield LH, 1999, ANTIOXID REDOX SIGN, V1, P385, DOI 10.1089/ars.1999.1.4-385; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Chung YM, 2001, ANTICANCER RES, V21, P1129; Dubey DP, 2000, MECH AGEING DEV, V113, P117, DOI 10.1016/S0047-6374(99)00102-5; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Frank J, 2000, HISTOL HISTOPATHOL, V15, P173, DOI 10.14670/HH-15.173; Friedman JS, 2001, J EXP MED, V193, P925, DOI 10.1084/jem.193.8.925; Henderson CJ, 1998, P NATL ACAD SCI USA, V95, P5275, DOI 10.1073/pnas.95.9.5275; HOFFMANNFEZER G, 1993, ANN HEMATOL, V67, P81, DOI 10.1007/BF01788131; ISHII T, 1993, J BIOL CHEM, V268, P18633; IWAHARA S, 1995, BIOCHEMISTRY-US, V34, P13398, DOI 10.1021/bi00041a017; Johnson RM, 2000, BLOOD, V96, P1985, DOI 10.1182/blood.V96.5.1985.h8001985_1985_1988; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Lyu MS, 1999, MAMM GENOME, V10, P1017, DOI 10.1007/s003359901150; Mu ZM, 2002, J BIOL CHEM, V277, P43175, DOI 10.1074/jbc.M206066200; Noh DY, 2001, ANTICANCER RES, V21, P2085; PROSPERI MT, 1993, J BIOL CHEM, V268, P11050; PROSPERI MT, 1994, GENOMICS, V19, P236, DOI 10.1006/geno.1994.1053; Prosperi MT, 1998, FEBS LETT, V423, P39, DOI 10.1016/S0014-5793(98)00057-X; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Sauri H, 1996, J LEUKOCYTE BIOL, V59, P925, DOI 10.1002/jlb.59.6.925; Shau HY, 1997, FREE RADICAL BIO MED, V22, P497, DOI 10.1016/S0891-5849(96)00372-3; SHAU HY, 1993, CELL IMMUNOL, V147, P1, DOI 10.1006/cimm.1993.1043; Struthers L, 1998, ANAL BIOCHEM, V255, P20, DOI 10.1006/abio.1997.2354; Takei F, 1997, IMMUNOL REV, V155, P67, DOI 10.1111/j.1600-065X.1997.tb00940.x; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Westphal GH, 1997, CURR BIOL, V7, P530, DOI 10.1016/S0960-9822(06)00224-7	31	612	642	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2003	424	6948					561	565		10.1038/nature01819	http://dx.doi.org/10.1038/nature01819			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891360	Green Published			2022-12-01	WOS:000184454700045
J	Williams, PA; Cosme, J; Ward, A; Angova, HC; Vinkovic, DM; Jhoti, H				Williams, PA; Cosme, J; Ward, A; Angova, HC; Vinkovic, DM; Jhoti, H			Crystal structure of human cytochrome P4502C9 with bound warfarin	NATURE			English	Article								Cytochrome P450 proteins (CYP450s) are membrane-associated haem proteins that metabolize physiologically important compounds in many species of microorganisms, plants and animals. Mammalian CYP450s recognize and metabolize diverse xenobiotics such as drug molecules, environmental compounds and pollutants(1). Human CYP450 proteins CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 are the major drug-metabolizing isoforms, and contribute to the oxidative metabolism of more than 90% of the drugs in current clinical use(2). Polymorphic variants have also been reported for some CYP450 isoforms, which has implications for the efficacy of drugs in individuals, and for the co-administration of drugs. The molecular basis of drug recognition by human CYP450s, however, has remained elusive. Here we describe the crystal structure of a human CYP450, CYP2C9, both unliganded and in complex with the anti-coagulant drug warfarin. The structure defines unanticipated interactions between CYP2C9 and warfarin, and reveals a new binding pocket. The binding mode of warfarin suggests that CYP2C9 may undergo an allosteric mechanism during its function. The newly discovered binding pocket also suggests that CYP2C9 may simultaneously accommodate multiple ligands during its biological function, and provides a possible molecular basis for understanding complex drug-drug interactions.	Astex Technol, Cambridge CB4 0QA, England		Jhoti, H (corresponding author), Astex Technol, 436 Cambridge Sci Pk,Milton Rd, Cambridge CB4 0QA, England.	h.jhoti@astex-technology.com		Williams, Pamela/0000-0002-1257-2351				Anzenbacher P, 2001, CELL MOL LIFE SCI, V58, P737, DOI 10.1007/PL00000897; de Groot MJ, 2002, J MED CHEM, V45, P1983, DOI 10.1021/jm0110791; Haines DC, 2001, BIOCHEMISTRY-US, V40, P13456, DOI 10.1021/bi011197q; Haining RL, 1999, BIOCHEMISTRY-US, V38, P3285, DOI 10.1021/bi982161+; Hemeryck A, 1999, EUR J CLIN PHARMACOL, V54, P947, DOI 10.1007/s002280050580; Hlavica P, 2001, EUR J BIOCHEM, V268, P4817, DOI 10.1046/j.1432-1327.2001.02412.x; Hodgson J, 2001, NAT BIOTECHNOL, V19, P722, DOI 10.1038/90761; Hutzler JM, 2001, DRUG METAB DISPOS, V29, P1029; Hutzler JM, 2003, ARCH BIOCHEM BIOPHYS, V410, P16; Ibeanu GC, 1996, J BIOL CHEM, V271, P12496, DOI 10.1074/jbc.271.21.12496; Jones BC, 1996, DRUG METAB DISPOS, V24, P260; Kaminsky LS, 1997, PHARMACOL THERAPEUT, V73, P67, DOI 10.1016/S0163-7258(96)00140-4; Lewis DFV, 2000, BIOCHEM PHARMACOL, V60, P293, DOI 10.1016/S0006-2952(00)00335-X; Li H, 1996, BIOCHIMIE, V78, P695, DOI 10.1016/S0300-9084(97)82526-6; Li HY, 1997, NAT STRUCT BIOL, V4, P140, DOI 10.1038/nsb0297-140; MANCY A, 1995, BIOCHEMISTRY-US, V34, P10365, DOI 10.1021/bi00033a007; Melet A, 2003, ARCH BIOCHEM BIOPHYS, V409, P80, DOI 10.1016/S0003-9861(02)00548-9; Modi S, 1996, NAT STRUCT BIOL, V3, P414, DOI 10.1038/nsb0596-414; Modi S, 1997, BIOCHEMISTRY-US, V36, P4461, DOI 10.1021/bi962633p; MURSHUDOV GN, 1997, ACTA CRYSTALLOGR D, V50, P760; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NAVE C, 1995, RADIAT PHYS CHEM, V45, P483, DOI 10.1016/0969-806X(95)92800-E; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; Ridderstrom M, 2000, BIOCHEM BIOPH RES CO, V270, P983, DOI 10.1006/bbrc.2000.2538; Schlichting I, 1997, FEBS LETT, V415, P253, DOI 10.1016/S0014-5793(97)01135-6; STRESSER DM, FLUOROMETRIC CYTOCHR; Takahashi H, 2001, CLIN PHARMACOKINET, V40, P587, DOI 10.2165/00003088-200140080-00003; Tang W, 2001, CURR DRUG METAB, V2, P185, DOI 10.2174/1389200013338658; Williams D, 2000, PERFORM RES, V5, P131	29	694	722	3	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					464	468		10.1038/nature01862	http://dx.doi.org/10.1038/nature01862			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12861225				2022-12-01	WOS:000184318400052
J	Hotary, KB; Allen, ED; Brooks, PC; Datta, NS; Long, MW; Weiss, SJ				Hotary, KB; Allen, ED; Brooks, PC; Datta, NS; Long, MW; Weiss, SJ			Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix	CELL			English	Article							TISSUE INHIBITOR; COLLAGEN MATRIX; CANCER-THERAPY; UP-REGULATION; ANGIOGENESIS; CELLS; PROLIFERATION; PROGRESSION; EXPRESSION; METASTASIS	Cancer cells are able to proliferate at accelerated rates within the confines of a three-dimensional (313) extracellular matrix (ECM) that is rich in type I collagen. The mechanisms used by tumor cells to circumvent endogenous antigrowth signals have yet to be clearly defined. We find that the matrix metalloproteinase, MT1-MMP, confers tumor cells with a distinct 3D growth advantage in vitro and in vivo. The replicative advantage conferred by MT1-MMP requires pericellular proteolysis of the ECM, as proliferation is fully suppressed when tumor cells are suspended in 3D gels of protease-resistant collagen. In the absence of proteolysis, tumor cells embedded in physiologically relevant ECM matrices are trapped in a compact, spherical configuration and unable to undergo changes in cell shape or cytoskeletal reorganization required for 3D growth. These observations identify MT1-MMP as a tumor-derived growth factor that regulates proliferation by controlling cell geometry within the confines of the 3D ECM.	Univ Michigan, Ctr Comprehens Canc, Div Mol Med & Genet, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Div Hemtol Oncol, Dept Pediat, Ann Arbor, MI 48109 USA; NYU, Sch Med, Dept Radiat Oncol, New York, NY 10016 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; New York University	Weiss, SJ (corresponding author), Univ Michigan, Ctr Comprehens Canc, Div Mol Med & Genet, Dept Internal Med, Ann Arbor, MI 48109 USA.				NCI NIH HHS [CA71699, CA88308] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA071699, R01CA088308] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Brand K, 2000, CANCER RES, V60, P5723; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Datta NS, 1996, MOL BIOL CELL, V7, P209, DOI 10.1091/mbc.7.2.209; Deryugina EI, 2002, CANCER RES, V62, P580; Eckes B, 2000, MATRIX BIOL, V19, P325, DOI 10.1016/S0945-053X(00)00077-9; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Feng XD, 1999, J INVEST DERMATOL, V113, P913, DOI 10.1046/j.1523-1747.1999.00786.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hay E.D., 1991, CELL BIOL EXTRACELLU, DOI 10.1007/978-1-4615-3770-0; Henriet P, 2000, P NATL ACAD SCI USA, V97, P10026, DOI 10.1073/pnas.170290997; Hidalgo M, 2001, JNCI-J NATL CANCER I, V93, P178, DOI 10.1093/jnci/93.3.178; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2002, J EXP MED, V195, P295, DOI 10.1084/jem.20010815; Ingber DE, 2003, P NATL ACAD SCI USA, V100, P1472, DOI 10.1073/pnas.0530201100; Koyama H, 1996, CELL, V87, P1069, DOI 10.1016/S0092-8674(00)81801-2; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; LIU X, 1995, J CELL BIOL, V130, P227, DOI 10.1083/jcb.130.1.227; MONTGOMERY AMP, 1994, CANCER RES, V54, P5467; NISHIYAMA T, 1989, MATRIX, V9, P193, DOI 10.1016/S0934-8832(89)80050-2; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Petitclerc E, 1999, CANCER RES, V59, P2724; SELKI M, 2002, CURR OPIN CELL BIOL, V14, P624; Sounni NE, 2002, FASEB J, V16, P555, DOI 10.1096/fj.01-0790com; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Walpita D, 2002, NAT REV MOL CELL BIO, V3, P137, DOI 10.1038/nrm727; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387	37	557	580	0	33	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 11	2003	114	1					33	45		10.1016/S0092-8674(03)00513-0	http://dx.doi.org/10.1016/S0092-8674(03)00513-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	702JC	12859896	Bronze			2022-12-01	WOS:000184219900004
J	Dillon, N				Dillon, N			Positions, please ...	NATURE			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC, Clin Sci Ctr,Gene Regulat & Chromatin Grp, London W12 0NN, England	Imperial College London	Dillon, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC, Clin Sci Ctr,Gene Regulat & Chromatin Grp, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.							Beurton P., 2000, CONCEPT GENE DEV EVO; Dillon N, 2000, BIOESSAYS, V22, P657, DOI 10.1002/1521-1878(200007)22:7<657::AID-BIES8>3.3.CO;2-U; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5	3	20	22	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2003	425	6957					457	457		10.1038/425457a	http://dx.doi.org/10.1038/425457a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727FN	14523423	Bronze			2022-12-01	WOS:000185648100023
J	Semmann, D; Krambeck, HJR; Milinski, M				Semmann, D; Krambeck, HJR; Milinski, M			Volunteering leads to rock-paper-scissors dynamics in a public goods game	NATURE			English	Article							SIZABLE GROUPS; EVOLUTION; COOPERATION; COMMONS; RECIPROCITY; PUNISHMENT; TRAGEDY; HUMANS	Collective efforts are a trademark of both insect and human societies(1). They are achieved through relatedness in the former(2) and unknown mechanisms in the latter. The problem of achieving cooperation among non-kin has been described as the 'tragedy of the commons', prophesying the inescapable collapse of many human enterprises(3,4). In public goods experiments, initial cooperation usually drops quickly to almost zero(5). It can be maintained by the opportunity to punish defectors(6) or the need to maintain good reputation(7). Both schemes require that defectors are identified. Theorists propose that a simple but effective mechanism operates under full anonymity. With optional participation in the public goods game, 'loners' (players who do not join the group), defectors and cooperators will coexist through rock-paper-scissors dynamics(8,9). Here we show experimentally that volunteering generates these dynamics in public goods games and that manipulating initial conditions can produce each predicted direction. If, by manipulating displayed decisions, it is pretended that defectors have the highest frequency, loners soon become most frequent, as do cooperators after loners and defectors after cooperators. On average, cooperation is perpetuated at a substantial level.	Max Planck Inst Limnol, Dept Evolutionary Ecol, D-24306 Plon, Germany	Max Planck Society	Milinski, M (corresponding author), Max Planck Inst Limnol, Dept Evolutionary Ecol, D-24306 Plon, Germany.							AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; BERKES F, 1989, NATURE, V340, P91, DOI 10.1038/340091a0; BOLTON GE, 2001, WHATS REPUTATION IND; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; BOYD R, 1988, J THEOR BIOL, V132, P337, DOI 10.1016/S0022-5193(88)80219-4; Colman A.M., 1995, GAME THEORY ITS APPL; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V422, P137, DOI 10.1038/nature01474; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Gintis H, 2000, GAME THEORY EVOLVING; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hardin G, 1998, SCIENCE, V280, P682, DOI 10.1126/science.280.5364.682; Hauert C, 2002, J THEOR BIOL, V218, P187, DOI 10.1006/jtbi.2002.3067; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Ledyard J., 1995, HDB EXPT EC, DOI DOI 10.3987/CONTENTS-12-85-7; MAGURRAN AE, 1987, PROC R SOC SER B-BIO, V229, P439, DOI 10.1098/rspb.1987.0004; Michor F, 2002, NATURE, V419, P677, DOI 10.1038/419677a; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Ostrom E., 1999, GOVERNING COMMONS; Ridley Matt, 1996, ORIGINS VIRTUE; SCHELLING TC, 1973, J CONFLICT RESOLUT, V17, P381, DOI 10.1177/002200277301700302; SEINEN I, 2001, T120010031 TINB I; SOBER E, 1999, OTHER EVOLUTION PSYC; Sugden R., 1986, EC RIGHTS COOPERATIO; Trivers R., 1985, SOCIAL EVOLUTION; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850	30	258	263	4	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 25	2003	425	6956					390	393		10.1038/nature01986	http://dx.doi.org/10.1038/nature01986			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	724TG	14508487				2022-12-01	WOS:000185502300039
J	Chalder, T; Goodman, R; Wessely, S; Hotopf, M; Meltzer, H				Chalder, T; Goodman, R; Wessely, S; Hotopf, M; Meltzer, H			Epidemiology of chronic fatigue syndrome and self reported myalgic encephalomyelitis in 5-15 year olds: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article									Guys Kings & St Thomass Sch Med, Dept Psychol Med, London SE5 8AZ, England; Inst Psychiat, Dept Child & Adolescent Psychiat, London SE5 8AF, England; Off Natl Stat, London SW1V 2QQ, England	University of London; King's College London; University of London; King's College London	Chalder, T (corresponding author), Guys Kings & St Thomass Sch Med, Dept Psychol Med, London SE5 8AZ, England.		Chalder, Trudie/A-5717-2011; Wessely, Simon C/A-8713-2008; Hotopf, Matthew/E-4971-2010	Wessely, Simon Charles/0000-0002-6743-9929; Chalder, Trudie/0000-0003-0775-1045; Hotopf, Matthew/0000-0002-3980-4466; Goodman, Robert/0000-0001-5596-1667				Colby J., 1997, J CHRONIC FATIGUE SY, V3, P29, DOI [10.1300/J092v03n02_04, DOI 10.1300/J092V03N02_04, DOI 10.1300/J092V03N02_]; Dobbins J.G., 1997, J CHRONIC FATIGUE SY, V3, P15, DOI DOI 10.1300/J092v03n02_03; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Goldberg DP., 1972, DETECTION PSYCHIAT I; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1111/j.1469-7610.2000.tb02345.x; Jordan K. M., 2000, J CHRONIC FATIGUE SY, V6, P3; Meltzer H., 2000, MENTAL HLTH CHILDREN; Richards J., 1998, PSYCHIAT B, V22, P203; SPEIGHT A, 2000, ARCH DIS CHILD, V82, pG215	9	94	95	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 20	2003	327	7416					654	655		10.1136/bmj.327.7416.654	http://dx.doi.org/10.1136/bmj.327.7416.654			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724AC	14500438	Bronze, Green Published			2022-12-01	WOS:000185463100022
J	Mair, W; Goymer, P; Pletcher, SD; Partridge, L				Mair, W; Goymer, P; Pletcher, SD; Partridge, L			Demography of dietary restriction and death in Drosophila	SCIENCE			English	Article							AGE-SPECIFIC MORTALITY; LIFE-SPAN; CALORIE RESTRICTION; OXIDATIVE STRESS; MELANOGASTER; LONGEVITY; MICE; RECEPTOR	Dietary restriction (DR) increases life-span in organisms from yeast to mammals, presumably by slowing the accumulation of aging-related damage. Here we show that in Drosophila, DR extends life-span entirely by reducing the short-term risk of death. Two days after the application of DR at any age for the first time, previously fully fed flies are no more likely to die than flies of the same age that have been subjected to long-term DR. DR of mammals may also reduce short-term risk of death, and hence DR instigated at any age could generate a full reversal of mortality.	UCL, Dept Biol, London WC1E 6BT, England; Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, NERC, Ascot SL5 7PY, Berks, England	University of London; University College London; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Partridge, L (corresponding author), UCL, Dept Biol, Darwin Bldg,Gower St, London WC1E 6BT, England.	l.partridge@ucl.ac.uk	Partridge, Linda/A-5501-2010; Partridge, Linda/E-7342-2015	Mair, William/0000-0002-0661-1342; Goymer, Patrick/0000-0002-2789-9373; Partridge, Linda/0000-0001-9615-0094	Biotechnology and Biological Sciences Research Council [SF19106] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Berrigan D, 2002, CARCINOGENESIS, V23, P817, DOI 10.1093/carcin/23.5.817; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Carey J. R., 2003, LONGEVITY BIOL DEMOG, DOI [10.1515/9780691224084, DOI 10.1515/9780691224084]; Carey JR, 1998, SCIENCE, V281, P996, DOI 10.1126/science.281.5379.996; Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; Good TP, 2001, J INSECT PHYSIOL, V47, P1467, DOI 10.1016/S0022-1910(01)00138-X; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Kealy RD, 2002, J AM VET MED ASSOC, V220, P1315, DOI 10.2460/javma.2002.220.1315; Kenyon C, 1996, CELL, V84, P501, DOI 10.1016/S0092-8674(00)81024-7; Lee E, 2013, STAT METHODS SURVIVA; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; MIQUEL J, 1976, MECH AGEING DEV, V5, P347, DOI 10.1016/0047-6374(76)90034-8; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; PARTRIDGE L, 1985, J INSECT PHYSIOL, V31, P393, DOI 10.1016/0022-1910(85)90084-8; Pearl R., 1928, RATE LIVING; Pletcher SD, 2000, J GERONTOL A-BIOL, V55, pB381, DOI 10.1093/gerona/55.8.B381; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Richardson AM, 1992, POTENTIAL NUTR MODUL, P177; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854	21	372	387	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2003	301	5640					1731	1733		10.1126/science.1086016	http://dx.doi.org/10.1126/science.1086016			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722QN	14500985				2022-12-01	WOS:000185387700047
J	Rothberg, MB; Bellantonio, S; Rose, DN				Rothberg, MB; Bellantonio, S; Rose, DN			Management of influenza in adults older than 65 years of age: Cost-effectiveness of rapid testing and antiviral therapy	ANNALS OF INTERNAL MEDICINE			English	Article							NEURAMINIDASE INHIBITOR OSELTAMIVIR; TREATING INFLUENZA; INHALED ZANAMIVIR; NURSING-HOME; EFFICACY; SAFETY; VACCINATION; AMANTADINE; IMPACT; PROPHYLAXIS	Background: Although antiviral therapy is cost-effective in adults, its cost-effectiveness in older adults has not been studied. Objective: To determine the cost-effectiveness of influenza testing and treatment strategies for older adults. Design: Cost-utility decision model. Data Sources: Clinical trials of antiviral drugs and epidemiologic data. Target Population: Noninstitutionalized adults older than 65 years of age with influenza-like illness. Time Horizon: Lifetime. Perspective: Societal. Interventions: Rapid diagnostic testing or empirical therapy with antiviral drugs. Outcome Measures: Cost per quality-adjusted life-year (QALY) saved. Results of Base-Case Analysis: Compared with no intervention, empirically treating an unvaccinated 75-year-old patient with amantadine increased life expectancy by 0.0014 QALY at a cost of $1.57, a cost-effectiveness ratio of $1129 per QALY saved. Compared with amantadine, rapid diagnostic testing followed by treatment with oseltamivir cost $5025 per QALY saved and empirical treatment with oseltamivir cost $10 296 per QALY saved. Testing and treatment strategies were less cost-effective if the patient was vaccinated, ranging from $2483 per QALY saved with amantadine to $70 300 per QALY saved with oseltamivir. Results of Sensitivity Analysis: The decision was sensitive to the probability of influenza, the efficacy of oseltamivir in preventing hospitalizations, and hospitalization and case-fatality rates. The decision was not sensitive to the probability or severity of medication side effects, the quality of life for influenza illness or hospitalization, the efficacy of antiviral therapy in shortening influenza illness, or the rapid diagnostic test characteristics. Conclusions: For unvaccinated or high-risk vaccinated patients during the influenza season, empirical oseltamivir treatment is cost-effective. For other patients, rapid diagnostic testing followed by treatment with oseltamivir is cost-effective. Empirical amantadine treatment offers a low-cost alternative if patients cannot afford oseltamivir.	Baystate Med Ctr, Div Gen Med & Geriatr, Springfield, MA 01199 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA	Baystate Medical Center; Tufts University	Rothberg, MB (corresponding author), Baystate Med Ctr, Div Gen Med & Geriatr, 759 Chestnut St, Springfield, MA 01199 USA.	Michael.Rothberg@bhs.org						[Anonymous], 1999, MED LETT DRUGS THER, V41, P121; BARKER WH, 1980, AM J EPIDEMIOL, V112, P798, DOI 10.1093/oxfordjournals.aje.a113052; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Bowles SK, 2002, J AM GERIATR SOC, V50, P608, DOI 10.1046/j.1532-5415.2002.50153.x; Bridges Carolyn B, 2002, MMWR Recomm Rep, V51, P1; *CDCP, 2002, REP SURV METH US CUR; Cox FM, 2000, AM J MANAG CARE, V6, P205; Crane M, 2001, Med Econ, V78, P50; CRANE M, 2001, MED ECON, V78, P55; DEMICHELI V, 2001, COCHRANE DB SYST REV; Diggory P, 2001, BRIT MED J, V322, P577, DOI 10.1136/bmj.322.7286.577; DOLIN R, 1982, NEW ENGL J MED, V307, P580, DOI 10.1056/NEJM198209023071002; *GLAX WELLC, 2001, REL ZAN INH PACK INS; Gold MR., 1996, COST EFFECTIVENESS H; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Govaert TME, 1998, FAM PRACT, V15, P16, DOI 10.1093/fampra/15.1.16; Gravenstein S, 2002, CLIN INFECT DIS, V35, P729, DOI 10.1086/341246; Griffin AD, 2001, PHARMACOECONOMICS, V19, P293, DOI 10.2165/00019053-200119030-00007; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Hayden FG, 1996, JAMA-J AM MED ASSOC, V275, P295, DOI 10.1001/jama.275.4.295; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Hayden FG, 1997, NEW ENGL J MED, V337, P874, DOI 10.1056/NEJM199709253371302; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; Jefferson T, 1999, PHARMACOECONOMICS, V16, P85, DOI 10.2165/00019053-199916001-00011; Kaiser L, 2000, ARCH INTERN MED, V160, P3234, DOI 10.1001/archinte.160.21.3234; Kerlikowske K, 1999, JAMA-J AM MED ASSOC, V282, P2156, DOI 10.1001/jama.282.22.2156; Keyser LA, 2000, ARCH INTERN MED, V160, P1485, DOI 10.1001/archinte.160.10.1485; Lalezari J, 2001, ARCH INTERN MED, V161, P212, DOI 10.1001/archinte.161.2.212; Lee PY, 2002, ANN INTERN MED, V137, P225, DOI 10.7326/0003-4819-137-4-200208200-00005; Libow LS, 1996, J AM GERIATR SOC, V44, P1153, DOI 10.1111/j.1532-5415.1996.tb01363.x; Matsumoto K, 1999, ANTIVIR THER, V4, P61; *MED EC, 2001, 2001 DRUG TOP RED BO; Monto AS, 1999, J ANTIMICROB CHEMOTH, V44, P23, DOI 10.1093/jac/44.suppl_2.23; Monto AS, 1999, J INFECT DIS, V180, P254, DOI 10.1086/314904; Muennig PA, 2001, CLIN INFECT DIS, V33, P1879, DOI 10.1086/324491; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Nicholson KG, 1997, BRIT MED J, V315, P1060, DOI 10.1136/bmj.315.7115.1060; Silagy C, 1998, LANCET, V352, P1877, DOI 10.1016/S0140-6736(98)10190-3; Simonsen L, 2000, J INFECT DIS, V181, P831, DOI 10.1086/315320; Smith KJ, 2002, AM J MED, V113, P300, DOI 10.1016/S0002-9343(02)01222-6; STANGE KC, 1991, J AM GERIATR SOC, V39, P700, DOI 10.1111/j.1532-5415.1991.tb03625.x; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; US Department of Labor Bureau of Labor Statistic, CONS PRIC IND ALL UR; Wenzel RP, 2000, JAMA-J AM MED ASSOC, V283, P1057, DOI 10.1001/jama.283.8.1057; Zambon M, 2001, ARCH INTERN MED, V161, P2116, DOI 10.1001/archinte.161.17.2116; 1999, MED LETT DRUGS THER, V41, P91	47	59	63	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 2	2003	139	5	1				321	329		10.7326/0003-4819-139-5_Part_1-200309020-00007	http://dx.doi.org/10.7326/0003-4819-139-5_Part_1-200309020-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	716PL	12965940				2022-12-01	WOS:000185037500002
J	Snowdon, DA				Snowdon, DA			Healthy aging and dementia: Findings from the Nun Study	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	8th Regenstrief Conference	SEP 30-OCT 02, 2002	MARSHALL, IN				ALZHEIMERS-DISEASE; EARLY-LIFE; LINGUISTIC ABILITY; COGNITIVE FUNCTION	The Nun Study is a longitudinal study of 678 Catholic sisters 75 to 107 years of age who are members of the School Sisters of Notre Dame congregation. Data collected for this study include early and middle-life risk factors from the convent archives, annual cognitive and physical function evaluations during old age, and postmortem neuropathologic evaluations of the participants' brains. The case histories presented include a centenarian who was a model of healthy aging, a 92-year-old with dementia and clinically significant Alzheimer disease neuropathology and vascular lesions, a cognitively and physically intact centenarian with almost no neuropathology, and an 85-year-old with well-preserved cognitive and physical function despite a genetic predisposition to Alzheimer disease and an abundance of Alzheimer disease lesions. These case histories provide examples of how healthy aging and dementia relate to the degree of pathology present in the brain and the level of resistance to the clinical expression of the neuropathology.	Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA	University of Kentucky	Snowdon, DA (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, 320 Hlth Sci Bldg, Lexington, KY 40536 USA.	dsnowdon@nunstudy.mi8.com			NIA NIH HHS [5P50AG05144, R01AG09862, K04AG00553] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K04AG000553, P50AG005144, R01AG009862] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Butler SM, 1996, J GERONTOL B-PSYCHOL, V51, pS201, DOI 10.1093/geronb/51B.4.S201; Danner DD, 2001, J PERS SOC PSYCHOL, V80, P804, DOI 10.1037/0022-3514.80.5.804; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; OHM TG, 1995, NEUROSCIENCE, V64, P209, DOI 10.1016/0306-4522(95)90397-P; Riley KP, 2002, ANN NEUROL, V51, P567, DOI 10.1002/ana.10161; Snowdon DA, 1997, GERONTOLOGIST, V37, P150, DOI 10.1093/geront/37.2.150; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.1997.03540340047031; Snowdon DA, 1999, 1ST INTERNATIONAL CONGRESS ON VASCULAR DEMENTIA, P19; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; Snowdon DA, 2000, ANN NY ACAD SCI, V903, P34, DOI 10.1111/j.1749-6632.2000.tb06347.x; SNOWDON DA, 1999, PARADOXES LONGEVITY, P103, DOI DOI 10.1007/978-3-642-60100-2_9; Snowdon David, 2001, AGING GRACE WHAT NUN; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248	15	192	204	3	46	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 2	2003	139	5	2	S			450	454		10.7326/0003-4819-139-5_Part_2-200309021-00014	http://dx.doi.org/10.7326/0003-4819-139-5_Part_2-200309021-00014			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	718FE	12965975				2022-12-01	WOS:000185133800014
J	Harris, HH; Pickering, IJ; George, GN				Harris, HH; Pickering, IJ; George, GN			The chemical form of mercury in fish	SCIENCE			English	Article									SLAC, Stanford Synchrotron Radiat Lab, Menlo Pk, CA 94025 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	George, GN (corresponding author), Univ Saskatchewan, Dept Geol Sci, 114 Sci Pl, Saskatoon, SK S7N 5E2, Canada.		Pickering, Ingrid J/A-4547-2013; Harris, Hugh/A-4983-2008; George, Graham N/E-3290-2013	Pickering, Ingrid J/0000-0002-0936-2994; Harris, Hugh/0000-0002-3472-8628; George, Graham/0000-0002-0420-7493				Allen F.H., 1993, CHEM DESIGN AUTOMATI, V8, P31; Goyer R., 2000, TOXICOLOGICAL EFFECT; Guallar E, 2002, NEW ENGL J MED, V347, P1747, DOI 10.1056/NEJMoa020157; Wagemann R, 1998, SCI TOTAL ENVIRON, V218, P19, DOI 10.1016/S0048-9697(98)00192-2	4	1140	1183	3	320	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 29	2003	301	5637					1203	1203		10.1126/science.1085941	http://dx.doi.org/10.1126/science.1085941			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZC	12947190				2022-12-01	WOS:000185003500031
J	Tagliabue, E; Agresti, R; Carcangiu, ML; Ghirelli, C; Morelli, D; Campiglio, M; Martel, M; Giovanazzi, R; Greco, M; Balsari, A; Menard, S				Tagliabue, E; Agresti, R; Carcangiu, ML; Ghirelli, C; Morelli, D; Campiglio, M; Martel, M; Giovanazzi, R; Greco, M; Balsari, A; Menard, S			Role of HER2 in wound-induced breast carcinoma proliferation	LANCET			English	Article							GROWTH-FACTOR; TUMOR RECURRENCE; CELLS; CANCER; MASTECTOMY; RESECTION; ANTIBODY; IMMUNOSUPPRESSION; PROGRESSION; IRRADIATION	Objective: Clinical and experimental data have suggested that surgical removal of primary tumours promotes the growth of metastatic lesions. We assessed the effect of surgery on proliferation of breast carcinomas, in particular those overexpressing HER2 oncoprotein. Methods: Proliferation of breast carcinoma cells was assessed by MIB-1 immunohistochemistry in sections of primary breast carcinomas and in residual tumour found in re-excision specimens, and in in-vitro cell lines by colorimetric assay. Epidermal growth factor (EGF)-like growth factors were measured by displacement of radiolabelled EGF from its receptor. Cellular damage was measured in terms of creatine phosphokinase level. Downmodulation of HER2 was investigated by cytoplasmic expression of anti-HER2 antibody and by inhibition with anti-HER2 antibody trastuzumab. Findings: Residual breast carcinomas that had been surgically removed within 48 days after first surgery showed a significant increase in proliferation if they were HER2-positive. Wound drainage fluid and postsurgical serum samples from patients stimulated in-vitro growth of HER2-overexpressing breast carcinoma cells. Removal of HER2 from the cell membrane led to a striking reduction of the induced proliferation. The amount of EGF-like growth factors in post-surgical serum samples, as well as the extent of drainage-fluid-induced proliferation, directly correlated with the amount of surgical damage assessed by creatine phosphokinase levels (r=0.77, p=0.002 and r=0.69, p=0.009, respectively). Treatment of HER2-positive tumour cells with trastuzumab before adding the growth stimulus abolished drainage-fluid-induced proliferation. Interpretation: HER2 overexpression by breast carcinoma cells has a role in postsurgery stimulation of growth of breast carcinoma cells.	Ist Nazl Tumori, Dept Expt Oncol, Mol Targeting Unit, I-20133 Milan, Italy; Ist Nazl Tumori, Gen Surg Breast Unit B, I-20133 Milan, Italy; Ist Nazl Tumori, Pathol Unit, I-20133 Milan, Italy; Ist Nazl Tumori, Med Lab Unit, I-20133 Milan, Italy; Univ Milan, Inst Pathol, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan	Menard, S (corresponding author), Ist Nazl Tumori, Dept Expt Oncol, Mol Targeting Unit, Via Venezian 1, I-20133 Milan, Italy.	sylvie.menard@istitutotumori.mi.it	Tagliabue, Elda/B-9377-2017; balsari, andrea/M-5657-2016; Agresti, Roberto/AAB-6062-2019; Morelli, Daniele/I-4113-2017; menard, sylvie mm/C-7940-2011	Tagliabue, Elda/0000-0001-9877-2903; balsari, andrea/0000-0002-3250-2668; Agresti, Roberto/0000-0003-4700-1951; Morelli, Daniele/0000-0002-1823-3764; 				BAKER DG, 1989, SURGERY, V106, P525; BLOTNICK S, 1994, P NATL ACAD SCI USA, V91, P2890, DOI 10.1073/pnas.91.8.2890; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; COLE WH, 1985, J SURG ONCOL, V30, P139; Decker D, 1996, SURGERY, V119, P316, DOI 10.1016/S0039-6060(96)80118-8; DEMICHELI R, 1994, J NATL CANCER I, V86, P45; FISHER B, 1989, CANCER RES, V49, P1996; FISHER B, 1992, SEMIN SURG ONCOL, V8, P153; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Haffty BG, 2002, SEMIN RADIAT ONCOL, V12, P329, DOI 10.1053/srao.2002.35252; HANSBROUGH JF, 1984, AM J SURG, V148, P303, DOI 10.1016/0002-9610(84)90459-8; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Hofer SOP, 1998, ARCH SURG-CHICAGO, V133, P383, DOI 10.1001/archsurg.133.4.383; HSU SM, 1981, AM J CLIN PATHOL, V75, P816, DOI 10.1093/ajcp/75.6.816; IOZZO RV, 1995, LAB INVEST, V73, P157; KLAUKE R, 1993, EUR J CLIN CHEM CLIN, V31, P901; MARIKOVSKY M, 1993, P NATL ACAD SCI USA, V90, P3889, DOI 10.1073/pnas.90.9.3889; Menard S, 2000, J CELL PHYSIOL, V182, P150, DOI 10.1002/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E; Menard S, 2002, CLIN CANCER RES, V8, P520; MIZUTANI J, 1992, BRIT J CANCER, V65, P794, DOI 10.1038/bjc.1992.170; MORGENSTERN L, 1973, AM J SURG, V125, P29, DOI 10.1016/0002-9610(73)90005-6; PIZAO PE, 1992, BRIT J CANCER, V66, P660, DOI 10.1038/bjc.1992.333; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Rowley DR, 1998, CANCER METAST REV, V17, P411, DOI 10.1023/A:1006129420005; Schindel DT, 1997, J PEDIATR SURG, V32, P995, DOI 10.1016/S0022-3468(97)90385-7; SCHUH AC, 1990, NATURE, V346, P756, DOI 10.1038/346756a0; SIEWEKE MH, 1994, CRIT REV ONCOGENESIS, V5, P297, DOI 10.1615/CritRevOncog.v5.i2-3.90; Tagliabue E, 2000, J BIOL CHEM, V275, P5388, DOI 10.1074/jbc.275.8.5388; TODARO GJ, 1980, P NATL ACAD SCI-BIOL, V77, P5258, DOI 10.1073/pnas.77.9.5258; VERONESI U, 1981, NEW ENGL J MED, V305, P6, DOI 10.1056/NEJM198107023050102; WATSON DI, 1995, MED J AUSTRALIA, V163, P106, DOI 10.5694/j.1326-5377.1995.tb126131.x	32	118	121	2	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2003	362	9383					527	533		10.1016/S0140-6736(03)14112-8	http://dx.doi.org/10.1016/S0140-6736(03)14112-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	712UW	12932384				2022-12-01	WOS:000184817600009
J	Kashefi, K; Lovley, DR				Kashefi, K; Lovley, DR			Extending the upper temperature limit for life	SCIENCE			English	Article							ELECTRON-ACCEPTOR; GEN. NOV.; FE(III)		Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Lovley, DR (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.							Blochl E, 1997, EXTREMOPHILES, V1, P14; Daniel RM, 2000, CELL MOL LIFE SCI, V57, P250, DOI 10.1007/PL00000688; GOLD T, 1992, P NATL ACAD SCI USA, V89, P6045, DOI 10.1073/pnas.89.13.6045; Jannasch H.W., 1995, GEOPHYS MONOGR SER, V91, P273, DOI DOI 10.1029/GM091P0273; Kashefi K, 2002, APPL ENVIRON MICROB, V68, P1735, DOI 10.1128/AEM.68.4.1735-1742.2002; Kashefi K, 2002, INT J SYST EVOL MICR, V52, P719, DOI 10.1099/00207713-52-3-719; Lovley DR, 2000, ENVIRONMENTAL MICROBE-METAL INTERACTIONS, P3; Russell MJ, 2002, GEOCHEM NEWS, V113, P6; Vargas M, 1998, NATURE, V395, P65, DOI 10.1038/25720	9	442	488	8	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2003	301	5635					934	934		10.1126/science.1086823	http://dx.doi.org/10.1126/science.1086823			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711RY	12920290				2022-12-01	WOS:000184755900028
J	Sakaba, T; Neher, E				Sakaba, T; Neher, E			Direct modulation of synaptic vesicle priming by GABA(B) receptor activation at a glutamatergic synapse	NATURE			English	Article							PRESYNAPTIC CALCIUM CURRENT; TRANSMITTER RELEASE; BRAIN-STEM; G-PROTEINS; INHIBITION; CAMP; RAT; TRANSMISSION; CURRENTS; CALYX	Second messenger cascades involving G proteins(1,2) and calcium(3) are known to modulate neurotransmitter release(4,5). A prominent effect of such a cascade is the downmodulation of presynaptic calcium influx(6,7), which markedly reduces evoked neurotransmitter release(5,7,8). Here we show that G-protein-mediated signalling, such as through GABA (gamma-amino butyric acid) subtype B (GABA(B)) receptors, retards the recruitment of synaptic vesicles during sustained activity and after short-term depression. This retardation occurs through a lowering of cyclic AMP, which blocks the stimulatory effect of increased calcium concentration on vesicle recruitment. In this signalling pathway, cAMP (functioning through the cAMP-dependent guanine nucleotide exchange factor) and calcium/calmodulin cooperate to enhance vesicle priming. The differential modulation of the two forms of synaptic plasticity, presynaptic inhibition and calcium-dependent recovery from synaptic depression, is expected to have interesting consequences for the dynamic behaviour of neural networks.	Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	Max Planck Society	Neher, E (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany.		Neher, Erwin/A-2109-2013	Sakaba, Takeshi/0000-0003-0688-7717				BARNESDAVIES M, 1995, J PHYSIOL-LONDON, V488, P387, DOI 10.1113/jphysiol.1995.sp020974; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; DALE N, 1990, J PHYSIOL-LONDON, V421, P203, DOI 10.1113/jphysiol.1990.sp017941; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dittman JS, 1996, J NEUROSCI, V16, P1623; Eliasson L, 2003, J GEN PHYSIOL, V121, P181, DOI 10.1085/jgp.20028707; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; GILMAN AG, 1995, BIOSCIENCE REP, V15, P65, DOI 10.1007/BF01200143; HESS SD, 1993, SCIENCE, V259, P1169, DOI 10.1126/science.8438167; Isaacson JS, 1998, J NEUROPHYSIOL, V80, P1571, DOI 10.1152/jn.1998.80.3.1571; Kajikawa Y, 2001, P NATL ACAD SCI USA, V98, P8054, DOI 10.1073/pnas.141031298; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Sakaba T, 2003, J NEUROSCI, V23, P837; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Sakaba T, 2001, P NATL ACAD SCI USA, V98, P331, DOI 10.1073/pnas.021541098; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; SILINSKY EM, 1984, J PHYSIOL-LONDON, V346, P243, DOI 10.1113/jphysiol.1984.sp015019; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Takahashi T, 2000, SCIENCE, V289, P460, DOI 10.1126/science.289.5478.460; Takahashi T, 1998, J NEUROSCI, V18, P3138; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Xu XZS, 1998, J BIOL CHEM, V273, P31297, DOI 10.1074/jbc.273.47.31297; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	30	184	191	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 14	2003	424	6950					775	778		10.1038/nature01859	http://dx.doi.org/10.1038/nature01859			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12917685				2022-12-01	WOS:000184733900040
J	Trompouki, E; Hatzivassiliou, E; Tsichritzis, T; Farmer, H; Ashworth, A; Mosialos, G				Trompouki, E; Hatzivassiliou, E; Tsichritzis, T; Farmer, H; Ashworth, A; Mosialos, G			CYLD is a deubiquitinating enzyme that negatively regulates NF-kappa B activation by TNFR family members	NATURE			English	Article							EPSTEIN-BARR-VIRUS; RECEPTOR-ASSOCIATED FACTOR-2; TRANSFORMING PROTEIN LMP1; ECTODERMAL DYSPLASIA; MEMBRANE-PROTEIN; COMPLEX; KINASE; TRAF2; IKK; IDENTIFICATION	Familial cylindromatosis is an autosomal dominant predisposition to tumours of skin appendages called cylindromas. Familial cylindromatosis is caused by mutations in a gene encoding the CYLD protein of previously unknown function(1). Here we show that CYLD is a deubiquitinating enzyme that negatively regulates activation of the transcription factor NF-kappaB by specific tumour-necrosis factor receptors (TNFRs). Loss of the deubiquitinating activity of CYLD correlates with tumorigenesis. CYLD inhibits activation of NF-kappaB by the TNFR family members CD40, XEDAR and EDAR in a manner that depends on the deubiquitinating activity of CYLD. Downregulation of CYLD by RNA-mediated interference augments both basal and CD40-mediated activation of NF-kappaB. The inhibition of NF-kappaB activation by CYLD is mediated, at least in part, by the deubiquitination and inactivation of TNFR-associated factor 2 (TRAF2) and, to a lesser extent, TRAF6. These results indicate that CYLD is a negative regulator of the cytokine-mediated activation of NF-kappaB that is required for appropriate cellular homeostasis of skin appendages.	Biomed Sci Res Ctr Alexander Fleming, Inst Immunol, Vari 16672, Greece; Inst Canc Res, Chester Beatty Labs, Breakthrough Breast Canc Res Ctr, Canc Res UK Gene Funct & Regulat Grp, London SW3 6JB, England	Alexander Fleming Biomedical Sciences Research Center; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Mosialos, G (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Inst Immunol, 34 Alexander Fleming St, Vari 16672, Greece.		Trompouki, Eirini/AAX-9539-2020	Trompouki, Eirini/0000-0002-7242-8810				Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Devergne O, 1996, MOL CELL BIOL, V16, P7098; Devin A, 2000, IMMUNITY, V12, P419, DOI 10.1016/S1074-7613(00)80194-6; Devin A, 2001, MOL CELL BIOL, V21, P3986, DOI 10.1128/MCB.21.12.3986-3994.2001; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hatzivassiliou E, 1997, BIOCHEMISTRY-US, V36, P9221, DOI 10.1021/bi963145k; Hatzivassiliou E, 2002, FRONT BIOSCI, V7, pD319, DOI 10.2741/hatziva; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kaye KM, 1996, P NATL ACAD SCI USA, V93, P11085, DOI 10.1073/pnas.93.20.11085; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; McKenna S, 2003, J BIOL CHEM, V278, P13151, DOI 10.1074/jbc.M212353200; MITCHELL T, 1995, J VIROL, V69, P2968, DOI 10.1128/JVI.69.5.2968-2976.1995; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; Naito A, 2002, P NATL ACAD SCI USA, V99, P8766, DOI 10.1073/pnas.132636999; Nguyen LT, 1999, IMMUNITY, V11, P379, DOI 10.1016/S1074-7613(00)80113-2; Schultheiss U, 2001, EMBO J, V20, P5678, DOI 10.1093/emboj/20.20.5678; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Yan MH, 2002, CURR BIOL, V12, P409, DOI 10.1016/S0960-9822(02)00687-5; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	27	757	787	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 14	2003	424	6950					793	796		10.1038/nature01803	http://dx.doi.org/10.1038/nature01803			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12917689	Green Published			2022-12-01	WOS:000184733900044
J	Santarelli, L; Saxe, M; Gross, C; Surget, A; Battaglia, F; Dulawa, S; Weisstaub, N; Lee, J; Duman, R; Arancio, O; Belzung, C; Hen, R				Santarelli, L; Saxe, M; Gross, C; Surget, A; Battaglia, F; Dulawa, S; Weisstaub, N; Lee, J; Duman, R; Arancio, O; Belzung, C; Hen, R			Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants	SCIENCE			English	Article							CHOLINERGIC SYSTEMS; CELL-PROLIFERATION; MAJOR DEPRESSION; ANXIETY DISORDER; DENTATE GYRUS; ANIMAL-MODEL; GREY-MATTER; ADULT; STRESS; DESIPRAMINE	Various chronic antidepressant treatments increase adult hippocampal neurogenesis, but the functional importance of this phenomenon remains unclear. Here, using genetic and radiological methods, we show that disrupting antidepressant-induced neurogenesis blocks behavioral responses to antidepressants. Serotonin 1A receptor null mice were insensitive to the neurogenic and behavioral effects of fluoxetine, a serotonin selective reuptake inhibitor. X-irradiation of a restricted region of mouse brain containing the hippocampus prevented the neurogenic and behavioral effects of two classes of antidepressants. These findings suggest that the behavioral effects of chronic antidepressants may be mediated by the stimulation of neurogenesis in the hippocampus.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Univ Tours, F-37200 Tours, France; NYU, Sch Med, Nathan Kline Res Inst, New York, NY 10016 USA; Yale Univ, Lab Mol Psychiat, Dept Psychiat, New Haven, CT 06508 USA	Columbia University; Universite de Tours; Nathan Kline Institute for Psychiatric Research; New York University; Yale University	Hen, R (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA.		Belzung, Catherine/P-6512-2016; Dulawa, Stephanie/M-8070-2016; arancio, ottavio/AAB-7959-2019; Surget, Alexandre/C-6630-2013; Weisstaub, Noelia/ABA-1706-2021	Belzung, Catherine/0000-0001-6095-5974; Dulawa, Stephanie/0000-0003-1281-782X; Surget, Alexandre/0000-0002-0333-4634; arancio, ottavio/0000-0001-6335-164X				Bannerman DM, 2002, BEHAV NEUROSCI, V116, P884, DOI 10.1037//0735-7044.116.5.884; BODNOFF SR, 1988, PSYCHOPHARMACOLOGY, V95, P298; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; Deacon RMJ, 2002, BEHAV NEUROSCI, V116, P494, DOI 10.1037//0735-7044.116.3.494; Degroot A, 2002, BRAIN RES, V949, P60, DOI 10.1016/S0006-8993(02)02965-7; Delgado PL, 1999, BIOL PSYCHIAT, V46, P212, DOI 10.1016/S0006-3223(99)00014-1; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Eichenbaum H, 1999, CURR BIOL, V9, pR482, DOI 10.1016/S0960-9822(99)80301-7; File SE, 2000, PHARMACOL BIOCHEM BE, V66, P65, DOI 10.1016/S0091-3057(00)00198-2; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Gorman JM, 2002, J CLIN PSYCHIAT, V63, P17; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Griebel G, 2002, P NATL ACAD SCI USA, V99, P6370, DOI 10.1073/pnas.092012099; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Kempermann G, 2002, BIPOLAR DISORD, V4, P17, DOI 10.1034/j.1399-5618.2002.40101.x; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; McNaughton N, 1997, PHARMACOL BIOCHEM BE, V56, P603, DOI 10.1016/S0091-3057(96)00419-4; Menard J, 2001, BRAIN RES, V888, P163, DOI 10.1016/S0006-8993(00)03046-8; Menard J, 1998, BEHAV PHARMACOL, V9, P93; Moore GJ, 2000, LANCET, V356, P1241, DOI 10.1016/S0140-6736(00)02793-8; Nagai R, 2000, SURG NEUROL, V53, P503, DOI 10.1016/S0090-3019(00)00214-7; Page ME, 1999, PSYCHOPHARMACOLOGY, V147, P162, DOI 10.1007/s002130051156; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Sapolsky RM, 1992, STRESS AGING BRAIN M; Sargent PA, 2000, ARCH GEN PSYCHIAT, V57, P174, DOI 10.1001/archpsyc.57.2.174; Shah PJ, 1998, BRIT J PSYCHIAT, V172, P527, DOI 10.1192/bjp.172.6.527; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Tada E, 2000, NEUROSCIENCE, V99, P33, DOI 10.1016/S0306-4522(00)00151-2; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wong ML, 2001, NAT REV NEUROSCI, V2, P343, DOI 10.1038/35072566	37	3268	3459	13	477	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					805	809		10.1126/science.1083328	http://dx.doi.org/10.1126/science.1083328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907793				2022-12-01	WOS:000184615700036
J	Gordon, JM; Feuermann, D; Huleihil, M; Mizrahi, S; Shaco-Levy, R				Gordon, JM; Feuermann, D; Huleihil, M; Mizrahi, S; Shaco-Levy, R			Fibre optics - Surgery by sunlight on live animals	NATURE			English	Editorial Material							SOLAR SURGERY		Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Dept Solar Energy & Environm Phys, IL-84990 Sede Boqer, Israel; Ben Gurion Univ Negev, Dept Mech Engn, Pearlstone Ctr Aeronaut Engn Studies, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Dept Surg A, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Dept Pathol, Soroka Med Ctr, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University	Gordon, JM (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Dept Solar Energy & Environm Phys, IL-84990 Sede Boqer, Israel.		feuermann, daniel/G-7545-2011; GORDON, JEFFREY/F-1432-2012	feuermann, daniel/0000-0002-9381-2387				De Sanctis JT, 1998, CARDIOVASC INTER RAD, V21, P273, DOI 10.1007/s002709900263; Feuermann D, 1998, OPT ENG, V37, P2760, DOI 10.1117/1.601813; Feuermann D, 2002, SOL ENERGY, V72, P459, DOI 10.1016/S0038-092X(02)00025-7; Fujitomi Y, 1999, LASER SURG MED, V24, P14, DOI 10.1002/(SICI)1096-9101(1999)24:1<14::AID-LSM4>3.0.CO;2-2; Gordon JM, 2003, J APPL PHYS, V93, P4843, DOI 10.1063/1.1558999; Gordon JM, 2002, APPL PHYS LETT, V81, P2653, DOI 10.1063/1.1510942; Katzir A., 1993, LASERS OPTICAL FIBER	7	14	14	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					510	510		10.1038/424510a	http://dx.doi.org/10.1038/424510a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891346				2022-12-01	WOS:000184454700030
J	Harris, KD; Csicsvari, J; Hirase, H; Dragoi, G; Buzsaki, G				Harris, KD; Csicsvari, J; Hirase, H; Dragoi, G; Buzsaki, G			Organization of cell assemblies in the hippocampus	NATURE			English	Article							PYRAMIDAL CELLS; PHASE PRECESSION; BEHAVING RAT; PLACE CELLS; NEURONS; OSCILLATIONS; ENSEMBLE; CODE; DYNAMICS; PATTERNS	Neurons can produce action potentials with high temporal precision(1). A fundamental issue is whether, and how, this capability is used in information processing. According to the 'cell assembly' hypothesis, transient synchrony of anatomically distributed groups of neurons underlies processing of both external sensory input and internal cognitive mechanisms(2-4). Accordingly, neuron populations should be arranged into groups whose synchrony exceeds that predicted by common modulation by sensory input. Here we find that the spike times of hippocampal pyramidal cells can be predicted more accurately by using the spike times of simultaneously recorded neurons in addition to the animals location in space. This improvement remained when the spatial prediction was refined with a spatially dependent theta phase modulation(5-8). The time window in which spike times are best predicted from simultaneous peer activity is 10-30 ms, suggesting that cell assemblies are synchronized at this timescale. Because this temporal window matches the membrane time constant of pyramidal neurons(9), the period of the hippocampal gamma oscillation(10) and the time window for synaptic plasticity(11), we propose that cooperative activity at this timescale is optimal for information transmission and storage in cortical circuits.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.		Hirase, Hajime/A-3709-2012; Harris, Kenneth/B-3469-2009	Hirase, Hajime/0000-0003-3806-6905; Harris, Kenneth/0000-0002-5930-6456; Buzsaki, Gyorgy/0000-0002-3100-4800				Brown EN, 1998, J NEUROSCI, V18, P7411; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; Cox D. R., 1980, POINT PROCESSES; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P3182, DOI 10.1073/pnas.95.6.3182; Freiwald W A, 2001, Prog Brain Res, V130, P111; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hebb D.O., 2002, CLIN PSYCHOL; Hirase H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-10-j0003.2001; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Quirk MC, 1999, J NEUROSCI METH, V94, P41, DOI 10.1016/S0165-0270(99)00124-7; Redish AD, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-05-j0004.2001; Reinagel P, 2002, J NEUROSCI, V22, P6837; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SPRUSTON N, 1992, J NEUROPHYSIOL, V67, P508, DOI 10.1152/jn.1992.67.3.508; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	30	553	558	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					552	556		10.1038/nature01834	http://dx.doi.org/10.1038/nature01834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891358				2022-12-01	WOS:000184454700043
J	Marquet, RL; Bartelds, A; Visser, GJ; Spreeuwenberg, P; Peters, L				Marquet, RL; Bartelds, A; Visser, GJ; Spreeuwenberg, P; Peters, L			Twenty five years of requests for euthanasia and physician assisted suicide in Dutch general practice: trend analysis	BRITISH MEDICAL JOURNAL			English	Article									Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands	Netherlands Institute for Health Services Research	Marquet, RL (corresponding author), Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands.							de Wit MAS, 2001, EMERG INFECT DIS, V7, P82, DOI 10.3201/eid0701.010113; Hughes J, 2000, J Appl Philos, V17, P213, DOI 10.1111/1468-5930.00155; Lavery JV, 2001, LANCET, V358, P362, DOI 10.1016/S0140-6736(01)05555-6; ONWUTEAKAPHILIP.BD, 1990, LANCET; Thynne Kelisiana, 2002, J Law Med, V10, P232	5	30	30	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2003	327	7408					201	202		10.1136/bmj.327.7408.201	http://dx.doi.org/10.1136/bmj.327.7408.201			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706DL	12881262	Bronze, Green Published			2022-12-01	WOS:000184437300018
J	Roman, J; Palumbi, SR				Roman, J; Palumbi, SR			Whales before whaling in the North Atlantic	SCIENCE			English	Article							POPULATION-SIZE; HUMPBACK WHALES; CONSERVATION; POLYMORPHISM; JAPANESE; COLLAPSE	It is well known that hunting dramatically reduced all baleen whale populations, yet reliable estimates of former whale abundances are elusive. Based on coalescent models for mitochondrial DNA sequence variation, the genetic diversity of North Atlantic whales suggests population sizes of approximately 240,000 humpback, 360,000 fin, and 265,000 minke whales. Estimates for fin and humpback whales are far greater than those previously calculated for prewhaling populations and 6 to 20 times higher than present-day population estimates. Such discrepancies suggest the need for a quantitative reevaluation of historical whale populations and a fundamental revision in our conception of the natural state of the oceans.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Roman, J (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 16 Divin Ave, Cambridge, MA 02138 USA.							Angliss RP, 1995, REP INT WHAL COMM, V45, P313; AVISE JC, 1988, MOL BIOL EVOL, V5, P331; Baker CS, 2000, P ROY SOC B-BIOL SCI, V267, P1191, DOI 10.1098/rspb.2000.1128; BAKER CS, 1993, P NATL ACAD SCI USA, V90, P8239, DOI 10.1073/pnas.90.17.8239; Barlow J, 1997, ECOLOGY, V78, P535; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; CHITTLEBOROUGH R. G., 1965, AUSTRALIAN J MAR FRESHWATER RES, V16, P33; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Horwood J, 1990, BIOL EXPLOITATION MI; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kellogg R., 1922, Proceedings of the United States National Museum, V61, P1; KISHINO H, 1991, ANN I STAT MATH, V43, P435, DOI 10.1007/BF00053365; Klinowska M., 1991, DOLPHINS PORPOISES W; Lockyer C, 1977, Report int Whal Commn, V27, P427; Lockyer C., 1984, REP INT WHAL COMMN S, V6, P27; Lockyer C, 1981, REP INT WHAL COMMN, V31, P389; MATHER R, 1850, J R MATHER; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Neigel JE, 2002, CONSERV GENET, V3, P167, DOI 10.1023/A:1015213626922; Nowak R.M., 1999, MAMMALS WORLD; NUNNEY L, 1993, EVOLUTION, V47, P1329, DOI [10.2307/2410151, 10.1111/j.1558-5646.1993.tb02158.x]; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Rand DM, 1996, CONSERV BIOL, V10, P665, DOI 10.1046/j.1523-1739.1996.10020665.x; ROMAN JM, UNPUB; Rooney AP, 2001, EVOLUTION, V55, P1678; Rosenbaum HC, 2002, J HERED, V93, P389, DOI 10.1093/jhered/93.6.389; Sergeant D. E., 1977, Report int. Whal. Commn, V27, P460; Sigurjonsson J, 1995, DEV MAR BIO, V4, P425; Smith TD, 1999, MAR MAMMAL SCI, V15, P1, DOI 10.1111/j.1748-7692.1999.tb00779.x; Soule M., 1976, Molecular evolution., P60; STEVICK PT, 2001, SC53NAH2 IWC; WADA S, 1991, REPORTS INT WHALING, V13, P125; WAPLES R, 1991, REP INT WHALING COMM, V15, P279; Weller David W., 2002, Journal of Cetacean Research and Management, V4, P7; Winn H.E., 1985, HDB MARINE MAMMALS, V3, P241	36	219	238	3	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2003	301	5632					508	510		10.1126/science.1084524	http://dx.doi.org/10.1126/science.1084524			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881568				2022-12-01	WOS:000184340500040
J	de Craen, AJ; Gussekloo, J; Teng, YKO; Macfarlane, PW; Westendorp, RGJ				de Craen, AJ; Gussekloo, J; Teng, YKO; Macfarlane, PW; Westendorp, RGJ			Prevalence of five common clinical abnormalities in very elderly people: population based cross sectional study	BRITISH MEDICAL JOURNAL			English	Article									Leiden Univ, Med Ctr, Sect Gerontol & Geriatr, Dept Gen Internal Med, NL-2300 RC Leiden, Netherlands; Univ Glasgow, Dept Med Cardiol, Glasgow G31 2ER, Lanark, Scotland	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Glasgow	de Craen, AJ (corresponding author), Leiden Univ, Med Ctr, Sect Gerontol & Geriatr, Dept Gen Internal Med, POB 9600, NL-2300 RC Leiden, Netherlands.		Teng, Yoe Kie Onno/S-1765-2019; Gussekloo, Jacobijn/ABE-3879-2021	Teng, Yoe Kie Onno/0000-0001-9920-2195; Gussekloo, Jacobijn/0000-0001-7186-8278				IZAKS GJ, 1999, JAMA-J AM MED ASSOC, V18, P714; Macfarlane PW, 1996, J ELECTROCARDIOL, V29, P29, DOI 10.1016/S0022-0736(96)80016-1; TOPOL E.J., 1998, TXB CARDIOVASCULAR M; von Faber M, 2001, ARCH INTERN MED, V161, P2694, DOI 10.1001/archinte.161.22.2694; *WHO, 1996, GUID ATC CLASS DDD A	5	7	7	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 19	2003	327	7407					131	132		10.1136/bmj.327.7407.131	http://dx.doi.org/10.1136/bmj.327.7407.131			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702WJ	12869453	Bronze, Green Accepted, Green Published			2022-12-01	WOS:000184247500016
J	Grimsby, J; Sarabu, R; Corbett, WL; Haynes, NE; Bizzarro, FT; Coffey, JW; Guertin, KR; Hilliard, DW; Kester, RF; Mahaney, PE; Marcus, L; Qi, LD; Spence, CL; Tengi, J; Magnuson, MA; Chu, CA; Dvorozniak, MT; Matschinsky, FM; Grippo, JF				Grimsby, J; Sarabu, R; Corbett, WL; Haynes, NE; Bizzarro, FT; Coffey, JW; Guertin, KR; Hilliard, DW; Kester, RF; Mahaney, PE; Marcus, L; Qi, LD; Spence, CL; Tengi, J; Magnuson, MA; Chu, CA; Dvorozniak, MT; Matschinsky, FM; Grippo, JF			Allosteric activators of glucokinase: Potential role in diabetes therapy	SCIENCE			English	Article							GLUCOSE-HOMEOSTASIS; BETA-CELL; MUTATIONS; MELLITUS; MUTANTS; MODY-2; LIVER; MICE	Glucokinase (GK) plays a key role in whole-body glucose homeostasis by catalyzing the phosphorylation of glucose in cells that express this enzyme, such as pancreatic beta cells and hepatocytes. We describe a class of antidiabetic agents that act as nonessential, mixed-type GK activators (GKAs) that increase the glucose affinity and maximum velocity (V-max) of GK. GKAs augment both hepatic glucose metabolism and glucose-induced insulin secretion from isolated rodent pancreatic islets, consistent with the expression and function of GK in both cell types. In several rodent models of type 2 diabetes mellitus, GKAs lowered blood glucose levels, improved the results of glucose tolerance tests, and increased hepatic glucose uptake. These findings may lead to the development of new drug therapies for diabetes.	Hoffmann La Roche Inc, Dept Metab Dis, Nutley, NJ 07110 USA; Vanderbilt Univ, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA; Univ Penn, Sch Med, Dept Biochem, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Diabet, Philadelphia, PA 19104 USA	Roche Holding; Vanderbilt University; University of Pennsylvania; University of Pennsylvania	Grippo, JF (corresponding author), Hoffmann La Roche Inc, Dept Metab Dis, 340 Kingsland St, Nutley, NJ 07110 USA.		Magnuson, Mark/AAY-7172-2021; Magnuson, Mark A/B-1335-2009	Magnuson, Mark/0000-0002-8824-6499; Magnuson, Mark A/0000-0002-8824-6499				BELL GI, 2002, ENCY MOL MED, P1437; Christesen HBT, 2002, DIABETES, V51, P1240, DOI 10.2337/diabetes.51.4.1240; Clement K, 1996, DIABETOLOGIA, V39, P82; Davis EA, 1999, DIABETOLOGIA, V42, P1175, DOI 10.1007/s001250051289; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Desai UJ, 2001, DIABETES, V50, P2287, DOI 10.2337/diabetes.50.10.2287; Ferre T, 1996, P NATL ACAD SCI USA, V93, P7225, DOI 10.1073/pnas.93.14.7225; GIDHJAIN M, 1993, P NATL ACAD SCI USA, V90, P1932, DOI 10.1073/pnas.90.5.1932; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; GRIMSBY J, UNPUB; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; LIANG Y, 1995, BIOCHEM J, V309, P167, DOI 10.1042/bj3090167; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Miller SP, 1999, DIABETES, V48, P1645, DOI 10.2337/diabetes.48.8.1645; Morral N, 2002, HUM GENE THER, V13, P1561, DOI 10.1089/10430340260201653; Segel I.H., 1993, ENZYME KINETICS, P227; Shiota M, 2001, DIABETES, V50, P622, DOI 10.2337/diabetes.50.3.622; Sweet IR, 1996, AM J PHYSIOL-ENDOC M, V271, pE606, DOI 10.1152/ajpendo.1996.271.3.E606; TAKEDA J, 1993, J BIOL CHEM, V268, P15200; Velho G, 1996, J CLIN INVEST, V98, P1755, DOI 10.1172/JCI118974; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0	21	403	458	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					370	373		10.1126/science.1084073	http://dx.doi.org/10.1126/science.1084073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869762				2022-12-01	WOS:000184207300045
J	Brandel, JP; Preece, M; Brown, P; Croes, E; Laplanche, JL; Agid, Y; Will, R; Alperovitch, A				Brandel, JP; Preece, M; Brown, P; Croes, E; Laplanche, JL; Agid, Y; Will, R; Alperovitch, A			Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK	LANCET			English	Article							CREUTZFELDT-JAKOB-DISEASE	Since homozygosity MM at codon 129 of the prion protein gene is a recognised risk factor in all forms of Creutzfeldt-Jakob disease (CJD), we studied the distribution of codon 129 polymorphism in patients in France and in the UK with CJD transmitted iatrogenically by human growth hormone. The overall frequencies of codon 1.29 genotypes in these patients differed from those in the population unaffected by CJD. An excess of VV homozygotes was noted among those with iatrogenic CJD compared with sporadic CJD cases. The proportion of MM genotype in UK patients was surprisingly low (4%) compared with that in French patients (62%). There is no evident explanation for this different distribution, which might be due to infection with different strains of prion in human growth hormone.	Salpetriere Hosp, Natl Reference Ctr Latrogen CJD, F-75651 Paris 13, France; Salpetriere Hosp, INSERM, U360, F-75651 Paris, France; Inst Child Hlth, London, England; NIH, Lab CNS Studies, Bethesda, MD 20892 USA; Erasmus Univ, Sch Med, Rotterdam, Netherlands; Lariboisiere Hosp, Cent Lab Biochem, Paris, France; Western Gen Hosp, CJD Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; National Institutes of Health (NIH) - USA; Erasmus University Rotterdam; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Edinburgh	Brandel, JP (corresponding author), Salpetriere Hosp, Natl Reference Ctr Latrogen CJD, F-75651 Paris 13, France.		LAPLANCHE, Jean-Louis/S-8707-2016	LAPLANCHE, Jean-Louis/0000-0003-2836-2903				Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; LAPLANCHE JL, 1994, NEUROLOGY, V44, P2347, DOI 10.1212/WNL.44.12.2347; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Swerdlow AJ, 2002, LANCET, V360, P273, DOI 10.1016/S0140-6736(02)09519-3	5	74	75	0	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 12	2003	362	9378					128	130		10.1016/S0140-6736(03)13867-6	http://dx.doi.org/10.1016/S0140-6736(03)13867-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699ZY	12867116				2022-12-01	WOS:000184089200015
J	Palanivelu, R; Brass, L; Edlund, AF; Preuss, D				Palanivelu, R; Brass, L; Edlund, AF; Preuss, D			Pollen tube growth and guidance is regulated by POP2, an Arabidopsis gene that controls GABA levels	CELL			English	Article							CELL-MOVEMENT; TIP GROWTH; GLUTAMATE; RECEPTORS; FEMALE; ACID; SIGNALS; IDENTIFICATION; FERTILIZATION; TRANSAMINASE	During angiosperm reproduction, pollen grains form a tube that navigates through female tissues to the micropyle, delivering sperm to the egg; the signals that mediate this process are poorly understood. Here, we describe a role for gamma-amino butyric acid (GABA) in pollen tube growth and guidance. In vitro, GABA stimulates pollen tube growth, although vast excesses are inhibitory. The Arabidopsis POP2 gene encodes a transaminase that degrades GABA and contributes to the formation of a gradient leading up to the micropyle. pop2 flowers accumulate GABA, and the growth of many pop2 pollen tubes is arrested, consistent with their in vitro GABA hypersensitivity. Some pop2 tubes continue to grow toward ovules, yet they are misguided, presumably because they target ectopic GABA on the ovule surface. Interestingly, wild-type tubes exhibit normal growth and guidance in pop2 pistils, perhaps by degrading excess GABA and sharpening the gradient leading to the micropyle.	Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago	Preuss, D (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA.	dpreuss@midway.uchicago.edu	Palanivelu, Ravishankar/AAE-6664-2020					Barker JL, 1998, PERSPECT DEV NEUROBI, V5, P305; Baum G, 1996, EMBO J, V15, P2988, DOI 10.1002/j.1460-2075.1996.tb00662.x; Behar TN, 2001, CEREB CORTEX, V11, P744, DOI 10.1093/cercor/11.8.744; BOWMAN JL, 1993, ARABIDOPSIS ATLAS MO, P135; Brenner ED, 2000, PLANT PHYSIOL, V124, P1615, DOI 10.1104/pp.124.4.1615; Brice NL, 2002, DIABETOLOGIA, V45, P242, DOI 10.1007/s00125-001-0750-0; CHAO CY, 1971, AM J BOT, V58, P649, DOI 10.2307/2441009; Christensen CA, 2002, PLANT CELL, V14, P2215, DOI 10.1105/tpc.002170; CHUNG ID, 1992, PLANT PHYSIOL, V99, P659, DOI 10.1104/pp.99.2.659; Firtel RA, 2000, CURR OPIN GENET DEV, V10, P421, DOI 10.1016/S0959-437X(00)00107-6; Gamel-Didelon K, 2002, NEUROENDOCRINOLOGY, V76, P170, DOI 10.1159/000064523; GIBSON KM, 1990, BIOMED ENVIRON MASS, V19, P89, DOI 10.1002/bms.1200190207; HANSEN GH, 1987, NEUROTROPHIC ACTIVIT, P109; Higashiyama T, 2001, SCIENCE, V293, P1480, DOI 10.1126/science.1062429; Huck N, 2003, DEVELOPMENT, V130, P2149, DOI 10.1242/dev.00458; Johnson MA, 2002, DEV CELL, V2, P273, DOI 10.1016/S1534-5807(02)00130-2; KANDASAMY MK, 1994, DEVELOPMENT, V120, P3405; KANDASAMY MK, 1989, DEV BIOL, V134, P462, DOI 10.1016/0012-1606(89)90119-X; KATER SB, 1991, J NEUROSCI, V11, P891; Kathiresan A, 1998, PLANT GROWTH REGUL, V26, P131, DOI 10.1023/A:1006107815064; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; Lam HM, 1998, NATURE, V396, P125, DOI 10.1038/24066; Lasswell J, 2000, PLANT CELL, V12, P2395, DOI 10.1105/tpc.12.12.2395; Li H, 1999, PLANT CELL, V11, P1731, DOI 10.1105/tpc.11.9.1731; Lord E, 2000, TRENDS PLANT SCI, V5, P368, DOI 10.1016/S1360-1385(00)01744-1; Maitre M, 2000, ALCOHOL, V20, P277, DOI 10.1016/S0741-8329(99)00092-0; MASCARENHAS JP, 1993, PLANT CELL, V5, P1303, DOI 10.1105/tpc.5.10.1303; Mayfield JA, 2001, SCIENCE, V292, P2482, DOI 10.1126/science.1060972; Medina-Kauwe LK, 1998, NEUROBIOL DIS, V5, P89, DOI 10.1006/nbdi.1998.0184; Mollet JC, 2000, PLANT CELL, V12, P1737, DOI 10.1105/tpc.12.9.1737; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; Palanivelu R, 2000, TRENDS CELL BIOL, V10, P517, DOI 10.1016/S0962-8924(00)01849-3; Pinal CS, 1998, PERSPECT DEV NEUROBI, V5, P109; Prell J, 2002, MICROBIOL-SGM, V148, P615, DOI 10.1099/00221287-148-2-615; PREUSS D, 1993, GENE DEV, V7, P974, DOI 10.1101/gad.7.6.974; Ray S, 1997, DEVELOPMENT, V124, P2489; Riffell JA, 2002, J EXP BIOL, V205, P1439; ROSENTHAL GA, 1994, BIOSYNTHESIS MOL REG, P245; Rotman N, 2003, CURR BIOL, V13, P432, DOI 10.1016/S0960-9822(03)00093-9; Satin LS, 1998, ENDOCRINE, V8, P213, DOI 10.1385/ENDO:8:3:213; Shelp BJ, 1999, TRENDS PLANT SCI, V4, P446, DOI 10.1016/S1360-1385(99)01486-7; Shimizu KK, 2000, DEVELOPMENT, V127, P4511; Van Cauwenberghe OR, 2002, CAN J BOT, V80, P933, DOI [10.1139/B02-087, 10.1139/b02-087]; Villanneva JM, 1999, GENE DEV, V13, P3160, DOI 10.1101/gad.13.23.3160; Wilhelmi LK, 1996, SCIENCE, V274, P1535, DOI 10.1126/science.274.5292.1535; Wolters-Arts M, 1998, NATURE, V392, P818, DOI 10.1038/33929; Wu HM, 2000, PLANT J, V22, P165, DOI 10.1046/j.1365-313x.2000.00731.x	47	390	422	2	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2003	114	1					47	59		10.1016/S0092-8674(03)00479-3	http://dx.doi.org/10.1016/S0092-8674(03)00479-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	702JC	12859897	Bronze			2022-12-01	WOS:000184219900005
J	Matsuo, T; Yamaguchi, S; Mitsui, S; Emi, A; Shimoda, F; Okamura, H				Matsuo, T; Yamaguchi, S; Mitsui, S; Emi, A; Shimoda, F; Okamura, H			Control mechanism of the circadian clock for timing of cell division in vivo	SCIENCE			English	Article							DNA-SYNTHESIS; PARTIAL-HEPATECTOMY; WEE1 KINASE; LIVER; RHYTHM; PROLIFERATION; MOUSE; RAT; EXPRESSION; CDC2	Cell division in many mammalian tissues is associated with specific times of day, but just how the circadian clock controls this timing has not been clear. Here, we show in the regenerating liver ( of mice) that the circadian clock controls the expression of cell cycle-related genes that in turn modulate the expression of active Cyclin B1-Cdc2 kinase, a key regulator of mitosis. Among these genes, expression of wee1 was directly regulated by the molecular components of the circadian clockwork. In contrast, the circadian clockwork oscillated independently of the cell cycle in single cells. Thus, the intracellular circadian clockwork can control the cell-division cycle directly and unidirectionally in proliferating cells.	Kobe Univ, Grad Sch Med, Dept Brain Sci, Div Mol Brain Sci,Chuo Ku, Kobe, Hyogo 6500017, Japan; Yamaguchi Univ, Dept Phys Informat & Biol, Yamaguchi 7538512, Japan	Kobe University; Yamaguchi University	Okamura, H (corresponding author), Kobe Univ, Grad Sch Med, Dept Brain Sci, Div Mol Brain Sci,Chuo Ku, Kobe, Hyogo 6500017, Japan.	okamurah@kobe-u.ac.jp	MATSUO, Takuya/I-7493-2014	Okamura, Hitoshi/0000-0002-3013-4881				Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; BADE EG, 1966, EXP CELL RES, V44, P676, DOI 10.1016/0014-4827(66)90484-8; Barbason H, 1995, IN VIVO, V9, P539; BARBIROLI B, 1971, SCIENCE, V172, P738, DOI 10.1126/science.172.3984.738; BARNUM CYRUS P., 1957, TEXAS REPTS BIOL AND MED, V15, P134; Bjarnason GA, 2001, AM J PATHOL, V158, P1793, DOI 10.1016/S0002-9440(10)64135-1; Bjarnason GA, 2000, PROG CELL CYC RES, V4, P193; BROWN WR, 1991, J INVEST DERMATOL, V97, P273, DOI 10.1111/1523-1747.ep12480379; BUCHI KN, 1991, GASTROENTEROLOGY, V101, P410, DOI 10.1016/0016-5085(91)90019-H; Garcia MN, 2001, CELL BIOL INT, V25, P179, DOI 10.1006/cbir.2000.0585; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Higgins GM, 1931, ARCH PATHOL, V12, P186; JAFFE JJ, 1954, ANAT REC, V120, P935, DOI 10.1002/ar.1091200408; Kawasaki H, 2001, EMBO J, V20, P4618, DOI 10.1093/emboj/20.16.4618; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Laconi S, 1999, J HEPATOL, V31, P1069, DOI 10.1016/S0168-8278(99)80320-1; Levi F, 2002, CHRONOBIOL INT, V19, P1, DOI 10.1081/CBI-120002676; Liu F, 1997, MOL CELL BIOL, V17, P571, DOI 10.1128/MCB.17.2.571; MATSUO T, UNPUB; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; Ohi R, 1999, CURR OPIN CELL BIOL, V11, P267, DOI 10.1016/S0955-0674(99)80036-2; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Rothblum-Oviatt CJ, 2001, CELL GROWTH DIFFER, V12, P581; SCHEVING LE, 1983, AM J ANAT, V168, P433, DOI 10.1002/aja.1001680405; SCHEVING LE, 1974, ACTA ANAT, V88, P411; Smaaland R, 1996, Prog Cell Cycle Res, V2, P241; SOUTO M, 1985, Chronobiology International, V2, P169, DOI 10.3109/07420528509055556; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323	32	849	891	4	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2003	302	5643					255	259		10.1126/science.1086271	http://dx.doi.org/10.1126/science.1086271			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HT	12934012				2022-12-01	WOS:000185825900033
J	Wiese, MF				Wiese, MF			British hospitals and different versions of the Glasgow coma scale: telephone survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Kings Coll Hosp London, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Wiese, MF (corresponding author), Kings Coll Hosp London, Denmark Hill, London SE5 9RS, England.	wiese@doctors.org.uk						*AM COLL SURG COMM, 1997, ADV TRAUM LIF SUPP S; Diringer MN, 1997, ARCH NEUROL-CHICAGO, V54, P606, DOI 10.1001/archneur.1997.00550170078017; Lenfant F, 1997, ANN FR ANESTH, V16, P239, DOI 10.1016/S0750-7658(97)86408-8; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81	5	10	10	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 4	2003	327	7418					782	783		10.1136/bmj.327.7418.782	http://dx.doi.org/10.1136/bmj.327.7418.782			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729ZQ	14525875	Bronze, Green Published			2022-12-01	WOS:000185805100019
J	Clubb, R; Mason, G				Clubb, R; Mason, G			Captivity effects on wide-ranging carnivores	NATURE			English	Editorial Material							DEPRIVATION; PHYLOGENY; ECOLOGY; SIZE		Univ Oxford, Dept Zool, Anim Behav Res Grp, Oxford OX1 3PS, England	University of Oxford	Clubb, R (corresponding author), Univ Oxford, Dept Zool, Anim Behav Res Grp, S Parks Rd, Oxford OX1 3PS, England.							Bahr NI, 1998, PHYSIOL BEHAV, V64, P429, DOI 10.1016/S0031-9384(98)00057-2; Bininda-Emonds ORP, 1999, BIOL REV, V74, P143, DOI 10.1017/S0006323199005307; CLUBB RE, 2001, THESIS U OXFORD; DAWKINS MS, 1988, APPL ANIM BEHAV SCI, V20, P209, DOI 10.1016/0168-1591(88)90047-0; GITTLEMAN JL, 1986, J MAMMAL, V67, P23, DOI 10.2307/1380998; GITTLEMAN JL, 1982, BEHAV ECOL SOCIOBIOL, V10, P57, DOI 10.1007/BF00296396; Lewis M.H., 1996, STEREOTYPED MOVEMENT, P37; Mason GJ, 2001, NATURE, V410, P35, DOI 10.1038/35065157; Meier J.E., 1986, P842; Mellen J.D., 1998, 2 NATURE ENV ENRICHM, P329; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Robbins TW, 1996, J PSYCHOPHARMACOL, V10, P39, DOI 10.1177/026988119601000107; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126	13	237	245	7	328	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2003	425	6957					473	474		10.1038/425473a	http://dx.doi.org/10.1038/425473a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727FN	14523435	Green Published			2022-12-01	WOS:000185648100033
J	Kefalov, V; Fu, YB; Marsh-Armstrong, N; Yau, KW				Kefalov, V; Fu, YB; Marsh-Armstrong, N; Yau, KW			Role of visual pigment properties in rod and cone phototransduction	NATURE			English	Article							RETINAL CONES; DARK NOISE; ABSORPTION-SPECTRA; XENOPUS-LAEVIS; PHOTORECEPTORS; SENSITIVITY; RHODOPSIN; GREEN; TRANSDUCIN; COMPONENTS	Retinal rods and cones share a phototransduction pathway involving cyclic GMP(1). Cones are typically 100 times less photosensitive than rods and their response kinetics are several times faster(2),but the underlying mechanisms remain largely unknown. Almost all proteins involved in phototransduction have distinct rod and cone variants. Differences in properties between rod and cone pigments have been described, such as a 10-fold shorter lifetime of the meta-II state (active conformation) of cone pigment(3-6) and its higher rate of spontaneous isomerization(7,8), but their contributions to the functional differences between rods and cones remain speculative. We have addressed this question by expressing human or salamander red cone pigment in Xenopus rods, and human rod pigment in Xenopus cones. Here we show that rod and cone pigments when present in the same cell produce light responses with identical amplification and kinetics, thereby ruling out any difference in their signalling properties. However, red cone pigment isomerizes spontaneously 10,000 times more frequently than rod pigment. This high spontaneous activity adapts the native cones even in darkness, making them less sensitive and kinetically faster than rods. Nevertheless, additional factors are probably involved in these differences.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute	Yau, KW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.			Kefalov, Vladimir/0000-0002-1659-008X	NEI NIH HHS [R01 EY014596, R37 EY006837, R01 EY006837-16A1, R37 EY006837-14, R37 EY006837-13, R37 EY006837-15S1, R01 EY014596-01, R01 EY014596-02, R01 EY006837, R37 EY006837-15] Funding Source: Medline; NIDCD NIH HHS [R01 DC006904, R01 DC006904-03] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY006837, R01EY014596, R37EY006837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BARLOW HB, 1958, VISUAL PROBLEMS COLO, V2, P617; BAYLOR DA, 1987, INVEST OPHTH VIS SCI, V28, P34; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; BOWMAKER JK, 1980, J PHYSIOL-LONDON, V298, P501, DOI 10.1113/jphysiol.1980.sp013097; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; HAROSI FI, 1975, J GEN PHYSIOL, V66, P357, DOI 10.1085/jgp.66.3.357; HAROSI FI, 1994, VISION RES, V34, P1359, DOI 10.1016/0042-6989(94)90134-1; IMAI H, 1995, BIOCHEMISTRY-US, V34, P10525, DOI 10.1021/bi00033a026; Imai H, 1997, BIOCHEMISTRY-US, V36, P12773, DOI 10.1021/bi970809x; KATZ B, 1972, J PHYSIOL-LONDON, V224, P665, DOI 10.1113/jphysiol.1972.sp009918; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Lyubarsky AL, 2000, J NEUROSCI, V20, P2209; Ma JX, 2001, NEURON, V32, P451, DOI 10.1016/S0896-6273(01)00482-2; Makino CL, 1999, BIOPHYS J, V77, P1024, DOI 10.1016/S0006-3495(99)76953-5; MERBS SL, 1992, NATURE, V356, P433, DOI 10.1038/356433a0; Miller James L., 1994, Current Opinion in Neurobiology, V4, P488, DOI 10.1016/0959-4388(94)90048-5; MILLER JL, 1993, VISUAL NEUROSCI, V10, P653, DOI 10.1017/S0952523800005356; Moritz OL, 2001, J BIOL CHEM, V276, P28242, DOI 10.1074/jbc.M101476200; NAKATANI K, 1989, J PHYSIOL-LONDON, V409, P525, DOI 10.1113/jphysiol.1989.sp017511; OKADA T, 1994, BIOCHEMISTRY-US, V33, P4940, DOI 10.1021/bi00182a024; Palacios AG, 1998, VISUAL NEUROSCI, V15, P319, DOI 10.1017/S0952523898152136; Rieke F, 1996, BIOPHYS J, V71, P2553, DOI 10.1016/S0006-3495(96)79448-1; Rieke F, 2000, NEURON, V26, P181, DOI 10.1016/S0896-6273(00)81148-4; Sampath AP, 2002, BIOPHYS J, V83, P184, DOI 10.1016/S0006-3495(02)75160-6; Starace DM, 1997, J BIOL CHEM, V272, P1095, DOI 10.1074/jbc.272.2.1095; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; WHITMORE AV, 1989, J COMP PHYSIOL A, V166, P103; WITKOVSKY P, 1981, VISION RES, V21, P867, DOI 10.1016/0042-6989(81)90187-5; YAU KW, 1994, INVEST OPHTH VIS SCI, V35, P9	30	97	100	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2003	425	6957					526	531		10.1038/nature01992	http://dx.doi.org/10.1038/nature01992			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727FN	14523449	Green Accepted			2022-12-01	WOS:000185648100048
J	Buchan, JC; Alberts, SC; Silk, JB; Altmann, J				Buchan, JC; Alberts, SC; Silk, JB; Altmann, J			True paternal care in a multi-male primate society	NATURE			English	Article							BARBARY MACAQUES; MACACA-SYLVANUS; FEMALE BABOONS; BODY ODOR; BEHAVIOR; CHIMPANZEES; PREFERENCES; SAMPLES; HUMANS; CHOICE	Although male parental care is rare among mammals 1, adult males of many cercopithecine primate species provide care for infants and juveniles. This care is often in the form of grooming, carrying, support in agonistic interactions, and protection against infanticide(2,3). For these behaviours to be interpreted as true parental care, males must selectively direct care towards their own offspring and this care must result in fitness benefits(4). With the exception of males defending probable offspring from infanticide(5), male primates living in multi-male, multi-female social groups have not been shown to selectively direct care towards their own offspring(6,7). We determined paternity for 75 juveniles in a population of wild savannah baboons (Papio cynocephalus) and collected data on interventions in agonistic disputes by adult males on behalf of juveniles as a form of male care. Here we show that adult males differentiate their offspring from unrelated juveniles and selectively support their offspring in agonistic disputes. As support in agonistic disputes is likely to contribute to rank acquisition and protect juveniles from injury and stress(2,3,5), this can be considered true parental care.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Natl Museums Kenya, Inst Primate Res, Nairobi, Kenya; Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90095 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Brookfield Zoo, Dept Conservat Biol, Brookfield, IL 60513 USA	Duke University; University of California System; University of California Los Angeles; Princeton University	Alberts, SC (corresponding author), Duke Univ, Dept Biol, Box 90338, Durham, NC 27708 USA.			Buchan, John/0000-0003-1005-7011				Alberts SC, 1999, P ROY SOC B-BIOL SCI, V266, P1501, DOI 10.1098/rspb.1999.0807; ALBERTS SC, 1995, BEHAV ECOL SOCIOBIOL, V36, P397, DOI 10.1007/BF00177335; Altmann J, 1996, P NATL ACAD SCI USA, V93, P5797, DOI 10.1073/pnas.93.12.5797; Borries C, 1999, BEHAV ECOL SOCIOBIOL, V46, P350, DOI 10.1007/s002650050629; HALPIN ZT, 1991, KIN RECOGNITION, P220; Hauber ME, 2001, TRENDS NEUROSCI, V24, P609, DOI 10.1016/S0166-2236(00)01916-0; Hausfater G., 1975, DOMINANCE REPROD BAB; Jacob S, 2002, NAT GENET, V30, P175, DOI 10.1038/ng830; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Menard N, 2001, CR ACAD SCI III-VIE, V324, P601, DOI 10.1016/S0764-4469(01)01339-7; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Ober C, 1997, AM J HUM GENET, V61, P497, DOI 10.1086/515511; Palombit RA, 1997, ANIM BEHAV, V54, P599, DOI 10.1006/anbe.1996.0457; Parr LA, 1999, NATURE, V399, P647, DOI 10.1038/21345; Paul A, 1996, ANIM BEHAV, V51, P155, DOI 10.1006/anbe.1996.0013; SHAIKH A A, 1982, Primates, V23, P444, DOI 10.1007/BF02381326; Sherman Paul W., 1997, P69; Silk JB, 2002, INT J PRIMATOL, V23, P849, DOI 10.1023/A:1015581016205; SILK JB, IN PRESS ANIM BEHAV; Singh D, 2001, P ROY SOC B-BIOL SCI, V268, P797, DOI 10.1098/rspb.2001.1589; Smith K, 2003, P ROY SOC B-BIOL SCI, V270, P503, DOI 10.1098/rspb.2002.2277; Smith KL, 2000, AM J PRIMATOL, V51, P219; Smuts B., 1992, FATHER CHILD RELATIO, P1, DOI DOI 10.1002/AJHB.1310060321; Soltis J, 2000, BEHAV ECOL SOCIOBIOL, V48, P195, DOI 10.1007/s002650000224; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; TRIVERS RL, 1972, SEXUAL SELECTION DES; van Schaik Carel, 1996, Evolutionary Anthropology, V5, P152, DOI 10.1002/(SICI)1520-6505(1996)5:5<152::AID-EVAN3>3.3.CO;2-9; Wedekind C, 1997, P ROY SOC B-BIOL SCI, V264, P1471, DOI 10.1098/rspb.1997.0204; WEDEKIND C, 1995, P ROY SOC B-BIOL SCI, V260, P245, DOI 10.1098/rspb.1995.0087; Widdig A, 2001, P NATL ACAD SCI USA, V98, P13769, DOI 10.1073/pnas.241210198; WOODROFFE R, 1994, TRENDS ECOL EVOL, V9, P294, DOI 10.1016/0169-5347(94)90033-7	31	245	254	2	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 11	2003	425	6954					179	181		10.1038/nature01866	http://dx.doi.org/10.1038/nature01866			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719ZT	12968180				2022-12-01	WOS:000185236000042
J	Hylek, EM; Go, AS; Chang, YC; Jensvold, NG; Henault, LE; Selby, JV; Singer, DE				Hylek, EM; Go, AS; Chang, YC; Jensvold, NG; Henault, LE; Selby, JV; Singer, DE			Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTITHROMBOTIC THERAPY; BLEEDING COMPLICATIONS; COST-EFFECTIVENESS; RISK-FACTORS; WARFARIN; ASPIRIN; THROMBOEMBOLISM; COMMUNITY; PROPHYLAXIS; OUTPATIENTS	Background: The incidence of stroke in patients with atrial fibrillation is greatly reduced by oral anticoagulation, with the full effect seen at international normalized ratio (INR) values of 2.0 or greater. The effect of the intensity of oral anticoagulation on the severity of atrial fibrillation-related stroke is not known but is central to the choice of the target INR. Methods: We studied incident ischemic strokes in a cohort of 13,559 patients with nonvalvular atrial fibrillation. Strokes were identified through hospitalization data bases and validated on the basis of medical records, which also provided information on the use of warfarin or aspirin, the INR at admission, and coexisting illnesses. The severity of stroke was graded according to a modified Rankin scale. Thirty-day mortality was ascertained from hospitalization and mortality files. Results: Of 596 ischemic strokes, 32 percent occurred during warfarin therapy, 27 percent during aspirin therapy, and 42 percent during neither type of therapy. Among patients who were taking warfarin, an INR of less than 2.0 at admission, as compared with an INR of 2.0 or greater, independently increased the odds of a severe stroke in a proportional-odds logistic-regression model (odds ratio, 1.9; 95 percent confidence interval, 1.1 to 3.4) across three severity categories and the risk of death within 30 days (hazard ratio, 3.4; 95 percent confidence interval, 1.1 to 10.1). An INR of 1.5 to 1.9 at admission was associated with a mortality rate similar to that for an INR of less than 1.5 (18 percent and 15 percent, respectively). The 30-day mortality rate among patients who were taking aspirin at the time of the stroke was similar to that among patients who were taking warfarin and who had an INR of less than 2.0. Conclusions: Among patients with nonvalvular atrial fibrillation, anticoagulation that results in an INR of 2.0 or greater reduces not only the frequency of ischemic stroke but also its severity and the risk of death from stroke. Our findings provide further evidence against the use of lower INR target levels in patients with atrial fibrillation.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gen Med Div,Clin Epidemiol Unit, Boston, MA 02114 USA; Kaiser Permanente No Calif, Div Res, Oakland, CA USA; Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hylek, EM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gen Med Div,Clin Epidemiol Unit, 50 Staniford St,9th Fl, Boston, MA 02114 USA.		Go, Alan S./AAE-7745-2019	Hylek, Elaine/0000-0001-8263-8304	NATIONAL INSTITUTE ON AGING [R01AG015478] Funding Source: NIH RePORTER; NIA NIH HHS [5 R01 AG15478] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Albers GW, 2001, CHEST, V119, p194S, DOI 10.1378/chest.119.1_suppl.194S; *AM MED ASS, 1999, INT CLASS DIS, V2; *AM MED ASS, 1999, INT CLASS DIS, V1; [Anonymous], 2001, CIRCULATION, V104, P2118; [Anonymous], 1994, ARCH INTERN MED, V154, P2254; ARELLANO MG, 1984, AM J PUBLIC HEALTH, V74, P1324, DOI 10.2105/AJPH.74.12.1324; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; Blackshear JL, 1996, LANCET, V348, P633; BOGOUSSLAVSKY J, 1990, NEUROLOGY, V40, P1046, DOI 10.1212/WNL.40.7.1046; BRITTON M, 1985, STROKE, V16, P182, DOI 10.1161/01.STR.16.2.182; CANDELISE L, 1991, STROKE, V22, P169, DOI 10.1161/01.STR.22.2.169; Chesebro JH, 1996, ARCH INTERN MED, V156, P409; Eckman MH, 1998, ARCH INTERN MED, V158, P1669, DOI 10.1001/archinte.158.15.1669; Evans A, 2001, ARCH INTERN MED, V161, P1443, DOI 10.1001/archinte.161.11.1443; GAGE BF, 1995, JAMA-J AM MED ASSOC, V274, P1839, DOI 10.1001/jama.274.23.1839; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; Go AS, 2002, CIRCULATION, V106, P515; Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004; GUSTAFSSON C, 1991, J INTERN MED, V230, P11, DOI 10.1111/j.1365-2796.1991.tb00400.x; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Hart RG, 2000, CEREBROVASC DIS, V10, P39, DOI 10.1159/000016023; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Hylek EM, 1996, NEW ENGL J MED, V335, P540, DOI 10.1056/NEJM199608223350802; Kaarisalo MM, 1997, STROKE, V28, P311, DOI 10.1161/01.STR.28.2.311; Kalbfleisch JD., 2002, STAT ANAL FAILURE TI, V2, DOI [10.1002/9781118032985, DOI 10.1016/0197-2456(81)90009-X]; Lamassa M, 2001, STROKE, V32, P392, DOI 10.1161/01.STR.32.2.392; LANDEFELD CS, 1989, AM J MED, V87, P144; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Lin HJ, 1996, STROKE, V27, P1760, DOI 10.1161/01.STR.27.10.1760; Longstreth WT, 2001, NEUROLOGY, V56, P368, DOI 10.1212/WNL.56.3.368; Man-Son-Hing M, 1999, ARCH INTERN MED, V159, P677, DOI 10.1001/archinte.159.7.677; MANNING WJ, 1995, ARCH INTERN MED, V155, P2193, DOI 10.1001/archinte.155.20.2193; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Miettinen O S, 1983, Stat Med, V2, P267, DOI 10.1002/sim.4780020222; Miller VT, 1996, NEUROLOGY, V46, P238, DOI 10.1212/WNL.46.1.238; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Penado S, 2002, AM J MED, V112, P572, DOI 10.1016/S0002-9343(02)01063-X; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; SANDERCOCK P, 1992, BRIT MED J, V305, P1460, DOI 10.1136/bmj.305.6867.1460; SHERMAN DG, 1984, ARCH NEUROL-CHICAGO, V41, P708, DOI 10.1001/archneur.1984.04050180030011; Thomson R, 2000, LANCET, V355, P1466; van Walraven C, 2002, JAMA-J AM MED ASSOC, V288, P2441, DOI 10.1001/jama.288.19.2441; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	45	947	993	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2003	349	11					1019	1026		10.1056/NEJMoa022913	http://dx.doi.org/10.1056/NEJMoa022913			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	719UH	12968085				2022-12-01	WOS:000185223100003
J	Melendez, A; Talloczy, Z; Seaman, M; Eskelinen, EL; Hall, DH; Levine, B				Melendez, A; Talloczy, Z; Seaman, M; Eskelinen, EL; Hall, DH; Levine, B			Autophagy genes are essential for dauer development and life-span extension in C-elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; MACROAUTOPHAGY; SENESCENCE; LONGEVITY; NEMATODE; MUTANTS; VACUOLE; DAF-2	Both dauer formation (a stage of developmental arrest) and adult life-span in Caenorhabditis elegans are negatively regulated by insulin-like signaling, but little is known about cellular pathways that mediate these processes. Autophagy, through the sequestration and delivery of cargo to the lysosomes, is the major route for degrading long-lived proteins and cytoplasmic organelles in eukaryotic cells. Using nematodes with a loss-of-function mutation in the insulin-like signaling pathway, we show that bec-1, the C. elegans ortholog of the yeast and mammalian autophagy gene APG6/VPS30/beclin1, is essential for normal dauer morphogenesis and life-span extension. Dauer formation is associated with increased autophagy and also requires C. elegans orthologs of the yeast autophagy genes APG1, APG7, APG8, and AUT10. Thus, autophagy is a cellular pathway essential for dauer development and life-span extension in C. elegans.	Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Addenbrookes Hosp, Cambridge Inst Med Res, Dept Clin Biochem, Cambridge CB2 2XY, England; Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; Albert Einstein Coll Med, Ctr C Elegans Anat, Bronx, NY 10461 USA	Columbia University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Kiel; Yeshiva University; Albert Einstein College of Medicine	Levine, B (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, 630 W 168th St, New York, NY 10032 USA.	levine@cancercenter.columbia.edu	Eskelinen, Eeva-Liisa/AAF-3496-2019	Eskelinen, Eeva-Liisa/0000-0003-0006-7785	NCI NIH HHS [CA84254] Funding Source: Medline; NCRR NIH HHS [R24 RR012596, RR 12596] Funding Source: Medline; NIH HHS [R24 OD010943] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084254] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR012596] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALBERT PS, 1988, DEV BIOL, V126, P270, DOI 10.1016/0012-1606(88)90138-8; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Bergamini E, 1995, AGING-CLIN EXP RES, V7, P473, DOI 10.1007/BF03324374; Doelling JH, 2002, J BIOL CHEM, V277, P33105, DOI 10.1074/jbc.M204630200; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gems D, 1998, GENETICS, V150, P129; GOLDEN JW, 1985, MOL GEN GENET, V198, P534, DOI 10.1007/BF00332953; GORDON PB, 1987, BIOCHIM BIOPHYS ACTA, V929, P128, DOI 10.1016/0167-4889(87)90167-4; Hanaoka H, 2002, PLANT PHYSIOL, V129, P1181, DOI 10.1104/pp.011024; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KENYON C, 1997, C ELEGANS, V2, P791; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kim J, 2002, J BIOL CHEM, V277, P763, DOI 10.1074/jbc.M109134200; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; LIU ZC, 1989, GENE DEV, V3, P2039, DOI 10.1101/gad.3.12b.2039; MELENDEZ A, UNPUB; OGURA K, 1994, GENE DEV, V8, P2389, DOI 10.1101/gad.8.20.2389; Otto GP, 2003, J BIOL CHEM, V278, P17636, DOI 10.1074/jbc.M212467200; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; QU X, UNPUB; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Riddle DL, 1997, C ELEGANS, P739; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E	31	977	1035	5	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2003	301	5638					1387	1391		10.1126/science.1087782	http://dx.doi.org/10.1126/science.1087782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717XQ	12958363				2022-12-01	WOS:000185116400044
J	Kurtz, J; Franz, K				Kurtz, J; Franz, K			Evidence for memory in invertebrate immunity	NATURE			English	Editorial Material							HOST		Max Planck Inst Limnol, Dept Evolut Ecol, D-24306 Plon, Germany	Max Planck Society	Kurtz, J (corresponding author), Max Planck Inst Limnol, Dept Evolut Ecol, August Thienemann Str 2, D-24306 Plon, Germany.		Kurtz, Joachim/A-9678-2008	Kurtz, Joachim/0000-0002-7258-459X				Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; FAULHABER LM, 1992, IMMUNOLOGY, V75, P378; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Janeway C.A., 1999, IMMUNOBIOLOGY IMMUNE; KLEIN J, 1989, SCAND J IMMUNOL, V29, P499, DOI 10.1111/j.1365-3083.1989.tb01152.x; Kurtz J, 2002, EXP PARASITOL, V100, P36, DOI 10.1006/expr.2001.4681; Little TJ, 2003, CURR BIOL, V13, P489, DOI 10.1016/S0960-9822(03)00163-5; Marques MRF, 2000, AQUACULTURE, V191, P23, DOI 10.1016/S0044-8486(00)00417-8; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0	11	295	308	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 4	2003	425	6953					37	38		10.1038/425037a	http://dx.doi.org/10.1038/425037a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717LD	12955131				2022-12-01	WOS:000185089200028
J	Agrawal, M; Emanuel, EJ				Agrawal, M; Emanuel, EJ			Ethics of phase 1 oncology studies - Reexamining the arguments and data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							I CLINICAL-TRIALS; QUALITY-OF-LIFE; RENAL-CELL CARCINOMA; ABL TYROSINE KINASE; INFORMED CONSENT; CANCER-PATIENTS; THERAPEUTIC RESPONSE; ANTICANCER AGENTS; FUNCTIONAL STATUS; DESIGN	Phase 1 oncology trials are critical to improving the treatment of cancer. Critics have raised 2 fundamental ethical challenges about phase 1 cancer research: the paucity of benefits with substantial risks and poor-quality informed consent. Despite 3 decades of controversy about phase 1 oncology research, there is little critical analysis of the arguments or of the data relevant to these questions. Existing but old data reveal that about 5% of patients in phase 1 trials experience shrinkage of their tumor, with a 0.5% mortality rate. In some notable cases, patients in phase 1 trials have been cured or sustained long-term remissions. Limited data suggest that patients in phase 1 trials may have better quality of life than comparable patients receiving supportive care. More important, the risks and benefits of phase 1 trials are not clearly worse than risk-benefit ratios used by the US Food and Drug Administration to approve chemotherapeutic agents for clinical use. The objections based on informed consent are deficiencies of disclosure, understanding, and voluntariness. The available data do not support the claim that disclosure is deficient. Although studies evaluating patient understanding have substantial methodological problems, they demonstrate that more than 70% of patients understand that they may not directly benefit even when they hope they will personally benefit. Finally, a closer look at issues of voluntariness reveals that patients with advanced cancer who participate in phase 1 research may have a different set of values than do critics and are not coerced. Overall, it appears that phase 1 oncology trials satisfy the requirement for a favorable risk-benefit ratio and that patients who enroll provide adequate informed consent.	NIH, Warren G Magnuson Clin Ctr, Dept Clin Bioeth, Bethesda, MD 20892 USA; NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Agrawal, M (corresponding author), NIH, Warren G Magnuson Clin Ctr, Dept Clin Bioeth, Bldg 10,Room 1C118,10 Ctr Dr, Bethesda, MD 20892 USA.							Agrawal Manish, 2002, J Palliat Med, V5, P729, DOI 10.1089/109662102320880552; *AM CANC SOC, 2003, CANC FACTS FIG; Annas G J, 1992, Health Matrix Clevel, V2, P119; [Anonymous], 1986, HIST THEORY INFORM C; Arbuck SG, 1996, ANN ONCOL, V7, P567; BERDEL WE, 1988, ANTICANCER RES, V8, P313; BERG JW, 2001, INFORMED CONSENT LEG; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Campbell S, 1999, J ADV NURS, V30, P335, DOI 10.1046/j.1365-2648.1999.01079.x; Cheng JD, 2000, J CLIN ONCOL, V18, P421, DOI 10.1200/JCO.2000.18.2.421; Cohen L, 2002, UROL ONCOL, V7, P119, DOI 10.1016/S1078-1439(01)00182-X; Cox K, 2000, PSYCHO-ONCOL, V9, P314, DOI 10.1002/1099-1611(200007/08)9:4<314::AID-PON464>3.0.CO;2-C; Creemers GJ, 1996, J CLIN ONCOL, V14, P3056, DOI 10.1200/JCO.1996.14.12.3056; DAUGHERTY C, 1995, J CLIN ONCOL, V13, P1062, DOI 10.1200/JCO.1995.13.5.1062; Daugherty C K, 2000, IRB, V22, P6, DOI 10.2307/3564113; Daugherty CK, 1997, ANN INTERN MED, V126, P892, DOI 10.7326/0003-4819-126-11-199706010-00008; DECOSTER G, 1990, ANN ONCOL, V1, P175, DOI 10.1093/oxfordjournals.annonc.a057716; Dent SF, 1996, ANN ONCOL, V7, P561; Druker BJ, 2002, ONCOGENE, V21, P8541, DOI 10.1038/sj.onc.1206081; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; EMANUEL EJ, 1995, J CLIN ONCOL, V13, P1049, DOI 10.1200/JCO.1995.13.5.1049; EPSTEIN AM, 1989, MED CARE, V27, P91; ESTEY E, 1986, CANCER TREAT REP, V70, P1105; Fisher B, 2001, JNCI-J NATL CANCER I, V93, P112, DOI 10.1093/jnci/93.2.112; Francis RJ, 2002, BRIT J CANCER, V87, P600, DOI 10.1038/sj.bjc.6600517; Frei E, 1997, CANCER J, V3, P127; FYFE G, 1995, J CLIN ONCOL, V13, P688, DOI 10.1200/JCO.1995.13.3.688; HIGBY DJ, 1974, CANCER, V33, P1219, DOI 10.1002/1097-0142(197405)33:5<1219::AID-CNCR2820330505>3.0.CO;2-U; Hope-Stone L D, 1997, Eur J Cancer Care (Engl), V6, P267, DOI 10.1046/j.1365-2354.1997.00053.x; Horng S, 2002, NEW ENGL J MED, V347, P2134, DOI 10.1056/NEJMsa021182; Hutchison C, 1998, Eur J Cancer Care (Engl), V7, P15, DOI 10.1046/j.1365-2354.1998.00062.x; Itoh K, 1997, BRIT J CANCER, V76, P107, DOI 10.1038/bjc.1997.344; ITOH K, 1994, CANCER CHEMOTH PHARM, V34, P451, DOI 10.1007/BF00685653; Joffe S, 2001, LANCET, V358, P1772, DOI 10.1016/S0140-6736(01)06805-2; King NMP, 2000, J LAW MED ETHICS, V28, P332, DOI 10.1111/j.1748-720X.2000.tb00685.x; KODISH E, 1992, J CLIN ONCOL, V10, P1810, DOI 10.1200/JCO.1992.10.11.1810; Lippman ME, 2001, JNCI-J NATL CANCER I, V93, P80, DOI 10.1093/jnci/93.2.80; LIPSETT MB, 1982, JAMA-J AM MED ASSOC, V248, P941, DOI 10.1001/jama.248.8.941; MAGAZINER J, 1988, J CLIN EPIDEMIOL, V41, P1065, DOI 10.1016/0895-4356(88)90076-5; MCCUSKER J, 1984, MED CARE, V22, P789, DOI 10.1097/00005650-198409000-00002; MELINK TJ, 1992, ANTI-CANCER DRUG, V3, P571, DOI 10.1097/00001813-199212000-00003; MEROPOL NJ, 2002, P AM SOC CLIN ONC MA; Meslin Eric M, 1990, IRB, V12, P7, DOI 10.2307/3563683; Miller M, 2000, HASTINGS CENT REP, V30, P34, DOI 10.2307/3527646; Miller M, 2001, Int Anesthesiol Clin, V39, P13; Moore S, 2001, J ADV NURS, V33, P738, DOI 10.1046/j.1365-2648.2001.01715.x; *NAT BIOETH ADV CO, 1998, RES INV PERS MENT DI; PENMAN DT, 1984, J CLIN ONCOL, V2, P849, DOI 10.1200/JCO.1984.2.7.849; Quantin X, 2000, AM J CLIN ONCOL-CANC, V23, P192, DOI 10.1097/00000421-200004000-00017; RATAIN MJ, 1993, J NATL CANCER I, V85, P1637, DOI 10.1093/jnci/85.20.1637; RODENHUIS S, 1984, EUR J CANCER CLIN ON, V20, P457, DOI 10.1016/0277-5379(84)90229-3; RUBENSTEIN LZ, 1984, J GERONTOL, V39, P686, DOI 10.1093/geronj/39.6.686; Saltz LB, 2000, NEW ENGL J MED, V343, P905, DOI 10.1056/NEJM200009283431302; Sherliker L, 2000, PATIENT EDUC COUNS, V40, P11, DOI 10.1016/S0738-3991(99)00047-6; Simon R, 1997, JNCI-J NATL CANCER I, V89, P1138, DOI 10.1093/jnci/89.15.1138; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; Smith TL, 1996, J CLIN ONCOL, V14, P287, DOI 10.1200/JCO.1996.14.1.287; Stolberg Sheryl Gay, 2000, NY TIMES 0215 NY TIMES 0215, P20; TOMAMICHEL M, 1995, ANN ONCOL, V6, P363, DOI 10.1093/oxfordjournals.annonc.a059185; van Luijn HEM, 2002, ANN ONCOL, V13, P1307, DOI 10.1093/annonc/mdf209; VONHOFF DD, 1991, INVEST NEW DRUG, V9, P115, DOI 10.1007/BF00194562; Weijer C, 2000, J LAW MED ETHICS, V28, P344, DOI 10.1111/j.1748-720X.2000.tb00686.x; Wertheimer A, 1987, COERCION; Yoder L H, 1997, Oncol Nurs Forum, V24, P891; ZWEIBEL NR, 1989, GERONTOLOGIST, V29, P615, DOI 10.1093/geront/29.5.615	66	142	143	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2003	290	8					1075	1082		10.1001/jama.290.8.1075	http://dx.doi.org/10.1001/jama.290.8.1075			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	715FA	12941681				2022-12-01	WOS:000184958900027
J	Kenniston, JA; Baker, TA; Fernandez, JM; Sauer, RT				Kenniston, JA; Baker, TA; Fernandez, JM; Sauer, RT			Linkage between ATP consumption and mechanical unfolding during the protein processing reactions of an AAA(+) degradation machine	CELL			English	Article							PROTEASES DEGRADE; ESCHERICHIA-COLI; CLPXP; SPECIFICITY; HYDROLYSIS; STABILITY; TRANSLOCATION; RECOGNITION; DYNAMICS; ATPASES	Proteolytic machines powered by ATP hydrolysis bind proteins with specific peptide tags, denature these substrates, and translocate them into a sequestered compartment for degradation. To determine how ATP is used during individual reaction steps, we assayed ClpXP degradation of ssrA-tagged titin variants with different stabilities in native and denatured forms. The rate of ATP turnover was 4-fold slower during denaturation than translocation. Importantly, this reduced turnover rate was constant during denaturation of native variants with different stabilities, but total ATP consumption increased with substrate stability, suggesting an iterative application of a uniform, mechanical unfolding force. Destabilization of substrate structure near the degradation tag accelerated degradation and dramatically reduced ATP consumption, revealing an important role for local protein stability in resisting denaturation. The ability to denature more stable proteins simply by using more ATP endows ClpX with a robust unfolding activity required for its biological roles in degradation and complex disassembly.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Columbia University	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu		Sauer, Robert/0000-0002-1719-5399	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015706, R01AI015706] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-15706] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Burton BM, 2001, MOL CELL, V8, P449, DOI 10.1016/S1097-2765(01)00307-0; Burton RE, 2003, PROTEIN SCI, V12, P893, DOI 10.1110/ps.0237603; Burton RE, 2001, EMBO J, V20, P3092, DOI 10.1093/emboj/20.12.3092; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; CARRIONVASQUEZ M, 2003, IN PRESS NAT STRUCT; Chamberlain AK, 1996, NAT STRUCT BIOL, V3, P782, DOI 10.1038/nsb0996-782; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Fowler SB, 2001, STRUCTURE, V9, P355, DOI 10.1016/S0969-2126(01)00596-2; Fowler SB, 2002, J MOL BIOL, V322, P841, DOI 10.1016/S0022-2836(02)00805-7; Gonciarz-Swiatek M, 1999, J BIOL CHEM, V274, P13999, DOI 10.1074/jbc.274.20.13999; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; Hollien J, 1999, P NATL ACAD SCI USA, V96, P13674, DOI 10.1073/pnas.96.24.13674; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Langer T, 2000, TRENDS BIOCHEM SCI, V25, P247, DOI 10.1016/S0968-0004(99)01541-8; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Li HB, 2000, NAT STRUCT BIOL, V7, P1117; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Matouschek A, 2003, CURR OPIN STRUC BIOL, V13, P98, DOI 10.1016/S0959-440X(03)00010-1; Neuwald AF, 1999, GENOME RES, V9, P27; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ortega J, 2002, EMBO J, V21, P4938, DOI 10.1093/emboj/cdf483; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; THOMPSON MW, 1994, J BIOL CHEM, V269, P18201; THOMPSON MW, 1994, J BIOL CHEM, V269, P18209; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Wah DA, 2002, CHEM BIOL, V9, P1237, DOI 10.1016/S1074-5521(02)00268-5; Wang JM, 1997, CELL, V91, P447, DOI 10.1016/S0092-8674(00)80431-6	36	220	222	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2003	114	4					511	520		10.1016/S0092-8674(03)00612-3	http://dx.doi.org/10.1016/S0092-8674(03)00612-3			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	714TD	12941278	Bronze			2022-12-01	WOS:000184928800013
J	Hoebe, K; Du, X; Georgel, P; Janssen, E; Tabeta, K; Kim, SO; Goode, J; Lin, P; Mann, N; Mudd, S; Crozat, K; Sovath, S; Han, J; Beutler, B				Hoebe, K; Du, X; Georgel, P; Janssen, E; Tabeta, K; Kim, SO; Goode, J; Lin, P; Mann, N; Mudd, S; Crozat, K; Sovath, S; Han, J; Beutler, B			Identification of Lps2 as a key transducer of MyD88-independent TIR signalling	NATURE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; ADAPTER MOLECULE; RECEPTOR; ACTIVATION; LIPOPOLYSACCHARIDE; MICE; RECOGNITION; ENDOTOXIN; RESPONSES	In humans, ten Toll-like receptor (TLR) paralogues sense molecular components of microbes, initiating the production of cytokine mediators that create the inflammatory response. Using N-ethyl-N-nitrosourea, we induced a germline mutation called Lps2, which abolishes cytokine responses to double-stranded RNA and severely impairs responses to the endotoxin lipopolysaccharide (LPS), indicating that TLR3 and TLR4 might share a specific, proximal transducer. Here we identify the Lps2 mutation: a distal frameshift error in a Toll/interleukin-1 receptor/resistance (TIR) adaptor protein known as Trif or Ticam-1. Trif Lps2 homozygotes are markedly resistant to the toxic effects of LPS, and are hypersusceptible to mouse cytomegalovirus, failing to produce type I interferons when infected. Compound homozygosity for mutations at Trif and MyD88 (a cytoplasmic TIR-domain-containing adaptor protein) loci ablates all responses to LPS, indicating that only two signalling pathways emanate from the LPS receptor. However, a Trif-independent cell population is detectable when Trif Lps2 mutant macrophages are stimulated with LPS. This reveals that an alternative MyD88-dependent 'adaptor X' pathway is present in some, but not all, macrophages, and implies afferent immune specialization.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA	Scripps Research Institute; La Jolla Institute for Immunology	Beutler, B (corresponding author), Scripps Res Inst, Dept Immunol, IMM-31,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bruce@scripps.edu	georgel, philippe/P-5676-2016; Kim, Sung Ouk/AAO-1795-2020; TABTA, KOICHI/AAG-6481-2020; Han, J/G-4671-2010; KIM, Sung Ouk/A-1309-2008; Crozat, Karine/L-7297-2019	georgel, philippe/0000-0001-6853-7080; Kim, Sung Ouk/0000-0002-0282-6661; TABTA, KOICHI/0000-0002-7019-1872; Crozat, Karine/0000-0003-4761-3675; Hoebe, Kasper/0000-0002-3626-8098				Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Beutler B, 2002, CURR TOP MICROBIOL, V270, P1; Beutler B, 2001, BIOCHEM SOC T, V29, P853, DOI 10.1042/0300-5127:0290853; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Du X, 1999, BLOOD CELL MOL DIS, V25, P328, DOI 10.1006/bcmd.1999.0262; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HEPPNER G, 1965, J BACTERIOL, V90, P696, DOI 10.1128/JB.90.3.696-703.1965; Hoebe K, 2003, J ENDOTOXIN RES, V9, P250, DOI 10.1179/096805103225001459; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kim SO, 2001, AM J PHYSIOL-LUNG C, V281, pL1095, DOI 10.1152/ajplung.2001.281.5.L1095; Orange JS, 1996, J IMMUNOL, V156, P4746; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Poltorak A, 1998, BLOOD CELL MOL DIS, V24, P340, DOI 10.1006/bcmd.1998.0201; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamaji M, 2002, PHOTOCH PHOTOBIO SCI, V1, P169, DOI 10.1039/b110092k; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182	32	966	1029	0	44	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 14	2003	424	6950					743	748		10.1038/nature01889	http://dx.doi.org/10.1038/nature01889			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12872135				2022-12-01	WOS:000184733900030
J	Losos, JB; Leal, M; Glor, RE; de Queiroz, K; Hertz, PE; Schettino, LR; Lara, AC; Jackman, TR; Larson, A				Losos, JB; Leal, M; Glor, RE; de Queiroz, K; Hertz, PE; Schettino, LR; Lara, AC; Jackman, TR; Larson, A			Niche lability in the evolution of a Caribbean lizard community	NATURE			English	Article							ANOLIS LIZARDS; PHYLOGENETIC-RELATIONSHIPS; ECOLOGY; SYSTEMS; MODEL	Niche conservatism-the tendency for closely related species to be ecologically similar - is widespread(1-3). However, most studies compare closely related taxa that occur in allopatry(3); in sympatry, the stabilizing forces that promote niche conservatism(4,5), and thus inhibit niche shifts, may be countered by natural selection favouring ecological divergence to minimize the intensity of interspecific interactions(6,7). Consequently, the relative importance of niche conservatism versus niche divergence in determining community structure has received little attention(7). Here, we examine a tropical lizard community in which species have a long evolutionary history of ecological interaction. We find that evolutionary divergence overcomes niche conservatism: closely related species are no more ecologically similar than expected by random divergence and some distantly related species are ecologically similar, leading to a community in which the relationship between ecological similarity and phylogenetic relatedness is very weak. Despite this lack of niche conservatism, the ecological structuring of the community has a phylogenetic component: niche complementarity only occurs among distantly related species, which suggests that the strength of ecological interactions among species may be related to phylogeny, but it is not necessarily the most closely related species that interact most strongly.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; Union Coll, Dept Biol Sci, Schenectady, NY 12308 USA; Smithsonian Inst, Natl Museum Amer Hist, Div Amphibians & Reptiles, Washington, DC 20560 USA; Columbia Univ Barnard Coll, Dept Biol, New York, NY 10027 USA; CITGMA, Inst Ecol & Sistemat, Havana 10800, Cuba; Villanova Univ, Dept Biol, Villanova, PA 19085 USA	Washington University (WUSTL); Union College; Smithsonian Institution; Smithsonian National Museum of Natural History; Columbia University; Villanova University	Losos, JB (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.		Leal, Manuel/A-7220-2010; Glor, Richard/N-4656-2013	Glor, Richard/0000-0002-3359-1631; Jackman, Todd/0000-0002-5391-8136				Butler MA, 2002, ECOL MONOGR, V72, P541, DOI 10.1890/0012-9615(2002)072[0541:MSDSSA]2.0.CO;2; Danley PD, 2001, MOL ECOL, V10, P1075, DOI 10.1046/j.1365-294X.2001.01283.x; de Queiroz Kevin, 1998, American Museum Novitates, V3249, P1; Gerber GP, 2000, OECOLOGIA, V124, P599, DOI 10.1007/s004420000414; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jackman TR, 1999, SYST BIOL, V48, P254, DOI 10.1080/106351599260283; LANGLEY CH, 1974, J MOL EVOL, V3, P161, DOI 10.1007/BF01797451; Leal M, 1998, OECOLOGIA, V117, P273, DOI 10.1007/s004420050658; LOSOS JB, 1994, ANNU REV ECOL SYST, V25, P467, DOI 10.1146/annurev.es.25.110194.002343; Losos JB, 1999, ECOLOGY, V80, P252, DOI 10.2307/176994; Macey JR, 1998, MOL PHYLOGENET EVOL, V10, P118, DOI 10.1006/mpev.1997.0478; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Petren K, 1999, P ROY SOC B-BIOL SCI, V266, P321, DOI 10.1098/rspb.1999.0641; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prinzing A, 2001, P ROY SOC B-BIOL SCI, V268, P2383, DOI 10.1098/rspb.2001.1801; REAGAN DP, 1992, COPEIA, P392; RICHMAN AD, 1992, NATURE, V355, P817, DOI 10.1038/355817a0; SCHOENER TW, 1980, J ANIM ECOL, V49, P19, DOI 10.2307/4276; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; SHOCHAT D, 1981, COMP BIOCHEM PHYS A, V68, P67, DOI 10.1016/0300-9629(81)90319-4; Silvertown J, 2001, J ECOL, V89, P428, DOI 10.1046/j.1365-2745.2001.00553.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448	22	242	250	1	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					542	545		10.1038/nature01814	http://dx.doi.org/10.1038/nature01814			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891355				2022-12-01	WOS:000184454700040
J	Masutomi, K; Yu, EY; Khurts, S; Ben-Porath, I; Currier, JL; Metz, GB; Brooks, MW; Kaneko, S; Murakami, S; DeCaprio, JA; Weinberg, RA; Stewart, SA; Hahn, WC				Masutomi, K; Yu, EY; Khurts, S; Ben-Porath, I; Currier, JL; Metz, GB; Brooks, MW; Kaneko, S; Murakami, S; DeCaprio, JA; Weinberg, RA; Stewart, SA; Hahn, WC			Telomerase maintains telomere structure in normal human cells	CELL			English	Article							REVERSE-TRANSCRIPTASE HTERT; HUMAN-DIPLOID FIBROBLASTS; CATALYTIC SUBUNIT; LIFE-SPAN; G-STRAND; SACCHAROMYCES-CEREVISIAE; HUMAN-LYMPHOCYTES; IMMORTAL CELLS; RNA COMPONENT; MOUSE CELLS	In normal human cells, telomeres shorten with successive rounds of cell division, and immortalization correlates with stabilization of telomere length. These observations suggest that human cancer cells achieve immortalization in large part through the illegitimate activation of telomerase expression. Here, we demonstrate that the rate-limiting telomerase catalytic subunit hTERT is expressed in cycling primary presenescent human fibroblasts, previously believed to lack hTERT expression and telomerase activity. Disruption of telomerase activity in normal human cells slows cell proliferation, restricts cell lifespan, and alters the maintenance of the 3' single-stranded telomeric overhang without changing the rate of overall telomere shortening. Together, these observations support the view that telomerase and telomere structure are dynamically regulated in normal human cells and that telomere length alone is unlikely to trigger entry into replicative senescence.	Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Kanazawa Univ, Canc Res Inst, Dept Mol Oncol, Kanazawa, Ishikawa 9200934, Japan; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa 9208641, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Kanazawa University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Kanazawa University	Hahn, WC (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.		Stewart, Sheila A/C-5213-2012		NATIONAL CANCER INSTITUTE [K01CA094223, R01CA078461, F32CA093033] Funding Source: NIH RePORTER; NCI NIH HHS [F32 CA93033, K01 CA94223, R01 CA78461] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allsopp RC, 2001, J EXP MED, V193, P917, DOI 10.1084/jem.193.8.917; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Cimino-Reale G, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e35; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902; Enomoto S, 2002, MOL BIOL CELL, V13, P2626, DOI 10.1091/mbc.02-02-0012; Etheridge KT, 2002, J BIOL CHEM, V277, P24764, DOI 10.1074/jbc.M201227200; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Goytisolo FA, 2001, MOL CELL BIOL, V21, P3642, DOI 10.1128/MCB.21.11.3642-3651.2001; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HARA E, 1991, BIOCHEM BIOPH RES CO, V179, P528, DOI 10.1016/0006-291X(91)91403-Y; HarleBachor C, 1996, P NATL ACAD SCI USA, V93, P6476, DOI 10.1073/pnas.93.13.6476; HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hiyama E, 1996, INT J ONCOL, V9, P453; HIYAMA K, 1995, J IMMUNOL, V155, P3711; Ijpma AS, 2003, MOL BIOL CELL, V14, P987, DOI 10.1091/mbc.02-04-0057; Jacob NK, 2003, MOL CELL, V11, P1021, DOI 10.1016/S1097-2765(03)00131-X; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Kirk KE, 1997, SCIENCE, V275, P1478, DOI 10.1126/science.275.5305.1478; Kolquist KA, 1998, NAT GENET, V19, P182, DOI 10.1038/554; Li GZ, 2003, P NATL ACAD SCI USA, V100, P527, DOI 10.1073/pnas.0235444100; Liu KB, 1999, P NATL ACAD SCI USA, V96, P5147, DOI 10.1073/pnas.96.9.5147; Martin-Rivera L, 1998, P NATL ACAD SCI USA, V95, P10471, DOI 10.1073/pnas.95.18.10471; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Masutomi K, 2000, J BIOL CHEM, V275, P22568, DOI 10.1074/jbc.M000622200; Matthews P, 2001, J PATHOL, V194, P183, DOI 10.1002/path.848; Nakamura TM, 1998, CELL, V92, P587, DOI 10.1016/S0092-8674(00)81123-X; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; SHAY JW, 1989, EXP CELL RES, V184, P109, DOI 10.1016/0014-4827(89)90369-8; Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433; Son NH, 2000, J IMMUNOL, V165, P1191, DOI 10.4049/jimmunol.165.3.1191; Steinert S, 2000, BIOCHEM BIOPH RES CO, V273, P1095, DOI 10.1006/bbrc.2000.3080; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Tahara H, 1999, ONCOGENE, V18, P1561, DOI 10.1038/sj.onc.1202458; Ulaner GA, 1998, CANCER RES, V58, P4168; Vaziri H, 1999, MOL CELL BIOL, V19, P2373; Wei WY, 1999, EXP CELL RES, V253, P519, DOI 10.1006/excr.1999.4665; Wong JMY, 2002, NAT CELL BIOL, V4, P731, DOI 10.1038/ncb846; Wright WE, 2002, NAT BIOTECHNOL, V20, P682, DOI 10.1038/nbt0702-682; Yasumoto S, 1996, ONCOGENE, V13, P433; Yuan XM, 1999, GENES CELLS, V4, P563, DOI 10.1046/j.1365-2443.1999.00284.x; Zhu XL, 1996, P NATL ACAD SCI USA, V93, P6091, DOI 10.1073/pnas.93.12.6091	60	597	662	4	68	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 25	2003	114	2					241	253		10.1016/S0092-8674(03)00550-6	http://dx.doi.org/10.1016/S0092-8674(03)00550-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887925	Bronze, Green Submitted			2022-12-01	WOS:000184378700013
J	Virtamo, J; Pietinen, P; Huttunen, JK; Malila, N; Virtanen, MJ; Albanes, D; Taylor, PR; Albert, P				Virtamo, J; Pietinen, P; Huttunen, JK; Malila, N; Virtanen, MJ; Albanes, D; Taylor, PR; Albert, P		ATBC Study Grp	Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation - A postintervention follow-up	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONTROLLED TRIAL FINLAND; LUNG-CANCER; CARDIOVASCULAR-DISEASE; CIGARETTE-SMOKE; PROSTATE-CANCER; VITAMIN-A; PREVENTION; MICRONUTRIENTS; FERRETS; RISK	Context In the Finnish Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) study, alpha-tocopherol supplementation decreased prostate cancer incidence, whereas beta-carotene increased the risk of lung cancer and total mortality. Postintervention follow-up provides information regarding duration of the intervention effects and may reveal potential late effects of these antioxidants. Objective To analyze postintervention effects of alpha-tocopherol and beta-carotene on cancer incidence and total and cause-specific mortality. Design, Setting, and Participants Postintervention follow-up assessment of cancer incidence and cause-specific mortality (6 years [May 1, 1993-April 30, 1999]) and total mortality (8 years [May 1, 1993-April 30, 2001]) of 25563 men. In the ATBC Study, 29133 male smokers aged 50 to 69 years received a-tocopherol (50 mg), beta-carotene (20 mg), both agents, or placebo daily for 5 to 8 years. End point information was obtained from the Finnish Cancer Registry and the Register of Causes of Death. Cancer cases were, confirmed through medical record review. Main Outcome Measures Site-specific cancer incidence and total and cause-specific mortality and calendar time-specific risk for lung cancer incidence and total mortality. Results Overall posttrial relative risk (RR) for lung cancer incidence (n = 1037) was 1.06 (95% confidence interval [CI], 0.94-1.20) among recipients of beta-carotene compared with nonrecipients. For prostate cancer incidence (n=672), the RR was 0.88 (95% CI, 0.76-1.03) for participants receiving alpha-tocopherol compared with nonrecipients. No late preventive effects on other cancers were observed for either supplement. There were 7261 individuals who died by April 30, 2001, during the posttrial follow-up period; the RR was 1.01 (95% CI, 0.96-1.05) for alpha-tocopherol recipients vs nonrecipients and 1.07 (95% CI, 1.02-1.12) for beta-carotene recipients vs nonrecipients. Regarding duration of intervention effects and potential late effects, the excess risk for beta-carotene recipients was no longer evident 4 to 6 years after ending the intervention and was primarily due to cardiovascular diseases. Conclusions The beneficial and adverse effects of supplemental alpha-tocopherol and beta-carotene disappeared during postintervention follow-up. The preventive effects of alpha-tocopherol on prostate cancer require confirmation in other trials. Smokers should avoid beta-carotene supplementation.	Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, FIN-00300 Helsinki, Finland; NCI, Bethesda, MD 20892 USA; Univ Helsinki, Cent Hosp, FIN-00014 Helsinki, Finland; Univ Turku, Cent Hosp, SF-20500 Turku, Finland; Jorvi Hosp, SF-02740 Espoo, Finland; Finnish Canc Registry, FIN-00170 Helsinki, Finland	Finland National Institute for Health & Welfare; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Helsinki; Helsinki University Central Hospital; University of Turku; Finnish Cancer Registry	Virtamo, J (corresponding author), Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Mannerheimintie 166, FIN-00300 Helsinki, Finland.		Albanes, Demetrius/B-9749-2015		NCI NIH HHS [N01-CN-45165] Funding Source: Medline; CCR NIH HHS [N01-RC-45035] Funding Source: Medline; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN045165] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CCR NIH HHS; DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albanes D, 1996, J NATL CANCER I, V88, P1560, DOI 10.1093/jnci/88.21.1560; Albanes D, 2000, CANCER CAUSE CONTROL, V11, P197, DOI 10.1023/A:1008936214087; Arora A, 2001, CARCINOGENESIS, V22, P1173, DOI 10.1093/carcin/22.8.1173; *ATBC CANC PREV ST, 1994, ANN EPIDEMIOL, V4, P1; BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; Breslow NE, 1987, STAT METHODS CANC RE, VII; Chan JM, 2001, EPIDEMIOL REV, V23, P82, DOI 10.1093/oxfordjournals.epirev.a000799; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; De Flora S, 1999, MUTAGENESIS, V14, P153, DOI 10.1093/mutage/14.2.153; DORGAN JF, 1991, HEMATOL ONCOL CLIN N, V5, P43, DOI 10.1016/S0889-8588(18)30453-2; Greenberg ER, 1996, JAMA-J AM MED ASSOC, V275, P699, DOI 10.1001/jama.275.9.699; Hastie TJ, 1990, GEN ADDITIVE MODELS; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Klein EA, 2001, J UROLOGY, V166, P1311, DOI 10.1016/S0022-5347(05)65759-X; Korhonen P, 2002, ACTA ONCOL, V41, P381, DOI 10.1080/028418602760169442; Liu C, 2000, CARCINOGENESIS, V21, P2245, DOI 10.1093/carcin/21.12.2245; Malila N, 2002, CANCER CAUSE CONTROL, V13, P617, DOI 10.1023/A:1019556227014; Mayne ST, 1996, J NATL CANCER I, V88, P1513; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Paolini M, 1999, NATURE, V398, P760, DOI 10.1038/19655; Paolini M, 2001, CARCINOGENESIS, V22, P1483, DOI 10.1093/carcin/22.9.1483; PETO R, 1981, NATURE, V290, P201, DOI 10.1038/290201a0; Rautalahti MT, 1999, CANCER-AM CANCER SOC, V86, P37, DOI 10.1002/(SICI)1097-0142(19990701)86:1&lt;37::AID-CNCR7&gt;3.0.CO;2-F; Shklar G, 2000, CANCER INVEST, V18, P214, DOI 10.3109/07357900009031826; Virtamo J, 2000, CANCER CAUSE CONTROL, V11, P933, DOI 10.1023/A:1026546803917; Wang XD, 1999, J NATL CANCER I, V91, P60, DOI 10.1093/jnci/91.1.60	28	299	311	0	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2003	290	4					476	485						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703JB	12876090				2022-12-01	WOS:000184275300019
J	Albrecht, C; Blank, K; Lalic-Multhaler, M; Hirler, S; Mai, T; Gilbert, I; Schiffmann, S; Bayer, T; Clausen-Schaumann, H; Gaub, HE				Albrecht, C; Blank, K; Lalic-Multhaler, M; Hirler, S; Mai, T; Gilbert, I; Schiffmann, S; Bayer, T; Clausen-Schaumann, H; Gaub, HE			DNA: A programmable force sensor	SCIENCE			English	Article							SINGLE; SPECTROSCOPY; MECHANICS	Direct quanti. cation of biomolecular interaction by single-molecule force spectroscopy has evolved into a powerful tool for materials and life sciences. We introduce an approach in which the unbinding forces required to break intermolecular bonds are measured in a differential format by comparison with a known reference bond (here, a short DNA duplex). In addition to a marked increase in sensitivity and force resolution, which enabled us to resolve single base pair mismatches, this concept allows for highly specific parallel assays. This option was exploited to overcome cross-reactions of antibodies in a protein biochip application.	Nanotype GmbH, D-82166 Grafelfing, Germany; Lehrstuhl Angew Phys, D-80799 Munich, Germany; Ctr Nanosci, D-80799 Munich, Germany	University of Munich; University of Munich	Clausen-Schaumann, H (corresponding author), Nanotype GmbH, Lochhamer Schlag 12, D-82166 Grafelfing, Germany.	hauke.clausen-schaumann@nanotype.de	Clausen-Schaumann, Hauke/W-1830-2017; Blank, Kerstin/C-6323-2008	Clausen-Schaumann, Hauke/0000-0002-9413-0310; Blank, Kerstin/0000-0001-5410-6984; Schiffmann, Susanne/0000-0001-5035-2504				Abbott A, 2002, NATURE, V415, P112, DOI 10.1038/415112a; Bernard A, 2001, ANAL CHEM, V73, P8, DOI 10.1021/ac0008845; Bockelmann U, 1997, PHYS REV LETT, V79, P4489, DOI 10.1103/PhysRevLett.79.4489; Bustamante C, 2000, NAT REV MOL CELL BIO, V1, P130, DOI 10.1038/35040072; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Clausen-Schaumann H, 2000, CURR OPIN CHEM BIOL, V4, P524, DOI 10.1016/S1367-5931(00)00126-5; Cutler P, 2003, PROTEOMICS, V3, P3, DOI 10.1002/pmic.200390007; EKINS RP, 1994, TRENDS BIOTECHNOL, V12, P89, DOI 10.1016/0167-7799(94)90111-2; EKINS RP, 1989, J PHARMACEUT BIOMED, V7, P155, DOI 10.1016/0731-7085(89)80079-2; EssevazRoulet B, 1997, P NATL ACAD SCI USA, V94, P11935, DOI 10.1073/pnas.94.22.11935; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Gittes F, 1998, EUR BIOPHYS J BIOPHY, V27, P75, DOI 10.1007/s002490050113; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; Hugel T, 2002, SCIENCE, V296, P1103, DOI 10.1126/science.1069856; Janshoff A, 2000, ANGEW CHEM INT EDIT, V39, P3213; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Krautbauer R, 2003, NANO LETT, V3, P493, DOI 10.1021/nl034049p; KUMAR A, 1995, ACCOUNTS CHEM RES, V28, P219, DOI 10.1021/ar00053a003; Lavery R, 2002, J PHYS-CONDENS MAT, V14, pR383, DOI 10.1088/0953-8984/14/14/202; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; Mehta AD, 1999, SCIENCE, V283, P1689, DOI 10.1126/science.283.5408.1689; Mendoza LG, 1999, BIOTECHNIQUES, V27, P778, DOI 10.2144/99274rr01; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; Merkel R, 2001, PHYS REP, V346, P344; Mitchell P, 2002, NAT BIOTECHNOL, V20, P225, DOI 10.1038/nbt0302-225; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; Naef F, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.040902; Nollau P, 1997, J Int Fed Clin Chem, V9, P162; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143; Petach H, 2002, CURR OPIN BIOTECH, V13, P309, DOI 10.1016/S0958-1669(02)00329-4; PORSCHKE D, 1971, J MOL BIOL, V62, P361, DOI 10.1016/0022-2836(71)90433-5; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1999, NAT STRUCT BIOL, V6, P346; SCHILDKRAUT C, 1965, BIOPOLYMERS, V3, P195, DOI 10.1002/bip.360030207; Schwesinger F, 2000, P NATL ACAD SCI USA, V97, P9972, DOI 10.1073/pnas.97.18.9972; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Strunz T, 1999, P NATL ACAD SCI USA, V96, P11277, DOI 10.1073/pnas.96.20.11277; Viani MB, 1999, J APPL PHYS, V86, P2258, DOI 10.1063/1.371039; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153	43	138	145	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2003	301	5631					367	370		10.1126/science.1084713	http://dx.doi.org/10.1126/science.1084713			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869761				2022-12-01	WOS:000184207300044
J	Whitney, D; Goltz, HC; Thomas, CG; Gati, JS; Menon, RS; Goodale, MA				Whitney, D; Goltz, HC; Thomas, CG; Gati, JS; Menon, RS; Goodale, MA			Flexible retinotopy: Motion-dependent position coding in the visual cortex	SCIENCE			English	Article							PERCEIVED POSITION; STRIATE CORTEX; ATTENTION; REPRESENTATION; PERCEPTION; FIELD; OBJECTS; MONKEYS; NEURONS; HUMANS	Although the visual cortex is organized retinotopically, it is not clear whether the cortical representation of position necessarily reflects perceived position. Using functional magnetic resonance imaging (fMRI), we show that the retinotopic representation of a stationary object in the cortex was systematically shifted when visual motion was present in the scene. Whereas the object could appear shifted in the direction of the visual motion, the representation of the object in the visual cortex was always shifted in the opposite direction. The results show that the representation of position in the primary visual cortex, as revealed by fMRI, can be dissociated from perceived location.	Univ Western Ontario, Dept Psychol, London, ON N6A 5C2, Canada; John P Robarts Res Inst, London, ON N6A 5K8, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Whitney, D (corresponding author), Univ Western Ontario, Dept Psychol, London, ON N6A 5C2, Canada.		Menon, Ravi/ABA-8654-2020; Goodale, Melvyn A/M-5907-2013; Gati, Joseph S/K-5476-2013; Menon, Ravi S/K-5500-2013	Menon, Ravi/0000-0002-7916-0263; Goodale, Melvyn A/0000-0001-6748-0561; Menon, Ravi S/0000-0002-7916-0263; Thomas, Christopher/0000-0002-5209-8797; Goltz, Herbert/0000-0002-6496-754X	NEI NIH HHS [F32 EY013899-01, F32 EY013899-02, F32 EY013899-03, F32 EY013899] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY013899] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BATTAGLINI PP, 1993, ARCH ITAL BIOL, V131, P303; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; BEX PJ, 1995, VISION RES, V35, P2539, DOI 10.1016/0042-6989(95)00060-D; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; BURR D, 1980, NATURE, V284, P164, DOI 10.1038/284164a0; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; DEVALOIS RL, 1991, VISION RES, V31, P1619, DOI 10.1016/0042-6989(91)90138-U; Fu YX, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-20-j0003.2001; Georgeson MA, 2002, P ROY SOC B-BIOL SCI, V269, P1429, DOI 10.1098/rspb.2002.2029; Kirschfeld K, 1999, VISION RES, V39, P3702, DOI 10.1016/S0042-6989(99)00089-9; LAMME VAF, 1993, NATURE, V363, P541, DOI 10.1038/363541a0; Musseler J, 1998, PERCEPT PSYCHOPHYS, V60, P683, DOI 10.3758/BF03206055; Nishida S, 1999, NATURE, V397, P610, DOI 10.1038/17600; RAMACHAN.VS, 1974, PERCEPTION, V3, P97, DOI 10.1068/p030097; RAMACHANDRAN VS, 1990, PERCEPTION, V19, P611, DOI 10.1068/p190611; Reppas JB, 1997, NATURE, V388, P175, DOI 10.1038/40633; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Snowden RJ, 1998, CURR BIOL, V8, P1343, DOI 10.1016/S0960-9822(07)00567-2; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Stasheff SF, 2002, J NEUROPHYSIOL, V88, P1026, DOI 10.1152/jn.2002.88.2.1026; TOOTELL RBH, 1982, SCIENCE, V218, P902, DOI 10.1126/science.7134981; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; Verstraten FAJ, 2000, VISION RES, V40, P3651, DOI 10.1016/S0042-6989(00)00213-3; VIRSU V, 1979, EXP BRAIN RES, V37, P475; Whitaker D, 1999, VISION RES, V39, P2999, DOI 10.1016/S0042-6989(99)00010-3; Whitney D, 2000, NAT NEUROSCI, V3, P954, DOI 10.1038/78878; WILSON JR, 1976, J NEUROPHYSIOL, V39, P512, DOI 10.1152/jn.1976.39.3.512	29	98	98	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2003	302	5646					878	881		10.1126/science.1087839	http://dx.doi.org/10.1126/science.1087839			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14500849	Green Accepted			2022-12-01	WOS:000186258000053
J	He, K; Merchant, A; Rimin, EB; Rosner, BA; Starripler, M; Willett, WC; Ascherio, A				He, K; Merchant, A; Rimin, EB; Rosner, BA; Starripler, M; Willett, WC; Ascherio, A			Dietary fat intake and risk of stroke in male US healthcare professionals: 14 year prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							FOOD FREQUENCY QUESTIONNAIRE; CORONARY-HEART-DISEASE; UNITED-STATES; CHOLESTEROL; ACID; MEN; ATHEROSCLEROSIS; REPRODUCIBILITY; PROTECTION; VALIDITY		Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	He, K (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.		Merchant, Anwar/B-5233-2009; Robles-Sardin, Alma E/M-7714-2015	Robles-Sardin, Alma E/0000-0003-2044-7793	NCI NIH HHS [CA55075] Funding Source: Medline; NHLBI NIH HHS [HL35464] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ascherio A, 1996, BMJ-BRIT MED J, V313, P84, DOI 10.1136/bmj.313.7049.84; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; DECATERINA R, 1994, ARTERIOSCLER THROMB, V14, P1829, DOI 10.1161/01.ATV.14.11.1829; DRISS F, 1984, THROMB RES, V36, P389, DOI 10.1016/0049-3848(84)90295-0; ENIG MG, 1983, J AM OIL CHEM SOC, V60, P1788, DOI 10.1007/BF02680357; Gillman MW, 1997, JAMA-J AM MED ASSOC, V278, P2145, DOI 10.1001/jama.278.24.2145; He K, 2002, JAMA-J AM MED ASSOC, V288, P3130, DOI 10.1001/jama.288.24.3130; HEBERT PR, 1995, ARCH INTERN MED, V155, P50, DOI 10.1001/archinte.155.1.50; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; HUNTER DJ, 1992, AM J EPIDEMIOL, V135, P418, DOI 10.1093/oxfordjournals.aje.a116302; Iso H, 2002, STROKE, V33, P2086, DOI 10.1161/01.STR.0000023890.25066.50; Iso H, 2001, CIRCULATION, V103, P856, DOI 10.1161/01.CIR.103.6.856; KEANEY JF, 1995, PROG CARDIOVASC DIS, V38, P129, DOI 10.1016/S0033-0620(05)80003-9; KEARNEY JF, 1995, PROG CARDIOVASC DIS, V38, P129; KEYS A, 1965, METABOLIS, V14, P747, DOI 10.1016/0026-0495(65)90001-6; LaBiche R, 2001, STROKE, V32, P855, DOI 10.1161/01.STR.32.4.855; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; Qizilbash N, 1995, LANCET, V346, P1647; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rimm EB, 1992, AM J EPIDEMIOL, V135, P1127, DOI DOI 10.1093/OXFORDJOURNALS.AJE.A116211; SASAKI S, 1995, STROKE, V26, P783, DOI 10.1161/01.STR.26.5.783; SIMON JA, 1995, STROKE, V26, P778, DOI 10.1161/01.STR.26.5.778; SIMON JA, 1995, STROKE, V26, P788; SLOVER HT, 1985, J AM OIL CHEM SOC, V62, P775, DOI 10.1007/BF03028753; TELL GS, 1994, AM J EPIDEMIOL, V139, P979, DOI 10.1093/oxfordjournals.aje.a116947; Walker A, 1981, STROKE S1, V12, P113; Walker AE, 1981, STROKE S1, V12, pI13; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086	28	131	136	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 4	2003	327	7418					777	781		10.1136/bmj.327.7418.777	http://dx.doi.org/10.1136/bmj.327.7418.777			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729ZQ	14525873	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000185805100017
J	Parker, GA; Chubb, JC; Ball, MA; Roberts, GN				Parker, GA; Chubb, JC; Ball, MA; Roberts, GN			Evolution of complex life cycles in helminth parasites	NATURE			English	Article							REPRODUCTION; GROWTH	The fundamental question of how complex life cycles-where there is typically more than one host-evolve in host-parasite systems remains largely unexplored. We suggest that complex cycles in helminths without penetrative infective stages evolve by two essentially different processes, depending on where in the cycle a new host is inserted. In 'upward incorporation', a new definitive host, typically higher up a food web and which preys on the original definitive host, is added. Advantages to the parasite are avoidance of mortality due to the predator, greater body size at maturity and higher fecundity. The original host typically becomes an intermediate host, in which reproduction is suppressed. In 'downward incorporation', a new intermediate host is added at a lower trophic level; this reduces mortality and facilitates transmission to the original definitive host. These two processes should also apply in helminths with penetrative infective stages, although the mathematical conditions differ.	Univ Liverpool, Sch Biol Sci, Populat & Evolut Biol Res Grp, Liverpool L69 7ZB, Merseyside, England; Univ Liverpool, Dept Math Sci, Div Appl Math, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Parker, GA (corresponding author), Univ Liverpool, Sch Biol Sci, Populat & Evolut Biol Res Grp, Liverpool L69 7ZB, Merseyside, England.	gap@liverpool.ac.uk	Parker, Geoff/C-4337-2008	Parker, Geoff/0000-0003-4795-6352				Anderson R. C., 2000, Nematode parasites of vertebrates: their development and transmission., DOI 10.1079/9780851994215.0000; BAER JG, 1952, ECOLOGY ANIMAL PARAS; BRIAND F, 1987, SCIENCE, V238, P956, DOI 10.1126/science.3672136; Brooks DR, 1993, PARASCRIPT PARASITES; Brown SP, 2001, J EVOLUTION BIOL, V14, P815, DOI 10.1046/j.1420-9101.2001.00318.x; Charnov Eric L., 1993, P1; EBERMAN B, 1992, AM NAT, V139, P990; Fernandez J.C, 1993, FUNCTIONAL BIOL PARA; Gemmill AW, 1999, J EVOLUTION BIOL, V12, P1148, DOI 10.1046/j.1420-9101.1999.00117.x; HARVEY PH, 1991, PHILOS T R SOC B, V332, P31, DOI 10.1098/rstb.1991.0030; KOZLOWSKI J, 1992, TRENDS ECOL EVOL, V7, P15, DOI 10.1016/0169-5347(92)90192-E; MACKIEWICZ JS, 1972, EXP PARASITOL, V31, P417, DOI 10.1016/0014-4894(72)90103-8; Matsuno K, 1996, J THEOR BIOL, V180, P105, DOI 10.1006/jtbi.1996.0085; MOLNAR K, 1968, FOLIA PARASIT, V14, P83; Morand S, 1996, FUNCT ECOL, V10, P210, DOI 10.2307/2389845; MORAND S, 1995, J ANIM ECOL, V64, P256, DOI 10.2307/5760; Moravec F., 1994, Parasitic nematodes of freshwater fishes of Europe.; Nickol B.B, 1985, BIOL ACANTHOCEPHALA; Parker GA, 2003, J EVOLUTION BIOL, V16, P47, DOI 10.1046/j.1420-9101.2003.00504.x; Poulin R, 2002, TRENDS PARASITOL, V18, P176, DOI 10.1016/S1471-4922(02)02262-6; POULIN R, 1998, EVOLUTIONARY ECOLOGY; Price P.W., 1980, EVOLUTIONARY BIOL PA; REDI F, 1671, EXPT CIRC GENERATION; Roff Derek A., 1992; STUNKARD HW, 1946, BIOL REV, V21, P148, DOI 10.1111/j.1469-185X.1946.tb00321.x; [No title captured]	26	152	157	0	64	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 2	2003	425	6957					480	484		10.1038/nature02012	http://dx.doi.org/10.1038/nature02012			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727FN	14523438				2022-12-01	WOS:000185648100036
J	Caudy, AA; Ketting, RF; Hammond, SM; Denli, AM; Bathoorn, AMP; Tops, BBJ; Silva, JM; Myers, MM; Hannon, GJ; Plasterk, RHA				Caudy, AA; Ketting, RF; Hammond, SM; Denli, AM; Bathoorn, AMP; Tops, BBJ; Silva, JM; Myers, MM; Hannon, GJ; Plasterk, RHA			A micrococcal nuclease homologue in RNAi effector complexes	NATURE			English	Article							STAPHYLOCOCCAL NUCLEASE; INTERFERENCE; COACTIVATOR; CELLS; ELEGANS; PROTEIN; P100; TRANSCRIPTION; CLEAVAGE; SIRNAS	RNA interference (RNAi) regulates gene expression by the cleavage of messenger RNA, by mRNA degradation and by preventing protein synthesis. These effects are mediated by a ribonucleoprotein complex known as RISC (RNA-induced silencing complex)(1). We have previously identified four Drosophila components (short interfering RNAs1, Argonaute 2 (ref. 2), VIG and FXR3) of a RISC enzyme that degrades specific mRNAs in response to a double-stranded-RNA trigger. Here we show that Tudor-SN (tudor staphylococcal nuclease)-a protein containing five staphylococcal/micrococcal nuclease domains and a tudor domain-is a component of the RISC enzyme in Caenorhabditis elegans, Drosophila and mammals. Although Tudor-SN contains non-canonical active-site sequences, we show that purified Tudor-SN exhibits nuclease activity similar to that of other staphylococcal nucleases. Notably, both purified Tudor-SN and RISC are inhibited by a specific competitive inhibitor of micrococcal nuclease. Tudor-SN is the first RISC subunit to be identified that contains a recognizable nuclease domain, and could therefore contribute to the RNA degradation observed in RNAi.	Hubrecht Lab, Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands; Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Cold Spring Harbor Laboratory	Hannon, GJ (corresponding author), Hubrecht Lab, Ctr Biomed Genet, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.		Hannon, Gregory/AAB-3568-2019; Tops, Bastiaan/L-4697-2015	Tops, Bastiaan/0000-0002-1699-8210; Ketting, Rene/0000-0001-6161-5621; Caudy, Amy/0000-0001-6307-8137				Avalos RT, 1997, J VIROL, V71, P2947, DOI 10.1128/JVI.71.4.2947-2958.1997; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Callebaut I, 1997, BIOCHEM J, V321, P125, DOI 10.1042/bj3210125; Capodici J, 2002, J IMMUNOL, V169, P5196, DOI 10.4049/jimmunol.169.9.5196; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; CUATRECA.P, 1967, J BIOL CHEM, V242, P3063; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hirayoshi K, 1999, METHOD ENZYMOL, V304, P351; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Keenan TW, 2000, BBA-GEN SUBJECTS, V1523, P84, DOI 10.1016/S0304-4165(00)00106-9; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Ponting CP, 1997, PROTEIN SCI, V6, P459; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; SERPERSU EH, 1987, BIOCHEMISTRY-US, V26, P1289, DOI 10.1021/bi00379a014; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Spankuch-Schmitt B, 2002, JNCI-J NATL CANCER I, V94, P1863, DOI 10.1093/jnci/94.24.1863; SPECTOR DL, 1986, EXP CELL RES, V163, P87, DOI 10.1016/0014-4827(86)90560-4; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; TONG X, 1995, MOL CELL BIOL, V15, P4735	30	348	380	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 25	2003	425	6956					411	414		10.1038/nature01956	http://dx.doi.org/10.1038/nature01956			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	724TG	14508492				2022-12-01	WOS:000185502300044
J	Krummel, EM; Macdonald, RW; Kimpe, LE; Gregory-Eaves, I; Demers, MJ; Smol, JP; Finney, B; Blais, JM				Krummel, EM; Macdonald, RW; Kimpe, LE; Gregory-Eaves, I; Demers, MJ; Smol, JP; Finney, B; Blais, JM			Delivery of pollutants by spawning salmon - Fish dump toxic industrial compounds in Alaskan lakes on their return from the ocean.	NATURE			English	Editorial Material							POLYCHLORINATED-BIPHENYLS; PACIFIC SALMON; SEDIMENTS; IMPACTS		Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada; Inst Ocean Sci, Dept Fisheries & Oceans, Sidney, BC V8L 4B2, Canada; Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada; Univ Alaska, Inst Marine Sci, Fairbanks, AK 99775 USA	University of Ottawa; Fisheries & Oceans Canada; Queens University - Canada; University of Alaska System; University of Alaska Fairbanks	Krummel, EM (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada.	jblais@science.ottawa.ca	Blais, Jules/AAV-2321-2020; Macdonald, Robie W/A-7896-2012; Smol, John P/A-8838-2015; Gregory-Eaves, Irene/U-9325-2019	Blais, Jules/0000-0002-7188-3598; Macdonald, Robie W/0000-0002-1141-8520; Gregory-Eaves, Irene/0000-0002-0380-5061; Smol, John/0000-0002-2499-6696				Arkoosh MR, 1998, J AQUAT ANIM HEALTH, V10, P182, DOI 10.1577/1548-8667(1998)010&lt;0182:EOPOFD&gt;2.0.CO;2; Blais JM, 2003, ENVIRON TOXICOL CHEM, V22, P126, DOI [10.1002/etc.5620220116, 10.1897/1551-5028(2003)022&lt;0126:AACOPB&gt;2.0.CO;2]; Burgner R.L., 1991, P1; Ewald G, 1998, ARCTIC, V51, P40; Finney BP, 2000, SCIENCE, V290, P795, DOI 10.1126/science.290.5492.795; *IND NO AFF, 2003, CAN ARCT CONT ASS RE; IWATA H, 1993, ENVIRON SCI TECHNOL, V27, P1080, DOI 10.1021/es00043a007; MacDonald RW, 2000, SCI TOTAL ENVIRON, V254, P93, DOI 10.1016/S0048-9697(00)00434-4; Muir DCG, 1996, ENVIRON SCI TECHNOL, V30, P3609, DOI 10.1021/es960393v; Naiman RJ, 2002, ECOSYSTEMS, V5, P399, DOI 10.1007/s10021-001-0083-3	10	103	108	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 18	2003	425	6955					255	256		10.1038/425255a	http://dx.doi.org/10.1038/425255a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722JA	13679906				2022-12-01	WOS:000185370900033
J	Goldacre, MJ; Roberts, SE; Yeates, D				Goldacre, MJ; Roberts, SE; Yeates, D			Case fatality rates for meningococcal disease in an English population, 1963-98: database study	BRITISH MEDICAL JOURNAL			English	Article							ACUTE BACTERIAL-MENINGITIS		Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England	University of Oxford	Goldacre, MJ (corresponding author), Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England.							Booy R, 2001, ARCH DIS CHILD, V85, P386, DOI 10.1136/adc.85.5.386; GOLDACRE MJ, 1976, INT J EPIDEMIOL, V5, P343, DOI 10.1093/ije/5.4.343; GOLDACRE MJ, 1976, LANCET, V1, P28; Sorensen HT, 1998, EUR J CLIN MICROBIOL, V17, P690, DOI 10.1007/s100960050162; Wylie PAL, 1997, BRIT MED J, V315, P774, DOI 10.1136/bmj.315.7111.774	5	40	40	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 13	2003	327	7415					596	597		10.1136/bmj.327.7415.596	http://dx.doi.org/10.1136/bmj.327.7415.596			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722CW	12969927	Bronze, Green Published			2022-12-01	WOS:000185358700023
J	Wei, JN; Sung, FC; Lin, CC; Lin, RS; Chiang, CC; Chuang, LM				Wei, JN; Sung, FC; Lin, CC; Lin, RS; Chiang, CC; Chuang, LM			National surveillance for type 2 diabetes mellitus in Taiwanese children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EPIDEMIOLOGY; ADOLESCENTS; PREVALENCE; OBESITY; RISK	Context Despite a disturbing trend of increasing prevalence of type 2 diabetes mellitus (DM) in childhood, little is known about the epidemiology of childhood type 2 DM, especially in the Taiwanese population. Objective To study the rate and risk factors for childhood type 2 DM based on a nationwide screening program in Taiwan. Design, Setting, and Participants Screening in 1999 for type 2 DM using urine and blood testing and confirmed by follow-up telephone survey among schoolchildren aged 6 to 18 years in Taiwan, followed by a nested case-control study conducted in 2002 comparing 137 children with type 2 DM with 1000 randomly selected children without diabetes chosen to represent the age and sex distribution of the whole student population. Main Outcome Measures Rate and identification of risk factors associated with childhood type 2 DM. Results The rate of newly identified diabetes was 9.0 per 100000 for boys and 15.3 per 100000 for girls. Follow-up at 3 years revealed that, of 253 children with newly diagnosed diabetes, 24 (9.5%) had type 1 DM, 137 (54.2%) had type 2 DM, and 22 (8.7%) had secondary diabetes. Compared with children aged 6 to 9 years, the odds ratios (ORs) and 95% confidence intervals (CIs) of type 2 DM increased to 6.59 (3.23-13.4) for those aged 13 to 15 years and to 4.59 (2.07-10.2) for those aged 16 to 18 years. The OR (95% CI) of type 2 DM in children with a body mass index in the 95th percentile or higher (obesity) was 18.8 (9.22-38.5) compared with those with a body mass index in less than the 50th percentile. Other factors significantly associated with type 2 DM were hypercholesterolemia (OR, 1.80; 95% CI, 1.04-3.23), blood pressure greater than the 85th percentile (OR, 1.70; 95% CI, 1.07-2.70), and positive family history of diabetes (OR, 3.95; 95% CI, 2.01-7.78). Conclusions Our mass screening program showed that type 2 DM is the leading cause of childhood DM in Taiwan. Obesity is a major risk factor for the development of type 2 DM in children.	Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; Natl Taiwan Univ, Coll Publ Hlth, Inst Environm Hlth, Taipei 10764, Taiwan; Natl Taiwan Univ, Coll Publ Hlth, Inst Prevent Med, Taipei 10764, Taiwan; Chinese Fdn Hlth, Taipei, Taiwan; Chia Nan Univ Pharm & Sci, Tainan, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Chia Nan University of Pharmacy & Science	Chuang, LM (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, 7 Chung Shan S Rd, Taipei 100, Taiwan.	leeming@ha.mc.ntu.edu.tw	Chuang, Lee-Ming/AAF-3324-2019	CHUANG, LEE-MING/0000-0003-0978-2662				*AM DIAB ASS, 2003, DIABETES CARE S1, V26, pS21, DOI DOI 10.2337/DIACARE.26.2007.S21; ANDERSSON DKG, 1993, DIABETIC MED, V10, P167, DOI 10.1111/j.1464-5491.1993.tb00036.x; Berg AO, 2003, ANN INTERN MED, V138, P212, DOI 10.7326/0003-4819-138-3-200302040-00014; Bloomgarden ZT, 2000, DIABETES CARE, V23, P1584, DOI 10.2337/diacare.23.10.1584; Boyko EJ, 2000, DIABETES CARE, V23, P465, DOI 10.2337/diacare.23.4.465; Caprio S, 1999, ENDOCRIN METAB CLIN, V28, P731, DOI 10.1016/S0889-8529(05)70099-2; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; Dabelea D, 1998, DIABETOLOGIA, V41, P904, DOI 10.1007/s001250051006; Dabelea D, 1999, ENDOCRIN METAB CLIN, V28, P709, DOI 10.1016/S0889-8529(05)70098-0; Dean H, 1998, CLIN PEDIATR, V37, P89, DOI 10.1177/000992289803700205; Fagot-Campagna A, 1999, CLIN CHIM ACTA, V286, P81, DOI 10.1016/S0009-8981(99)00095-9; Forum Health Promotion and Disease Prevention Committee, 2000, ASS CHILDR ANTHR ITS, P33; Friderichsen B, 1997, J PUBLIC HEALTH MED, V19, P55, DOI 10.1093/oxfordjournals.pubmed.a024588; Gavin JR, 1997, DIABETES CARE, V20, P1183; Goran MI, 2001, DIABETES, V50, P2444, DOI 10.2337/diabetes.50.11.2444; Harris SB, 1996, CAN FAM PHYSICIAN, V42, P869; Hosmer D. W., 1989, APPL LOGISTIC REGRES, P132; Jeruc J, 2000, WIEN KLIN WOCHENSCHR, V112, P702; KIDA K, 2003, TYPE 2 DIABETES CHIL; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; KITAGAWA T, 1994, DIABETES RES CLIN PR, V24, pS7, DOI 10.1016/0168-8227(94)90221-6; Kitagawa T, 1998, CLIN PEDIATR, V37, P111, DOI 10.1177/000992289803700208; Kwamura T, 1999, DIABETES, V48, pA168; Moran A, 1999, DIABETES, V48, P2039, DOI 10.2337/diabetes.48.10.2039; *NAT CHOL ED PROGR, 1992, PEDIATRICS, V89, P525; Neufeld ND, 1998, DIABETES CARE, V21, P80, DOI 10.2337/diacare.21.1.80; ORIT PH, 1996, J PEDIATR, V128, P608; OSULLIVAN JB, 1991, DIABETES, V40, P131, DOI 10.2337/diab.40.2.S131; PANDIT MK, 1993, ANN INTERN MED, V118, P529, DOI 10.7326/0003-4819-118-7-199304010-00008; Pihoker C, 1998, CLIN PEDIATR, V37, P97, DOI 10.1177/000992289803700206; Rosenbloom A, 2000, DIABETES CARE, V23, P381; Rosenbloom AL, 1999, DIABETES CARE, V22, P345, DOI 10.2337/diacare.22.2.345; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SHINOZAKI T, 1999, JPN J PUBLIC HLTH, V46, P790; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; TAI TY, 1992, INT J EPIDEMIOL, V21, P511, DOI 10.1093/ije/21.3.511; van der Sande MAB, 1999, TROP MED INT HEALTH, V4, P506; Wei JN, 2003, DIABETES RES CLIN PR, V59, P201, DOI 10.1016/S0168-8227(02)00247-4; WILLI SM, 2000, CURR OPIN ENDOCRINOL, V7, P71; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	40	155	168	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2003	290	10					1345	1350		10.1001/jama.290.10.1345	http://dx.doi.org/10.1001/jama.290.10.1345			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	719DP	12966126	Bronze, Green Published			2022-12-01	WOS:000185188600027
J	Changela, A; Chen, K; Xue, Y; Holschen, J; Outten, CE; O'Halloran, TV; Mondragon, A				Changela, A; Chen, K; Xue, Y; Holschen, J; Outten, CE; O'Halloran, TV; Mondragon, A			Molecular basis of metal-ion selectivity and zeptomolar sensitivity by CueR	SCIENCE			English	Article							MERR METALLOREGULATORY PROTEIN; P-TYPE ATPASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TRANSCRIPTIONAL ACTIVATION; COPPER HOMEOSTASIS; RECEPTOR-SITE; OXIDASE; COPA; DNA	The earliest of a series of copper efflux genes in Escherichia coli are controlled by CueR, a member of the MerR family of transcriptional activators. Thermodynamic calibration of CueR reveals a zeptomolar (10(-21) molar) sensitivity to free Cu+, which is far less than one atom per cell. Atomic details of this extraordinary sensitivity and selectivity for +1 transition-metal ions are revealed by comparing the crystal structures of CueR and a Zn2+-sensing homolog, ZntR. An unusual buried metal-receptor site in CueR restricts the metal to a linear, two-coordinate geometry and uses helix-dipole and hydrogen-bonding interactions to enhance metal binding. This binding mode is rare among metalloproteins but well suited for an ultrasensitive genetic switch.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University; Northwestern University	O'Halloran, TV (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2205 Tech Dr, Evanston, IL 60208 USA.		O'Halloran, Thomas/ABE-6125-2021; Outten, Caryn E./I-9433-2019; Johnson, Michael D. L./B-4352-2012	O'Halloran, Thomas/0000-0001-8732-5059; Outten, Caryn E./0000-0003-0335-6531; 	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK061868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM038784, R01GM051350, R01GM038784, R37GM038784] Funding Source: NIH RePORTER; NIDDK NIH HHS [F32 DK61868] Funding Source: Medline; NIGMS NIH HHS [GM38784, GM08382, R01 GM051350, GM51350] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramson J, 2000, NAT STRUCT BIOL, V7, P910; Alderighi L, 1999, COORDIN CHEM REV, V184, P311, DOI 10.1016/S0010-8545(98)00260-4; CHEN K, IN PRESS J AM CHEM S; Corazza A, 1996, EUR J BIOCHEM, V236, P697, DOI 10.1111/j.1432-1033.1996.0697d.x; Demple B, 2002, METHOD ENZYMOL, V348, P355, DOI 10.1016/S0076-6879(02)48654-5; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Godsey MH, 2001, J BIOL CHEM, V276, P47178, DOI 10.1074/jbc.M105819200; Grass G, 2001, BIOCHEM BIOPH RES CO, V286, P902, DOI 10.1006/bbrc.2001.5474; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; HELMANN JD, 1990, SCIENCE, V247, P946, DOI 10.1126/science.2305262; Hitomi Y, 2001, J AM CHEM SOC, V123, P8614, DOI 10.1021/ja016146v; Huffman DL, 2002, BIOCHEMISTRY-US, V41, P10046, DOI 10.1021/bi0259960; Khan S, 2002, BIOCHEM BIOPH RES CO, V299, P438, DOI 10.1016/S0006-291X(02)02660-8; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; MARTELL AE, 2001, NATL I STANDARDS TEC, V46; Noll M, 1998, J BIOL CHEM, V273, P21393, DOI 10.1074/jbc.273.33.21393; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; OHALLORAN T, 1987, SCIENCE, V235, P211, DOI 10.1126/science.3798107; OSTERBERG R, 1979, J INORG BIOCHEM, V10, P341, DOI 10.1016/S0162-0134(00)80200-7; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Outten FW, 2000, J BIOL CHEM, V275, P31024, DOI 10.1074/jbc.M006508200; Pesce A, 1997, J MOL BIOL, V274, P408, DOI 10.1006/jmbi.1997.1400; Petersen C, 2000, GENE, V261, P289, DOI 10.1016/S0378-1119(00)00509-6; RALSTON DM, 1990, P NATL ACAD SCI USA, V87, P3846, DOI 10.1073/pnas.87.10.3846; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Roberts SA, 2002, P NATL ACAD SCI USA, V99, P2766, DOI 10.1073/pnas.052710499; ROH JH, 1995, BIOCHEM BIOPH RES CO, V212, P1107, DOI 10.1006/bbrc.1995.2083; ROSS W, 1989, J BACTERIOL, V171, P4009, DOI 10.1128/jb.171.7.4009-4018.1989; SHEWCHUK LM, 1989, BIOCHEMISTRY-US, V28, P2340, DOI 10.1021/bi00431a053; Stoyanov JV, 2003, J BIOL CHEM, V278, P1407, DOI 10.1074/jbc.C200580200; Stoyanov JV, 2001, MOL MICROBIOL, V39, P502, DOI 10.1046/j.1365-2958.2001.02264.x; UTSCHIG LM, 1995, SCIENCE, V268, P380, DOI 10.1126/science.7716541; Wilmot CM, 1999, SCIENCE, V286, P1724, DOI 10.1126/science.286.5445.1724; WRIGHT JG, 1990, J AM CHEM SOC, V112, P2434, DOI 10.1021/ja00162a062	35	493	508	4	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 5	2003	301	5638					1383	1387		10.1126/science.1085950	http://dx.doi.org/10.1126/science.1085950			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717XQ	12958362				2022-12-01	WOS:000185116400043
J	Deffenbaugh, AE; Scaglione, KM; Zhang, LX; Moore, JM; Buranda, T; Sklar, LA; Skowyra, D				Deffenbaugh, AE; Scaglione, KM; Zhang, LX; Moore, JM; Buranda, T; Sklar, LA; Skowyra, D			Release of ubiquitin-charged Cdc34-S similar to Ub from the RING domain is essential for ubiquitination of the SCFCdc4-bound substrate Sic1	CELL			English	Article							CDC34 SELF-ASSOCIATION; CONJUGATING ENZYME; MULTIUBIQUITIN CHAIN; LIGASE COMPLEX; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; TERMINAL DOMAIN; E2 ENZYME; F-BOX; SCF	The S. cerevisiae SCFCdc4 is a prototype of RING-type SCF E3s, which recruit substrates for polyubiquitination by the Cdc34 ubiquitin-conjugating enzyme. Current models propose that Cdc34 ubiquitinates the substrate while remaining bound to the RING domain. In contrast, we found that the formation of a ubiquitin thiol ester regulates the Cdc34/SCFCdc4 binding equilibrium by increasing the dissociation rate constant, with only a minor effect on the association rate. By using a F72VCdc34 mutant with increased affinity for the RING domain, we demonstrate that release of ubiquitin-charged Cdc34-Ssimilar toUb from the RING is essential for ubiquitination of the SCFCdc4-bound substrate Sic1. Release of ubiquitin-charged E2 from E3 prior to ubiquitin transfer is a previously unrecognized step in ubiquitination, which can explain both the modification of multiple lysines on the recruited substrate and the extension of polyubiquitin chains. We discuss implications of this finding for function of other ubiquitin ligases.	St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA	Saint Louis University; University of New Mexico	Skowyra, D (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.			Scaglione, Kenneth/0000-0002-3858-9418	NCI NIH HHS [CA88339] Funding Source: Medline; NIGMS NIH HHS [GM60799/EB00264, GM65267] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R24CA088339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065267, R24GM060799] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BANERJEE A, 1993, J BIOL CHEM, V268, P5668; Buranda T, 1999, J PHYS CHEM B, V103, P3399, DOI 10.1021/jp983842h; Buranda T, 2001, ANAL BIOCHEM, V298, P151, DOI 10.1006/abio.2001.5363; COOK WJ, 1994, J MOL BIOL, V236, P601, DOI 10.1006/jmbi.1994.1169; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; FELDMAN RM, 1997, CELL, V91, P149; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GOEBL MG, 1994, MOL CELL BIOL, V14, P3022, DOI 10.1128/MCB.14.5.3022; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; KOLMAN CJ, 1992, EMBO J, V11, P3081, DOI 10.1002/j.1460-2075.1992.tb05380.x; KORNITZER D, 1994, EMBO J, V13, P6021, DOI 10.1002/j.1460-2075.1994.tb06948.x; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Mathias N, 1998, J BIOL CHEM, V273, P4040, DOI 10.1074/jbc.273.7.4040; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; PTAK C, 1994, J BIOL CHEM, V269, P26539; Ptak C, 2001, MOL CELL BIOL, V21, P6537, DOI 10.1128/MCB.21.19.6537-6548.2001; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; SILVER ET, 1992, EMBO J, V11, P3091, DOI 10.1002/j.1460-2075.1992.tb05381.x; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Ulrich HD, 2003, J BIOL CHEM, V278, P7051, DOI 10.1074/jbc.M212195200; VanDemark AP, 2002, CURR OPIN STRUC BIOL, V12, P822, DOI 10.1016/S0959-440X(02)00389-5; Varelas X, 2003, MOL CELL BIOL, V23, P5388, DOI 10.1128/MCB.23.15.5388-5400.2003; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Verma R, 1997, MOL BIOL CELL, V8, P1427, DOI 10.1091/mbc.8.8.1427; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; You JX, 1999, BIOTECHNIQUES, V27, P950, DOI 10.2144/99275st01; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	48	75	76	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 5	2003	114	5					611	622		10.1016/S0092-8674(03)00641-X	http://dx.doi.org/10.1016/S0092-8674(03)00641-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	719FN	13678584	Bronze			2022-12-01	WOS:000185193100010
J	Herrera, E; Brown, L; Aruga, J; Rachel, RA; Dolen, G; Mikoshiba, K; Brown, S; Mason, CA				Herrera, E; Brown, L; Aruga, J; Rachel, RA; Dolen, G; Mikoshiba, K; Brown, S; Mason, CA			Zic2 patterns binocular vision by specifying the uncrossed retinal projection	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; LIM HOMEOBOX GENES; OPTIC CHIASM; AXON DIVERGENCE; GANGLION-CELLS; TRANSCRIPTIONAL CODES; ALBINO FERRETS; VISUAL-SYSTEM; SPINAL-CORD; EXPRESSION	During CNS development, combinatorial expression of transcription factors controls neuronal subtype identity and subsequent axonal trajectory. Regulatory genes designating the routing of retinal ganglion cell (RGC) axons at the optic chiasm to the appropriate hemisphere, a pattern critical for proper binocular vision, have not been identified. Here, we show that the zinc finger transcription factor Zic2, a vertebrate homolog of the Drosophila gene odd-paired, is expressed in RGCs with an uncrossed trajectory during the period when this subpopulation grows from the ventrotemporal retina toward the optic chiasm. Loss-and gain-of-function analyses indicate that Zic2 is necessary and sufficient to regulate RGC axon repulsion by cues at the optic chiasm midline. Moreover, Zic2 expression reflects the extent of binocularity in different species, suggesting that Zic2 is an evolutionarily conserved determinant of RGCs that project ipsilaterally. These data provide evidence for transcriptional coding of axon pathfinding at the midline.	Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA; RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan	Columbia University; Columbia University; Columbia University; RIKEN	Mason, CA (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Pathol, 630 W 168th St, New York, NY 10032 USA.	cam4@columbia.edu	Mikoshiba, Katsuhiko/N-7943-2015; Aruga, Jun/H-5837-2011; Dolen, Gul/J-3073-2015; Herrera, Eloísa/A-5377-2008	Aruga, Jun/0000-0001-7936-1375; Dolen, Gul/0000-0003-1780-995X; Herrera, Eloísa/0000-0001-9525-5441	NEI NIH HHS [R01 EY015290, R01 EY012736, T32 EY013933, EY12736] Funding Source: Medline; NINDS NIH HHS [NS42730] Funding Source: Medline; PHS HHS [P030532] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY013933, R01EY012736, R01EY015290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042730] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Aruga J, 2002, J NEUROSCI, V22, P218, DOI 10.1523/JNEUROSCI.22-01-00218.2002; Aruga J, 1996, J BIOL CHEM, V271, P1043, DOI 10.1074/jbc.271.2.1043; BENEDYK MJ, 1994, GENE DEV, V8, P105, DOI 10.1101/gad.8.1.105; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Brown LY, 2001, HUM MOL GENET, V10, P791, DOI 10.1093/hmg/10.8.791; BROWN LY, 2003, MECH DEVELOP, V3, P361; Brown SA, 1998, NAT GENET, V20, P180, DOI 10.1038/2484; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chalupa LM, 1998, J COMP NEUROL, V392, P35, DOI 10.1002/(SICI)1096-9861(19980302)392:1<35::AID-CNE3>3.0.CO;2-Q; Chung KY, 2000, DEVELOPMENT, V127, P2673; COLELLO RJ, 1990, DEVELOPMENT, V108, P515; CUCCHIARO JB, 1991, J COMP NEUROL, V312, P193, DOI 10.1002/cne.903120203; DEITCHER DL, 1994, J NEUROSCI, V14, P486; DRAGER UC, 1985, PROC R SOC SER B-BIO, V224, P57, DOI 10.1098/rspb.1985.0021; Erskine L, 2000, J NEUROSCI, V20, P4975; GalliResta L, 1997, J NEUROSCI, V17, P7831; GUILLERY RW, 1995, J NEUROSCI, V15, P4727; HATINI V, 1994, J NEUROBIOL, V25, P1293, DOI 10.1002/neu.480251010; HOSKINS SG, 1985, J NEUROSCI, V5, P911; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kandel ER., 2000, PRINCIPLES NEURAL SC, P67; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kitaguchi T, 2000, DEVELOPMENT, V127, P4787; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Lustig M, 2001, J COMP NEUROL, V434, P13, DOI 10.1002/cne.1161; Mann F, 2001, BIOESSAYS, V23, P319, DOI 10.1002/bies.1046; Marcus RC, 2000, DEV BIOL, V221, P132, DOI 10.1006/dbio.2000.9660; MARCUS RC, 1995, J NEUROSCI, V15, P3716; Marcus RC, 1996, DEVELOPMENT, V122, P859; Mason C, 2000, J NEUROBIOL, V44, P260, DOI 10.1002/1097-4695(200008)44:2<260::AID-NEU14>3.0.CO;2-H; Nagai T, 2000, P NATL ACAD SCI USA, V97, P1618, DOI 10.1073/pnas.97.4.1618; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; OLEARY DDM, 1983, DEV BRAIN RES, V10, P93, DOI 10.1016/0165-3806(83)90124-4; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Polyak S., 1957, VERTEBRATE VISUAL SY; Purandare SM, 2002, DEVELOPMENT, V129, P2293; Rachel RA, 2002, J NEUROSCI, V22, P4249, DOI 10.1523/JNEUROSCI.22-11-04249.2002; RICE DS, 1995, J COMP NEUROL, V354, P459, DOI 10.1002/cne.903540312; Rubin JB, 2002, DEVELOPMENT, V129, P2223; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schulte D, 1999, NEURON, V24, P541, DOI 10.1016/S0896-6273(00)81111-3; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Thanos S, 2001, BRAIN RES REV, V35, P205, DOI 10.1016/S0165-0173(01)00049-2; THOMPSON ID, 1993, EUR J NEUROSCI, V5, P341, DOI 10.1111/j.1460-9568.1993.tb00502.x; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Wang LC, 1995, NEURON, V15, P1349, DOI 10.1016/0896-6273(95)90013-6; Warner SJ, 2003, DEV DYNAM, V226, P702, DOI 10.1002/dvdy.10262; WILLIAMS SE, 2003, IN PRESS NEURON, V39; XIANG MQ, 1995, J NEUROSCI, V15, P4762	55	197	199	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2003	114	5					545	557		10.1016/S0092-8674(03)00684-6	http://dx.doi.org/10.1016/S0092-8674(03)00684-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	719FN	13678579	Bronze			2022-12-01	WOS:000185193100005
J	Hirota, T; Kunitoku, N; Sasayama, T; Marumoto, T; Zhang, DW; Nitta, M; Hatakeyama, K; Saya, H				Hirota, T; Kunitoku, N; Sasayama, T; Marumoto, T; Zhang, DW; Nitta, M; Hatakeyama, K; Saya, H			Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells	CELL			English	Article							CHROMOSOME SEGREGATION; DEPENDENT MANNER; MAMMALIAN-CELLS; KINASE; CENTROSOMES; MATURATION; SPINDLE; MICROTUBULES; CHECKPOINT; DIVISION	Aurora family kinases contribute to regulation of mitosis. Using RNA interference in synchronized HeLa cells, we now show that Aurora-A is required for mitotic entry. We found that initial activation of Aurora-A in late G2 phase of the cell cycle is essential for recruitment of the cyclin B1-Cdk1 complex to centrosomes, where it becomes activated and commits cells to mitosis. A two-hybrid screen identified the LIM protein Ajuba as an Aurora-A binding protein. Ajuba and Aurora-A interact in mitotic cells and become phosphorylated as they do so. In vitro analyses revealed that Ajuba induces the autophosphorylation and consequent activation of Aurora-A. Depletion of Ajuba prevented activation of Aurora-A at centrosomes in late G2 phase and inhibited mitotic entry. Overall, our data suggest that Ajuba is an essential activator of Aurora-A in mitotic commitment.	Kumamoto Univ, Grad Sch Med Sci, Dept Tumor Genet & Biol, Kumamoto 8608556, Japan; Niigata Univ, Grad Sch Med & Dent Sci, Dept Surg, Niigata 9518510, Japan	Kumamoto University; Niigata University	Saya, H (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Tumor Genet & Biol, 1-1-1 Honjo, Kumamoto 8608556, Japan.		Saya, Hideyuki/J-4325-2013	Sasayama, Takashi/0000-0002-5593-9045				Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Andreu V, 1998, COMPUTAT STUDIES, V2, P17; BAILLY E, 1989, EMBO J, V8, P3985, DOI 10.1002/j.1460-2075.1989.tb08581.x; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Giet R, 2002, J CELL BIOL, V156, P437, DOI 10.1083/jcb.200108135; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Goyal RK, 1999, MOL CELL BIOL, V19, P4379; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hirota T, 2000, J CELL BIOL, V149, P1073, DOI 10.1083/jcb.149.5.1073; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Katayama H, 2001, J BIOL CHEM, V276, P46219, DOI 10.1074/jbc.M107540200; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Marumoto T, 2002, GENES CELLS, V7, P1173, DOI 10.1046/j.1365-2443.2002.00592.x; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Pines J, 2001, NAT CELL BIOL, V3, pE3, DOI 10.1038/35050676; Roghi C, 1998, J CELL SCI, V111, P557; Terada Y, 2001, CELL STRUCT FUNCT, V26, P653, DOI 10.1247/csf.26.653; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847	22	514	537	0	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 5	2003	114	5					585	598		10.1016/S0092-8674(03)00642-1	http://dx.doi.org/10.1016/S0092-8674(03)00642-1			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	719FN	13678582	Bronze			2022-12-01	WOS:000185193100008
J	Lee, KS; Zhan, XM; Gao, JJ; Ji, Q; Feng, YA; Meganathan, R; Cohen, SN; Georgiou, G				Lee, KS; Zhan, XM; Gao, JJ; Ji, Q; Feng, YA; Meganathan, R; Cohen, SN; Georgiou, G			RraA: a protein inhibitor of RNase E activity that globally modulates RNA abundance in E. coli	CELL			English	Article							DISULFIDE BOND FORMATION; ESCHERICHIA-COLI; MESSENGER-RNA; RIBONUCLEASE-E; GENE-EXPRESSION; RIBOSOMAL-RNA; IN-VIVO; CATALYTIC DOMAIN; DNA MICROARRAY; TERMINAL HALF	Ribonuclease E (RNase E) has a key role in mRNA degradation and the processing of catalytic and structural RNAs in E. coli. We report the discovery of an evolutionarily conserved 17.4 kDa protein, here named RraA (regulator of ribonuclease activity A) that binds to RNase E and inhibits RNase E endonucleolytic cleavages without altering cleavage site specificity or interacting detectably with substrate RNAs. Overexpression of RraA circumvents the effects of an autoregulatory mechanism that normally maintains the RNase E cellular level within a narrow range, resulting in the genome-wide accumulation of RNase E-targeted transcripts. While not required for RraA action the C-terminal RNase E region that serves as a scaffold for formation of a multiprotein degradosome complex modulates the inhibition of RNase E catalytic activity by RraA. Our results reveal a possible mechanism for the dynamic regulation of RNA decay and processing by inhibitory RNase binding proteins.	Univ Texas, Inst Cell & Mol Biol, Austin, TX 78712 USA; Univ Texas, Dept Chem Engn, Austin, TX 78712 USA; Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Stanford University; Stanford University; Northern Illinois University	Georgiou, G (corresponding author), Univ Texas, Inst Cell & Mol Biol, Austin, TX 78712 USA.		Meganathan, R./A-6878-2009		NIGMS NIH HHS [GM64511-01, GM 54158, GM55090] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM064511, R01GM054158, R01GM055090] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANEYX F, 1990, J BACTERIOL, V172, P491, DOI 10.1128/JB.172.1.491-494.1990; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Bessette PH, 2001, J BACTERIOL, V183, P980, DOI 10.1128/JB.183.3.980-988.2001; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; CARPOUSIS AJ, 1994, CELL, V76, P889, DOI 10.1016/0092-8674(94)90363-8; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Coburn GA, 1999, PROG NUCLEIC ACID RE, V62, P55; Cohen SN, 1997, MOL MICROBIOL, V23, P1099, DOI 10.1111/j.1365-2958.1997.tb02593.x; CORMACK RS, 1992, J MOL BIOL, V228, P1078, DOI 10.1016/0022-2836(92)90316-C; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; ELISH ME, 1988, J GEN MICROBIOL, V134, P1355; Feng Y, 2001, J BIOL CHEM, V276, P31651, DOI 10.1074/jbc.M102855200; Feng YA, 2002, P NATL ACAD SCI USA, V99, P14746, DOI 10.1073/pnas.202590899; GEORGELLIS D, 1993, MOL MICROBIOL, V9, P375, DOI 10.1111/j.1365-2958.1993.tb01698.x; GHORA BK, 1978, CELL, V15, P1055, DOI 10.1016/0092-8674(78)90289-1; GOLDBLUM K, 1981, J BACTERIOL, V146, P128, DOI 10.1128/JB.146.1.128-132.1981; GUREVITZ M, 1983, P NATL ACAD SCI-BIOL, V80, P4450, DOI 10.1073/pnas.80.14.4450; HELMERCITTERICH M, 1988, EMBO J, V7, P557, DOI 10.1002/j.1460-2075.1988.tb02845.x; Huang HJ, 1998, NATURE, V391, P99, DOI 10.1038/34219; Jain C, 2002, MOL MICROBIOL, V43, P1053, DOI 10.1046/j.1365-2958.2002.02808.x; JAIN C, 1995, GENE DEV, V9, P84, DOI 10.1101/gad.9.1.84; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kalapos MP, 1997, BIOCHIMIE, V79, P493, DOI 10.1016/S0300-9084(97)82741-1; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P12170, DOI 10.1073/pnas.220414297; Kido M, 1996, J BACTERIOL, V178, P3917, DOI 10.1128/jb.178.13.3917-3925.1996; Lee K, 2003, MOL MICROBIOL, V48, P349, DOI 10.1046/j.1365-2958.2003.03435.x; Lee K, 2002, MOL MICROBIOL, V43, P1445, DOI 10.1046/j.1365-2958.2002.02848.x; Leroy A, 2002, MOL MICROBIOL, V45, P1231, DOI 10.1046/j.1365-2958.2002.03104.x; Li ZW, 2002, RNA, V8, P97, DOI 10.1017/S1355838202014929; Li ZW, 1999, EMBO J, V18, P2878, DOI 10.1093/emboj/18.10.2878; Lin-Chao S, 1999, P NATL ACAD SCI USA, V96, P12406, DOI 10.1073/pnas.96.22.12406; LINCHAO S, 1994, J BIOL CHEM, V269, P10797; LINCHAO S, 1991, CELL, V65, P1233, DOI 10.1016/0092-8674(91)90018-T; Liou GG, 2001, P NATL ACAD SCI USA, V98, P63, DOI 10.1073/pnas.011535498; Lopez PJ, 1999, MOL MICROBIOL, V33, P188, DOI 10.1046/j.1365-2958.1999.01465.x; MACKIE GA, 1992, J BIOL CHEM, V267, P1054; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; MCDOWALL KJ, 1993, J BACTERIOL, V175, P4245, DOI 10.1128/JB.175.13.4245-4249.1993; MCDOWALL KJ, 1995, NATURE, V374, P287, DOI 10.1038/374287a0; MCDOWALL KJ, 1994, J BIOL CHEM, V269, P10790; McDowall KJ, 1996, J MOL BIOL, V255, P349, DOI 10.1006/jmbi.1996.0027; MEGANATHAN R, 1996, ESCHERICHIA COLI SAL, P642; Miczak A, 1996, P NATL ACAD SCI USA, V93, P3865, DOI 10.1073/pnas.93.9.3865; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; MUDD EA, 1993, MOL MICROBIOL, V9, P557, DOI 10.1111/j.1365-2958.1993.tb01716.x; Ow MC, 2002, GENE DEV, V16, P1102, DOI 10.1101/gad.983502; Ow MC, 2000, MOL MICROBIOL, V38, P854, DOI 10.1046/j.1365-2958.2000.02186.x; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Qiu J, 1998, APPL ENVIRON MICROB, V64, P4891; Raynal LC, 1999, MOL MICROBIOL, V32, P765, DOI 10.1046/j.1365-2958.1999.01394.x; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Scott DJ, 2000, BIOCHEM J, V352, P539, DOI 10.1042/0264-6021:3520539; Steege DA, 2000, RNA, V6, P1079, DOI 10.1017/S1355838200001023; Sun WM, 2001, BIOCHEMISTRY-US, V40, P5102, DOI 10.1021/bi010022d; TARASEVICIENE L, 1995, J BIOL CHEM, V270, P26391, DOI 10.1074/jbc.270.44.26391; Tsao KL, 1996, GENE, V169, P59, DOI 10.1016/0378-1119(95)00762-8; Vanzo NF, 1998, GENE DEV, V12, P2770, DOI 10.1101/gad.12.17.2770; Walsh AP, 2001, NUCLEIC ACIDS RES, V29, P1864, DOI 10.1093/nar/29.9.1864; ZHAN X, 2002, THESIS U TEXAS AUSTI	62	116	118	6	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 5	2003	114	5					623	634		10.1016/j.cell.2003.08.003	http://dx.doi.org/10.1016/j.cell.2003.08.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	719FN	13678585	Bronze			2022-12-01	WOS:000185193100011
J	Lipman, EA; Schuler, B; Bakajin, O; Eaton, WA				Lipman, EA; Schuler, B; Bakajin, O; Eaton, WA			Single-molecule measurement of protein folding kinetics	SCIENCE			English	Article							RESONANCE ENERGY-TRANSFER; TRANSFER CONFOCAL MICROSCOPY; FLUORESCENCE SPECTROSCOPY; DYNAMICS; PEPTIDES; TIME	In order to investigate the behavior of single molecules under conditions far from equilibrium, we have coupled a microfabricated laminar-flow mixer to a confocal optical system. This combination enables time-resolved measurement of Forster resonance energy transfer after an abrupt change in solution conditions. Observations of a small protein show the evolution of the intramolecular distance distribution as folding progresses. This technique can expose subpopulations, such as unfolded protein under conditions favoring the native structure, that would be obscured in equilibrium experiments.	NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; Lawrence Livermore Natl Lab, Biosecur Nanosci Lab, Livermore, CA 94550 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Eaton, WA (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bldg 5,Room 104, Bethesda, MD 20892 USA.		Schuler, Benjamin/E-7342-2011; Lipman, Everett/D-1696-2009; Bakajin, Olgica/A-9745-2008	Schuler, Benjamin/0000-0002-5970-4251; 	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK029010, ZIADK029010] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chan CK, 1997, P NATL ACAD SCI USA, V94, P1779, DOI 10.1073/pnas.94.5.1779; Deniz AA, 2000, P NATL ACAD SCI USA, V97, P5179, DOI 10.1073/pnas.090104997; Deniz AA, 1999, P NATL ACAD SCI USA, V96, P3670, DOI 10.1073/pnas.96.7.3670; DOI M, 1996, INTRO POLYM PHYSICS; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Hagen SJ, 2000, J MOL BIOL, V301, P1019, DOI 10.1006/jmbi.2000.3969; Hagen SJ, 2001, J MOL BIOL, V305, P1161, DOI 10.1006/jmbi.2000.4366; Jia YW, 1999, CHEM PHYS, V247, P69, DOI 10.1016/S0301-0104(99)00127-5; Kauffmann E, 2001, P NATL ACAD SCI USA, V98, P6646, DOI 10.1073/pnas.101122898; Perl D, 1998, NAT STRUCT BIOL, V5, P229, DOI 10.1038/nsb0398-229; Pollack L, 1999, P NATL ACAD SCI USA, V96, P10115, DOI 10.1073/pnas.96.18.10115; Rhoades E, 2003, P NATL ACAD SCI USA, V100, P3197, DOI 10.1073/pnas.2628068100; Schuler B, 2003, NATURE, V421, P94, DOI 10.1038/nature01291; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Shastry MCR, 1998, NAT STRUCT BIOL, V5, P385, DOI 10.1038/nsb0598-385; Talaga DS, 2000, P NATL ACAD SCI USA, V97, P13021, DOI 10.1073/pnas.97.24.13021; Van Der Meer B. W., 1994, RESONANCE ENERGY TRA; Wassenberg D, 1999, J MOL BIOL, V289, P187, DOI 10.1006/jmbi.1999.2772; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Zhuang XW, 2002, SCIENCE, V296, P1473, DOI 10.1126/science.1069013; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	21	322	334	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 29	2003	301	5637					1233	1235		10.1126/science.1085399	http://dx.doi.org/10.1126/science.1085399			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZC	12947198				2022-12-01	WOS:000185003500041
J	Dore, JE; Lukas, R; Sadler, DW; Karl, DM				Dore, JE; Lukas, R; Sadler, DW; Karl, DM			Climate-driven changes to the atmospheric CO2 sink in the subtropical North Pacific Ocean	NATURE			English	Article							INORGANIC CARBON; ATLANTIC OCEAN; SEAWATER; GYRE; DISSOCIATION; VARIABILITY; EQUILIBRIUM; CONSTANTS; EXCHANGE; DIOXIDE	The oceans represent a significant sink for atmospheric carbon dioxide(1). Variability in the strength of this sink occurs on interannual timescales, as a result of regional and basin-scale changes in the physical and biological parameters that control the flux of this greenhouse gas into and out of the surface mixed layer(2,3). Here we analyse a 13-year time series of oceanic carbon dioxide measurements from station ALOHA in the subtropical North Pacific Ocean near Hawaii(4), and find a significant decrease in the strength of the carbon dioxide sink over the period 1989-2001. We show that much of this reduction in sink strength can be attributed to an increase in the partial pressure of surface ocean carbon dioxide caused by excess evaporation and the accompanying concentration of solutes in the water mass. Our results suggest that carbon dioxide uptake by ocean waters can be strongly influenced by changes in regional precipitation and evaporation patterns brought on by climate variability.	Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA	University of Hawaii System	Dore, JE (corresponding author), Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Oceanog, 1000 Pope Rd, Honolulu, HI 96822 USA.		Lukas, Roger B/B-3715-2009; Karl, David/AFP-3837-2022	Karl, David/0000-0002-6660-6721				[Anonymous], 1998, ORNLCDIAC105 US DEP; Bates NR, 2002, NATURE, V420, P489, DOI 10.1038/nature01253; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Dickson A.G., 2001, OCEANOGRAPHY, V14, P21; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; *DOE, 1994, HDB METH AN VAR PAR; Dore JE, 2002, LIMNOL OCEANOGR, V47, P1595, DOI 10.4319/lo.2002.47.6.1595; Gruber N, 2002, SCIENCE, V298, P2374, DOI 10.1126/science.1077077; Hoerling M, 2003, SCIENCE, V299, P691, DOI 10.1126/science.1079053; Houghton J.T., 1990, CLIMATE CHANGE IPCC; Ishii M, 2001, MAR CHEM, V75, P17, DOI 10.1016/S0304-4203(01)00023-8; Karl DM, 1996, DEEP-SEA RES PT II, V43, P129, DOI 10.1016/0967-0645(96)00005-7; Keeling CD., 2002, TRENDS COMPENDIUM DA; KEELING CD, 1993, NATO ASI SERIES, V115; Lee K, 2000, GEOPHYS RES LETT, V27, P229, DOI 10.1029/1999GL002345; Lueker TJ, 2000, MAR CHEM, V70, P105, DOI 10.1016/S0304-4203(00)00022-0; Lukas R, 2001, GEOPHYS RES LETT, V28, P3485, DOI 10.1029/2001GL013116; MERBACH C, 1973, LIMNOL OCEANOGR, V18, P897; Minobe S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014447; SIEGENTHALER U, 1993, NATURE, V365, P119, DOI 10.1038/365119a0; TUPAS L, 1993, 9314 SOEST U HAW; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Waple AM, 2002, B AM METEOROL SOC, V83, pS1; WEISS RF, 1982, NATURE, V300, P511, DOI 10.1038/300511a0; WINN CD, 1994, GLOBAL BIOGEOCHEM CY, V8, P157, DOI 10.1029/94GB00387	25	114	121	5	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 14	2003	424	6950					754	757		10.1038/nature01885	http://dx.doi.org/10.1038/nature01885			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12917678				2022-12-01	WOS:000184733900033
J	Mann, NH; Cook, A; Millard, A; Bailey, S; Clokie, M				Mann, NH; Cook, A; Millard, A; Bailey, S; Clokie, M			Marine ecosystems: Bacterial photosynthesis genes in a virus	NATURE			English	Editorial Material									Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Mann, NH (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.	n.h.mann@warwick.ac.uk	chen, qi/C-8585-2011; millard, andrew D/B-3893-2011	Clokie, Martha/0000-0002-6069-8936; Millard, Andrew/0000-0002-3895-2854				ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Deshpande NN, 1997, RNA, V3, P37; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Hambly E, 2001, P NATL ACAD SCI USA, V98, P11411, DOI 10.1073/pnas.191174498; Partensky F., 1999, B I OCEANOGR MONACO, V19, P457; Piazena H, 2002, DEEP-SEA RES PT II, V49, P3513, DOI 10.1016/S0967-0645(02)00093-0; Seaton GGR, 1996, FEBS LETT, V389, P319, DOI 10.1016/0014-5793(96)00615-1; WILSON WH, 1993, APPL ENVIRON MICROB, V59, P3736, DOI 10.1128/AEM.59.11.3736-3743.1993	8	303	335	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2003	424	6950					741	741		10.1038/424741a	http://dx.doi.org/10.1038/424741a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12917674	Bronze			2022-12-01	WOS:000184733900027
J	Kaspar, BK; Llado, J; Sherkat, N; Rothstein, JD; Gage, FH				Kaspar, BK; Llado, J; Sherkat, N; Rothstein, JD; Gage, FH			Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; SUSTAINED EXPRESSION; SUPEROXIDE-DISMUTASE; DISEASE PROGRESSION; LENTIVIRAL VECTORS; NERVOUS-SYSTEM; GENE DELIVERY; MICE; GDNF	Amyotrophic lateral sclerosis (ALS) is a progressive, lethal neuromuscular disease that is associated with the degeneration of spinal and brainstem motor neurons, leading to atrophy of limb, axial, and respiratory muscles. The cause of ALS is unknown, and there is no effective therapy. Neurotrophic factors are candidates for therapeutic evaluation in ALS. Although chronic delivery of molecules to the central nervous system has proven difficult, we recently discovered that adeno-associated virus can be retrogradely transported efficiently from muscle to motor neurons of the spinal cord. We report that insulin-like growth factor 1 prolongs life and delays disease progression, even when delivered at the time of overt disease symptoms.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21287 USA	Salk Institute; Johns Hopkins University; Johns Hopkins University	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Lladó, Jerònia/A-2633-2011; rothstein, jeffrey d/C-9470-2013; Kaspar, Brian/E-3349-2011; Kaspar, Brian/E-6490-2010	Lladó, Jerònia/0000-0002-8489-427X; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021876, P01AG012992] Funding Source: NIH RePORTER; NIA NIH HHS [AG21876, AG12992] Funding Source: Medline; NINDS NIH HHS [NS33958] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acsadi G, 2002, HUM GENE THER, V13, P1047, DOI 10.1089/104303402753812458; Azzouz M, 2000, HUM MOL GENET, V9, P803, DOI 10.1093/hmg/9.5.803; Bilak MM, 2001, AMYOTROPH LATERAL SC, V2, P83; Boulis NM, 2003, NEUROSURGERY, V52, P381, DOI 10.1227/01.NEU.0000044459.24519.3E; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Corse AM, 1999, NEUROBIOL DIS, V6, P335, DOI 10.1006/nbdi.1999.0253; Davidson BL, 2000, P NATL ACAD SCI USA, V97, P3428, DOI 10.1073/pnas.050581197; Drachman DB, 2000, ANN NEUROL, V48, P792, DOI 10.1002/1531-8249(200011)48:5<792::AID-ANA14>3.3.CO;2-X; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Kafri T, 1997, NAT GENET, V17, P314, DOI 10.1038/ng1197-314; Kaspar BK, 2002, MOL THER, V5, P50, DOI 10.1006/mthe.2001.0520; KASPAR BK, UNPUB; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; Levine JB, 1999, GLIA, V28, P215; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Lu YY, 2003, NEUROSCI RES, V45, P33, DOI 10.1016/S0168-0102(02)00195-5; Manabe Y, 2003, NEUROL RES, V25, P195, DOI 10.1179/016164103101201193; Manabe Y, 2002, APOPTOSIS, V7, P329, DOI 10.1023/A:1016123413038; Mazarakis ND, 2001, HUM MOL GENET, V10, P2109, DOI 10.1093/hmg/10.19.2109; MILLER RG, 2001, COCHRANE DB SYST REV, V4, P1447; MITCHELL JD, 2002, COCHRANE DB SYST REV, V3; Mohajeri MH, 1999, HUM GENE THER, V10, P1853, DOI 10.1089/10430349950017536; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Vincent AM, 2002, GROWTH HORM IGF RES, V12, P193, DOI 10.1016/S1096-6374(02)00017-5; Wang LJ, 2002, J NEUROSCI, V22, P6920; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Yoshihara T, 2002, J NEUROCHEM, V80, P158, DOI 10.1046/j.0022-3042.2001.00683.x; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	33	670	759	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					839	842		10.1126/science.1086137	http://dx.doi.org/10.1126/science.1086137			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907804				2022-12-01	WOS:000184615700047
J	DeRenzo, C; Reese, KJ; Seydoux, G				DeRenzo, C; Reese, KJ; Seydoux, G			Exclusion of germ plasm proteins from somatic lineages by cullin-dependent degradation	NATURE			English	Article							CAENORHABDITIS-ELEGANS EMBRYOS; ZINC-FINGER PROTEINS; C-ELEGANS; GENE-EXPRESSION; PIE-1 PROTEIN; SOCS-BOX; LOCALIZATION; RNA; UBIQUITINATION; SPECIFICATION	In many animals, establishment of the germ line depends on segregation of a specialized cytoplasm, or 'germplasm', to a small number of germline precursor cells during early embryogenesis(1). Germ plasm asymmetry involves targeting of RNAs and proteins to a specific region of the oocyte and/or embryo(2). Here we demonstrate that germ plasm asymmetry also depends on degradation of germline proteins in non-germline (somatic) cells. We show that five CCCH finger proteins, components of the Caenorhabditis elegans germ plasm, are targeted for degradation by the novel CCCH-finger-binding protein ZIF-1. ZIF-1 is a SOCS-box protein that interacts with the E3 ubiquitin ligase subunit elongin C. Elongin C, the cullin CUL-2, the ring finger protein RBX-1 and the E2 ubiquitin conjugation enzyme UBC5 (also known as LET-70) are all required in vivo for CCCH finger protein degradation. Degradation is activated in somatic cells by the redundant CCCH finger proteins MEX-5 and MEX-6, which are counteracted in the germ line by the PAR-1 kinase. We propose that segregation of the germ plasm involves both stabilization of germline proteins in the germ line and cullin-dependent degradation in the soma.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University	Seydoux, G (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.		SEYDOUX, Geraldine/AAA-2005-2020	Seydoux, Geraldine/0000-0001-8257-0493	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037047] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD037047] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Detwiler MR, 2001, DEV CELL, V1, P187, DOI 10.1016/S1534-5807(01)00026-0; Feng H, 1999, NAT CELL BIOL, V1, P486, DOI 10.1038/70272; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Guedes S, 1997, DEVELOPMENT, V124, P731; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hird SN, 1996, DEVELOPMENT, V122, P1303; Houston DW, 2000, CURR TOP DEV BIOL, V50, P155, DOI 10.1016/S0070-2153(00)50008-8; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kloc M, 2001, INT REV CYTOL, V203, P63; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Riechmann V, 2002, NAT CELL BIOL, V4, P337, DOI 10.1038/ncb782; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Seydoux G, 1995, METHOD CELL BIOL, V48, P323; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Styhler S, 2002, DEV CELL, V3, P865, DOI 10.1016/S1534-5807(02)00361-1; Tabara H, 1999, DEVELOPMENT, V126, P1; Tenenhaus C, 1998, DEV BIOL, V200, P212, DOI 10.1006/dbio.1998.8940; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	28	134	148	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					685	689		10.1038/nature01887	http://dx.doi.org/10.1038/nature01887			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12894212	Green Accepted			2022-12-01	WOS:000184578800048
J	Li, Y; Brown, JH; Reshetnikova, L; Blazsek, A; Farkas, L; Nyitray, L; Cohen, C				Li, Y; Brown, JH; Reshetnikova, L; Blazsek, A; Farkas, L; Nyitray, L; Cohen, C			Visualization of an unstable coiled coil from the scallop myosin rod	NATURE			English	Article							SMOOTH-MUSCLE MYOSIN; JUNCTION; DESIGN; STABILITY; FEATURES; CALCIUM; BINDING; DOMAIN; MODEL	alpha-Helical coiled coils in muscle exemplify simplicity and economy of protein design: small variations in sequence lead to remarkable diversity in cellular functions(1,2). Myosin II is the key protein in muscle contraction, and the molecule's two-chain alpha-helical coiled-coil rod region-towards the carboxy terminus of the heavy chain-has unusual structural and dynamic features. The amino-terminal subfragment-2 (S2) domains of the rods can swing out from the thick filament backbone at a hinge in the coiled coil, allowing the two myosin 'heads' and their motor domains to interact with actin and generate tension(3). Most of the S2 rod appears to be a flexible coiled coil, but studies suggest that the structure at the N-terminal region is unstable(4-6), and unwinding or bending of the alpha-helices near the head-rod junction seems necessary for many of myosin's functional properties(7,8). Here we show the physical basis of a particularly weak coiled-coil segment by determining the 2.5-Angstrom-resolution crystal structure of a leucine-zipper-stabilized fragment of the scallop striated-muscle myosin rod adjacent to the head-rod junction. The N-terminal 14 residues are poorly ordered; the rest of the S2 segment forms a flexible coiled coil with poorly packed core residues. The unusual absence of inter-helical salt bridges here exposes apolar core atoms to solvent.	Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; Brandeis Univ, Biophys & Struct Biol Program, Waltham, MA 02454 USA; Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary	Brandeis University; Brandeis University; Eotvos Lorand University	Cohen, C (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA.	ccohen@brandeis.edu	Nyitray, László/AAE-5910-2020	Nyitray, László/0000-0003-4717-5994				ADELSTEIN RS, 1980, ANNU REV BIOCHEM, V49, P921, DOI 10.1146/annurev.bi.49.070180.004421; Arndt KM, 2002, STRUCTURE, V10, P1235, DOI 10.1016/S0969-2126(02)00838-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; Burgess S, 2002, BIOPHYS J, V82, p356A; Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3; Burkhard P, 2002, J MOL BIOL, V318, P901, DOI 10.1016/S0022-2836(02)00114-6; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Buss F, 2001, FEBS LETT, V508, P295, DOI 10.1016/S0014-5793(01)03065-4; Chakrabarty T, 2002, P NATL ACAD SCI USA, V99, P6011, DOI 10.1073/pnas.082024299; COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102; CONWAY JF, 1990, INT J BIOL MACROMOL, V12, P328, DOI 10.1016/0141-8130(90)90023-4; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; Kammerer RA, 1998, P NATL ACAD SCI USA, V95, P13419, DOI 10.1073/pnas.95.23.13419; Knight PJ, 1996, J MOL BIOL, V255, P269, DOI 10.1006/jmbi.1996.0022; Lauzon AM, 2001, BIOPHYS J, V80, P1900, DOI 10.1016/S0006-3495(01)76159-0; Li Y, 2002, P NATL ACAD SCI USA, V99, P7378, DOI 10.1073/pnas.102179999; Liu J, 2003, J MOL BIOL, V329, P963, DOI 10.1016/S0022-2836(03)00516-3; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/S0968-0004(96)10052-9; Malnasi-Csizmadia A, 1998, BIOCHEM BIOPH RES CO, V252, P595, DOI 10.1006/bbrc.1998.9603; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; MCLACHLAN AD, 1983, J MOL BIOL, V164, P605, DOI 10.1016/0022-2836(83)90053-0; Meier M, 2002, J STRUCT BIOL, V137, P65, DOI 10.1006/jsbi.2002.4467; Nyitrai M, 2002, BIOCHEM J, V365, P19, DOI 10.1042/BJ20020099; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Stafford WF, 2001, J MOL BIOL, V307, P137, DOI 10.1006/jmbi.2000.4490; Tomishige M, 2000, J CELL BIOL, V151, P1081, DOI 10.1083/jcb.151.5.1081; TRYBUS KM, 1994, J BIOL CHEM, V269, P20819; WOOLFSON DN, 1995, PROTEIN SCI, V4, P1596, DOI 10.1002/pro.5560040818	31	72	72	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2003	424	6946					341	345		10.1038/nature01801	http://dx.doi.org/10.1038/nature01801			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867988				2022-12-01	WOS:000184183900049
J	Yoshida, T; Jones, LE; Ellner, SP; Fussmann, GF; Hairston, NG				Yoshida, T; Jones, LE; Ellner, SP; Fussmann, GF; Hairston, NG			Rapid evolution drives ecological dynamics in a predator-prey system	NATURE			English	Article							CYCLES	Ecological and evolutionary dynamics can occur on similar timescales(1-7). However, theoretical predictions of how rapid evolution can affect ecological dynamics(8) are inconclusive and often depend on untested model assumptions(8). Here we report that rapid prey evolution in response to oscillating predator density affects predator-prey (rotifer-algal) cycles in laboratory microcosms. Our experiments tested explicit predictions from a model for our system that allows prey evolution(9). We verified the predicted existence of an evolutionary tradeoff between algal competitive ability and defence against consumption, and examined its effects on cycle dynamics by manipulating the evolutionary potential of the prey population. Single-clone algal cultures (lacking genetic variability) produced short cycle periods and typical quarter-period phase lags between prey and predator densities, whereas multi-clonal (genetically variable) algal cultures produced long cycles with prey and predator densities nearly out of phase, exactly as predicted. These results confirm that prey evolution can substantially alter predator-prey dynamics, and therefore that attempts to understand population oscillations in nature(10,11) cannot neglect potential effects from ongoing rapid evolution.	Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	Cornell University	Hairston, NG (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	NGH1@cornell.edu	Yoshida, Takehito/ABB-2490-2020; Yoshida, Takehito/O-9983-2014	Yoshida, Takehito/0000-0001-9178-3634; Yoshida, Takehito/0000-0001-9178-3634; Fussmann, Gregor/0000-0001-9576-0122				Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Berryman, 2002, POPULATION CYCLES CA, DOI 10.1093/oso/9780195140989.001.0001; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; Hairston NG, 1999, NATURE, V401, P446, DOI 10.1038/46731; HALBACH U, 1974, ARCH HYDROBIOL, V73, P273; Hendry AP, 2000, SCIENCE, V290, P516, DOI 10.1126/science.290.5491.516; Hillborn R., 1997, ECOLOGICAL DETECTIVE; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Kendall BE, 1999, ECOLOGY, V80, P1789, DOI 10.1890/0012-9658(1999)080[1789:WDPCAS]2.0.CO;2; Lambin X, 2002, POPULATION CYCLES: THE CASE FOR TROPHIC INTERACTIONS, P155; McCauley E, 1999, NATURE, V402, P653, DOI 10.1038/45223; MONOD J, 1950, ANN I PASTEUR PARIS, V79, P390; Palumbi Stephen R., 2001, EVOLUTION EXPLOSION; Pickett-Heaps J. D., 1975, GREEN ALGAE STRUCTUR; Rothhaupt KO, 1995, LIMNOL OCEANOGR, V40, P1201, DOI 10.4319/lo.1995.40.7.1201; Shertzer KW, 2002, J ANIM ECOL, V71, P802, DOI 10.1046/j.1365-2656.2002.00645.x; Sinervo B, 2000, NATURE, V406, P985, DOI 10.1038/35023149; Thompson JN, 2001, BIOSCIENCE, V51, P15, DOI 10.1641/0006-3568(2001)051[0015:FOE]2.0.CO;2; Tollrian R., 1999, ECOLOGY EVOLUTION IN; TURCHIN P, IN PRESS ECOLOGY; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Vermeij G.J, 1987, EVOLUTION ESCALATION; VERMEIJ GJ, 1994, ANNU REV ECOL SYST, V25, P219, DOI 10.1146/annurev.es.25.110194.001251	25	736	745	9	405	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 17	2003	424	6946					303	306		10.1038/nature01767	http://dx.doi.org/10.1038/nature01767			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867979				2022-12-01	WOS:000184183900039
J	Berman, DM; Karhadkar, SS; Maitra, A; de Oca, RM; Gerstenblith, MR; Briggs, K; Parker, AR; Shimada, Y; Eshleman, JR; Watkins, DN; Beachy, PA				Berman, DM; Karhadkar, SS; Maitra, A; de Oca, RM; Gerstenblith, MR; Briggs, K; Parker, AR; Shimada, Y; Eshleman, JR; Watkins, DN; Beachy, PA			Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours	NATURE			English	Article							INHIBITION; PATHWAY; CANCER; MOUSE; MEDULLOBLASTOMA; CARCINOGENESIS; CYCLOPAMINE; MODULATION; SIGNALS	Activation of the Hedgehog (Hh) signalling pathway by sporadic mutations or in familial conditions such as Gorlin's syndrome is associated with tumorigenesis in skin, the cerebellum and skeletal muscle(1,2). Here we show that a wide range of digestive tract tumours, including most of those originating in the oesophagus, stomach, biliary tract and pancreas, but not in the colon, display increased Hh pathway activity, which is suppressible by cyclopamine, a Hh pathway antagonist. Cyclopamine also suppresses cell growth in vitro and causes durable regression of xenograft tumours in vivo. Unlike in Gorlin's syndrome tumours, pathway activity and cell growth in these digestive tract tumours are driven by endogenous expression of Hh ligands, as indicated by the presence of Sonic hedgehog and Indian hedgehog transcripts, by the pathway- and growth-inhibitory activity of a Hh-neutralizing antibody, and by the dramatic growth-stimulatory activity of exogenously added Hh ligand. Our results identify a group of common lethal malignancies in which Hh pathway activity, essential for tumour growth, is activated not by mutation but by ligand expression.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; Kyoto Univ, Dept Surg, Kyoto 6068507, Japan	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Kyoto University	Beachy, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.		Watkins, David N/I-6113-2013; Karhadkar, Sunil/Y-9235-2019	Karhadkar, Sunil/0000-0001-7943-0203; berman, david/0000-0001-5985-3698				Bale AE, 2001, HUM MOL GENET, V10, P757, DOI 10.1093/hmg/10.7.757; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen XX, 2001, CARCINOGENESIS, V22, P1119, DOI 10.1093/carcin/22.8.1119; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hebrok M, 2003, MECH DEVELOP, V120, P45, DOI 10.1016/S0925-4773(02)00331-3; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Lowenfels AB, 2002, HEMATOL ONCOL CLIN N, V16, P1, DOI 10.1016/S0889-8588(01)00003-X; Peek RM, 2002, J GASTROENTEROL, V37, P10, DOI 10.1007/BF02990093; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Roberts DJ, 1998, DEVELOPMENT, V125, P2791; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; van den Brink GR, 2001, GASTROENTEROLOGY, V121, P317, DOI 10.1053/gast.2001.26261; Wang LC, 2000, J INVEST DERMATOL, V114, P901, DOI 10.1046/j.1523-1747.2000.00951.x; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385	23	1056	1168	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2003	425	6960					846	851		10.1038/nature01972	http://dx.doi.org/10.1038/nature01972			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735ME	14520411				2022-12-01	WOS:000186118500047
J	Fitzgerald, DW; Pape, JW; Wasserheit, JN; Counts, GW; Corey, L				Fitzgerald, DW; Pape, JW; Wasserheit, JN; Counts, GW; Corey, L			Provision of treatment in HIV-1 vaccine trials in developing countries	LANCET			English	Editorial Material							AIDS		HVTN, Seattle, WA 98109 USA		Fitzgerald, DW (corresponding author), HVTN, Seattle, WA 98109 USA.							Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Council for International Organizations of Medical Sciences (CIOMS), 2002, INT ETH GUID BIOM RE; UNAIDS and WHO, 2000, ETH CONS HIV PREV VA; World Health Organization, 2002, SCAL ANT THER RES LT	5	26	29	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 20	2003	362	9388					993	994		10.1016/S0140-6736(03)14372-3	http://dx.doi.org/10.1016/S0140-6736(03)14372-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	724LT	14513852				2022-12-01	WOS:000185489600025
J	Heckenberger, MJ; Kuikuro, A; Kuikuro, UT; Russell, JC; Schmidt, M; Fausto, C; Franchetto, B				Heckenberger, MJ; Kuikuro, A; Kuikuro, UT; Russell, JC; Schmidt, M; Fausto, C; Franchetto, B			Amazonia 1492: Pristine forest or cultural parkland?	SCIENCE			English	Article							LANDSCAPE; SCALE	Archaeology and indigenous history of Native Amazonian peoples in the Upper Xingu region of Brazil reveal unexpectedly complex regional settlement patterns and large-scale transformations of local landscapes over the past millennium. Mapping and excavation of archaeological structures document pronounced human-induced alteration of the forest cover, particularly in relation to large, dense late-prehistoric settlements ( circa 1200 to 1600 A. D.). The findings contribute to debates on human carrying capacity, population size and settlement patterns, anthropogenic impacts on the environment, and the importance of indigenous knowledge, as well as contributing to the pride of place of the native peoples in this part of the Amazon.	Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; Univ Florida, Land Use & Environm Change Inst, Gainesville, FL 32611 USA; Univ Florida, Dept Geog, Gainesville, FL 32611 USA; Associacao Indigena kuikuro Alto Xingu, Parque Indigena Xingu, Mato Grosso, Brazil; Univ Fed Rio de Janeiro, Museu nacl, Dept Anthropol, BR-20940040 Rio De Janeiro, Brazil	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Universidade Federal do Rio de Janeiro	Heckenberger, MJ (corresponding author), Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA.	mheckenb@anthro.ufl.edu	Fausto, Carlos/I-4550-2013	Fausto, Carlos/0000-0002-0617-6643				[Anonymous], 2001, UNKNOWN AMAZON CULTU; Balee W., 1989, Advances in Economic Botany, V7, P1; CARNEIRO R, 1957, SUBSISTENCE SOCIAL S; Carneiro R., 1984, ADAPTIVE RESPONSES N, P65, DOI [10.1016/B978-0-12-321250-4.50007-5, DOI 10.1016/B978-0-12-321250-4.50007-5]; Denevan William M., 2001, CULTIVATED LANDSCAPE; Denevan William M, 1992, J STEWARD ANTHR SOC, V20, P153; DENEVAN WM, 1992, ANN ASSOC AM GEOGR, V82, P369, DOI 10.1111/j.1467-8306.1992.tb01965.x; Erickson CL, 2000, NATURE, V408, P190, DOI 10.1038/35041555; HECKENBERGER M, 2001, COMP ARAWAK HIST RET, P99; HECKENBERGER M, 2001, OS POVOS INDIGENAS A, P77; Heckenberger MJ, 1998, ANTIQUITY, V72, P633, DOI 10.1017/S0003598X00087056; Heckenberger MJ, 1999, LAT AM ANTIQ, V10, P353, DOI 10.2307/971962; Lathrap D. W., 1970, UPPER AMAZON; Mann CC, 2000, SCIENCE, V287, P786, DOI 10.1126/science.287.5454.786; MANN CC, 2002, ATLANTIC MONTHLY MAR, P41; METRAUX A, 1948, B BUR AM ETHNOL, V143, P349; Roosevelt AC., 1999, ARCHEOLOGICAL PAPERS, V9, P2, DOI DOI 10.1525/AP3A.1999.9.1.13; Smith N.J.H., 1995, AMAZONIA RESILIENCY; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; TAMBIAH S, 1985, RITUAL PERFORMANCE T; Woods W.I., 1999, YB C LAT AM GEOGR, V25, P7; 2002, AM BROADCASTING 0919; 2002, BRIT BROADCASTI 1219	23	309	331	3	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2003	301	5640					1710	1714		10.1126/science.1086112	http://dx.doi.org/10.1126/science.1086112			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722QN	14500979				2022-12-01	WOS:000185387700041
J	Yuan, JP; Kiselyov, K; Shin, DM; Chen, J; Shcheynikov, N; Kang, SH; Dehoff, MH; Schwarz, MK; Seeburg, PH; Muallem, S; Worley, PF				Yuan, JP; Kiselyov, K; Shin, DM; Chen, J; Shcheynikov, N; Kang, SH; Dehoff, MH; Schwarz, MK; Seeburg, PH; Muallem, S; Worley, PF			Homer binds TRPC family channels and is required for gating of TRPC1 by IP3 receptors	CELL			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; OPERATED HTRP3 CHANNELS; PROLINE-RICH MOTIF; EVH1 DOMAIN; PROTEINS; CELLS; CALCIUM; COMPLEX; ASSOCIATION	Receptor signaling at the plasma membrane often releases calcium from intracellular stores. For example, inositol triphosphate (IP3) produced by receptor-coupled phospholipase C activates an intracellular store calcium channel, the IP3R. Conversely, stores can induce extracellular calcium to enter the cell through plasma membrane channels, too. How this "reverse" coupling works was unclear, but store IP(3)Rs were proposed to bind and regulate plasma membrane TRIP cation channels. Here, we demonstrate that the adaptor protein, termed Homer, facilitates a physical association between TRPC1 and the IP3R that is required for the TRP channel to respond to signals. The TRPC1-Homer-IP3R complex is dynamic and its disassembly parallels TRPC1 channel activation. Homer's action depends on its ability to crosslink and is blocked by the dominant-negative immediate early gene form, H1a. Since H1a is transcriptionally regulated by cellular activity, this mechanism can affect both short and long-term regulation of TRPC1 function.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Yonsei Univ, Dept Oral Biol, Brain Korea 21 Project Med Sci, Seoul 120752, South Korea; Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany	Johns Hopkins University; Johns Hopkins University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Yonsei University; Max Planck Society	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	shmuel.muallem@utsouthwestern.edu; pworley@jhmi.edu		Shin, Dong Min/0000-0001-6042-0435; Kiselyov, Kirill/0000-0001-6683-2895				Baltensperger H, 1997, J BIOL CHEM, V272, P10151; Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; FAGNI L, 2002, SCI STKE; Feng W, 2002, J BIOL CHEM, V277, P44722, DOI 10.1074/jbc.M207675200; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Irie K, 2002, J MOL BIOL, V318, P1117, DOI 10.1016/S0022-2836(02)00170-5; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Kiselyov K, 1999, MOL CELL, V4, P423, DOI 10.1016/S1097-2765(00)80344-5; Klingelhofer J, 2003, ONCOGENE, V22, P1181, DOI 10.1038/sj.onc.1206245; Liu XB, 2000, J BIOL CHEM, V275, P3403, DOI 10.1074/jbc.275.5.3403; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Montell C., 2001, SCI STKE; Nucifora FC, 1996, MOL BIOL CELL, V7, P949, DOI 10.1091/mbc.7.6.949; Putney JW, 2001, NATURE, V410, P648, DOI 10.1038/35070704; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shin DM, 2003, J CELL BIOL, V162, P293, DOI 10.1083/jcb.200210109; Soloviev MM, 2000, EUR J BIOCHEM, V267, P634, DOI 10.1046/j.1432-1327.2000.01078.x; Soloviev MM, 2000, J MOL BIOL, V295, P1185; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Vaca L, 2002, J BIOL CHEM, V277, P42178, DOI 10.1074/jbc.M204531200; Vazdarjanova A, 2002, J NEUROSCI, V22, P10067; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Venkatachalam K, 2001, J BIOL CHEM, V276, P33980, DOI 10.1074/jbc.C100321200; Vennekens R, 2002, CELL CALCIUM, V31, P253, DOI 10.1016/S0143-4160(02)00055-6; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8	33	398	416	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2003	114	6					777	789		10.1016/S0092-8674(03)00716-5	http://dx.doi.org/10.1016/S0092-8674(03)00716-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	724AL	14505576	Bronze			2022-12-01	WOS:000185464000014
J	Sinclair, ARE; Mduma, S; Brashares, JS				Sinclair, ARE; Mduma, S; Brashares, JS			Patterns of predation in a diverse predator-prey system	NATURE			English	Article							TROPHIC CASCADES; BOTTOM-UP; FOOD WEBS; TOP-DOWN; COMPETITION; COMMUNITY; HETEROGENEITY; ECOSYSTEM	There are many cases where animal populations are affected by predators and resources in terrestrial ecosystems(1-3),but the factors that determine when one or the other predominates remain poorly understood(4-5). Here we show, using 40 years of data from the highly diverse mammal community of the Serengeti ecosystem, East Africa, that the primary cause of mortality for adults of a particular species is determined by two factors-the species diversity of both the predators and prey and the body size of that prey species relative to other prey and predators. Small ungulates in Serengeti are exposed to more predators, owing to opportunistic predation, than are larger ungulates; they also suffer greater predation rates, and experience strong predation pressure. A threshold occurs at prey body sizes of similar to150 kg, above which ungulate species have few natural predators and exhibit food limitation. Thus, biodiversity allows both predation (top-down) and resource limitation (bottom-up) to act simultaneously to affect herbivore populations. This result may apply generally in systems where there is a diversity of predators and prey.	Univ British Columbia, Ctr Biodivers Res, Vancouver, BC V6T 1Z4, Canada; Tanzania Wildlife Res Inst, Arusha, Tanzania	University of British Columbia	Sinclair, ARE (corresponding author), Univ British Columbia, Ctr Biodivers Res, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.							Bertram B. C. B., 1979, SERENGETI DYNAMICS E, P221; BRASHARES JS, IN PRESS MAMMALS AFR; BROTEN M, 1995, SERENGETI, V2, P169; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Dyer LA, 2003, ECOL LETT, V6, P60, DOI 10.1046/j.1461-0248.2003.00398.x; Dyer LA, 1999, P NATL ACAD SCI USA, V96, P5072, DOI 10.1073/pnas.96.9.5072; ELLIOTT JP, 1977, CAN J ZOOL, V55, P1811, DOI 10.1139/z77-235; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Heinisch O., 1963, SAMPLING TECHNIQUES, V7, P203, DOI [10.1002/bimj.19650070312, DOI 10.1002/BIMJ.19650070312]; Hofer H., 1995, SERENGETI, P332, DOI DOI 10.1186/1471-2148-9-253; HUNTER MD, 1992, ECOLOGY, V73, P724; JOLLY G M, 1969, East African Agricultural and Forestry Journal, V34, P46; Kruuk H., 1972, SPOTTED HYENA STUDY; LAMPRECHT J, 1978, Z SAUGETIERKD, V43, P210; Mduma SAR, 1999, J ANIM ECOL, V68, P1101, DOI 10.1046/j.1365-2656.1999.00352.x; MDUMA SAR, 1995, SERENGETI, V2, P220; Nowak R.M., 1999, MAMMALS WORLD; Persson L, 1999, OIKOS, V85, P385, DOI 10.2307/3546688; Polis GA, 1999, OIKOS, V86, P3, DOI 10.2307/3546565; Post E, 1999, NATURE, V401, P905, DOI 10.1038/44814; Schaller G. B., 1972, SERENGETI LION STUDY; Scheel, 1995, SERENGETI; Schoener TW, 1996, NATURE, V381, P691, DOI 10.1038/381691a0; Sinclair A. R. E., 1979, SERENGETI DYNAMICS E, P82; Sinclair A.R.E., 1979, SERENGETI DYNAMICS E; Sinclair ARE, 2000, OIKOS, V89, P313, DOI 10.1034/j.1600-0706.2000.890213.x; SINCLAIR ARE, 1985, J ANIM ECOL, V54, P899, DOI 10.2307/4386; SINCLAIR ARE, 1995, SERENGETI, V2, P194; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; [No title captured]	30	523	534	5	314	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 18	2003	425	6955					288	290		10.1038/nature01934	http://dx.doi.org/10.1038/nature01934			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722JA	13679915				2022-12-01	WOS:000185370900043
J	Higginson, I				Higginson, I			For and against - Doctors should not discuss resuscitation with terminally ill patients - Against	BRITISH MEDICAL JOURNAL			English	Article							CARE; PHYSICIANS; LIFE; COMMUNICATION; PREFERENCES; CANCER; END		Kings Coll London, Weston Educ Ctr, Dept Palliat Care & Policy, London SE5 9RJ, England	University of London; King's College London	Higginson, I (corresponding author), Kings Coll London, Weston Educ Ctr, Dept Palliat Care & Policy, London SE5 9RJ, England.	irene.higginson@kcl.ac.uk	Higginson, Irene J/C-7309-2012	Higginson, Irene J/0000-0002-3687-1313				Davies E, 2003, SUPPORT CARE CANCER, V11, P21, DOI 10.1007/s00520-002-0392-x; Edmonds P, 2003, CLIN MED, V3, P149, DOI 10.7861/clinmedicine.3-2-149; Fallowfield LJ, 2002, PALLIATIVE MED, V16, P297, DOI 10.1191/0269216302pm575oa; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; GYSELS M, 2003, IMPROVING SUPPORTIVE; Koffman J, 2001, PALLIATIVE MED, V15, P337, DOI 10.1191/026921601678320322; MURRAY E, 2001, BRIT MED J, V323, P496; *NAT CANC RES I, 2002, STRAT AN 2002 OV CAN; Perron NJ, 2002, SWISS MED WKLY, V132, P562; Silvestri G, 1998, BRIT MED J, V317, P771, DOI 10.1136/bmj.317.7161.771; Steinhauser KE, 2001, J PAIN SYMPTOM MANAG, V22, P727, DOI 10.1016/S0885-3924(01)00334-7; Teno JM, 1998, J GEN INTERN MED, V13, P439, DOI 10.1046/j.1525-1497.1998.00132.x	12	12	13	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 13	2003	327	7415					615	616		10.1136/bmj.327.7415.615	http://dx.doi.org/10.1136/bmj.327.7415.615			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722CW	12969935	Green Published			2022-12-01	WOS:000185358700031
J	Sorenson, MD; Sefc, KM; Payne, RB				Sorenson, MD; Sefc, KM; Payne, RB			Speciation by host switch in brood parasitic indigobirds	NATURE			English	Article							VIDUA-CHALYBEATA; SYMPATRIC SPECIATION; SPECIES ASSOCIATIONS; GENETIC-EVIDENCE; COMMON CUCKOO; SONG MIMICRY; FINCHES; ORIGIN; DIFFERENTIATION; COEVOLUTION	A growing body of empirical and theoretical work supports the plausibility of sympatric speciation(1-3), but there remain few examples in which all the essential components of the process are well understood. The African indigobirds Vidua spp. are host-specific brood parasites. Indigobird nestlings are reared along with host young, and mimic the mouth markings of their respective hosts(4-6). As adults, male indigobirds mimic host song(4-7), whereas females use these songs to choose both their mates and the nests they parasitize(8). These behavioural mechanisms promote the cohesion of indigobird populations associated with a given host species, and provide a mechanism for reproductive isolation after a new host is colonized. Here we show that all indigobird species are similar genetically, but are significantly differentiated in both mitochondrial haplotype and nuclear allele frequencies. These data support a model of recent sympatric speciation. In contrast to the cuckoo Cuculus canorus, in which only female lineages are faithful to specific hosts(9,10), host switches have led to speciation in indigobirds because both males and females imprint on their hosts(8,11).	Boston Univ, Dept Biol, Boston, MA 02215 USA; Univ Michigan, Museum Zool, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	Boston University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sorenson, MD (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.		Sorenson, Michael/D-8065-2011	Sorenson, Michael/0000-0001-5375-2917; Sefc, Kristina/0000-0001-8108-8339				Avise JC, 2000, PHYLOGEOGRAPHY HIST; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Berlocher SH, 2002, ANNU REV ENTOMOL, V47, P773, DOI 10.1146/annurev.ento.47.091201.145312; de Queiroz K, 1998, ENDLESS FORMS, P57; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Edwards SV, 2000, EVOLUTION, V54, P1839; Gibbs HL, 2000, NATURE, V407, P183, DOI 10.1038/35025058; Goodman SJ, 1997, MOL ECOL, V6, P881, DOI 10.1046/j.1365-294X.1997.00260.x; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Klein NK, 1998, EVOLUTION, V52, P566, DOI 10.1111/j.1558-5646.1998.tb01655.x; LOTEM A, 1995, ANIM BEHAV, V49, P1185, DOI 10.1006/anbe.1995.0152; Marchetti K, 1998, SCIENCE, V282, P471, DOI 10.1126/science.282.5388.471; Nicolai J., 1964, Zeitschrift fuer Tierpsychologie, V21, P129; Payne R.B., 1982, Miscellaneous Publications Museum of Zoology University of Michigan, V162, P1; Payne R. B., 1973, ORNITHOL MONOGR, V11, P1; Payne RB, 2000, ANIM BEHAV, V59, P69, DOI 10.1006/anbe.1999.1283; Payne RB, 1998, ANIM BEHAV, V55, P1537, DOI 10.1006/anbe.1997.0701; Payne RB, 2002, IBIS, V144, P373, DOI 10.1046/j.1474-919X.2002.00065.x; Payne RB, 2001, ANIM BEHAV, V62, P473, DOI 10.1006/anbe.2001.1773; PAYNE RB, 1994, IBIS, V136, P291, DOI 10.1111/j.1474-919X.1994.tb01098.x; Payne Robert B., 1996, Bulletin of the African Bird Club, V3, P14; SANDERSON MJ, 2003, R8S VERSION 1 60 AN; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Sefc KM, 2001, MOL ECOL NOTES, V1, P252, DOI 10.1046/j.1471-8278.2001.00095.x; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Sorenson MD, 2002, INTEGR COMP BIOL, V42, P388, DOI 10.1093/icb/42.2.388; Sorenson MD, 2001, EVOLUTION, V55, P2550; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; [No title captured]	30	180	190	0	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 21	2003	424	6951					928	931		10.1038/nature01863	http://dx.doi.org/10.1038/nature01863			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713EH	12931185	Green Published			2022-12-01	WOS:000184843600038
J	Hay, P				Hay, P			Commentary: Putting the research into practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Adelaide, Royal Adelaide Hosp, Dept Psychiat, Adelaide, SA 5001, Australia	Royal Adelaide Hospital; University of Adelaide	Hay, P (corresponding author), Univ Adelaide, Royal Adelaide Hosp, Dept Psychiat, Adelaide, SA 5001, Australia.	phillipa.hay@adelaide.edu.au		Hay, Phillipa/0000-0003-0296-6856				American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; [Anonymous], 2000, Am J Psychiatry, V157, P1; [Anonymous], 1992, Arch Gen Psychiatry, V49, P139; Cooper P. J., 1995, BULIMIA NERVOSA BING; Fairburn CG, 2003, LANCET, V361, P407, DOI 10.1016/S0140-6736(03)12378-1; Fairburn CG, 1996, AM J PSYCHIAT, V153, P386; Hay P, 2003, INT J EAT DISORDER, V33, P434, DOI 10.1002/eat.10162; Hay P. J., 1998, PRIMARY CARE COMMUN, V4, P95; HAY PJ, 2003, CLIN EVIDENCE, P1388	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2003	327	7411					381	381		10.1136/bmj.327.7411.381	http://dx.doi.org/10.1136/bmj.327.7411.381			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	713NJ	12919993	Green Published			2022-12-01	WOS:000184864200023
J	Chin, JW; Cropp, TA; Anderson, JC; Mukherji, M; Zhang, ZW; Schultz, PG				Chin, JW; Cropp, TA; Anderson, JC; Mukherji, M; Zhang, ZW; Schultz, PG			An expanded eukaryotic genetic code	SCIENCE			English	Article							SITE-SPECIFIC INCORPORATION; TRANSFER-RNA-SYNTHETASE; TYROSINE TRANSFER-RNA; UNNATURAL AMINO-ACIDS; PHOTO-CROSS-LINKING; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; PROTEIN-STRUCTURE; REVERSE 2-HYBRID; YEAST	We describe a general and rapid route for the addition of unnatural amino acids to the genetic code of Saccharomyces cerevisiae. Five amino acids have been incorporated into proteins efficiently and with high fidelity in response to the nonsense codon TAG. The side chains of these amino acids contain a keto group, which can be uniquely modified in vitro and in vivo with a wide range of chemical probes and reagents; a heavy atom-containing amino acid for structural studies; and photocrosslinkers for cellular studies of protein interactions. This methodology not only removes the constraints imposed by the genetic code on our ability to manipulate protein structure and function in yeast, it provides a gateway to the systematic expansion of the genetic codes of multicellular eukaryotes.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Biol Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Schultz, PG (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062159] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 62159] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARKER DG, 1982, FEBS LETT, V150, P419, DOI 10.1016/0014-5793(82)80781-3; BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BRICK P, 1989, J MOL BIOL, V208, P83, DOI 10.1016/0022-2836(89)90090-9; Burke D., 2000, METHODS YEAST GENETI; Chin JW, 2003, CHEM BIOL, V10, P511, DOI 10.1016/S1074-5521(03)00123-6; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Chin JW, 2002, CHEMBIOCHEM, V3, P1135, DOI 10.1002/1439-7633(20021104)3:11<1135::AID-CBIC1135>3.0.CO;2-M; Corey E.J., 1995, LOGIC CHEM SYNTHESIS; CORNISH VW, 1995, ANGEW CHEM INT EDIT, V34, P621, DOI 10.1002/anie.199506211; Cornish VW, 1996, J AM CHEM SOC, V118, P8150, DOI 10.1021/ja961216x; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; Dougherty DA, 2000, CURR OPIN CHEM BIOL, V4, P645, DOI 10.1016/S1367-5931(00)00148-4; EDWARDS H, 1990, MOL CELL BIOL, V10, P1633, DOI 10.1128/MCB.10.4.1633; EDWARDS H, 1991, P NATL ACAD SCI USA, V88, P1153, DOI 10.1073/pnas.88.4.1153; ELLMAN JA, 1992, SCIENCE, V255, P197, DOI 10.1126/science.1553546; Furter R, 1998, PROTEIN SCI, V7, P419; GOODMAN HM, 1968, NATURE, V217, P1019, DOI 10.1038/2171019a0; Hughes Timothy R, 2002, Funct Integr Genomics, V2, P199, DOI 10.1007/s10142-002-0059-1; JACKSON DY, 1994, SCIENCE, V266, P243, DOI 10.1126/science.7939659; Kirshenbaum K, 2002, CHEMBIOCHEM, V3, P235, DOI 10.1002/1439-7633(20020301)3:2/3<235::AID-CBIC235>3.0.CO;2-7; KISHORE GM, 1988, ANNU REV BIOCHEM, V57, P627, DOI 10.1146/annurev.bi.57.070188.003211; Liu DR, 1999, P NATL ACAD SCI USA, V96, P4780, DOI 10.1073/pnas.96.9.4780; MENDEL D, 1995, ANNU REV BIOPH BIOM, V24, P435, DOI 10.1146/annurev.biophys.24.1.435; Merrifield RB, 1976, SCIENCE, V232, P341, DOI DOI 10.1126/SCIENCE.3961484; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; Sakamoto K, 2002, NUCLEIC ACIDS RES, V30, P4692, DOI 10.1093/nar/gkf589; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; TREZEGUET V, 1991, MOL CELL BIOL, V11, P2744, DOI 10.1128/MCB.11.5.2744; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10321, DOI 10.1073/pnas.93.19.10321; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10315, DOI 10.1073/pnas.93.19.10315; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang L, 2003, P NATL ACAD SCI USA, V100, P56, DOI 10.1073/pnas.0234824100; Wang L, 2002, CHEM COMMUN, P1, DOI 10.1039/b108185n; Wolin SL, 1999, GENE DEV, V13, P1, DOI 10.1101/gad.13.1.1; ZHANG Z, 2003, BIOCHEMISTRY-US, V42, pL375; Zhang ZW, 2002, ANGEW CHEM INT EDIT, V41, P2840, DOI 10.1002/1521-3773(20020802)41:15<2840::AID-ANIE2840>3.0.CO;2-#; [No title captured]	41	605	746	11	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2003	301	5635					964	967		10.1126/science.1084772	http://dx.doi.org/10.1126/science.1084772			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711RY	12920298				2022-12-01	WOS:000184755900039
J	Gutmann, S; Haebel, PW; Metzinger, L; Sutter, M; Felden, B; Ban, N				Gutmann, S; Haebel, PW; Metzinger, L; Sutter, M; Felden, B; Ban, N			Crystal structure of the transfer-RNA domain of transfer-messenger RNA in complex with SmpB	NATURE			English	Article							PHENYLALANINE TRANSFER-RNA; ESCHERICHIA-COLI; ANGSTROM RESOLUTION; RIBOSOME RESCUE; BINDING PROTEIN; TAGGING SYSTEM; 10SA RNA; TMRNA; DEGRADATION; IDENTITY	Accurate translation of genetic information into protein sequence depends on complete messenger RNA molecules. Truncated mRNAs cause synthesis of defective proteins, and arrest ribosomes at the end of their incomplete message. In bacteria, a hybrid RNA molecule that combines the functions of both transfer and messenger RNAs (called tmRNA) rescues stalled ribosomes, and targets aberrant, partially synthesized, proteins for proteolytic degradation(1,2). Here we report the 3.2-Angstrom-resolution structure of the tRNA-like domain of tmRNA (tmRNA(Delta)) in complex with small protein B (SmpB), a protein essential for biological functions of tmRNA. We find that the flexible RNA molecule adopts an open L-shaped conformation and SmpB binds to its elbow region, stabilizing the single-stranded D-loop in an extended conformation. The most striking feature of the structure of tmRNA(Delta) is a 90degrees rotation of the TPsiC-arm around the helical axis. Owing to this unusual conformation, the SmpB-tmRNA(Delta) complex positioned into the A-site of the ribosome orients SmpB towards the small ribosomal subunit, and directs tmRNA towards the elongation-factor binding region of the ribosome. On the basis of this structure, we propose a model for the binding of tmRNA on the ribosome.	ETH, Inst Mol Biol & Biophys, HPK Gebaude, CH-8093 Zurich, Switzerland; Univ Rennes 1, UPRES JE2311, F-35043 Rennes, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Universite de Rennes 1	Ban, N (corresponding author), ETH, Inst Mol Biol & Biophys, HPK Gebaude, CH-8093 Zurich, Switzerland.		felden, brice/L-4825-2015; Metzinger, Laurent/B-1426-2016; metzinger, laurent/AAY-4634-2021	Metzinger, Laurent/0000-0002-7636-8480; metzinger, laurent/0000-0002-7636-8480; Sutter, Markus/0000-0001-6290-4820; Gutmann, Sascha/0000-0002-4242-8510				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Barends S, 2001, J MOL BIOL, V314, P9, DOI 10.1006/jmbi.2001.5114; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Corvaisier S, 2003, J BIOL CHEM, V278, P14788, DOI 10.1074/jbc.M212830200; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dong G, 2002, EMBO J, V21, P1845, DOI 10.1093/emboj/21.7.1845; Felden B, 1997, RNA, V3, P89; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Hanawa-Suetsugu K, 2001, NUCLEIC ACIDS RES, V29, P4663, DOI 10.1093/nar/29.22.4663; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Keiler KC, 2000, P NATL ACAD SCI USA, V97, P7778, DOI 10.1073/pnas.97.14.7778; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; KIM SH, 1973, SCIENCE, V179, P285, DOI 10.1126/science.179.4070.285; Komine Y, 1996, J BIOCHEM-TOKYO, V119, P463; MCCLAIN WH, 1991, P NATL ACAD SCI USA, V88, P9272, DOI 10.1073/pnas.88.20.9272; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; Rudinger-Thirion J, 1999, RNA, V5, P989, DOI 10.1017/S135583829999101X; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Someya T, 2003, FEBS LETT, V535, P94, DOI 10.1016/S0014-5793(02)03880-2; Stagg SM, 2001, J MOL BIOL, V309, P727, DOI 10.1006/jmbi.2001.4632; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; USHIDA C, 1994, NUCLEIC ACIDS RES, V22, P3392, DOI 10.1093/nar/22.16.3392; Valle M, 2003, SCIENCE, V300, P127, DOI 10.1126/science.1081798; Williams KP, 1996, RNA, V2, P1306; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	30	100	103	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					699	703		10.1038/nature01831	http://dx.doi.org/10.1038/nature01831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904796				2022-12-01	WOS:000184578800051
J	Abramson, J; Smirnova, I; Kasho, V; Verner, G; Kaback, HR; Iwata, S				Abramson, J; Smirnova, I; Kasho, V; Verner, G; Kaback, HR; Iwata, S			Structure and mechanism of the lactose permease of Escherichia coli	SCIENCE			English	Article								Membrane transport proteins that transduce free energy stored in electrochemical ion gradients into a concentration gradient are a major class of membrane proteins. We report the crystal structure at 3.5 angstroms of the Escherichia coli lactose permease, an intensively studied member of the major facilitator superfamily of transporters. The molecule is composed of N- and C-terminal domains, each with six transmembrane helices, symmetrically positioned within the permease. A large internal hydrophilic cavity open to the cytoplasmic side represents the inward-facing conformation of the transporter. The structure with a bound lactose homolog, beta-D-galactopyranosyl-1-thio-beta-D-galactopyranoside, reveals the sugar-binding site in the cavity, and residues that play major roles in substrate recognition and proton translocation are identified. We propose a possible mechanism for lactose/proton symport (cotransport) consistent with both the structure and a large body of experimental data.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England; Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, London SW7 2AZ, England; Univ Calif Los Angeles, Inst Mol Biol, Howard Hughes Med Inst, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Howard Hughes Med Inst, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA	Imperial College London; Imperial College London; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Kaback, HR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England.	ronaldk@hhmi.ucla.edu; s.iwata@imperial.ac.uk			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051131] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK51131: 08] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CALAMIA J, 1990, P NATL ACAD SCI USA, V87, P4937, DOI 10.1073/pnas.87.13.4937; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; FOSTER DL, 1983, J BIOL CHEM, V258, P31; FRANCO PJ, 1994, J BIOL CHEM, V269, P7379; Frillingos S, 1997, PROTEIN SCI, V6, P438; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; Guan L, 2003, BIOCHEMISTRY-US, V42, P1377, DOI 10.1021/bi027152m; Guan L, 2002, P NATL ACAD SCI USA, V99, P3475, DOI 10.1073/pnas.052703699; Guan L, 2002, P NATL ACAD SCI USA, V99, P6613, DOI 10.1073/pnas.102178299; HENDERSON PJF, 1990, J BIOENERG BIOMEMBR, V22, P525, DOI 10.1007/BF00762961; Hirai T, 2003, J BACTERIOL, V185, P1712, DOI 10.1128/JB.185.5.1712-1718.2003; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; JUNG K, 1995, BIOCHEMISTRY-US, V34, P6272, DOI 10.1021/bi00019a003; JUNG K, 1993, BIOCHEMISTRY-US, V32, P12273, DOI 10.1021/bi00097a001; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; le Coutre J, 1998, P NATL ACAD SCI USA, V95, P6114, DOI 10.1073/pnas.95.11.6114; Merritt EA, 1997, STRUCTURE, V5, P1485, DOI 10.1016/S0969-2126(97)00298-0; Miller C, 2000, CURR OPIN CHEM BIOL, V4, P148, DOI 10.1016/S1367-5931(99)00068-X; Muller-Hill B, 1996, LAC OPERON SHORT HIS, V1st; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Patzlaff JS, 1998, BIOCHEMISTRY-US, V37, P15363, DOI 10.1021/bi981142x; ROEPE PD, 1989, BIOCHEMISTRY-US, V28, P6127, DOI 10.1021/bi00440a060; Sahin-Toth M, 2000, BIOCHEMISTRY-US, V39, P5097, DOI 10.1021/bi0000263; Sahin-Toth M, 2001, BIOCHEMISTRY-US, V40, P13015, DOI 10.1021/bi011233l; Sahin-Toth M, 2001, P NATL ACAD SCI USA, V98, P6068, DOI 10.1073/pnas.111139698; SAHINTOTH M, 1992, P NATL ACAD SCI USA, V89, P10547, DOI 10.1073/pnas.89.21.10547; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; Smirnova IN, 2003, BIOCHEMISTRY-US, V42, P3025, DOI 10.1021/bi027329c; Sorgen PL, 2002, P NATL ACAD SCI USA, V99, P14037, DOI 10.1073/pnas.182552199; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; UJWAL ML, 1994, MOL MEMBR BIOL, V11, P9, DOI 10.3109/09687689409161024; Venkatesan P, 1998, P NATL ACAD SCI USA, V95, P9802, DOI 10.1073/pnas.95.17.9802; Weinglass AB, 2002, J MOL BIOL, V315, P561, DOI 10.1006/jmbi.2001.5289; WIDDAS WF, 1952, J PHYSIOL-LONDON, V118, P23, DOI 10.1113/jphysiol.1952.sp004770; Wolin CD, 2000, BIOCHEMISTRY-US, V39, P6130, DOI 10.1021/bi0001269; Wolin CD, 2001, BIOCHEMISTRY-US, V40, P1996, DOI 10.1021/bi0025767; Zhao M, 1999, BIOCHEMISTRY-US, V38, P7407, DOI 10.1021/bi9906524	37	1180	1205	1	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2003	301	5633					610	615		10.1126/science.1088196	http://dx.doi.org/10.1126/science.1088196			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893935				2022-12-01	WOS:000184473600030
J	Thomson, RE; Mihaly, SF; Rabinovich, AB; McDuff, RE; Veirs, SR; Stahr, FR				Thomson, RE; Mihaly, SF; Rabinovich, AB; McDuff, RE; Veirs, SR; Stahr, FR			Constrained circulation at Endeavour ridge facilitates colonization by vent larvae	NATURE			English	Article							DE-FUCA RIDGE; MID-ATLANTIC RIDGE; HYDROTHERMAL PLUMES; NORTHEAST PACIFIC; HEAT-FLUX; BIOLOGY; EVOLUTION; OCEAN	Understanding how larvae from extant hydrothermal vent fields colonize neighbouring regions of the mid-ocean ridge system remains a major challenge in oceanic research(1,2). Among the factors considered important in the recruitment of deep-sea larvae are metabolic lifespan, the connectivity of the seafloor topography, and the characteristics of the currents(3). Here we use current velocity measurements from Endeavour ridge to examine the role of topographically constrained circulation on larval transport along-ridge. We show that the dominant tidal and wind-generated currents in the region are strongly attenuated within the rift valley that splits the ridge crest, and that hydrothermal plumes rising from vent fields in the valley drive a steady near-bottom inflow within the valley. Extrapolation of these findings suggests that the suppression of oscillatory currents within rift valleys of mid-ocean ridges shields larvae from cross-axis dispersal into the inhospitable deep ocean. This effect, augmented by plume-driven circulation within rift valleys having active hydrothermal venting, helps retain larvae near their source. Larvae are then exported preferentially down-ridge during regional flow events that intermittently over-ride the currents within the valley.	Inst Ocean Sci, Sidney, BC V8L 4B2, Canada; PP Shirshov Oceanol Inst, Moscow 117851, Russia; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	Russian Academy of Sciences; Shirshov Institute of Oceanology; University of Washington; University of Washington Seattle	Thomson, RE (corresponding author), Inst Ocean Sci, 9860 W Saanich Rd, Sidney, BC V8L 4B2, Canada.		Rabinovich, Alexander/ABD-5745-2020	Veirs, Scott/0000-0001-7395-9085				BAKER ET, 1987, EARTH PLANET SC LETT, V85, P59, DOI 10.1016/0012-821X(87)90021-5; BEMIS KG, 1993, J GEOPHYS RES-SOL EA, V98, P6351, DOI 10.1029/92JB02273; Cannon GA, 1996, GEOPHYS RES LETT, V23, P1613, DOI 10.1029/96GL01370; GERMAN CR, 1993, EARTH PLANET SC LETT, V116, P129, DOI 10.1016/0012-821X(93)90049-F; GINSTER U, 1994, J GEOPHYS RES-SOL EA, V99, P4937, DOI 10.1029/93JB02800; Kelley D. S., 2001, EOS T AGU, V82, pF612; Lavelle JW, 2001, J GEOPHYS RES-OCEANS, V106, P31099, DOI 10.1029/2001JC000865; LUPTON JE, 1985, NATURE, V316, P621, DOI 10.1038/316621a0; Marsh AG, 2001, NATURE, V411, P77, DOI 10.1038/35075063; Mcduff R.E., 1995, PHYSICAL CHEM BIOL G, P357; Mihaly SF, 1998, GEOPHYS RES LETT, V25, P1205, DOI 10.1029/98GL00722; Murton BJ, 1999, EARTH PLANET SC LETT, V171, P301, DOI 10.1016/S0012-821X(99)00157-0; ROSENBERG ND, 1988, NATURE, V334, P604, DOI 10.1038/334604a0; STAHR FR, 2000, EOS T AGU S, V81; THOMSON RE, 1992, EARTH PLANET SC LETT, V111, P141, DOI 10.1016/0012-821X(92)90175-U; Thurnherr AM, 2002, J PHYS OCEANOGR, V32, P1763, DOI 10.1175/1520-0485(2002)032<1763:FAMITR>2.0.CO;2; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; VEIRS SR, 2003, THESIS U WASHINGTON	19	81	83	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					545	549		10.1038/nature01824	http://dx.doi.org/10.1038/nature01824			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891356				2022-12-01	WOS:000184454700041
J	Webster, AJ; Payne, RJH; Pagel, M				Webster, AJ; Payne, RJH; Pagel, M			Molecular Phylogenies link rates of evolution and speciation	SCIENCE			English	Article							DIVERSITY		Univ Reading, Sch Anim & Microbial Sci, Reading RG6 2AH, Berks, England	University of Reading	Pagel, M (corresponding author), Univ Reading, Sch Anim & Microbial Sci, Reading RG6 2AH, Berks, England.							Barraclough TG, 2001, EVOLUTION, V55, P677, DOI 10.1554/0014-3820(2001)055[0677:ERASDI]2.0.CO;2; GOULD SJ, 1993, NATURE, V366, P223, DOI 10.1038/366223a0; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Mayr E., 1954, EVOLUTION PROCESS, P157; MINDELL DP, 1990, J EVOLUTION BIOL, V3, P125, DOI 10.1046/j.1420-9101.1990.3010125.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Weller SG, 1996, EVOLUTION, V50, P23, DOI 10.1111/j.1558-5646.1996.tb04469.x	7	122	125	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2003	301	5632					478	478		10.1126/science.1083202	http://dx.doi.org/10.1126/science.1083202			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881561				2022-12-01	WOS:000184340500031
J	Cobb, KM; Charles, CD; Cheng, H; Edwards, RL				Cobb, KM; Charles, CD; Cheng, H; Edwards, RL			El Nino/Southern Oscillation and tropical Pacific climate during the last millennium	NATURE			English	Article							SOUTHERN-OSCILLATION; SOLAR IRRADIANCE; NINO; VARIABILITY; ENSO; CORAL; DROUGHT; MODEL; STABILITY; FREQUENCY	Any assessment of future climate change requires knowledge of the full range of natural variability in the El Nino/Southern Oscillation (ENSO) phenomenon. Here we splice together fossil-coral oxygen isotopic records from Palmyra Island in the tropical Pacific Ocean to provide 30-150-year windows of tropical Pacific climate variability within the last 1,100 years. The records indicate mean climate conditions in the central tropical Pacific ranging from relatively cool and dry during the tenth century to increasingly warmer and wetter climate in the twentieth century. But the corals also document a broad range of ENSO behaviour that correlates poorly with these estimates of mean climate. The most intense ENSO activity within the reconstruction occurred during the mid-seventeenth century. Taken together, the coral data imply that the majority of ENSO variability over the last millennium may have arisen from dynamics internal to the ENSO system itself.	Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Univ Minnesota, Dept Geol & Geophys, Minnesota Isotope Lab, Minneapolis, MN 55455 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Minnesota System; University of Minnesota Twin Cities	Cobb, KM (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	kcobb@gps.caltech.edu	CHENG, HAI/H-3413-2017; Edwards, R. Lawrence/I-3124-2014	CHENG, HAI/0000-0002-5305-9458; Edwards, R. Lawrence/0000-0002-7027-5881; Cobb, Kim/0000-0002-2125-9164				Bard E, 2000, TELLUS B, V52, P985, DOI 10.1034/j.1600-0889.2000.d01-7.x; Black DE, 1999, SCIENCE, V286, P1709, DOI 10.1126/science.286.5445.1709; Cane M. A., 1995, NATURAL CLIMATE VARI, P442; Cobb KM, 2003, EARTH PLANET SC LETT, V210, P91, DOI 10.1016/S0012-821X(03)00138-9; Cobb KM, 2001, GEOPHYS RES LETT, V28, P2209, DOI 10.1029/2001GL012919; COLE JE, 1993, SCIENCE, V260, P1790, DOI 10.1126/science.260.5115.1790; Correge T, 2001, GEOPHYS RES LETT, V28, P3477, DOI 10.1029/2001GL013216; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; Dai A, 2000, GEOPHYS RES LETT, V27, P1283, DOI 10.1029/1999GL011140; Evans M., 2001, INTERHEMISPHERIC CLI, DOI [10.1016/b978-012472670-3/50007-0, DOI 10.1016/B978-012472670-3/50007-0]; Evans MN, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000590; Evans MN, 1999, J GEOPHYS RES-OCEANS, V104, P13409, DOI 10.1029/1999JC900001; Fedorov AV, 2001, J CLIMATE, V14, P3086, DOI 10.1175/1520-0442(2001)014<3086:ASAOTO>2.0.CO;2; GRAHAM NE, 1988, SCIENCE, V240, P1293, DOI 10.1126/science.240.4857.1293; Gu DF, 1997, SCIENCE, V275, P805, DOI 10.1126/science.275.5301.805; Harrison DE, 1997, GEOPHYS RES LETT, V24, P1779, DOI 10.1029/97GL01789; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Hendy EJ, 2002, SCIENCE, V295, P1511, DOI 10.1126/science.1067693; Hodell DA, 2001, SCIENCE, V292, P1367, DOI 10.1126/science.1057759; HODELL DA, 1995, NATURE, V375, P391, DOI 10.1038/375391a0; Hughen KA, 1999, GEOPHYS RES LETT, V26, P3129, DOI 10.1029/1999GL006062; JIN FF, 1994, SCIENCE, V264, P70, DOI 10.1126/science.264.5155.70; Jin FF, 1997, J ATMOS SCI, V54, P811, DOI 10.1175/1520-0469(1997)054<0811:AEORPF>2.0.CO;2; JONES PD, 1986, J CLIM APPL METEOROL, V25, P161, DOI 10.1175/1520-0450(1986)025<0161:NHSATV>2.0.CO;2; Kaplan A, 1998, J GEOPHYS RES-OCEANS, V103, P18567, DOI [10.1029/97JC01736, 10.1029/97JC01734]; KEEMAN R, 1994, TELLUS A, V46, P529, DOI 10.1034/j.1600-0870.1994.00014.x; Knutson TR, 1997, J CLIMATE, V10, P138, DOI 10.1175/1520-0442(1997)010<0138:SEIAGC>2.0.CO;2; Latif M, 1997, J CLIMATE, V10, P2221, DOI 10.1175/1520-0442(1997)010<2221:GWDVOE>2.0.CO;2; LEAN J, 1995, GEOPHYS RES LETT, V22, P3195, DOI 10.1029/95GL03093; Linsley BK, 1999, CORAL REEFS, V18, P13, DOI 10.1007/s003380050148; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; Mann ME, 2000, EL NINO SO OSCILLATI, P357, DOI 10.1017/CBO9780511573125.011; McCulloch M, 1996, EARTH PLANET SC LETT, V138, P169, DOI 10.1016/0012-821X(95)00230-A; McPhaden MJ, 2002, NATURE, V415, P603, DOI 10.1038/415603a; Neelin JD, 1998, J GEOPHYS RES-OCEANS, V103, P14261, DOI 10.1029/97JC03424; Parker DE, 1995, CLIMATIC CHANGE, V31, P559, DOI 10.1007/BF01095162; Rajagopalan B, 1997, J CLIMATE, V10, P2351, DOI 10.1175/1520-0442(1997)010<2351:AEOAAV>2.0.CO;2; Robock A, 2000, REV GEOPHYS, V38, P191, DOI 10.1029/1998RG000054; SCOFFIN TP, 1993, CORAL REEFS, V12, P203, DOI 10.1007/BF00334480; STINE S, 1994, NATURE, V369, P546, DOI 10.1038/369546a0; TETT S, 1995, J CLIMATE, V8, P1473, DOI 10.1175/1520-0442(1995)008<1473:SOENSO>2.0.CO;2; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Timmermann A, 2001, GEOPHYS RES LETT, V28, P2061, DOI 10.1029/2001GL012879; Trenberth KE, 1996, GEOPHYS RES LETT, V23, P57, DOI 10.1029/95GL03602; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; TZIPERMAN E, 1994, SCIENCE, V264, P72, DOI 10.1126/science.264.5155.72; Urban FE, 2000, NATURE, V407, P989, DOI 10.1038/35039597; Verschuren D, 2000, NATURE, V403, P410, DOI 10.1038/35000179; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2; Zhang Y, 1997, J CLIMATE, V10, P1004, DOI 10.1175/1520-0442(1997)010<1004:ELIV>2.0.CO;2	50	648	675	6	231	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2003	424	6946					271	276		10.1038/nature01779	http://dx.doi.org/10.1038/nature01779			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867972				2022-12-01	WOS:000184183900031
J	Jiang, GY; Giannone, G; Critchley, DR; Fukumoto, E; Sheetz, MP				Jiang, GY; Giannone, G; Critchley, DR; Fukumoto, E; Sheetz, MP			Two-piconewton slip bond between fibronectin and the cytoskeleton depends on talin	NATURE			English	Article								Mechanical forces on matrix-integrin-cytoskeleton linkages are crucial for cell viability, morphology and organ function(1). The production of force depends on the molecular connections from extracellular-matrix-integrin complexes to the cytoskeleton(2,3). The minimal matrix complex causing integrin-cytoskeleton connections is a trimer of fibronectin's integrin-binding domain FNIII7-10 (ref. 4). Here we report a specific, molecular slip bond that was broken repeatedly by a force of 2 pN at the cellular loading rate of 60 nm s(-1); this occurred with single trimer beads but not with monomer. Talin1, which binds to both integrins and actin filaments in vitro, is required for the 2-pN slip bond and rapid cytoskeleton binding. Further, inhibition of fibronectin binding to alpha(v)beta(3) and deletion of beta(3) markedly decreases the 2-pN force peak. We suggest that talin1 initially forms a molecular slip bond between closely packed fibronectin-integrin complexes and the actin cytoskeleton, which can apply a low level of force to fibronectin until many bonds form or a signal is received to activate a force response.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; NIH, Natl Inst Dent & Craniofacial Res, Bethesda, MD 20892 USA	Columbia University; University of Leicester; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Sheetz, MP (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.			Giannone, Gregory/0000-0002-0932-1690	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000524] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Coussen F, 2002, J CELL SCI, V115, P2581; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Felsenfeld DP, 1996, NATURE, V383, P438, DOI 10.1038/383438a0; FINER JT, 1995, BIOPHYS J, V68, P291; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; GIANNONE G, UNPUB J CELL BIOL; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; NISHIZAKA T, 1995, NATURE, V377, P251, DOI 10.1038/377251a0; Nishizaka T, 2000, P NATL ACAD SCI USA, V97, P692, DOI 10.1073/pnas.97.2.692; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sheetz MP, 1998, TRENDS CELL BIOL, V8, P51, DOI 10.1016/S0962-8924(98)80005-6; Sonnenberg A, 1993, Curr Top Microbiol Immunol, V184, P7; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Suzuki K, 2001, BIOPHYS J, V81, P2181, DOI 10.1016/S0006-3495(01)75866-3; Thoumine O, 2000, EUR BIOPHYS J BIOPHY, V29, P398, DOI 10.1007/s002490000087; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Watanabe K, 2002, J BIOL CHEM, V277, P11549, DOI 10.1074/jbc.M200356200; Xing BD, 2001, J BIOL CHEM, V276, P44373, DOI 10.1074/jbc.M108587200	30	347	367	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					334	337		10.1038/nature01805	http://dx.doi.org/10.1038/nature01805			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867986				2022-12-01	WOS:000184183900047
J	Slabbekoorn, H; Peet, M				Slabbekoorn, H; Peet, M			Ecology: Birds sing at a higher pitch in urban noise - Great tits hit the high notes to ensure that their mating calls are heard above the city's din.	NATURE			English	Editorial Material							PARUS-MAJOR; SONG; HYPOTHESIS; SELECTION; ROADS		Leiden Univ, Inst Biol Leiden, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Slabbekoorn, H (corresponding author), Leiden Univ, Inst Biol Leiden, NL-2300 RA Leiden, Netherlands.							Catterall CP, 1998, BIOL CONSERV, V84, P65, DOI 10.1016/S0006-3207(97)00076-1; Clergeau P, 1998, CONDOR, V100, P413, DOI 10.2307/1369707; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; HANSEN P, 1979, ANIM BEHAV, V27, P1270, DOI 10.1016/0003-3472(79)90073-3; HUNTER ML, 1979, J ANIM ECOL, V48, P759, DOI 10.2307/4194; Junker-Bornholdt R, 1998, J ORNITHOL, V139, P131, DOI 10.1007/BF01651222; Klump Georg M., 1996, P321; MCGREGOR PK, 1989, BEHAVIOUR, V108, P139, DOI 10.1163/156853989X00105; Rabin LA, 2002, J COMP PSYCHOL, V116, P137, DOI 10.1037//0735-7036.116.2.137; REIJNEN R, 1995, J APPL ECOL, V32, P187, DOI 10.2307/2404428; Skiba R, 2000, J ORNITHOL, V141, P160, DOI 10.1007/BF01651907; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Slabbekoorn H, 2002, EVOLUTION, V56, P1849	13	672	709	5	454	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					267	267		10.1038/424267a	http://dx.doi.org/10.1038/424267a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867967				2022-12-01	WOS:000184183900026
J	Hudson, MM; Mertens, AC; Yasui, Y; Hobbie, W; Chen, HG; Gurney, JG; Yeazel, M; Recklitis, CJ; Marina, N; Robison, LR; Oeffinger, KC				Hudson, MM; Mertens, AC; Yasui, Y; Hobbie, W; Chen, HG; Gurney, JG; Yeazel, M; Recklitis, CJ; Marina, N; Robison, LR; Oeffinger, KC		Childhood Canc Survivor Study Inve	Health status of adult long-term survivors of childhood cancer - A report from the childhood cancer survivor study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SIBLING ADAPTATION; ADOLESCENT CANCER; HODGKINS-DISEASE; LATE MORTALITY; LATE DEATHS; DIAGNOSIS; LEUKEMIA; SYSTEM; CURE	Context Adult survivors of childhood cancer are at risk for medical and psychosocial sequelae that may adversely affect their health status. Objectives To compare the health status of adult survivors of childhood cancer and siblings and to identify factors associated with adverse outcomes. Design, Setting, and Participants Health status was assessed in 9535 adult participants of the Childhood Cancer Survivor Study, a cohort of long-term survivors of childhood cancer who were diagnosed between 1970 and 1986. A randomly selected cohort of the survivors' siblings (n=2916) served as a comparison group. Main Outcome Measures Six health status domains were assessed: general health, mental health, functional status, activity limitations, cancer-related pain, and cancer-related anxiety/fears. The first 4 domains were assessed in the control group. Results Survivors were significantly more likely to report adverse general health (odds ratio [OR], 2.5; 95% confidence interval [Cl], 2.1-3.0; P<.001), mental health (OR, 1.8; 95% Cl, 1.6-2.1; P<.001), activity limitations (OR, 2.7; 95% Cl, 2.3-3.3; P<.001), and functional impairment(OR, 5.2; 95% Cl, 4.1-6.6; P<.001), compared with siblings. Forty-four percent of survivors reported at least 1 adversely affected health status domain. Sociodemographic factors associated with reporting at least 1 adverse health status domain included being female (OR, 1.4; 95% Cl, 1.3-1.6; P<.001), lower level of educational attainment (OR, 2.0; 95% Cl, 1.8-2.2; P<.001), and annual income less than $20000 (OR, 1.8; 95% Cl, 1.6-2.1; P<.001). Relative to those survivors with childhood leukemia, an increased risk was observed for at least 1 adverse health status domain among those with bone tumors (OR, 2.1; 95% CI, 1.8-2.5; P<.001), central nervous system tumors (OR, 1.7; 95% Cl, 1.5-2.0; P<.001), and sarcomas (OR, 1.2; 95% Cl, 1.1-1.5; P=.01). Conclusion Clinicians caring for adult survivors of childhood cancer should be aware of the substantial risk for adverse health status, especially among females, those with low educational attainment, and those with low household incomes.	St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; Univ Tennessee, Coll Med, Memphis, TN 38163 USA; Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Family Practice, Minneapolis, MN USA; Univ Minnesota, Dept Biostat, Minneapolis, MN USA; Fred Hutchinson Canc Res Ctr, Canc Prevent Res Program, Seattle, WA 98104 USA; Childrens Hosp Philadelphia, Dept Oncol, Philadelphia, PA 19104 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Stanford Univ, Med Ctr, Dept Pediat, Stanford, CA 94305 USA; Univ Texas, SW Med Ctr, Dept Family Practice & Community Med, Dallas, TX USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Fred Hutchinson Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Dana-Farber Cancer Institute; Stanford University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Hudson, MM (corresponding author), St Jude Childrens Res Hosp, Dept Hematol Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	melissa.hudson@stjude.org	Robison, Leslie/N-8122-2018; Hudson, Melissa M/N-4441-2018; Yasui, Yutaka/E-2564-2015; Marina, Neyssa/B-7449-2009	Hudson, Melissa M/0000-0001-6984-2407; Yasui, Yutaka/0000-0002-7717-8638; Marina, Neyssa/0000-0002-7195-8887; Recklitis, Christopher/0000-0003-1336-8261	NCI NIH HHS [5U24-CA-55727, CA 21765, U24 CA055727] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765, U24CA055727] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson DM, 2001, CANCER-AM CANCER SOC, V92, P2709, DOI 10.1002/1097-0142(20011115)92:10<2709::AID-CNCR1625>3.0.CO;2-D; Barbarin OA, 1995, J PSYCHOSOC ONCOL, V13, P1, DOI 10.1300/J077V13N03_01; *CDCP, 1993, BEH RISK FACT SURV S; Centers for Disease Control and Prevention (CDC), 1993, NAT HLTH INT SURV; Chen E, 1998, J Health Psychol, V3, P23, DOI 10.1177/135910539800300102; Crom DB, 1999, INT J CANCER, P25; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT; Diggle P. J., 2002, J R STAT SOC, V2nd, DOI DOI 10.2307/2983303; Dolgin MJ, 1997, J PSYCHOSOC ONCOL, V15, P1, DOI 10.1300/J077v15n01_01; DREYER ZE, 2002, PRINCIPLES PRACTICE, P1431; Elkin TD, 1997, MED PEDIATR ONCOL, V29, P582, DOI 10.1002/(SICI)1096-911X(199712)29:6<582::AID-MPO13>3.0.CO;2-8; Ettner SL, 1996, J HEALTH ECON, V15, P67, DOI 10.1016/0167-6296(95)00032-1; FEENY D, 1992, J CLIN ONCOL, V10, P923, DOI 10.1200/JCO.1992.10.6.923; GARRE ML, 1994, AM J PEDIAT HEMATOL, V16, P143; GREEN DM, 1994, MED PEDIATR ONCOL, V22, P91, DOI 10.1002/mpo.2950220206; Green DM, 1999, J CLIN ONCOL, V17, P3207, DOI 10.1200/JCO.1999.17.10.3207; Gurney JG, 2003, CANCER-AM CANCER SOC, V97, P663, DOI 10.1002/cncr.11095; Hankin BL, 1999, ANN MED, V31, P372, DOI 10.3109/07853899908998794; HAVERMANS T, 1994, CHILD CARE HLTH DEV, V20, P309, DOI 10.1111/j.1365-2214.1994.tb00393.x; HAWKINS MM, 1990, ARCH DIS CHILD, V65, P1356, DOI 10.1136/adc.65.12.1356; Hobbie WL, 2000, J CLIN ONCOL, V18, P4060, DOI 10.1200/JCO.2000.18.24.4060; HORWITZ WA, 1990, J CLIN CHILD PSYCHOL, V4, P462; Hudson MM, 1998, J CLIN ONCOL, V16, P3592, DOI 10.1200/JCO.1998.16.11.3592; Hudson MM, 1997, J CLIN ONCOL, V15, P2205, DOI 10.1200/JCO.1997.15.6.2205; Kadan-Lottick NS, 2002, JAMA-J AM MED ASSOC, V287, P1832, DOI 10.1001/jama.287.14.1832; Marina N, 1997, PEDIATR CLIN N AM, V44, P1021, DOI 10.1016/S0031-3955(05)70543-5; Mertens AC, 2001, J CLIN ONCOL, V19, P3163, DOI 10.1200/JCO.2001.19.13.3163; NICHOLSON HS, 1994, CANCER, V73, P3094; ROBERTSON CM, 1994, BRIT MED J, V309, P162, DOI 10.1136/bmj.309.6948.162; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; ROURKE M, 2002, 7 INT C LONG TERM CO; Rourke M T, 1999, J Pediatr Oncol Nurs, V16, P126, DOI 10.1177/104345429901600303; Sahler OJZ, 1997, J DEV BEHAV PEDIATR, V18, P233; SAHLER OJZ, 1994, J DEV BEHAV PEDIATR, V15, P353; Sloper P, 1996, J CHILD PSYCHOL PSYC, V37, P597, DOI 10.1111/j.1469-7610.1996.tb01446.x; Zabora J, 2001, PSYCHOSOMATICS, V42, P241, DOI 10.1176/appi.psy.42.3.241; Zebrack BJ, 2002, PEDIATRICS, V110, P42, DOI 10.1542/peds.110.1.42; Zeltzer LK, 1997, J CLIN ONCOL, V15, P547, DOI 10.1200/JCO.1997.15.2.547	38	588	593	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2003	290	12					1583	1592		10.1001/jama.290.12.1583	http://dx.doi.org/10.1001/jama.290.12.1583			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	723ZK	14506117	Bronze			2022-12-01	WOS:000185461300023
J	Mora, S; Redberg, RF; Cui, YD; Whiteman, MK; Flaws, JA; Sharrett, AR; Blumenthal, RS				Mora, S; Redberg, RF; Cui, YD; Whiteman, MK; Flaws, JA; Sharrett, AR; Blumenthal, RS			Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women - A 20-year follow-up of the lipid research clinics prevalence study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEART-RATE RECOVERY; NORTH-AMERICAN MEN; PHYSICAL-ACTIVITY; CAUSE MORTALITY; CARDIORESPIRATORY FITNESS; PROGNOSTIC VALUE; RISK ASSESSMENT; DISEASE; CARDIOLOGY; STATEMENT	Context The value of exercise testing in women has been questioned. Objective To determine the prognostic value of exercise testing in a population: based cohort of asymptomatic women followed up for 20 years. Design and Setting Near-maximal Bruce-protocol treadmill test data from the Lipid Research Clinics Prevalence Study (1972-1976) with follow-up through 1995. Participants A total of 2994 asymptomatic North American women, aged 30 to 80 years, without known cardiovascular disease. Main Outcome Measures Cardiovascular and all-cause mortality. Results There were 427 (14%) deaths during 20 years of follow-up, of which 147 were due to cardiovascular causes. Low exercise capacity, low heart rate recovery (HRR), and not achieving target heart rate were independently associated with increased all-cause and cardiovascular mortality. There was no increased cardiovascular death risk for exercise-induced ST-segment depression (age-adjusted hazard ratio, 1.02; 95% confidence interval [CI], 0.57-1.80; P=96). The age-adjusted hazard ratio for cardiovascular death for every metabolic equivalent (MET) decrement in exercise capacity was 1.20 (95% Cl, 1.18-1.30; P<.001); for every 10 beats per minute decrement in HRR, the hazard ratio was 1.36 (95% Cl, 1.19-1.55; P<.001). After adjusting for multiple other risk factors, women who were below the median for both exercise capacity and HRR had a 3.5-fold increased risk of cardiovascular death (95% Cl, 1.57-7.86; P=.002) compared with those above the median for both variables. Among women with low risk Framingham scores, those with below median levels of both exercise capacity and HRR had significantly increased risk compared with women who had above median levels of these 2 exercise variables, 44.5 and 3.5 cardiovascular deaths per 10000 person-years, respectively (hazard ratio for cardiovascular death, 12.93; 95% Cl, 5.62-29.73; P<.001). Conclusion The prognostic value of exercise testing in asymptomatic women derives not from electrocardiographic ischemia but from fitness-related variables.	Johns Hopkins Med Inst, Dept Med, Ciccarone Prevent Cardiol Ctr, Baltimore, MD 21205 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA; Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California San Francisco; University System of Maryland; University of Maryland Baltimore	Blumenthal, RS (corresponding author), Johns Hopkins Univ Hosp, Ciccarone Prevent Cardiol Ctr, Div Cardiol, Carnegie 538,600 N Wolfe St, Baltimore, MD 21287 USA.	rblument@jhmi.edu	Blumenthal, Roger S/H-3223-2018	Blumenthal, Roger S/0000-0003-1910-3168; Flaws, Jodi/0000-0001-5579-9268; Mora, Samia/0000-0001-6283-0980	NHLBI NIH HHS [T32-HL07024] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007024] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abramson JL, 2002, ARCH INTERN MED, V162, P1286, DOI 10.1001/archinte.162.11.1286; Albert CM, 2003, CIRCULATION, V107, P2096, DOI 10.1161/01.CIR.0000065223.21530.11; ALLEN WH, 1980, CIRCULATION, V62, P522, DOI 10.1161/01.CIR.62.3.522; *AM HEART ASS, 2002, HEART DIS STROK STAT; BASS KM, 1993, ARCH INTERN MED, V153, P2209, DOI 10.1001/archinte.153.19.2209; BILLMAN GE, 1984, CIRCULATION, V69, P1182, DOI 10.1161/01.CIR.69.6.1182; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Bokhari S, 2002, J AM COLL CARDIOL, V40, P1092, DOI 10.1016/S0735-1097(02)02111-3; BRUCE RA, 1973, AM HEART J, V85, P546, DOI 10.1016/0002-8703(73)90502-4; BRUCE RA, 1983, J AM COLL CARDIOL, V2, P565, DOI 10.1016/S0735-1097(83)80286-1; Carter JB, 2003, SPORTS MED, V33, P33, DOI 10.2165/00007256-200333010-00003; Cheng YLJ, 2003, DIABETES CARE, V26, P2052, DOI 10.2337/diacare.26.7.2052; Cole CR, 2000, ANN INTERN MED, V132, P552, DOI 10.7326/0003-4819-132-7-200004040-00007; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Cui YD, 2001, ARCH INTERN MED, V161, P1413, DOI 10.1001/archinte.161.11.1413; De Leo V, 2000, MATURITAS, V36, P43, DOI 10.1016/S0378-5122(00)00123-7; EKELUND LG, 1988, NEW ENGL J MED, V319, P1379, DOI 10.1056/NEJM198811243192104; Elhendy A, 2002, AM J CARDIOL, V90, P95, DOI 10.1016/S0002-9149(02)02428-1; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; GORDON DJ, 1986, CIRCULATION, V74, P252, DOI 10.1161/01.CIR.74.2.252; Greenland P, 2001, CIRCULATION, V104, P1863, DOI 10.1161/hc4201.097189; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; IMAI K, 1994, J AM COLL CARDIOL, V24, P1529, DOI 10.1016/0735-1097(94)90150-3; Jouven X, 2000, NEW ENGL J MED, V343, P826, DOI 10.1056/NEJM200009213431201; KANNEL WB, 1985, AM HEART J, V109, P876, DOI 10.1016/0002-8703(85)90653-2; Kwok Y, 1999, AM J CARDIOL, V83, P660, DOI 10.1016/S0002-9149(98)00963-1; LAKKA TA, 1994, NEW ENGL J MED, V330, P1549, DOI 10.1056/NEJM199406023302201; Mosca L, 1999, CIRCULATION, V99, P2480, DOI 10.1161/01.CIR.99.18.2480; Mosca L, 1997, CIRCULATION, V96, P2468; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nishime EO, 2000, JAMA-J AM MED ASSOC, V284, P1392, DOI 10.1001/jama.284.11.1392; Palinkas A, 2002, EUR HEART J, V23, P1587, DOI 10.1053/euhj.2002.3170; Partington S, 2003, AM HEART J, V145, P139, DOI 10.1067/mhj.2003.60; Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032; RAUTAHARJU PM, 1986, J AM COLL CARDIOL, V8, P1, DOI 10.1016/S0735-1097(86)80084-5; Rice T, 2002, CIRCULATION, V105, P1904, DOI 10.1161/01.CIR.0000014969.85364.9F; Rosenwinkel Eric T., 2001, Cardiology Clinics, V19, P369, DOI 10.1016/S0733-8651(05)70223-X; Shetler K, 2001, J AM COLL CARDIOL, V38, P1980, DOI 10.1016/S0735-1097(01)01652-7; *STAT CORP, 2001, STATA REF MAN REL 7; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; US Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; 1997, ARCH INTERN MED, V157, P2413	44	374	394	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2003	290	12					1600	1607		10.1001/jama.290.12.1600	http://dx.doi.org/10.1001/jama.290.12.1600			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	723ZK	14506119	Bronze			2022-12-01	WOS:000185461300025
J	Colombani, J; Raisin, S; Pantalacci, S; Radimerski, T; Montagne, J; Leopold, P				Colombani, J; Raisin, S; Pantalacci, S; Radimerski, T; Montagne, J; Leopold, P			A nutrient sensor mechanism controls Drosophila growth	CELL			English	Article							INSULIN-LIKE PEPTIDES; CELL-GROWTH; DIRECT TARGET; S6 KINASE; FAT-BODY; SIZE; RHEB; TOR; PROLIFERATION; TRANSLATION	Organisms modulate their growth according to nutrient availability. Although individual cells in a multicellular animal may respond directly to nutrient levels, growth of the entire organism needs to be coordinated. Here, we provide evidence that in Drosophila, coordination of organismal growl, originates from the fat body, an insect organ that retains endocrine and storage functions of the vertebrate liver. In a genetic screen for growth modifiers, we identified slimfast, a gene that encodes an amino acid transporter. Remarkably, downregulation of slimfast specifically within the fat body causes a global growth defect similar to that seen in Drosophila raised under poor nutritional conditions. This involves TSC/TOR signaling in the fat body, and a remote inhibition of organismal growth via local repression of P13-kinase signaling in peripheral tissues. Our results demonstrate that the fat body functions as a nutrient sensor that restricts global growth through a humoral mechanism.	Inst Signaling Dev Biol & Canc Res, UMR 6543, CNRS, F-06108 Nice 2, France; Friedrich Miescher Inst, CH-4058 Basel, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Friedrich Miescher Institute for Biomedical Research	Leopold, P (corresponding author), Inst Signaling Dev Biol & Canc Res, UMR 6543, CNRS, F-06108 Nice 2, France.	leopold@unice.fr		Colombani, Julien/0000-0002-8250-4899				ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Boisclair YR, 2001, J ENDOCRINOL, V170, P63, DOI 10.1677/joe.0.1700063; Britton JS, 1998, DEVELOPMENT, V125, P2149; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Butler AA, 2001, ANNU REV PHYSIOL, V63, P141, DOI 10.1146/annurev.physiol.63.1.141; Campbell LE, 1999, BIOCHEM J, V344, P433, DOI 10.1042/0264-6021:3440433; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; CRACE CJ, 1991, UPSALA J MED SCI, V96, P17, DOI 10.3109/03009739109179255; DAVIS KT, 1977, SCIENCE, V196, P438, DOI 10.1126/science.403606; Dean R.L., 1985, P155; Duan C, 2002, J ENDOCRINOL, V175, P41, DOI 10.1677/joe.0.1750041; Efstratiadis A, 1998, INT J DEV BIOL, V42, P955; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hennig KM, 2002, GENESIS, V34, P107, DOI 10.1002/gene.10139; Huang H, 1999, DEVELOPMENT, V126, P5365; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Kawamura K, 1999, DEVELOPMENT, V126, P211; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kimball Sr, 2000, COLD SPRING HARBOR M, V39, P561; Kimball SR, 1999, J BIOL CHEM, V274, P11647, DOI 10.1074/jbc.274.17.11647; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Martin JF, 2000, MECH DEVELOP, V92, P155, DOI 10.1016/S0925-4773(99)00338-X; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Radimerski T, 2002, NAT CELL BIOL, V4, P251, DOI 10.1038/ncb763; Raisin S, 2003, GENETICS, V164, P1015; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Stern D, 2001, CURR BIOL, V11, pR917, DOI 10.1016/S0960-9822(01)00554-1; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600; Zinke I, 1999, DEVELOPMENT, V126, P5275	51	570	583	4	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2003	114	6					739	749		10.1016/S0092-8674(03)00713-X	http://dx.doi.org/10.1016/S0092-8674(03)00713-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	724AL	14505573	Bronze			2022-12-01	WOS:000185464000011
J	Harrison, T; Samuel, BU; Akompong, T; Hamm, H; Mohandas, N; Lomasney, JW; Haldar, K				Harrison, T; Samuel, BU; Akompong, T; Hamm, H; Mohandas, N; Lomasney, JW; Haldar, K			Erythrocyte G protein-coupled receptor signaling in malarial infection	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; CHOLESTEROL; TRANSDUCTION; RAFTS	Erythrocytic mechanisms involved in malarial infection are poorly understood. We have found that signaling via the erythrocyte beta2-adrenergic receptor and heterotrimeric guanine nucleotide - binding protein (Galphas) regulated the entry of the human malaria parasite Plasmodium falciparum. Agonists that stimulate cyclic adenosine 3', 5'-monophosphate production led to an increase in malarial infection that could be blocked by specific receptor antagonists. Moreover, peptides designed to inhibit Galphas protein function reduced parasitemia in P. falciparum cultures in vitro, and beta-antagonists reduced parasitemia of P. berghei infections in an in vivo mouse model. Thus, signaling via the erythrocyte beta2-adrenergic receptor and Galphas may regulate malarial infection across parasite species.	Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Immunol Microbiol, Chicago, IL 60611 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37240 USA; New York Blood Ctr, New York, NY 10021 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Vanderbilt University; New York Blood Center	Lomasney, JW (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, 303 Chicago Ave, Chicago, IL 60611 USA.	j-lomasney@northwestern.edu; k-haldar@northwestern.edu	Hamm, Heidi E/G-2374-2014; Haldar, Kasturi/C-6685-2014		NATIONAL EYE INSTITUTE [R01EY006062, R01EY010291] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069630, R01HL055591, R29HL055591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK032094] Funding Source: NIH RePORTER; NEI NIH HHS [EY06062, EY10291] Funding Source: Medline; NHLBI NIH HHS [HL03961, HL69630, HL55591] Funding Source: Medline; NIAID NIH HHS [AI39071] Funding Source: Medline; NIDDK NIH HHS [DK32094] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOND RA, 1995, NATURE, V374, P272, DOI 10.1038/374272a0; Brittain JE, 2001, J CLIN INVEST, V107, P1555, DOI 10.1172/JCI10817; CHASIS JA, 1989, BLOOD, V74, P1112, DOI 10.1182/blood.V74.3.1112.1112; Desai SA, 1997, P NATL ACAD SCI USA, V94, P2045, DOI 10.1073/pnas.94.5.2045; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; Dyer M, 2000, MOL BIOCHEM PARASIT, V110, P435, DOI 10.1016/S0166-6851(00)00312-1; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gilchrist A, 1999, J BIOL CHEM, V274, P6610, DOI 10.1074/jbc.274.10.6610; Gilchrist A, 1998, J BIOL CHEM, V273, P14912, DOI 10.1074/jbc.273.24.14912; Green JM, 1999, J CELL BIOL, V146, P673, DOI 10.1083/jcb.146.3.673; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Kenakin T, 2002, ANNU REV PHARMACOL, V42, P349, DOI 10.1146/annurev.pharmtox.42.091401.113012; Lauer S, 2000, EMBO J, V19, P3556, DOI 10.1093/emboj/19.14.3556; Maack K, 2001, BRIT J PHARMACOL, V132, P1817, DOI 10.1038/sj.bjp.0703992; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Nagao E, 2002, EXP PARASITOL, V102, P57, DOI 10.1016/S0014-4894(02)00143-1; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; PETERS W, 1984, ANN TROP MED PARASIT, V78, P561, DOI 10.1080/00034983.1984.11811866; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Samuel BU, 2001, J BIOL CHEM, V276, P29319, DOI 10.1074/jbc.M101268200; SCHRIER SL, 1985, CLIN HAEMATOL, V14, P1; Vanhauwe JF, 2002, J BIOL CHEM, V277, P34143, DOI 10.1074/jbc.M204477200	23	120	123	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2003	301	5640					1734	1736		10.1126/science.1089324	http://dx.doi.org/10.1126/science.1089324			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722QN	14500986				2022-12-01	WOS:000185387700048
J	Stelter, P; Ulrich, HD				Stelter, P; Ulrich, HD			Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-REPAIR; SPONTANEOUS MUTATION; YEAST; GENE; RAD6; POLYMERASE; EUKARYOTES; PROTEIN; ENCODES	Protein modification by ubiquitin is emerging as a signal for various biological processes in eukaryotes, including regulated proteolysis, but also for non-degradative functions such as protein localization, DNA repair and regulation of chromatin structure(1-4). A small ubiquitin-related modifier (SUMO) uses a similar conjugation system that sometimes counteracts the effects of ubiquitination(5). Ubiquitin and SUMO compete for modification of proliferating cell nuclear antigen (PCNA), an essential processivity factor for DNA replication and repair(6). Whereas multi-ubiquitination is mediated by components of the RAD6 pathway and promotes error-free repair, SUMO modification is associated with replication(6-9). Here we show that RAD6-mediated mono-ubiquitination of PCNA activates translesion DNA synthesis by the damage-tolerant polymerases eta and zeta in yeast. Moreover, polymerase zeta is differentially affected by mono-ubiquitin and SUMO modification of PCNA. Whereas ubiquitination is required for damage-induced mutagenesis, both SUMO and mono-ubiquitin contribute to spontaneous mutagenesis in the absence of DNA damage. Our findings assign a function to SUMO during S phase and demonstrate how ubiquitin and SUMO, by regulating the accuracy of replication and repair, contribute to overall genomic stability.	Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany	Max Planck Society	Ulrich, HD (corresponding author), Max Planck Inst Terr Microbiol, Karl von Frisch Str, D-35043 Marburg, Germany.			Ulrich, Helle D./0000-0003-0431-2223				Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; BROODBAKKER JTW, 1983, OPHTHALMIC PAED GEN, V2, P95, DOI 10.3109/13816818309007797; Brusky J, 2000, CURR GENET, V37, P168, DOI 10.1007/s002940050515; CASSIERCHAUVAT C, 1991, MUTAT RES, V254, P247, DOI 10.1016/0921-8777(91)90063-U; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Haracska L, 2001, MOL CELL, V8, P407, DOI 10.1016/S1097-2765(01)00319-7; HASTINGS PJ, 1976, NATURE, V264, P719, DOI 10.1038/264719a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; LAWRENCE C, 1994, BIOESSAYS, V16, P253, DOI 10.1002/bies.950160408; Lawrence CW, 2001, PHILOS T R SOC B, V356, P41, DOI 10.1098/rstb.2000.0001; LAWRENCE CW, 1976, GENETICS, V82, P207; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; McDonald JP, 1997, GENETICS, V147, P1557; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; MORRISON A, 1989, J BACTERIOL, V171, P5659, DOI 10.1128/jb.171.10.5659-5667.1989; Prakash S, 2002, GENE DEV, V16, P1872, DOI 10.1101/gad.1009802; QUAH SK, 1980, GENETICS, V96, P819; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; SUNG P, 1990, P NATL ACAD SCI USA, V87, P2695, DOI 10.1073/pnas.87.7.2695; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Ulrich HD, 2002, EUKARYOT CELL, V1, P1, DOI 10.1128/EC.1.1.1-10.2002; von Borstel RC, 1998, GENETICS, V148, P1647; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.0.CO;2-#	30	658	682	7	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 11	2003	425	6954					188	191		10.1038/nature01965	http://dx.doi.org/10.1038/nature01965			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719ZT	12968183				2022-12-01	WOS:000185236000045
J	Schwab, SR; Li, KC; Kang, C; Shastri, N				Schwab, SR; Li, KC; Kang, C; Shastri, N			Constitutive display of cryptic translation products by MHC class I molecules	SCIENCE			English	Article							NEWLY SYNTHESIZED PROTEINS; DENDRITIC CELLS; DEGRADATION; INITIATION; ANTIGENS; PEPTIDES; GENERATION; GENE; H60	Major histocompatibility complex (MHC) class I molecules display tens of thousands of peptides on the cell surface, derived from virtually all endogenous proteins, for inspection by cytotoxic T cells (CTLs). We show that, in normal mouse cells, MHC I molecules present a peptide encoded in the 3' "untranslated" region. Despite its rarity, the peptide elicits CTL responses and induces self-tolerance, establishing that immune surveillance extends well beyond conventional polypeptides. Furthermore, translation of this cryptic peptide occurs by a previously unknown mechanism that decodes the CUG initiation codon as leucine rather than the canonical methionine.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Shastri, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA.			Schwab, Susan/0000-0002-0834-0822				Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BOON T, 1989, IMMUNOGENETICS, V29, P75, DOI 10.1007/BF00395854; Choi EY, 2002, IMMUNITY, V17, P593, DOI 10.1016/S1074-7613(02)00428-4; Greenfield A, 1996, NAT GENET, V14, P474, DOI 10.1038/ng1296-474; KOZAK M, 1992, CRIT REV BIOCHEM MOL, V27, P385, DOI 10.3109/10409239209082567; Malarkannan S, 2000, IMMUNITY, V13, P333, DOI 10.1016/S1074-7613(00)00033-9; Malarkannan S, 1998, J IMMUNOL, V161, P3501; Malarkannan S, 1999, IMMUNITY, V10, P681, DOI 10.1016/S1074-7613(00)80067-9; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; PIRCHER H, 1989, EMBO J, V8, P719, DOI 10.1002/j.1460-2075.1989.tb03431.x; Rajbhandary Uttam L., 1995, P511; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Scott D, 2000, IMMUNITY, V12, P711, DOI 10.1016/S1074-7613(00)80221-6; Shastri N, 2002, ANNU REV IMMUNOL, V20, P463, DOI 10.1146/annurev.immunol.20.100301.064819; STJACQUES S, 1994, ENDOCRINOLOGY, V134, P2645, DOI 10.1210/en.134.6.2645; Yewdell J, 2002, MOL IMMUNOL, V39, P139, DOI 10.1016/S0161-5890(02)00097-4	19	92	94	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 5	2003	301	5638					1367	1371		10.1126/science.1085650	http://dx.doi.org/10.1126/science.1085650			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717XQ	12958358				2022-12-01	WOS:000185116400038
J	Danial, NN; Gramm, CF; Scorrano, L; Zhang, CY; Krauss, S; Ranger, AM; Datta, SR; Greenberg, ME; Licklider, LJ; Lowell, BB; Gygi, SP; Korsmeyer, SJ				Danial, NN; Gramm, CF; Scorrano, L; Zhang, CY; Krauss, S; Ranger, AM; Datta, SR; Greenberg, ME; Licklider, LJ; Lowell, BB; Gygi, SP; Korsmeyer, SJ			BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis	NATURE			English	Article							ALDRICH-SYNDROME PROTEIN; GLUCOSE-HOMEOSTASIS; CELL-SURVIVAL; TOM COMPLEX; PHOSPHORYLATION; GROWTH; DEATH; GENE; BETA; CHROMATOGRAPHY	Glycolysis and apoptosis are considered major but independent pathways that are critical for cell survival(1-4). The activity of BAD, a pro-apoptotic BCL-2 family member, is regulated by phosphorylation in response to growth/survival factors(5-8). Here we undertook a proteomic analysis to assess whether BAD might also participate in mitochondrial physiology. In liver mitochondria, BAD resides in a functional holoenzyme complex together with protein kinase A(7) and protein phosphatase 1 (PP1) catalytic units(9), Wiskott-Aldrich family member WAVE-1 as an A kinase anchoring protein(10), and glucokinase (hexokinase IV)(11). BAD is required to assemble the complex in that Bad-deficient hepatocytes lack this complex, resulting in diminished mitochondria-based glucokinase activity and blunted mitochondrial respiration in response to glucose. Glucose deprivation results in dephosphorylation of BAD, and BAD-dependent cell death. Moreover, the phosphorylation status of BAD helps regulate glucokinase activity. Mice deficient for BAD or bearing a non-phosphorylatable BAD(3SA) mutant(12) display abnormal glucose homeostasis including profound defects in glucose tolerance. This combination of proteomics, genetics and physiology indicates an unanticipated role for BAD in integrating pathways of glucose metabolism and apoptosis.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Childrens Hosp, Dept Neurobiol,Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Taplin Biol Mass Spectrometry Facil, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Korsmeyer, SJ (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst, 44 Binney St, Boston, MA 02115 USA.		Scorrano, Luca/K-3967-2019; Scorrano, Luca/A-6652-2008	Scorrano, Luca/0000-0002-8515-8928; Scorrano, Luca/0000-0002-8515-8928; Datta, Sandeep/0000-0002-8068-3862				Abdul KM, 2000, BIOCHEM BIOPH RES CO, V276, P1028, DOI 10.1006/bbrc.2000.3589; Ayllon V, 2000, EMBO J, V19, P2237, DOI 10.1093/emboj/19.10.2237; BALI D, 1995, J BIOL CHEM, V270, P21464, DOI 10.1074/jbc.270.37.21464; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; Garland JM, 1997, J BIOL CHEM, V272, P4680, DOI 10.1074/jbc.272.8.4680; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Krimmer T, 2001, J CELL BIOL, V152, P289, DOI 10.1083/jcb.152.2.289; Licklider LJ, 2002, ANAL CHEM, V74, P3076, DOI 10.1021/ac025529o; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; MOORHEAD G, 1995, FEBS LETT, V362, P101, DOI 10.1016/0014-5793(95)00197-H; Murata T, 1997, FEBS LETT, V406, P109, DOI 10.1016/S0014-5793(97)00253-6; Niswender KD, 1997, J BIOL CHEM, V272, P22564, DOI 10.1074/jbc.272.36.22564; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Postic C, 2001, RECENT PROG HORM RES, V56, P195, DOI 10.1210/rp.56.1.195; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	30	550	572	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 21	2003	424	6951					952	956		10.1038/nature01825	http://dx.doi.org/10.1038/nature01825			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713EH	12931191				2022-12-01	WOS:000184843600044
J	Li, DK; Liu, LY; Douh, R				Li, DK; Liu, LY; Douh, R			Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							ASPIRIN	Objective To evaluate whether prenatal use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with increased risk of miscarriage. Design Population based cohort study. Prenatal use of NSAIDs, aspirin, and paracetamol (acetaminophen) ascertained by in-person interview. Setting Kaiser Permanente Medical Care Program, a healthcare delivery system, in the San Francisco area of the United States. Participants 1055 pregnant women recruited and interviewed immediately after their positive pregnancy test. Median gestational age at entry to the study was 40 days. Main outcome measures Pregnancy outcomes up to 20 weeks of gestation. Results 53 women (5%) reported prenatal NSAID use around conception or during pregnancy. After adjustment for potential confounders, prenatal NSAID use was associated with an 80% increased risk of miscarriage (adjusted hazard ratio 1.8 (95% confidence interval 1.0 to 3.2)). The association was stronger if the initial NSAID use was around the time of conception or if NSAID use lasted more than a week. Prenatal aspirin use was similarly associated with an increased risk of miscarriage. However, prenatal use of paracetamol, pharmacologically different from NSAIDs and aspirin, was not associated with increased risk of miscarriage regardless of timing and duration of use. Conclusion Prenatal use of NSAIDs and aspirin increased the risk of miscarriage. These findings need confirmation in studies designed specifically to examine the apparent association.	Kaiser Permanente, Kaiser Fdn Res Inst, Div Res, Oakland, CA 94612 USA	Kaiser Permanente	Li, DK (corresponding author), Kaiser Permanente, Kaiser Fdn Res Inst, Div Res, 2000 Broadway, Oakland, CA 94612 USA.							ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Brooks P., 1998, AM J MED, V104, p9S, DOI DOI 10.1016/S0002-9343(97)00204-0; DAWOOD MY, 1993, AM J OBSTET GYNECOL, V169, P1255; Hernandez-Diaz Sonia, 2001, American Journal of Medicine, V110, p20S; HERTZPICCIOTTO I, 1990, EPIDEMIOL REV, V12, P108, DOI 10.1093/oxfordjournals.epirev.a036049; Howards PP, 2002, AM J EPIDEMIOL, V155, ps35; Janssen NM, 2000, ARCH INTERN MED, V160, P610, DOI 10.1001/archinte.160.5.610; Li DK, 2002, EPIDEMIOLOGY, V13, P9, DOI 10.1097/00001648-200201000-00004; Nielsen GL, 2001, BRIT MED J, V322, P266, DOI 10.1136/bmj.322.7281.266; Setter S M, 2001, Home Care Provid, V6, P100, DOI 10.1067/mhc.2001.116262; STREISSGUTH AP, 1987, TERATOLOGY, V35, P211, DOI 10.1002/tera.1420350207; TM Therneau., 2000, MODELING SURVIVAL DA, DOI DOI 10.1007/978; vanderWeiden RMF, 1996, AM J OBSTET GYNECOL, V174, P1614, DOI 10.1016/S0002-9378(96)70616-6; vanderWeiden RMF, 1997, BRIT J RHEUMATOL, V36, P605; VANDERWEIDEN RMF, 1991, HUM REPROD, V6, P436, DOI 10.1093/oxfordjournals.humrep.a137354; WERLER MM, 1989, NEW ENGL J MED, V321, P1639, DOI 10.1056/NEJM198912143212404; [No title captured]	17	208	221	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 16	2003	327	7411					368	371		10.1136/bmj.327.7411.368	http://dx.doi.org/10.1136/bmj.327.7411.368			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	713NJ	12919986	Bronze, Green Published			2022-12-01	WOS:000184864200016
J	Whitaker, RJ; Grogan, DW; Taylor, JW				Whitaker, RJ; Grogan, DW; Taylor, JW			Geographic barriers isolate endemic populations of hyperthermophilic archaea	SCIENCE			English	Article							DIFFERENT OCEANIC PROVINCES; BACTERIA; SULFOLOBUS; DIVERSITY; BIOGEOGRAPHY; TEMPERATURE; VIRUSES; SOIL; SEA	Barriers to dispersal between populations allow them to diverge through local adaptation or random genetic drift. High-resolution multilocus sequence analysis revealed that, on a global scale, populations of hyperthermophilic microorganisms are isolated from one another by geographic barriers and have diverged over the course of their recent evolutionary history. The identification of a biogeographic pattern in the archaeon Sulfolobus challenges the current model of microbial biodiversity in which unrestricted dispersal constrains the development of global species richness.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA	University of California System; University of California Berkeley; University System of Ohio; University of Cincinnati	Whitaker, RJ (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, 111 Koshland Hall, Berkeley, CA 94720 USA.							Beja O, 2002, APPL ENVIRON MICROB, V68, P335, DOI 10.1128/AEM.68.1.335-345.2002; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Casamayor EO, 2002, APPL ENVIRON MICROB, V68, P1706, DOI 10.1128/AEM.68.4.1706-1714.2002; Castenholz R. W., 1996, NOVA HEDWIGIA, V112, P33; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Fulthorpe RR, 1998, APPL ENVIRON MICROB, V64, P1620; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Hjort K, 1999, J BACTERIOL, V181, P5669, DOI 10.1128/JB.181.18.5669-5675.1999; Massana R, 2000, APPL ENVIRON MICROB, V66, P1777, DOI 10.1128/AEM.66.5.1777-1787.2000; MUSSER JM, 1990, REV INFECT DIS, V12, P75; Oda Y, 2002, APPL ENVIRON MICROB, V68, P3467, DOI 10.1128/AEM.68.7.3467-3477.2002; Palys T, 1997, INT J SYST BACTERIOL, V47, P1145, DOI 10.1099/00207713-47-4-1145; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Petursdottir SK, 2000, EXTREMOPHILES, V4, P267, DOI 10.1007/s007920070012; Rice G, 2001, P NATL ACAD SCI USA, V98, P13341, DOI 10.1073/pnas.231170198; Roberts MS, 1995, EVOLUTION, V49, P1081, DOI 10.1111/j.1558-5646.1995.tb04435.x; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; SMITH JM, 1991, NATURE, V349, P29, DOI 10.1038/349029a0; Staley JT, 1999, ANNU REV MICROBIOL, V53, P189, DOI 10.1146/annurev.micro.53.1.189; STETTER KO, 1993, NATURE, V365, P743, DOI 10.1038/365743a0; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; ZILLIG W, 1994, SYST APPL MICROBIOL, V16, P609	25	605	637	4	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2003	301	5635					976	978		10.1126/science.1086909	http://dx.doi.org/10.1126/science.1086909			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711RY	12881573				2022-12-01	WOS:000184755900043
J	Smith, GCS; Pell, JP; Dobbie, R				Smith, GCS; Pell, JP; Dobbie, R			Interpregnancy interval and risk of preterm birth and neonatal death: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							PERINATAL OUTCOMES; PREGNANCY INTERVAL; GESTATIONAL-AGE; BLACK-WOMEN; WEIGHT; ASSOCIATION; DELIVERY; LABOR; WHITE	Objective To determine whether a short interval between pregnancies is an independent risk factor for adverse obstetric outcome. Design Retrospective cohort study. Setting Scotland. Subjects 89 143 women having second births in 1992-8 who conceived within five years of their first birth. Main outcome measures Intrauterine growth restriction (birth weight less than the 5th centile for gestational acre), extremely preterm birth (24-32 weeks), moderately preterm birth (33-36 weeks), and perinatal death. Results Women whose subsequent interpregnancy interval was less than six months were more likely than other women to have had a first birth complicated by 4-itrauterine growth restriction (odds ratio 1.3, 95% confidence interval 1.1 to 1.5), extremely preterm birth (4.1, 3.2 to 5.3), moderately preterm birth (1.5, 1.3 to 1.7), or perinatal death (24.4, 18.9 to 31.5). They were also shorter, less likely to be married, mid more likely to be aged less than 20 years at the time of the second birth, to smoke, and to live in an area of high socioeconomic deprivation. When the outcome of die second birth was analysed in relation to the preceding interpregnancy interval and the analysis confined to women whose first birth was a term live birth (n = 69 055), no significant association occurred (adjusted for age, marital status, height, socioeconomic deprivation, smoking, previous birth weight vigesimal, and previous caesarean delivery) between interpregnancy interval and intrauterine growth restriction or stillbirth. However, a short interpregnancy interval (< 6 months) was an independent risk factor for extremely preterm birth (adjusted odds ratio 2.2, 1.3 to 3.6), moderately preterm birth (1.6,1.3 to 2.0), and neonatal death unrelated to congenital abnormality (3.6, 1.2 to 10.7). The adjusted attributable fractions for these associations were 6.1%,3.9%, and 13.8%. The associations were very similar when the analysis was confined to married non-smokers aged 25 and above. Conclusions A short interpregnancy interval is an independent risk factor for preterm delivery and neonatal death in the second birth.	Univ Cambridge, Rosie Hosp, Dept Obstet & Gynaecol, Cambridge CB2 2QQ, England; Greater Glasgow NHS Board, Dept Publ Hlth, Glasgow, Lanark, Scotland; Common Serv Agcy, Informat & Stat Div, Edinburgh, Midlothian, Scotland	University of Cambridge	Smith, GCS (corresponding author), Univ Cambridge, Rosie Hosp, Dept Obstet & Gynaecol, Box 223, Cambridge CB2 2QQ, England.		Smith, Gordon/A-8070-2008	Smith, Gordon/0000-0003-2124-0997; Pell, Jill/0000-0002-8898-7035				Adams MM, 1997, PAEDIATR PERINAT EP, V11, P48, DOI 10.1046/j.1365-3016.11.s1.8.x; Adams MM, 1997, PAEDIATR PERINAT EP, V11, P1; Basso O, 1998, AM J OBSTET GYNECOL, V178, P259, DOI 10.1016/S0002-9378(98)80010-0; BRODY DJ, 1987, AM J PERINAT, V4, P50, DOI 10.1055/s-2007-999736; Campbell S., 1993, ULTRASOUND OBSTET GY, P1432; COLE SK, 1986, BRIT J OBSTET GYNAEC, V93, P1204, DOI 10.1111/j.1471-0528.1986.tb07853.x; COLE SK, 1980, PERINATAL AUDIT SURV, P39; ERICKSON JD, 1978, J EPIDEMIOL COMMUN H, V32, P124, DOI 10.1136/jech.32.2.124; Fuentes-Afflick E, 2000, OBSTET GYNECOL, V95, P383, DOI 10.1016/S0029-7844(99)00583-9; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; *INF STAT DIV NHS, 2002, SCOTT PER INF MORT M; Kaharuza FM, 2001, ACTA OBSTET GYN SCAN, V80, P532, DOI 10.1034/j.1600-0412.2001.080006532.x; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; Khoshnood B, 1998, AM J EPIDEMIOL, V148, P798; KLEBANOFF MA, 1988, AM J PUBLIC HEALTH, V78, P667, DOI 10.2105/AJPH.78.6.667; LIEBERMAN E, 1989, OBSTET GYNECOL, V74, P1; MCILWAINE GM, 1985, BRIT J OBSTET GYNAEC, V92, P9, DOI 10.1111/j.1471-0528.1985.tb01041.x; Norwitz ER, 1999, NEW ENGL J MED, V341, P660, DOI 10.1056/NEJM199908263410906; RAWLINGS JS, 1995, NEW ENGL J MED, V332, P69, DOI 10.1056/NEJM199501123320201; Shults RA, 1999, EPIDEMIOLOGY, V10, P250, DOI 10.1097/00001648-199905000-00010; Smith GCS, 2002, JAMA-J AM MED ASSOC, V287, P2684, DOI 10.1001/jama.287.20.2684; Smith GCS, 2001, BRIT MED J, V323, P476, DOI 10.1136/bmj.323.7311.476; Zhu BP, 2001, AM J OBSTET GYNECOL, V185, P1403, DOI 10.1067/mob.2001.118307; Zhu BP, 1999, NEW ENGL J MED, V340, P589, DOI 10.1056/NEJM199902253400801	25	184	191	0	13	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2003	327	7410					313	316		10.1136/bmj.327.7410.313	http://dx.doi.org/10.1136/bmj.327.7410.313			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	710JE	12907483	Bronze, Green Published			2022-12-01	WOS:000184676400015
J	Hacker, J; Hentschel, U; Dobrindt, U				Hacker, J; Hentschel, U; Dobrindt, U			Prokaryotic chromosomes and disease	SCIENCE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; BACTERIAL PATHOGENICITY; HORIZONTAL TRANSFER; GENOME SEQUENCE; MISMATCH REPAIR; YERSINIA-PESTIS; HIGH-FREQUENCY; VIRULENCE; RESISTANCE; EVOLUTION	Recent insights into bacterial genome organization and function have improved our understanding of the nature of pathogenic bacteria and their ability to cause disease. It is becoming increasingly clear that the bacterial chromosome constantly undergoes structural changes due to gene acquisition and loss, recombination, and mutational events that have an impact on the pathogenic potential of the bacterium. Even though the bacterial genome includes additional genetic elements, the chromosome represents the most important entity in this context. Here, we will show that various processes of genomic instability have an influence on the many manifestations of infectious disease.	Univ Wurzburg, Inst Mol Infekt Biol, D-97070 Wurzburg, Germany	University of Wurzburg	Hacker, J (corresponding author), Univ Wurzburg, Inst Mol Infekt Biol, Rontgenring 11, D-97070 Wurzburg, Germany.	j.hacker@mail.uni-wuerzburg.de	Hentschel, Ute/ABD-6624-2021; Dobrindt, Ulrich/AEU-2378-2022; Hentschel, Ute/H-8343-2013	Hentschel, Ute/0000-0003-0596-790X; Dobrindt, Ulrich/0000-0001-9949-1898; Hentschel, Ute/0000-0003-0596-790X				Boddicker JD, 2002, MOL MICROBIOL, V45, P1255, DOI 10.1046/j.1365-2958.2002.03121.x; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; Brown EW, 2001, J BACTERIOL, V183, P1631, DOI 10.1128/JB.183.5.1631-1644.2001; Brumell JH, 2003, TRAFFIC, V4, P36, DOI 10.1034/j.1600-0854.2003.40106.x; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; de Boer P, 2002, MOL MICROBIOL, V44, P351, DOI 10.1046/j.1365-2958.2002.02930.x; Denamur E, 2000, CELL, V103, P711, DOI 10.1016/S0092-8674(00)00175-6; Dobrindt U, 2003, J BACTERIOL, V185, P1831, DOI 10.1128/JB.185.6.1831-1840.2003; Dobrindt U, 2002, MOL GENET GENOMICS, V267, P370, DOI 10.1007/s00438-002-0668-3; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Gross Roy, 2003, Molecular Microbiology, V47, P1749, DOI 10.1046/j.1365-2958.2003.03443.x; Gunther NW, 2001, INFECT IMMUN, V69, P2838, DOI 10.1128/IAI.69.5.2838-2846.2001; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001; Hentschel U, 2000, TRENDS MICROBIOL, V8, P226, DOI 10.1016/S0966-842X(00)01758-3; Hinnebusch BJ, 2002, MOL MICROBIOL, V46, P349, DOI 10.1046/j.1365-2958.2002.03159.x; Ho TD, 2002, J BACTERIOL, V184, P5234, DOI 10.1128/JB.184.19.5234-5239.2002; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Loessner I, 2002, J BACTERIOL, V184, P4709, DOI 10.1128/JB.184.17.4709-4714.2002; Maurelli AT, 1998, P NATL ACAD SCI USA, V95, P3943, DOI 10.1073/pnas.95.7.3943; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Oelschlaeger TA, 2003, J BACTERIOL, V185, P1107, DOI 10.1128/JB.185.3.1107-1111.2003; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Picard B, 2001, INFECT IMMUN, V69, P9, DOI 10.1128/IAI.69.1.9-14.2001; Prunier AL, 2003, J INFECT DIS, V187, P1709, DOI 10.1086/374937; Richardson AR, 2001, MOL MICROBIOL, V40, P645, DOI 10.1046/j.1365-2958.2001.02408.x; Rowe-Magnus DA, 2003, GENOME RES, V13, P428, DOI 10.1101/gr.617103; Saunders NJ, 2000, MOL MICROBIOL, V37, P207, DOI 10.1046/j.1365-2958.2000.02000.x; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Umeda A, 2002, J ANTIMICROB CHEMOTH, V50, P253, DOI 10.1093/jac/dkf105; Weissman SJ, 2003, TRENDS MICROBIOL, V11, P115, DOI 10.1016/S0966-842X(03)00010-6	35	86	91	2	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2003	301	5634					790	793		10.1126/science.1086802	http://dx.doi.org/10.1126/science.1086802			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907788				2022-12-01	WOS:000184615700031
J	Lamb, J; Ramaswamy, S; Ford, HL; Contreras, B; Martinez, RV; Kittrell, FS; Zahnow, CA; Patterson, N; Golub, TR; Ewen, ME				Lamb, J; Ramaswamy, S; Ford, HL; Contreras, B; Martinez, RV; Kittrell, FS; Zahnow, CA; Patterson, N; Golub, TR; Ewen, ME			A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer	CELL			English	Article							BINDING-PROTEIN-BETA; MESSENGER-RNA; TRANSCRIPTION FACTOR; ESTROGEN-RECEPTOR; BREAST-CANCER; MOLECULAR CLASSIFICATION; RETINOBLASTOMA PROTEIN; INHIBITORY PROTEIN; CDK INHIBITORS; IN-SITU	Here we describe how patterns of gene expression in human tumors have been deconvoluted to reveal a mechanism of action for the cyclin D1 oncogene. Computational analysis of the expression patterns of thousands of genes across hundreds of tumor specimens suggested that a transcription factor, C/EBPbeta/Nf-II6, participates in the consequences of cyclin Di overexpression. Functional analyses confirmed the involvement of C/EBPbeta in the regulation of genes affected by cyclin D1 and established this protein as an indispensable effector of a potentially important facet of cyclin D1 biology. This work demonstrates that tumor gene expression databases can be used to study the function of a human oncogene in situ.	Harvard Univ, Sch Med, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biochem, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02139 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21231 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Baylor College of Medicine; Johns Hopkins University; Johns Hopkins Medicine	Ewen, ME (corresponding author), Harvard Univ, Sch Med, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.		Villena, Rodolfo/HDM-2742-2022		NATIONAL CANCER INSTITUTE [P01CA080111, P50CA088843, F32CA079197, R01CA065842] Funding Source: NIH RePORTER; NCI NIH HHS [CA88843, F32-CA79197, P01-CA80111, R01-CA61253, R01-CA65842] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bienvenu F, 2001, J BIOL CHEM, V276, P16840, DOI 10.1074/jbc.M100795200; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Desprez Pierre-Yves, 1993, Molecular and Cellular Differentiation, V1, P99; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; GAUGITSCH HW, 1992, J BIOL CHEM, V267, P11267; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hall M, 1996, ADV CANCER RES, V68, P67, DOI 10.1016/S0065-230X(08)60352-8; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HINDS PW, 1994, P NATL ACAD SCI USA, V91, P709, DOI 10.1073/pnas.91.2.709; Hollander M, 1999, NONPARAMETRIC STAT M; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Inoue K, 1998, MOL CELL BIOL, V18, P1590, DOI 10.1128/MCB.18.3.1590; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Kamano H, 1997, ONCOGENE, V14, P1223, DOI 10.1038/sj.onc.1200945; KITTRELL FS, 1992, CANCER RES, V52, P1924; Knudsen KE, 1999, CANCER RES, V59, P2297; Lamb J, 2000, MOL CELL BIOL, V20, P8667, DOI 10.1128/MCB.20.23.8667-8675.2000; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Neuman E, 1997, MOL CELL BIOL, V17, P5338, DOI 10.1128/MCB.17.9.5338; Oyama T, 1998, CANCER RES, V58, P2876; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Ratineau C, 2002, J BIOL CHEM, V277, P8847, DOI 10.1074/jbc.M110747200; RAUGHT B, 1995, MOL ENDOCRINOL, V9, P1223, DOI 10.1210/me.9.9.1223; Raught B, 1996, CANCER RES, V56, P4382; ROSENBERG CL, 1991, P NATL ACAD SCI USA, V88, P9638, DOI 10.1073/pnas.88.21.9638; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Siu F, 2001, J BIOL CHEM, V276, P48100, DOI 10.1074/jbc.M109533200; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Su AI, 2001, CANCER RES, V61, P7388; TSUKADA J, 1994, MOL CELL BIOL, V14, P7285, DOI 10.1128/MCB.14.11.7285; Ubeda M, 1999, BIOCHEM BIOPH RES CO, V262, P31, DOI 10.1006/bbrc.1999.1140; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vos CBJ, 1999, J PATHOL, V187, P279; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WEINSTATSASLOW D, 1995, NAT MED, V1, P1257, DOI 10.1038/nm1295-1257; Zahnow CA, 1997, J NATL CANCER I, V89, P1887, DOI 10.1093/jnci/89.24.1887; Zahnow CA, 2001, CANCER RES, V61, P261; ZUKERBERG LR, 1995, MODERN PATHOL, V8, P560; Zukerberg LR, 1996, BLOOD, V88, P268, DOI 10.1182/blood.V88.1.268.bloodjournal881268; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	48	337	352	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 8	2003	114	3					323	334		10.1016/S0092-8674(03)00570-1	http://dx.doi.org/10.1016/S0092-8674(03)00570-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914697	Bronze			2022-12-01	WOS:000184679200009
J	Chittka, L; Dyer, AG; Bock, F; Dornhaus, A				Chittka, L; Dyer, AG; Bock, F; Dornhaus, A			Psychophysics - Bees trade off foraging speed for accuracy	NATURE			English	Article									Univ Wurzburg, Biozentrum, D-97074 Wurzburg, Germany; Univ London, Queen Mary, London E1 4NS, England; La Trobe Univ, Fac Hlth Sci, Sch Orthopt, Bundoora, Vic 3086, Australia; Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of Wurzburg; University of London; La Trobe University; University of Bristol	Chittka, L (corresponding author), Univ Wurzburg, Biozentrum, Hubland, D-97074 Wurzburg, Germany.	l.chittka@qmul.ac.uk	Chittka, Lars/C-3110-2012	Chittka, Lars/0000-0001-8153-1732				CHITTKA L, 1995, ANIM BEHAV, V49, P159, DOI 10.1016/0003-3472(95)80163-4; DUKAS R, 1994, ANIM BEHAV, V48, P1001, DOI 10.1006/anbe.1994.1332; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Maleszka R, 2000, BEHAV BRAIN RES, V115, P49, DOI 10.1016/S0166-4328(00)00235-7; Menzel R., 1990, NEUROBIOLOGY COMP CO, P237; Rival C, 2003, NEUROSCI LETT, V336, P65, DOI 10.1016/S0304-3940(02)01246-6; SMITH BH, 1991, J COMP PSYCHOL, V105, P345, DOI 10.1037/0735-7036.105.4.345; Thomson JD, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P191, DOI 10.1017/CBO9780511542268.011; Zenger B, 1997, J EXP PSYCHOL HUMAN, V23, P1783, DOI 10.1037/0096-1523.23.6.1783	9	276	277	2	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					388	388		10.1038/424388a	http://dx.doi.org/10.1038/424388a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879057				2022-12-01	WOS:000184318400030
J	Bauch, D; Darling, K; Simstich, J; Bauch, HA; Erlenkeuser, H; Kroon, D				Bauch, D; Darling, K; Simstich, J; Bauch, HA; Erlenkeuser, H; Kroon, D			Palaeoceanographic implications of genetic variation in living North Atlantic Neogloboquadrina pachyderma	NATURE			English	Article								The shells of the planktonic foraminifer Neogloboquadrina pachyderma have become a classical tool for reconstructing glacial-interglacial climate conditions in the North Atlantic Ocean(1-3). Palaeoceanographers utilize its left- and right-coiling variants, which exhibit a distinctive reciprocal temperature and water mass related shift in faunal abundance both at present and in late Quaternary sediments(1,2,4,5). Recently discovered cryptic genetic diversity in planktonic foraminifers(6-8) now poses significant questions for these studies. Here we report genetic evidence demonstrating that the apparent 'single species' shell-based records of right-coiling N. pachyderma used in palaeoceanographic reconstructions contain an alternation in species as environmental factors change. This is reflected in a species-dependent incremental shift in right-coiling N. pachyderma shell calcite delta(18)O between the Last Glacial Maximum and full Holocene conditions. Guided by the percentage dextral coiling ratio, our findings enhance the use of delta(18)O records of right-coiling N. pachyderma for future study. They also highlight the need to genetically investigate other important morphospecies to refine their accuracy and reliability as palaeoceanographic proxies.	GEOMAR, D-24148 Kiel, Germany; Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JG, Midlothian, Scotland; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JG, Midlothian, Scotland; Mainz Acad Sci Human & Lit, D-55131 Mainz, Germany; Univ Kiel, Leibniz Lab, D-24118 Kiel, Germany; Vrije Univ Amsterdam, NL-1081 HV Amsterdam, Netherlands	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Edinburgh; University of Edinburgh; University of Kiel; Vrije Universiteit Amsterdam	Bauch, D (corresponding author), GEOMAR, Wischhofstr 1-3, D-24148 Kiel, Germany.			Bauch, Dorothea/0000-0002-1419-9714	Natural Environment Research Council [NER/J/S/2000/00860] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		BANDY O L, 1972, Micropaleontology (New York), V18, P294, DOI 10.2307/1485010; Bauch D, 2002, MAR MICROPALEONTOL, V45, P83, DOI 10.1016/S0377-8398(02)00038-5; Bauch H. A., 1999, LAND OCEAN SYSTEMS S, DOI [10.1007/978- 3, DOI 10.1007/978-3-642-60134-7_46, 10.1007/978-3-642-60134-7_46]; Bauch HA, 2001, QUATERNARY SCI REV, V20, P659, DOI 10.1016/S0277-3791(00)00098-6; Bemis BE, 2002, MAR MICROPALEONTOL, V46, P405, DOI 10.1016/S0377-8398(02)00083-X; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Bu A., 1971, MICROPALEONTOLOGY OC, P105; CIFELLI R, 1973, Journal of Foraminiferal Research, V3, P157; CLIMAP PM, 1976, SCIENCE, V191, P1131, DOI DOI 10.1126/SCIENCE.191.4232.1131; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; Darling KF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000723; de Vargas C, 2001, PALEOBIOLOGY, V27, P104, DOI 10.1666/0094-8373(2001)027<0104:PARIGT>2.0.CO;2; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; EMILIANI C, 1955, J GEOL, V63, P538, DOI 10.1086/626295; ERICSON DB, 1959, SCIENCE, V130, P219, DOI 10.1126/science.130.3369.219; HEALYWILLIAMS N, 1984, ANTARCT J US, V18, P138; Huber R, 2000, PALAEOGEOGR PALAEOCL, V160, P193, DOI 10.1016/S0031-0182(00)00066-3; Jansen E., 1989, Quaternary International, V1, P151, DOI 10.1016/1040-6182(89)90013-X; Kandiano ES, 2002, J FORAMIN RES, V32, P245, DOI 10.2113/32.3.245; KELLOGG TB, 1978, BOREAS, V7, P61, DOI 10.1111/j.1502-3885.1978.tb00051.x; KIPP NG, 1976, GEOL SOC AM MEM, V145, P3, DOI DOI 10.1130/MEM145-P3; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Oppo DW, 1998, SCIENCE, V279, P1335, DOI 10.1126/science.279.5355.1335; Oppo DW, 2001, PALEOCEANOGRAPHY, V16, P280, DOI 10.1029/2000PA000527; Pflaumann U, 1996, PALEOCEANOGRAPHY, V11, P15, DOI 10.1029/95PA01743; SIMSTICH J, 1999, BER REP I GEOWISS U, V2, P1; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; Stewart IA, 2001, MAR MICROPALEONTOL, V43, P143, DOI 10.1016/S0377-8398(01)00024-X; WILLIAMS DF, 1988, PALAEOGEOGR PALAEOCL, V64, P153, DOI 10.1016/0031-0182(88)90004-1	29	65	70	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					299	302		10.1038/nature01778	http://dx.doi.org/10.1038/nature01778			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867978	Green Published			2022-12-01	WOS:000184183900038
J	Mao, YH; Abrieu, A; Cleveland, DW				Mao, YH; Abrieu, A; Cleveland, DW			Activating and silencing the mitotic checkpoint through CENP-E-dependent activation/inactivation of BubR1	CELL			English	Article							SPINDLE ASSEMBLY CHECKPOINT; ANAPHASE-PROMOTING COMPLEX; PUTATIVE KINETOCHORE MOTOR; SACCHAROMYCES-CEREVISIAE; UNATTACHED KINETOCHORES; CHROMOSOME ALIGNMENT; CHROMATID SEPARATION; KINASE-ACTIVITY; PROTEIN BUBR1; MAD2	The mitotic checkpoint prevents advance to anaphase prior to successful attachment of every centromere/ kinetochore to mitotic spindle microtubules. Using purified components and Xenopus egg extracts, the kinetochore-associated microtubule motor CENP-E is now shown to be the activator of the essential checkpoint kinase BubR1. Since kinase activity and the checkpoint are silenced following CENP-E-dependent microtubule attachment in extracts or binding of CENP-E antibodies that do not disrupt CENP-E association with BubR1, CENP-E mediates silencing of BubR1 signaling. Checkpoint signaling requires the normal level of BubR1 containing a functional Mad3 domain implicated in Cdc20 binding, but only a small fraction need be kinase competent. This supports bifunctional roles for BubR1 in the checkpoint: an enzymatic one requiring CENP-E-dependent activation of its kinase activity at kinetochores and a stoichiometric one as a direct inhibitor of Cdc20.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.		Abrieu, Ariane/P-3307-2019; Abrieu, Ariane/G-6336-2013; Cleveland, Don/AAN-9783-2021	Abrieu, Ariane/0000-0002-0942-8877; Cleveland, Don/0000-0002-1934-3682; Mao, Yinghui/0000-0002-4078-129X				Abrieu A, 2000, CELL, V102, P817, DOI 10.1016/S0092-8674(00)00070-2; Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; BROWN KD, 1994, J CELL BIOL, V125, P1303, DOI 10.1083/jcb.125.6.1303; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chan GKT, 1998, J CELL BIOL, V143, P49, DOI 10.1083/jcb.143.1.49; Chen RH, 1998, J CELL BIOL, V143, P283, DOI 10.1083/jcb.143.2.283; Chen RH, 2002, J CELL BIOL, V158, P487, DOI 10.1083/jcb.200204048; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Farr KA, 1998, MOL CELL BIOL, V18, P2738, DOI 10.1128/MCB.18.5.2738; Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Huang JY, 1999, EMBO J, V18, P2184, DOI 10.1093/emboj/18.8.2184; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; ROBERTS BT, 1994, MOL CELL BIOL, V14, P8282, DOI 10.1128/MCB.14.12.8282; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Sharp-Baker H, 2001, J CELL BIOL, V153, P1239, DOI 10.1083/jcb.153.6.1239; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Taylor SS, 2001, J CELL SCI, V114, P4385; Taylor TE, 1998, TROP MED INT HEALTH, V3, P3, DOI 10.1046/j.1365-3156.1998.00166.x; Wassmann K, 2003, EMBO J, V22, P797, DOI 10.1093/emboj/cdg071; WEAVER BAA, 2003, IN PRESS J CELL BIOL; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Wu HY, 2000, ONCOGENE, V19, P4557, DOI 10.1038/sj.onc.1203803; Yamaguchi S, 2003, EMBO J, V22, P1075, DOI 10.1093/emboj/cdg100; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	42	189	195	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 11	2003	114	1					87	98		10.1016/S0092-8674(03)00475-6	http://dx.doi.org/10.1016/S0092-8674(03)00475-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	702JC	12859900	Bronze			2022-12-01	WOS:000184219900008
J	Markowitz, JS; Donovan, JL; DeVane, CL; Taylor, RM; Ruan, Y; Wang, JS; Chavin, KD				Markowitz, JS; Donovan, JL; DeVane, CL; Taylor, RM; Ruan, Y; Wang, JS; Chavin, KD			Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HYPERICUM-PERFORATUM; MAJOR DEPRESSION; PHARMACOKINETICS; ALPRAZOLAM; EXTRACT; DEXTROMETHORPHAN; INHIBITION; PLASMA; IMIPRAMINE; PLACEBO	Context St John's wort is a popular herbal product used to treat depression but it has been implicated in drug interactions. Objective To assess the potential of St John's wort administration to alter the activity of the cytochrome P450 (CYP) enzymes extensively involved in drug metabolism. Design, Setting, and Participants Open-label crossover study with fixed treatment order conducted March 2002 to February 2003 in a US general clinical research center involving 12 healthy volunteers (6 men and 6 women) aged 22 to 38 years before and after 14 days of administration of St John's wort. Intervention Participants were given probe drugs (30 mg of dextromethorphan and 2 mg of alprazolam) to establish baseline CYP 3A4 and CYP 2D6 activity. After a minimum 7-day washout period, participants began taking one 300-mg tablet 3 times per day. After 14 days of St John's wort administration, participants were given the probe drugs along with 1 St John's wort tablet to establish postadministration CYP activity; the St John's wort dosing regimen was continued for 48 hours. Main Outcome Measures Changes in plasma pharmacokinetics of alprazolam as a probe for CYP 3A4 activity and the ratio of dextromethorphan to its metabolite, dextrorphan, in urine as a probe for CYP 2D6 activity. Results A 2-fold decrease in the area under the curve for alprazolam plasma concentration vs time (P<.001) and a 2-fold increase in alprazolam clearance (P<.001) were observed following St John's wort administration. Alprazolam elimination half life was shortened from a mean (SD) of 12.4 (3.9) hours to 6.0 (2.4) hours (P<.001). The mean (SD) urinary ratio of dextromethorphan to its metabolite was 0.006 (0.010) at baseline and 0.014 (0.025) after St John's wort administration (P=.26). Conclusions A 14-day course of St John's wort administration significantly induced the activity of CYP 3A4 as measured by changes in alprazolam pharmacokinetics. This suggests that long-term administration of St John's wort may result in diminished clinical effectiveness or increased dosage requirements for all CYP 3A4 substrates, which represent at least 50% of all marketed medications.	Med Univ S Carolina, Inst Psychiat, Lab Drug Disposit & Pharmacogenet, Dept Pharmaceut Sci, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Surg, Div Transplantat, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Markowitz, JS (corresponding author), Med Univ S Carolina, Inst Psychiat, Lab Drug Disposit & Pharmacogenet, Dept Pharmaceut Sci, RM 246 N,67 President St, Charleston, SC 29425 USA.	markowij@musc.edu	DeVane, Lindsay/B-6645-2012		NCCIH NIH HHS [R21 AT00511] Funding Source: Medline; NCRR NIH HHS [M01 RR01070-18] Funding Source: Medline; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT000511] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001070] Funding Source: NIH RePORTER	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Barnes J, 2001, J PHARM PHARMACOL, V53, P583, DOI 10.1211/0022357011775910; BLUMENTHAL M, 2003, HERBALGRAM, V58, P71; Brosen K, 1996, THER DRUG MONIT, V18, P393, DOI 10.1097/00007691-199608000-00014; Constantine GH, 1998, PHARM BIOL, V36, P365, DOI 10.1076/phbi.36.5.365.4651; Cui YY, 2002, J CHROMATOGR B, V780, P129, DOI 10.1016/S1570-0232(02)00439-7; Davidson JRT, 2002, JAMA-J AM MED ASSOC, V287, P1807, DOI 10.1001/jama.287.14.1807; de Maat MMR, 2001, AIDS, V15, P420, DOI 10.1097/00002030-200102160-00019; Donovan JL, 2003, FOOD CHEM TOXICOL, V41, P1199, DOI 10.1016/S0278-6915(03)00112-1; Donovan JL, 2003, DRUG METAB DISPOS, V31, P519, DOI 10.1124/dmd.31.5.519; Durr D, 2000, CLIN PHARMACOL THER, V68, P598, DOI 10.1067/mcp.2000.112240; Furukori H, 1998, NEUROPSYCHOPHARMACOL, V18, P364; Gorski JC, 1999, XENOBIOTICA, V29, P931, DOI 10.1080/004982599238173; Greeson JM, 2001, PSYCHOPHARMACOLOGY, V153, P402, DOI 10.1007/s002130000625; Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1; HENDERSON L, 2003, BR J CLIN PHARM, V55, P112; Hoskins JM, 1997, J CHROMATOGR B, V696, P81, DOI 10.1016/S0378-4347(97)00225-9; Johne A, 2002, J CLIN PSYCHOPHARM, V22, P46, DOI 10.1097/00004714-200202000-00008; Johne A, 1999, CLIN PHARMACOL THER, V66, P338, DOI 10.1053/cp.1999.v66.a101944; Kerb R, 1996, ANTIMICROB AGENTS CH, V40, P2087, DOI 10.1128/AAC.40.9.2087; Lecrubier Y, 2002, AM J PSYCHIAT, V159, P1361, DOI 10.1176/appi.ajp.159.8.1361; Liston HL, 2002, J CLIN PSYCHOPHARM, V22, P169, DOI 10.1097/00004714-200204000-00010; Mai I, 2003, NEPHROL DIAL TRANSPL, V18, P819, DOI 10.1093/ndt/gfg002; Markowitz J S, 2001, Psychopharmacol Bull, V35, P53; MARKOWITZ JS, IN PRESS J CLIN PSYC; Markusen A, 2001, ANTIPODE, V33, P39, DOI 10.1111/1467-8330.00160; MILLER RL, 1988, J CHROMATOGR-BIOMED, V430, P180, DOI 10.1016/S0378-4347(00)83150-3; Moore LB, 2000, P NATL ACAD SCI USA, V97, P7500, DOI 10.1073/pnas.130155097; Obach RS, 2000, J PHARMACOL EXP THER, V294, P88; Perloff MD, 2001, BRIT J PHARMACOL, V134, P1601, DOI 10.1038/sj.bjp.0704399; Perloff MD, 1999, BIOCHEM PHARMACOL, V57, P1227, DOI 10.1016/S0006-2952(99)00054-4; Philipp M, 1999, BRIT MED J, V319, P1534, DOI 10.1136/bmj.319.7224.1534; Piscitelli SC, 2000, LANCET, V355, P547, DOI 10.1016/S0140-6736(99)05712-8; Ruschitzka F, 2000, LANCET, V355, P548, DOI 10.1016/S0140-6736(99)05467-7; SCHMID B, 1985, CLIN PHARMACOL THER, V38, P618, DOI 10.1038/clpt.1985.235; Schmider J, 1999, PHARMACOGENETICS, V9, P725, DOI 10.1097/01213011-199912000-00007; Shelton RC, 2001, JAMA-J AM MED ASSOC, V285, P1978, DOI 10.1001/jama.285.15.1978; Simmen U, 2003, EUR J PHARMACOL, V458, P251, DOI 10.1016/S0014-2999(02)02818-2; Smith DA, 1998, XENOBIOTICA, V28, P1095, DOI 10.1080/004982598238859; SMITH RB, 1984, PSYCHOPHARMACOLOGY, V84, P452, DOI 10.1007/BF00431449; Sugimoto K, 2001, CLIN PHARMACOL THER, V70, P518, DOI 10.1067/mcp.2001.120025; Venkatakrishnan K, 1998, J CLIN PSYCHOPHARM, V18, P256, DOI 10.1097/00004714-199806000-00015; Wang ZQ, 2002, CLIN PHARMACOL THER, V71, P414, DOI 10.1067/mcp.2002.124080; Wang ZQ, 2001, CLIN PHARMACOL THER, V70, P317, DOI 10.1067/mcp.2001.118522; Woelk H, 2000, BMJ-BRIT MED J, V321, P536, DOI 10.1136/bmj.321.7260.536; WRIGHTON SA, 1992, CRIT REV TOXICOL, V22, P1, DOI 10.3109/10408449209145319; ZHANG Y, 1992, CLIN PHARMACOL THER, V51, P647, DOI 10.1038/clpt.1992.77	46	263	272	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2003	290	11					1500	1504		10.1001/jama.290.11.1500	http://dx.doi.org/10.1001/jama.290.11.1500			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721RE	13129991				2022-12-01	WOS:000185329000033
J	Peretti-Watel, P; Bendiane, MK; Pegliasco, H; Lapiana, JM; Favre, R; Galinier, A; Moatti, JP				Peretti-Watel, P; Bendiane, MK; Pegliasco, H; Lapiana, JM; Favre, R; Galinier, A; Moatti, JP			Doctors' opinions on euthanasia, end of life care, and doctor-patient communication: telephone survey in France	BRITISH MEDICAL JOURNAL			English	Article							PHYSICIAN-ASSISTED SUICIDE; ATTITUDES		Reg Ctr Dis Control SE, F-13006 Marseille, France; Inst J Paoli I Calmettes, Hlth & Med Res Natl Inst, Unit 379, F-13009 Marseille, France; Departmental Ctr Private Profess, Marseille, France; Assistance Publ Hop Marseille, Med Oncol Serv, Marseille, France; Assistance Publ Hop Marseille, Dept Penitentiary Care, Marseille, France; Univ Aix Marseille 2, Dept Econ, F-13284 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Peretti-Watel, P (corresponding author), Reg Ctr Dis Control SE, F-13006 Marseille, France.		Bendiane, Marc-Karim/M-7060-2019; Peretti-Watel, Patrick/P-4535-2017; Bendiane, Marc-Karim K/F-5414-2010	Bendiane, Marc-Karim K/0000-0003-4329-8807				Ben Diane MK, 2003, PRESSE MED, V32, P488; Emanuel EJ, 2000, ANN INTERN MED, V133, P527, DOI 10.7326/0003-4819-133-7-200010030-00011; Grassi L, 1999, J PAIN SYMPTOM MANAG, V17, P188, DOI 10.1016/S0885-3924(98)00155-9; Hermsen MA, 2002, J PAIN SYMPTOM MANAG, V23, P517, DOI 10.1016/S0885-3924(02)00401-3; Seale C, 2000, SOC SCI MED, V51, P917, DOI 10.1016/S0277-9536(00)00071-X	5	39	40	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 13	2003	327	7415					595	596		10.1136/bmj.327.7415.595	http://dx.doi.org/10.1136/bmj.327.7415.595			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722CW	12969926	Bronze, Green Published			2022-12-01	WOS:000185358700022
J	Marambaud, P; Wen, PH; Dutt, A; Shioi, J; Takashima, A; Siman, R; Robakis, NK				Marambaud, P; Wen, PH; Dutt, A; Shioi, J; Takashima, A; Siman, R; Robakis, NK			A CBP binding transcriptional repressor produced by the PS1/is an element of-cleavage of N-cadherin is inhibited by PS1FAD mutations	CELL			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE ACTIVITY; ALZHEIMERS-DISEASE; C-FOS; DROSOPHILA-MELANOGASTER; ADHERENS JUNCTIONS; ADHESION SYSTEM; FACTOR CREB; PRESENILIN-1; CLEAVAGE	Presenilin1 (PS1), a protein implicated in Alzheimer's disease (AD), forms complexes with N-cadherin, a transmembrane protein with important neuronal and synaptic functions. Here, we show that a PS1-dependent T-secretase protease activity promotes an epsilon-like cleavage of N-cadherin to produce its intracellular domain peptide, N-Cad/CTF2. NMDA receptor agonists stimulate N-Cad/CTF2 production suggesting that this receptor regulates the epsilon-cleavage of N-cadherin. N-Cad/ CTF2 binds the transcription factor CBP and promotes its proteasomal degradation, inhibiting CRE-dependent transactivation. Thus, the PS1-dependent epsilon-cleavage product N-Cad/CTF2 functions as a potent repressor of CBP/CREB-mediated transcription. Importantly, PS1 mutations associated with familial AD (FAD) and a gamma-secretase dominant-negative mutation inhibit N-Cad/CTF2 production and upregulate CREB-mediated transcription indicating that FAD mutations cause a gain of transcriptional function by inhibiting production of transcriptional repressor N-Cad/CTF2. These data raise the possibility that FAD mutation-induced transcriptional abnormalities maybe causally related to the dementia associated with FAD.	Mt Sinai Med Ctr, Sch Med, Dept Psychiat, New York, NY 10029 USA; Inst Phys & Chem Res, Lab Alzheimers Dis, Wako, Saitama 3510198, Japan; Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Mt Sinai Med Ctr, Sch Med, Fishberg Res Ctr Neurobiol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; RIKEN; University of Pennsylvania; Icahn School of Medicine at Mount Sinai	Robakis, NK (corresponding author), Mt Sinai Med Ctr, Sch Med, Dept Psychiat, New York, NY 10029 USA.		Robakis, Nikolaos/AAA-1838-2021	Marambaud, Philippe/0000-0002-8983-1497	NATIONAL INSTITUTE ON AGING [R37AG017926, R01AG017926, R01AG008200] Funding Source: NIH RePORTER; NIA NIH HHS [AG-08200, AG-05138, R01 AG017926-05, AG-17926, R01 AG008200-18, P50 AG005138-190025] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Amtul Z, 2002, NEUROBIOL DIS, V9, P269, DOI 10.1006/nbdi.2001.0473; ANDERSON AJ, 1994, EXP NEUROL, V125, P286, DOI 10.1006/exnr.1994.1031; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; Baki L, 2001, P NATL ACAD SCI USA, V98, P2381, DOI 10.1073/pnas.041603398; Banker G, 1991, CULTURING NERVE CELL; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; Dawson TM, 2002, NAT MED, V8, P450, DOI 10.1038/nm0502-450; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Freiman RN, 2002, SCIENCE, V296, P2149, DOI 10.1126/science.1073845; Georgakopoulos A, 1999, MOL CELL, V4, P893, DOI 10.1016/S1097-2765(00)80219-1; Gillardon F, 1996, BRAIN RES, V706, P169, DOI 10.1016/0006-8993(95)01332-6; Goda Y, 2002, NEURON, V35, P1, DOI 10.1016/S0896-6273(02)00765-1; Goodman RH, 2000, GENE DEV, V14, P1553; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Huntley GW, 2002, CELL, V108, P1, DOI 10.1016/S0092-8674(01)00631-6; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Ludlam WH, 2002, MOL CELL BIOL, V22, P3832, DOI 10.1128/MCB.22.11.3832-3841.2002; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marcus DL, 1998, NEUROBIOL AGING, V19, P393, DOI 10.1016/S0197-4580(98)00077-3; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McLendon C, 2000, FASEB J, V14, P2383; Murayama O, 1999, NEUROSCI LETT, V265, P61, DOI 10.1016/S0304-3940(99)00187-1; Nowotny P, 2000, MOL CELL NEUROSCI, V15, P88, DOI 10.1006/mcne.1999.0805; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Siman R, 2001, J BIOL CHEM, V276, P44736, DOI 10.1074/jbc.M104092200; Siman R, 2000, J NEUROSCI, V20, P8717; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xia XF, 2001, P NATL ACAD SCI USA, V98, P10863, DOI 10.1073/pnas.191284198; ZHANG P, 1992, NEUROSCIENCE, V46, P9, DOI 10.1016/0306-4522(92)90004-L	45	407	420	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 5	2003	114	5					635	645		10.1016/j.cell.2003.08.008	http://dx.doi.org/10.1016/j.cell.2003.08.008			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	719FN	13678586	Bronze			2022-12-01	WOS:000185193100012
J	Kile, BT; Hentges, KE; Clark, AT; Nakamura, H; Salinger, AP; Liu, B; Box, N; Stockton, DW; Johnson, RL; Behringer, RR; Bradley, A; Justice, MJ				Kile, BT; Hentges, KE; Clark, AT; Nakamura, H; Salinger, AP; Liu, B; Box, N; Stockton, DW; Johnson, RL; Behringer, RR; Bradley, A; Justice, MJ			Functional genetic analysis of mouse chromosome 11	NATURE			English	Article							RENAL TUBULAR-ACIDOSIS; ETHYL-N-NITROSOUREA; TARGETED DISRUPTION; MEMBRANE SKELETON; MOUSE; MUTATIONS; BAND-3; MUTAGENESIS; GENOME; MICE	Now that the mouse and human genome sequences are complete, biologists need systematic approaches to determine the function of each gene(1,2). A powerful way to discover gene function is to determine the consequence of mutations in living organisms. Large-scale production of mouse mutations with the point mutagen N-ethyl-N-nitrosourea (ENU) is a key strategy for analysing the human genome because mouse mutants will reveal functions unique to mammals, and many may model human diseases(3). To examine genes conserved between human and mouse, we performed a recessive ENU mutagenesis screen that uses a balancer chromosome, inversion chromosome 11 (refs 4, 5). Initially identified in the fruitfly, balancer chromosomes are valuable genetic tools that allow the easy isolation of mutations on selected chromosomes(6). Here we show the isolation of 230 new recessive mouse mutations, 88 of which are on chromosome 11. This genetic strategy efficiently generates and maps mutations on a single chromosome, even as mutations throughout the genome are discovered. The mutations reveal new defects in haematopoiesis, craniofacial and cardiovascular development, and fertility.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Justice, MJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	mjustice@bcm.tmc.edu	Kile, Benjamin T/F-6593-2011; Kile, Benjamin/GNP-3246-2022; Box, Neil/F-3591-2010	Kile, Benjamin T/0000-0002-8836-8947; Kile, Benjamin/0000-0002-8836-8947; Box, Neil/0000-0002-3486-0346; Bradley, Allan/0000-0002-2349-8839; Liu, Bin/0000-0002-9113-9694; Hentges, Kathryn/0000-0001-8917-3765				Barrow JR, 1996, DEVELOPMENT, V122, P3817; BEHRINGER RR, 2003, BIOMEDNET; Bruce LJ, 1997, J CLIN INVEST, V100, P1693, DOI 10.1172/JCI119694; Conway SJ, 2003, GENESIS, V35, P1, DOI 10.1002/gene.10152; Hentges K, 1999, DEVELOPMENT, V126, P1601; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; HITOTSUMACHI S, 1985, P NATL ACAD SCI USA, V82, P6619, DOI 10.1073/pnas.82.19.6619; JAROLIM P, 1995, BLOOD, V85, P634, DOI 10.1182/blood.V85.3.634.bloodjournal853634; JUSTICE MJ, 1999, GENETICS TRANSGENICS, P185; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Karet FE, 1998, P NATL ACAD SCI USA, V95, P6337, DOI 10.1073/pnas.95.11.6337; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Kile BT, 2003, MAMM GENOME, V14, P81, DOI 10.1007/s00335-002-2160-0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Miklos GLG, 1996, CELL, V86, P521, DOI 10.1016/S0092-8674(00)80126-9; Muller HJ, 1918, GENETICS, V3, P422; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Noveroske JK, 2002, GENESIS, V32, P218, DOI 10.1002/gene.10060; NUSSLEINVOLHARD C, 1987, SCIENCE, V238, P1675, DOI 10.1126/science.3686007; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Peters LL, 1996, CELL, V86, P917, DOI 10.1016/S0092-8674(00)80167-1; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Rinchik EM, 1999, GENETICS, V152, P373; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; SHEDLOVSKY A, 1988, P NATL ACAD SCI USA, V85, P180, DOI 10.1073/pnas.85.1.180; Southgate CD, 1996, NAT GENET, V14, P227, DOI 10.1038/ng1096-227; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zheng BH, 1999, NUCLEIC ACIDS RES, V27, P2354, DOI 10.1093/nar/27.11.2354; Zheng BH, 1999, NAT GENET, V22, P375, DOI 10.1038/11949	30	159	162	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 4	2003	425	6953					81	86		10.1038/nature01865	http://dx.doi.org/10.1038/nature01865			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717LD	12955145				2022-12-01	WOS:000185089200042
J	Wang, YJ; Wang, J; Sun, HQ; Martinez, M; Sun, YX; Macia, E; Kirchhausen, T; Albanesi, JP; Roth, MG; Yin, HL				Wang, YJ; Wang, J; Sun, HQ; Martinez, M; Sun, YX; Macia, E; Kirchhausen, T; Albanesi, JP; Roth, MG; Yin, HL			Phosphatidylinositol 4 phosphate regulates targeting of clathrin adaptor AP-1 complexes to the golgi	CELL			English	Article							PLASMA-MEMBRANE; SORTING SIGNALS; 4,5-BISPHOSPHATE; 4-KINASE; PROTEIN; DOMAIN; YEAST; PHOSPHOINOSITIDES; RECRUITMENT; SECRETION	Phosphatidylinositol 4 phosphate [PI(4)P] is essential for secretion in yeast, but its role in mammalian cells is unclear. Current paradigms propose that PI(4)P acts primarily as a precursor to phosphatidylinositol 4,5 bisphosphate (PIP2), an important plasma membrane regulator. We found that PI(4)P is enriched in the mammalian Golgi, and used RNA interference (RNAi) of PI4KIIalpha, a Golgi resident phosphatidylinositol 4 kinase, to determine whether PI(4)P directly regulates the Golgi. PI4KIIalpha RNAi decreases Golgi PI(4)P, blocks the recruitment of clathrin adaptor AP-1 complexes to the Golgi, and inhibits AP-1-dependent functions. This AP-1 binding defect is rescued by adding back PI(4)P. In addition, purified AP-1 binds PI(4)P, and anti-PI(4)P inhibits the in vitro recruitment of cytosolic AP-1 to normal cellular membranes. We propose that PI4KIIalpha establishes the Golgi's unique lipid-defined organelle identity by generating PI(4)P-rich domains that specify the docking of the AP-1 coat machinery.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Yin, HL (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA.	helen.yin@utsouthwestern.edu	Macia, Eric/AAW-2964-2021	Roth, Michael/0000-0002-9056-332X; macia, eric/0000-0003-3686-2000	NIGMS NIH HHS [R01 GM55562, R01 GM51112, GM37547, GM36548, GM21681] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055562, R01GM036548, R01GM051112, R01GM037547, P50GM021681] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Balla A, 2002, J BIOL CHEM, V277, P20041, DOI 10.1074/jbc.M111807200; Barylko B, 2001, J BIOL CHEM, V276, P7705, DOI 10.1074/jbc.C000861200; Barylko B, 2002, J BIOL CHEM, V277, P44366, DOI 10.1074/jbc.M203241200; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Cockcroft S, 2001, J MEMBRANE BIOL, V180, P187, DOI 10.1007/s002320010069; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Cremona O, 2001, J CELL SCI, V114, P1041; Crottet P, 2002, MOL BIOL CELL, V13, P3672, DOI 10.1091/mbc.E02-05-0309; De Matteis MA, 2002, CURR OPIN CELL BIOL, V14, P434, DOI 10.1016/S0955-0674(02)00357-5; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Guo J, 2003, P NATL ACAD SCI USA, V100, P3995, DOI 10.1073/pnas.0230488100; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Han P, 2002, CYTOTHERAPY, V4, P277, DOI 10.1080/146532402320219790; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Lin S, 1997, J BIOL CHEM, V272, P26300, DOI 10.1074/jbc.272.42.26300; Lin SS, 1998, J CELL BIOL, V142, P51, DOI 10.1083/jcb.142.1.51; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Meyer C, 2001, J CELL SCI, V114, P4469; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Minogue S, 2001, J BIOL CHEM, V276, P16635, DOI 10.1074/jbc.M100982200; Munro S, 2002, CURR OPIN CELL BIOL, V14, P506, DOI 10.1016/S0955-0674(02)00350-2; Ozaki S, 2000, P NATL ACAD SCI USA, V97, P11286, DOI 10.1073/pnas.210197897; Panaretou C, 2002, BIOCHEM J, V363, P289, DOI 10.1042/0264-6021:3630289; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Rohde G, 2002, J CELL BIOL, V158, P209, DOI 10.1083/jcb.200203103; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Shelton SN, 2003, BIOCHEM J, V371, P533, DOI 10.1042/BJ20021407; Siddhanta A, 2000, J BIOL CHEM, V275, P12023, DOI 10.1074/jbc.275.16.12023; Skippen A, 2002, J BIOL CHEM, V277, P5823, DOI 10.1074/jbc.M110274200; Tran D, 1999, J HISTOCHEM CYTOCHEM, V47, P601, DOI 10.1177/002215549904700503; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Wei YJ, 2002, J BIOL CHEM, V277, P46586, DOI 10.1074/jbc.M206860200; Wong K, 1997, J BIOL CHEM, V272, P13236, DOI 10.1074/jbc.272.20.13236; Yamamoto M, 2001, J CELL BIOL, V152, P867, DOI 10.1083/jcb.152.5.867; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zhu Y.-P., 1998, J SURFACTANTS DETERG, V1, P1; Zhu YX, 1999, P NATL ACAD SCI USA, V96, P5013, DOI 10.1073/pnas.96.9.5013	51	386	396	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2003	114	3					299	310		10.1016/S0092-8674(03)00603-2	http://dx.doi.org/10.1016/S0092-8674(03)00603-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914695	Bronze			2022-12-01	WOS:000184679200007
J	Lyss, SB; Kamb, ML; Peterman, TA; Moran, JS; Newman, DR; Bolan, G; Douglas, JM; Iatesta, M; Malotte, CK; Zenilman, JM; Ehret, J; Gaydos, C; Newhall, WJ				Lyss, SB; Kamb, ML; Peterman, TA; Moran, JS; Newman, DR; Bolan, G; Douglas, JM; Iatesta, M; Malotte, CK; Zenilman, JM; Ehret, J; Gaydos, C; Newhall, WJ		RESPECT Study Grp	Chlamydia trachomatis among patients infected with and treated for Neisseria gonorrhoeae in sexually transmitted disease clinics in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							NONGONOCOCCAL URETHRITIS; GENITAL INFECTIONS; ADOLESCENT WOMEN; VENEREAL-DISEASE; PREVALENCE; MEN; COINFECTION; URINE; TRACT; INTERVENTION	Background: For two decades, treatment guidelines for sexually transmitted diseases (STDs) have recommended empirical co-treatment for chlamydia when patients are treated for gonorrhea. Because the epidemiology of and diagnostic testing for STDs have changed over time, co-treatment may no longer be needed as a clinical or public health strategy. Objective: To assess the prevalence of chlamydia among patients at STD clinics who are infected with and treated for Neisseria gonorrhoeae and to determine whether co-treatment recommendations are still justified. Design: Cross-sectional analysis of data from a multisite study. Setting: Five public STD clinics (Baltimore, Maryland; Denver, Colorado; Long Beach, California; Newark, New Jersey; and San Francisco, California), July 1993 through October 1995. Patients: 3885 heterosexual patients (2184 men and 1701 women) who agreed to participate in a trial of counseling interventions and had conclusive results from diagnostic tests for gonorrhea and chlamydia performed routinely as part of the trial. Measurements: infection with Chlamydia trachomatis as determined by polymerase chain reaction. Results: Chlamydia trachomatis was detected in 20% (95% CI, 16% to 24%) of 411 men and 42% (CI, 35% to 50%) of 151 women with laboratory-confirmed N. gonorrhoeae. Chlamydia trachomatis was detected in 19% (CI, 15% to 22%) of 410 men and 35% (CI, 28% to 43%) of 154 women with treatment indications for gonorrhea who would not otherwise have been treated for chlamydia: chlamydia prevalence among these patients was significantly higher than among patients without treatment indications for either gonorrhea or chlamydia: 7% in men and 9% in women (relative risk, 2.58 [CI, 1.92 to 3.47] and 4.12 [CI, 3.05 to 5.57], respectively). Conclusion: The frequent presence of chlamydia among patients at STD clinics who received treatment for gonorrhea, including sex partners of gonorrhea-infected patients, supports continuing current recommendations for co-treatment.	Ctr Dis Control & Prevent, Off Commun, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; San Francisco Hlth Dept, San Francisco, CA USA; Denver Publ Hlth, Denver, CO USA; New Jersey State Dept Hlth, Newark, NJ USA; Calif State Univ Long Beach, Long Beach, CA 90840 USA; Baltimore City Dept Hlth, Baltimore, MD USA; Johns Hopkins Univ, Baltimore, MD 21218 USA	Centers for Disease Control & Prevention - USA; New Jersey Department of Health & Senior Services; California State University System; California State University Long Beach; Johns Hopkins University	Lyss, SB (corresponding author), Ctr Dis Control & Prevent, Off Commun, Natl Ctr HIV STD & TB Prevent, 1600 Clifton Rd NE,Mailstop E-07, Atlanta, GA 30333 USA.		Gaydos, Charlotte A./E-9937-2010					ALANI MD, 1977, BRIT J VENER DIS, V53, P88; [Anonymous], 2002, MMWR MORB MORTAL WKL, V51; ARYA OP, 1981, BRIT J VENER DIS, V57, P118; BIRO FM, 1995, CLIN PEDIATR, V34, P419, DOI 10.1177/000992289503400804; Black CM, 1997, CLIN MICROBIOL REV, V10, P160, DOI 10.1128/CMR.10.1.160; BOWIE WR, 1981, CAN MED ASSOC J, V124, P1477; BRUNHAM R, 1981, CLIN RES, V29, pA47; BURNS DCM, 1975, BRIT J VENER DIS, V51, P314; Carroll KC, 1998, J CLIN MICROBIOL, V36, P1630, DOI 10.1128/JCM.36.6.1630-1633.1998; *CDCP, 2000, TRACK HIDD EP TRENDS; *CDCP, 2002, SEX TRANS DIS SURV 2; Chernesky M, 1999, SEX TRANSM DIS, V26, pS8, DOI 10.1097/00007435-199904001-00003; CHOW JM, 2001, INT C SEX TRANSM INF; CHRISTMAS JT, 1989, OBSTET GYNECOL, V74, P295; Ciemins EL, 2000, SEX TRANSM DIS, V27, P249, DOI 10.1097/00007435-200005000-00002; Creighton S, 2003, INT J STD AIDS, V14, P109, DOI 10.1258/095646203321156872; David LM, 1997, INT J STD AIDS, V8, P311, DOI 10.1258/0956462971920154; DEVORE JL, 1991, PROBABILITY STAT ENG, P266; Dicker LW, 2003, SEX TRANSM DIS, V30, P472, DOI 10.1097/00007435-200305000-00016; Embling ML, 2000, ANN EMERG MED, V36, P28, DOI 10.1067/mem.2000.105930; GREYDANUS DE, 1980, J FAM PRACTICE, V10, P611; HANDSFIELD HH, 1997, INT C SEX TRANSM DIS; Hijazi L, 2002, SEX TRANSM INFECT, V78, P387, DOI 10.1136/sti.78.5.387; HILTON AL, 1974, BRIT J VENER DIS, V50, P1; HOLMES KK, 1975, NEW ENGL J MED, V292, P1199, DOI 10.1056/NEJM197506052922301; HOLMES KK, 1999, SEXUALLY TRANSMITTED; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; Lin JSL, 1998, J INFECT DIS, V178, P1707, DOI 10.1086/314485; LYCKE E, 1980, SEX TRANSM DIS, V7, P6, DOI 10.1097/00007435-198001000-00002; MARDH PA, 1980, BRIT J VENER DIS, V56, P327; Mehta SD, 2001, SEX TRANSM DIS, V28, P33, DOI 10.1097/00007435-200101000-00008; Mertz KJ, 1997, SEX TRANSM DIS, V24, P169, DOI 10.1097/00007435-199703000-00009; METCALF CA, 2002, 14 INT AIDS C BARC S; NAYYAR KC, 1976, BRIT J VENER DIS, V52, P396; Oh MK, 1998, ARCH PEDIAT ADOL MED, V152, P52; ORIEL JD, 1974, BRIT J VENER DIS, V50, P11; ORIEL JD, 1976, J INFECT DIS, V133, P568, DOI 10.1093/infdis/133.5.568; ORIEL JD, 1975, J INFECT DIS, V131, P376, DOI 10.1093/infdis/131.4.376; PERROUD HM, 1978, BRIT J VENER DIS, V54, P45; RICHMOND SJ, 1972, BRIT J VENER DIS, V48, P437; RUDEN AK, 1986, ACTA DERM-VENEREOL, V66, P453; SCHACHTER J, 1975, JAMA-J AM MED ASSOC, V231, P1252, DOI 10.1001/jama.231.12.1252; SMITH TF, 1978, AM J CLIN PATHOL, V70, P333; STAMM WE, 1984, NEW ENGL J MED, V310, P545, DOI 10.1056/NEJM198403013100901; SVENSSON L, 1981, BRIT J VENER DIS, V57, P259; TERHO P, 1978, BRIT J VENER DIS, V54, P326; WONG JL, 1977, SEX TRANSM DIS, V4, P4, DOI 10.1097/00007435-197701000-00002; WOOLFITT JMG, 1977, BRIT J VENER DIS, V53, P93; Xu KY, 1998, SEX TRANSM DIS, V25, P533, DOI 10.1097/00007435-199811000-00007; 2002, MMWR MORB MORTAL WKL, V51, P36; 1985, MMWR MORB MORTAL S3, V34, pS53; 1982, MMWR MORB MORTAL  S2, V31, pS33	53	58	63	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2003	139	3					178	185		10.7326/0003-4819-139-3-200308050-00007	http://dx.doi.org/10.7326/0003-4819-139-3-200308050-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707RH	12899585				2022-12-01	WOS:000184523300003
J	Liou, YC; Sun, A; Ryo, A; Zhou, XZ; Yu, ZX; Huang, HK; Uchida, T; Bronson, R; Bing, GY; Li, XJ; Hunter, T; Lu, KP				Liou, YC; Sun, A; Ryo, A; Zhou, XZ; Yu, ZX; Huang, HK; Uchida, T; Bronson, R; Bing, GY; Li, XJ; Hunter, T; Lu, KP			Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration	NATURE			English	Article							PAIRED HELICAL FILAMENTS; PROLINE-DIRECTED PHOSPHORYLATION; ALZHEIMERS-DISEASE; TRANSGENIC MICE; TAU-PROTEIN; NEUROFIBRILLARY TANGLES; P301L TAU; ISOMERIZATION; HYPERPHOSPHORYLATION; DEPHOSPHORYLATION	The neuropathological hallmarks of Alzheimer's disease and other tauopathies include senile plaques and/or neurofibrillary tangles(1-4). Although mouse models have been created by overexpressing specific proteins including beta-amyloid precursor protein, presenilin and tau(1-10), no model has been generated by gene knockout. Phosphorylation of tau and other proteins on serine or threonine residues preceding proline seems to precede tangle formation and neurodegeneration in Alzheimer's disease(11-14). Notably, these phospho(Ser/Thr)-Pro motifs exist in two distinct conformations, whose conversion in some proteins is catalysed by the Pin1 prolyl isomerase(15-17). Pin1 activity can directly restore the conformation and function of phosphorylated tau or it can do so indirectly by promoting its dephosphorylation, which suggests that Pin1 is involved in neurodegeneration(14,18,19); however, genetic evidence is lacking. Here we show that Pin1 expression is inversely correlated with predicted neuronal vulnerability and actual neurofibrillary degeneration in Alzheimer's disease. Pin1 knockout in mice causes progressive age-dependent neuropathy characterized by motor and behavioural deficits, tau hyperphosphorylation, tau filament formation and neuronal degeneration. Thus, Pin1 is pivotal in protecting against age-dependent neurodegeneration, providing insight into the pathogenesis and treatment of Alzheimer's disease and other tauopathies.	Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Canc Biol Program, Boston, MA 02215 USA; Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; Tohoku Univ, Dept Pathol, Sendai, Miyagi 9808575, Japan; Tufts Univ, Sch Vet Med, North Grafton, MA 01536 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Kentucky; Emory University; Salk Institute; Tohoku University; Tufts University	Lu, KP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Canc Biol Program, Boston, MA 02215 USA.		bing, guoying/F-7084-2012	Bing, Guoying/0000-0003-0609-8152; Uchida, Takafumi/0000-0003-3665-4906				Allen B, 2002, J NEUROSCI, V22, P9340; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; DAVIES DC, 1992, ACTA NEUROPATHOL, V83, P510, DOI 10.1007/BF00310028; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Gordon-Krajcer W, 2000, BRAIN RES, V856, P163, DOI 10.1016/S0006-8993(99)02391-4; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Holzer M, 2002, ACTA NEUROPATHOL, V104, P471, DOI 10.1007/s00401-002-0581-1; Husseman JW, 2000, NEUROBIOL AGING, V21, P815, DOI 10.1016/S0197-4580(00)00221-9; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Kins S, 2001, J BIOL CHEM, V276, P38193; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu KP, 2003, BIOESSAYS, V25, P174, DOI 10.1002/bies.10223; Lu PJ, 1999, NATURE, V399, P784; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Mandelkow EM, 1998, TRENDS CELL BIOL, V8, P425, DOI 10.1016/S0962-8924(98)01368-3; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Preuss U, 1998, EUR J CELL BIOL, V76, P176, DOI 10.1016/S0171-9335(98)80032-0; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Vincent I, 1998, NEUROBIOL AGING, V19, P287, DOI 10.1016/S0197-4580(98)00071-2; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; Wong PC, 2002, NAT NEUROSCI, V5, P633, DOI 10.1038/nn0702-633; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(05)00083-3	30	353	372	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					556	561		10.1038/nature01832	http://dx.doi.org/10.1038/nature01832			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891359				2022-12-01	WOS:000184454700044
J	Okada, Y; Higuchi, H; Hirokawa, N				Okada, Y; Higuchi, H; Hirokawa, N			Processivity of the single-headed kinesin KIF1A through biased binding to tubulin	NATURE			English	Article							SUPERFAMILY PROTEIN KIF1A; MOTOR PROTEIN; MECHANISM; MOLECULES; MICROTUBULES; TRANSPORT; MOVEMENT; ATPASE; MUTANT; STEPS	Conventional isoforms of the motor protein kinesin behave functionally not as 'single molecules' but as 'two molecules' paired. This dimeric structure poses a barrier to solving its mechanism(1-4). To overcome this problem, we used an unconventional kinesin KIF1A (refs 5, 6) as a model molecule. KIF1A moves processively as an independent monomer(7,8), and can also work synergistically as a functional dimer(9). Here we show, by measuring its movement with an optical trapping system(10), that a single ATP hydrolysis triggers a single stepping movement of a single KIF1A monomer. The step size is distributed stochastically around multiples of 8 nm with a gaussian-like envelope and a standard deviation of 15 nm. On average, the step is directional to the microtubule's plus-end against a load force of up to 0.15 pN. As the source for this directional movement, we show that KIF1A moves to the microtubule's plus-end by similar to3 nm on average on binding to the microtubule, presumably by preferential binding to tubulin on the plus-end side. We propose a simple physical formulation to explain the movement of KIF1A.	Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Tohoku Univ, Grad Sch Engn, Dept Met, Sendai, Miyagi 9808579, Japan; Tohoku Univ, Interdisciplinary Res Ctr, Sendai, Miyagi 9808579, Japan	University of Tokyo; Tohoku University; Tohoku University	Hirokawa, N (corresponding author), Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan.		Okada, Yasushi/N-5067-2015	Okada, Yasushi/0000-0003-2601-3689				Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; BERLINER E, 1995, NATURE, V373, P718, DOI 10.1038/373718a0; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; deCastro MJ, 2000, NAT CELL BIOL, V2, P724, DOI 10.1038/35036357; Endow SA, 2000, NATURE, V406, P913, DOI 10.1038/35022617; Farrell CM, 2002, J BIOL CHEM, V277, P17079, DOI 10.1074/jbc.M108793200; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Hackney DD, 2002, BIOCHEMISTRY-US, V41, P4437, DOI 10.1021/bi0159229; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; HOWARD J, 1993, METHOD CELL BIOL, V39, P105, DOI 10.1016/S0091-679X(08)60164-8; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; Inoue Y, 1997, P NATL ACAD SCI USA, V94, P7275, DOI 10.1073/pnas.94.14.7275; Julicher F, 1997, REV MOD PHYS, V69, P1269, DOI 10.1103/RevModPhys.69.1269; Kaseda K, 2002, P NATL ACAD SCI USA, V99, P16058, DOI 10.1073/pnas.252409199; Kikkawa M, 2000, CELL, V100, P241, DOI 10.1016/S0092-8674(00)81562-7; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Nishiyama M, 2002, NAT CELL BIOL, V4, P790, DOI 10.1038/ncb857; Nishiyama M, 2001, NAT CELL BIOL, V3, P425, DOI 10.1038/35070116; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104	25	137	142	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					574	577		10.1038/nature01804	http://dx.doi.org/10.1038/nature01804			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891363				2022-12-01	WOS:000184454700048
J	Schmitz, C; Perraud, AL; Johnson, CO; Inabe, K; Smith, MK; Penner, R; Kurosaki, T; Fleig, A; Scharenberg, AM				Schmitz, C; Perraud, AL; Johnson, CO; Inabe, K; Smith, MK; Penner, R; Kurosaki, T; Fleig, A; Scharenberg, AM			Regulation of vertebrate cellular Mg2+ Homeostasis by TRPM7	CELL			English	Article							MAGNESIUM TRANSPORT; ADP-RIBOSE; CHANNEL; PROTEIN; ION; MEMBRANE; LTRPC2; FAMILY; KINASE; YEAST	TRPM7 is a polypeptide with intrinsic ion channel and protein kinase domains whose targeted deletion causes cells to experience growth arrest within 24 hr and eventually die. Here, we show that while TRPM7's kinase domain is not essential for activation of its channel, a functional coupling exists such that structural alterations of the kinase domain alter the sensitivity of channel activation to Mg2+. Investigation of the relationship between Mg2+ and the cell biological role of TRPM7 revealed that TRPM7-deficient cells become Mg2+ deficient, that both the viability and proliferation of TRPM7-deficient cells are rescued by supplementation of extracellular Mg2+, and that the capacity of heterologously expressed TRPM7 mutants to complement TRPM7 deficiency correlates with their sensitivity to Mg2+. Overall, our results indicate that TRPM7 has a central role in Mg2+ homeostasis as a Mg2+ uptake pathway regulated through a functional coupling between its channel and kinase domains.	Univ Washington, Dept Immunol, Dept Pediat, Seattle, WA 98195 USA; Childrens Hosp & Reg Med Ctr, Seattle, WA 98195 USA; Natl Jewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA; Kansai Med Univ, Inst Liver Res, Dept Mol Genet, Osaka 5708506, Japan; RIKEN, Res Ctr Allergy & Immunol, Lab Lymphocyte Differentiat, Osaka, Japan; Univ Hawaii, Queens Med Ctr, Ctr Biomed Res, Lab Cell & Mol Signaling, Honolulu, HI 96813 USA; Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96813 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; National Jewish Health; Kansai Medical University; RIKEN; The Queen's Medical Center; University of Hawaii System; University of Hawaii System	Scharenberg, AM (corresponding author), Univ Washington, Dept Immunol, Dept Pediat, Seattle, WA 98195 USA.		Kurosaki, Tomohiro/D-1306-2009	Kurosaki, Tomohiro/0000-0002-6352-304X; Penner, Reinhold/0000-0002-5366-1537; Fleig, Andrea/0000-0001-8396-7249	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040927] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI64316] Funding Source: Medline; NIGMS NIH HHS [R01-GM065360] Funding Source: Medline; NINDS NIH HHS [R01-NS040927] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bui DM, 1999, J BIOL CHEM, V274, P20438, DOI 10.1074/jbc.274.29.20438; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Elliott AC, 2001, CELL CALCIUM, V30, P73, DOI 10.1054/ceca.2001.0215; Graschopf A, 2001, J BIOL CHEM, V276, P16216, DOI 10.1074/jbc.M101504200; Gregan J, 2001, MOL GEN GENET, V264, P773, DOI 10.1007/s004380000366; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hermosura MC, 2002, J PHYSIOL-LONDON, V539, P445, DOI 10.1113/jphysiol.2001.013361; Hofmann T, 2000, J MOL MED, V78, P14, DOI 10.1007/s001090050378; Li LG, 2001, PLANT CELL, V13, P2761, DOI 10.1105/tpc.13.12.2761; MacDiarmid CW, 1998, J BIOL CHEM, V273, P1727, DOI 10.1074/jbc.273.3.1727; MONTEILHZOLLER MK, 2003, J PHYSL, V121, P1; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; PERRAUD AL, 2003, CELL CALCIUM, V382, P1; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanov AG, 2002, FEBS LETT, V514, P26, DOI 10.1016/S0014-5793(02)02299-8; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Smith RL, 1998, MOL MICROBIOL, V28, P217, DOI 10.1046/j.1365-2958.1998.00810.x; Vennekens R, 2002, CELL CALCIUM, V31, P253, DOI 10.1016/S0143-4160(02)00055-6; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Zhang Y, 1998, EMBO J, V17, P7304, DOI 10.1093/emboj/17.24.7304	26	568	592	1	36	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 25	2003	114	2					191	200		10.1016/S0092-8674(03)00556-7	http://dx.doi.org/10.1016/S0092-8674(03)00556-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887921	Bronze			2022-12-01	WOS:000184378700009
J	Gozani, O; Karuman, P; Jones, DR; Ivanov, D; Cha, J; Lugovskoy, AA; Baird, CL; Zhu, H; Field, SJ; Lessnick, SL; Villasenor, J; Mehrotra, B; Chen, J; Rao, VR; Brugge, JS; Ferguson, CG; Payrastre, B; Myszka, DG; Cantley, LC; Wagner, G; Divecha, N; Prestwich, GD; Yuan, JY				Gozani, O; Karuman, P; Jones, DR; Ivanov, D; Cha, J; Lugovskoy, AA; Baird, CL; Zhu, H; Field, SJ; Lessnick, SL; Villasenor, J; Mehrotra, B; Chen, J; Rao, VR; Brugge, JS; Ferguson, CG; Payrastre, B; Myszka, DG; Cantley, LC; Wagner, G; Divecha, N; Prestwich, GD; Yuan, JY			The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor	CELL			English	Article							PLECKSTRIN-HOMOLOGY-DOMAIN; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; ZINC-FINGER; CELL-CYCLE; BINDING; DNA; COMPLEX; PTDINS(4,5)P-2; IDENTIFICATION; TRANSCRIPTION	Phosphoinositides (PtdInsPs) play critical roles in cytoplasmic signal transduction pathways. However, their functions in the nucleus are unclear, as specific nuclear receptors for PtdInsPs have not been identified. Here, we show that ING2, a candidate tumor suppressor protein, is a nuclear PtdInsP receptor. ING2 contains a plant homeodomain (PHD) finger, a motif common to many chromatin-regulatory proteins. We find that the PHD fingers of ING2 and other diverse nuclear proteins bind in vitro to PtdInsPs, including the rare PtdInsP species, phosphatidylinositol 5-phosphate (PtdIns(5)P). Further, we demonstrate that the ING2 PHD finger interacts with PtdIns(5)P in vivo and provide evidence that this interaction regulates the ability of ING2 to activate p53 and p53-dependent apoptotic pathways. Together, our data identify the PHD finger as a phosphoinositide binding module and a nuclear PtdInsP receptor, and suggest that PHD-phosphoinositide interactions directly regulate nuclear responses to DNA damage.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Univ Utah, Ctr Biomol Interact Anal, Salt Lake City, UT 84132 USA; Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Echelon Biosci Inc, Salt Lake City, UT 84108 USA; Hop Purpan, INSERM, U563, Dept Oncogenesis,IFR30, F-31059 Toulouse, France	Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah; Netherlands Cancer Institute; Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Yuan, JY (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	jyuan@hms.harvard.edu	Baird, Cheryl/AGM-0065-2022; Ivanov, Dmitri/B-4600-2011; Baird, Cheryl L/F-6569-2011; Gozani, Or P/I-6157-2013; Ferguson, Colin/AAY-2524-2021; Cantley, Lewis C/D-1800-2014	Ferguson, Colin/0000-0002-9021-4533; Cantley, Lewis C/0000-0002-1298-7653; divecha, nullin/0000-0001-9695-6039; Gozani, Or/0000-0002-1365-4463; , Bernard/0000-0002-8693-0190; Field, Seth/0000-0002-8893-4806; Zhu, Hong/0000-0002-2575-4031	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R41GM057705, R42GM057705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016674, K08AG019245] Funding Source: NIH RePORTER; NIA NIH HHS [KO8AG19245, AG16674] Funding Source: Medline; NIGMS NIH HHS [GM36624, GM57705] Funding Source: Medline; NINDS NIH HHS [NS29632] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Aravind L, 2003, CELL CYCLE, V2, P123, DOI 10.4161/cc.2.2.335; Boronenkov IV, 1998, MOL BIOL CELL, V9, P3547, DOI 10.1091/mbc.9.12.3547; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Capili AD, 2001, EMBO J, V20, P165, DOI 10.1093/emboj/20.1.165; Chen RY, 2002, J HISTOCHEM CYTOCHEM, V50, P697, DOI 10.1177/002215540205000511; Clarke JH, 2001, BIOCHEM J, V357, P905, DOI 10.1042/0264-6021:3570905; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Degterev A, 2001, NAT CELL BIOL, V3, P173, DOI 10.1038/35055085; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; DOWLER S, 2002, PROTEIN LIPID OVERLA; Ellson CD, 2001, NAT CELL BIOL, V3, P679, DOI 10.1038/35083076; Feng XL, 2002, TRENDS CELL BIOL, V12, P532, DOI 10.1016/S0962-8924(02)02391-7; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fyodorov DV, 2002, MOL CELL BIOL, V22, P6344, DOI 10.1128/MCB.22.18.6344-6353.2002; Garkavtsev I, 1998, NATURE, V391, P295, DOI 10.1038/34675; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Hanakahi LA, 2002, EMBO J, V21, P2038, DOI 10.1093/emboj/21.8.2038; Hurley JH, 2000, ANNU REV BIOPH BIOM, V29, P49, DOI 10.1146/annurev.biophys.29.1.49; IRVINE R, 2000, NUCL LIPID SIGNALING; James SR, 1996, BIOCHEM J, V315, P709, DOI 10.1042/bj3150709; Kalkhoven E, 2002, MOL CELL BIOL, V22, P1961, DOI 10.1128/MCB.22.7.1961-1970.2002; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kutateladze T, 2001, SCIENCE, V291, P1793, DOI 10.1126/science.291.5509.1793; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Lau WTW, 1998, GENETICS, V150, P1349; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Ma YM, 2002, J BIOL CHEM, V277, P10756, DOI 10.1074/jbc.C200030200; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Misra S, 2001, CELL, V107, P559, DOI 10.1016/S0092-8674(01)00594-3; Morris JB, 2000, FEBS LETT, V475, P57, DOI 10.1016/S0014-5793(00)01625-2; Nagashima M, 2001, P NATL ACAD SCI USA, V98, P9671, DOI 10.1073/pnas.161151798; Niebuhr K, 2002, EMBO J, V21, P5069, DOI 10.1093/emboj/cdf522; Osborne SL, 2001, J CELL SCI, V114, P2501; Pascual J, 2000, J MOL BIOL, V304, P723, DOI 10.1006/jmbi.2000.4308; Payrastre B, 2001, CELL SIGNAL, V13, P377, DOI 10.1016/S0898-6568(01)00158-9; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Rao VR, 1999, J BIOL CHEM, V274, P37893, DOI 10.1074/jbc.274.53.37893; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Schaletzky J, 2003, CURR BIOL, V13, P504, DOI 10.1016/S0960-9822(03)00132-5; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Shimada Y, 1998, CYTOGENET CELL GENET, V83, P232, DOI 10.1159/000015188; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Stenmark H, 2002, FEBS LETT, V513, P77, DOI 10.1016/S0014-5793(01)03308-7; Tanaka K, 1999, J BIOL CHEM, V274, P3919, DOI 10.1074/jbc.274.7.3919; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Yokogawa T, 2000, FEBS LETT, V473, P222, DOI 10.1016/S0014-5793(00)01535-0; York JD, 2001, ADV ENZYME REGUL, V41, P57, DOI 10.1016/S0065-2571(00)00025-X; Zhang XL, 1997, J BIOL CHEM, V272, P17756, DOI 10.1074/jbc.272.28.17756; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	56	399	414	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2003	114	1					99	111		10.1016/S0092-8674(03)00480-X	http://dx.doi.org/10.1016/S0092-8674(03)00480-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	702JC	12859901	Bronze			2022-12-01	WOS:000184219900009
J	Zavialov, AV; Ehrenberg, M				Zavialov, AV; Ehrenberg, M			Peptidyl-tRNA regulates the GTPase activity of translation factors	CELL			English	Article							ELONGATION-FACTOR-G; RIBOSOME RECYCLING FACTOR; ESCHERICHIA-COLI RIBOSOME; INITIATION-FACTOR IF2; RELEASE FACTORS; 70S RIBOSOME; TERMINATION COMPLEX; PROTEIN-SYNTHESIS; BINDING-SITES; GGQ MOTIF	Rapid protein synthesis in bacteria requires the G proteins IF2, EF-Tu, EF-G, and RF3. These factors catalyze all major steps of mRNA translation in a GTP-dependent manner. Here, it is shown how the position of peptidyl-tRNA in the ribosome and presence of its peptide control the binding and GTPase activity of these translation factors. The results explain how idling GTPase activity and negative interference between different translation factors are avoided and suggest that hybrid sites for tRNA on the ribosome play essential roles in translocation of tRNAs, recycling of class 1 release factors by RF3, and recycling of ribosomes back to a new round of initiation. We also propose a model for translocation of tRNAs in two separate steps, which clarifies the roles of EF-G(.)GTP and GTP hydrolysis in this process.	Uppsala Univ, BMC, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden	Uppsala University	Zavialov, AV (corresponding author), Uppsala Univ, BMC, Dept Cell & Mol Biol, Box 596, S-75124 Uppsala, Sweden.			Zavialov, Andrey/0000-0001-6420-0368				Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Borowski C, 1996, P NATL ACAD SCI USA, V93, P4202, DOI 10.1073/pnas.93.9.4202; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BRETSCHER MS, 1968, NATURE, V218, P675, DOI 10.1038/218675a0; BURNS K, 1974, FEBS LETT, V40, P219, DOI 10.1016/0014-5793(74)80932-4; Cameron DM, 2002, J MOL BIOL, V319, P27, DOI 10.1016/S0022-2836(02)00235-8; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Hirokawa G, 2002, EMBO J, V21, P2272, DOI 10.1093/emboj/21.9.2272; INOUEYOKOSAWA N, 1974, J BIOL CHEM, V249, P4321; Karimi R, 1999, MOL CELL, V3, P601, DOI 10.1016/S1097-2765(00)80353-6; Katunin VI, 2002, BIOCHEMISTRY-US, V41, P12806, DOI 10.1021/bi0264871; Kisselev L, 2003, EMBO J, V22, P175, DOI 10.1093/emboj/cdg017; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; LAALAMI S, 1991, BIOCHIMIE, V73, P1557, DOI 10.1016/0300-9084(91)90191-3; Lancaster L, 2002, CELL, V111, P129, DOI 10.1016/S0092-8674(02)00938-8; LILL R, 1986, BIOCHEMISTRY-US, V25, P3245, DOI 10.1021/bi00359a025; Marquez V, 2002, BIOCHEM SOC T, V30, P133, DOI 10.1042/BST0300133; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Mora L, 2003, MOL MICROBIOL, V47, P267, DOI 10.1046/j.1365-2958.2003.03301.x; Noller HF, 2002, FEBS LETT, V514, P11, DOI 10.1016/S0014-5793(02)02327-X; Pavlov MY, 1997, EMBO J, V16, P4134, DOI 10.1093/emboj/16.13.4134; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; RUUSALA T, 1982, EMBO J, V1, P741, DOI 10.1002/j.1460-2075.1982.tb01240.x; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; THOMPSON RC, 1977, P NATL ACAD SCI USA, V74, P198, DOI 10.1073/pnas.74.1.198; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Wower J, 2000, J BIOL CHEM, V275, P37887, DOI 10.1074/jbc.M005031200; Wu XQ, 1997, J BIOL CHEM, V272, P1891, DOI 10.1074/jbc.272.3.1891; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6	34	112	117	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 11	2003	114	1					113	122		10.1016/S0092-8674(03)00478-1	http://dx.doi.org/10.1016/S0092-8674(03)00478-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	702JC	12859902	Bronze			2022-12-01	WOS:000184219900010
J	Chen, XM				Chen, XM			A microRNA as a translational repressor of APETALA2 in Arabidopsis flower development	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; EXPRESSION; PROTEIN; TARGETS; PLANTS; MIRNA; HEN1	Plant microRNAs ( miRNAs) show a high degree of sequence complementarity to, and are believed to guide the cleavage of, their target messenger RNAs. Here, I show that miRNA172, which can base-pair with the messenger RNA of a. oral homeotic gene, APETALA2, regulates APETALA2 expression primarily through translational inhibition. Elevated miRNA172 accumulation results in. oral organ identity defects similar to those in loss-of-function apetala2 mutants. Elevated levels of mutant APETALA2 RNA with disrupted miRNA172 base pairing, but not wild-type APETALA2 RNA, result in elevated levels of APETALA2 protein and severe. oral patterningdefects. Therefore, miRNA172 likely acts in cell-fate specification as a translational repressor of APETALA2 in Arabidopsis flower development.	Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Chen, XM (corresponding author), Rutgers State Univ, Waksman Inst, POB 759, Piscataway, NJ 08854 USA.	xuemei@waksman.rutgers.edu		Chen, Xuemei/0000-0002-5209-1157	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM61146, R01 GM061146] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061146] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; AUKERMAN M, PLANT CELL, V15, P2730; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Chen X., UNPUB; Chen XM, 2002, DEVELOPMENT, V129, P1085; Chen XM, 1999, MOL CELL, V3, P349, DOI 10.1016/S1097-2765(00)80462-1; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lohmann JU, 2002, DEV CELL, V2, P135, DOI 10.1016/S1534-5807(02)00122-3; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1	19	1284	1479	20	262	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2004	303	5666					2022	2025		10.1126/science.1088060	http://dx.doi.org/10.1126/science.1088060			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806JI	12893888	Green Accepted			2022-12-01	WOS:000220429800043
J	Lee, CH; Chawla, A; Urbiztondo, N; Liao, D; Boisvert, WA; Evans, RM				Lee, CH; Chawla, A; Urbiztondo, N; Liao, D; Boisvert, WA; Evans, RM			Transcriptional repression of atherogenic inflammation: Modulation by PPAR delta	SCIENCE			English	Article							REDUCES ATHEROSCLEROSIS; GENE-EXPRESSION; DEFICIENT MICE; MACROPHAGES; GAMMA; BCL-6; COREPRESSOR; ABSENCE	The formation of an atherosclerotic lesion is mediated by lipid-laden macrophages (foam cells), which also establish chronic inflammation associated with lesion progression. The peroxisome proliferator-activated receptor (PPAR) gamma promotes lipid uptake and efflux in these atherogenic cells. In contrast, we found that the closely related receptor PPARdelta controls the inflammatory status of the macrophage. Deletion of PPARdelta from foam cells increased the availability of inflammatory suppressors, which in turn reduced atherosclerotic lesion area by more than 50%. We propose an unconventional ligand-dependent transcriptional pathway in which PPARdelta controls an inflammatory switch through its association and disassociation with transcriptional repressors. PPARdelta and its ligands may thus serve as therapeutic targets to attenuate inflammation and slow the progression of atherosclerosis.	Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA; Brigham & Womens Hosp, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Salk Institute; Harvard University; Brigham & Women's Hospital	Evans, RM (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Evans, Ronald/AAF-4001-2019; Lee, Chih-Hao/E-9635-2018	Evans, Ronald/0000-0002-9986-5965; Lee, Chih-Hao/0000-0002-3898-6421	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069474] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL69474] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Chawla A, 2003, P NATL ACAD SCI USA, V100, P1268, DOI 10.1073/pnas.0337331100; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Dawson TC, 1999, ATHEROSCLEROSIS, V143, P205; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Huynh KD, 2000, GENE DEV, V14, P1810; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Lee C., UNPUB; Lee CH, 2002, TRENDS ENDOCRIN MET, V13, P331, DOI 10.1016/S1043-2760(02)00668-9; Lemercier C, 2002, J BIOL CHEM, V277, P22045, DOI 10.1074/jbc.M201736200; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Steinberg D, 2002, NAT MED, V8, P1211, DOI 10.1038/nm1102-1211; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Toney LM, 2000, NAT IMMUNOL, V1, P214, DOI 10.1038/79749; Vosper H, 2001, J BIOL CHEM, V276, P44258, DOI 10.1074/jbc.M108482200	22	482	519	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2003	302	5644					453	457		10.1126/science.1087344	http://dx.doi.org/10.1126/science.1087344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UD	12970571				2022-12-01	WOS:000185963200045
J	Roberts, SE; Goldacre, MJ				Roberts, SE; Goldacre, MJ			Time trends and demography of mortality after fractured neck of femur in an English population, 1968-98: database study	BRITISH MEDICAL JOURNAL			English	Article							PROXIMAL FEMORAL FRACTURE; HIP FRACTURE; STROKE INCIDENCE; MONICA PROJECT; CORONARY-EVENT; CASE-FATALITY; SURVIVAL; ENGLAND; RATES; ADMISSIONS	Objectives To investigate time trends in mortality after admission to hospital for fractured neck of femur from 1968 to 1998, and to report on the effects of demographic factors on mortality. Design Analysis of hospital inpatient statistics for fractured neck of femur, incorporating linkage to death certificates. Setting Four counties in southern England. Subjects 32 590 people aged 65 years or over admitted to hospital with fractured neck of femur between 1968 and 1998. Main outcome measures Case fatality nates at 30,90, and 365 days after admission, and standardised mortality ratios at monthly intervals up to one year after admission. Results Case fatality rates declined between the 1960s and the early 1980s, but there was no appreciable fall thereafter. They increased sharply with increasing age: for example, fatality rates at 30 days in 1984-98 increased from 4% in men aged 64-69 years to 3 1 % in those aged greater than or equal to90. They were higher in men than women, and in social classes IV and V than in classes I and R. In the first month after fracture, standardised mortality ratios in women were 16 times higher, and those in men 12 times higher, than mortality in the same age group in the general population Conclusions The high mortality rates, and the fact that they have not fallen over the past 20 years, reinforce the need for measures to prevent osteoporosis and falls and their consequences in elderly people. Whether post-fracture mortality has fallen to an irreducible minimum, or whether further decline is possible, is unclear.	Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England	University of Oxford	Roberts, SE (corresponding author), Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England.							Balacco Giuseppe, 2000, Molecular Biology Today, V1, P23; Balasegaram S, 2001, J PUBLIC HEALTH MED, V23, P11, DOI 10.1093/pubmed/23.1.11; BERINGER TRO, 1991, ULSTER MED J, V60, P28; BOEREBOOM FTJ, 1992, NETH J MED, V41, P4; BOYCE WJ, 1985, LANCET, V1, P150; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; Evans JG, 1997, J EPIDEMIOL COMMUN H, V51, P424, DOI 10.1136/jech.51.4.424; EVANS JG, 1979, AGE AGEING, V8, P246, DOI 10.1093/ageing/8.4.246; FALCH JA, 1993, BONE, V14, P643, DOI 10.1016/8756-3282(93)90086-P; Fitzpatrick P, 2001, IRISH J MED SCI, V170, P49, DOI 10.1007/BF03167722; Goldacre MJ, 2002, BRIT MED J, V325, P868, DOI 10.1136/bmj.325.7369.868; HEDLUND R, 1987, CLIN ORTHOP RELAT R, P132; Kannus P, 1999, LANCET, V353, P802, DOI 10.1016/S0140-6736(98)04235-4; KEENE GS, 1993, BRIT MED J, V307, P1248, DOI 10.1136/bmj.307.6914.1248; LAU EMC, 1993, MED J AUSTRALIA, V158, P604, DOI 10.5694/j.1326-5377.1993.tb137627.x; *ORG EC COOP DEV, 2003, DIS BAS COMP HLTH SY; SEAGROATT V, 1991, BRIT MED J, V303, P1431, DOI 10.1136/bmj.303.6815.1431; SPECTOR TD, 1990, BRIT MED J, V300, P1173, DOI 10.1136/bmj.300.6733.1173; THORVALDSEN P, 1995, STROKE, V26, P361, DOI 10.1161/01.STR.26.3.361; TODD CJ, 1995, BRIT MED J, V310, P904, DOI 10.1136/bmj.310.6984.904; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; Volmink JA, 1998, HEART, V80, P40, DOI 10.1136/hrt.80.1.40; Walker N, 1999, NEW ZEAL MED J, V112, P269; WEATHERALL M, 1994, NEW ZEAL MED J, V107, P308; Wolfe CDA, 2000, STROKE, V31, P2074, DOI 10.1161/01.STR.31.9.2074	25	222	232	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 4	2003	327	7418					771	774		10.1136/bmj.327.7418.771	http://dx.doi.org/10.1136/bmj.327.7418.771			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729ZQ	14525871	Green Published, Bronze			2022-12-01	WOS:000185805100015
J	Skinner, J; Weinstein, JN; Sporer, SM; Wennberg, JE				Skinner, J; Weinstein, JN; Sporer, SM; Wennberg, JE			Racial, ethnic, and geographic disparities in rates of knee arthroplasty among Medicare patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; RESIDENTIAL SEGREGATION; REVASCULARIZATION PROCEDURES; DECISION-MAKING; UNITED-STATES; HEALTH-CARE; FOLLOW-UP; TOTAL HIP; OSTEOARTHRITIS; REPLACEMENT	BACKGROUND: There are large variations in the use of knee arthroplasty among Medicare enrollees according to race or ethnic group and sex. Are racial and ethnic disparities more pronounced in some regions than in others, and if so, why? METHODS: We used all Medicare fee-for-service claims data for 1998 through 2000 to determine the incidence of knee arthroplasty according to Hospital Referral Region, sex, and race or ethnic group. A total of 430,726 knee arthroplasties were performed during the three-year study period. RESULTS: At the national level, the annual rate of knee arthroplasty was higher for non-Hispanic white women (5.97 procedures per 1000) than for Hispanic women (5.37 per 1000) and black women (4.84 per 1000). The rate for non-Hispanic white men (4.82 procedures per 1000) was higher than that for Hispanic men (3.46 per 1000) and more than double that for black men (1.84 per 1000). The rates were significantly lower for black men than for non-Hispanic white men in nearly every region of the country (P<0.05). For the Hispanic population and for black women, racial or ethnic disparities at the national level were due in part to geographic differences rather than to differences in the rates for different racial and ethnic groups within geographic areas. Residential segregation and low income levels contributed to racial and ethnic disparities in arthroplasty rates. CONCLUSIONS: In the Medicare population, the rate of surgical treatment for osteoarthritis of the knee varies dramatically according to sex, race or ethnic group, and region. These variations underscore the importance of geography and sex in determining racial or ethnic barriers to health care.	Dartmouth Hitchcock Med Ctr, Dept Orthoped, Lebanon, NH 03756 USA; Dartmouth Coll Sch Med, Ctr Evaluat Clin Sci & Community & Family Med, Lebanon, NH USA; Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA	Dartmouth College; Dartmouth College; Dartmouth College; National Bureau of Economic Research	Weinstein, JN (corresponding author), Dartmouth Hitchcock Med Ctr, Dept Orthoped, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	james.weinstein@dartmouth.edu	Sporer, Scott/AAQ-6186-2020		NIAMS NIH HHS [60-AR048094-01A1, U01-AR45444-01A1] Funding Source: Medline; NIA NIH HHS [P01 AG019783-03, KO1 AG00752, P01 AG19783, P01 AG019783] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR048094, U01AR045444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019783, K01AG000752] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Acevedo-Garcia D, 2000, SOC SCI MED, V51, P1143, DOI 10.1016/S0277-9536(00)00016-2; ALTONJI J, 2000, HDB LABOR EC C, V3; ANDERSON JJ, 1988, AM J EPIDEMIOL, V128, P179, DOI 10.1093/oxfordjournals.aje.a114939; Arday SL, 2000, HEALTH CARE FINANC R, V21, P107; AYANIAN JZ, 1993, JAMA-J AM MED ASSOC, V269, P2642, DOI 10.1001/jama.269.20.2642; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; BLINDER AS, 1973, J HUM RESOUR, V8, P436, DOI 10.2307/144855; Callaghan JJ, 2000, J BONE JOINT SURG AM, V82A, P487, DOI 10.2106/00004623-200004000-00004; CHANDRA A, 2003, 9513 NAT BUR EC RES; Cromley EK., 2002, GIS PUBLIC HLTH; Deaton A., 1997, The analysis of household surveys: a microeconometric approach to development policy.; *DEP COMM, 2002, CENS 2000 SUMM FIL 3; DIEHR P, 1992, MED CARE, V30, P484, DOI 10.1097/00005650-199206000-00003; Duncan OD, 1955, AM SOCIOL REV, V20, P210, DOI 10.2307/2088328; Escalante A, 2000, ARTHRITIS RHEUM-US, V43, P390, DOI 10.1002/1529-0131(200002)43:2<390::AID-ANR20>3.0.CO;2-R; Ferguson JA, 1998, ARCH INTERN MED, V158, P1450, DOI 10.1001/archinte.158.13.1450; FISHER L, 1993, BIOSTATISTICS METHOD, P769; FORMAN MD, 1983, J RHEUMATOL, V10, P282; GLAESER E, 2001, SURVEY SERIES RACIAL, P1; Gomes C, 2001, IDENTIFYING SOURCES; Hawker G, 1998, J BONE JOINT SURG AM, V80A, P163, DOI 10.2106/00004623-199802000-00003; Hawker GA, 2000, NEW ENGL J MED, V342, P1016, DOI 10.1056/NEJM200004063421405; Hawker GA, 2001, MED CARE, V39, P206, DOI 10.1097/00005650-200103000-00002; Hirsch R, 2001, ARTHRITIS RHEUM, V44, pS225; Ibrahim SA, 2001, ARTHRIT RHEUM-ARTHR, V45, P340, DOI 10.1002/1529-0131(200108)45:4<340::AID-ART346>3.0.CO;2-5; Ibrahim SA, 2002, MED CARE, V40, P44; Institute of Medicine, 2002, UNEQUAL TREATMENT WH; KATZ JN, 1994, ARTHRITIS RHEUM, V37, P687, DOI 10.1002/art.1780370512; Katz JN, 2001, JAMA-J AM MED ASSOC, V286, P1506, DOI 10.1001/jama.286.12.1506; Lavernia CJ, 1997, CLIN ORTHOP RELAT R, P134; MASSEY DS, 1988, SOC FORCES, V67, P281, DOI 10.2307/2579183; MIYASAKA KC, 1997, CLIN ORTHOP RELAT R, V345, P29; OAXACA RL, 1975, J HUM RESOUR, V10, P529, DOI 10.2307/144990; Petersen LA, 2002, MED CARE, V40, P86; Peterson ED, 1997, NEW ENGL J MED, V336, P480, DOI 10.1056/NEJM199702133360706; PETERSON MGE, 1992, J BONE JOINT SURG AM, V74A, P1530, DOI 10.2106/00004623-199274100-00012; Phelan EA, 2001, SPINE, V26, P206, DOI 10.1097/00007632-200101150-00016; Polednak AP, 1996, AM J PUBLIC HEALTH, V86, P723, DOI 10.2105/AJPH.86.5.723; Schneider EC, 2001, ANN INTERN MED, V135, P328, DOI 10.7326/0003-4819-135-5-200109040-00009; Schulman KA, 1999, NEW ENGL J MED, V340, P1130; Schwartz LM, 1999, NEW ENGL J MED, V341, P279, DOI 10.1056/NEJM199907223410411; Sedlis SP, 1997, J CLIN EPIDEMIOL, V50, P899, DOI 10.1016/S0895-4356(97)00089-9; WEINSTEIN J, 2000, DARTMOUTH ATLAS MUSC; Weinstein JN, 2000, SPINE, V25, P1; WENNBERG J, 1986, NEW ENGL J MED, V314, P310, DOI 10.1056/NEJM198601303140509; Wennberg JE, 1999, DARTMOUTH ATLAS HLTH; WHITTLE J, 1993, NEW ENGL J MED, V329, P621, DOI 10.1056/NEJM199308263290907; Wilson Marcus Garvey, 1994, Ethnicity and Disease, V4, P57	48	402	403	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2003	349	14					1350	1359		10.1056/NEJMsa021569	http://dx.doi.org/10.1056/NEJMsa021569			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	727EM	14523144				2022-12-01	WOS:000185644000011
J	Tucker, T; Slack, C				Tucker, T; Slack, C			Not if but how? Caring for HIV-1 vaccine trial participants in South Africa	LANCET			English	Editorial Material									S African AIDS Vaccine Initiat, ZA-7505 Tygerberg, South Africa; Univ Natal, HIV AIDS Vaccines Eth Grp, ZA-3200 Pietermaritzburg, South Africa	University of Kwazulu Natal	Tucker, T (corresponding author), S African AIDS Vaccine Initiat, POB 19070, ZA-7505 Tygerberg, South Africa.							Benatar SR, 2000, BMJ-BRIT MED J, V321, P824, DOI 10.1136/bmj.321.7264.824	1	15	15	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 20	2003	362	9388					995	995		10.1016/S0140-6736(03)14374-7	http://dx.doi.org/10.1016/S0140-6736(03)14374-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724LT	14513854				2022-12-01	WOS:000185489600027
J	Chen, JG; Willard, FS; Huang, J; Liang, JS; Chasse, SA; Jones, AM; Siderovski, DP				Chen, JG; Willard, FS; Huang, J; Liang, JS; Chasse, SA; Jones, AM; Siderovski, DP			A seven-transmembrane RGS protein that modulates plant cell proliferation	SCIENCE			English	Article							HETEROTRIMERIC G-PROTEIN; ALPHA-SUBUNIT; ARABIDOPSIS; REGULATOR; EXPRESSION; GPA1	G protein coupled receptors (GPCRs) at the cell surface activate heterotrimeric G proteins by inducing the G protein alpha (Galpha) subunit to exchange guanosine diphosphate for guanosine triphosphate. Regulators of G protein signaling (RGS) proteins accelerate the deactivation of Galpha subunits to reduce GPCR signaling. Here we identified an RGS protein (AtRGS1) in Arabidopsis that has a predicted structure similar to a GPCR as well as an RGS box with GTPase accelerating activity. Expression of AtRGS1 complemented the pheromone supersensitivity phenotype of a yeast RGS mutant, sst2Delta. Loss of AtRGS1 increased the activity of the Arabidopsis Galpha subunit, resulting in increased cell elongation in hypocotyls in darkness and increased cell production in roots grown in light. These findings suggest that AtRGS1 is a critical modulator of plant cell proliferation.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Yangzhou Univ, Coll Biosci & Biotechnol, Yangzhou 225009, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Yangzhou University	Jones, AM (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	alan_jones@unc.edu	Chen, Jin-Gui/A-4773-2011; Chen, Jin-Gui/AFV-6337-2022; Siderovski, David Peter/AAA-9603-2019	Chen, Jin-Gui/0000-0002-1752-4201; Chen, Jin-Gui/0000-0002-1752-4201; Siderovski, David Peter/0000-0002-0688-8210	NIGMS NIH HHS [R01 GM065989-02, GM62338, GM65533, R01 GM065989, R01 GM065989-04, R01 GM065989-03, R01 GM065989-01, GM055316, GM65989] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM055316, R01GM065989, R01GM062338, R01GM055316, P01GM065533] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Assmann SM, 2002, PLANT CELL, V14, pS355, DOI 10.1105/tpc.001792; de Alba E, 1999, J MOL BIOL, V291, P927, DOI 10.1006/jmbi.1999.2989; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; HUANG H, 1994, INT J PLANT SCI, V155, P3, DOI 10.1086/297142; Jones AM, 2003, PLANT PHYSIOL, V131, P1623, DOI 10.1104/pp.102.017624; Jones AM, 2002, CURR OPIN PLANT BIOL, V5, P402, DOI 10.1016/S1369-5266(02)00288-1; Kim MC, 2002, NATURE, V416, P447, DOI 10.1038/416447a; Kimple RJ, 2003, COMB CHEM HIGH T SCR, V6, P399; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040	18	241	266	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2003	301	5640					1728	1731		10.1126/science.1087790	http://dx.doi.org/10.1126/science.1087790			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722QN	14500984				2022-12-01	WOS:000185387700046
J	Pintard, L; Willis, JH; Willems, A; Johnson, JLF; Srayko, M; Kurz, T; Glaser, S; Mains, PE; Tyers, M; Bowerman, B; Peter, M				Pintard, L; Willis, JH; Willems, A; Johnson, JLF; Srayko, M; Kurz, T; Glaser, S; Mains, PE; Tyers, M; Bowerman, B; Peter, M			The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitin-ligase	NATURE			English	Article							CAENORHABDITIS-ELEGANS; DEGRADATION; GENE; FAMILY; MEI-1; COMPLEX; TARGET; MEMBER	Many biological processes, such as development and cell cycle progression are tightly controlled by selective ubiquitin-dependent degradation of key substrates. In this pathway, the E3-ligase recognizes the substrate and targets it for degradation by the 26S proteasome. The SCF (Skp1-Cul1-F-box) and ECS (Elongin C-Cul2-SOCS box) complexes are two well-defined cullin-based E3-ligases(1-3). The cullin subunits serve a scaffolding function and interact through their C terminus with the RING-finger-containing protein Hrt1/Roc1/Rbx1, and through their N terminus with Skp1 or Elongin C, respectively. In Caenorhabditis elegans, the ubiquitin-ligase activity of the CUL-3 complex is required for degradation of the microtubule-severing protein MEI-1/katanin at the meiosis-to-mitosis transition(4). However, the molecular composition of this cullin-based E3-ligase is not known. Here we identified the BTB-containing protein MEL-26 as a component required for degradation of MEI-1 in vivo. Importantly, MEL-26 specifically interacts with CUL-3 and MEI-1 in vivo and in vitro, and displays properties of a substrate-specific adaptor. Our results suggest that BTB-containing proteins may generally function as substrate-specific adaptors in Cul3-based E3-ubiquitin ligases.	ETH Honggerberg, Inst Biochem, CH-8093 Zurich, Switzerland; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med Genet & Microbiol, Toronto, ON M5G 1X5, Canada; Univ Calgary, Genes & Dev Res Grp, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Oregon; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Calgary; University of Calgary	Pintard, L (corresponding author), ETH Honggerberg, Inst Biochem, CH-8093 Zurich, Switzerland.	lionel.pintard@bc.biol.ethz.ch; matthias.peter@bc.biol.ethz.ch	Tyers, Michael/ABE-3194-2021; pintard, lionel/AAD-8356-2020; PINTARD, Lionel/AAP-7361-2020; PINTARD, Lionel/H-3756-2018; Srayko, Martin/A-3755-2014; Kurz, Thimo/E-4116-2012	PINTARD, Lionel/0000-0003-0286-4630; PINTARD, Lionel/0000-0003-0286-4630; Kurz, Thimo/0000-0003-0700-6993; Peter, Matthias/0000-0002-2160-6824; Srayko, Martin/0000-0003-0196-0364				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ausubel FM, 1991, CURRENT PROTOCOLS MO; Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; BRENNER S, 1974, GENETICS, V77, P71; CLARKMAGUIRE S, 1994, GENETICS, V136, P533; CLARKMAGUIRE S, 1994, J CELL BIOL, V126, P199, DOI 10.1083/jcb.126.1.199; Dow MR, 1998, GENETICS, V150, P119; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; HARPER JW, 1993, CELL, V75, P805; Kurz T, 2002, SCIENCE, V295, P1294, DOI 10.1126/science.1067765; MAINS PE, 1990, GENETICS, V126, P593; Pintard L, 2003, CURR BIOL, V13, P911, DOI 10.1016/S0960-9822(03)00336-1; Robinson DN, 1997, J CELL BIOL, V138, P799, DOI 10.1083/jcb.138.4.799; SALAMA SR, 1994, MOL CELL BIOL, V14, P7953, DOI 10.1128/MCB.14.12.7953; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Seibert V, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-22; Soltysik-Espanola M, 1999, MOL BIOL CELL, V10, P2361, DOI 10.1091/mbc.10.7.2361; Srayko M, 2000, GENE DEV, V14, P1072; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; Wolf DA, 1999, CURR BIOL, V9, P373, DOI 10.1016/S0960-9822(99)80165-1; XU L, 2003, NATURE          0903, DOI DOI 10.1038/NATURE01985; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	27	337	351	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2003	425	6955					311	316		10.1038/nature01959	http://dx.doi.org/10.1038/nature01959			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722JA	13679921				2022-12-01	WOS:000185370900049
J	Quigg, A; Finkel, ZV; Irwin, AJ; Rosenthal, Y; Ho, TY; Reinfelder, JR; Schofield, O; Morel, FMM; Falkowski, PG				Quigg, A; Finkel, ZV; Irwin, AJ; Rosenthal, Y; Ho, TY; Reinfelder, JR; Schofield, O; Morel, FMM; Falkowski, PG			The evolutionary inheritance of elemental stoichiometry in marine phytoplankton	NATURE			English	Article							CADMIUM; ZINC	Phytoplankton is a nineteenth century ecological construct for a biologically diverse group of pelagic photoautotrophs that share common metabolic functions but not evolutionary histories(1). In contrast to terrestrial plants, a major schism occurred in the evolution of the eukaryotic phytoplankton that gave rise to two major plastid superfamilies(2-4). The green superfamily appropriated chlorophyll b, whereas the red superfamily uses chlorophyll c as an accessory photosynthetic pigment(5). Fossil evidence suggests that the green superfamily dominated Palaeozoic oceans. However, after the end-Permian extinction, members of the red superfamily rose to ecological prominence. The processes responsible for this shift are obscure. Here we present an analysis of major nutrients and trace elements in 15 species of marine phytoplankton from the two superfamilies. Our results indicate that there are systematic phylogenetic differences in the two plastid types where macronutrient (carbon:nitrogen:phosphorus) stoichiometries primarily reflect ancestral pre-symbiotic host cell phenotypes, but trace element composition reflects differences in the acquired plastids. The compositional differences between the two plastid superfamilies suggest that changes in ocean redox state strongly influenced the evolution and selection of eukaryotic phytoplankton since the Proterozoic era.	Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08901 USA; Rutgers State Univ, Dept Geol Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Dept Environm Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Coastal Ocean Observat Lab, New Brunswick, NJ 08901 USA; Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Princeton University	Quigg, A (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08901 USA.	aquigg@imcs.rutgers.edu; falko@imcs.rutgers.edu	Finkel, Zoe V/B-9626-2008; Quigg, Antonietta S/A-9345-2010; Morel, Francois M M/A-8107-2008; Irwin, Andrew/B-2245-2008; Ho, Tung-Yuan/F-2323-2017; Reinfelder, John/C-7214-2016; Schofield, Oscar/H-4169-2018	Finkel, Zoe V/0000-0003-4212-3917; Reinfelder, John/0000-0002-3737-604X; Irwin, Andrew/0000-0001-7784-2319; Schofield, Oscar/0000-0003-2359-4131				Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cullen JT, 2001, J ANAL ATOM SPECTROM, V16, P1307, DOI 10.1039/b104398f; Delwiche CF, 1999, AM NAT, V154, pS164, DOI 10.1086/303291; Des Marais DJ, 2000, SCIENCE, V289, P1703; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Falkowski PG, 2000, J PHYCOL, V36, P3, DOI 10.1046/j.1529-8817.2000.99161.x; FALKOWSKI PG, 1981, PLANT PHYSIOL, V68, P969, DOI 10.1104/pp.68.4.969; FALKOWSKI PG, IN PRESS COCCOLITHOP; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; Grzebyk D, 2003, J PHYCOL, V39, P259, DOI 10.1046/j.1529-8817.2003.02082.x; HAECKEL E, 1990, PLANKTON STUDIEN VER; HO TY, UNPUB J PHYCOL; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; LEE JG, 1995, MAR ECOL PROG SER, V127, P305, DOI 10.3354/meps127305; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Palmer JD, 2003, J PHYCOL, V39, P4, DOI 10.1046/j.1529-8817.2003.02185.x; PRICE N M, 1988, Biological Oceanography, V6, P443; PRICE NM, 1990, NATURE, V344, P658, DOI 10.1038/344658a0; Raven JA, 1999, PHOTOSYNTH RES, V60, P111, DOI 10.1023/A:1006282714942; Redfield A. C., 1934, P176; Sterner R.W., 2002, ECOLOGICAL STOICHIOM, DOI 10.1515/9781400885695; Sverdrup H. V, 1942, OCEANS; Venables W., 2013, MODERN APPL STAT S, V53, P86; Whitfield M, 2001, ADV MAR BIOL, V41, P1, DOI 10.1016/S0065-2881(01)41002-9; Williams R. J. P., 1996, NATURAL SELECTION CH	27	376	392	8	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2003	425	6955					291	294		10.1038/nature01953	http://dx.doi.org/10.1038/nature01953			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722JA	13679916				2022-12-01	WOS:000185370900044
J	Bleharski, JR; Li, HY; Meinken, C; Graeber, TG; Ochoa, MT; Yamamura, M; Burdick, A; Sarno, EN; Wagner, M; Rollinghoff, M; Rea, TH; Colonna, M; Stenger, S; Bloom, BR; Eisenberg, D; Modlin, RL				Bleharski, JR; Li, HY; Meinken, C; Graeber, TG; Ochoa, MT; Yamamura, M; Burdick, A; Sarno, EN; Wagner, M; Rollinghoff, M; Rea, TH; Colonna, M; Stenger, S; Bloom, BR; Eisenberg, D; Modlin, RL			Use of genetic profiling in leprosy to discriminate clinical forms of the disease	SCIENCE			English	Article							INTRACELLULAR INFECTION; CELL RESPONSES; EXPRESSION; LESIONS; ACTIVATION; PATHOGENS; RECEPTORS; PATTERNS; SUBSETS; GAMMA	Leprosy presents as a clinical and immunological spectrum of disease. With the use of gene expression pro. ling, we observed that a distinction in gene expression correlates with and accurately classifies the clinical form of the disease. Genes belonging to the leukocyte immunoglobulin-like receptor (LIR) family were significantly up-regulated in lesions of lepromatous patients suffering from the disseminated form of the infection. In functional studies, LIR-7 suppressed innate host defense mechanisms by shifting monocyte production from interleukin-12 toward interleukin-10 and by blocking antimicrobial activity triggered by Toll-like receptors. Gene expression profiles may be useful in de. ning clinical forms of disease and providing insights into the regulation of immune responses to pathogens.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, UCLA Dept Energy Inst Genom & Proteom, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Erlangen Nurnberg, Inst Klin Mikrobiol Immunol & Hyg, D-91054 Erlangen, Germany; Okayama Univ, Grad Sch Med & Dent, Okayama, Japan; Univ Miami, Dept Dermatol & Cutaneous Surg, Miami, FL 33101 USA; Inst Oswaldo Cruz, Leprosy Lab, BR-20001 Rio De Janeiro, Brazil; Klinikum Nurnberg, Med Klin 3, D-90340 Nurnberg, Germany; Univ So Calif, Sch Med, Dermatol Sect, Los Angeles, CA 90033 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Harvard Univ, Sch Publ Hlth, Off Dean, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Erlangen Nuremberg; Okayama University; University of Miami; Fundacao Oswaldo Cruz; Klinikum Nurnberg Nord; University of Southern California; Washington University (WUSTL); Harvard University; Harvard T.H. Chan School of Public Health	Modlin, RL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.		Modlin, Robert L/M-7941-2014	Modlin, Robert L/0000-0003-4720-031X; Ochoa, Maria T/0000-0001-6550-5008; Graeber, Thomas/0000-0001-8574-9181; Nunes Sarno, Euzenir/0000-0003-0129-2159; Colonna, Marco/0000-0001-5222-4987	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI147868, R01AI022553, R01AI047868, R37AI047868, R22AI022553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040312] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 47868, AI 22553, AI 07118] Funding Source: Medline; NIAMS NIH HHS [AR 40312] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; BLEHARSKI JR, UNPUB; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Borges L, 2000, CYTOKINE GROWTH F R, V11, P209, DOI 10.1016/S1359-6101(00)00007-1; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; EISEN MB, TREEVIEW 1 60; Garcia VE, 2001, J IMMUNOL, V167, P5719, DOI 10.4049/jimmunol.167.10.5719; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Jullien D, 1997, J IMMUNOL, V158, P800; Krutzik SR, 2003, NAT MED, V9, P525, DOI 10.1038/nm864; MODLIN RL, 1983, J AM ACAD DERMATOL, V8, P182, DOI 10.1016/S0190-9622(83)70021-6; MODLIN RL, 1988, P NATL ACAD SCI USA, V85, P1213, DOI 10.1073/pnas.85.4.1213; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Nakajima H, 1999, J IMMUNOL, V162, P5; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; SALGAME P, 1991, SCIENCE, V254, P279, DOI 10.1126/science.1681588; Sieling PA, 1999, J IMMUNOL, V162, P1851; SIELING PA, 1994, J IMMUNOL, V153, P3639; SIELING PA, 1995, J IMMUNOL, V154, P2775; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; YAMAMURA M, 1991, SCIENCE, V254, P277, DOI 10.1126/science.1925582	23	125	130	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2003	301	5639					1527	1530		10.1126/science.1087785	http://dx.doi.org/10.1126/science.1087785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	720HL	12970564				2022-12-01	WOS:000185255300048
J	Christensen, EF; Hoyer, CCS				Christensen, EF; Hoyer, CCS			Prehospital tracheal intubation in severely injured patients: a Danish observational study	BRITISH MEDICAL JOURNAL			English	Article							TRAUMA		Aarhus Univ Hosp, Dept Anaesthesiol & Intens Care Med, DK-8000 Aarhus, Denmark	Aarhus University	Christensen, EF (corresponding author), Aarhus Univ Hosp, Dept Anaesthesiol & Intens Care Med, DK-8000 Aarhus, Denmark.		Høyer, Christian Bjerre/H-3393-2019; Christensen, Erika Frischknecht/H-8753-2017	Høyer, Christian Bjerre/0000-0001-5917-1777; Christensen, Erika Frischknecht/0000-0003-3673-9694				Liberman M, 2000, J TRAUMA, V49, P584, DOI 10.1097/00005373-200010000-00003; Lockey D, 2001, BRIT MED J, V323, P141, DOI 10.1136/bmj.323.7305.141; Sethi D, 2003, COCHRANE LIB	3	19	21	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 6	2003	327	7414					533	534		10.1136/bmj.327.7414.533	http://dx.doi.org/10.1136/bmj.327.7414.533			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720WW	12958112	Green Published, Bronze			2022-12-01	WOS:000185283700017
J	Wegner, KM; Kalbe, M; Kurtz, J; Reusch, TBH; Milinski, M				Wegner, KM; Kalbe, M; Kurtz, J; Reusch, TBH; Milinski, M			Parasite selection for immunogenetic optimality	SCIENCE			English	Article							MHC; STICKLEBACKS		Max Planck Inst Limnol, Dept Evolutionary Ecol, D-24306 Plon, Germany	Max Planck Society	Wegner, KM (corresponding author), Max Planck Inst Limnol, Dept Evolutionary Ecol, August Thienemann Str 2, D-24306 Plon, Germany.	wegner@mpil-ploen.mpg.de	Reusch, Thorsten B.H./G-4141-2011; Reusch, Thorsten B. H./B-9311-2019; Wegner, Mathias/B-6674-2009; Kurtz, Joachim/A-9678-2008; Wegner, K. Mathias/P-1149-2015	Kurtz, Joachim/0000-0002-7258-459X; Wegner, K. Mathias/0000-0002-2410-8898; Reusch, Thorsten B. H./0000-0002-8961-4337				Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; DEBOER RJ, 1993, P ROY SOC B-BIOL SCI, V252, P171, DOI 10.1098/rspb.1993.0062; Kalbe M, 2002, J FISH BIOL, V60, P1529, DOI [10.1111/j.1095-8649.2002.tb02445.x, 10.1006/jfbi.2002.2013]; NOWAK MA, 1992, P NATL ACAD SCI USA, V89, P10896, DOI 10.1073/pnas.89.22.10896; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Reusch TBH, 2001, NATURE, V414, P300, DOI 10.1038/35104547; VIDOVIC D, 1988, NATURE, V336, P222, DOI 10.1038/336222a0; Wegner KM, 2003, J EVOLUTION BIOL, V16, P224, DOI 10.1046/j.1420-9101.2003.00519.x; Wootton R.J., 1976, BIOL STICKLEBACKS	9	238	241	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2003	301	5638					1343	1343		10.1126/science.1088293	http://dx.doi.org/10.1126/science.1088293			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717XQ	12958352				2022-12-01	WOS:000185116400029
J	Crown, J				Crown, J			Chemotherapy dose and schedule in adjuvant treatment of breast cancer: phoenix, turkey, or dodo?	LANCET			English	Editorial Material							RANDOMIZED-TRIAL		St Vincents Univ Hosp, Dublin 4, Ireland	University College Dublin; Saint Vincent's University Hospital	Crown, J (corresponding author), St Vincents Univ Hosp, Dublin 4, Ireland.		Crown, John/AAL-3367-2020	Crown, John/0000-0002-3125-7613				Bergh J, 2000, LANCET, V356, P1384, DOI 10.1016/S0140-6736(00)02841-5; Bergh J, 2000, LANCET, V356, P2196; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; CROWN J, 1995, ANN ONCOL         S4, V6, pS21; CROWN J, 2003, P AN M AM SOC CLIN, V22, pA23; *EARL BREAST CANC, 1992, LANCET, V339, P1; Henderson IC, 2003, J CLIN ONCOL, V21, P976, DOI 10.1200/JCO.2003.02.063; HRYNIUK W, 1984, J CLIN ONCOL, V2, P81; Nabholtz JM PT, 2002, P AN M AM SOC CLIN, V21, p36a; NITZ UA, 2003, P AN M AM SOC CLIN, V22, pA832; NORTON L, 1988, CANCER RES, V48, P7067; RODENHUIS S, 2003, P ASCO, V22, pA6; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101	13	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 30	2003	362	9385					677	678		10.1016/S0140-6736(03)14242-0	http://dx.doi.org/10.1016/S0140-6736(03)14242-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	716NH	12957087				2022-12-01	WOS:000185034800005
J	Greenland, P; Knoll, MD; Stamler, J; Neaton, JD; Dyer, AR; Garside, DB; Wilson, PW				Greenland, P; Knoll, MD; Stamler, J; Neaton, JD; Dyer, AR; Garside, DB; Wilson, PW			Major risk factors as antecedents of fatal and nonfatal coronary heart disease events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; CHOLESTEROL LEVELS; CURRENT KNOWLEDGE; FOLLOW-UP; MORTALITY; ASSOCIATION; PREDICTION; BURDEN	Context A frequently cited concept is that individual major risk factors for coronary heart disease (CHD) are absent in many patients (perhaps >50%) with CHD. However, prior studies have not systematically evaluated the extent to which CHD patients have previous exposure to at least 1 risk factor, including diabetes, cigarette smoking, or clinically elevated levels of cholesterol or blood pressure. Objective To determine the, frequency of exposure to major CHD risk factors. Design, Setting, and Participants Three prospective cohort studies were included: the Chicago Heart Association Detection Project in Industry, with a population sample of 35642 employed men and women aged 18 to 59 years; screenees for the Multiple Risk Factor Intervention Trial, including 347978 men aged 35 to 57 years; and a population-based sample of 3295 men and women aged 34 to 59 years from the Framingham Heart Study (FHS). Follow-up lasted 21 to 30 years across the studies. Main Outcome Measures Fatal CHD in all cohorts and nonfatal myocardial infarction (MI) in the FHS, compared by exposure to major CHD risk factors, defined as total cholesterol of at least 240 mg/dL (greater than or equal to6.22 mmol/L), systolic blood pressure of at least 140 mm Hg, diastolic blood pressure of at least 90 mm Hg, cigarette smoking, and diabetes. Participants were stratified by sex and age (18-39 vs 40-59 years). Results For fatal CHD (n=20995), exposure to at least 1 clinically elevated major risk factor ranged from 87% to 100%. Among those aged 40 to 59 years at baseline with fatal CHD (n=19263), exposure to at least 1 major risk factor ranged from 87% to 94%. For nonfatal MI, prior exposure was documented in 92% (95% Cl, 87%-96%) (n=167) of men aged 40 to 59 years at baseline and in 87% (95% Cl, 80%-94%) (n=94) of women in this age group. Conclusions Antecedent major CHD risk factor exposures were very common among those who developed CHD, emphasizing the importance of considering all major risk factors in determining CHD risk estimation and in attempting to prevent clinical CHD. These results challenge claims that CHD events commonly occur in persons without exposure to at least 1 major CHD risk factor.	Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; Boston Univ, Sch Med, Boston, MA 02118 USA	Northwestern University; Feinberg School of Medicine; University of Minnesota System; University of Minnesota Twin Cities; Boston University	Greenland, P (corresponding author), 680 N Lake Shore Dr,Suite 1102, Chicago, IL 60611 USA.	p-greenland@northwestern.edu	Greenland, Philip/ABD-5528-2021; Wilson, Peter W.F./J-2455-2016	Deloria Knoll, Maria/0000-0001-9041-2671	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068140, R01HL021010] Funding Source: NIH RePORTER	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABELL LL, 1952, J BIOL CHEM, V195, P357; AGMON J, 1992, CIRCULATION, V86, P839; Barker MH, 1939, AM HEART J, V18, P95; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DAVIS CE, 1990, JAMA-J AM MED ASSOC, V264, P3044, DOI 10.1001/jama.264.23.3044; Grundy SM, 1999, CIRCULATION, V100, P1481, DOI 10.1161/01.CIR.100.13.1481; Hennekens CH, 1998, CIRCULATION, V97, P1095, DOI 10.1161/01.CIR.97.11.1095; JOHNSON NL, 1969, DISCRETE DISTRIBUTIO, P58; Lefkowitz RJ, 2001, JAMA-J AM MED ASSOC, V285, P581, DOI 10.1001/jama.285.5.581; Magnus P, 2001, ARCH INTERN MED, V161, P2657, DOI 10.1001/archinte.161.22.2657; Mosca L, 2002, NEW ENGL J MED, V347, P1615, DOI 10.1056/NEJMe020127; Nelson N, 1944, J BIOL CHEM, V153, P375; *NIH, 1974, PUBL NIH, P1; Pasternak RC, 1996, J AM COLL CARDIOL, V27, P978, DOI 10.1016/0735-1097(96)87731-X; Ridker PM, 1999, ANN INTERN MED, V130, P933, DOI 10.7326/0003-4819-130-11-199906010-00018; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; ROSE G, 1982, BRIT MED J, V284, P1600, DOI 10.1136/bmj.284.6329.1600; ROSENMAN RH, 1974, MED CLIN N AM, V58, P269, DOI 10.1016/S0025-7125(16)32158-7; RUBINS HB, 1995, AM J CARDIOL, V75, P1196, DOI 10.1016/S0002-9149(99)80761-9; STAMLER J, 1975, J CHRON DIS, V28, P527, DOI 10.1016/0021-9681(75)90060-0; STAMLER J, 1993, CARDIOLOGY, V82, P191, DOI 10.1159/000175868; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; The Inter-Society Commission for Heart Disease Resources, 1970, CIRCULATION, V42, pA55; Vasan RS, 2002, CIRCULATION, V105, P48, DOI 10.1161/hc0102.101774; Wilson PWF, 1997, NEW ENGL J MED, V337, P516, DOI 10.1056/NEJM199708213370802; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Winkelmann BR, 2000, AM HEART J, V140, pS11, DOI 10.1067/mhj.2000.109636; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	29	699	737	2	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2003	290	7					891	897		10.1001/jama.290.7.891	http://dx.doi.org/10.1001/jama.290.7.891			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	712ZE	12928465	Bronze			2022-12-01	WOS:000184828800025
J	Kwiterovich, PO; Vining, EPG; Pyzik, P; Skolasky, R; Freeman, JM				Kwiterovich, PO; Vining, EPG; Pyzik, P; Skolasky, R; Freeman, JM			Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; A-I; CHOLESTEROL; EFFICACY; DISEASE; HEALTH; ARTERY	Context Little prospective long-term information is available on the effect of a ketogenic diet on plasma lipoproteins in children with difficult-to-control seizures. Objective To determine the effect in children with intractable seizures of a high-fat ketogenic diet on plasma levels of the major apolipoprotein B (apoB)-containing lipoproteins, low-density lipoprotein (LDL) and very LDL (VLDL); and the major apolipoprotein A-I (apoA-I)-containing lipoprotein, high-density lipoprotein (HDL). Design, Setting, and Patients A 6-month prospective cohort study of 141 children (mean [SD] age, 5.2 [3.8] years for 70 boys and 6.1 [4.4] years for 71 girls) with difficult-to-treat seizures who were hospitalized for initiation of a high-fat ketogenic diet and followed up as outpatients. This cohort constituted a subgroup of the 371 patients accepted into the ketogenic diet program between 1994 and 2001. A subset of the cohort was also studied after 12 (n = 59) and 24 (n = 27) months. Intervention A ketogenic diet consisting of a high ratio of fat to carbohydrate and protein combined (4:1 [n = 102], 3.5:1 [n = 7], or 3:1 [n = 32]). After diet initiation, the calories and ratio were adjusted to maintain ideal body weight for height and maximal urinary ketosis for seizure control. Main Outcome Measures Differences at baseline and 6-month follow-up for levels of total, VLDL, LDL, HDL, and non-HDL cholesterol; triglycerides; total apoB; and apoA-I., Results At 6 months, the high-fat ketogenic diet significantly increased the mean plasma levels of total (58 mg/dL [1.50 mmol/L]), LDL (50 mg/dL (1.30 mmol/L]), VLDL (8 mg/dL [0.21 mmol/L]), and non-HDL cholesterol (63 mg/dL [1.63 mmol/L]) (P<.001 vs baseline for each); triglycerides (58 mg/dL [0.66 mmol/L]) (P<.001); and total apoB (49 mg/dL) (P<.001). Mean HDL cholesterol decreased significantly (P<.001), although apoA-I increased (4 mg/dL) (P =.23). Significant but less marked changes persisted in children observed after 12 and 24 months. Conclusions A high-fat ketogenic diet produced significant increases in the atherogenic apoB-containing lipoproteins and a decrease in the antiatherogenic HDL cholesterol. Further studies are necessary to determine if such a diet adversely affects endothelial vascular function and promotes inflammation and formation of atherosclerotic lesions.	Johns Hopkins Med Inst, Dept Neurol, Lipid Res Atherosclerosis Div, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Neurol, Pediat Epilepsy Ctr, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Kwiterovich, PO (corresponding author), Johns Hopkins Univ, Lipid Clin, Lipid Res Atherosclerosis Div, 550 N Broadway,Suite 308, Baltimore, MD 21205 USA.	pkwitero@jhmi.edu		Skolasky, Richard/0000-0002-2598-4427	NCRR NIH HHS [M01-RR-00052] Funding Source: Medline; NICHD NIH HHS [N01-HD-7-3268] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD073268] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Anderson JW, 2000, J AM COLL NUTR, V19, P578, DOI 10.1080/07315724.2000.10718955; BACHORIK PS, 1994, CLIN CHEM, V40, P1915; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Chesney D, 1999, CLIN PEDIATR, V38, P107, DOI 10.1177/000992289903800207; CORTNER JA, 1990, J PEDIATR-US, V116, P514, DOI 10.1016/S0022-3476(05)81595-1; de Jongh S, 2002, ATHEROSCLEROSIS, V163, P193, DOI 10.1016/S0021-9150(02)00003-5; DEKABAN AS, 1966, ARCH NEUROL-CHICAGO, V15, P177, DOI 10.1001/archneur.1966.00470140067009; DIGGLE PJ, 1994, OXFORD STAT SCI SERI, V13; *EXP PAN BLOOD CHO, 1992, PEDIATRICS, V89, P524; Freeman J. M., 2000, KETOGENIC DIET TREAT; Freeman JM, 1998, PEDIATRICS, V102, P1358, DOI 10.1542/peds.102.6.1358; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gilbert DL, 2000, J CHILD NEUROL, V15, P787, DOI 10.1177/088307380001501203; Hemingway C, 2001, PEDIATRICS, V108, P898, DOI 10.1542/peds.108.4.898; HUTTENLOCHER PR, 1976, PEDIATR RES, V10, P536, DOI 10.1203/00006450-197605000-00006; Katyal NG, 2000, CLIN PEDIATR, V39, P153, DOI 10.1177/000992280003900303; KLAG MJ, 1993, NEW ENGL J MED, V328, P313, DOI 10.1056/NEJM199302043280504; Kwiterovich PO, 2002, AM J CARDIOL, V90, p30I; Kwiterovich PO, 2002, AM J CARDIOL, V90, p1I, DOI 10.1016/S0002-9149(02)02796-0; Lefevre F, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e46; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; MCGILL HC, 1990, JAMA-J AM MED ASSOC, V264, P3018; Rice JA, 1988, MATH STAT DATA ANAL; SCHWARTZ RM, 1989, DEV MED CHILD NEUROL, V31, P152; Schwartzkroin PA, 1999, EPILEPSY RES, V37, P171, DOI 10.1016/S0920-1211(99)00069-8; Sharman MJ, 2002, J NUTR, V132, P1879, DOI 10.1093/jn/132.7.1879; Shih WJ, 2000, CLIN CHEM, V46, P351; Srinivasan SR, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.3.e29; SRINIVASAN SR, 1994, METABOLISM, V43, P1042, DOI 10.1016/0026-0495(94)90187-2; SRINIVASAN SR, 1995, CLIN CHEM, V41, P159; Stafstrom CE, 2000, NEUROLOGY, V54, P282, DOI 10.1212/WNL.54.2.282; Swink T D, 1997, Adv Pediatr, V44, P297; Urbina EM, 2002, AM J CARDIOL, V90, P953, DOI 10.1016/S0002-9149(02)02660-7; *US DEP HHS, 1980, PHS NIH PUBL; Vining EPG, 2002, DEV MED CHILD NEUROL, V44, P796, DOI 10.1017/S0012162201002961; Volek JS, 2000, J AM COLL NUTR, V19, P383, DOI 10.1080/07315724.2000.10718935; Willi SM, 1998, PEDIATRICS, V101, P61, DOI 10.1542/peds.101.1.61	38	190	201	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2003	290	7					912	920		10.1001/jama.290.7.912	http://dx.doi.org/10.1001/jama.290.7.912			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	712ZE	12928468	Bronze			2022-12-01	WOS:000184828800028
J	Ross, L; Johansen, C; Dalton, SO; Mellemkjae, L; Thomassen, LH; Mortensen, PB; Olsen, JH				Ross, L; Johansen, C; Dalton, SO; Mellemkjae, L; Thomassen, LH; Mortensen, PB; Olsen, JH			Psychiatric hospitalizations among survivors of cancer in childhood or adolescence	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VOLUME CHANGES; SCHIZOPHRENIA; DISORDER; REGISTER; CONSEQUENCES; RADIATION; DENMARK	BACKGROUND We investigated whether children and adolescents who survive cancer are at increased risk for psychiatric hospitalization. METHODS In a nationwide, population-based, retrospective cohort study, 3710 persons who survived at least three years after a diagnosis of cancer in childhood or adolescence in the period from 1943 to 1990, and who were alive on January 1, 1970, or were born after that date, were identified in the Danish Cancer Registry. This population was followed up for psychiatric hospitalization from January 1, 1970, through 1993 by linkage with the Danish national Psychiatric Central Register. The number of expected cases was based on the national rates of hospitalization for psychiatric disease. RESULTS Among the 3710 survivors of cancer in childhood or adolescence, there was a total of 88 psychiatric hospitalizations. The risk of hospitalization for any psychiatric disease was higher among the survivors than in the general population, but the excess risk was restricted to survivors of brain tumor (the standardized hospitalization ratio [SHR], corresponding to the ratio of observed to expected cases of hospitalization for psychiatric disease, was 1.8; 95 percent confidence interval, 1.5 to 2.2). An increased risk of psychoses of somatic, cerebral causes (SHR, 7.7; 95 percent confidence interval, 4.1 to 13.2), psychiatric disorders in somatic disease (SHR, 5.1; 95 percent confidence interval, 2.5 to 9.1), and schizophrenia and related disorders (SHR, 2.4; 95 percent confidence interval, 1.2 to 4.4) was observed among survivors of brain tumor. There was no evidence of a significantly increased risk of major depression. CONCLUSIONS The risk of hospitalization for a psychiatric disorder is not increased among survivors of cancer in childhood or adolescence, except among survivors of brain tumor.	Danish Canc Soc, Inst Canc Epidemiol, DK-2100 Copenhagen, Denmark; Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark	Danish Cancer Society; Aarhus University	Johansen, C (corresponding author), Danish Canc Soc, Inst Canc Epidemiol, Strandblvd 49, DK-2100 Copenhagen, Denmark.	christof@cancer.dk	Mortensen, Preben B/D-2358-2015; Johansen, Christoffer/AAG-7916-2020	Mortensen, Preben B/0000-0002-5230-9865; Johansen, Christoffer/0000-0002-4384-206X; Olsen, Jorgen Helge/0000-0001-9633-5662; Ross, Lone/0000-0002-4406-604X; Dalton, Susanne Oksbjerg/0000-0002-5485-2730				Arvidson J, 1999, PSYCHO-ONCOLOGY, V8, P123; BIRCH JM, 1987, INT J CANCER, V40, P620, DOI 10.1002/ijc.2910400508; BROWN PD, 1995, ACTA PAEDIATR, V84, P316, DOI 10.1111/j.1651-2227.1995.tb13636.x; COUSENS P, 1988, J CHILD PSYCHOL PSYC, V29, P839, DOI 10.1111/j.1469-7610.1988.tb00757.x; *DAN NAT BOARD HLT, 2003, CANC INC DENM 1998; *DAN NAT BOARD HLT, 1976, KLASS SYGD; Eiser C, 1998, J CHILD PSYCHOL PSYC, V39, P621, DOI 10.1111/1469-7610.00362; Garwicz S, 2000, INT J CANCER, V88, P672, DOI 10.1002/1097-0215(20001115)88:4<672::AID-IJC24>3.0.CO;2-N; GLAUSER TA, 1991, CHILD NERV SYST, V7, P2, DOI 10.1007/BF00263824; Gray R. E., 1992, PSYCHO-ONCOLOGY, V1, P235, DOI [10.1002/pon.2960010406, DOI 10.1002/PON.2960010406]; GREENBERG HS, 1989, J PEDIATR-US, V114, P488, DOI 10.1016/S0022-3476(89)80581-5; Hulshoff HE, 2002, AM J PSYCHIAT, V159, P244, DOI 10.1176/appi.ajp.159.2.244; *I PSYCH DEM, 1994, ANN REP 1993; Kessing LV, 1998, EUR PSYCHIAT, V13, P392, DOI 10.1016/S0924-9338(99)80685-3; Kokkonen J, 1997, PEDIATR HEMAT ONCOL, V14, P223, DOI 10.3109/08880019709009492; LESKO LM, 1990, PROG CLIN BIOL RES, V352, P423; Lieberman JA, 1999, BIOL PSYCHIAT, V46, P729, DOI 10.1016/S0006-3223(99)00147-X; LOFFLER W, 1994, ACTA PSYCHIAT SCAND, V90, P196, DOI 10.1111/j.1600-0447.1994.tb01577.x; Loganovsky KN, 2000, SCHIZOPHRENIA BULL, V26, P751, DOI 10.1093/oxfordjournals.schbul.a033492; Mathalon DH, 2001, ARCH GEN PSYCHIAT, V58, P148, DOI 10.1001/archpsyc.58.2.148; McGlashan TH, 2000, ARCH GEN PSYCHIAT, V57, P637, DOI 10.1001/archpsyc.57.7.637; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; MUNKJORGENSEN P, 1992, BRIT J PSYCHIAT, V161, P489, DOI 10.1192/bjp.161.4.489; Percy C., 1990, INT CLASSIFICATION D; ROMAN DD, 1995, INT J RADIAT ONCOL, V31, P983, DOI 10.1016/0360-3016(94)00550-8; Rothman K, 1979, NIH PUBL; SCHMALE AH, 1983, PSYCHOSOM MED, V45, P163, DOI 10.1097/00006842-198305000-00008; Storm HH, 1997, DAN MED BULL, V44, P535; TETA MJ, 1986, J CHRON DIS, V39, P751, DOI 10.1016/0021-9681(86)90158-X; Woods BT, 1998, AM J PSYCHIAT, V155, P1661, DOI 10.1176/ajp.155.12.1661	30	50	51	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2003	349	7					650	657		10.1056/NEJMoa022672	http://dx.doi.org/10.1056/NEJMoa022672			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711FL	12917301				2022-12-01	WOS:000184728900005
J	Witte, U; Wenzhofer, F; Sommer, S; Boetius, A; Heinz, P; Aberle, N; Sand, M; Cremer, A; Abraham, WR; Jorgensen, BB; Pfannkuche, O				Witte, U; Wenzhofer, F; Sommer, S; Boetius, A; Heinz, P; Aberle, N; Sand, M; Cremer, A; Abraham, WR; Jorgensen, BB; Pfannkuche, O			In situ experimental evidence of the fate of a phytodetritus pulse at the abyssal sea floor	NATURE			English	Article							EASTERN NORTH PACIFIC; DEEP-SEA; ORGANIC-MATTER; BENTHIC COMMUNITY; SEASONAL DEPOSITION; ARABIAN SEA; NE ATLANTIC; CARBON; BACTERIA; SEDIMENTATION	More than 50% of the Earth's surface is sea floor below 3,000 m of water. Most of this major reservoir in the global carbon cycle and final repository for anthropogenic wastes is characterized by severe food limitation. Phytodetritus is the major food source for abyssal benthic communities, and a large fraction of the annual food load can arrive in pulses within a few days(1,2). Owing to logistical constraints, the available data concerning the fate of such a pulse are scattered(3,4) and often contradictory(5-10), hampering global carbon modelling and anthropogenic impact assessments. We quantified (over a period of 2.5 to 23 days) the response of an abyssal benthic community to a phytodetritus pulse, on the basis of 11 in situ experiments. Here we report that, in contrast to previous hypotheses(5-11), the sediment community oxygen consumption doubled immediately, and that macrofauna were very important for initial carbon degradation. The retarded response of bacteria and Foraminifera, the restriction of microbial carbon degradation to the sediment surface, and the low total carbon turnover distinguish abyssal from continental-slope 'deep-sea' sediments.	Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; GEOMAR Res Ctr, D-24148 Kiel, Germany; Univ Tubingen, Inst Geosci, D-72076 Tubingen, Germany; Gesell Biotechnol Forsch mbH, D-38124 Braunschweig, Germany	Max Planck Society; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Eberhard Karls University of Tubingen; Gesellschaft fur Biotechnologische Forschung mbH	Witte, U (corresponding author), Max Planck Inst Marine Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	uwitte@mpi-bremen.de	Aberle, Nicole/C-7366-2014; Boetius, Antje/D-5459-2013; Abraham, Wolf-Rainer/I-2179-2019; Jorgensen, Bo B/C-2214-2013	Aberle, Nicole/0000-0003-3254-5710; Boetius, Antje/0000-0003-2117-4176; Abraham, Wolf-Rainer/0000-0002-2850-2649; Jorgensen, Bo B/0000-0001-9398-8027; Heinz, Petra/0000-0002-3428-3374				Aberle N, 2003, MAR ECOL PROG SER, V251, P37, DOI 10.3354/meps251037; Bett BJ, 2001, PROG OCEANOGR, V50, P349, DOI 10.1016/S0079-6611(01)00066-0; BILLETT DSM, 1983, NATURE, V302, P520, DOI 10.1038/302520a0; Billett DSM, 2001, PROG OCEANOGR, V50, P13, DOI 10.1016/S0079-6611(01)00046-5; Billett DSM, 2001, PROG OCEANOGR, V50, P325, DOI 10.1016/S0079-6611(01)00060-X; Boetius A, 2000, DEEP-SEA RES PT II, V47, P2835, DOI 10.1016/S0967-0645(00)00051-5; Boetius A, 1996, MAR ECOL PROG SER, V140, P239, DOI 10.3354/meps140239; Boschker HTS, 1999, LIMNOL OCEANOGR, V44, P309, DOI 10.4319/lo.1999.44.2.0309; Drazen JC, 1998, DEEP-SEA RES PT II, V45, P893, DOI 10.1016/S0967-0645(98)00007-1; Gooday AJ, 2002, J OCEANOGR, V58, P305, DOI 10.1023/A:1015865826379; GRAF G, 1989, NATURE, V341, P437, DOI 10.1038/341437a0; LAMPITT RS, 1985, DEEP-SEA RES, V32, P885, DOI 10.1016/0198-0149(85)90034-2; Lampitt RS, 2001, PROG OCEANOGR, V50, P27, DOI 10.1016/S0079-6611(01)00047-7; Levin L, 1997, J MAR RES, V55, P595, DOI 10.1357/0022240973224337; LOCHTE K, 1988, NATURE, V333, P67, DOI 10.1038/333067a0; Middelburg JJ, 2000, LIMNOL OCEANOGR, V45, P1224, DOI 10.4319/lo.2000.45.6.1224; Moodley L, 2002, MAR ECOL PROG SER, V236, P23, DOI 10.3354/meps236023; PFANNKUCHE O, 1993, DEEP-SEA RES PT II, V40, P135, DOI 10.1016/0967-0645(93)90010-K; ROWE G, 1991, MAR ECOL PROG SER, V79, P99, DOI 10.3354/meps079099; SAYLES FL, 1994, NATURE, V371, P686, DOI 10.1038/371686a0; Smith KL, 1999, SCIENCE, V284, P1174, DOI 10.1126/science.284.5417.1174; Smith KL, 2002, DEEP-SEA RES PT I, V49, P971, DOI 10.1016/S0967-0637(02)00006-7; SMITH KL, 1984, NATURE, V307, P624, DOI 10.1038/307624a0; Turley C, 2000, FEMS MICROBIOL ECOL, V33, P89, DOI 10.1111/j.1574-6941.2000.tb00731.x; TYLER PA, 1988, OCEANOGR MAR BIOL, V26, P227; Wenzhofer F, 2001, DEEP-SEA RES PT I, V48, P1741, DOI 10.1016/S0967-0637(00)00108-4; Witbaard R, 2000, J SEA RES, V43, P15, DOI 10.1016/S1385-1101(99)00040-4; Witte U, 2000, DEEP-SEA RES PT II, V47, P2785, DOI 10.1016/S0967-0645(00)00049-7; Witte U, 2003, MAR ECOL PROG SER, V251, P27, DOI 10.3354/meps251027	29	188	194	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2003	424	6950					763	766		10.1038/nature01799	http://dx.doi.org/10.1038/nature01799			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12917681	Green Published			2022-12-01	WOS:000184733900036
J	Renesto, P; Crapoulet, N; Ogata, H; La Scola, B; Vestris, G; Claverie, JM; Raoult, D				Renesto, P; Crapoulet, N; Ogata, H; La Scola, B; Vestris, G; Claverie, JM; Raoult, D			Genome-based design of a cell-free culture medium for Tropheryma whipplei	LANCET			English	Article								Empirical approaches have guided the development of bacterial cultures. The availability of sequenced genomes now provides opportunities to define culture media for growth of fastidious pathogens with computer modelling of metabolic networks. A key issue the possibility of growing host-dependent bacteria in cell-free conditions. The sequenced Tropheryma whipplei genome was analysed to identify specific metabolic deficiencies. We used this information to design a comprehensive medium that allowed three established T whipplei strains from culture with human cells and one new strain from a clinical sample to grow axenically. Genomic information can, therefore, provide sufficient clues for designing axenic media for fastidious and uncultured pathogens.	CNRS, Fac Med, UMR 6020, Unite Rickettsies, F-13385 Marseille, France; Informat Genom & Struct, UPR 2589, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Franche-Comte; UDICE-French Research Universities; Aix-Marseille Universite	Raoult, D (corresponding author), CNRS, Fac Med, UMR 6020, Unite Rickettsies, 27 Blvd Jean Moulin, F-13385 Marseille, France.	Didier.Raoult@medecine.univ-mrs.fr	LA SCOLA, Bernard/P-6477-2016; RAOULT, Didier/A-8434-2008; Claverie, Jean Michel/Z-2183-2019; Renesto, patricia/M-6105-2014; Claverie, Jean-Michel/AAG-4889-2019; renesto, patricia/T-6446-2019	LA SCOLA, Bernard/0000-0001-8006-7704; RAOULT, Didier/0000-0002-0633-5974; Claverie, Jean-Michel/0000-0003-1424-0315; renesto, patricia/0000-0002-6749-7862				Bentley SD, 2003, LANCET, V361, P637, DOI 10.1016/S0140-6736(03)12597-4; Davey HM, 1996, MICROBIOL REV, V60, P641, DOI 10.1128/MMBR.60.4.641-696.1996; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; La Scola B, 2001, INT J SYST EVOL MICR, V51, P1471, DOI 10.1099/00207713-51-4-1471; RAOULT D, IN PRESS GENOME RES; Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999	6	142	147	2	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2003	362	9382					447	449		10.1016/S0140-6736(03)14071-8	http://dx.doi.org/10.1016/S0140-6736(03)14071-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	709XD	12927433				2022-12-01	WOS:000184651100013
J	Reefhuis, J; Honein, MA; Whitney, CG; Chamany, S; Mann, EA; Biernath, KR; Broder, K; Manning, S; Avashia, S; Victor, M; Costa, P; Devine, O; Graham, A; Boyle, C				Reefhuis, J; Honein, MA; Whitney, CG; Chamany, S; Mann, EA; Biernath, KR; Broder, K; Manning, S; Avashia, S; Victor, M; Costa, P; Devine, O; Graham, A; Boyle, C			Risk of bacterial meningitis in children with cochlear implants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECURRENT MENINGITIS; DYSPLASIA	BACKGROUND: In June 2002, the Food and Drug Administration received reports of bacterial meningitis in patients with cochlear implants for treatment of hearing loss. Implants that included a positioner (a wedge inserted next to the implanted electrode to facilitate transmission of the electrical signal by pushing the electrode against the medial wall of the cochlea) were voluntarily recalled in the United States in July 2002. METHODS: We identified patients with meningitis and conducted a cohort study and a nested case-control investigation involving 4264 children who had received cochlear implants in the United States between January 1, 1997, and August 6, 2002, and who were less than six years of age when they received the implants. We calculated the incidence of meningitis in the cohort and assessed risk factors for meningitis among patients and among 199 controls, using data from interviews with parents and abstracted from medical records. RESULTS: We identified 26 children with bacterial meningitis. The incidence of meningitis caused by Streptococcus pneumoniae was 138.2 cases per 100,000 person-years - more than 30 times the incidence in a cohort of the same age in the general U.S. population. Postimplantation bacterial meningitis was strongly associated with the use of an implant with a positioner (odds ratio, 4.5 [95 percent confidence interval, 1.3 to 17.9], with adjustment for medical, surgical, and environmental factors) and with the joint presence of radiographic evidence of a malformation of the inner ear and a cerebrospinal fluid leak (adjusted odds ratio, 9.3 [95 percent confidence interval, 1.2 to 94.5]). The incidence of meningitis among patients who had received an implant with a positioner remained higher than the incidence among those whose implants did not have a positioner for the duration of follow-up (24 months from the time of implantation). CONCLUSIONS: Parents and health care providers should ensure that all children who receive cochlear implants are appropriately vaccinated and are then monitored and treated promptly for any bacterial infections after receiving the implant.	Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Epidemiol Program Off, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA; US FDA, Rockville, MD 20857 USA; New York City Dept Hlth & Mental Hyg, New York, NY USA; Texas Dept Hlth, Austin, TX 78756 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA); New York City Department of Health & Mental Hygiene; Texas Department of State Health Services	Reefhuis, J (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 1600 Clifton Rd NE,MS E-86, Atlanta, GA 30333 USA.		Reefhuis, Jennita/E-1793-2011	Reefhuis, Jennita/0000-0002-4747-4831				*ADV BION CORP, EL POS; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Arnold W, 2002, ORL J OTO-RHINO-LARY, V64, P382, DOI 10.1159/000067579; BERMAN S, 1995, NEW ENGL J MED, V332, P1560, DOI 10.1056/NEJM199506083322307; GATES GA, 1995, JAMA-J AM MED ASSOC, V274, P1955, DOI 10.1001/jama.1995.03530240065043; Govaerts PJ, 2002, OTOL NEUROTOL, V23, P885, DOI 10.1097/00129492-200211000-00013; Greenland S., 1998, MODERN EPIDEMIOLOGY; Hammes DM, 2002, ANN OTO RHINOL LARYN, V111, P74, DOI 10.1177/00034894021110S516; HAYASHI N, 1989, CLIN PEDIATR, V28, P139, DOI 10.1177/000992288902800308; HERTHER C, 1985, LARYNGOSCOPE, V95, P655; Iles K, 2001, J PAEDIATR CHILD H, V37, P388, DOI 10.1046/j.1440-1754.2001.00698.x; JACKLER RK, 1987, LARYNGOSCOPE, V97, P2; KLEIN JO, 1994, CLIN INFECT DIS, V19, P823, DOI 10.1093/clinids/19.5.823; KLINE MW, 1989, PEDIATR INFECT DIS J, V8, P630, DOI 10.1097/00006454-198909000-00013; *NAT I DEAFN OTH C, 2003, COCHL IMPL; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; OHLMS LA, 1990, ARCH OTOLARYNGOL, V116, P608; PHELPS PD, 1994, AM J OTOL, V15, P551; Richter B, 2002, J LARYNGOL OTOL, V116, P507, DOI 10.1258/002221502760132584; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Sharman RL, 2002, AM BOOK REV, V23, P9; VALMARI P, 1986, INFECTION, V14, P36, DOI 10.1007/BF01644809; 2002, MMWR MORB MORTAL WKL, V51, P931; 2003, MMWR MORB MORTAL WKL, V52, P191; 2002, MMWR MORB MORTAL WKL, V51, P706; 2003, MMWR MORB MORTAL WKL, V52, pQ1	26	185	197	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2003	349	5					435	445		10.1056/NEJMoa031101	http://dx.doi.org/10.1056/NEJMoa031101			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706FV	12890842				2022-12-01	WOS:000184443700005
J	Kim, PJ; Plescia, J; Clevers, H; Fearon, ER; Altieri, DC				Kim, PJ; Plescia, J; Clevers, H; Fearon, ER; Altieri, DC			Survivin and molecular pathogenesis of colorectal cancer	LANCET			English	Article							ANTI-APOPTOSIS GENE; BETA-CATENIN; C-MYC; COLON-CARCINOMA; EXPRESSION; APC; ACTIVATION; IDENTIFICATION; TRANSFORMATION; TRANSCRIPTION	Background Colorectal cancer is thought to originate in the expansion of colonic crypt cells as a result of aberrant gene expression caused by transcription factors of the T-cell factor (TCF)/beta-catenin family. Survivin is a bifunctional regulator of cell death and cell proliferation expressed during embryonic development but undetectable in healthy adult tissues and re-expressed in many cancers, including colorectal cancer. Methods We investigated gene expression by promoter analysis, mutagenesis, and electrophoretic mobility shift assay in colorectal cancer cells. Survivin expression in human and mouse embryonic intestine was determined by in-situ hybridisation and immunohistochemistry. Changes in apoptosis were monitored in cell lines engineered to express stabilising mutations in beta catenin. Findings TCF/beta catenin stimulated a six-fold to 12-fold increased expression of the survivin gene in colorectal cancer cells. Three TCF-binding elements (TBE) in the survivin promoter were occupied by nuclear factors in colorectal cancer cells, and mutagenesis of the two proximal TBE sites abolished survivin gene expression by 75-79%. Strongly expressed at the bottom of human and mouse embryonic intestinal crypts, expression of survivin was lost in TCF-4 knockout animals, and a TCF-4 dominant negative mutant blocked survivin gene transcription in colorectal cancer cells. Expression of non-destructible beta catenin mutants increased survivin expression and protected against ultraviolet-B-induced apoptosis. Interpretation Stimulation of survivin expression by TCF/beta catenin might impose a stem cell-like phenotype to colonic crypt epithelium coupling enhanced cell proliferation with resistance to apoptosis, and contribute to the molecular pathogenesis of colorectal cancer.	Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01605 USA; Ctr Biomed Genet, Humbrecht Lab, NL-3584 CT Utrecht, Netherlands; Univ Michigan, Sch Med, Div Med & Mol Genet, Ann Arbor, MI USA; Univ Michigan, Sch Med, Ctr Canc, Ann Arbor, MI USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Altieri, DC (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, LRB-428,364 Plantat St, Worcester, MA 01605 USA.				NCI NIH HHS [CA90917, CA78810, CA85463] Funding Source: Medline; NHLBI NIH HHS [HL54131] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090917, R01CA085463, R01CA078810] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL054131, R01HL054131] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adida C, 1998, LANCET, V351, P882, DOI 10.1016/S0140-6736(05)70294-4; Adida C, 1998, AM J PATHOL, V152, P43; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Grossman D, 1999, J INVEST DERMATOL, V113, P1076, DOI 10.1046/j.1523-1747.1999.00776.x; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Kawasaki H, 1998, CANCER RES, V58, P5071; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Li FZ, 1999, BIOCHEM J, V344, P305, DOI 10.1042/0264-6021:3440305; Mesri M, 2001, J CLIN INVEST, V108, P981, DOI 10.1172/JCI200112983; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NUSSE R, WNT GENE HOMEPAGE; Polakis P, 2000, GENE DEV, V14, P1837; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sarela AI, 2001, ANN SURG ONCOL, V8, P305; Smith SD, 2001, JAMA-J AM MED ASSOC, V285, P324, DOI 10.1001/jama.285.3.324; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; You ZB, 2002, J CELL BIOL, V157, P429, DOI 10.1083/jcb.200201110; Zhang T, 2001, CANCER RES, V61, P8664	28	282	304	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 19	2003	362	9379					205	209		10.1016/S0140-6736(03)13910-4	http://dx.doi.org/10.1016/S0140-6736(03)13910-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702PJ	12885482				2022-12-01	WOS:000184232000011
J	Hohnloser, SH; Ikeda, T; Bloomfield, DM; Dabbous, OH; Cohen, RJ				Hohnloser, SH; Ikeda, T; Bloomfield, DM; Dabbous, OH; Cohen, RJ			T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation	LANCET			English	Article							MYOCARDIAL-INFARCTION	In a trial of prophylactic implantation of a defibrillator, a mortality benefit was seen among patients with previous myocardial infarction and a left-ventricular ejection fraction of 0.30 or less. We identified 1.29 similar patients from two previously published clinical trials in which microvolt T-wave altemans testing was prospectively assessed. At 24 months of follow-up, no sudden cardiac death or cardiac arrest was seen among patients who tested T-wave alternans negative, compared with an event rate of 15.6% among the remaining patients. Testing of T-wave alternans seems to identify patients who are at low risk of ventricular tachyarrhythimic event and who may not benefit from defibrillator therapy.	MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02142 USA; Univ Frankfurt, D-6000 Frankfurt, Germany; Toho Univ, Tokyo, Japan; Columbia Univ, New York, NY USA; Univ Massachusetts, Worcester, MA 01605 USA	Harvard University; Massachusetts Institute of Technology (MIT); Goethe University Frankfurt; Toho University; Columbia University; University of Massachusetts System; University of Massachusetts Worcester	Cohen, RJ (corresponding author), MIT, Harvard MIT Div Hlth Sci & Technol, Room E25-335A,45 Carleton St, Cambridge, MA 02142 USA.							Bloomfield DM, 2002, J CARDIOVASC ELECTR, V13, P502, DOI 10.1046/j.1540-8167.2002.00502.x; Ikeda T, 2002, AM J CARDIOL, V89, P79, DOI 10.1016/S0002-9149(01)02171-3; Klingenheben T, 2000, LANCET, V356, P651, DOI 10.1016/S0140-6736(00)02609-X; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474	4	124	128	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 12	2003	362	9378					125	126		10.1016/S0140-6736(03)13865-2	http://dx.doi.org/10.1016/S0140-6736(03)13865-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699ZY	12867114				2022-12-01	WOS:000184089200013
J	Uehlein, N; Lovisolo, C; Siefritz, F; Kaldenhoff, R				Uehlein, N; Lovisolo, C; Siefritz, F; Kaldenhoff, R			The tobacco aquaporin NtAQP1 is a membrane CO2 pore with physiological functions	NATURE			English	Article							NICOTIANA-TABACUM; EXPRESSION; PERMEABILITY; LEAVES; MALATE; PLANTS	Aquaporins, found in virtually all living organisms, are membrane-intrinsic proteins that form water-permeable complexes. The mammalian aquaporin AQP1 has also shown CO2 permeability when expressed heterologously in Xenopus oocytes(1), although whether this is a biochemical curiosity or of physiological significance is a matter of debate(2,3). Here we report that, in the same expression system, a CO2 permeability comparable to that of the human AQP1 is observed for the tobacco plasma membrane aquaporin NtAQP1. NtAQP1 facilitates CO2 membrane transport in the homologous plant system at the cellular level, and has a significant function in photosynthesis and in stomatal opening. NtAQP1 overexpression heightens membrane permeability for CO2 and water, and increases leaf growth. The results indicate that NtAQP1-related CO2 permeability is of physiological importance under conditions where the CO2 gradient across a membrane is small, as is the case between the atmosphere and the inside of a plant cell.	Inst Bot, D-64287 Darmstadt, Germany; Univ Turin, Dept Agr & Pomol, I-10095 Grugliaso, Italy	University of Turin	Kaldenhoff, R (corresponding author), Inst Bot, Schnittspahnstr 3, D-64287 Darmstadt, Germany.		Lovisolo, Claudio/A-6610-2010	Lovisolo, Claudio/0000-0001-8825-2904				Biela A, 1999, PLANT J, V18, P565, DOI 10.1046/j.1365-313X.1999.00474.x; Cooper GJ, 2002, J PHYSIOL-LONDON, V542, P17, DOI 10.1113/jphysiol.2002.023218; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; Evans JR, 1996, PLANT PHYSIOL, V110, P339, DOI 10.1104/pp.110.2.339; Gallois P, 1995, Methods Mol Biol, V49, P39; Gatz C, 1997, ANNU REV PLANT PHYS, V48, P89, DOI 10.1146/annurev.arplant.48.1.89; GATZ C, 1992, PLANT J, V2, P397, DOI 10.1046/j.1365-313X.1992.t01-37-00999.x; HEDRICH R, 1994, PLANT J, V6, P741, DOI 10.1046/j.1365-313X.1994.6050741.x; Hedrich R, 2001, PLANTA, V213, P594, DOI 10.1007/s004250100524; KAISER WM, 1982, PLANTA, V154, P538, DOI 10.1007/BF00402997; MANSFIELD TA, 1990, ANNU REV PLANT PHYS, V41, P55, DOI 10.1146/annurev.pp.41.060190.000415; Nakhoul NL, 1998, AM J PHYSIOL-CELL PH, V274, pC543, DOI 10.1152/ajpcell.1998.274.2.C543; Otto B, 2000, PLANTA, V211, P167, DOI 10.1007/s004250000275; RASCHKE K, 1975, ANNU REV PLANT PHYS, V26, P309, DOI 10.1146/annurev.pp.26.060175.001521; RASCHKE K, 1972, PLANT PHYSIOL, V49, P229, DOI 10.1104/pp.49.2.229; Siefritz F, 2002, PLANT CELL, V14, P869, DOI 10.1105/tpc.000901; Verkman AS, 2002, J PHYSIOL-LONDON, V542, P31, DOI 10.1113/jphysiol.2002.024398; Yang BX, 2000, J BIOL CHEM, V275, P2686, DOI 10.1074/jbc.275.4.2686	18	471	527	7	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2003	425	6959					734	737		10.1038/nature02027	http://dx.doi.org/10.1038/nature02027			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732DA	14520414				2022-12-01	WOS:000185924500045
J	Stenzel-Poore, MP; Stevens, SL; Xiong, ZG; Lessov, NS; Harrington, CA; Mori, M; Meller, R; Rosenzweig, HL; Tobar, E; Shaw, TE; Chu, XP; Simon, RP				Stenzel-Poore, MP; Stevens, SL; Xiong, ZG; Lessov, NS; Harrington, CA; Mori, M; Meller, R; Rosenzweig, HL; Tobar, E; Shaw, TE; Chu, XP; Simon, RP			Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states	LANCET			English	Article							PROTEIN-SYNTHESIS; BRAIN INJURY; INHIBITION; CHANNEL; STROKE; MICE; SUPPRESSION; MACROPHAGES; ELONGATION; EXPRESSION	Background Molecular mechanisms of neuroprotection that lead to ischaemic tolerance are incompletely understood. Identification of genes involved in the process would provide insight into cell survival and therapeutic approaches for stroke. We developed a mouse model of neuroprotection in stroke and did gene expression profiling to identify potential neuroprotective genes and their associated pathways. Methods Eight mice per condition were subjected to occlusion of the middle cerebral artery for 15 min (preconditioning), 60 min (injurious ischaemia), or preconditioning followed 72 h later by injurious ischaemia. RNA was extracted from the cortical regions of the ischaemic and non-ischaemic hemispheres. Three pools per condition were generated, and RNA was hybridised to oligonucleotide microarrays for comparison of ischaemic and non-ischaemic hemispheres. Real-time PCR and western blots were used to validate results. Follow-up experiments were done to address the biological relevance of findings. Findings Microarray analysis revealed changes in gene expression with little overlap among the conditions of injurious ischaemia, ischaemic preconditioning, or both. Injurious ischaemia induced upregulation of gene expression; 49 (86%) of 57 genes regulated showed increased expression in the ischaemic hemisphere. By contrast, preconditioning followed by injurious ischaemia resulted in pronounced downregulation; 47 (77%) of 61 regulated genes showed lower expression. Preconditioning resulted in transcriptional changes involved in suppression of metabolic pathways and immune responses, reduction of ion-channel activity, and decreased blood coagulation. Interpretation Preconditioning reprogrammes the response to ischaemic injury. Similar changes reported by others support an evolutionarily conserved endogenous response to decreased blood flow and oxygen limitation such as seen during hibernation.	Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Oregon Stroke Ctr, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Biostat & Bioinformat Shared Resource Canc Inst, Portland, OR 97201 USA; Robert S Dow Neurobiol Labs, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Stenzel-Poore, MP (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, L220,3181 Sam Jackson Pk Rd, Portland, OR 97239 USA.			Chu, Xiang-Ping/0000-0002-6781-0468	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS035965, R01NS024728, R01NS039492] Funding Source: NIH RePORTER; NINDS NIH HHS [NS39492, NS24728, NS35965] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barone FC, 1998, STROKE, V29, P1937, DOI 10.1161/01.STR.29.9.1937; BUCK LT, 1993, AM J PHYSIOL, V265, pR1020, DOI 10.1152/ajpregu.1993.265.5.R1020; Chen Y, 2001, BIOCHEMISTRY-US, V40, P11565, DOI 10.1021/bi010649w; DIRNAGL U, IN PRESS TRENDS NEUR; Drew KL, 2001, FREE RADICAL BIO MED, V31, P563, DOI 10.1016/S0891-5849(01)00628-1; Esfandiari A, 1997, DEV NEUROSCI-BASEL, V19, P312, DOI 10.1159/000111227; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA; FRERICHS KU, 1994, J CEREBR BLOOD F MET, V14, P193, DOI 10.1038/jcbfm.1994.26; Frerichs KU, 1999, ACT NEUR S, V73, P57; Frerichs KU, 1998, P NATL ACAD SCI USA, V95, P14511, DOI 10.1073/pnas.95.24.14511; Frerichs KU, 1998, J CEREBR BLOOD F MET, V18, P168, DOI 10.1097/00004647-199802000-00007; Ghai HS, 1999, AM J PHYSIOL-REG I, V277, pR887, DOI 10.1152/ajpregu.1999.277.3.R887; HASLBERGER A, 1988, CIRC SHOCK, V26, P185; Heusch G, 2000, TRENDS CARDIOVAS MED, V10, P108, DOI 10.1016/S1050-1738(00)00058-X; Hill JK, 1999, BRAIN RES, V820, P45, DOI 10.1016/S0006-8993(98)01140-8; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Iadecola C, 2001, J CEREBR BLOOD F MET, V21, P1436, DOI 10.1097/00004647-200112000-00008; Kasischke K, 1999, STROKE, V30, P1256, DOI 10.1161/01.STR.30.6.1256; Kersten JR, 1997, ANESTHESIOLOGY, V87, P361, DOI 10.1097/00000542-199708000-00024; Lin H, 2002, CIRCULATION, V105, P1962, DOI 10.1161/01.CIR.0000015365.49180.05; LOPASCHUK GD, 1989, CIRC RES, V65, P378, DOI 10.1161/01.RES.65.2.378; MONCADA S, 1983, STROKE, V14, P157, DOI 10.1161/01.STR.14.2.157; Rudolf J, 1999, J CHILD NEUROL, V14, P543, DOI 10.1177/088307389901400813; Shnyra A, 1998, J IMMUNOL, V160, P3729; SIMON RP, 1993, NEUROSCI LETT, V163, P135, DOI 10.1016/0304-3940(93)90364-Q; SRERE HK, 1995, AM J PHYSIOL-REG I, V268, pR1507, DOI 10.1152/ajpregu.1995.268.6.R1507; STOREY KB, 1990, Q REV BIOL, V65, P145, DOI 10.1086/416717; Tasaki K, 1997, BRAIN RES, V748, P267, DOI 10.1016/S0006-8993(96)01383-2; Weih M, 1999, STROKE, V30, P1851, DOI 10.1161/01.STR.30.9.1851; Xiong ZG, 1997, P NATL ACAD SCI USA, V94, P7012, DOI 10.1073/pnas.94.13.7012	30	313	334	2	23	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 27	2003	362	9389					1028	1037		10.1016/S0140-6736(03)14412-1	http://dx.doi.org/10.1016/S0140-6736(03)14412-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725WD	14522533				2022-12-01	WOS:000185564600010
J	Sanchez-Villagra, MR; Aguilera, O; Horovitz, I				Sanchez-Villagra, MR; Aguilera, O; Horovitz, I			The anatomy of the world's largest extinct rodent	SCIENCE			English	Article							LONG BONES	Phoberomys is reported to be the largest rodent that ever existed, although it has been known only from isolated teeth and fragmentary postcranial bones. An exceptionally complete skeleton of Phoberomys pattersoni was discovered in a rich locality of fossil vertebrates in the Upper Miocene of Venezuela. Reliable body mass estimates yield similar to 700 kilograms, more than 10 times the mass of the largest living rodent, the capybara. With Phoberomys, Rodentia becomes one of the mammalian orders with the largest size range, second only to diprotodontian marsupials. Several postcranial features support an evolutionary relationship of Phoberomys with pakaranas from the South American rodent radiation. The associated fossil fauna is diverse and suggests that Phoberomys lived in marginal lagoons and wetlands.	Univ Tubingen, D-72076 Tubingen, Germany; Univ Nacl Expt Francisco Miranda, CICBA, Coro 4101, Estado Falcon, Venezuela; Univ Calif Los Angeles, Dept Organism Biol Ecol & Evolut, Los Angeles, CA 90095 USA	Eberhard Karls University of Tubingen; University of California System; University of California Los Angeles	Sanchez-Villagra, MR (corresponding author), Univ Tubingen, Morgenstelle 28, D-72076 Tubingen, Germany.	marcelo.sanchez@uni-tuebingen.de	Aguilera, Orangel/D-5055-2013					BERTRAM JEA, 1990, J MORPHOL, V204, P157, DOI 10.1002/jmor.1052040205; Biknevicius A.R., 1993, American Museum Novitates, V3079, P1; BIKNEVICIUS AR, 1993, J MAMMAL, V74, P95, DOI 10.2307/1381908; DEMES B, 1989, FOLIA PRIMATOL, V52, P58, DOI 10.1159/000156381; Flynn JJ, 1998, TRENDS ECOL EVOL, V13, P449, DOI 10.1016/S0169-5347(98)01457-8; FRANCIS J C, 1966, Kraglieviana, V1, P89; Huchon D, 2001, MOL PHYLOGENET EVOL, V20, P238, DOI 10.1006/mpev.2001.0961; Kay R., 1997, VERTEBRATE PALEONTOL; KRAGLIEVICH LUCAS, 1932, ANALES SOC CIENT ARGENTINA, V114, P155; LANDRY STUART O., 1957, UNIV CALIFORNIA PUBL ZOOL, V56, P1; McKenna MC, 1997, CLASSIFICATION MAMMA; *MIN EN MIN, 1997, MIN EN MIN B GEOL; MONES A, 1980, Ameghiniana, V17, P277; Mones Alvaro, 1997, Comunicaciones Paleontologicas del Museo de Historia Natural de Montevideo, V2, P1; NEGRI FR, 1999, B MUSEU PARAENSE EMI, V11, P1; Nowak R.M., 1999, MAMMALS WORLD; Paula Couto C., 1979, TRATADO PALEOMASTOZO; SANCHEZVILLAGRA MR, UNPUB; Springer MS, 2001, P NATL ACAD SCI USA, V98, P6241, DOI 10.1073/pnas.111551998; Starck D., 1995, LEHRBUCH SPEZIELLE 5; Vucetich MG, 1999, CR ACAD SCI II A, V329, P763; Wood R.C., 1976, Breviora, VNo. 436, P1	22	91	97	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2003	301	5640					1708	1710		10.1126/science.1089332	http://dx.doi.org/10.1126/science.1089332			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722QN	14500978				2022-12-01	WOS:000185387700040
J	Khosla, S; Melton, LJ; Dekutoski, MB; Oberg, AL; Riggs, BL				Khosla, S; Melton, LJ; Dekutoski, MB; Oberg, AL; Riggs, BL			Incidence of childhood distal forearm fractures over 30 years - A population-based study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEFINED POPULATION; PHYSICAL-ACTIVITY; OSTEOPOROSIS PREVENTION; LIMB FRACTURES; SUBSEQUENT HIP; BONE MASS; CHILDREN; GROWTH; EPIDEMIOLOGY; CALCIUM	Context The incidence of distal forearm fractures in children peaks around the time of the pubertal growth spurt, possibly because physical activity increases at the time of a transient deficit in cortical bone mass due to the increased calcium demand during maximal skeletal growth. Changes in physical activity or diet may therefore influence risk of forearm fracture. Objective To determine whether there has been a change in the incidence of distal forearm fractures in children in recent years. Design, Setting and Patients Population-based study among Rochester, Minn, residents younger than 35 years with distal forearm fractures in 1969-1971, 19791981, 1989-1991, and 1999-2001. Main Outcome Measure Estimated incidence of distal forearm fractures in 4 time periods. Results Comparably age- and sex-adjusted annual incidence rates per 100000 increased from 263.3 (95% confidence interval [Cl], 231.1-295.4) in 1969-1971 to 322.3 (95% Cl, 285.3-359.4) in 1979-1981 and to 399.8 (95% Cl, 361.0-438.6) in 19891991 before leveling off at 372.9 (95% Cl, 339.1-406.7) in 1999-2001. Age-adjusted incidence rates per 100000 were 32% greater Among male residents in 1999-2001 compared with 1969-1971 (409.4 [95% Cl, 359.9-459.0] vs 309.4 [95% Cl, 259.3-359.5]; P=.01) and 56% greater among female residents in the same time periods (334.3 [95% Cl, 288.6-380.1] vs 214.6 [95% Cl, 174.9-254.4]; P<.001). The peak incidence and greatest increase occurred between ages 11 and 14 years in boys and 8 and 11 years in girls. Conclusions There has been a statistically significant increase in the incidence of distal forearm fractures in children and adolescents, but whether this is due to changing patterns of physical activity, decreased bone acquisition due to poor calcium intake, or both is unclear at present. Given the large number of childhood fractures, however, studies are needed to define the cause(s) of this increase.	Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Internal Med, Div Metab Endocrinol & Nutr, Endocrine Res Unit, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Orthoped Surg, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Melton, LJ (corresponding author), Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, 200 1st St SW, Rochester, MN 55905 USA.		Khosla, Sundeep/AAE-6170-2020	Khosla, Sundeep/0000-0002-2936-4372	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004875] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR30582] Funding Source: Medline; NIA NIH HHS [AG04875] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bailey DA, 2000, J BONE MINER RES, V15, P2245, DOI 10.1359/jbmr.2000.15.11.2245; Bailey DA, 1999, J BONE MINER RES, V14, P1672, DOI 10.1359/jbmr.1999.14.10.1672; BAILEY DA, 1989, J BONE JOINT SURG AM, V71A, P1225, DOI 10.2106/00004623-198971080-00016; Baker SS, 1999, PEDIATRICS, V104, P1152, DOI 10.1542/peds.104.5.1152; BENGNER U, 1985, ACTA ORTHOP SCAND, V56, P158, DOI 10.3109/17453678508994345; BERGSTRALH EJ, 1992, TECHNICAL REPORT SER; BORRUD L, 1997, NUTR WEEK       0418, P4; Bryant RJ, 1999, J AM COLL NUTR, V18, p406S, DOI 10.1080/07315724.1999.10718905; BUHR AJ, 1959, LANCET, V1, P531; CALVO MS, 1993, J NUTR, V123, P1627, DOI 10.1093/jn/123.9.1627; *COMM PROF HOSP AC, 1998, INT CLASS DIS 9 REV, V1; COOPER C, 1995, J BONE MINER RES, V10, P940; Cooper C, 2001, OSTEOPOROSIS INT, V12, P623, DOI 10.1007/s001980170061; Cuddihy MT, 1999, OSTEOPOROSIS INT, V9, P469, DOI 10.1007/s001980050172; DONALDSON LJ, 1990, J EPIDEMIOL COMMUN H, V44, P241, DOI 10.1136/jech.44.3.241; GARRAWAY WM, 1979, MAYO CLIN PROC, V54, P701; GARRAWAY WM, 1979, MAYO CLIN PROC, V54, P708; Golden NH, 2000, ARCH PEDIAT ADOL MED, V154, P542, DOI 10.1001/archpedi.154.6.542; Goulding A, 1998, J BONE MINER RES, V13, P143, DOI 10.1359/jbmr.1998.13.1.143; Goulding A, 2000, J BONE MINER RES, V15, P2011, DOI 10.1359/jbmr.2000.15.10.2011; HAGINO H, 1989, ARCH ORTHOP TRAUM SU, V109, P43, DOI 10.1007/BF00441909; Jonsson B, 1999, ACTA ORTHOP SCAND, V70, P129, DOI 10.3109/17453679909011249; Kemper HCG, 2000, BONE, V27, P847, DOI 10.1016/S8756-3282(00)00397-5; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; KRAMHOFT M, 1988, ACTA ORTHOP SCAND, V59, P557, DOI 10.3109/17453678809148784; LANDIN LA, 1983, ACTA ORTHOP SCAND, V54, P1; LAURITZEN JB, 1993, OSTEOPOROSIS INT, V3, P133, DOI 10.1007/BF01623274; MALLMIN H, 1993, CALCIFIED TISSUE INT, V52, P269, DOI 10.1007/BF00296650; Melton LJ, 1997, NEW ENGL J MED, V337, P1466, DOI 10.1056/NEJM199711133372012; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Melton LJ, 1999, OSTEOPOROSIS INT, V9, P29, DOI 10.1007/s001980050113; MELTON LJ, 1988, OSTEOPOROSIS ETIOLOG, P111; MMCCULLAGH P, 1983, GEN LINEAR MODELS, P127; *NAT RES COUNC, 1989, REC DIET ALL, P174; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Oskam J, 1998, INJURY, V29, P353, DOI 10.1016/S0020-1383(97)00212-X; PARFITT AM, 1994, OSTEOPOROSIS INT, V4, P382, DOI 10.1007/BF01622201; Powell EC, 1996, PEDIATR EMERG CARE, V12, P259, DOI 10.1097/00006565-199608000-00006; Rauch F, 2001, J BONE MINER RES, V16, P1547, DOI 10.1359/jbmr.2001.16.8.1547; Riggs BL, 2002, J BONE MINER RES, V17, P11, DOI 10.1359/jbmr.2002.17.1.11; Tiderius CJ, 1999, ACTA ORTHOP SCAND, V70, P622, DOI 10.3109/17453679908997853; US Department of Agriculture, 1998, 962 USDA NAT FOOD SU; *USDA, 1993, 8711 USDA NAT FOOD C, P1; WONG PCN, 1965, ACTA ORTHOP SCAND, V36, P153, DOI 10.3109/17453676508989381	44	301	308	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2003	290	11					1479	1485		10.1001/jama.290.11.1479	http://dx.doi.org/10.1001/jama.290.11.1479			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721RE	13129988	Bronze			2022-12-01	WOS:000185329000030
J	Biggins, JB; Onwueme, KC; Thorson, JS				Biggins, JB; Onwueme, KC; Thorson, JS			Resistance to enediyne antitumor antibiotics by calC self-sacrifice	SCIENCE			English	Article							DNA CLEAVAGE; CALICHEAMICIN; ACTIVATION; BINDING; AGENTS	Antibiotic self-resistance mechanisms, which include drug elimination, drug modi. cation, target modi. cation, and drug sequestration, contribute substantially to the growing problem of antibiotic resistance among pathogenic bacteria. Enediynes are among the most potent naturally occurring antibiotics, yet the mechanism of resistance to these toxins has remained a mystery. We characterize an enediyne self-resistance protein that reveals a self-sacrificing paradigm for resistance to highly reactive antibiotics, and thus another opportunity for nonpathogenic or pathogenic bacteria to evade extremely potent small molecules.	Univ Wisconsin, Sch Pharm, Pharmaceut Sci Div, Lab Biosynthet Chem, Madison, WI 53705 USA; Cornell Univ, Joan & Sanford I Weill Grad Sch Med, Sloan Kettering Div, Mol Pharmacol & Therapeut Program, New York, NY 10021 USA	University of Wisconsin System; University of Wisconsin Madison; Cornell University; Memorial Sloan Kettering Cancer Center	Thorson, JS (corresponding author), Univ Wisconsin, Sch Pharm, Pharmaceut Sci Div, Lab Biosynthet Chem, 777 Highland Ave, Madison, WI 53705 USA.	jsthorson@pharmacy.wisc.edu	Thorson, Jon S/L-3696-2013	Thorson, Jon S/0000-0002-7148-0721; Biggins, John B./0000-0002-0825-3593	NCI NIH HHS [CA84374] Funding Source: Medline; NIAID NIH HHS [AI52218] Funding Source: Medline; NIGMS NIH HHS [GM58196] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052218, R37AI052218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058196] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; BERGMAN RG, 1973, ACCOUNTS CHEM RES, V6, P25, DOI 10.1021/ar50061a004; Biggins JB, 2000, P NATL ACAD SCI USA, V97, P13537, DOI 10.1073/pnas.240460997; Chatterjee M, 1996, J AM CHEM SOC, V118, P1938, DOI 10.1021/ja953162h; CHATTERJEE M, 1993, J AM CHEM SOC, V115, P3374, DOI 10.1021/ja00061a064; DAVIES MJ, 1997, RADICAL MEDIATED PRO, pCH2; DEVOSS JJ, 1990, J AM CHEM SOC, V112, P4554, DOI 10.1021/ja00167a069; Durr F. E., 1995, ENEDIYNE ANTIBIOTICS; ERMACORA MR, 1992, P NATL ACAD SCI USA, V89, P6383, DOI 10.1073/pnas.89.14.6383; GOLDBERG IH, 1997, ENEDIYNE ANTIBIOTICS, pCH16; HOYER D, 1990, J AM CHEM SOC, V112, P3249, DOI 10.1021/ja00164a076; Jones GB, 2000, ORG LETT, V2, P1863, DOI 10.1021/ol005926q; Jones GB, 2000, ORG LETT, V2, P811, DOI 10.1021/ol0055566; Kumar CV, 2002, P NATL ACAD SCI USA, V99, P5810, DOI 10.1073/pnas.082119599; McDonald LA, 1996, J AM CHEM SOC, V118, P10898, DOI 10.1021/ja961122n; MUCHMORE DC, 1989, METHOD ENZYMOL, V177, P44; MYERS AG, 1994, J AM CHEM SOC, V116, P1255, DOI 10.1021/ja00083a012; Oku N, 2003, J AM CHEM SOC, V125, P2044, DOI 10.1021/ja0296780; Plourde G, 2002, BIOORG MED CHEM LETT, V12, P2985; RANA TM, 1991, P NATL ACAD SCI USA, V88, P10578, DOI 10.1073/pnas.88.23.10578; Tenover FC, 2001, CLIN INFECT DIS, V33, pS108, DOI 10.1086/321834; Thorson JS, 2000, CURR PHARM DESIGN, V6, P1841, DOI 10.2174/1381612003398564; Walsh C., 2003, ANTIBIOTICS ACTIONS; Waugh DS, 1996, J BIOMOL NMR, V8, P184; Whitwam RE, 2000, J AM CHEM SOC, V122, P1556, DOI 10.1021/ja993612w	25	71	74	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2003	301	5639					1537	1541		10.1126/science.1086695	http://dx.doi.org/10.1126/science.1086695			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	720HL	12970566				2022-12-01	WOS:000185255300051
J	Yin, Y; Manoury, B; Fahraeus, R				Yin, Y; Manoury, B; Fahraeus, R			Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1	SCIENCE			English	Article							CLASS-I MOLECULES; NUCLEAR ANTIGEN-1; PEPTIDE; DEGRADATION; TRANSLATION; INITIATION; PROTEINS; DRIPS; CELLS	The glycine-alanine repeat domain (GAr) of Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1) prevents major histocompatibility complex (MHC) class I restricted presentation of EBNA1 epitopes to cytotoxic T cells. This effect has previously been attributed to the ability of GAr to inhibit its own proteasomal degradation. Here we show, both in vitro and in vivo, that GAr also inhibits messenger RNA translation of EBNA1 in cis and that this effect can be distinguished from its effect on proteasomal degradation. Hence, inhibition of messenger RNA translation, but not protein degradation, is essential to prevent antigen presentation on MHC class I molecules. Thus, by minimizing translation of the EBNA1 transcript, cells expressing EBNA1 avoid cytotoxic T cell recognition. At the same time, blocking degradation maintains the EBNA1 expression level.	Univ Dundee, Fac Life Sci, Div Mol Physiol, Dundee DD1 5EH, Scotland; Univ Dundee, Fac Life Sci, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland	University of Dundee; University of Dundee	Fahraeus, R (corresponding author), Univ Dundee, Fac Life Sci, Div Mol Physiol, Dundee DD1 5EH, Scotland.		fahraeus, robin/K-8726-2014	Manoury, Benedicte/0000-0001-7784-3389; , robin/0000-0003-0402-8492				Blake N, 1997, IMMUNITY, V7, P791, DOI 10.1016/S1074-7613(00)80397-0; Blake N, 2000, J IMMUNOL, V165, P7078, DOI 10.4049/jimmunol.165.12.7078; CHEN F, 1995, J VIROL, V69, P3752, DOI 10.1128/JVI.69.6.3752-3758.1995; DILLNER J, 1984, P NATL ACAD SCI-BIOL, V81, P4652, DOI 10.1073/pnas.81.15.4652; GEBALLE AP, 1994, TRENDS BIOCHEM SCI, V19, P159, DOI 10.1016/0968-0004(94)90277-1; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6021; Khanna R, 1995, VIROLOGY, V214, P633, DOI 10.1006/viro.1995.0076; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; Lovett PS, 1996, MICROBIOL REV, V60, P366, DOI 10.1128/MMBR.60.2.366-385.1996; PEERY T, 2000, TRANSLATIONAL CONTRO; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sharipo A, 1998, NAT MED, V4, P939, DOI 10.1038/nm0898-939; TIERNEY RJ, 1994, J VIROL, V68, P7374, DOI 10.1128/JVI.68.11.7374-7385.1994; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Wu H, 2002, J VIROL, V76, P2480, DOI 10.1128/JVI.76.5.2480-2490.2002; Yewdell JW, 2002, NAT IMMUNOL, V3, P1019, DOI 10.1038/ni1102-1019; Yewdell JW, 1996, J IMMUNOL, V157, P1823; Yewdell JW, 2001, J CELL SCI, V114, P845; Yin Y.G., UNPUB	23	203	219	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 5	2003	301	5638					1371	1374		10.1126/science.1088902	http://dx.doi.org/10.1126/science.1088902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717XQ	12958359				2022-12-01	WOS:000185116400039
J	Iglehart, JK				Iglehart, JK			Prescription-drug coverage for Medicare beneficiaries	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	4	4	1	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 4	2003	349	10					923	925		10.1056/NEJMp038139	http://dx.doi.org/10.1056/NEJMp038139			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	717HJ	12954738				2022-12-01	WOS:000185081400001
J	Wusthoff, C				Wusthoff, C			The dilemma of confidentiality in Huntington disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DISCLOSURE		Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Wusthoff, C (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.			Wusthoff, Courtney/0000-0002-1882-5567				ADAMS J, 1990, J MED ETHICS, V16, P195; BALL D, 1993, J MED GENET, V30, P1028; Bernstein T, 1994, RADON RENTAL HOUSING; BLOCH M, 1993, AM J MED GENET, V47, P368, DOI 10.1002/ajmg.1320470314; Evers-Kiebooms G, 1998, PATIENT EDUC COUNS, V35, P15, DOI 10.1016/S0738-3991(98)00086-X; Hakimian R, 2000, GENET TEST, V4, P359, DOI 10.1089/109065700750065090; Knoppers BM, 1998, AM J HUM GENET, V62, P474; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1983, SCREEN COUNS GEN CON	8	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2003	290	9					1219	1220		10.1001/jama.290.9.1219	http://dx.doi.org/10.1001/jama.290.9.1219			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	717LK	12953009	Bronze			2022-12-01	WOS:000185090400022
J	Belotserkovskaya, R; Oh, S; Bondarenko, VA; Orphanides, G; Studitsky, VM; Reinberg, D				Belotserkovskaya, R; Oh, S; Bondarenko, VA; Orphanides, G; Studitsky, VM; Reinberg, D			FACT facilitates transcription-dependent nucleosome alteration	SCIENCE			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; IN-VIVO; ELONGATION; CHROMATIN; PROTEIN; COMPLEX; POB3; SSRP1; CDC68	The FACT (facilitates chromatin transcription) complex is required for transcript elongation through nucleosomes by RNA polymerase II (Pol II) in vitro. Here, we show that FACT facilitates Pol II-driven transcription by destabilizing nucleosomal structure so that one histone H2A-H2B dimer is removed during enzyme passage. We also demonstrate that FACT possesses intrinsic histone chaperone activity and can deposit core histones onto DNA. Importantly, FACT activity requires both of its constituent subunits and is dependent on the highly acidic C terminus of its larger subunit, Spt16. These findings define the mechanism by which Pol II can transcribe through chromatin without disrupting its epigenetic status.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Howard Hughes Med Inst, Dept Biochem,Div Nucl Acids enzymol, Piscataway, NJ 08854 USA; Wayne State Univ, Sch Med, Dept Biochem, Detroit, MI 48201 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Wayne State University	Reinberg, D (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Howard Hughes Med Inst, Dept Biochem,Div Nucl Acids enzymol, Piscataway, NJ 08854 USA.		Bondarenko, Vladimir/AFY-8370-2022; Studitsky, Vasily/A-9382-2014	Reinberg, Danny/0000-0003-4288-2016	NIGMS NIH HHS [GM58650, GM37120] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037120, R01GM037120, R01GM058650] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELOTSERKOVSKAY.R, UNPUB; BONDARENKO VA, UNPUB; BRUHN SL, 1992, P NATL ACAD SCI USA, V89, P2307, DOI 10.1073/pnas.89.6.2307; Evans DRH, 1998, GENETICS, V150, P1393; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Formosa T, 2002, GENETICS, V162, P1557; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; Keller DM, 2002, J BIOL CHEM, V277, P50206, DOI 10.1074/jbc.M209820200; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; Lindstrom DL, 2001, GENETICS, V159, P487; LYCAN D, 1994, MOL CELL BIOL, V14, P7455, DOI 10.1128/MCB.14.11.7455; Okuhara K, 1999, CURR BIOL, V9, P341, DOI 10.1016/S0960-9822(99)80160-2; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; Philpott A, 2000, SEMIN CELL DEV BIOL, V11, P7, DOI 10.1006/scdb.1999.0346; Santisteban MS, 1997, EMBO J, V16, P2493, DOI 10.1093/emboj/16.9.2493; SAUNDERS, 2003, SCIENCE, V301, P1094; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; STUDITSKY VM, 1995, CELL, V83, P19, DOI 10.1016/0092-8674(95)90230-9; TENHEGGELERBORDIER B, 1995, EMBO J, V14, P2561, DOI 10.1002/j.1460-2075.1995.tb07254.x; Wittmeyer J, 1999, BIOCHEMISTRY-US, V38, P8961, DOI 10.1021/bi982851d; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; XU QL, 1993, MOL CELL BIOL, V13, P7553, DOI 10.1128/MCB.13.12.7553; Yarnell AT, 2001, J BIOL CHEM, V276, P25736, DOI 10.1074/jbc.M101208200	28	624	640	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 22	2003	301	5636					1090	1093		10.1126/science.1085703	http://dx.doi.org/10.1126/science.1085703			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713RP	12934006				2022-12-01	WOS:000184872400038
J	Zhao, YD; Dai, XH; Blackwell, HE; Schreiber, SL; Chory, J				Zhao, YD; Dai, XH; Blackwell, HE; Schreiber, SL; Chory, J			SIR1, an upstream component in auxin signaling identified by chemical genetics	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; AUX/IAA PROTEINS; RAPID INDUCTION; TRANSPORT; ROOT; GRAVITROPISM; DEGRADATION; REGULATOR; MECHANISM; MUTATION	Auxin is a plant hormone that regulates many aspects of plant growth and development. We used a chemical genetics approach to identify SIR1, a regulator of many auxin-inducible genes. The sir1 mutant was resistant to sirtinol, a small molecule that activates many auxin-inducible genes and promotes auxin-related developmental phenotypes. SIR1 is predicted to encode a protein composed of a ubiquitin-activating enzyme E1-like domain and a Rhodanese-like domain homologous to that of prolyl isomerase. We suggest a molecular context for how the auxin signal is propagated to exert its biological effects.	Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; Harvard Univ, Howard Hughes Med Inst, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; HHMI, Plant Biol Lab, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Harvard University; Howard Hughes Medical Institute; Salk Institute; Howard Hughes Medical Institute	Zhao, YD (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052413, R01GM068631] Funding Source: NIH RePORTER; NIGMS NIH HHS [2R01GM52413, 1R01GM68631-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Friml J, 2002, PLANT MOL BIOL, V49, P273, DOI 10.1023/A:1015248926412; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; HAGEN G, 1985, MOL CELL BIOL, V5, P1197, DOI 10.1128/MCB.5.6.1197; Harper RM, 2000, PLANT CELL, V12, P757, DOI 10.1105/tpc.12.5.757; Hellmann H, 2002, SCIENCE, V297, P793, DOI 10.1126/science.1072831; HOBBIE L, 1994, PLANT CELL ENVIRON, V17, P525, DOI 10.1111/j.1365-3040.1994.tb00147.x; King JJ, 1995, PLANT CELL, V7, P2023, DOI 10.1105/tpc.7.12.2023; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; LEYSER HMO, 1993, NATURE, V364, P161, DOI 10.1038/364161a0; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Nieder Joerg, 1997, P275; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Ruegger M, 1997, PLANT CELL, V9, P745, DOI 10.1105/tpc.9.5.745; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Schroeder DF, 2002, CURR BIOL, V12, P1462, DOI 10.1016/S0960-9822(02)01106-5; THEOLOGIS A, 1985, J MOL BIOL, V183, P53, DOI 10.1016/0022-2836(85)90280-3; TIMPTE C, 1994, GENETICS, V138, P1239; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306	27	134	140	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 22	2003	301	5636					1107	1110		10.1126/science.1084161	http://dx.doi.org/10.1126/science.1084161			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713RP	12893885				2022-12-01	WOS:000184872400044
J	van Ommeren, M; Saxena, S; Loretti, A; Saraceno, B				van Ommeren, M; Saxena, S; Loretti, A; Saraceno, B			Ensuring care for patients in custodial psychiatric hospitals in emergencies	LANCET			English	Editorial Material									WHO, Dept Mental Hlth & Subst Dependence, CH-1211 Geneva, Switzerland; WHO, Hlth Act Crises, CH-1211 Geneva, Switzerland	World Health Organization; World Health Organization	van Ommeren, M (corresponding author), WHO, Dept Mental Hlth & Subst Dependence, Ave Appia, CH-1211 Geneva, Switzerland.	vanommerenm@who.int		Saraceno, Benedetto/0000-0001-7119-5712				BISE G, 2001, MALADES MENTAUX GUER; Health organization, 2001, WORLD HLTH REPORT 20; Silove D, 2000, LANCET, V355, P1548, DOI 10.1016/S0140-6736(00)02177-2; WEISS MG, IN PRESS J NERV MENT	4	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2003	362	9383					574	574		10.1016/S0140-6736(03)14123-2	http://dx.doi.org/10.1016/S0140-6736(03)14123-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	712UW	12938670				2022-12-01	WOS:000184817600029
J	Hamuy, M; Phillips, MM; Suntzeff, NB; Maza, J; Gonzalez, LE; Roth, M; Krisciunas, K; Morrell, N; Green, EM; Persson, SE; McCarthy, PJ				Hamuy, M; Phillips, MM; Suntzeff, NB; Maza, J; Gonzalez, LE; Roth, M; Krisciunas, K; Morrell, N; Green, EM; Persson, SE; McCarthy, PJ			An asymptotic-giant-branch star in the progenitor system of a type Ia supernova	NATURE			English	Article							DENSE WINDS; 1999EE; 1988Z	Stars that explode as supernovae come in two main classes. A type Ia supernova is recognized by the absence of hydrogen and the presence of elements such as silicon and sulphur in its spectrum; this class of supernova is thought to produce the majority of iron-peak elements in the Universe. They are also used as precise 'standard candles' to measure the distances to galaxies. While there is general agreement that a type Ia supernova is produced by an exploding white dwarf star(1), no progenitor system has ever been directly observed. Significant effort has gone into searching for circumstellar material to help discriminate between the possible kinds of progenitor systems(2), but no such material has hitherto been found associated with a type Ia supernova(3). Here we report the presence of strong hydrogen emission associated with the type Ia supernova SN2002ic, indicating the presence of large amounts of circumstellar material. We infer from this that the progenitor system contained a massive asymptotic-giant-branch star that lost several solar masses of hydrogen-rich gas before the supernova explosion.	Carnegie Inst Washington Observ, Pasadena, CA 91101 USA; Carnegie Observ, Las Campanas Observ, La Serena, Chile; Cerro Tololo Interamer Observ, Natl Opt Astron Observ, La Serena, Chile; Univ Chile, Dept Astron, Santiago, Chile; Univ Arizona, Steward Observ, Tucson, AZ 85721 USA	Carnegie Institution for Science; Carnegie Institution for Science; National Optical Astronomy Observatory; Universidad de Chile; University of Arizona	Hamuy, M (corresponding author), Carnegie Inst Washington Observ, 813 Santa Barbara St, Pasadena, CA 91101 USA.		Maza, José/I-5722-2016; Hamuy, Mario/G-7541-2016	Maza, José/0000-0003-2068-1328; Phillips, Mark/0000-0003-2734-0796; Suntzeff, Nicholas/0000-0002-8102-181X				Aretxaga I, 1999, MON NOT R ASTRON SOC, V309, P343, DOI 10.1046/j.1365-8711.1999.02830.x; Arnett D., 1996, SUPERNOVAE NUCLEOSYN; Chugai NN, 1997, ASTRON REP+, V41, P672; Chugai NN, 1997, ASTROPHYS SPACE SCI, V252, P225, DOI 10.1023/A:1000847125928; Cumming RJ, 1996, MON NOT R ASTRON SOC, V283, P1355, DOI 10.1093/mnras/283.4.1355; Germany LM, 2000, ASTROPHYS J, V533, P320, DOI 10.1086/308639; HAMUY M, 1993, PUBL ASTRON SOC PAC, V105, P787, DOI 10.1086/133231; Hamuy M, 2002, ASTRON J, V124, P417, DOI 10.1086/340968; Hamuy M, 1996, ASTRON J, V112, P2438, DOI 10.1086/118193; Hamuy M., 2003, PREPRINT; HAMUY M, IN PRESS CORE COLLAP; Henry RBC, 1999, PUBL ASTRON SOC PAC, V111, P919, DOI 10.1086/316403; IBEN I, 1983, ANNU REV ASTRON ASTR, V21, P271, DOI 10.1146/annurev.aa.21.090183.001415; Lentz EJ, 2002, ASTROPHYS J, V580, P374, DOI 10.1086/343073; Li WD, 2001, ASTROPHYS J, V546, P734, DOI 10.1086/318299; Livio M, 2001, SPACE TEL S, V13, P334; Phillips MM, 1999, ASTRON J, V118, P1766, DOI 10.1086/301032; PHILLIPS MM, 1992, ASTRON J, V103, P1632, DOI 10.1086/116177; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; SCHLEGEL EM, 1990, MON NOT R ASTRON SOC, V244, P269; Stritzinger M, 2002, ASTRON J, V124, P2100, DOI 10.1086/342544; Strolger LG, 2002, ASTRON J, V124, P2905, DOI 10.1086/343058; SUNTZEFF NB, 1996, IAU COLLOQ, V145, P41; Turatto M, 2000, ASTROPHYS J, V534, pL57, DOI 10.1086/312653; TURATTO M, 1993, MON NOT R ASTRON SOC, V262, P128, DOI 10.1093/mnras/262.1.128; Weidemann V, 2000, ASTRON ASTROPHYS, V363, P647; WOODVASEY WM, 2002, 8019 IAU	27	318	321	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					651	654		10.1038/nature01854	http://dx.doi.org/10.1038/nature01854			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904786	Green Submitted			2022-12-01	WOS:000184578800038
J	Bilukha, OO; Brennan, M; Woodruff, BA				Bilukha, OO; Brennan, M; Woodruff, BA			Death and injury from landmines and unexploded ordnance in Afghanistan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LAND MINES; MOZAMBIQUE	Context Afghanistan is one of the countries most affected by injuries due to landmines and unexploded ordnance. Objective To understand the epidemiological patterns and risk factors for injury due to landmines and unexploded ordnance. Design and Setting Analysis of surveillance data on landmine and unexploded ordnance injuries in Afghanistan collected by the International Committee of the Red Cross in 390 health facilities in Afghanistan. Surveillance data were used to describe injury trends, injury types, demographics, and risk behaviors of those injured and explosive types related to landmine and unexploded ordnance incidents. Participants A total of 1636 individuals injured by landmines and unexploded ordnance, March 2001 through June 2002. Results Eighty-one percent of those injured were civilians, 91.6% were men and boys, and 45.9% were younger than 16 years. Children were more likely to be injured by unexploded ordnance (which includes grenades, bombs, mortar shells, and cluster munitions), whereas adults were injured mostly by landmines. The most common risk behaviors for children were playing and tending animals; for adults, these risk behaviors were military activity and activities of economic necessity (eg, farming, traveling). The case-fatality rate of 9.4% is probably underestimated because surveillance predominantly detects those who survive long enough to receive medical care. Conclusions Landmine risk education should focus on hazards due to unexploded ordnance for children and on landmine hazards for adults and should address age-specific risk behaviors. Expanding community-based and clinic-based reporting will improve the sensitivity and representativeness of surveillance.	CDCP, Int Emergency & Refugee Hlth Branch, Div Emergency & Environm Hlth Serv, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA; CDP, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Bilukha, OO (corresponding author), CDCP, Int Emergency & Refugee Hlth Branch, Div Emergency & Environm Hlth Serv, Natl Ctr Environm Hlth, 4770 Buford Hwy,Mailstop F-48, Atlanta, GA 30341 USA.		Bilukha, Oleg/ABC-5095-2020					ANDERSSON N, 1995, BRIT MED J, V311, P718, DOI 10.1136/bmj.311.7007.718; ASCHERIO A, 1995, LANCET, V346, P721, DOI 10.1016/S0140-6736(95)91501-X; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P724; Coupland RM, 1999, BRIT MED J, V319, P410, DOI 10.1136/bmj.319.7207.410; Gall C, 2002, NY TIMES, pA15; Giannou C, 1997, BRIT MED J, V315, P1453, DOI 10.1136/bmj.315.7120.1453; Hanevik K, 2000, BRIT MED J, V321, P1189, DOI 10.1136/bmj.321.7270.1189; *INT CAMP BAN LAND, 2002, LANDM MON REP 2002; *INT COMM RED CROS, 2002, SEM ANN REP JAN JUN; Jeffrey SJ, 1996, J ACCID EMERG MED, V13, P343; Kakar F, 1996, Prehosp Disaster Med, V11, P2; *OFF HUM DEM PROGR, 1998, HIDD KILL GLOB LANDM; *TRANS ISL GOV AFG, 2002, AFGH NAT HLTH RES AS	13	49	50	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2003	290	5					650	653		10.1001/jama.290.5.650	http://dx.doi.org/10.1001/jama.290.5.650			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708GH	12902369				2022-12-01	WOS:000184558500020
J	Vasudevan, AR; Kabinoff, GS; Keltz, TN; Gitler, B				Vasudevan, AR; Kabinoff, GS; Keltz, TN; Gitler, B			Blunt chest trauma producing acute myocardial infarction in a rugby player	LANCET			English	Editorial Material							DISSECTION; INJURY		New York Med Coll, Sound Shore Med Ctr Westchester, Dept Cardiol, Westchester, NY 10802 USA; New York Med Coll, Sound Shore Med Ctr Westchester, Dept Med, Westchester, NY 10802 USA	New York Medical College; New York Medical College	Gitler, B (corresponding author), New York Med Coll, Sound Shore Med Ctr Westchester, Dept Cardiol, Westchester, NY 10802 USA.							FOUSSAS SG, 1989, ANGIOLOGY, V40, P313, DOI 10.1177/000331978904000412; Fu M, 1999, J FORMOS MED ASSOC, V98, P136; Ginzburg E, 1998, J TRAUMA, V45, P157, DOI 10.1097/00005373-199807000-00034; MARIK PE, 1990, S AFR MED J, V77, P586; SUTHERLAND GR, 1983, AM J CARDIOL, V52, P1099, DOI 10.1016/0002-9149(83)90540-4	5	26	30	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 2	2003	362	9381					370	370		10.1016/S0140-6736(03)14024-X	http://dx.doi.org/10.1016/S0140-6736(03)14024-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907010				2022-12-01	WOS:000184498700010
J	Matsumoto, A; Comatas, KE; Liu, LM; Stamler, JS				Matsumoto, A; Comatas, KE; Liu, LM; Stamler, JS			Screening for nitric oxide-dependent protein-protein interactions	SCIENCE			English	Article								Because nitric oxide (NO) may be a ubiquitous regulator of cellular signaling, we have modified the yeast two-hybrid system to explore the possibility of NO-dependent protein-protein interactions. We screened for binding partners of procaspase-3, a protein implicated in apoptotic signaling pathways, and identified multiple NO-dependent interactions. Two such interactions, with acid sphingomyelinase and NO synthase, were shown to occur in mammalian cells dependent on endogenous NO. Nitrosylation may thus provide a broad-based mechanism for regulating interactions between proteins. If so, systematic proteomic analyses in which redox state and NO bioavailability are carefully controlled will reveal a large array of novel interactions.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University	Stamler, JS (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.			Matsumoto, Akio/0000-0002-3402-6992; Stamler, Jonathan/0000-0002-6866-1572				BREDT DS, 1992, J BIOL CHEM, V267, P10976; Bulotta S, 2001, J BIOL CHEM, V276, P6529, DOI 10.1074/jbc.M006535200; De Nadai C, 2000, P NATL ACAD SCI USA, V97, P5480, DOI 10.1073/pnas.070062397; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; Haneline LS, 1998, BLOOD, V91, P4092; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; HURWITZ R, 1994, J BIOL CHEM, V269, P5440; Huwiler A, 1999, J BIOL CHEM, V274, P7190, DOI 10.1074/jbc.274.11.7190; Igarashi J, 1999, P NATL ACAD SCI USA, V96, P12583, DOI 10.1073/pnas.96.22.12583; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Kumar A, 2002, NATURE, V415, P123, DOI 10.1038/415123a; Lipton SA, 2002, CELL, V111, P147, DOI 10.1016/S0092-8674(02)01046-2; Liu LM, 2000, P NATL ACAD SCI USA, V97, P4672, DOI 10.1073/pnas.090083597; Liu LM, 1999, CELL DEATH DIFFER, V6, P937, DOI 10.1038/sj.cdd.4400578; LIU PS, 1995, J BIOL CHEM, V270, P27179, DOI 10.1074/jbc.270.45.27179; Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; MANNICK JB, 1994, CELL, V79, P1137, DOI 10.1016/0092-8674(94)90005-1; Matsumoto A., UNPUB; Nedvetsky PI, 2002, P NATL ACAD SCI USA, V99, P16510, DOI 10.1073/pnas.262701999; Schwandner R, 1998, J BIOL CHEM, V273, P5916, DOI 10.1074/jbc.273.10.5916; SESSA WC, 1995, J BIOL CHEM, V270, P17641, DOI 10.1074/jbc.270.30.17641; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Takeda Y, 1999, J BIOL CHEM, V274, P10654, DOI 10.1074/jbc.274.15.10654; Zech B, 1999, J BIOL CHEM, V274, P20931, DOI 10.1074/jbc.274.30.20931	28	115	118	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2003	301	5633					657	661		10.1126/science.1079319	http://dx.doi.org/10.1126/science.1079319			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893946				2022-12-01	WOS:000184473600043
J	Kasthuri, N; Lichtman, JW				Kasthuri, N; Lichtman, JW			The role of neuronal identity in synaptic competition	NATURE			English	Article							SKELETAL-MUSCLE; ELIMINATION; REORGANIZATION; INNERVATION	In developing mammalian muscle, axon branches of several motor neurons co-innervate the same muscle fibre. Competition among them results in the strengthening of one and the withdrawal of the rest(1,2). It is not known why one particular axon branch survives or why some competitions resolve sooner than others(3). Here we show that the fate of axonal branches is strictly related to the identity of the axons with which they compete. When two neurons co-innervate multiple target cells, the losing axon branches in each contest belong to the same neuron and are at nearly the same stage of withdrawal. The axonal arbor of one neuron engages in multiple sets of competitions simultaneously. Each set proceeds at a different rate and heads towards a common outcome based on the identity of the competitor. Competitive vigour at each of these sets of local competitions depends on a globally distributed resource: neurons with larger arborizations are at a competitive disadvantage when confronting neurons with smaller arborizations. An accompanying paper tests the idea that the amount of neurotransmitter released is this global resource(4).	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Lichtman, JW (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	jeff@pcg.wustl.edu						BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; Barber MJ, 1999, J NEUROSCI, V19, P9975; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387, DOI 10.1113/jphysiol.1976.sp011565; Buffelli M, 2002, P NATL ACAD SCI USA, V99, P13200, DOI 10.1073/pnas.202471199; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gan WB, 1998, SCIENCE, V282, P1508, DOI 10.1126/science.282.5393.1508; JANSEN JKS, 1990, PROG NEUROBIOL, V34, P39, DOI 10.1016/0301-0082(90)90025-C; Keller-Peck CR, 2001, NEURON, V31, P381, DOI 10.1016/S0896-6273(01)00383-X; LICHTMAN JW, 1977, J PHYSIOL-LONDON, V273, P155, DOI 10.1113/jphysiol.1977.sp012087; Personius KE, 2000, BRAIN RES BULL, V53, P513, DOI 10.1016/S0361-9230(00)00384-1; Personius KE, 2001, NEURON, V31, P395, DOI 10.1016/S0896-6273(01)00369-5; Press W., 1992, NUMERICAL RECIPES, V2nd; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; Wong ROL, 2003, FUNDAMENTAL NEUROSCI, P533	18	98	101	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					426	430		10.1038/nature01836	http://dx.doi.org/10.1038/nature01836			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879070				2022-12-01	WOS:000184318400043
J	Lee, K; Jessop, H; Suswillo, R; Zaman, G; Lanyon, L				Lee, K; Jessop, H; Suswillo, R; Zaman, G; Lanyon, L			Endocrinology - Bone adaptation requires oestrogen receptor-alpha	NATURE			English	Article									Univ London Royal Vet Coll, Dept Vet Basic Sci, London NW1 0TU, England	University of London; University of London Royal Veterinary College	Lee, K (corresponding author), Univ London Royal Vet Coll, Dept Vet Basic Sci, 32 Belgrave Sq, London NW1 0TU, England.	llanyon@rvc.ac.uk						Ankrom MA, 1998, BIOCHEM J, V333, P787, DOI 10.1042/bj3330787; Hoyland JA, 1999, J PATHOL, V188, P294; Lee KCL, 2002, BONE, V31, P407, DOI 10.1016/S8756-3282(02)00842-6; Lim SK, 1999, J BONE MINER RES, V14, P1189, DOI 10.1359/jbmr.1999.14.7.1189; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Sutherland MK, 1996, BONE, V18, P361, DOI 10.1016/8756-3282(96)00016-6; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; TZUKERMAN MT, 1994, MOL ENDOCRINOL, V8, P21, DOI 10.1210/me.8.1.21; Zaman G, 2000, BONE, V27, P233, DOI 10.1016/S8756-3282(00)00324-0	9	242	264	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					389	389		10.1038/424389a	http://dx.doi.org/10.1038/424389a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879058	Bronze			2022-12-01	WOS:000184318400031
J	Pullman, D; Latus, A				Pullman, D; Latus, A			Clinical trials, genetic add-ons, and the question of benefit-sharing	LANCET			English	Editorial Material							ETHICS	Discussion of benefit-sharing has become common in the sphere of human genetic research. Roughly, this term means that individuals or organisations who could reap financial rewards from research into human genetics have some obligation to share the benefits of this research, perhaps with the people who made the research possible in the first place, or with humankind more broadly. This idea has met with some acceptance, finding its way into policy recommendations and statements of several prominent groups. However, the issue of benefit-sharing is generally raised in the context of large-scale population-based genetic studies. Other sources of human DNA are often ignored. In particular, little attention has been paid to the increasingly common practice of collecting genetic samples as addons to clinical drug trials. Generally such trials do not specify a use for these samples, which are collected for purposes of potential future research. We argue that if a case for benefit-sharing can be made for genetic studies in general, it can be made for add-on studies as well. We suggest some ways in which benefit-sharing might be implemented for genetic add-on studies.	Mem Univ Newfoundland, Fac Med, St Johns, NF A1B 3V6, Canada; Mem Univ Newfoundland, Dept Philosophy, St Johns, NF A1B 3V6, Canada	Memorial University Newfoundland; Memorial University Newfoundland	Pullman, D (corresponding author), Mem Univ Newfoundland, Fac Med, St Johns, NF A1B 3V6, Canada.							Berg K, 2001, CLIN GENET, V59, P240, DOI 10.1034/j.1399-0004.2001.590404.x; El Setouhy M, 2002, SCIENCE, V298, P2133; FELDBAUM CB, 2003, BIO 2002 C TOR ONT J; Frank L, 1999, SCIENCE, V286, P1262, DOI 10.1126/science.286.5443.1262; Greely HT, 2001, PERSPECT BIOL MED, V44, P221, DOI 10.1353/pbm.2001.0026; *HUM GEN ORG ETH C, 2003, STAT BEN SHAR; LITMAN MM, 1997, HUMAN DNA LAW POLICY, P17; Merz JF, 2002, AM J HUM GENET, V70, P965, DOI 10.1086/339767; Rose H., 2003, COMMODIFICATION BIOI; *STANF WASH PROGR, 2003, WORLD SURV FUND GEN; *WHO, 2003, GEN WORLD HLTH REP A; *WHO HUM GEN PROGR, 2003, WHO M APR 2	12	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 19	2003	362	9379					242	244		10.1016/S0140-6736(03)13916-5	http://dx.doi.org/10.1016/S0140-6736(03)13916-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702PJ	12885490				2022-12-01	WOS:000184232000028
J	Gomez-Gutierrez, J; Peterson, WT; De Robertis, A; Brodeur, RD				Gomez-Gutierrez, J; Peterson, WT; De Robertis, A; Brodeur, RD			Mass mortality of krill caused by parasitoid ciliates	SCIENCE			English	Article							EUPHAUSIID THYSANOESSA-INERMIS		Ctr Interdisciplinario Ciencias Marinas, La Paz 23096, BCS, Mexico; Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; Natl Marine Fisheries Serv, Natl Ocean & Atmospher Adm, NW Fisheries Sci Ctr, Newport, OR 97365 USA	Oregon State University; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Gomez-Gutierrez, J (corresponding author), Ctr Interdisciplinario Ciencias Marinas, La Paz 23096, BCS, Mexico.		Riley, Eleanor M/C-8960-2013	Riley, Eleanor M/0000-0003-3447-3570; Brodeur, Richard/0000-0002-6629-5564				ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; BRADBURY PC, 1994, PARASITIC PROTOZOA, V8, P139; CAPRIULO GM, 1991, MAR ECOL PROG SER, V72, P203, DOI 10.3354/meps072203; CAPRIULO GM, 1986, DIS AQUAT ORGAN, V1, P141; SIEGEL V, 2000, KRILL BIOL ECOLOGY F, P00103, DOI DOI 10.1002/9780470999493.CH5	5	63	69	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					339	339		10.1126/science.1085164	http://dx.doi.org/10.1126/science.1085164			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869754				2022-12-01	WOS:000184207300034
J	Oyama, N; Chan, I; Neill, SM; Hamada, T; South, AP; Wessagowit, V; Wojnarowska, F; D'Cruz, D; Hughes, GJ; Black, MM; McGrath, JA				Oyama, N; Chan, I; Neill, SM; Hamada, T; South, AP; Wessagowit, V; Wojnarowska, F; D'Cruz, D; Hughes, GJ; Black, MM; McGrath, JA			Autoantibodies to extracellular matrix protein 1 in lichen sclerosus	LANCET			English	Article							BENIGN EPIDERMOLYSIS-BULLOSA; HUMAN KERATINOCYTES; LIPOID PROTEINOSIS; PEMPHIGOID ANTIGEN; SKIN DISEASES; GENE ECM1; MUTATIONS; EXPRESSION; ATROPHICUS; HEMIDESMOSOMES	Background Lichen sclerosus is a common acquired inflammatory disorder of skin and mucous membranes. The aetiology is unknown, although HLA-subtype susceptibility and high rates of other autoimmune disorders suggest that autoantibodies to specific mucocutaneous antigens are involved. The clinicopathological similarities between lichen sclerosus and lipoid proteinosis, which results from mutations in extracellular matrix protein 1 (ECM1), suggest this protein as an autoantigen. Methods We analysed serum autoantibody profiles in 171 individuals (86 with lichen sclerosus, 85 healthy controls) by immunoblotting of extracts from normal human skin and lipoid proteinosis skin (lacking ECM1). We generated a full-length glutathione-S-transferase fusion protein for ECM1 to confirm specific immunoreactivity. We affinity-purified serum from patients with lichen sclerosus and did indirect immunofluorescence microscopy on normal skin with or without preabsorption with recombinant ECM1. Findings By immunoblotting, IgG autoantibodies were found in 20 (67% [95% Cl 45-84]) of 30 lichen sclerosus serum samples. The highest titre was 1 in 20. The bands were not detected in ECM1-deficient substrate. These samples, and those from 56 other patients with lichen sclerosus, showed immunoreactivity to the recombinant ECM1 protein (64 of 86 positive; 74% [65-84]). Only six (7% [2-13]) of 85 control serum samples were positive. Affinity-purified IgG from serum of patients with lichen sclerosus labelled skin similarly to a polyclonal antibody to ECM1. The positive staining was blocked by preabsorption with excess recombinant ECM1 protein. Interpretation These findings provide evidence for a specific humoral immune response to ECM1 in lichen sclerosus and offer insight into disease diagnosis, monitoring, and approaches to treatment.	St Thomas Hosp, St Johns Inst Dermatol, Div Skin Sci,Genet Skin Dis Grp, Guys Kings & St Thomas Sch Med, London SE1 7EH, England; St Thomas Hosp, St Johns Inst Dermatol, Div Skin Sci,Dept Immunofluorescence, Guys Kings & St Thomas Sch Med, London SE1 7EH, England; Churchill Hosp, Dept Dermatol, Oxford, England; St Thomas Hosp, Rayne Inst, Dept Immunol, Lupus Res Unit, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	McGrath, JA (corresponding author), St Thomas Hosp, St Johns Inst Dermatol, Div Skin Sci,Genet Skin Dis Grp, Guys Kings & St Thomas Sch Med, London SE1 7EH, England.	john.mcgrath@kcl.ac.uk	McGrath, John/N-3529-2019; McGrath, John/D-6824-2012	McGrath, John/0000-0002-3708-9964; Oyama, Noritaka/0000-0003-4934-5205				Azurdia RM, 1999, BRIT J DERMATOL, V140, P79; BERNARD P, 1992, J INVEST DERMATOL, V99, P174, DOI 10.1111/1523-1747.ep12616797; Bhogal BS., 1990, MANAGEMENT BLISTERIN, P15; BUSHKELL LL, 1981, ACTA DERM-VENEREOL, V61, P157; Chan LS, 2002, ARCH DERMATOL, V138, P370, DOI 10.1001/archderm.138.3.370; DOMLOGEHULTSCH N, 1994, ARCH DERMATOL, V130, P1521, DOI 10.1001/archderm.130.12.1521; Hamada T, 2003, J INVEST DERMATOL, V120, P345, DOI 10.1046/j.1523-1747.2003.12073.x; Hamada T, 2002, HUM MOL GENET, V11, P833, DOI 10.1093/hmg/11.7.833; Han ZQ, 2001, FASEB J, V15, P988, DOI 10.1096/fj.99-0934com; HARRINGTON CI, 1981, BRIT J DERMATOL, V104, P563, DOI 10.1111/j.1365-2133.1981.tb08172.x; IRVINE HG, 1913, JAMA-J AM MED ASSOC, V61, P396; Jonkman MF, 1999, J DERMATOL SCI, V20, P103, DOI 10.1016/S0923-1811(99)00017-1; MACFARLANE AW, 1989, CLIN EXP DERMATOL, V14, P245, DOI 10.1111/j.1365-2230.1989.tb00944.x; MCGRATH JA, 1995, J INVEST DERMATOL, V104, P467, DOI 10.1111/1523-1747.ep12605904; MCGRATH JA, 1995, NAT GENET, V11, P83, DOI 10.1038/ng0995-83; MEFFERT JJ, 1995, J AM ACAD DERMATOL, V32, P393, DOI 10.1016/0190-9622(95)90060-8; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; Ohata Y, 1995, CLIN EXP DERMATOL, V20, P454, DOI 10.1111/j.1365-2230.1995.tb01376.x; Oyama N, 1999, J INVEST DERMATOL, V113, P600, DOI 10.1046/j.1523-1747.1999.00734.x; Powell J, 2000, BRIT J DERMATOL, V142, P481, DOI 10.1046/j.1365-2133.2000.03360.x; Powell JJ, 1999, LANCET, V353, P1777, DOI 10.1016/S0140-6736(98)08228-2; SAHN EE, 1994, PEDIATR DERMATOL, V11, P160, DOI 10.1111/j.1525-1470.1994.tb00572.x; Smits P, 1997, GENOMICS, V45, P487, DOI 10.1006/geno.1997.4918; Smits P, 2000, J INVEST DERMATOL, V114, P718, DOI 10.1046/j.1523-1747.2000.00916.x; Tasker GL, 2003, CLIN EXP DERMATOL, V28, P128, DOI 10.1046/j.1365-2230.2003.01211.x; THOMAS RHM, 1986, BRIT J DERMATOL, V114, P377, DOI 10.1111/j.1365-2133.1986.tb02831.x; THOMAS RHM, 1998, BRIT J DERMATOL, V118, P41; Wallace H J, 1971, Trans St Johns Hosp Dermatol Soc, V57, P9; Yancey KB, 2000, JAMA-J AM MED ASSOC, V284, P350, DOI 10.1001/jama.284.3.350; Zillikens D, 1999, J DERMATOL SCI, V20, P134, DOI 10.1016/S0923-1811(99)00019-5	30	189	206	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2003	362	9378					118	123		10.1016/S0140-6736(03)13863-9	http://dx.doi.org/10.1016/S0140-6736(03)13863-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699ZY	12867112				2022-12-01	WOS:000184089200011
J	Steed, PM; Tansey, MG; Zalevsky, J; Zhukovsky, EA; Desjarlais, JR; Szymkowski, DE; Abbott, C; Carmichael, D; Chan, C; Cherry, L; Cheung, P; Chirino, AJ; Chung, HH; Doberstein, SK; Eivazi, A; Filikov, AV; Gao, SX; Hubert, RS; Hwang, M; Hyun, L; Kashi, S; Kim, A; Kim, E; Kung, J; Martinez, SP; Muchhal, US; Nguyen, DHT; O'Brien, C; O'Keefe, D; Singer, K; Vafa, O; Vielmetter, J; Yoder, SC; Dahiyat, BI				Steed, PM; Tansey, MG; Zalevsky, J; Zhukovsky, EA; Desjarlais, JR; Szymkowski, DE; Abbott, C; Carmichael, D; Chan, C; Cherry, L; Cheung, P; Chirino, AJ; Chung, HH; Doberstein, SK; Eivazi, A; Filikov, AV; Gao, SX; Hubert, RS; Hwang, M; Hyun, L; Kashi, S; Kim, A; Kim, E; Kung, J; Martinez, SP; Muchhal, US; Nguyen, DHT; O'Brien, C; O'Keefe, D; Singer, K; Vafa, O; Vielmetter, J; Yoder, SC; Dahiyat, BI			Inactivation of TNF signaling by rationally designed dominant-negative TNF variants	SCIENCE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; MUTATIONAL ANALYSIS; THERAPY; INVOLVEMENT; TOXICITY	Tumor necrosis factor (TNF) is a key regulator of inflammatory responses and has been implicated in many pathological conditions. We used structure-based design to engineer variant TNF proteins that rapidly form heterotrimers with native TNF to give complexes that neither bind to nor stimulate signaling through TNF receptors. Thus, TNF is inactivated by sequestration. Dominant-negative TNFs represent a possible approach to anti-inflammatory biotherapeutics, and experiments in animal models show that the strategy can attenuate TNF-mediated pathology. Similar rational design could be used to engineer inhibitors of additional TNF superfamily cytokines as well as other multimeric ligands.	Xencor, Monrovia, CA 91016 USA		Dahiyat, BI (corresponding author), Xencor, 111 W Lemon Ave, Monrovia, CA 91016 USA.	baz@xencor.com	Zhukovsky, Eugene/Q-3218-2019	Szymkowski, David/0000-0002-8934-7902				AGGARWAL BB, 2000, CYTOKINE REFERENCE; Ameloot P, 2001, J BIOL CHEM, V276, P27098, DOI 10.1074/jbc.M104486200; Bendele AM, 2000, ARTHRITIS RHEUM-US, V43, P2648, DOI 10.1002/1529-0131(200012)43:12<2648::AID-ANR4>3.0.CO;2-M; Beutler B, 2001, IMMUNITY, V15, P5, DOI 10.1016/S1074-7613(01)00176-5; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BROUCKAERT P, 1992, LYMPHOKINE CYTOK RES, V11, P193; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Filikov AV, 2002, PROTEIN SCI, V11, P1452, DOI 10.1110/ps.3500102; Goldbach-Mansky R, 2003, ANNU REV MED, V54, P197, DOI 10.1146/annurev.med.54.101601.152342; Hayes RJ, 2002, P NATL ACAD SCI USA, V99, P15926, DOI 10.1073/pnas.212627499; HISHINUMA I, 1990, HEPATOLOGY, V12, P1187, DOI 10.1002/hep.1840120518; Horiuchi T, 1999, ENDOCR J, V46, P643, DOI 10.1507/endocrj.46.643; Li YP, 2001, BIOL PHARM BULL, V24, P666, DOI 10.1248/bpb.24.666; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Luo P, 2002, PROTEIN SCI, V11, P1218, DOI 10.1110/ps.4580102; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; Ruuls SR, 2001, IMMUNITY, V15, P533, DOI 10.1016/S1074-7613(01)00215-1; Sakaguchi S, 2000, INT J IMMUNOPHARMACO, V22, P935, DOI 10.1016/S0192-0561(00)00056-4; SREEKRISHNA K, 1989, BIOCHEMISTRY-US, V28, P4117, DOI 10.1021/bi00435a074; Steiner G, 1999, RHEUMATOLOGY, V38, P202, DOI 10.1093/rheumatology/38.3.202; Ulfgren AK, 2000, ARTHRITIS RHEUM, V43, P2391, DOI 10.1002/1529-0131(200011)43:11<2391::AID-ANR3>3.0.CO;2-F; Ware CF, 2000, J EXP MED, V192, pF35, DOI 10.1084/jem.192.11.F35; YAMAGISHI J, 1990, PROTEIN ENG, V3, P713, DOI 10.1093/protein/3.8.713; ZHANG XM, 1992, J BIOL CHEM, V267, P24069	27	175	200	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2003	301	5641					1895	1898		10.1126/science.1081297	http://dx.doi.org/10.1126/science.1081297			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725GW	14512626				2022-12-01	WOS:000185536700048
J	Staller, P; Sulitkova, J; Liszlwan, J; Moch, H; Oakeley, EJ; Krek, W				Staller, P; Sulitkova, J; Liszlwan, J; Moch, H; Oakeley, EJ; Krek, W			Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL	NATURE			English	Article							INDUCIBLE FACTOR-I; RENAL-CELL CARCINOMA; HYPOXIA; CANCER; GENES; METASTASIS; PROTEIN; GROWTH; PHOSPHORYLATION; FACTOR-1-ALPHA	Organ-specific metastasis is governed, in part, by interactions between chemokine receptors on cancer cells and matching chemokines in target organs. For example, malignant breast cancer cells express the chemokine receptor CXCR4 and commonly metastasize to organs that are an abundant source of the CXCR4-specific ligand stromal cell-derived factor-1alpha (ref. 1). It is still uncertain how an evolving tumour cell is reprogrammed to express CXCR4, thus implementing the tendency to metastasize to specific organs. Here we show that the von Hippel-Lindau tumour suppressor protein pVHL negatively regulates CXCR4 expression owing to its capacity to target hypoxia-inducible factor (HIF) for degradation under normoxic conditions. This process is suppressed under hypoxic conditions, resulting in HIF-dependent CXCR4 activation. An analysis of clear cell renal carcinoma that manifests mutation of the VHL gene in most cases revealed an association of strong CXCR4 expression with poor tumour-specific survival. These results suggest a mechanism for CXCR4 activation during tumour cell evolution and imply that VHL inactivation acquired by incipient tumour cells early in tumorigenesis confers not only a selective survival advantage but also the tendency to home to selected organs.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; Univ Basel, Inst Pathol, CH-4031 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel	Krek, W (corresponding author), ETH Honggerberg, Inst Cell Biol, HPM F 42, CH-8093 Zurich, Switzerland.							Aebersold DM, 2001, CANCER RES, V61, P2911; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Liotta LA, 2001, NATURE, V410, P24, DOI 10.1038/35065180; Lisztwan J, 1998, EMBO J, V17, P368, DOI 10.1093/emboj/17.2.368; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Moch H, 2000, CANCER, V89, P604, DOI 10.1002/1097-0142(20000801)89:3<604::AID-CNCR16>3.0.CO;2-Q; Moch H, 1999, AM J PATHOL, V154, P981, DOI 10.1016/S0002-9440(10)65349-7; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; OBERLEY LW, 1982, SUPEROXIDE DISMUTASE, V1, P1; PASTOREKOVA S, 1992, VIROLOGY, V187, P620, DOI 10.1016/0042-6822(92)90464-Z; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Pugh CW, 2003, SEMIN CANCER BIOL, V13, P83, DOI 10.1016/S1044-579X(02)00103-7; Rempel SA, 2000, CLIN CANCER RES, V6, P102; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Takahashi Y, 2000, J BIOL CHEM, V275, P14139, DOI 10.1074/jbc.275.19.14139; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Wiesener MS, 2001, CANCER RES, V61, P5215	30	712	754	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 18	2003	425	6955					307	311		10.1038/nature01874	http://dx.doi.org/10.1038/nature01874			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722JA	13679920				2022-12-01	WOS:000185370900048
J	Adachi, M; Saito, H; Kobayashi, H; Horie, Y; Kato, S; Yoshioka, M; Ishii, H				Adachi, M; Saito, H; Kobayashi, H; Horie, Y; Kato, S; Yoshioka, M; Ishii, H			Hepatic injury in 12 patients taking the herbal weight loss aids Chaso or Onshido	ANNALS OF INTERNAL MEDICINE			English	Article							HEPATOTOXICITY; SUPPLEMENTS; REMEDIES	Background: The Chinese herbal dietary supplements Chaso and Onshido are marketed for weight loss in Japan. The safety of these weight loss aids is unknown. Objective: To describe patients who developed liver injury while taking Chaso or Onshido. Design: Case series. Setting: Keio University Hospital, Tokyo, Japan, and other hospitals in Japan. Patients: 6 patients who took Chaso and 6 patients who took Onshido before presenting with liver injury. Measurements: Pathologic, clinical, and laboratory evaluations and chemical analysis of the herbal weight loss aids. Results: All 12 patients developed acute liver injury characterized by a marked increase in serum liver chemistry values (mean alanine aminotransferase level, 1978 U/L [range, 283 to 4074 U/L]) after ingesting these products. Two patients developed fulminant hepatic failure: 1 patient required liver transplantation, and the other patient died. N-nitroso-fenfluramine, a variant of the appetite-depressant drug fenfluramine, was present in these products. Conclusions: The use of the weight loss aids Chaso and Onshido may be associated with acute liver injury. N-nitroso-fenfluramine is a possible hepatotoxic ingredient.	Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo 1608582, Japan	Keio University	Ishii, H (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.							Allison DB, 2001, CRIT REV FOOD SCI, V41, P1, DOI 10.1080/20014091091661; Barnes J, 1998, BRIT J CLIN PHARMACO, V45, P496, DOI 10.1046/j.1365-2125.1998.00715.x; Chitturi S, 2000, J GASTROEN HEPATOL, V15, P1093, DOI 10.1046/j.1440-1746.2000.02349.x; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; DANAN G, 1993, J CLIN EPIDEMIOL, V46, P1323, DOI 10.1016/0895-4356(93)90101-6; ELIASON BC, 1994, J FAM PRACTICE, V38, P287; Favreau JT, 2002, ANN INTERN MED, V136, P590, DOI 10.7326/0003-4819-136-8-200204160-00008; HANAWA N, 2003, ACTAZ HEPATOLOGICA J, V44, P21; Hasegawa R, 1998, CANCER LETT, V123, P185, DOI 10.1016/S0304-3835(97)00417-5; Hutchins GM, 2001, NEW ENGL J MED, V344, P1095; KATO Y, 1979, Gastroenterologia Japonica, V14, P216; Nadir A, 1996, AM J GASTROENTEROL, V91, P1436; Shaw D, 1997, DRUG SAFETY, V17, P342, DOI 10.2165/00002018-199717050-00006; Sheikh NM, 1997, ARCH INTERN MED, V157, P913, DOI 10.1001/archinte.157.8.913; Trey C, 1970, Prog Liver Dis, V3, P282; Zimmerman H J, 2000, Clin Liver Dis, V4, P73, DOI 10.1016/S1089-3261(05)70097-0	16	59	60	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2003	139	6					488	492		10.7326/0003-4819-139-6-200309160-00012	http://dx.doi.org/10.7326/0003-4819-139-6-200309160-00012			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721PE	13679326				2022-12-01	WOS:000185324100005
J	Bais, HP; Vepachedu, R; Gilroy, S; Callaway, RM; Vivanco, JM				Bais, HP; Vepachedu, R; Gilroy, S; Callaway, RM; Vivanco, JM			Allelopathy and exotic plant invasion: From molecules and genes to species interactions	SCIENCE			English	Article							ROOT; NEIGHBORS	Here we present evidence that Centaurea maculosa (spotted knapweed), an invasive species in the western United States, displaces native plant species by exuding the phytotoxin (-)-catechin from its roots. Our results show inhibition of native species' growth and germination in field soils at natural concentrations of (-)- catechin. In susceptible species such as Arabidopsis thaliana, the allelo-chemical triggers a wave of reactive oxygen species (ROS) initiated at the root meristem, which leads to a Ca2+ signaling cascade triggering genome-wide changes in gene expression and, ultimately, death of the root system. Our results support a "novel weapons hypothesis" for invasive success.	Colorado State Univ, Dept Hort & Landscape Architecture, Cell & Mol Biol Program, Ft Collins, CO 80523 USA; Colorado State Univ, Dept Hort & Landscape Architecture, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	Colorado State University; Colorado State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Montana System; University of Montana	Vivanco, JM (corresponding author), Colorado State Univ, Dept Hort & Landscape Architecture, Cell & Mol Biol Program, Ft Collins, CO 80523 USA.	jvivanco@lamar.colostate.edu	Rechsteiner, Cynthia/C-5894-2011	Gilroy, Simon/0000-0001-9597-6839				Bais HP, 2002, PLANT PHYSIOL, V128, P1173, DOI 10.1104/pp.011019; Bais HP, 2001, IN VITRO CELL DEV-PL, V37, P730; BAIS HP, UNPUB; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2002, TRENDS ECOL EVOL, V17, P104, DOI 10.1016/S0169-5347(01)02438-7; Fasano JM, 2001, PLANT CELL, V13, P907, DOI 10.1105/tpc.13.4.907; Gheldof N, 2002, J AGR FOOD CHEM, V50, P5870, DOI 10.1021/jf0256135; Goslee SC, 2001, ECOL MODEL, V139, P31, DOI 10.1016/S0304-3800(01)00231-9; Grant JJ, 2000, PLANT PHYSIOL, V124, P21, DOI 10.1104/pp.124.1.21; Jones DL, 1998, PLANTA, V206, P378, DOI 10.1007/s004250050413; KEANE S, 2002, TRENDS ECOL EVOL, V17, P170; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Ridenour WM, 2001, OECOLOGIA, V126, P444, DOI 10.1007/s004420000533	14	776	997	14	624	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2003	301	5638					1377	1380		10.1126/science.1083245	http://dx.doi.org/10.1126/science.1083245			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717XQ	12958360				2022-12-01	WOS:000185116400041
J	Kiers, ET; Rousseau, RA; West, SA; Denison, RF				Kiers, ET; Rousseau, RA; West, SA; Denison, RF			Host sanctions and the legume-rhizobium mutualism	NATURE			English	Article							NITROGENASE ACTIVITY; ROOT-NODULES; EVOLUTION; STABILITY; PERMEABILITY; COMPETITION	Explaining mutualistic cooperation between species remains one of the greatest problems for evolutionary biology(1-4). Why do symbionts provide costly services to a host, indirectly benefiting competitors sharing the same individual host? Host monitoring of symbiont performance and the imposition of sanctions on 'cheats' could stabilize mutualism(5,6). Here we show that soybeans penalize rhizobia that fail to fix N-2 inside their root nodules. We prevented a normally mutualistic rhizobium strain from cooperating (fixing N-2) by replacing air with an N-2-free atmosphere (Ar:O-2). A series of experiments at three spatial scales (whole plants, half root systems and individual nodules) demonstrated that forcing non-cooperation (analogous to cheating) decreased the reproductive success of rhizobia by about 50%. Non-invasive monitoring implicated decreased O-2 supply as a possible mechanism for sanctions against cheating rhizobia. More generally, such sanctions by one or both partners may be important in stabilizing a wide range of mutualistic symbioses.	Univ Calif Davis, Davis, CA 95616 USA; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of California System; University of California Davis; University of Edinburgh	Denison, RF (corresponding author), Univ Calif Davis, 1 Shields Ave, Davis, CA 95616 USA.	rfdenison@ucdavis.edu	Toby, Kiers/H-4819-2017; West, Stuart A/M-3608-2014	Toby, Kiers/0000-0002-0597-1653; West, Stuart A/0000-0003-2152-3153				AMARGER N, 1981, SOIL BIOL BIOCHEM, V13, P475, DOI 10.1016/0038-0717(81)90037-7; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Burdon JJ, 1999, J APPL ECOL, V36, P398, DOI 10.1046/j.1365-2664.1999.00409.x; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; DENISON RF, 1991, PLANT PHYSIOL, V96, P137, DOI 10.1104/pp.96.1.137; Denison RF, 2000, AM NAT, V156, P567, DOI 10.1086/316994; DENISON RF, 1995, PLANT PHYSIOL, V107, P1355, DOI 10.1104/pp.107.4.1355; Ferriere R, 2002, P ROY SOC B-BIOL SCI, V269, P773, DOI 10.1098/rspb.2001.1900; FRANK SA, 1995, NATURE, V377, P520, DOI 10.1038/377520a0; Frank SA., 1998, FDN SOCIAL EVOLUTION, DOI [10.1515/9780691206820, DOI 10.1515/9780691206820]; HAHN M, 1986, FEMS MICROBIOL LETT, V33, P143; HARTWIG U, 1987, ANN BOT-LONDON, V59, P285, DOI 10.1093/oxfordjournals.aob.a087317; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; KIJNE JW, 1975, PHYSIOL PLANT PATHOL, V7, P17, DOI 10.1016/0048-4059(75)90055-7; KING BJ, 1991, PLANT PHYSIOL, V96, P376, DOI 10.1104/pp.96.2.376; Layzell D. B., 1989, Applications of continuous and steady-state methods to root biology., P1; LAYZELL DB, 1979, PLANT PHYSIOL, V64, P888, DOI 10.1104/pp.64.5.888; Lodwig EM, 2003, NATURE, V422, P722, DOI 10.1038/nature01527; PELLMYR O, 1994, NATURE, V372, P257, DOI 10.1038/372257a0; RASCHE ME, 1989, PLANT PHYSIOL, V91, P663, DOI 10.1104/pp.91.2.663; Ratnieks FLW, 2001, ANN ZOOL FENN, V38, P201; SEN D, 1980, PLANT SCI LETT, V18, P315, DOI 10.1016/0304-4211(80)90122-4; SHEEHY JE, 1983, ANN BOT-LONDON, V52, P565, DOI 10.1093/oxfordjournals.aob.a086611; SINGLETON PW, 1987, PLANT PHYSIOL, V83, P552, DOI 10.1104/pp.83.3.552; SINGLETON PW, 1983, CROP SCI, V23, P69, DOI 10.2135/cropsci1983.0011183X002300010019x; SPRENT JI, 1985, P ROY SOC EDINB B, V85, P215, DOI 10.1017/S0269727000004036; UDVARDI MK, 1993, SYMBIOSIS, V14, P87; West SA, 2002, J EVOLUTION BIOL, V15, P830, DOI 10.1046/j.1420-9101.2002.00441.x; West SA, 2002, P ROY SOC B-BIOL SCI, V269, P685, DOI 10.1098/rspb.2001.1878; Yu DW, 2001, BIOL J LINN SOC, V72, P529, DOI [10.1111/j.1095-8312.2001.tb01336.x, 10.1006/bijl.2000.0514]	30	618	642	7	415	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2003	425	6953					78	81		10.1038/nature01931	http://dx.doi.org/10.1038/nature01931			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717LD	12955144	Green Published			2022-12-01	WOS:000185089200041
J	Bibby, TS; Mary, I; Nield, J; Partensky, F; Barber, J				Bibby, TS; Mary, I; Nield, J; Partensky, F; Barber, J			Low-light-adapted Prochlorococcus species possess specific antennae for each photosystem	NATURE			English	Article							CYANOBACTERIA/; PROKARYOTE; RESOLUTION; COMPLEXES; PHYLOGENY; PROTEINS; GENES; RING	Prochlorococcus, the most abundant genus of photosynthetic organisms(1), owes its remarkably large depth distribution in the oceans to the occurrence of distinct genotypes adapted to either low- or high-light niches(2,3). The pcb genes, encoding the major chlorophyll-binding, light-harvesting antenna proteins in this genus(4), are present in multiple copies in low- light strains but as a single copy in high-light strains(5). The basis of this differentiation, however, has remained obscure. Here we show that the moderate low- light-adapted strain Prochlorococcus sp. MIT 9313 has one iron-stress-induced pcb gene encoding an antenna protein serving photosystem I (PSI)-comparable to isiA genes from cyanobacteria(6,7) -and a constitutively expressed pcb gene encoding a photosystem II (PSII) antenna protein. By comparison, the very low- light-adapted strain SS120 has seven pcb genes encoding constitutive PSI and PSII antennae, plus one PSI iron-regulated pcb gene, whereas the high-light-adapted strain MED4 has only a constitutive PSII antenna. Thus, it seems that the adaptation of Prochlorococcus to low light environments has triggered a multiplication and specialization of Pcb proteins comparable to that found for Cab proteins in plants and green algae(8).	Univ London Imperial Coll Sci Technol & Med, Wolfson Labs, Dept Biol Sci, London SW7 2AZ, England; CNRS, Biol Stn, UMR 7127, F-29682 Roscoff, France; Univ Paris 06, F-29682 Roscoff, France	Imperial College London; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Barber, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Wolfson Labs, Dept Biol Sci, Biochem Bldg,S Kensington Campus, London SW7 2AZ, England.		Nield, Jon/C-5892-2013; Partensky, Frédéric/B-9194-2018; Partensky, Frédéric/AAH-1170-2021; Bibby, Thomas/C-9159-2014	Nield, Jon/0000-0001-9983-0239; Partensky, Frédéric/0000-0003-1274-4050; Partensky, Frédéric/0000-0003-1274-4050; Bibby, Thomas/0000-0003-1743-473X				Bhaya D, 2000, J BACTERIOL, V182, P5692, DOI 10.1128/JB.182.20.5692-5699.2000; Bibby TS, 2001, NATURE, V413, P590, DOI 10.1038/35098153; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; Garczarek L, 2001, PLANT MOL BIOL, V46, P683, DOI 10.1023/A:1011681726654; Green BR, 1996, ANNU REV PLANT PHYS, V47, P685, DOI 10.1146/annurev.arplant.47.1.685; Hankamer B, 1997, EUR J BIOCHEM, V243, P422, DOI 10.1111/j.1432-1033.1997.0422a.x; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; LaRoche J, 1996, P NATL ACAD SCI USA, V93, P15244; MARY I, IN PRESS FEMS MICROB; Moore LR, 1999, LIMNOL OCEANOGR, V44, P628, DOI 10.4319/lo.1999.44.3.0628; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Partensky F, 1997, PHOTOSYNTH RES, V51, P209, DOI 10.1023/A:1005807408161; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; PARTENSKY F, IN PRESS ADV PHOTOSY; SIDLER W, 1994, MOL BIOL CYANOBACTER, V14, P139; Straus N.A., 1994, MOL BIOL CYANOBACTER, P731, DOI DOI 10.1007/978-94-011-0227-8_25; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/S0304-3991(81)80197-0; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004	20	127	156	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2003	424	6952					1051	1054		10.1038/nature01933	http://dx.doi.org/10.1038/nature01933			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715QR	12944966				2022-12-01	WOS:000184984200042
J	Culley, AI; Lang, AS; Suttle, CA				Culley, AI; Lang, AS; Suttle, CA			High diversity of unknown picorna-like viruses in the sea	NATURE			English	Article							MARINE VIRUSES; RNA; POLYMERASES; EVOLUTION; TAXONOMY; MOTIFS	Picorna-like viruses are a loosely defined group of positive-sense single-stranded RNA viruses that are major pathogens of animals, plants and insects. They include viruses that are of enormous economic and public-health concern and are responsible for animal diseases (such as poliomyelitis(1)), plant diseases (such as sharka(2)) and insect diseases (such as sacbrood(3)). Viruses from the six divergent families (the Picornaviridae, Caliciviridae, Comoviridae, Sequiviridae, Dicistroviridae and Potyviridae) that comprise the picorna-like virus superfamily(4) have the following features in common: a genome with a protein attached to the(5)' end and no overlapping open reading frames, all the RNAs are translated into a polyprotein before processing, and a conserved RNA-dependent RNA polymerase (RdRp) protein. Analyses of RdRp sequences from these viruses produce phylogenies that are congruent with established picorna-like virus family assignments(5-7); hence, this gene is an excellent molecular marker for examining the diversity of picorna-like viruses in nature. Here we report, on the basis of analysis of RdRp sequences amplified from marine virus communities, that a diverse array of picorna-like viruses exists in the ocean. All of the sequences amplified were divergent from known picorna-like viruses, and fell within four monophyletic groups that probably belong to at least two new families. Moreover, we show that an isolate belonging to one of these groups is a lytic pathogen of Heterosigma akashiwo, a toxic-bloom-forming alga responsible for severe economic losses to the finfish aquaculture industry, suggesting that picorna-like viruses are important pathogens of marine phytoplankton.	Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Suttle, CA (corresponding author), Univ British Columbia, Dept Bot, 1461-6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	csuttle@eos.ubc.ca	suttle, c/N-1144-2019; Suttle, Curtis A/C-3150-2008	suttle, c/0000-0002-0372-0033; Suttle, Curtis A/0000-0002-0372-0033; Lang, Andrew/0000-0002-4510-7683				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2001, FIELDS VIROLOGY; BAILEY L, 1964, VIROLOGY, V23, P425, DOI 10.1016/0042-6822(64)90266-1; BERNARD J, 1995, VET RES, V26, P341; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; KAMER G, 1984, NUCLEIC ACIDS RES, V12, P7269, DOI 10.1093/nar/12.18.7269; Kingsley DH, 2002, APPL ENVIRON MICROB, V68, P3914, DOI 10.1128/AEM.68.8.3914-3918.2002; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; Liljas L, 2002, ARCH VIROL, V147, P59, DOI 10.1007/s705-002-8303-1; Mann NH, 2003, FEMS MICROBIOL REV, V27, P17, DOI 10.1016/S0168-6445(03)00016-0; Mari J, 2002, J GEN VIROL, V83, P915, DOI 10.1099/0022-1317-83-4-915; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Short SM, 2002, APPL ENVIRON MICROB, V68, P1290, DOI 10.1128/AEM.68.3.1290-1296.2002; Smayda T.J., 1998, PHYSL ECOLOGY HARMFU, P113; SMITH AW, 1973, NATURE, V244, P108, DOI 10.1038/244108a0; Smith AW, 2000, VIRAL ECOLOGY, P447, DOI 10.1016/B978-012362675-2/50013-6; SUTTLE CA, 1991, APPL ENVIRON MICROB, V57, P721, DOI 10.1128/AEM.57.3.721-726.1991; Suttle CA, 2000, VIRAL ECOLOGY, P247, DOI 10.1016/B978-012362675-2/50007-0; SUTTLE CA, 1992, APPL ENVIRON MICROB, V58, P3721, DOI 10.1128/AEM.58.11.3721-3729.1992; Tai V, 2003, J PHYCOL, V39, P343, DOI 10.1046/j.1529-8817.2003.01162.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Bressem MF, 1999, DIS AQUAT ORGAN, V38, P53, DOI 10.3354/dao038053; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Zanotto PMD, 1996, J VIROL, V70, P6083, DOI 10.1128/JVI.70.9.6083-6096.1996; [No title captured]	30	148	155	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2003	424	6952					1054	1057		10.1038/nature01886	http://dx.doi.org/10.1038/nature01886			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715QR	12944967				2022-12-01	WOS:000184984200043
J	Mossessova, E; Bickford, LC; Goldberg, J				Mossessova, E; Bickford, LC; Goldberg, J			SNARE selectivity of the COPII coat	CELL			English	Article							N-TERMINAL DOMAIN; ENDOPLASMIC-RETICULUM; MEMBRANE-FUSION; TRANSPORT VESICLES; CRYSTAL-STRUCTURE; CARGO SELECTION; GOLGI-COMPLEX; YEAST; PROTEINS; ER	The COPII coat buds transport vesicles from the endoplasmic reticulum that incorporate cargo and SNARE molecules. Here, we show that recognition of the ER-Golgi SNAREs Bet1, Sed5, and Sec22 occurs through three binding sites on the Sec23/24 subcomplex of yeast COPII. The A site binds to the YNNSNPF motif of Sed5. The B site binds to Lxx-UM-E sequences present in both the Bet1 and Sed5 molecules, as well as to the DxE cargo-sorting signal. A third, spatially distinct site binds to Sec22. COPII selects the free v-SNARE form of Bet1 because the LxxLE sequence is sequestered in the four-helix bundle of the v-/t-SNARE complex. COPII favors Sed5 within the Sed5/Bos1/ Sec22 t-SNARE complex because t-SNARE assembly removes autoinhibitory contacts to expose the YNNSNPF motif. The COPII coat seems to be a specific conductor of the fusogenic forms of these SNAREs, suggesting how vesicle fusion specificity may be programmed during budding.	Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Goldberg, J (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, 1275 York Ave, New York, NY 10021 USA.	jonathan@ximpact4.ski.mskcc.org						[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao XC, 2000, J CELL BIOL, V149, P55, DOI 10.1083/jcb.149.1.55; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; DASCHER C, 1991, MOL CELL BIOL, V11, P872, DOI 10.1128/MCB.11.2.872; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Gonzalez LC, 2001, J BIOL CHEM, V276, P24203, DOI 10.1074/jbc.M101584200; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; Kiessling V, 2003, BIOPHYS J, V84, P408, DOI 10.1016/S0006-3495(03)74861-9; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Lang T, 2002, J CELL BIOL, V158, P751, DOI 10.1083/jcb.200203088; Margittai M, 2003, BIOCHEMISTRY-US, V42, P4009, DOI 10.1021/bi027437z; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Munson M, 2000, NAT STRUCT BIOL, V7, P894; NEWMAN AP, 1990, MOL CELL BIOL, V10, P3405, DOI 10.1128/MCB.10.7.3405; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parlati F, 2000, NATURE, V407, P194, DOI 10.1038/35025076; Pelham HRB, 1999, EXP CELL RES, V247, P1, DOI 10.1006/excr.1998.4356; Peng RW, 1999, P NATL ACAD SCI USA, V96, P3751, DOI 10.1073/pnas.96.7.3751; Rowe T, 1998, SCIENCE, V279, P696, DOI 10.1126/science.279.5351.696; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Thoma NH, 2000, BIOCHEMISTRY-US, V39, P12043, DOI 10.1021/bi000835m; Tochio H, 2001, SCIENCE, V293, P698, DOI 10.1126/science.1062950; Votsmeier C, 2001, EMBO J, V20, P6742, DOI 10.1093/emboj/20.23.6742; Waters MG, 2000, TRAFFIC, V1, P588, DOI 10.1034/j.1600-0854.2000.010802.x; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9	42	284	297	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2003	114	4					483	495		10.1016/S0092-8674(03)00608-1	http://dx.doi.org/10.1016/S0092-8674(03)00608-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	714TD	12941276	Bronze			2022-12-01	WOS:000184928800011
J	Thordarson, P; Bijsterveld, EJA; Rowan, AE; Nolte, RJM				Thordarson, P; Bijsterveld, EJA; Rowan, AE; Nolte, RJM			Epoxidation of polybutadiene by a topologically linked catalyst	NATURE			English	Article							DNA; ROTAXANE; METALLOPORPHYRINS; OXIDATION; MOTION	Nature has evolved complex enzyme architectures that facilitate the synthesis and manipulation of the biopolymers DNA and RNA, including enzymes capable of attaching to the biopolymer substrate and performing several rounds of catalysis before dissociating(1-5). Many of these 'processive' enzymes have a toroidal shape and completely enclose the biopolymer while moving along its chain, as exemplified by the DNA enzymes T4 DNA polymerase holoenzyme(6) and lambda-exonucleoase(7). The overall architecture of these systems resembles that of rotaxanes, in which a long molecule or polymer is threaded through a macrocycle. Here we describe a rotaxane that mimics the ability of processive enzymes to catalyse multiple rounds of reaction while the polymer substrate stays bound. The catalyst consists of a substrate binding cavity incorporating a manganese( III) porphyrin complex that oxidizes alkenes within the toroid cavity, provided a ligand has been attached to the outer face of the toroid to both activate the porphyrin complex and shield it from being able to oxidize alkenes outside the cavity. We find that when threaded onto a polybutadiene polymer strand, this catalyst epoxidizes the double bonds of the polymer, thereby acting as a simple analogue of the enzyme systems.	Univ Nijmegen, Dept Organ Chem, NSRIM, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Rowan, AE (corresponding author), Univ Nijmegen, Dept Organ Chem, NSRIM, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.	rowan@sci.kun.nl	Thordarson, Pall/A-2138-2015; Rowan, Alan E/F-9702-2015; Nolte, Roeland/C-9930-2013	Thordarson, Pall/0000-0002-1200-8814; Rowan, Alan E/0000-0003-0728-3851; Nolte, Roeland/0000-0002-5612-7815				Ashton PR, 1998, J AM CHEM SOC, V120, P11190, DOI 10.1021/ja981889a; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; BISSELL RA, 1994, NATURE, V369, P133, DOI 10.1038/369133a0; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Brouwer AM, 2001, SCIENCE, V291, P2124, DOI 10.1126/science.1057886; Collier CP, 1999, SCIENCE, V285, P391, DOI 10.1126/science.285.5426.391; Davis AP, 1999, NATURE, V401, P120, DOI 10.1038/43576; Elemans JAAW, 2000, CHEM COMMUN, P2443, DOI 10.1039/b008567g; Elemans JAAW, 1999, J ORG CHEM, V64, P7009, DOI 10.1021/jo990112c; FARRINGT.JA, 1969, J CHEM SOC CHEM COMM, P259, DOI 10.1039/c29690000259; GUENGERICH FP, 1991, J BIOL CHEM, V266, P10019; HARADA A, 1992, NATURE, V356, P325, DOI 10.1038/356325a0; HOLLIS BW, 1990, P NATL ACAD SCI USA, V87, P6009, DOI 10.1073/pnas.87.16.6009; Jimenez MC, 2000, ANGEW CHEM INT EDIT, V39, P3284, DOI 10.1002/1521-3773(20000915)39:18<3284::AID-ANIE3284>3.0.CO;2-7; Kool ET, 1998, ACCOUNTS CHEM RES, V31, P502, DOI 10.1021/ar9602462; Kool ET, 2000, ANGEW CHEM INT EDIT, V39, P990, DOI 10.1002/(SICI)1521-3773(20000317)39:6<990::AID-ANIE990>3.0.CO;2-0; Kovall R, 1997, SCIENCE, V277, P1824, DOI 10.1126/science.277.5333.1824; LIN SM, 1993, NUCLEASES; MEUNIER B, 1992, CHEM REV, V92, P1411, DOI 10.1021/cr00014a008; Perkins TT, 2001, BIOPHYS J, V80, p349A; Rowan AE, 1998, CHEM COMMUN, P611, DOI 10.1039/a708373d; Sacco HC, 2001, J CHEM SOC PERK T 2, P181, DOI 10.1039/b006755p; Sauvage JP, 1998, ACCOUNTS CHEM RES, V31, P611, DOI 10.1021/ar960263r; Schalley CA, 2001, ACCOUNTS CHEM RES, V34, P465, DOI 10.1021/ar000179i; SHEN YX, 1994, J AM CHEM SOC, V116, P537, DOI 10.1021/ja00081a014; TORNARITIS MJ, 1992, POLYMER, V33, P1771, DOI 10.1016/0032-3861(92)91081-C; Trakselis MA, 2001, P NATL ACAD SCI USA, V98, P8368, DOI 10.1073/pnas.111006698; Tsuda Y, 1998, J MOL CATAL A-CHEM, V130, P285, DOI 10.1016/S1381-1169(97)00220-3	28	324	326	1	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2003	424	6951					915	918		10.1038/nature01925	http://dx.doi.org/10.1038/nature01925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	713EH	12931181				2022-12-01	WOS:000184843600034
J	Ri-Li, G; Chase, PJ; Witkowski, S; Wyrick, BL; Stone, JA; Levine, BD; Babb, TG				Ri-Li, G; Chase, PJ; Witkowski, S; Wyrick, BL; Stone, JA; Levine, BD; Babb, TG			Obesity: Associations with acute mountain sickness	ANNALS OF INTERNAL MEDICINE			English	Article							RESEARCH ISSUES; HIGH-ALTITUDE; SLEEP-APNEA; EXERCISE	Background: Although few retrospective studies of high altitude have reported that obesity might be associated with the development of acute mountain sickness (AMS), this association has not been studied prospectively. Objective: To determine whether obesity is associated with the development of AMS. Design: Obese and nonobese men were compared at a simulated altitude of 3658 m (12000 ft). Setting: 24 hours in a hypobaric environmental chamber. Participants: 9 obese and 10 nonobese men. Measurements: Percentage body fat (by hydrostatic weighing), Lake Louise AMS score, and Sao(2) level (by pulse oximetry) were measured. Results: Average AMS scores increased more rapidly with time spent at simulated high altitudes for obese men than for nonobese men (P<0.001). The response of Sao(2) with exposure differed between nonobese and obese men. After 24 hours in the altitude chamber, seven obese men (78%) and four nonobese men (40%) had AMS scores of 4 or more. Conclusion: Obesity seems to be associated with the development of AMS, which may be partly related to greater nocturnal desaturation with altitude exposure.	Presbyterian Med Ctr, Inst Exercise & Environm Med, Dallas, TX 75231 USA; Univ Texas, SW Med Ctr, Dallas, TX USA; Qinghai Med Coll, Inst High Altitude Med, Xining, Qinghai, Peoples R China	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Qinghai University	Babb, TG (corresponding author), Presbyterian Med Ctr, Inst Exercise & Environm Med, 7232 Greenville Ave,Suite 435, Dallas, TX 75231 USA.		Chase, Paul/H-3462-2019	Chase, Paul/0000-0003-2127-0889				Ahmed Q, 1997, HUM PATHOL, V28, P264, DOI 10.1016/S0046-8177(97)90122-2; Becker HF, 1999, AM J RESP CRIT CARE, V159, P112, DOI 10.1164/ajrccm.159.1.9803037; Eichenberger U, 1996, AM J RESP CRIT CARE, V154, P1748, DOI 10.1164/ajrccm.154.6.8970365; Flegal KM, 1999, MED SCI SPORT EXER, V31, pS509, DOI 10.1097/00005768-199911001-00004; GE R, 1995, CHINESE J APPL PHYSL, V11, P205; GE RL, 1987, CHINESE J INT MED, V13, P115; GOLDSTEIN JL, 1992, EUR HEART J, V13, P34, DOI 10.1093/eurheartj/13.suppl_B.34; HACKETT PH, 2001, WILDERNESS MED, P1; Hill JO, 1999, MED SCI SPORT EXER, V31, pS515, DOI 10.1097/00005768-199911001-00005; HIRATA K, 1989, LANCET, V2, P1040; HONIGMAN B, 1993, ANN INTERN MED, V118, P587, DOI 10.7326/0003-4819-118-8-199304150-00003; KAYSER B, 1991, J WILDERNESS MED, V2, P110, DOI 10.1580/0953-9859-2.2.110; LUPIHERRERA E, 1980, CHEST, V78, P553, DOI 10.1378/chest.78.4.553; Maggiorini M, 1998, AVIAT SPACE ENVIR MD, V69, P1186; PACY PJ, 1986, SPORTS MED, V3, P89, DOI 10.2165/00007256-198603020-00002; Roach RC, 2000, J APPL PHYSIOL, V88, P581, DOI 10.1152/jappl.2000.88.2.581; Sutton J., 1992, HYPOXIA MOUNTAIN MED; WEST JB, 1986, J APPL PHYSIOL, V61, P280, DOI 10.1152/jappl.1986.61.1.280; WHITE DP, 1985, MED CLIN N AM, V69, P1205, DOI 10.1016/S0025-7125(16)30983-X	19	70	77	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2003	139	4					253	257		10.7326/0003-4819-139-4-200308190-00007	http://dx.doi.org/10.7326/0003-4819-139-4-200308190-00007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	712JY	12965980				2022-12-01	WOS:000184795600003
J	Pui, CH; Cheng, C; Leung, W; Rai, SN; Rivera, GK; Sandlund, JT; Ribeiro, RC; Relling, MV; Kun, LE; Evans, WE; Hudson, MM				Pui, CH; Cheng, C; Leung, W; Rai, SN; Rivera, GK; Sandlund, JT; Ribeiro, RC; Relling, MV; Kun, LE; Evans, WE; Hudson, MM			Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SECONDARY BRAIN-TUMORS; CENTRAL-NERVOUS-SYSTEM; CRANIAL RADIOTHERAPY; ADOLESCENT CANCER; ADULT SURVIVORS; COMPETING RISK; LATE MORTALITY; 2ND NEOPLASMS; TOTAL-THERAPY; CHILDREN	BACKGROUND Children who survive acute lymphoblastic leukemia are at risk for leukemia-related or treatment-related complications, which can adversely affect survival and socioeconomic status. We determined the long-term survival and the rates of health insurance coverage, marriage, and employment among patients who had attained at least 10 years of event-free survival. METHODS A total of 856 eligible patients were treated between 1962 and 1992 in 13 consecutive clinical trials. Survival rates, the cumulative risk of a second neoplasm, and selected indicators of socioeconomic status were analyzed for the entire group and for patients who did or did not receive cranial or craniospinal radiation therapy during initial treatment. RESULTS Fifty-six patients had major adverse events, including 8 deaths during remission, 4 relapses, and 44 second neoplasms (41 of them radiation-related); most of the second neoplasms were benign or of a low grade of malignant potential. The risk of a second neoplasm was significantly higher in the 597 patients who received radiation therapy (irradiated group) than in the 259 patients who did not receive radiation therapy (nonirradiated group) (P=0.04; estimated cumulative risk [+/-SE] at 20 years, 20.9+/-3.9 percent vs. 0.95+/-0.9 percent). The death rate for the irradiated group slightly exceeded the expected rate in the general U.S. population (standardized mortality ratio, 1.90; 95 percent confidence interval, 1.12 to 3.00), whereas that for the nonirradiated group did not differ from the population norm (standardized mortality ratio, 1.75; 95 percent confidence interval, 0.34 to 5.00). The rates of health insurance coverage, marriage, and employment in the nonirradiated group were similar to the age- and sex-adjusted national averages. Despite having health insurance rates similar to those in the general population, men and women in the irradiated group had higher-than-average unemployment rates (15.1 percent vs. 5.4 percent and 35.4 percent vs. 5.2 percent, respectively), and women in the irradiated group were less likely to be married (35.2 percent vs. 48.8 percent). CONCLUSIONS Children with acute lymphoblastic leukemia who did not receive radiation therapy and who have attained 10 or more years of event-free survival can expect a normal long-term survival. Irradiation is associated with the development of second neoplasms, a slight excess in mortality, and an increased unemployment rate.	St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Radiat Oncol, Memphis, TN 38105 USA; Univ Tennessee, Hlth Sci Ctr, Coll Med, Knoxville, TN 37996 USA; Univ Tennessee, Hlth Sci Ctr, Coll Pharm, Knoxville, TN 37996 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Pui, CH (corresponding author), St Jude Childrens Res Hosp, Dept Hematol Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	pui@stjude.org	Hudson, Melissa M/N-4441-2018; Cheng, Cheng/N-8075-2018; Relling, Mary/N-5032-2018; Pui, Ching-Hon/N-8076-2018; Evans, William E./C-2069-2012	Hudson, Melissa M/0000-0001-6984-2407; Pui, Ching-Hon/0000-0003-0303-5658; Evans, William E./0000-0002-9333-5322; Leung, Wing Hang/0000-0002-2996-7229	PHS HHS [21765] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bhatia S, 2002, BLOOD, V99, P4257, DOI 10.1182/blood.V99.12.4257; Blackwell D. L., 2002, VITAL HLTH STAT SERI; Brenner H, 2001, CANCER, V92, P1977, DOI 10.1002/1097-0142(20011001)92:7<1977::AID-CNCR1717>3.0.CO;2-W; Breslow N E, 1987, IARC Sci Publ, P1; *BUR LAB STAT, 2002, CURR POP SURV REP; BYRNE J, 1989, JAMA-J AM MED ASSOC, V262, P2693, DOI 10.1001/jama.262.19.2693; CHRISTIE D, 1995, ARCH DIS CHILD, V73, P136, DOI 10.1136/adc.73.2.136; *CTR COST FIN STUD, 2000, MED EXP PAN SURV HOU; Dalton VMK, 1998, J CLIN ONCOL, V16, P2848, DOI 10.1200/JCO.1998.16.8.2848; *EP SOFTW, 1993, EP PLUS STAT PACK EP; Evans WE, 1998, NEW ENGL J MED, V338, P499, DOI 10.1056/NEJM199802193380803; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; GREEN DM, 1991, CANCER, V67, P206, DOI 10.1002/1097-0142(19910101)67:1<206::AID-CNCR2820670134>3.0.CO;2-2; Green DM, 1999, J CLIN ONCOL, V17, P3207, DOI 10.1200/JCO.1999.17.10.3207; HAUPT R, 1994, JAMA-J AM MED ASSOC, V272, P1427, DOI 10.1001/jama.272.18.1427; HAYS DM, 1992, J CLIN ONCOL, V10, P1397, DOI 10.1200/JCO.1992.10.9.1397; Hoffman B, 1999, ONCOLOGY-NY, V13, P841; HOLMES GE, 1986, CANCER, V57, P190, DOI 10.1002/1097-0142(19860101)57:1<190::AID-CNCR2820570136>3.0.CO;2-8; Hudson MM, 1997, J CLIN ONCOL, V15, P2205, DOI 10.1200/JCO.1997.15.6.2205; Kamps WA, 2002, LEUKEMIA, V16, P1099, DOI 10.1038/sj.leu.2402489; Loning L, 2000, BLOOD, V95, P2770, DOI 10.1182/blood.V95.9.2770.009k16_2770_2775; Manera R, 2000, LEUKEMIA, V14, P1354, DOI 10.1038/sj.leu.2401835; Marina N, 1997, PEDIATR CLIN N AM, V44, P1021, DOI 10.1016/S0031-3955(05)70543-5; Mertens AC, 2001, J CLIN ONCOL, V19, P3163, DOI 10.1200/JCO.2001.19.13.3163; NEGLIA JP, 1991, NEW ENGL J MED, V325, P1330, DOI 10.1056/NEJM199111073251902; Novakovic B, 1997, J PEDIAT HEMATOL ONC, V19, P220, DOI 10.1097/00043426-199705000-00008; NYGAARD R, 1991, ACTA PAEDIATR SCAND, V80, P1220, DOI 10.1111/j.1651-2227.1991.tb11812.x; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PINKEL D, 1979, AM CANC SOC P NAT C, P191; Pui CH, 2003, J CLIN ONCOL, V21, P179, DOI 10.1200/JCO.2003.10.032; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; PUI CH, 1991, J CLIN ONCOL, V9, P1341, DOI 10.1200/JCO.1991.9.8.1341; Pui CH, 1998, BLOOD, V92, P411, DOI 10.1182/blood.V92.2.411.414k34_411_415; Rauck AM, 1999, MED PEDIATR ONCOL, V33, P60, DOI 10.1002/(SICI)1096-911X(199907)33:1<60::AID-MPO11>3.0.CO;2-H; Reis LAG, 2001, SEER CANC STAT REV 1; Relling MV, 1999, LANCET, V354, P34, DOI 10.1016/S0140-6736(98)11079-6; RIVERA GK, 1993, NEW ENGL J MED, V329, P1289, DOI 10.1056/NEJM199310283291801; RIVERA GK, 1991, LANCET, V337, P61, DOI 10.1016/0140-6736(91)90733-6; Schrappe M, 2000, BLOOD, V95, P3310; Silverman LB, 2001, BLOOD, V97, P1211, DOI 10.1182/blood.V97.5.1211; SIMONE J, 1972, CANCER-AM CANCER SOC, V30, P1488, DOI 10.1002/1097-0142(197212)30:6<1488::AID-CNCR2820300612>3.0.CO;2-D; TEBBI CK, 1989, CANCER, V63, P213, DOI 10.1002/1097-0142(19890101)63:1<213::AID-CNCR2820630134>3.0.CO;2-T; TEETER M A, 1987, Journal of Psychosocial Oncology, V5, P59; TETA MJ, 1986, J CHRON DIS, V39, P751, DOI 10.1016/0021-9681(86)90158-X; *US BUR CENS, 2001, CURR POP SURV REP; VANN JCJ, 1995, MED PEDIATR ONCOL, V25, P389, DOI 10.1002/mpo.2950250505; Vilmer E, 2000, LEUKEMIA, V14, P2257, DOI 10.1038/sj.leu.2401960; von der Weid N, 2003, EUR J CANCER, V39, P359, DOI 10.1016/S0959-8049(02)00260-5; Vora A, 1998, BLOOD, V92, P2334, DOI 10.1182/blood.V92.7.2334.2334_2334_2337; Waber Deborah P, 1997, Oncology (Williston Park), V11, P259; Walter AW, 1998, J CLIN ONCOL, V16, P3761, DOI 10.1200/JCO.1998.16.12.3761; ZEVON MA, 1990, AM J PEDIAT HEMATOL, V12, P454; 1991, FED REG, V56, P35725	54	312	325	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2003	349	7					640	649		10.1056/NEJMoa035091	http://dx.doi.org/10.1056/NEJMoa035091			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711FL	12917300				2022-12-01	WOS:000184728900004
J	Huang, YF; Lemieux, MJ; Song, JM; Auer, M; Wang, DN				Huang, YF; Lemieux, MJ; Song, JM; Auer, M; Wang, DN			Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli	SCIENCE			English	Article								The major facilitator superfamily represents the largest group of secondary membrane transporters in the cell. Here we report the 3.3 angstrom resolution structure of a member of this superfamily, GlpT, which transports glycerol-3-phosphate into the cytoplasm and inorganic phosphate into the periplasm. The amino- and carboxyl-terminal halves of the protein exhibit a pseudo two-fold symmetry. Closed off to the periplasm, a centrally located substrate-translocation pore contains two arginines at its closed end, which comprise the substrate-binding site. Upon substrate binding, the protein adopts a more compact conformation. We propose that GlpT operates by a single-binding site, alternating-access mechanism through a rocker-switch type of movement.	NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University	Wang, DN (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, 540 1st Ave, New York, NY 10016 USA.			Wang, Da-Neng/0000-0002-6496-4699; Lemieux, Joanne/0000-0003-4745-9153				AMBUDKAR SV, 1990, J BIOL CHEM, V265, P12287; AMBUDKAR SV, 1986, J BIOL CHEM, V261, P9083; ASANO T, 1992, FEBS LETT, V298, P129, DOI 10.1016/0014-5793(92)80038-I; Auer M, 2001, BIOCHEMISTRY-US, V40, P6628, DOI 10.1021/bi010138+; Chamberlain AK, 2003, ADV PROTEIN CHEM, V63, P19; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Chen LY, 2002, HUM MOL GENET, V11, P3199, DOI 10.1093/hmg/11.25.3199; CHIN JJ, 1986, J BIOL CHEM, V261, P7101; CREIGHTON TE, 1983, PROTEINS STRUCTURES, P137; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; ELVIN CM, 1985, J BACTERIOL, V161, P1054, DOI 10.1128/JB.161.3.1054-1058.1985; Fann MC, 1998, J MEMBRANE BIOL, V164, P187, DOI 10.1007/s002329900404; Fann MC, 1998, J BIOL CHEM, V273, P33735, DOI 10.1074/jbc.273.50.33735; GOTT P, 1988, MOL MICROBIOL, V2, P655, DOI 10.1111/j.1365-2958.1988.tb00074.x; Green AL, 2000, J BIOL CHEM, V275, P23240, DOI 10.1074/jbc.M909202199; Hall JA, 1999, J BIOL CHEM, V274, P6148, DOI 10.1074/jbc.274.10.6148; HAYASHI S, 1964, J BIOL CHEM, V239, P3098; Henderson PJF, 1993, CURR OPIN CELL BIOL, V5, P708, DOI 10.1016/0955-0674(93)90144-F; Hirai T, 2003, J BACTERIOL, V185, P1712, DOI 10.1128/JB.185.5.1712-1718.2003; Hirai T, 2002, NAT STRUCT BIOL, V9, P597, DOI 10.1038/nsb821; Jencks W P, 1980, Adv Enzymol Relat Areas Mol Biol, V51, P75; JessenMarshall AE, 1996, J BIOL CHEM, V271, P1400, DOI 10.1074/jbc.271.3.1400; JUNG EKY, 1986, J BIOL CHEM, V261, P9155; Kaback HR, 1997, Q REV BIOPHYS, V30, P333, DOI 10.1017/S0033583597003387; KAHN BB, 1992, J CLIN INVEST, V89, P1367, DOI 10.1172/JCI115724; LEMIEUX MA, UNPUB; Levy SB, 2002, J APPL MICROBIOL, V92, p65S, DOI 10.1046/j.1365-2672.92.5s1.4.x; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; MAIDEN MCJ, 1987, NATURE, V325, P641, DOI 10.1038/325641a0; MALONEY PC, 1990, MICROBIOL REV, V54, P1; Matos M, 1996, J BIOL CHEM, V271, P18571, DOI 10.1074/jbc.271.31.18571; Mitchell P, 1963, BIOCH SOC S, V22, P141; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OLSEN SG, 1993, J BACTERIOL, V175, P6269, DOI 10.1128/JB.175.19.6269-6275.1993; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; REIZER J, 1993, PROTEIN SCI, V2, P20, DOI 10.1002/pro.5560020103; RIORDAN JF, 1979, MOL CELL BIOCHEM, V26, P71; ROCK CO, 1985, BIOCH LIPIDS MEMBRAN, P73; Sato M, 1999, J BIOL CHEM, V274, P24721, DOI 10.1074/jbc.274.35.24721; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; TANFORD C, 1983, ANNU REV BIOCHEM, V52, P379, DOI 10.1146/annurev.bi.52.070183.002115; Wang D, 2000, HUM MUTAT, V16, P224, DOI 10.1002/1098-1004(200009)16:3<224::AID-HUMU5>3.0.CO;2-P; West IC, 1997, BBA-REV BIOMEMBRANES, V1331, P213, DOI 10.1016/S0304-4157(97)00007-5	44	822	848	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2003	301	5633					616	620		10.1126/science.1087619	http://dx.doi.org/10.1126/science.1087619			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893936				2022-12-01	WOS:000184473600031
J	Takaoka, A; Hayakawa, S; Yanai, H; Stoiber, D; Negishi, H; Kikuchi, H; Sasaki, S; Imai, K; Shibue, T; Honda, K; Taniguchi, T				Takaoka, A; Hayakawa, S; Yanai, H; Stoiber, D; Negishi, H; Kikuchi, H; Sasaki, S; Imai, K; Shibue, T; Honda, K; Taniguchi, T			Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence	NATURE			English	Article							DNA-DAMAGE; TRANSCRIPTIONAL ACTIVATION; P53-INDUCED APOPTOSIS; CANCER-CELLS; GENE; PHOSPHORYLATION; VIRUSES; PROTEIN; PATHWAY; AGENTS	Swift elimination of undesirable cells is an important feature in tumour suppression and immunity. The tumour suppressor p53 and interferon-alpha and -beta (IFN-alpha/beta) are essential for the induction of apoptosis in cancerous cells and in antiviral immune responses, respectively, but little is known about their interrelationship. Here we show that transcription of the p53 gene is induced by IFN-alpha/beta, accompanied by an increase in p53 protein level. IFN-alpha/beta signalling itself does not activate p53; rather, it contributes to boosting p53 responses to stress signals. We show examples in which p53 gene induction by IFN-alpha/beta contributes to tumour suppression. Furthermore, we show that p53 is activated in virally infected cells to evoke an apoptotic response and that p53 is critical for antiviral defence of the host. Our study reveals a hitherto unrecognized link between p53 and IFN-alpha/beta in tumour suppression and antiviral immunity, which may have therapeutic implications.	Univ Tokyo, Fac Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Sapporo Med Univ, Sch Med, Dept Internal Med 1, Chuo Ku, Sapporo, Hokkaido 0608556, Japan	University of Tokyo; University of Tokyo; Sapporo Medical University	Taniguchi, T (corresponding author), Univ Tokyo, Fac Med, Dept Immunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.		Yanai, Hideyuki/AGK-5933-2022; Honda, Kenya/N-5297-2015; Yang, Chen/G-1379-2010	Yanai, Hideyuki/0000-0002-0115-9000; Stoiber-Sakaguchi, Dagmar/0000-0002-8824-0767				Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Bluyssen Hans A. R., 1996, Cytokine and Growth Factor Reviews, V7, P11, DOI 10.1016/1359-6101(96)00005-6; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; BUTZ K, 1995, ONCOGENE, V10, P927; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Demaeyer E., 1988, INTERFERONS OTHER RE; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; FUJITA T, 1985, CELL, V41, P489, DOI 10.1016/S0092-8674(85)80022-2; GINSBERG D, 1990, ONCOGENE, V5, P1285; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Gresser I, 2002, CYTOKINE GROWTH F R, V13, P111, DOI 10.1016/S1359-6101(01)00035-1; GUTTERMAN JU, 1994, P NATL ACAD SCI USA, V91, P1198, DOI 10.1073/pnas.91.4.1198; HAQUE SJ, 1994, J BIOL CHEM, V269, P19523; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HSU IC, 1993, CARCINOGENESIS, V14, P987, DOI 10.1093/carcin/14.5.987; Jacks T, 1996, NATURE, V381, P643, DOI 10.1038/381643a0; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; Koromilas AE, 2001, CYTOKINE GROWTH F R, V12, P157, DOI 10.1016/S1359-6101(00)00023-X; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Mendonca MS, 1999, CANCER RES, V59, P3972; Miyamoto A, 2000, J GASTROEN HEPATOL, V15, P1447, DOI 10.1046/j.1440-1746.2000.02289.x; Neil JC, 1997, TRENDS MICROBIOL, V5, P115, DOI 10.1016/S0966-842X(96)10083-4; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; OREN M, 1994, SEMIN CANCER BIOL, V5, P221; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Pfeffer LM, 1998, CANCER RES, V58, P2489; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Prives C, 1999, J PATHOL, V187, P112; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Strander H, 1996, BIOTHERAPY, V8, P213, DOI 10.1007/BF01877207; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; TSUKADA T, 1993, ONCOGENE, V8, P3313; Veldman T, 2001, J VIROL, V75, P4467, DOI 10.1128/JVI.75.9.4467-4472.2001; VILCEK J, 1996, FIELDS VIROLOGY, P375; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WADLER S, 1990, CANCER RES, V50, P3473; Westphal CH, 1997, CANCER RES, V57, P1664; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	50	692	772	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					516	523		10.1038/nature01850	http://dx.doi.org/10.1038/nature01850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12872134	Bronze			2022-12-01	WOS:000184454700033
J	Cheng, EHY; Sheiko, TV; Fisher, JK; Craigen, WJ; Korsmeyer, SJ				Cheng, EHY; Sheiko, TV; Fisher, JK; Craigen, WJ; Korsmeyer, SJ			VDAC2 inhibits BAK activation and mitochondrial apoptosis	SCIENCE			English	Article							DEPENDENT ANION CHANNEL; BCL-X-L; CYTOCHROME-C; PERMEABILITY TRANSITION; PROTEIN; FAMILY; DEATH; RELEASE; DYSFUNCTION; RESPIRATION	The multidomain proapoptotic molecules BAK or BAX are required to initiate the mitochondrial pathway of apoptosis. How cells maintain the potentially lethal proapoptotic effector BAK in a monomeric inactive conformation at mitochondria is unknown. In viable cells, we found BAK complexed with mitochondrial outer-membrane protein VDAC2, a VDAC isoform present in low abundance that interacts specifically with the inactive conformer of BAK. Cells deficient in VDAC2, but not cells lacking the more abundant VDAC1, exhibited enhanced BAK oligomerization and were more susceptible to apoptotic death. Conversely, overexpression of VDAC2 selectively prevented BAK activation and inhibited the mitochondrial apoptotic pathway. Death signals activate "BH3-only" molecules such as tBID, BIM, or BAD, which displace VDAC2 from BAK, enabling homo-oligomerization of BAK and apoptosis. Thus, VDAC2, an isoform restricted to mammals, regulates the activity of BAK and provides a connection between mitochondrial physiology and the core apoptotic pathway.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Baylor College of Medicine	Korsmeyer, SJ (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst, 44 Binney St, Boston, MA 02115 USA.	stanley_korsmeyer@dfci.harvard.edu			NCI NIH HHS [R37CA50239] Funding Source: Medline; NINDS NIH HHS [NS42319] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA050239] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anflous K, 2001, J BIOL CHEM, V276, P1954, DOI 10.1074/jbc.M006587200; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; CHENG EH, UNPUB; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; CRAIGEN WJ, UNPUB; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; Sampson MJ, 1997, J BIOL CHEM, V272, P18966, DOI 10.1074/jbc.272.30.18966; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2000, J BIOL CHEM, V275, P12321, DOI 10.1074/jbc.275.16.12321; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Vander Heiden MG, 1999, MOL CELL, V3, P159; Weeber EJ, 2002, J BIOL CHEM, V277, P18891, DOI 10.1074/jbc.M201649200; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Wu SL, 1999, BBA-MOL CELL RES, V1452, P68, DOI 10.1016/S0167-4889(99)00120-2; Xu X, 1999, J MEMBRANE BIOL, V170, P89, DOI 10.1007/s002329900540; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	29	619	643	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2003	301	5632					513	517		10.1126/science.1083995	http://dx.doi.org/10.1126/science.1083995			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881569				2022-12-01	WOS:000184340500042
J	Buffelli, M; Burgess, RW; Feng, GP; Lobe, CG; Lichtman, JW; Sanes, JR				Buffelli, M; Burgess, RW; Feng, GP; Lobe, CG; Lichtman, JW; Sanes, JR			Genetic evidence that relative synaptic efficacy biases the outcome of synaptic competition	NATURE			English	Article								Synaptic activity drives synaptic rearrangement in the vertebrate nervous system; indeed, this appears to be a main way in which experience shapes neural connectivity(1,2). One rearrangement that occurs in many parts of the nervous system during early postnatal life is a competitive process called 'synapse elimination'(3,4). At the neuromuscular junction, where synapse elimination has been analysed in detail, muscle fibres are initially innervated by multiple axons, then all but one are withdrawn and the 'winner' enlarges(4-6). In support of the idea that synapse elimination is activity dependent, it is slowed or speeded when total neuromuscular activity is decreased or increased, respectively(4,7-13). However, most hypotheses about synaptic rearrangement postulate that change depends less on total activity than on the relative activity of the competitors(1-4,13,14). Intuitively, it seems that the input best able to excite its postsynaptic target would be most likely to win the competition, but some theories and results make other predictions(14-18). Here we use a genetic method to selectively inhibit neurotransmission from one of two inputs to a single target cell. We show that more powerful inputs are strongly favoured competitors during synapse elimination.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Univ Verona, Dipartimento Sci Neurol & Vis, I-37129 Verona, Italy; Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON MN4 3M5, Canada	Washington University (WUSTL); University of Verona; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Sanes, JR (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid, St Louis, MO 63110 USA.	sanesj@pcg.wustl.edu	Buffelli, Mario/C-6953-2018; Feng, Guoping/Y-2827-2019	Buffelli, Mario/0000-0002-3709-013X; Burgess, Robert/0000-0002-9229-3407				Barber MJ, 1999, J NEUROSCI, V19, P9975; BENOIT P, 1975, BRAIN RES, V99, P354, DOI 10.1016/0006-8993(75)90036-0; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Buffelli M, 2002, P NATL ACAD SCI USA, V99, P13200, DOI 10.1073/pnas.202471199; Busetto G, 2000, J NEUROSCI, V20, P685, DOI 10.1523/JNEUROSCI.20-02-00685.2000; CALLAWAY EM, 1987, NATURE, V328, P422, DOI 10.1038/328422a0; Costanzo EM, 2000, NAT NEUROSCI, V3, P694, DOI 10.1038/76649; DING R, 1983, J NEUROCYTOL, V12, P887, DOI 10.1007/BF01153341; DUXSON MJ, 1982, J NEUROCYTOL, V11, P395, DOI 10.1007/BF01257985; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Hata Y, 1999, NEURON, V22, P375, DOI 10.1016/S0896-6273(00)81097-1; Kasthuri N, 2003, NATURE, V424, P426, DOI 10.1038/nature01836; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Keller-Peck CR, 2001, NEURON, V31, P381, DOI 10.1016/S0896-6273(01)00383-X; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; OBRIEN RAD, 1978, J PHYSIOL-LONDON, V282, P571, DOI 10.1113/jphysiol.1978.sp012482; Personius KE, 2002, NEUROSCIENTIST, V8, P414, DOI 10.1177/107385802236970; Personius KE, 2001, NEURON, V31, P395, DOI 10.1016/S0896-6273(01)00369-5; RIDGE RMAP, 1984, J NEUROSCI, V4, P2614; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sengpiel F, 2002, CURR BIOL, V12, pR818, DOI 10.1016/S0960-9822(02)01318-0; THOMPSON W, 1983, NATURE, V302, P614, DOI 10.1038/302614a0; THOMPSON W, 1979, NEUROSCIENCE, V4, P271, DOI 10.1016/0306-4522(79)90088-5; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X	30	230	233	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					430	434		10.1038/nature01844	http://dx.doi.org/10.1038/nature01844			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879071				2022-12-01	WOS:000184318400044
J	Punglia, RS; D'Amico, AV; Catalona, WJ; Roehl, KA; Kuntz, KM				Punglia, RS; D'Amico, AV; Catalona, WJ; Roehl, KA; Kuntz, KM			Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RADICAL PROSTATECTOMY; REFERENCE RANGES; BIOPSY STRATEGY; 4.0 NG/ML; FREE PSA; MEN; POPULATION; DISEASE; AGE; HYPERPLASIA	Background: The sensitivity and specificity of a screening test are biased when disease status is not verified in all subjects and when the likelihood of confirmation depends on the test result itself. We assessed the screening characteristics of the prostate-specific antigen (PSA) measurement after correction for verification bias. Methods: Between 1995 and 2001, 6691 men underwent PSA-based screening for prostate cancer. Of these men, 705 (11 percent) subsequently underwent biopsy of the prostate. Under the assumption that the chance of undergoing a biopsy depends only on the PSA-test result and other observed clinical variables, we used a mathematical model to estimate adjusted receiver-operating-characteristic (ROC) curves. Results: Adjusting for verification bias significantly increased the area under the ROC curve (i.e., the overall diagnostic performance) of the PSA test, as compared with an unadjusted analysis (0.86 vs. 0.69, P<0.001, for men less than 60 years of age; 0.72 vs. 0.62, P=0.008, for men 60 years of age or older). If the threshold PSA value for undergoing biopsy were set at 4.1 ng per milliliter, 82 percent of cancers in younger men and 65 percent of cancers in older men would be missed. A digital rectal examination that is abnormal but not suspicious for cancer does not affect the overall performance characteristics of the test. Conclusions: A lower threshold level of PSA for recommending prostate biopsy, particularly in younger men, may improve the clinical value of the PSA test.	Harvard Univ, Sch Med, Joint Ctr Radiat Therapy, Boston, MA USA; Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Washington Univ, Sch Med, Div Urol Surg, St Louis, MO USA; Northwestern Univ, Fineberg Sch Med, Dept Urol, Chicago, IL USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Washington University (WUSTL); Northwestern University; Feinberg School of Medicine; Harvard University; Harvard T.H. Chan School of Public Health	Kuntz, KM (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, 718 Huntington Ave, Boston, MA 02115 USA.				AHRQ HHS [T32 HS00020-16] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000020] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Babaian RJ, 2000, J UROLOGY, V163, P152, DOI 10.1016/S0022-5347(05)67993-1; Babaian RJ, 2001, J UROLOGY, V165, P757, DOI 10.1016/S0022-5347(05)66519-6; BEGG CB, 1983, BIOMETRICS, V39, P207, DOI 10.2307/2530820; Carvalhal GF, 1999, J UROLOGY, V161, P835, DOI 10.1016/S0022-5347(01)61785-3; Catalona WJ, 2000, UROLOGY, V55, P791, DOI 10.1016/S0090-4295(99)00602-0; CATALONA WJ, 1993, JAMA-J AM MED ASSOC, V270, P948, DOI 10.1001/jama.270.8.948; Catalona WJ, 1997, JAMA-J AM MED ASSOC, V277, P1452, DOI 10.1001/jama.277.18.1452; Cotter MP, 2002, PROSTATE, V50, P216, DOI 10.1002/pros.10051; Durkan GC, 2002, BJU INT, V89, P33, DOI 10.1046/j.1464-410X.2002.02555.x; Eskew LA, 1997, J UROLOGY, V157, P199, DOI 10.1016/S0022-5347(01)65322-9; Froelicher VF, 1998, ANN INTERN MED, V128, P965, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00001; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; GIANROSSI R, 1989, CIRCULATION, V80, P87, DOI 10.1161/01.CIR.80.1.87; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Holmberg L, 2002, NEW ENGL J MED, V347, P781, DOI 10.1056/NEJMoa012794; Krumholtz JS, 2002, UROLOGY, V60, P469, DOI 10.1016/S0090-4295(02)01875-7; Meigs JB, 1996, J GEN INTERN MED, V11, P505, DOI 10.1007/BF02599596; Miller MC, 2001, UROLOGY, V57, P1105, DOI 10.1016/S0090-4295(01)00953-0; Morgan TO, 1996, NEW ENGL J MED, V335, P304, DOI 10.1056/NEJM199608013350502; NADLER RB, 1995, J UROLOGY, V154, P407, DOI 10.1016/S0022-5347(01)67064-2; Naughton CK, 2000, J UROLOGY, V164, P388, DOI 10.1016/S0022-5347(05)67367-3; OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V270, P860, DOI 10.1001/jama.270.7.860; Richter F, 2001, J CANCER EDUC, V16, P38; Sirovich BE, 2002, J GEN INTERN MED, V17, P212; Smith DS, 1998, J UROLOGY, V160, P1734, DOI 10.1016/S0022-5347(01)62395-4; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Walsh P C, 1994, Important Adv Oncol, P211; Wolff JM, 1996, UROL INT, V57, P170, DOI 10.1159/000282904	28	237	261	2	11	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2003	349	4					335	342		10.1056/NEJMoa021659	http://dx.doi.org/10.1056/NEJMoa021659			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703ZH	12878740				2022-12-01	WOS:000184312800006
J	Vincentelli, A; Susen, S; Le Tourneau, T; Six, I; Fabre, O; Juthier, F; Bauters, A; Decoene, C; Goudemand, J; Prat, A; Jude, B				Vincentelli, A; Susen, S; Le Tourneau, T; Six, I; Fabre, O; Juthier, F; Bauters, A; Decoene, C; Goudemand, J; Prat, A; Jude, B			Acquired von Willebrand syndrome in aortic stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLEEDING GASTROINTESTINAL ANGIODYSPLASIA; VONWILLEBRAND-FACTOR; SHEAR-STRESS; VALVE REPLACEMENT; DISEASE; PLASMA; PROTEOLYSIS; SUBTYPES; CLEAVAGE; TESTS	Background: Aortic-valve stenosis can be complicated by bleeding that is associated with acquired type 2A von Willebrand syndrome. However, the prevalence and cause of the hemostatic abnormality in aortic stenosis are unknown. Methods: We enrolled 50 consecutive patients with aortic stenosis, who completed a standardized screening questionnaire to detect a history of bleeding. Forty-two patients with severe aortic stenosis underwent valve replacement. Platelet function under conditions of high shear stress, von Willebrand factor collagen-binding activity and antigen levels, and the multimeric structure of von Willebrand factor were assessed at base line and one day, seven days, and six months postoperatively. Results: Skin or mucosal bleeding occurred in 21 percent of the patients with severe aortic stenosis. Platelet-function abnormalities under conditions of high shear stress, decreased von Willebrand factor collagen-binding activity and the loss of the largest multimers, or a combination of these was present in 67 to 92 percent of patients with severe aortic stenosis and correlated significantly with the severity of valve stenosis. Primary hemostatic abnormalities were completely corrected on the first day after surgery but tended to recur at six months, especially when there was a mismatch between patient and prosthesis (with an effective orifice area of less than 0.8 cm(sup 2) per square meter of body-surface area). Conclusions: Type 2A von Willebrand syndrome is common in patients with severe aortic stenosis. Von Willebrand factor abnormalities are directly related to the severity of aortic stenosis and are improved by valve replacement in the absence of mismatch between patient and prosthesis.	Univ Lille 2, Equipe Accueil 2693, Fac Med, Lille, France; Clin Chirurg Cardiovasc, Lille, France; Inst Hematol Biol & Hemobiol Transfus, Lille, France; Serv Explorat Fonct Cardiol, Lille, France	Universite de Franche-Comte; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Jude, B (corresponding author), Hop Cardiol, Inst Hematol Biol & Hemobiol Transfus, Blvd Prof J Leclercq, F-59037 Lille, France.		susen, sophie/G-4337-2018; Le Tourneau, Thierry/D-5428-2015	Vincentelli, Andre/0000-0003-4081-786X; Juthier, Francis/0000-0002-5072-9073; Susen, Sophie/0000-0001-5953-163X				Anderson RP, 1996, LANCET, V347, P689, DOI 10.1016/S0140-6736(96)91240-4; BLERY C, 1986, LANCET, V1, P139; Bonow R O, 1998, J Heart Valve Dis, V7, P672; CAPPELL MS, 1986, ANN INTERN MED, V105, P54, DOI 10.7326/0003-4819-105-1-54; Carabello BA, 2002, NEW ENGL J MED, V346, P677, DOI 10.1056/NEJMcp010846; DENT JA, 1990, P NATL ACAD SCI USA, V87, P6306, DOI 10.1073/pnas.87.16.6306; Favaloro EJ, 2000, THROMB HAEMOSTASIS, V84, P541; Federici, 2000, THROMB HAEMOSTASIS, V84, P739; Federici AB, 2000, THROMB HAEMOSTASIS, V84, P345; Fressinaud E, 1998, BLOOD, V91, P1325, DOI 10.1182/blood.V91.4.1325; GILL JC, 1986, BLOOD, V67, P758; GREENSTEIN RJ, 1986, AM J SURG, V151, P347, DOI 10.1016/0002-9610(86)90465-4; HEYDE EC, 1958, NEW ENGL J MED, V259, P196; KING RM, 1987, ANN THORAC SURG, V44, P514, DOI 10.1016/S0003-4975(10)62112-1; MAMMEN EF, 1995, SEMIN THROMB HEMOST, V21, P113; Mazurier C, 1998, HAEMOPHILIA, V4, P40; Pareti FI, 2000, CIRCULATION, V102, P1290, DOI 10.1161/01.CIR.102.11.1290; RAPAPORT SI, 1983, BLOOD, V61, P229; RUGGERI ZM, 1980, J CLIN INVEST, V65, P1318, DOI 10.1172/JCI109795; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Sugimoto M, 2003, BLOOD, V101, P915, DOI 10.1182/blood-2002-03-0944; TSAI HM, 1994, BLOOD, V83, P2171; Veyradier A, 2001, GASTROENTEROLOGY, V120, P346, DOI 10.1053/gast.2001.21204; Veyradier A, 2000, THROMB HAEMOSTASIS, V84, P175, DOI 10.1055/s-0037-1613993; WARKENTIN TE, 1992, LANCET, V340, P35, DOI 10.1016/0140-6736(92)92434-H; Warkentin TE, 2002, NEW ENGL J MED, V347, P858, DOI 10.1056/NEJM200209123471122; ZIMMERMAN TS, 1986, J CLIN INVEST, V77, P947, DOI 10.1172/JCI112394	27	570	589	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2003	349	4					343	349		10.1056/NEJMoa022831	http://dx.doi.org/10.1056/NEJMoa022831			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703ZH	12878741				2022-12-01	WOS:000184312800007
J	Lew, TWK; Kwek, TK; Tai, D; Earnest, A; Loo, S; Singh, K; Kwan, KM; Chan, Y; Yim, CF; Bek, SL; Kor, AC; Yap, WS; Chelliah, YR; Lai, YC; Goh, SK				Lew, TWK; Kwek, TK; Tai, D; Earnest, A; Loo, S; Singh, K; Kwan, KM; Chan, Y; Yim, CF; Bek, SL; Kor, AC; Yap, WS; Chelliah, YR; Lai, YC; Goh, SK			Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LUNG INJURY; CLINICAL-FEATURES; MORTALITY; SARS; OUTBREAK; OUTCOMES; CARE; ARDS	Context Severe acute respiratory syndrome (SARS) is an emerging infectious disease with a 25% incidence of progression to acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) and mortality exceeding 10%. Objective To describe the clinical spectrum and outcomes of ALI/ARDS in patients with SARS-related critical illness. Design, Setting, and Patients Retrospective case series of adult patients with probable SARS admitted to the intensive care unit (ICU) of a hospital in Singapore between March 6 and June 6, 2003. Main Outcome Measures The primary outcome measure was 28-day mortality after symptom onset. Results Of 199 patients hospitalized with SARS, 46 (23%) were admitted to the ICU, including 45 who fulfilled criteria for ALI/ARDS. Mortality at 28 days for the entire cohort was 20 (10.1%) of 199 and for ICU patients was 17 (37%) of 46. Intensive care unit mortality at 13 weeks was 24 (52.2%) of 46. Nineteen of 24 ICU deaths occurred late ( greater than or equal to7 days after ICU admission) and were attributed to complications related to severe ARDS, multiorgan failure, thromboembolic complications, or septicemic shock. ARDS was characterized by ease of derecruitment of alveoli and paucity of airway secretion, bronchospasm, or dynamic hyperinflation. Lower Acute Physiology and Chronic Health Evaluation if scores and higher baseline ratios of Pao(2) to fraction of inspired oxygen were associated with earlier recovery. Conclusions Critically ill patients with SARS and ALI/ARDS had characteristic clinical findings, high rates of complications; and high mortality. These findings may provide useful information for optimizing supportive care for SARS-related critical illness.	Tan Tock Seng Hosp, Dept Anaesthesiol, Singapore 308433, Singapore; Tan Tock Seng Hosp, Dept Gen Med, Med Intens Care Unit, Singapore, Singapore; Tan Tock Seng Hosp, Clin Res Unit, Singapore, Singapore; Tan Tock Seng Hosp, Dept Resp Med, Singapore, Singapore; Alexandra Hosp, Dept Anaesthesia, Singapore, Singapore	Tan Tock Seng Hospital; Tan Tock Seng Hospital; Tan Tock Seng Hospital; Tan Tock Seng Hospital	Lew, TWK (corresponding author), Tan Tock Seng Hosp, Dept Anaesthesiol, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	thomas_lew@ttsh.com.sg	Earnest, Arul/L-4747-2013	Earnest, Arul/0000-0003-2693-5034				*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; BERNARD GR, 1987, NEW ENGL J MED, V317, P1565, DOI 10.1056/NEJM198712173172504; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bersten AD, 2002, AM J RESP CRIT CARE, V165, P443, DOI 10.1164/ajrccm.165.4.2101124; BONE RC, 1989, CHEST, V96, P849, DOI 10.1378/chest.96.4.849; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Brochard L, 1998, AM J RESP CRIT CARE, V158, P1831, DOI 10.1164/ajrccm.158.6.9801044; *CDCP, 2003, INF CONTR PREC AER G; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P405; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Ferring M, 1997, EUR RESPIR J, V10, P1297, DOI 10.1183/09031936.97.10061297; Hsu LY, 2003, EMERG INFECT DIS, V9, P713; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Lemanske RF, 2003, J PEDIATR-US, V142, pS3, DOI 10.1067/mpd.2003.19; LUCE JM, 1988, AM REV RESPIR DIS, V138, P62, DOI 10.1164/ajrccm/138.1.62; Masur H, 2003, JAMA-J AM MED ASSOC, V289, P2861, DOI 10.1001/jama.289.21.JED30036; MONTGOMERY AB, 1985, AM REV RESPIR DIS, V132, P485; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Stewart TE, 1998, NEW ENGL J MED, V338, P355, DOI 10.1056/NEJM199802053380603; Vincent JL, 2003, CRIT CARE MED, V31, pS296, DOI 10.1097/01.CCM.0000057906.89552.8F; *WHO, CAS DEF SURV SEV AC; World Health Organization, HOSP INF CONTR GUID; World Health Organization, 2003, CUM NUMB REP PROB CA	25	290	310	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2003	290	3					374	380		10.1001/jama.290.3.374	http://dx.doi.org/10.1001/jama.290.3.374			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699WK	12865379				2022-12-01	WOS:000184078800032
J	Lee, HH; Norris, A; Weiss, JB; Frasch, M				Lee, HH; Norris, A; Weiss, JB; Frasch, M			Jelly belly protein activates the receptor tyrosine kinase Alk to specify visceral muscle pioneers	NATURE			English	Article							ANAPLASTIC LYMPHOMA KINASE; CELL FATES; DROSOPHILA MESODERM; BOX-GENE; FUSION; IDENTIFICATION; SEGMENTATION; EMBRYOGENESIS; SPECIFICATION; INDUCTION	The secreted protein Jelly belly (Jeb) is required for an essential signalling event in Drosophila muscle development. In the absence of functional Jeb, visceral muscle precursors are normally specified but fail to migrate and differentiate(1). The structure and distribution of Jeb protein implies that Jeb functions as a signal to organize the development of visceral muscles(1). Here we show that the Jeb receptor is the Drosophila homologue of anaplastic lymphoma kinase (Alk), a receptor tyrosine kinase of the insulin receptor superfamily. Human ALK was originally identified as a proto-oncogene, but its normal function in mammals is not known(2). In Drosophila, localized Jeb activates Alk and the downstream Ras/mitogen-activated protein kinase cascade to specify a select group of visceral muscle precursors as muscle-patterning pioneers. Jeb/Alk signalling induces the myoblast fusion gene dumbfounded (duf; also known as kirre) as well as org-1, a Drosophila homologue of mammalian TBX1, in these cells.	Oregon Hlth Sci Univ, Portland, OR 97201 USA; Mt Sinai Sch Med, Brookdale Dept Mol Cell & Dev Biol, New York, NY 10029 USA	Oregon Health & Science University; Icahn School of Medicine at Mount Sinai	Weiss, JB (corresponding author), Oregon Hlth Sci Univ, 3181 SW Sam Jackson Pk Rd NRC3, Portland, OR 97201 USA.		Frasch, Manfred/H-7002-2013	Frasch, Manfred/0000-0003-1373-9798; LEE, HSIU-HSIANG/0000-0001-7707-8461				AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Azpiazu N, 1996, GENE DEV, V10, P3183, DOI 10.1101/gad.10.24.3183; Baldini A, 2002, HUM MOL GENET, V11, P2363, DOI 10.1093/hmg/11.20.2363; BATE M, 1990, DEVELOPMENT, V110, P791; Baylies MK, 2001, CURR OPIN GENET DEV, V11, P431, DOI 10.1016/S0959-437X(00)00214-8; BODMER R, 1993, DEVELOPMENT, V118, P719; Carmena A, 1998, GENE DEV, V12, P3910, DOI 10.1101/gad.12.24.3910; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; DOHRMANN C, 1990, GENE DEV, V4, P2098, DOI 10.1101/gad.4.12a.2098; Duyster J, 2001, ONCOGENE, V20, P5623, DOI 10.1038/sj.onc.1204594; Dworak HA, 2002, BIOESSAYS, V24, P591, DOI 10.1002/bies.10115; Flanagan JG, 2000, METHOD ENZYMOL, V327, P198, DOI 10.1016/S0076-6879(00)27277-7; FRASCH M, 1995, NATURE, V374, P464, DOI 10.1038/374464a0; Gabay L, 1997, DEVELOPMENT, V124, P3535; Gobron S, 1999, NEUROSCIENCE, V88, P655, DOI 10.1016/S0306-4522(98)00252-8; Ishihara T, 2002, CELL, V109, P639, DOI 10.1016/S0092-8674(02)00748-1; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Klapper R, 2002, MECH DEVELOP, V110, P85, DOI 10.1016/S0925-4773(01)00567-6; Lee HH, 2000, DEVELOPMENT, V127, P5497; Li L, 2000, J EXP MED, V191, P1077, DOI 10.1084/jem.191.6.1077; Loren CE, 2001, GENES CELLS, V6, P531, DOI 10.1046/j.1365-2443.2001.00440.x; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Porsch M, 1998, GENE, V212, P237, DOI 10.1016/S0378-1119(98)00180-2; Riechmann V, 1997, DEVELOPMENT, V124, P2915; San Martin B, 2001, DEVELOPMENT, V128, P3331; STAEHLINGHAMPTON K, 1994, NATURE, V372, P783; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; Sym M, 1999, CELL, V98, P25, DOI 10.1016/S0092-8674(00)80603-0; Weiss JB, 2001, CELL, V107, P387, DOI 10.1016/S0092-8674(01)00540-2; Zaffran S, 2001, GENE DEV, V15, P2900	30	133	135	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2003	425	6957					507	512		10.1038/nature01916	http://dx.doi.org/10.1038/nature01916			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727FN	14523446				2022-12-01	WOS:000185648100044
J	Perkins, TT; Dalal, RV; Mitsis, PG; Block, SM				Perkins, TT; Dalal, RV; Mitsis, PG; Block, SM			Sequence-dependent pausing of single lambda exonuclease molecules	SCIENCE			English	Article							BACTERIOPHAGE-LAMBDA; ESCHERICHIA-COLI; RNA-POLYMERASE; DNA; FORCE; TRANSLOCATION; ENDS	Lambda exonuclease processively degrades one strand of duplex DNA, moving 5'-to-3' in an ATP-independent fashion. When examined at the single-molecule level, the speeds of digestion were nearly constant at 4 nanometers per second (12 nucleotides per second), interspersed with pauses of variable duration. Long pauses, occurring at stereotypical locations, were strand-specific and sequence-dependent. Pause duration and probability varied widely. The strongest pause, GGCGATTCT, was identified by gel electrophoresis. Correlating single-molecule dwell positions with sequence independently identified the motif GGCGA. This sequence is found in the left lambda cohesive end, where exonuclease inhibition may contribute to the reduced recombination efficiency at that end.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Praelux Inc, Lawrenceville, NJ 08646 USA	Stanford University; Stanford University; Stanford University	Perkins, TT (corresponding author), Natl Inst Stand & Technol, 325 Broadway, Boulder, CO 80309 USA.			Perkins, Thomas/0000-0003-4826-9490	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057035, R37GM057035] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG 011821-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM057035, GM 57035] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; Dohoney KM, 2001, NATURE, V409, P370, DOI 10.1038/35053124; DOKTYCZ MJ, 1995, J BIOL CHEM, V270, P8439, DOI 10.1074/jbc.270.15.8439; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Kovall R, 1997, SCIENCE, V277, P1824, DOI 10.1126/science.277.5333.1824; Kovall RA, 1998, P NATL ACAD SCI USA, V95, P7893, DOI 10.1073/pnas.95.14.7893; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0; LITTLE JW, 1967, J BIOL CHEM, V242, P679; Mitsis PG, 1999, NUCLEIC ACIDS RES, V27, P3057, DOI 10.1093/nar/27.15.3057; RADDING CM, 1966, J MOL BIOL, V18, P235, DOI 10.1016/S0022-2836(66)80243-7; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Soultanas P, 2000, CURR OPIN STRUC BIOL, V10, P124, DOI 10.1016/S0959-440X(99)00059-7; STAHL FW, 1972, P NATL ACAD SCI USA, V69, P3598, DOI 10.1073/pnas.69.12.3598; Subramanian K, 2003, NUCLEIC ACIDS RES, V31, P1585, DOI 10.1093/nar/gkg266; TRIFONOV EN, 1985, CRC CR REV BIOCH MOL, V19, P89, DOI 10.3109/10409238509082540; Visscher K, 1996, IEEE J SEL TOP QUANT, V2, P1066, DOI 10.1109/2944.577338; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; WU R, 1971, J MOL BIOL, V57, P491, DOI 10.1016/0022-2836(71)90105-7; Yang Q, 1997, BIOCHEMISTRY-US, V36, P2744, DOI 10.1021/bi9622682	22	117	126	3	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2003	301	5641					1914	1918		10.1126/science.1088047	http://dx.doi.org/10.1126/science.1088047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725GW	12947034	Green Accepted			2022-12-01	WOS:000185536700053
J	Yan, H; Park, SH; Finkelstein, G; Reif, JH; LaBean, TH				Yan, H; Park, SH; Finkelstein, G; Reif, JH; LaBean, TH			DNA-templated self-assembly of protein arrays and highly conductive nanowires	SCIENCE			English	Article							CONSTRUCTION; COMPUTATION; MACHINE	A DNA nanostructure consisting of four four-arm junctions oriented with a square aspect ratio was designed and constructed. Programmable self-assembly of 4x4 tiles resulted in two distinct lattice morphologies: uniform-width nanoribbons and two-dimensional nanogrids, which both display periodic square cavities. Periodic protein arrays were achieved by templated self-assembly of streptavidin onto the DNA nanogrids containing biotinylated oligonucleotides. On the basis of a two-step metallization procedure, the 4x4 nanoribbons acted as an excellent scaffold for the production of highly conductive, uniform-width, silver nanowires.	Duke Univ, Dept Comp Sci, Durham, NC 27708 USA; Duke Univ, Dept Phys, Durham, NC 27708 USA	Duke University; Duke University	Yan, H (corresponding author), Duke Univ, Dept Comp Sci, Durham, NC 27708 USA.	hy1@cs.duke.edu; thl@cs.duke.edu	LaBean, Thomas H/G-2859-2011; Reif, John H/C-2684-2008	LaBean, Thomas H/0000-0002-6739-2059; 				ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Benenson Y, 2001, NATURE, V414, P430, DOI 10.1038/35106533; Braich RS, 2002, SCIENCE, V296, P499, DOI 10.1126/science.1069528; Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826; FENG L, IN PRESS ANGEW CHEM; Ford WE, 2001, ADV MATER, V13, P1793, DOI 10.1002/1521-4095(200112)13:23<1793::AID-ADMA1793>3.3.CO;2-M; Keren K, 2002, SCIENCE, V297, P72, DOI 10.1126/science.1071247; LaBean T. H., 2003, COMPUTATIONAL BIOL G, P35; LaBean TH, 2000, J AM CHEM SOC, V122, P1848, DOI 10.1021/ja993393e; Li JWJ, 2002, NANO LETT, V2, P315, DOI [10.1021/nl015713+, 10.1021/n1015713+]; Liu QH, 2000, NATURE, V403, P175, DOI 10.1038/35003155; Mao CD, 1999, NATURE, V397, P144, DOI 10.1038/16437; Mao CD, 1999, J AM CHEM SOC, V121, P5437, DOI 10.1021/ja9900398; Mao CD, 2000, NATURE, V407, P493, DOI 10.1038/35035038; Mirkin CA, 2000, INORG CHEM, V39, P2258, DOI 10.1021/ic991123r; Monson CF, 2003, NANO LETT, V3, P359, DOI 10.1021/nl034016+; Niemeyer CM, 1998, ANGEW CHEM INT EDIT, V37, P2265, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2265::AID-ANIE2265>3.0.CO;2-F; Patolsky F, 2002, ANGEW CHEM INT EDIT, V41, P2323, DOI 10.1002/1521-3773(20020703)41:13<2323::AID-ANIE2323>3.0.CO;2-H; Richter J, 2000, ADV MATER, V12, P507, DOI 10.1002/(SICI)1521-4095(200004)12:7<507::AID-ADMA507>3.0.CO;2-G; Seeman NC, 1999, TRENDS BIOTECHNOL, V17, P437, DOI 10.1016/S0167-7799(99)01360-8; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Sha RJ, 2000, CHEM BIOL, V7, P743, DOI 10.1016/S1074-5521(00)00024-7; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Winfree E, 2000, J BIOMOL STRUCT DYN, P263; Xiao SJ, 2002, J NANOPART RES, V4, P313, DOI 10.1023/A:1021145208328; Yan H, 2002, NATURE, V415, P62, DOI 10.1038/415062a; Yan H, 2003, P NATL ACAD SCI USA, V100, P8103, DOI 10.1073/pnas.1032954100; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	29	1457	1542	13	643	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2003	301	5641					1882	1884		10.1126/science.1089389	http://dx.doi.org/10.1126/science.1089389			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725GW	14512621				2022-12-01	WOS:000185536700043
J	von Schwedler, UK; Stuchell, M; Muller, B; Ward, DM; Chung, HY; Morita, E; Wang, HE; Davis, T; He, GP; Cimbora, DM; Scott, A; Krausslich, HG; Kaplan, J; Morham, SG; Sundquist, WI				von Schwedler, UK; Stuchell, M; Muller, B; Ward, DM; Chung, HY; Morita, E; Wang, HE; Davis, T; He, GP; Cimbora, DM; Scott, A; Krausslich, HG; Kaplan, J; Morham, SG; Sundquist, WI			The protein network of HIV budding	CELL			English	Article							LATE-DOMAIN; MULTIVESICULAR-BODY; PLASMA-MEMBRANE; VIRUS; TSG101; HRS; GAG; P6; TRAFFICKING; UBIQUITIN	HIV release requires TSG101, a cellular factor that sorts proteins into vesicles that bud into multivesicular bodies (MVB). To test whether other proteins involved in MVB biogenesis (the class E proteins) also participate in HIV release, we identified 22 candidate human class E proteins. These proteins were connected into a coherent network by 43 different protein-protein interactions, with AIP1 playing a key role in linking complexes that act early (TSG101/ESCRT-I) and late (CHMP4/ESCRT-III) in the pathway. AIP1 also binds the HIV-1 p6(Gag) and EIAV p9(Gag) proteins, indicating that it can function directly in virus budding. Human class E proteins were found in HIV-1 particles, and dominant-negative mutants of late-acting human class E proteins arrested HIV-1 budding through plasmal and endosomal membranes. These studies define a protein network required for human MVB biogenesis and indicate that the entire network participates in the release of HIV and probably many other viruses.	Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA; Univ Utah, Dept Pathol, Salt Lake City, UT 84132 USA; Univ Klinikum Heidelburg, Abt Virol, D-69120 Heidelberg, Germany; Myriad Pharmaceut Inc, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Ruprecht Karls University Heidelberg; Myriad Genetics, Inc	Sundquist, WI (corresponding author), Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA.	wes@biochem.utah.edu	Morita, Eiji/D-2453-2015	Morita, Eiji/0000-0002-3781-6121; Muller, Barbara/0000-0001-5726-5585				Asao H, 1997, J BIOL CHEM, V272, P32785, DOI 10.1074/jbc.272.52.32785; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Basyuk E, 2003, DEV CELL, V5, P161, DOI 10.1016/S1534-5807(03)00188-6; Biscone MJ, 2002, CURR OPIN PHARMACOL, V2, P529, DOI 10.1016/S1471-4892(02)00200-X; Bishop N, 2002, J CELL BIOL, V157, P91, DOI 10.1083/jcb.200112080; Bishop N, 2001, J BIOL CHEM, V276, P11735, DOI 10.1074/jbc.M009863200; Chatellard-Causse C, 2002, J BIOL CHEM, V277, P29108, DOI 10.1074/jbc.M204019200; Cook RF, 1998, J VIROL, V72, P1383, DOI 10.1128/JVI.72.2.1383-1393.1998; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; Demirov DG, 2002, J VIROL, V76, P105, DOI 10.1128/JVI.76.1.105-117.2002; Denzer K, 2000, J CELL SCI, V113, P3365; Dettenhofer M, 1999, J VIROL, V73, P1460, DOI 10.1128/JVI.73.2.1460-1467.1999; Freed EO, 2002, J VIROL, V76, P4679, DOI 10.1128/JVI.76.10.4679-4687.2002; Fujita H, 2003, J CELL SCI, V116, P401, DOI 10.1242/jcs.00213; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100; Gross I, 1997, EUR J BIOCHEM, V249, P592, DOI 10.1111/j.1432-1033.1997.t01-1-00592.x; Hermida-Matsumoto L, 2000, J VIROL, V74, P8670, DOI 10.1128/JVI.74.18.8670-8679.2000; Howard TL, 2001, J CELL SCI, V114, P2395; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Kamura T, 2001, J BIOL CHEM, V276, P16528, DOI 10.1074/jbc.M010142200; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Licata JM, 2003, J VIROL, V77, P1812, DOI 10.1128/JVI.77.3.1812-1819.2003; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Muller B, 2002, J VIROL, V76, P1015, DOI 10.1128/JVI.76.3.1015-1024.2002; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; Ott DE, 2000, VIROLOGY, V266, P42, DOI 10.1006/viro.1999.0075; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; POMILLOS O, 2002, NAT STRUCT BIOL, V9, P812; POMILLOS O, 2003, J CELL BIOL, V162, P425; POMILLOS O, 2002, EMBO J, V21, P2397; Pornillos O, 2002, TRENDS CELL BIOL, V12, P569, DOI 10.1016/S0962-8924(02)02402-9; Puffer BA, 1998, J VIROL, V72, P10218, DOI 10.1128/JVI.72.12.10218-10221.1998; Puffer BA, 1997, J VIROL, V71, P6541, DOI 10.1128/JVI.71.9.6541-6546.1997; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Scheuring S, 2001, J MOL BIOL, V312, P469, DOI 10.1006/jmbi.2001.4917; SHERER NM, 2003, IN PRESS TRAFFIC; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Vincent O, 2003, MOL CELL BIOL, V23, P1647, DOI 10.1128/MCB.23.5.1647-1655.2003; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Welker R, 2000, J VIROL, V74, P1168, DOI 10.1128/JVI.74.3.1168-1177.2000	52	656	691	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2003	114	6					701	713		10.1016/S0092-8674(03)00714-1	http://dx.doi.org/10.1016/S0092-8674(03)00714-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	724AL	14505570	Bronze			2022-12-01	WOS:000185464000008
J	Allen, MR				Allen, MR			Possible or probable?	NATURE			English	Editorial Material									Univ Oxford, Dept Phys, Oxford OX11 0QXJ, England	University of Oxford	Allen, MR (corresponding author), Univ Oxford, Dept Phys, Oxford OX11 0QXJ, England.		Allen, Myles R/A-5172-2012					ALLEN MR, P 2002 EOMWF PRED SE, P275; Houghton J. T., 2001, CLIMATE CHANGE 2001; Schneider SH, 2002, CLIMATIC CHANGE, V52, P441, DOI 10.1023/A:1014221225434	3	22	22	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 18	2003	425	6955					242	242		10.1038/425242a	http://dx.doi.org/10.1038/425242a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722JA	13679894				2022-12-01	WOS:000185370900023
J	Gray, N; Boyle, P				Gray, N; Boyle, P			The future of the nicotine-addiction market	LANCET			English	Editorial Material							HEALTH		European Inst Oncol, Div Epidemiol & Biostat, I-20141 Milan, Italy	IRCCS European Institute of Oncology (IEO)	Gray, N (corresponding author), European Inst Oncol, Div Epidemiol & Biostat, I-20141 Milan, Italy.		Boyle, Peter/A-4380-2014	Boyle, Peter/0000-0001-6251-0610				Gray N, 2000, TOB CONTROL, V9, P351, DOI 10.1136/tc.9.3.351; Henningfield JE, 2001, TOB CONTROL, V10, P253, DOI 10.1136/tc.10.3.253; Ramstrom L., 2000, NICOTINE PUBLIC HLTH, P159; Sumner W, 2003, TOB CONTROL, V12, P124, DOI 10.1136/tc.12.2.124; 1991, LANCET, V337, P1191; DATABASE ED RESOURCE	6	20	21	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 13	2003	362	9387					845	846		10.1016/S0140-6736(03)14348-6	http://dx.doi.org/10.1016/S0140-6736(03)14348-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721RH	13678968				2022-12-01	WOS:000185329400005
J	Cecchi, F; Olivotto, I; Gistri, R; Lorenzoni, R; Chiriatti, G; Camici, PG				Cecchi, F; Olivotto, I; Gistri, R; Lorenzoni, R; Chiriatti, G; Camici, PG			Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; POSITRON-EMISSION TOMOGRAPHY; MYOCARDIAL PERFUSION ABNORMALITIES; SUDDEN-DEATH; VASODILATOR RESERVE; ATRIAL-FIBRILLATION; CLINICAL COURSE; CARDIAC-ARREST; ISCHEMIA; RISK	Background: Microvascular dysfunction, reflected by an inadequate increase in myocardial blood flow in response to dipyridamole infusion, is a recognized feature of hypertrophic cardiomyopathy. Its long-term effect on the prognosis is unknown. We prospectively evaluated a cohort of patients with hypertrophic cardiomyopathy after they had undergone quantitative assessment of myocardial blood flow by positron-emission tomography (PET). Methods: Fifty-one patients (New York Heart Association class I or II) were followed for a mean (+/-SD) of 8.1+/-2.1 years after PET. Twelve subjects with atypical chest pain served as controls. Measurement of flow was performed at base line and after the infusion of the coronary vasodilator dipyridamole, with the use of nitrogen-13-labeled ammonia. Patients were then divided into three equal groups with increasing values of myocardial blood flow. Results: The response of myocardial blood flow to dipyridamole was severely blunted in the patients, as compared with the controls (1.50+/-0.69 vs. 2.71+/-0.94 ml per minute per gram of tissue, P<0.001). Sixteen patients (31 percent) had an unfavorable outcome (death from cardiovascular causes, progression to New York Heart Association class III or IV, or sustained ventricular arrhythmias requiring the implantation of a cardioverter-defibrillator) 2.2 to 9.1 years after PET. Reduced blood flow in response to dipyridamole was strongly associated with an unfavorable outcome. Multivariate analysis showed that among patients in the lowest of the three flow groups the age-adjusted relative hazard of death from cardiovascular causes was 9.6 (P=0.02) and the relative hazard of an unfavorable outcome (a combined end point) was 20.1 (P=0.003), as compared with patients in the two other flow groups. Specifically, all four patients who died from heart failure and three of five who died suddenly were in this subgroup. Conclusions: In patients with hypertrophic cardiomyopathy, the degree of microvascular dysfunction is a strong, independent predictor of clinical deterioration and death. Severe microvascular dysfunction is often present in patients with mild or no symptoms and may precede clinical deterioration by years.	Azienda Osped Careggi, Reg Referral Ctr Myocardial Dis, Florence, Italy; Osped Lucca, Cardiol Unit, Lucca, Italy; Osped Pescia, Cardiol Unit, Pescia, Italy; CNR, Inst Clin Physiol, I-56100 Pisa, Italy; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Med Res Ctr, London SW7 2AZ, England	University of Florence; Azienda Ospedaliero Universitaria Careggi; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Imperial College London	Cecchi, F (corresponding author), Via Jacopo Nardi 30, I-50132 Florence, Italy.		Camici, Paolo/AAN-1959-2020; Olivotto, Iacopo/AAC-5950-2022; Lorenzoni, Roberto/G-4139-2018	Camici, Paolo/0000-0001-5584-0750; Olivotto, Iacopo/0000-0003-1751-9266; Lorenzoni, Roberto/0000-0002-5703-715X; Cecchi, Franco/0000-0002-2035-5621				Basso C, 2000, HUM PATHOL, V31, P988, DOI 10.1053/hupa.2000.16659; CAMICI P, 1991, J AM COLL CARDIOL, V17, P879, DOI 10.1016/0735-1097(91)90869-B; CAMICI PG, 1991, CORONARY ARTERY DIS, V2, P837; CANNON RO, 1991, CIRCULATION, V83, P1660, DOI 10.1161/01.CIR.83.5.1660; CANNON RO, 1985, CIRCULATION, V71, P234, DOI 10.1161/01.CIR.71.2.234; CECCHI F, 1995, J AM COLL CARDIOL, V26, P1529, DOI 10.1016/0735-1097(95)00353-3; Choudhury L, 1997, EUR HEART J, V18, P108; Choudhury L, 1999, BASIC RES CARDIOL, V94, P49, DOI 10.1007/s003950050126; DILSIZIAN V, 1993, J AM COLL CARDIOL, V22, P796, DOI 10.1016/0735-1097(93)90193-5; Elliott PM, 1996, EUR HEART J, V17, P1056; Elliott PM, 2001, LANCET, V357, P420, DOI 10.1016/S0140-6736(00)04005-8; Elliott PM, 2000, J AM COLL CARDIOL, V36, P2212, DOI 10.1016/S0735-1097(00)01003-2; GISTRI R, 1994, AM J CARDIOL, V74, P363, DOI 10.1016/0002-9149(94)90404-9; Gnecchi-Ruscone T, 1999, MUSCLE NERVE, V22, P1549, DOI 10.1002/(SICI)1097-4598(199911)22:11<1549::AID-MUS10>3.0.CO;2-A; Krams R, 1998, CIRCULATION, V97, P230, DOI 10.1161/01.CIR.97.3.230; Lazzeroni E, 1997, CIRCULATION, V96, P4268; Lorenzoni R, 1998, AM HEART J, V136, P972, DOI 10.1016/S0002-8703(98)70152-8; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 2000, CIRCULATION, V102, P858; Maron BJ, 2000, NEW ENGL J MED, V342, P365, DOI 10.1056/NEJM200002103420601; MARON BJ, 1981, AM J CARDIOL, V48, P418, DOI 10.1016/0002-9149(81)90068-0; MARON BJ, 1986, J AM COLL CARDIOL, V8, P545, DOI 10.1016/S0735-1097(86)80181-4; Maron MS, 2003, NEW ENGL J MED, V348, P295, DOI 10.1056/NEJMoa021332; MCKENNA WJ, 1990, BRIT HEART J, V63, P287; Neglia D, 2002, CIRCULATION, V105, P186, DOI 10.1161/hc0202.102119; OGARA PT, 1987, CIRCULATION, V76, P1214, DOI 10.1161/01.CIR.76.6.1214; Olivotto I, 2003, J AM COLL CARDIOL, V41, P315, DOI 10.1016/S0735-1097(02)02713-4; Olivotto I, 2001, CIRCULATION, V104, P2517, DOI 10.1161/hc4601.097997; Rajappan K, 2002, CIRCULATION, V105, P470, DOI 10.1161/hc0402.102931; Schwartzkopff B, 1998, J AM COLL CARDIOL, V31, P1089, DOI 10.1016/S0735-1097(98)00036-9; Spirito P, 2000, NEW ENGL J MED, V342, P1778, DOI 10.1056/NEJM200006153422403; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; STAFFORD WJ, 1986, J AM COLL CARDIOL, V7, P701, DOI 10.1016/S0735-1097(86)80484-3; TANAKA M, 1986, BRIT HEART J, V55, P575; UDELSON JE, 1989, CIRCULATION, V79, P1052, DOI 10.1161/01.CIR.79.5.1052; Yoshida N, 1998, J AM COLL CARDIOL, V32, P1938, DOI 10.1016/S0735-1097(98)00498-7	36	525	548	4	17	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2003	349	11					1027	1035		10.1056/NEJMoa025050	http://dx.doi.org/10.1056/NEJMoa025050			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	719UH	12968086				2022-12-01	WOS:000185223100004
J	Han, SC; Tang, RH; Anderson, LK; Woerner, TE; Pei, ZM				Han, SC; Tang, RH; Anderson, LK; Woerner, TE; Pei, ZM			A cell surface receptor mediates extracellular Ca2+ sensing in guard cells	NATURE			English	Article							CALCIUM; ARABIDOPSIS; PLANT; OSCILLATIONS; REGULATOR; PROTEINS; CHANNEL; BINDING	Extracellular Ca2+ (Ca-o(2+)) is required for various physiological and developmental processes in animals and plants(1-3). In response to varied Ca-o(2+) levels, plants maintain relatively constant internal Ca2+ content, suggesting a precise regulatory mechanism for Ca2+ homeostasis(4). However, little is known about how plants monitor Ca-o(2+) status and whether Ca-o(2+)-sensing receptors exist. The effects of Ca-o(2+) on guard cells in promoting stomatal closure by inducing increases in the concentration of cytosolic Ca2+ ([Ca2+](i))(5-8) provide a clue to Ca-o(2+) sensing. Here we have used a functional screening assay in mammalian cells 9 to isolate an Arabidopsis complementary DNA clone encoding a Ca2+-sensing receptor, CAS. CAS is localized to the plasma membrane, exhibits low-affinity/high-capacity Ca2+ binding, and mediates Ca-o(2+)-induced [Ca2+](i) increases. CAS is expressed predominantly in the shoot, including guard cells. Repression of CAS disrupts Ca-o(2+) signalling in guard cells, and impairs bolting (swift upward growth at the transition to seed production) in response to Ca2+ deficiency, so we conclude that CAS may be a primary transducer of Ca-o(2+) in plants.	Duke Univ, Dept Biol, Dev Cell & Mol Biol Grp, Durham, NC 27708 USA; Duke Univ, Dept Chem, Durham, NC 27708 USA	Duke University; Duke University	Pei, ZM (corresponding author), Duke Univ, Dept Biol, Dev Cell & Mol Biol Grp, Durham, NC 27708 USA.	zpei@duke.edu		Pei, Zhen-Ming/0000-0003-1473-696X; Tang, Ruhang/0000-0003-4918-3525; Han, Shengcheng/0000-0002-4039-7589				Allen GJ, 2001, NATURE, V411, P1053, DOI 10.1038/35082575; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; CLARKSON DT, 1984, PLANT CELL ENVIRON, V7, P449, DOI 10.1111/j.1365-3040.1984.tb01435.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; GILROY S, 1990, NATURE, V346, P769, DOI 10.1038/346769a0; HEPLER PK, 1985, ANNU REV PLANT PHYS, V36, P397, DOI 10.1146/annurev.pp.36.060185.002145; Li X, 1999, CELL, V98, P329, DOI 10.1016/S0092-8674(00)81962-5; LONERAGAN JF, 1969, AUST J AGR RES, V20, P465, DOI 10.1071/AR9690465; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; MACROBBIE EAC, 1992, PHILOS T R SOC B, V338, P5, DOI 10.1098/rstb.1992.0124; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; MCAINSH MR, 1995, PLANT CELL, V7, P1207, DOI 10.1105/tpc.7.8.1207; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Pei ZM, 1998, P NATL ACAD SCI USA, V95, P6548, DOI 10.1073/pnas.95.11.6548; Roelfsema MRG, 2002, NEW PHYTOL, V153, P425, DOI 10.1046/j.0028-646X.2001.Documedoc.doc.x; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Sattelmacher B, 2001, NEW PHYTOL, V149, P167, DOI 10.1046/j.1469-8137.2001.00034.x; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; SCHWARTZ A, 1985, PLANT PHYSIOL, V79, P1003, DOI 10.1104/pp.79.4.1003; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Wakabayashi H, 2002, BIOCHEMISTRY-US, V41, P8485, DOI 10.1021/bi025589o	26	163	179	5	62	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 11	2003	425	6954					196	200		10.1038/nature01932	http://dx.doi.org/10.1038/nature01932			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719ZT	12968184				2022-12-01	WOS:000185236000047
J	Garrison, A				Garrison, A			Between a rock and a hard place	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUNTINGTONS-DISEASE		Duke Univ, Sch Med, Durham, NC 27706 USA	Duke University	Garrison, A (corresponding author), Duke Univ, Sch Med, Durham, NC 27706 USA.							Beauchamp T.L., 2012, PRINCIPLES BIOMEDICA; Bernstein T, 1994, RADON RENTAL HOUSING; CLOUSER KD, 1990, J MED PHILOS, V15, P219, DOI 10.1093/jmp/15.2.219; FAGOTLARGEAULT A, 1994, PRINCIPLES HLTH CARE; Feigin A, 2002, CURR OPIN NEUROL, V15, P483, DOI 10.1097/00019052-200208000-00013; Goizet C, 2002, NEUROLOGY, V59, P1330, DOI 10.1212/01.WNL.0000032255.75650.C2; Jonsen Albert., 1988, ABUSE CASUISTRY HIST; Lammers StephenE., 1998, MORAL MED THEOLOGICA; LUYNCH A, 1990, HASTINGS CENT REP, V20, P31; McAbee GN, 1998, PEDIATRICS, V102, P140, DOI 10.1542/peds.102.1.140; NICHOLSON RH, 1994, PRINCIPLES HLTH CARE; NOZICK R, 1968, NATURAL LAW FORUM, V13, P1; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1983, SCREEN COUNS GEN CON; TERRENOIRE G, 1943, J MED ETHICS, V1879, P92	14	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2003	290	9					1217	1218		10.1001/jama.290.9.1217	http://dx.doi.org/10.1001/jama.290.9.1217			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	717LK	12953008				2022-12-01	WOS:000185090400021
J	van Oijen, AM; Blainey, PC; Crampton, DJ; Richardson, CC; Ellenberger, T; Xie, XS				van Oijen, AM; Blainey, PC; Crampton, DJ; Richardson, CC; Ellenberger, T; Xie, XS			Single-molecule kinetics of lambda exonuclease reveal base dependence and dynamic disorder	SCIENCE			English	Article							DNA DIGESTION; ELASTICITY; TENSION	We used a multiplexed approach based on flow-stretched DNA to monitor the enzymatic digestion of lambda-phage DNA by individual bacteriophage lambda exonuclease molecules. Statistical analyses of multiple single-molecule trajectories observed simultaneously reveal that the catalytic rate is dependent on the local base content of the substrate DNA. By relating single-molecule kinetics to the free energies of hydrogen bonding and base stacking, we establish that the melting of a base from the DNA is the rate-limiting step in the catalytic cycle. The catalytic rate also exhibits large fluctuations independent of the sequence, which we attribute to conformational changes of the enzyme-DNA complex.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Biol Chem & Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu	van Oijen, Antoine/I-3167-2014	van Oijen, Antoine/0000-0002-1794-5161; Blainey, Paul/0000-0002-4889-8783	NIGMS NIH HHS [5R01GM61577-03, R01GM55390-07] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055390, R01GM061577] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bommarito S, 2000, NUCLEIC ACIDS RES, V28, P1929, DOI 10.1093/nar/28.9.1929; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Dapprich J, 1999, CYTOMETRY, V36, P163, DOI 10.1002/(SICI)1097-0320(19990701)36:3<163::AID-CYTO3>3.0.CO;2-R; Dickson KS, 2000, J BIOL CHEM, V275, P15828, DOI 10.1074/jbc.M910044199; Fersht A, 1999, STRUCTURE MECH PROTE; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Kool ET, 2001, ANNU REV BIOPH BIOM, V30, P1, DOI 10.1146/annurev.biophys.30.1.1; Kovall R, 1997, SCIENCE, V277, P1824, DOI 10.1126/science.277.5333.1824; Kovall RA, 1998, P NATL ACAD SCI USA, V95, P7893, DOI 10.1073/pnas.95.14.7893; Lam WC, 2002, BIOCHEMISTRY-US, V41, P3943, DOI 10.1021/bi0120603; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Matsuura S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.16.e79; Mitsis PG, 1999, NUCLEIC ACIDS RES, V27, P3057, DOI 10.1093/nar/27.15.3057; Polakowski R, 2000, J AM CHEM SOC, V122, P4853, DOI 10.1021/ja994488j; Rauch C, 2002, J MOL BIOL, V324, P491, DOI 10.1016/S0022-2836(02)01089-6; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Strick TR, 1998, BIOPHYS J, V74, P2016, DOI 10.1016/S0006-3495(98)77908-1; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Subramanian K, 2003, NUCLEIC ACIDS RES, V31, P1585, DOI 10.1093/nar/gkg266; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; Xie XS, 2002, J CHEM PHYS, V117, P11024, DOI 10.1063/1.1521159; XUE QF, 1995, NATURE, V373, P681, DOI 10.1038/373681a0; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	28	270	285	6	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2003	301	5637					1235	1238		10.1126/science.1084387	http://dx.doi.org/10.1126/science.1084387			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZC	12947199	Green Submitted			2022-12-01	WOS:000185003500042
J	Geng, Y; Yu, QY; Sicinska, E; Das, M; Schneider, JE; Bhattacharya, S; Rideout, WM; Bronson, RT; Gardner, H; Sicinski, P				Geng, Y; Yu, QY; Sicinska, E; Das, M; Schneider, JE; Bhattacharya, S; Rideout, WM; Bronson, RT; Gardner, H; Sicinski, P			Cyclin E ablation in the mouse	CELL			English	Article							MINICHROMOSOME MAINTENANCE PROTEINS; HISTONE GENE-TRANSCRIPTION; CELL-FREE SYSTEM; S-PHASE; DROSOPHILA EMBRYOGENESIS; RETINOBLASTOMA PROTEIN; DNA-REPLICATION; HUMAN CANCERS; COMPLEX; CDK2	E type cyclins (E1 and E2) are believed to drive cell entry into the S phase. It is widely assumed that the two E type cyclins are critically required for proliferation of all cell types. Here, we demonstrate that E type cyclins are largely dispensable for mouse development. However, endoreplication of trophoblast giant cells and megakaryocytes is severely impaired in the absence of cyclin E. Cyclin E-deficient cells proliferate actively under conditions of continuous cell cycling but are unable to reenter the cell cycle from the quiescent Go state. Molecular analyses revealed that cells lacking cyclin E fail to normally incorporate MCM proteins into DNA replication origins during G(0)-->S progression. We also found that cyclin E-deficient cells are relatively resistant to oncogenic transformation. These findings define a molecular function for E type cyclins in cell cycle reentry and reveal a differential requirement for cyclin E in normal versus oncogenic proliferation.	Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Oxford, Dept Cardiovasc Med, Oxford OX3 7BN, England; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Tufts Univ, Sch Vet Med, North Grafton, MA 01536 USA; Tufts Univ, Sch Vet Med, North Grafton, MA 01536 USA; Biogen Inc, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Oxford; Massachusetts Institute of Technology (MIT); Whitehead Institute; Tufts University; Tufts University; Biogen	Sicinski, P (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.		Bhattacharya, Shoumo/F-4127-2010	Bhattacharya, Shoumo/0000-0002-5571-0478	NCI NIH HHS [CA83688, CA85296] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA083688, R01CA085296] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams PD, 2001, BBA-REV CANCER, V1471, pM123, DOI 10.1016/S0304-419X(01)00019-1; Arata Y, 2000, J BIOL CHEM, V275, P6337, DOI 10.1074/jbc.275.9.6337; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; Cross JC, 2002, MOL CELL ENDOCRINOL, V187, P207, DOI 10.1016/S0303-7207(01)00703-1; Cross JC, 2000, SEMIN CELL DEV BIOL, V11, P105, DOI 10.1006/scdb.2000.0156; Donnellan R, 1999, FASEB J, V13, P773, DOI 10.1096/fasebj.13.8.773; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; DURONIO RJ, 1995, GENE DEV, V9, P1456, DOI 10.1101/gad.9.12.1456; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Fay DS, 2000, DEVELOPMENT, V127, P4049; Geisen C, 2002, J BIOL CHEM, V277, P39909, DOI 10.1074/jbc.M205919200; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; Geng Y, 2001, P NATL ACAD SCI USA, V98, P13138, DOI 10.1073/pnas.231487798; Gudas JM, 1999, MOL CELL BIOL, V19, P612; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; HOFFMANN I, 1994, EMBO J, V13, P4302, DOI 10.1002/j.1460-2075.1994.tb06750.x; Hogan B., 1986, MANIPULATING MOUSE E; Kaufman M.H., 1999, ANATOMICAL BASIS MOU; Kelly BL, 1998, P NATL ACAD SCI USA, V95, P2535, DOI 10.1073/pnas.95.5.2535; KIRBY ML, 1995, CIRC RES, V77, P211, DOI 10.1161/01.RES.77.2.211; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Kohn MJ, 2003, DEVELOPMENT, V130, P1295, DOI 10.1242/dev.00355; Krude T, 1997, CELL, V88, P109, DOI 10.1016/S0092-8674(00)81863-2; Lauper N, 1998, ONCOGENE, V17, P2637, DOI 10.1038/sj.onc.1202477; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; Madine MA, 2000, J STRUCT BIOL, V129, P198, DOI 10.1006/jsbi.2000.4218; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Morris L, 2000, NAT CELL BIOL, V2, P232, DOI 10.1038/35008660; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; SAUER K, 1995, GENE DEV, V9, P1327, DOI 10.1101/gad.9.11.1327; Schneider JE, 2003, J MOL CELL CARDIOL, V35, P217, DOI 10.1016/S0022-2828(02)00291-2; SEARLE AG, 1974, MUTAT RES, V22, P63, DOI 10.1016/0027-5107(74)90009-8; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Stoeber K, 1998, EMBO J, V17, P7219, DOI 10.1093/emboj/17.24.7219; Su TT, 1998, J CELL BIOL, V140, P451, DOI 10.1083/jcb.140.3.451; Tanaka M, 1997, DEV BIOL, V190, P55, DOI 10.1006/dbio.1997.8685; Webb S, 1998, CIRC RES, V82, P645, DOI 10.1161/01.RES.82.6.645; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417; Zariwala M, 1998, ONCOGENE, V17, P2787, DOI 10.1038/sj.onc.1202505; ZerfassThome K, 1997, MOL CELL BIOL, V17, P407, DOI 10.1128/MCB.17.1.407; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000; Zou XH, 2002, GENE DEV, V16, P2923, DOI 10.1101/gad.1033002; Zybina EV, 1996, INT REV CYTOL, V165, P53, DOI 10.1016/S0074-7696(08)62220-2	53	537	545	1	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 22	2003	114	4					431	443		10.1016/S0092-8674(03)00645-7	http://dx.doi.org/10.1016/S0092-8674(03)00645-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	714TD	12941272	Bronze			2022-12-01	WOS:000184928800007
J	Rahn, T; Eiler, JM; Boering, KA; Wennberg, PO; McCarthy, MC; Tyler, S; Schauffler, S; Donnelly, S; Atlas, E				Rahn, T; Eiler, JM; Boering, KA; Wennberg, PO; McCarthy, MC; Tyler, S; Schauffler, S; Donnelly, S; Atlas, E			Extreme deuterium enrichment in stratospheric hydrogen and the global atmospheric budget of H-2	NATURE			English	Article							LIQUEFIED PETROLEUM GAS; ISOTOPIC COMPOSITION; MOLECULAR-HYDROGEN; RATE COEFFICIENTS; AIR; TRITIUM; LEAKAGE; CARBON; IMPACT	Molecular hydrogen (H-2) is the second most abundant trace gas in the atmosphere after methane(1) (CH4). In the troposphere, the D/H ratio of H-2 is enriched by 120parts per thousand relative to the world's oceans(2-4). This cannot be explained by the sources of H-2 for which the D/H ratio has been measured to date (for example, fossil fuels and biomass burning)(5,6). But the isotopic composition of H-2 from its single largest source-the photochemical oxidation of methane-has yet to be determined. Here we show that the D/H ratio of stratospheric H-2 develops enrichments greater than 440parts per thousand, the most extreme D/H enrichment observed in a terrestrial material. We estimate the D/H ratio of H-2 produced from CH4 in the stratosphere, where production is isolated from the influences of non-photochemical sources and sinks, showing that the chain of reactions producing H-2 from CH4 concentrates D in the product H-2. This enrichment, which we estimate is similar on a global average in the troposphere, contributes substantially to the D/H ratio of tropospheric H-2.	CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; Univ Calif Irvine, Earth Syst Sci Dept, Irvine, CA 92697 USA; Natl Ctr Atmospher Res, Boulder, CO 80307 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Irvine; National Center Atmospheric Research (NCAR) - USA; California Institute of Technology	Rahn, T (corresponding author), Los Alamos Natl Lab, EES-6,MS-D462, Los Alamos, NM 87545 USA.	trahn@lanl.gov	McCarthy, Michael/E-5970-2010; Wennberg, Paul O/A-5460-2012; Atlas, Elliot/J-8171-2015; Rahn, Thom/C-5211-2012; Atlas, Elliot/AAE-4605-2021	Wennberg, Paul O/0000-0002-6126-3854; Boering, Kristie/0000-0003-0920-0503; Atlas, Elliot/0000-0003-3847-5346				BLAKE DR, 1995, SCIENCE, V269, P953, DOI 10.1126/science.269.5226.953; Boering KA, 1996, SCIENCE, V274, P1340, DOI 10.1126/science.274.5291.1340; Brasseur G., 1984, AERONOMY MIDDLE ATMO; Chen TY, 2001, GEOPHYS RES LETT, V28, P2193, DOI 10.1029/2000GL012703; DEMORE WB, 1997, CHEM KINETICS PHOTOC, P278; EHHALT D, 1963, J GEOPHYS RES, V68, P3747, DOI 10.1029/JZ068i013p03747; EHHALT DH, 1989, J GEOPHYS RES-ATMOS, V94, P9831, DOI 10.1029/JD094iD07p09831; FRIEDMAN I, 1974, J GEOPHYS RES, V79, P785, DOI 10.1029/JC079i006p00785; Gerst S, 2000, J GEOPHYS RES-ATMOS, V105, P26433, DOI 10.1029/2000JD900387; Gerst S, 2001, J GEOPHYS RES-ATMOS, V106, P5021, DOI 10.1029/2000JD900593; GONSIOR B, 1966, TELLUS, V18, P256; Hauglustaine DA, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001156; HOLTON JR, 1990, J ATMOS SCI, V47, P392, DOI 10.1175/1520-0469(1990)047<0392:OTGEOM>2.0.CO;2; Hurst DF, 1999, J GEOPHYS RES-ATMOS, V104, P8191, DOI 10.1029/1998JD100092; KHALIL MAK, 1990, NATURE, V347, P743, DOI 10.1038/347743a0; Leshin LA, 1996, GEOCHIM COSMOCHIM AC, V60, P2635, DOI 10.1016/0016-7037(96)00122-6; MOORTGAT GK, 1983, J CHEM PHYS, V78, P1185, DOI 10.1063/1.444911; NEWMAN PA, 2002, J GEOPHYS RES, V107; Novelli PC, 1999, J GEOPHYS RES-ATMOS, V104, P30427, DOI 10.1029/1999JD900788; Rahn T, 2002, GEOCHIM COSMOCHIM AC, V66, P2475, DOI 10.1016/S0016-7037(02)00858-X; Rice AL, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003042; ROBERT F, 1982, GEOCHIM COSMOCHIM AC, V46, P81, DOI 10.1016/0016-7037(82)90293-9; Saueressig G, 2001, J GEOPHYS RES-ATMOS, V106, P23127, DOI 10.1029/2000JD000120; Saueressig G, 1996, GEOPHYS RES LETT, V23, P3619, DOI 10.1029/96GL03292; SCHAUFFLER SM, 2003, J GEOPHYS RES, V108, DOI DOI 10.1029/2001JGD002040; Taatjes CA, 1999, CHEM PHYS LETT, V306, P33, DOI 10.1016/S0009-2614(99)00420-0; Talukdar RK, 1996, CHEM PHYS LETT, V253, P177, DOI 10.1016/0009-2614(96)00203-5; Talukdar RK, 1996, J PHYS CHEM-US, V100, P3037, DOI 10.1021/jp9518724	28	73	74	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2003	424	6951					918	921		10.1038/nature01917	http://dx.doi.org/10.1038/nature01917			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713EH	12931182				2022-12-01	WOS:000184843600035
J	Flanagan, JR; Johansson, RS				Flanagan, JR; Johansson, RS			Action plans used in action observation	NATURE			English	Article							GRASP REPRESENTATIONS; MAGNETIC STIMULATION; PREMOTOR CORTEX; MIRROR NEURONS; EYE-MOVEMENTS; MOTOR; IMITATION; COORDINATION; MODULATION; LOCALIZATION	How do we understand the actions of others? According to the direct matching hypothesis, action understanding results from a mechanism that maps an observed action onto motor representations of that action(1-4). Although supported by neurophysiological (1,5-13) and brain- imaging(3,14-18) studies, direct evidence for this hypothesis is sparse. In visually guided actions, task-specific proactive eye movements are crucial for planning and control (19-22). Because the eyes are free to move when observing such actions, the direct matching hypothesis predicts that subjects should produce eye movements similar to those produced when they perform the tasks. If an observer analyses action through purely visual means, however, eye movements will be linked reactively to the observed action. Here we show that when subjects observe a block stacking task, the coordination between their gaze and the actor's hand is predictive, rather than reactive, and is highly similar to the gaze-hand coordination when they perform the task themselves. These results indicate that during action observation subjects implement eye motor programs directed by motor representations of manual actions and thus provide strong evidence for the direct matching hypothesis.	Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada; Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada; Umea Univ, Dept Integrat Med Biol, Physiol Sect, SE-90187 Umea, Sweden	Queens University - Canada; Queens University - Canada; Umea University	Flanagan, JR (corresponding author), Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada.		Johansson, Roland S/A-5890-2009	Johansson, Roland S/0000-0003-3288-8326				Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Avikainen S, 2002, NEUROIMAGE, V15, P640, DOI 10.1006/nimg.2001.1029; BALLARD DH, 1995, J COGNITIVE NEUROSCI, V7, P66, DOI 10.1162/jocn.1995.7.1.66; BALLARD DH, 1992, PHILOS T R SOC B, V337, P331, DOI 10.1098/rstb.1992.0111; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2001, P NATL ACAD SCI USA, V98, P13995, DOI 10.1073/pnas.241474598; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; JOHANSSON RS, 1992, CURR OPIN NEUROBIOL, V2, P815, DOI 10.1016/0959-4388(92)90139-C; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Koski L, 2002, CEREB CORTEX, V12, P847, DOI 10.1093/cercor/12.8.847; Land M, 1999, PERCEPTION, V28, P1311, DOI 10.1068/p2935; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Land MF, 1997, PHILOS T ROY SOC B, V352, P1231, DOI 10.1098/rstb.1997.0105; Mataric MJ, 1998, COGNITIVE BRAIN RES, V7, P191, DOI 10.1016/S0926-6410(98)00025-1; Nishitani N, 2000, P NATL ACAD SCI USA, V97, P913, DOI 10.1073/pnas.97.2.913; PERRY HM, 1989, BONE MINERAL RES, V6, P113; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 1996, EXP BRAIN RES, V111, P246; Rizzolatti G, 1999, ARCH ITAL BIOL, V137, P85; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3	29	470	476	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 14	2003	424	6950					769	771		10.1038/nature01861	http://dx.doi.org/10.1038/nature01861			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12917683				2022-12-01	WOS:000184733900038
J	Kulasingam, SL; Myers, ER				Kulasingam, SL; Myers, ER			Potential health and economic impact of adding a human papillomavirus vaccine to screening programs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATYPICAL SQUAMOUS CELLS; CERVICAL-CANCER; COST-EFFECTIVENESS; NATURAL-HISTORY; FOLLOW-UP; STRATEGIES; NEOPLASIA; BENEFITS; WOMEN; ABNORMALITIES	Context Recently published results suggest that effective vaccines against cervical cancer-associated human papillomavirus (HPV) may become available within the next decade. Objective To examine the potential health and economic effects of an HPV vaccine in a setting of existing screening. Design, Setting, and Population A Markov model was used to estimate the lifetime (age 12-85 years) costs and life expectancy of a hypothetical cohort of women screened for cervical cancer in the United States. Three strategies were compared: (1) vaccination only; (2) conventional cytological screening only; and (3) vaccination followed by screening. Two of the strategies incorporated a vaccine targeted against a defined proportion of high-risk (oncogenic) HPV types. Screening intervals of 1, 2, 3, and 5 years and starting ages for screening of 18, 22, 24, 26, and 30 years were chosen for 2 of the strategies (conventional cytological screening only and vaccination followed by screening). Main Outcome Measures Incremental cost per life-year gained. Results Vaccination only or adding vaccination to screening conducted every 3 and 5 years was not cost-effective. However, at more frequent screening intervals, strategies combining vaccination and screening were preferred. Vaccination plus biennial screening delayed until age 24 years had the most attractive cost-effectiveness ratio ($44889) compared with screening only beginning at age 18 years and conducted every 3 years. However, the strategy of vaccination with annual screening beginning at age 18 years had the largest overall reduction in cancer incidence and mortality at a cost of $236250 per life-year gained compared with vaccination and annual screening beginning at age 22 years. The cost-effectiveness of vaccination plus delayed screening was highly sensitive to age of vaccination, duration of vaccine efficacy, and cost of vaccination. Conclusions Vaccination for HPV in combination with screening can be a cost-effective health intervention, but it depends on maintaining effectiveness during the ages of peak oncogenic HPV incidence. Identifying the optimal age for vaccination should be a top research priority.	Duke Univ, Ctr Clin Hlth Policy Res, Durham, NC 27705 USA; Duke Univ, Dept Obstet & Gynecol, Durham, NC 27705 USA	Duke University; Duke University	Kulasingam, SL (corresponding author), Duke Univ, Ctr Clin Hlth Policy Res, 1st Union Tower,Suite 220,2200 W Main St, Durham, NC 27705 USA.	kulas002@mc.duke.edu		Kulasingam, Shalini/0000-0002-0932-9166				ANDERSON RM, 1995, P ROY SOC B-BIOL SCI, V261, P147, DOI 10.1098/rspb.1995.0129; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Brown AD, 1999, JAMA-J AM MED ASSOC, V281, P347, DOI 10.1001/jama.281.4.347; Conaglen HM, 2001, INT J STD AIDS, V12, P651, DOI 10.1258/0956462011923877; Coste J, 2003, BMJ-BRIT MED J, V326, P733, DOI 10.1136/bmj.326.7392.733; Crum CP, 2002, NEW ENGL J MED, V347, P1702; CUZICK J, 1995, LANCET, V345, P1533, DOI 10.1016/S0140-6736(95)91086-7; EDDY DM, 1990, ANN INTERN MED, V113, P214, DOI 10.7326/0003-4819-113-3-214; FAHS MC, 1992, ANN INTERN MED, V117, P520, DOI 10.7326/0003-4819-117-6-520; Gold MR., 1996, COST EFFECTIVENESS H; Goldie SJ, 2001, JAMA-J AM MED ASSOC, V285, P3107, DOI 10.1001/jama.285.24.3107; Gustafsson L, 1997, CANCER CAUSE CONTROL, V8, P755, DOI 10.1023/A:1018435522475; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Hueston WJ, 2000, J COMMUN HEALTH, V25, P23, DOI 10.1023/A:1005136817158; Hughes JP, 2002, EPIDEMIOLOGY, V13, P631, DOI 10.1097/00001648-200211000-00006; Jacobs MV, 2000, INT J CANCER, V87, P221, DOI 10.1002/1097-0215(20000715)87:2&lt;221::AID-IJC11&gt;3.0.CO;2-2; Jones MH, 1996, J ROY SOC MED, V89, P257, DOI 10.1177/014107689608900506; Kim JJ, 2002, JAMA-J AM MED ASSOC, V287, P2382, DOI 10.1001/jama.287.18.2382; Klee M, 2000, GYNECOL ONCOL, V76, P5, DOI 10.1006/gyno.1999.5644; Koutsky LA, 2000, J NATL CANCER I, V92, P397, DOI 10.1093/jnci/92.5.397; KOUTSKY LA, 1992, NEW ENGL J MED, V327, P1272, DOI 10.1056/NEJM199210293271804; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; KULASINGAM S, 2002, 20 INT PAP C OCT 5 9; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; LEIGH BC, 1994, J ADOLESCENT HEALTH, V15, P117, DOI 10.1016/1054-139X(94)90538-X; Li CR, 1999, MATURITAS, V32, P95, DOI 10.1016/S0378-5122(99)00020-1; Liaw KL, 1999, J NATL CANCER I, V91, P954, DOI 10.1093/jnci/91.11.954; Mandelblatt JS, 2002, JAMA-J AM MED ASSOC, V287, P2372, DOI 10.1001/jama.287.18.2372; Maxwell GL, 2002, OBSTET GYNECOL, V100, P740, DOI 10.1016/S0029-7844(02)02195-6; MCCRORY DC, 1999, PUBLICATION AG HLTH; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Myers ER, 2000, OBSTET GYNECOL, V96, P645, DOI 10.1016/S0029-7844(00)00979-0; Myers ER, 2000, AM J EPIDEMIOL, V151, P1158, DOI 10.1093/oxfordjournals.aje.a010166; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; *NAT CANC I, 2000, SURV EP END RES; Obwegeser JH, 2001, ACTA CYTOL, V45, P709, DOI 10.1159/000328292; PHELPS CE, 1988, MED DECIS MAKING, V8, P279, DOI 10.1177/0272989X8800800409; Ratnam S, 2000, CANCER EPIDEM BIOMAR, V9, P945; Saslow D, 2002, CA-CANCER J CLIN, V52, P342, DOI 10.3322/canjclin.52.6.342; SherlawJohnson C, 1997, INT J CANCER, V72, P210, DOI 10.1002/(SICI)1097-0215(19970717)72:2&lt;210::AID-IJC2&gt;3.0.CO;2-U; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Stratton K.R., 2000, VACCINES 21 CENTURY; Thomas KK, 2000, J INFECT DIS, V182, P1097, DOI 10.1086/315805; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Winkelmayer WC, 2002, MED DECIS MAKING, V22, P417, DOI 10.1177/027298902236927	46	248	254	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2003	290	6					781	789		10.1001/jama.290.6.781	http://dx.doi.org/10.1001/jama.290.6.781			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	709VU	12915431	Bronze			2022-12-01	WOS:000184647700029
J	Celeste, A; Difilippantonio, S; Difilippantonio, MJ; Fernandez-Capetillo, O; Pilch, DR; Sedelnikova, OA; Eckhaus, M; Ried, T; Bonner, WM; Nussenzweig, A				Celeste, A; Difilippantonio, S; Difilippantonio, MJ; Fernandez-Capetillo, O; Pilch, DR; Sedelnikova, OA; Eckhaus, M; Ried, T; Bonner, WM; Nussenzweig, A			H2AX haploinsufficiency modifies genomic stability and tumor susceptibility	CELL			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX; CHROMOSOMAL-ABERRATIONS; HAPLO-INSUFFICIENCY; V(D)J RECOMBINATION; GENE AMPLIFICATION; DNA; MICE; P53; REPAIR	Histone H2AX becomes phosphorylated in chromatin domains flanking sites of DNA double-strand breakage associated with gamma-irradiation, meiotic recombination, DNA replication, and antigen receptor rearrangements. Here, we show that loss of a single H2AX allele compromises genomic integrity and enhances the susceptibility to cancer in the absence of p53. In comparison with heterozygotes, tumors arise earlier in the H2AX homozygous null background, and H2AX(-/-) p53(-/-) lymphomas harbor an increased frequency of clonal nonreciprocal translocations and amplifications. These include complex rearrangements that juxtapose the c-myc oncogene to antigen receptor loci. Restoration of the H2AX null allele with wild-type H2AX restores genomic stability and radiation resistance, but this effect is abolished by substitution of the conserved serine phosphorylation sites in H2AX with alanine or glutamic acid residues. Our results establish H2AX as genomic caretaker that requires the function of both gene alleles for optimal protection against tumorigenesis.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NCI, Genet Branch, NIH, Bethesda, MD 20892 USA; NIH, Vet Resources Program, Off Res Serv, Bethesda, MD 20892 USA; NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nussenzweig, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	Difilippantonio, Michael/AAF-2839-2021; Fernandez-Capetillo, Oscar/H-3508-2015	Difilippantonio, Michael/0000-0002-4676-7034; Fernandez-Capetillo, Oscar/0000-0002-2690-6885; Martin (nee Sedelnikova), Olga/0000-0003-3470-2935	Intramural NIH HHS [Z99 CA999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Agrawal A, 1997, CELL, V89, P43, DOI 10.1016/S0092-8674(00)80181-6; Alt JR, 2003, EMBO J, V22, P1442, DOI 10.1093/emboj/cdg133; Bai F, 2003, MOL CELL BIOL, V23, P1269, DOI 10.1128/MCB.23.4.1269-1277.2003; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Cook WD, 2000, ONCOGENE, V19, P3434, DOI 10.1038/sj.onc.1203653; Coquelle A, 1997, CELL, V89, P215, DOI 10.1016/S0092-8674(00)80201-9; Desiderio S, 1996, CURR TOP MICROBIOL, V217, P45; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Gladdy RA, 2003, CANCER CELL, V3, P37, DOI 10.1016/S1535-6108(02)00236-2; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Goss KH, 2002, SCIENCE, V297, P2051, DOI 10.1126/science.1074340; Gruber SB, 2002, SCIENCE, V297, P2013, DOI 10.1126/science.1074399; Guidos CJ, 1996, GENE DEV, V10, P2038, DOI 10.1101/gad.10.16.2038; Hiom K, 1998, MOL CELL, V1, P1011, DOI 10.1016/S1097-2765(00)80101-X; Inoue K, 2001, GENE DEV, V15, P2934, DOI 10.1101/gad.929901; Karanjawala ZE, 1999, CURR BIOL, V9, P1501, DOI 10.1016/S0960-9822(00)80123-2; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; KNUDSON AG, 1985, CANCER RES, V45, P1437; Lim DS, 2000, MOL CELL BIOL, V20, P3772, DOI 10.1128/MCB.20.11.3772-3780.2000; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Magee JA, 2003, CANCER CELL, V3, P273, DOI 10.1016/S1535-6108(03)00047-3; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Mak TW, 2000, NAT IMMUNOL, V1, P77, DOI 10.1038/76950; Monni O, 2001, LEUKEMIA LYMPHOMA, V40, P259, DOI 10.3109/10428190109057924; Nacht M, 1996, GENE DEV, V10, P2055, DOI 10.1101/gad.10.16.2055; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Quon KC, 2001, GENE DEV, V15, P2917, DOI 10.1101/gad.949001; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Sharpless NE, 2001, MOL CELL, V8, P1187, DOI 10.1016/S1097-2765(01)00425-7; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Stankovic T, 2002, LEUKEMIA LYMPHOMA, V43, P1563, DOI 10.1080/1042819021000002884; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Vanasse GJ, 1999, J CLIN INVEST, V103, P1669, DOI 10.1172/JCI6658; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Weaver ZA, 1999, GENE CHROMOSOME CANC, V25, P251, DOI 10.1002/(SICI)1098-2264(199907)25:3<251::AID-GCC7>3.3.CO;2-V; Xu Y, 1998, MOL CELL BIOL, V18, P4385, DOI 10.1128/MCB.18.7.4385; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	62	456	476	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2003	114	3					371	383		10.1016/S0092-8674(03)00567-1	http://dx.doi.org/10.1016/S0092-8674(03)00567-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914701	Green Accepted, Bronze			2022-12-01	WOS:000184679200013
J	Pasterkamp, RJ; Peschon, JJ; Spriggs, MK; Kolodkin, AL				Pasterkamp, RJ; Peschon, JJ; Spriggs, MK; Kolodkin, AL			Semaphorin 7A promotes axon outgrowth through integrins and MAPKs	NATURE			English	Article								Striking parallels exist between immune and nervous system cellular signalling mechanisms. Molecules originally shown to be critical for immune responses also serve neuronal functions, and similarly neural guidance cues can modulate immune function. We show here that semaphorin 7A (Sema7A), a membrane-anchored member of the semaphorin family of guidance proteins previously known for its immunomodulatory effects, can also mediate neuronal functions. Unlike many other semaphorins, which act as repulsive guidance cues, Sema7A enhances central and peripheral axon growth and is required for proper axon tract formation during embryonic development. Unexpectedly, Sema7A enhancement of axon outgrowth requires integrin receptors and activation of MAPK signalling pathways. These findings define a previously unknown biological function for semaphorins, identify an unexpected role for integrins and integrin-dependent intracellular signalling in mediating semaphorin responses, and provide a framework for understanding and interfering with Sema7A function in both immune and nervous systems.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Amgen Corp, Dept Mol Biol, Seattle, WA 98119 USA; Amgen Corp, Dept Funct Genom, Seattle, WA 98119 USA	Johns Hopkins University	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	kolodkin@jhmi.edu		Pasterkamp, Jeroen/0000-0003-1631-6440				Angelisova P, 1999, IMMUNOBIOLOGY, V200, P234, DOI 10.1016/S0171-2985(99)80073-4; Bagnard D, 1998, DEVELOPMENT, V125, P5043; BISMUTH G, 2002, SCI STKE, pRE4; BOBOLIS KA, 1992, BLOOD, V79, P1574; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; de Castro F, 1999, J NEUROSCI, V19, P4428; de Fougerolles AR, 2002, IMMUNOL REV, V186, P208, DOI 10.1034/j.1600-065X.2002.18617.x; Doherty P, 2000, MOL CELL NEUROSCI, V16, P283, DOI 10.1006/mcne.2000.0907; Frank I, 1996, AIDS, V10, P1611, DOI 10.1097/00002030-199612000-00004; Fujioka S, 2003, BIOCHEM BIOPH RES CO, V301, P304, DOI 10.1016/S0006-291X(02)03023-1; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; He Zhigang, 2002, Sci STKE, V2002, pre1, DOI 10.1126/stke.2002.119.re1; Hirata T, 1997, J NEUROBIOL, V32, P415, DOI 10.1002/(SICI)1097-4695(199704)32:4<415::AID-NEU5>3.0.CO;2-9; Holmes S, 2002, SCAND J IMMUNOL, V56, P270, DOI 10.1046/j.1365-3083.2002.01129.x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Kikutani H, 2003, NAT REV IMMUNOL, V3, P159, DOI 10.1038/nri1003; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Lange C, 1998, GENOMICS, V51, P340, DOI 10.1006/geno.1998.5256; Milner R, 2002, J NEUROSCI RES, V69, P286, DOI 10.1002/jnr.10321; Mine T, 2000, TISSUE ANTIGENS, V55, P429, DOI 10.1034/j.1399-0039.2000.550505.x; Nguyen-Ba-Charvet KT, 2002, J NEUROSCI, V22, P5473; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Pasterkamp RJ, 1998, J NEUROSCI, V18, P9962; PFAFF M, 1994, CELL ADHES COMMUN, V2, P491, DOI 10.3109/15419069409014213; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sakai T, 1999, J BIOL CHEM, V274, P29666, DOI 10.1074/jbc.274.42.29666; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SCHWOB JE, 1984, J COMP NEUROL, V223, P177, DOI 10.1002/cne.902230204; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Soussi-Yanicostas N, 2002, CELL, V109, P217, DOI 10.1016/S0092-8674(02)00713-4; Sugisaki N, 1996, J NEUROBIOL, V29, P127, DOI 10.1002/(SICI)1097-4695(199602)29:2<127::AID-NEU1>3.0.CO;2-C; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Xu XM, 1998, J BIOL CHEM, V273, P22428, DOI 10.1074/jbc.273.35.22428; Yamada A, 1999, J IMMUNOL, V162, P4094; Yip PM, 1998, MOL BIOL CELL, V9, P277, DOI 10.1091/mbc.9.2.277; Zhou XF, 2001, J NEUROSCI RES, V66, P1054, DOI 10.1002/jnr.10029; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	46	376	388	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					398	405		10.1038/nature01790	http://dx.doi.org/10.1038/nature01790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879062				2022-12-01	WOS:000184318400035
J	Muller, MM; Malinowski, P; Gruber, T; Hillyard, SA				Muller, MM; Malinowski, P; Gruber, T; Hillyard, SA			Sustained division of the attentional spotlight	NATURE			English	Article							SPATIAL SELECTIVE ATTENTION; VISUAL-EVOKED POTENTIALS; FOCAL ATTENTION; EXTRASTRIATE; ALLOCATION; LOCATIONS; STRIATE; BRAIN; SPACE; TASKS	By voluntarily directing attention to a specific region of a visual scene, we can improve our perception of stimuli at that location(1). This ability to focus attention upon specific zones of the visual field has been described metaphorically as a moveable spotlight or zoom lens that facilitates the processing of stimuli within its 'beam'(2,3). A long-standing controversy has centred on the question of whether the spotlight of spatial attention has a unitary beam or whether it can be divided flexibly to disparate locations(2,4-6). Evidence supporting the unitary spotlight view has come from numerous behavioural(3,7-10) and electrophysiological(11,12) studies. Recent experiments, however, indicate that the spotlight of spatial attention may be divided between noncontiguous zones of the visual field for very brief stimulus exposures (<100 ms)(13,14). Here we use an electrophysiological measure of attentional allocation (the steady-state visual evoked potential) to show that the spotlight may be divided between spatially separated locations (excluding interposed locations) over more extended time periods. This spotlight division appears to be accomplished at an early stage of visual-cortical processing.	Univ Leipzig, Inst Allgemeine Psychol, D-04103 Leipzig, Germany; Liverpool John Moores Univ, Sch Psychol, Liverpool L3 2ET, Merseyside, England; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Leipzig University; Liverpool John Moores University; University of Liverpool; University of California System; University of California San Diego	Muller, MM (corresponding author), Univ Leipzig, Inst Allgemeine Psychol, Seeburgstr 14-20, D-04103 Leipzig, Germany.	m.mueller@rz.uni-leipzig.de	Malinowski, Peter/A-4394-2009	Malinowski, Peter/0000-0001-5074-4508				Awh E, 2000, J EXP PSYCHOL HUMAN, V26, P834, DOI 10.1037/0096-1523.26.2.834; CASTIELLO U, 1992, J EXP PSYCHOL HUMAN, V18, P837, DOI 10.1037/0096-1523.18.3.837; Clark V.P., 1994, HUMAN BRAIN MAPPING, V2, P170, DOI [10.1002/hbm.460020306, DOI 10.1002/HBM.460020306]; Clark VP, 1996, J COGNITIVE NEUROSCI, V8, P387, DOI 10.1162/jocn.1996.8.5.387; Di Russo F, 1999, NEUROREPORT, V10, P2755; DUNCAN J, 1994, NATURE, V369, P313, DOI 10.1038/369313a0; Eimer M, 1999, PSYCHOPHYSIOLOGY, V36, P491, DOI 10.1017/S0048577299980915; ERIKSEN CW, 1985, J EXP PSYCHOL HUMAN, V11, P583, DOI 10.1037/0096-1523.11.5.583; Hahn S, 1998, VIS COGN, V5, P217, DOI 10.1080/713756781; HEINZE HJ, 1994, PERCEPT PSYCHOPHYS, V56, P42, DOI 10.3758/BF03211689; Hillyard SA, 1997, HUM BRAIN MAPP, V5, P287, DOI 10.1002/(SICI)1097-0193(1997)5:4<287::AID-HBM14>3.0.CO;2-B; KIEFER RJ, 1987, CAN J PSYCHOL, V41, P474, DOI 10.1037/h0084168; LABERGE D, 1989, PSYCHOL REV, V96, P101, DOI 10.1037/0033-295X.96.1.101; Laberge D., 1995, ATTENTIONAL PROCESSI; Martinez A, 2001, VISION RES, V41, P1437, DOI 10.1016/S0042-6989(00)00267-4; McCormick PA, 1998, J EXP PSYCHOL HUMAN, V24, P350, DOI 10.1037/0096-1523.24.1.350; Moore CM, 1996, PSYCHON B REV, V3, P360, DOI 10.3758/BF03210761; MULLER M, 1994, NATO ADV SCI INST SE, V271, P325; Muller MM, 1997, BRAIN TOPOGR, V9, P163, DOI 10.1007/BF01190385; Muller MM, 1998, COGNITIVE BRAIN RES, V6, P249, DOI 10.1016/S0926-6410(97)00036-0; Muller MM, 2002, PSYCHOL SCI, V13, P119, DOI 10.1111/1467-9280.00422; Muller MM, 1998, NAT NEUROSCI, V1, P631, DOI 10.1038/2865; PAN KY, 1993, PERCEPT PSYCHOPHYS, V53, P134, DOI 10.3758/BF03211723; Peterson MS, 2000, J GEN PSYCHOL, V127, P6, DOI 10.1080/00221300009598568; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; REEVES A, 1986, PSYCHOL REV, V93, P180, DOI 10.1037/0033-295X.93.2.180; Regan D., 1989, HUMAN BRAIN ELECTROP; SHAW ML, 1977, J EXP PSYCHOL HUMAN, V3, P201, DOI 10.1037/0096-1523.3.2.201; WEICHSELGARTNER E, 1987, SCIENCE, V238, P778, DOI 10.1126/science.3672124	30	307	309	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					309	312		10.1038/nature01812	http://dx.doi.org/10.1038/nature01812			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867981				2022-12-01	WOS:000184183900041
J	Dueber, JE; Yeh, BJ; Chak, K; Lim, WA				Dueber, JE; Yeh, BJ; Chak, K; Lim, WA			Reprogramming control of an allosteric signaling switch through modular recombination	SCIENCE			English	Article							WASP-FAMILY PROTEINS; ARP2/3 COMPLEX; SH3 DOMAINS; N-WASP; ACTIVATION; BINDING; SYSTEMS; CDC42	Many eukaryotic signaling proteins are composed of simple modular binding domains, yet they can display sophisticated behaviors such as allosteric gating and multi-input signal integration, properties essential for complex cellular circuits. To understand how such behavior can emerge from combinations of simple domains, we engineered variants of the actin regulatory protein N-WASP (neuronal Wiskott-Aldrich syndrome protein) in which the "output" domain of N-WASP was recombined with heterologous autoinhibitory "input" domains. Synthetic switch proteins were created with diverse gating behaviors in response to nonphysiological inputs. Thus, this type of modular framework can facilitate the evolution or engineering of cellular signaling circuits.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biol Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	wlim@itsa.ucsf.edu						Buck M, 2001, BIOCHEMISTRY-US, V40, P14115, DOI 10.1021/bi0157215; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lim WA, 2002, CURR OPIN STRUC BIOL, V12, P61, DOI 10.1016/S0959-440X(02)00290-7; Mayer BJ, 2001, J CELL SCI, V114, P1253; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Mullins RD, 2000, METHOD ENZYMOL, V325, P214; Mullins RD, 2000, CURR OPIN CELL BIOL, V12, P91, DOI 10.1016/S0955-0674(99)00061-7; Pawson T, 2000, GENE DEV, V14, P1027; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Zalevsky J, 2001, CURR BIOL, V11, P1903, DOI 10.1016/S0960-9822(01)00603-0; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8	18	231	240	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2003	301	5641					1904	1908		10.1126/science.1085945	http://dx.doi.org/10.1126/science.1085945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725GW	14512628				2022-12-01	WOS:000185536700050
J	Strack, B; Calistri, A; Craig, S; Popova, E; Gottlinger, HG				Strack, B; Calistri, A; Craig, S; Popova, E; Gottlinger, HG			AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding	CELL			English	Article							LATE ASSEMBLY DOMAIN; ROUS-SARCOMA-VIRUS; GAG PROTEIN; MULTIVESICULAR-BODY; SACCHAROMYCES-CEREVISIAE; PARTICLE-PRODUCTION; TERMINAL DOMAIN; ESCRT-I; UBIQUITIN; TSG101	HIV-1 and other retroviruses exit infected cells by budding from the plasma membrane, a process requiring membrane fission. The primary late assembly (L) domain in the p6 region of HIV-1 Gag mediates the detachment of the virion by recruiting host Tsg101, a component of the class E vacuolar protein sorting (Vps) machinery. We now show that HIV Gag p6 contains a second region involved in L domain function that binds AIP1, a homolog of the yeast class E Vps protein Bro1. Further, AIP1 interacts with Tsg101 and homologs of a subunit of the yeast class E Vps protein complex ESCRT-III. AIP1 also binds to the L domain in EIAV p9, and this binding correlates perfectly with L domain function. These observations identify AIP1 as a component of the viral budding machinery, which serves to link a distinct region in the L domain of HIV-1 p6 and EIAV p9 to ESCRT-III.	Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Gottlinger, HG (corresponding author), Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA.			Gottlinger, Heinrich/0000-0003-4124-5824; Calistri, Arianna/0000-0002-6881-7936; Popova, Elena/0000-0001-8470-8994	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029873, R37AI029873] Funding Source: NIH RePORTER; NIAID NIH HHS [AI29873] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Accola MA, 2000, J VIROL, V74, P5395, DOI 10.1128/JVI.74.12.5395-5402.2000; Accola MA, 1999, J VIROL, V73, P9992, DOI 10.1128/JVI.73.12.9992-9999.1999; Alexander L, 2000, J VIROL, V74, P4361, DOI 10.1128/JVI.74.9.4361-4376.2000; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Borsetti A, 1998, J VIROL, V72, P9313, DOI 10.1128/JVI.72.11.9313-9317.1998; Chatellard-Causse C, 2002, J BIOL CHEM, V277, P29108, DOI 10.1074/jbc.M204019200; Chen B, 2000, J BIOL CHEM, V275, P19275, DOI 10.1074/jbc.M908994199; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; Demirov DG, 2002, J VIROL, V76, P105, DOI 10.1128/JVI.76.1.105-117.2002; Forsberg H, 2001, GENETICS, V158, P973; Freed EO, 2002, J VIROL, V76, P4679, DOI 10.1128/JVI.76.10.4679-4687.2002; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Howard TL, 2001, J CELL SCI, V114, P2395; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Le Blanc I, 2002, J VIROL, V76, P10024, DOI 10.1128/JVI.76.19.10024-10029.2002; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; PARENT LJ, 1995, J VIROL, V69, P5455, DOI 10.1128/JVI.69.9.5455-5460.1995; Puffer BA, 1998, J VIROL, V72, P10218, DOI 10.1128/JVI.72.12.10218-10221.1998; Puffer BA, 1997, J VIROL, V71, P6541, DOI 10.1128/JVI.71.9.6541-6546.1997; Springael JY, 2002, FEBS LETT, V517, P103, DOI 10.1016/S0014-5793(02)02586-3; Strack B, 2002, J VIROL, V76, P5472, DOI 10.1128/JVI.76.11.5472-5479.2002; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Vincent O, 2003, MOL CELL BIOL, V23, P1647, DOI 10.1128/MCB.23.5.1647-1655.2003; Vito P, 1999, J BIOL CHEM, V274, P1533, DOI 10.1074/jbc.274.3.1533; Vogt VM, 2000, P NATL ACAD SCI USA, V97, P12945, DOI 10.1073/pnas.97.24.12945; WILLS JW, 1994, J VIROL, V68, P6605, DOI 10.1128/JVI.68.10.6605-6618.1994; Xiang Y, 1996, J VIROL, V70, P5695, DOI 10.1128/JVI.70.8.5695-5700.1996; Yasuda J, 1998, J VIROL, V72, P4095, DOI 10.1128/JVI.72.5.4095-4103.1998; Yuan B, 1999, EMBO J, V18, P4700, DOI 10.1093/emboj/18.17.4700; Yuan B, 2000, J VIROL, V74, P7250, DOI 10.1128/JVI.74.16.7250-7260.2000	40	634	650	2	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 19	2003	114	6					689	699		10.1016/S0092-8674(03)00653-6	http://dx.doi.org/10.1016/S0092-8674(03)00653-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	724AL	14505569	Bronze			2022-12-01	WOS:000185464000007
J	Kaufman, AJ; Xiao, SH				Kaufman, AJ; Xiao, SH			High CO2 levels in the Proterozoic atmosphere estimated from analyses of individual microfossils	NATURE			English	Article							CARBON ISOTOPIC COMPOSITION; GROWTH-RATE	Solar luminosity on the early Earth was significantly lower than today. Therefore, solar luminosity models suggest that, in the atmosphere of the early Earth, the concentration of greenhouse gases such as carbon dioxide and methane must have been much higher(1,2). However, empirical estimates of Proterozoic levels of atmospheric carbon dioxide concentrations have not hitherto been available. Here we present ion microprobe analyses of the carbon isotopes in individual organic-walled microfossils extracted from a Proterozoic (similar to1.4-gigayear-old) shale in North China. Calculated magnitudes of the carbon isotope fractionation in these large, morphologically complex microfossils suggest elevated levels of carbon dioxide in the ancient atmosphere-between 10 and 200 times the present atmospheric level. Our results indicate that carbon dioxide was an important greenhouse gas during periods of lower solar luminosity, probably dominating over methane after the atmosphere and hydrosphere became pervasively oxygenated between 2 and 2.2 gigayears ago.	Univ Maryland, Dept Geol, College Pk, MD 20742 USA; Tulane Univ, Dept Earth & Environm Sci, New Orleans, LA 70118 USA	University System of Maryland; University of Maryland College Park; Tulane University	Kaufman, AJ (corresponding author), Univ Maryland, Dept Geol, College Pk, MD 20742 USA.	kaufman@geol.umd.edu; xiao@vt.edu	Xiao, Shuhai/A-2190-2009	Xiao, Shuhai/0000-0003-4655-2663				Bidigare RR, 1999, GLOBAL BIOGEOCHEM CY, V13, P251, DOI 10.1029/1998GB900011; Brasier MD, 1998, GEOLOGY, V26, P555, DOI 10.1130/0091-7613(1998)026<0555:ABYOES>2.3.CO;2; Cristy SS, 2000, PRACT SPECTROSC SERI, V23, P159; Farquhar J, 1999, EARTH PLANET SC LETT, V171, P607, DOI 10.1016/S0012-821X(99)00177-6; GROTZINGER JP, 1993, J GEOL, V101, P235, DOI 10.1086/648218; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Hayes JM, 1999, CHEM GEOL, V161, P103, DOI 10.1016/S0009-2541(99)00083-2; Holland H. D., 1994, EARLY LIFE EARTH, V84, P237; House CH, 2000, GEOLOGY, V28, P707, DOI 10.1130/0091-7613(2000)28<707:CICOIP>2.0.CO;2; Javaux EJ, 2001, NATURE, V412, P66, DOI 10.1038/35083562; Karhu JA, 1996, GEOLOGY, V24, P867, DOI 10.1130/0091-7613(1996)024<0867:CIATRO>2.3.CO;2; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; KNOLL AH, 1984, J PALEONTOL, V58, P131; Laws EA, 1997, LIMNOL OCEANOGR, V42, P1552, DOI 10.4319/lo.1997.42.7.1552; LAWS EA, 1995, GEOCHIM COSMOCHIM AC, V59, P1131, DOI 10.1016/0016-7037(95)00030-4; Pavlov AA, 2003, GEOLOGY, V31, P87, DOI 10.1130/0091-7613(2003)031<0087:MRPA>2.0.CO;2; Popp BN, 1998, GEOCHIM COSMOCHIM AC, V62, P69, DOI 10.1016/S0016-7037(97)00333-5; RYE R, 1995, NATURE, V378, P603, DOI 10.1038/378603a0; Schulz HN, 1999, SCIENCE, V284, P493, DOI 10.1126/science.284.5413.493; SHIVELY JM, 1991, VARIATIONS AUTOTROPH, P1; Ueno Y, 2001, INT GEOL REV, V43, P196, DOI 10.1080/00206810109465008; Xiao SH, 1997, PRECAMBRIAN RES, V84, P197, DOI 10.1016/S0301-9268(97)00029-6	22	124	137	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2003	425	6955					279	282		10.1038/nature01902	http://dx.doi.org/10.1038/nature01902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722JA	13679912				2022-12-01	WOS:000185370900040
J	Sheppard, CRC				Sheppard, CRC			Predicted recurrences of mass coral mortality in the Indian Ocean	NATURE			English	Article							REEFS; RECOVERY; FUTURE; EVENT	In 1998, more than 90% of shallow corals were killed on most Indian Ocean reefs(1). High sea surface temperature (SST) was a primary cause(2,3), acting directly or by interacting with other factors(3-7). Mean SSTs have been forecast to rise above the 1998 values in a few decades(2,3); however, forecast SSTs rarely flow seamlessly from historical data, or may show erroneous seasonal oscillations, precluding an accurate prediction of when lethal SSTs will recur. Differential acclimation by corals in different places complicates this further(3,7,8). Here I scale forecast SSTs at 33 Indian Ocean sites where most shallow corals died in 1998 (ref. 1) to identify geographical patterns in the timing of probable repeat occurrences. Reefs located 10-15degrees south will be affected every 5 years by 2010-2025. North and south from this, dates recede in a pattern not directly related to present SSTs; paradoxically, some of the warmest sites may be affected last. Temperatures lethal to corals vary in this region by 6degreesC, and acclimation of a modest 2degreesC by corals could prolong their survival by nearly 100 years.	Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Sheppard, CRC (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.			sheppard, charles/0000-0002-2579-5124				CESAR HSJ, 2000, EC CORAL REEFS, P244; Cubasch U., 2001, PROJECTIONS FUTURE C, P525; Douglas AE, 2003, MAR POLLUT BULL, V46, P385, DOI 10.1016/S0025-326X(03)00037-7; Gates RD, 1999, AM ZOOL, V39, P30; Harrison P.L., 1990, CORAL REEFS, V25, P133; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; LINDEN O, 2002, CORAL REEF DEGRADATI, P284; McAvaney BJ, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P471; McClanahan TR, 2000, MAR POLLUT BULL, V40, P587, DOI 10.1016/S0025-326X(00)00064-3; Nakamura T, 2001, MAR ECOL PROG SER, V212, P301, DOI 10.3354/meps212301; Pittock AB, 1999, AM ZOOL, V39, P10; RAYNER NA, IN PRESS J GEOPHYS R; Riegl B, 2002, MAR BIOL, V140, P29, DOI 10.1007/s002270100676; Sheppard C, 2002, MAR POLLUT BULL, V44, P303, DOI 10.1016/S0025-326X(02)00059-0; Sheppard C, 2001, MAR POLLUT BULL, V42, P1199, DOI 10.1016/S0025-326X(01)00238-7; Sheppard Charles, 2002, Aquatic Ecosystem Health & Management, V5, P395, DOI 10.1080/14634980290002020; SHEPPARD CRC, 1988, J NAT HIST, V22, P263, DOI 10.1080/00222938800770201; Sheppard CRC, 2002, AMBIO, V31, P40, DOI 10.1639/0044-7447(2002)031[0040:EVROCR]2.0.CO;2; SHEPPARD CRC, 1991, FAUNA SAUDI ARABIA, V12, P7; Spencer T, 2000, MAR POLLUT BULL, V40, P569, DOI 10.1016/S0025-326X(00)00026-6; Turner J., 2000, CORAL REEF DEGRADATI, P94; Veron JEN, 2000, CORALS WORLD, V1-3; Wilkinson C, 1999, AMBIO, V28, P188; WILKINSON C, 2000, SEAS MILLENNIUM ENV, V3, P43	24	272	287	6	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 18	2003	425	6955					294	297		10.1038/nature01987	http://dx.doi.org/10.1038/nature01987			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722JA	13679917				2022-12-01	WOS:000185370900045
J	Buchner, DA; Trudeau, M; Meisler, MH				Buchner, DA; Trudeau, M; Meisler, MH			SCNM1, a putative RNA splicing factor that modifies disease severity in mice	SCIENCE			English	Article							SODIUM-CHANNEL SCN8A; MOUSE; MUTATION; GENES; IDENTIFICATION; NA(V)1.6; PROTEINS; ALLELES; ABSENCE; SNRNP	The severity of many inherited disorders is influenced by genetic background. We describe a modifier interaction in C57BL/6J mice that converts a chronic movement disorder into a lethal neurological disease. The primary mutation (med(J)) changes a splice donor site of the sodium channel gene Scn8a (Na(v) 1.6). The modifier mutation is characteristic of strain C57BL/6J and introduces a nonsense codon into sodium channel modifier 1 (SCNM1), a zinc finger protein and a putative splice factor. An internally deleted SCNM1 protein is also predicted as a result of exon skipping associated with disruption of a consensus exonic splicing enhancer. The effect of the modifier mutation is to reduce the abundance of correctly spliced sodium channel transcripts below the threshold for survival. Our finding that genetic variation in a putative RNA splicing factor influences disease susceptibility in mice raises the possibility that a similar mechanism modifies the severity of human inherited disorders.	Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Meisler, MH (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA.	meislerm@umich.edu		Buchner, David/0000-0003-3920-4871	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544, R01GM024872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000011] Funding Source: NIH RePORTER; NHGRI NIH HHS [T32 HG00040] Funding Source: Medline; NIDCD NIH HHS [T32 DC00011] Funding Source: Medline; NIGMS NIH HHS [T32 GM07544, GM24872] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1931, INBORN FACTORS DIS E; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Bedford MT, 1998, P NATL ACAD SCI USA, V95, P10602, DOI 10.1073/pnas.95.18.10602; BUCHNER DA, IN PRESS GENOMICS; BURGESS DL, 1995, NAT GENET, V10, P461, DOI 10.1038/ng0895-461; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Christophe D, 2000, CELL SIGNAL, V12, P337, DOI 10.1016/S0898-6568(00)00077-2; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Cryns K, 2002, GENOME RES, V12, P613, DOI 10.1101/gr.218402; Du HS, 2002, NATURE, V419, P86, DOI 10.1038/nature00947; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Haywood MEK, 2000, ARTHRITIS RHEUM, V43, P349, DOI 10.1002/1529-0131(200002)43:2<349::AID-ANR14>3.0.CO;2-M; Kearney JA, 2002, HUM MOL GENET, V11, P2765, DOI 10.1093/hmg/11.22.2765; Kohrman DC, 1996, J BIOL CHEM, V271, P17576, DOI 10.1074/jbc.271.29.17576; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Meisler MH, 2001, NEUROSCIENTIST, V7, P136, DOI 10.1177/107385840100700208; Miki R, 2001, P NATL ACAD SCI USA, V98, P2199, DOI 10.1073/pnas.041605498; Nadeau JH, 2003, CURR OPIN GENET DEV, V13, P290, DOI 10.1016/S0959-437X(03)00061-3; Nesic D, 2001, MOL CELL BIOL, V21, P6406, DOI 10.1128/MCB.21.19.6406-6417.2001; Nissim-Rafinia M, 2002, TRENDS GENET, V18, P123, DOI 10.1016/S0168-9525(01)02619-1; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Slavotinek A, 2003, HUM MOL GENET, V12, pR45, DOI 10.1093/hmg/ddg099; Sprunger LK, 1999, HUM MOL GENET, V8, P471, DOI 10.1093/hmg/8.3.471; Stoilov P, 2002, DNA CELL BIOL, V21, P803, DOI 10.1089/104454902320908450; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Tarantino LM, 1998, ALCOHOL CLIN EXP RES, V22, P1099	29	96	100	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2003	301	5635					967	969		10.1126/science.1086187	http://dx.doi.org/10.1126/science.1086187			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711RY	12920299				2022-12-01	WOS:000184755900040
J	Bassing, CH; Suh, H; Ferguson, DO; Chua, KF; Manis, J; Eckersdorff, M; Gleason, M; Bronson, R; Lee, C; Alt, FW				Bassing, CH; Suh, H; Ferguson, DO; Chua, KF; Manis, J; Eckersdorff, M; Gleason, M; Bronson, R; Lee, C; Alt, FW			Histone H2AX: A dosage-dependent suppressor of oncogenic translocations and tumors	CELL			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE CHECKPOINT; GENOMIC INSTABILITY; V(D)J RECOMBINATION; GENE AMPLIFICATION; THYMIC LYMPHOMA; PATHOGENIC ROLE; MICE; 53BP1; ATM	We employed gene targeting to study H2AX, a histone variant phosphorylated in chromatin surrounding DNA double-strand breaks. Mice deficient for both H2AX and p53 ((HP-/-)-P-Delta/Delta) rapidly developed immature T and B lymphomas and solid tumors. Moreover, H2AX haploinsufficiency caused genomic instability in normal cells and, on a p53-deficient background, early onset of various tumors including more mature B lymphomas. Most H2AX(Delta/Delta)p53(-/-) or H2AX(+/Delta) p53(-/-) B lineage lymphomas harbored chromosome 12 (IgH)/15 (c-myc) translocations with hallmarks of either aberrant V(D)J or class switch recombination. In contrast, H2AX(Delta/Delta)p53(-/-) thymic lymphomas had clonal translocations that did not involve antigen receptor loci and which likely occurred during cellular expansion. Thus, H2AX helps prevent aberrant repair of both programmed and general DNA breakage and, thereby, functions as a dosage-dependent suppressor of genomic instability and tumors in mice. Notably, H2AX maps to a cytogenetic region frequently altered in human cancers, possibily implicating similar functions in man.	Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst,Dept Genet, Boston, MA 02115 USA; Ctr Blood Res, Boston, MA 02115 USA; Tufts Univ, Sch Vet Med, North Grafton, MA 01536 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cytogenet, Boston, MA 02155 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02155 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Tufts University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Alt, FW (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst,Dept Genet, Boston, MA 02115 USA.				NATIONAL CANCER INSTITUTE [P01CA092625] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL067580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035714] Funding Source: NIH RePORTER; NCI NIH HHS [CA92625] Funding Source: Medline; NHLBI NIH HHS [K08 HL67580-03] Funding Source: Medline; NIAID NIH HHS [AI35714] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson G, 1999, IMMUNOL TODAY, V20, P463, DOI 10.1016/S0167-5699(99)01524-8; Bachelier R, 2003, ONCOGENE, V22, P528, DOI 10.1038/sj.onc.1206208; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bosco G, 1998, GENETICS, V150, P1037; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; CHERIF D, 1994, LEUKEMIA, V8, P578; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Fodde R, 2002, SCIENCE, V298, P761, DOI 10.1126/science.1077707; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Gladdy RA, 2003, CANCER CELL, V3, P37, DOI 10.1016/S1535-6108(02)00236-2; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Jack MT, 2002, P NATL ACAD SCI USA, V99, P9825, DOI 10.1073/pnas.152053599; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Liao MJ, 1998, MOL CELL BIOL, V18, P3495, DOI 10.1128/MCB.18.6.3495; Liyanage M, 2000, BLOOD, V96, P1940, DOI 10.1182/blood.V96.5.1940.h8001940_1940_1946; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Mak TW, 2000, NAT IMMUNOL, V1, P77, DOI 10.1038/76950; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Monteiro ANA, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.4.e51; NOTTENBURG C, 1987, J IMMUNOL, V139, P1718; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schaffner C, 1999, BLOOD, V94, P748, DOI 10.1182/blood.V94.2.748.414k02_748_753; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stilgenbauer S, 1999, BLOOD, V94, P3262, DOI 10.1182/blood.V94.9.3262.421a33_3262_3264; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	53	410	421	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 8	2003	114	3					359	370		10.1016/S0092-8674(03)00566-X	http://dx.doi.org/10.1016/S0092-8674(03)00566-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914700	Bronze			2022-12-01	WOS:000184679200012
J	Li, Z; Hannigan, M; Mo, ZC; Liu, B; Lu, W; Wu, Y; Smrcka, AV; Wu, GQ; Li, L; Liu, MY; Huang, CK; Wu, DQ				Li, Z; Hannigan, M; Mo, ZC; Liu, B; Lu, W; Wu, Y; Smrcka, AV; Wu, GQ; Li, L; Liu, MY; Huang, CK; Wu, DQ			Directional sensing requires G beta gamma-mediated PAK1 and PIX alpha-dependent activation of cdc42	CELL			English	Article							NUCLEOTIDE EXCHANGE FACTOR; ADAPTER PROTEIN NCK; P21-ACTIVATED KINASES; SIGNALING PATHWAYS; MEMBRANE LOCALIZATION; HUMAN NEUTROPHILS; MAMMALIAN-CELLS; LIPID PRODUCTS; RHO-GTPASES; CHEMOTAXIS	Efficient chemotaxis requires directional sensing and cell polarization. We describe a signaling mechanism involving Gbetagamma, PAK-associated guanine nucleotide exchange factor (PIXalpha), Cdc42, and p21-activated kinase (PAK) 1. This pathway is utilized by chemoattractants to regulate directional sensing and directional migration of myeloid cells. Our results suggest that Gbetagamma binds PAKI and, via PAK-associated PIXa, activates Cdc42, which in turn activates PAK1. Thus, in this pathway, PAKII is not only an effector for Cdc42, but it also functions as a scaffold protein required for Cdc42 activation. This Gbetagamma-PAK1/PIXalpha/Cdc42 pathway is essential for the localization of F-actin formation to the leading edge, the exclusion of PTEN from the leading edge, directional sensing, and the persistent directional migration of chemotactic leukocytes. Although ligand-induced production Of PIP3 is not required for activation of this pathway, PIP3 appears to localize the activation of Cdc42 by the pathway.	Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; Texas A&M Univ, Syst Hlth Sci Ctr, Alkek Inst Biosci & Technol, Dept Med Biochem & Genet, Houston, TX 77030 USA; Univ Connecticut, Ctr Hlth, Dept Pathol, Farmington, CT 06030 USA; Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; Vanderbilt Univ, Dept Med Med Genet, Nashville, TN 37232 USA; Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	University of Connecticut; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Connecticut; University of Rochester; Vanderbilt University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wu, DQ (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA.	dwu@neuron.uchc.edu		Liu, Mingyao/0000-0001-7339-5048				Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bokoch GM, 2000, IMMUNOL RES, V21, P139, DOI 10.1385/IR:21:2-3:139; Bourne HR, 2002, NATURE, V419, P21, DOI 10.1038/419021a; Butty AC, 1998, SCIENCE, V282, P1511, DOI 10.1126/science.282.5393.1511; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; Chung CY, 1999, J CELL BIOL, V147, P559, DOI 10.1083/jcb.147.3.559; Daniels RH, 1999, TRENDS BIOCHEM SCI, V24, P350, DOI 10.1016/S0968-0004(99)01442-5; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; Dharmawardhane S, 1999, J LEUKOCYTE BIOL, V66, P521, DOI 10.1002/jlb.66.3.521; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feng QY, 2002, J BIOL CHEM, V277, P5644, DOI 10.1074/jbc.M107704200; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Hannigan M, 2002, P NATL ACAD SCI USA, V99, P3603, DOI 10.1073/pnas.052010699; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; HUANG CK, 1991, J LEUKOCYTE BIOL, V49, P158, DOI 10.1002/jlb.49.2.158; Huang RY, 1998, MOL CELL BIOL, V18, P7130, DOI 10.1128/MCB.18.12.7130; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Leeuw T, 1998, NATURE, V391, P191, DOI 10.1038/34448; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Lim L, 1996, EUR J BIOCHEM, V242, P171, DOI 10.1111/j.1432-1033.1996.0171r.x; Lu WG, 1999, ONCOGENE, V18, P797, DOI 10.1038/sj.onc.1202361; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.immunol.12.1.593; Nern A, 1999, J CELL BIOL, V144, P1187, DOI 10.1083/jcb.144.6.1187; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Wang J, 1999, J BIOL CHEM, V274, P31641, DOI 10.1074/jbc.274.44.31641; Wang YJ, 2001, CANCER LETT, V164, P69, DOI 10.1016/S0304-3835(00)00723-0; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153; ZIGMOND SH, 1988, METHOD ENZYMOL, V162, P65	50	319	322	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2003	114	2					215	227		10.1016/S0092-8674(03)00559-2	http://dx.doi.org/10.1016/S0092-8674(03)00559-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887923	Bronze			2022-12-01	WOS:000184378700011
J	Xu, JS; Wang, F; Van Keymeulen, A; Herzmark, P; Straight, A; Kelly, K; Takuwa, Y; Sugimoto, N; Mitchison, T; Bourne, HR				Xu, JS; Wang, F; Van Keymeulen, A; Herzmark, P; Straight, A; Kelly, K; Takuwa, Y; Sugimoto, N; Mitchison, T; Bourne, HR			Divergent signals and cytoskeletal assemblies regulate self-organizing polarity in neutrophils	CELL			English	Article							BIOLOGICAL PATTERN FORMATION; BINDING PROTEIN-RHO; CELL POLARITY; LYSOPHOSPHATIDIC ACID; FOCAL ADHESIONS; CULTURED-CELLS; DISTINCT ROLES; LEADING-EDGE; P115 RHOGEF; CHEMOTAXIS	Like neutrophilic leukocytes, differentiated HL-60 cells respond to chemoattractant by adopting a polarized morphology, with F-actin in a protruding pseudopod at the leading edge and contractile actin-myosin complexes at the back and sides. Experiments with pharmacological inhibitors, toxins, and mutant proteins show that this polarity depends on divergent, opposing "frontness" and "backness" signals generated by different receptor-activated trimeric G proteins. Frontness depends upon Gi-mediated production of X-phosphoinositol lipids (PI3Ps), the activated form of Rac, a small GTPase, and F-actin. G12 and G13 trigger backness signals, including activation of a second GTPase (Rho), a Rho-dependent kinase, and myosin If. Functional incompatibility causes the two resulting actin assemblies to aggregate into separate domains, making the leading edge more sensitive to attractant than the back. The latter effect explains both the neutrophil's ability to polarize in uniform concentrations of chemoattractant and its response to reversal of an attractant gradient by performing a U-turn.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Free Univ Brussels, Inst Rech Interdisciplinaire Biol Humaine & Mol, B-1070 Brussels, Belgium; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; NCI, Ctr Canc Res, Cell & Canc Biol Branch, NIH, Bethesda, MD 20892 USA; Kanazawa Univ, Dept Physiol, Kanazawa, Ishikawa 9208640, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Kanazawa University	Bourne, HR (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	bourne@cmp.ucsf.edu	Sugimoto, Naotoshi/C-4739-2015; Wang, Fei/A-7968-2013	Sugimoto, Naotoshi/0000-0003-1995-5002; Straight, Aaron/0000-0001-5885-7881	NHLBI NIH HHS [HL07713] Funding Source: Medline; NIGMS NIH HHS [GM 27810] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Cassimeris L, 1990, Semin Cell Biol, V1, P125; Chung CY, 1999, J CELL BIOL, V147, P559, DOI 10.1083/jcb.147.3.559; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; DOWNEY GP, 1994, CURR OPIN IMMUNOL, V6, P113, DOI 10.1016/0952-7915(94)90042-6; Eddy RJ, 2000, J CELL SCI, V113, P1287; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Firtel RA, 2000, CURR OPIN GENET DEV, V10, P421, DOI 10.1016/S0959-437X(00)00107-6; Fishburn CS, 2000, P NATL ACAD SCI USA, V97, P1085, DOI 10.1073/pnas.97.3.1085; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Gohla A, 1998, J BIOL CHEM, V273, P4653, DOI 10.1074/jbc.273.8.4653; GOLDMAN DW, 1985, J EXP MED, V162, P145, DOI 10.1084/jem.162.1.145; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hauert AB, 2002, INT J BIOCHEM CELL B, V34, P838, DOI 10.1016/S1357-2725(02)00010-9; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Just I, 1996, J BIOL CHEM, V271, P10149, DOI 10.1074/jbc.271.17.10149; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; KELLER HU, 1993, CELL MOTIL CYTOSKEL, V25, P10, DOI 10.1002/cm.970250103; Kirschner M, 2000, CELL, V100, P79, DOI 10.1016/S0092-8674(00)81685-2; KOLEGA J, 1986, J CELL BIOL, V102, P1400, DOI 10.1083/jcb.102.4.1400; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; MAUPIN P, 1994, J CELL SCI, V107, P3077; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; MEINHARDT H, 1974, J CELL SCI, V15, P321; Niggli V, 2000, FEBS LETT, V473, P217, DOI 10.1016/S0014-5793(00)01534-9; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2001, J CELL SCI, V114, P2713; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Sah VP, 1996, J BIOL CHEM, V271, P31185, DOI 10.1074/jbc.271.49.31185; Sehr P, 1998, BIOCHEMISTRY-US, V37, P5296, DOI 10.1021/bi972592c; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Seveau S, 2001, MOL BIOL CELL, V12, P3550, DOI 10.1091/mbc.12.11.3550; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; SHEFCYK J, 1985, BIOCHEM BIOPH RES CO, V126, P1174, DOI 10.1016/0006-291X(85)90309-2; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sugimoto N, 2003, MOL CELL BIOL, V23, P1534, DOI 10.1128/MCB.23.5.1534-1545.2003; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; VLAHOS CJ, 1995, J IMMUNOL, V154, P2413; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Ward Y, 2002, J CELL BIOL, V157, P291, DOI 10.1083/jcb.200111026; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; WESSELS D, 1988, DEV BIOL, V128, P164, DOI 10.1016/0012-1606(88)90279-5; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; ZIGMOND SH, 1981, J CELL BIOL, V89, P585, DOI 10.1083/jcb.89.3.585	67	542	550	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2003	114	2					201	214		10.1016/S0092-8674(03)00555-5	http://dx.doi.org/10.1016/S0092-8674(03)00555-5			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887922	Bronze			2022-12-01	WOS:000184378700010
J	Bellaby, P				Bellaby, P			Communication and miscommunication of risk: understanding UK parents' attitudes to combined MMR vaccination	BRITISH MEDICAL JOURNAL			English	Article							CREUTZFELDT-JAKOB-DISEASE; RUBELLA VACCINE; TREND ANALYSIS; MEASLES; MUMPS; IMMUNIZATION; CHILDREN; ENGLAND; AUTISM; POLICY	In this article on the public perception of risks Paul Bellaby considers three examples of risks to children in the UK-an insignificant risk (autism caused by MMR vaccine), a real but probably small risk (vCJD from BSE), and a real and demonstrably larger risk (injuries from road crashes) and contrasts the perceptions of the risks by parents.	Univ Salford, Inst Publ Hlth Res & Policy, Salford M5 4QA, Greater Manches, England	University of Salford	Bellaby, P (corresponding author), Univ Salford, Inst Publ Hlth Res & Policy, Salford M5 4QA, Greater Manches, England.							Adams J, 1998, INTERDISCIPL SCI REV, V23, P146; Bartlett DMC, 1998, CRIME LAW SOCIAL CH, V30, P237, DOI 10.1023/A:1008386621333; BEDFORD H, 2003, BMJ-BRIT MED J, V326, P718; BOBO JK, 1993, PEDIATRICS, V91, P308; Boulianne N, 2003, CAN J PUBLIC HEALTH, V94, P218, DOI 10.1007/BF03405070; Brown P, 2001, EMERG INFECT DIS, V7, P6, DOI 10.3201/eid0701.010102; Cousens S, 2003, STAT METHODS MED RES, V12, P235, DOI 10.1191/0962280203sm332ra; DiGuiseppi C, 1997, BRIT MED J, V314, P710, DOI 10.1136/bmj.314.7082.710; Durbach N, 2000, SOC HIST MED, V13, P45, DOI 10.1093/shm/13.1.45; Evans M, 2001, BRIT J GEN PRACT, V51, P904; Ghani AC, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-4; Hennock EP, 1998, SOC HIST MED, V11, P49, DOI 10.1093/shm/11.1.49; HILLMAN M, 1990, ONE FALSE MOVE STUDY; Huxley RR, 2000, BRIT J NUTR, V84, P247, DOI 10.1017/S0007114500001483; Kaye JA, 2001, BRIT MED J, V322, P460, DOI 10.1136/bmj.322.7284.460; Lutwick SM, 2000, PEDIATR CLIN N AM, V47, P427, DOI 10.1016/S0031-3955(05)70215-7; Marks Lara, 1996, METROPOLITAN MATERNI; Middleton E, 2003, BMJ-BRIT MED J, V326, P854, DOI 10.1136/bmj.326.7394.854; Mullany L, 2003, AM J MANAG CARE, V9, pS23; *OFF NAT STAT, 2003, ANN ABSTR STAT; Petrovic M, 2001, BRIT MED J, V322, P82, DOI 10.1136/bmj.322.7278.82; Ramsay ME, 2002, BRIT J GEN PRACT, V52, P912; *SCI MED CTR, 2002, MMR LEARN LESS; Szreter S., 1988, SOC HIST MED, V1, P1, DOI [https://doi.org/10.1093/shm/1.1.1, DOI 10.1093/SHM/1.1.1]; Taylor B, 2002, BRIT MED J, V324, P393, DOI 10.1136/bmj.324.7334.393; Vernon JG, 2003, BRIT J GEN PRACT, V53, P399; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; 2003, INDEPENDENT     0731, P16; 2003, INDEPENDENT     0731, P4	29	64	64	0	24	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 27	2003	327	7417					725	728		10.1136/bmj.327.7417.725	http://dx.doi.org/10.1136/bmj.327.7417.725			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	728FZ	14512482	Green Published			2022-12-01	WOS:000185708300022
J	Jackson, H; Hubbard, R				Jackson, H; Hubbard, R			Detecting chronic obstructive pulmonary disease using peak flow rate: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article									City Hosp Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG5 1PB, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital	Hubbard, R (corresponding author), City Hosp Nottingham, Div Epidemiol & Publ Hlth, Hucknall Rd, Nottingham NG5 1PB, England.							ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; British Medical Association, 2003, INV GEN PRACT NEW GE; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Nolan D, 1999, THORAX, V54, P468, DOI 10.1136/thx.54.5.468d; [No title captured], DOI DOI 10.1136/THX.52.2008.S1]	5	56	57	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 20	2003	327	7416					653	654		10.1136/bmj.327.7416.653	http://dx.doi.org/10.1136/bmj.327.7416.653			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724AC	14500437	Green Published, Bronze			2022-12-01	WOS:000185463100021
J	Koekkoek, SKE; Hulscher, HC; Dortland, BR; Hensbroek, RA; Elgersma, Y; Ruigrok, TJH; De Zeeuw, CI				Koekkoek, SKE; Hulscher, HC; Dortland, BR; Hensbroek, RA; Elgersma, Y; Ruigrok, TJH; De Zeeuw, CI			Cerebellar LTD and learning-dependent timing of conditioned eyelid responses	SCIENCE			English	Article							LONG-TERM DEPRESSION; KINASE-C INHIBITOR; MUTANT MICE; VESTIBULOOCULAR REFLEX; EXPRESSION; ADAPTATION	Mammals can be trained to make a conditioned movement at a precise time, which is correlated to the interval between the conditioned stimulus and unconditioned stimulus during the learning. This learning-dependent timing has been shown to depend on an intact cerebellar cortex, but which cellular process is responsible for this form of learning remains to be demonstrated. Here, we show that protein kinase C-dependent long-term depression in Purkinje cells is necessary for learning-dependent timing of Pavlovian-conditioned eyeblink responses.	Erasmus MC, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	De Zeeuw, CI (corresponding author), Erasmus MC, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands.	c.dezeeuw@erasmusmc.nl	Elgersma, Ype/F-5164-2013	Elgersma, Ype/0000-0002-3758-1297				AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; BUONOMANO DV, 1994, NEURAL COMPUT, V6, P38, DOI 10.1162/neco.1994.6.1.38; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Gao WC, 2003, J NEUROSCI, V23, P1859; Garcia KS, 1998, NEUROPHARMACOLOGY, V37, P471, DOI 10.1016/S0028-3908(98)00055-0; Garcia KS, 1999, J NEUROSCI, V19, P10940, DOI 10.1523/JNEUROSCI.19-24-10940.1999; Goossens J, 2001, J NEUROSCI, V21, P5813, DOI 10.1523/JNEUROSCI.21-15-05813.2001; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.neuro.12.1.85; Kistler WM, 2003, CEREBELLUM, V2, P44, DOI 10.1080/14734220309426; Koekkoek SKE, 2002, J NEUROPHYSIOL, V88, P2124, DOI 10.1152/jn.2002.88.4.2124; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; Miyata M, 2001, EUR J NEUROSCI, V13, P1945, DOI 10.1046/j.0953-816x.2001.01570.x; PERRETT SP, 1993, J NEUROSCI, V13, P1708; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; van Alphen AM, 2002, EUR J NEUROSCI, V16, P486, DOI 10.1046/j.1460-9568.2002.02094.x; Yeo CH, 1998, TRENDS COGN SCI, V2, P322, DOI 10.1016/S1364-6613(98)01219-4	18	213	219	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2003	301	5640					1736	1739		10.1126/science.1088383	http://dx.doi.org/10.1126/science.1088383			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722QN	14500987				2022-12-01	WOS:000185387700049
J	Thornton, JW; Need, E; Crews, D				Thornton, JW; Need, E; Crews, D			Resurrecting the ancestral steroid receptor: Ancient origin of estrogen signaling	SCIENCE			English	Article							REPRODUCTIVE-SYSTEM; OCTOPUS-VULGARIS; EVOLUTION; MECHANISMS; INDUCTION; BINDING; GENOME; FEMALE; GENE	Receptors for sex and adrenal steroid hormones are absent from fully sequenced invertebrate genomes and have not been recovered from other invertebrates. Here we report the isolation of an estrogen receptor ortholog from the mollusk Aplysia californica and the reconstruction, synthesis, and experimental characterization of functional domains of the ancestral protein from which all extant steroid receptors (SRs) evolved. Our findings indicate that SRs are extremely ancient and widespread, having diversified from a primordial gene before the origin of bilaterally symmetric animals, and that this ancient receptor had estrogen receptor - like functionality. This gene was lost in the lineage leading to arthropods and nematodes and became independent of hormone regulation in the Aplysia lineage.	Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA; Univ Texas, Sect Integrat Biol, Austin, TX 78712 USA	University of Oregon; University of Texas System; University of Texas Austin	Thornton, JW (corresponding author), Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA.	joet@uoregon.edu	Thornton, Joseph/GSN-4190-2022		PHS HHS [41770] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Baker ME, 2003, BIOESSAYS, V25, P396, DOI 10.1002/bies.10252; Bentley P., 1998, COMP VERTEBRATE ENDO; Benton MJ, 2003, SCIENCE, V300, P1698, DOI 10.1126/science.1077795; Berrevoets CA, 1998, MOL ENDOCRINOL, V12, P1172, DOI 10.1210/me.12.8.1172; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Di Cosmo A, 2002, MOL REPROD DEV, V61, P367, DOI 10.1002/mrd.10014; Di Cosmo A, 2001, J EXP ZOOL, V289, P33, DOI 10.1002/1097-010X(20010101/31)289:1<33::AID-JEZ4>3.0.CO;2-A; Escriva H, 1997, P NATL ACAD SCI USA, V94, P6803, DOI 10.1073/pnas.94.13.6803; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; GREEN S, 1987, NATURE, V325, P75, DOI 10.1038/325075a0; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; MAGLICH JM, 2001, GENOME BIOL, V2; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Oberdorster E, 2002, MAR ENVIRON RES, V54, P715, DOI 10.1016/S0141-1136(02)00118-6; Peterson KJ, 2001, EVOL DEV, V3, P170, DOI 10.1046/j.1525-142x.2001.003003170.x; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; *US EPA, 2003, END DISR SCREEN TEST; ZILLIACUS J, 1994, P NATL ACAD SCI USA, V91, P4175, DOI 10.1073/pnas.91.10.4175	19	485	507	6	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2003	301	5640					1714	1717		10.1126/science.1086185	http://dx.doi.org/10.1126/science.1086185			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722QN	14500980				2022-12-01	WOS:000185387700042
J	Cook, D; Rocker, G; Marshall, J; Sjokvist, P; Dodek, P; Griffith, L; Freitag, A; Varon, J; Bradley, C; Levy, M; Finfer, S; Hamielec, C; McMullin, J; Weaver, B; Walter, S; Guyatt, G				Cook, D; Rocker, G; Marshall, J; Sjokvist, P; Dodek, P; Griffith, L; Freitag, A; Varon, J; Bradley, C; Levy, M; Finfer, S; Hamielec, C; McMullin, J; Weaver, B; Walter, S; Guyatt, G		Level Care Study Investigators; Canadian Critical Care Trials Grp	Withdrawal of mechanical ventilation in anticipation of death in the intensive care unit	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LIFE-SUSTAINING TREATMENTS; CRITICALLY ILL; CARDIOPULMONARY-RESUSCITATION; DECISION-MAKING; SUPPORT; PHYSICIAN; PREFERENCES; END; DIRECTIVES; HOSPITALS	BACKGROUND: In critically ill patients who are receiving mechanical ventilation, the factors associated with physicians' decisions to withdraw ventilation in anticipation of death are unclear. The objective of this study was to examine the clinical determinants that were associated with the withdrawal of mechanical ventilation. METHODS: We studied adults who were receiving mechanical ventilation in 15 intensive care units, recording base-line physiological characteristics, daily Multiple Organ Dysfunction Scores, the patient's decision-making ability, the type of life support administered, the use of do-not-resuscitate orders, the physician's prediction of the patient's status, and the physician's perceptions of the patient's preferences about the use of life support. We examined the relation between these factors and withdrawal of mechanical ventilation, using Cox proportional-hazards regression analysis. RESULTS: Of 851 patients who were receiving mechanical ventilation, 539 (63.3 percent) were successfully weaned, 146 (17.2 percent) died while receiving mechanical ventilation, and 166 (19.5 percent) had mechanical ventilation withdrawn. The need for inotropes or vasopressors was associated with withdrawal of the ventilator (hazard ratio, 1.78; 95 percent confidence interval, 1.20 to 2.66; P=0.004), as were the physician's prediction that the patient's likelihood of survival in the intensive care unit was less than 10 percent (hazard ratio, 3.49; 95 percent confidence interval, 1.39 to 8.79; P=0.002), the physician's prediction that future cognitive function would be severely impaired (hazard ratio, 2.51; 95 percent confidence interval, 1.28 to 4.94; P=0.04), and the physician's perception that the patient did not want life support used (hazard ratio, 4.19; 95 percent confidence interval, 2.57 to 6.81; P<0.001). CONCLUSIONS: Rather than age or the severity of the illness and organ dysfunction, the strongest determinants of the withdrawal of ventilation in critically ill patients were the physician's perception that the patient preferred not to use life support, the physician's predictions of a low likelihood of survival in the intensive care unit and a high likelihood of poor cognitive function, and the use of inotropes or vasopressors.	McMaster Univ, Dept Med, Hamilton, ON, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; Dalhousie Univ, Dept Med, Halifax, NS, Canada; Univ Toronto, Dept Surg, Toronto, ON, Canada; Huddinge Univ, Dept Anesthesia & Intens Care, Stockholm, Sweden; Univ British Columbia, Program Crit Care Med, Vancouver, BC V5Z 1M9, Canada; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Brown Univ, Dept Med, Providence, RI 02912 USA; Univ Sydney, Royal N Shore Hosp, Intens Therapy Unit, Sydney, NSW 2006, Australia; Toronto Hosp, Toronto, ON M5T 2S8, Canada; London Hlth Sci Ctr, London, ON, Canada; Hamilton Hlth Sci Ctr, Hamilton, ON, Canada	McMaster University; McMaster University; Dalhousie University; University of Toronto; University of British Columbia; Baylor College of Medicine; Brown University; Royal North Shore Hospital; University of Sydney; University of Toronto; University Toronto Affiliates; University Health Network Toronto; London Health Sciences Centre; McMaster University	Cook, D (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.		Varon, Joseph/R-5198-2019; Walter, Stephen/AAB-5548-2022; Varon, Joseph/T-9481-2019	Walter, Stephen/0000-0003-4157-8928; Finfer, Simon/0000-0002-2785-5864; Varon, Joseph/0000-0002-7622-9974				Asch DA, 1996, MED CARE, V34, P103, DOI 10.1097/00005650-199602000-00002; CHRISTAKIS NA, 1993, LANCET, V342, P642, DOI 10.1016/0140-6736(93)91759-F; CHRISTAKIS NA, 1995, J GEN INTERN MED, V10, P491, DOI 10.1007/BF02602399; COOK DJ, 1995, JAMA-J AM MED ASSOC, V273, P703, DOI 10.1001/jama.273.9.703; Cook DJ, 2001, LANCET, V358, P1941, DOI 10.1016/S0140-6736(01)06960-4; DANIS M, 1994, ANN INTERN MED, V120, P567, DOI 10.7326/0003-4819-120-7-199404010-00006; DETSKY AS, 1981, NEW ENGL J MED, V305, P667, DOI 10.1056/NEJM198109173051204; EMANUEL EJ, 1992, JAMA-J AM MED ASSOC, V267, P2221, DOI 10.1001/jama.267.16.2221; Esteban A, 2001, INTENS CARE MED, V27, P1744, DOI 10.1007/s00134-001-1111-7; FaberLangendoen K, 1996, ARCH INTERN MED, V156, P2130, DOI 10.1001/archinte.156.18.2130; FABERLANGENDOEN K, 1994, CHEST, V106, P880, DOI 10.1378/chest.106.3.880; FABERLANGENDOEN K, 1992, CRIT CARE MED, V20, P570, DOI 10.1097/00003246-199205000-00005; Ferrand E, 2001, LANCET, V357, P9, DOI 10.1016/S0140-6736(00)03564-9; Hall RI, 2000, CHEST, V118, P1424, DOI 10.1378/chest.118.5.1424; Hamel Mary Beth, 1995, JAMA (Journal of the American Medical Association), V273, P1842, DOI 10.1001/jama.273.23.1842; JAYES RL, 1993, JAMA-J AM MED ASSOC, V270, P2213, DOI 10.1001/jama.270.18.2213; Kalbfleisch JD., 2002, STAT ANAL FAILURE TI, V2, DOI [10.1002/9781118032985, DOI 10.1016/0197-2456(81)90009-X]; Kaplan SH, 1996, ANN INTERN MED, V124, P497, DOI 10.7326/0003-4819-124-5-199603010-00007; Keenan SP, 1998, CRIT CARE MED, V26, P245, DOI 10.1097/00003246-199802000-00018; Keenan SP, 1997, CRIT CARE MED, V25, P1324, DOI 10.1097/00003246-199708000-00019; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LANKEN PN, 1991, ANN INTERN MED, V115, P478; LEE DKP, 1994, JAMA-J AM MED ASSOC, V271, P1358, DOI 10.1001/jama.271.17.1358; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; McLean RF, 2000, CRIT CARE MED, V28, P100, DOI 10.1097/00003246-200001000-00016; MORRISON RS, 1995, JAMA-J AM MED ASSOC, V274, P478, DOI 10.1001/jama.274.6.478; Novack DH, 1997, JAMA-J AM MED ASSOC, V278, P502, DOI 10.1001/jama.278.6.502; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; Prendergast TJ, 1997, AM J RESP CRIT CARE, V155, P15, DOI 10.1164/ajrccm.155.1.9001282; Quill TE, 1996, ANN INTERN MED, V125, P763, DOI 10.7326/0003-4819-125-9-199611010-00010; SLOMKA J, 1992, SOC SCI MED, V35, P251, DOI 10.1016/0277-9536(92)90021-H; SMEDIRA NG, 1990, NEW ENGL J MED, V322, P309, DOI 10.1056/NEJM199002013220506; Smucker WD, 2000, MED DECIS MAKING, V20, P271, DOI 10.1177/0272989X0002000303; TENO JM, 1995, J GEN INTERN MED, V10, P179, DOI 10.1007/BF02600252; Vincent JL, 1999, CRIT CARE MED, V27, P1626, DOI 10.1097/00003246-199908000-00042; WOOD GG, 1995, CAN J ANAESTH, V42, P186, DOI 10.1007/BF03010673	36	298	304	0	19	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2003	349	12					1123	1132		10.1056/NEJMoa030083	http://dx.doi.org/10.1056/NEJMoa030083			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722HQ	13679526				2022-12-01	WOS:000185369700005
J	Manisty, C; Waxman, J				Manisty, C; Waxman, J			For and against - Doctors should not discuss resuscitation with terminally ill patients - For	BRITISH MEDICAL JOURNAL			English	Article							CARDIAC-ARREST; CANCER		Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Canc Med, London W12 0NN, England	Imperial College London	Waxman, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Canc Med, Hammersmith Campus, London W12 0NN, England.		Manisty, Charlotte/AAN-3723-2021	Manisty, Charlotte/0000-0003-0245-7090				BMA Resuscitation Council UK and Royal College of Nursing, DEC REL CARD RES; Ewer MS, 2001, CANCER, V92, P1905, DOI 10.1002/1097-0142(20011001)92:7<1905::AID-CNCR1708>3.0.CO;2-6; Haidet P, 1998, AM J MED, V105, P222, DOI 10.1016/S0002-9343(98)00242-3; Varon J, 1998, RESUSCITATION, V36, P165, DOI 10.1016/S0300-9572(98)00015-X	4	20	21	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 13	2003	327	7415					614	615		10.1136/bmj.327.7415.614	http://dx.doi.org/10.1136/bmj.327.7415.614			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722CW	12969934	Green Published			2022-12-01	WOS:000185358700030
J	Bunce, M; Worthy, TH; Ford, T; Hoppitt, W; Willerslev, E; Drummond, A; Cooper, A				Bunce, M; Worthy, TH; Ford, T; Hoppitt, W; Willerslev, E; Drummond, A; Cooper, A			Extreme reversed sexual size dimorphism in the extinct New Zealand moa Dinornis	NATURE			English	Article							DNA; SEQUENCES; EVOLUTION	The ratite moa(Aves; Dinornithiformes) were massive graviportal browsers weighing up to 250 kg (ref. 1) that dominated the New Zealand biota until their extinction approximately 500 yr ago. Despite an extensive Quaternary fossil record, moa taxonomy remains problematic(1-4) and currently 11 species are recognized. Three Dinornis species were found throughout New Zealand and differed markedly in size(1-2 m height at back) and mass (from similar to34 to 242 kg)(1). Surprisingly, ancient mitochondrial DNA sequences show that the three species were genetically indistinguishable within each island, but formed separate North and South Island clades. Here we show, using the first sex-linked nuclear sequences from an extinct species, that on each island the three morphological forms actually represent just one species, whose size varied markedly according to sex and habitat. The largest females in this example of extreme reversed sexual size dimorphism were about 280% the weight and 150% the height of the largest males, which is unprecedented among birds and terrestrial mammals. The combination of molecular and palaeontological data highlights the difficulties of analysing extinct groups, even those with detailed fossil records.	Univ Oxford, Dept Zool, Henry Wellcome Ancient Biomol Ctr, Oxford OX1 3PS, England; Palaeofaunal Surveys, Masterton, New Zealand; Univ Copenhagen, Inst Zool, Dept Evolutionary Biol, DK-2100 Copenhagen, Denmark; Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Oxford; University of Copenhagen; University of Oxford	Cooper, A (corresponding author), Univ Oxford, Dept Zool, Henry Wellcome Ancient Biomol Ctr, S Parks Rd, Oxford OX1 3PS, England.	alan.cooper@zoo.ox.ac.uk	Hoppitt, William/A-8216-2008; Worthy, Trevor/B-3781-2012; Drummond, Alexei J/A-3209-2010; Willerslev, Eske/AAA-5686-2019; Cooper, Alan/E-8171-2012; Willerslev, Eske/A-9619-2011	Hoppitt, William/0000-0003-0815-5720; Worthy, Trevor/0000-0001-7047-4680; Drummond, Alexei J/0000-0003-4454-2576; Cooper, Alan/0000-0002-7738-7851; Willerslev, Eske/0000-0002-7081-6748; Ford, Tom/0000-0002-1131-8335; Bunce, Michael/0000-0002-0302-4206				Andersson Malte, 1994; Archey G., 1941, Bull Aukland Inst Mus, Vno. 1, P1; ATKINSON IAE, 1989, NEW ZEAL J ECOL, V12, P67; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; BERTRAM B.C.R., 1979, P 17 INT ORN C S ALT, P890; Cooper A, 2000, SCIENCE, V289, P1139; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; CRACRAFT J, 1976, Paleobiology, V2, P166; Davies S.J.J.F., 2002, RATITES TINAMOUS; Drummond AJ, 2002, GENETICS, V161, P1307; Greenwood AD, 1999, MOL BIOL EVOL, V16, P1466, DOI 10.1093/oxfordjournals.molbev.a026058; HJELMQVIST L, 1995, FEBS LETT, V367, P306, DOI 10.1016/0014-5793(95)00554-M; Hutton FW, 1892, T P NZ I, V24, P93; Huynen L, 2002, MOL ECOL, V11, P851, DOI 10.1046/j.1365-294X.2002.01483.x; LEWIS KB, 1994, MAR GEOL, V116, P293, DOI 10.1016/0025-3227(94)90047-7; MARCHANG M, 1990, HDB AUSTR NZ ANTARCT; Oliver W. R. B., 1949, Dominion Mus. Bull. Wellington N.Z., V15, P1; Owen, 1879, MEMOIRS EXTINCT WING; Owen R, 1840, P ZOOL SOC LOND, VVII, P169, DOI [10.1080/00222934009496800, DOI 10.1080/00222934009496800]; Shetty S, 1999, CHROMOSOME RES, V7, P289, DOI 10.1023/A:1009278914829; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; WORTHY T H, 1987, National Museum of New Zealand Records, V3, P59; WORTHY TH, 1994, NEW ZEAL J ZOOL, V21, P113, DOI 10.1080/03014223.1994.9517981; Worthy TH, 2002, LOST WORLD MOA	24	135	143	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2003	425	6954					172	175		10.1038/nature01871	http://dx.doi.org/10.1038/nature01871			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719ZT	12968178				2022-12-01	WOS:000185236000040
J	Vestergaard, P; Mosekilde, L				Vestergaard, P; Mosekilde, L			Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM; FOLLOW-UP; RISK; MORBIDITY; SURVIVAL; TRIAL; DEATH	Objectives To assess the effects of surgery compared with conservative treatment (no surgery) for primary hyperparathyroidism. Design Cohort study. Setting Nationwide Danish cohort. Participants 3213 patients, mean age 61 (SD 16) years, with a diagnosis of primary hyperparathyroidism between 1980 and 1999. 1934 (60%) underwent surgery and 1279 (40%) were treated conservatively. Main outcome measures Occurrence of fractures, osteoporosis, kidney or urinary tract stones, acute myocardial infarction, angina pectoris, cardiac arrhythmias, arterial hypertension, heart failure, stroke, acute pancreatitis, stomach or duodenal ulcers, muscle pain, malignant diseases, psychiatric disorders, and mortality. Results At diagnosis of primary hyperparathyroidism, patients who subsequently underwent surgery had a lower prevalence of previous fracture (odds ratio 0.64, 95% confidence interval 0.51 to 0.80), acute myocardial infarction (0.59, 0.42 to 0.83), stroke (0.57, 0.37 to 0.88), psychiatric disorders (0.54, 0.31 to 0.94), and painful muscle disorders (0.44, 0.26 to 0.76), whereas kidney stones (2.49, 1.93 to 3.23) and acute pancreatitis (2.77, 1.33 to 5.76) were more prevalent. After diagnosis, the risks of fractures (hazards ratio 0.69, 0.56 to 0.84) and gastric ulcers (0.59, 0.41 to 0.84) were lower in patients treated surgically than those treated conservatively. Events involving kidney or urinary tact stones were more prevalent in patients treated surgically than patients treated conservatively (1.87, 1.30 to 2.68). Mortality was lower in patients treated surgically (0.65, 0.57 to 0.73). Conclusions Patients treated surgically for primary hyperparathyroidism have a lower prevalence of fractures and gastric ulcers than patients treated conservatively. The type of treatment had no effect on the occurrence of cardiovascular events.	Aarhus Univ Hosp, Aarhus Kommune Hosp, Dept Endocrinol & Metab C, DK-8000 Aarhus, Denmark	Aarhus University	Vestergaard, P (corresponding author), Aarhus Kommune Hosp, Osteoporosis Clin, Tage Hansens Gade 2, DK-8000 Aarhus C, Denmark.	p-vest@post4.tele.dk						Andersen TF, 1999, DAN MED BULL, V46, P263; Bilezikian JP, 2002, J BONE MINER RES, V17, pN2; *CAN BUR STAT, 1998, STAT YB 1998; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christiansen P, 1999, BONE, V25, P589, DOI 10.1016/S8756-3282(99)00207-0; DANIELS J, 1983, AM J MED, V75, P17, DOI 10.1016/0002-9343(83)91162-2; HEATH H, 1980, NEW ENGL J MED, V302, P189, DOI 10.1056/NEJM198001243020402; Hedback G, 1998, EUR J CLIN INVEST, V28, P271; HEDBACK G, 1991, WORLD J SURG, V15, P399, DOI 10.1007/BF01658740; Jurgensen H J, 1984, Ugeskr Laeger, V146, P3303; Leifsson BG, 1996, J CLIN ENDOCR METAB, V81, P2149, DOI 10.1210/jc.81.6.2149; MADSEN M, 1990, Ugeskrift for Laeger, V152, P308; Mollerup CL, 2002, BMJ-BRIT MED J, V325, P807, DOI 10.1136/bmj.325.7368.807; Mosbech J, 1995, Ugeskr Laeger, V157, P3741; PALMER M, 1987, SURGERY, V102, P1; PALOYAN D, 1982, AM SURGEON, V48, P366; Rao D, 2000, J BONE MINER RES, V15, pS164; ROBERTS WC, 1981, AM J MED, V71, P371, DOI 10.1016/0002-9343(81)90163-7; SANCHO JJ, 1992, WORLD J SURG, V16, P732, DOI 10.1007/BF02067371; Soreide JA, 1997, SURGERY, V122, P1117, DOI 10.1016/S0039-6060(97)90216-6; Stefenelli T, 1997, SURGERY, V121, P157, DOI 10.1016/S0039-6060(97)90285-3; Talpos GB, 2000, SURGERY, V128, P1013, DOI 10.1067/msy.2000.110844; Vestergaard P, 2000, BRIT MED J, V321, P598, DOI 10.1136/bmj.321.7261.598; Wermers RA, 1997, ANN INTERN MED, V126, P433, DOI 10.7326/0003-4819-126-6-199703150-00003	24	103	107	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2003	327	7414					530	533		10.1136/bmj.327.7414.530	http://dx.doi.org/10.1136/bmj.327.7414.530			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720WW	12958111	Green Published, Bronze			2022-12-01	WOS:000185283700016
J	Gibbons, DL; Erk, I; Reilly, B; Navaza, J; Kielian, M; Rey, FA; Lepault, J				Gibbons, DL; Erk, I; Reilly, B; Navaza, J; Kielian, M; Rey, FA; Lepault, J			Visualization of the target-membrane-inserted fusion protein of Semliki Forest virus by combined electron microscopy and crystallography	CELL			English	Article							BORNE ENCEPHALITIS-VIRUS; CELL-CELL FUSION; INFLUENZA HEMAGGLUTININ; CHOLESTEROL DEPENDENCE; ENVELOPE GLYCOPROTEIN; CONFORMATIONAL-CHANGE; LOW-PH; BINDING; ENTRY; ACTIVATION	Semliki Forest virus enters cells by receptor-mediated endocytosis. The acidic environment of the endosome triggers a membrane fusion reaction that is mediated by the E1 glycoprotein. During fusion, E1 rearranges from an E1/E2 heterodimer to a highly stable, membrane-inserted E1 homotrimer (E1HT). In this study, we analyzed E1HT by a combination of electron cryomicroscopy, electron crystallography of negatively stained 2D crystals, and fitting of the available X-ray structure of the monomeric E1 ectodomain into the resulting 3D reconstruction. The visualized E1HT reveals that the ectodomain has reoriented vertically and inserted the distal tip of domain II into the lipid bilayer. Our data allow the visualization of a viral fusion protein inserted in its target membrane and demonstrate that insertion is a cooperative process, resulting in rings composed of five to six homotrimers.	Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; CNRS, INRA, UMR 2472 1157, F-91198 Gif Sur Yvette, France	Yeshiva University; Albert Einstein College of Medicine; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Kielian, M (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	kielian@aecom.yu.edu; mem-vms@gv.cnrs-gif.fr	Lepault, Jean/AAN-8859-2020; Rey, Felix/B-6497-2012	Kielian, Margaret/0000-0002-7395-4791; Rey, Felix/0000-0002-9953-7988	NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052929, T32GM007288] Funding Source: NIH RePORTER; NCI NIH HHS [P30-CA13330] Funding Source: Medline; NIGMS NIH HHS [R01 GM52929, T32 GM07288] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn A, 2002, J VIROL, V76, P3267, DOI 10.1128/JVI.76.7.3267-3275.2002; AMOS LA, 1983, PROG BIOPHYS MOL BIO, V39, P183, DOI 10.1016/0079-6107(83)90017-2; Blumenthal R, 2003, CHEM REV, V103, P53, DOI 10.1021/cr000036+; Blumenthal R, 1996, J CELL BIOL, V135, P63, DOI 10.1083/jcb.135.1.63; Chatterjee PK, 2002, J VIROL, V76, P12712, DOI 10.1128/JVI.76.24.12712-12722.2002; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Danieli T, 1996, J CELL BIOL, V133, P559, DOI 10.1083/jcb.133.3.559; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; GAROFF H, 1980, NATURE, V288, P236, DOI 10.1038/288236a0; Gaudin Y, 1996, J VIROL, V70, P7371, DOI 10.1128/JVI.70.11.7371-7378.1996; Gibbons DL, 2000, J VIROL, V74, P7772, DOI 10.1128/JVI.74.17.7772-7780.2000; Gibbons DL, 2002, J VIROL, V76, P1194, DOI 10.1128/JVI.76.3.1194-1205.2002; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; HARTER C, 1989, J BIOL CHEM, V264, P6459; HELENIUS A, 1977, J CELL BIOL, V75, P866, DOI 10.1083/jcb.75.3.866; HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404; HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; KAARIAINEN L, 1969, ANN MED EXP BIOL FEN, V47, P235; Kanaseki T, 1997, J CELL BIOL, V137, P1041, DOI 10.1083/jcb.137.5.1041; Kielian M, 1996, J CELL BIOL, V134, P863, DOI 10.1083/jcb.134.4.863; Kielian M, 2000, Subcell Biochem, V34, P409; KIELIAN M, 1985, J CELL BIOL, V101, P2284, DOI 10.1083/jcb.101.6.2284; KLIMJACK MR, 1994, J VIROL, V68, P6940, DOI 10.1128/JVI.68.11.6940-6946.1994; LEPAULT J, 1983, J MICROSC-OXFORD, V129, P89, DOI 10.1111/j.1365-2818.1983.tb04163.x; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; Markovic I, 2001, J CELL BIOL, V155, P833, DOI 10.1083/jcb.200103005; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Pletnev SV, 2001, CELL, V105, P127, DOI 10.1016/S0092-8674(01)00302-6; Plonsky I, 1996, J CELL BIOL, V135, P1831, DOI 10.1083/jcb.135.6.1831; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Roche S, 2002, VIROLOGY, V297, P128, DOI 10.1006/viro.2002.1429; SCHLESINGER S, 2001, FIELDS VIROLOGY, P895; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stiasny K, 2001, J VIROL, V75, P7392, DOI 10.1128/JVI.75.16.7392-7398.2001; Vashishtha M, 1998, J CELL BIOL, V140, P91, DOI 10.1083/jcb.140.1.91; WAHLBERG JM, 1992, J VIROL, V66, P7309, DOI 10.1128/JVI.66.12.7309-7318.1992; Weissenhorn W, 1999, MOL MEMBR BIOL, V16, P3, DOI 10.1080/096876899294706; Wengler G, 1999, VIROLOGY, V257, P472, DOI 10.1006/viro.1999.9661; WILSCHUT J, 1995, MOL MEMBR BIOL, V12, P143, DOI 10.3109/09687689509038510; Yeager M, 1999, Methods Enzymol, V294, P135; Zhang W, 2002, J VIROL, V76, P11645, DOI 10.1128/JVI.76.22.11645-11658.2002	45	91	91	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2003	114	5					573	583		10.1016/S0092-8674(03)00683-4	http://dx.doi.org/10.1016/S0092-8674(03)00683-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	719FN	13678581	Bronze			2022-12-01	WOS:000185193100007
J	Rueness, EK; Stenseth, NC; O'Donoghue, M; Boutin, S; Ellegren, H; Jakobsen, KS				Rueness, EK; Stenseth, NC; O'Donoghue, M; Boutin, S; Ellegren, H; Jakobsen, KS			Ecological and genetic spatial structuring in the Canadian lynx	NATURE			English	Article							CLADISTIC-ANALYSIS; SNOWSHOE HARE; GEOGRAPHICAL-DISTRIBUTION; PHENOTYPIC ASSOCIATIONS; POPULATION-DYNAMICS; HAPLOTYPES; DISPERSAL; SPECIATION; PATTERNS; PROGRAM	The Canadian lynx, distributed all across the northern part of North America, is well known for its regular population cycles-cycles that have different underlying structures in different parts of Canada(1). Using both nuclear and mitochondrial DNA markers, we report here a close resemblance between the earlier observed spatial ecological structuring of the Canadian lynx(1) and its spatial genetic structuring. Specifically, we demonstrate that the Rocky Mountains represent a barrier to gene flow in western Canada, and, somewhat surprisingly, we detect the presence of a geographically invisible barrier south of Hudson Bay (coinciding with the separation between the ecological Continental and Atlantic regions(1)). No evidence for isolation in different glacial refugia within North America was found. We suggest that ecological factors underlying the spatial dynamic structuring also strongly influence the genetic structuring of the Canadian lynx.	Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, N-0315 Oslo, Norway; Yukon Dept Environm, Fish & Wildlife Branch, Mayo, YT Y0B 1M0, Canada; Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; Uppsala Univ, Dept Evolutionary Biol, SE-75236 Uppsala, Sweden	University of Oslo; University of Alberta; Uppsala University	Stenseth, NC (corresponding author), Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, POB 1031 Blindern, N-0315 Oslo, Norway.		Boutin, Stan A/A-2619-2014; Stenseth, Nils Chr./G-5212-2016	Boutin, Stan A/0000-0001-6317-038X; Stenseth, Nils Chr./0000-0002-1591-5399				Avise JC, 2000, PHYLOGEOGRAPHY HIST; Burton C, 2002, MOL ECOL, V11, P1689, DOI 10.1046/j.1365-294X.2002.01566.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dawson AG, 1992, ICE AGE EARTH LATE Q; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Elton C, 1942, J ANIM ECOL, V11, P215, DOI 10.2307/1358; Fedorov VB, 2002, P ROY SOC B-BIOL SCI, V269, P2071, DOI 10.1098/rspb.2002.2126; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; JANCZEWSKI DN, 1995, MOL BIOL EVOL, V12, P690; Krebs C.J., 2001, ECOSYSTEM DYNAMICS B; KREBS CJ, 1995, SCIENCE, V269, P1112, DOI 10.1126/science.269.5227.1112; Kurtun B., 1980, PLEISTOCENE MAMMALS; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Mowat G, 1998, CAN FIELD NAT, V112, P32; Mowat Garth, 2000, P265; Poole KG, 1997, J WILDLIFE MANAGE, V61, P497, DOI 10.2307/3802607; Posada D, 2000, MOL ECOL, V9, P487, DOI 10.1046/j.1365-294x.2000.00887.x; Ranta E, 1997, ECOGRAPHY, V20, P454, DOI 10.1111/j.1600-0587.1997.tb00412.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; Schneider S., 2000, ARLEQUIN SOFTWARE PO; Schwartz MK, 2002, NATURE, V415, P520, DOI 10.1038/415520a; Slough BG, 1996, J WILDLIFE MANAGE, V60, P946, DOI 10.2307/3802397; Stenseth NC, 1999, SCIENCE, V285, P1071, DOI 10.1126/science.285.5430.1071; Stenseth NC, 1997, P NATL ACAD SCI USA, V94, P5147, DOI 10.1073/pnas.94.10.5147; Stenseth NC, 1998, P NATL ACAD SCI USA, V95, P15430, DOI 10.1073/pnas.95.26.15430; TEMPLETON AR, 1995, GENETICS, V140, P767; TEMPLETON AR, 1992, GENETICS, V132, P619; TEMPLETON AR, 1993, GENETICS, V134, P659	30	91	97	2	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 4	2003	425	6953					69	72		10.1038/nature01942	http://dx.doi.org/10.1038/nature01942			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717LD	12955141				2022-12-01	WOS:000185089200038
J	Spath, GF; Lye, LF; Segawa, H; Sacks, DL; Turco, SJ; Beverley, SM				Spath, GF; Lye, LF; Segawa, H; Sacks, DL; Turco, SJ; Beverley, SM			Persistence without pathology in phosphoglycan-deficient Leishmania major	SCIENCE			English	Article							MURINE CUTANEOUS LEISHMANIASIS; LATENT LEISHMANIASIS; VIRULENCE FACTOR; LIPOPHOSPHOGLYCAN; MICE; PARASITES; HOST; PROMASTIGOTES; REACTIVATION; IMMUNITY	Leishmania infections involve an acute phase of replication within macrophages, typically associated with pathology. After recovery parasites persist for long periods, which can lead to severe disease upon reactivation. Unlike the role of host factors, parasite factors affecting persistence are poorly understood. Leishmania major lacking phosphoglycans (lpg2(-)) were unable to survive in sand flies and macrophages, but retained the ability to persist indefinitely in the mammalian host without inducing disease. The L. major lpg2(-) thus provides a platform for probing parasite factors implicated in persistence and its role in disease and immunity.	Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA; Univ Kentucky, Dept Biochem, Lexington, KY 40536 USA; NIAID, Parasit Dis Lab, Bethesda, MD 20892 USA	Washington University (WUSTL); University of Kentucky; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Beverley, SM (corresponding author), Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA.		Späth, Gerald/B-1393-2014	Spaeth, Gerald/0000-0002-0256-2029; Beverley, Stephen/0000-0001-5319-0811	NIAID NIH HHS [AI31078] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000256, R01AI031078, ZIAAI000256] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AEBISCHER T, 1993, INFECT IMMUN, V61, P220, DOI 10.1128/IAI.61.1.220-226.1993; Alexander J, 1998, J IMMUNOL, V161, P6794; Alvar J, 1997, CLIN MICROBIOL REV, V10, P298, DOI 10.1128/CMR.10.2.298; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Bogdan C, 1998, INT J PARASITOL, V28, P121, DOI 10.1016/S0020-7519(97)00169-0; Bogdan C, 2000, J EXP MED, V191, P2121, DOI 10.1084/jem.191.12.2121; Bogdan C, 1996, CURR OPIN IMMUNOL, V8, P517, DOI 10.1016/S0952-7915(96)80040-9; DESCOTEAUX A, 1995, SCIENCE, V269, P1869, DOI 10.1126/science.7569927; GREEN PJ, 1994, MOL BIOCHEM PARASIT, V66, P319, DOI 10.1016/0166-6851(94)90158-9; Ilg T, 1999, BIOCHEM SOC T, V27, P518; Ilg T, 2001, J BIOL CHEM, V276, P4988, DOI 10.1074/jbc.M008030200; Ilgoutz SC, 2001, INT J PARASITOL, V31, P899, DOI 10.1016/S0020-7519(01)00197-7; Ma DQ, 1997, J BIOL CHEM, V272, P3799, DOI 10.1074/jbc.272.6.3799; MOODY SF, 1993, J BIOL CHEM, V268, P18457; ORLANDI PA, 1987, J BIOL CHEM, V262, P10384; Piedrafita D, 1999, EUR J IMMUNOL, V29, P235, DOI 10.1002/(SICI)1521-4141(199901)29:01&lt;235::AID-IMMU235&gt;3.0.CO;2-S; Rittig MG, 2000, PARASITOL TODAY, V16, P292, DOI 10.1016/S0169-4758(00)01692-6; Sacks DL, 2000, P NATL ACAD SCI USA, V97, P406, DOI 10.1073/pnas.97.1.406; Spath GF, 2000, P NATL ACAD SCI USA, V97, P9258, DOI 10.1073/pnas.160257897; Spath GF, 2003, P NATL ACAD SCI USA, V100, P9536, DOI 10.1073/pnas.1530604100; Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656; Stenger S, 1996, J EXP MED, V183, P1501, DOI 10.1084/jem.183.4.1501; TITUS RG, 1991, EUR J IMMUNOL, V21, P559, DOI 10.1002/eji.1830210305; TITUS RG, 1995, P NATL ACAD SCI USA, V92, P10267, DOI 10.1073/pnas.92.22.10267; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; Turco SJ, 2001, TRENDS PARASITOL, V17, P223, DOI 10.1016/S1471-4922(01)01895-5; UZONNA J, UNPUB; Uzonna JE, 2001, J IMMUNOL, V167, P6967, DOI 10.4049/jimmunol.167.12.6967	30	134	142	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 29	2003	301	5637					1241	1243		10.1126/science.1087499	http://dx.doi.org/10.1126/science.1087499			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZC	12947201				2022-12-01	WOS:000185003500044
J	Sullivan, MB; Waterbury, JB; Chisholm, SW				Sullivan, MB; Waterbury, JB; Chisholm, SW			Cyanophages infecting the oceanic cyanobacterium Prochlorococcus	NATURE			English	Article							MARINE SYNECHOCOCCUS; SARGASSO SEA; DIVERSITY; ABUNDANCE; BACTERIOPHAGE; ECOTYPES; ECOLOGY; VIRUSES; WH7803; PHAGES	Prochlorococcus is the numerically dominant phototroph in the tropical and subtropical oceans, accounting for half of the photosynthetic biomass in some areas(1,2). Here we report the isolation of cyanophages that infect Prochlorococcus, and show that although some are host-strain-specific, others cross-infect with closely related marine Synechococcus as well as between high-light-and low-light-adapted Prochlorococcus isolates, suggesting a mechanism for horizontal gene transfer. Highlight-adapted Prochlorococcus hosts yielded Podoviridae exclusively, which were extremely host-specific, whereas low-light-adapted Prochlorococcus and all strains of Synechococcus yielded primarily Myoviridae, which has a broad host range. Finally, both Prochlorococcus and Synechococcus strain-specific cyanophage titres were low (< 10(3) ml(-1)) in stratified oligotrophic waters even where total cyanobacterial abundances were high (> 10(5) cells ml(-1)). These low titres in areas of high total host cell abundance seem to be a feature of open ocean ecosystems. We hypothesize that gradients in cyanobacterial population diversity, growth rates, and/or the incidence of lysogeny underlie these trends.	MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; MIT, Woods Hole Oceanog Inst, Joint Program Biol Oceanog, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution; Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution	Chisholm, SW (corresponding author), MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA.		Sullivan, Matthew B/H-3256-2011	Sullivan, Matthew B/0000-0003-4040-9831; Chisholm, Sallie/0000-0003-1480-2445				Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Cavender-Bares KK, 2001, DEEP-SEA RES PT I, V48, P2373, DOI 10.1016/S0967-0637(01)00027-9; Fuller NJ, 2003, APPL ENVIRON MICROB, V69, P2430, DOI 10.1128/AEM.69.5.2430-2443.2003; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Liu HB, 1997, AQUAT MICROB ECOL, V12, P39, DOI 10.3354/ame012039; Lu J, 2001, APPL ENVIRON MICROB, V67, P3285, DOI 10.1128/AEM.67.7.3285-3290.2001; Mann EL, 2002, LIMNOL OCEANOGR, V47, P976, DOI 10.4319/lo.2002.47.4.0976; Moore LR, 1999, LIMNOL OCEANOGR, V44, P628, DOI 10.4319/lo.1999.44.3.0628; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Murphy FA, 1995, VIRUS TAXONOMY CLASS; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rohwer F, 2000, LIMNOL OCEANOGR, V45, P408, DOI 10.4319/lo.2000.45.2.0408; Scanlan DJ, 2002, FEMS MICROBIOL ECOL, V40, P1, DOI 10.1111/j.1574-6941.2002.tb00930.x; Steward GF, 1996, MAR ECOL PROG SER, V131, P287, DOI 10.3354/meps131287; Suttle C.A., 2000, ECOLOGY CYANOBACTERI, DOI DOI 10.1007/0-306-46855-7_20; SUTTLE CA, 1994, APPL ENVIRON MICROB, V60, P3167, DOI 10.1128/AEM.60.9.3167-3174.1994; SUTTLE CA, 1993, MAR ECOL PROG SER, V92, P99, DOI 10.3354/meps092099; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Urbach E, 1998, LIMNOL OCEANOGR, V43, P1615, DOI 10.4319/lo.1998.43.7.1615; Waterbury J.B., 1986, PHOTOSYNTHETIC PICOP, P71; WATERBURY JB, 1993, APPL ENVIRON MICROB, V59, P3393, DOI 10.1128/AEM.59.10.3393-3399.1993; Wichels A, 1998, APPL ENVIRON MICROB, V64, P4128; Wilson WH, 1996, J PHYCOL, V32, P506, DOI 10.1111/j.0022-3646.1996.00506.x; WILSON WH, 1993, APPL ENVIRON MICROB, V59, P3736, DOI 10.1128/AEM.59.11.3736-3743.1993; Woese CR, 2000, P NATL ACAD SCI USA, V97, P8392, DOI 10.1073/pnas.97.15.8392	29	384	412	3	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2003	424	6952					1047	1051		10.1038/nature01929	http://dx.doi.org/10.1038/nature01929			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715QR	12944965				2022-12-01	WOS:000184984200041
J	Bandfield, JL; Glotch, TD; Christensen, PR				Bandfield, JL; Glotch, TD; Christensen, PR			Spectroscopic identification of carbonate minerals in the martian dust	SCIENCE			English	Article							THERMAL EMISSION; MARS; SPECTROMETER; SOIL; SURFACES; SPECTRA; CLIMATE; CLAYS	Thermal infrared spectra of the martian surface indicate the presence of small concentrations (similar to2 to 5 weight %) of carbonates, specifically dominated by magnesite (MgCO3). The carbonates are widely distributed in the martian dust, and there is no indication of a concentrated source. The presence of small concentrations of carbonate minerals in the surface dust and in martian meteorites can sequester several bars of atmospheric carbon dioxide and may have been an important sink for a thicker carbon dioxide atmosphere in the martian past.	Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Bandfield, JL (corresponding author), Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA.		Glotch, Timothy/B-6829-2008	Bandfield, Joshua/0000-0003-3571-3716				Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Bandfield JL, 2003, ICARUS, V161, P47, DOI 10.1016/S0019-1035(02)00025-8; BANDFIELD JL, 2002, J GEOPHYS RES; BANIN A, 1979, J MOL EVOL, V14, P133, DOI 10.1007/BF01732373; BETTS BH, 1995, J GEOPHYS RES-PLANET, V100, P5285, DOI 10.1029/95JE00226; BLANEY DL, 1989, J GEOPHYS RES-SOLID, V94, P10159, DOI 10.1029/JB094iB08p10159; BOOTH MC, 1978, J GEOPHYS RES, V83, P1809, DOI 10.1029/JB083iB04p01809; CALVIN WM, 1994, J GEOPHYS RES-PLANET, V99, P14659, DOI 10.1029/94JE01090; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23823, DOI 10.1029/2000JE001370; Fanale F.P., 1992, MARS, P1135; FANALE FP, 1982, ICARUS, V50, P381, DOI 10.1016/0019-1035(82)90131-2; Farmer V.C., 1974, INFRARED SPECTRA MIN; Gaffey S.J., 1993, REMOTE GEOCHEMICAL A, P43; GOODING JL, 1978, ICARUS, V33, P483, DOI 10.1016/0019-1035(78)90186-0; GOODING JL, 1992, ICARUS, V99, P28, DOI 10.1016/0019-1035(92)90168-7; HUGUENIN RL, 1974, J GEOPHYS RES, V79, P3895, DOI 10.1029/JB079i026p03895; JAKOSKY BM, 1990, GEOPHYS RES LETT, V17, P985, DOI 10.1029/GL017i007p00985; KAHN R, 1985, ICARUS, V62, P175, DOI 10.1016/0019-1035(85)90116-2; Lane MD, 1997, J GEOPHYS RES-PLANET, V102, P25581, DOI 10.1029/97JE02046; Lellouch E, 2000, PLANET SPACE SCI, V48, P1393, DOI 10.1016/S0032-0633(00)00118-5; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; POLLACK JB, 1990, J GEOPHYS RES-SOLID, V95, P14595, DOI 10.1029/JB095iB09p14595; RUFF SW, 2002, EOS S, V83, P1059; RUFF SW, 2002, J GEOPHYS RES; Salisbury J.W., 1991, INFRARED 2 1 25 MUM; SALISBURY JW, 1989, J GEOPHYS RES-SOLID, V94, P9192, DOI 10.1029/JB094iB07p09192; SETTLE M, 1979, J GEOPHYS RES, V84, P8343, DOI 10.1029/JB084iB14p08343; TOON OB, 1980, ICARUS, V44, P552, DOI 10.1016/0019-1035(80)90130-X; Wagner C, 1996, ICARUS, V123, P256, DOI 10.1006/icar.1996.0156	29	256	262	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 22	2003	301	5636					1084	1087		10.1126/science.1088054	http://dx.doi.org/10.1126/science.1088054			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713RP	12934004				2022-12-01	WOS:000184872400036
J	Wu, S; Huang, JB; Dong, JX; Pan, DJ				Wu, S; Huang, JB; Dong, JX; Pan, DJ			hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts	CELL			English	Article							TUMOR SUPPRESSORS; IMAGINAL DISC; CYCLIN-E; DROSOPHILA; GROWTH; SIZE; ACTIVATION; MOSAICS; DEATH; SHAPE	The coordination between cell proliferation and cell death is essential to maintain homeostasis within multicellular organisms. The mechanisms underlying this regulation are yet to be completely understood. Here, we report the identification of hippo (hpo) as a gene that regulates both cell proliferation and cell death in Drosophila. hpo encodes a Ste-20 family protein kinase that binds to and phosphorylates the tumor suppressor protein Salvador (Sav), which is known to interact with the Warts (Wts) protein kinase. Loss of hpo results in elevated transcription of the cell cycle regulator cyclin E and the cell-death inhibitor diap1, leading to increased proliferation and reduced apoptosis. Further, we show that hpo, sav, and wts define a pathway that regulates diap1 at the transcriptional level. A human homolog of hpo completely rescues the overgrowth phenotype of Drosophila hpo mutants, suggesting that hpo might play a conserved role for growth control in mammals.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Pan, DJ (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.			Wu, Shian/0000-0003-4990-6594	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062323] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62323] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chen B, 1998, GENETICS, V149, P157; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hisaoka M, 2002, LAB INVEST, V82, P1427, DOI 10.1097/01.LAB.0000032381.68634.CA; Johnston LA, 2002, BIOESSAYS, V24, P54, DOI 10.1002/bies.10021; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Martin SJ, 2002, CELL, V109, P793, DOI 10.1016/S0092-8674(02)00802-4; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; RICHARDSON H, 1995, DEVELOPMENT, V121, P3371; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; Wolff Tanya, 1993, P1277; XU TA, 1995, DEVELOPMENT, V121, P1053; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Zallen JA, 2000, MOL BIOL CELL, V11, P3177, DOI 10.1091/mbc.11.9.3177	30	798	838	5	75	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 22	2003	114	4					445	456		10.1016/S0092-8674(03)00549-X	http://dx.doi.org/10.1016/S0092-8674(03)00549-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	714TD	12941273	Bronze			2022-12-01	WOS:000184928800008
J	Cinatl, J; Morgenstern, B; Bauer, G; Chandra, P; Rabenau, H; Doerr, HW				Cinatl, J; Morgenstern, B; Bauer, G; Chandra, P; Rabenau, H; Doerr, HW			Treatment of SARS with human interferons	LANCET			English	Article							IDENTIFICATION; CORONAVIRUS; VIRUS	Effective antiviral agents are needed to treat severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infection. We assessed the antiviral potential of recombinant interferons against two clinical isolates of SARS-CoV-FFM-1, from Frankfurt patients, and Hong Kong-replicated in Vero and Caco2 cells. Interferon beta was five to ten times more effective in Caco2 cells. Interferon alpha effectively inhibited SARS-CoV replication, but with a selectivity index 50-90 times lower than that for interferon beta. Interferon gamma was slightly better than interferon alpha in Vero cell cultures, but was completely ineffective in Caco2 cell cultures. Interferon beta could be useful alone or in combination with other antiviral drugs for the treatment of SARS.	Univ Frankfurt, Sch Med, Inst Med Virol, D-60596 Frankfurt, Germany	Goethe University Frankfurt	Cinatl, J (corresponding author), Univ Frankfurt, Sch Med, Inst Med Virol, Paul Ehrlich Str 40, D-60596 Frankfurt, Germany.	cinatl@em.uni-frankfurt.de						Cinatl J, 2003, LANCET, V361, P2045, DOI 10.1016/S0140-6736(03)13615-X; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Garcia S, 2001, J CLIN MICROBIOL, V39, P4456, DOI 10.1128/JCM.39.12.4456-4461.2001; Pitkaranta A, 1999, J CLIN VIROL, V14, P199, DOI 10.1016/S1386-6532(99)00056-6	5	318	362	0	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					293	294		10.1016/S0140-6736(03)13973-6	http://dx.doi.org/10.1016/S0140-6736(03)13973-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892961	Green Published, Bronze			2022-12-01	WOS:000184413400013
J	Kim, M; McCormick, S; Timmermans, M; Sinha, N				Kim, M; McCormick, S; Timmermans, M; Sinha, N			The expression domain of PHANTASTICA determines leaflet placement in compound leaves	NATURE			English	Article								Diverse leaf forms in nature can be categorized as simple or compound. Simple leaves, such as those of petunia, have a single unit of blade, whereas compound leaves, such as those of tomato, have several units of blades called leaflets. Compound leaves can be pinnate, with leaflets arranged in succession on a rachis, or palmate, with leaflets clustered together at the leaf tip. The mechanisms that generate these various leaf forms are largely unknown. The upper (adaxial) surface is usually different from the bottom (abaxial) surface in both simple and compound leaves. In species with simple leaves, the specification of adaxial and abaxial cells is important for formation of the leaf blade(1,2), and the MYB transcription factor gene PHANTASTICA (PHAN) is involved in maintaining the leaf adaxial (upper) domain(3,4). Here we show that downregulation of PHAN is sufficient to reduce the adaxial domain of leaf primordia and to change pinnate compound leaves into palmate compound leaves. Furthermore, this mechanism seems to be shared among compound leaves that arose independently.	Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA; USDA ARS, Ctr Plant Gene Express, Albany, CA 94710 USA; Univ Calif Berkeley, Albany, CA 94710 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of California System; University of California Davis; United States Department of Agriculture (USDA); University of California System; University of California Berkeley; Cold Spring Harbor Laboratory	Sinha, N (corresponding author), Univ Calif Davis, Plant Biol Sect, 1 Shields Ave, Davis, CA 95616 USA.	nrsinha@ucdavis.edu		Sinha, Neelima/0000-0002-1494-7065; McCormick, Sheila/0000-0001-9106-9385				Averof M, 1997, NATURE, V388, P682, DOI 10.1038/41786; Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; Carroll SB, 2000, CELL, V101, P577, DOI 10.1016/S0092-8674(00)80868-5; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Gellon G, 1998, BIOESSAYS, V20, P116, DOI 10.1002/(SICI)1521-1878(199802)20:2<116::AID-BIES4>3.3.CO;2-N; Gleissberg S, 1999, INT J PLANT SCI, V160, P787, DOI 10.1086/314165; JACKSON D, 1994, DEVELOPMENT, V120, P405; Kessler S, 2001, INT J PLANT SCI, V162, P475, DOI 10.1086/320136; Koltai H, 2000, PLANT J, V22, P455, DOI 10.1046/j.1365-313X.2000.00754.x; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; MCCORMICK S, 1991, PLANT TISSUE CULTU B, V6, P1; Pien S, 2001, PLANT J, V25, P663, DOI 10.1046/j.1365-313x.2001.01002.x; Ruiz-Medrano R, 1999, DEVELOPMENT, V126, P4405; Sun Y, 2002, PLANTA, V214, P694, DOI 10.1007/s004250100673; Timmermans MCP, 1999, SCIENCE, V284, P151, DOI 10.1126/science.284.5411.151; Tsiantis M, 1999, SCIENCE, V284, P154, DOI 10.1126/science.284.5411.154; WAITES R, 1995, DEVELOPMENT, V121, P2143; Waites R, 1998, CELL, V93, P779, DOI 10.1016/S0092-8674(00)81439-7	19	109	116	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					438	443		10.1038/nature01820	http://dx.doi.org/10.1038/nature01820			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879073				2022-12-01	WOS:000184318400046
J	Tournaire-Roux, C; Sutka, M; Javot, H; Gout, E; Gerbeau, P; Luu, DT; Bligny, R; Maurel, C				Tournaire-Roux, C; Sutka, M; Javot, H; Gout, E; Gerbeau, P; Luu, DT; Bligny, R; Maurel, C			Cytosolic pH regulates root water transport during anoxic stress through gating of aquaporins	NATURE			English	Article							PLASMA-MEMBRANE AQUAPORINS; PLANT-CELLS; PHOSPHORYLATION; PERMEABILITY; CHANNELS; INHIBITION; EXPRESSION; TIP	Flooding of soils results in acute oxygen deprivation (anoxia) of plant roots during winter in temperate latitudes, or after irrigation(1), and is a major problem for agriculture. One early response of plants to anoxia and other environmental stresses is down-regulation of water uptake due to inhibition of the water permeability (hydraulic conductivity) of roots (Lp(r))(2-5). Root water uptake is mediated largely by water channel proteins (aquaporins) of the plasma membrane intrinsic protein (PIP) subgroup(6-8). These aquaporins may mediate stress-induced inhibition of Lp(r)(2,4,9) but the mechanisms involved are unknown. Here we delineate the whole-root and cell bases for inhibition of water uptake by anoxia and link them to cytosol acidosis. We also uncover a molecular mechanism for aquaporin gating by cytosolic pH. Because it is conserved in all PIPs, this mechanism provides a basis for explaining the inhibition of Lp(r) by anoxia and possibly other stresses. More generally, our work opens new routes to explore pH-dependent cell signalling processes leading to regulation of water transport in plant tissues or in animal epithelia(10).	Univ Montpellier 2, INRA, CNRS, Unite Mixte Rech 5004, F-34060 Montpellier 1, France; Ecole Natl Agron, F-34060 Montpellier, France; CEA, Physiol Cellulaire Vegetale, F-38054 Grenoble 9, France	INRAE; Institut Agro; Montpellier SupAgro; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Maurel, C (corresponding author), Univ Montpellier 2, INRA, CNRS, Unite Mixte Rech 5004, Pl Viala, F-34060 Montpellier 1, France.		Javot, Helene/AAX-8986-2021	Javot, Helene/0000-0002-4577-2747; Luu, Doan Trung/0000-0001-9765-2125; Tournaire Roux, Colette/0000-0002-2966-5597				Baxter-Burrell A, 2002, SCIENCE, V296, P2026, DOI 10.1126/science.1071505; BIRNER TP, 1993, PLANTA, V190, P474, DOI 10.1007/BF00224786; Clarkson DT, 2000, J EXP BOT, V51, P61, DOI 10.1093/jexbot/51.342.61; Felle HH, 2001, PLANT BIOLOGY, V3, P577, DOI 10.1055/s-2001-19372; Gerbeau P, 2002, PLANT J, V30, P71, DOI 10.1046/j.1365-313X.2002.01268.x; Gout E, 2001, PLANT PHYSIOL, V125, P912, DOI 10.1104/pp.125.2.912; Han ZQ, 1998, J BIOL CHEM, V273, P6001, DOI 10.1074/jbc.273.11.6001; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Javot H, 2003, PLANT CELL, V15, P509, DOI 10.1105/tpc.008888; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; Kamaluddin M, 2001, J EXP BOT, V52, P739, DOI 10.1093/jexbot/52.357.739; Lacombe B, 2000, FEBS LETT, V466, P351, DOI 10.1016/S0014-5793(00)01093-0; Martre P, 2002, PLANT PHYSIOL, V130, P2101, DOI 10.1104/pp.009019; MAUREL C, 1995, EMBO J, V14, P3028, DOI 10.1002/j.1460-2075.1995.tb07305.x; MAUREL C, 1993, EMBO J, V12, P2241, DOI 10.1002/j.1460-2075.1993.tb05877.x; Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777; PARISI M, 1984, AM J PHYSIOL, V246, pC157, DOI 10.1152/ajpcell.1984.246.1.C157; Siefritz F, 2002, PLANT CELL, V14, P869, DOI 10.1105/tpc.000901; Steudle E, 1998, J EXP BOT, V49, P775, DOI 10.1093/jexbot/49.322.775; SUBBAIAH CC, 1994, PLANT CELL, V6, P1747, DOI 10.1105/tpc.6.12.1747; Tomos AD, 1999, ANNU REV PLANT PHYS, V50, P447, DOI 10.1146/annurev.arplant.50.1.447; VARAPETIAN BB, 1997, ANN BOT SA, V79, P3; Yasui M, 1999, NATURE, V402, P184, DOI 10.1038/46045; Zeuthen T, 1999, J BIOL CHEM, V274, P21631, DOI 10.1074/jbc.274.31.21631; ZHANG WH, 1991, AUST J PLANT PHYSIOL, V18, P603, DOI 10.1071/PP9910603; Zhang WH, 1999, PLANT PHYSIOL, V120, P849, DOI 10.1104/pp.120.3.849	26	493	531	8	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 25	2003	425	6956					393	397		10.1038/nature01853	http://dx.doi.org/10.1038/nature01853			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	724TG	14508488				2022-12-01	WOS:000185502300040
J	Neuberger, J; Price, D				Neuberger, J; Price, D			Role of living liver donation in the United Kingdom	BRITISH MEDICAL JOURNAL			English	Article							TRANSPLANTATION; DONOR; ADULT; EXPERIENCE; SELECTION; HEALTH		Queen Elizabeth Hosp, Liver Unit, Birmingham B15 2TH, W Midlands, England; De Montfort Univ, Leicester LE1 9BH, Leics, England	University of Birmingham; De Montfort University	Neuberger, J (corresponding author), Queen Elizabeth Hosp, Liver Unit, Birmingham B15 2TH, W Midlands, England.							Abecassis M, 2000, JAMA-J AM MED ASSOC, V284, P2919; Baker A, 1999, BRIT J SURG, V86, P200, DOI 10.1046/j.1365-2168.1999.00991.x; Beavers KL, 2001, LIVER TRANSPLANT, V7, P943, DOI 10.1053/jlts.2001.28443; Broering DC, 2003, J HEPATOL, V38, pS119, DOI 10.1016/S0168-8278(03)00009-6; Brown RS, 2003, NEW ENGL J MED, V348, P818, DOI 10.1056/NEJMsa021345; DAVIES MH, 1992, GUT, V33, P1397, DOI 10.1136/gut.33.10.1397; FISHER NC, 2002, BRIT MED J, V325, P512; Johnson E M, 1997, Clin Transpl, P231; Kahn J, 2002, TRANSPLANTATION, V74, P421, DOI 10.1097/00007890-200208150-00026; Karliova M, 2002, TRANSPLANTATION, V73, P1799, DOI 10.1097/00007890-200206150-00017; Malago M, 2001, LIVER TRANSPLANT, V7, P921, DOI 10.1053/jlts.2001.28301; Marcos A, 2000, LIVER TRANSPLANT, V6, pS59, DOI 10.1053/jlts.2000.19011; Marcos A, 2000, TRANSPLANTATION, V69, P2410, DOI 10.1097/00007890-200006150-00034; Neuberger J, 1999, LANCET, V354, P1636, DOI 10.1016/S0140-6736(99)90002-8; NEUBERGER J, IN PRESS TRANSPLANTA; RAIA S, 1989, LANCET, V2, P497; Ross LF, 2002, TRANSPLANTATION, V74, P418; Shiffman ML, 2002, LIVER TRANSPLANT, V8, P174, DOI 10.1053/jlts.2002.30981; Williams RS, 2003, EUR J GASTROEN HEPAT, V15, P7, DOI 10.1097/00042737-200301000-00003	19	15	15	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 20	2003	327	7416					676	679		10.1136/bmj.327.7416.676	http://dx.doi.org/10.1136/bmj.327.7416.676			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724AC	14500445	Green Published			2022-12-01	WOS:000185463100029
J	Brosnan, SF; de Waal, FBM				Brosnan, SF; de Waal, FBM			Monkeys reject unequal pay	NATURE			English	Article							HUMAN COOPERATION; ULTIMATUM GAME; CAPUCHINS; SOCIOLOGY; BEHAVIOR; ALTRUISM; FAIRNESS; PUZZLE	During the evolution of cooperation it may have become critical for individuals to compare their own efforts and pay-offs with those of others. Negative reactions may occur when expectations are violated. One theory proposes that aversion to inequity can explain human cooperation within the bounds of the rational choice model(1), and may in fact be more inclusive than previous explanations(2-8). Although there exists substantial cultural variation in its particulars, this 'sense of fairness' is probably a human universal(9,10) that has been shown to prevail in a wide variety of circumstances(11-13). However, we are not the only cooperative animals(14), hence inequity aversion may not be uniquely human. Many highly cooperative nonhuman species seem guided by a set of expectations about the outcome of cooperation and the division of resources(15,16). Here we demonstrate that a nonhuman primate, the brown capuchin monkey (Cebus apella), responds negatively to unequal reward distribution in exchanges with a human experimenter. Monkeys refused to participate if they witnessed a conspecific obtain a more attractive reward for equal effort, an effect amplified if the partner received such a reward without any effort at all. These reactions support an early evolutionary origin of inequity aversion.	Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA	Emory University	Brosnan, SF (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.							ANDREONI J, 1995, AM ECON REV, V85, P891; Andreoni J, 2002, GAME ECON BEHAV, V40, P1, DOI 10.1006/game.2001.0904; Brosnan SF, 2002, HUM NATURE-INT BIOS, V13, P129, DOI 10.1007/s12110-002-1017-2; de Waal F. B. M., 1996, GOOD NATURED ORIGINS; de Waal F.B.M., 2002, NEUROPSYCHOLOGIA, V1492, P1; de Waal FBM, 1997, J COMP PSYCHOL, V111, P370, DOI 10.1037/0735-7036.111.4.370; de Waal FBM, 2000, NATURE, V404, P563, DOI 10.1038/35007138; DiBitetti MS, 1997, ANIM BEHAV, V54, P199, DOI 10.1006/anbe.1996.0416; Dugatkin LA., 1997, COOPERATION ANIMALS; Falk A, 2003, ECON INQ, V41, P20, DOI 10.1093/ei/41.1.20; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2003, NATURE, V422, P137, DOI 10.1038/nature01474; Fehr E, 2003, NATURE, V421, P912, DOI 10.1038/421912a; Frank R.H., 2001, EVOLUTION CAPACITY C, P57; Frank R.H., 1988, PASSIONS REASON STRA; Henrich J, 2000, AM ECON REV, V90, P973, DOI 10.1257/aer.90.4.973; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Hirshleifer J., 1987, LATEST BEST ESSAYS E, P307; Johnson DDP, 2003, NATURE, V421, P911, DOI 10.1038/421912a; KAHNEMAN D, 1986, AM ECON REV, V76, P728; Mendres KA, 2000, ANIM BEHAV, V60, P523, DOI 10.1006/anbe.2000.1512; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Nesse R., 2001, EVOLUTION CAPACITY C, P120; Nesse RM, 2001, EVOLUTION CAPACITY C, P1; Oswald Zizzo, 2001, ANN EC STAT, P39, DOI DOI 10.2307/20076295; Roberts G, 1998, NATURE, V394, P175, DOI 10.1038/28160; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Tinklepaugh OL, 1928, J COMP PSYCHOL, V8, P197, DOI 10.1037/h0075798; WENEKIND C, 2000, SCIENCE, V200, P850	30	682	700	14	411	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 18	2003	425	6955					297	299		10.1038/nature01963	http://dx.doi.org/10.1038/nature01963			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	722JA	13679918				2022-12-01	WOS:000185370900046
J	Ruggeri, M; Tosetto, A; Frezzato, M; Rodeghiero, F				Ruggeri, M; Tosetto, A; Frezzato, M; Rodeghiero, F			The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosis	ANNALS OF INTERNAL MEDICINE			English	Article							APPARENT POLYCYTHEMIA; OLMSTED COUNTY; POPULATION; DIAGNOSIS; RISK; EPIDEMIOLOGY; MANAGEMENT; MINNESOTA; SURVIVAL; RANGES	Background: The clinical relevance of mild erythrocytosis (hematocrit > 0.48 in women or > 0.51 in men) or thrombocytosis (platelet count > 400 x 10(9) cells/L) in asymptomatic persons is uncertain. Objective: To estimate the frequency of polycythemia vera or essential thrombocythemia in persons with erythrocytosis or thrombocytosis in a general population. Design: Cohort study. Setting: Vicenza, Italy. Participants: 10000 community dwellers age 18 to 65 years and enrolled in the Vicenza Thrombophilia and Atherosclerosis project. Measurements: Platelet count and hematocrit at baseline in all participants and at second follow-up if baseline results were abnormal. Measurement of erythrocyte sedimentation rate, peripheral arterial saturation, serum erythropoietin level, and leukocyte alkaline phosphatase level; chest radiography; abdominal ultrasonography; and occult fecal blood testing were done in persons with confirmed high hematocrit or platelet counts. Polycythemia vera and essential thrombocythemia were diagnosed according to the Polycythemia Study Group criteria. Results: At baseline examination, 1 person had polycythemia vera, 1 had essential thrombocythemia, 88 had erythrocytosis, and 99 had thrombocytosis. Second examination confirmed erythrocytosis in 40% (95% Cl, 29% to 51%) and thrombocytosis in 8% (Cl, 4% to 15%) of those with abnormal baseline results. Among persons with confirmed abnormalities, further evaluation revealed 11 with idiopathic erythrocytosis, 2 with polycythemia vera (3/ 10 000 [Cl, 0.6 to 8.7/10 000]), and 3 with essential thrombocythemia (4/10 000 [Cl, 1.09 to 10.2/10 000]). After 5 years of follow-up, 1 additional person with a high platelet count developed essential thrombocythemia, and no persons developed hemorrhagic or thrombotic complications. Conclusions: The prevalences of polycythemia vera and essential thrombocythemia were higher than expected in this general population. However, the risks for developing polycythemia vera, essential thrombocythemia, or associated vascular complications in persons with erythrocytosis or thrombocytosis were low.	San Bortolo Hosp, Dept Hematol, I-36100 Vicenza, Italy	ULSS 8 Berica; Ospedale San Bortolo di Vicenza	Rodeghiero, F (corresponding author), San Bortolo Hosp, Dept Hematol, I-36100 Vicenza, Italy.	rodeghiero@hemato.ven.it	Tosetto, Alberto/AAB-9320-2022; Tosetto, Alberto/AAM-3200-2020	Tosetto, Alberto/0000-0002-0119-5204				ANIA BJ, 1994, AM J HEMATOL, V47, P89, DOI 10.1002/ajh.2830470205; BERGLUND S, 1992, EUR J HAEMATOL, V48, P20; Berk PD, 1997, SEMIN HEMATOL, V34, P77; BERLIN NI, 1975, SEMIN HEMATOL, V12, P339; CARLI PM, 1994, NOUV REV FR HEMATOL, V36, P147; CHAITER Y, 1992, LEUKEMIA LYMPHOMA, V7, P251, DOI 10.3109/10428199209053630; Clayton D., 1993, STAT MODELS EPIDEMIO; CORTELAZZO S, 1995, NEW ENGL J MED, V332, P1132, DOI 10.1056/NEJM199504273321704; DOUGAN LE, 1981, CANCER, V48, P866, DOI 10.1002/1097-0142(19810801)48:3<866::AID-CNCR2820480334>3.0.CO;2-Y; Fairbanks VF, 2000, EUR J HAEMATOL, V65, P285, DOI 10.1034/j.1600-0609.2000.065005285.x; Frezzato M, 1996, AM J EPIDEMIOL, V143, P1257; Lengfelder E, 1998, BRIT J HAEMATOL, V100, P15, DOI 10.1046/j.1365-2141.1998.00529.x; Mesa RA, 1999, AM J HEMATOL, V61, P10, DOI 10.1002/(SICI)1096-8652(199905)61:1<10::AID-AJH3>3.0.CO;2-I; MESSINEZY M, 1993, EUR J HAEMATOL, V51, P125; MODAN B, 1965, BLOOD-J HEMATOL, V26, P657, DOI 10.1182/blood.V26.5.657.657; MODAN B, 1971, BLOOD-J HEMATOL, V37, P172, DOI 10.1182/blood.V37.2.172.172; Murphy S, 1997, SEMIN HEMATOL, V34, P29; MURPHY S, 1986, SEMIN HEMATOL, V23, P177; Najean Y, 1998, HEMATOL CELL THER, V40, P159; PROCHAZKA AV, 1986, BRIT J CANCER, V53, P59, DOI 10.1038/bjc.1986.9; RIUNITI O, 1995, ANN INTERN MED, V123, P656, DOI 10.7326/0003-4819-123-9-199511010-00003; Rodeghiero F, 1996, THROMB HAEMOSTASIS, V76, P226; Ruggeri M, 1998, BRIT J HAEMATOL, V103, P772; SILVERSTEIN MN, 1971, MAYO CLIN PROC, V46, P751; Streiff MB, 2002, BLOOD, V99, P1144, DOI 10.1182/blood.V99.4.1144; Tefferi A, 1999, MAYO CLIN PROC, V74, P159, DOI 10.4065/74.2.159	26	49	51	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2003	139	6					470	475		10.7326/0003-4819-139-6-200309160-00009	http://dx.doi.org/10.7326/0003-4819-139-6-200309160-00009			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721PE	13679323				2022-12-01	WOS:000185324100002
J	Yamashita, YM; Jones, DL; Fuller, MT				Yamashita, YM; Jones, DL; Fuller, MT			Orientation of asymmetric stem cell division by the APC tumor suppressor and centrosome	SCIENCE			English	Article							DROSOPHILA APC2; MITOTIC SPINDLES; SELF-RENEWAL; PROTEIN; MICROTUBULES; CAPTURE; ENCODES	Stem cell self-renewal can be specified by local signals from the surrounding microenvironment, or niche. However, the relation between the niche and the mechanisms that ensure the correct balance between stem cell self-renewal and differentiation is poorly understood. Here, we show that dividing Drosophila male germline stem cells use intracellular mechanisms involving centrosome function and cortically localized Adenomatous Polyposis Coli tumor suppressor protein to orient mitotic spindles perpendicular to the niche, ensuring a reliably asymmetric outcome in which one daughter cell remains in the niche and self-renews stem cell identity, whereas the other, displaced away, initiates differentiation.	Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Fuller, MT (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	fuller@cmgm.stanford.edu		Fuller, Margaret T/0000-0002-3804-4987; Yamashita, Yukiko/0000-0001-5541-0216	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053074] Funding Source: NIH RePORTER; NIDDK NIH HHS [1P01 DK53074] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akong K, 2002, DEV BIOL, V250, P71, DOI 10.1006/dbio.2002.0777; BLENZ M, 2001, NATURE CELL BIOL, V3, pE67; Bloom K, 2001, CURR BIOL, V11, pR326, DOI 10.1016/S0960-9822(01)00176-2; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; HEUER JG, 1995, DEVELOPMENT, V121, P3861; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; HYMAN AA, 1987, J CELL BIOL, V105, P2123, DOI 10.1083/jcb.105.5.2123; Jones D. B., UNPUB; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Liakopoulos D, 2003, CELL, V112, P561, DOI 10.1016/S0092-8674(03)00119-3; Lu BW, 2001, NATURE, V409, P522, DOI 10.1038/35054077; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; McCartney BM, 2001, NAT CELL BIOL, V3, P933, DOI 10.1038/ncb1001-933; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Schuyler SC, 2001, J CELL SCI, V114, P247; Segal M, 2001, TRENDS CELL BIOL, V11, P160, DOI 10.1016/S0962-8924(01)01954-7; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Yu X, 1999, NAT CELL BIOL, V1, P144, DOI 10.1038/11064	23	551	574	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2003	301	5639					1547	1550		10.1126/science.1087795	http://dx.doi.org/10.1126/science.1087795			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	720HL	12970569				2022-12-01	WOS:000185255300054
J	Spies, M; Bianco, PR; Dillingham, MS; Handa, N; Baskin, RJ; Kowalczykowski, SC				Spies, M; Bianco, PR; Dillingham, MS; Handa, N; Baskin, RJ; Kowalczykowski, SC			A molecular throttle: The recombination hotspot chi controls DNA translocation by the RecBCD helicase	CELL			English	Article							HOT SPOT ACTIVITY; ESCHERICHIA-COLI; BACTERIOPHAGE-LAMBDA; RECA PROTEIN; ENZYME; RECOGNITION; SEQUENCE; DEGRADATION; MUTATION; POLARITY	RecBCD enzyme is a heterotrimeric helicase/nuclease that initiates homologous recombination at double-stranded DNA breaks. Several of its activities are regulated by the DNA sequence chi (5'-GCTGGTGG-3'), which is recognized in cis by the translocating enzyme. When RecBCD enzyme encounters chi, the intensity and polarity of its nuclease activity are changed, and the enzyme gains the ability to load RecA protein onto the chi-containing, unwound single-stranded DNA. Here, we show that interaction with chi also affects translocation by RecBCD enzyme. By observing translocation of individual enzymes along single molecules of DNA, we could see RecBCD enzyme pause precisely at chi. Furthermore, and more unexpectedly, after pausing at chi, the enzyme continues translocating but at approximately one-half the initial rate. We propose that interaction with chi results in an enzyme in which one of the two motor subunits, likely the RecD motor, is uncoupled from the holoenzyme to produce the slower translocase.	Univ Calif Davis, Ctr Genet & Dev, Microbiol Sect, Davis, CA 95616 USA; Univ Calif Davis, Ctr Genet & Dev, Sect Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Ctr Genet & Dev, Microbiol Sect, Davis, CA 95616 USA.		Handa, Naofumi/H-6640-2017	Handa, Naofumi/0000-0003-3695-1871; Dillingham, Mark/0000-0002-4612-7141; Spies, Maria/0000-0002-7375-8037	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064745, R01GM041347] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-64745, R01 GM064745, GM-41347] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Anderson DG, 1997, GENE DEV, V11, P571, DOI 10.1101/gad.11.5.571; Anderson DG, 1999, J BIOL CHEM, V274, P27139, DOI 10.1074/jbc.274.38.27139; Anderson DG, 1997, GENES CELLS, V2, P117, DOI 10.1046/j.1365-2443.1997.1130311.x; Arnold DA, 1998, J BIOL CHEM, V273, P16476, DOI 10.1074/jbc.273.26.16476; ARNOLD DA, 1999, ENCY LIFE SCI; Bianco PR, 1997, P NATL ACAD SCI USA, V94, P6706, DOI 10.1073/pnas.94.13.6706; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; DIXON DA, 1991, CELL, V66, P361, DOI 10.1016/0092-8674(91)90625-9; DIXON DA, 1993, CELL, V73, P87, DOI 10.1016/0092-8674(93)90162-J; DIXON DA, 1995, J BIOL CHEM, V270, P16360, DOI 10.1074/jbc.270.27.16360; DIXON DA, 1994, P NATL ACAD SCI USA, V91, P2980, DOI 10.1073/pnas.91.8.2980; Dohoney KM, 2001, NATURE, V409, P370, DOI 10.1038/35053124; KORANGY F, 1994, BIOCHEMISTRY-US, V33, P9552, DOI 10.1021/bi00198a022; KUZMINOV A, 1994, EMBO J, V13, P2764, DOI 10.1002/j.1460-2075.1994.tb06570.x; LAM ST, 1974, GENETICS, V77, P425; LARSSON A, 1994, J AM CHEM SOC, V116, P8459, DOI 10.1021/ja00098a004; LEBOWITZ J, 1985, THESIS J HOPKINS U B; MYERS RS, 1995, P NATL ACAD SCI USA, V92, P6244, DOI 10.1073/pnas.92.14.6244; RINKEN R, 1992, J BACTERIOL, V174, P5424, DOI 10.1128/JB.174.16.5424-5429.1992; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2863, DOI 10.1021/bi00433a018; ROMAN LJ, 1992, J BIOL CHEM, V267, P4207; STAHL FW, 1975, J MOL BIOL, V94, P203, DOI 10.1016/0022-2836(75)90078-9; STAHL FW, 1975, MOL GEN GENET, V140, P29, DOI 10.1007/BF00268986; TAYLOR A, 1980, CELL, V22, P447, DOI 10.1016/0092-8674(80)90355-4; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; TAYLOR AF, 1985, CELL, V41, P153, DOI 10.1016/0092-8674(85)90070-4; Taylor AF, 1999, GENE DEV, V13, P890, DOI 10.1101/gad.13.7.890; TAYLOR AF, 1992, P NATL ACAD SCI USA, V89, P5226, DOI 10.1073/pnas.89.12.5226	30	145	150	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 5	2003	114	5					647	654		10.1016/S0092-8674(03)00681-0	http://dx.doi.org/10.1016/S0092-8674(03)00681-0			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	719FN	13678587	Bronze			2022-12-01	WOS:000185193100013
J	Kuroda, H; Maliga, P				Kuroda, H; Maliga, P			The plastid clpP1 protease gene is essential for plant development	NATURE			English	Article							ARABIDOPSIS-THALIANA; MOLECULAR-CLONING; PHOTOSYSTEM-II; TOBACCO; TRANSFORMATION; GENOME; RNA; RECOMBINATION; CHLOROPLASTS; MUTAGENESIS	Plastids of higher plants are semi-autonomous cellular organelles that have their own genome and transcription-translation machinery(1). Examples of plastid functions are photosynthesis and biosynthesis of starch, amino acids, lipids and pigments(2). Plastid functions are encoded in similar to120 plastid genes(1) and similar to3,000 nuclear genes(2,3). Although many embryo and seedling lethal nuclear genes are required for chloroplast biogenesis(4-6), until now deletion of plastid genes either had no phenotypic consequence (8 genes), or caused a mutant phenotype but did not affect viability (13 genes)(7-10). Here we identify an essential plastid gene. By using the CRE-lox site-specific recombination system(11,12) we have deleted clpP1 (caseinolytic protease P1), one of the three genes (clpP1, ycf1 and ycf2) whose disruption had previously only been possible in a fraction of the 1,000-10,000 plastid genome copies in a cell(7,13). Loss of the clpP1 gene product, the ClpP1 protease subunit(14), results in ablation of the shoot system of tobacco plants, suggesting that ClpP1-mediated protein degradation is essential for shoot development.	Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Maliga, P (corresponding author), Rutgers State Univ, Waksman Inst Microbiol, 190 Frelinghuysen Rd, Piscataway, NJ 08854 USA.							Adam Z, 2002, TRENDS PLANT SCI, V7, P451, DOI 10.1016/S1360-1385(02)02326-9; Bock Ralph, 2002, V63, P106; Budziszewski GJ, 2001, GENETICS, V159, P1765; Cahoon AB, 2003, PLANT CELL PHYSIOL, V44, P93, DOI 10.1093/pcp/pcg003; Corneille S, 2001, PLANT J, V27, P171, DOI 10.1046/j.1365-313x.2001.01068.x; CORNEILLE S, IN PRESS PLANT J; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Hager M, 2002, J BIOL CHEM, V277, P14031, DOI 10.1074/jbc.M112053200; Hajdukiewicz PTJ, 2001, PLANT J, V27, P161, DOI 10.1046/j.1365-313x.2001.01067.x; HAN CD, 1992, EMBO J, V11, P4037, DOI 10.1002/j.1460-2075.1992.tb05497.x; HESS WR, 1993, EMBO J, V12, P563, DOI 10.1002/j.1460-2075.1993.tb05688.x; Kuroda H, 2002, PLANT PHYSIOL, V129, P1600, DOI 10.1104/pp.004986; Leister D, 2003, TRENDS GENET, V19, P47, DOI 10.1016/S0168-9525(02)00003-3; Marechal Eric, 2002, Trends Plant Sci, V7, P99, DOI 10.1016/S1360-1385(02)02248-3; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; McElver J, 2001, GENETICS, V159, P1751; Ow DW, 2002, PLANT MOL BIOL, V48, P183, DOI 10.1023/A:1013718106742; Peltier JB, 2001, J BIOL CHEM, V276, P16318, DOI 10.1074/jbc.M010503200; Shikanai T, 2001, PLANT CELL PHYSIOL, V42, P264, DOI 10.1093/pcp/pce031; Springer PS, 2000, PLANT CELL, V12, P1007, DOI 10.1105/tpc.12.7.1007; STAUB JM, 1993, EMBO J, V12, P601, DOI 10.1002/j.1460-2075.1993.tb05692.x; SUGIURA M, 1992, PLANT MOL BIOL, V19, P149, DOI 10.1007/BF00015612; SVAB Z, 1993, P NATL ACAD SCI USA, V90, P913, DOI 10.1073/pnas.90.3.913; Swiatek M, 2003, CURR GENET, V43, P45, DOI 10.1007/s00294-003-0369-4; Swiatek M, 2003, MOL GENET GENOMICS, V268, P699, DOI 10.1007/s00438-002-0791-1; WALBOT V, 1979, P NATL ACAD SCI USA, V76, P2760, DOI 10.1073/pnas.76.6.2760; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Zhou YN, 2001, GENE DEV, V15, P627, DOI 10.1101/gad.864401; Zubko MK, 1998, PLANT J, V15, P265, DOI 10.1046/j.1365-313X.1998.00195.x	30	146	151	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 4	2003	425	6953					86	89		10.1038/nature01909	http://dx.doi.org/10.1038/nature01909			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717LD	12955146				2022-12-01	WOS:000185089200043
J	Sung, BJ; Hwang, KY; Jeon, YH; Lee, JI; Heo, YS; Kim, JH; Moon, J; Yoon, JM; Hyun, YL; Kim, E; Eum, SJ; Park, SY; Lee, JO; Lee, TG; Ro, S; Cho, JM				Sung, BJ; Hwang, KY; Jeon, YH; Lee, JI; Heo, YS; Kim, JH; Moon, J; Yoon, JM; Hyun, YL; Kim, E; Eum, SJ; Park, SY; Lee, JO; Lee, TG; Ro, S; Cho, JM			Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules	NATURE			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; CGMP-BINDING; INHIBITORS; MECHANISM; COMPLEX; PDE5	Phosphodiesterases (PDEs) are a superfamily of enzymes that degrade the intracellular second messengers cyclic AMP and cyclic GMP(1-3). As essential regulators of cyclic nucleotide signalling with diverse physiological functions, PDEs are drug targets for the treatment of various diseases, including heart failure, depression, asthma, inflammation and erectile dysfunction(4-7). Of the 12 PDE gene families, cGMP-specific PDE5 carries out the principal cGMP-hydrolysing activity in human corpus cavernosum tissue. It is well known as the target of sildenafil citrate (Viagra) and other similar drugs for the treatment of erectile dysfunction. Despite the pressing need to develop selective PDE inhibitors as therapeutic drugs, only the cAMP-specific PDE4 structures are currently available(8,9). Here we present the three-dimensional structures of the catalytic domain (residues 537-860) of human PDE5 complexed with the three drug molecules sildenafil, tadalafil (Cialis) and vardenafil (Levitra). These structures will provide opportunities to design potent and selective PDE inhibitors with improved pharmacological profiles.	CrystalGenom Inc, Div Drug Discovery, Taejon 305390, South Korea; Yokohama City Univ, Prot Design Lab, Yokohama, Kanagawa 2300045, Japan; Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea	Yokohama City University; Korea Advanced Institute of Science & Technology (KAIST)	Ro, S (corresponding author), CrystalGenom Inc, Div Drug Discovery, Daedeok Biocommunity, Taejon 305390, South Korea.	sgro@crystalgenomics.com; jmcho@crystalgenomics.com	Lee, Jie-Oh/C-1581-2011; Lee, Jie-Oh/AAG-4302-2020; Jeon, Young Ho/F-4483-2011	Lee, Jie-Oh/0000-0001-6519-6049				BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CONTI M, 1995, ENDOCR REV, V16, P370, DOI 10.1210/er.16.3.370; Corbin JD, 1999, J BIOL CHEM, V274, P13729, DOI 10.1074/jbc.274.20.13729; Corbin JD, 2002, INT J CLIN PRACT, V56, P453; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lee JY, 2002, J NANOPART RES, V4, P53, DOI 10.1023/A:1020107522135; Mehats C, 2002, TRENDS ENDOCRIN MET, V13, P29, DOI 10.1016/S1043-2760(01)00523-9; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Orme M W, 2002, [No title captured], Patent No. [WO 0236593, 0236593]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rotella DP, 2002, NAT REV DRUG DISCOV, V1, P674, DOI 10.1038/nrd893; Rybalkin SD, 2003, EMBO J, V22, P469, DOI 10.1093/emboj/cdg051; SEKHAR KR, 1996, PHOSPHODIESTERASE IN, P135; Soderling SH, 2000, CURR OPIN CELL BIOL, V12, P174, DOI 10.1016/S0955-0674(99)00073-3; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Torphy TJ, 1998, AM J RESP CRIT CARE, V157, P351, DOI 10.1164/ajrccm.157.2.9708012; Turko IV, 1998, J BIOL CHEM, V273, P6460, DOI 10.1074/jbc.273.11.6460; Xu RX, 2000, SCIENCE, V288, P1822, DOI 10.1126/science.288.5472.1822; Young JM, 2002, EXPERT OPIN INV DRUG, V11, P1487, DOI 10.1517/13543784.11.10.1487	23	207	222	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2003	425	6953					98	102		10.1038/nature01914	http://dx.doi.org/10.1038/nature01914			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717LD	12955149				2022-12-01	WOS:000185089200046
J	Velicer, GJ; Yu, YTN				Velicer, GJ; Yu, YTN			Evolution of novel cooperative swarming in the bacterium Myxococcus xanthus	NATURE			English	Article							CELL-INTERACTIONS; SOCIAL MOTILITY; GLIDING MOTILITY; GENE; MULTICELLULARITY; EXPRESSION; EXCITATION; COHESION; FIBRILS; SYSTEMS	Cooperation among individuals is necessary for evolutionary transitions to higher levels of biological organization(1-3). In such transitions, groups of individuals at one level (such as single cells) cooperate to form selective units at a higher level (such as multicellular organisms). Though the evolution of cooperation is difficult to observe directly in higher eukaryotes, microorganisms do offer such an opportunity(4). Here we report the evolution of novel cooperative behaviour in experimental lineages of the bacterium Myxococcus xanthus. Wild-type strains of M. xanthus exhibit socially dependent swarming across soft surfaces(5) by a mechanism known as 'S-motility' that requires the presence of extracellular type IV pili(6). In lineages of M. xanthus unable to make pili, a new mechanistic basis for cooperative swarming evolved. Evolved swarming is mediated, at least in part, by enhanced production of an extracellular fibril matrix that binds cells-and their evolutionary interests-together. Though costly to individuals, fibril production greatly enhanced population expansion in groups of interconnected cells. These results show that fundamental transitions to primitive cooperation can readily occur in bacteria.	Max Planck Inst Dev Biol, Dept Evolutionary Biol, D-72076 Tubingen, Germany; Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany	Max Planck Society; Max Planck Society	Velicer, GJ (corresponding author), Max Planck Inst Dev Biol, Dept Evolutionary Biol, Spemannstr 35, D-72076 Tubingen, Germany.							ARNOLD JW, 1988, J BACTERIOL, V170, P5765, DOI 10.1128/jb.170.12.5765-5770.1988; BEHMLANDER RM, 1994, J BACTERIOL, V176, P6295, DOI 10.1128/jb.176.20.6295-6303.1994; BEHMLANDER RM, 1991, J BACTERIOL, V173, P7810, DOI 10.1128/jb.173.24.7810-7820.1991; Buss L. W., 1987, EVOLUTION INDIVIDUAL; Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; DANA JR, 1993, J BACTERIOL, V175, P3636, DOI 10.1128/jb.175.11.3636-3647.1993; HODGKIN J, 1979, MOL GEN GENET, V171, P177, DOI 10.1007/BF00270004; Kearns DB, 2001, TRENDS MICROBIOL, V9, P126, DOI 10.1016/S0966-842X(01)01948-5; Kearns DB, 2002, J BACTERIOL, V184, P1678, DOI 10.1128/JB.184.6.1678-1684.2002; Kearns DB, 2000, P NATL ACAD SCI USA, V97, P11505, DOI 10.1073/pnas.210448597; Krause J., 2002, LIVING GROUPS; Lancero H, 2002, J BACTERIOL, V184, P1462, DOI 10.1128/JB.184.5.1462-1465.2002; Li YN, 2003, P NATL ACAD SCI USA, V100, P5443, DOI 10.1073/pnas.0836639100; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; Michod RE, 2001, HEREDITY, V86, P1, DOI 10.1046/j.1365-2540.2001.00808.x; Pfeiffer T, 2003, P NATL ACAD SCI USA, V100, P1095, DOI 10.1073/pnas.0335420100; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Rodriguez AM, 1999, J BACTERIOL, V181, P4381, DOI 10.1128/JB.181.14.4381-4390.1999; SHI WY, 1993, P NATL ACAD SCI USA, V90, P3378, DOI 10.1073/pnas.90.8.3378; SHIMKETS LJ, 1986, J BACTERIOL, V166, P842, DOI 10.1128/jb.166.3.842-848.1986; Shimkets LJ, 1999, ANNU REV MICROBIOL, V53, P525, DOI 10.1146/annurev.micro.53.1.525; Velicer GJ, 1998, P NATL ACAD SCI USA, V95, P12376, DOI 10.1073/pnas.95.21.12376; Velicer GJ, 2003, TRENDS MICROBIOL, V11, P330, DOI 10.1016/S0966-842X(03)00152-5; Velicer GJ, 2002, J BACTERIOL, V184, P2719, DOI 10.1128/JB.184.10.2719-2727.2002; Wolgemuth C, 2002, CURR BIOL, V12, P369, DOI 10.1016/S0960-9822(02)00716-9; Wu SS, 1996, J BACTERIOL, V178, P5817, DOI 10.1128/jb.178.19.5817-5821.1996; WU SS, 1995, MOL MICROBIOL, V18, P547, DOI 10.1111/j.1365-2958.1995.mmi_18030547.x; Wu SS, 1997, J BACTERIOL, V179, P7748, DOI 10.1128/jb.179.24.7748-7758.1997	30	132	136	3	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 4	2003	425	6953					75	78		10.1038/nature01908	http://dx.doi.org/10.1038/nature01908			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717LD	12955143				2022-12-01	WOS:000185089200040
J	Mercer, CH; Fenton, KA; Johnson, AM; Wellings, K; Macdowall, W; McManus, S; Nanchahal, K; Erens, B				Mercer, CH; Fenton, KA; Johnson, AM; Wellings, K; Macdowall, W; McManus, S; Nanchahal, K; Erens, B			Sexual function problems and help seeking behaviour in Britain: national probability sample survey	BRITISH MEDICAL JOURNAL			English	Article							ERECTILE DYSFUNCTION; PREVALENCE; QUESTIONNAIRE; POPULATION		UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, Ctr Infect Dis Epidemiol, London WC1E 6AU, England; UCL Royal Free & Univ Coll Med Sch, Dept Sexually Transmitted Dis, London WC1E 6AU, England; Hlth Protect Agcy, Ctr Communicable Dis Surveillance, HIV STI Div, London NW9 5EQ, England; Univ London London Sch Hyg & Trop Med, Ctr Sexual & Reprod Hlth Res, London WC1E 7HT, England; Natl Ctr Social Res, Hlth Res Grp, London EC1V 0AX, England	University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School; Health Protection Agency; University of London; London School of Hygiene & Tropical Medicine	Mercer, CH (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, Ctr Infect Dis Epidemiol, London WC1E 6AU, England.	cmercer@gum.ucl.ac.uk	McManus, Sally/S-4697-2019	McManus, Sally/0000-0003-2711-0819; Macdowall, Wendy/0000-0001-5868-8336; Nanchahal, Kiran/0000-0001-8812-7628; Erens, Bob/0000-0002-4430-954X; Johnson, Anne/0000-0003-1330-7100; Mercer, Catherine/0000-0002-4220-5034; Erens, Robert/0000-0002-3054-504X				Akkus E, 2002, EUR UROL, V41, P298, DOI 10.1016/S0302-2838(02)00027-1; CRENSHAW TL, 1996, SEXUAL PHARM DRUGS A; Daker-White G, 2002, ARCH SEX BEHAV, V31, P197, DOI 10.1023/A:1014743304566; Dunn KM, 1998, FAM PRACT, V15, P519, DOI 10.1093/fampra/15.6.519; ERENS B, 2001, NATL SURVEY SEXUAL A, V2; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Finkelhor D, 1991, VIOLENCE AM PUBLIC H, P79; Goldberg D., 1988, USERS GUIDE GEN HLTH; Humphery S, 2001, FAM PRACT, V18, P516, DOI 10.1093/fampra/18.5.516; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; Kell P, 2001, INT J STD AIDS, V12, P395, DOI 10.1258/0956462011923183; Kinsey A.C., 1948, SEXUAL BEHAV HUMAN M, V27, P720, DOI 10.1037/t17515-000; Laumann E.O., 2000, SOCIAL ORG SEXUALITY; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; MCCORMICK A, 1995, MORBIDITY STAT GEN P; MERCER CH, 2003, IN PRESS BMJ; Mirone V, 2002, EUR UROL, V41, P294, DOI 10.1016/S0302-2838(02)00005-2; Moreira ED, 2001, UROLOGY, V58, P583, DOI 10.1016/S0090-4295(01)01274-2; Moynihan R, 2003, BRIT MED J, V326, P45, DOI 10.1136/bmj.326.7379.45; National Centre for Classification in Health, 2010, INT STAT CLASS DIS R; PEACH C, 1998, ETHNICITY 1991 CENSU, V2, P206; REYNOLDS CF, 1988, PSYCHIAT RES, V24, P231, DOI 10.1016/0165-1781(88)90106-0; Simons JS, 2001, ARCH SEX BEHAV, V30, P177, DOI 10.1023/A:1002729318254; TAYLOR JF, 1994, ARCH SEX BEHAV, V23, P627, DOI 10.1007/BF01541816; Tiefer L, 2000, J SEX RES, V37, P273, DOI 10.1080/00224490009552048; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003	26	262	264	0	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 23	2003	327	7412					426	427		10.1136/bmj.327.7412.426	http://dx.doi.org/10.1136/bmj.327.7412.426			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	715YY	12933730	Green Submitted, Green Published, Green Accepted			2022-12-01	WOS:000185003100020
J	Lloyd-Williams, M; Dennis, M; Taylor, F; Baker, I				Lloyd-Williams, M; Dennis, M; Taylor, F; Baker, I			Is asking patients in palliative care, "Are you depressed?" appropriate? Prospective study	BRITISH MEDICAL JOURNAL			English	Article							SINGLE QUESTION; TERMINALLY ILL		Univ Liverpool, Sch Med, Dept Primary Care, Liverpool L69 3GB, Merseyside, England; Univ Leicester, Leicester Gen Hosp, Dept Psychiat, Leicester LE5 4PW, Leics, England; LOROS Hospice, Leicester LE3 9QE, Leics, England	University of Liverpool; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester	Lloyd-Williams, M (corresponding author), Univ Liverpool, Sch Med, Dept Primary Care, Liverpool L69 3GB, Merseyside, England.							Chochinov HM, 1997, AM J PSYCHIAT, V154, P674; Hotopf M, 2002, PALLIATIVE MED, V16, P81, DOI 10.1191/02169216302pm507oa; Lloyd-Williams M, 1999, PALLIATIVE MED, V13, P243, DOI 10.1191/026921699676753309; MAHONEY J, 1994, J AM GERIATR SOC, V42, P1006; Watkins C, 2001, BRIT MED J, V323, P1159, DOI 10.1136/bmj.323.7322.1159	5	54	54	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 16	2003	327	7411					372	373		10.1136/bmj.327.7411.372	http://dx.doi.org/10.1136/bmj.327.7411.372			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	713NJ	12919988	Green Published, Bronze			2022-12-01	WOS:000184864200018
J	Abram, NJ; Gagan, MK; McCulloch, MT; Chappell, J; Hantoro, WS				Abram, NJ; Gagan, MK; McCulloch, MT; Chappell, J; Hantoro, WS			Coral reef death during the 1997 Indian Ocean dipole linked to Indonesian wildfires	SCIENCE			English	Article							WATER; IRON; PHYTOPLANKTON; PACIFIC; BIOMASS; FIRES; FRACTIONATION; LANTHANIDES; TEMPERATURE; ECOSYSTEMS	Geochemical anomalies and growth discontinuities in Porites corals from western Sumatra, Indonesia, record unanticipated reef mortality during anomalous Indian Ocean Dipole upwelling and a giant red tide in 1997. Sea surface temperature reconstructions show that although some past upwelling events have been stronger, there were no analogous episodes of coral mortality during the past 7000 years, indicating that the 1997 red tide was highly unusual. We show that iron fertilization by the 1997 Indonesian wild. res was sufficient to produce the extraordinary red tide, leading to reef death by asphyxiation. These findings highlight tropical wild. res as an escalating threat to coastal marine ecosystems.	Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Indonesian Inst Sci, Res & Dev Ctr Geotechnol, Bandung 40135, Indonesia	Australian National University; Indonesian Institute of Sciences	Abram, NJ (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia.		McCulloch, Malcolm T/C-3651-2009; Abram, Nerilie/AAT-5171-2021; Gagan, Michael/L-5014-2018	McCulloch, Malcolm T/0000-0003-1538-1558; Gagan, Michael/0000-0002-8279-323X; Abram, Nerilie/0000-0003-1246-2344				Aronson RB, 2000, NATURE, V405, P36, DOI 10.1038/35011132; Bau M, 1997, MAR CHEM, V56, P123, DOI 10.1016/S0304-4203(96)00091-6; BEHRA P, 1990, NATURE, V344, P419, DOI 10.1038/344419a0; Bishop JKB, 2002, SCIENCE, V298, P817, DOI 10.1126/science.1074961; Byrne R.H., 1996, HANDB PHYSI, VVolume 23, P497; DARRIGO RD, 1994, TERR ATMOS OCIAN SCI, V5, P349; EATON P, 2001, FOREST FIRES REGIONA; Frogner P, 2001, GEOLOGY, V29, P487, DOI 10.1130/0091-7613(2001)029<0487:FPOVAI>2.0.CO;2; Gagan MK, 1998, SCIENCE, V279, P1014, DOI 10.1126/science.279.5353.1014; Gao Y, 2001, GEOPHYS RES LETT, V28, P29, DOI 10.1029/2000GL011926; GENIN A, 1995, NATURE, V377, P507, DOI 10.1038/377507a0; Gruber N, 1999, GLOBAL BIOGEOCHEM CY, V13, P307, DOI 10.1029/1999GB900019; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; INDRAWADI, 2000, 9 INT COR REEF S A, V16, P86; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Johnson KS, 2001, GEOPHYS RES LETT, V28, P1247, DOI 10.1029/2000GL012433; Joint I, 2000, J EXP MAR BIOL ECOL, V250, P233, DOI 10.1016/S0022-0981(00)00199-4; Kinkade C, 1997, DEEP-SEA RES PT I, V44, P581, DOI 10.1016/S0967-0637(97)00002-2; Koe LCC, 2001, ATMOS ENVIRON, V35, P2723, DOI 10.1016/S1352-2310(00)00395-2; Levine JS, 1999, GEOPHYS RES LETT, V26, P815, DOI 10.1029/1999GL900067; Maenhaut W, 2002, NUCL INSTRUM METH B, V189, P259, DOI 10.1016/S0168-583X(01)01054-0; Measures CI, 1999, DEEP-SEA RES PT II, V46, P1597, DOI 10.1016/S0967-0645(99)00037-5; Murtugudde RG, 1999, J GEOPHYS RES-OCEANS, V104, P18351, DOI 10.1029/1999JC900135; Nakajima T, 1999, GEOPHYS RES LETT, V26, P2421, DOI 10.1029/1999GL900208; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43855; SHOLKOVITZ ER, 1994, GEOCHIM COSMOCHIM AC, V58, P1567, DOI 10.1016/0016-7037(94)90559-2; Siegert F, 2001, NATURE, V414, P437, DOI 10.1038/35106547; Sieh K, 1999, GEOPHYS RES LETT, V26, P3141, DOI 10.1029/1999GL005409; SIMPSON CJ, 1993, CORAL REEFS, V12, P185, DOI 10.1007/BF00334478; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; TOMASCIK T, 1997, ECOLOGY INDONESIAN S, V8, P1249; Walsh JJ, 2001, J GEOPHYS RES-OCEANS, V106, P11597, DOI 10.1029/1999JC000123; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; Wilkinson C., 2000, STATUS CORAL REEFS W, P1; WYNDHAM TD, UNPUB; Yamasoe MA, 2000, ATMOS ENVIRON, V34, P1641, DOI 10.1016/S1352-2310(99)00329-5; Zachariasen J, 1999, J GEOPHYS RES-SOL EA, V104, P895, DOI 10.1029/1998JB900050	39	170	180	4	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2003	301	5635					952	955		10.1126/science.1083841	http://dx.doi.org/10.1126/science.1083841			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711RY	12920295				2022-12-01	WOS:000184755900035
J	O'Reilly, CM; Alin, SR; Plisnier, PD; Cohen, AS; McKee, BA				O'Reilly, CM; Alin, SR; Plisnier, PD; Cohen, AS; McKee, BA			Climate change decreases aquatic ecosystem productivity of Lake Tanganyika, Africa	NATURE			English	Article							ORGANIC-MATTER; ISOTOPIC COMPOSITION; WATER; INDICATORS; SEDIMENTS; CHEMISTRY; CARBON	Although the effects of climate warming on the chemical and physical properties of lakes have been documented(1), biotic and ecosystem-scale responses to climate change have been only estimated or predicted by manipulations and models(1). Here we present evidence that climate warming is diminishing productivity in Lake Tanganyika, East Africa. This lake has historically supported a highly productive pelagic fishery that currently provides 25-40% of the animal protein supply for the populations of the surrounding countries(2). In parallel with regional warming patterns since the beginning of the twentieth century, a rise in surface-water temperature has increased the stability of the water column. A regional decrease in wind velocity has contributed to reduced mixing, decreasing deep-water nutrient upwelling and entrainment into surface waters. Carbon isotope records in sediment cores suggest that primary productivity may have decreased by about 20%, implying a roughly 30% decrease in fish yields. Our study provides evidence that the impact of regional effects of global climate change on aquatic ecosystem functions and services can be larger than that of local anthropogenic activity or overfishing.	Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; Namur Univ, Dept Biol, B-5000 Namur, Belgium; Royal Museum Cent Africa, B-3080 Tervuren, Belgium; Tulane Univ, Dept Earth & Environm Sci, New Orleans, LA 70118 USA	University of Arizona; University of Namur; Royal Museum for Central Africa; Tulane University	O'Reilly, CM (corresponding author), Vassar Coll, Environm Sci Program, Poughkeepsie, NY 12603 USA.		Plisnier, Pierre-Denis/ABG-2933-2020; Alin, Simone/J-6836-2017	Alin, Simone/0000-0002-8283-1910				BEAUCHAMP R. S. A., 1939, INTERNAL REV GES HYDROBIOL U HYDROGR, V39, P316, DOI 10.1002/iroh.19390390303; BEAUCHAMP RSA, 1953, J ECOL, V41, P226, DOI 10.2307/2257037; Brenner M, 1999, J PALEOLIMNOL, V22, P205, DOI 10.1023/A:1008078222806; Craig H., 1974, LAKE TANGANYIKA GEOC; DEGENS ET, 1971, NATURWISSENSCHAFTEN, V58, P229, DOI 10.1007/BF00602986; DUBOIS J. T., 1958, HYDROBIOLOGIA, V10, P215, DOI 10.1007/BF00142188; EDMOND JM, 1993, LIMNOL OCEANOGR, V38, P725, DOI 10.4319/lo.1993.38.4.0725; Goddard L, 1999, J GEOPHYS RES-ATMOS, V104, P19099, DOI 10.1029/1999JD900326; HECKY RE, 1994, LIMNOL OCEANOGR, V39, P1476, DOI 10.4319/lo.1994.39.6.1476; Hodell DA, 1998, LIMNOL OCEANOGR, V43, P200, DOI 10.4319/lo.1998.43.2.0200; Houghton J. T., 2001, CLIMATE CHANGE 2001; Hulme M, 2001, CLIM RES, V17, P145, DOI 10.3354/cr017145; IDSO SB, 1973, LIMNOL OCEANOGR, V18, P681, DOI 10.4319/lo.1973.18.4.0681; LEHMAN J. T., 1998, ENV CHANGE RESPONSE, P157; Mannini P., 1998, GEOGRAPHICAL DISTRIB; MARQUARDSEN H, 1916, MITTEILUNGEN DTSCH S, V29, P97; McKnight Diane, 1996, Limnology and Oceanography, V41, P815; MEYERS PA, 1993, ORG GEOCHEM, V20, P867, DOI 10.1016/0146-6380(93)90100-P; Molsa H, 1999, HYDROBIOLOGIA, V407, P1, DOI 10.1023/A:1003712708969; NIXON SW, 1988, LIMNOL OCEANOGR, V33, P1005, DOI 10.4319/lo.1988.33.4_part_2.1005; O'Reilly CM, 2002, LIMNOL OCEANOGR, V47, P306, DOI 10.4319/lo.2002.47.1.0306; PATTERSON G, 1995, FISHERY POTENTIAL PR, P1; Plisnier PD, 1999, HYDROBIOLOGIA, V407, P45, DOI 10.1023/A:1003762119873; Popp BN, 1998, GEOCHIM COSMOCHIM AC, V62, P69, DOI 10.1016/S0016-7037(97)00333-5; Shirakihara Kunio, 1992, African Study Monographs, V13, P57; TALBOT MR, 1992, EARTH PLANET SC LETT, V110, P23, DOI 10.1016/0012-821X(92)90036-U; Tiercelin J., 1991, LAKE TANGANYIKA ITS, P7; van Zwieten PAM, 2002, FISH RES, V54, P329, DOI 10.1016/S0165-7836(01)00267-3; VANMEEL L, 1987, CONTRIBUTION LIMNOLO, V2; VANMEEL LIJ, 1987, CONTRIBUTION LIMNOLO, V1; VERBURG P, 1997, HYDRODYNAMICS LAKE T	31	436	475	13	249	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 14	2003	424	6950					766	768		10.1038/nature01833	http://dx.doi.org/10.1038/nature01833			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12917682				2022-12-01	WOS:000184733900037
J	Hannan, EL; Racz, MJ; Walford, G; Ryan, TJ; Isom, OW; Bennett, E; Jones, RH				Hannan, EL; Racz, MJ; Walford, G; Ryan, TJ; Isom, OW; Bennett, E; Jones, RH			Predictors of readmission for complications of coronary artery bypass graft surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEW-YORK-STATE; HOSPITAL READMISSION; OUTCOMES; QUALITY; MORTALITY; CHOICE; RATES; CARE	Context Risk factors for perioperative mortality after coronary artery bypass graft (CABG) surgery have been extensively studied. However, which factors are associated with early readmissions following CABG surgery are less clear. Objective To identify significant predictors of readmission within 30 days following CABG surgery. Design, Setting, and Patients Causes for readmission within 30 days were investigated for all patients discharged after CABG surgery in the state of New York from January 1, 1999, through December 31, 1999. A variety of patient demographics, preoperative risk factors, complications, operative and postoperative factors, and provider characteristics were considered as potential predictors of readmissions. Main Outcome Measure Hospital readmissions within 30 days of discharge following CABG surgery. Results Of 16325 total patients, 2111 (12.9%) were readmitted within 30 days for reasons related to CABG surgery. The most common causes of readmission were postsurgical infection (n=598 [28%]) and heart failure (n=331 [16%]). Eleven risk factors were found to be independently associated with higher readmission rates: older age, female sex, African American race, greater body surface area, previous myocardial infarction within 1 week, and 6 comorbidities. After controlling for these preoperative patient-level risk factors, 2 provider characteristics (annual surgeon CABG volume <100, hospital risk-adjusted mortality rate in the highest decile) and 2 postoperative factors (discharge to nursing home or rehabilitation/acute care facility, length of stay during index CABG admission of &GE;5 days) were also related to higher readmission rates. Conclusions Readmission within 30 days following discharge is an important adverse outcome of CABG surgery. Continued attempts should be made to explore the potential of readmission as a supplement to mortality in assessing provider quality.	SUNY Albany, Sch Publ Hlth, Dept Hlth Policy Management & Behav, Rensselaer, NY 12144 USA; St Josephs Hosp, Cardiac Catheterizat Lab, Syracuse, NY USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; New York Hosp Cornell, Dept Cardiothorac Surg, New York, NY USA; St Peters Hosp, Dept Cardiac Surg, Albany, NY USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; Boston University; NewYork-Presbyterian Hospital; Duke University	Hannan, EL (corresponding author), SUNY Albany, Sch Publ Hlth, Dept Hlth Policy Management & Behav, 1 Univ Pl, Rensselaer, NY 12144 USA.							*AM HEART ASS, 2002, 2002 HEART STROK STA; Cowper PA, 1997, J AM COLL CARDIOL, V30, P908, DOI 10.1016/S0735-1097(97)00243-X; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HANNAN EL, 1990, JAMA-J AM MED ASSOC, V264, P2768, DOI 10.1001/jama.264.21.2768; HANNAN EL, 1995, JAMA-J AM MED ASSOC, V273, P209, DOI 10.1001/jama.273.3.209; HANNAN EL, 1994, ANN THORAC SURG, V58, P1852, DOI 10.1016/0003-4975(94)91726-4; HANNAN EL, 1994, JAMA-J AM MED ASSOC, V271, P761, DOI 10.1001/jama.271.10.761; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; Kiefe C, 1999, MED CARE, V37, P621, DOI 10.1097/00005650-199907000-00001; *NJ DEP HLTH SEN S, 1997, COR ART BYP GRAFT SU; *NY STAT DEP HLTH, 2002, COR ART BYP SURG NEW; OCONNOR GT, 1992, CIRCULATION, V85, P2110, DOI 10.1161/01.CIR.85.6.2110; *PA HLTH CAR COST, 2002, PENNS GUID COR ART B; *PAC BUS GROUP HLT, 2001, CAL REP COR ART BYP; *PENNS HLTH CAR CO, 2001, HOSP READM FOLL COR; RILEY G, 1993, MED CARE, V31, P921, DOI 10.1097/00005650-199310000-00005; ROSENTHAL GE, 1994, JOINT COMM J QUAL IM, V20, P425, DOI 10.1016/S1070-3241(16)30088-8; Silber JH, 1997, INT J QUAL HEALTH C, V9, P193, DOI 10.1093/intqhc/9.3.193; SILBER JH, 1995, JAMA-J AM MED ASSOC, V274, P317, DOI 10.1001/jama.274.4.317; STANTON BA, 1985, JAMA-J AM MED ASSOC, V253, P3568; Steuer J, 2002, ANN THORAC SURG, V73, P1380, DOI 10.1016/S0003-4975(02)03467-7; Stewart RD, 2000, ANN THORAC SURG, V70, P169, DOI 10.1016/S0003-4975(00)01386-2; Thomas JW, 1996, INQUIRY-J HEALTH CAR, V33, P258; Tu JV, 1998, CAN MED ASSOC J, V159, P221; *US DEP HHS, 1998, INT CLASS DIS; Zitser-Gurevich Y, 1999, MED CARE, V37, P625, DOI 10.1097/00005650-199907000-00002	26	190	193	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2003	290	6					773	780		10.1001/jama.290.6.773	http://dx.doi.org/10.1001/jama.290.6.773			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	709VU	12915430	Bronze			2022-12-01	WOS:000184647700028
J	Seidenbecher, T; Laxmi, TR; Stork, O; Pape, HC				Seidenbecher, T; Laxmi, TR; Stork, O; Pape, HC			Amygdalar and hippocampal theta rhythm synchronization during fear memory retrieval	SCIENCE			English	Article							LONG-TERM POTENTIATION; BASOLATERAL AMYGDALA; IN-VIVO; SYNAPTIC PLASTICITY; PERIRHINAL CORTEX; LATERAL AMYGDALA; CONSCIOUS CATS; DENTATE GYRUS; STIMULATION; OSCILLATIONS	The amygdalohippocampal circuit plays a pivotal role in Pavlovian fear memory. We simultaneously recorded electrical activity in the lateral amygdala (LA) and the CA1 area of the hippocampus in freely behaving fear-conditioned mice. Patterns of activity were related to fear behavior evoked by conditioned and indifferent sensory stimuli and contexts. Rhythmically synchronized activity at theta frequencies increased between the LA and the CA1 after fear conditioning and became significant during confrontation with conditioned fear stimuli and expression of freezing behavior. Synchronization of theta activities in the amygdalohippocampal network represents a neuronal correlate of conditioned fear, apt to improve neuronal communication during memory retrieval.	Otto Von Guericke Univ, Inst Physiol, D-39120 Magdeburg, Germany	Otto von Guericke University	Pape, HC (corresponding author), Otto Von Guericke Univ, Inst Physiol, Leipziger Str 44, D-39120 Magdeburg, Germany.		Laxmi, T. R./T-9769-2019	Laxmi, T. R./0000-0001-8147-9559; Stork, Oliver/0000-0003-4285-7507				Akirav I, 1999, J NEUROSCI, V19, P10530; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Cahill L, 2000, PROG BRAIN RES, V126, P29; CAHILL L, 2001, AMYGDALA FUNCTIONAL, P425; Collins DR, 1999, NEUROSCIENCE, V89, P1025, DOI 10.1016/S0306-4522(98)00396-0; Frey S, 2001, J NEUROSCI, V21, P3697, DOI 10.1523/JNEUROSCI.21-10-03697.2001; Heinbockel T, 2000, J NEUROSCI, V20; IKEGAYA Y, 1994, BRAIN RES, V656, P157, DOI 10.1016/0006-8993(94)91377-3; IKEGAYA Y, 1995, J NEUROPHYSIOL, V74, P2201, DOI 10.1152/jn.1995.74.5.2201; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Maren S, 1999, TRENDS NEUROSCI, V22, P561, DOI 10.1016/S0166-2236(99)01465-4; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; MAREN S, 1995, J NEUROSCI, V15, P7548; Maren S, 2001, NEUROBIOL LEARN MEM, V76, P268, DOI 10.1006/nlme.2001.4042; PACKARD MG, 1994, P NATL ACAD SCI USA, V91, P8477, DOI 10.1073/pnas.91.18.8477; Pape HC, 1998, J NEUROPHYSIOL, V79, P205, DOI 10.1152/jn.1998.79.1.205; PARE D, 1995, J NEUROPHYSIOL, V74, P1179, DOI 10.1152/jn.1995.74.3.1179; Pare D, 1996, J NEUROSCI, V16, P3334; Pare D, 2000, J NEUROSCI, V20, P2701; Pare D, 2002, TRENDS COGN SCI, V6, P306, DOI 10.1016/S1364-6613(02)01924-1; PHILLIPS RG, 1994, LEARN MEMORY, V1, P34; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Vertes RP, 2001, NEUROSCIENCE, V104, P619, DOI 10.1016/S0306-4522(01)00131-2; Vertes RP, 1997, NEUROSCIENCE, V81, P893; Willingham DB, 1997, NEURON, V18, P5, DOI 10.1016/S0896-6273(01)80040-4	28	524	533	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					846	850		10.1126/science.1085818	http://dx.doi.org/10.1126/science.1085818			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907806				2022-12-01	WOS:000184615700049
J	Goriely, A; McVean, GAT; Rojmyr, M; Ingemarsson, B; Wilkie, AOM				Goriely, A; McVean, GAT; Rojmyr, M; Ingemarsson, B; Wilkie, AOM			Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line	SCIENCE			English	Article								Observed mutation rates in humans appear higher in male than female gametes and often increase with paternal age. This bias, usually attributed to the accumulation of replication errors or inefficient repair processes, has been difficult to study directly. Here, we describe a sensitive method to quantify substitutions at nucleotide 755 of the fibroblast growth factor receptor 2 (FGFR2) gene in sperm. Although substitution levels increase with age, we show that even high levels originate from infrequent mutational events. We propose that these FGFR2 mutations, although harmful to embryonic development, are paradoxically enriched because they confer a selective advantage to the spermatogonial cells in which they arise.	Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DS, England; Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Pyrosequencing AB, SE-75228 Uppsala, Sweden	University of Oxford; University of Oxford; University of Oxford	Wilkie, AOM (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.		Goriely, Anne/AAR-1133-2020; Wilkie, Andrew/AAC-3820-2020	Wilkie, Andrew/0000-0002-2972-5481; Goriely, Anne/0000-0001-9229-7216				Anderson J, 1998, HUM MOL GENET, V7, P1475, DOI 10.1093/hmg/7.9.1475; COHEN MM, 1992, AM J MED GENET, V42, P655, DOI 10.1002/ajmg.1320420505; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Ibrahimi OA, 2001, P NATL ACAD SCI USA, V98, P7182, DOI 10.1073/pnas.121183798; Jang JH, 2001, CANCER RES, V61, P3541; Kan S, 2002, AM J HUM GENET, V70, P472, DOI 10.1086/338758; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Lajeunie E, 1999, J NEUROSURG, V90, P443, DOI 10.3171/jns.1999.90.3.0443; Li WH, 2002, CURR OPIN GENET DEV, V12, P650, DOI 10.1016/S0959-437X(02)00354-4; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; MUENKE M, 2001, METABOLIC MOL BASES, P6117; Nachman MW, 2000, GENETICS, V156, P297; Oldridge M, 1997, HUM MOL GENET, V6, P137, DOI 10.1093/hmg/6.1.137; OROURKE AW, UNPUB; Otto SP, 1998, GENETICA, V102-3, P507, DOI 10.1023/A:1017074823337; RISCH N, 1987, AM J HUM GENET, V41, P218; Tiemann-Boege I, 2002, P NATL ACAD SCI USA, V99, P14952, DOI 10.1073/pnas.232568699; Tolarova MM, 1997, AM J MED GENET, V72, P394, DOI 10.1002/(SICI)1096-8628(19971112)72:4<394::AID-AJMG4>3.0.CO;2-R; Tomlinson IPM, 1996, P NATL ACAD SCI USA, V93, P14800, DOI 10.1073/pnas.93.25.14800; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; Wilkie AOM, 2002, AM J MED GENET, V112, P266, DOI 10.1002/ajmg.10775; Yu K, 2000, P NATL ACAD SCI USA, V97, P14536, DOI 10.1073/pnas.97.26.14536	24	202	214	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2003	301	5633					643	646		10.1126/science.1085710	http://dx.doi.org/10.1126/science.1085710			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893942				2022-12-01	WOS:000184473600039
J	Gu, C; Jan, YN; Jan, LY				Gu, C; Jan, YN; Jan, LY			A conserved domain in axonal targeting of Kv1 (shaker) voltage-gated potassium channels	SCIENCE			English	Article							BETA-SUBUNIT; K+ CHANNEL; SURFACE; RELEASE; MICE; GENE	Axonal voltage-gated potassium (Kv1) channels regulate action-potential invasion and hence transmitter release. Although evolutionarily conserved, what mediates their axonal targeting is not known. We found that Kv1 axonal targeting required its T1 tetramerization domain. When fused to unpolarized CD4 or dendritic transferrin receptor, T1 promoted their axonal surface expression. Moreover, T1 mutations eliminating Kvbeta association compromised axonal targeting, but not surface expression, of CD4-T1 fusion proteins. Thus, proper association of Kvbeta with the Kv1 T1 domain is essential for axonal targeting.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.		Gu, Chen/E-3163-2011	Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498				Baccus SA, 2000, J NEUROPHYSIOL, V83, P1693, DOI 10.1152/jn.2000.83.3.1693; Brody DL, 2000, J NEUROSCI, V20, P2480; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Campomanes CR, 2002, J BIOL CHEM, V277, P8298, DOI 10.1074/jbc.M110276200; Debanne D, 1997, NATURE, V390, P536, DOI 10.1038/37406; Fili O, 2001, J NEUROSCI, V21, P1964, DOI 10.1523/JNEUROSCI.21-06-01964.2001; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Hattan D, 2002, J BIOL CHEM, V277, P38596, DOI 10.1074/jbc.M205005200; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; Kosolapov A, 2003, J BIOL CHEM, V278, P4305, DOI 10.1074/jbc.M209422200; Lambe EK, 2001, J NEUROSCI, V21, P9955, DOI 10.1523/JNEUROSCI.21-24-09955.2001; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Manganas LN, 2000, J BIOL CHEM, V275, P29685, DOI 10.1074/jbc.M005010200; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Monaghan MM, 2001, J NEUROSCI, V21, P5973, DOI 10.1523/JNEUROSCI.21-16-05973.2001; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Schulteis CT, 1998, J BIOL CHEM, V273, P26210, DOI 10.1074/jbc.273.40.26210; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Zhou L, 1998, J NEUROSCI, V18, P7200	23	126	130	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2003	301	5633					646	649		10.1126/science.1086998	http://dx.doi.org/10.1126/science.1086998			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893943				2022-12-01	WOS:000184473600040
J	de Lemos, JA; McGuire, DK; Drazner, MH				de Lemos, JA; McGuire, DK; Drazner, MH			B-type natriuretic peptide in cardiovascular disease	LANCET			English	Review							CHRONIC HEART-FAILURE; N-TERMINAL PROATRIAL; LEFT-VENTRICULAR DYSFUNCTION; BETA-BLOCKER THERAPY; NEUROHORMONAL ACTIVATION; DIASTOLIC DYSFUNCTION; PROGNOSTIC VALUE; GENE-EXPRESSION; PLASMA-LEVELS; DOUBLE-BLIND	Natriuretic peptide hormones, a family of vasoactive peptides with many favourable physiological properties, have emerged as important candidates for development of diagnostic tools and therapeutic agents in cardiovascular disease. The rapid incorporation into clinical practice of bioassays to measure natriuretic peptide concentrations, and drugs that augment the biological actions of this system, show the potential for translational research to improve patient care. Here, we focus on the physiology of the natriuretic peptide system, measurement of circulating concentrations of B-type natriuretic peptide (BNP) and the N-terminal fragment of its prohormone (N-terminal SNP) to diagnose heart failure and left ventricular dysfunction, measurement of BNP and N-terminal BNP to assess prognosis in patients with cardiac abnormalities, and use of recombinant human BNP (nesiritide) and vasopeptidase inhibitors to treat heart failure.	Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	de Lemos, JA (corresponding author), Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA.	james.delemos@utsouthwestern.edu	de Lemos, James/ABD-6669-2021					Abraham W T, 1998, J Card Fail, V4, P37, DOI 10.1016/S1071-9164(98)90506-1; ATARASHI K, 1985, J CLIN INVEST, V76, P1807, DOI 10.1172/JCI112172; Bando M, 1999, RESP MED, V93, P507, DOI 10.1016/S0954-6111(99)90094-X; Berger R, 2002, CIRCULATION, V105, P2392, DOI 10.1161/01.CIR.0000016642.15031.34; Bolger AP, 2002, CIRCULATION, V106, P92, DOI 10.1161/01.CIR.0000020009.30736.3F; Bruneau BG, 1997, AM J PHYSIOL-HEART C, V273, pH2678, DOI 10.1152/ajpheart.1997.273.6.H2678; Brunner-La Rocca HP, 2001, J AM COLL CARDIOL, V37, P1221, DOI 10.1016/S0735-1097(01)01172-X; Burger AJ, 2001, AM J CARDIOL, V88, P35, DOI 10.1016/S0002-9149(01)01581-8; BURNETT JC, 1984, AM J PHYSIOL, V247, pF863, DOI 10.1152/ajprenal.1984.247.5.F863; CAO L, 1995, HYPERTENSION, V25, P227, DOI 10.1161/01.HYP.25.2.227; CHARLES CJ, 1995, PEPTIDES, V16, P129, DOI 10.1016/0196-9781(94)00160-8; Cheng V, 2001, J AM COLL CARDIOL, V37, P386, DOI 10.1016/S0735-1097(00)01157-8; CHRISTENSEN G, 1991, CIRC RES, V68, P638, DOI 10.1161/01.RES.68.3.638; Cirillo W, 2000, CIRCULATION, V101, P378, DOI 10.1161/01.CIR.101.4.378; CLARKSON PBM, 1995, CLIN SCI, V88, P159, DOI 10.1042/cs0880159; Colucci WS, 2000, NEW ENGL J MED, V343, P246, DOI 10.1056/NEJM200007273430403; Corti R, 2001, CIRCULATION, V104, P1856, DOI 10.1161/hc4001.097191; Cowie MR, 1997, LANCET, V350, P1349, DOI 10.1016/S0140-6736(97)06031-5; Dao Q, 2001, J AM COLL CARDIOL, V37, P379, DOI 10.1016/S0735-1097(00)01156-6; DAVIS M, 1994, LANCET, V343, P440, DOI 10.1016/S0140-6736(94)92690-5; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; Doyama K, 1998, J AM COLL CARDIOL, V32, P1832, DOI 10.1016/S0735-1097(98)00494-X; EDWARDS BS, 1988, CIRC RES, V62, P191, DOI 10.1161/01.RES.62.2.191; FLORAS JS, 1990, CIRCULATION, V81, P1860, DOI 10.1161/01.CIR.81.6.1860; HAMA N, 1995, CIRCULATION, V92, P1558, DOI 10.1161/01.CIR.92.6.1558; Hammerer-Lercher A, 2001, CLIN CHIM ACTA, V310, P193, DOI 10.1016/S0009-8981(01)00578-2; Harrison A, 2002, ANN EMERG MED, V39, P131, DOI 10.1067/mem.2002.121483; HENRY JP, 1956, J PHYSIOL-LONDON, V131, P572, DOI 10.1113/jphysiol.1956.sp005483; Hobbs RE, 1996, AM J CARDIOL, V78, P896, DOI 10.1016/S0002-9149(96)00464-X; HOLMES SJ, 1993, J CLIN ENDOCR METAB, V76, P91, DOI 10.1210/jc.76.1.91; HOSODA K, 1991, HYPERTENSION, V17, P1152, DOI 10.1161/01.HYP.17.6.1152; HUNT PJ, 1994, J CLIN ENDOCR METAB, V78, P1428, DOI 10.1210/jc.78.6.1428; Ishii J, 2000, CLIN CHIM ACTA, V301, P19, DOI 10.1016/S0009-8981(00)00312-0; Isnard R, 2000, AM J CARDIOL, V86, P417, DOI 10.1016/S0002-9149(00)00957-7; ITOH H, 1990, J CLIN INVEST, V86, P1690, DOI 10.1172/JCI114893; Jernberg T, 2002, J AM COLL CARDIOL, V40, P437, DOI 10.1016/S0735-1097(02)01986-1; Johnson W, 2002, J AM COLL CARDIOL, V39, P1623, DOI 10.1016/S0735-1097(02)01814-4; KANGAWA K, 1984, BIOCHEM BIOPH RES CO, V119, P933, DOI 10.1016/0006-291X(84)90863-5; Kawai K, 2001, AM HEART J, V141, P925, DOI 10.1067/mhj.2001.115435; Kazanegra R, 2001, J CARD FAIL, V7, P21, DOI 10.1054/jcaf.2001.23355; KISCH B, 1956, Exp Med Surg, V14, P99; Klapholz M, 2001, AM J CARDIOL, V88, P657, DOI 10.1016/S0002-9149(01)01809-4; Koglin J, 2001, J AM COLL CARDIOL, V38, P1934, DOI 10.1016/S0735-1097(01)01672-2; LADENSON PW, 1988, ENDOCRINOLOGY, V123, P652, DOI 10.1210/endo-123-1-652; Lainchbury JG, 1997, HYPERTENSION, V30, P398, DOI 10.1161/01.HYP.30.3.398; Latini R, 2002, CIRCULATION, V106, P2454, DOI 10.1161/01.CIR.0000036747.68104.AC; Lubien E, 2002, CIRCULATION, V105, P595, DOI 10.1161/hc0502.103010; Luchner A, 2000, J HYPERTENS, V18, P1121, DOI 10.1097/00004872-200018080-00018; Maeda K, 2000, J AM COLL CARDIOL, V36, P1587, DOI 10.1016/S0735-1097(00)00912-8; Maisel AS, 2001, AM HEART J, V141, P367, DOI 10.1067/mhj.2001.113215; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Mallamaci F, 2001, KIDNEY INT, V59, P1559, DOI 10.1046/j.1523-1755.2001.0590041559.x; Marcus LS, 1996, CIRCULATION, V94, P3184, DOI 10.1161/01.CIR.94.12.3184; MARGULIES KB, 1995, CIRCULATION, V91, P2036, DOI 10.1161/01.CIR.91.7.2036; MARINGREZ M, 1986, NATURE, V324, P473, DOI 10.1038/324473a0; Matsuo K, 1998, CIRCULATION, V98, P2433, DOI 10.1161/01.CIR.98.22.2433; McClean DR, 2000, J AM COLL CARDIOL, V36, P479, DOI 10.1016/S0735-1097(00)00741-5; McCullough PA, 2002, CIRCULATION, V106, P416, DOI 10.1161/01.CIR.0000025242.79963.4C; McDonagh TA, 2001, HEART, V86, P21, DOI 10.1136/heart.86.1.21; Messerli FH, 2000, LANCET, V356, P608, DOI 10.1016/S0140-6736(00)02596-4; MINAMINO N, 1991, BIOCHEM BIOPH RES CO, V179, P535, DOI 10.1016/0006-291X(91)91404-Z; Mitchell GF, 2002, CIRCULATION, V105, P2955, DOI 10.1161/01.CIR.0000020500.77568.3C; Mizuno Y, 2000, AM J CARDIOL, V86, P1036, DOI 10.1016/S0002-9149(00)01147-4; Morrison LK, 2002, J AM COLL CARDIOL, V39, P202, DOI 10.1016/S0735-1097(01)01744-2; MOTWANI JG, 1993, LANCET, V341, P1109, DOI 10.1016/0140-6736(93)93126-L; MUKOYAMA M, 1991, J CLIN INVEST, V87, P1402, DOI 10.1172/JCI115146; Murdoch DR, 1999, AM HEART J, V138, P1126, DOI 10.1016/S0002-8703(99)70079-7; Nagaya N, 1998, AM HEART J, V135, P21, DOI 10.1016/S0002-8703(98)70338-2; Nagaya N, 1998, J AM COLL CARDIOL, V31, P202, DOI 10.1016/S0735-1097(97)00452-X; Nagaya N, 2000, CIRCULATION, V102, P865; NAKAMURA S, 1991, AM J HYPERTENS, V4, P909, DOI 10.1093/ajh/4.11.909; NAKAO K, 1991, CAN J PHYSIOL PHARM, V69, P1500, DOI 10.1139/y91-225; Nishimori T, 1997, J MOL CELL CARDIOL, V29, P2125, DOI 10.1006/jmcc.1997.0460; Okumura H, 2000, ACTA HAEMATOL-BASEL, V104, P158, DOI 10.1159/000046508; Omland T, 1996, CIRCULATION, V93, P1963, DOI 10.1161/01.CIR.93.11.1963; Omland T, 1996, HEART, V76, P232, DOI 10.1136/hrt.76.3.232; Omland T, 2002, AM J CARDIOL, V89, P463, DOI 10.1016/S0002-9149(01)02271-8; Onuoha GN, 1998, NEUROPEPTIDES, V32, P319, DOI 10.1016/S0143-4179(98)90054-3; Osca JQ, 2001, CIRCULATION, V104, P501; Packer M, 2002, CIRCULATION, V106, P920, DOI 10.1161/01.CIR.0000029801.86489.50; PUCCI A, 1992, INT J CARDIOL, V34, P237, DOI 10.1016/0167-5273(92)90020-4; Qi W, 2001, AM HEART J, V142, P725, DOI 10.1067/mhj.2001.117131; Rame JE, 2001, AM HEART J, V142, P714, DOI 10.1067/mhj.2001.118473; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; RICHARDS AM, 1988, J CLIN ENDOCR METAB, V67, P1134, DOI 10.1210/jcem-67-6-1134; Richards AM, 1998, CIRCULATION, V97, P1921, DOI 10.1161/01.CIR.97.19.1921; Richards AM, 1999, HEART, V81, P114, DOI 10.1136/hrt.81.2.114; Richards AM, 1999, CIRCULATION, V99, P786, DOI 10.1161/01.CIR.99.6.786; Richards AM, 2001, J AM COLL CARDIOL, V37, P1781, DOI 10.1016/S0735-1097(01)01269-4; RICHARDS AM, 1993, BRIT HEART J, V69, P414; RIDDERVOLD F, 1991, AM J PHYSIOL, V260, pH1953, DOI 10.1152/ajpheart.1991.260.6.H1953; Rouleau JL, 2000, LANCET, V356, P615, DOI 10.1016/S0140-6736(00)02602-7; SANDERSON JE, 1995, BRIT HEART J, V74, P502; SONNENBERG JL, 1988, PEPTIDES, V9, P173, DOI 10.1016/0196-9781(88)90024-1; Stanek B, 2001, J AM COLL CARDIOL, V38, P436, DOI 10.1016/S0735-1097(01)01383-3; Struthers AD, 2002, LANCET, V359, P1430, DOI 10.1016/S0140-6736(02)08358-7; SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; SUGA S, 1992, J CLIN INVEST, V90, P1145, DOI 10.1172/JCI115933; SUGA SI, 1992, ENDOCRINOLOGY, V130, P229, DOI 10.1210/en.130.1.229; SUMIDA H, 1995, J AM COLL CARDIOL, V25, P1105, DOI 10.1016/0735-1097(94)00525-U; Takemura G, 1998, J AM COLL CARDIOL, V31, P754, DOI 10.1016/S0735-1097(98)00045-X; TONOLO G, 1989, CIRCULATION, V80, P893, DOI 10.1161/01.CIR.80.4.893; Troughton RW, 2000, LANCET, V355, P1126, DOI 10.1016/S0140-6736(00)02060-2; Tsutamoto T, 2001, J AM COLL CARDIOL, V37, P1228, DOI 10.1016/S0735-1097(01)01116-0; *UMAC INV, 2002, JAMA-J AM MED ASSOC, V287, P1531; van Veldhuisen DJ, 1998, J AM COLL CARDIOL, V32, P1811, DOI 10.1016/S0735-1097(98)00464-1; Vasan RS, 2002, JAMA-J AM MED ASSOC, V288, P1252, DOI 10.1001/jama.288.10.1252; Wallen T, 1997, HEART, V77, P264, DOI 10.1136/hrt.77.3.264; Wang TJ, 2002, AM J CARDIOL, V90, P254, DOI 10.1016/S0002-9149(02)02464-5; Wiese S, 2000, CIRCULATION, V102, P3074; Williams ES, 2002, J AM COLL CARDIOL, V40, P1; Yamamoto K, 1996, HYPERTENSION, V28, P988, DOI 10.1161/01.HYP.28.6.988; YASUE H, 1994, CIRCULATION, V90, P195, DOI 10.1161/01.CIR.90.1.195; YOSHIMURA M, 1993, CIRCULATION, V87, P464, DOI 10.1161/01.CIR.87.2.464; Yu CM, 1996, EUR HEART J, V17, P1694	117	792	810	0	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					316	322		10.1016/S0140-6736(03)13976-1	http://dx.doi.org/10.1016/S0140-6736(03)13976-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892964				2022-12-01	WOS:000184413400025
J	Kikule, E				Kikule, E			A good death in Uganda: survey of needs for palliative care for terminally ill people in urban areas	BRITISH MEDICAL JOURNAL			English	Article								Objective To identify the palliative care needs of terminally ill people in Uganda. Design Descriptive cross sectional study. Setting Home care programmes in and around Kampala that look after terminally ill people in their homes. Participants 173 terminally ill patients registered with the home care programmes. Results Most of the participants had either HIV/AIDS or cancer or both; 145 were aged under 50 years, and 107 were women. Three main needs were identified: the control or relief of pain and other symptoms; counselling; and financial assistance for basic needs such as food, shelter, and school fees for their children. The preferred site of care was the home, though all these people lived in urban areas with access to healthcare services within 5 kin of their homes. Conclusion A "good death" in a developing country occurs when the dying person is being cared for at home, is free from pain or other distressing symptoms, feels no stigma, is at peace, and has their basic needs met without feeling dependent on others.	Hospice Africa Uganda, Kampala, Uganda		Kikule, E (corresponding author), Hospice Africa Uganda, POB 7757, Kampala, Uganda.							KATABIRA E, 1998, WORLD HLTH, P16; Kish L, 1965, SURVEY SAMPLING; *MIN ENV, 1999, POLL CHECK RES 98 EV, P10; Murray SA, 2003, BRIT MED J, V326, P368, DOI 10.1136/bmj.326.7385.368; OKUONZI SA, 2003, UGANDA HLTH B J  JAN, P9; REGNARD FBC, 1998, GUIDE SYMPTOM RELIEF; SIMS R, 1995, TERMINAL CARE PEOPLE, P1; *UN DEV PROGR, 2000, UG HUM DEV REP; *UNAIDS WHO, 1998, AIDS EP UPD DEC, P1; 1990, WHO TECH REP SER, V804, P1	10	72	73	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2003	327	7408					192	194		10.1136/bmj.327.7408.192	http://dx.doi.org/10.1136/bmj.327.7408.192			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706DL	12881259	Bronze, Green Published			2022-12-01	WOS:000184437300015
J	Norris, JM; Barriga, K; Klingensmith, G; Hoffman, M; Eisenbarth, GS; Erlich, HA; Rewers, M				Norris, JM; Barriga, K; Klingensmith, G; Hoffman, M; Eisenbarth, GS; Erlich, HA; Rewers, M			Timing of initial cereal exposure in infancy and risk of islet autoimmunity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEPENDENT DIABETES-MELLITUS; BETA-CELL AUTOIMMUNITY; CELIAC-DISEASE; COWS MILK; YOUNG DAISY; AUTOANTIBODIES; INSULIN; CHILDHOOD; IDDM; ASSOCIATION	Context Dietary exposures in infancy have been implicated, albeit inconsistently, in the etiology of type 1 diabetes mellitus (DM). Objective To examine the association between cereal exposures in the infant diet and appearance of islet autoimmunity (IA). Design Birth cohort study conducted from 1994 to 2002 with a mean follow-up of 4 years. Setting Newborn screening for HLA was done at St Joseph's Hospital in Denver, Colo. First-degree relatives of type 1 DM individuals were recruited from the Denver metropolitan area. Participants We enrolled 1183 children at increased type 1 DM risk, defined as either HLA genotype or having a first-degree relative with type 1 DM, at birth and followed them prospectively. We obtained exposure and outcome measures for 76% of enrolled children. Participants had variable lengths of follow-up (9 months to 9 years). Main Outcome Measures Blood draws for the detection of insulin autoantibody, glutamic acid decarboxylase autoantibody, or IA-2 autoantibody were performed at 9, 15, and 24 months and annually thereafter. Children with A (n=34) were defined as those testing positive for at least 1 of the autoantibodies on 2 or more consecutive visits and who tested positive or had diabetes on their most recent visit. Results Children initially exposed to cereals between ages 0 and 3 months (hazard ratio [HR], 4.32; 95% confidence interval [CI], 2.0-9.35) and those who were exposed at 7 months or older (HR, 5.36; 95% Cl, 2.08-13.8) had increased hazard of A compared with those who were exposed during the fourth through sixth month, after adjustment for HLA genotype, family history of type 1 DM, ethnicity, and maternal age. In children who were positive for the HLA-DRB1*03/04,DQB8 genotype, adjusted HRs Were 5.55 (95% Cl, 1.92-16.03) and 12.53 (95% Cl, 3.19-49.23) for initial cereal exposure between ages 0 to 3 months and at 7 months or older, respectively. Conclusion There maybe a window of exposure to cereals in infancy outside which initial exposure increases A risk in susceptible children.	Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA; Roche Mol Syst Inc, Dept Human Genet, Alameda, CA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Roche Holding	Norris, JM (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, 4200 E 9th Ave,Box B119, Denver, CO 80262 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032493, R01DK049654] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK32493, R01-DK49654] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allison P., 1995, SURVIVAL ANAL USING; Ascher H, 2001, ACTA PAEDIATR, V90, P1217, DOI 10.1080/080352501317130209; BJORK E, 1992, DIABETOLOGIA, V35, P490, DOI 10.1007/BF02342450; Couper JJ, 1999, DIABETES, V48, P2145, DOI 10.2337/diabetes.48.11.2145; Haglund B, 1996, DIABETES CARE, V19, P873, DOI 10.2337/diacare.19.8.873; HAYWARD AR, 1992, J LAB CLIN MED, V119, P503; Ho E, 2001, EXP BIOL MED, V226, P103, DOI 10.1177/153537020122600207; Hummel M, 2002, DIABETES CARE, V25, P1111, DOI 10.2337/diacare.25.7.1111; Hummel M, 2000, DIABETES CARE, V23, P969, DOI 10.2337/diacare.23.7.969; Hypponen E, 1999, DIABETES CARE, V22, P1961, DOI 10.2337/diacare.22.12.1961; Ivarsson A, 2002, AM J CLIN NUTR, V75, P914, DOI 10.1093/ajcn/75.5.914; Kimpimaki T, 2001, DIABETOLOGIA, V44, P63, DOI 10.1007/s001250051581; KLEINMAN RE, 1998, PEDIAT NUTR HDB, P43; Knekt P, 1999, J INTERN MED, V245, P99, DOI 10.1046/j.1365-2796.1999.00416.x; KOSTRABA JN, 1993, DIABETES, V42, P288, DOI 10.2337/diabetes.42.2.288; KOSTRABA JN, 1992, EPIDEMIOLOGY, V3, P232, DOI 10.1097/00001648-199205000-00008; LaGasse JM, 2002, DIABETES CARE, V25, P505, DOI 10.2337/diacare.25.3.505; Leslie RDG, 1999, DIABETOLOGIA, V42, P3, DOI 10.1007/s001250051105; MacFarlane AJ, 2003, J BIOL CHEM, V278, P54, DOI 10.1074/jbc.M210636200; Meloni T, 1997, DIABETES CARE, V20, P340, DOI 10.2337/diacare.20.3.340; Norris JM, 1999, J ENDOCRINOL INVEST, V22, P568, DOI 10.1007/BF03343611; Norris JM, 1996, JAMA-J AM MED ASSOC, V276, P609, DOI 10.1001/jama.276.8.609; PEREZBRAVO E, 1996, J MOL MED, V74, P105; Rewers M, 1996, DIABETOLOGIA, V39, P807, DOI 10.1007/s001250050514; Roll U, 1996, DIABETES, V45, P967, DOI 10.2337/diabetes.45.7.967; Scott FW, 2002, DIABETES, V51, P73, DOI 10.2337/diabetes.51.1.73; Ventura A, 2000, J PEDIATR-US, V137, P263, DOI 10.1067/mpd.2000.107160; Verge CF, 1996, DIABETES, V45, P926, DOI 10.2337/diabetes.45.7.926; VIRTANEN SM, 1993, DIABETES, V42, P1786, DOI 10.2337/diabetes.42.12.1786; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697; Yu LP, 1996, J CLIN ENDOCR METAB, V81, P4264, DOI 10.1210/jc.81.12.4264; Zhao HX, 2001, DIABETIC MED, V18, P709, DOI 10.1046/j.1464-5491.2001.00554.x	32	343	350	0	25	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2003	290	13					1713	1720		10.1001/jama.290.13.1713	http://dx.doi.org/10.1001/jama.290.13.1713			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	726NQ	14519705	Bronze			2022-12-01	WOS:000185606100020
J	Lilic, M; Galkin, VE; Orlova, A; VanLoock, MS; Egelman, EH; Stebbins, CE				Lilic, M; Galkin, VE; Orlova, A; VanLoock, MS; Egelman, EH; Stebbins, CE			Salmonella SipA polymerizes actin by stapling filaments with nonglobular protein arms	SCIENCE			English	Article							BINDING PROTEIN	Like many bacterial pathogens, Salmonella spp. use a type III secretion system to inject virulence proteins into host cells. The Salmonella invasion protein A ( SipA) binds host actin, enhances its polymerization near adherent extracellular bacteria, and contributes to cytoskeletal rearrangements that internalize the pathogen. By combining x-ray crystallography of SipA with electron microscopy and image analysis of SipA-actin. laments, we show that SipA functions as a "molecular staple," in which a globular domain and two nonglobular "arms" mechanically stabilize the. lament by tethering actin subunits in opposing strands. Deletion analysis of the tethering arms provides strong support for this model.	Rockefeller Univ, Lab Struct Microbiol, New York, NY 10021 USA; Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Rockefeller University; University of Virginia	Stebbins, CE (corresponding author), Rockefeller Univ, Lab Struct Microbiol, 1230 York Ave, New York, NY 10021 USA.	stebbins@rockefeller.edu	Stebbins, Erec/N-2565-2018; Galkin, Vitold/AAD-2844-2019; Egelman, Edward H/A-2488-2009	Stebbins, Erec/0000-0001-6229-5308; Egelman, Edward/0000-0003-4844-5212				Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Galkin VE, 2002, NAT STRUCT BIOL, V9, P518, DOI 10.1038/nsb811; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lukoyanova N, 2002, CURR BIOL, V12, P383, DOI 10.1016/S0960-9822(02)00678-4; McGhie EJ, 2001, EMBO J, V20, P2131, DOI 10.1093/emboj/20.9.2131; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mitra K, 2000, FEBS LETT, V482, P81, DOI 10.1016/S0014-5793(00)02040-8; PANG T, 1995, TRENDS MICROBIOL, V3, P253, DOI 10.1016/S0966-842X(00)88937-4; Schurmann G, 2001, MOL BIOL CELL, V12, P1765, DOI 10.1091/mbc.12.6.1765; Torok TJ, 1997, JAMA-J AM MED ASSOC, V278, P389, DOI 10.1001/jama.278.5.389; Tsolis RM, 2000, INFECT IMMUN, V68, P3158, DOI 10.1128/IAI.68.6.3158-3163.2000; Zhang SP, 2002, INFECT IMMUN, V70, P3843, DOI 10.1128/IAI.70.7.3843-3855.2002; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092	18	90	94	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2003	301	5641					1918	1921		10.1126/science.1088433	http://dx.doi.org/10.1126/science.1088433			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725GW	14512630				2022-12-01	WOS:000185536700054
J	Beltrami, AP; Barlucchi, L; Torella, D; Baker, M; Limana, F; Chimenti, S; Kasahara, H; Rota, M; Musso, E; Urbanek, K; Leri, A; Kajstura, J; Nadal-Ginard, B; Anversa, P				Beltrami, AP; Barlucchi, L; Torella, D; Baker, M; Limana, F; Chimenti, S; Kasahara, H; Rota, M; Musso, E; Urbanek, K; Leri, A; Kajstura, J; Nadal-Ginard, B; Anversa, P			Adult cardiac stem cells are multipotent and support myocardial regeneration	CELL			English	Article							PROGENITOR CELLS; HEART; LINEAGE; TRANSPLANTATION; EXPRESSION; INFARCTION; MYOCYTES; PROLIFERATION; CHIMERISM; FAILURE	The notion of the adult heart as terminally differentiated organ without self-renewal potential has been undermined by the existence of a subpopulation of replicating myocytes in normal and pathological states. The origin and significance of these cells has remained obscure for lack of a proper biological context. We report the existence of Lin(-) c-kit(POS) cells with the properties of cardiac stem cells. They are self-renewing, clonogenic, and multipotent, giving rise to myocytes, smooth muscle, and endothelial cells. When injected into an ischemic heart, these cells or their clonal progeny reconstitute well-differentiated myocardium, formed by blood-carrying new vessels and myocytes with the characteristics of young cells, encompassing similar to70% of the ventricle. Thus, the adult heart, like the brain, is mainly composed of terminally differentiated cells, but is not a terminally differentiated organ because it contains stem cells supporting its regeneration. The existence of these cells opens new opportunities for myocardial repair.	New York Med Coll, Dept Med, Inst Cardiovasc Res, Valhalla, NY 10595 USA; Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA	New York Medical College; State University System of Florida; University of Florida	Anversa, P (corresponding author), New York Med Coll, Dept Med, Inst Cardiovasc Res, Valhalla, NY 10595 USA.	piero_anversa@nymc.edu	Beltrami, Antonio/C-5291-2008	Beltrami, Antonio/0000-0002-0679-2710; TORELLA, Daniele/0000-0002-4915-5084	NHLBI NIH HHS [HL-66923, HL-38132, HL-39902, HL-65573, HL-65557] Funding Source: Medline; NIA NIH HHS [AG-17042, AG-15756] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066923, R01HL065573, R01HL039902, R01HL038132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015756, R01AG017042] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alison MR, 2003, J CELL SCI, V116, P599, DOI 10.1242/jcs.00269; Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; Anversa P, 2002, CIRCULATION, V106, pE129, DOI 10.1161/01.CIR.0000035926.40150.D0; Anversa P, 2002, NATURE, V415, P240, DOI 10.1038/415240a; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Chien KR, 2002, CELL, V110, P153, DOI 10.1016/S0092-8674(02)00834-6; Frangogiannis NG, 1998, CIRCULATION, V98, P687, DOI 10.1161/01.CIR.98.7.687; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Glaser R, 2002, CIRCULATION, V106, P17, DOI 10.1161/01.CIR.0000021923.58307.8F; Hellermann JP, 2002, AM J MED, V113, P324, DOI 10.1016/S0002-9343(02)01185-3; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kajstura J, 1998, P NATL ACAD SCI USA, V95, P8801, DOI 10.1073/pnas.95.15.8801; Kasahara H, 1998, CIRC RES, V82, P936, DOI 10.1161/01.RES.82.9.936; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kosaka M, 1998, EXP CELL RES, V245, P245, DOI 10.1006/excr.1998.4211; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kunisada T, 1998, DEVELOPMENT, V125, P2915; Laflamme MA, 2002, CIRC RES, V90, P634, DOI 10.1161/01.RES.0000014822.62629.EB; MacLellan WR, 2000, ANNU REV PHYSIOL, V62, P289, DOI 10.1146/annurev.physiol.62.1.289; Mahmud N, 2001, BLOOD, V97, P3061, DOI 10.1182/blood.V97.10.3061; MCDONNELL TJ, 1984, CELL TISSUE RES, V235, P583; Mikawa T, 1999, HEART DEV, P19; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Muller P, 2002, CIRCULATION, V106, P31, DOI 10.1161/01.CIR.0000022405.68464.CA; Nadal-Ginard B, 2003, CIRC RES, V92, P139, DOI 10.1161/01.RES.0000053618.86362.DF; Nadin BM, 2003, BLOOD, V102, P2436, DOI 10.1182/blood-2003-01-0118; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Rosenthal N, 2003, NEW ENGL J MED, V349, P267, DOI 10.1056/NEJMra020849; RUMYANTSEV PP, 1987, BIOMED BIOCHIM ACTA, V46, pS610; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sellers SE, 2001, BLOOD, V97, P1888, DOI 10.1182/blood.V97.6.1888; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Teyssier-Le Discorde M, 1999, BRIT J HAEMATOL, V107, P247, DOI 10.1046/j.1365-2141.1999.01725.x; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Tse HF, 2003, LANCET, V361, P47, DOI 10.1016/S0140-6736(03)12111-3; Urbanek K, 2003, P NATL ACAD SCI USA, V100, P10440, DOI 10.1073/pnas.1832855100; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387	44	2620	2918	3	340	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2003	114	6					763	776		10.1016/S0092-8674(03)00687-1	http://dx.doi.org/10.1016/S0092-8674(03)00687-1			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	724AL	14505575	Bronze			2022-12-01	WOS:000185464000013
J	Kim, PW; Sun, ZYJ; Blacklow, SC; Wagner, G; Eck, MJ				Kim, PW; Sun, ZYJ; Blacklow, SC; Wagner, G; Eck, MJ			A zinc clasp structure tethers Lck to T cell coreceptors CD4 and CD8	SCIENCE			English	Article							TYROSINE-PROTEIN-KINASE; AMINO-TERMINAL DOMAIN; CYTOPLASMIC TAIL; SERINE PHOSPHORYLATION; DOWN-REGULATION; COATED PITS; P56LCK; P56(LCK); ANTIGEN; COMPLEX	The T cell coreceptors CD4 and CD8 both associate via their cytoplasmic tails with the N-terminus of the Src-family tyrosine kinase Lck. These interactions require zinc and are critical for T cell development and activation. We examined the folding and solution structures of ternary CD4-Lck-Zn2+ and CD8alpha-LckZn(2+) complexes. The coreceptor tails and the Lck N-terminus are unstructured in isolation but assemble in the presence of zinc to form compactly folded heterodimeric domains. The cofolded complexes have similar "zinc clasp" cores that are augmented by distinct structural elements. A dileucine motif required for clathrin-mediated endocytosis of CD4 is masked by Lck.	Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Eck, MJ (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	eck@red.dfci.harvard.edu			NATIONAL CANCER INSTITUTE [R01CA080942] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061001] Funding Source: NIH RePORTER; NCI NIH HHS [CA080942] Funding Source: Medline; NHLBI NIH HHS [HL61001] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ACRES RB, 1986, J BIOL CHEM, V261, P6210; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; COLLINS TL, 1992, J IMMUNOL, V148, P2159; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; GLAICHENHAUS N, 1991, CELL, V64, P511, DOI 10.1016/0092-8674(91)90235-Q; Huse M, 1998, J BIOL CHEM, V273, P18729, DOI 10.1074/jbc.273.30.18729; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Kim Philip, UNPUB; Lin RS, 1998, J BIOL CHEM, V273, P32878, DOI 10.1074/jbc.273.49.32878; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; PELCHENMATTHEWS A, 1992, J CELL BIOL, V117, P279, DOI 10.1083/jcb.117.2.279; PELCHENMATTHEWS A, 1993, J EXP MED, V178, P1209, DOI 10.1084/jem.178.4.1209; Pitcher C, 1999, MOL BIOL CELL, V10, P677, DOI 10.1091/mbc.10.3.677; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SALGHETTI S, 1995, P NATL ACAD SCI USA, V92, P349, DOI 10.1073/pnas.92.2.349; SHAW AS, 1990, MOL CELL BIOL, V10, P1853, DOI 10.1128/MCB.10.5.1853; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; SHIN J, 1990, EMBO J, V9, P425, DOI 10.1002/j.1460-2075.1990.tb08127.x; SHIN JY, 1991, J BIOL CHEM, V266, P10658; SLECKMAN BP, 1992, P NATL ACAD SCI USA, V89, P7566, DOI 10.1073/pnas.89.16.7566; Trobridge PA, 2001, J IMMUNOL, V166, P809, DOI 10.4049/jimmunol.166.2.809; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; WEYAND CM, 1987, J IMMUNOL, V138, P1351; Wray V, 1998, BIOCHEMISTRY-US, V37, P8527, DOI 10.1021/bi9723111	26	179	188	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2003	301	5640					1725	1728		10.1126/science.1085643	http://dx.doi.org/10.1126/science.1085643			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722QN	14500983				2022-12-01	WOS:000185387700045
J	Schroeder, CM; Babcock, HP; Shaqfeh, ESG; Chu, S				Schroeder, CM; Babcock, HP; Shaqfeh, ESG; Chu, S			Observation of polymer conformation hysteresis in extensional flow	SCIENCE			English	Article							COIL-STRETCH TRANSITION; ELONGATIONAL FLOW; HYDRODYNAMIC INTERACTION; FLEXIBLE POLYMERS; LIGHT-SCATTERING; DYNAMICS; BIREFRINGENCE; COEFFICIENTS; POINT; DNA	Highly extensible Escherichia coli DNA molecules in planar extensional flow were visualized in dilute solution by fluorescence microscopy. For a narrow range of flow strengths, the molecules were found in either a coiled or highly extended conformation, depending on the deformation history of the polymer. This conformation hysteresis persists for many polymer relaxation times and is due to conformation-dependent hydrodynamic forces. Polymer conformational free-energy landscapes were calculated from computer simulations and show two free-energy minima for flow strengths near the coil-stretch transition. Hysteresis cycles may directly influence bulk-solution stresses and the development of stress-strain relations for dilute polymer flows.	Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Chu, S (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.			Babcock, Hazen/0000-0003-4835-3692; Schroeder, Charles/0000-0001-6023-2274				[Anonymous], 1987, DYNAMICS POLYM LIQUI; Babcock HP, 2003, MACROMOLECULES, V36, P4544, DOI 10.1021/ma034073p; BATCHELOR GK, 1970, J FLUID MECH, V44, P419, DOI 10.1017/S002211207000191X; BENTLEY BJ, 1986, J FLUID MECH, V167, P219, DOI 10.1017/S002211208600280X; BRESTKIN YV, 1987, ACTA POLYM, V38, P470, DOI 10.1002/actp.1987.010380803; de Gennes P.-G., 1990, INTRO POLYM DYNAMICS; De Gennes P-G., 1979, SCALING CONCEPTS POL; DEGENNES PG, 1974, J CHEM PHYS, V60, P5030, DOI 10.1063/1.1681018; FAN XJ, 1985, J NON-NEWTON FLUID, V18, P255, DOI 10.1016/0377-0257(85)87002-6; FULLER GG, 1980, RHEOL ACTA, V19, P580, DOI 10.1007/BF01517512; HINCH EJ, 1974, C INT CNRS, V233, P241; HSIEH CC, IN PRESS J RHEOL; Hunkeler D, 1996, POLYMER, V37, P4257, DOI 10.1016/0032-3861(96)00290-X; Jendrejack RM, 2002, J CHEM PHYS, V116, P7752, DOI 10.1063/1.1466831; Larson R., 1999, RHEOLOGY STRUCTURE C; Lee EC, 1999, MACROMOLECULES, V32, P3295, DOI 10.1021/ma981277a; Lumley J. L., 1973, Journal of Polymer Science, Macromolecular Reviews, V7, P263, DOI 10.1002/pol.1973.230070104; MAGDA JJ, 1988, J CHEM PHYS, V89, P2504, DOI 10.1063/1.455044; MENASVETA MJ, 1991, MACROMOLECULES, V24, P3427, DOI 10.1021/ma00011a060; Perkins TT, 1997, SCIENCE, V276, P2016, DOI 10.1126/science.276.5321.2016; PERKINS TT, 1995, SCIENCE, V268, P83, DOI 10.1126/science.7701345; RALLISON JM, 1988, J NON-NEWTON FLUID, V29, P37, DOI 10.1016/0377-0257(88)85049-3; Reif F., 1965, FUNDAMENTALS STAT TH; ROTNE J, 1969, J CHEM PHYS, V50, P4831, DOI 10.1063/1.1670977; Smith DE, 1996, MACROMOLECULES, V29, P1372, DOI 10.1021/ma951455p; Smith DE, 1998, SCIENCE, V281, P1335, DOI 10.1126/science.281.5381.1335; TANNER RI, 1975, T SOC RHEOL, V19, P557, DOI 10.1122/1.549385; TOMS BA, 1948, 1 P INT C RHEOL, V2, P135; VIRK PS, 1975, AICHE J, V21, P625, DOI 10.1002/aic.690210402; WIEST JM, 1989, J CHEM PHYS, V90, P587, DOI 10.1063/1.456457; [No title captured]	31	296	300	4	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2003	301	5639					1515	1519		10.1126/science.1086070	http://dx.doi.org/10.1126/science.1086070			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	720HL	12970560				2022-12-01	WOS:000185255300044
J	Wardemann, H; Yurasov, S; Schaefer, A; Young, JW; Meffre, E; Nussenzweig, MC				Wardemann, H; Yurasov, S; Schaefer, A; Young, JW; Meffre, E; Nussenzweig, MC			Predominant autoantibody production by early human B cell precursors	SCIENCE			English	Article							IMMUNOGLOBULIN HEAVY; CHAIN GENE; ANTIBODY; EXPRESSION; REPERTOIRE; POLYREACTIVITY; LYMPHOCYTES; SELECTION; REGION; MICE	During B lymphocyte development, antibodies are assembled by random gene segment reassortment to produce a vast number of specificities. A potential disadvantage of this process is that some of the antibodies produced are self-reactive. We determined the prevalence of self-reactive antibody formation and its regulation in human B cells. A majority (55 to 75%) of all antibodies expressed by early immature B cells displayed self-reactivity, including poly-reactive and anti-nuclear specificities. Most of these autoantibodies were removed from the population at two discrete checkpoints during B cell development. Inefficient checkpoint regulation would lead to substantial increases in circulating autoantibodies.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, Allogeneic Bone Marrow Transplant Serv, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, Clin Immunol Serv, New York, NY 10021 USA; Cornell Univ, Hosp Special Surg, Weill Med Coll, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Meffre, E (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.	meffree@hss.edu; nussen@mail.rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019	Wardemann, Hedda/0000-0003-3921-5933; Young, James/0000-0002-0032-6559				Aguilera I, 2001, IMMUNOLOGY, V102, P273, DOI 10.1046/j.1365-2567.2001.01159.x; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; BARBAS SM, 1995, P NATL ACAD SCI USA, V92, P2529, DOI 10.1073/pnas.92.7.2529; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Billips LG, 1995, ANN NY ACAD SCI, V764, P1; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; CROUZIER R, 1995, J IMMUNOL, V154, P4526; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; GUIGOU V, 1991, J IMMUNOL, V146, P1368; ICHIYOSHI Y, 1994, J EXP MED, V180, P885, DOI 10.1084/jem.180.3.885; King LB, 2000, IMMUNOL REV, V176, P86; KLEINFIELD R, 1986, NATURE, V322, P843, DOI 10.1038/322843a0; Klonowski KD, 1999, J IMMUNOL, V162, P1566; Landsteiner K, 1936, SPECIFICITY SEROLOGI; Leslie D, 2001, J CLIN INVEST, V108, P1417, DOI 10.1172/JCI200114452; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1111/j.1600-065X.2000.imr017515.x; Meffre E, 2001, J CLIN INVEST, V108, P879, DOI 10.1172/JCI200113051; Monroe RJ, 1999, IMMUNITY, V11, P201, DOI 10.1016/S1074-7613(00)80095-3; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0; Retter MW, 1998, J EXP MED, V188, P1231, DOI 10.1084/jem.188.7.1231; ROLINK A, 1993, J EXP MED, V178, P1263, DOI 10.1084/jem.178.4.1263; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; SEIGNEURIN JM, 1988, BLOOD, V71, P581; Shiokawa S, 1999, J IMMUNOL, V162, P6060; Silverstein AM, 2001, NAT IMMUNOL, V2, P279, DOI 10.1038/86280; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287	34	1439	1507	3	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2003	301	5638					1374	1377		10.1126/science.1086907	http://dx.doi.org/10.1126/science.1086907			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717XQ	12920303				2022-12-01	WOS:000185116400040
J	Ludwig, MG; Vanek, M; Guerini, D; Gasser, JA; Jones, CE; Junker, U; Hofstetter, H; Wolf, RM; Seuwen, K				Ludwig, MG; Vanek, M; Guerini, D; Gasser, JA; Jones, CE; Junker, U; Hofstetter, H; Wolf, RM; Seuwen, K			Proton-sensing G-protein-coupled receptors	NATURE			English	Article							MEDIATED BONE-RESORPTION; ACTIVATION; ACIDOSIS; TISSUE; SPHINGOSYLPHOSPHORYLCHOLINE; NOCICEPTION; RHODOPSIN; CHANNELS; PAIN; PH	Blood pH is maintained in a narrow range around pH 7.4 mainly through regulation of respiration and renal acid extrusion(1,2). The molecular mechanisms involved in pH homeostasis are not completely understood. Here we show that ovarian cancer G-protein-coupled receptor 1 (OGR1), previously described as a receptor for sphingosylphosphorylcholine 3, acts as a proton-sensing receptor stimulating inositol phosphate formation. The receptor is inactive at pH 7.8, and fully activated at pH 6.8-site-directed mutagenesis shows that histidines at the extracellular surface are involved in pH sensing. We find that GPR4, a close relative of OGR1, also responds to pH changes, but elicits cyclic AMP formation. It is known that the skeleton participates in pH homeostasis as a buffering organ, and that osteoblasts respond to pH changes in the physiological range(4), but the pH-sensing mechanism operating in these cells was hitherto not known. We detect expression of OGR1 in osteosarcoma cells and primary human osteoblast precursors, and show that these cells exhibit strong pH-dependent inositol phosphate formation. Immunohistochemistry on rat tissue sections confirms the presence of OGR1 in osteoblasts and osteocytes. We propose that OGR1 and GPR4 are proton-sensing receptors involved in pH homeostasis.	Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; Novartis Horsham Res Ctr, Horsham RH12 5AB, W Sussex, England	Novartis; Novartis	Seuwen, K (corresponding author), Novartis Inst Biomed Res, CH-4002 Basel, Switzerland.		Gasser, Juerg Andreas/AAT-5389-2020	Gasser, Juerg Andreas/0000-0002-0106-364X				AN SZ, 1995, FEBS LETT, V375, P121, DOI 10.1016/0014-5793(95)01196-L; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Brechter AB, 2002, REGUL PEPTIDES, V103, P39, DOI 10.1016/S0167-0115(01)00325-1; Bushinsky DA, 2001, EUR J NUTR, V40, P238, DOI 10.1007/s394-001-8351-5; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; ELLING CE, 1995, NATURE, V374, P74, DOI 10.1038/374074a0; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; Gijon MA, 1999, J LEUKOCYTE BIOL, V65, P330, DOI 10.1002/jlb.65.3.330; GOLDHABER P, 1987, AM J PHYSIOL, V253, pE90, DOI 10.1152/ajpendo.1987.253.1.E90; Heming TA, 2001, CLIN SCI, V101, P267, DOI 10.1042/CS20010139; Ishizaka H, 1999, CIRCULATION, V99, P558, DOI 10.1161/01.CIR.99.4.558; Krieger NS, 2000, AM J PHYSIOL-RENAL, V279, pF1077, DOI 10.1152/ajprenal.2000.279.6.F1077; Meghji S, 2001, AM J PHYSIOL-ENDOC M, V280, pE112, DOI 10.1152/ajpendo.2001.280.1.E112; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PARIS S, 1986, EMBO J, V5, P55, DOI 10.1002/j.1460-2075.1986.tb04177.x; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; Salomon Y, 1979, Adv Cyclic Nucleotide Res, V10, P35; SEUWEN K, 1988, EMBO J, V7, P161, DOI 10.1002/j.1460-2075.1988.tb02796.x; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Sottile V, 2002, BONE, V30, P699, DOI 10.1016/S8756-3282(02)00674-9; Swenson E R, 2001, Respir Care, V46, P342; Waldmann R, 1999, ANN NY ACAD SCI, V868, P67, DOI 10.1111/j.1749-6632.1999.tb11274.x; Xu Y, 2000, NAT CELL BIOL, V2, P261, DOI 10.1038/35010529; Zhu K, 2001, J BIOL CHEM, V276, P41325, DOI 10.1074/jbc.M008057200	29	481	503	5	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 4	2003	425	6953					93	98		10.1038/nature01905	http://dx.doi.org/10.1038/nature01905			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717LD	12955148				2022-12-01	WOS:000185089200045
J	Callahan, CM; McHorney, CA				Callahan, CM; McHorney, CA			Successful aging and the humility of perspective	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	8th Regenstrief Conference	SEP 30-OCT 02, 2002	MARSHALL, IN						Indiana Univ, Ctr Aging Res, Regenstrief Inst, Richard L Roudebush Vet Adm Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Callahan, CM (corresponding author), Indiana Univ, Ctr Aging Res, Regenstrief Inst, Richard L Roudebush Vet Adm Med Ctr, 1050 Wishard Blvd,RG6, Indianapolis, IN 46202 USA.	ccallaha@iupui.edu						[Anonymous], 1994, WHY ARE SOME PEOPLE; Institute of Medicine (US) Committee on Assuring the Health of the Public in the 21st Century, 2002, FUT PUBL HLTH 21 CEN	2	11	12	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 2	2003	139	5	2	S			389	390		10.7326/0003-4819-139-5_Part_2-200309021-00001	http://dx.doi.org/10.7326/0003-4819-139-5_Part_2-200309021-00001			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	718FE	12965962				2022-12-01	WOS:000185133800001
J	Ensslin, MA; Shur, BD				Ensslin, MA; Shur, BD			Identification of mouse sperm SED1, a bimotif EGF repeat and discoidin-domain protein involved in sperm-egg binding	CELL			English	Article							COAGULATION-FACTOR-V; ZONA-PELLUCIDA; FACTOR-VIII; CRYSTAL-STRUCTURES; SURFACE; MICE; ZP3; CLONING; ADHESION; BETA-1,4-GALACTOSYLTRANSFERASE	We report the identification of SED1, a protein required for mouse sperm binding to the egg zona pellucida. SED1 is homologous to a small group of secreted cell-matrix adhesive proteins that contain Notch-like EGF repeats and discoidin/F5/8 type C domains. SED1 is expressed in spermatogenic cells and is secreted by the initial segment of the caput epididymis, resulting in SED1 localization on the sperm plasma membrane overlying the acrosome. SED1 binds specifically to the zona pellucida of unfertilized oocytes, but not to the zona of fertilized eggs. Recombinant SED1 and anti-SED1 antibodies competitively inhibit sperm-egg binding, as do truncated SED1 proteins containing a discoidin/C domain. SED1 null males are subfertile and their sperm are unable to bind to the egg coat in vitro. These studies illustrate that Notch-like EGF and discoidin/C domains, protein motifs that facilitate a variety of cellular interactions, participate in gamete recognition as well.	Emory Univ, Sch Med, Dept Cell Biol, Whitehead Inst Biomed Res, Atlanta, GA 30322 USA	Emory University; Massachusetts Institute of Technology (MIT); Whitehead Institute	Shur, BD (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, Whitehead Inst Biomed Res, 615 Michael St,Room 405, Atlanta, GA 30322 USA.	barry@cellbio.emory.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023479] Funding Source: NIH RePORTER; NICHD NIH HHS [HD23479] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Andersen MH, 2000, BIOCHEMISTRY-US, V39, P6200, DOI 10.1021/bi992221r; Andersen MH, 1997, BIOCHEMISTRY-US, V36, P5441, DOI 10.1021/bi963119m; Aviles M, 1997, BIOL REPROD, V57, P1155, DOI 10.1095/biolreprod57.5.1155; Blazar M, 2001, MOL CELL BIOL, V21, P2570, DOI 10.1128/MCB.21.7.2570-2580.2001; Buckley CD, 1999, NATURE, V397, P534, DOI 10.1038/17409; Couto JR, 1996, DNA CELL BIOL, V15, P281, DOI 10.1089/dna.1996.15.281; Ensslin M, 1998, BIOL REPROD, V58, P1057, DOI 10.1095/biolreprod58.4.1057; FLORMAN HM, 1985, CELL, V41, P313, DOI 10.1016/0092-8674(85)90084-4; Fuentes-Prior P, 2002, CURR PROTEIN PEPT SC, V3, P313, DOI 10.2174/1389203023380639; Fusi FM, 1996, MOL HUM REPROD, V2, P169, DOI 10.1093/molehr/2.3.169; GONG XH, 1995, SCIENCE, V269, P1718, DOI 10.1126/science.7569899; Haltiwanger RS, 2002, CURR OPIN STRUC BIOL, V12, P593, DOI 10.1016/S0959-440X(02)00371-8; JANSSEN PJ, 1994, J HISTOCHEM CYTOCHEM, V42, P1169, DOI 10.1177/42.8.8027537; Johnston DS, 1998, J BIOL CHEM, V273, P1888, DOI 10.1074/jbc.273.4.1888; Larson JL, 1999, MOL REPROD DEV, V52, P445, DOI 10.1002/(SICI)1098-2795(199904)52:4&lt;445::AID-MRD14&gt;3.0.CO;2-6; Lawrence N, 2000, DEVELOPMENT, V127, P3185; Lonhienne T, 2001, J MOL BIOL, V310, P291, DOI 10.1006/jmbi.2001.4774; Lu QX, 1997, DEVELOPMENT, V124, P4121; Macedo-Ribeiro S, 1999, NATURE, V402, P434, DOI 10.1038/46594; MILLER DJ, 1992, NATURE, V357, P589, DOI 10.1038/357589a0; NAGDAS SK, 1994, BIOL REPROD, V51, P262, DOI 10.1095/biolreprod51.2.262; Nayernia K, 2002, MOL CELL BIOL, V22, P3046, DOI 10.1128/MCB.22.9.3046-3052.2002; NELLES LP, 1976, ANAL BIOCHEM, V73, P522, DOI 10.1016/0003-2697(76)90202-5; Nishimura H, 2001, DEV BIOL, V233, P204, DOI 10.1006/dbio.2001.0166; Ogura K, 1996, BIOCHEM BIOPH RES CO, V225, P932, DOI 10.1006/bbrc.1996.1274; Oshima K, 2002, EUR J BIOCHEM, V269, P1209, DOI 10.1046/j.1432-1033.2002.02758.x; Pearse RV, 1997, P NATL ACAD SCI USA, V94, P7555, DOI 10.1073/pnas.94.14.7555; Penta K, 1999, J BIOL CHEM, V274, P11101, DOI 10.1074/jbc.274.16.11101; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; Primakoff P, 2002, SCIENCE, V296, P2183, DOI 10.1126/science.1072029; Rankin TL, 2003, DEV CELL, V5, P33, DOI 10.1016/S1534-5807(03)00195-3; Rankin TL, 1998, DEVELOPMENT, V125, P2415; REITHERMAN RW, 1975, P NATL ACAD SCI USA, V72, P3541, DOI 10.1073/pnas.72.9.3541; ROBAIRE B, 1994, PHYSL REPROD, P999; Shi XD, 2001, DEVELOPMENT, V128, P645; Singson A, 1998, CELL, V93, P71, DOI 10.1016/S0092-8674(00)81147-2; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; Trubner M, 1997, ANDROLOGIA, V29, P253; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; Wolfer DP, 2002, TRENDS NEUROSCI, V25, P336, DOI 10.1016/S0166-2236(02)02192-6; Worthylake RA, 2001, CURR OPIN CELL BIOL, V13, P569, DOI 10.1016/S0955-0674(00)00253-2; YOUAKIM A, 1994, J CELL BIOL, V126, P1573, DOI 10.1083/jcb.126.6.1573	42	191	201	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2003	114	4					405	417		10.1016/S0092-8674(03)00643-3	http://dx.doi.org/10.1016/S0092-8674(03)00643-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	714TD	12941270	Bronze			2022-12-01	WOS:000184928800005
J	Eckstein-Ludwig, U; Webb, RJ; van Goethem, IDA; East, JM; Lee, AG; Kimura, M; O'Neill, PM; Bray, PG; Ward, SA; Krishna, S				Eckstein-Ludwig, U; Webb, RJ; van Goethem, IDA; East, JM; Lee, AG; Kimura, M; O'Neill, PM; Bray, PG; Ward, SA; Krishna, S			Artemisinins target the SERCA of Plasmodium falciparum	NATURE			English	Article							CALCIUM-PUMP; ANTIMALARIAL; DERIVATIVES; MALARIA; INVITRO; RESISTANCE; RETICULUM; QINGHAOSU; PARASITE; DRUGS	Artemisinins are extracted from sweet wormwood (Artemisia annua) and are the most potent antimalarials available(1), rapidly killing all asexual stages of Plasmodium falciparum(2). Artemisinins are sesquiterpene lactones widely used to treat multidrug-resistant malaria(1), a disease that annually claims 1 million lives. Despite extensive clinical and laboratory experience(3-5) their molecular target is not yet identified. Activated artemisinins form adducts with a variety of biological macromolecules, including haem, translationally controlled tumour protein (TCTP) and other higher-molecular-weight proteins(6). Here we show that artemisinins, but not quinine or chloroquine, inhibit the SERCA orthologue (PfATP6) of Plasmodium falciparum in Xenopus oocytes with similar potency to thapsigargin (another sesquiterpene lactone and highly specific SERCA inhibitor). As predicted, thapsigargin also antagonizes the parasiticidal activity of artemisinin. Desoxyartemisinin lacks an endoperoxide bridge and is ineffective both as an inhibitor of PfATP6 and as an antimalarial. Chelation of iron by desferrioxamine abrogates the antiparasitic activity of artemisinins and correspondingly attenuates inhibition of PfATP6. Imaging of parasites with BODIPY-thapsigargin labels the cytosolic compartment and is competed by artemisinin. Fluorescent artemisinin labels parasites similarly and irreversibly in an Fe2+-dependent manner. These data provide compelling evidence that artemisinins act by inhibiting PfATP6 outside the food vacuole after activation by iron.	St George Hosp, Sch Med, Dept Cellular & Mol Med, London SW17 0RE, England; Univ Southampton, Dept Biochem & Mol Biol, Southampton SO16 7PX, Hants, England; Osaka City Univ, Sch Med, Radioisotope Ctr, Abeno Ku, Osaka 5458585, Japan; Univ Liverpool, Robert Robinson Labs, Dept Chem, Liverpool L69 7ZD, Merseyside, England; Univ Liverpool, Liverpool Sch Trop Med, Mol & Biochem Parasitol Grp, Liverpool L3 5QA, Merseyside, England	St Georges University London; University of Southampton; Osaka Metropolitan University; University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool	Krishna, S (corresponding author), St George Hosp, Sch Med, Dept Cellular & Mol Med, Cranmer Terrace, London SW17 0RE, England.	s.krishna@sghms.ac.uk	Ward, Steve/G-6003-2015	Ward, Steve/0000-0003-2331-3192; Krishna, Sanjeev/0000-0003-0066-0634				Akompong T, 1999, MOL BIOCHEM PARASIT, V101, P71, DOI 10.1016/S0166-6851(99)00056-0; ALLEN DG, 1985, NATURE, V316, P674, DOI 10.1038/316674a0; ASAWAMAHASAKDA W, 1994, ANTIMICROB AGENTS CH, V38, P1854, DOI 10.1128/AAC.38.8.1854; BERENBAUM MC, 1978, J INFECT DIS, V137, P122, DOI 10.1093/infdis/137.2.122; BERS DM, 1994, METHOD CELL BIOL, V40, P3; Bhisutthibhan J, 1998, J BIOL CHEM, V273, P16192, DOI 10.1074/jbc.273.26.16192; Bray PG, 1998, MOL PHARMACOL, V54, P170, DOI 10.1124/mol.54.1.170; East J M, 1994, Methods Mol Biol, V27, P87; ELLIS DS, 1985, ANN TROP MED PARASIT, V79, P367, DOI 10.1080/00034983.1985.11811933; GU HM, 1984, T ROY SOC TROP MED H, V78, P265, DOI 10.1016/0035-9203(84)90296-7; Hawley SR, 1998, ANTIMICROB AGENTS CH, V42, P682, DOI 10.1128/AAC.42.3.682; Haynes RK, 2003, ANTIMICROB AGENTS CH, V47, P1175, DOI 10.1128/AAC.47.3.1175.2003; Haynes RK, 2001, CURR OPIN INFECT DIS, V14, P719, DOI 10.1097/00001432-200112000-00010; HIEN TT, 1993, LANCET, V341, P603; Jefford CW, 2001, CURR MED CHEM, V8, P1803, DOI 10.2174/0929867013371608; Krishna S, 2001, J BIOL CHEM, V276, P10782, DOI 10.1074/jbc.M010554200; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; MESHNICK SR, 1993, ANTIMICROB AGENTS CH, V37, P1108, DOI 10.1128/AAC.37.5.1108; O'Neill PM, 2000, J ORG CHEM, V65, P1578, DOI 10.1021/jo991585m; Olliaro PL, 2001, TRENDS PARASITOL, V17, P122, DOI 10.1016/S1471-4922(00)01838-9; ONO T, 1991, Japanese Journal of Parasitology, V40, P587; Pandey AV, 1999, J BIOL CHEM, V274, P19383, DOI 10.1074/jbc.274.27.19383; Price RN, 1999, ANTIMICROB AGENTS CH, V43, P2943, DOI 10.1128/AAC.43.12.2943; Robert A, 2002, ACCOUNTS CHEM RES, V35, P167, DOI 10.1021/ar990164o; SCHATZMANN HJ, 1953, HELV PHYSIOL PHARM A, V11, P346; Simpson PB, 1997, BIOCHEM J, V325, P239, DOI 10.1042/bj3250239; TERKUILE F, 1993, EXP PARASITOL, V76, P85, DOI 10.1006/expr.1993.1010; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Woodrow CJ, 1999, J BIOL CHEM, V274, P7272, DOI 10.1074/jbc.274.11.7272	30	767	805	7	372	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2003	424	6951					957	961		10.1038/nature01813	http://dx.doi.org/10.1038/nature01813			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713EH	12931192				2022-12-01	WOS:000184843600045
J	Ng, SKC				Ng, SKC			Possible role of an animal vector in the SARS outbreak at Amoy Gardens	LANCET			English	Article							TRANSMISSION DYNAMICS; CORONAVIRUS; AGENT	A mass outbreak of severe acute respiratory syndrome (SARS) in the Amoy Gardens housing complex in Hong Kong at the end of March, 2003, affected more than 300 residents in less than a month, and has epidemiologists all over the world puzzled about the mode of transmission of this new disease, which until then was thought to be transmitted solely by respiratory droplets. The source of the outbreak was later traced to an individual with SARS who spent two nights at Amoy Gardens. Official explanations failed to account for the large number of residents infected over a wide area within a short time., A powerful environmental mechanism that efficiently amplified and distributed the causal agent must. have been at work to cause this outbreak. One such mechanism could be an animal vector, most probably roof rats, that was infected by the index patient and subsequently spread the disease to more than 150 households.	Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Columbia University	Ng, SKC (corresponding author), Unit A-C,11-F,Power Ind Bldg,9-15 Wo Heung St, Shatin, Hong Kong, Peoples R China.	skcng@hotmail.com						BENITEZ MA, 2003, S CHINA MORNING 0528, pC1; Bradsher K, 2003, NY TIMES, pA1; *DEP HLTH HONG KIO, 1908, OUTBR SEV AC RESP SY; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Haijema BJ, 2003, J VIROL, V77, P4528, DOI 10.1128/JVI.77.8.4528-4538.2003; JACBOY RO, 1986, VIRAL MYCOPLASMAL IN, P625; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; *PROF PEST MAN ASS, 2003, ROOF BLACK SHIP RAT; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; *U AZ COOP EXT, 2003, ROOF RAT CONTR HOM O; WHO, 2003, 1 DAT STAB RES SARS; *WHO, 2003, COR NEV BEF SEEN  HU; 2003, MING PAO HONG K 0505, pA11; 2003, MING PAO HONG K 0508, pA4; 2003, S CHINA MORNING 0517; 2003, MING PAO HONG K 0411, pA2	20	66	72	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2003	362	9383					570	572		10.1016/S0140-6736(03)14121-9	http://dx.doi.org/10.1016/S0140-6736(03)14121-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	712UW	12932393	Bronze, Green Published			2022-12-01	WOS:000184817600027
J	Dumoulin, M; Last, AM; Desmyter, A; Decanniere, K; Canet, D; Larsson, G; Spencer, A; Archer, DB; Sasse, J; Muyldermans, S; Wyns, L; Redfield, C; Matagne, A; Robinson, CV; Dobson, CM				Dumoulin, M; Last, AM; Desmyter, A; Decanniere, K; Canet, D; Larsson, G; Spencer, A; Archer, DB; Sasse, J; Muyldermans, S; Wyns, L; Redfield, C; Matagne, A; Robinson, CV; Dobson, CM			A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme	NATURE			English	Article							HEREDITARY RENAL AMYLOIDOSIS; ALZHEIMERS-DISEASE; PRION REPLICATION; TRANSTHYRETIN; AGGREGATION; STRATEGIES; VARIANTS; BINDING	Amyloid diseases are characterized by an aberrant assembly of a specific protein or protein fragment into fibrils and plaques that are deposited in various organs and tissues(1-3), often with serious pathological consequences. Non-neuropathic systemic amyloidosis (4-6) is associated with single point mutations in the gene coding for human lysozyme. Here we report that a single-domain fragment of a camelid antibody(7-9) raised against wild-type human lysozyme inhibits the in vitro aggregation of its amyloidogenic variant, D67H. Our structural studies reveal that the epitope includes neither the site of mutation nor most residues in the region of the protein structure that is destabilized by the mutation. Instead, the binding of the antibody fragment achieves its effect by restoring the structural cooperativity characteristic of the wild-type protein. This appears to occur at least in part through the transmission of long-range conformational effects to the interface between the two structural domains of the protein. Thus, reducing the ability of an amyloidogenic protein to form partly unfolded species can be an effective method of preventing its aggregation, suggesting approaches to the rational design of therapeutic agents directed against protein deposition diseases.	Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; Univ Oxford, Oxford Ctr Mol Sci, Oxford OX1 3QH, England; Free Univ Brussels, Dept Ultrastruct, B-1050 Brussels, Belgium; Inst Food Res, Norwich NR4 7UA, Norfolk, England; Univ Nottingham, Sch Life & Environm Sci, Nottingham NG7 2RD, England; Cent Vet Res Lab, Dubai, U Arab Emirates; Univ Liege, Inst Chim B6, Ctr Ingn Prot, Enzymol Lab, B-4000 Liege, Sart Tilman, Belgium	University of Cambridge; University of Oxford; Universite Libre de Bruxelles; Vrije Universiteit Brussel; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Nottingham; University of Liege	Dobson, CM (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	cmd44@cam.ac.uk	Muyldermans, Serge V/C-6418-2016; Muyldermans, Serge/AAC-7374-2019	Muyldermans, Serge V/0000-0002-3678-3575; Muyldermans, Serge/0000-0002-3678-3575; robinson, carol/0000-0001-7829-5505; Matagne, Andre/0000-0001-6417-6791; Redfield, Christina/0000-0001-7297-7708				Aguzzi A, 2001, NAT REV NEUROSCI, V2, P745, DOI 10.1038/35094590; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Branden C. I., 2012, INTRO PROTEIN STRUCT; Canet D, 2002, NAT STRUCT BIOL, V9, P308, DOI 10.1038/nsb768; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Dobson CM, 2003, NAT REV DRUG DISCOV, V2, P154, DOI 10.1038/nrd1013; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1293, DOI 10.1177/37.8.2666512; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; May BCH, 2003, P NATL ACAD SCI USA, V100, P3416, DOI 10.1073/pnas.2627988100; McCammon MG, 2002, STRUCTURE, V10, P851, DOI 10.1016/S0969-2126(02)00771-2; Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264; Muyldermans S, 2001, J Biotechnol, V74, P277; OHKUBO T, 1991, J BIOCHEM-TOKYO, V110, P1022, DOI 10.1093/oxfordjournals.jbchem.a123672; Pepys MB, 2002, NATURE, V417, P254, DOI 10.1038/417254a; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938; Spencer A, 1999, PROTEIN EXPRES PURIF, V16, P171, DOI 10.1006/prep.1999.1036; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; TAN SY, 1994, HISTOPATHOLOGY, V25, P403, DOI 10.1111/j.1365-2559.1994.tb00001.x; Valleix S, 2002, KIDNEY INT, V61, P907, DOI 10.1046/j.1523-1755.2002.00205.x; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Wolfe MS, 2002, NAT REV DRUG DISCOV, V1, P859, DOI 10.1038/nrd938; Yazaki M, 2003, KIDNEY INT, V63, P1652, DOI 10.1046/j.1523-1755.2003.00904.x	30	202	293	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 14	2003	424	6950					783	788		10.1038/nature01870	http://dx.doi.org/10.1038/nature01870			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12917687	Green Published			2022-12-01	WOS:000184733900042
J	Kovalenko, A; Chable-Bessia, C; Cantarella, G; Israel, A; Wallach, D; Courtois, G				Kovalenko, A; Chable-Bessia, C; Cantarella, G; Israel, A; Wallach, D; Courtois, G			The tumour suppressor CYLD negatively regulates NF-kappa B signalling by deubiquitination	NATURE			English	Article							KINASE COMPLEX; INTERFERING RNAS; ACTIVATION; IKK; PATHWAYS; ENZYMES; SYSTEM; GAMMA; TRAF2; GENE	NF-kappaB transcription factors have key roles in inflammation, immune response, oncogenesis and protection against apoptosis (1,2). In most cells, these factors are kept inactive in the cytoplasm through association with IkappaB inhibitors. After stimulation by various reagents, IkappaB is phosphorylated by the IkappaB kinase (IKK) complex(3) and degraded by the proteasome, allowing NF-kappaB to translocate to the nucleus and activate its target genes. Here we report that CYLD, a tumour suppressor that is mutated in familial cylindromatosis(4), interacts with NEMO, the regulatory subunit of IKK5,6. CYLD also interacts directly with tumour-necrosis factor receptor (TNFR)-associated factor 2 (TRAF2), an adaptor molecule involved in signalling by members of the family of TNF/ nerve growth factor receptors. CYLD has deubiquitinating activity that is directed towards non-K48-linked polyubiquitin chains, and negatively modulates TRAF-mediated activation of IKK, strengthening the notion that ubiquitination is involved in IKK activation by TRAFs and suggesting that CYLD functions in this process. Truncations of CYLD found in cylindromatosis result in reduced enzymatic activity, indicating a link between impaired deubiquitination of CYLD substrates and human pathophysiology.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; Inst Pasteur, CNRS, URA 2582, Unite Biol Mol Express Gen, F-75015 Paris, France; Univ Catania, Dept Expt & Clin Pharmacol, Sch Med, I-95125 Catania, Italy	Weizmann Institute of Science; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of Catania	Wallach, D (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.		Cantarella, Giuseppina/AHD-9609-2022	COURTOIS, Gilles/0000-0003-3117-9595				Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chu ZL, 1998, J BIOL CHEM, V273, P15891, DOI 10.1074/jbc.273.26.15891; Courtois G, 2001, TRENDS MOL MED, V7, P427, DOI 10.1016/S1471-4914(01)02154-2; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2	22	811	840	5	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 14	2003	424	6950					801	805		10.1038/nature01802	http://dx.doi.org/10.1038/nature01802			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12917691				2022-12-01	WOS:000184733900046
J	Galli, C; Lagutina, I; Crotti, G; Colleoni, S; Turini, P; Ponderato, N; Duchi, R; Lazzari, G				Galli, C; Lagutina, I; Crotti, G; Colleoni, S; Turini, P; Ponderato, N; Duchi, R; Lazzari, G			A cloned horse born to its dam twin - A birth announcement calls for a rethink on the immunological demands of pregnancy.	NATURE			English	Editorial Material									CIZ Srl, Ist Sperimentale Italiano Lazzaro Spallanzani, Lab Tecnol Riproduz, I-26100 Cremona, Italy	IRCCS Lazzaro Spallanzani	Galli, C (corresponding author), CIZ Srl, Ist Sperimentale Italiano Lazzaro Spallanzani, Lab Tecnol Riproduz, I-26100 Cremona, Italy.		王, 士勇/B-5170-2012					[Anonymous], 2003, CLONING STEM CELLS, V5, P1, DOI 10.1089/153623003321512102; Galli C, 2002, THERIOGENOLOGY, V58, P705; Lagutina I., 2003, Theriogenology, V59, P269; Lazzari G, 2002, J REPROD FERTIL ABST, V28, P73; Szekeres-Bartho Julia, 2002, Int Rev Immunol, V21, P471, DOI 10.1080/08830180215017; WOODS GL, 2003, SCIENCE	6	311	369	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					635	635		10.1038/424635a	http://dx.doi.org/10.1038/424635a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904778				2022-12-01	WOS:000184578800030
J	Ono, M; Terabe, H; Hori, H; Sasaki, M				Ono, M; Terabe, H; Hori, H; Sasaki, M			Components of giant hornet alarm pheromone	NATURE			English	Editorial Material							VOLATILES		Tamagawa Univ, Res Inst, Ctr Excellence Integrat Human Sci Program, Tokyo 1948610, Japan; Tamagawa Univ, Grad Sch Agr, Tokyo 1948610, Japan; Tamagawa Univ, Dept Appl Biol Chem, Tokyo 1948610, Japan		Ono, M (corresponding author), Tamagawa Univ, Res Inst, Ctr Excellence Integrat Human Sci Program, Tokyo 1948610, Japan.							Dani FR, 2000, PHYSIOL ENTOMOL, V25, P363, DOI 10.1046/j.1365-3032.2000.00205.x; HEATH RR, 1988, EXPERIENTIA, V44, P82, DOI 10.1007/BF01960257; ONO M, 1995, NATURE, V377, P334, DOI 10.1038/377334a0; Ono M., 1997, SCI JAPANESE HORNETS; Rossiter K. J., 1996, PERFUM FLAVOR, V21, P33; SHIOTA H, 1993, J AGR FOOD CHEM, V41, P2056, DOI 10.1021/jf00035a046; VEITH HJ, 1984, NATURWISSENSCHAFTEN, V71, P328, DOI 10.1007/BF00396622	7	68	71	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					637	638		10.1038/424637a	http://dx.doi.org/10.1038/424637a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904781				2022-12-01	WOS:000184578800033
J	Tei, S; Kitajima, N; Takahashi, K; Mishiro, S				Tei, S; Kitajima, N; Takahashi, K; Mishiro, S			Zoonotic transmission of hepatitis E virus from deer to human beings	LANCET			English	Article								Zoonosis has been suggested for hepatitis E virus (HEV) infection, but so far is based only on indirect evidence. We experienced a series of cases of HEV infection among people who had eaten uncooked deer meat 6-7 weeks before. On testing, a left over portion of the deer meat, kept frozen to eat in the future, was positive for HEV RNA, whose nucleotide sequence was identical to those from the patients. Patients' family members who ate none or very little of the deer meat remained uninfected. These findings provide direct evidence for HEV infection to be a zoonosis.	Toshiba Gen Hosp, Dept Med Sci, Shinagawa Ku, Tokyo 1408522, Japan; Kasai City Hosp, Dept Internal Med, Kasai, Hyogo, Japan	Toshiba Corporation	Mishiro, S (corresponding author), Toshiba Gen Hosp, Dept Med Sci, Shinagawa Ku, 6-3-22 Higashi Oh I, Tokyo 1408522, Japan.	shunji.mishiro@po.toshiba.co.jp		Mishiro, Shunji/0000-0001-9618-6468				MENG XJ, 2000, INFECT DIS REV, V2, P35; Schlauder GG, 1998, J GEN VIROL, V79, P447, DOI 10.1099/0022-1317-79-3-447; Schlauder GG, 1999, J MED VIROL, V57, P243, DOI 10.1002/(SICI)1096-9071(199903)57:3&lt;243::AID-JMV6&gt;3.0.CO;2-R; Takahashi K, 2002, J INFECT DIS, V185, P1342, DOI 10.1086/340023; Takahashi K, 2001, VIROLOGY, V287, P9, DOI 10.1006/viro.2001.1017	5	727	770	3	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2003	362	9381					371	373		10.1016/S0140-6736(03)14025-1	http://dx.doi.org/10.1016/S0140-6736(03)14025-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907011				2022-12-01	WOS:000184498700011
J	Kanold, PO; Kara, P; Reid, RC; Shatz, CJ				Kanold, PO; Kara, P; Reid, RC; Shatz, CJ			Role of subplate neurons in functional maturation of visual cortical columns	SCIENCE			English	Article							OCULAR DOMINANCE COLUMNS; LATERAL GENICULATE-NUCLEUS; THALAMOCORTICAL SYNAPSES; CORTEX; CONNECTIONS; EXPRESSION; PLASTICITY; ABSENCE; SYSTEM; INPUT	The subplate forms a transient circuit required for development of connections between the thalamus and the cerebral cortex. When subplate neurons are ablated, ocular dominance columns do not form in the visual cortex despite the robust presence of thalamic axons in layer 4. We show that subplate ablation also prevents formation of orientation columns. Visual responses are weak and poorly tuned to orientation. Furthermore, thalamocortical synaptic transmission fails to strengthen, whereas intracortical synapses are unaffected. Thus, subplate circuits are essential not only for the anatomical segregation of thalamic inputs but also for key steps in synaptic remodeling and maturation needed to establish the functional architecture of visual cortex.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Shatz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.			Kanold, Patrick/0000-0002-7529-5435	NEI NIH HHS [R01 EY02858, R01 EY10115, F32 EY013526-01, F32 EY1352, P30 EY12196, F32 EY013526] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY013526, R01EY002858, R01EY010115, P30EY012196] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185; ANTONINI A, 1993, J NEUROSCI, V13, P3549; Cai DQ, 1997, J NEUROPHYSIOL, V78, P1045, DOI 10.1152/jn.1997.78.2.1045; Chapman B, 1996, J NEUROSCI, V16, P6443; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crair MC, 2001, J COMP NEUROL, V430, P235, DOI 10.1002/1096-9861(20010205)430:2<235::AID-CNE1028>3.0.CO;2-P; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Fine A, 1997, NEUROSCIENCE, V81, P331, DOI 10.1016/S0306-4522(97)00208-X; Finney EM, 1998, J COMP NEUROL, V398, P105; FRIAUF E, 1991, J NEUROPHYSIOL, V66, P2059, DOI 10.1152/jn.1991.66.6.2059; GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; KANOLD PO, UNPUB; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Lein ES, 1999, P NATL ACAD SCI USA, V96, P13491, DOI 10.1073/pnas.96.23.13491; Lein ES, 2000, J COMP NEUROL, V420, P1, DOI 10.1002/(SICI)1096-9861(20000424)420:1<1::AID-CNE1>3.0.CO;2-H; Mrzljak L, 1998, J COMP NEUROL, V390, P112; PIORO EP, 1990, NEUROSCIENCE, V34, P57, DOI 10.1016/0306-4522(90)90304-M; SHATZ CJ, 1986, J NEUROSCI, V6, P3655; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599	26	220	223	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2003	301	5632					521	525		10.1126/science.1084152	http://dx.doi.org/10.1126/science.1084152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881571				2022-12-01	WOS:000184340500044
J	Wang, X; Huong, SM; Chiu, ML; Raab-Traub, N; Huang, ES				Wang, X; Huong, SM; Chiu, ML; Raab-Traub, N; Huang, ES			Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus	NATURE			English	Article								Human cytomegalovirus (HCMV) is a widespread opportunistic herpesvirus that causes severe and fatal diseases in immune-compromised individuals, including organ transplant recipients and individuals with AIDS(1). It is also a leading cause of virus-associated birth defects and is associated with atherosclerosis and letters to nature and coronary restenosis(1-3). HCMV initiates infection and intracellular signalling by binding to its cognate cellular receptors 4,5 and by activating several signalling pathways including those mediated by mitogen-activated protein kinase(5-7), phosphatidylinositol-3-OH kinase(8), interferons(5,9), and G proteins(10). But a cellular receptor responsible for viral entry and HCMV-induced signalling has yet to be identified. Here we show that HCMV infects cells by interacting with epidermal growth factor receptor (EGFR) and inducing signalling. Transfecting EGFR-negative cells with an EGFR complementary DNA renders non-susceptible cells susceptible to HCMV. Ligand displacement and crosslinking analyses show that HCMV interacts with EGFR through gB, its principal envelope glycoprotein. gB preferentially binds EGFR and EGFR-ErbB3 oligomeric molecules in Chinese hamster ovary cells transfected with erbB family cDNAs. Taken together, these data indicate that EGFR is a necessary component for HCMV-triggered signalling and viral entry.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Huang, ES (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	eshuang@med.unc.edu						Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Baulida J, 1996, J BIOL CHEM, V271, P5251; Boyle KA, 1999, MOL CELL BIOL, V19, P3607; COMPTON T, 1992, VIROLOGY, V191, P387, DOI 10.1016/0042-6822(92)90200-9; EARP HS, 1995, BREAST CANCER RES TR, V35, P115, DOI 10.1007/BF00694752; Fairley JA, 2002, J GEN VIROL, V83, P2803, DOI 10.1099/0022-1317-83-11-2803; Huang ES, 1993, MOL ASPECTS HUMAN CY, P1; Johnson RA, 2000, J VIROL, V74, P1158, DOI 10.1128/JVI.74.3.1158-1167.2000; Johnson RA, 2001, J VIROL, V75, P6022, DOI 10.1128/JVI.75.13.6022-6032.2001; Johnson RA, 2001, J GEN VIROL, V82, P493, DOI 10.1099/0022-1317-82-3-493; Kanda S, 1997, J BIOL CHEM, V272, P23347, DOI 10.1074/jbc.272.37.23347; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; MELNICK JL, 1993, EUR HEART J, V14, P30; Miyazawa N, 1999, J VIROL, V73, P6056, DOI 10.1128/JVI.73.7.6056-6065.1999; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; PELES E, 1993, BIOESSAYS, V15, P815, DOI 10.1002/bies.950151207; Pietropaolo RL, 1997, J VIROL, V71, P9803, DOI 10.1128/JVI.71.12.9803-9807.1997; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sexl V, 1997, J BIOL CHEM, V272, P5792, DOI 10.1074/jbc.272.9.5792; Shibutani T, 1997, J CLIN INVEST, V100, P2054, DOI 10.1172/JCI119738; Simmen KA, 2001, P NATL ACAD SCI USA, V98, P7140, DOI 10.1073/pnas.121177598; SPEIR E, 1994, SCIENCE, V265, P391, DOI 10.1126/science.8023160; Tvorogov D, 2002, EXP CELL RES, V277, P86, DOI 10.1006/excr.2002.5545; Tzahar E, 1998, EMBO J, V17, P5948, DOI 10.1093/emboj/17.20.5948; Tzahar E, 1997, EMBO J, V16, P4938, DOI 10.1093/emboj/16.16.4938; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; Yurochko AD, 1997, J VIROL, V71, P5051, DOI 10.1128/JVI.71.7.5051-5059.1997	30	309	336	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					456	461		10.1038/nature01818	http://dx.doi.org/10.1038/nature01818			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879076				2022-12-01	WOS:000184318400050
J	Watanabe, H; Vriens, J; Prenen, J; Droogmans, G; Voets, T; Nilius, B				Watanabe, H; Vriens, J; Prenen, J; Droogmans, G; Voets, T; Nilius, B			Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels	NATURE			English	Article								TRPV4 is a widely expressed cation channel of the 'transient receptor potential' (TRP) family(1) that is related to the vanilloid receptor VR1 (TRPV1). It functions as a Ca2+ entry channel(2) and displays remarkable gating promiscuity by responding to both physical stimuli (cell swelling, innoxious heat(2-7)) and the synthetic ligand 4alphaPDD(8). An endogenous ligand for this channel has not yet been identified. Here we show that the endocannabinoid anandamide and its metabolite arachidonic acid activate TRPV4 in an indirect way involving the cytochrome P450 epoxygenase-dependent formation of epoxyeicosatrienoic acids. Application of 5',6'-epoxyeicosatrienoic acid at submicromolar concentrations activates TRPV4 in a membrane-delimited manner and causes Ca2+ influx through TRPV4- like channels in vascular endothelial cells. Activation of TRPV4 in vascular endothelial cells might therefore contribute to the relaxant effects of endocannabinoids and their P450 epoxygenase-dependent metabolites on vascular tone(9-12).	Katholieke Univ Leuven, Dept Physiol, B-3000 Louvain, Belgium	KU Leuven	Nilius, B (corresponding author), Katholieke Univ Leuven, Dept Physiol, Campus Gasthuisberg, B-3000 Louvain, Belgium.	bernd.nilius@med.kuleuven.ac.be	Voets, Thomas/AAD-4389-2019; Vriens, Joris/G-9966-2018; Voets, Thomas/E-2466-2012	Voets, Thomas/0000-0001-5526-5821; Vriens, Joris/0000-0002-2502-0409; Voets, Thomas/0000-0001-5526-5821				Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Fleming I, 2001, CIRC RES, V89, P753, DOI 10.1161/hh2101.099268; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Fuloria M, 2002, AM J PHYSIOL-LUNG C, V283, pL383, DOI 10.1152/ajplung.00444.2001; GRAIER WF, 1995, J PHYSIOL-LONDON, V482, P259, DOI 10.1113/jphysiol.1995.sp020515; Grainger J, 2001, BRIT J PHARMACOL, V134, P1003, DOI 10.1038/sj.bjp.0704340; Guler AD, 2002, J NEUROSCI, V22, P6408; Jarai Z, 1999, P NATL ACAD SCI USA, V96, P14136, DOI 10.1073/pnas.96.24.14136; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; Randall MD, 1998, EUR J PHARMACOL, V346, P51, DOI 10.1016/S0014-2999(98)00003-X; Randall MD, 1998, TRENDS PHARMACOL SCI, V19, P55, DOI 10.1016/S0165-6147(97)01161-9; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Rzigalinski BA, 1999, J BIOL CHEM, V274, P175, DOI 10.1074/jbc.274.1.175; Seegers HC, 2002, J PHARMACOL EXP THER, V302, P918, DOI 10.1124/jpet.302.3.918; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suh SH, 1999, PFLUG ARCH EUR J PHY, V438, P612, DOI 10.1007/s004240051084; Tan JZ, 1997, ADV EXP MED BIOL, V407, P561; Ueda N, 2002, PROSTAG OTH LIPID M, V68-9, P521, DOI 10.1016/S0090-6980(02)00053-9; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; WILLAN RL, 1990, MULTIPURPOSE TREE SP, V2, P11; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Xie Q, 2002, J BIOL CHEM, V277, P16559, DOI 10.1074/jbc.M109518200; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	27	727	763	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					434	438		10.1038/nature01807	http://dx.doi.org/10.1038/nature01807			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879072				2022-12-01	WOS:000184318400045
J	Yamazaki, D; Suetsugu, S; Miki, H; Kataoka, Y; Nishikawa, SI; Fujiwara, T; Yoshida, N; Takenawa, T				Yamazaki, D; Suetsugu, S; Miki, H; Kataoka, Y; Nishikawa, SI; Fujiwara, T; Yoshida, N; Takenawa, T			WAVE2 is required for directed cell migration and cardiovascular development	NATURE			English	Article								WAVE2, a protein related to Wiskott-Aldrich syndrome protein, is crucial for Rac-induced membrane ruffling, which is important in cell motility(1-4). Cell movement is essential for morphogenesis, but it is unclear how cell movement is regulated or related to morphogenesis. Here we show the physiological functions of WAVE2 by disruption of the WAVE2 gene in mice. WAVE2 was expressed predominantly in vascular endothelial cells during embryogenesis. WAVE2(-/-) embryos showed haemorrhages and died at about embryonic day 10. Deficiency in WAVE2 had no significant effect on vasculogenesis, but it decreased sprouting and branching of endothelial cells from existing vessels during angiogenesis. In WAVE2(-/-) endothelial cells, cell polarity formed in response to vascular endothelial growth factor, but the formation of lamellipodia at leading edges and capillaries was severely impaired. These findings indicate that WAVE2-regulated actin reorganization might be required for proper cell movement and that a lack of functional WAVE2 impairs angiogenesis in vivo.	Univ Tokyo, Dept Biochem, Mianato Ku, Tokyo 1088639, Japan; Univ Tokyo, Div Canc Genom, Mianato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Div Gene Express & Regulat, Mianato Ku, Tokyo 1088639, Japan; Japan Sci & Technol Corp, CREST, Tokyo, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Japan; Kyoto Univ, Grad Sch Med, Dept Mol Genet, Sakyo Ku, Kyoto 6068509, Japan; Ehime Univ, Sch Med, Lab Anim Ctr, Shigenobu, Ehime 7910295, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Kyoto University; Ehime University	Takenawa, T (corresponding author), Univ Tokyo, Dept Biochem, Mianato Ku, 4-6-1 Shirokanedai, Mianato ku, Tokyo 1088639, Japan.	takenawa@ims.u-tokyo.ac.jp	Suetsugu, Shiro/ABB-6033-2020; Suetsugu, Shiro/AAF-4427-2019; Suetsugu, Shiro/B-3300-2010	Suetsugu, Shiro/0000-0002-4612-0628; Suetsugu, Shiro/0000-0002-4612-0628				Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Hashi H, 2001, J IMMUNOL, V166, P3702, DOI 10.4049/jimmunol.166.6.3702; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Miki H, 2002, BIOCHEM BIOPH RES CO, V293, P93, DOI 10.1016/S0006-291X(02)00218-8; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; SHIMADA T, 1983, J ELECTRON MICROSC, V32, P187; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Takenawa T, 2001, J CELL SCI, V114, P1801; Yamaguchi H, 2002, CANCER RES, V62, P2503	16	182	184	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					452	456		10.1038/nature01770	http://dx.doi.org/10.1038/nature01770			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879075				2022-12-01	WOS:000184318400049
J	Jasmin, L; Rabkin, SD; Granato, A; Boudah, A; Ohara, PT				Jasmin, L; Rabkin, SD; Granato, A; Boudah, A; Ohara, PT			Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex	NATURE			English	Article								It is known that pain perception can be altered by mood, attention and cognition, or by direct stimulation of the cerebral cortex(1), but we know little of the neural mechanisms underlying the cortical modulation of pain. One of the few cortical areas consistently activated by painful stimuli is the rostral agranular insular cortex (RAIC) where, as in other parts of the cortex, the neurotransmitter gamma-aminobutyric acid (GABA) robustly inhibits neuronal activity. Here we show that changes in GABA neurotransmission in the RAIC can raise or lower the pain threshold-producing analgesia or hyperalgesia, respectively-in freely moving rats. Locally increasing GABA, by using an enzyme inhibitor or gene transfer mediated by a viral vector, produces lasting analgesia by enhancing the descending inhibition of spinal nociceptive neurons. Selectively activating GABA(B)-receptor-bearing RAIC neurons produces hyperalgesia through projections to the amygdala, an area involved in pain and fear. Whereas most studies focus on the role of the cerebral cortex as the end point of nociceptive processing, we suggest that cerebral cortex activity can change the set-point of pain threshold in a top-down manner.	Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurosurg, Boston, MA 02129 USA; Catholic Univ, Dept Psychol, I-20123 Milan, Italy	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Massachusetts General Hospital; Catholic University of the Sacred Heart	Jasmin, L (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.		rabkin, samuel/C-2443-2012	rabkin, samuel/0000-0003-2344-2795; GRANATO, Alberto/0000-0003-3755-1036				BERENDSE HW, 1992, J COMP NEUROL, V316, P314, DOI 10.1002/cne.903160305; BERTHIER M, 1988, ANN NEUROL, V24, P41, DOI 10.1002/ana.410240109; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; Burkey AR, 1999, J NEUROSCI, V19, P4169; Calejesan AA, 2000, EUR J PAIN, V4, P83, DOI 10.1053/eujp.1999.0158; EVERITT B J, 1992, P401; Fields HL, 2000, PROG BRAIN RES, V122, P245; GREENSPAN JD, 1992, PAIN, V50, P29, DOI 10.1016/0304-3959(92)90109-O; Helmstetter FJ, 1998, BRAIN RES, V779, P104, DOI 10.1016/S0006-8993(97)01104-9; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Jasmin L, 2003, J COMP NEUROL, V460, P38, DOI 10.1002/cne.10633; Jasmin L, 2001, J NEUROSCI METH, V110, P81, DOI 10.1016/S0165-0270(01)00420-4; JUNG MJ, 1977, J NEUROCHEM, V29, P797, DOI 10.1111/j.1471-4159.1977.tb10721.x; Killcross S, 1997, NATURE, V388, P377, DOI 10.1038/41097; LeDoux JE., 2000, AMYGDALA FUNCTIONAL, P289; Lopantsev V, 1999, J NEUROPHYSIOL, V82, P1218, DOI 10.1152/jn.1999.82.3.1218; Manning BH, 1998, J NEUROSCI, V18, P9453; Margeta-Mitrovic M, 1999, J COMP NEUROL, V405, P299, DOI 10.1002/(SICI)1096-9861(19990315)405:3<299::AID-CNE2>3.0.CO;2-6; Nandigama P, 2003, BRAIN RES, V959, P343, DOI 10.1016/S0006-8993(02)03884-2; New KC, 1996, MOL BRAIN RES, V37, P317, DOI 10.1016/0169-328X(95)00262-Q; New KC, 1998, MOL BRAIN RES, V61, P121, DOI 10.1016/S0169-328X(98)00203-4; New KC, 1998, J NEUROCHEM, V71, P2304; Ostrowsky K, 2002, CEREB CORTEX, V12, P376, DOI 10.1093/cercor/12.4.376; Pitkanen A., 2000, AMYGDALA FUNCTIONAL, V2; PROUDFIT HK, 1991, PROG BRAIN RES, V88, P123; SAGEN J, 1984, BRAIN RES, V310, P295, DOI 10.1016/0006-8993(84)90152-5; Somogyi J, 2001, EUR J NEUROSCI, V14, P219, DOI 10.1046/j.0953-816x.2001.01638.x; Suzuki R, 2002, NAT NEUROSCI, V5, P1319, DOI 10.1038/nn966; Watkins LR, 1998, BEHAV NEUROSCI, V112, P360; Zhang S, 1997, NEUROSCI LETT, V224, P142, DOI 10.1016/S0304-3940(97)13478-4	30	253	262	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					316	320		10.1038/nature01808	http://dx.doi.org/10.1038/nature01808			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867983				2022-12-01	WOS:000184183900043
J	Courchesne, E; Carper, R; Akshoomoff, N				Courchesne, E; Carper, R; Akshoomoff, N			Evidence of brain overgrowth in the first year of life in autism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEAD CIRCUMFERENCE; YOUNG-CHILDREN; ABNORMALITIES; CORTEX; WEIGHT; VOLUME; AGE; CEREBELLAR; PATTERNS	Context Autism most commonly appears by 2 to 3 years of life, at which time the brain is already abnormally large. This raises the possibility that brain overgrowth begins much earlier, perhaps before the first clinically noticeable behavioral symptoms. Objectives To determine whether pathological brain overgrowth precedes the first clinical signs of autism spectrum disorder (ASD) and whether the rate of overgrowth during the first year is related to neuroanatomical and clinical outcome in early childhood. Design, Setting, and Participants Head circumference (HQ, body length, and body weight measurements during the first year were obtained from the medical records of 48 children with ASD aged 2 to 5 years who had participated in magnetic resonance imaging studies. Of these children, 15 (longitudinal group) had measurement at 4 periods during infancy: birth, 1 to 2 months, 3 to months, and 6 to 14 months; and 33 (partial HC data group) had measurements at birth and 6 to 14 months (n=7), and at birth only (n=28). Main Outcome Measures Age-related changes in infants with ASD who had multiple-age measurements, and the relationship of these changes to brain anatomy and clinical and diagnostic outcome at 2 to 5 years were evaluated by using 2 nationally recognized normative databases: cross-sectional normative data from a national survey and longitudinal data of individual growth. Results Compared with normative data of healthy infants, birth HC in infants with ASD was significantly smaller (z= -0.66, P<.001); after birth, HC increased 1.67 SDS and mean HC was at the 84th percentile by 6 to 14 months. Birth HC was related to cerebellar gray matter volume at 2 to 5 years, although the excessive increase in HC between birth and 6 to 14 months was related to greater cerebral cortex volume at 2 to 5 years. Within the ASD group, every child with autistic disorder had a greater increase in HC between birth and 6 to 14 months (mean [SD], 2.19 [0.98]) than infants with pervasive developmental disorder-not otherwise specified (0.58 [0.35]). Only 6% of the individual healthy infants in the longitudinal data showed accelerated HC growth trajectories (>2.0 SDs) from birth to 6 to 14 months; 59% of infants with autistic disorder showed these accelerated growth trajectories. Conclusions The clinical onset of autism appears to be preceded by 2 phases of brain growth abnormality: a reduced head size at birth and a sudden and excessive increase in head size between 1 to 2 months and 6 to 14 months. Abnormally accelerated rate of growth may serve as an early warning signal of risk for autism.	Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA; Childrens Hosp Res Ctr, Ctr Autism Res, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Courchesne, E (corresponding author), Ctr Autism Res, 8110 La Jolla Shores Dr, La Jolla, CA 92037 USA.	ecourchesne@ucsd.edu	Warfield, Simon/B-3352-2009	Warfield, Simon/0000-0002-7659-3880	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019855] Funding Source: NIH RePORTER; NINDS NIH HHS [2-RO1-NS-19855] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akshoomoff N, 2002, DEV PSYCHOPATHOL, V14, P613, DOI 10.1017/S0954579402003115; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; ARTHUR G, 1980, ARTHUR ADAPTATION LE; Aylward EH, 2002, NEUROLOGY, V59, P175, DOI 10.1212/WNL.59.2.175; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; BARONCOHEN S, 1992, BRIT J PSYCHIAT, V161, P839, DOI 10.1192/bjp.161.6.839; Bartholomeusz HH, 2002, NEUROPEDIATRICS, V33, P239, DOI 10.1055/s-2002-36735; Blinkov SM, 1968, HUMAN BRAIN FIGURES; Carper RA, 2000, BRAIN, V123, P836, DOI 10.1093/brain/123.4.836; Carper RA, 2002, NEUROIMAGE, V16, P1038, DOI 10.1006/nimg.2002.1099; Casanova MF, 2002, NEUROLOGY, V58, P428, DOI 10.1212/WNL.58.3.428; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; COOKE RWI, 1977, EARLY HUM DEV, V1, P145, DOI 10.1016/0378-3782(77)90015-9; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Courchesne E, 1997, CURR OPIN NEUROBIOL, V7, P269, DOI 10.1016/S0959-4388(97)80016-5; Courchesne E, 1999, NEUROLOGY, V52, P1057, DOI 10.1212/WNL.52.5.1057; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; COURCHESNE E, 1994, MANUAL DEV PSYCHOPAT, P195; COURCHESNE E, IN PRESS BIOL PSYCHI; DAHLGREN SO, 1989, EUR ARCH PSY CLIN N, V238, P169; De Giacomo A, 1998, EUR CHILD ADOLES PSY, V7, P131, DOI 10.1007/s007870050058; Durston S, 2001, J AM ACAD CHILD PSY, V40, P1012, DOI 10.1097/00004583-200109000-00009; Fatemi SH, 2001, NEUROREPORT, V12, P929, DOI 10.1097/00001756-200104170-00013; FRIEDLANDER MJ, 1991, J NEUROSCI, V11, P3268; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; GUO S, 1988, J PEDIATR-US, V113, P490, DOI 10.1016/S0022-3476(88)80634-6; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kemper TL, 1998, J NEUROPATH EXP NEUR, V57, P645, DOI 10.1097/00005072-199807000-00001; Kuczmarski RJ., 2000, CDC GROWTH CHARTS US; Lainhart JE, 1997, J AM ACAD CHILD PSY, V36, P282, DOI 10.1097/00004583-199702000-00019; Lamb JA, 2000, HUM MOL GENET, V9, P861, DOI 10.1093/hmg/9.6.861; LECOUTEUR A, 1989, J AUTISM DEV DISORD, V19, P363, DOI 10.1007/BF02212936; Lee M, 2002, BRAIN, V125, P1483, DOI 10.1093/brain/awf160; LEMONS JA, 1981, HUM BIOL, V53, P351; Lord C, 2001, AM J MED GENET, V105, P36, DOI 10.1002/1096-8628(20010108)105:1<36::AID-AJMG1053>3.3.CO;2-W; LORD C, 2000, AUTISM SPECTRUM DISO, P167; LORD C, 1998, AUTISM DIAGNOSTIC OB; Mercado E, 2001, NEUROREPORT, V12, P2283, DOI 10.1097/00001756-200107200-00047; Mullen E. M., 1995, MULLEN SCALES EARLY; Nelson KB, 2001, ANN NEUROL, V49, P597, DOI 10.1002/ana.1024.abs; Orstavik KH, 1997, J MED GENET, V34, P849, DOI 10.1136/jmg.34.10.849; Penn AA, 1999, PEDIATR RES, V45, P447, DOI 10.1203/00006450-199904010-00001; Perry EK, 2001, AM J PSYCHIAT, V158, P1058, DOI 10.1176/appi.ajp.158.7.1058; Quartz SR, 1997, BEHAV BRAIN SCI, V20, P537; Rodier PM, 1996, J COMP NEUROL, V370, P247, DOI 10.1002/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2; ROGERS SJ, 1990, J AM ACAD CHILD PSY, V29, P863, DOI 10.1097/00004583-199011000-00004; Rutter M., 1995, AUTISM DIAGNOSTIC IN; SANES DH, 1983, SCIENCE, V221, P1183, DOI 10.1126/science.6612332; Schopler E., 1988, CHILDHOOD AUTISM RAT; Sparks BF, 2002, NEUROLOGY, V59, P184, DOI 10.1212/WNL.59.2.184; Stevenson RE, 1997, LANCET, V349, P1744, DOI 10.1016/S0140-6736(05)62956-X; Thorndike R.L., 1986, STANFORD BINET INTEL; Wechsler D, 1991, WECHSLER INTELLIGENC, V3rd; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Zhang LI, 2002, P NATL ACAD SCI USA, V99, P2309, DOI 10.1073/pnas.261707398	55	704	726	2	65	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2003	290	3					337	344		10.1001/jama.290.3.337	http://dx.doi.org/10.1001/jama.290.3.337			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	699WK	12865374	Bronze			2022-12-01	WOS:000184078800027
J	Sanders, J; Evans, M; Premawardhana, LDKE; Depraetere, H; Jeffreys, J; Richards, T; Furmaniak, J; Smith, BR				Sanders, J; Evans, M; Premawardhana, LDKE; Depraetere, H; Jeffreys, J; Richards, T; Furmaniak, J; Smith, BR			Human monoclonal thyroid stimulating autoantibody	LANCET			English	Article								A monoclonal autoantibody (MAb) with powerful thyroid stimulating activity has been produced from lymphocytes from a patient with Graves' disease. The autoantibody and its Fab fragment bind to the thyroid stimulating hormone (TSH) receptor (TSHR) with high affinity, inhibit labelled TSH binding to the receptor and stimulate cyclic AMP production in Chinese hamster ovary cells transfected with TSHR. TSHR autoantibodies with TSH agonist or antagonist activities from patients' serum samples are effective inhibitors of labelled monoclonal autoantibody binding to TSHR. Thus, the human monoclonal autoantilbody has all the characteristics of serum TSHR autoantibodies. Its availability has important implications for new studies on the pathogenesis of Graves' disease.	RSR Ltd, FIRS Labs, Cardiff CF14 5DU, S Glam, Wales; Caerphilly Dist Miners Hosp, Dept Adult Med, Caerphilly, Wales	RSR LTD	Smith, BR (corresponding author), RSR Ltd, FIRS Labs, Parc Ty Glas, Cardiff CF14 5DU, S Glam, Wales.	firs.rsrltd@virgin.net	Premawardhana, Lakdasa/L-4031-2019	Premawardhana, Lakdasa/0000-0003-0931-3700; Depraetere, Hilde/0000-0001-7196-7911				Ando T, 2002, J CLIN INVEST, V110, P1667, DOI 10.1172/JCI200216991; Hayakawa N, 2002, AUTOIMMUNITY, V35, P343, DOI 10.1080/0891693021000003206; McLachlan SM, 1996, J CLIN ENDOCR METAB, V81, P3152, DOI 10.1210/jc.81.9.3152; Sanders J, 2002, THYROID, V12, P1043, DOI 10.1089/105072502321085135; SMITH BR, 1988, ENDOCR REV, V9, P106, DOI 10.1210/edrv-9-1-106	5	133	136	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2003	362	9378					126	128		10.1016/S0140-6736(03)13866-4	http://dx.doi.org/10.1016/S0140-6736(03)13866-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699ZY	12867115				2022-12-01	WOS:000184089200014
J	Valle, M; Zavialov, A; Sengupta, J; Rawat, U; Ehrenberg, M; Frank, J				Valle, M; Zavialov, A; Sengupta, J; Rawat, U; Ehrenberg, M; Frank, J			Locking and unlocking of ribosomal motions	CELL			English	Article							ELONGATION-FACTOR-G; COLI 70S RIBOSOME; 3-DIMENSIONAL CRYOELECTRON MICROSCOPY; TRANSFER-RNA TRANSLOCATION; AMINOACYL-TRANSFER-RNA; ESCHERICHIA-COLI; ANGSTROM RESOLUTION; PROTEIN-SYNTHESIS; GTPASE ACTIVITY; PROMOTES TRANSLOCATION	During the ribosomal translocation, the binding of elongation factor G (EF-G) to the pretranslocational ribosome leads to a ratchet-like rotation of the 30S subunit relative to the 50S subunit in the direction of the mRNA movement. By means of cryo-electron microscopy we observe that this rotation is accompanied by a 20 Angstrom movement of the L1 stalk of the 50S subunit, implying that this region is involved in the translocation of deacylated tRNAs from the P to the E site. These ribosomal motions can occur only when the P-site tRNA is deacylated. Prior to peptidyl-transfer to the A-site tRNA or peptide removal, the presence of the charged P-site tRNA locks the ribosome and prohibits both of these motions.	SUNY Albany, Howard Hughes Med Inst, Albany, NY 12201 USA; SUNY Albany, Htlh Res Inc, Wadsworth Ctr, Albany, NY 12201 USA; SUNY Albany, Htlh Res Inc, Dept Biomed Sci, Albany, NY 12201 USA; Biomed Ctr, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden	Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Frank, J (corresponding author), SUNY Albany, Howard Hughes Med Inst, Empire State Plaza, Albany, NY 12201 USA.		Valle, Mikel/F-7598-2011	Valle, Mikel/0000-0001-8268-6912; Zavialov, Andrey/0000-0001-6420-0368	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029169, R01GM055440] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM29169, R01 GM55440] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P53; Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Borowski C, 1996, P NATL ACAD SCI USA, V93, P4202, DOI 10.1073/pnas.93.9.4202; BRETSCHER MS, 1968, NATURE, V218, P675, DOI 10.1038/218675a0; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 2000, METHOD ENZYMOL, V317, P276; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gao HX, 2003, CELL, V113, P789, DOI 10.1016/S0092-8674(03)00427-6; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; HIGHLAND JH, 1975, J BIOL CHEM, V250, P1141; Hirokawa G, 2002, EMBO J, V21, P2272, DOI 10.1093/emboj/21.9.2272; ISHITSUKA H, 1970, J BIOL CHEM, V245, P3346; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joseph S, 1998, EMBO J, V17, P3478, DOI 10.1093/emboj/17.12.3478; Karimi R, 1999, MOL CELL, V3, P601, DOI 10.1016/S1097-2765(00)80353-6; Lancaster L, 2002, CELL, V111, P129, DOI 10.1016/S0092-8674(02)00938-8; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; LILL R, 1989, EMBO J, V8, P3933, DOI 10.1002/j.1460-2075.1989.tb08574.x; Lodmell JS, 1997, SCIENCE, V277, P1262, DOI 10.1126/science.277.5330.1262; Marquez V, 2002, BIOCHEM SOC T, V30, P133, DOI 10.1042/BST0300133; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Noller HF, 2002, FEBS LETT, V514, P11, DOI 10.1016/S0014-5793(02)02327-X; Peske F, 2000, MOL CELL, V6, P501, DOI 10.1016/S1097-2765(00)00049-6; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Rodnina MV, 2001, MOL BIOL+, V35, P559, DOI 10.1023/A:1010523026531; Savelsbergh A, 2000, J BIOL CHEM, V275, P890, DOI 10.1074/jbc.275.2.890; Schmeing TM, 2002, NAT STRUCT BIOL, V9, P225, DOI 10.1038/nsb758; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; SUBRAMANIAN AR, 1980, EUR J BIOCHEM, V112, P425, DOI 10.1111/j.1432-1033.1980.tb07222.x; TRAUT RR, 1964, J MOL BIOL, V10, P63, DOI 10.1016/S0022-2836(64)80028-0; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; VanLoock MS, 2000, J MOL BIOL, V304, P507, DOI 10.1006/jmbi.2000.4213; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wower J, 2000, J BIOL CHEM, V275, P37887, DOI 10.1074/jbc.M005031200; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zavialov AV, 2003, CELL, V114, P113, DOI 10.1016/S0092-8674(03)00478-1; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6	48	485	507	0	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 11	2003	114	1					123	134		10.1016/S0092-8674(03)00476-8	http://dx.doi.org/10.1016/S0092-8674(03)00476-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	702JC	12859903	Bronze			2022-12-01	WOS:000184219900011
J	Zhou, Q; Renard, JP; Le Friec, G; Brochard, V; Beaujean, N; Cherifi, Y; Fraichard, A; Cozzi, J				Zhou, Q; Renard, JP; Le Friec, G; Brochard, V; Beaujean, N; Cherifi, Y; Fraichard, A; Cozzi, J			Generation of fertile cloned rats by regulating oocyte activation	SCIENCE			English	Article									INRA, Dev Biol & Reprod Unit, Jouy En Josas, France; Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; GenOway, Lyon, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Chinese Academy of Sciences; Institute of Zoology, CAS	Renard, JP (corresponding author), INRA, Dev Biol & Reprod Unit, Jouy En Josas, France.		Beaujean, Nathalie/C-9883-2011	Beaujean, Nathalie/0000-0003-0188-9190				Hirabayashi M, 2003, CLONING STEM CELLS, V5, P35, DOI 10.1089/153623003321512148; Jabob H. J., 2002, NATURE REV GENET, V3, P33; Josefsberg LBY, 2000, BIOL REPROD, V62, P1270, DOI 10.1095/biolreprod62.5.1270; Zan YH, 2003, NAT BIOTECHNOL, V21, P645, DOI 10.1038/nbt830; ZERNICKAGOETZ M, 1991, MOL REPROD DEV, V28, P169, DOI 10.1002/mrd.1080280210	5	298	376	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2003	302	5648					1179	1179		10.1126/science.1088313	http://dx.doi.org/10.1126/science.1088313			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742XW	14512506	Green Submitted			2022-12-01	WOS:000186544300044
J	Ansley, SJ; Badano, JL; Blacque, OE; Hill, J; Hoskins, BE; Leitch, CC; Kim, JC; Ross, AJ; Eichers, ER; Teslovich, TM; Mah, AK; Johnsen, RC; Cavender, JC; Lewis, RA; Leroux, MR; Beales, PL; Katsanis, N				Ansley, SJ; Badano, JL; Blacque, OE; Hill, J; Hoskins, BE; Leitch, CC; Kim, JC; Ross, AJ; Eichers, ER; Teslovich, TM; Mah, AK; Johnsen, RC; Cavender, JC; Lewis, RA; Leroux, MR; Beales, PL; Katsanis, N			Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl syndrome	NATURE			English	Article							HUMAN OBESITY SYNDROME; C-ELEGANS; INTRAFLAGELLAR TRANSPORT; TRIALLELIC INHERITANCE; KIDNEY-DISEASE; PROTEIN; CILIA; GENE; IDENTIFICATION; MUTATIONS	Bardet-Biedl syndrome (BBS) is a genetically heterogeneous disorder characterized primarily by retinal dystrophy, obesity, polydactyly, renal malformations and learning disabilities. Although five BBS genes have been cloned(1-6), the molecular basis of this syndrome remains elusive. Here we show that BBS is probably caused by a defect at the basal body of ciliated cells. We have cloned a new BBS gene, BBS8, which encodes a protein with a prokaryotic domain, pilF, involved in pilus formation and twitching mobility. In one family, a homozygous null BBS8 mutation leads to BBS with randomization of left-right body axis symmetry, a known defect of the nodal cilium. We have also found that BBS8 localizes specifically to ciliated structures, such as the connecting cilium of the retina and columnar epithelial cells in the lung. In cells, BBS8 localizes to centrosomes and basal bodies and interacts with PCM1, a protein probably involved in ciliogenesis. Finally, we demonstrate that all available Caenorhabditis elegans BBS homologues are expressed exclusively in ciliated neurons, and contain regulatory elements for RFX, a transcription factor that modulates the expression of genes associated with ciliogenesis and intraflagellar transport.	Johns Hopkins Univ, Inst Med Genet, Baltimore, MD 21287 USA; Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21287 USA; Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; King Khalid Eye Specialist Hosp, Riyadh 11462, Saudi Arabia	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Simon Fraser University; University of London; University College London; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; King Khaled Eye Specialist Hospital	Katsanis, N (corresponding author), Johns Hopkins Univ, Inst Med Genet, Baltimore, MD 21287 USA.	katsanis@jhmi.edu	Katsanis, Nicholas/E-1837-2012; Beales, Philip L/C-7367-2009; Blacque, Oliver/AAL-8860-2021	Katsanis, Nicholas/0000-0002-2480-0171; Blacque, Oliver/0000-0003-1598-2695; Badano, Jose/0000-0002-0706-8652				Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Badano JL, 2003, AM J HUM GENET, V72, P650, DOI 10.1086/368204; Beales PL, 1999, J MED GENET, V36, P437; Beales PL, 2003, AM J HUM GENET, V72, P1187, DOI 10.1086/375178; BRENNER S, 1974, GENETICS, V77, P71; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Fujiwara M, 1999, DEVELOPMENT, V126, P4839; Haycraft CJ, 2001, DEVELOPMENT, V128, P1493; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 2002, AM J HUM GENET, V71, P22, DOI 10.1086/341031; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; MAURER L, 1987, J BACTERIOL, V169, P640, DOI 10.1128/jb.169.2.640-645.1987; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Morgan D, 2002, HUM MOL GENET, V11, P3345, DOI 10.1093/hmg/11.26.3345; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407	29	496	526	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 9	2003	425	6958					628	633		10.1038/nature02030	http://dx.doi.org/10.1038/nature02030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729XU	14520415				2022-12-01	WOS:000185801000040
J	Friedrich, R; Panizzi, P; Fuentes-Prior, P; Richter, K; Verhamme, I; Anderson, PJ; Kawabata, SI; Huber, R; Bode, W; Bock, PE				Friedrich, R; Panizzi, P; Fuentes-Prior, P; Richter, K; Verhamme, I; Anderson, PJ; Kawabata, SI; Huber, R; Bode, W; Bock, PE			Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation	NATURE			English	Article							BINDING-PROTEIN; STREPTOCOCCUS-AGALACTIAE; STAPHYLOCOCCUS-AUREUS; CRYSTAL-STRUCTURE; GENOME SEQUENCE; THROMBIN; STREPTOKINASE; PROTHROMBIN; PLASMINOGEN; FIBRONECTIN	Many bacterial pathogens secrete proteins that activate host trypsinogen-like enzyme precursors, most notably the proenzymes of the blood coagulation and fibrinolysis systems(1,2). Staphylococcus aureus, an important human pathogen implicated in sepsis and endocarditis(3), secretes the cofactor staphylocoagulase, which activates prothrombin, without the usual proteolytic cleavages, to directly initiate blood clotting(4,5). Here we present the 2.2 Angstrom crystal structures of human alpha-thrombin and prethrombin-2 bound to a fully active staphylocoagulase variant. The cofactor consists of two domains, each with three-helix bundles; this is a novel fold that is distinct from known serine proteinase activators, particularly the streptococcal plasminogen activator streptokinase(6). The staphylocoagulase fold is conserved in other bacterial plasma-protein-binding factors and extracellular-matrix-binding factors(7-9). Kinetic studies confirm the importance of isoleucine 1 and valine 2 at the amino terminus of staphylocoagulase for zymogen activation. In addition to making contacts with the 148 loop and (pro)exosite I of pre-thrombin-2, staphylocoagulase inserts its N-terminal peptide into the activation pocket of bound prethrombin-2, allosterically inducing functional catalytic machinery. These investigations demonstrate unambiguously the validity of the zymogen-activation mechanism known as 'molecular sexuality'(10).	Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany; Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA; Tech Univ Munich, Lehrstuhl Biotechnol, D-85747 Garching, Germany; Kyushu Univ, Dept Biol, Fukuoka 8128581, Japan	Max Planck Society; Vanderbilt University; Technical University of Munich; Kyushu University	Bode, W (corresponding author), Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany.		Richter, Klaus/A-2673-2010; Panizzi, Peter/A-6072-2019	Richter, Klaus/0000-0002-8952-9642; Panizzi, Peter/0000-0003-0141-8807; Fuentes-Prior, Pablo/0000-0002-6618-3204	NHLBI NIH HHS [R00 HL094533] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL094533] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson PJ, 2000, J BIOL CHEM, V275, P16428, DOI 10.1074/jbc.M001254200; Bjerketorp J, 2002, MICROBIOL-SGM, V148, P2037, DOI 10.1099/00221287-148-7-2037; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; BOCK PE, 1992, J BIOL CHEM, V267, P14974; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; Boxrud PD, 2001, J BIOL CHEM, V276, P26084, DOI 10.1074/jbc.M101966200; Boyle MDP, 1997, THROMB HAEMOSTASIS, V77, P1; CHEUNG AI, 1995, INFECT IMMUN, V63, P1914, DOI 10.1128/IAI.63.5.1914-1920.1995; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; HEMKER HC, 1975, BIOCHIM BIOPHYS ACTA, V379, P180, DOI 10.1016/0005-2795(75)90020-3; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Jeng A, 2003, J BACTERIOL, V185, P1208, DOI 10.1128/JB.185.4.1208-1217.2003; Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6; KAWABATA SI, 1987, J PROTEIN CHEM, V6, P17; Khan AR, 1998, PROTEIN SCI, V7, P815; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Parry MAA, 1998, NAT STRUCT BIOL, V5, P917, DOI 10.1038/2359; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; TAGER M, 1965, ANN NY ACAD SCI, V128, P92, DOI 10.1111/j.1749-6632.1965.tb11632.x; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; VIJAYALAKSHMI J, 1994, PROTEIN SCI, V3, P2254, DOI 10.1002/pro.5560031211; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662	25	194	214	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2003	425	6957					535	539		10.1038/nature01962	http://dx.doi.org/10.1038/nature01962			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727FN	14523451				2022-12-01	WOS:000185648100050
J	Liu, QH; Rand, TA; Kalidas, S; Du, FH; Kim, HE; Smith, DP; Wang, XD				Liu, QH; Rand, TA; Kalidas, S; Du, FH; Kim, HE; Smith, DP; Wang, XD			R2D2, a bridge between the initiation and effector steps of the Drosophila RNAi pathway	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; GENETIC INTERFERENCE; MESSENGER-RNA; C-ELEGANS; REQUIREMENTS	The RNA interference (RNAi) pathway is initiated by processing long double-stranded RNA into small interfering RNA (siRNA). The siRNA-generating enzyme was puriFIed from Drosophila S2 cells and consists of two stoichiometric subunits: Dicer-2 (DCR-2) and a previously unknown protein that we named R2D2. R2D2 is homologous to the Caenorhabditis elegans RNAi protein RDE-4. Association with R2D2 does not affect the enzymatic activity of DCR-2. Rather, the DCR-2/R2D2 complex, but not DCR-2 alone, binds to siRNA and enhances sequence-specific messenger RNA degradation mediated by the RNA-initiated silencing complex(RISC). These results indicate that R2D2 bridges the initiation and effector steps of the Drosophila RNAi pathway by facilitating siRNA passage from Dicer to RISC.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Wang, XD (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA.		Kim, Hyun-Eui/GOV-5988-2022	Kim, Hyun-Eui/0000-0003-1495-1993; Wang, Xiaodong/0000-0001-9885-356X; Smith, Dean/0000-0002-4271-0436	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002539] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC02539] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; KALIDAS S, UNPUB; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zenobi, UNPUB	16	536	585	6	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2003	301	5641					1921	1925		10.1126/science.1088710	http://dx.doi.org/10.1126/science.1088710			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725GW	14512631				2022-12-01	WOS:000185536700055
J	Kim, M; Carman, CV; Springer, TA				Kim, M; Carman, CV; Springer, TA			Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins	SCIENCE			English	Article							INSIDE-OUT ACTIVATION; ALPHA-SUBUNIT; AFFINITY; TAILS; LFA-1; FLOW; ALPHA-IIB-BETA-3; ADHESIVENESS; CHEMOKINES; REVEALS	Although critical for development, immunity, wound healing, and metastasis, integrins represent one of the few classes of plasma membrane receptors for which the basic signaling mechanism remains a mystery. We investigated cytoplasmic conformational changes in the integrin LFA-1 (alpha(L)beta(2)) in living cells by measuring fluorescence resonance energy transfer between cyan fluorescent protein - fused and yellow fluorescent protein - fused alpha(L) and beta(2) cytoplasmic domains. In the resting state these domains were close to each other, but underwent significant spatial separation upon either intracellular activation of integrin adhesiveness (inside-out signaling) or ligand binding (outside-in signaling). Thus, bidirectional integrin signaling is accomplished by coupling extracellular conformational changes to an unclasping and separation of the alpha and beta cytoplasmic domains, a distinctive mechanism for transmitting information across the plasma membrane.	Harvard Univ, Sch Med, Dept Pathol, CBR Inst Biomed Res, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, Dept Pathol, CBR Inst Biomed Res, 200 Longwood Ave, Boston, MA 02115 USA.	springeroffice@cbr.med.harvard.edu	Carman, Christopher/L-8108-2016; Carman, Christopher V./AAX-8995-2020	Carman, Christopher/0000-0001-7358-2548; Carman, Christopher V./0000-0001-7358-2548	NCI NIH HHS [CA31798] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA031798, R01CA031798] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Leitinger B, 2000, BBA-MOL CELL RES, V1498, P91, DOI 10.1016/S0167-4889(00)00086-0; Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Liu SC, 2000, J CELL SCI, V113, P3563; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2387, DOI 10.1073/pnas.041606398; Lu CF, 1997, J IMMUNOL, V159, P268; Lu CF, 2001, J BIOL CHEM, V276, P14642, DOI 10.1074/jbc.M100600200; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2393, DOI 10.1073/pnas.041618598; Lub M, 1997, MOL BIOL CELL, V8, P719, DOI 10.1091/mbc.8.4.719; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Stewart M, 1996, J CELL BIOCHEM, V61, P554, DOI 10.1002/(SICI)1097-4644(19960616)61:4<554::AID-JCB8>3.0.CO;2-N; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Ulmer TS, 2001, BIOCHEMISTRY-US, V40, P7498, DOI 10.1021/bi010338l; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Weljie AM, 2002, P NATL ACAD SCI USA, V99, P5878, DOI 10.1073/pnas.092515799; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	31	610	630	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2003	301	5640					1720	1725		10.1126/science.1084174	http://dx.doi.org/10.1126/science.1084174			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722QN	14500982				2022-12-01	WOS:000185387700044
J	Palatnik, JF; Allen, E; Wu, XL; Schommer, C; Schwab, R; Carrington, JC; Weigel, D				Palatnik, JF; Allen, E; Wu, XL; Schommer, C; Schwab, R; Carrington, JC; Weigel, D			Control of leaf morphogenesis by microRNAs	NATURE			English	Article							VIRAL SUPPRESSOR; DICER HOMOLOG; C-ELEGANS; RNA; ARABIDOPSIS; GENE; DROSOPHILA; PLANTS; EMBRYO; PREDICTION	Plants with altered microRNA metabolism have pleiotropic developmental defects, but direct evidence for microRNAs regulating specific aspects of plant morphogenesis has been lacking. In a genetic screen, we identified the JAW locus, which produces a microRNA that can guide messenger RNA cleavage of several TCP genes controlling leaf development. MicroRNA-guided cleavage of TCP4 mRNA is necessary to prevent aberrant activity of the TCP4 gene expressed from its native promoter. In addition, overexpression of wild-type and microRNA-resistant TCP variants demonstrates that mRNA cleavage is largely sufficient to restrict TCP function to its normal domain of activity. TCP genes with microRNA target sequences are found in a wide range of species, indicating that microRNA-mediated control of leaf morphogenesis is conserved in plants with very different leaf forms.	Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Oregon State Univ, Ctr Gene Res & Biotechnol, Corvallis, OR 97331 USA; Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Max Planck Society; Salk Institute; Oregon State University; Oregon State University	Weigel, D (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.		Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/C-1418-2008; Weigel, Detlef/GSJ-0799-2022; Schommer, Carla/AAV-7958-2021; Carrington, James C/A-4656-2012; Schwab, Rebecca/I-9352-2012	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Carrington, James C/0000-0003-3572-129X; Schwab, Rebecca/0000-0001-9933-9669; Allen, Edwards/0000-0002-8318-6319; Palatnik, Javier/0000-0001-7996-5224				Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; CHEN X, 2003, SCIENCE         0731; Citerne HL, 2003, PLANT PHYSIOL, V131, P1042, DOI 10.1104/pp.102.016311; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Golden TA, 2002, PLANT PHYSIOL, V130, P808, DOI 10.1104/pp.003491; Hadfi K, 1998, DEVELOPMENT, V125, P879; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kawasaki H, 2003, NATURE, V423, P838, DOI 10.1038/nature01730; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mallory AC, 2002, P NATL ACAD SCI USA, V99, P15228, DOI 10.1073/pnas.232434999; MAYER U, 1991, NATURE, V353, P402, DOI 10.1038/353402a0; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; SWOFFORD DL, 1993, GEN PHYSL, V102, pA9; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Weigel D., 2002, ARABIDOPSIS LAB MANU; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	40	1289	1488	22	276	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 18	2003	425	6955					257	263		10.1038/nature01958	http://dx.doi.org/10.1038/nature01958			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722JA	12931144				2022-12-01	WOS:000185370900035
J	Mallam, KM; Metcalf, BS; Kirkby, J; Voss, LD; Wilkin, TJ				Mallam, KM; Metcalf, BS; Kirkby, J; Voss, LD; Wilkin, TJ			Contribution of timetabled physical education to total physical activity in primary school children: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							ACTIVITY MONITOR		Derriford Hosp, Peninsula Med Sch, Dept Endocrinol & Metab, Plymouth PL6 8DH, Devon, England	Derriford Hospital; University of Plymouth	Wilkin, TJ (corresponding author), Derriford Hosp, Peninsula Med Sch, Dept Endocrinol & Metab, Plymouth PL6 8DH, Devon, England.							Ekelund U, 2001, MED SCI SPORT EXER, V33, P275; Metcalf BS, 2002, MED SCI SPORT EXER, V34, P1533, DOI 10.1097/00005768-200209000-00022; MURPHY MJ, IN PRESS PEDIATRICS; Rowe N, 2000, YOUNG PEOPLE SPORT N	4	84	84	1	16	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 13	2003	327	7415					592	593		10.1136/bmj.327.7415.592	http://dx.doi.org/10.1136/bmj.327.7415.592			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722CW	12969924	Bronze, Green Published			2022-12-01	WOS:000185358700020
J	Arpigny, C; Jehin, E; Manfroid, J; Hutsemekers, D; Schulz, R; Stuwe, JA; Zucconi, JM; Ilyin, I				Arpigny, C; Jehin, E; Manfroid, J; Hutsemekers, D; Schulz, R; Stuwe, JA; Zucconi, JM; Ilyin, I			Anomalous nitrogen isotope ratio in comets	SCIENCE			English	Article							ABUNDANCE RATIO; PRESOLAR GRAINS; INTERSTELLAR; NUCLEOSYNTHESIS; PHOTOLYSIS; CHEMISTRY; ORIGIN; CN	High-resolution spectra of the CN B-2 Sigma(+)- X-2 Sigma(+) (0,0) band at 390 nanometers yield isotopic ratios for comets C/ 1995 O1 (Hale-Bopp) and C/ 2000 WM1 (LINEAR) as follows: 165 +/- 40 and 115 +/- 20 for C-12/C-13, 140 +/- 35 and 140 +/- 30 for N-14/N-15. Our N isotopic measurements are lower than the terrestrial N-14/N-15 = 272 and the ratio for Hale-Bopp from measurements of HCN, the presumed parent species of CN. This isotopic anomaly suggests the existence of other parent(s) of CN, with an even lower N isotopic ratio. Organic compounds like those found in interplanetary dust particles are good candidates.	Inst Astrophys & Geophys, B-4000 Liege, Belgium; European So Observ, Santiago 19, Chile; European Space Technol Ctr, European Space Agcy, RSSD, NL-2200 AG Noordwijk, Netherlands; Leiden Observ, NL-2300 RA Leiden, Netherlands; Observ Besancon, F-25010 Besancon, France; Univ Oulu, Astron Div, FIN-90014 Oulu, Finland	European Southern Observatory; European Space Agency; Leiden University; Leiden University - Excl LUMC; University of Oulu	Arpigny, C (corresponding author), Inst Astrophys & Geophys, Sart Tilman,Batiment B5c, B-4000 Liege, Belgium.	Claude.Arpigny@ulg.ac.be						AHEARN MF, 1986, NATURE, V324, P649, DOI 10.1038/324649a0; ALEON J, IN PRESS GEOCHIM COS; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; ARPIGNY C, 2000, B AM ASTRON SOC, V32, P1074; BERNSTEIN MP, 1995, ASTROPHYS J, V454, P327, DOI 10.1086/176485; Bernstein MP, 2002, ASTROPHYS J, V576, P1115, DOI 10.1086/341863; Charnley SB, 2002, ASTROPHYS J, V569, pL133, DOI 10.1086/340484; Chin YN, 1999, ASTROPHYS J, V512, pL143, DOI 10.1086/311875; Clayton DD, 1997, ASTROPHYS J, V486, P824, DOI 10.1086/304545; Cochran AL, 2002, ICARUS, V157, P297, DOI 10.1006/icar.2002.6850; Cochran AL, 2000, ICARUS, V146, P583, DOI 10.1006/icar.2000.6413; DAHMEN G, 1995, ASTRON ASTROPHYS, V295, P194; Dekker H, 2000, P SOC PHOTO-OPT INS, V4008, P534, DOI 10.1117/12.395512; FLOSS C, 2003, LUNAR PLANET SCI, V34, P1234; Hashizume K, 2000, SCIENCE, V290, P1142, DOI 10.1126/science.290.5494.1142; Henkel C, 1999, ESO ASTROPHY SYMP, P103; Hoppe P, 1997, ASTROPHYS J, V487, pL101, DOI 10.1086/310869; Ikeda M, 2002, ASTROPHYS J, V575, P250, DOI 10.1086/341287; Jessberger EK, 1999, SPACE SCI REV, V90, P91, DOI 10.1023/A:1005233727874; Jessberger EK, 2001, ASTR AST LI, P253; Jewitt DC, 1997, SCIENCE, V278, P90, DOI 10.1126/science.278.5335.90; Kallenbach R, 1998, ASTROPHYS J, V507, pL185, DOI 10.1086/311702; KELLER LP, 1998, LUNAR PLANET SCI, V28, P1811; KLAVETTER JJ, 2000, ICARUS, V146, P583; KLEINE M, 1995, ASTROPHYS J, V439, P1021, DOI 10.1086/175239; Lucas R, 1998, ASTRON ASTROPHYS, V337, P246; Meier R, 1999, SPACE SCI REV, V90, P33, DOI 10.1023/A:1005269208310; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; Mostefaoui S, 2002, EARTH PLANET SC LETT, V204, P89, DOI 10.1016/S0012-821X(02)00964-0; Owen T, 2001, ASTROPHYS J, V553, pL77, DOI 10.1086/320501; Rauer H, 2003, ASTRON ASTROPHYS, V397, P1109, DOI 10.1051/0004-6361:20021550; RETTIG TW, 1992, ASTROPHYS J, V393, P398; Terzieva R, 2000, MON NOT R ASTRON SOC, V317, P563, DOI 10.1046/j.1365-8711.2000.03618.x; Woodney LM, 2002, ICARUS, V157, P193, DOI 10.1006/icar.2001.6798; Wyckoff S, 2000, ASTROPHYS J, V535, P991, DOI 10.1086/308863; Zinner E, 1998, ANNU REV EARTH PL SC, V26, P147, DOI 10.1146/annurev.earth.26.1.147; Ziurys LM, 1999, ASTROPHYS J, V527, pL67, DOI 10.1086/312388; ZUCCONI JM, 1985, ASTRON ASTROPHYS, V150, P180	38	85	85	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2003	301	5639					1522	1524		10.1126/science.1086711	http://dx.doi.org/10.1126/science.1086711			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	720HL	12970562				2022-12-01	WOS:000185255300046
J	Hoffmeister, KM; Josefsson, EC; Isaac, NA; Clausen, H; Hartwig, JH; Stossel, TP				Hoffmeister, KM; Josefsson, EC; Isaac, NA; Clausen, H; Hartwig, JH; Stossel, TP			Glycosylation restores survival of chilled blood platelets	SCIENCE			English	Article							GLYCOPROTEIN IB-ALPHA; CARBOHYDRATE MOIETY; COLLAGEN ADHESION; RECEPTOR; ERYTHROCYTES; GLYCOCALICIN; COMPLEX; CLONING	Cooling of blood platelets clusters the von Willebrand factor receptor complex. Macrophage alpha(M)beta(2) integrins bind to the GPIbalpha subunit of the clustered complex, resulting in rapid clearance of transfused, cooled platelets. This precludes refrigeration of platelets for transfusion, but the current practice of room temperature storage has major drawbacks. We document that alpha(M)beta(2) is a lectin that recognizes exposed beta-N-acetylglucosamine residues of N-linked glycans on GPIbalpha. Enzymatic galactosylation of chilled platelets blocks alpha(M)beta(2) recognition, prolonging the circulation of functional cooled platelets. Platelet-associated galactosyltransferase produces efficient galactosylation when uridine diphosphate - galactose is added, affording a potentially simple method for storing platelets in the cold.	Harvard Univ, Sch Med, Dept Med, Div Hematol, Boston, MA 02115 USA; Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; Univ Copenhagen, Sch Dent, Dept Oral Diag, Copenhagen, Denmark; Zymequest Inc, Beverly, MA 01915 USA	Harvard University; Harvard Medical School; University of Gothenburg; University of Copenhagen	Hoffmeister, KM (corresponding author), Harvard Univ, Sch Med, Dept Med, Div Hematol, Boston, MA 02115 USA.	khoffmeister@rics.bwh.harvard.edu	clausen, henrik/AAD-8016-2021	Josefsson, Emma/0000-0001-6478-5204; Clausen, Henrik/0000-0002-0915-5055	NHLBI NIH HHS [HL19429, HL56949] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL019429, R37HL019429, P01HL056949] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARTHUR PG, 1991, J PEDIATR GASTR NUTR, V13, P260, DOI 10.1097/00005176-199110000-00004; BARBER AJ, 1971, BIOCHIM BIOPHYS ACTA, V252, P533, DOI 10.1016/0304-4165(71)90156-5; BECKER GA, 1973, TRANSFUSION, V13, P61, DOI 10.1111/j.1537-2995.1973.tb05442.x; BERNDT MC, 1985, EUR J BIOCHEM, V151, P637, DOI 10.1111/j.1432-1033.1985.tb09152.x; Berndt MC, 2001, THROMB HAEMOSTASIS, V86, P178; BERRY GT, 1995, LANCET, V346, P1073, DOI 10.1016/S0140-6736(95)91745-4; Blajchman MA, 2001, TRANSFUS APHER SCI, V24, P245, DOI 10.1016/S1473-0502(01)00063-5; Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099; Fotinopoulou A, 2003, BIOTECHNOL APPL BIOC, V37, P1, DOI 10.1042/BA20020023; Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; HOPPER KE, 1986, BLOOD, V68, P167; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; JAMIESON GA, 1971, NATURE-NEW BIOL, V234, P5, DOI 10.1038/newbio234005a0; KORREL SAM, 1988, FEBS LETT, V228, P321, DOI 10.1016/0014-5793(88)80024-3; Kuehnert MJ, 2001, TRANSFUSION, V41, P1493, DOI 10.1046/j.1537-2995.2001.41121493.x; LOPEZ JA, 1987, P NATL ACAD SCI USA, V84, P5615, DOI 10.1073/pnas.84.16.5615; MCCULLOUGH J, 2003, BLOOD PRINCIPLES PRA, P2011; Mi YL, 2002, J CLIN INVEST, V109, P269, DOI 10.1172/JCI13997; *NAT BLOOD DAT RES, 2001, COMPR REP BLOOD COLL, P3; Park EI, 2003, J BIOL CHEM, V278, P4597, DOI 10.1074/jbc.M210612200; RENDU F, 1984, THROMB RES, V36, P447, DOI 10.1016/0049-3848(84)90301-3; ROBBINS PW, 1992, GENE, V111, P69, DOI 10.1016/0378-1119(92)90604-N; ROSS GD, 1985, J IMMUNOL, V134, P3307; Simon DI, 2000, J EXP MED, V192, P193, DOI 10.1084/jem.192.2.193; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Thornton BP, 1996, J IMMUNOL, V156, P1235; TSUJI T, 1987, J BIOCHEM-TOKYO, V101, P241, DOI 10.1093/oxfordjournals.jbchem.a121897; TSUJI T, 1983, J BIOL CHEM, V258, P6335; VAYSSE J, 1986, P NATL ACAD SCI USA, V83, P1339, DOI 10.1073/pnas.83.5.1339; WARD C, 1996, BIOCHEMISTRY-US, V28, P8326	30	189	206	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2003	301	5639					1531	1534		10.1126/science.1085322	http://dx.doi.org/10.1126/science.1085322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	720HL	12970565				2022-12-01	WOS:000185255300049
J	Zagotta, WN; Olivier, NB; Black, KD; Young, EC; Olson, R; Gouaux, E				Zagotta, WN; Olivier, NB; Black, KD; Young, EC; Olson, R; Gouaux, E			Structural basis for modulation and agonist specificity of HCN pacemaker channels	NATURE			English	Article							NUCLEOTIDE-GATED CHANNELS; CAMP MODULATION; MOLECULAR-MECHANISM; BINDING DOMAIN; PROTEIN-KINASE; STOICHIOMETRY; ACTIVATION; DEPENDENCE; SUBUNIT; K+	The family of hyperpolarization-activated, cyclic nucleotide-modulated (HCN) channels are crucial for a range of electrical signalling, including cardiac and neuronal pacemaker activity, setting resting membrane electrical properties and dendritic integration(1). These nonselective cation channels, underlying the I-f, I-h and I-q currents of heart and nerve cells, are activated by membrane hyperpolarization and modulated by the binding of cyclic nucleotides such as cAMP and cGMP(2). The cAMP-mediated enhancement of channel activity is largely responsible for the increase in heart rate caused by beta-adrenergic agonists(3). Here we have investigated the mechanism underlying this modulation by studying a carboxy-terminal fragment of HCN2 containing the cyclic nucleotide-binding domain (CNBD) and the C-linker region that connects the CNBD to the pore. X-ray crystallographic structures of this C-terminal fragment bound to cAMP or cGMP, together with equilibrium sedimentation analysis, identify a tetramerization domain and the mechanism for cyclic nucleotide specificity, and suggest a model for ligand-dependent channel modulation. On the basis of amino acid sequence similarity to HCN channels, the cyclic nucleotide-gated, and eag- and KAT1-related families of channels are probably related to HCN channels in structure and mechanism.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA; Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Columbia University; Howard Hughes Medical Institute	Gouaux, E (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 650 W 168th St, New York, NY 10032 USA.	zagotta@u.washington.edu; jeg52@columbia.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360; Young, Edgar C./0000-0002-8453-088X	NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY010329, R01 EY010329-10] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALTENHOFEN W, 1991, P NATL ACAD SCI USA, V88, P9868, DOI 10.1073/pnas.88.21.9868; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Biel M, 2002, TRENDS CARDIOVAS MED, V12, P206, DOI 10.1016/S1050-1738(02)00162-7; BRUGGEMANN A, 1993, NATURE, V365, P445, DOI 10.1038/365445a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; HOSHI T, 1995, J GEN PHYSIOL, V105, P309, DOI 10.1085/jgp.105.3.309; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KUMAR VD, 1992, BIOCHEMISTRY-US, V31, P4643, DOI 10.1021/bi00134a015; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Matulef K, 1999, NEURON, V24, P443, DOI 10.1016/S0896-6273(00)80857-0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rothberg BS, 2002, J GEN PHYSIOL, V119, P83, DOI 10.1085/jgp.119.1.83; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Ulens C, 2003, BIOPHYS J, V84, p137A; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; WEBER IT, 1989, BIOCHEMISTRY-US, V28, P6122, DOI 10.1021/bi00440a059; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315	30	456	474	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2003	425	6954					200	205		10.1038/nature01922	http://dx.doi.org/10.1038/nature01922			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719ZT	12968185				2022-12-01	WOS:000185236000048
J	Schirmer, EC; Florens, L; Guan, TL; Yates, JR; Gerace, L				Schirmer, EC; Florens, L; Guan, TL; Yates, JR; Gerace, L			Nuclear membrane proteins with potential disease links found by subtractive proteomics	SCIENCE			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; PORE COMPLEX; IDENTIFICATION TECHNOLOGY; GENE; ENVELOPE; LAMINA	To comprehensively identify integral membrane proteins of the nuclear envelope (NE), we prepared separately NEs and organelles known to cofractionate with them from liver. Proteins detected by multidimensional protein identification technology in the cofractionating organelles were subtracted from the NE data set. In addition to all 13 known NE integral proteins, 67 uncharacterized open reading frames with predicted membrane-spanning regions were identified. All of the eight proteins tested targeted to the NE, indicating that there are substantially more integral proteins of the NE than previously thought. Furthermore, 23 of these mapped within chromosome regions linked to a variety of dystrophies.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Yates, JR (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.			Schirmer, Eric/0000-0003-2635-1338; Florens, Laurence/0000-0002-9310-6650	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM019085, R01GM028521] Funding Source: NIH RePORTER; NCRR NIH HHS [RR11823] Funding Source: Medline; NIGMS NIH HHS [GM28521, F32 GM19085] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; Dreger M, 2001, P NATL ACAD SCI USA, V98, P11943, DOI 10.1073/pnas.211201898; DWYER N, 1976, J CELL BIOL, V70, P581, DOI 10.1083/jcb.70.3.581; GERACE L, 1982, J CELL BIOL, V95, P826, DOI 10.1083/jcb.95.3.826; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Kitaguchi T, 2001, NEUROMUSCULAR DISORD, V11, P542, DOI 10.1016/S0960-8966(01)00207-3; Lin F, 2000, J BIOL CHEM, V275, P4840, DOI 10.1074/jbc.275.7.4840; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.0.CO;2-8; Satow R, 2002, BIOCHEM BIOPH RES CO, V295, P85, DOI 10.1016/S0006-291X(02)00641-1; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Vasu SK, 2001, CURR OPIN CELL BIOL, V13, P363, DOI 10.1016/S0955-0674(00)00221-0; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Worman HJ, 2002, TRENDS CELL BIOL, V12, P591, DOI 10.1016/S0962-8924(02)02401-7; Zhang QP, 2001, J CELL SCI, V114, P4485; [No title captured]	21	490	528	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 5	2003	301	5638					1380	1382		10.1126/science.1088176	http://dx.doi.org/10.1126/science.1088176			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717XQ	12958361				2022-12-01	WOS:000185116400042
J	McDermott, R; Tulip, F; Schmidt, B; Sinha, A				McDermott, R; Tulip, F; Schmidt, B; Sinha, A			Sustaining better diabetes care in remote indigenous Australian communities	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Problem Inhabitants of Torres Strait Islands have the highest prevalence of diabetes in Australia and many preventable complications. In 1999, a one year randomised cluster trial showed improved diabetes care processes and reduced admissions to hospital when local indigenous health workers used registers, recall and reminder systems, and basic diabetes care plans, supported by a specialist outreach service. This study looked at whether those improvements were sustained two years after the end of the trial. Design Three year follow up clinical audit of 21 primary healthcare centres, and review of admissions to hospital in the previous 12 months. Background and setting Remote indigenous communities in far north east Australia, population about 9600, including 921 people with diabetes. Key measures for improvement Number of people on registers, care processes (regular measures of weight, blood pressure, haemoglobin A(1c), urinary protein concentration, and concentrations of serum lipids and creatinine), appropriate clinical interventions (drug treatment and vaccinations), and intermediate patient outcome measures (weight, blood pressure, and glycaemic control). Admissions to hospital. Strategies for change Audit and feedback to clinicians and managers; provision of clinical guidelines and a clear management structure; workshops and training. Effects of change The number of people on registers increased from 555 in 1999 to 921 in 2002. Most care processes and clinical interventions improved. The proportion of people with good glycaemic control (haemoglobin A(1c), less than or equal to 7%) increased from 18% to 25% in line with increased use of insulin (from 7% to 16%). The proportion of those with well controlled hypertension (<140/90) increased from 40% to 64%. The proportion admitted to hospital with a diabetes related condition fell from 25% to 20%. Mean weight increased from 87 kg to 91 kg. Lessons learnt In remote settings, appropriate management structures and clinical support for people with diabetes can lead to improvements in care processes, control of blood pressure, and preventable complications that result in admission to hospital. Control of weight and glycaemia are more difficult and requires more active community engagement. Priorities now include increasing the availability and affordability of good food, achieving weight loss, and increasing appropriate use of hypoglycaemic agents, including insulin.	Queensland Hlth, Trop Publ Hlth Unit, Cairns, Qld 4870, Australia; James Cook Univ N Queensland, Townsville, Qld 4811, Australia; Queensland Hlth, Cairns Diabet Ctr, Cairns, Qld 4870, Australia	Queensland Health; James Cook University; Queensland Health	McDermott, R (corresponding author), Queensland Hlth, Trop Publ Hlth Unit, Cairns, Qld 4870, Australia.	robyn_mcdermott@health.qld.gov.au	McDermott, Robyn A/C-5824-2008					Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P965; Leonard D, 1995, AUST J PUBLIC HEALTH, V19, P589; Leonard D, 2002, AUST NZ J PUBL HEAL, V26, P144, DOI 10.1111/j.1467-842X.2002.tb00907.x; McDermott RA, 2001, MED J AUSTRALIA, V174, P497, DOI 10.5694/j.1326-5377.2001.tb143397.x; *QUEENSL HLTH, 2002, CHRON DIS STRAT IMPL, V1, P76; *QUEENSL HLTH, 2000, HLTH FOOD ACC BASK; *TORR STRAIT NO PE, 1996, MER ZAG DIAB OUR WOR	7	63	66	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2003	327	7412					428	430		10.1136/bmj.327.7412.428	http://dx.doi.org/10.1136/bmj.327.7412.428			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	715YY	12933731	Green Accepted, Green Published			2022-12-01	WOS:000185003100021
J	Sucena, E; Delon, I; Jones, I; Payre, F; Stern, DL				Sucena, E; Delon, I; Jones, I; Payre, F; Stern, DL			Regulatory evolution of shavenbaby/ovo underlies multiple cases of morphological parallelism	NATURE			English	Article							WINGLESS; EPIDERMIS	Cases of convergent evolution that involve changes in the same developmental pathway, called parallelism, provide evidence that a limited number of developmental changes are available to evolve a particular phenotype(1). To our knowledge, in no case are the genetic changes underlying morphological convergence understood. However, morphological convergence is not generally assumed to imply developmental parallelism(2). Here we investigate a case of convergence of larval morphology in insects and show that the loss of particular trichomes, observed in one species of the Drosophila melanogaster species group, has independently evolved multiple times in the distantly related D. virilis species group(3). We present genetic and gene expression data showing that regulatory changes of the shavenbaby/ovo (svb/ovo) gene underlie all independent cases of this morphological convergence. Our results indicate that some developmental regulators might preferentially accumulate evolutionary changes and that morphological parallelism might therefore be more common than previously appreciated.	Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Ctr Dev Biol, F-31062 Toulouse 4, France; Vanguard High Sch, New York, NY 10021 USA	Princeton University	Stern, DL (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	dstern@princeton.edu	Sucena, Élio/ABF-6684-2020; Sucena, Élio/M-1753-2015	Sucena, Élio/0000-0001-8810-870X; Sucena, Élio/0000-0001-8810-870X; PAYRE, Francois/0000-0002-8144-6711; Stern, David/0000-0002-1847-6483	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063622] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM063622] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bokor P, 1996, DEVELOPMENT, V122, P1083; Darwin C., 1859, ORIGIN SPECIES MEANS; DICKINSON WJ, 1993, EVOLUTION, V47, P1396, DOI [10.2307/2410155, 10.1111/j.1558-5646.1993.tb02162.x]; Endler J.A., 1986, Monographs in Population Biology, pviii; FFRENCHCONSTANT RH, 1994, INSECT BIOCHEM MOLEC, V24, P335, DOI 10.1016/0965-1748(94)90026-4; Hatini V, 2000, GENE DEV, V14, P1364; Hodin J, 2000, J EXP ZOOL, V288, P1; HSU TC, 1951, THESIS U TEXAS; KUHN DT, 1992, DROSOPHILA INFORMATI, V71, P218; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Spicer GS, 2002, ANN ENTOMOL SOC AM, V95, P156, DOI 10.1603/0013-8746(2002)095[0156:MPOTDV]2.0.CO;2; STEWART CB, 1987, COLD SPRING HARB SYM, V52, P891, DOI 10.1101/SQB.1987.052.01.097; Sucena E, 2000, P NATL ACAD SCI USA, V97, P4530, DOI 10.1073/pnas.97.9.4530; Throckmorton L.H., 1982, Genetics and Biology of Drosophila, V3b, P227; Wittkopp PJ, 2003, P NATL ACAD SCI USA, V100, P1808, DOI 10.1073/pnas.0336368100; Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2; Wray GA, 1998, CURR OPIN GENET DEV, V8, P675, DOI 10.1016/S0959-437X(98)80036-1	17	168	174	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2003	424	6951					935	938		10.1038/nature01768	http://dx.doi.org/10.1038/nature01768			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713EH	12931187				2022-12-01	WOS:000184843600040
J	de la Hoya, M; Fernandez, JM; Tosar, A; Godino, J; de Abajo, AS; Vidart, JA; Perez-Segura, P; Diaz-Rubio, E; Caldes, T				de la Hoya, M; Fernandez, JM; Tosar, A; Godino, J; de Abajo, AS; Vidart, JA; Perez-Segura, P; Diaz-Rubio, E; Caldes, T			Association between BRCA1 mutations and ratio of female to male births in offspring of families with breast cancer, ovarian cancer, or both	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							X-CHROMOSOME; INACTIVATION	Context Defects in X-chromosome inactivation distort sex ratio in mice. The BRCA1 gene is also involved in X-chromosome inactivation, suggesting the possibility that some sex-ratio distortion may be associated with BRCA1-related human cancer syndromes. Objective To determine whether BRCA1 mutations are associated with distortion of the sex ratio of births in families with breast cancer, ovarian cancer, or both. Design and Setting Analysis of germline mutations in participants from Spain who had been screened for BRCA between 1998 and 2002. Participants Sixty-eight families with at least 3 breast cancer cases or ovarian cancer cases, or both types of cancer in 2 generations (germline mutations: BRCA1, n = 17; BRCA2, n = 15; and BRCA unrelated, n = 36). An average of 4 relatives per family were tested for the corresponding BRCA mutation. Main Outcome Measure Male and female births registered in breast and/or ovarian pedigrees tested for the presence of BRCA1 and BRCA2 germline mutations. Results Of BRCA1-related breast and/or ovarian cancer pedigrees, there was a 2-fold excess of female births (218 female vs 109 male births). Of BRCA2-related or BRCA-unrelated breast and/or ovarian cancer pedigrees, there was not an excess of female births (1175 fernale/150 male and 344 female/315 male, respectively). Of 327 BRCA1 births, 218 (67%) were female births compared with 54% among BRCA2 pedigrees 0 75/327; P<.001) and 52% among BRCA-unrelated pedigrees (344/659; P<.001). Female births increased in the offspring of BRCA1 carriers compared with BRCA2 carriers (67% vs 52%; P=.004). Conclusion In these families with breast and/or ovarian cancer, mutations in BRCA1 but not BRCA2 were associated with a sex ratio skewed against male births.	Hosp Clin San Carlos, Mol Oncol Lab, Mol Oncol Unit, Madrid 28040, Spain; Hosp Clin San Carlos, Dept Gynecol, Madrid 28040, Spain; Hosp Clin San Carlos, Dept Clin Oncol, Madrid 28040, Spain	Hospital Clinico San Carlos; Hospital Clinico San Carlos; Hospital Clinico San Carlos	Caldes, T (corresponding author), Hosp Clin San Carlos, Mol Oncol Lab, Mol Oncol Unit, Martin Lagos S-N, Madrid 28040, Spain.		Godino, Javier/M-3753-2018; de la Hoya, MIguel/Z-2911-2019	Godino, Javier/0000-0002-5653-2722; de la Hoya, Miguel/0000-0002-8113-1410; Diaz-Rubio, Eduardo/0000-0003-2792-5348				Buller RE, 1999, JNCI-J NATL CANCER I, V91, P339, DOI 10.1093/jnci/91.4.339; de la Hoya M, 2002, INT J CANCER, V97, P466, DOI 10.1002/ijc.1627; Ganesan S, 2002, CELL, V111, P393, DOI 10.1016/S0092-8674(02)01052-8; Lee JT, 2002, NAT GENET, V32, P195, DOI 10.1038/ng939; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3	5	27	28	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2003	290	7					929	931		10.1001/jama.290.7.929	http://dx.doi.org/10.1001/jama.290.7.929			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	712ZE	12928470	Bronze			2022-12-01	WOS:000184828800030
J	Zschokke, S				Zschokke, S			Spider-web silk from the Early Cretaceous	NATURE			English	Editorial Material							ORB-WEBS		Univ Basel, Dept Integrat Biol, Sect Conservat Biol, CH-4056 Basel, Switzerland	University of Basel	Zschokke, S (corresponding author), Univ Basel, Dept Integrat Biol, Sect Conservat Biol, CH-4056 Basel, Switzerland.		Zschokke, Samuel/B-2583-2009	Zschokke, Samuel/0000-0002-5307-9010				Bachofen-Echt A., 1934, Biologia Generalis Wien Bd, V10, P179; Benjamin SP, 2003, BIOL J LINN SOC, V78, P293, DOI 10.1046/j.1095-8312.2003.00110.x; Coddington J., 1986, P319; ESKOV KY, 1984, NEUES JB GEOLOGIE PA, P645; Opell BD, 2002, J ARACHNOL, V30, P494, DOI 10.1636/0161-8202(2002)030[0494:ETSOIA]2.0.CO;2; Opell BD, 1998, FUNCT ECOL, V12, P613, DOI 10.1046/j.1365-2435.1998.00222.x; Penney D, 2002, J ARACHNOL, V30, P487, DOI 10.1636/0161-8202(2002)030[0487:TOLSIL]2.0.CO;2; SCHLEE D, 1970, NEUES JB GEOLOGIE PA, P40; SELDEN PA, 1989, NATURE, V340, P711, DOI 10.1038/340711a0; SHEAR WA, 1989, SCIENCE, V246, P479, DOI 10.1126/science.246.4929.479; VOLLRATH F, 1990, NATURE, V345, P526, DOI 10.1038/345526a0	11	28	31	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					636	637		10.1038/424636a	http://dx.doi.org/10.1038/424636a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904780				2022-12-01	WOS:000184578800032
J	Micheau, O; Tschopp, J				Micheau, O; Tschopp, J			Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes	CELL			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; FLICE-INHIBITORY PROTEINS; DEATH RECEPTORS; C-FLIP; FAS; ACTIVATION; FADD; RECRUITMENT; REQUIREMENT	Apoptosis induced by TNF-receptor I (TNFR1) is thought to proceed via recruitment of the adaptor FADD and caspase-8 to the receptor complex. TNFR1 signaling is also known to activate the transcription factor NF-kappaB and promote survival. The mechanism by which this decision between cell death and survival is arbitrated is not clear. We report that TNFR1-induced apoptosis involves two sequential signaling complexes. The initial plasma membrane bound complex (complex I) consists of TNFR1, the adaptor TRADD, the kinase RIP1, and TRAF2 and rapidly signals activation of NF-kappaB. In a second step, TRADD and RIP1 associate with FADD and caspase-8, forming a cytoplasmic complex (complex II). When NF-kappaB is activated by complex I, complex II harbors the caspase-8 inhibitor FLIPL and the cell survives. Thus, TNFR1-mediated-signal transduction includes a checkpoint, resulting in cell death (via complex II) in instances where the initial signal (via complex I, NF-kappaB) fails to be activated.	Univ Lausanne, Inst Biochem, BIL Biomed Res Ctr, CH-1066 Epalinges, Switzerland	University of Lausanne	Tschopp, J (corresponding author), Univ Lausanne, Inst Biochem, BIL Biomed Res Ctr, Chem Boveresses 155, CH-1066 Epalinges, Switzerland.		micheau, olivier/C-3574-2011	micheau, olivier/0000-0001-8499-7984				Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Devin A, 2001, MOL CELL BIOL, V21, P3986, DOI 10.1128/MCB.21.12.3986-3994.2001; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jones SJ, 1999, J IMMUNOL, V162, P1042; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Micheau O, 1999, J BIOL CHEM, V274, P7987, DOI 10.1074/jbc.274.12.7987; Morgan M, 2002, J CELL BIOL, V157, P975, DOI 10.1083/jcb.200204039; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Scaffidi C, 1999, CURR OPIN IMMUNOL, V11, P277, DOI 10.1016/S0952-7915(99)80045-4; Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203; Sprick MR, 2002, EMBO J, V21, P4520, DOI 10.1093/emboj/cdf441; Thomas LR, 2002, J BIOL CHEM, V277, P34343, DOI 10.1074/jbc.M204169200; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; Varfolomeev EE, 1996, J EXP MED, V183, P1271, DOI 10.1084/jem.183.3.1271; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	39	1873	1955	3	120	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 25	2003	114	2					181	190		10.1016/S0092-8674(03)00521-X	http://dx.doi.org/10.1016/S0092-8674(03)00521-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887920	Green Submitted, Bronze			2022-12-01	WOS:000184378700008
J	Wellik, DM; Capecchi, MR				Wellik, DM; Capecchi, MR			Hox10 and Hox11 genes are required to globally pattern the mammalian skeleton	SCIENCE			English	Article							AXIAL SKELETON; MICE LACKING; EXPRESSION; COMPLEX; FORELIMB; HOXD-11	Mice in which all members of the Hox10 or Hox11 paralogous group are disrupted provide evidence that these Hox genes are involved in global patterning of the axial and appendicular skeleton. In the absence of Hox10 function, no lumbar vertebrae are formed. Instead, ribs project from all posterior vertebrae, extending caudally from the last thoracic vertebrae to beyond the sacral region. In the absence of Hox11 function, sacral vertebrae are not formed and instead these vertebrae assume a lumbar identity. The redundancy among these paralogous family members is so great that this global aspect of Hox patterning is not apparent in mice that are mutant for five of the six paralogous alleles.	Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; Univ Utah, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Capecchi, MR (corresponding author), Howard Hughes Med Inst, Salt Lake City, UT 84112 USA.							BURKE AC, 1995, DEVELOPMENT, V121, P333; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; CONDIE BG, 1994, NATURE, V370, P304, DOI 10.1038/370304a0; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; DOLLE P, 1991, GENE DEV, V5, P1767, DOI 10.1101/gad.5.10.1767; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; Favier B, 1996, DEVELOPMENT, V122, P449; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Herault Y, 1999, DEV BIOL, V208, P157, DOI 10.1006/dbio.1998.9179; Hildebrand M., 1995, ANAL VERTEBRATE STRU; HORAN GSB, 1995, GENE DEV, V9, P1667, DOI 10.1101/gad.9.13.1667; Hostikka SL, 1998, MECH DEVELOP, V70, P133, DOI 10.1016/S0925-4773(97)00182-2; Kmita M, 2002, DEVELOPMENT, V129, P5521, DOI 10.1242/dev.00151; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Nowicki JL, 2000, DEVELOPMENT, V127, P4265; Suzuki M, 2002, MECH DEVELOP, V118, P241, DOI 10.1016/S0925-4773(02)00257-5; van den Akker E, 2001, DEVELOPMENT, V128, P1911; Wahba GM, 2001, DEV BIOL, V231, P87, DOI 10.1006/dbio.2000.0130	19	388	398	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					363	367		10.1126/science.1085672	http://dx.doi.org/10.1126/science.1085672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869760				2022-12-01	WOS:000184207300043
J	Chen, LM; Friedman, RM; Roe, AW				Chen, LM; Friedman, RM; Roe, AW			Optical Imaging of a tactile illusion in area 3b of the primary somatosensory cortex	SCIENCE			English	Article							CUTANEOUS STIMULI; SQUIRREL-MONKEYS; PARIETAL CORTEX; BODY-SURFACE; POINT; SKIN; REPRESENTATIONS; ORGANIZATION; INTEGRATION; RESPONSES	In the tactile funneling illusion, the simultaneous presentation of brief stimuli at multiple points on the skin produces a single focal sensation at the center of the stimulus pattern even when no physical stimulus occurs at that site. Consistent with the funneling percept, we show with optical imaging in area 3b of the primary somatosensory cortex (SI) that simultaneous stimulation of two fingertips produces a single focal cortical activation between the single fingertip activation regions. Thus, in contrast to traditional views of the body map, topographic representation in the SI reflects the perceived rather than the physical location of peripheral stimulation.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06520 USA	Yale University; Yale University	Roe, AW (corresponding author), Vanderbilt Univ, Dept Psychol, 066 Wilson Hall,111 21st Ave S, Nashville, TN 37203 USA.		Chen, Li Min/C-3554-2011	Roe, Anna Wang/0000-0003-4146-9705				ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Bonhoeffer Tobias, 1996, P55; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Chen LM, 2001, J NEUROPHYSIOL, V86, P3011, DOI 10.1152/jn.2001.86.6.3011; GARDNER EP, 1981, J NEUROPHYSIOL, V46, P479, DOI 10.1152/jn.1981.46.3.479; GARDNER EP, 1972, J NEUROPHYSIOL, V35, P925, DOI 10.1152/jn.1972.35.6.925; GARDNER EP, 1972, J NEUROPHYSIOL, V35, P954, DOI 10.1152/jn.1972.35.6.954; GARDNER EP, 1980, J NEUROPHYSIOL, V43, P420, DOI 10.1152/jn.1980.43.2.420; Hashimoto I, 1999, NEUROREPORT, V10, P3201, DOI 10.1097/00001756-199910190-00014; IWAMURA Y, 1983, EXP BRAIN RES, V51, P315; Kapadia MK, 2000, J NEUROPHYSIOL, V84, P2048, DOI 10.1152/jn.2000.84.4.2048; MCKENNA TM, 1982, J NEUROPHYSIOL, V48, P289, DOI 10.1152/jn.1982.48.2.289; NELSON RJ, 1980, J COMP NEUROL, V192, P611, DOI 10.1002/cne.901920402; PONS TP, 1987, SOMATOSENS MOT RES, V4, P309, DOI 10.3109/07367228709144612; Ramsden BM, 2001, CEREB CORTEX, V11, P648, DOI 10.1093/cercor/11.7.648; SCHROEDER CE, 1995, J NEUROPHYSIOL, V74, P722, DOI 10.1152/jn.1995.74.2.722; SHERRICK CE, 1964, AM J PSYCHOL, V77, P42, DOI 10.2307/1419270; SUR M, 1982, J COMP NEUROL, V211, P177, DOI 10.1002/cne.902110207; Tommerdahl M, 1998, J NEUROPHYSIOL, V80, P3272, DOI 10.1152/jn.1998.80.6.3272; von Bekesy G, 1967, SENSORY INHIBITION	20	124	125	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2003	302	5646					881	885		10.1126/science.1087846	http://dx.doi.org/10.1126/science.1087846			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737XQ	14500850				2022-12-01	WOS:000186258000054
J	Guermonprez, P; Saveanu, L; Kleijmeer, M; Davoust, J; van Endert, P; Amigorena, S				Guermonprez, P; Saveanu, L; Kleijmeer, M; Davoust, J; van Endert, P; Amigorena, S			ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells	NATURE			English	Article							ANTIGEN PRESENTATION; MEMBRANE-PROTEINS; DEGRADATION; MOLECULES; TRANSPORT; COMPLEX; CYTOSOL	Induction of cytotoxic T-cell immunity requires the phagocytosis of pathogens, virus-infected or dead tumour cells by dendritic cells(1). Peptides derived from phagocytosed antigens are then presented to CD8(+) T lymphocytes on major histocompatibility complex (MHC) class I molecules, a process called "cross-presentation"(2,3). After phagocytosis, antigens are exported into the cytosol and degraded by the proteasome(4-6). The resulting peptides are thought to be translocated into the lumen of the endoplasmic reticulum (ER) by specific transporters associated with antigen presentation (TAP), and loaded onto MHC class I molecules by a complex "loading machinery" (which includes tapasin, calreticulin and Erp57)(7). Here we show that soon after or during formation, phagosomes fuse with the ER. After antigen export to the cytosol and degradation by the proteasome, peptides are translocated by TAP into the lumen of the same phagosomes, before loading on phagosomal MHC class I molecules. Therefore, cross-presentation in dendritic cells occurs in a specialized, self-sufficient, ER-phagosome mix compartment.	Inst Curie, INSERM, U520, F-75005 Paris, France; Inst Necker, INSERM, U580, F-75015 Paris, France; UMC Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; Genethon, CNRS, UMR 8115, F-91002 Evry 02, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Utrecht University; Utrecht University Medical Center; Centre National de la Recherche Scientifique (CNRS)	Amigorena, S (corresponding author), Inst Curie, INSERM, U520, 26 Rue Ulm, F-75005 Paris, France.	sebastian.amigorena@curie.fr	Guermonprez, Pierre/ABE-7718-2020; van Endert, Peter/R-4606-2017; Saveanu, Loredana/K-6821-2017; Davoust, Jean/ABB-6720-2020; SAVEANU, Loredana/Q-1241-2019	Guermonprez, Pierre/0000-0001-5621-2262; van Endert, Peter/0000-0003-3782-0750; SAVEANU, Loredana/0000-0003-3138-7968; Davoust, Jean/0000-0002-3098-7665; Amigorena, Sebastian/0000-0001-8583-8416				Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; Daniel S, 1997, J IMMUNOL, V159, P2350; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; GRIFFITHS G, 1983, J CELL BIOL, V96, P835, DOI 10.1083/jcb.96.3.835; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Lemonnier FA, 2002, VIRUS RES, V82, P87; Norbury CC, 1997, EUR J IMMUNOL, V27, P280, DOI 10.1002/eji.1830270141; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Ramachandra L, 1998, J IMMUNOL METHODS, V213, P53, DOI 10.1016/S0022-1759(98)00017-9; RAPOSO G, 1997, HDB EXPT IMMUNOLOGY, P1; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Rock KL, 2002, ADV IMMUNOL, V80, P1, DOI 10.1016/S0065-2776(02)80012-8; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3	22	589	613	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2003	425	6956					397	402		10.1038/nature01911	http://dx.doi.org/10.1038/nature01911			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	724TG	14508489				2022-12-01	WOS:000185502300041
J	Little, J; Khoury, MJ				Little, J; Khoury, MJ			Mendelian randomisation: a new spin or real progress?	LANCET			English	Editorial Material							METHYLENETETRAHYDROFOLATE REDUCTASE MTHFR; POPULATION STRATIFICATION; LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; C677T POLYMORPHISM; ENZYME-ACTIVITY; HUMAN-GENOME; DISEASE; SUSCEPTIBILITY; HOMOCYSTEINE		Ctr Dis Control & Prevent, Off Genom & Dis Prevent, Atlanta, GA 30341 USA; Univ Aberdeen, Dept Med & Therapeut, Epidemiol Grp, Aberdeen, Scotland	Centers for Disease Control & Prevention - USA; University of Aberdeen	Little, J (corresponding author), Ctr Dis Control & Prevent, Off Genom & Dis Prevent, Atlanta, GA 30341 USA.		Little, Julian/AAR-6117-2020	Little, Julian/0000-0001-5026-5531				Andreassi MG, 2003, HUM GENET, V112, P171, DOI 10.1007/s00439-002-0859-3; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Ardlie KG, 2002, AM J HUM GENET, V71, P304, DOI 10.1086/341719; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Clayton D, 2001, LANCET, V358, P1356, DOI 10.1016/S0140-6736(01)06418-2; Collins R, 2001, LANCET, V357, P373, DOI 10.1016/S0140-6736(00)03651-5; Crott JW, 2001, CARCINOGENESIS, V22, P1019, DOI 10.1093/carcin/22.7.1019; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; KHOURY MJ, 1987, AM J EPIDEMIOL, V126, P561, DOI 10.1093/oxfordjournals.aje.a114695; Lievers KJA, 2001, J MOL MED-JMM, V79, P522, DOI 10.1007/s001090100253; Little J, 2003, AM J EPIDEMIOL, V157, P667, DOI 10.1093/aje/kwg048; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Nallamothu BK, 2000, ARCH INTERN MED, V160, P3406, DOI 10.1001/archinte.160.22.3406; NARAYANAN S, 2001, THESIS U ABERDEEN AB; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Rozen R, 1997, THROMB HAEMOSTASIS, V78, P523; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Strachan T., 2004, HUM MOL GENET, V3; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; 2003, LANCET, V361, P357	23	51	52	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 20	2003	362	9388					930	931		10.1016/S0140-6736(03)14396-6	http://dx.doi.org/10.1016/S0140-6736(03)14396-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724LT	14511923				2022-12-01	WOS:000185489600004
J	Morris, CA; Avorn, J				Morris, CA; Avorn, J			Internet marketing of herbal products	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	19th International Conference on Pharmacoepidermiology/Annual Meeting of the International-Society-for-Pharmacoepidemiology	AUG   22, 2003	PHILADELPHIA, PENNSYLVANIA	Internat Soc Pharmacoepidemiol			DIETARY-SUPPLEMENTS; UNITED-STATES; HEALTH; MEDICINE; NEED; WEB	Context Passage of the Dietary Supplement Health and Education Act in 1994 restricted the Food and Drug Administration's control over dietary supplements, leading to enormous growth in their promotion. The Internet is often used by consumers as a source of information on such therapies. Objective To assess the information presented and indications claimed on the Internet for the 8 best-selling herbal products. Data Sources We searched the Internet using the 5 most commonly used search engines. For each, we entered the names of the 8 most widely used herbal supplements (ginkgo biloba, St John's wort, echinacea, ginseng, garlic, saw palmetto, kava kava, and valerian root). We analyzed the health content of all Web sites listed on the first page of the search results. Study Selection We analyzed all accessible, English-language Web sites that pertained to oral herbal supplements. A total of 522 Web sites were identified; of these, 443 sites met inclusion criteria for the analysis. Data Extraction The nature of the Web site (retail or nonretail), whether it was a sponsored link, and all references, indications, claims, and disclaimers were recorded. Two reviewers independently categorized medical claims as disease or nondisease according to Food and Drug Administration criteria. Data Synthesis Among 443 Web sites, 338 (76%) were retail sites either selling product or directly linked to a vendor. A total of 273 (81%) of the 338 retail Web sites made 1 or more health claims; of these, 149 (55%) claimed to treat, prevent, diagnose, or cure specific diseases. More than half (153/292; 52%) of sites with a health claim omitted the standard federal disclaimer. Nonretail sites were more likely than retail sites to include literature references, although only 52 (12%) of the 443 Web sites provided referenced information without a link to a distributor or vendor. Conclusions Consumers maybe misled, by vendors' claims that herbal products can treat, prevent, diagnose, or cure specific diseases, despite regulations prohibiting such statements. Physicians should be aware of this widespread and easily accessible information. More effective regulation is required to put this class of therapeutics on the same evidence-based footing as other medicinal products.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Morris, CA (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.							[Anonymous], COMMUNICATION; Blendon RJ, 2001, ARCH INTERN MED, V161, P805, DOI 10.1001/archinte.161.6.805; Bonakdar RA, 2002, FAM MED, V34, P522; CHALLENER C, 2002, CHEM MARKET REP 0617, pFR11; Drazen JM, 2003, NEW ENGL J MED, V348, P777, DOI 10.1056/NEJMp030021; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Fontanarosa PB, 2003, JAMA-J AM MED ASSOC, V289, P1568, DOI 10.1001/jama.289.12.1568; *FOOD DRUG ADM, CONS ADV KAV DIET SU; *FOOD DRUG ADM, FDA ADV DIET SUPPL M; Fox S., 2002, VITAL DECISIONS INTE; *GEN ACC OFF, 2002, 83177 GEN ACC OFF; JELLIN JM, 2002, PHARM LETT PRESCRIBE; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Linde K, 1996, BRIT MED J, V313, P253, DOI 10.1136/bmj.313.7052.253; Lipman MM, 2003, NEW ENGL J MED, V348, P1498; Marcus DM, 2002, NEW ENGL J MED, V347, P2073, DOI 10.1056/NEJMsb022858; Palmer ME, 2003, LANCET, V361, P101, DOI 10.1016/S0140-6736(03)12227-1; Slater MD, 2002, JAMA-J AM MED ASSOC, V288, P316, DOI 10.1001/jama.288.3.316; SULLIVAN D, 2002, JUPITER MEDIA METRIX; Troger U, 1998, BMJ-BRIT MED J, V317, P1069, DOI 10.1136/bmj.317.7165.1069; *US DEP COMM, 2002, NAT ONL AM AR EXP TH; Wilson P, 2002, BMJ-BRIT MED J, V324, P598, DOI 10.1136/bmj.324.7337.598; Wilt TJ, 1998, JAMA-J AM MED ASSOC, V280, P1604, DOI 10.1001/jama.280.18.1604; 2002, NUTR BUSINESS J  MAY, P1; 2001, FED REG, V65, P56035	25	172	178	0	31	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2003	290	11					1505	1509		10.1001/jama.290.11.1505	http://dx.doi.org/10.1001/jama.290.11.1505			5	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721RE	13129992				2022-12-01	WOS:000185329000034
J	Richter, J; Hatz, C; Haussinger, D				Richter, J; Hatz, C; Haussinger, D			Ultrasound in tropical and parasitic diseases	LANCET			English	Review							SCHISTOSOMIASIS-MANSONI; ECHINOCOCCOSIS; EVOLUTION	Context Migration and worldwide travel mean that western clinicians and radiologists more and more face imported tropical diseases. Diseases with unclear signs and symptoms are likely to be investigated with ultrasound Many tropical diseases have particular ultrasonographic features that are not familiar to the examiner and which may lead to further unnecessary or even harmful diagnostic investigations. In developing countries, ultrasound machines are becoming more widely distributed and are fairly cheap. Portable devices allow field use of ultrasound for population studies and individual diagnosis of tropical diseases Starting point Recently, WHO introduced a standardised classification of ultrasonographic images of cystic echinococcosis (Acta Trop 2003; 85: 253-61), to obtain comparable results in patients worldwide and to link disease status with each morphological type of echinococcosis cyst. WHO also defined guidelines for the puncture, aspiration, injection of ethanol, and re-aspiration of such cysts. Ultrasound allows diagnosis of schistosomiasis-induced periportal fibrosis and bladder abnormalities. Liver abscesses can be differentiated from other focal lesions such as cysts or neoplasms. For amoebic abscesses, invasive procedures are usually not required. In doubtful cases ultrasound-guided puncture can give adequate material for microscopy and culture. Helminths (eg, ascaris), flukes, and filariae can be seen directly with ultrasound. Filaria-induced damage also includes hypoechogenic splenic foci and ultrasonographic abnormalities due to tropical hypereosinophilia. Where next? Classification of cysts and procedures that are less invasive than conventional surgery are being developed further for cystic echinococcosis. Novel methods are needed for the assessment of polycystic and alveolar echinococcosis. Ultrasound protocols for schistosomiasis are being evaluated for interobserver reliability, relation to clinical disease status, and power to predict complications. A WHO expert-group is also developing a standardised protocol for Asian schistosomiasis. International consensus on an algorithm for managing amoebic liver abscesses,is needed.	Univ Dusseldorf, Univ Clin, Clin Gastroenterol Hepatol & Infect Dis, D-4000 Dusseldorf, Germany; Swiss Trop Inst, CH-4002 Basel, Switzerland	Heinrich Heine University Dusseldorf; University of Basel; Swiss Tropical & Public Health Institute	Richter, J (corresponding author), Univ Dusseldorf, Klin Gastroenterol Hepatol & Infektiol, Tropenmed Ambulanz, D-40225 Dusseldorf, Germany.							ACQUATELLA H, 1983, CIRCULATION, V67, P1219, DOI 10.1161/01.CIR.67.6.1219; AMARAL F, 1994, AM J TROP MED HYG, V50, P753, DOI 10.4269/ajtmh.1994.50.753; Bartholomot B, 2002, AM J TROP MED HYG, V66, P23, DOI 10.4269/ajtmh.2002.66.23; Brunetti E, 2001, LANCET, V358, P1464, DOI 10.1016/S0140-6736(01)06518-7; Burchard GD, 1996, CLIN INFECT DIS, V23, P979, DOI 10.1093/clinids/23.5.979; CERRI GG, 1984, RADIOLOGY, V153, P777, DOI 10.1148/radiology.153.3.6387793; DAlessandro A, 1997, ACTA TROP, V67, P43, DOI 10.1016/S0001-706X(97)00048-X; Hatz CF, 1998, AM J TROP MED HYG, V59, P775, DOI 10.4269/ajtmh.1998.59.775; King CH, 2003, TROP MED INT HEALTH, V8, P109, DOI 10.1046/j.1365-3156.2003.00994.x; LEICHSENRING M, 1990, AM J TROP MED HYG, V43, P380, DOI 10.4269/ajtmh.1990.43.380; Macpherson CNL, 2003, ACTA TROP, V85, P253, DOI 10.1016/S0001-706X(02)00213-9; MUELLER PR, 1985, RADIOLOGY, V155, P627, DOI 10.1148/radiology.155.3.3890001; Niamey Working Group, 2000, ULTR SCHIST PRACT GU; Richter J, 1999, TROP MED INT HEALTH, V4, P774, DOI 10.1046/j.1365-3156.1999.00482.x; *WHO, 1995, MAN DIAGN ULTR; *WHO, 1998, WHO TECH REP SER, V875; WHO Informal Working Group on Echinococcosis (WHO-IGWE), 2001, PAIR PUNCT ASP INJ R	17	64	65	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 13	2003	362	9387					900	902		10.1016/S0140-6736(03)14334-6	http://dx.doi.org/10.1016/S0140-6736(03)14334-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721RH	13678978				2022-12-01	WOS:000185329400023
J	Ekstrom, AD; Kahana, MJ; Caplan, JB; Fields, TA; Isham, EA; Newman, EL; Fried, I				Ekstrom, AD; Kahana, MJ; Caplan, JB; Fields, TA; Isham, EA; Newman, EL; Fried, I			Cellular networks underlying human spatial navigation	NATURE			English	Article							HUMAN HIPPOCAMPUS; HEAD DIRECTION; SINGLE-NEURON; CELLS; RESPONSES	Place cells of the rodent hippocampus constitute one of the most striking examples of a correlation between neuronal activity and complex behaviour in mammals(1,2). These cells increase their firing rates when the animal traverses specific regions of its surroundings, providing a context-dependent map of the environment(3-5). Neuroimaging studies implicate the hippocampus and the parahippocampal region in human navigation(6-8). However, these regions also respond selectively to visual stimuli(9-13). It thus remains unclear whether rodent place coding has a homologue in humans or whether human navigation is driven by a different, visually based neural mechanism. We directly recorded from 317 neurons in the human medial temporal and frontal lobes while subjects explored and navigated a virtual town. Here we present evidence for a neural code of human spatial navigation based on cells that respond at specific spatial locations and cells that respond to views of landmarks. The former are present primarily in the hippocampus, and the latter in the parahippocampal region. Cells throughout the frontal and temporal lobes responded to the subjects' navigational goals and to conjunctions of place, goal and view.	Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA; Univ Calif Los Angeles, Div Neurosurg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Tel Aviv Med Ctr, Funct Neurosurg Unit, IL-69978 Tel Aviv, Israel	Brandeis University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Kahana, MJ (corresponding author), Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA.	kahana@brandeis.edu; ifried@mednet.ucla.edu	Ekstrom, Arne/A-1329-2013	Ekstrom, Arne/0000-0002-6812-2368; Newman, Ehren/0000-0001-7006-4112				Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cameron KA, 2001, NEURON, V30, P289, DOI 10.1016/S0896-6273(01)00280-X; Caplan JB, 2003, J NEUROSCI, V23, P4726; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fried I, 1999, J NEUROSURG, V91, P697, DOI 10.3171/jns.1999.91.4.0697; Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3; Georges-Francois P, 1999, CEREB CORTEX, V9, P197, DOI 10.1093/cercor/9.3.197; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; Matsumura N, 1999, J NEUROSCI, V19, P2381; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1987, J NEUROSCI, V7, P1935; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Ojemann GA, 2002, NAT NEUROSCI, V5, P64, DOI 10.1038/nn785; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; Robertson RG, 1999, HIPPOCAMPUS, V9, P206, DOI 10.1002/(SICI)1098-1063(1999)9:3<206::AID-HIPO2>3.3.CO;2-8; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Witter M., 2002, PARAHIPPOCAMPAL REGI, P3, DOI DOI 10.1093/ACPROF:OSO/9780198509172.001.0001	27	799	824	6	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2003	425	6954					184	187		10.1038/nature01964	http://dx.doi.org/10.1038/nature01964			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719ZT	12968182				2022-12-01	WOS:000185236000044
J	Fu, J; Gaetani, S; Oveisi, F; Lo Verme, J; Serrano, A; de Fonseca, FR; Rosengarth, A; Luecke, H; Di Giacomo, B; Tarzia, G; Piomelli, D				Fu, J; Gaetani, S; Oveisi, F; Lo Verme, J; Serrano, A; de Fonseca, FR; Rosengarth, A; Luecke, H; Di Giacomo, B; Tarzia, G; Piomelli, D			Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha	NATURE			English	Article							FATTY-ACIDS; GAMMA ACTIVATORS; GENE-EXPRESSION; NITRIC-OXIDE; MICE; RAT; EICOSANOIDS; TRANSPORT; LIGANDS; PROTEIN	Oleylethanolamide (OEA) is a naturally occurring lipid that regulates satiety and body weight(1,2). Although structurally related to the endogenous cannabinoid anandamide, OEA does not bind to cannabinoid receptors and its molecular targets have not been defined. Here we show that OEA binds with high affinity to the peroxisome-proliferator-activated receptor-alpha (PPAR-alpha), a nuclear receptor that regulates several aspects of lipid metabolism. Administration of OEA produces satiety and reduces body weight gain in wild-type mice, but not in mice deficient in PPAR-alpha. Two distinct PPAR-alpha agonists have similar effects that are also contingent on PPAR-alpha expression, whereas potent and selective agonists for PPAR-gamma and PPAR-beta/delta are ineffective. In the small intestine of wild-type but not PPAR-alpha-null mice, OEA regulates the expression of several PPAR-alpha target genes: it initiates the transcription of proteins involved in lipid metabolism and represses inducible nitric oxide synthase, an enzyme that may contribute to feeding stimulation. Our results, which show that OEA induces satiety by activating PPAR-alpha, identify an unexpected role for this nuclear receptor in regulating behaviour, and raise possibilities for the treatment of eating disorders.	Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; Fdn Hosp Carlos Haya, Malaga, Spain; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Urbino, Inst Med Chem, I-61029 Urbino, Italy	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Urbino	Piomelli, D (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA.		Gaetani, Silvana/D-3455-2009; DE FONSECA, FERNANDO RODRIGUEZ/E-9767-2012; Fu, Jin/A-3510-2012; Luecke, Hartmut/F-4712-2012	Luecke, Hartmut/0000-0002-4938-0775; Serrano, Antonia/0000-0002-8017-9754				Akiyama TE, 2001, J BIOL CHEM, V276, P39088, DOI 10.1074/jbc.M107073200; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Best JD, 2001, EXPERT OPIN INV DRUG, V10, P1901; BROWN PJ, 2000, Patent No. 32; Butler A A, 2001, Trends Genet, V17, pS50, DOI 10.1016/S0168-9525(01)02481-7; CHANG AY, 1983, DIABETES, V32, P830, DOI 10.2337/diabetes.32.9.830; CHAO EYH, 2001, Patent No. 83; Chaput E, 2000, BIOCHEM BIOPH RES CO, V271, P445, DOI 10.1006/bbrc.2000.2647; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; CLEARY MP, 1987, ATHEROSCLEROSIS, V66, P107, DOI 10.1016/0021-9150(87)90185-7; Colville-Nash PR, 1998, J IMMUNOL, V161, P978; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Escher P, 2001, ENDOCRINOLOGY, V142, P4195, DOI 10.1210/en.142.10.4195; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Gaetani S, 2003, NEUROPSYCHOPHARMACOL, V28, P1311, DOI 10.1038/sj.npp.1300166; Giuffrida A, 2000, ANAL BIOCHEM, V280, P87, DOI 10.1006/abio.2000.4509; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Gregoire FM, 2002, AM J PHYSIOL-ENDOC M, V282, pE703, DOI 10.1152/ajpendo.00072.2001; Janero DR, 2001, NUTRITION, V17, P896, DOI 10.1016/S0899-9007(01)00647-5; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Lazennec G, 2000, MOL ENDOCRINOL, V14, P1962, DOI 10.1210/me.14.12.1962; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210; Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; STICKERKRONGRAD A, 1996, LIFE SCI, V58, pPL9; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g	30	837	905	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 4	2003	425	6953					90	93		10.1038/nature01921	http://dx.doi.org/10.1038/nature01921			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717LD	12955147				2022-12-01	WOS:000185089200044
J	Askari, AT; Unzek, S; Popovic, ZB; Goldman, CK; Forudi, F; Kiedrowski, M; Rovner, A; Ellis, SG; Thomas, JD; DiCorleto, PE; Topol, EJ; Penn, MS				Askari, AT; Unzek, S; Popovic, ZB; Goldman, CK; Forudi, F; Kiedrowski, M; Rovner, A; Ellis, SG; Thomas, JD; DiCorleto, PE; Topol, EJ; Penn, MS			Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy	LANCET			English	Article							MYOCARDIAL-INFARCTION; PROGENITOR CELLS; HEART FUNCTION; TRANSPLANTATION; MOBILIZATION; SDF-1; NEOVASCULARIZATION; RECRUITMENT; MIGRATION; REQUIRES	Background Myocardial regeneration via stem-cell mobilisation at the time of myocardial infarction is known to occur, although the mechanism for stem-cell homing to infarcted tissue subsequently and whether this approach can be used for treatment of ischaemic cardiomyopathy are unknown. We investigated these issues in a Lewis rat model (ligation of the left anterior descending artery) of ischaemic cardiomyopathy. Methods We studied the effects of stem-cell mobilisation by use of granulocyte colony-stimulating factor (filgrastim) with or without transplantation of syngeneic cells. Shortening fraction and myocardial strain by tissue doppler imaging were quantified by echocardiography. Findings Stem-cell mobilisation with filgrastim alone did not lead to engraftment of bone-marrow-derived cells. Stromal-cell-derived factor 1 (SDF-1), required for stem-cell homing to bone marrow, was upregulated immediately after myocardial infarction and downregulated within 7 days. 8 weeks after myocardial infarction, transplantation into the peri-infarct zone of syngeneic cardiac fibroblasts stably transfected to express SDF-1 induced homing of CD117-positive stem cells to injured myocardium after filgrastim administration (control vs SDF-1-expressing cardiac fibroblasts mean 7.2 [SD 3.4] vs 33.2 [6.0] cells/mm(2), n=4 per group, p<0.02) resulting in greater left-ventricular mass (1.24 [0.29] vs 1.57 [0.27] g) and better cardiac function (shortening fraction 9.2 [4.9] vs 17.2 [4.2]%, n=8 per group, p<0.05). Interpretation These findings show that SDF-1 is sufficient to induce therapeutic stem-cell homing to injured myocardium and suggest a strategy for directed stem-cell engraftment into injured tissues. Our findings also indicate that therapeutic strategies focused on stem-cell mobilisation for regeneration of myocardial tissue must be initiated within days of myocardial infarction unless signalling for stem-cell homing is re-established.	Cleveland Clin Fdn, Dept Cardiovasc Med, Expt Anim Lab, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Ctr Stem Cell & Regenerat Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Penn, MS (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, Expt Anim Lab, NC10, Cleveland, OH 44195 USA.	pennm@ccf.org		popovic, zoran/0000-0001-5692-2299; Topol, Eric/0000-0002-1478-4729				Askari AT, 2003, J EXP MED, V197, P615, DOI 10.1084/jem.20021426; Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com; Collins KA, 2001, AM J PHYSIOL-HEART C, V280, pH1954, DOI 10.1152/ajpheart.2001.280.5.H1954; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Etzion S, 2001, J MOL CELL CARDIOL, V33, P1321, DOI 10.1006/jmcc.2000.1391; FIRSTENBERG MS, 2000, CURR SURG, V57, P466, DOI DOI 10.1016/S0149-7944(00)00296-8; Greenberg NL, 2002, CIRCULATION, V105, P99, DOI 10.1161/hc0102.101396; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Liesveld JL, 2001, J HEMATOTH STEM CELL, V10, P643, DOI 10.1089/152581601753193850; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Penn MS, 2002, PROG CARDIOVASC DIS, V45, P21, DOI 10.1053/pcad.2002.123466; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; ROBBINS MA, 1998, MANAGEMENT END STAGE, P3; Sakai T, 1999, J THORAC CARDIOV SUR, V118, P715, DOI 10.1016/S0022-5223(99)70018-8; Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929; Tomita S, 2002, J THORAC CARDIOV SUR, V123, P1132, DOI 10.1067/mtc.2002.120716; Topol EJ, 2001, LANCET, V357, P1905; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yong K, 1999, BRIT J HAEMATOL, V107, P441, DOI 10.1046/j.1365-2141.1999.01714.x; Yoo KJ, 2002, YONSEI MED J, V43, P296, DOI 10.3349/ymj.2002.43.3.296; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	30	1033	1137	0	70	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 30	2003	362	9385					697	703		10.1016/S0140-6736(03)14232-8	http://dx.doi.org/10.1016/S0140-6736(03)14232-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	716NH	12957092				2022-12-01	WOS:000185034800010
J	Tsuda, M; Sasaoka, Y; Kiso, M; Abe, K; Haraguchi, S; Kobayashi, S; Saga, Y				Tsuda, M; Sasaoka, Y; Kiso, M; Abe, K; Haraguchi, S; Kobayashi, S; Saga, Y			Conserved role of nanos proteins in germ cell development	SCIENCE			English	Article							DROSOPHILA; MOUSE; GENERATION; PUMILIO; EMBRYOS; GENES	In Drosophila, maternally supplied Nanos functions in the migration of primordial germ cells (PGCs) into the gonad; in mice, zygotic genes are involved instead. We report the cloning and the functional analyses of nanos2 and nanos3 in mice. These genes are differentially expressed in mouse PGCs. nanos2 is predominantly expressed in male germ cells, and the elimination of this gene results in a complete loss of spermatogonia. However, nanos3 is found in migrating PGCs, and the elimination of this factor results in the complete loss of germ cells in both sexes. Hence, although mice and flies differ in their mechanisms for germ cell specification, there seems to be conserved function for nanos proteins among invertebrates and vertebrates.	SOKENDAI, Natl Inst Genet, Div Mammalian Dev, Shizuoka 4118540, Japan; Japan Sci & Technol Corp, CREST, Minato Ku, Tokyo 1050011, Japan; RIKEN, Bioresource Ctr, Tsukuba, Ibaraki 3050074, Japan; Shiga Univ Med Sci, Dept Microbiol, Otsu, Shiga 5202192, Japan; Okazaki Natl Res Inst, Natl Inst Basic Biol, Ctr Integrat Biosci, Okazaki, Aichi 4448585, Japan	Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Science & Technology Agency (JST); RIKEN; Shiga University of Medical Science; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Saga, Y (corresponding author), SOKENDAI, Natl Inst Genet, Div Mammalian Dev, Yata 1111, Shizuoka 4118540, Japan.	ysaga@lab.nig.ac.jp						Abe K, 1996, DEV BIOL, V180, P468, DOI 10.1006/dbio.1996.0320; Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; Forbes A, 1998, DEVELOPMENT, V125, P679; Haraguchi S, 2003, MECH DEVELOP, V120, P721, DOI 10.1016/S0925-4773(03)00043-1; Jaruzelska J, 2003, DEV GENES EVOL, V213, P120, DOI 10.1007/s00427-003-0303-2; Kobayashi S, 1996, NATURE, V380, P708, DOI 10.1038/380708a0; Koprunner M, 2001, GENE DEV, V15, P2877; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Mochizuki K, 2000, DEV GENES EVOL, V210, P591, DOI 10.1007/s004270000105; MOSQUERA L, 1993, DEVELOPMENT, V117, P377; Pilon M, 1997, DEVELOPMENT, V124, P1771; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Subramaniam K, 1999, DEVELOPMENT, V126, P4861; WANG C, 1991, CELL, V66, P637, DOI 10.1016/0092-8674(91)90110-K; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053	15	438	472	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2003	301	5637					1239	1241		10.1126/science.1085222	http://dx.doi.org/10.1126/science.1085222			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZC	12947200				2022-12-01	WOS:000185003500043
J	Lee, PN; Callaerts, P; de Couet, HG; Martindale, MQ				Lee, PN; Callaerts, P; de Couet, HG; Martindale, MQ			Cephalopod Hox genes and the origin of morphological novelties	NATURE			English	Article							SQUID EUPRYMNA-SCOLOPES; B-LIKE GENE; EXPRESSION; EVOLUTION; SHELL; BRAIN; ORGAN	Cephalopods are a diverse group of highly derived molluscs, including nautiluses, squids, octopuses and cuttlefish. Evolution of the cephalopod body plan from a monoplacophoran-like ancestor(1) entailed the origin of several key morphological innovations contributing to their impressive evolutionary success(2). Recruitment of regulatory genes(3), or even pre-existing regulatory networks(4), may be a common genetic mechanism for generating new structures. Hox genes encode a family of transcriptional regulatory proteins with a highly conserved role in axial patterning in bilaterians(5); however, examples highlighting the importance of Hox gene recruitment for new developmental functions are also known(6,7). Here we examined developmental expression patterns for eight out of nine Hox genes(8) in the Hawaiian bobtail squid Euprymna scolopes, by whole-mount in situ hybridization. Our data show that Hox orthologues have been recruited multiple times and in many ways in the origin of new cephalopod structures. The manner in which these genes have been co-opted during cephalopod evolution provides insight to the nature of the molecular mechanisms driving morphological change in the Lophotrochozoa, a clade exhibiting the greatest diversity of body plans in the Metazoa.	Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA; Univ Hawaii, Kewalo Marine Lab, Pacific Biomed Res Ctr, Honolulu, HI 96813 USA; Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Houston System; University of Houston	de Couet, HG (corresponding author), Univ Hawaii Manoa, Dept Zool, 2538 McCarthy Mall, Honolulu, HI 96822 USA.		Callaerts, Patrick/I-8118-2013; de Couet, Heinz/J-9522-2012	de Couet, Heinz/0000-0002-0307-2881; Callaerts, Patrick/0000-0003-4530-4561				Averof M, 1997, NATURE, V388, P682, DOI 10.1038/41786; Brusca R. C., 2003, INVERTEBRATES; Budelrnann B, 1995, NERVOUS SYSTEM INVER, P115; BURKE AC, 1995, DEVELOPMENT, V121, P333; Callaerts P, 2002, P NATL ACAD SCI USA, V99, P2088, DOI 10.1073/pnas.042683899; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Hartmann B, 2003, MECH DEVELOP, V120, P177, DOI 10.1016/S0925-4773(02)00456-2; HINMAN VF, IN PRESS EVOL DEV; HOLLAND CH, 1987, J GEOL SOC LONDON, V144, P1, DOI 10.1144/gsjgs.144.1.0001; House M., 1988, CEPHALOPODS PRESENT, P1; Keys DN, 1999, SCIENCE, V283, P532, DOI 10.1126/science.283.5401.532; Kulakova MA, 2002, MECH DEVELOP, V115, P177, DOI 10.1016/S0925-4773(02)00113-2; Lowe CJ, 1997, NATURE, V389, P718, DOI 10.1038/39580; MCFALLNGAI M, 1990, BIOL BULL, V179, P332, DOI 10.2307/1542325; Moshel SM, 1998, DEV GENES EVOL, V208, P135, DOI 10.1007/s004270050164; Nederbragt AJ, 2002, DEV BIOL, V246, P341, DOI 10.1006/dbio.2002.0653; Nogi T, 2001, DEV GROWTH DIFFER, V43, P177; RUNNEGAR B, 1974, SCIENCE, V186, P311, DOI 10.1126/science.186.4161.311; Seaver EC, 2001, DEV BIOL, V236, P195, DOI 10.1006/dbio.2001.0309; Shigeno S, 2001, J COMP NEUROL, V437, P449, DOI 10.1002/cne.1295; Shigeno S, 2001, ZOOL SCI, V18, P527, DOI 10.2108/zsj.18.527; SUNDERMANN G, 1990, ZOOMORPHOLOGY, V109, P343, DOI 10.1007/BF00803575; Telford MJ, 2000, CURR BIOL, V10, P349, DOI 10.1016/S0960-9822(00)00387-0; von Boletzky S, 1970, C. r. hebd. Seanc. Acad. Sci., Paris, V270D, P2182; VONBOLETSKY S, 1994, MCGRAWHILL YB SCI TE, P73; VONBOLETZKY S, 1988, CEPHALOPODS PRESENT, P167; Wanninger A, 2001, EVOL DEV, V3, P312, DOI 10.1046/j.1525-142X.2001.01034.x; Weatherbee, 2001, DNA DIVERSITY MOL GE; YOUNG JZ, 1972, PHILOS T R SOC B, V263, P409, DOI 10.1098/rstb.1972.0005; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262	30	137	139	4	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2003	424	6952					1061	1065		10.1038/nature01872	http://dx.doi.org/10.1038/nature01872			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715QR	12944969				2022-12-01	WOS:000184984200045
J	Kaplan, CD; Laprade, L; Winston, F				Kaplan, CD; Laprade, L; Winston, F			Transcription elongation factors repress transcription initiation from cryptic sites	SCIENCE			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; CHROMATIN-STRUCTURE; CELL-CYCLE; IN-VIVO; SPT6; YEAST; GENES; DROSOPHILA; MUTATIONS	Previous studies have suggested that transcription elongation results in changes in chromatin structure. Here we present studies of Saccharomyces cerevisiae Spt6, a conserved protein implicated in both transcription elongation and chromatin structure. Our results show that, surprisingly, an spt6 mutant permits aberrant transcription initiation from within coding regions. Furthermore, transcribed chromatin in the spt6 mutant is hypersensitive to micrococcal nuclease, and this hypersensitivity is suppressed by mutational inactivation of RNA polymerase II. These results suggest that Spt6 plays a critical role in maintaining normal chromatin structure during transcription elongation, thereby repressing transcription initiation from cryptic promoters. Other elongation and chromatin factors, including Spt16 and histone H3, appear to contribute to this control.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Winston, F (corresponding author), Harvard Univ, Sch Med, Dept Genet, 200 Longwood Ave, Boston, MA 02115 USA.	winston@rascal.med.harvard.edu	Kaplan, Craig/AAO-4500-2021	Kaplan, Craig/0000-0002-7518-695X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032967, R01GM032967] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32967] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adelman K, 2002, MOL CELL, V9, P451, DOI 10.1016/S1097-2765(02)00487-2; Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; CLARKADAMS CD, 1987, MOL CELL BIOL, V7, P679, DOI 10.1128/MCB.7.2.679; DENIS CL, 1984, GENETICS, V108, P833; DOLLARD C, 1994, MOL CELL BIOL, V14, P5223, DOI 10.1128/MCB.14.8.5223; Formosa T, 2002, GENETICS, V162, P1557; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; HAN M, 1987, CELL, V48, P589, DOI 10.1016/0092-8674(87)90237-6; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Hartzog GA, 2002, BBA-GENE STRUCT EXPR, V1577, P276, DOI 10.1016/S0167-4781(02)00458-X; Kaplan CD, 2000, GENE DEV, V14, P2623, DOI 10.1101/gad.831900; KAPLAN CD, UNPUB; KIM UJ, 1988, EMBO J, V7, P2211, DOI 10.1002/j.1460-2075.1988.tb03060.x; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Lindstrom DL, 2001, GENETICS, V159, P487; MALONE EA, 1991, MOL CELL BIOL, V11, P5710, DOI 10.1128/MCB.11.11.5710; MORSE RH, 1992, TRENDS BIOCHEM SCI, V17, P23, DOI 10.1016/0968-0004(92)90422-6; NATSOULIS G, 1994, GENETICS, V136, P93; NEIGEBORN L, 1987, MOL CELL BIOL, V7, P672, DOI 10.1128/MCB.7.2.672; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; NORRIS D, 1988, SCIENCE, V242, P759, DOI 10.1126/science.2847314; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; PRELICH G, 1993, GENETICS, V135, P665; SWANSON MS, 1992, GENETICS, V132, P325; VANHOLDE KE, 1992, J BIOL CHEM, V267, P2837; Winkler M, 2000, J VIROL, V74, P8053, DOI 10.1128/JVI.74.17.8053-8064.2000; WINSTON F, 1984, GENETICS, V107, P179	32	442	450	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2003	301	5636					1096	1099		10.1126/science.1087374	http://dx.doi.org/10.1126/science.1087374			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713RP	12934008				2022-12-01	WOS:000184872400040
J	Lo, B; Chou, V; Cedars, MI; Gates, E; Taylor, RN; Wagner, RM; Wolf, L; Yamamoto, KR				Lo, B; Chou, V; Cedars, MI; Gates, E; Taylor, RN; Wagner, RM; Wolf, L; Yamamoto, KR			Consent from donors for embryo and stem cell research	SCIENCE			English	Editorial Material							ATTITUDES		Univ Calif San Francisco, Program Med Eth, Sch Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Sch Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Human Subjects Protect Program, Sch Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lo, B (corresponding author), Univ Calif San Francisco, Program Med Eth, Sch Med, San Francisco, CA 94143 USA.	bernie@medicine.ucsf.edu		Wolf, Leslie/0000-0002-4660-8383				*ABCNEWS COM, 2001, PUBL BACKS STEM CELL; American Society for Reproductive Medicine, 2002, Fertil Steril, V77, pS2; *CAN I HLTH RES AD, 2002, HUM PLUR STEM CELL R; *CIHR, 2003, HUM STEM CELL RES OP; *COMM EUR COMM, 2003, REP HUM EMBR STEM CE; Ethics Comm, 2002, FERTIL STERIL, V78, P957; Feinberg J., 1988, HARMLESS WRONGDOING; *HL, 2002, REP SEL COMM STEM CE; *HUM FERT EMBR AUT, 2001, COD PRACT; Kalfoglou AL, 2000, FERTIL STERIL, V74, P660, DOI 10.1016/S0015-0282(00)01489-8; Kimbrell Andrew, 1997, HUMAN BODY SHOP CLON; McMahon CA, 2003, HUM REPROD, V18, P871, DOI 10.1093/humrep/deg167; *NAT BIOETH ADV CO, 1999, ETH ISS STEM CELL RE; National Bioethics Advisory Commission, 1999, RES INV HUM BIOL MAT; National Institute of Health, 1994, REP HUM EMBR RES PAN; *NY STAT TASK FORC, 1998, ASS REPR TECHN REC P; Radin MargaretJ., 1996, CONTESTED COMMODITIE; Robertson JA., 1994, CHILDREN CHOICE FREE; *VA COMM U CTR PUB, 2002, VCU LIF SCI SURV; 2000, FED REG, V65, P51975	20	21	21	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2003	301	5635					921	921		10.1126/science.1087038	http://dx.doi.org/10.1126/science.1087038			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711RY	12920284				2022-12-01	WOS:000184755900021
J	Corrie, P; Shaw, J; Harris, R				Corrie, P; Shaw, J; Harris, R			Rate limiting factors in recruitment of patients to clinical trials in cancer research: descriptive study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Addenbrookes NHS Trust, Ctr Oncol, Cambridge CB2 2QQ, England	Addenbrooke's Hospital	Corrie, P (corresponding author), Addenbrookes NHS Trust, Ctr Oncol, Box 193, Cambridge CB2 2QQ, England.	pippa.corrie@addenbrookes.nhs.uk						Baum M, 2002, EUR J CANCER, V38, P1984, DOI 10.1016/S0959-8049(02)00154-5; Comis RL, 2003, J CLIN ONCOL, V21, P830, DOI 10.1200/JCO.2003.02.105; KMIETOWICZ Z, 2001, BRIT MED J, V325, P920; *NAT CANC RES I, 2002, STRAT AN OV CANC RES	4	31	31	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2003	327	7410					320	321		10.1136/bmj.327.7410.320	http://dx.doi.org/10.1136/bmj.327.7410.320			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	710JE	12907485	Green Published, Bronze			2022-12-01	WOS:000184676400017
J	Pockley, AG				Pockley, AG			Heat shock proteins as regulators of the immune response	LANCET			English	Review							T-CELL RESPONSES; RECEPTOR-MEDIATED ENDOCYTOSIS; TYPE-16 E7-EXPRESSING TUMOR; JUVENILE CHRONIC ARTHRITIS; SMOOTH-MUSCLE CELLS; STRESS PROTEINS; MOLECULAR CHAPERONES; CUTTING EDGE; HUMAN HEAT-SHOCK-PROTEIN-60; MYCOBACTERIUM-TUBERCULOSIS	Until recently, heat shock proteins (also known as heat stress proteins) have mostly been regarded as intracellular molecules that mediate a range of essential housekeeping and cytoprotective functions. However, interest in their role as intercellular signalling molecules has been fuelled by the observations that these molecules can be released and re present in the extracellular environment under physiological conditions. They can elicit cytokine production by, and adhesion molecule expression of, a range of cell types, and they can deliver maturation signals and peptides to antigen presenting cells through receptor-mediated interactions. These functions suggest that heat shock proteins could be immunoregulatory agents with potent and widely-applicable therapeutic uses. Furthermore, the induction of self heat shock protein immune reactivity can attenuate autoimmunity and delay transplant rejection, and heat shock proteins derived from tumours and pathogens can elicit specific, protective immunity. This review will focus on this rapidly evolving area of heat shock protein biology.	Univ Sheffield, No Gen Hosp, Ctr Clin Sci, Div Clin Sci N,Immunobiol Res Grp, Sheffield S5 7AU, S Yorkshire, England	Northern General Hospital; University of Sheffield	Pockley, AG (corresponding author), Univ Sheffield, No Gen Hosp, Ctr Clin Sci, Div Clin Sci N,Immunobiol Res Grp, Herries Rd, Sheffield S5 7AU, S Yorkshire, England.	g.pockley@sheffield.ac.uk	Pockley, Alan G/I-4704-2015; Xia, Xianfeng/F-9169-2011	Pockley, Alan G/0000-0001-9593-6431; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL069726] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL69726] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson KM, 2000, IMMUNOL LETT, V74, P35, DOI 10.1016/S0165-2478(00)00246-7; ANDERTON SM, 1995, J EXP MED, V181, P943, DOI 10.1084/jem.181.3.943; ANDERTON SM, 1996, STRESS PROTEINS MED, P73; Anthony LSD, 1999, VACCINE, V17, P373, DOI 10.1016/S0264-410X(98)00199-6; Arnold-Schild D, 1999, J IMMUNOL, V162, P3757; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Bassan M, 1998, NEUROSCI LETT, V250, P37, DOI 10.1016/S0304-3940(98)00428-5; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Basu S, 1999, J EXP MED, V189, P797, DOI 10.1084/jem.189.5.797; Becker T, 2002, J CELL BIOL, V158, P1277, DOI 10.1083/jcb.200208083; Berwin B, 2002, J IMMUNOL, V168, P4282, DOI 10.4049/jimmunol.168.9.4282; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; Binder RJ, 2001, J IMMUNOL, V166, P4968, DOI 10.4049/jimmunol.166.8.4968; Birk OS, 1999, P NATL ACAD SCI USA, V96, P5159, DOI 10.1073/pnas.96.9.5159; BLACHERE NE, 1993, J IMMUNOTHER, V14, P352, DOI 10.1097/00002371-199311000-00016; Blachere NE, 1997, J EXP MED, V186, P1315, DOI 10.1084/jem.186.8.1315; Castellino F, 2000, J EXP MED, V191, P1957, DOI 10.1084/jem.191.11.1957; Chandawarkar RY, 1999, J EXP MED, V189, P1437, DOI 10.1084/jem.189.9.1437; CHILD DF, 1993, J ROY SOC MED, V86, P217; CHILD DF, 1995, DIABETIC MED, V12, P595, DOI 10.1111/j.1464-5491.1995.tb00548.x; CHOUCHANE L, 1994, J INFECT DIS, V169, P253, DOI 10.1093/infdis/169.2.253; Chu NR, 2000, CELL STRESS CHAPERON, V5, P401, DOI 10.1379/1466-1268(2000)005<0401:IOAHPT>2.0.CO;2; Chu NR, 2000, CLIN EXP IMMUNOL, V121, P216, DOI 10.1046/j.1365-2249.2000.01293.x; Ciupitu AMT, 2002, CANCER IMMUNOL IMMUN, V51, P163, DOI 10.1007/s00262-002-0263-9; Ciupitu AMT, 1998, J EXP MED, V187, P685, DOI 10.1084/jem.187.5.685; COHEN IR, 1996, STRESS PROTEINS MED, P93; DEGRAEFFMEEDER ER, 1995, J CLIN INVEST, V95, P934, DOI 10.1172/JCI117801; DEGRAEFFMEEDER ER, 1991, LANCET, V337, P1368, DOI 10.1016/0140-6736(91)93057-G; DONATI YRA, 1990, BIOCHEM PHARMACOL, V40, P2571, DOI 10.1016/0006-2952(90)90573-4; ELIAS D, 1990, P NATL ACAD SCI USA, V87, P1576, DOI 10.1073/pnas.87.4.1576; FINCATO G, 1991, BLOOD, V77, P579; Galdiero M, 1997, INFECT IMMUN, V65, P699, DOI 10.1128/IAI.65.2.699-707.1997; Gaston JSH, 2002, CLIN EXP IMMUNOL, V127, P1, DOI 10.1046/j.1365-2249.2002.01759.x; GASTON JSH, 1990, J EXP MED, V171, P831, DOI 10.1084/jem.171.3.831; GEORGOPOULOS C, 1993, IMMUNOL TODAY, V14, P373, DOI 10.1016/0167-5699(93)90135-8; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Habich C, 2002, J IMMUNOL, V168, P569, DOI 10.4049/jimmunol.168.2.569; Heikema A, 1997, IMMUNOL LETT, V57, P69, DOI 10.1016/S0165-2478(97)00048-5; HIGHTOWER LE, 1989, J CELL PHYSIOL, V138, P257, DOI 10.1002/jcp.1041380206; HIGHTOWER LE, 1991, CELL, V66, P191, DOI 10.1016/0092-8674(91)90611-2; Hoshino K, 1999, J IMMUNOL, V162, P3749; Janetzki S, 2000, INT J CANCER, V88, P232, DOI 10.1002/1097-0215(20001015)88:2<232::AID-IJC14>3.0.CO;2-8; Jurivich D.A., 1994, BIOL HEAT SHOCK PROT, P417; KAUFMANN SHE, 1990, IMMUNOL TODAY, V11, P129, DOI 10.1016/0167-5699(90)90050-J; Kim Y, 1997, J CELL BIOCHEM, V67, P43, DOI 10.1002/(SICI)1097-4644(19971001)67:1<43::AID-JCB5>3.0.CO;2-W; Kingston AE, 1996, CLIN EXP IMMUNOL, V103, P77, DOI 10.1046/j.1365-2249.1996.929628.x; KIRBY AC, 1995, J CLIN INVEST, V96, P1185, DOI 10.1172/JCI118150; Knauf U, 1996, GENE DEV, V10, P2782, DOI 10.1101/gad.10.21.2782; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; Kol A, 1999, J CLIN INVEST, V103, P571, DOI 10.1172/JCI5310; Lamb J R, 1989, Int Immunol, V1, P191, DOI 10.1093/intimm/1.2.191; LATHANGUE NB, 1988, EXP CELL RES, V178, P169; Lewthwaite J, 2002, CELL STRESS CHAPERON, V7, P130, DOI 10.1379/1466-1268(2002)007<0130:RLCBNC>2.0.CO;2; Lewthwaite J, 2002, CIRCULATION, V106, P196, DOI 10.1161/01.CIR.0000021121.26290.2C; Lewthwaite JC, 2001, INFECT IMMUN, V69, P7349, DOI 10.1128/IAI.69.12.7349-7355.2001; Liao DF, 2000, J BIOL CHEM, V275, P189, DOI 10.1074/jbc.275.1.189; Macht LM, 2000, IMMUNOLOGY, V99, P208, DOI 10.1046/j.1365-2567.2000.00966.x; Mathew A, 2001, MOL CELL BIOL, V21, P7163, DOI 10.1128/MCB.21.21.7163-7171.2001; Meghji S, 1997, J EXP MED, V186, P1241, DOI 10.1084/jem.186.8.1241; Mizzen L, 1998, BIOTHERAPY, V10, P173, DOI 10.1007/BF02678295; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; MUNK ME, 1989, J IMMUNOL, V143, P2844; NAKAI A, 1993, MOL CELL BIOL, V13, P1983, DOI 10.1128/MCB.13.4.1983; Nollen EAA, 2002, J CELL SCI, V115, P2809; NOVER I, 1991, HEAT SHOCK RESPONSE; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Paul AGA, 2000, J IMMUNOL, V165, P7270, DOI 10.4049/jimmunol.165.12.7270; PEETERMANS WE, 1994, SCAND J IMMUNOL, V39, P613, DOI 10.1111/j.1365-3083.1994.tb03421.x; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Pockley AG, 2002, J HYPERTENS, V20, P1815, DOI 10.1097/00004872-200209000-00027; Pockley AG, 1999, CELL STRESS CHAPERON, V4, P29, DOI 10.1054/csac.1998.0121; Pockley AG, 1998, IMMUNOL INVEST, V27, P367, DOI 10.3109/08820139809022710; Pockley AG, 2000, HYPERTENSION, V36, P303, DOI 10.1161/01.HYP.36.2.303; Ramage JM, 1999, J IMMUNOL, V162, P704; RANFORD JC, 2000, EXP REV MOL MED; Rea IM, 2001, EXP GERONTOL, V36, P341, DOI 10.1016/S0531-5565(00)00215-1; Reddi K, 1998, J BONE MINER RES, V13, P1260, DOI 10.1359/jbmr.1998.13.8.1260; RES PCM, 1988, LANCET, V2, P478, DOI 10.1016/S0140-6736(88)90123-7; RETZLAFF C, 1994, INFECT IMMUN, V62, P5689, DOI 10.1128/IAI.62.12.5689-5693.1994; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; Robert J, 2001, EUR J IMMUNOL, V31, P186, DOI 10.1002/1521-4141(200101)31:1<186::AID-IMMU186>3.0.CO;2-D; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SARGE KD, 1991, GENE DEV, V5, P1902, DOI 10.1101/gad.5.10.1902; Satyal SH, 1998, GENE DEV, V12, P1962, DOI 10.1101/gad.12.13.1962; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Singh-Jasuja H, 2000, J EXP MED, V191, P1965, DOI 10.1084/jem.191.11.1965; Singh-Jasuja H, 2000, EUR J IMMUNOL, V30, P2211, DOI 10.1002/1521-4141(2000)30:8<2211::AID-IMMU2211>3.0.CO;2-0; SRIVASTAVA PK, 1986, P NATL ACAD SCI USA, V83, P3407, DOI 10.1073/pnas.83.10.3407; SRIVASTAVA PK, 1994, CURR OPIN IMMUNOL, V6, P728, DOI 10.1016/0952-7915(94)90076-0; STINISSEN P, 1995, J IMMUNOL, V154, P4883; SUTO R, 1995, SCIENCE, V269, P1585, DOI 10.1126/science.7545313; Suzue K, 1996, J IMMUNOL, V156, P873; Tanaka S, 1999, J IMMUNOL, V163, P5560; THOMPSON SJ, 1990, EUR J IMMUNOL, V20, P2479, DOI 10.1002/eji.1830201118; TISSIERES A, 1974, J MOL BIOL, V84, P389, DOI 10.1016/0022-2836(74)90447-1; TUN RYM, 1994, DIABETIC MED, V11, P66, DOI 10.1111/j.1464-5491.1994.tb00232.x; UDONO H, 1994, J IMMUNOL, V152, P5398; UDONO H, 1993, J EXP MED, V178, P1391, DOI 10.1084/jem.178.4.1391; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; van Eden W, 2000, DRUG DISCOV TODAY, V5, P115, DOI 10.1016/S1359-6446(99)01464-6; van Eden W, 1998, IMMUNOL TODAY, V19, P303, DOI 10.1016/S0167-5699(98)01283-3; VANDENBROEK MF, 1989, J EXP MED, V170, P449, DOI 10.1084/jem.170.2.449; VanRoon J, 1996, FASEB J, V10, P1801; vanRoon JAG, 1997, J CLIN INVEST, V100, P459, DOI 10.1172/JCI119553; Voellmy Richard, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P357; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wang XY, 2001, J IMMUNOL, V166, P490, DOI 10.4049/jimmunol.166.1.490; WELCH WJ, 1993, SCI AM, V268, P56, DOI 10.1038/scientificamerican0593-56; Wendling U, 2000, J IMMUNOL, V164, P2711, DOI 10.4049/jimmunol.164.5.2711; Wright BH, 2000, HEART VESSELS, V15, P18, DOI 10.1007/s003800070043; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cb.11.110195.002301; WUCHERPFENNIG KW, 1992, P NATL ACAD SCI USA, V89, P4588, DOI 10.1073/pnas.89.10.4588; Xu QB, 2000, CIRCULATION, V102, P14, DOI 10.1161/01.CIR.102.1.14; Yoshida N, 2001, NATURE, V411, P44, DOI 10.1038/35075148; YOUNG D, 1993, PHILOS T ROY SOC B, V339, P363, DOI 10.1098/rstb.1993.0035; YOUNG RA, 1990, ANNU REV IMMUNOL, V8, P401, DOI 10.1146/annurev.immunol.8.1.401; ZUO J, 1994, MOL CELL BIOL, V14, P7447	119	527	566	3	47	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2003	362	9382					469	476		10.1016/S0140-6736(03)14075-5	http://dx.doi.org/10.1016/S0140-6736(03)14075-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	709XD	12927437				2022-12-01	WOS:000184651100025
J	Ahlborg, HG; Johnell, O; Turner, CH; Rannevik, G; Karlsson, MK				Ahlborg, HG; Johnell, O; Turner, CH; Rannevik, G; Karlsson, MK			Bone loss and bone size after menopause	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VOLUMETRIC DENSITY; MINERAL DENSITY; SEX-DIFFERENCES; HEALTHY WOMEN; HIP FRACTURE; BODY-SIZE; AGE; RISK; MEN; OSTEOPOROSIS	Background: Bone loss increases after menopause. However, bone strength also depends on structural characteristics such as bone size. Whether bone size increases as a result of periosteal apposition and whether a strength index accounting for both bone density and bone size might predict the risk of fracture better than bone density alone are unclear. Methods: Bone mass and the skeletal structure of the distal radius were evaluated by single-photon absorptiometry every other year in 108 women, all of whom were followed from the time of menopause for a mean period of 15 years. Postmenopausal serum estradiol levels and fractures of the distal radius were noted. Results: The mean (+/-SD) annual decrease in bone mineral density was 1.9+/-0.7 percent. The medullary bone diameter increased annually by 1.1+/-0.9 percent, and the periosteal diameter by 0.7+/-0.3 percent; the strength index decreased by 0.7+/-0.7 percent. The expansion of the medullary diameter and the expansion of the periosteal diameter were correlated with one another (r = 0.54, P<0.001), and women in the highest quartile of medullary expansion had more loss of bone mineral density and greater periosteal apposition than women in the lowest quartile (P<0.001 for both comparisons). The postmenopausal serum estradiol level was correlated with changes in the periosteal diameter (r = -0.25, P=0.009) and with changes in bone mineral density (r = 0.34, P<0.001). A 1-SD decrement in the strength index at base line was associated with a risk ratio for fracture of the distal radius of 3.8 (95 percent confidence interval, 1.8 to 8.0). Conclusions: Increased bone loss after menopause is associated with increased periosteal apposition, which partially preserves bone strength. A strength index may be a helpful predictor of the risk of fracture.	Malmo Univ Hosp, Dept Orthoped, SE-20502 Malmo, Sweden; Malmo Univ Hosp, Dept Obstet & Gynecol, SE-20502 Malmo, Sweden; Indiana Univ, Dept Orthoped Surg, Indianapolis, IN 46204 USA; Indiana Univ, Biomech & Biomat Res Ctr, Indianapolis, IN 46204 USA	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Ahlborg, HG (corresponding author), Malmo Univ Hosp, Dept Orthoped, SE-20502 Malmo, Sweden.	henrik.ahlborg@skane.se						Ahlborg HG, 2001, BONE, V28, P327, DOI 10.1016/S8756-3282(00)00451-8; Augat P, 1996, J BONE MINER RES, V11, P1356; BALENA R, 1992, J BONE MINER RES, V7, P1475; BENGNER U, 1985, ACTA ORTHOP SCAND, V56, P158, DOI 10.3109/17453678508994345; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; BOUXSEIN ML, 1994, CALCIFIED TISSUE INT, V54, P113, DOI 10.1007/BF00296061; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Duan YB, 2001, J BONE MINER RES, V16, P2276, DOI 10.1359/jbmr.2001.16.12.2276; Duan YB, 1999, J BONE MINER RES, V14, P1796, DOI 10.1359/jbmr.1999.14.10.1796; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P2124; Ferretti JL, 1996, BONE, V18, P97, DOI 10.1016/8756-3282(95)00438-6; Frost HM, 1999, J BONE MINER RES, V14, P1473, DOI 10.1359/jbmr.1999.14.9.1473; HAYES WC, 1982, SCIENCE, V217, P945, DOI 10.1126/science.7112107; Heaney RP, 1997, OSTEOPOROSIS INT, V7, P426, DOI 10.1007/PL00004150; HSU ES, 1993, J BIOMECH, V26, P1307, DOI 10.1016/0021-9290(93)90354-H; JOHNELL O, 1984, CALCIFIED TISSUE INT, V36, P354, DOI 10.1007/BF02405345; JONSSON B, 1994, J EPIDEMIOL COMMUN H, V48, P489, DOI 10.1136/jech.48.5.489; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; MOSEKILDE L, 1990, BONE, V11, P67, DOI 10.1016/8756-3282(90)90052-Z; Naucler L, 1974, OPUSC MED TECH LUND, V12, P19; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; RANNEVIK G, 1995, MATURITAS, V21, P103, DOI 10.1016/0378-5122(94)00869-9; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; RIGGS BL, 1986, J CLIN INVEST, V77, P1487, DOI 10.1172/JCI112462; RUFF CB, 1988, J ORTHOP RES, V6, P886, DOI 10.1002/jor.1100060613; Seeman E, 2001, J BONE MINER RES, V16, P120, DOI 10.1359/jbmr.2001.16.1.120; SMITH RW, 1964, SCIENCE, V145, P156, DOI 10.1126/science.145.3628.156; THORELL JI, 1978, RADIOIMMUNOASSAY REL, P137; TURNER RT, 1987, J BONE MINER RES, V2, P115; World Health Organization (WHO), 1981, WHO TECHN REP SER, V670, P1	31	439	458	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2003	349	4					327	334		10.1056/NEJMoa022464	http://dx.doi.org/10.1056/NEJMoa022464			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703ZH	12878739	Green Published			2022-12-01	WOS:000184312800005
J	Serini, G; Valdembri, D; Zanivan, S; Morterra, G; Burkhardt, C; Caccavari, F; Zammataro, L; Primo, L; Tamagnone, L; Logan, M; Tesssier-Lavigne, M; Taniguchi, M; Puschel, AW; Bussolino, F				Serini, G; Valdembri, D; Zanivan, S; Morterra, G; Burkhardt, C; Caccavari, F; Zammataro, L; Primo, L; Tamagnone, L; Logan, M; Tesssier-Lavigne, M; Taniguchi, M; Puschel, AW; Bussolino, F			Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function	NATURE			English	Article							SUPPRESSES TUMOR-FORMATION; ENDOTHELIAL-CELLS; MOUSE EMBRYOS; SEMAPHORIN; ACTIVATION; GROWTH; GENE; ALPHA(V)BETA(3); ALPHA-V-BETA-3; ANGIOGENESIS	The motility and morphogenesis of endothelial cells is controlled by spatio-temporally regulated activation of integrin adhesion receptors, and integrin activation is stimulated by major determinants of vascular remodelling. In order for endothelial cells to be responsive to changes in activator gradients, the adhesiveness of these cells to the extracellular matrix must be dynamic, and negative regulators of integrins could be required. Here we show that during vascular development and experimental angiogenesis, endothelial cells generate autocrine chemorepulsive signals of class 3 semaphorins (SEMA3 proteins) that localize at nascent adhesive sites in spreading endothelial cells. Disrupting endogenous SEMA3 function in endothelial cells stimulates integrin-mediated adhesion and migration to extracellular matrices, whereas exogenous SEMA3 proteins antagonize integrin activation. Misexpression of dominant negative SEMA3 receptors in chick embryo endothelial cells locks integrins in an active conformation, and severely impairs vascular remodelling. Sema3a null mice show vascular defects as well. Thus during angiogenesis endothelial SEMA3 proteins endow the vascular system with the plasticity required for its reshaping by controlling integrin function.	Univ Turin, Sch Med, Div Mol Angiogenesis, I-10060 Candiolo, TO, Italy; Univ Turin, Sch Med, Inst Canc Res & Treatment, IRCC,Div Mol Oncol, I-10060 Candiolo, TO, Italy; Univ Turin, Sch Med, Dept Oncol Sci, I-10060 Candiolo, TO, Italy; Univ Munster, Inst Allgemeine Zool & Genet, Mol Biol Abt, D-48149 Munster, Germany; Natl Inst Med Res, Div Dev Biol, London NW7 1AA, England; Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA; Univ Tokyo, Grad Sch Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan	University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; University of Turin; University of Munster; MRC National Institute for Medical Research; Howard Hughes Medical Institute; Stanford University; University of Tokyo	Serini, G (corresponding author), Univ Turin, Sch Med, Div Mol Angiogenesis, I-10060 Candiolo, TO, Italy.	guido.serini@ircc.it; federico.bussolino@ircc.it	Serini, Guido/AAF-2873-2021; Bussolino, Federico/AES-3951-2022; Zanivan, Sara/GOV-5505-2022; Tamagnone, Luca/J-8948-2018; Zanivan, Sara/C-4340-2008; Bussolino, Federico/K-2500-2016	Serini, Guido/0000-0002-3502-8367; Tamagnone, Luca/0000-0002-2884-7946; Bussolino, Federico/0000-0002-5348-1341; Valdembri, Donatella/0000-0003-4590-417X; PRIMO, Luca/0000-0002-1294-0441; Zammataro, Luca/0000-0002-4348-6341; Zanivan, Sara/0000-0002-9880-9099				Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Brown CB, 2001, DEVELOPMENT, V128, P3071; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Cruz MT, 1997, J CELL SCI, V110, P2647; Evans HM, 1909, ANAT REC, V3, P498, DOI 10.1002/ar.1090030903; Feiner L, 2001, DEVELOPMENT, V128, P3061; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; Garlanda C, 1997, ARTERIOSCL THROM VAS, V17, P1193, DOI 10.1161/01.ATV.17.7.1193; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Grignani F, 1998, CANCER RES, V58, P14; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; Martin-Bermudo MD, 1998, J CELL BIOL, V141, P1073, DOI 10.1083/jcb.141.4.1073; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2; NEUGEBAUER KM, 1991, NATURE, V350, P68, DOI 10.1038/350068a0; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Primo L, 2000, ONCOGENE, V19, P3632, DOI 10.1038/sj.onc.1203708; Robson Paul, 2002, P97; Sabin FR, 1917, CONTRIB EMBRYOL, V6, P63; SEIFERT R, 1992, ANAT EMBRYOL, V186, P601; Sigmund CD, 2000, ARTERIOSCL THROM VAS, V20, P1425, DOI 10.1161/01.ATV.20.6.1425; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; STUPACK DG, 2002, SCI STKE, V119, pPE7; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Trusolino L, 1998, J CELL BIOL, V142, P1145, DOI 10.1083/jcb.142.4.1145; Tse C, 2002, CANCER RES, V62, P542; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; Xiang RH, 2002, CANCER RES, V62, P2637; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	49	464	497	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					391	397		10.1038/nature01784	http://dx.doi.org/10.1038/nature01784			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879061				2022-12-01	WOS:000184318400034
J	Coppin, H; Bensaid, M; Fruchon, S; Borot, N; Blanche, H; Roth, MP				Coppin, H; Bensaid, M; Fruchon, S; Borot, N; Blanche, H; Roth, MP			Longevity and carrying the C282Y mutation for haemochromatosis on the HFE gene: case control study of 492 French centenarians	BRITISH MEDICAL JOURNAL			English	Article							RISK		CHU Purpan, Unite Physiopathol Cellulaire, CNRS, UPR 2163, F-31059 Toulouse 3, France; Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, F-75010 Paris, France	Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Foundation Jean Dausset-CEPH	Roth, MP (corresponding author), CHU Purpan, Unite Physiopathol Cellulaire, CNRS, UPR 2163, F-31059 Toulouse 3, France.		Coppin, Hélène/G-4326-2013; Roth, Marie-Paule/Q-2866-2018	Coppin, Hélène/0000-0001-7911-6353; Roth, Marie-Paule/0000-0001-9691-4234; bensaid, Mounia/0000-0001-7322-0627				Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Blanche H, 2001, CR ACAD SCI III-VIE, V324, P129, DOI 10.1016/S0764-4469(00)01274-9; Fruchon S, 2003, CLIN CHEM, V49, P822, DOI 10.1373/49.5.822; Fuchs J, 2002, TOXICOLOGY, V180, P169, DOI 10.1016/S0300-483X(02)00389-X; Worwood M, 2002, BEST PRACT RES CL HA, V15, P295, DOI 10.1053/beha.2002.0005	5	35	37	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 19	2003	327	7407					132	133		10.1136/bmj.327.7407.132	http://dx.doi.org/10.1136/bmj.327.7407.132			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702WJ	12869454	Green Published, Bronze			2022-12-01	WOS:000184247500017
J	Kikuchi, S; Satoh, K; Nagata, T; Kawagashira, N; Doi, K; Kishimoto, N; Yazaki, J; Ishikawa, M; Yamada, H; Ooka, H; Hotta, I; Kojima, K; Namiki, T; Ohneda, E; Yahagi, W; Suzuki, K; Li, CJ; Ohtsuki, K; Shishiki, T; Otomo, Y; Murakami, K; Iida, Y; Sugano, S; Fujimura, T; Suzuki, Y; Tsunoda, Y; Kurosaki, T; Kodama, T; Masuda, H; Kobayashi, M; Xie, QH; Lu, M; Narikawa, R; Sugiyama, A; Mizuno, K; Yokomizo, S; Niikura, J; Ikeda, R; Ishibiki, J; Kawamata, M; Yoshimura, A; Miura, J; Kusumegi, T; Oka, M; Ryu, R; Ueda, M; Matsubara, K; Kawai, J; Carninci, P; Adachi, J; Aizawa, K; Arakawa, T; Fukuda, S; Hara, A; Hashizume, W; Hayatsu, N; Imotani, K; Ishii, Y; Itoh, M; Kagawa, I; Kondo, S; Konno, H; Miyazaki, A; Osato, N; Ota, Y; Saito, R; Sasaki, D; Sato, K; Shibata, K; Shinagawa, A; Shiraki, T; Yoshino, M; Hayashizaki, Y; Yasunishi, A				Kikuchi, S; Satoh, K; Nagata, T; Kawagashira, N; Doi, K; Kishimoto, N; Yazaki, J; Ishikawa, M; Yamada, H; Ooka, H; Hotta, I; Kojima, K; Namiki, T; Ohneda, E; Yahagi, W; Suzuki, K; Li, CJ; Ohtsuki, K; Shishiki, T; Otomo, Y; Murakami, K; Iida, Y; Sugano, S; Fujimura, T; Suzuki, Y; Tsunoda, Y; Kurosaki, T; Kodama, T; Masuda, H; Kobayashi, M; Xie, QH; Lu, M; Narikawa, R; Sugiyama, A; Mizuno, K; Yokomizo, S; Niikura, J; Ikeda, R; Ishibiki, J; Kawamata, M; Yoshimura, A; Miura, J; Kusumegi, T; Oka, M; Ryu, R; Ueda, M; Matsubara, K; Kawai, J; Carninci, P; Adachi, J; Aizawa, K; Arakawa, T; Fukuda, S; Hara, A; Hashizume, W; Hayatsu, N; Imotani, K; Ishii, Y; Itoh, M; Kagawa, I; Kondo, S; Konno, H; Miyazaki, A; Osato, N; Ota, Y; Saito, R; Sasaki, D; Sato, K; Shibata, K; Shinagawa, A; Shiraki, T; Yoshino, M; Hayashizaki, Y; Yasunishi, A		Rice Full-length cDNA Consortium; Natl Inst Agrobological Sci; Fdn Adv Int Sci Genome Sequencing; RIKEN	Collection, mapping, and annotation of over 28,000 cDNA clones from japonica rice	SCIENCE			English	Article							DRAFT SEQUENCE; DATABASE	We collected and completely sequenced 28,469 full-length complementary DNA clones from Oryza sativa L. ssp. japonica cv. Nipponbare. Through homology searches of publicly available sequence data, we assigned tentative protein functions to 21,596 clones (75.86%). Mapping of the cDNA clones to genomic DNA revealed that there are 19,000 to 20,500 transcription units in the rice genome. Protein informatics analysis against the InterPro database revealed the existence of proteins presented in rice but not in Arabidopsis. Sixty-four percent of our cDNAs are homologous to Arabidopsis proteins.	Natl Inst Agrobiol Sci, Dept Mol Biol, Tsukuba, Ibaraki 3058602, Japan; Hitachi Software Engn Co, Naka Ku, Yokohama, Kanagawa 2310015, Japan; FAIS, Lab Genome Sequencing, Tsukuba, Ibaraki 3050062, Japan; Univ Tokyo, Inst Med Sci, Dept Virol, Minato Ku, Tokyo 1088639, Japan; Univ Tsukuba, Inst Agr & Forest Engn, Tsukuba, Ibaraki 3058577, Japan; NAIST, Nara 6300101, Japan; RIKEN, RIKEN Yokohama Inst, Inst Phys & Chem Res, Lab Genome Explorat Res Grp,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Genome Sci Lab, Wako, Saitama 3510198, Japan; FAIS, Anal Grp, Tsukuba, Ibaraki 3050062, Japan	National Institute of Agrobiological Sciences - Japan; University of Tokyo; University of Tsukuba; Nara Institute of Science & Technology; RIKEN	Kikuchi, S (corresponding author), Natl Inst Agrobiol Sci, Dept Mol Biol, 2-1-2 Kannon Dai, Tsukuba, Ibaraki 3058602, Japan.	skikuchi@nias.affrc.go.jp	Kawai, Jun/A-6451-2016; Hayashizaki, Yoshihide/N-6590-2015; Itoh, Masayoshi/N-5363-2015; shibata, kazuhiro/A-9527-2008; Konno, Hideaki/N-4366-2014; Yazaki, Junshi/B-1557-2012; Carninci, Piero/K-1568-2014; Konno, Hideaki/A-9191-2012; Kurosaki, Tomohiro/D-1306-2009	Itoh, Masayoshi/0000-0002-1772-318X; Konno, Hideaki/0000-0002-8470-4835; Carninci, Piero/0000-0001-7202-7243; Kurosaki, Tomohiro/0000-0002-6352-304X; Fukuda, Shiro/0000-0002-0065-662X; Osato, Naoki/0000-0002-7584-5388; Osato, Naoki/0000-0001-9716-6725				Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; NAGATA T, COMMUNICATION; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	13	680	3047	7	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2003	301	5631					376	379		10.1126/science.1081288	http://dx.doi.org/10.1126/science.1081288			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869764				2022-12-01	WOS:000184207300047
J	Hviid, A; Stellfeld, M; Wohlfahrt, J; Melbye, M				Hviid, A; Stellfeld, M; Wohlfahrt, J; Melbye, M			Association between thimerosal-containing vaccine and autism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POPULATION; REGISTER; MERCURY	Context Mercuric compounds are nephrotoxic and neurotoxic at high doses. Thimerosal, a preservative used widely in vaccine formulations, contains ethylmercury. Thus it has been suggested that childhood vaccination with thimerosal-containing vaccine could be causally related to neurodevelopmental disorders such as autism. Objective To determine whether vaccination with a thimerosal-containing vaccine is associated with development of autism. Design, Setting, and Participants Population-based cohort study of all children born in Denmark from January 1, 1990, until December 31, 1996 (N =467450) comparing children vaccinated with a thimerosal-containing vaccine with children vaccinated with a thimerosal-free formulation of the same vaccine. Main Outcome Measures Rate ratio (RR) for autism and other autistic-spectrum disorders, including trend with dose of ethylmercury. Results During 2986654 person-years, we identified 440 autism cases and 787 cases of other autistic-spectrum disorders. The risk of autism and other autistic-spectrum disorders did not differ significantly between children vaccinated with thimerosal-containing vaccine and children vaccinated with thimerosal-free vaccine (RR, 0.85 [95% confidence interval (0), 0.60-1.20] for autism; RR, 1.12 [95% Cl, 0.88-1.43] for other autistic-spectrum disorders). Furthermore, we found no evidence of a dose-response association (increase in RR per 25 mug of ethylmercury, 0.98 [95% Cl, 0.90-1.06] for autism and 1.03 [95% Cl, 0.98-1.09] for other autistic-spectrum disorders). Conclusion The results do not support a causal relationship between childhood vaccination with thimerosal-containing vaccines and development of autistic-spectrum disorders.	Statens Serum Inst, Dept Epidemiol Res, Danish Epidemiol Sci Ctr, DK-2300 Copenhagen S, Denmark; Statens Serum Inst, Dept Med, DK-2300 Copenhagen, Denmark	Aarhus University; Statens Serum Institut; Statens Serum Institut	Hviid, A (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Danish Epidemiol Sci Ctr, Artillerivej 5, DK-2300 Copenhagen S, Denmark.		Hviid, Anders/AAH-4319-2020	Hviid, Anders/0000-0002-7509-9127; melbye, mads/0000-0001-8264-6785				Andersen TF, 1999, DAN MED BULL, V46, P263; Ball LK, 2001, PEDIATRICS, V107, P1147, DOI 10.1542/peds.107.5.1147; Bertrand J, 2001, PEDIATRICS, V108, P1155, DOI 10.1542/peds.108.5.1155; Clarkson TW, 1997, CRIT REV CL LAB SCI, V34, P369, DOI 10.3109/10408369708998098; Clayton D., 1993, STAT MODELS EPIDEMIO; Knudsen LB, 1998, DAN MED BULL, V45, P320; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; MALIG C, 1996, 6 IIVRS; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; Pichichero ME, 2002, LANCET, V360, P1737, DOI 10.1016/S0140-6736(02)11682-5; Plesner A M, 1994, Ugeskr Laeger, V156, P7497; Ronne T, 1997, Ugeskr Laeger, V159, P1584; Stratton K, 2001, IMMUNIZATION SAFETY	13	175	183	0	108	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2003	290	13					1763	1766		10.1001/jama.290.13.1763	http://dx.doi.org/10.1001/jama.290.13.1763			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	726NQ	14519711				2022-12-01	WOS:000185606100026
J	Fewell, JH				Fewell, JH			Social insect networks	SCIENCE			English	Editorial Material							DIVISION-OF-LABOR; COLLECTIVE DECISION-MAKING; SELF-ORGANIZATION; SELECTION; EVOLUTION; COLONIES; RECRUITMENT; BEE	Social insect colonies have many of the properties of adaptive networks. The simple rules governing how local interactions among individuals translate into group behaviors are found across social groups, giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution.	Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Fewell, JH (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	j.fewell@asu.edu						Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; Barabasi A.--L., 2002, FORMULA UNIVERSAL LA; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; Bonabeau E, 1998, J THEOR BIOL, V195, P157, DOI 10.1006/jtbi.1998.0789; Bray D, 2003, SCIENCE, V301, P1864, DOI 10.1126/science.1089118; CAMAZINE S, 1993, BEHAV ECOL SOCIOBIOL, V32, P265, DOI 10.1007/BF00166516; Camazine S., 2001, SELF ORG BIOL SYSTEM; Fewell JH, 1999, EVOL ECOL RES, V1, P537; FEWELL JH, 1992, BEHAV ECOL SOCIOBIOL, V30, P387, DOI 10.1007/BF00176173; Gordon DM, 2002, AM NAT, V159, P509, DOI 10.1086/339461; GOSS S, 1989, NATURWISSENSCHAFTEN, V76, P579, DOI 10.1007/BF00462870; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hemelrijk CK, 2002, BIOL BULL-US, V202, P283, DOI 10.2307/1543480; Hemelrijk CK, 2002, ETHOLOGY, V108, P655, DOI 10.1046/j.1439-0310.2002.00812.x; HOGEWEG P, 1983, BEHAV ECOL SOCIOBIOL, V12, P271, DOI 10.1007/BF00302895; Holldobler B., 1990, pi; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; NAUMANN K, 1991, BEHAV ECOL SOCIOBIOL, V29, P321, DOI 10.1007/BF00165956; Pacala SW, 1996, EVOL ECOL, V10, P127, DOI 10.1007/BF01241782; Page RE, 2002, NATURWISSENSCHAFTEN, V89, P91, DOI 10.1007/s00114-002-0299-x; Page RE, 1998, APIDOLOGIE, V29, P171, DOI 10.1051/apido:19980110; Robson SK, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P239; Saffre F, 1999, J THEOR BIOL, V198, P507, DOI 10.1006/jtbi.1999.0927; Seeley TD, 1997, AM NAT, V150, pS22, DOI 10.1086/286048; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; SOLE R, 2000, SANTA FE WORKING PAP; Sole Ricard, 2000, SIGNS LIFE COMPLEXIT; Theraulaz G, 1998, P ROY SOC B-BIOL SCI, V265, P327, DOI 10.1098/rspb.1998.0299; Wilson DS, 1997, AM NAT, V149, P336, DOI 10.1086/285993; Wilson DS, 1997, AM NAT, V150, pS1, DOI 10.1086/286046	32	203	204	2	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2003	301	5641					1867	1870		10.1126/science.1088945	http://dx.doi.org/10.1126/science.1088945			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725GW	14512616				2022-12-01	WOS:000185536700038
J	McMurray, MA; Gottschling, DE				McMurray, MA; Gottschling, DE			An age-induced switch to a hyper-recombinational state	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; MITOTIC RECOMBINATION; GENE CONVERSION; LIFE-SPAN; YEAST; MUTATION; CELLS; REPLICATION; TELOMERE; CANCER	There is a strong correlation between age and cancer, but the mechanism by which this phenomenon occurs is unclear. We chose Saccharomyces cerevisiae to examine one of the hallmarks of cancer-genomic instability as a function of cellular age. As diploid yeast mother cells aged, an similar to100-fold increase in loss of heterozygosity (LOH) occurred. Extending life-span altered neither the onset nor the frequency of age-induced LOH; the switch to hyper-LOH appears to be on its own clock. In young cells, LOH occurs by reciprocal recombination, whereas LOH in old cells was nonreciprocal, occurring predominantly in the old mother's progeny. Thus, nuclear genomes may be inherently unstable with age.	Univ Washington, Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gottschling, DE (corresponding author), Univ Washington, Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043893] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM43893] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACUNA G, 1994, ENVIRON MOL MUTAGEN, V24, P307, DOI 10.1002/em.2850240408; Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Aguilera A, 2000, YEAST, V16, P731, DOI 10.1002/1097-0061(20000615)16:8<731::AID-YEA586>3.0.CO;2-L; Cairns J, 2002, P NATL ACAD SCI USA, V99, P10567, DOI 10.1073/pnas.162369899; Cost GJ, 1996, YEAST, V12, P939, DOI 10.1002/(SICI)1097-0061(199608)12:10<939::AID-YEA988>3.3.CO;2-C; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; DMELLO NP, 1991, J BACTERIOL, V173, P6709, DOI 10.1128/jb.173.21.6709-6713.1991; FOGEL S, 1963, GENETICS, V48, P321; Frank SA, 2003, GENETICS, V163, P1527; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Jazwinski SM, 2001, MECH AGEING DEV, V122, P865, DOI 10.1016/S0047-6374(01)00244-5; JUDD SR, 1988, GENETICS, V118, P401; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kraus E, 2001, P NATL ACAD SCI USA, V98, P8255, DOI 10.1073/pnas.151008198; MCMURRAY MA, UNPUB; Morley A, 1998, ANN NY ACAD SCI, V854, P20, DOI 10.1111/j.1749-6632.1998.tb09888.x; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; MURRAY AW, 1983, CELL, V34, P961, DOI 10.1016/0092-8674(83)90553-6; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; ROMAN H, 1956, COLD SPRING HARB SYM, V21, P175, DOI 10.1101/SQB.1956.021.01.015; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; ZIMMERMANN FK, 1975, MUTAT RES, V31, P71, DOI 10.1016/0165-1161(75)90069-2	25	178	181	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2003	301	5641					1908	1911		10.1126/science.1087706	http://dx.doi.org/10.1126/science.1087706			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725GW	14512629				2022-12-01	WOS:000185536700051
J	Holland, A; Whittington, J; Hinton, E				Holland, A; Whittington, J; Hinton, E			The paradox of Prader-Willi syndrome: a genetic model of starvation	LANCET			English	Article							GROWTH-HORMONE; ACYLATED PEPTIDE; IMPRINTED GENES; GHRELIN; LEPTIN; FETAL; ILLNESS; OBESITY; PEOPLE; WOMEN	The neurodevelopmental disorder, Prader-Willi syndrome, is generally regarded as a genetic model of obesity. Although the values of some hypothalamic neuropeptides are as expected in obesity, and should result in satiety, we propose that abnormal hypothalamic pathways mean that these are ineffective. We postulate that the body incorrectly interprets the absence of satiation as starvation, and therefore, paradoxically, this syndrome should be redefined as one of starvation that manifests as obesity in a food-rich environment. Also, this syndrome is generally believed to be a contiguous gene disorder, which results from the absence of expression of the paternally derived alleles of maternally imprinted genes on chromosome 15 (15q11-13). We argue, however, that the whole phenotype can be explained by one mechanism and, by implication, the failure of expression of the paternal allele of a single maternally imprinted gene that controls energy balance. We suggest clinical and laboratory approaches to test our hypotheses.	Sect Dev Psychiat, Cambridge CB2 2AH, England		Holland, A (corresponding author), Sect Dev Psychiat, Douglas House, Cambridge CB2 2AH, England.	ajh1008@cam.ac.uk		Hinton, Elanor/0000-0003-2793-8552				Bajoria R, 2002, PLACENTA, V23, P103, DOI 10.1053/plac.2001.0769; Boer H, 2002, LANCET, V359, P135, DOI 10.1016/S0140-6736(02)07340-3; Casanueva Felipe F, 2002, Rev Endocr Metab Disord, V3, P325, DOI 10.1023/A:1020901624103; Chanoine JP, 2002, J PEDIATR GASTR NUTR, V35, P282, DOI 10.1097/00005176-200209000-00009; Date Y, 2000, BIOCHEM BIOPH RES CO, V275, P477, DOI 10.1006/bbrc.2000.3342; DelPparigi A, 2002, J CLIN ENDOCR METAB, V87, P5461, DOI 10.1210/jc.2002-020871; Gallagher RC, 2002, AM J HUM GENET, V71, P669, DOI 10.1086/342408; Ge YL, 2002, BRAIN RES, V957, P42, DOI 10.1016/S0006-8993(02)03583-7; Goldstone AP, 2002, J CLIN ENDOCR METAB, V87, P927, DOI 10.1210/jc.87.2.927; Goldstone AP, 2002, AM J CLIN NUTR, V75, P468, DOI 10.1093/ajcn/75.3.468; Holland AJ, 2003, PSYCHOL MED, V33, P141, DOI 10.1017/S0033291702006736; HOLLAND AJ, 1993, INT J OBESITY, V17, P527; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lobie PE, 2000, GROWTH HORM IGF RES, V10, P51; Miozzo M, 2002, BIOL NEONATE, V81, P217, DOI 10.1159/000056752; Muller J, 1997, ACTA PAEDIATR, V86, P58; Reik W, 2001, NOVART FDN SYMP, V237, P19, DOI 10.1002/0470846666.ch3; Schwartz MW, 2002, NATURE, V418, P595, DOI 10.1038/418595a; Tolle V, 2003, J CLIN ENDOCR METAB, V88, P109, DOI 10.1210/jc.2002-020645; WHITMAN BY, 2001, 4 TRIENN IPWSO SCI C	20	58	64	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2003	362	9388					989	991		10.1016/S0140-6736(03)14370-X	http://dx.doi.org/10.1016/S0140-6736(03)14370-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724LT	14511934				2022-12-01	WOS:000185489600023
J	Rainey, PB; Rainey, K				Rainey, PB; Rainey, K			Evolution of cooperation and conflict in experimental bacterial populations	NATURE			English	Article							COMPETITION; DIVERGENCE; DIVERSITY; ORIGIN	A fundamental problem in biology is the evolutionary transition from single cells to multicellular life forms(1-3). During this transition the unit of selection shifts from individual cells to groups of cooperating cells(1,3,4). Although there is much theory(5-15), there are few empirical studies(16). Here we describe an evolutionary transition that occurs in experimental populations of Pseudomonas fluorescens propagated in a spatially heterogeneous environment(17). Cooperating groups are formed by over-production of an adhesive polymer(18), which causes the interests of individuals to align with those of the group. The costs and benefits of cooperation, plus evolutionary susceptibility to defecting genotypes, were analysed to determine conformation to theory(1,3,12). Cooperation was costly to individuals, but beneficial to the group. Defecting genotypes evolved in populations founded by the cooperating type and were fitter in the presence of this type than in its absence. In the short term, defectors sabotaged the viability of the group; but these findings nevertheless show that transitions to higher orders of complexity are readily achievable, provide insights into the selective conditions, and facilitate experimental analysis of the evolution of individuality.	Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Oxford; University of Auckland	Rainey, PB (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	p.rainey@auckland.ac.nz	Rainey, Paul/A-3207-2008	Rainey, Paul/0000-0003-0879-5795				AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bell G., 1985, ORIGIN EVOLUTION SEX, P221; Bonner JT., 2000, 1 SIGNALS EVOLUTION; Boraas ME, 1998, EVOL ECOL, V12, P153, DOI 10.1023/A:1006527528063; Buckling A, 2000, NATURE, V408, P961, DOI 10.1038/35050080; Buss L. W., 1987, EVOLUTION INDIVIDUAL; Dawkins R., 1976, SELFISH GENE; Ferriere R, 1996, AM NAT, V147, P692, DOI 10.1086/285875; Foster KR, 2002, P ROY SOC B-BIOL SCI, V269, P2357, DOI 10.1098/rspb.2002.2163; FRANK SA, 1995, NATURE, V377, P520, DOI 10.1038/377520a0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; Kerszberg M, 1998, J THEOR BIOL, V193, P535, DOI 10.1006/jtbi.1998.0714; KOUFOPANOU V, 1993, P ROY SOC B-BIOL SCI, V254, P107, DOI 10.1098/rspb.1993.0134; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Maynard Smith J., 1988, EVOLUTIONARY PROGR, P219; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; Michod Richard E., 1999, DARWINIAN DYNAMICS; Pfeiffer T, 2003, P NATL ACAD SCI USA, V100, P1095, DOI 10.1073/pnas.0335420100; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Smith J, 2001, P ROY SOC B-BIOL SCI, V268, P61, DOI 10.1098/rspb.2000.1330; Sober E., 1998, POPUL ENVIRON; Spiers AJ, 2002, GENETICS, V161, P33; Velicer GJ, 2003, NATURE, V425, P75, DOI 10.1038/nature01908; Williams G. C., 1966, P307; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143; Wolf JB, 2003, P NATL ACAD SCI USA, V100, P4655, DOI 10.1073/pnas.0635741100; WOLPERT L, 1990, BIOL J LINN SOC, V39, P109, DOI 10.1111/j.1095-8312.1990.tb00506.x	31	394	402	2	239	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2003	425	6953					72	74		10.1038/nature01906	http://dx.doi.org/10.1038/nature01906			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717LD	12955142				2022-12-01	WOS:000185089200039
J	Hamilton, SR; Bobrowicz, P; Bobrowicz, B; Davidson, RC; Li, HJ; Mitchell, T; Nett, JH; Rausch, S; Stadheim, TA; Wischnewski, H; Wildt, S; Gerngross, TU				Hamilton, SR; Bobrowicz, P; Bobrowicz, B; Davidson, RC; Li, HJ; Mitchell, T; Nett, JH; Rausch, S; Stadheim, TA; Wischnewski, H; Wildt, S; Gerngross, TU			Production of complex human glycoproteins in yeast	SCIENCE			English	Article							LINKED GLYCOSYLATION; PICHIA-PASTORIS; OLIGOSACCHARIDES; GOLGI	We report the humanization of the glycosylation pathway in the yeast Pichia pastoris to secrete a human glycoprotein with uniform complex N-glycosylation. The process involved eliminating endogenous yeast glycosylation pathways, while properly localizing five active eukaryotic proteins, including mannosidases I and II, N-acetylglucosaminyl transferases I and II, and uridine 5'-diphosphate (UDP)-N-acetylglucosamine transporter. Targeted localization of the enzymes enabled the generation of a synthetic in vivo glycosylation pathway, which produced the complex human N-glycan N-acetylglucosamine(2)-mannose(3)-N-acetylglucosamine(2) (GlcNAc(2)Man(3)GlcNAc(2)). The ability to generate human glycoproteins with homogeneous N-glycan structures in a fungal host is a step toward producing therapeutic glycoproteins and could become a tool for elucidating the structure-function relation of glycoproteins.	Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Gerngross, TU (corresponding author), Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.				NIGMS NIH HHS [1R43GM66690-1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM066690] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALLOU CE, 1990, METHOD ENZYMOL, V185, P440; Choi BK, 2003, P NATL ACAD SCI USA, V100, P5022, DOI 10.1073/pnas.0931263100; Cregg JM, 2000, MOL BIOTECHNOL, V16, P23, DOI 10.1385/MB:16:1:23; Dean N, 1999, BBA-GEN SUBJECTS, V1426, P309, DOI 10.1016/S0304-4165(98)00132-9; FOSTER JM, 1995, GENE, V154, P183, DOI 10.1016/0378-1119(94)00867-R; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200	7	282	403	4	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 29	2003	301	5637					1244	1246		10.1126/science.1088166	http://dx.doi.org/10.1126/science.1088166			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZC	12947202				2022-12-01	WOS:000185003500045
J	Rieseberg, LH; Raymond, O; Rosenthal, DM; Lai, Z; Livingstone, K; Nakazato, T; Durphy, JL; Schwarzbach, AE; Donovan, LA; Lexer, C				Rieseberg, LH; Raymond, O; Rosenthal, DM; Lai, Z; Livingstone, K; Nakazato, T; Durphy, JL; Schwarzbach, AE; Donovan, LA; Lexer, C			Major ecological transitions in wild sunflowers facilitated by hybridization	SCIENCE			English	Article							HYBRID SPECIATION; TRANSGRESSIVE SEGREGATION; HELIANTHUS-PARADOXUS; EVOLUTION; ANCIENT; ASTERACEAE; ORIGINS	Hybridization is frequent in many organismal groups, but its role in adaptation is poorly understood. In sunflowers, species found in the most extreme habitats are ancient hybrids, and new gene combinations generated by hybridization are speculated to have contributed to ecological divergence. This possibility was tested through phenotypic and genomic comparisons of ancient and synthetic hybrids. Most trait differences in ancient hybrids could be recreated by complementary gene action in synthetic hybrids and were favored by selection. The same combinations of parental chromosomal segments required to generate extreme phenotypes in synthetic hybrids also occurred in ancient hybrids. Thus, hybridization facilitated ecological divergence in sunflowers.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Univ Lyon 1, Lab Biol Mol & Phytochim, F-69622 Villeurbanne, France; Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA; Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA	Indiana University System; Indiana University Bloomington; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University System of Georgia; University of Georgia; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Rieseberg, LH (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	lriesebe@indiana.edu	Rieseberg, Loren H/B-3591-2013; Rosenthal, David/C-9559-2012; Lexer, Christian/N-3702-2013; Donovan, Lisa A/H-4754-2016; Raymond, Olivier/AAO-5868-2020	Rieseberg, Loren H/0000-0002-2712-2417; Rosenthal, David/0000-0002-4822-5861; Donovan, Lisa A/0000-0001-9814-0666; Raymond, Olivier/0000-0002-9664-5377; Lexer, Christian/0000-0002-7221-7482	PHS HHS [R01 G59065] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ABBOTT RJ, 1992, TRENDS ECOL EVOL, V7, P401, DOI 10.1016/0169-5347(92)90020-C; Anderson E., 1949, INTROGRESSIVE HYBRID; Arnold ML, 1997, NATURAL HYBRIDIZATIO; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Buerkle CA, 2000, HEREDITY, V84, P441, DOI 10.1046/j.1365-2540.2000.00680.x; DANIN A, 1991, J ARID ENVIRON, V21, P193, DOI 10.1016/S0140-1963(18)30682-7; DEVICENTE MC, 1993, GENETICS, V134, P585; Ellstrand NC, 1996, P NATL ACAD SCI USA, V93, P5090, DOI 10.1073/pnas.93.10.5090; Gibson AC, 1998, BIOSCIENCE, V48, P911, DOI 10.2307/1313295; GOULD SJ, 1979, P ROY SOC LOND B BIO, V205, P581, DOI DOI 10.1098/RSPB.1979.0086; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Grant V., 1981, PLANT SPECIATION; Greig D, 2002, SCIENCE, V298, P1773, DOI 10.1126/science.1076374; GROSS BL, IN PRESS AM J BOT; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; Lexer C, 2003, MOL ECOL, V12, P1225, DOI 10.1046/j.1365-294X.2003.01803.x; MAYR E, 1992, AM J BOT, V79, P222, DOI 10.2307/2445111; MCCARTHY EM, 1995, HEREDITY, V74, P502, DOI 10.1038/hdy.1995.71; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rieseberg LH, 1996, SCIENCE, V272, P741, DOI 10.1126/science.272.5262.741; RIESEBERG LH, 1991, AM J BOT, V78, P1218, DOI 10.2307/2444926; Rieseberg LH, 2000, EVOLUTION, V54, P859, DOI 10.1111/j.0014-3820.2000.tb00086.x; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Rosenthal DM, 2002, INT J PLANT SCI, V163, P387, DOI 10.1086/339237; Schemske D.W., 2000, EVOLUTION, V54, P1069, DOI DOI 10.1111/J.0014-3820.2000.TB00111.X; Schwarzbach AE, 2002, MOL ECOL, V11, P1703, DOI 10.1046/j.1365-294X.2002.01557.x; Sokal R., 2000, BIOMETRY, V3rd ed., P451; Ungerer MC, 1998, P NATL ACAD SCI USA, V95, P11757, DOI 10.1073/pnas.95.20.11757; Wagner W. H. Jun., 1970, Taxon, P146; Welch ME, 2002, EVOLUTION, V56, P2126, DOI 10.1111/j.0014-3820.2002.tb00138.x; Welch ME, 2002, AM J BOT, V89, P472, DOI 10.3732/ajb.89.3.472; Wendel J.F., 1998, MOL SYSTEMATICS PLAN, P265, DOI DOI 10.1007/978-1-4615-5419-6_10	33	853	891	1	248	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2003	301	5637					1211	1216		10.1126/science.1086949	http://dx.doi.org/10.1126/science.1086949			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZC	12907807				2022-12-01	WOS:000185003500033
J	Stovring, H; Andersen, M; Beck-Nielsen, H; Green, A; Vach, W				Stovring, H; Andersen, M; Beck-Nielsen, H; Green, A; Vach, W			Rising prevalence of diabetes: Evidence from a Danish pharmaco-epidemiological database.	LANCET			English	Article								The prevalence of diabetes has Increased worldwide. We have undertaken an epidemiological analysis of drug-treated diabetes In a well defined community. We present estimates of prevalence, incidence, and mortality of patients with such diabetes during 1993-99, based on data for all 470 000 people living in the county of Fyn, Denmark. Although prevalence increased (odds ratio: female, 1.026 [95% CI 1.020-1.032]; male, 1.041 [1.036-1.047]), mortality in those treated declined (rate ratio: female, 0.976 [95% CI 0.952-1.001]; male, 0.966 [0.943-0.990]). We did not identify a clear trend for incidence. Future research into the causes of rising diabetes prevalence should take this fall in mortality into account to avoid incorrect conclusions about the relation between western lifestyle and the growing number of diabetics.	Univ So Denmark, Res Unit Gen Practice, DK-5000 Odense, Denmark; Aarhus Univ, Natl Ctr Registerbased Res, Aarhus, Denmark; Aarhus Univ, Dept Epidemiol & Social Med, DK-8000 Aarhus C, Denmark; Univ So Denmark, Inst Publ Hlth, Odense, Denmark; Univ So Denmark, Dept Stat & Demog, Odense, Denmark; Odense Univ Hosp, Diabet Res Ctr, DK-5000 Odense, Denmark	University of Southern Denmark; Aarhus University; Aarhus University; University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital	Stovring, H (corresponding author), Univ So Denmark, Res Unit Gen Practice, DK-5000 Odense, Denmark.		Støvring, Henrik/I-4683-2012; Andersen, Morten/H-3555-2011; Støvring, Henrik/H-5754-2019; Vach, Werner/F-2512-2011	Støvring, Henrik/0000-0002-5821-2351; Andersen, Morten/0000-0001-7029-2860; Støvring, Henrik/0000-0002-5821-2351; Vach, Werner/0000-0003-1865-8399				*DAN MED AG, 1998, ANT FORBR ANT 1994 1; HALLAS J, 1994, EUR J CLIN PHARMACOL, V47, P367; HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523; *WHO, 2001, ATC DDDS GUID ATC CL; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	5	74	77	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 16	2003	362	9383					537	538		10.1016/S0140-6736(03)14116-5	http://dx.doi.org/10.1016/S0140-6736(03)14116-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	712UW	12932388				2022-12-01	WOS:000184817600013
J	Tonks, A				Tonks, A			Commentary: Information for patients: What happens during cognitive behaviour therapy for bulimia	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ Unified, London WC1H 9JR, England		Tonks, A (corresponding author), BMJ Unified, London WC1H 9JR, England.								0	0	0	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 16	2003	327	7411					382	382		10.1136/bmj.327.7411.382	http://dx.doi.org/10.1136/bmj.327.7411.382			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	713NJ	12919995	Green Published			2022-12-01	WOS:000184864200024
J	Keenan, HT; Runyan, DK; Marshall, SW; Nocera, MA; Merten, DF; Sinal, SH				Keenan, HT; Runyan, DK; Marshall, SW; Nocera, MA; Merten, DF; Sinal, SH			A population-based study of inflicted traumatic brain injury in young children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SHAKEN IMPACT SYNDROME; ABUSIVE HEAD TRAUMA; BABY SYNDROME; INFANTS; RISK	Context Physical abuse is a leading cause of serious head injury and death in children aged 2 years or younger. The incidence of inflicted traumatic brain injury (TBI) in US children is unknown. Objective To determine the incidence of serious or fatal inflicted TBI in a defined US population of approximately 230000 children aged 2 years or younger. Design, Setting, and Subjects All North Carolina children aged 2 years or younger who were admitted to a pediatric intensive care unit or who died with a TBI in 2000 and 2001 were identified prospectively. Injuries were considered inflicted if accompanied by a confession or a medical and social service agency determination of abuse. Main Outcome Measure Incidence of inflicted TBI. Multivariate logistic regression models were used to compare children with inflicted injuries with those with non-inflicted injuries and with the general state population aged 2 years or younger. Results A total of 152 cases of serious or fatal TBI were identified, with 80 (53%) incurring inflicted TBI. The incidence of inflicted traumatic brain injury in the first 2 years of life was 17.0 (95% confidence interval [CI], 13.3-20.7) per 100000 person-years. Infants had a higher incidence than children in the second year of life (29.7 [95% CI, 22.9-36.7] vs 3.8 [95% CI, 1.3-6.4] per 100000 person-years). Boys had a higher incidence than girls (21.0 [95% CI, 15.1-26.6] vs 13.0 [95% CI, 8.4-17.7] per 100000 person-years). Relative to the general population, children who incurred an increased risk of inflicted injury were born to young mothers (less than or equal to21 years), non-European American, or products of multiple births. Conclusions In this population of North Carolina children, the incidence of inflicted TBI varied by characteristics of the injured children and their mothers. These data may be helpful for informing preventive interventions.	Univ N Carolina, Sch Med, Dept Social Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Orthoped, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Radiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA; Wake Forest Univ, Bowman Gray Sch Med, Brenner Childrens Hosp, Dept Pediat, Winston Salem, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University; Wake Forest Baptist Medical Center	Keenan, HT (corresponding author), Univ N Carolina, Sch Med, Dept Social Med, Wing D,CB7240, Chapel Hill, NC 27599 USA.		Runyan, Desmond/S-3974-2016	Runyan, Desmond/0000-0001-5571-9029; Marshall, Stephen/0000-0002-2664-9233	ODCDC CDC HHS [R49/CCR402444] Funding Source: Medline	ODCDC CDC HHS		Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; GESSNER RR, 1995, ARCH PEDIAT ADOL MED, V149, P467; GROOTHUIS JR, 1982, PEDIATRICS, V70, P769; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Lane WG, 2002, JAMA-J AM MED ASSOC, V288, P1603, DOI 10.1001/jama.288.13.1603; LUDWIG S, 1984, ANN EMERG MED, V13, P104, DOI 10.1016/S0196-0644(84)80571-5; LUDWIG S, 1990, AJDC, V144, P724; *NC CTR HLTH STAT, HLTH STAT STAT CTR; Overpeck MD, 1998, NEW ENGL J MED, V339, P1211, DOI 10.1056/NEJM199810223391706; Sinal SH, 2000, CHILD ABUSE NEGLECT, V24, P1241, DOI 10.1016/S0145-2134(00)00177-0; STARLING SP, 1995, PEDIATRICS, V95, P259; STIER DM, 1993, PEDIATRICS, V91, P642; *US DEP HHS, 1988, INT CLASS DIS 9 REV	20	401	409	2	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2003	290	5					621	626		10.1001/jama.290.5.621	http://dx.doi.org/10.1001/jama.290.5.621			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708GH	12902365	Bronze			2022-12-01	WOS:000184558500016
J	Fischle, W; Wang, YM; Allis, CD				Fischle, W; Wang, YM; Allis, CD			Binary switches and modification cassettes in histone biology and beyond	NATURE			English	Article							POSITION-EFFECT VARIEGATION; MAMMALIAN-CELLS; LYSINE METHYLATION; MOLECULAR-BASIS; H3; HP1; CHROMATIN; PHOSPHORYLATION; CORE; IDENTIFICATION	An immense number of post-translational modifications on histone proteins have been described and additional sites of modification are still being uncovered. Whereas many direct and indirect connections between certain histone modifications and distinct biological phenomena have now been established, concepts for comprehending the extreme density and variety of these covalent modifications are lacking. Here, we formally introduce localized 'binary switches' and 'modification cassettes' as new concepts in histone biology, elucidating mechanisms that might govern the biological readout of distinct modification patterns. Specifically, our hypotheses provide missing models for the dynamic readout of stable histone modifications and offer explanations for several long-standing questions embedded in the literature. Our ideas might also apply to non-histone proteins and are open to direct experimental examination.	Rockefeller Univ, Lab Chromat Biol, New York, NY 10021 USA	Rockefeller University	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromat Biol, 1230 York Ave, New York, NY 10021 USA.			Wang, Yanming/0000-0002-0710-043X				Appella E, 2000, PATHOL BIOL, V48, P227; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Baarends WM, 1999, DEV BIOL, V207, P322, DOI 10.1006/dbio.1998.9155; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; DAVIE JR, 1991, BIOCHEM CELL BIOL, V69, P66, DOI 10.1139/o91-009; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; FUJITAKI JM, 1981, BIOCHEMISTRY-US, V20, P3658, DOI 10.1021/bi00515a055; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; KELLUM R, 1995, J CELL SCI, V108, P1407; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Li YH, 2003, DEVELOPMENT, V130, P1817, DOI 10.1242/dev.00405; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Park JH, 2002, NAT GENET, V32, P273, DOI 10.1038/ng982; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Prives C, 2001, CELL, V107, P815, DOI 10.1016/S0092-8674(01)00619-5; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; REUTER G, 1992, BIOESSAYS, V14, P605, DOI 10.1002/bies.950140907; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thompson JS, 2003, GENETICS, V163, P447; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; WATERBORG JH, 1990, J BIOL CHEM, V265, P17157; Zhang KL, 2002, ANAL BIOCHEM, V306, P259, DOI 10.1006/abio.2002.5719; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	38	522	535	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2003	425	6957					475	479		10.1038/nature02017	http://dx.doi.org/10.1038/nature02017			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727FN	14523437				2022-12-01	WOS:000185648100035
J	Yanagisawa, S; Yoo, SD; Sheen, J				Yanagisawa, S; Yoo, SD; Sheen, J			Differential regulation of EIN3 stability by glucose and ethylene signalling in plants	NATURE			English	Article							INDUCIBLE GENE-EXPRESSION; PROTEASOME PATHWAY; RESPONSE PATHWAY; ABSCISIC-ACID; ARABIDOPSIS; PROTEIN; LIGHT; TRANSDUCTION; MAIZE; ETHYLENE-INSENSITIVE3	Glucose is a global regulator of growth and metabolism that is evolutionarily conserved from unicellular microorganisms to multicellular animals and plants(1). In photosynthetic plants, glucose shows hormone-like activities and modulates many essential processes, including embryogenesis, germination, seedling development, vegetative growth, reproduction and senescence(2,3). Genetic and phenotypic analyses of Arabidopsis mutants with glucose-insensitive (gin) and glucose-oversensitive (glo) phenotypes have identified an unexpected antagonistic interaction between glucose and the plant stress hormone ethylene. The ethylene-insensitive etr1 and ein2 mutants have glo phenotypes, whereas the constitutive ethylene signalling mutant ctr1 is allelic to gin4 (refs 4, 5). The precise molecular mechanisms underlying the complex signalling network that governs plant growth and development in response to nutrients and plant hormones are mostly unknown. Here we show that glucose enhances the degradation of ETHYLENE-INSENSITIVE3 (EIN3), a key transcriptional regulator in ethylene signalling(6,7), through the plant glucose sensor hexokinase(8). Ethylene, by contrast, enhances the stability of EIN3. The ein3 mutant has a glo phenotype, and overexpression of EIN3 in transgenic Arabidopsis decreases glucose sensitivity.	Okayama Univ, Bioresources Res Inst, Kurashiki, Okayama 7100046, Japan; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Genet,Dept Mol Biol, Boston, MA 02114 USA	Okayama University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Yanagisawa, S (corresponding author), Okayama Univ, Bioresources Res Inst, Chuo 2-20-1, Kurashiki, Okayama 7100046, Japan.	yanagi-s@rib.okayama-u.ac.jp						Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chang CC, 1999, PLANT CELL, V11, P911, DOI 10.1105/tpc.11.5.911; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; JANG JC, 1994, PLANT CELL, V6, P1665, DOI 10.1105/tpc.6.11.1665; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kosugi S, 2000, NUCLEIC ACIDS RES, V28, P960, DOI 10.1093/nar/28.4.960; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Ravid T, 2000, J BIOL CHEM, V275, P35840, DOI 10.1074/jbc.M004793200; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Rolland F, 2001, TRENDS BIOCHEM SCI, V26, P310, DOI 10.1016/S0968-0004(01)01805-9; SHEEN J, 1993, EMBO J, V12, P3497, DOI 10.1002/j.1460-2075.1993.tb06024.x; SHEEN JY, 1986, EMBO J, V5, P3417, DOI 10.1002/j.1460-2075.1986.tb04663.x; Silverstone AL, 2001, PLANT CELL, V13, P1555, DOI 10.1105/tpc.13.7.1555; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Vierstra RD, 2003, TRENDS PLANT SCI, V8, P135, DOI 10.1016/S1360-1385(03)00014-1; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Yanagisawa S, 1998, PLANT CELL, V10, P75, DOI 10.1105/tpc.10.1.75; Zhou L, 1998, P NATL ACAD SCI USA, V95, P10294, DOI 10.1073/pnas.95.17.10294; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	30	375	411	4	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2003	425	6957					521	525		10.1038/nature01984	http://dx.doi.org/10.1038/nature01984			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727FN	14523448				2022-12-01	WOS:000185648100047
J	Nathoo, S; Serghides, L; Kain, KC				Nathoo, S; Serghides, L; Kain, KC			Effect of HIV-1 antiretroviral drugs on cytoadherence and phagocytic clearance of Plasmodium falciparum-parasitised erythrocytes	LANCET			English	Article							MALARIA	In response to the HIV/AIDS pandemic, antiretroviral treatment is currently being implemented in sub-Saharan Africa, where malaria and HIV-1 co-infections are highly prevalent. The effectiveness and tolerability of antiretrovirals in patients with malaria and HIV-1 co-infection have not been investigated. Antiretrovirals decrease CD36 surface concentrations in vivo, which might impair receptor function and affect parasite-host interactions. Thus, we investigated the effects of these drugs on CD36-mediated cytoadherence and non-opsonic phagocytosis of Plasmodium falciparum parasitised erythrocytes in vitro. The protease-inhibitor class of antiretrovirals particularly impairs CD36-mediated cytoadherence and non-opsonic phagocytosis of parasitised erythrocytes by human macrophages. Such treatment might therefore contribute to altered malaria disease outcomes in co-infected patients.	Toronto Gen Hosp, Trop Dis Unit, Div Infect Dis, Dept Med,Univ Hlth Network, Toronto, ON M5G 2C4, Canada; Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto	Kain, KC (corresponding author), Toronto Gen Hosp, Trop Dis Unit, Div Infect Dis, Dept Med,Univ Hlth Network, 200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	kevin.kain@uhn.on.ca	Serghides, Lena/C-7968-2018	Serghides, Lena/0000-0002-2817-6134; Kain, Kevin/0000-0001-6068-1272				Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636; Corbett EL, 2002, LANCET, V359, P2177, DOI 10.1016/S0140-6736(02)09095-5; Rogerson SJ, 1999, AM J TROP MED HYG, V61, P467, DOI 10.4269/ajtmh.1999.61.467; Serghides L, 2001, J IMMUNOL, V166, P6742, DOI 10.4049/jimmunol.166.11.6742; Serghides L, 2002, AIDS, V16, P353, DOI 10.1097/00002030-200202150-00006	5	51	52	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 27	2003	362	9389					1039	1041		10.1016/S0140-6736(03)14414-5	http://dx.doi.org/10.1016/S0140-6736(03)14414-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725WD	14522535				2022-12-01	WOS:000185564600012
J	Kamal, A; Thao, L; Sensintaffar, J; Zhang, L; Boehm, MF; Fritz, LC; Burrows, FJ				Kamal, A; Thao, L; Sensintaffar, J; Zhang, L; Boehm, MF; Fritz, LC; Burrows, FJ			A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors	NATURE			English	Article							HEAT-SHOCK PROTEINS; ATP BINDING; GELDANAMYCIN; CHAPERONE; DEGRADATION; EXPRESSION; DESTABILIZATION; HYDROLYSIS; CAPACITOR; RECEPTOR	Heat shock protein 90 (Hsp90) is a molecular chaperone that plays a key role in the conformational maturation of oncogenic signalling proteins, including HER-2/ErbB2, Akt, Raf-1, Bcr-Abl and mutated p53(1-7). Hsp90 inhibitors bind to Hsp90, and induce the proteasomal degradation of Hsp90 client proteins(6,8-11). Although Hsp90 is highly expressed in most cells, Hsp90 inhibitors selectively kill cancer cells compared to normal cells, and the Hsp90 inhibitor 17-allylaminogeldanamycin (17-AAG) is currently in phase I clinical trials(12,13). However, the molecular basis of the tumour selectivity of Hsp90 inhibitors is unknown. Here we report that Hsp90 derived from tumour cells has a 100-fold higher binding affinity for 17-AAG than does Hsp90 from normal cells. Tumour Hsp90 is present entirely in multi-chaperone complexes with high ATPase activity, whereas Hsp90 from normal tissues is in a latent, uncomplexed state. In vitro reconstitution of chaperone complexes with Hsp90 resulted in increased binding affinity to 17-AAG, and increased ATPase activity. These results suggest that tumour cells contain Hsp90 complexes in an activated, high-affinity conformation that facilitates malignant progression, and that may represent a unique target for cancer therapeutics.	Conforma Therapeut Corp, San Diego, CA 92121 USA		Burrows, FJ (corresponding author), Conforma Therapeut Corp, 9393 Towne Ctr dr,Suite 240, San Diego, CA 92121 USA.	fburrows@conformacorp.com						An WG, 2000, CELL GROWTH DIFFER, V11, P355; Basso AD, 2002, ONCOGENE, V21, P1159, DOI 10.1038/sj.onc.1205184; Blagosklonny MV, 2002, LEUKEMIA, V16, P455, DOI 10.1038/sj.leu.2402415; BLAGOSKLONNY MV, 1995, ONCOGENE, V11, P933; Chiosis G, 2003, MOL CANCER THER, V2, P123; Chiosis G, 2001, CHEM BIOL, V8, P289, DOI 10.1016/S1074-5521(01)00015-1; EGORIN MJ, 1999, P AM ASSOC CANC RES, V40, P3409; Grenert JP, 1999, J BIOL CHEM, V274, P17525, DOI 10.1074/jbc.274.25.17525; GRESS TM, 1994, CANCER RES, V54, P547; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; MILLER P, 1994, CANCER RES, V54, P2724; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; SCHUH S, 1985, J BIOL CHEM, V260, P4292; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Schulte TW, 1997, BIOCHEM BIOPH RES CO, V239, P655, DOI 10.1006/bbrc.1997.7527; Solit DB, 2002, CLIN CANCER RES, V8, P986; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Workman P, 2003, MOL CANCER THER, V2, P131; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Yano M, 1996, JPN J CANCER RES, V87, P908, DOI 10.1111/j.1349-7006.1996.tb02119.x	32	1122	1189	10	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2003	425	6956					407	410		10.1038/nature01913	http://dx.doi.org/10.1038/nature01913			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	724TG	14508491				2022-12-01	WOS:000185502300043
J	Davidson, AJ; Ernst, P; Wang, Y; Dekens, MPS; Kingsley, PD; Palis, J; Korsmeyer, SJ; Daley, GQ; Zon, LI				Davidson, AJ; Ernst, P; Wang, Y; Dekens, MPS; Kingsley, PD; Palis, J; Korsmeyer, SJ; Daley, GQ; Zon, LI			cdx4 mutants fail to specify blood progenitors and can be rescued by multiple hox genes	NATURE			English	Article							HOMEOBOX GENE; HEMATOPOIETIC-CELLS; MYELOID-LEUKEMIA; CAUDAL HOMOLOG; TAIL FORMATION; STEM-CELL; EXPRESSION; MICE; DROSOPHILA; EXPANSION	Organogenesis is dependent on the formation of distinct cell types within the embryo. Important to this process are the hox genes, which are believed to confer positional identities to cells along the anteroposterior axis(1-3). Here, we have identified the caudal-related gene cdx4 as the locus mutated in kugelig (kgg), a zebrafish mutant with an early defect in haematopoiesis that is associated with abnormal anteroposterior patterning and aberrant hox gene expression. The blood deficiency in kgg embryos can be rescued by overexpressing hoxb7a or hoxa9a but not hoxb8a, indicating that the haematopoietic defect results from perturbations in specific hox genes. Furthermore, the haematopoietic defect in kgg mutants is not rescued by scl overexpression, suggesting that cdx4 and hox genes act to make the posterior mesoderm competent for blood development. Overexpression of cdx4 during zebrafish development or in mouse embryonic stem cells induces blood formation and alters hox gene expression. Taken together, these findings demonstrate that cdx4 regulates hox genes and is necessary for the specification of haematopoietic cell fate during vertebrate embryogenesis.	Childrens Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02115 USA; Howard Hughes Med Inst, Dana Farber Canc Inst, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pathol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Max Planck Inst Entwicklungsbiol, Genet Abt, D-72076 Tubingen, Germany; Univ Rochester, Dept Pediat, Ctr Human Genet & Mol Pediat Dis, Rochester, NY 14642 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Max Planck Society; University of Rochester	Zon, LI (corresponding author), Childrens Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02115 USA.			wang, Yuan/0000-0002-0939-1269; Palis, James/0000-0001-7324-1049; Ernst, Patricia/0000-0001-7638-2939; Dekens, Marcus P.S./0000-0003-1689-3491				Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Beck F, 1999, P NATL ACAD SCI USA, V96, P7318, DOI 10.1073/pnas.96.13.7318; Bjornsson JM, 2003, MOL CELL BIOL, V23, P3872, DOI 10.1128/MCB.23.11.3872-3883.2003; Buske C, 2002, BLOOD, V100, P862, DOI 10.1182/blood-2002-01-0220; Charite J, 1998, DEVELOPMENT, V125, P4349; Chase A, 1999, BLOOD, V93, P1025, DOI 10.1182/blood.V93.3.1025.403a20_1025_1031; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Chen F, 1998, MECH DEVELOP, V77, P49, DOI 10.1016/S0925-4773(98)00126-9; Edgar LG, 2001, DEV BIOL, V229, P71, DOI 10.1006/dbio.2000.9977; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; HUNT P, 1991, CELL, V66, P1075, DOI 10.1016/0092-8674(91)90029-X; Hunter CP, 1999, DEVELOPMENT, V126, P805; JOLY JS, 1992, DIFFERENTIATION, V50, P75, DOI 10.1111/j.1432-0436.1992.tb00488.x; Kappen C, 2000, AM J HEMATOL, V65, P111, DOI 10.1002/1096-8652(200010)65:2<111::AID-AJH4>3.0.CO;2-Z; Katsuyama Y, 1999, DEV BIOL, V213, P257, DOI 10.1006/dbio.1999.9403; Kingsley PD, 2001, DEV GROWTH DIFFER, V43, P133; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MLODZIK M, 1985, EMBO J, V4, P2961, DOI 10.1002/j.1460-2075.1985.tb04030.x; Owens BM, 2002, STEM CELLS, V20, P364, DOI 10.1634/stemcells.20-5-364; PERKINS AC, 1993, EMBO J, V12, P3835, DOI 10.1002/j.1460-2075.1993.tb06062.x; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; STRUHL G, 1982, P NATL ACAD SCI-BIOL, V79, P7380, DOI 10.1073/pnas.79.23.7380; SUBRAMANIAN V, 1995, CELL, V83, P641, DOI 10.1016/0092-8674(95)90104-3; Tamai Y, 1999, CANCER RES, V59, P2965; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; van den Akker E, 2002, DEVELOPMENT, V129, P2181	30	197	213	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 18	2003	425	6955					300	306		10.1038/nature01973	http://dx.doi.org/10.1038/nature01973			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722JA	13679919				2022-12-01	WOS:000185370900047
J	Wilson, JF				Wilson, JF			How cloning could change medicine	ANNALS OF INTERNAL MEDICINE			English	Article													Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136					0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2003	139	6					535	538		10.7326/0003-4819-139-6-200309160-00036	http://dx.doi.org/10.7326/0003-4819-139-6-200309160-00036			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721PE	13679343				2022-12-01	WOS:000185324100026
J	Lassen, A; Hallas, J; de Muckadell, OBS				Lassen, A; Hallas, J; de Muckadell, OBS			Eradication of Helicobacter pylori and use of antisecretory drugs: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							DISEASE		Odense Univ Hosp, Dept Med Gastroenterol, DK-5000 Odense, Denmark; Odense Univ Hosp, Dept Internal Med, DK-5000 Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Lassen, A (corresponding author), Odense Univ Hosp, Dept Med Gastroenterol, DK-5000 Odense, Denmark.		Lassen, Annmarie/AAA-5816-2019	Lassen, Annmarie/0000-0003-4942-6152; Hallas, Jesper/0000-0002-8097-8708; Schaffalitzky de Muckadell, Ove B/0000-0003-1969-2329				De Boer WA, 2001, GUT, V48, P567, DOI 10.1136/gut.48.4.567; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Gaist D, 1997, DAN MED BULL, V44, P445; Malfertheiner P, 2002, ALIMENT PHARM THER, V16, P167, DOI 10.1046/j.1365-2036.2002.01169.x; McColl KEL, 2000, AM J GASTROENTEROL, V95, P101	5	10	11	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 13	2003	327	7415					603	603		10.1136/bmj.327.7415.603	http://dx.doi.org/10.1136/bmj.327.7415.603			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722CW	12969930	Green Published, Bronze			2022-12-01	WOS:000185358700026
J	Tkachev, D; Mimmack, ML; Ryan, MM; Wayland, M; Freeman, T; Jones, PB; Starkey, M; Webster, MJ; Yolken, RH; Bahn, S				Tkachev, D; Mimmack, ML; Ryan, MM; Wayland, M; Freeman, T; Jones, PB; Starkey, M; Webster, MJ; Yolken, RH; Bahn, S			Oligodendrocyte dysfunction in schizophrenia and bipolar disorder	LANCET			English	Article							GENE-EXPRESSION; PSYCHIATRIC-DISORDERS; UP-REGULATION; TARGET GENES; BRAIN; MYELIN; MICROARRAY; SUSCEPTIBILITY; PATHOLOGY; PROTEINS	Background Results of array studies have suggested abnormalities in expression of lipid and myelin-related genes in schizophrenia. Here, we investigated oligodendrocyte-specific and myelination-associated gene expression in schizophrenia and bipolar affective disorder. Methods We used samples from the Stanley brain collection, consisting of 15 schizophrenia, 15 bipolar affective disorder, and 15 control brains. Indexing-based differential display PCR was done to screen for differences in gene expression in schizophrenia patients versus controls. Results were cross-validated with quantitative PCR,, which was also used to investigate expression profiles of 16 other oligodendrocyte and myelin genes in schizophrenia and bipolar disorder. These genes were further investigated with an ongoing microarray analysis. Findings Results of differential display and quantitative PCR analysis showed a reduction of key oligodendrocyte-related and myelin-related genes in schizophrenia and bipolar patients; expression changes for both disorders showed a high degree of overlap. Microarray results of the same genes investigated by quantitative PCR correlated well overall. Interpretation Schizophrenia and bipolar brains showed downregulation of key oligodendrocyte and myelination genes, including transcription factors that regulate these genes, compared with control brains. These results lend support to and extend observations from other microarray investigations. Our study also showed similar expression changes to the schizophrenia group in bipolar brains, which thus lends support to the notion that the disorders share common causative and pathophysiological pathways.	Babraham Inst, Dept Neurobiol, Cambridge, England; UK Human Genome Mapping Project Resource Ctr, Cambridge, England; Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 2QQ, England; Uniformed Serv Univ Hlth Sci, Dept Psychiat, Stanley Lab Brain Res, Bethesda, MD 20814 USA; Johns Hopkins Univ, Sch Med, Stanley Div Dev Neurovirol, Baltimore, MD USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Uniformed Services University of the Health Sciences - USA; Johns Hopkins University	Bahn, S (corresponding author), Univ Cambridge, Dept Psychiat, Cambridge CB2 2QQ, England.		Wayland, Matthew/V-6751-2019; yolken, robert/AAW-2556-2021	Wayland, Matthew/0000-0002-8095-858X; Jones, Peter Brian/0000-0002-0387-880X				Bahn S, 2002, LANCET, V359, P310, DOI 10.1016/S0140-6736(02)07497-4; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; BENES FM, 1986, ARCH GEN PSYCHIAT, V43, P31; Bertolino A, 2001, BIOL PSYCHIAT, V49, P39, DOI 10.1016/S0006-3223(00)00997-5; Bertolino A, 1998, BIOL PSYCHIAT, V43, P641, DOI 10.1016/S0006-3223(97)00555-6; Buchsbaum MS, 1998, NEUROREPORT, V9, P425, DOI 10.1097/00001756-199802160-00013; Colantuoni C, 2001, NEUROBIOL DIS, V8, P847, DOI 10.1006/nbdi.2001.0428; CONNOR JR, 1994, DEV NEUROSCI-BASEL, V16, P233, DOI 10.1159/000112115; Erikson KM, 1997, J NUTR, V127, P2030, DOI 10.1093/jn/127.10.2030; Foong J, 2000, J NEUROL NEUROSUR PS, V68, P70, DOI 10.1136/jnnp.68.1.70; Garbern JY, 2002, BRAIN, V125, P551, DOI 10.1093/brain/awf043; GOTTESMAN II, 1987, SCHIZOPHRENIA BULL, V13, P23, DOI 10.1093/schbul/13.1.23; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Hata R, 2001, BIOCHEM BIOPH RES CO, V284, P310, DOI 10.1006/bbrc.2001.4968; Ho L, 2001, NEUROSCI LETT, V298, P191, DOI 10.1016/S0304-3940(00)01753-5; Hof PR, 2002, NEUROCHEM RES, V27, P1193, DOI 10.1023/A:1020981510759; Horrobin DF, 1999, PROSTAG LEUKOTR ESS, V60, P141, DOI 10.1054/plef.1999.0027; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lim KO, 1999, ARCH GEN PSYCHIAT, V56, P367, DOI 10.1001/archpsyc.56.4.367; Lu QR, 2001, P NATL ACAD SCI USA, V98, P10851, DOI 10.1073/pnas.181340798; Marcus J, 2002, J CELL BIOL, V156, P567, DOI 10.1083/jcb.200111047; Mayanil CSK, 2001, J BIOL CHEM, V276, P49299, DOI 10.1074/jbc.M107933200; Mayfield RD, 2002, J NEUROCHEM, V81, P802, DOI 10.1046/j.1471-4159.2002.00860.x; Maziade M, 1997, AM J MED GENET, V74, P311, DOI 10.1002/(SICI)1096-8628(19970531)74:3<311::AID-AJMG13>3.3.CO;2-C; Mimmack ML, 2002, P NATL ACAD SCI USA, V99, P4680, DOI 10.1073/pnas.032069099; Pongrac J, 2002, NEUROCHEM RES, V27, P1049, DOI 10.1023/A:1020904821237; Snider JV, 2001, DRUG DISCOV TODAY, V6, P1062, DOI 10.1016/S1359-6446(01)01988-2; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9; Uranova N, 2001, BRAIN RES BULL, V55, P597, DOI 10.1016/S0361-9230(01)00528-7; Whitney LW, 1999, ANN NEUROL, V46, P425; Wood JN, 2000, J PAIN, V1, P19, DOI 10.1054/jpai.2000.9807a; Wurmbach E, 2001, J BIOL CHEM, V276, P47195, DOI 10.1074/jbc.M108716200; Yool DA, 2000, HUM MOL GENET, V9, P987, DOI 10.1093/hmg/9.6.987; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	36	721	750	1	36	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 6	2003	362	9386					798	805		10.1016/S0140-6736(03)14289-4	http://dx.doi.org/10.1016/S0140-6736(03)14289-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	719DN	13678875				2022-12-01	WOS:000185188500014
J	Chen, W; ten Berge, D; Brown, J; Ahn, S; Hu, LA; Miller, WE; Caron, MG; Barak, LS; Nusse, R; Lefkowitz, RJ				Chen, W; ten Berge, D; Brown, J; Ahn, S; Hu, LA; Miller, WE; Caron, MG; Barak, LS; Nusse, R; Lefkowitz, RJ			Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4	SCIENCE			English	Article							COUPLED RECEPTOR KINASES; BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; PROTEINS; ACTIVATION; SIGNALS; ADAPTER	Wnt proteins, regulators of development in many organisms, bind to seven transmembrane-spanning (7TMS) receptors called frizzleds, thereby recruiting the cytoplasmic molecule dishevelled (Dvl) to the plasma membrane. Frizzled-mediated endocytosis of Wg (a Drosophila Wnt protein) and lysosomal degradation may regulate the formation of morphogen gradients. Endocytosis of Frizzled 4 (Fz4) in human embryonic kidney 293 cells was dependent on added Wnt5A protein and was accomplished by the multifunctional adaptor protein beta-arrestin 2 (betaarr2), which was recruited to Fz4 by binding to phosphorylated Dvl2. These findings provide a previously unrecognized mechanism for receptor recruitment of beta-arrestin and demonstrate that Dvl plays an important role in the endocytosis of frizzled, as well as in promoting signaling.	Stanford Univ, Sch Med, Beckman Ctr, Dept Dev Biol,Howard Hughes Med Inst, Stanford, CA 94305 USA; Duke Univ, Med Ctr, Dept Med, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Howard Hughes Med Inst, Durham, NC 27710 USA	Howard Hughes Medical Institute; Stanford University; Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute	Nusse, R (corresponding author), Stanford Univ, Sch Med, Beckman Ctr, Dept Dev Biol,Howard Hughes Med Inst, Stanford, CA 94305 USA.		Lefkowitz, Robert/AAW-2649-2021; Berge, Derk ten/C-1967-2012; Berge, Derk ten/ABF-2591-2020	Berge, Derk ten/0000-0002-5863-0860; Chen, Wei/0000-0002-9934-4000	NHLBI NIH HHS [HL 61365, HL 16037] Funding Source: Medline; NINDS NIH HHS [NS 19576] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061365, R01HL016037, R37HL016037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Chen W, 2001, P NATL ACAD SCI USA, V98, P14889, DOI 10.1073/pnas.211572798; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Lee JS, 1999, J BIOL CHEM, V274, P21464, DOI 10.1074/jbc.274.30.21464; Luttrell LM, 2002, J CELL SCI, V115, P455; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59	22	259	270	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 5	2003	301	5638					1391	1394		10.1126/science.1082808	http://dx.doi.org/10.1126/science.1082808			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717XQ	12958364				2022-12-01	WOS:000185116400045
J	Bloss, TA; Witze, ES; Rothman, JH				Bloss, TA; Witze, ES; Rothman, JH			Suppression of CED-3-independent apoptosis by mitochondrial beta NAC in Caenorhabditis elegans	NATURE			English	Article							PROGRAMMED CELL-DEATH; C-ELEGANS; IDENTIFICATION	To ensure cell survival, it is essential that the ubiquitous proapoptotic machinery is kept quiescent. As death is irreversible, cells must continually integrate developmental information with regulatory inputs to control the switch between repressing and activating apoptosis. Inappropriate activation or suppression of apoptosis can lead to degenerative pathologies(1) or tumorigenesis(2), respectively. Here we report that Caenorhabditis elegans inhibitor of cell death-1 (ICD-1) is necessary and sufficient to prevent apoptosis. Loss of ICD-1 leads to inappropriate apoptosis in developing and differentiated cells in various tissues. Although this apoptosis requires CED-4, it occurs independently of CED-3-the caspase essential for developmental apoptosis(3) showing that these core pro-apoptotic proteins have separable roles. Overexpressing ICD-1 inhibits the apoptosis of cells that are normally programmed to die. ICD-1 is the beta-subunit of the nascent polypeptide-associated complex (bNAC) and contains a putative caspase-cleavage site and caspase recruitment domain. It localizes primarily to mitochondria, underscoring the role of mitochondria in coordinating apoptosis(4). Human bNAC is a caspase substrate that is rapidly eliminated in dying cells(5,6), suggesting that ICD-1 apoptosis-suppressing activity may be inactivated by caspases.	Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Rothman, JH (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.							Brockstedt E, 1999, J PROTEIN CHEM, V18, P225, DOI 10.1023/A:1020636308270; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; HALL D, 1995, CAENORHABDITIS ELEGA, P396; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Hersh BM, 2002, P NATL ACAD SCI USA, V99, P4355, DOI 10.1073/pnas.062065399; Hodgkin J, 1997, C ELEGANS, P881; Kamath C, 2001, MASSIVE COMP, V2, P1; Ledwich D, 2000, METHOD ENZYMOL, V322, P76; LEWIS JA, 1995, CAENORHABDITIS ELEGA, P4; Liu QA, 1999, ANN NY ACAD SCI, V887, P92, DOI 10.1111/j.1749-6632.1999.tb07925.x; Loo DT, 1998, METHOD CELL BIOL, V57, P251; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; MILLER DM, 1995, CAENORHABDITIS ELEGA, P365; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Ravagnan L, 2002, J CELL PHYSIOL, V192, P131, DOI 10.1002/jcp.10111; Rospert S, 2002, CELL MOL LIFE SCI, V59, P1632, DOI 10.1007/PL00012490; Sambrook J., 1989, MOL CLONING LAB MANU; Seshagiri S, 1998, FEBS LETT, V428, P71, DOI 10.1016/S0014-5793(98)00493-1; Shaham S, 1998, J BIOL CHEM, V273, P35109, DOI 10.1074/jbc.273.52.35109; SUGIMOTO A, 1994, EMBO J, V13, P2023, DOI 10.1002/j.1460-2075.1994.tb06475.x; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; Takahashi M, 1998, P NATL ACAD SCI USA, V95, P11566, DOI 10.1073/pnas.95.20.11566; Thiede B, 2001, J BIOL CHEM, V276, P26044, DOI 10.1074/jbc.M101062200; Vaughn DE, 1999, J MOL BIOL, V293, P439, DOI 10.1006/jmbi.1999.3177; WILLIAMS GT, 1991, CELL, V65, P1097, DOI 10.1016/0092-8674(91)90002-G; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	29	86	105	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2003	424	6952					1066	1071		10.1038/nature01920	http://dx.doi.org/10.1038/nature01920			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715QR	12944970				2022-12-01	WOS:000184984200046
J	Bourlat, SJ; Nielsen, C; Lockyer, AE; Littlewood, DTJ; Telford, MJ				Bourlat, SJ; Nielsen, C; Lockyer, AE; Littlewood, DTJ; Telford, MJ			Xenoturbella is a deuterostome that eats molluscs	NATURE			English	Article							PHYLUM UNCERTAIN; BOCKI; PLATYHELMINTHES; FLATWORMS; SEQUENCE; SUPPORT	Xenoturbella bocki, first described in 1949 (ref. 1), is a delicate, ciliated, marine worm with a simple body plan: it lacks a through gut, organized gonads, excretory structures and coelomic cavities. Its nervous system is a diffuse nerve net with no brain. Xenoturbella's affinities have long been obscure and it was initially linked to turbellarian flatworms(1). Subsequent authors considered it variously as related to hemichordates and echinoderms owing to similarities of nerve net and epidermal ultrastructure (2,3), to acoelomorph flatworms based on body plan and ciliary ultrastructure(4-6) (also shared by hemichordates(7)), or as among the most primitive of Bilateria(8). In 1997 two papers seemed to solve this uncertainty: molecular phylogenetic analyses(9) placed Xenoturbella within the bivalve molluscs, and eggs and larvae resembling those of bivalves were found within specimens of Xenoturbella(10,11). This molluscan origin implies that all bivalve characters are lost during a radical metamorphosis into the adult Xenoturbella. Here, using data from three genes, we show that the samples in these studies were contaminated by bivalve embryos eaten by Xenoturbella and that Xenoturbella is in fact a deuterostome related to hemichordates and echinoderms.	Univ Cambridge, Dept Zool, Museum Zool, Cambridge CB2 3EJ, England; Univ Copenhagen, Zool Museum, DK-2100 Copenhagen, Denmark; Nat Hist Museum, Dept Zool, London SW7 5BD, England	University of Cambridge; University of Copenhagen; Natural History Museum London	Telford, MJ (corresponding author), Univ Cambridge, Dept Zool, Museum Zool, Downing St, Cambridge CB2 3EJ, England.		Bourlat, Sarah/AAR-2251-2020; Littlewood, Tim/B-5230-2008; Bourlat, Sarah/A-5232-2009; Nielsen, Claus/A-4794-2013; Telford, Maximilian J/B-7178-2008; Lockyer, Anne/AAO-4327-2021	Littlewood, Tim/0000-0002-2718-4001; Bourlat, Sarah/0000-0003-0218-0298; Telford, Maximilian J/0000-0002-3749-5620; Lockyer, Anne/0000-0002-3498-2423; Nielsen, Claus/0000-0001-6898-7655				Castresana J, 1998, P NATL ACAD SCI USA, V95, P3703, DOI 10.1073/pnas.95.7.3703; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Ehlers U, 1997, ZOOMORPHOLOGY, V117, P71; FRANZEN A, 1987, ZOOL SCR, V16, P9, DOI 10.1111/j.1463-6409.1987.tb00046.x; Gee H., 1996, BACKBONE VIEWS ORIGI; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Israelsson O, 1999, P ROY SOC B-BIOL SCI, V266, P835, DOI 10.1098/rspb.1999.0713; Israelsson O, 1997, NATURE, V390, P32, DOI 10.1038/36246; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lundin K, 1998, ZOOL SCR, V27, P263, DOI 10.1111/j.1463-6409.1998.tb00440.x; Lundin K, 2001, BELG J ZOOL, V131, P153; Maddison D.R., 2000, MACCLADE 4 ANAL PHYL; Noren M, 1997, NATURE, V390, P31, DOI 10.1038/36242; PARDOS F, 1988, ACTA ZOOL-STOCKHOLM, V69, P1, DOI 10.1111/j.1463-6395.1988.tb00895.x; PEDERSEN KJ, 1986, ACTA ZOOL-STOCKHOLM, V67, P103, DOI 10.1111/j.1463-6395.1986.tb00854.x; REISINGER ERICH, 1960, ZEITSCHR WISS ZOOL, V164, P188; Swofford DL, 1998, PHYLOGENETIC ANAL US; Telford MJ, 2003, P ROY SOC B-BIOL SCI, V270, P1077, DOI 10.1098/rspb.2003.2342; Telford MJ, 2000, P NATL ACAD SCI USA, V97, P11359, DOI 10.1073/pnas.97.21.11359; Westblad E., 1949, ARK ZOOL, V1, P3	21	128	131	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 21	2003	424	6951					925	928		10.1038/nature01851	http://dx.doi.org/10.1038/nature01851			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713EH	12931184				2022-12-01	WOS:000184843600037
J	Sugiura, R; Kita, A; Shimizu, Y; Shuntoh, H; Sio, SO; Kuno, T				Sugiura, R; Kita, A; Shimizu, Y; Shuntoh, H; Sio, SO; Kuno, T			Feedback regulation of MAPK signalling by an RNA-binding protein	NATURE			English	Article							FISSION YEAST; KH-DOMAIN; IN-VIVO; KINASE; PHOSPHATASE; PATHWAYS; ENCODES; STRESS; POMBE	Mitogen-activated protein kinases (MAPKs) are evolutionarily conserved enzymes that convert extracellular signals into various outputs such as cell growth, differentiation and cell death(1-4). MAPK phosphatases selectively inactivate MAPKs by dephosphorylating critical phosphothreonine and phosphotyrosine residues(5,6). The transcriptional induction of MAPK phosphatase expression by various stimuli, including MAPK activation, has been well documented as a negative-feedback mechanism of MAPK signalling(7,8). Here we show that Rnc1, a novel K-homology-type RNA-binding protein in fission yeast, binds and stabilizes Pmp1 messenger RNA(9), the MAPK phosphatase for Pmk1 (refs 10, 11). Rnc1 therefore acts as a negative regulator of Pmk1 signalling. Notably, Pmk1 phosphorylates Rnc1, causing enhancement of the RNA-binding activity of Rnc1. Thus, Rnc1 is a component of a new negative-feedback loop that regulates the Pmk1 pathway through its binding to Pmp1 mRNA. Our findings-the post-transcriptional mRNA stabilization of a MAPK phosphatase mediated by an RNA-binding protein-provide an additional regulatory mechanism for fine-tuning of MAPK signalling pathways.	Kobe Univ, Grad Sch Med, Dept Genome Sci, Div Mol Pharmacol & Pharmacogenom, Kobe, Hyogo 6500017, Japan; Kobe Univ, Sch Med, Fac Hlth Sci, Suma Ku, Kobe, Hyogo 6540142, Japan	Kobe University; Kobe University	Sugiura, R (corresponding author), Kobe Univ, Grad Sch Med, Dept Genome Sci, Div Mol Pharmacol & Pharmacogenom, Kobe, Hyogo 6500017, Japan.							Buckanovich RJ, 1997, MOL CELL BIOL, V17, P3194, DOI 10.1128/MCB.17.6.3194; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; KOHRER K, 1988, NUCLEIC ACIDS RES, V6, P9457; LEVIN DE, 1995, CURR OPIN CELL BIOL, V7, P197, DOI 10.1016/0955-0674(95)80028-X; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Loewith R, 2000, J CELL SCI, V113, P153; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; RODRIGUEZ PL, 1994, BIOTECHNIQUES, V17, P702; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Sugiura R, 1999, NATURE, V399, P479, DOI 10.1038/20951; Sugiura R, 1998, EMBO J, V17, P140, DOI 10.1093/emboj/17.1.140; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Toda T, 1996, MOL CELL BIOL, V16, P6752; YOSHIDA T, 1994, J CELL SCI, V107, P1725; ZaitsevskayaCarter T, 1997, EMBO J, V16, P1318, DOI 10.1093/emboj/16.6.1318	24	57	61	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 21	2003	424	6951					961	965		10.1038/nature01907	http://dx.doi.org/10.1038/nature01907			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713EH	12931193				2022-12-01	WOS:000184843600046
J	KewalRamani, VN; Coffin, JM				KewalRamani, VN; Coffin, JM			Weapons of mutational destruction	SCIENCE			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; VIRAL VIF PROTEIN; REVERSE TRANSCRIPTION; G->A HYPERMUTATION; HIV-1 VIRIONS; TYPE-1 VIF; SOR GENE; DNA; REPLICATION; INFECTION		NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA; Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tufts University	KewalRamani, VN (corresponding author), NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA.		KewalRamani, Vineet/V-5084-2019		NATIONAL CANCER INSTITUTE [ZIABC010487, Z01BC010487] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Emerman M, 1998, SCIENCE, V280, P1880, DOI 10.1126/science.280.5371.1880; FISHER AG, 1987, SCIENCE, V237, P888, DOI 10.1126/science.3497453; Fouchier RAM, 1996, J VIROL, V70, P8263, DOI 10.1128/JVI.70.12.8263-8269.1996; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Gaddis NC, 2003, J VIROL, V77, P5810, DOI 10.1128/JVI.77.10.5810-5820.2003; GAO F, 1992, NATURE, V358, P495, DOI 10.1038/358495a0; Goncalves J, 1996, J VIROL, V70, P8701, DOI 10.1128/JVI.70.12.8701-8709.1996; Gunther S, 1997, VIROLOGY, V235, P104, DOI 10.1006/viro.1997.8676; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Klarmann GJ, 2003, J BIOL CHEM, V278, P7902, DOI 10.1074/jbc.M207223200; Korth MJ, 2000, CURR TOP MICROBIOL, V242, P197; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; LI YX, 1991, J VIROL, V65, P3973, DOI 10.1128/JVI.65.8.3973-3985.1991; Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Ochsenbauer C, 1997, J GEN VIROL, V78, P627, DOI 10.1099/0022-1317-78-3-627; PATHAK VK, 1990, P NATL ACAD SCI USA, V87, P6019, DOI 10.1073/pnas.87.16.6019; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; SIMON JHM, 1995, J VIROL, V69, P4166, DOI 10.1128/JVI.69.7.4166-4172.1995; Simon JHM, 1996, J VIROL, V70, P5297, DOI 10.1128/JVI.70.8.5297-5305.1996; Simon JHM, 1998, EMBO J, V17, P1259, DOI 10.1093/emboj/17.5.1259; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; VARTANIAN JP, 1991, J VIROL, V65, P1779, DOI 10.1128/JVI.65.4.1779-1788.1991; Vartanian JP, 2002, J GEN VIROL, V83, P801, DOI 10.1099/0022-1317-83-4-801; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; WAINHOBSON S, 1995, VIROLOGY, V209, P297, DOI 10.1006/viro.1995.1261; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	29	29	31	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2003	301	5635					923	925		10.1126/science.1088965	http://dx.doi.org/10.1126/science.1088965			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711RY	12920286	Green Published			2022-12-01	WOS:000184755900023
J	Bala, ADS; Spitzer, MW; Takahashi, TT				Bala, ADS; Spitzer, MW; Takahashi, TT			Prediction of auditory spatial acuity from neural images on the owl's auditory space map	NATURE			English	Article							INTERAURAL TIME DIFFERENCE; SOUND-LOCALIZATION; SINGLE NEURONS; BARN OWL; PSYCHOPHYSICAL PERFORMANCE; PERCEPTUAL DECISION; RECEPTIVE-FIELDS; MACAQUE MONKEY; VISUAL-MOTION; DISCRIMINATION	The owl can discriminate changes in the location of sound sources as small as 3degrees and can aim its head to within 2degrees of a source(1,2). Atypical neuron in its midbrain space map has a spatial receptive field that spans 40degrees- a width that is many times the behavioural threshold(3). Here we have quantitatively examined the relationship between neuronal activity and perceptual acuity in the auditory space map in the barn owl midbrain. By analysing changes in firing rate resulting from small changes of stimulus azimuth, we show that most neurons can reliably signal changes in source location that are smaller than the behavioural threshold. Each source is represented in the space map by a focus of activity in a population of neurons. Displacement of the source causes the pattern of activity in this population to change. We show that this change predicts the owl's ability to detect a change in source location.	Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Bala, ADS (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.		Bala, Avinash/B-7923-2013	Bala, Avinash/0000-0002-8531-5110				AHISSAR M, 1992, J NEUROPHYSIOL, V67, P203, DOI 10.1152/jn.1992.67.1.203; [Anonymous], 1998, NEURAL NETWORKS BRAI; Bala ADS, 2000, J COMP PHYSIOL A, V186, P425, DOI 10.1007/s003590050442; BALDI P, 1988, BIOL CYBERN, V59, P313, DOI 10.1007/BF00332921; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Bell CC, 2001, CURR OPIN NEUROBIOL, V11, P481, DOI 10.1016/S0959-4388(00)00238-5; Britten KH, 1999, J NEUROSCI, V19, P5074; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; COLBURN HS, 1973, J ACOUST SOC AM, V54, P1458, DOI 10.1121/1.1914445; Eurich CW, 1997, BIOL CYBERN, V76, P357, DOI 10.1007/s004220050349; FAREL PB, 1976, J NEUROPHYSIOL, V39, P661, DOI 10.1152/jn.1976.39.4.661; Fitzpatrick DC, 1997, NATURE, V388, P871, DOI 10.1038/42246; FUJITA I, 1991, J NEUROSCI, V11, P722; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; HALL JL, 1965, J ACOUST SOC AM, V37, P813; Kandel E R, 1976, Cold Spring Harb Symp Quant Biol, V40, P465; Keller CH, 1998, HEARING RES, V118, P13, DOI 10.1016/S0378-5955(98)00014-8; KNUDSEN EI, 1977, SCIENCE, V198, P1278, DOI 10.1126/science.929202; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P13, DOI 10.1007/BF00663106; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; O'Reilly RC, 2002, TRENDS COGN SCI, V6, P505, DOI 10.1016/S1364-6613(02)02005-3; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2723, DOI 10.1152/jn.2000.83.5.2723; ROLLS ET, 1989, EUR J NEUROSCI, V1, P53, DOI 10.1111/j.1460-9568.1989.tb00774.x; SAKITT B, 1973, NATURE, V241, P133, DOI 10.1038/241133a0; Shackleton TM, 2003, J NEUROSCI, V23, P716, DOI 10.1523/JNEUROSCI.23-02-00716.2003; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Siebert WM., 1968, RECOGNIZING PATTERNS, V104, P602; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	30	76	76	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 14	2003	424	6950					771	774		10.1038/nature01835	http://dx.doi.org/10.1038/nature01835			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12917684				2022-12-01	WOS:000184733900039
J	Xu, XZS; Sternberg, PW				Xu, XZS; Sternberg, PW			A C-elegans sperm TRP protein required for sperm-egg interactions during fertilization	CELL			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; CA2+ ENTRY; CALCIUM-ENTRY; MOUSE SPERM; CHANNELS; GENE; FUSION; MICE; EXPRESSION; DIFFERENTIATION	Fertilization, a critical step in animal reproduction, is triggered by a series of specialized sperm-egg interactions. However, the molecular mechanisms underlying fertilization are not well understood. Here, we identify a sperm-enriched C. elegans TRPC homolog, TRP-3. Mutations in trp-3 lead to sterility in both hermaphrodites and males due to a defect in their sperm. trp-3 mutant sperm are motile, but fail to fertilize oocytes after gamete contact. TRP-3 is initially localized in intracellular vesicles, and then translocates to the plasma membrane during sperm activation. This translocation coincides with a marked increase in store-operated calcium entry, providing an in vivo mechanism for the regulation of TRP-3 activity. As C. elegans oocytes lack egg coats, our data suggest that some TRPC family channels might function to mediate calcium influx during sperm-egg plasma membrane interactions leading to fertilization.	CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Sternberg, PW (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.			Sternberg, Paul/0000-0002-7699-0173				Achanzar WE, 1997, J CELL SCI, V110, P1073; Bahner M, 2002, NEURON, V34, P83, DOI 10.1016/S0896-6273(02)00630-X; Bernheim L, 2002, NEWS PHYSIOL SCI, V17, P22; Browning H, 1996, DEVELOPMENT, V122, P391; Castellano LE, 2003, FEBS LETT, V541, P69, DOI 10.1016/S0014-5793(03)00305-3; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Kelly WG, 1998, DEVELOPMENT, V125, P2451; L'Hernault SW, 1997, C ELEGANS, P271; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; LHERNAULT SW, 1988, GENETICS, V120, P435; Machaca K, 1996, DEV BIOL, V176, P1, DOI 10.1006/dbio.1996.9999; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; O'Toole CMB, 2000, MOL BIOL CELL, V11, P1571, DOI 10.1091/mbc.11.5.1571; OKAMOTO H, 1985, J NEUROSCI, V5, P643; Park JY, 2002, BIOCHEM BIOPH RES CO, V290, P1176, DOI 10.1006/bbrc.2001.6323; Primakoff P, 2002, SCIENCE, V296, P2183, DOI 10.1126/science.1072029; Putney JW, 2001, J CELL SCI, V114, P2223; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; SHAINBERG A, 1969, EXP CELL RES, V58, P163, DOI 10.1016/0014-4827(69)90127-X; Singson A, 1998, CELL, V93, P71, DOI 10.1016/S0092-8674(00)81147-2; Singson A, 2001, DEV BIOL, V230, P101, DOI 10.1006/dbio.2000.0118; Singson A, 1999, GENETICS, V152, P201; SPENCE AM, 1990, CELL, V60, P981, DOI 10.1016/0092-8674(90)90346-G; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; TETI A, 1993, AM J PHYSIOL, V265, pC113, DOI 10.1152/ajpcell.1993.265.1.C113; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; Yanagimachi R., 1994, P189; YANAGIMACHI R, 1978, BIOL REPROD, V19, P949, DOI 10.1095/biolreprod19.5.949; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	41	94	106	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 8	2003	114	3					285	297		10.1016/S0092-8674(03)00565-8	http://dx.doi.org/10.1016/S0092-8674(03)00565-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914694	Bronze			2022-12-01	WOS:000184679200006
J	Choe, H; Li, WH; Wright, PL; Vasilieva, N; Venturi, M; Huang, CC; Grundner, C; Dorfman, T; Zwick, MB; Wang, LP; Rosenberg, ES; Kwong, PD; Burton, DR; Robinson, JE; Sodroski, JG; Farzan, M				Choe, H; Li, WH; Wright, PL; Vasilieva, N; Venturi, M; Huang, CC; Grundner, C; Dorfman, T; Zwick, MB; Wang, LP; Rosenberg, ES; Kwong, PD; Burton, DR; Robinson, JE; Sodroski, JG; Farzan, M			Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120	CELL			English	Article							HUMAN MONOCLONAL-ANTIBODY; AMINO-TERMINAL DOMAIN; ENVELOPE GLYCOPROTEIN; CHEMOKINE RECEPTORS; CORECEPTOR USAGE; DISTINCT CCR5; N-TERMINUS; ENTRY; NEUTRALIZATION; MACROPHAGE	Sulfated tyrosines at the amino terminus of the principal HIV-1 coreceptor CCR5 play a critical role in its ability to bind the HIV-1 envelope glycoprotein gp120 and mediate HIV-1 infection. Here, we show that a number of human antibodies directed against gp120 are tyrosine sulfated at their antigen binding sites. Like that of CCR5, antibody association with gp120 is dependent on sulfate moieties, enhanced by CD4, and inhibited by sulfated CCR5-derived peptides. Most of these antibodies preferentially associate with gp120 molecules of CCR5-utilizing (R5) isolates and neutralize primary R5 isolates more efficiently than laboratory-adapted isolates. These studies identify a distinct subset of CD4-induced HIV-1 neutralizing antibodies that closely emulate CCR5 and demonstrate that tyrosine sulfation can contribute to the potency and diversity of the human humoral response.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med Microbiol & Mol Genet,Div AIDS, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat, Boston, MA 02115 USA; NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol,Div AIDS, Boston, MA 02115 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA; Tulane Univ, Med Ctr, Dept Pediat, New Orleans, LA 70012 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Scripps Research Institute; Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Tulane University; Harvard University; Harvard T.H. Chan School of Public Health	Farzan, M (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med Microbiol & Mol Genet,Div AIDS, Boston, MA 02115 USA.	farzan@mbcrr.harvard.edu		Farzan, Michael/0000-0002-2990-5319; Li, Wenhui/0000-0003-1305-7404	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043891, Z01AI005022] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI043891] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; ALZARI PM, 1988, ANNU REV IMMUNOL, V6, P555; Atchison RE, 1996, SCIENCE, V274, P1924, DOI 10.1126/science.274.5294.1924; Beisswanger R, 1998, P NATL ACAD SCI USA, V95, P11134, DOI 10.1073/pnas.95.19.11134; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Blanpain C, 1999, J BIOL CHEM, V274, P34719, DOI 10.1074/jbc.274.49.34719; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Cormier EG, 2000, P NATL ACAD SCI USA, V97, P5762, DOI 10.1073/pnas.97.11.5762; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Doranz BJ, 1997, J VIROL, V71, P6305, DOI 10.1128/JVI.71.9.6305-6314.1997; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; EARL PL, 1990, P NATL ACAD SCI USA, V87, P648, DOI 10.1073/pnas.87.2.648; Farzan M, 2000, J BIOL CHEM, V275, P33516, DOI 10.1074/jbc.M007228200; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Farzan M, 2002, J BIOL CHEM, V277, P29484, DOI 10.1074/jbc.M203361200; Farzan M, 2002, J BIOL CHEM, V277, P40397, DOI 10.1074/jbc.M206784200; Farzan M, 1997, J BIOL CHEM, V272, P6854, DOI 10.1074/jbc.272.11.6854; Farzan M, 2001, J EXP MED, V193, P1059, DOI 10.1084/jem.193.9.1059; Farzan M, 1998, J VIROL, V72, P1160, DOI 10.1128/JVI.72.2.1160-1164.1998; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lefranc M. P., 2001, IMMUNOGLOBULIN FACTS; Lu ZH, 1997, P NATL ACAD SCI USA, V94, P6426, DOI 10.1073/pnas.94.12.6426; Montefiori DC, 2001, J VIROL, V75, P10200, DOI 10.1128/JVI.75.21.10200-10207.2001; Moulard M, 2002, P NATL ACAD SCI USA, V99, P6913, DOI 10.1073/pnas.102562599; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ouyang YB, 1998, P NATL ACAD SCI USA, V95, P2896, DOI 10.1073/pnas.95.6.2896; Parren PWHI, 1998, J VIROL, V72, P10270, DOI 10.1128/JVI.72.12.10270-10274.1998; Picard L, 1997, VIROLOGY, V231, P105, DOI 10.1006/viro.1997.8506; Poignard P, 2001, ANNU REV IMMUNOL, V19, P253, DOI 10.1146/annurev.immunol.19.1.253; POSNER MR, 1993, J ACQ IMMUN DEF SYND, V6, P7; POSNER MR, 1991, J IMMUNOL, V146, P4325; POUYANI T, 1995, CELL, V83, P333, DOI 10.1016/0092-8674(95)90174-4; Preobrazhensky AA, 2000, J IMMUNOL, V165, P5295, DOI 10.4049/jimmunol.165.9.5295; Rabut GEE, 1998, J VIROL, V72, P3464, DOI 10.1128/JVI.72.4.3464-3468.1998; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; ROSENQUIST GL, 1993, PROTEIN SCI, V2, P215; Ross TM, 1998, J VIROL, V72, P1918, DOI 10.1128/JVI.72.3.1918-1924.1998; Rucker J, 1996, CELL, V87, P437, DOI 10.1016/S0092-8674(00)81364-1; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Sullivan N, 1998, J VIROL, V72, P4694, DOI 10.1128/JVI.72.6.4694-4703.1998; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; VUJCIC LK, 1995, AIDS RES HUM RETROV, V11, P783, DOI 10.1089/aid.1995.11.783; Wojtowicz WM, 2002, J BIOL CHEM, V277, P35019, DOI 10.1074/jbc.M203518200; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Xiang SH, 2002, AIDS RES HUM RETROV, V18, P1207, DOI 10.1089/08892220260387959; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	55	160	172	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2003	114	2					161	170		10.1016/S0092-8674(03)00508-7	http://dx.doi.org/10.1016/S0092-8674(03)00508-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887918	Bronze			2022-12-01	WOS:000184378700006
J	Arnqvist, G; Jones, TM; Elgar, MA				Arnqvist, G; Jones, TM; Elgar, MA			Insect behaviour: Reversal of sex roles in nuptial feeding	NATURE			English	Article							MALES		Uppsala Univ, Evolutionary Biol Ctr, Dept Anim Ecol, S-75236 Uppsala, Sweden; Univ Melbourne, Dept Zool, Parkville, Vic 3010, Australia	Uppsala University; University of Melbourne	Arnqvist, G (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Anim Ecol, S-75236 Uppsala, Sweden.	goran.arnqvist@ebc.uu.se	Arnqvist, Göran/E-6782-2015; Jones, Theresa M/B-9124-2009	Arnqvist, Göran/0000-0002-3501-3376; Jones, Theresa M/0000-0002-5300-0018; Elgar, Mark/0000-0003-0861-6064				Andersen NM, 2001, INVERTEBR TAXON, V15, P217, DOI 10.1071/IT00015; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; GWYNNE DT, 1984, NATURE, V307, P361, DOI 10.1038/307361a0; MARKOW TA, 1984, SCIENCE, V224, P302, DOI 10.1126/science.224.4646.302; PARKER GA, 1989, ETHOLOGY, V82, P3; Polhemus Dan A., 2000, Tijdschrift voor Entomologie, V143, P91; THORNHILL R, 1976, AM NAT, V110, P153, DOI 10.1086/283055; Vahed K, 1998, BIOL REV, V73, P43, DOI 10.1017/S0006323197005112; Vollrath F, 1998, TRENDS ECOL EVOL, V13, P159, DOI 10.1016/S0169-5347(97)01283-4; WEDELL N, 1991, EVOLUTION, V45, P1975, DOI 10.1111/j.1558-5646.1991.tb02704.x	10	23	23	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					387	387		10.1038/424387a	http://dx.doi.org/10.1038/424387a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879056	Bronze			2022-12-01	WOS:000184318400029
J	Xu, K; Evans, DB; Kawabata, K; Zeramdini, R; Klavus, J; Murray, CJL				Xu, K; Evans, DB; Kawabata, K; Zeramdini, R; Klavus, J; Murray, CJL			Household catastrophic health expenditure: a multicountry analysis	LANCET			English	Article							CARE EXPENDITURES; POLICY; POOR	Background Health policy makers have long been concerned with protecting people from the possibility that ill health will lead to catastrophic financial payments and subsequent impoverishment. Yet catastrophic expenditure is not rare. We investigated the extent of catastrophic health expenditure as a first step to developing appropriate policy responses. Methods We used a cross-country analysis design. Data from household surveys in 59 countries were used to explore, by regression analysis, variables associated with catastrophic health expenditure. We defined expenditure as being catastrophic if a household's financial contributions to the health system exceed 40% of income remaining after subsistence needs have been met. Findings The proportion of households facing catastrophic payments from out-of-pocket health expenses varied widely between countries. Catastrophic spending rates were highest in some countries in transition, and in certain Latin American countries. Three key preconditions for catastrophic payments were identified: the availability of health services requiring payment, low capacity to pay, and the lack of prepayment or health insurance. Interpretation People, particularly in poor households, can be protected from catastrophic health expenditures by reducing a health system's reliance on out-of-pocket payments and providing more financial risk protection. Increase in the availability of health services is critical to improving health in poor countries, but this approach could raise the proportion of households facing catastrophic expenditure; risk protection policies would be especially important in this situation.	WHO, EIP, CH-1211 Geneva 27, Switzerland	World Health Organization	Kawabata, K (corresponding author), WHO, EIP, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.				NIA NIH HHS [P01 AG17625-01] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG017625] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANAND S, 1994, AM ECON REV, V84, P226; [Anonymous], WORLD HLTH REP 2002; ARHINTENKORANG D, MOBILIZING RESOURCES; BERKI SE, 1986, HEALTH AFFAIR, V5, P139; Bidani B, 1997, J ECONOMETRICS, V77, P125, DOI 10.1016/S0304-4076(95)01809-3; BOVBJERG RR, 2001, COVERING CATASTRO 66; Davison A.C., 1997, BOOTSTRAP METHODS TH; Deaton A., 1980, EC CONSUMER BEHAV; Filmer D, 2002, WORLD BANK RES OBSER, V17, P47, DOI 10.1093/wbro/17.1.47; Frenk J, 2002, B WORLD HEALTH ORGAN, V80, P88; Gilson L, 1997, HEALTH POLICY PLANN, V12, P273, DOI 10.1093/oxfordjournals.heapol.a018882; Health organization, 2001, WORLD HLTH REPORT 20; Kawabata K, 2002, B WORLD HEALTH ORGAN, V80, P612; Kuznets J, 1997, WHOSHSNHP955; MERLIS M, FAMILY OUT OF POCKET; MUSGROVE P, 2000, HLTH POLICY, V53, P61; NAJMAN JM, 1984, SOC SCI MED, V18, P949, DOI 10.1016/0277-9536(84)90265-X; Pannarunothai S, 1997, SOC SCI MED, V44, P1781, DOI 10.1016/S0277-9536(96)00287-0; Pradhan M, 2002, HEALTH ECON, V11, P431, DOI 10.1002/hec.689; Ranson MK, 2002, B WORLD HEALTH ORGAN, V80, P613; RICE T, 1990, HEALTH AFFAIR, V9, P75, DOI 10.1377/hlthaff.9.3.75; Russell S, 1997, INT J HEALTH SERV, V27, P359, DOI 10.2190/YHL2-F0EA-JW1M-DHEJ; Skarbinski J, 2002, JAMA-J AM MED ASSOC, V287, P1043, DOI 10.1001/jama.287.8.1043; TRAPNELL G, 1983, STRATEGIES INSURING; VISARIA P, 1980, 2 LIV STAND MEAS STU; Wagstaff A, 2002, B WORLD HEALTH ORGAN, V80, P97; World Health Organization, 2000, WORLD HLTH REP 2000; WYSZEWIANSKI L, 1986, INQUIRY-J HEALTH CAR, V23, P382; WYSZEWIANSKI L, 1986, HEALTH SERV RES, V21, P617; XU K, IN PRESS HLTH SYSTEM	30	1222	1261	13	141	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 12	2003	362	9378					111	117		10.1016/S0140-6736(03)13861-5	http://dx.doi.org/10.1016/S0140-6736(03)13861-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	699ZY	12867110				2022-12-01	WOS:000184089200009
J	Sorensen, JB; Nagy, G; Varoqueaux, F; Nehring, RB; Brose, N; Wilson, MC; Neher, E				Sorensen, JB; Nagy, G; Varoqueaux, F; Nehring, RB; Brose, N; Wilson, MC; Neher, E			Differential control of the releasable vesicle pools by SNAP-25 splice variants and SNAP-23	CELL			English	Article							SYNAPTOSOME-ASSOCIATED PROTEIN; TRANSMITTER RELEASE; CHROMAFFIN CELLS; MEMBRANE-FUSION; ISOFORMS; SYNAPTOTAGMIN; EXOCYTOSIS; EXPRESSION; BINDING; NEUROTRANSMITTER	The SNARE complex, consisting of synaptobrevin, syntaxin, and SNAP-25, is essential for calcium-triggered exocytosis in neurosecretory cells. Little is known, however, about how developmentally regulated isoforms and other cognate SNARE components regulate vesicular fusion. To address this question, we examined neuroexocytosis from chromaffin cells of Snap25 null mice rescued by the two splice variants SNAP-25a and SNAP-25b and the ubiquitously expressed homolog SNAP-23. In the absence of SNAP25, vesicle docking persisted, but primed vesicle pools were empty and fast calcium-triggered release abolished. Single vesicular fusion events showed normal characteristics, except for a shorter duration of the fusion pore. Overexpression of SNAP-25a, SNAP-25b, and SNAP-23 resulted in three distinct phenotypes; SNAP-25b induced larger primed vesicle pools than SNAP-25a, whereas SNAP-23 did not support a standing pool of primed vesicles. We conclude that three alternative SNARE components support exocytosis, but they differ in their ability to stabilize vesicles in the primed state.	Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; Max Planck Inst Expt Med, D-37075 Gottingen, Germany; Univ New Mexico, Ctr Hlth Sci, Dept Neurosci, Albuquerque, NM 87131 USA	Max Planck Society; Max Planck Society; University of New Mexico	Sorensen, JB (corresponding author), Max Planck Inst Biophys Chem, Am Fassberg 11, D-37077 Gottingen, Germany.	jsoeren@gwdg.de	Varoqueaux, Frederique/AAC-1834-2021; Neher, Erwin/A-2109-2013; Oka, Yoshitaka/C-9670-2010	Varoqueaux, Frederique/0000-0002-3614-3121; Oka, Yoshitaka/0000-0002-3482-3051; Sorensen, Jakob/0000-0001-5465-3769	NIMH NIH HHS [R01 MH048989, MH48989] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048989] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; BARK IC, 1994, GENE, V139, P291, DOI 10.1016/0378-1119(94)90773-0; BARK IC, 1995, P NATL ACAD SCI USA, V92, P1510, DOI 10.1073/pnas.92.5.1510; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chieregatti E, 2002, TRAFFIC, V3, P496, DOI 10.1034/j.1600-0854.2002.30706.x; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Colliver TL, 2000, J NEUROCHEM, V74, P1086; Deitcher DL, 1998, J NEUROSCI, V18, P2028; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gil A, 2002, J BIOL CHEM, V277, P9904, DOI 10.1074/jbc.M110182200; Gonelle-Gispert C, 1999, BIOCHEM J, V339, P159, DOI 10.1042/0264-6021:3390159; Grant NJ, 1999, J NEUROCHEM, V72, P363, DOI 10.1046/j.1471-4159.1999.0720363.x; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hepp R, 2001, NEUROREPORT, V12, P673, DOI 10.1097/00001756-200103260-00011; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Koticha DK, 1999, J BIOL CHEM, V274, P9053, DOI 10.1074/jbc.274.13.9053; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Nagy G, 2002, J NEUROSCI, V22, P9278; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; Puffer EB, 2001, BIOCHEMISTRY-US, V40, P9374, DOI 10.1021/bi010362z; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Scales SJ, 2001, SCIENCE, V294, P1015, DOI 10.1126/science.1066728; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Schulte A, 1996, ANAL CHEM, V68, P3054, DOI 10.1021/ac960210n; Shin OH, 2003, NEURON, V37, P99, DOI 10.1016/S0896-6273(02)01145-5; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sorensen JB, 2002, P NATL ACAD SCI USA, V99, P1627, DOI 10.1073/pnas.251673298; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Voets T, 2001, P NATL ACAD SCI USA, V98, P11680, DOI 10.1073/pnas.201398798; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; Vogel K, 1999, BIOCHEM BIOPH RES CO, V258, P407, DOI 10.1006/bbrc.1999.0652; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Wang GY, 1997, J CELL SCI, V110, P505; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2	41	265	275	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2003	114	1					75	86		10.1016/S0092-8674(03)00477-X	http://dx.doi.org/10.1016/S0092-8674(03)00477-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	702JC	12859899	Green Published, Bronze			2022-12-01	WOS:000184219900007
J	Kozlova, T; Thummel, CS				Kozlova, T; Thummel, CS			Essential roles for ecdysone signaling during Drosophila mid-embryonic development	SCIENCE			English	Article							GERM-BAND RETRACTION; RETINOID-X-RECEPTOR; MORPHOGENESIS; MELANOGASTER; ISOFORMS; TISSUE; METAMORPHOSIS; ULTRASPIRACLE; EMBRYOGENESIS; ECDYSTEROIDS	Although functions for the steroid hormone ecdysone during Drosophila metamorphosis have been well established, roles for the embryonic ecdysone pulse remain poorly understood. We show that the EcR-USP ecdysone receptor is first activated in the extraembryonic amnioserosa, implicating this tissue as a source of active ecdysteroids in the early embryo. Ecdysone signaling is required for germ band retraction and head involution, morphogenetic movements that shape the first instar larva. This mechanism for coordinating morphogenesis during Drosophila embryonic development parallels the role of ecdysone during metamorphosis. It also provides an intriguing parallel with the role of mammalian extraembryonic tissues as a critical source of steroid hormones during embryonic development.	Univ Utah, Sch Med, Dept Human Genet, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Kozlova, T (corresponding author), Univ S Florida, Dept Biol, 4202 E Fowler Ave, Tampa, FL 33620 USA.							Antoniewski C, 1996, MOL CELL BIOL, V16, P2977; Bender M, 1997, CELL, V91, P777, DOI 10.1016/S0092-8674(00)80466-3; BOWNES M, 1988, P NATL ACAD SCI USA, V85, P1554, DOI 10.1073/pnas.85.5.1554; Buszczak M, 1999, DEVELOPMENT, V126, P4581; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; CLIFFORD R, 1992, DEVELOPMENT, V115, P853; D'Avino PP, 2000, DEV BIOL, V220, P211, DOI 10.1006/dbio.2000.9650; Frank LH, 1996, DEVELOPMENT, V122, P1343; GAREN A, 1977, P NATL ACAD SCI USA, V74, P5099, DOI 10.1073/pnas.74.11.5099; Ghbeish N, 2001, P NATL ACAD SCI USA, V98, P3867, DOI 10.1073/pnas.061437798; Hoffmann J.A., 1985, P435; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Kozlova T, 2002, DEVELOPMENT, V129, P1739; Lamka ML, 1999, DEV BIOL, V214, P102, DOI 10.1006/dbio.1999.9409; MAROY P, 1988, J INSECT PHYSIOL, V34, P633, DOI 10.1016/0022-1910(88)90071-6; ORO AE, 1992, DEVELOPMENT, V115, P449; PERRIMON N, 1985, GENETICS, V111, P23; Riddiford LM, 2001, VITAM HORM, V60, P1; ROOTE CE, 1995, DEV BIOL, V169, P322, DOI 10.1006/dbio.1995.1147; Schock F, 2003, GENE DEV, V17, P597, DOI 10.1101/gad.1068403; Schock F, 2002, DEV BIOL, V248, P29, DOI 10.1006/dbio.2002.0698; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; VONKALM L, 1995, BIOESSAYS, V17, P693, DOI 10.1002/bies.950170806; WARD RE, IN PRESS GENETICS; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; Yip MLR, 1997, DEVELOPMENT, V124, P2129	27	123	125	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2003	301	5641					1911	1914		10.1126/science.1087419	http://dx.doi.org/10.1126/science.1087419			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725GW	12958367				2022-12-01	WOS:000185536700052
J	Garcia-Garcia, MJ; Anderson, KV				Garcia-Garcia, MJ; Anderson, KV			Essential role of glycosaminoglycans in Fgf signaling during mouse gastrulation	CELL			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; UDP-GLUCOSE DEHYDROGENASE; ENDOTHELIAL-CELL PRECURSORS; ANTERIOR PRIMITIVE ENDODERM; SURFACE PROTEOGLYCAN; TARGETED DISRUPTION; MOLECULAR-CLONING; GROWTH-FACTORS; GENE ENCODES; TOUT-VELU	In vitro studies have suggested that proteoglycans facilitate signaling by mammalian growth factors, but genetic evidence supporting this role has been lacking. Here, we characterize the ENU-induced mutation lazy mesoderm (Izme), which disrupts the single mouse gene encoding UDP-glucose dehydrogenase (Ugdh), an enzyme required for the synthesis of the glycosaminoglycan (GAG) side chains of proteoglycans. lzme mutants arrest during gastrulation with defects in migration of mesoderm and endoderm, a phenotype similar to that of mutants in the fibroblast growth factor (Fgf) pathway. Analysis of the expression of molecular markers indicates that Fgf signaling is blocked in lzme mutant embryos. In contrast, signaling by the growth factors Nodal and Wnt3, which are also essential during mouse gastrulation, appears to be normal in lzme embryos. The results demonstrate that proteoglycans are required during mouse gastrulation specifically to promote Fgf signaling.	Sloan Kettering Inst, Dev Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Anderson, KV (corresponding author), Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10021 USA.	k-anderson@ski.mskcc.org		Anderson, Kathryn/0000-0003-1657-2161	NICHD NIH HHS [HD35455] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD035455, R37HD035455] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R55HD035455] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Baeg GH, 2001, DEVELOPMENT, V128, P87; Baeg GH, 2000, CURR OPIN CELL BIOL, V12, P575, DOI 10.1016/S0955-0674(00)00134-4; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Bellosta P, 2001, MOL CELL BIOL, V21, P5946, DOI 10.1128/MCB.21.17.5946-5957.2001; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; BERNFIELD M, 1990, PHILOS T R SOC B, V327, P171, DOI 10.1098/rstb.1990.0052; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Binari RC, 1997, DEVELOPMENT, V124, P2623; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; BURDSAL CA, 1993, DEVELOPMENT, V118, P829; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chiao E, 2002, DEV BIOL, V243, P185, DOI 10.1006/dbio.2001.0554; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Costell M, 2002, CIRC RES, V91, P158, DOI 10.1161/01.RES.0000026056.81424.DA; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; DAMJANOV I, 1986, DEV BIOL, V116, P194, DOI 10.1016/0012-1606(86)90056-4; DasGupta R, 1999, DEVELOPMENT, V126, P4557; De Cat B, 2001, SEMIN CELL DEV BIOL, V12, P117, DOI 10.1006/scdb.2000.0240; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; Furukawa K, 2002, BBA-GEN SUBJECTS, V1573, P377, DOI 10.1016/S0304-4165(02)00406-3; Hacker U, 1997, DEVELOPMENT, V124, P3565; Haerry TE, 1997, DEVELOPMENT, V124, P3055; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HEMPEL J, 1994, PROTEIN SCI, V3, P1074, DOI 10.1002/pro.5560030710; HOGAN BLM, 1994, DEVELOPMENT, P53; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Li YF, 1997, MATRIX BIOL, V16, P49, DOI 10.1016/S0945-053X(97)90071-8; Lin XH, 1999, DEVELOPMENT, V126, P3715; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Luo JM, 1997, NATURE, V388, P778, DOI 10.1038/42022; MAKOVER A, 1989, DIFFERENTIATION, V40, P17, DOI 10.1111/j.1432-0436.1989.tb00809.x; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Minowada G, 1999, DEVELOPMENT, V126, P4465; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Ornitz DM, 2001, GENOME BIOL, V2; ORRURTREGER A, 1991, DEVELOPMENT, V113, P1419; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; Rousseau F, 1996, HUM MOL GENET, V5, P509, DOI 10.1093/hmg/5.4.509; Saga Y, 1999, DEVELOPMENT, V126, P3437; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; Spicer AP, 1998, J BIOL CHEM, V273, P25117, DOI 10.1074/jbc.273.39.25117; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Stickens D, 1996, NAT GENET, V14, P25, DOI 10.1038/ng0996-25; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; SUTHERLAND AE, 1991, DEVELOPMENT, V113, P339; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Thomas PQ, 1998, DEVELOPMENT, V125, P85; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Wang YL, 2000, GENOMICS, V66, P333, DOI 10.1006/geno.2000.6221; WILKINSON DG, 1988, EMBO J, V7, P691, DOI 10.1002/j.1460-2075.1988.tb02864.x; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032	69	95	96	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2003	114	6					727	737		10.1016/S0092-8674(03)00715-3	http://dx.doi.org/10.1016/S0092-8674(03)00715-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	724AL	14505572	Bronze			2022-12-01	WOS:000185464000010
J	Feinberg, EH; Hunter, CP				Feinberg, EH; Hunter, CP			Transport of dsRNA into cells by the transmembrane protein SID-1	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; C-ELEGANS; CAENORHABDITIS-ELEGANS; GENETIC INTERFERENCE; IDENTIFICATION; RECEPTOR; RDE-1	RNA interference (RNAi) spreads systemically in plants and nematodes to silence gene expression distant from the site of initiation. We previously identified a gene, sid-1, essential for systemic but not cell-autonomous RNAi in Caenorhabditis elegans. Here, we demonstrate that SID-1 is a multispan transmembrane protein that sensitizes Drosophila cells to soaking RNAi with a potency that is dependent on double-stranded RNA ( dsRNA) length. Further analyses revealed that SID-1 enables passive cellular uptake of dsRNA. These data indicate that systemic RNAi in C. elegans involves SID-1-mediated intercellular transport of dsRNA.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Hunter, CP (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069891] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM069891] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Draper BW, 1996, CELL, V87, P205, DOI 10.1016/S0092-8674(00)81339-2; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FEINBERG EH, UNPUB; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Han K, 2001, MOL CELLS, V12, P267; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Li XJ, 1996, NEURON, V17, P1015, DOI 10.1016/S0896-6273(00)80231-7; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Shibuya A, 2000, NAT IMMUNOL, V1, P441, DOI 10.1038/80886; SILHAVY TJ, 1985, MICROBIOL REV, V49, P398, DOI 10.1128/MMBR.49.4.398-418.1985; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Worby C A, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.95.pl1	21	386	420	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2003	301	5639					1545	1547		10.1126/science.1087117	http://dx.doi.org/10.1126/science.1087117			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	720HL	12970568				2022-12-01	WOS:000185255300053
J	Le Roch, KG; Zhou, YY; Blair, PL; Grainger, M; Moch, JK; Haynes, JD; De la Vega, P; Holder, AA; Batalov, S; Carucci, DJ; Winzeler, EA				Le Roch, KG; Zhou, YY; Blair, PL; Grainger, M; Moch, JK; Haynes, JD; De la Vega, P; Holder, AA; Batalov, S; Carucci, DJ; Winzeler, EA			Discovery of gene function by expression profiling of the malaria parasite life cycle	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; STABLE TRANSFECTION; ANTIGENIC VARIATION; EBL FAMILY; SEQUENCE; PROTEIN; SPOROZOITE; CHROMOSOME-2; SURFACE; KINASE	The completion of the genome sequence for Plasmodium falciparum, the species responsible for most malaria human deaths, has the potential to reveal hundreds of new drug targets and proteins involved in pathogenesis. However, only similar to35% of the genes code for proteins with an identifiable function. The absence of routine genetic tools for studying Plasmodium parasites suggests that this number is unlikely to change quickly if conventional serial methods are used to characterize encoded proteins. Here, we use a high-density oligonucleotide array to generate expression profiles of human and mosquito stages of the malaria parasite's life cycle. Genes with highly correlated levels and temporal patterns of expression were often involved in similar functions or cellular processes.	Scripps Res Inst, Dept Cell Biol ICND202, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; USN, Med Res Ctr, Malaria Program, Silver Spring, MD 20910 USA; Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; Walter Reed Army Inst Res, Dept Immunol, Silver Spring, MD 20910 USA	Scripps Research Institute; Novartis; United States Department of Defense; United States Navy; MRC National Institute for Medical Research; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Le Roch, KG (corresponding author), Scripps Res Inst, Dept Cell Biol ICND202, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Holder, Anthony A/A-7554-2013; Winzeler, Elizabeth/AAP-6752-2020	Holder, Anthony A/0000-0002-8490-6058; Winzeler, Elizabeth/0000-0002-4049-2113; Batalov, Sergey/0000-0002-0925-0554	MRC [MC_U117532067] Funding Source: UKRI; Medical Research Council [MC_U117532067] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams JH, 2001, TRENDS PARASITOL, V17, P297, DOI 10.1016/S1471-4922(01)01948-1; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Birago C, 2003, MOL BIOCHEM PARASIT, V126, P209, DOI 10.1016/S0166-6851(02)00275-X; Blair PL, 2002, MOL BIOCHEM PARASIT, V122, P35, DOI 10.1016/S0166-6851(02)00067-1; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; Breman JG, 2001, AM J TROP MED HYG, V64, pIV, DOI 10.4269/ajtmh.2001.64.iv; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289; Doerig CM, 1996, GENE, V177, P1, DOI 10.1016/0378-1119(96)00281-8; Dorin D, 1999, J BIOL CHEM, V274, P29912, DOI 10.1074/jbc.274.42.29912; Dorin D, 2001, EUR J BIOCHEM, V268, P2600, DOI 10.1046/j.1432-1327.2001.02151.x; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Fidock DA, 1997, EUR J IMMUNOL, V27, P2502, DOI 10.1002/eji.1830271007; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; Gatton ML, 2003, TRENDS PARASITOL, V19, P202, DOI 10.1016/S1471-4922(03)00067-9; Ghai M, 2002, MOL BIOCHEM PARASIT, V123, P35, DOI 10.1016/S0166-6851(02)00123-8; Hall N, 2002, NATURE, V419, P527, DOI 10.1038/nature01095; Haynes J David, 2002, Methods Mol Med, V72, P489, DOI 10.1385/1-59259-271-6:489; Hyman RW, 2002, NATURE, V419, P534, DOI 10.1038/nature01102; Kappe SHI, 2001, P NATL ACAD SCI USA, V98, P9895, DOI 10.1073/pnas.171185198; Kaviratne M, 2002, EUKARYOT CELL, V1, P926, DOI 10.1128/EC.1.6.926-935.2002; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Le Roch KG, 2002, AM J TROP MED HYG, V67, P233, DOI 10.4269/ajtmh.2002.67.233; LEROCH KG, UNPUB; Ling, UNPUB; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Matuschewski K, 2002, J BIOL CHEM, V277, P41948, DOI 10.1074/jbc.M207315200; Rathod PK, 2002, TRENDS PARASITOL, V18, P39, DOI 10.1016/S1471-4922(01)02153-5; SHERMAN IW, 1979, MICROBIOL REV, V43, P453, DOI 10.1128/MMBR.43.4.453-495.1979; Spielmann T, 2003, MOL BIOL CELL, V14, P1529, DOI 10.1091/mbc.E02-04-0240; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tachibana M, 2001, MOL BIOCHEM PARASIT, V113, P341, DOI 10.1016/S0166-6851(01)00231-6; Trenholme KR, 2000, P NATL ACAD SCI USA, V97, P4029, DOI 10.1073/pnas.040561197; VANDIJK MR, 1995, SCIENCE, V268, P1358, DOI 10.1126/science.7761856; Winter G, 2003, MOL BIOCHEM PARASIT, V127, P179, DOI 10.1016/S0166-6851(03)00004-5; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973; Zhou YY, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-3	44	963	980	1	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2003	301	5639					1503	1508		10.1126/science.1087025	http://dx.doi.org/10.1126/science.1087025			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	720HL	12893887				2022-12-01	WOS:000185255300040
J	Chen, W; Kirkbride, KC; How, T; Nelson, CD; Mo, JY; Frederick, JP; Wang, XF; Lefkowitz, RJ; Blobe, GC				Chen, W; Kirkbride, KC; How, T; Nelson, CD; Mo, JY; Frederick, JP; Wang, XF; Lefkowitz, RJ; Blobe, GC			beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling	SCIENCE			English	Article							GROWTH-FACTOR-BETA; PROTEIN-COUPLED RECEPTORS; INTERNALIZATION; ARRESTIN; EXPRESSION; MODULATION; TRANSDUCTION; MECHANISM; DISTINCT; KINASES	beta-Arrestins bind to activated seven transmembrane-spanning (7TMS) receptors (G protein-coupled receptors) after the receptors are phosphorylated by G protein-coupled receptor kinases (GRKs), thereby regulating their signaling and internalization. Here, we demonstrate an unexpected and analogous role of beta-arrestin 2 (betaarr2) for the single transmembrane-spanning type III transforming growth factor-beta (TGF-beta) receptor (TbetaRIII, also referred to as betaglycan). Binding of betaarr2 to TbetaRIII was also triggered by phosphorylation of the receptor on its cytoplasmic domain (likely at threonine 841). However, such phosphorylation was mediated by the type II TGF-beta receptor (TbetaRII), which is itself a kinase, rather than by a GRK. Association with betaarr2 led to internalization of both receptors and down-regulation of TGF-beta signaling. Thus, the regulatory actions of beta-arrestins are broader than previously appreciated, extending to the TGF-beta receptor family as well.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med & Pharmacol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med, Durham, NC 27710 USA.		Lefkowitz, Robert/AAW-2649-2021; Blobe, Gerard/AAJ-5945-2020	Blobe, Gerard/0000-0002-4274-8901; Chen, Wei/0000-0002-9934-4000	NATIONAL CANCER INSTITUTE [R01CA075368, K22CA091816] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R37HL016037] Funding Source: NIH RePORTER; NCI NIH HHS [CA 91816, CA 75368] Funding Source: Medline; NHLBI NIH HHS [HL 16037] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARRICK BA, 1992, J CELL BIOL, V118, P715, DOI 10.1083/jcb.118.3.715; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Blobe GC, 2001, J BIOL CHEM, V276, P24627, DOI 10.1074/jbc.M100188200; Blobe GC, 2001, J BIOL CHEM, V276, P39608, DOI 10.1074/jbc.M106831200; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Chen W., UNPUB; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Deng XB, 1999, CELL GROWTH DIFFER, V10, P11; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Ehrlich M, 2001, J CELL SCI, V114, P1777; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Lu ZX, 2002, J BIOL CHEM, V277, P29363, DOI 10.1074/jbc.M203495200; Luttrell LM, 2002, J CELL SCI, V115, P455; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; SIPES NJ, 1990, MOL CARCINOGEN, V3, P12, DOI 10.1002/mc.2940030106; Wang XJ, 1997, P NATL ACAD SCI USA, V94, P2386, DOI 10.1073/pnas.94.6.2386; Yao DY, 2002, MOL BIOL CELL, V13, P4001, DOI 10.1091/mbc.02-07-0104; Zwaagstra JC, 1999, EXP CELL RES, V252, P352, DOI 10.1006/excr.1999.4640; Zwaagstra JC, 2001, J BIOL CHEM, V276, P27237, DOI 10.1074/jbc.M100033200	25	215	233	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 5	2003	301	5638					1394	1397		10.1126/science.1083195	http://dx.doi.org/10.1126/science.1083195			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717XQ	12958365				2022-12-01	WOS:000185116400046
J	Nishimoto, S; Kawane, K; Watanabe-Fukunaga, R; Fukuyama, H; Ohsawa, Y; Uchiyama, Y; Hashida, N; Ohguro, N; Tano, Y; Morimoto, T; Fukuda, Y; Nagata, S				Nishimoto, S; Kawane, K; Watanabe-Fukunaga, R; Fukuyama, H; Ohsawa, Y; Uchiyama, Y; Hashida, N; Ohguro, N; Tano, Y; Morimoto, T; Fukuda, Y; Nagata, S			Nuclear cataract caused by a lack of DNA degradation in the mouse eye lens	NATURE			English	Article							DIFFERENTIATION; APOPTOSIS; DEOXYRIBONUCLEASE; EXPRESSION; DENUCLEATION; TRANSMISSION; PROTEINS; CELLS; ALPHA	The eye lens is composed of fibre cells, which develop from the epithelial cells on the anterior surface of the lens(1-3). Differentiation into a lens fibre cell is accompanied by changes in cell shape, the expression of crystallins(4) and the degradation of cellular organelles(5,6). The loss of organelles is believed to ensure the transparency of the lens, but the molecular mechanism behind this process is not known. Here we show that DLAD ('DNase II-like acid DNase'(7), also called DNase IIbeta(8)) is expressed in human and murine lens cells, and that mice deficient in the DLAD gene are incapable of degrading DNA during lens cell differentiation-the undigested DNA accumulates in the fibre cells. The DLAD(-/-) mice develop cataracts of the nucleus lentis, and their response to light on electroretinograms is severely reduced. These results indicate that DLAD is responsible for the degradation of nuclear DNA during lens cell differentiation, and that if DNA is left undigested in the lens, it causes cataracts of the nucleus lentis, blocking the light path.	Osaka Univ, Sch Med, Dept Genet, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Cell Biol & Neurosci, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Ophthalmol, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Physiol & Biosignaling, Osaka 5650871, Japan; Osaka Univ, Grad Sch Frontier Biosci, Integrated Biol Labs, Genet Lab, Osaka 5650871, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Nagata, S (corresponding author), Trans Gen Inc, Prod Dept, Kumamoto 8612202, Japan.		Fukuyama, Hidehiro/N-5276-2018; Nagata, Shigekazu/AAG-3203-2019; , nhashida/ABI-4299-2020; Fukuyama, Hidehiro/AAY-6256-2021	Fukuyama, Hidehiro/0000-0002-6457-0630; Nagata, Shigekazu/0000-0001-9758-8426; Fukuyama, Hidehiro/0000-0002-6457-0630; Kawane, Kohki/0000-0003-1125-9483				Bassnett S, 1997, J CELL BIOL, V137, P37, DOI 10.1083/jcb.137.1.37; Bassnett S, 2002, EXP EYE RES, V74, P1, DOI 10.1006/exer.2001.1111; Bernardi G., 1971, HYDROLYSIS, P271; CHAUDUN E, 1994, J CELL PHYSIOL, V158, P354, DOI 10.1002/jcp.1041580218; Dahm R, 1998, EUR J CELL BIOL, V75, P237, DOI 10.1016/S0171-9335(98)80118-0; Ezaki J, 1996, J NEUROCHEM, V67, P1677, DOI 10.1046/j.1471-4159.1996.67041677.x; Fleming TP, 1998, INVEST OPHTH VIS SCI, V39, P1387; GRAINGER RM, 1992, EYE, V6, P117, DOI 10.1038/eye.1992.26; IMOTO Y, IN PRESS JPN J OPHTH; Ishizaki Y, 1998, J CELL BIOL, V140, P153, DOI 10.1083/jcb.140.1.153; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Krieser RJ, 2002, CELL DEATH DIFFER, V9, P956, DOI 10.1038/sj.cdd.4401056; Krieser RJ, 2001, GENE, V269, P205, DOI 10.1016/S0378-1119(01)00434-6; KUWABARA T, 1974, INVEST OPHTH VISUAL, V13, P973; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; McAvoy JW, 1999, EYE, V13, P425, DOI 10.1038/eye.1999.117; McIlroy D, 2000, GENE DEV, V14, P549; Nagata S, 2003, CELL DEATH DIFFER, V10, P108, DOI 10.1038/sj.cdd.4401161; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; Shiokawa D, 1999, NUCLEIC ACIDS RES, V27, P4083, DOI 10.1093/nar/27.20.4083; Torriglia A, 1998, MOL CELL BIOL, V18, P3612, DOI 10.1128/MCB.18.6.3612; VRENSEN GFJM, 1991, EXP EYE RES, V52, P647, DOI 10.1016/0014-4835(91)90017-9; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403; Wride MA, 1998, EXP EYE RES, V66, P371, DOI 10.1006/exer.1997.0440	29	153	159	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2003	424	6952					1071	1074		10.1038/nature01895	http://dx.doi.org/10.1038/nature01895			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715QR	12944971				2022-12-01	WOS:000184984200047
J	Miller, EA; Beilharz, TH; Malkus, PN; Lee, MCS; Hamamoto, S; Orci, L; Schekman, R				Miller, EA; Beilharz, TH; Malkus, PN; Lee, MCS; Hamamoto, S; Orci, L; Schekman, R			Multiple cargo binding sites on the COPII subunit Sec24p ensure capture of diverse membrane proteins into transport vesicles	CELL			English	Article							ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; SELECTIVE EXPORT; CYTOPLASMIC TAIL; STRUCTURAL BASIS; GOLGI-COMPLEX; ER EXPORT; COAT; YEAST; SIGNAL	We have characterized the mechanisms of cargo selection into ER-derived vesicles by the COPII subunit Sec24p. We identified a site on Sec24p that recognizes the v-SNARE Bet1p and show that packaging of a number of cargo molecules is disrupted when mutations are introduced at this site. Surprisingly, cargo proteins affected by these mutations did not share a single common sorting signal, nor were proteins sharing a putative class of signal affected to the same degree. We show that the same site is conserved as a cargo-interaction domain on the Sec24p homolog Lst1p, which only packages a subset of the cargoes recognized by Sec24p. Finally, we identified an additional mutation that defines another cargo binding domain on Sec24p, which specifically interacts with the SNARE Sec22p. Together, our data support a model whereby Sec24p proteins contain multiple independent cargo binding domains that allow for recognition of a diverse set of sorting signals.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Geneva, Sch Med, Dept Morphol, CH-1211 Geneva, Switzerland	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Geneva	Schekman, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.		Beilharz, Traude/I-1438-2014; Beilharz, Traude/O-5457-2019	Beilharz, Traude/0000-0002-8942-9502; Beilharz, Traude/0000-0002-8942-9502; Lee, Marcus/0000-0002-4973-0915; Miller, Elizabeth/0000-0002-1033-8369				Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Aridor M, 2002, TRAFFIC, V3, P537, DOI 10.1034/j.1600-0854.2002.30804.x; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Belden WJ, 2001, J BIOL CHEM, V276, P43040, DOI 10.1074/jbc.M108113200; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Kuehn MJ, 1996, J CELL BIOL, V135, P585, DOI 10.1083/jcb.135.3.585; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Kurihara T, 2000, MOL BIOL CELL, V11, P983, DOI 10.1091/mbc.11.3.983; Malkus P, 2002, J CELL BIOL, V159, P915, DOI 10.1083/jcb.200208074; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; Nakamura N, 1998, MOL BIOL CELL, V9, P3493, DOI 10.1091/mbc.9.12.3493; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Nufer O, 2002, J CELL SCI, V115, P619; Otte S, 2002, EMBO J, V21, P6095, DOI 10.1093/emboj/cdf598; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Owen DJ, 2001, TRAFFIC, V2, P105, DOI 10.1034/j.1600-0854.2001.020205.x; Peng RW, 1999, P NATL ACAD SCI USA, V96, P3751, DOI 10.1073/pnas.96.7.3751; Roberg KJ, 1999, J CELL BIOL, V145, P659, DOI 10.1083/jcb.145.4.659; Sato K, 2002, MOL BIOL CELL, V13, P2518, DOI 10.1091/mbc.E02-01-0027; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Shiba T, 2002, NATURE, V415, P937, DOI 10.1038/415937a; Shimoni Y, 2000, J CELL BIOL, V151, P973, DOI 10.1083/jcb.151.5.973; SIKORSKI RS, 1989, GENETICS, V122, P19; Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698; Stockklausner C, 2001, FEBS LETT, V493, P129, DOI 10.1016/S0014-5793(01)02286-4; Trilla JA, 1999, J CELL BIOL, V145, P1153, DOI 10.1083/jcb.145.6.1153; Votsmeier C, 2001, EMBO J, V20, P6742, DOI 10.1093/emboj/20.23.6742; Wickner W, 2000, ANNU REV BIOCHEM, V69, P247, DOI 10.1146/annurev.biochem.69.1.247; WUESTEHUBE LJ, 1992, METHOD ENZYMOL, V219, P124	39	384	392	1	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 22	2003	114	4					497	509		10.1016/S0092-8674(03)00609-3	http://dx.doi.org/10.1016/S0092-8674(03)00609-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	714TD	12941277	Bronze			2022-12-01	WOS:000184928800012
J	Iwashita, T; Kruger, GM; Pardal, R; Kiel, MJ; Morrison, SJ				Iwashita, T; Kruger, GM; Pardal, R; Kiel, MJ; Morrison, SJ			Hirschsprung disease is linked to defects in neural crest stem cell function	SCIENCE			English	Article							ENTERIC NERVOUS-SYSTEM; MICE LACKING GDNF; TYROSINE KINASE; SELF-RENEWAL; IN-VITRO; C-RET; KIDNEY; DIFFERENTIATION; GFR-ALPHA-1; EXPRESSION	Genes associated with Hirschsprung disease, a failure to form enteric ganglia in the hindgut, were highly up-regulated in gut neural crest stem cells relative to whole-fetus RNA. One of these genes, the glial cell line-derived neurotrophic factor (GDNF) receptor Ret, was necessary for neural crest stem cell migration in the gut. GDNF promoted the migration of neural crest stem cells in culture but did not affect their survival or proliferation. Gene expression pro. ling, combined with reverse genetics and analyses of stem cell function, suggests that Hirschsprung disease is caused by defects in neural crest stem cell function.	Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.		Pardal, Ricardo/C-4370-2015; Morrison, Sean/ABD-5326-2021; Crane, Genevieve M/AAK-9224-2020; IBIS, FISIOPATOLOGIA/O-9510-2015	Pardal, Ricardo/0000-0003-1085-0714; Crane, Genevieve M/0000-0001-9274-0214; Morrison, Sean/0000-0003-1587-8329	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD040760] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048310, P60AR020557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040750] Funding Source: NIH RePORTER; NCI NIH HHS [CA46592] Funding Source: Medline; NIAMS NIH HHS [P60-AR20557, P30 AR48310] Funding Source: Medline; NICHD NIH HHS [R21 HD40760-02] Funding Source: Medline; NIDDK NIH HHS [DK58771, NIH5P60-DK20572] Funding Source: Medline; NINDS NIH HHS [R01 NS040750-01, R01 NS040750, R01 NS40750-01] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Chalazonitis A, 1998, DEV BIOL, V204, P385, DOI 10.1006/dbio.1998.9090; Durbec PL, 1996, DEVELOPMENT, V122, P349; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Eketjall S, 2002, HUM MOL GENET, V11, P325, DOI 10.1093/hmg/11.3.325; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; Geschwind DH, 2001, NEURON, V29, P325, DOI 10.1016/S0896-6273(01)00209-4; Heuckeroth RO, 1998, DEV BIOL, V200, P116, DOI 10.1006/dbio.1998.8955; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; LO LC, 1995, NEURON, V15, P527, DOI 10.1016/0896-6273(95)90142-6; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268; Natarajan D, 2002, DEVELOPMENT, V129, P5151; Newgreen D, 2002, PEDIATR DEVEL PATHOL, V5, P224, DOI 10.1007/s10024-001-0142-y; Park IK, 2002, BLOOD, V99, P488, DOI 10.1182/blood.V99.2.488; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Taraviras S, 1999, DEVELOPMENT, V126, P2785; Terskikh AV, 2001, P NATL ACAD SCI USA, V98, P7934, DOI 10.1073/pnas.131200898; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Young HM, 2001, DEV BIOL, V229, P503, DOI 10.1006/dbio.2000.0100	37	162	174	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2003	301	5635					972	976		10.1126/science.1085649	http://dx.doi.org/10.1126/science.1085649			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711RY	12920301	Green Accepted			2022-12-01	WOS:000184755900042
J	Daubin, V; Moran, NA; Ochman, H				Daubin, V; Moran, NA; Ochman, H			Phylogenetics and the cohesion of bacterial genomes	SCIENCE			English	Article							MAXIMUM-LIKELIHOOD METHOD; ESCHERICHIA-COLI; SEQUENCE DATA; GENE-TRANSFER; RECOMBINATION; TOPOLOGIES; EVOLUTION; BLAST	Gene acquisition is an ongoing process in many bacterial genomes, contributing to adaptation and ecological diversification. Lateral gene transfer is considered the primary explanation for discordance among gene phylogenies and as an obstacle to reconstructing the tree of life. We measured the extent of phylogenetic conflict and alien-gene acquisition within quartets of sequenced genomes. Although comparisons of complete gene inventories indicate appreciable gain and loss of genes, orthologs available for phylogenetic reconstruction are consistent with a single tree.	Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA; Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Ochman, H (corresponding author), Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA.	hochman@email.arizona.edu	chen, qi/C-8585-2011; Moran, Nancy A/G-1591-2010	Daubin, Vincent/0000-0001-8269-9430				Adachi J, 1996, MOL PHYLOGENET EVOL, V6, P72, DOI 10.1006/mpev.1996.0059; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brown JR, 1997, MICROBIOL MOL BIOL R, V61, P456, DOI 10.1128/.61.4.456-502.1997; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; DOOLITTLE WF, 1999, TRENDS CELL BIOL, V9, P5, DOI DOI 10.1016/S0168-9525(99)01877-6; DYKHUIZEN DE, 1991, J BACTERIOL, V173, P7257, DOI 10.1128/jb.173.22.7257-7268.1991; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; GRAUR D, 1991, NATURE, V351, P649, DOI 10.1038/351649a0; GUTTMAN DS, 1994, SCIENCE, V266, P1380, DOI 10.1126/science.7973728; Hedges SB, 1999, SCIENCE, V283, P998, DOI 10.1126/science.283.5404.998; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Hughes S, 2001, J MOL EVOL, V53, P70, DOI 10.1007/s002390010194; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Millman KL, 2001, J BACTERIOL, V183, P5997, DOI 10.1128/JB.183.20.5997-6008.2001; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Nesbo CL, 2001, J MOL EVOL, V53, P340, DOI 10.1007/s002390010224; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Philippe Herve, 1994, Journal of Mammalian Evolution, V2, P133, DOI 10.1007/BF01464365; Raymond J, 2002, SCIENCE, V298, P1616, DOI 10.1126/science.1075558; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Zhaxybayeva O, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-4	27	192	203	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2003	301	5634					829	832		10.1126/science.1086568	http://dx.doi.org/10.1126/science.1086568			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907801				2022-12-01	WOS:000184615700044
J	Wiedemann, N; Kozjak, V; Chacinska, A; Schonfisch, B; Rospert, S; Ryan, MT; Pfanner, N; Meisinger, C				Wiedemann, N; Kozjak, V; Chacinska, A; Schonfisch, B; Rospert, S; Ryan, MT; Pfanner, N; Meisinger, C			Machinery for protein sorting and assembly in the mitochondrial outer membrane	NATURE			English	Article							GENERAL IMPORT PORE; TOM COMPLEX; RECEPTORS; PREPROTEINS; BIOGENESIS; CHANNEL; TRANSLOCATION	Mitochondria contain translocases for the transport of precursor proteins across their outer and inner membranes(1-5). It has been assumed that the translocases also mediate the sorting of proteins to their submitochondrial destination(1,2,5-10). Here we show that the mitochondrial outer membrane contains a separate sorting and assembly machinery (SAM) that operates after the translocase of the outer membrane (TOM). Mas37 forms a constituent of the SAM complex. The central role of the SAM complex in the sorting and assembly pathway of outer membrane proteins explains the various pleiotropic functions that have been ascribed to Mas37 (refs 4, 11-15). These results suggest that the TOM complex, which can transport all kinds of mitochondrial precursor proteins, is not sufficient for the correct integration of outer membrane proteins with a complicated topology, and instead transfers precursor proteins to the SAM complex.	Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle Saale, Germany	University of Freiburg; University of Freiburg; Max Planck Society	Pfanner, N (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Hermann Herder Str 7, D-79104 Freiburg, Germany.		Ryan, Michael/X-2152-2019; Kozjak-Pavlovic, Vera/E-1494-2013; Pfanner, Nikolaus/AAV-7878-2021; Ryan, Michael T/C-6673-2011; Meisinger, Chris/J-1110-2014	Ryan, Michael/0000-0003-2586-8829; Kozjak-Pavlovic, Vera/0000-0001-9658-7018; Ryan, Michael T/0000-0003-2586-8829; Meisinger, Chris/0000-0002-8326-3548; Rospert, Sabine/0000-0002-3089-9614; Chacinska, Agnieszka/0000-0002-2832-2568; Wiedemann, Nils/0000-0001-8305-6728				Abdul KM, 2000, BIOCHEM BIOPH RES CO, V276, P1028, DOI 10.1006/bbrc.2000.3589; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; Dietmeier K, 1997, NATURE, V388, P195, DOI 10.1038/40663; Endo T, 2002, BBA-MOL CELL RES, V1592, P3, DOI 10.1016/S0167-4889(02)00259-8; GRATZER S, 1995, J CELL BIOL, V129, P25, DOI 10.1083/jcb.129.1.25; HACHIYA N, 1995, NATURE, V376, P705, DOI 10.1038/376705a0; Herrmann JM, 2000, CURR OPIN MICROBIOL, V3, P210, DOI 10.1016/S1369-5274(00)00077-1; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Jensen RE, 2001, NAT STRUCT BIOL, V8, P1008, DOI 10.1038/nsb1201-1008; Koehler CM, 1999, TRENDS BIOCHEM SCI, V24, P428, DOI 10.1016/S0968-0004(99)01462-0; Krimmer T, 2001, J CELL BIOL, V152, P289, DOI 10.1083/jcb.152.2.289; LITHGOW T, 1994, P NATL ACAD SCI USA, V91, P11973, DOI 10.1073/pnas.91.25.11973; Martelli Pier Luigi, 2002, Bioinformatics, V18 Suppl 1, pS46; Matouschek A, 2001, NAT STRUCT BIOL, V8, P284, DOI 10.1038/86140; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Rapaport D, 1999, J CELL BIOL, V146, P321, DOI 10.1083/jcb.146.2.321; Rapaport D, 2002, TRENDS BIOCHEM SCI, V27, P191, DOI 10.1016/S0968-0004(02)02065-0; Ryan MT, 1999, J BIOL CHEM, V274, P20619, DOI 10.1074/jbc.274.29.20619; Sesaki H, 2001, J CELL BIOL, V152, P1123, DOI 10.1083/jcb.152.6.1123; SOGO LF, 1994, J CELL BIOL, V126, P1361, DOI 10.1083/jcb.126.6.1361; Taylor RD, 2003, J BIOL CHEM, V278, P765, DOI 10.1074/jbc.M208083200; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802	24	288	302	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					565	571		10.1038/nature01753	http://dx.doi.org/10.1038/nature01753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891361				2022-12-01	WOS:000184454700046
J	Johansson, L; Rytkonen, A; Bergman, P; Albiger, B; Kallstrom, H; Hokfelt, T; Agerberth, B; Cattaneo, R; Jonsson, AB				Johansson, L; Rytkonen, A; Bergman, P; Albiger, B; Kallstrom, H; Hokfelt, T; Agerberth, B; Cattaneo, R; Jonsson, AB			CD46 in meningococcal disease	SCIENCE			English	Article							MEMBRANE COFACTOR PROTEIN; MEASLES-VIRUS; PATHOGENIC NEISSERIA; MULTIPLE ISOFORMS; CELLULAR RECEPTOR; EXPRESSION; COMPLEMENT; MCP; MENINGITIDIS; CELLS	The human-specific bacterial pathogen Neisseria meningitidis is a major cause of sepsis and/or meningitis. The pili of N. meningitidis interact with CD46, a human cell-surface protein involved in regulation of complement activation. Transgenic mice expressing human CD46 were susceptible to meningococcal disease, because bacteria crossed the blood-brain barrier in these mice. Development of disease was more efficient with piliated bacteria after intranasal, but not intraperitoneal, challenge of CD46 transgenic mice, suggesting that human CD46 facilitates pilus-dependent interactions at the epithelial mucosa. Hence, the human CD46 transgenic mice model is a potentially useful tool for studying pathogenesis and for vaccine development against meningococcal disease.	Ctr Microbiol & Tumor Biol, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Neurosci, SE-17177 Stockholm, Sweden; Swedish Inst Infect Dis Control, SE-17182 Solna, Sweden; Mayo Clin & Mayo Fdn, Program Mol Med, Rochester, MN 55905 USA	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Swedish Institute for Infectious Disease Control; Mayo Clinic	Jonsson, AB (corresponding author), Ctr Microbiol & Tumor Biol, Nobels Vag 16,Box 280, SE-17177 Stockholm, Sweden.			Bergman, Peter/0000-0003-3306-3713				ADAMS JC, 1992, J HISTOCHEM CYTOCHEM, V40, P1457, DOI 10.1177/40.10.1527370; Albiger B, 2003, INFECT IMMUN, V71, P155, DOI 10.1128/IAI.71.1.155-162.2003; Ayala BP, 2001, CELL MICROBIOL, V3, P265, DOI 10.1046/j.1462-5822.2001.00112.x; Brumovsky PR, 2002, EXP NEUROL, V174, P1, DOI 10.1006/exnr.2001.7845; Danielii J.F., 1958, GENERAL CYTOCHEMICAL, P399; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; DYER DW, 1987, MICROB PATHOGENESIS, V3, P351, DOI 10.1016/0882-4010(87)90005-2; JOHANSSON LS, UNPUB; JONSSON AB, 1991, EMBO J, V10, P477, DOI 10.1002/j.1460-2075.1991.tb07970.x; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Kallstrom H, 1998, J BIOL CHEM, V273, P21777, DOI 10.1074/jbc.273.34.21777; Kemper C, 2001, CLIN EXP IMMUNOL, V124, P180, DOI 10.1046/j.1365-2249.2001.01458.x; Lee SW, 2002, J CELL BIOL, V156, P951, DOI 10.1083/jcb.200109005; Liszewski MK, 1996, J IMMUNOL, V156, P4415; MANCHESTER M, 1994, P NATL ACAD SCI USA, V91, P2161, DOI 10.1073/pnas.91.6.2161; Marie JC, 2002, NAT IMMUNOL, V3, P659, DOI 10.1038/ni810; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; Mrkic B, 1998, J VIROL, V72, P7420, DOI 10.1128/JVI.72.9.7420-7427.1998; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; Nassif X, 1999, MOL MICROBIOL, V32, P1124, DOI 10.1046/j.1365-2958.1999.01416.x; OKADA N, 1995, P NATL ACAD SCI USA, V92, P2489, DOI 10.1073/pnas.92.7.2489; POST TW, 1991, J EXP MED, V174, P93, DOI 10.1084/jem.174.1.93; PURCELL DFJ, 1991, IMMUNOGENETICS, V33, P335, DOI 10.1007/BF00216692; Rahman M, 1997, MOL MICROBIOL, V25, P11, DOI 10.1046/j.1365-2958.1997.4601823.x; Santoro F, 1999, CELL, V99, P817, DOI 10.1016/S0092-8674(00)81678-5; Shusta EV, 2002, J NEUROPATH EXP NEUR, V61, P597, DOI 10.1093/jnen/61.7.597; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2	27	131	140	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					373	375		10.1126/science.1086476	http://dx.doi.org/10.1126/science.1086476			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869763				2022-12-01	WOS:000184207300046
J	Kelley, SP; Dunlop, JI; Kirkness, EF; Lambert, JJ; Peters, JA				Kelley, SP; Dunlop, JI; Kirkness, EF; Lambert, JJ; Peters, JA			A cytoplasmic region determines single-channel conductance in 5-HT3 receptors	NATURE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; STRUCTURAL BASIS; GATING KINETICS; ION PERMEATION; SUBUNIT; SELECTIVITY; EXPRESSION; PORE	5-Hydroxytryptamine type 3 (5-HT3) receptors are cation-selective transmitter-gated ion channels of the Cys-loop superfamily(1-9). The single-channel conductance of human recombinant 5-HT3 receptors assembled as homomers of 5-HT3A subunits, or heteromers of 5-HT3A and 5-HT3B subunits, are markedly different, being 0.4 pS (refs 6, 9) and 16 pS (ref. 7), respectively. Paradoxically, the channel-lining M2 domain of the 5-HT3A subunit would be predicted to promote cation conduction, whereas that of the 5-HT3B subunit would not(7). Here we describe a determinant of single-channel conductance that can explain these observations. By constructing chimaeric 5-HT3A and 5-HT3B subunits we identified a region (the 'HA-stretch')(10) within the large cytoplasmic loop of the receptor that markedly influences channel conductance. Replacement of three arginine residues unique to the HA-stretch of the 5-HT3A subunit by their 5-HT3B subunit counterparts increased single-channel conductance 28-fold. Significantly, ultrastructural studies of the Torpedo nicotinic acetylcholine receptor(11) indicate that the key residues might frame narrow openings that contribute to the permeation pathway. Our findings solve the conundrum of the anomalously low conductance of homomeric 5-HT3A receptors and indicate an important function for the HA-stretch in Cys-loop transmitter-gated ion channels.	Univ Dundee, Ninewells Hosp & Med Sch, Inst Neurosci, Dept Pharmacol & Neurosci, Dundee DD1 9SY, Scotland; Inst Genom Res, Rockville, MD 20850 USA	University of Dundee; J. Craig Venter Institute	Peters, JA (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Inst Neurosci, Dept Pharmacol & Neurosci, Dundee DD1 9SY, Scotland.	j.a.peters@dundee.ac.uk						Akk G, 2000, J PHYSIOL-LONDON, V527, P405, DOI 10.1111/j.1469-7793.2000.t01-2-00405.x; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; Boyd GW, 2002, MOL CELL NEUROSCI, V21, P38, DOI 10.1006/mcne.2002.1160; Brown AM, 1998, J PHYSIOL-LONDON, V507, P653, DOI 10.1111/j.1469-7793.1998.653bs.x; Davies PA, 2003, J BIOL CHEM, V278, P712, DOI 10.1074/jbc.M208814200; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; DERKACH V, 1989, NATURE, V339, P706, DOI 10.1038/339706a0; Dubin AE, 1999, J BIOL CHEM, V274, P30799, DOI 10.1074/jbc.274.43.30799; FINERMOORE J, 1984, P NATL ACAD SCI-BIOL, V81, P155, DOI 10.1073/pnas.81.1.155; GILL CH, 1995, BRIT J PHARMACOL, V114, P1211, DOI 10.1111/j.1476-5381.1995.tb13335.x; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; Hanna MC, 2000, J NEUROCHEM, V75, P240, DOI 10.1046/j.1471-4159.2000.0750240.x; Higgins MK, 2002, EMBO J, V21, P2087, DOI 10.1093/emboj/21.9.2087; HUSSY N, 1994, J PHYSIOL-LONDON, V481, P311, DOI 10.1113/jphysiol.1994.sp020441; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; Panicker S, 2002, J NEUROSCI, V22, P1629, DOI 10.1523/JNEUROSCI.22-05-01629.2002; Reeves DC, 2001, J BIOL CHEM, V276, P42035, DOI 10.1074/jbc.M106066200; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; Sokolova O, 2001, STRUCTURE, V9, P215, DOI 10.1016/S0969-2126(01)00578-0; Unwin N, 2000, PHILOS T R SOC B, V355, P1813, DOI 10.1098/rstb.2000.0737; YAKEL JL, 1988, NEURON, V1, P615, DOI 10.1016/0896-6273(88)90111-0; YAKEL JL, 1990, BRAIN RES, V533, P46, DOI 10.1016/0006-8993(90)91793-G; YANG J, 1990, J GEN PHYSIOL, V96, P1177, DOI 10.1085/jgp.96.6.1177; YU XM, 1994, NEURON, V13, P247, DOI 10.1016/0896-6273(94)90473-1	29	227	238	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2003	424	6946					321	324		10.1038/nature01788	http://dx.doi.org/10.1038/nature01788			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867984	Green Accepted			2022-12-01	WOS:000184183900044
J	Wilson, JE				Wilson, JE			Building African AIDS care from the ground up	ANNALS OF INTERNAL MEDICINE			English	Editorial Material													Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136					0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2003	139	2					157	160		10.7326/0003-4819-139-2-200307150-00028	http://dx.doi.org/10.7326/0003-4819-139-2-200307150-00028			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701HX	12859173				2022-12-01	WOS:000184163100017
J	Nam, JM; Thaxton, CS; Mirkin, CA				Nam, JM; Thaxton, CS; Mirkin, CA			Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins	SCIENCE			English	Article							PROSTATE-SPECIFIC ANTIGEN; POLYMERASE-CHAIN-REACTION; IMMUNO-PCR; DNA; ASSAY; TIME; AMPLIFICATION; DIAGNOSIS	An ultrasensitive method for detecting protein analytes has been developed. The system relies on magnetic microparticle probes with antibodies that specifically bind a target of interest [prostate-specific antigen (PSA) in this case] and nanoparticle probes that are encoded with DNA that is unique to the protein target of interest and antibodies that can sandwich the target captured by the microparticle probes. Magnetic separation of the complexed probes and target followed by dehybridization of the oligonucleotides on the nanoparticle probe surface allows the determination of the presence of the target protein by identifying the oligonucleotide sequence released from the nanoparticle probe. Because the nanoparticle probe carries with it a large number of oligonucleotides per protein binding event, there is substantial amplification and PSA can be detected at 30 attomolar concentration. Alternatively, a polymerase chain reaction on the oligonucleotide bar codes can boost the sensitivity to 3 attomolar. Comparable clinically accepted conventional assays for detecting the same target have sensitivity limits of similar to3 picomdar, six orders of magnitude less sensitive than what is observed with this method.	Northwestern Univ, Dept Chem, Evanston, IL 60201 USA; Northwestern Univ, Inst Nanotechnol, Evanston, IL 60201 USA	Northwestern University; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60201 USA.		Mirkin, Chad A/E-3911-2010; Abrams, William R/A-5782-2008; Nam, Jwa-Min/F-2062-2019	Nam, Jwa-Min/0000-0002-7891-8482; Mirkin, Chad/0000-0002-6634-7627				Black MH, 2000, CLIN CANCER RES, V6, P467; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cao YWC, 2002, SCIENCE, V297, P1536, DOI 10.1126/science.297.5586.1536; Demers LM, 2000, ANAL CHEM, V72, P5535, DOI 10.1021/ac0006627; Ferguson RA, 1996, CLIN CHEM, V42, P675; GIBBS RA, 1991, CURR OPIN BIOTECH, V2, P69, DOI 10.1016/0958-1669(91)90063-B; Haab BB, 2001, GENOME BIOL, V2; HENDRICKSON ER, 1995, NUCLEIC ACIDS RES, V23, P522, DOI 10.1093/nar/23.3.522; MacBeath G, 2000, SCIENCE, V289, P1760; McKie A, 2002, J IMMUNOL METHODS, V270, P135, DOI 10.1016/S0022-1759(02)00325-3; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Nam JM, 2002, J AM CHEM SOC, V124, P3820, DOI 10.1021/ja0178766; Niemeyer CM, 1999, NUCLEIC ACIDS RES, V27, P4553, DOI 10.1093/nar/27.23.4553; Niemeyer CM, 2002, TRENDS BIOTECHNOL, V20, P395, DOI 10.1016/S0167-7799(02)02022-X; Ries LAG, 2002, SEER CANC STAT REV 1; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANO T, 1992, SCIENCE, V258, P120, DOI 10.1126/science.1439758; Schweitzer B, 2000, P NATL ACAD SCI USA, V97, P10113, DOI 10.1073/pnas.170237197; STANFORD JL, 1999, NIH PUBLICATION; Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757; YU H, 1995, CLIN CHEM, V41, P430; ZHOU H, 1993, NUCLEIC ACIDS RES, V21, P6038, DOI 10.1093/nar/21.25.6038; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	23	2139	2299	23	931	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2003	301	5641					1884	1886		10.1126/science.1088755	http://dx.doi.org/10.1126/science.1088755			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725GW	14512622				2022-12-01	WOS:000185536700044
J	Coureux, PD; Wells, AL; Menetry, J; Yengo, CM; Morris, CA; Sweeney, HL; Houdusse, A				Coureux, PD; Wells, AL; Menetry, J; Yengo, CM; Morris, CA; Sweeney, HL; Houdusse, A			A structural state of the myosin V motor without bound nucleotide	NATURE			English	Article							SMOOTH-MUSCLE MYOSIN; X-RAY STRUCTURES; CRYSTAL-STRUCTURE; LIGHT-CHAIN; ACTIN; BINDING; SUBFRAGMENT-1; DOMAIN; DELETION; CLOSURE	The myosin superfamily of molecular motors use ATP hydrolysis and actin-activated product release to produce directed movement and force(1). Although this is generally thought to involve movement of a mechanical lever arm attached to a motor core(1,2), the structural details of the rearrangement in myosin that drive the lever arm motion on actin attachment are unknown. Motivated by kinetic evidence that the processive unconventional myosin, myosin V, populates a unique state in the absence of nucleotide and actin, we obtained a 2.0 Angstrom structure of a myosin V fragment. Here we reveal a conformation of myosin without bound nucleotide. The nucleotide-binding site has adopted new conformations of the nucleotide-binding elements that reduce the affinity for the nucleotide. The major cleft in the molecule has closed, and the lever arm has assumed a position consistent with that in an actomyosin rigor complex. These changes have been accomplished by relative movements of the subdomains of the molecule, and reveal elements of the structural communication between the actin-binding interface and nucleotide-binding site of myosin that underlie the mechanism of chemo-mechanical transduction.	CNRS, UMR 144, Inst Curie, F-75248 Paris 05, France; Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite; University of Pennsylvania	Houdusse, A (corresponding author), CNRS, UMR 144, Inst Curie, 26 Rue Ulm, F-75248 Paris 05, France.	lsweeney@mail.med.upenn.edu; anne.houdusse@curie.fr	Ménétrey, Julie/AAM-6408-2021; Sweeney, H Lee/F-1862-2010					BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bauer CB, 2000, J BIOL CHEM, V275, P38494, DOI 10.1074/jbc.M005585200; COATES JH, 1985, BIOCHEM J, V232, P351, DOI 10.1042/bj2320351; De la Cruz EM, 2000, BIOCHEMISTRY-US, V39, P14196, DOI 10.1021/bi001701b; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Houdusse A, 2001, CURR OPIN STRUC BIOL, V11, P182, DOI 10.1016/S0959-440X(00)00188-3; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; Joel PB, 2001, J BIOL CHEM, V276, P2998, DOI 10.1074/jbc.M006930200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kollmar M, 2002, EMBO J, V21, P2517, DOI 10.1093/emboj/21.11.2517; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Sasaki N, 1999, J BIOL CHEM, V274, P37840, DOI 10.1074/jbc.274.53.37840; Sasaki N, 2000, J BIOL CHEM, V275, P38705, DOI 10.1074/jbc.M001966200; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; TAYLOR EW, 1991, J BIOL CHEM, V266, P294; Titus MA, 1997, CURR BIOL, V7, pR301, DOI 10.1016/S0960-9822(06)00143-6; Volkmann N, 2000, NAT STRUCT BIOL, V7, P1147; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; Yengo CM, 2002, J BIOL CHEM, V277, P24114, DOI 10.1074/jbc.M111253200; Yengo CM, 2002, BIOCHEMISTRY-US, V41, P8508, DOI 10.1021/bi015969u	30	238	239	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2003	425	6956					419	423		10.1038/nature01927	http://dx.doi.org/10.1038/nature01927			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	724TG	14508494				2022-12-01	WOS:000185502300046
J	Winickoff, DE; Winickoff, RN				Winickoff, DE; Winickoff, RN			The charitable trust as a model for genomic biobanks	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFORMED CONSENT; TISSUE		Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard University; Massachusetts General Hospital	Winickoff, DE (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA.							Annas GJ, 2000, NEW ENGL J MED, V342, P1830, DOI 10.1056/NEJM200006153422412; Annas GJ, 2001, JAMA-J AM MED ASSOC, V286, P2326, DOI 10.1001/jama.286.18.2326; Ashburn TT, 2000, ARCH INTERN MED, V160, P3377, DOI 10.1001/archinte.160.22.3377; Barnes M, 2002, J LAW MED ETHICS, V30, P390, DOI 10.1111/j.1748-720X.2002.tb00408.x; Beskow LM, 2001, JAMA-J AM MED ASSOC, V286, P2315, DOI 10.1001/jama.286.18.2315; BOGERT GG, 1992, LAW TRUSTS TRUSTEES, P323; CONNOLLY A, 2002, BOSTON BUSINESS 1122; Eiseman E., 1999, HDB HUMAN TISSUE SOU; Faden Ruth R., 1986, HIST THEORY INFORMED, P151; GOTTLIEB K, 1998, STORED TISSUE SAMPLE; Greely H T, 1999, Wake Forest Law Rev, V34, P737; Greely H T, 1997, Houst Law Rev, V33, P1397; Harrison CH, 2002, AM J LAW MED, V28, P77; Jeffers BR, 2001, ADV NURS SCI, V24, P32, DOI 10.1097/00012272-200112000-00005; Kaiser J, 2002, SCIENCE, V298, P1158, DOI 10.1126/science.298.5596.1158; KOLATA G, 2000, NY TIMES        0317, pA1; Malone T, 2002, J NATL CANCER I, V94, P769; *NAT BIOETH ADV CO, 2001, ETH POL ISS RES INV, pR17; *NAT RES COUNC COM, 1997, EV HUM GEN DIV; National Bioethics Advisory Commission, 1999, RES INV HUM BIOL MAT; Nelkin D, 1998, HASTINGS CENT REP, V28, P30, DOI 10.2307/3528230; *OFF INSP GEN, 1998, I REV BOARDS EM IND; *OFF INSP GEN, 1998, I REV BOARDS TIM REF; Olden K, 2000, NAT REV GENET, V1, P149, DOI 10.1038/35038586; Rose Hilary, 2001, COMMODIFICATION BIOI; Rosenberg R., 2001, BOSTON GLOBE    0221, pD4; Rothstein MA, 2002, J LAW MED ETHICS, V30, P105, DOI 10.1111/j.1748-720X.2002.tb00726.x; Shalala D, 2000, NEW ENGL J MED, V343, P808, DOI 10.1056/NEJM200009143431112; Singer Joseph, 2000, ENTITLEMENT PARADOXE, p[29, 38]; Smaglik P, 2000, NATURE, V407, P821, DOI 10.1038/35038209; Steinbrook R, 2002, NEW ENGL J MED, V346, P1842, DOI 10.1056/NEJMp020046; Steinbrook R, 2002, NEW ENGL J MED, V346, P1425, DOI 10.1056/NEJM200205023461828; Winickoff David E, 2003, Jurimetrics, V43, P187	33	141	141	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2003	349	12					1180	1184		10.1056/NEJMsb030036	http://dx.doi.org/10.1056/NEJMsb030036			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	722HQ	13679534				2022-12-01	WOS:000185369700014
J	Bertomeu, A; Garcia-Vidal, O; Farre, X; Galobart, A; Vazquez, M; Laguna, JC; Ros, E				Bertomeu, A; Garcia-Vidal, O; Farre, X; Galobart, A; Vazquez, M; Laguna, JC; Ros, E			Preclinical coronary atherosclerosis in a population with low incidence of myocardial infarction: cross sectional autopsy study	BRITISH MEDICAL JOURNAL			English	Article							HEART-DISEASE MORTALITY		Inst Med Legal Catalunya, E-08911 Badalona, Spain; Hosp St Jaume, E-08370 Barcelona, Spain; Ctr Nacl Invest Oncol, E-28029 Madrid, Spain; Hosp Municipal Badalona, E-08911 Badalona, Spain; Univ Barcelona, Fac Farm, Dept Farmacol, E-08028 Barcelona, Spain; Inst Invest Biomed August Pi & Sunyer, Serv Nutr & Dietet, Unidad Lipidos, E-08036 Barcelona, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Bertomeu, A (corresponding author), Inst Med Legal Catalunya, C Prim 32-40, E-08911 Badalona, Spain.		Vázquez-Carrera, Manuel/H-2612-2015; Laguna, JCLaguna - Juan C./C-5481-2017; Farré, Xavier/M-9768-2014	Vázquez-Carrera, Manuel/0000-0001-7138-8207; Laguna, JCLaguna - Juan C./0000-0002-7082-0704; Farré, Xavier/0000-0001-8702-4643; Ros, Emilio/0000-0002-2573-1294				ALVAREZ FV, 2003, ENFERMEDADES CARDIOV; Law M, 1999, BRIT MED J, V318, P1471, DOI 10.1136/bmj.318.7196.1471; MARRUGAT J, 1998, CARDIOVASCULAR RISK, V8, P196; McGill HC, 2000, AM J CLIN NUTR, V72, p1307S, DOI 10.1093/ajcn/72.5.1307s; Tunstall-Pedoe H, 2000, LANCET, V355, P688, DOI 10.1016/S0140-6736(99)11181-4	5	21	21	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 13	2003	327	7415					591	592		10.1136/bmj.327.7415.591	http://dx.doi.org/10.1136/bmj.327.7415.591			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722CW	12969923	Bronze, Green Published			2022-12-01	WOS:000185358700019
J	Schadt, CW; Martin, AP; Lipson, DA; Schmidt, SK				Schadt, CW; Martin, AP; Lipson, DA; Schmidt, SK			Seasonal dynamics of previously unknown fungal lineages in tundra soils	SCIENCE			English	Article							ALPINE ECOSYSTEM; CO2 EFFLUX; DIVERSITY; EVOLUTION; NITROGEN; BUDGETS; WINTER; N2O	The finding that microbial communities are active under snow has changed the estimated global rates of biogeochemical processes beneath seasonal snow packs. We used microbiological and molecular techniques to elucidate the phylogenetic composition of undersnow microbial communities in Colorado, the United States. Here, we show that tundra soil microbial biomass reaches its annual peak under snow, and that fungi account for most of the biomass. Phylogenetic analysis of tundra soil fungi revealed a high diversity of fungi and three novel clades that constitute major new groups of fungi (divergent at the subphylum or class level). An abundance of previously unknown fungi that are active beneath the snow substantially broadens our understanding of both the diversity and biogeochemical functioning of fungi in cold environments.	Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	University of Colorado System; University of Colorado Boulder; California State University System; San Diego State University	Schmidt, SK (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.		Schadt, Christopher W./B-7143-2008; Schadt, Christopher/M-8746-2019; Schmidt, Steven K/G-2771-2010	Schadt, Christopher W./0000-0001-8759-2448; Schadt, Christopher/0000-0001-8759-2448; Schmidt, Steven K/0000-0002-9175-2085				Brooks PD, 1997, OECOLOGIA, V110, P403, DOI 10.1007/PL00008814; Brown J.H., 1998, BIOGEOGRAPHY; Eriksson OE., 2001, MYCONET, V7, P1; Fahnestock JT, 1999, GLOBAL BIOGEOCHEM CY, V13, P775, DOI 10.1029/1999GB900006; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Jaeger CH, 1999, ECOLOGY, V80, P1883, DOI 10.1890/0012-9658(1999)080[1883:SPONBP]2.0.CO;2; Lipson DA, 2002, MICROB ECOL, V43, P307, DOI 10.1007/s00248-001-1057-x; Lipson DA, 1999, ECOLOGY, V80, P1623; LIPSON DA, UNPUB; MELILLO JM, 1995, GLOBAL BIOGEOCHEM CY, V9, P407; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; SCHADT CW, UNPUB; SCHMIDT SK, IN PRESS BIOGEOCHEMI; SOMMERFELD RA, 1993, NATURE, V361, P140, DOI 10.1038/361140a0; Vandenkoornhuyse P, 2002, SCIENCE, V295, P2051, DOI 10.1126/science.295.5562.2051; VILGALYS R, COMMUNICATION; Zimov SA, 1996, CLIMATIC CHANGE, V33, P111, DOI 10.1007/BF00140516	18	443	503	4	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 5	2003	301	5638					1359	1361		10.1126/science.1086940	http://dx.doi.org/10.1126/science.1086940			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717XQ	12958355				2022-12-01	WOS:000185116400035
J	Ojo, AO; Held, PJ; Port, FK; Wolfe, RA; Leichtman, AB; Young, EW; Arndorfer, J; Christensen, L; Merion, RM				Ojo, AO; Held, PJ; Port, FK; Wolfe, RA; Leichtman, AB; Young, EW; Arndorfer, J; Christensen, L; Merion, RM			Chronic renal failure after transplantation of a nonrenal organ	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CYCLOSPORINE NEPHROTOXICITY; LIVER-TRANSPLANTATION; CARDIAC TRANSPLANTATION; HEART-TRANSPLANTATION; RISK-FACTORS; RECIPIENTS; TACROLIMUS; INSUFFICIENCY; IMPAIRMENT; SURVIVAL	Background: Transplantation of nonrenal organs is often complicated by chronic renal disease with multifactorial causes. We conducted a population-based cohort analysis to evaluate the incidence of chronic renal failure, risk factors for it, and the associated hazard of death in recipients of nonrenal transplants. Methods: Pretransplantation and post-transplantation clinical variables and data from a registry of patients with end-stage renal disease (ESRD) were linked in order to estimate the cumulative incidence of chronic renal failure (defined as a glomerular filtration rate of 29 ml per minute per 1.73 m(2) of body-surface area or less or the development of ESRD) and the associated risk of death among 69,321 persons who received nonrenal transplants in the United States between 1990 and 2000. Results: During a median follow-up of 36 months, chronic renal failure developed in 11,426 patients (16.5 percent). Of these patients, 3297 (28.9 percent) required maintenance dialysis or renal transplantation. The five-year risk of chronic renal failure varied according to the type of organ transplanted -- from 6.9 percent among recipients of heart-lung transplants to 21.3 percent among recipients of intestine transplants. Multivariate analysis indicated that an increased risk of chronic renal failure was associated with increasing age (relative risk per 10-year increment, 1.36; P<0.001), female sex (relative risk among male patients as compared with female patients, 0.74; P<0.001), pretransplantation hepatitis C infection (relative risk, 1.15; P<0.001), hypertension (relative risk, 1.18; P<0.001), diabetes mellitus (relative risk, 1.42; P<0.001), and postoperative acute renal failure (relative risk, 2.13; P<0.001). The occurrence of chronic renal failure significantly increased the risk of death (relative risk, 4.55; P<0.001). Treatment of ESRD with kidney transplantation was associated with a five-year risk of death that was significantly lower than that associated with dialysis (relative risk, 0.56; P=0.02). Conclusions: The five-year risk of chronic renal failure after transplantation of a nonrenal organ ranges from 7 to 21 percent, depending on the type of organ transplanted. The occurrence of chronic renal failure among patients with a nonrenal transplant is associated with an increase by a factor of more than four in the risk of death.	Univ Michigan, Sch Med, Div Nephrol, Sci Registry Transplant Recipients, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ojo, AO (corresponding author), Univ Michigan, Sch Med, Div Nephrol, Sci Registry Transplant Recipients, 3914 Taubman Ctr,Box 0364, Ann Arbor, MI 48109 USA.	aojo@umich.edu			NIDDK NIH HHS [K24 DK62234] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK062234] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arend SM, 1997, NEPHROL DIAL TRANSPL, V12, P1672, DOI 10.1093/ndt/12.8.1672; Baid S, 2000, TRANSPLANTATION, V70, P255, DOI 10.1097/00007890-200007270-00001; Bennett WM, 1996, INT J CLIN PHARM TH, V34, P515; Bennett WM, 1996, KIDNEY INT, V50, P1089, DOI 10.1038/ki.1996.415; Brown RS, 1996, TRANSPLANTATION, V62, P1788, DOI 10.1097/00007890-199612270-00018; BRUNNER FP, 1988, NEPHROL DIAL TRANSPL, V3, P585, DOI 10.1093/oxfordjournals.ndt.a091710; Coopersmith CM, 2001, SURGERY, V130, P457, DOI 10.1067/msy.2001.115834; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; English RF, 2002, AM J TRANSPLANT, V2, P769, DOI 10.1034/j.1600-6143.2002.20811.x; Fisher NC, 1998, TRANSPLANTATION, V66, P59, DOI 10.1097/00007890-199807150-00010; GARCIAGARCIA G, 1985, AM J KIDNEY DIS, V5, P10, DOI 10.1016/S0272-6386(85)80129-3; Goldstein DJ, 1997, TRANSPLANTATION, V63, P664, DOI 10.1097/00007890-199703150-00009; GONWA TA, 1992, J HEART LUNG TRANSPL, V11, P926; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; GREENBERG A, 1987, AM J KIDNEY DIS, V9, P12, DOI 10.1016/S0272-6386(87)80156-7; GREENBERG A, 1990, TRANSPLANTATION, V50, P589, DOI 10.1097/00007890-199010000-00012; Israni A, 2002, AM J KIDNEY DIS, V39, DOI 10.1053/ajkd.2002.31427; IWATSUKI S, 1984, TRANSPLANT P, V17, P191; Kasiske BL, 1998, AM J KIDNEY DIS, V32, pS142, DOI 10.1053/ajkd.1998.v32.pm9820472; KASISKE BL, 1993, MINER ELECTROL METAB, V19, P186; Khanna A, 2002, KIDNEY INT, V62, P2257, DOI 10.1046/j.1523-1755.2002.00668.x; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; MAUGER EA, 1995, STAT MED, V14, P1553, DOI 10.1002/sim.4780141406; MCCAULEY J, 1990, NEPHRON, V55, P121, DOI 10.1159/000185938; MCDIARMID SV, 1990, TRANSPLANTATION, V49, P81, DOI 10.1097/00007890-199001000-00018; Molmenti EP, 2001, TRANSPLANTATION, V71, P267, DOI 10.1097/00007890-200101270-00018; MYERS BD, 1986, KIDNEY INT, V30, P964, DOI 10.1038/ki.1986.280; MYERS BD, 1984, NEW ENGL J MED, V311, P699, DOI 10.1056/NEJM198409133111103; *NAT I DIAB DIG KI, 2001, REN DAT SYST USRDS 2, P204; PATTISON JM, 1995, AM J KIDNEY DIS, V26, P643, DOI 10.1016/0272-6386(95)90602-9; PLATZ KP, 1994, TRANSPLANTATION, V58, P170, DOI 10.1097/00007890-199405820-00007; PORAYKO MK, 1995, TRANSPLANT P, V27, P1114; PORT FK, 1993, JAMA-J AM MED ASSOC, V270, P1339, DOI 10.1001/jama.270.11.1339; PUSCHETT JB, 1990, AM J NEPHROL, V10, P296, DOI 10.1159/000168123; RIMOLA A, 1987, GASTROENTEROLOGY, V93, P148, DOI 10.1016/0016-5085(87)90327-1; Ruilope LM, 2001, J AM COLL CARDIOL, V38, P1782, DOI 10.1016/S0735-1097(01)01627-8; SAKHUJA V, 1995, TRANSPL P, V27, P2728; Satchithananda DK, 2002, J HEART LUNG TRANSPL, V21, P651, DOI 10.1016/S1053-2498(01)00411-9; Sehgal AR, 1998, AM J KIDNEY DIS, V31, P593, DOI 10.1053/ajkd.1998.v31.pm9531174; SEHGAL V, 1995, AM J KIDNEY DIS, V26, P193, DOI 10.1016/0272-6386(95)90174-4; Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006; Trompeter R, 2002, PEDIATR NEPHROL, V17, P141, DOI 10.1007/s00467-001-0795-9; van Gelder T, 1998, NEPHROL DIAL TRANSPL, V13, P2322, DOI 10.1093/ndt/13.9.2322; VANBUREN DH, 1994, J AM SOC NEPHROL, V4, pS17; Waller JR, 2002, TRANSPLANT P, V34, P1587, DOI 10.1016/S0041-1345(02)03033-6; WASER M, 1993, J HEART LUNG TRANSPL, V12, P846; WHEATLEY HC, 1987, TRANSPLANTATION, V43, P641, DOI 10.1097/00007890-198705000-00007; Wilkinson AH, 1999, J AM SOC NEPHROL, V10, P1136; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; YOUNG EW, 1994, KIDNEY INT, V46, P1216, DOI 10.1038/ki.1994.387; ZALTZMAN JS, 1992, TRANSPLANTATION, V54, P875, DOI 10.1097/00007890-199211000-00021	51	1596	1640	1	77	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 4	2003	349	10					931	940		10.1056/NEJMoa021744	http://dx.doi.org/10.1056/NEJMoa021744			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	717HJ	12954741				2022-12-01	WOS:000185081400004
J	Nurse, P				Nurse, P			Understanding cells	NATURE			English	Editorial Material									Canc Res UK, Cell Cycle Lab, London WC2A 3PX, England	Cancer Research UK	Nurse, P (corresponding author), Canc Res UK, Cell Cycle Lab, Lincolns Inn Fields, London WC2A 3PX, England.							[Anonymous], 1993, ORIGINS ORDER; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Bray D, 2002, P NATL ACAD SCI USA, V99, P7, DOI 10.1073/pnas.022641699; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; NOVAK B, 1993, J CELL SCI, V106, P1153; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6	6	44	44	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2003	424	6951					883	883		10.1038/424883a	http://dx.doi.org/10.1038/424883a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713EH	12931164	Bronze			2022-12-01	WOS:000184843600019
J	Khot, UN; Khot, MB; Bajzer, CT; Sapp, SK; Ohman, EM; Brener, SJ; Ellis, SG; Lincoff, AM; Topol, EJ				Khot, UN; Khot, MB; Bajzer, CT; Sapp, SK; Ohman, EM; Brener, SJ; Ellis, SG; Lincoff, AM; Topol, EJ			Prevalence of conventional risk factors in. patients with coronary heart disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; DIRECTIONAL ATHERECTOMY; ATHEROSCLEROSIS RISK; PRIMARY PREVENTION; DIABETES-MELLITUS; FOLLOW-UP; MORTALITY; STROKE	Context It is commonly suggested that more than 50% of patients with coronary heart disease (CHD) lack any of the conventional risk factors (cigarette smoking, diabetes, hyperlipidemia, and hypertension). This claim implies that other factors play a significant role in CHID and has led to considerable interest in nontraditional risk factors and genetic causes of CHD. Objective To determine the prevalence of the 4 conventional risk factors among patients with CHD. Design, Setting, and Patients In 2002-2003, we analyzed data for 122458 patients enrolled in 14 international randomized clinical trials of CHD conducted during the prior decade. Patients included 76716 with ST-elevation myocardial infarction, 35527 with unstable angina/non-ST-elevation myocardial infarction, and 10215 undergoing percutaneous coronary intervention. Main Outcome Measures Prevalence of each conventional risk factor and number of conventional risk factors present among patients with CHID, compared between men and women and by age at trial entry. Results Among patients with CHD, at least 1 of the 4 conventional risk factors was present in 84.6% of women and 80.6% of men. In younger patients (men : :55 years and women : 65 years) and most patients presenting either with unstable angina or for percutaneous coronary intervention, only 10% to 15% of patients lacked any of the 4 conventional risk factors. This pattern was largely independent of sex, geographic region, trial entry criteria, or prior CHD. Premature CHD was related to cigarette smoking in men and cigarette smoking and diabetes in women. Smoking decreased the age at the time of CHD event (at trial entry) by nearly 1 decade in all risk factor combinations. Conclusions In direct contrast with conventional,thinking, 80% to 90% of patients with CHID have conventional risk factors. Although research on nontraditional risk factors and genetic causes of heart disease is important, clinical medicine, public health policies, and research efforts should place significant emphasis on the 4 conventional risk factors and the lifestyle behaviors causing them to reduce the epidemic of CHD.	Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA; Univ N Carolina, Sch Med, Dept Med, Div Cardiol, Chapel Hill, NC USA	Cleveland Clinic Foundation; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Khot, UN (corresponding author), Indiana Heart Phys, 112 N 17th Ave,Suite 300, Beech Grove, IN 46107 USA.	khot@cvresearch.net	Manoj, Deepa/AAE-7083-2021	Topol, Eric/0000-0002-1478-4729				ARONOW WS, 1989, J AM GERIATR SOC, V37, P501, DOI 10.1111/j.1532-5415.1989.tb05679.x; BARRETTCONNOR EL, 1991, JAMA-J AM MED ASSOC, V265, P627, DOI 10.1001/jama.265.5.627; BOWLIN SJ, 1993, J CLIN EPIDEMIOL, V46, P561, DOI 10.1016/0895-4356(93)90129-O; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; CALIFF RM, 1994, NEW ENGL J MED, V330, P956, DOI 10.1056/nejm199404073301402; *CDCP, 2000, BEH RISK FACT SURV S; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Dobs AS, 1999, AM J EPIDEMIOL, V150, P1055, DOI 10.1093/oxfordjournals.aje.a009929; Fager G, 1997, ARTERIOSCL THROM VAS, V17, P3527, DOI 10.1161/01.ATV.17.12.3527; Franse LV, 2001, DIABETES CARE, V24, P2065, DOI 10.2337/diacare.24.12.2065; Futterman L G, 1998, Am J Crit Care, V7, P240; Grundy SM, 1998, CIRCULATION, V97, P1876, DOI 10.1161/01.CIR.97.18.1876; GURWITZ JH, 1992, JAMA-J AM MED ASSOC, V268, P1417, DOI 10.1001/jama.268.11.1417; Harrington RA, 2002, CIRCULATION, V105, P316; Hennekens CH, 1998, CIRCULATION, V97, P1095, DOI 10.1161/01.CIR.97.11.1095; HERTOG MGL, 1995, ARCH INTERN MED, V155, P381, DOI 10.1001/archinte.155.4.381; HOLMES DR, 1995, CIRCULATION, V91, P1966, DOI 10.1161/01.CIR.91.7.1966; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; Hyman DJ, 2000, ARCH INTERN MED, V160, P2281, DOI 10.1001/archinte.160.15.2281; JEFFREY S, INTER HEART LARGEST; Jha P, 1996, J AM COLL CARDIOL, V27, P1335, DOI 10.1016/0735-1097(96)00018-6; Jomini V, 2002, J AM COLL CARDIOL, V40, P676, DOI 10.1016/S0735-1097(02)02017-X; Kannel WB, 1998, AM HEART J, V136, P205, DOI 10.1053/hj.1998.v136.90226; Kannel William B, 2002, Am J Geriatr Cardiol, V11, P101, DOI 10.1111/j.1076-7460.2002.00995.x; Keil U, 1998, EUR HEART J, V19, P1197, DOI 10.1053/euhj.1998.1089; KNOPP RH, 2002, TXB CARDIOVASCULAR M, P175; Lefkowitz RJ, 2001, JAMA-J AM MED ASSOC, V285, P581, DOI 10.1001/jama.285.5.581; Levi F, 2002, HEART, V88, P119, DOI 10.1136/heart.88.2.119; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Magnus P, 2001, ARCH INTERN MED, V161, P2657, DOI 10.1001/archinte.161.22.2657; McKechnie RS, 2002, ACC CURR J REV, V11, P32; NIETO FJ, 1995, ARCH INTERN MED, V155, P677, DOI 10.1001/archinte.155.7.677; Norhammar A, 2002, LANCET, V359, P2140, DOI 10.1016/S0140-6736(02)09089-X; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Prasad A, 2002, CIRCULATION, V106, P184, DOI 10.1161/01.CIR.0000021125.83697.21; ROBINSON K, 2002, TXB CARDIOVASCULAR M, P200; Simoons ML, 1997, LANCET, V349, P1429; Simoons ML, 2001, LANCET, V357, P1915; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Tavazzi L, 1999, AM HEART J, V138, pS48, DOI 10.1016/S0002-8703(99)70320-0; Tcheng JE, 1997, LANCET, V349, P1422; Topol E, 1997, NEW ENGL J MED, V337, P1118; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Topol E, 1998, NEW ENGL J MED, V339, P436; Topol E, 1998, CIRCULATION, V97, P2386; Topol EJ, 1997, NEW ENGL J MED, V336, P1689; Topol EJ, 1996, NEW ENGL J MED, V335, P775; TOPOL EJ, 1993, NEW ENGL J MED, V329, P221, DOI 10.1056/NEJM199307223290401; Topol EJ, 2001, LANCET, V357, P1905; *US DEP HHS, 1990, DHHS PUBL CDC; VERSCHUREN WMM, 1995, JAMA-J AM MED ASSOC, V274, P131, DOI 10.1001/jama.274.2.131; WILLETT WC, 1987, NEW ENGL J MED, V317, P1303, DOI 10.1056/NEJM198711193172102; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; WORTH RM, 1975, AM J EPIDEMIOL, V102, P481, DOI 10.1093/oxfordjournals.aje.a112186	55	974	1039	2	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2003	290	7					898	904		10.1001/jama.290.7.898	http://dx.doi.org/10.1001/jama.290.7.898			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	712ZE	12928466				2022-12-01	WOS:000184828800026
J	Strang, J; Sheridan, S				Strang, J; Sheridan, S			Effect of national guidelines on prescription of methadone: analysis of NHS prescription data, England 1990-2001	BRITISH MEDICAL JOURNAL			English	Article							DEPENDENCE		Maudsley Inst Psychiat, Natl Addict Ctr, London SE5 8AF, England	University of London; King's College London	Strang, J (corresponding author), Maudsley Inst Psychiat, Natl Addict Ctr, London SE5 8AF, England.		Strang, John/H-5460-2011	Strang, John/0000-0002-5413-2725; Sheridan, Janie/0000-0002-0312-3095				Gabbay MB, 2000, BRIT J GEN PRACT, V50, P92; Keen J, 1999, BMJ-BRIT MED J, V318, P1503, DOI 10.1136/bmj.318.7197.1503; Strang J, 1996, BMJ-BRIT MED J, V313, P270, DOI 10.1136/bmj.313.7052.270; Strang J, 1998, BRIT MED J, V317, P1489, DOI 10.1136/bmj.317.7171.1489; Ward J, 1999, LANCET, V353, P221, DOI 10.1016/S0140-6736(98)05356-2	5	14	14	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2003	327	7410					321	322		10.1136/bmj.327.7410.321	http://dx.doi.org/10.1136/bmj.327.7410.321			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	710JE	12907486	Bronze, Green Published			2022-12-01	WOS:000184676400018
J	Harley, HE; Putman, EA; Roitblat, HL				Harley, HE; Putman, EA; Roitblat, HL			Bottlenose dolphins perceive object features through echolocation	NATURE			English	Article							TURSIOPS-TRUNCATUS; RECOGNITION; INFORMATION; INTEGRATION	How organisms (including people) recognize distant objects is a fundamental question(1). The correspondence between object characteristics (distal stimuli), like visual shape, and sensory characteristics (proximal stimuli), like retinal projection, is ambiguous. The view that sensory systems are 'designed' to 'pick up' ecologically useful information is vague about how such mechanisms might work(2). In echolocating dolphins, which are studied as models for object recognition sonar systems, the correspondence between echo characteristics and object characteristics is less clear(3). Many cognitive scientists assume that object characteristics are extracted from proximal stimuli, but evidence for this remains ambiguous. For example, a dolphin may store 'sound templates' in its brain and identify whole objects by listening for a particular sound. Alternatively, a dolphin's brain may contain algorithms, derived through natural endowments or experience or both, which allow it to identify object characteristics based on sounds. The standard method used to address this question in many species(4-7) is indirect and has led to equivocal results with dolphins(8-10). Here we outline an appropriate method and test it to show that dolphins extract object characteristics directly from echoes.	New Coll Florida, Div Social Sci, Sarasota, FL 34243 USA; Walt Disney World Resort, Anim Programs, Epcots Living Seas, Lake Buena Vista, FL 32830 USA; DolphinSearch Inc, Ventura, CA 93001 USA	State University System of Florida; New College Florida; Walt Disney Company	Harley, HE (corresponding author), New Coll Florida, Div Social Sci, 5700 N Tamiami Trail, Sarasota, FL 34243 USA.							Au W. W., 1993, SONAR DOLPHINS; AU WWL, 1980, ANIMAL SONAR SYSTEMS, P859; AU WWL, 1992, J COMP PHYSIOL A, V172, P41; DAVENPORT RK, 1976, ANN NY ACAD SCI, V280, P143, DOI 10.1111/j.1749-6632.1976.tb25482.x; EVANS WE, 1973, J ACOUST SOC AM, V54, P191, DOI 10.1121/1.1913562; GARBIN CP, 1988, J EXP PSYCHOL HUMAN, V14, P547, DOI 10.1037/0096-1523.14.4.547; Gibson J.J., 1979, ECOLOGICAL APPROACH; GOLDSTEIN EB, 2001, BLACKWELL HDB PERCEP; GUNDERSON VM, 1990, DEV PSYCHOL, V26, P576, DOI 10.1037/0012-1649.26.4.576; Harley HE, 1996, J EXP PSYCHOL ANIM B, V22, P164, DOI 10.1037/0097-7403.22.2.164; Herman LM, 1998, J COMP PSYCHOL, V112, P292, DOI 10.1037/0735-7036.112.3.292; Nachtigall PE., 1980, ANIMAL SONAR SYSTEMS, P945, DOI [10.1007/978-1-4684-7254-7_64, DOI 10.1007/978-1-4684-7254-7_64]; PACK AA, 1995, J ACOUST SOC AM, V98, P722, DOI 10.1121/1.413566; ROITBLAT HL, 1990, J EXP PSYCHOL ANIM B, V16, P85, DOI 10.1037/0097-7403.16.1.85; WEISKRANTZ L, 1975, NEUROPSYCHOLOGIA, V13, P257, DOI 10.1016/0028-3932(75)90001-9; Xitco MJ, 1996, ANIM LEARN BEHAV, V24, P355, DOI 10.3758/BF03199007	16	57	58	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					667	669		10.1038/nature01846	http://dx.doi.org/10.1038/nature01846			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	708QE	12904791				2022-12-01	WOS:000184578800043
J	Yamamoto, M; Sato, S; Hemmi, H; Hoshino, K; Kaisho, T; Sanjo, H; Takeuchi, O; Sugiyama, M; Okabe, M; Takeda, K; Akira, S				Yamamoto, M; Sato, S; Hemmi, H; Hoshino, K; Kaisho, T; Sanjo, H; Takeuchi, O; Sugiyama, M; Okabe, M; Takeda, K; Akira, S			Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway	SCIENCE			English	Article								Stimulation of Toll-like receptors (TLRs) triggers activation of a common MyD88-dependent signaling pathway as well as a MyD88-independent pathway that is unique to TLR3 and TLR4 signaling pathways leading to interferon (IFN)-beta production. Here we disrupted the gene encoding a Toll/IL-1 receptor (TIR) domain- containing adaptor, TRIF. TRIF-deficient mice were defective in both TLR3- and TLR4-mediated expression of IFN-beta and activation of IRF-3. Furthermore, inflammatory cytokine production in response to the TLR4 ligand, but not to other TLR ligands, was severely impaired in TRIF-deficient macrophages. Mice deficient in both MyD88 and TRIF showed complete loss of nuclear factor kappa B activation in response to TLR4 stimulation. These findings demonstrate that TRIF is essential for TLR3- and TLR4-mediated signaling pathways facilitating mammalian antiviral host defense.	Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, ERATO, Suita, Osaka 5650871, Japan; Genome Informat Res Ctr, Suita, Osaka 5650871, Japan; RIKEN, Res Ctr Allergy & Immunol, Tsurumi Ku, Kanagawa 2300045, Japan	Osaka University; Japan Science & Technology Agency (JST); RIKEN	Akira, S (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Host Def, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.		Hoshino, Katsuaki/L-9162-2014; Kaisho, Tsuneyasu/B-4130-2012; Takeda, Kiyoshi/C-9331-2009; Hoshino, Katsuaki/AAE-2830-2022; Akira, Shizuo/C-3134-2009; Takeuchi, Osamu/AAG-9359-2019; Takeuchi, Osamu/D-6007-2011; Okabe, Masaru/B-6917-2015	Hoshino, Katsuaki/0000-0003-0493-4815; Hoshino, Katsuaki/0000-0003-0493-4815; Takeuchi, Osamu/0000-0002-1260-6232; Sato, Shintaro/0000-0001-5156-3354; Okabe, Masaru/0000-0002-0803-9044				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Nomura F, 2000, GENES CELLS, V5, P191; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; TAKEUCHI O, UNPUB; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	21	2388	2507	4	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2003	301	5633					640	643		10.1126/science.1087262	http://dx.doi.org/10.1126/science.1087262			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12855817				2022-12-01	WOS:000184473600038
J	Fukami, T; Morin, PJ				Fukami, T; Morin, PJ			Productivity-biodiversity relationships depend on the history of community assembly	NATURE			English	Article							SPECIES-DIVERSITY; GRADIENTS; RICHNESS; PATTERNS	Identification of the causes of productivity-species diversity relationships remains a central topic of ecological research(1,2). Different relations have been attributed to the influence of disturbance(3,4), consumers(5,6), niche specialization 7 and spatial scale(8-14). One unexplored cause is the history of community assembly, the partly stochastic sequential arrival of species from a regional pool of potential community members. The sequence of species arrival can greatly affect community structure(15-19). If assembly sequence interacts with productivity to influence diversity, different sequences can contribute to variation in productivity-diversity relationships. Here we report a test of this hypothesis by assembling aquatic microbial communities at five productivity levels using four assembly sequences. About 30 generations after assembly, productivity-diversity relationships took various forms, including a positive, a hump-shaped, a U-shaped and a non-significant pattern, depending on assembly sequence. This variation resulted from idiosyncratic joint effects of assembly sequence, productivity and species identity on species abundances. We suggest that the history of community assembly should be added to the growing list of factors that influence productivity-biodiversity patterns.	Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA	University of Tennessee System; University of Tennessee Knoxville; Rutgers State University New Brunswick	Fukami, T (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	tfukami@utk.edu	Fukami, Tadashi/A-2934-2010	Fukami, Tadashi/0000-0001-5654-4785				ABRAMS PA, 1995, ECOLOGY, V76, P2019, DOI 10.2307/1941677; Chase JM, 1999, AM NAT, V154, P559, DOI 10.1086/303260; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; CONNELL JH, 1964, AM NAT, V98, P399, DOI 10.1086/282335; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; DRAKE JA, 1991, AM NAT, V137, P1, DOI 10.1086/285143; GILPIN ME, 1976, NATURE, V261, P40, DOI 10.1038/261040a0; Gross KL, 2000, OIKOS, V89, P417, DOI 10.1034/j.1600-0706.2000.890301.x; Holt RD, 1997, AM NAT, V149, P745, DOI 10.1086/286018; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; Kondoh M, 2001, P ROY SOC B-BIOL SCI, V268, P269, DOI 10.1098/rspb.2000.1384; LAW R, 1993, ECOLOGY, V74, P1347, DOI 10.2307/1940065; Leibold MA, 1997, ANNU REV ECOL SYST, V28, P467, DOI 10.1146/annurev.ecolsys.28.1.467; LEIGH EG, 1965, P NATL ACAD SCI USA, V53, P777, DOI 10.1073/pnas.53.4.777; Magurran A.E, 1995, BIOL DIVERSITY, V32, P668, DOI 10.2307/2404662; MITCHELLOLDS T, 1987, EVOLUTION, V41, P1149, DOI [10.2307/2409084, 10.1111/j.1558-5646.1987.tb02457.x]; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Morin PJ, 2000, NATURE, V406, P463, DOI 10.1038/35020160; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; POST WM, 1983, MATH BIOSCI, V64, P169, DOI 10.1016/0025-5564(83)90002-0; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; ROSENZWEIG ML, 1992, J MAMMAL, V73, P715, DOI 10.2307/1382191; Scheiner SM, 2000, EVOL ECOL RES, V2, P791; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Tilman David, 1993, P13; vandeKoppel J, 1996, ECOLOGY, V77, P736, DOI 10.2307/2265498; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; WILSON DS, 1992, ECOLOGY, V73, P1984, DOI 10.2307/1941449; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830; Wright David H., 1993, P66	30	193	202	8	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					423	426		10.1038/nature01785	http://dx.doi.org/10.1038/nature01785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879069				2022-12-01	WOS:000184318400042
J	Keppler, H; Wiedenbeck, M; Shcheka, SS				Keppler, H; Wiedenbeck, M; Shcheka, SS			Carbon solubility in olivine and the mode of carbon storage in the Earth's mantle	NATURE			English	Article							CO2	The total amount of carbon in the atmosphere, oceans and other near-surface reservoirs is thought to be negligible compared to that stored in the Earth's mantle(1-3). Although the mode of carbon storage in the mantle is largely unknown, observations of microbubbles on dislocations in minerals from mantle xenoliths has led to the suggestion that carbon may be soluble in silicates at high pressure(4,5). Here we report measurements of carbon solubility in olivine, the major constituent of the upper mantle, at pressures up to 3.5 GPa. We have found that, contrary to previous expectations, carbon solubility in olivine is exceedingly low- of the order of 0.1 to 1 parts per million by weight. Together with similar data for pyroxenes, garnet and spinel, we interpret this to imply that most carbon must be present as a separate phase in the deeper parts of the upper mantle, probably as a carbonate phase(6,7). Large-scale volcanic eruptions tapping such a carbonate-bearing mantle reservoir might therefore rapidly transfer large amounts of carbon dioxide into the atmosphere, consistent with models that link global mass extinctions to flood basalt eruptions via a sudden increase in atmospheric carbon dioxide levels(8-11)	Univ Tubingen, Inst Geowissensch, D-72074 Tubingen, Germany; Geoforschungszentrum Potsdam, Projektbereich 4 2, D-14473 Potsdam, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences	Keppler, H (corresponding author), Univ Tubingen, Inst Geowissensch, Wilhelmstr 56, D-72074 Tubingen, Germany.	Hans.Keppler@uni-tuebingen.de		Shcheka, Svyatoslav/0000-0003-0865-0828				Beerling D, 2002, NATURE, V415, P386, DOI 10.1038/415386a; BELL DR, 1992, SCIENCE, V255, P1391, DOI 10.1126/science.255.5050.1391; FREUND F, 1980, GEOCHIM COSMOCHIM AC, V44, P1319, DOI 10.1016/0016-7037(80)90092-7; GREEN HW, 1972, NATURE-PHYS SCI, V238, P2, DOI 10.1038/physci238002a0; GREEN HW, 1975, GEOL SOC AM BULL, V86, P846, DOI 10.1130/0016-7606(1975)86<846:FPIRFT>2.0.CO;2; HAURI E, 2002, EOS, V83, P383; HAURI EH, 1993, NATURE, V365, P221, DOI 10.1038/365221a0; JAMBON A, 1994, REV MINERAL, V30, P479; JAVOY M, 1982, NATURE, V300, P171, DOI 10.1038/300171a0; Kerrick DM, 2001, REV GEOPHYS, V39, P565, DOI 10.1029/2001RG000105; Kohlstedt DL, 1996, CONTRIB MINERAL PETR, V123, P345, DOI 10.1007/s004100050161; Marzoli A, 1999, SCIENCE, V284, P616, DOI 10.1126/science.284.5414.616; MATHEZ EA, 1987, J GEOPHYS RES-SOLID, V92, P3500, DOI 10.1029/JB092iB05p03500; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; NEWTON RC, 1975, EARTH PLANET SC LETT, V26, P239, DOI 10.1016/0012-821X(75)90091-6; Putnis A., 1992, INTRO MINERAL SCI, Vfirst; Saal AE, 2002, NATURE, V419, P451, DOI 10.1038/nature01073; TINGLE TN, 1988, J GEOPHYS RES-SOLID, V93, P15289, DOI 10.1029/JB093iB12p15289; TSONG IST, 1985, PHYS CHEM MINER, V12, P261, DOI 10.1007/BF00310338; WYLLIE PJ, 1976, CONTRIB MINERAL PETR, V54, P79, DOI 10.1007/BF00372117; ZHANG YX, 1993, EARTH PLANET SC LETT, V117, P331, DOI 10.1016/0012-821X(93)90088-Q	21	125	133	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					414	416		10.1038/nature01828	http://dx.doi.org/10.1038/nature01828			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879066				2022-12-01	WOS:000184318400039
J	Neuner, JM; Hamel, MB; Phillips, RS; Bona, K; Aronson, MD				Neuner, JM; Hamel, MB; Phillips, RS; Bona, K; Aronson, MD			Diagnosis and management of adults with pharyngitis - A cost-effectiveness analysis	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	24th Annual Meeting of the Society-of-General-Internal-Medicine	MAY 02-05, 2001	SAN DIEGO, CA	Soc Gen Internal Med			GROUP-A STREPTOCOCCI; ACUTE RHEUMATIC-FEVER; BETA-HEMOLYTIC STREPTOCOCCI; APPROPRIATE ANTIBIOTIC USE; RESPIRATORY-TRACT INFECTIONS; MANAGING SORE THROAT; OPTICAL IMMUNOASSAY; DECISION-ANALYSIS; GENERAL-PRACTICE; RAPID DETECTION	Background: Rheumatic fever has become uncommon in the United States while rapid diagnostic test technology for streptococcal antigens has improved. However, little is known about the effectiveness or cost-effectiveness of various strategies for managing pharyngitis caused by group A beta-hemolytic streptococcus (GAS) in U.S. adults. Objective: To examine the cost-effectiveness of several diagnostic and management strategies for patients with suspected GAS pharyngitis. Design: Cost-effectiveness analysis. Data Sources: Published literature, including systematic reviews where possible. When costs were not available in the literature, we estimated them from our institution and Medicare charges. Target Population: Adults in the general U.S. population. Time Horizon: 1 year. Perspective: Societal. Interventions: Five strategies for the management of adult patients with pharyngitis: 1) observation without testing or treatment, 2) empirical treatment with penicillin, 3) throat culture using a two-plate selective culture technique, 4) optical immunoassay (OIA) followed by culture to confirm negative OIA test results, or 5) OIA alone. Outcome Measures: Cost per lost quality-adjusted life-days (converted to life-years where appropriate) and incremental cost-effectiveness. Results of Base-Case Analysis: Empirical treatment was the least effective strategy at a GAS pharyngitis prevalence of 10% (resulting in 0.41 lost quality-adjusted life-day). Although the other four strategies had similar effectiveness (all resulted in about 0.27 lost quality-adjusted life-day), culture was the least expensive strategy. Results of Sensitivity Analyses: Results were sensitive to the prevalence of GAS pharyngitis: OIA followed by culture was most effective when GAS pharyngitis prevalence was greater than 20%. Observation was least expensive when prevalence was less than 6%, and empirical treatment was least expensive when prevalence was greater than 71%. The effectiveness of strategies was also very sensitive to the probability of anaphylaxis: When the probability of anaphylaxis was about half the baseline probability, OIA/culture was most effective; when the probability was 1.6 times that of baseline, observation was most effective. Only at an OIA cost less than half of baseline did the OIA alone strategy become less expensive than culture. Results were not sensitive to other variations in probabilities or costs of diagnosis or treatment of GAS pharyngitis. Conclusions: Observation, culture, and two rapid antigen test strategies for diagnostic testing and treatment of suspected GAS pharyngitis in adults have very similar effectiveness and costs, although culture is the least expensive and most effective strategy when the GAS pharyngitis prevalence is 10%. Empirical treatment was not the most effective or least expensive strategy at any prevalence of GAS pharyngitis in adults, although it may be reasonable for individual patients at very high risk for GAS pharyngitis as assessed by a clinical decision rule.	Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA	Harvard University; Beth Israel Deaconess Medical Center; Medical College of Wisconsin	Aronson, MD (corresponding author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave,Rose Bldg,Room 118, Boston, MA 02215 USA.							ANHALT JP, 1992, J CLIN MICROBIOL, V30, P2135, DOI 10.1128/JCM.30.8.2135-2138.1992; BAKER DM, 1995, DIAGN MICR INFEC DIS, V21, P61, DOI 10.1016/0732-8893(95)00023-4; BELLON J, 1991, J CLIN MICROBIOL, V29, P2084, DOI 10.1128/JCM.29.9.2084-2085.1991; Bisno AL, 1997, CLIN INFECT DIS, V25, P574, DOI 10.1086/513768; BRINK WR, 1951, AM J MED, V10, P300, DOI 10.1016/0002-9343(51)90274-4; BRUMFITT W, 1957, LANCET, V1, P8; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; CATANZARO FJ, 1954, AM J MED, V17, P749, DOI 10.1016/0002-9343(54)90219-3; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; CENTOR RM, 1986, J GEN INTERN MED, V1, P248, DOI 10.1007/BF02596194; CENTOR RM, 1986, ANN INTERN MED, V105, P892, DOI 10.7326/0003-4819-105-6-892; CHAMOVITZ R, 1954, NEW ENGL J MED, V251, P466, DOI 10.1056/NEJM195409162511203; Cooper RJ, 2001, ANN INTERN MED, V134, P509, DOI 10.7326/0003-4819-134-6-200103200-00019; CRAWFORD G, 1979, ANN INTERN MED, V90, P293, DOI 10.7326/0003-4819-90-3-293; Dagnelie CF, 1996, BRIT J GEN PRACT, V46, P589; DAJANI A, 1995, PEDIATRICS, V96, P758; DALY JA, 1994, J CLIN MICROBIOL, V32, P531, DOI 10.1128/JCM.32.2.531-532.1994; DELMAR C, 1992, MED J AUSTRALIA, V156, P644, DOI 10.5694/j.1326-5377.1992.tb121463.x; DELMAR CB, 2002, COCHRANE DATABASE SY, P2; DEMEYERE M, 1992, EUR J CLIN PHARMACOL, V43, P581, DOI 10.1007/BF02284954; DENNY FW, 1950, JAMA-J AM MED ASSOC, V143, P151, DOI 10.1001/jama.1950.02910370001001; DENNY FW, 1953, PEDIATRICS, V11, P7; deShazo RD, 1997, JAMA-J AM MED ASSOC, V278, P1895, DOI 10.1001/jama.278.22.1895; Dobbs F, 1996, BRIT J GEN PRACT, V46, P461; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Ebell MH, 2000, JAMA-J AM MED ASSOC, V284, P2912, DOI 10.1001/jama.284.22.2912; FEINSTEIN AR, 1964, ANN INTERN MED, V60, P87, DOI 10.7326/0003-4819-60-2-87; FINKLER SA, 1982, ANN INTERN MED, V96, P102, DOI 10.7326/0003-4819-96-1-102; FRIES SM, 1995, J PEDIATR-US, V126, P933, DOI 10.1016/S0022-3476(95)70213-X; Gerber MA, 1997, JAMA-J AM MED ASSOC, V277, P899, DOI 10.1001/jama.277.11.899; GERBER MA, 1989, PEDIATR INFECT DIS J, V8, P820, DOI 10.1097/00006454-198911000-00032; Gold MR., 1996, COST EFFECTIVENESS H; Goldman L., 2000, CECIL TXB MED; Gonzales R, 2001, ANN INTERN MED, V134, P479, DOI 10.7326/0003-4819-134-6-200103200-00013; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; GOSLINGS WR, 1963, NEW ENGL J MED, V268, P687, DOI 10.1056/NEJM196303282681301; GRAHAM L, 1986, J CLIN MICROBIOL, V24, P644, DOI 10.1128/JCM.24.4.644-646.1986; Gunnarsson RK, 1997, SCAND J PRIM HEALTH, V15, P149, DOI 10.3109/02813439709018506; HARBECK RJ, 1993, J CLIN MICROBIOL, V31, P839, DOI 10.1128/JCM.31.4.839-844.1993; HEITER BJ, 1995, J CLIN MICROBIOL, V33, P1408, DOI 10.1128/JCM.33.5.1408-1410.1995; HERMAN JM, 1984, J FAM PRACTICE, V19, P767; HILLNER BE, 1992, JAMA-J AM MED ASSOC, V267, P2055, DOI 10.1001/jama.267.15.2055; HILLNER BE, 1987, J GEN INTERN MED, V2, P244, DOI 10.1007/BF02596449; HOFFMANN S, 1990, DIAGN MICR INFEC DIS, V13, P209, DOI 10.1016/0732-8893(90)90061-Y; Hoffmann Steen, 1992, Scandinavian Journal of Primary Health Care, V10, P295, DOI 10.3109/02813439209014077; HOLMBERG SD, 1983, JAMA-J AM MED ASSOC, V250, P2307, DOI 10.1001/jama.250.17.2307; HORDER J, 1954, Practitioner, V173, P177; HUOVINEN P, 1989, ANN INTERN MED, V110, P612, DOI 10.7326/0003-4819-110-8-612; Kaltwasser G, 1997, PEDIATR INFECT DIS J, V16, P748, DOI 10.1097/00006454-199708000-00004; KAPLAN EL, 1971, J INFECT DIS, V123, P490, DOI 10.1093/infdis/123.5.490; KELLOGG JA, 1986, JAMA-J AM MED ASSOC, V255, P2638, DOI 10.1001/jama.255.19.2638; KELLOGG JA, 1990, J CLIN MICROBIOL, V28, P165, DOI 10.1128/JCM.28.2.165-169.1990; KIRSCHNER CG, 1994, CPT 95; KIRSCHNER CG, 1997, PHYSICIANS CURRENT P; KJAKOVIC M, 1993, NZ MED J, V106, P381; KOMAROFF AL, 1986, J GEN INTERN MED, V1, P1, DOI 10.1007/BF02596317; Kuhn S, 1999, DIAGN MICR INFEC DIS, V34, P275, DOI 10.1016/S0732-8893(99)00027-9; LAUER BA, 1983, J CLIN MICROBIOL, V17, P338, DOI 10.1128/JCM.17.2.338-340.1983; Linder JA, 2001, JAMA-J AM MED ASSOC, V286, P1181, DOI 10.1001/jama.286.10.1181; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Little P, 1999, BRIT MED J, V319, P736, DOI 10.1136/bmj.319.7212.736; MANDELL GL, 1995, GOODMAN GILMANS PHAR, P272; Martin JM, 2002, NEW ENGL J MED, V346, P1200, DOI 10.1056/NEJMoa013169; McIsaac WJ, 1998, CAN MED ASSOC J, V158, P75; *MED EC, 2000, DRUG TOP RED BOOK; MELAND E, 1993, SCAND J INFECT DIS, V25, P177, DOI 10.3109/00365549309008482; MOYER NP, 1990, J CLIN MICROBIOL, V28, P1661, DOI 10.1128/JCM.28.7.1661-1663.1990; Petersen K, 1997, J GEN INTERN MED, V12, P95, DOI 10.1046/j.1525-1497.1997.00013.x; Pitetti RD, 1998, PEDIATR EMERG CARE, V14, P396, DOI 10.1097/00006565-199812000-00004; POSES RM, 1986, ANN INTERN MED, V105, P586, DOI 10.7326/0003-4819-105-4-586; RODDEY OF, 1995, JAMA-J AM MED ASSOC, V274, P1863, DOI 10.1001/jama.274.23.1863; SANFORD JP, 1984, PHARYNGITIS MANAGEME, P251; SAVOIA D, 1994, MICROBIOS, V77, P253; SCHAPPERT SM, 1998, AMBULATORY CARE VISI; Schlager TA, 1996, ARCH PEDIAT ADOL MED, V150, P245, DOI 10.1001/archpedi.1996.02170280015002; SEPPALA H, 1992, NEW ENGL J MED, V326, P292, DOI 10.1056/NEJM199201303260503; SIEGEL AC, 1961, NEW ENGL J MED, V265, P559, DOI 10.1056/NEJM196109212651201; SMITH JM, 1995, LAB MED, V26, P408, DOI 10.1093/labmed/26.6.408; Snow V, 2001, ANN INTERN MED, V134, P506, DOI 10.7326/0003-4819-134-6-200103200-00018; Steinhoff MC, 1997, LANCET, V350, P918, DOI 10.1016/S0140-6736(97)03317-5; STOLLERMAN GH, 1982, ADV INTERNAL MED, V27, P373; Tengs TO, 2000, MED CARE, V38, P583, DOI 10.1097/00005650-200006000-00004; TOMPKINS RK, 1977, ANN INTERN MED, V86, P481, DOI 10.7326/0003-4819-86-4-481; TSEVAT J, 1995, J AM COLL CARDIOL, V26, P914, DOI 10.1016/0735-1097(95)00284-1; TSEVAT J, 1991, J PEDIATR-US, V118, P546, DOI 10.1016/S0022-3476(05)83375-X; Tsevat J, 1999, ARCH PEDIAT ADOL MED, V153, P681, DOI 10.1001/archpedi.153.7.681; VALKENBURG HA, 1971, J INFECT DIS, V124, P348, DOI 10.1093/infdis/124.4.348; VEASY LG, 1994, J PEDIATR-US, V124, P9, DOI 10.1016/S0022-3476(94)70247-0; WALLACE MR, 1989, JAMA-J AM MED ASSOC, V262, P2557, DOI 10.1001/jama.262.18.2557; WALSH BT, 1975, ARCH INTERN MED, V135, P1493, DOI 10.1001/archinte.135.11.1493; WANNAMAKER LW, 1951, AM J MED, V10, P673, DOI 10.1016/0002-9343(51)90336-1; Webb KH, 1998, PEDIATRICS, V101, part. no., DOI 10.1542/peds.101.2.e2; WEGNER DL, 1992, JAMA-J AM MED ASSOC, V267, P695, DOI 10.1001/jama.267.5.695; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; WIGTON RS, 1986, ARCH INTERN MED, V146, P81, DOI 10.1001/archinte.146.1.81; Zwart S, 2000, BRIT MED J, V320, P150, DOI 10.1136/bmj.320.7228.150	96	66	69	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2003	139	2					113	122		10.7326/0003-4819-139-2-200307150-00011	http://dx.doi.org/10.7326/0003-4819-139-2-200307150-00011			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	701HX	12859161				2022-12-01	WOS:000184163100005
J	Harper, SM; Neil, LC; Gardner, KH				Harper, SM; Neil, LC; Gardner, KH			Structural basis of a phototropin light switch	SCIENCE			English	Article							PHOTOACTIVE YELLOW PROTEIN; SIGNAL-TRANSDUCTION; RHIZOBIUM-MELILOTI; CHEMICAL-SHIFT; LOV2 DOMAIN; PAS DOMAIN; BINDING; RECEPTOR; KINASE; PHOTOCYCLE	Phototropins are light-activated kinases important for plant responses to blue light. Light initiates signaling in these proteins by generating a covalent protein . flavin mononucleotide (FMN) adduct within sensory Per-ARNT-Sim ( PAS) domains. We characterized the light-dependent changes of a phototropin PAS domain by solution nuclear magnetic resonance spectroscopy and found that an alpha helix located outside the canonical domain plays a key role in this activation process. Although this helix associates with the PAS core in the dark, photoinduced changes in the domain structure disrupt this interaction. We propose that this mechanism couples light-dependent bond formation to kinase activation and identifies a signaling pathway conserved among PAS domains.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Gardner, KH (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Gardner, Kevin/K-5493-2019; Gardner, Kevin H./K-7802-2012	Gardner, Kevin H./0000-0002-8671-2556	NATIONAL CANCER INSTITUTE [R01CA090601] Funding Source: NIH RePORTER; NCI NIH HHS [CA90601] Funding Source: Medline; NIGMS NIH HHS [GM08297] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amezcua CA, 2002, STRUCTURE, V10, P1349, DOI 10.1016/S0969-2126(02)00857-2; BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Corchnoy SB, 2003, J BIOL CHEM, V278, P724, DOI 10.1074/jbc.M209119200; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Creighton T.E., 1984, PROTEINS STRUCTURE M; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Dux P, 1998, BIOCHEMISTRY-US, V37, P12689, DOI 10.1021/bi9806652; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Fedorov R, 2003, BIOPHYS J, V84, P2474, DOI 10.1016/S0006-3495(03)75052-8; GILLESGONZALEZ MA, 1993, J BIOL CHEM, V268, P16293; Harper S. R., UNPUB; Hellingwerf KJ, 2003, J PHYS CHEM A, V107, P1082, DOI 10.1021/jp027005y; Hoff WD, 1999, BIOCHEMISTRY-US, V38, P1009, DOI 10.1021/bi980504y; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; MONSON EK, 1995, J BIOL CHEM, V270, P5243, DOI 10.1074/jbc.270.10.5243; Rubinstenn G, 1999, J MAGN RESON, V137, P443, DOI 10.1006/jmre.1999.1705; Rubinstenn G, 1998, NAT STRUCT BIOL, V5, P568, DOI 10.1038/823; Rutter J, 2001, P NATL ACAD SCI USA, V98, P8991, DOI 10.1073/pnas.161284798; Sakamoto K, 2002, PLANT CELL, V14, P1723, DOI 10.1105/tpc.003293; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Salomon M, 2001, P NATL ACAD SCI USA, V98, P12357, DOI 10.1073/pnas.221455298; Swartz TE, 2002, BIOCHEMISTRY-US, V41, P7183, DOI 10.1021/bi025861u; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; WISHART DS, 1994, J BIOMOL NMR, V4, P171	29	605	621	3	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2003	301	5639					1541	1544		10.1126/science.1086810	http://dx.doi.org/10.1126/science.1086810			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	720HL	12970567				2022-12-01	WOS:000185255300052
J	Hastings, A				Hastings, A			Metapopulation persistence with age-dependent disturbance or succession	SCIENCE			English	Article							CANADIAN BOREAL FOREST; LANDSCAPE-SCALE TEST; HABITAT DESTRUCTION; DYNAMICS; MANAGEMENT; COEXISTENCE; MODEL; BIRDS; FROG	Simple metapopulation models with random disturbances are used in species conservation or management, relying on the condition for persistence that the per-patch colonization rate be greater than the per-patch extinction rate. For a general model incorporating the role of succession or patch age - dependent extinction, I show that persistence requires the per-patch colonization rate to be greater than the inverse of mean patch age, where age is the time since the patch became available for colonization. Because mean patch age can be arbitrarily large relative to the extinction rate, currently persisting metapopulations may be persisting despite small colonization rates, and management approaches that do not consider the role of mean patch age may unnecessarily doom populations to extinction.	Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	University of California System; University of California Davis	Hastings, A (corresponding author), Univ Calif Davis, Dept Environm Sci & Policy, 1 Shields Ave, Davis, CA 95616 USA.		Hastings, Alan/O-6864-2019; Hastings, Alan/A-7423-2008	Hastings, Alan/0000-0002-0717-8026; 				Amarasekare P, 2001, J THEOR BIOL, V209, P333, DOI 10.1006/jtbi.2001.2269; Bengtsson J, 2000, FOREST ECOL MANAG, V132, P39, DOI 10.1016/S0378-1127(00)00378-9; Bergeron Y, 2002, SILVA FENN, V36, P81, DOI 10.14214/sf.553; Bergeron Y, 2001, CAN J FOREST RES, V31, P384, DOI 10.1139/cjfr-31-3-384; Bergman KO, 2002, BIOL CONSERV, V108, P361, DOI 10.1016/S0006-3207(02)00104-0; Carlson A, 2000, P ROY SOC B-BIOL SCI, V267, P1311, DOI 10.1098/rspb.2000.1143; Ellner SP, 2003, ECOLOGY, V84, P882, DOI 10.1890/0012-9658(2003)084[0882:EOSDOM]2.0.CO;2; Feller W., 2008, INTRO PROBABILITY TH; GULVE PS, 1994, ECOLOGY, V75, P1357, DOI 10.2307/1937460; Gyllenberg M, 1997, THEOR POPUL BIOL, V52, P198, DOI 10.1006/tpbi.1997.1333; Hanski I. A., 1999, METAPOPULATION ECOLO; HASTINGS A, 1994, ANNU REV ECOL SYST, V25, P167; HASTINGS A, 1991, BIOL J LINN SOC, V42, P57, DOI 10.1111/j.1095-8312.1991.tb00551.x; Johnson MP, 2000, P ROY SOC B-BIOL SCI, V267, P1967, DOI 10.1098/rspb.2000.1237; Johnson MP, 2000, OIKOS, V88, P67, DOI 10.1034/j.1600-0706.2000.880108.x; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Lewis OT, 2001, CONSERV BIOL, V15, P389, DOI 10.1046/j.1523-1739.2001.015002389.x; Lindenmayer D, 2002, FOREST ECOL MANAG, V155, P319, DOI 10.1016/S0378-1127(01)00569-2; Lindenmayer DB, 2001, OIKOS, V92, P445, DOI 10.1034/j.1600-0706.2001.920306.x; Lindenmayer DB, 2001, J APPL ECOL, V38, P36, DOI 10.1046/j.1365-2664.2001.00558.x; NEE S, 1992, J ANIM ECOL, V61, P37, DOI 10.2307/5506; PAINE RT, 1981, ECOL MONOGR, V51, P145, DOI 10.2307/2937261; Poulsen BO, 2002, BIODIVERS CONSERV, V11, P1551, DOI 10.1023/A:1016839518172; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Richards SA, 1999, ECOL APPL, V9, P880, DOI 10.1890/1051-0761(1999)009[0880:OFMFMC]2.0.CO;2; Spence JR, 2001, TRENDS ECOL EVOL, V16, P591, DOI 10.1016/S0169-5347(01)02335-7; Stelter C, 1997, J ANIM ECOL, V66, P508, DOI 10.2307/5945; Wahlberg N, 2002, ECOGRAPHY, V25, P224, DOI 10.1034/j.1600-0587.2002.250210.x; Whitman AA, 1998, BIOTROPICA, V30, P449, DOI 10.1111/j.1744-7429.1998.tb00079.x	29	59	60	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2003	301	5639					1525	1526		10.1126/science.1087570	http://dx.doi.org/10.1126/science.1087570			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	720HL	12970563				2022-12-01	WOS:000185255300047
J	Murray, L; Watson, P; Johnston, B; Sloan, J; Mainie, IML; Gavin, A				Murray, L; Watson, P; Johnston, B; Sloan, J; Mainie, IML; Gavin, A			Risk of adenocarcinoma in Barrett's oesophagus: population based study	BRITISH MEDICAL JOURNAL			English	Article							CANCER-RISK; SURVEILLANCE		Queens Univ Belfast, Dept Epidemiol & Publ Hlth, No Ireland Canc Registry, Belfast BT12 6BJ, Antrim, North Ireland; Royal Hosp Trust, Belfast BT12 6BA, Antrim, North Ireland; Ulster Hosp, Belfast BT16 1RB, Antrim, North Ireland	Queens University Belfast	Murray, L (corresponding author), Queens Univ Belfast, Dept Epidemiol & Publ Hlth, No Ireland Canc Registry, Belfast BT12 6BJ, Antrim, North Ireland.							Conio M, 2001, GUT, V48, P304, DOI 10.1136/gut.48.3.304; Gross CP, 1999, AM J GASTROENTEROL, V94, P3440, DOI 10.1111/j.1572-0241.1999.01606.x; Macdonald CE, 2000, BMJ-BRIT MED J, V321, P1252, DOI 10.1136/bmj.321.7271.1252; Provenzale D, 1999, AM J GASTROENTEROL, V94, P2043; Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302	5	90	95	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 6	2003	327	7414					534	535		10.1136/bmj.327.7414.534	http://dx.doi.org/10.1136/bmj.327.7414.534			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720WW	12958113	Bronze, Green Published			2022-12-01	WOS:000185283700018
J	Luo, HBR; Huang, YE; Chen, JMC; Saiardi, A; Iijima, M; Ye, KQ; Huang, YF; Nagata, E; Devreotes, P; Snyder, SH				Luo, HBR; Huang, YE; Chen, JMC; Saiardi, A; Iijima, M; Ye, KQ; Huang, YF; Nagata, E; Devreotes, P; Snyder, SH			Inositol pyrophosphates mediate chemotaxis in Dictyostelium via pleckstrin homology domain-PtdIns (3,4,5)P3 interactions	CELL			English	Article							DIPHOSPHOINOSITOL PENTAKISPHOSPHATE; SACCHAROMYCES-CEREVISIAE; HEXAKISPHOSPHATE KINASE/; SIGNAL-TRANSDUCTION; TUMOR-SUPPRESSOR; EXCHANGE FACTOR; LEADING-EDGE; PROTEIN; BINDING; CELLS	Inositol phosphates are well-known signaling molecules, whereas the inositol pyrophosphates, such as diphosphoinositol pentakisphosphate (InsP7/IP7) and bis-diphosphoinositol tetrakisphosphate (InsP8/IP8), are less well characterized. We demonstrate physiologic regulation of Dictyostelium chemotaxis by InsP7 mediated by its competition with PtdIns(3,4,5)P3 for binding pleckstrin homology (PH) domain-containing proteins. Chemoattractant stimulation triggers rapid and sustained elevations in InsP7/InsP8 levels. Depletion of InsP7 and InsP8 by deleting the gene for InsP6 kinase (InsP6K/IP6K), which converts inositol hexakisphosphate (InsP6/IP6) to InsP7, causes rapid aggregation of mutant cells and increased sensitivity to cAMP. Chemotaxis is mediated by membrane translocation of certain PH domain-containing proteins via specific binding to PtdIns(3,4,5)P3. InsP7 competes for PH domain binding with PtdIns(3,4,5)P3 both in vitro and in vivo. InsP7 depletion enhances PH domain membrane translocation and augments downstream chemotactic signaling activity.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Emory University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028007, R01GM028007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH018501, R01MH018501] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-00074] Funding Source: Medline; NIGMS NIH HHS [GM-28007] Funding Source: Medline; NIMH NIH HHS [MH-18501] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALI N, 1995, BIOCHEM J, V310, P279, DOI 10.1042/bj3100279; Caffrey JJ, 2000, J BIOL CHEM, V275, P12730, DOI 10.1074/jbc.275.17.12730; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; Couchman JR, 2002, J BIOL CHEM, V277, P49296, DOI 10.1074/jbc.M209679200; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Funamoto S, 2001, J CELL BIOL, V153, P795, DOI 10.1083/jcb.153.4.795; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; GLENNON MC, 1993, BIOCHEM J, V293, P583, DOI 10.1042/bj2930583; HammondsOdie LP, 1996, J BIOL CHEM, V271, P18859, DOI 10.1074/jbc.271.31.18859; Hanakahi LA, 2002, EMBO J, V21, P2038, DOI 10.1093/emboj/21.8.2038; Hemmings BA, 1997, SCIENCE, V277, P534, DOI 10.1126/science.277.5325.534; Huang CF, 1998, BIOCHEMISTRY-US, V37, P14998, DOI 10.1021/bi981920l; HUANG KN, 1995, GENETICS, V141, P1275; Huang YE, 2003, MOL BIOL CELL, V14, P1913, DOI 10.1091/mbc.E02-10-0703; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; KONIJN TM, 1970, EXPERIENTIA, V26, P367, DOI 10.1007/BF01896891; Laussmann T, 2000, EUR J BIOCHEM, V267, P2447, DOI 10.1046/j.1432-1327.2000.01264.x; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Luo HBR, 2002, BIOCHEMISTRY-US, V41, P2509, DOI 10.1021/bi0118153; Luo HR, 2001, NEURON, V31, P439, DOI 10.1016/S0896-6273(01)00384-1; Ma YM, 2002, J BIOL CHEM, V277, P10756, DOI 10.1074/jbc.C200030200; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Mehrotra B, 1997, J BIOL CHEM, V272, P4237, DOI 10.1074/jbc.272.7.4237; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Morrison BH, 2001, J BIOL CHEM, V276, P24965, DOI 10.1074/jbc.M101161200; NORRIS FA, 1995, J BIOL CHEM, V270, P214, DOI 10.1074/jbc.270.1.214; Parent CA, 1996, ANNU REV BIOCHEM, V65, P411; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Safrany ST, 1998, EMBO J, V17, P1710, DOI 10.1093/emboj/17.6.1710; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Saiardi A, 2001, J BIOL CHEM, V276, P39179, DOI 10.1074/jbc.M106842200; Schell MJ, 1999, FEBS LETT, V461, P169, DOI 10.1016/S0014-5793(99)01462-3; STEPHENS L, 1993, J BIOL CHEM, V268, P4009; Venkateswarlu K, 1998, BIOCHEM J, V335, P139, DOI 10.1042/bj3350139; VOGLMAIER SM, 1992, BIOCHEM BIOPH RES CO, V187, P158, DOI 10.1016/S0006-291X(05)81473-1; Wang DS, 1997, BIOCHEM BIOPH RES CO, V234, P183, DOI 10.1006/bbrc.1997.6589; Williams RSB, 1999, EMBO J, V18, P2734, DOI 10.1093/emboj/18.10.2734; Ye KQ, 2000, CELL, V103, P919, DOI 10.1016/S0092-8674(00)00195-1; YE WL, 1995, J BIOL CHEM, V270, P1564, DOI 10.1074/jbc.270.4.1564	45	155	161	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 5	2003	114	5					559	572		10.1016/S0092-8674(03)00640-8	http://dx.doi.org/10.1016/S0092-8674(03)00640-8			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	719FN	13678580	Bronze			2022-12-01	WOS:000185193100006
J	Volkov, I; Banavar, JR; Hubbell, SP; Maritan, A				Volkov, I; Banavar, JR; Hubbell, SP; Maritan, A			Neutral theory and relative species abundance in ecology	NATURE			English	Article							SAMPLING THEORY	The theory of island biogeography(1) asserts that an island or a local community approaches an equilibrium species richness as a result of the interplay between the immigration of species from the much larger metacommunity source area and local extinction of species on the island (local community). Hubbell(2) generalized this neutral theory to explore the expected steady-state distribution of relative species abundance (RSA) in the local community under restricted immigration. Here we present a theoretical framework for the unified neutral theory of biodiversity(2) and an analytical solution for the distribution of the RSA both in the metacommunity (Fisher's log series) and in the local community, where there are fewer rare species. Rare species are more extinction-prone, and once they go locally extinct, they take longer to re-immigrate than do common species. Contrary to recent assertions(3), we show that the analytical solution provides a better fit, with fewer free parameters, to the RSA distribution of tree species on Barro Colorado Island, Panama(4), than the lognormal distribution(5,6).	Penn State Univ, Dept Phys, University Pk, PA 16802 USA; Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; Smithsonian Trop Res Inst, Balboa, Panama; Scuola Int Super Studi Avanzati, SISSA, I-34014 Trieste, Italy; INFM, Trieste, Italy; Abdus Salam Int Ctr Theoret Phys, Trieste, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Georgia; University of Georgia; Smithsonian Institution; Smithsonian Tropical Research Institute; International School for Advanced Studies (SISSA); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Abdus Salam International Centre for Theoretical Physics (ICTP)	Banavar, JR (corresponding author), Penn State Univ, Dept Phys, 104 Davey Lab, University Pk, PA 16802 USA.	banavar@psu.edu; shubbell@dogwood.botany.uga.edu	Volkov, Igor/GVT-6571-2022	Maritan, Amos/0000-0002-3535-7873				Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; BOSWELL MT, 1979, STAT DISTRIBUTIONS E, P3; CARACO T, 1979, STATISTICAL DISTRIBU, P371; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Diamond J.M., 1986, COMMUNITY ECOLOGY; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Feller W., 1968, INTRO PROBABILITY TH, V1; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Hubbell Stephen P., 2001, V32, pi; KARLIN S, 1972, THEOR POPUL BIOL, V3, P113, DOI 10.1016/0040-5809(72)90036-6; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kimura M., 1983, NEUTRAL THEORY MOL E; Kimura M., 1971, THEORETICAL ASPECTS; MAC ARTHUR ROBERT H., 1967; MANOKARAN N, 1992, STAND TABLES SPECIES; Masters T., 1993, PRACTICAL NN RECIPES; May R.M., 1975, P81; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; McKane A, 2000, PHYS REV E, V62, P8466, DOI 10.1103/PhysRevE.62.8466; Morse P., 1953, METHODS THEORETICA 1; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Rao C. R., 1971, STATISTICAL ECOLOGY, V1, P131; Sugihara G, 2003, P NATL ACAD SCI USA, V100, P5246, DOI 10.1073/pnas.0831096100; TILMAN D, 1988; van Kampen N., 2001, STOCHASTIC PROCESSES; WATTERSON GA, 1974, THEOR POPUL BIOL, V6, P217, DOI 10.1016/0040-5809(74)90025-2; Weiher E., 1999, ECOLOGICAL ASSEMBLY	28	538	574	4	398	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2003	424	6952					1035	1037		10.1038/nature01883	http://dx.doi.org/10.1038/nature01883			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715QR	12944964	Green Submitted			2022-12-01	WOS:000184984200038
J	Fitzmaurice, DA				Fitzmaurice, DA			Commentary: The faults of expert reviews are already well known	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Fitzmaurice, DA (corresponding author), Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.								0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2003	327	7409					269	269		10.1136/bmj.327.7409.269	http://dx.doi.org/10.1136/bmj.327.7409.269			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708KP	12896941	Green Published			2022-12-01	WOS:000184566300022
J	Swarte, NB; van der Lee, ML; van der Bom, JG; van den Bout, J; Heintz, APM				Swarte, NB; van der Lee, ML; van der Bom, JG; van den Bout, J; Heintz, APM			Effects of euthanasia on the bereaved family and friends: a cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHYSICIAN-ASSISTED SUICIDE; NATIONWIDE; LIFE; END	Objective To assess how euthanasia in terminally ill cancer patients affects the grief response of bereaved family and friends. Design Cross sectional study Setting Tertiary referral centre for oncology patients in Utrecht, the Netherlands. Participants 189 bereaved family members and close friends of terminally ill cancer patients who died by euthanasia and 316 bereaved family members and close friends of comparable cancer patients who died a natural death between 1992 and 1999. Main outcome measures Symptoms of traumatic grief assessed by the inventory of traumatic grief, current feelings of grief assessed by the Texas revised inventory of grief, and post-traumatic stress reactions assessed by the impact of event scale. Results The bereaved family and friends of cancer patients who died by euthanasia had less traumatic grief symptoms (adjusted difference - 5.29 (95% confidence interval - 8.44 to - 2.15)), less current feeling of grief (adjusted difference 2.93 (0.85 to 5.01)); and less post-traumatic stress reactions (adjusted difference - 2.79 (- 5.33 to - 0.25)) than the family and friends of patients who died of natural causes. These differences were independent of other risk factors. Conclusions The bereaved family and friends of cancer patients who died by euthanasia coped better with respect to grief symptoms and post-traumatic stress reactions than the bereaved of comparable cancer patients who died a natural death. These results should not be interpreted as a plea for euthanasia, but as a plea for the same level of care and openness in all patients who are terminally ill.	Univ Med Ctr Utrecht, Dept Gynaecol, NL-3508 GA Utrecht, Netherlands; Univ Utrecht, Dept Clin Psychol, NL-3508 TC Utrecht, Netherlands; Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University; Utrecht University Medical Center	Swarte, NB (corresponding author), Univ Med Ctr Utrecht, Dept Gynaecol, F05-829,POB 85500, NL-3508 GA Utrecht, Netherlands.	n.swarte@azu.nl	van der Bom, Johanna G./G-1965-2018	van der Bom, Johanna G./0000-0001-9095-2475				Arrindell WA, 1986, SCL 90 MANUAL MULTID; Boelen PA, 2003, DEATH STUD, V27, P227, DOI 10.1080/07481180302889; BrintzenhofeSzoc KM, 1999, CANCER PRACT, V7, P233, DOI 10.1046/j.1523-5394.1999.75006.x; Chochinov HM, 2000, PSYCHOSOMATICS, V41, P500, DOI 10.1176/appi.psy.41.6.500; Emanuel EJ, 2002, ARCH INTERN MED, V162, P142, DOI 10.1001/archinte.162.2.142; FASCHINGBAUER RRZ, 1987, BIOPSYCHOSOCIAL ASPE, P127; Goldstein H., 1998, USERS GUIDE MLWIN; Groenewoud JH, 2000, NEW ENGL J MED, V342, P551, DOI 10.1056/NEJM200002243420805; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Jacobs S, 2000, DEATH STUD, V24, P185, DOI 10.1080/074811800200531; Kelly BJ, 1996, AUST NZ J PSYCHIAT, V30, P3, DOI 10.3109/00048679609076068; Koop P M, 1997, Can J Nurs Res, V29, P33; LUBIN B, 1965, ARCH GEN PSYCHIAT, V12, P57; PIJNENBORG L, 1994, BMJ-BRIT MED J, V309, P1209, DOI 10.1136/bmj.309.6963.1209; SANDERMAN R, 1995, EYSENCK PERSONALITY; STROEBE MS, 1989, OMEGA-J DEATH DYING, V20, P1, DOI 10.2190/C3JE-C9L1-5R91-DWDU; STROEBE W, 2001, HDB BEREAVEMENT RES, P613; Swarte NB, 2001, BEST PRACT RES CL OB, V15, P313, DOI 10.1053/beog.2000.0171; Swarte NB, 1999, ANN MED, V31, P364, DOI 10.3109/07853899908998793; SWARTE NB, 2000, BAILLIERE CLIN OB GY, V15, P313; Valdimarsdottir U, 2002, BRIT J CANCER, V86, P1540, DOI 10.1038/sj.bjc.6600271; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227; vandenBoom F, 1995, AIDS CARE, V7, pS175; VANDERWAL G, 1994, BRIT MED J, V308, P1346, DOI 10.1136/bmj.308.6940.1346; WEGNER M, 1993, MEASUREMENT PERCEIVE	25	64	64	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2003	327	7408					189	192		10.1136/bmj.327.7408.189	http://dx.doi.org/10.1136/bmj.327.7408.189			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	706DL	12881258	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000184437300014
J	Katoh, H; Negishi, M				Katoh, H; Negishi, M			RhoG activates Rac1 by direct interaction with the Dock180-binding protein Elmo	NATURE			English	Article								The small GTPase Rac has a central role in regulating the actin cytoskeleton during cell migration and axon guidance(1). Elmo has been identified as an upstream regulator of Rac1 that binds to and functionally cooperates with Dock180 (refs 2-4). Dock180 does not contain a conventional catalytic domain for guanine nucleotide exchange on Rac, but possesses a domain that directly binds to and specifically activates Rac1 (refs 5, 6). The small GTPase RhoG mediates several cellular morphological processes, such as neurite outgrowth in neuronal cells, through a signalling cascade that activates Rac1 (refs 7-12); however, the downstream target of RhoG and the mechanism by which RhoG regulates Rac1 activity remain unclear. Here we show that RhoG interacts directly with Elmo in a GTP-dependent manner and forms a ternary complex with Dock180 to induce activation of Rac1. The RhoG-Elmo-Dock180 pathway is required for activation of Rac1 and cell spreading mediated by integrin, as well as for neurite outgrowth induced by nerve growth factor. We conclude that RhoG activates Rac1 through Elmo and Dock180 to control cell morphology.	Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Katoh, H (corresponding author), Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068502, Japan.	hirokato@pharm.kyoto-u.ac.jp		Katoh, Hironori/0000-0002-8191-8117				Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Blangy A, 2000, J CELL SCI, V113, P729; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gauthier-Rouviere C, 1998, MOL BIOL CELL, V9, P1379, DOI 10.1091/mbc.9.6.1379; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; May V, 2002, J NEUROSCI, V22, P6980; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Vigorito E, 2003, ONCOGENE, V22, P330, DOI 10.1038/sj.onc.1206116; Wu YC, 2002, DEV BIOL, V250, P145, DOI 10.1006/dbio.2002.0785; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Zhou WS, 2001, J VIS COMMUN IMAGE R, V12, P1, DOI 10.1006/jvci.2000.0459	25	270	274	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					461	464		10.1038/nature01817	http://dx.doi.org/10.1038/nature01817			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879077				2022-12-01	WOS:000184318400051
J	Lee, KH; Dinner, AR; Tu, C; Campi, G; Raychaudhuri, S; Varma, R; Sims, TN; Burack, WR; Wu, H; Kanagawa, O; Markiewicz, M; Allen, PM; Dustin, ML; Chakraborty, AK; Shaw, AS				Lee, KH; Dinner, AR; Tu, C; Campi, G; Raychaudhuri, S; Varma, R; Sims, TN; Burack, WR; Wu, H; Kanagawa, O; Markiewicz, M; Allen, PM; Dustin, ML; Chakraborty, AK; Shaw, AS			The immunological synapse balances T cell receptor signaling and degradation	SCIENCE			English	Article							CD2-ASSOCIATED PROTEIN; ANTIGEN RECEPTOR; DOWN-MODULATION; ACTIVATION; DYNAMICS; TRANSDUCTION; STIMULATION; SPECIFICITY; COMPLEXES	The immunological synapse is a specialized cell-cell junction between T cell and antigen-presenting cell surfaces. It is characterized by a central cluster of antigen receptors, a ring of integrin family adhesion molecules, and temporal stability over hours. The role of this specific organization in signaling for T cell activation has been controversial. We use in vitro and in silico experiments to determine that the immunological synapse acts as a type of adaptive controller that both boosts T cell receptor triggering and attenuates strong signals.	NYU, Skirball Inst Biomol Med, Program Mol Pathogenesis, New York, NY 10016 USA; NYU, Dept Pathol, New York, NY 10016 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci & Mat Sci Div, Berkeley, CA 94720 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA	New York University; New York University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Washington University (WUSTL); Roche Holding; Genentech; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Dustin, ML (corresponding author), NYU, Skirball Inst Biomol Med, Program Mol Pathogenesis, New York, NY 10016 USA.		Dustin, Michael/AAM-4611-2020; Varma, Rajat/I-1209-2012	Varma, Rajat/0000-0001-5131-0402; Raychaudhuri, Subhadip/0000-0003-3426-8382; Raychaudhuri, Subhadip/0000-0002-9873-6475; Dustin, Michael/0000-0003-4983-6389				Chan C, 2001, P NATL ACAD SCI USA, V98, P5758, DOI 10.1073/pnas.101113698; Coombs D, 2002, NAT IMMUNOL, V3, P926, DOI 10.1038/ni838; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Itoh Y, 1999, J IMMUNOL, V162, P2073; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; Koretzky GA, 2001, NAT REV IMMUNOL, V1, P95, DOI 10.1038/35100523; Krummel MF, 2002, CURR OPIN IMMUNOL, V14, P66, DOI 10.1016/S0952-7915(01)00299-0; Lanzavecchia A, 2000, CURR OPIN IMMUNOL, V12, P92, DOI 10.1016/S0952-7915(99)00056-4; Lee K. T., UNPUB; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Martin S, 1998, EUR J IMMUNOL, V28, P2991, DOI 10.1002/(SICI)1521-4141(199810)28:10<2991::AID-IMMU2991>3.3.CO;2-2; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Schrum AG, 2002, J EXP MED, V196, P793, DOI 10.1084/jem.20020158; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266	29	437	454	3	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2003	302	5648					1218	1222		10.1126/science.1086507	http://dx.doi.org/10.1126/science.1086507			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742XW	14512504				2022-12-01	WOS:000186544300057
J	Ziegler, AG; Schmid, S; Huber, D; Hummel, M; Bonifacio, E				Ziegler, AG; Schmid, S; Huber, D; Hummel, M; Bonifacio, E			Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BETA-CELL AUTOIMMUNITY; CELIAC-DISEASE PATIENTS; COWS MILK; GERMAN BABYDIAB; ISLET AUTOIMMUNITY; IMMUNE-RESPONSE; GENETIC RISK; YOUNG DAISY; T-CELLS; INSULIN	Context Dietary factors modifying type 1 diabetes mellitus (DM) risk have been proposed, but little is known if they trigger the islet autoimmunity that precedes clinical disease. Objective To determine whether breastfeeding duration, food supplementation, or age at introduction of gluten-containing foods influences the risk of developing islet autoantibodies. Design and Setting Prospective natural history cohort study conducted from 1989 to 2003 in inpatient/outpatient clinics in Germany. Participants The BABYDIAB study follows newborn children of parents with type 1 DM. Eligibility requirements were met in 1610 children. Blood samples were obtained at birth, age 9 months, 2, 5, and 8 years. Dropout rate was 14.4% by age 5 years. Breastfeeding data were obtained by prospective questionnaires (91% complete), and food supplementation data were obtained by family interview (72% for food supplementation and 80% for age of gluten introduction). Main Outcome Measure Development of islet autoantibodies (insulin, glutamic acid decarboxylase, or IA-2 antibodies) in 2 consecutive blood samples. Results Life-table islet autoantibody frequency was 5.8% (SE, 0.6%) by age 5 years. Reduced total or exclusive breastfeeding duration did not significantly increase the risk of developing islet autoantibodies. Food supplementation with gluten-containing foods before age 3 months, however, was associated with significantly increased islet autoantibody risk (adjusted hazard ratio, 4.0; 95% confidence interval, 1.4-11.5; P=.01 vs children who received only breast milk until age 3 months). Four of 17 children who received gluten foods before age 3 months developed islet autoantibodies (life-table 5-year risk, 24%; SE, 10%). All 4 children had the high-risk DRB1*03/04,DQB1*0302 genotype. Early exposure to gluten did not significantly increase the risk of developing celiac disease-associated autoantibodies. Children who first received gluten foods after age 6 months did not have increased risks for islet or celiac disease autoantibodies. Conclusion Ensuring compliance to infant feeding guidelines is a possible way to reduce the risk of development of type 1 DM autoantibodies.	Diabet Res Inst & Hosp Munchen Schwabing, Munich, Germany; Ist Sci San Raffaele, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Ziegler, AG (corresponding author), Diabet Res Inst, Koelner Pl 1, D-80804 Munich, Germany.		Ziegler, Anette-Gabriele/M-4614-2014; Bonifacio, Ezio/E-7700-2010; Hummel, Sandra/Q-3538-2016	Ziegler, Anette-Gabriele/0000-0002-6290-5548; Bonifacio, Ezio/0000-0002-8704-4713; 				Atkinson MA, 1997, J AM COLL NUTR, V16, P334, DOI 10.1080/07315724.1997.10718694; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Bingley PJ, 2003, DIABETES, V52, P1128, DOI 10.2337/diabetes.52.5.1128; BORCHJOHNSEN K, 1984, LANCET, V2, P1083; Cavallo MG, 1996, LANCET, V348, P926, DOI 10.1016/S0140-6736(95)12065-3; Challacombe DN, 1997, ARCH DIS CHILD, V77, P206, DOI 10.1136/adc.77.3.206; Couper JJ, 1999, DIABETES, V48, P2145, DOI 10.2337/diabetes.48.11.2145; Cronin CC, 1997, LANCET, V349, P1096, DOI 10.1016/S0140-6736(96)09153-2; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Funda DP, 1999, DIABETES-METAB RES, V15, P323; GERSTEIN HC, 1994, DIABETES CARE, V17, P13, DOI 10.2337/diacare.17.1.13; GRECO L, 1985, J PEDIATR GASTR NUTR, V4, P52, DOI 10.1097/00005176-198502000-00010; Hummel M, 2000, DIABETOLOGIA, V43, P1005, DOI 10.1007/s001250051483; Hummel M, 2000, DIABETES CARE, V23, P969, DOI 10.2337/diacare.23.7.969; Ivarsson A, 2000, ACTA PAEDIATR, V89, P165, DOI 10.1080/080352500750028771; KARJALAINEN J, 1992, NEW ENGL J MED, V327, P302, DOI 10.1056/NEJM199207303270502; Kimpimaki T, 2001, DIABETOLOGIA, V44, P63, DOI 10.1007/s001250051581; LESLIE RDG, 1994, DIABETES, V43, P843, DOI 10.2337/diabetes.43.7.843; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; MacFarlane AJ, 2003, J BIOL CHEM, V278, P54, DOI 10.1074/jbc.M210636200; Naserke HE, 1999, J CLIN ENDOCR METAB, V84, P1239, DOI 10.1210/jc.84.4.1239; Norris JM, 2002, DIABETES, V51, pA234; Norris JM, 1996, JAMA-J AM MED ASSOC, V276, P609, DOI 10.1001/jama.276.8.609; Schenker M, 1999, DIABETOLOGIA, V42, P671, DOI 10.1007/s001250051214; Strobel S, 1998, IMMUNOL TODAY, V19, P173, DOI 10.1016/S0167-5699(97)01239-5; Vaarala O, 1999, DIABETES, V48, P1389, DOI 10.2337/diabetes.48.7.1389; Vaarala O, 1996, DIABETES, V45, P178, DOI 10.2337/diabetes.45.2.178; van de Wal Y, 1998, P NATL ACAD SCI USA, V95, P10050, DOI 10.1073/pnas.95.17.10050; Ventura A, 2000, J PEDIATR-US, V137, P263, DOI 10.1067/mpd.2000.107160; WEILE B, 1995, J PEDIATR GASTR NUTR, V21, P64, DOI 10.1097/00005176-199507000-00011; Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460	32	361	372	0	28	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2003	290	13					1721	1728		10.1001/jama.290.13.1721	http://dx.doi.org/10.1001/jama.290.13.1721			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	726NQ	14519706	Bronze			2022-12-01	WOS:000185606100021
J	Bray, D				Bray, D			Molecular networks: The top-down view	SCIENCE			English	Editorial Material							SMALL-WORLD	Network theory can give a useful overview of how a biological system works. But to make testable predictions, we need the details.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Bray, D (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.							Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; Barabasi A.--L., 2002, FORMULA UNIVERSAL LA; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Fell D., 1997, UNDERSTANDING CONTRO; HINTON GE, 1992, SCI AM, V267, P145, DOI 10.1038/scientificamerican0992-144; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; KACSER H, 1973, S SOC EXP BIOL, V32, P65; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Wagner A, 2001, MOL BIOL EVOL, V18, P1283, DOI 10.1093/oxfordjournals.molbev.a003913; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	15	143	153	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2003	301	5641					1864	1865		10.1126/science.1089118	http://dx.doi.org/10.1126/science.1089118			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725GW	14512614				2022-12-01	WOS:000185536700036
J	Fortey, R; Chatterton, B				Fortey, R; Chatterton, B			A Devonian trilobite with an eyeshade	SCIENCE			English	Article							LENSES		Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada	Natural History Museum London; University of Oxford; University of Alberta	Fortey, R (corresponding author), Nat Hist Museum, Dept Palaeontol, Cromwell Rd, London SW7 5BD, England.	raf@nhm.ac.uk						Clarkson E.N.K., 1979, Palaeontology (Oxford), V22, P1; CLARKSON ENK, 1975, NATURE, V254, P613; Gal J, 2000, VISION RES, V40, P843, DOI 10.1016/S0042-6989(99)00216-3; McCormick T, 1998, PALEOBIOLOGY, V24, P235; MILLER WH, 1979, HDB SENSORY PHYSL, V7, P70; MORZADEC P, 1995, NEUES JB GEOL PAL, P577; STOCKTON W L, 1976, Paleobiology, V2, P304; TOWE KM, 1973, SCIENCE, V179, P1007, DOI 10.1126/science.179.4077.1007	8	12	13	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2003	301	5640					1689	1689		10.1126/science.1088713	http://dx.doi.org/10.1126/science.1088713			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722QN	14500973				2022-12-01	WOS:000185387700034
J	Wardle, DA; Yeates, GW; Barker, GM; Bellingham, PJ; Bonner, KI; Williamson, WM				Wardle, DA; Yeates, GW; Barker, GM; Bellingham, PJ; Bonner, KI; Williamson, WM			Island biology and ecosystem functioning in epiphytic soil communities	SCIENCE			English	Article							SPECIES-DIVERSITY; MODEL SYSTEMS; POPULATIONS; ABUNDANCE; DYNAMICS; FOREST	Although island attributes such as size and accessibility to colonizing organisms can influence community structure, the consequences of these for ecosystem functioning are little understood. A study of the suspended soils of spatially discrete epiphytes or treetop "islands" in the canopies of New Zealand rainforest trees revealed that different components of the decomposer community responded either positively or negatively to island size, as well as to the tree species that the islands occurred in. This in turn led to important differences between islands in the rates of ecosystem processes driven by the decomposer biota. This system serves as a model for better understanding how attributes of both real and habitat islands may affect key ecosystem functions through determining the community structure of organisms that drive these functions.	Swedish Univ Agr Sci, Fac Forestry, Dept Forest Vegetat Ecol, S-90183 Umea, Sweden; Landcare Res, Lincoln, New Zealand; Landcare Res, Palmerston North, New Zealand; Landcare Res, Hamilton, New Zealand	Swedish University of Agricultural Sciences; Landcare Research - New Zealand; Landcare Research - New Zealand; Landcare Research - New Zealand	Wardle, DA (corresponding author), Swedish Univ Agr Sci, Fac Forestry, Dept Forest Vegetat Ecol, S-90183 Umea, Sweden.	david.wardle@svek.slu.se	Wardle, David A./F-6031-2011; Barker, Gary M/C-9974-2011; Bellingham, Peter/AAP-4302-2020	Wardle, David A./0000-0002-0476-7335; Barker, Gary M/0000-0002-0049-9804; 				Anderson WB, 1999, OECOLOGIA, V118, P324, DOI 10.1007/s004420050733; Armbruster P, 2002, OIKOS, V96, P225, DOI 10.1034/j.1600-0706.2002.960204.x; Collinge SK, 2000, ECOLOGY, V81, P2211, DOI 10.1890/0012-9658(2000)081[2211:EOGFOI]2.0.CO;2; Gonzalez A, 1998, SCIENCE, V281, P2045, DOI 10.1126/science.281.5385.2045; Gonzalez A, 2002, J ANIM ECOL, V71, P594, DOI 10.1046/j.1365-2656.2002.00625.x; Grime J. P, 2001, PLANT STRATEGIES VEG; LAWTON JH, 1994, OIKOS, V71, P367, DOI 10.2307/3545824; Levine JM, 2000, SCIENCE, V288, P852, DOI 10.1126/science.288.5467.852; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; MAC ARTHUR ROBERT H., 1967; MOEED A, 1983, NEW ZEAL J ECOL, V6, P39; NADKARNI NM, 1994, AM ZOOL, V34, P70; Richardson BA, 2000, J TROP ECOL, V16, P167, DOI 10.1017/S0266467400001346; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SCHOENER TW, 1983, SCIENCE, V219, P1353, DOI 10.1126/science.219.4590.1353; Setala H, 2002, ECOL RES, V17, P207, DOI 10.1046/j.1440-1703.2002.00480.x; SIMBERLOFF D, 1976, ECOLOGY, V57, P629, DOI 10.2307/1936179; Spiller DA, 1997, OIKOS, V78, P15, DOI 10.2307/3545795; Tscharntke T, 2002, ECOL APPL, V12, P354, DOI 10.2307/3060947; Vitousek PM, 2002, J BIOGEOGR, V29, P573, DOI 10.1046/j.1365-2699.2002.00707.x; Vitousek PM, 1995, ISLANDS BIOL DIVERSI; Wardle DA, 2002, J BIOGEOGR, V29, P583, DOI 10.1046/j.1365-2699.2002.00708.x; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296; Wardle DA., 2002, COMMUNITIES ECOSYSTE, P7; Whittaker R.J., 1998, ISLAND BIOGEOGRAPHY	26	69	76	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2003	301	5640					1717	1720		10.1126/science.1087809	http://dx.doi.org/10.1126/science.1087809			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722QN	14500981				2022-12-01	WOS:000185387700043
J	Arnold, DH; Johnston, A				Arnold, DH; Johnston, A			Motion-induced spatial conflict	NATURE			English	Article							PERCEIVED POSITION; CONTRAST; PATTERN; JITTER; SPEED	Borders defined by small changes in brightness (luminance contrast) or by differences in colour (chromatic contrast) appear to move more slowly than those defined by strong luminance contrast(1-4). As spatial coding is influenced by motion(5-7), if placed in close proximity, the different types of moving border might appear to drift apart(8). Using this configuration, we show here that observers instead report a clear illusory spatial jitter of the low-luminance-contrast boundary. This visible interaction between motion and spatial-position coding occurred at a characteristic rate (similar to22.3 Hz), although the stimulus motion was continuous and invariant. The jitter rate did not vary with the speed of movement. The jitter was not due to small involuntary movements of the eyes, because it only occurred at a specific point within the stimulus, the low-luminance-contrast boundary. These findings show that the human visual system contains a neural mechanism that periodically resolves the spatial conflict created by adjacent moving borders that have the same physical but different perceptual speeds.	UCL, Dept Psychol, London WC1E 6BT, England; UCL, Inst Cognit Neurosci, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Arnold, DH (corresponding author), UCL, Dept Psychol, Gower St, London WC1E 6BT, England.	derek.arnold@ucl.ac.uk	Johnston, Alan/B-5393-2008	Johnston, Alan/0000-0001-9026-1199; Arnold, Derek/0000-0003-1027-6222				Anstis S, 2001, PERCEPTION, V30, P785, DOI 10.1068/p3211; Anstis S. M., 1983, COLOUR VISION PHYSL, P155; Blakemore MR, 1999, PERCEPTION, V28, P33, DOI 10.1068/p2722; BRIDGEMAN B, 1991, VISION RES, V31, P1903, DOI 10.1016/0042-6989(91)90185-8; CAMPBELL FW, 1959, J PHYSIOL-LONDON, V145, P579, DOI 10.1113/jphysiol.1959.sp006164; CAVANAGH P, 1984, J OPT SOC AM A, V1, P893, DOI 10.1364/JOSAA.1.000893; DEVALOIS RL, 1991, VISION RES, V31, P1619, DOI 10.1016/0042-6989(91)90138-U; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Helmholtz H., 1962, TREATISE PHYSL OPTIC; Murakami I, 2003, VISION RES, V43, P957, DOI 10.1016/S0042-6989(03)00070-1; Murakami I, 1998, NATURE, V395, P798, DOI 10.1038/27435; Nguyen-Tri D, 2003, PERCEPTION, V32, P627, DOI 10.1068/p3228; Nishida S, 1999, NATURE, V397, P610, DOI 10.1038/17600; Sherrington CS, 1918, BRAIN, V41, P332, DOI 10.1093/brain/41.3-4.332; THOMPSON P, 1982, VISION RES, V22, P377, DOI 10.1016/0042-6989(82)90153-5; Von Grunau M W, 1976, Vision Res, V16, P397, DOI 10.1016/0042-6989(76)90203-0; VONDERMALSBURG C, 1986, BIOL CYBERN, V54, P29, DOI 10.1007/BF00337113; Whitney D, 2000, NAT NEUROSCI, V3, P954, DOI 10.1038/78878; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115	20	23	23	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2003	425	6954					181	184		10.1038/nature01955	http://dx.doi.org/10.1038/nature01955			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719ZT	12968181				2022-12-01	WOS:000185236000043
J	Higginson, IJ; Thompson, M				Higginson, IJ; Thompson, M			Children and young people who die from cancer: epidemiology and place of death in England (1995-9)	BRITISH MEDICAL JOURNAL			English	Article									Kings Coll London, Guys Kings & St Thomass Sch Med, Dept Palliat Care & Policy, London SE5 9RJ, England	University of London; King's College London	Higginson, IJ (corresponding author), Kings Coll London, Guys Kings & St Thomass Sch Med, Dept Palliat Care & Policy, London SE5 9RJ, England.	irene.higginson@kcl.ac.uk	Higginson, Irene J/C-7309-2012	Higginson, Irene J/0000-0002-3687-1313				Bleyer WA, 2002, MED PEDIATR ONCOL, V38, P1, DOI 10.1002/mpo.1257; Edwards J, 2001, Int J Palliat Nurs, V7, P485; Feudtner C, 2002, PEDIATRICS, V109, P656, DOI 10.1542/peds.109.4.656; GOLDMAN A, 1990, ARCH DIS CHILD, V65, P641, DOI 10.1136/adc.65.6.641; Higginson IJ, 1998, PALLIATIVE MED, V12, P353, DOI 10.1191/026921698672530176	5	33	33	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 30	2003	327	7413					478	479		10.1136/bmj.327.7413.478	http://dx.doi.org/10.1136/bmj.327.7413.478			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	717LA	12946969	Green Published, Bronze			2022-12-01	WOS:000185088900015
J	Jin, HJ; Kaplan, DL				Jin, HJ; Kaplan, DL			Mechanism of silk processing in insects and spiders	NATURE			English	Article							BOMBYX-MORI SILK; FIBROIN SOLUTION; SOLID-STATE; FIBERS; WATER; BIOMATERIALS; ORGANIZATION; SPECTROSCOPY; GENE; NMR	Silk spinning by insects and spiders leads to the formation of fibres that exhibit high strength and toughness(1). The lack of understanding of the protein processing in silk glands has prevented the recapitulation of these properties in vitro from reconstituted or genetically engineered silks. Here we report the identification of emulsion formation and micellar structures from aqueous solutions of reconstituted silkworm silk fibroin as a first step in the process to control water and protein-protein interactions. The sizes (100-200 nm diameter) of these structures could be predicted from hydrophobicity plots of silk protein primary sequence(2). These micelles subsequently aggregated into larger 'globules' and gel-like states as the concentration of silk fibroin increased, while maintaining solubility owing to the hydrophilic regions of the protein interspersed among the larger hydrophobic regions. Upon physical shearing or stretching structural transitions, increased birefringence and morphological alignment were demonstrated, indicating that this process mimics the behaviour of similar native silk proteins in vivo. Final morphological features of these silk materials are similar to those observed in native silkworm fibres.	Tufts Univ, Dept Biol & Chem Engn, Medford, MA 02155 USA; Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	Tufts University; Tufts University	Kaplan, DL (corresponding author), Tufts Univ, Dept Biol & Chem Engn, Medford, MA 02155 USA.							Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4; ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009; AUVRAY X, 1992, LANGMUIR, V8, P2671, DOI 10.1021/la00047a017; Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972; ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017; Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u; Knight DP, 2002, PHILOS T R SOC B, V357, P155, DOI 10.1098/rstb.2001.1030; Knight DP, 1999, P ROY SOC B-BIOL SCI, V266, P519, DOI 10.1098/rspb.1999.0667; Kwon KW, 2002, POLYMER, V43, P3353, DOI 10.1016/S0032-3861(02)00155-6; Lele AK, 2001, CHEM ENG SCI, V56, P5793, DOI 10.1016/S0009-2509(01)00288-3; MAGOSHI J, 1979, J POLYM SCI POL PHYS, V17, P515, DOI 10.1002/pol.1979.180170315; MALSTOM M, 1992, MACROMOLECULES, V25, P5440; MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5; MITA K, 1994, J MOL EVOL, V38, P583; Ochi A, 2002, BIOMACROMOLECULES, V3, P1187, DOI 10.1021/bm020056g; Perez-Rigueiro J, 1998, J APPL POLYM SCI, V70, P2439, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2439::AID-APP16>3.0.CO;2-J; Poza P, 2002, ENG FRACT MECH, V69, P1035, DOI 10.1016/S0013-7944(01)00120-5; Putthanarat S, 2000, POLYMER, V41, P7735, DOI 10.1016/S0032-3861(00)00036-7; ROSEMAN MA, 1988, J MOL BIOL, V200, P513, DOI 10.1016/0022-2836(88)90540-2; Seidel A, 2000, MACROMOLECULES, V33, P775, DOI 10.1021/ma990893j; Shen Y, 1998, MACROMOLECULES, V31, P8857, DOI 10.1021/ma980281j; Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7; Tanaka T, 1998, POLYM INT, V45, P175, DOI 10.1002/(SICI)1097-0126(199802)45:2<175::AID-PI883>3.0.CO;2-K; Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s; van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299; Viney C, 1997, SUPRAMOL SCI, V4, P75, DOI 10.1016/S0968-5677(96)00059-4; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5; Yamada H, 2001, MAT SCI ENG C-BIO S, V14, P41, DOI 10.1016/S0928-4931(01)00207-7; Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413	31	1039	1101	42	768	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2003	424	6952					1057	1061		10.1038/nature01809	http://dx.doi.org/10.1038/nature01809			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715QR	12944968				2022-12-01	WOS:000184984200044
J	Ling, H; Boudsocq, F; Plosky, BS; Woodgate, R; Yang, W				Ling, H; Boudsocq, F; Plosky, BS; Woodgate, R; Yang, W			Replication of a cis-syn thymine dimer at atomic resolution	NATURE			English	Article							DNA-POLYMERASE-ETA; CRYSTAL-STRUCTURE; SULFOLOBUS-SOLFATARICUS; XERODERMA-PIGMENTOSUM; EXCISION-REPAIR; ERROR-PRONE; DAMAGED DNA; Y-FAMILY; BYPASS; MUTATIONS	Ultraviolet light damages DNA by catalysing covalent bond formation between adjacent pyrimidines, generating cis-syn cyclobutane pyrimidine dimers (CPDs) as the most common lesion(1). CPDs block DNA replication by high-fidelity DNA polymerases, but they can be efficiently bypassed by the Y-family DNA polymerase pol eta(2,3). Mutations in POLH encoding pol h are implicated in nearly 20% of xeroderma pigmentosum, a human disease characterized by extreme sensitivity to sunlight and predisposition to skin cancer(4-6). Here we have determined two crystal structures of Dpo4, an archaeal pol eta homologue, complexed with CPD-containing DNA, where the 3' and 5' thymine of the CPD separately serves as a templating base. The 3' thymine of the CPD forms a Watson-Crick base pair with the incoming dideoxyATP, but the 5' thymine forms a Hoogsteen base pair with the dideoxyATP in syn conformation. Dpo4 retains a similar tertiary structure, but each unusual DNA structure is individually fitted into the active site for catalysis. A model of the pol eta-CPD complex built from the crystal structures of Saccharomyces cerevisiae apo-pol eta and the Dpo4-CPD complex suggests unique features that allow pol eta to efficiently bypass CPDs.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; NICHHD, Lab Genom Integr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Yang, W (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.		Ling, Hong/E-3729-2010; Yang, Wei/ABB-4785-2020; Yang, Wei/D-4926-2011	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195; Woodgate, Roger/0000-0001-5581-4616	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001500] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036119, ZIADK036119] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aishima J, 2002, NUCLEIC ACIDS RES, V30, P5244, DOI 10.1093/nar/gkf661; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bunting KA, 2003, NUCLEIC ACIDS RES, V31, P1633, DOI 10.1093/nar/gkg273; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; Glick E, 2001, EMBO J, V20, P7303, DOI 10.1093/emboj/20.24.7303; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lehmann AR, 2002, MUTAT RES-FUND MOL M, V509, P23, DOI 10.1016/S0027-5107(02)00227-0; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; PARK JY, 1995, J BIOCHEM-TOKYO, V118, P989, DOI 10.1093/jb/118.5.989; Patel PH, 2001, J MOL BIOL, V308, P823, DOI 10.1006/jmbi.2001.4619; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Silvian LF, 2001, NAT STRUCT BIOL, V8, P984, DOI 10.1038/nsb1101-984; Szekeres ES, 1996, J BACTERIOL, V178, P2559, DOI 10.1128/jb.178.9.2559-2563.1996; Thoma F, 1999, EMBO J, V18, P6585, DOI 10.1093/emboj/18.23.6585; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; VASSYLYEV DG, 1995, CELL, V83, P773, DOI 10.1016/0092-8674(95)90190-6; Washington MT, 2001, CELL, V107, P917, DOI 10.1016/S0092-8674(01)00613-4; Yang W, 2003, CURR OPIN STRUC BIOL, V13, P23, DOI 10.1016/S0959-440X(02)00003-9; Zhang H, 2002, NUCLEIC ACIDS RES, V30, P1262, DOI 10.1093/nar/30.5.1262; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	30	188	189	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2003	424	6952					1083	1087		10.1038/nature01919	http://dx.doi.org/10.1038/nature01919			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715QR	12904819				2022-12-01	WOS:000184984200050
J	Palenik, B; Brahamsha, B; Larimer, FW; Land, M; Hauser, L; Chain, P; Lamerdin, J; Regala, W; Allen, EE; McCarren, J; Paulsen, I; Dufresne, A; Partensky, F; Webb, EA; Waterbury, J				Palenik, B; Brahamsha, B; Larimer, FW; Land, M; Hauser, L; Chain, P; Lamerdin, J; Regala, W; Allen, EE; McCarren, J; Paulsen, I; Dufresne, A; Partensky, F; Webb, EA; Waterbury, J			The genome of a motile marine Synechococcus	NATURE			English	Article							CYANOBACTERIUM SYNECHOCOCCUS; SP PCC7942; POLYPEPTIDE; IDENTIFICATION; GENE; PROCHLOROCOCCUS; DEGRADATION; SEQUENCE; STRAINS; ECOLOGY	Marine unicellular cyanobacteria are responsible for an estimated 20-40% of chlorophyll biomass and carbon fixation in the oceans(1). Here we have sequenced and analysed the 2.4-megabase genome of Synechococcus sp. strain WH8102, revealing some of the ways that these organisms have adapted to their largely oligotrophic environment. WH8102 uses organic nitrogen and phosphorus sources and more sodium-dependent transporters than a model freshwater cyanobacterium. Furthermore, it seems to have adopted strategies for conserving limited iron stores by using nickel and cobalt in some enzymes, has reduced its regulatory machinery (consistent with the fact that the open ocean constitutes a far more constant and buffered environment than fresh water), and has evolved a unique type of swimming motility. The genome of WH8102 seems to have been greatly influenced by horizontal gene transfer, partially through phages. The genetic material contributed by horizontal gene transfer includes genes involved in the modification of the cell surface and in swimming motility. On the basis of its genome, WH8102 is more of a generalist than two related marine cyanobacteria(2).	Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; Joint Genome Inst, Walnut Creek, CA 94598 USA; Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; TIGR, Rockville, MD 20850 USA; CNRS, Biol Stn, UMR 7127, F-29682 Roscoff, France; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; J. Craig Venter Institute; Centre National de la Recherche Scientifique (CNRS); Woods Hole Oceanographic Institution	Palenik, B (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.		Partensky, Frédéric/B-9194-2018; Paulsen, Ian T/K-3832-2012; Partensky, Frédéric/AAH-1170-2021; Palenik, Brian/AAA-1822-2020; Chain, Patrick/O-4140-2019; Hauser, Loren J/H-3881-2012; chain, patrick/B-9777-2013; Land, Miriam L/A-6200-2011	Partensky, Frédéric/0000-0003-1274-4050; Paulsen, Ian T/0000-0001-9015-9418; Partensky, Frédéric/0000-0003-1274-4050; Palenik, Brian/0000-0002-3717-9046; Chain, Patrick/0000-0003-3949-3634; Land, Miriam L/0000-0001-7102-0031; Brahamsha, Bianca/0000-0002-5316-5939				Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Badger MR, 2002, FUNCT PLANT BIOL, V29, P161, DOI 10.1071/PP01213; Brahamsha B, 1996, P NATL ACAD SCI USA, V93, P6504, DOI 10.1073/pnas.93.13.6504; Brahamsha B, 1996, APPL ENVIRON MICROB, V62, P1747, DOI 10.1128/AEM.62.5.1747-1751.1996; Bushman F, 2002, LATERAL DNA TRANSFER; Clark LL, 1998, NATURE, V393, P426, DOI 10.1038/30881; COLLIER JL, 1994, EMBO J, V13, P1039, DOI 10.1002/j.1460-2075.1994.tb06352.x; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DELORIMIER R, 1990, ARCH MICROBIOL, V153, P541, DOI 10.1007/BF00245263; Dolganov N, 1999, J BACTERIOL, V181, P610, DOI 10.1128/JB.181.2.610-617.1999; Ferris MJ, 1998, NATURE, V396, P226, DOI 10.1038/24297; Goto-Seki A, 1999, MOL MICROBIOL, V34, P473, DOI 10.1046/j.1365-2958.1999.01608.x; Harano Y, 1997, J BACTERIOL, V179, P5744, DOI 10.1128/jb.179.18.5744-5750.1997; Long RA, 2001, APPL ENVIRON MICROB, V67, P4975, DOI 10.1128/AEM.67.11.4975-4983.2001; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mann EL, 2002, LIMNOL OCEANOGR, V47, P976, DOI 10.4319/lo.2002.47.4.0976; Monger BC, 1999, LIMNOL OCEANOGR, V44, P1917, DOI 10.4319/lo.1999.44.8.1917; NOMURA M, 1995, PLANT PHYSIOL, V107, P703, DOI 10.1104/pp.107.3.703; Nyyssola A, 2000, J BIOL CHEM, V275, P22196, DOI 10.1074/jbc.M910111199; PALENIK B, 1998, PHOSPHORUS PLANT BIO, P26; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Scanlan DJ, 2002, FEMS MICROBIOL ECOL, V40, P1, DOI 10.1111/j.1574-6941.2002.tb00930.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toledo G, 1999, APPL ENVIRON MICROB, V65, P5247; Volz K., 1995, 2 COMPONENT SIGNAL T, P53; WATERBURY JB, 1986, PHOTOSYNTHETIC PICOP, P71; WILLEY JM, 1989, APPL ENVIRON MICROB, V55, P1888, DOI 10.1128/AEM.55.8.1888-1894.1989; Zehr JP, 2002, APPL ENVIRON MICROB, V68, P1015, DOI 10.1128/AEM.68.3.1015-1024.2002	30	516	966	1	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2003	424	6952					1037	1042		10.1038/nature01943	http://dx.doi.org/10.1038/nature01943			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715QR	12917641	Bronze			2022-12-01	WOS:000184984200039
J	Beye, M; Hasselmann, M; Fondrk, MK; Page, RE; Omholt, SW				Beye, M; Hasselmann, M; Fondrk, MK; Page, RE; Omholt, SW			The gene csd is the primary signal for sexual development in the honeybee and encodes an SR-type protein	CELL			English	Article							APIS-MELLIFERA; DROSOPHILA-MELANOGASTER; TRANSFORMER GENE; PREMESSENGER RNA; MUSCA-DOMESTICA; LOCUS REGION; SPLICE SITE; DIFFERENTIATION; EVOLUTION; GENOME	Haplodiploid organisms comprise about 20% of animals. Males develop from unfertilized eggs while females are derived from fertilized eggs. The underlying mechanisms of sex determination, however, appear to be diverse and are poorly understood. We have dissected the complementary sex determiner (csd) locus in the honeybee to understand its molecular basis. In this species, csd acts as the primary sex-determining signal with several alleles segregating in populations. Males are hemizygous and females are heterozygous at this locus; nonreproducing diploid males occur when the locus is homozygous. We have characterized csd by positional cloning and repression analysis. csd alleles are highly variable and no transcription differences were found between sexes. These results establish csd as a primary signal that governs sexual development by its allelic composition. Structural similarity of csd with tra genes of Dipteran insects suggests some functional relation of what would otherwise appear to be unrelated sex-determination mechanisms.	Univ Halle Wittenberg, Inst Zool, Biozentrum, D-06120 Halle Saale, Germany; Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; Agr Univ Norway, Dept Anim Sci, N-1432 As, Norway	Martin Luther University Halle Wittenberg; University of California System; University of California Davis; Norwegian University of Life Sciences	Beye, M (corresponding author), Univ Halle Wittenberg, Inst Zool, Biozentrum, Weinberg Weg 22, D-06120 Halle Saale, Germany.		Hasselmann, Martin/ABB-6485-2021; Hasselmann, Martin/E-7681-2014	Hasselmann, Martin/0000-0003-3305-4024; 				ADAMS J, 1977, GENETICS, V86, P583; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bell G., 1982, MASTERPIECE NATURE E; BELOTE JM, 1989, DEV GENET, V10, P143, DOI 10.1002/dvg.1020100304; Beye M, 1998, GENOMICS, V49, P317, DOI 10.1006/geno.1998.5253; Beye M, 1999, GENETICS, V153, P1701; Beye M, 2002, INSECT MOL BIOL, V11, P527, DOI 10.1046/j.1365-2583.2002.00361.x; BEYE M, 1994, NATURWISSENSCHAFTEN, V81, P460; Blencowe BJ, 1999, BIOCHEM CELL BIOL, V77, P277, DOI 10.1139/bcb-77-4-277; Blencowe BJ, 1998, GENE DEV, V12, P996, DOI 10.1101/gad.12.7.996; BOGGS RT, 1987, CELL, V50, P739, DOI 10.1016/0092-8674(87)90332-1; Bull J.J., 1983, EVOLUTION SEX DETERM; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; BUTLER B, 1986, EMBO J, V5, P3607, DOI 10.1002/j.1460-2075.1986.tb04689.x; Casselton LA, 2002, HEREDITY, V88, P142, DOI 10.1038/sj.hdy.6800035; Charlesworth D, 2002, CURR BIOL, V12, pR424, DOI 10.1016/S0960-9822(02)00915-6; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; COOK JM, 1993, HEREDITY, V71, P421, DOI 10.1038/hdy.1993.157; CROZIER RH, 1971, AM NAT, V105, P399, DOI 10.1086/282733; Dauwalder B, 1996, P NATL ACAD SCI USA, V93, P9004, DOI 10.1073/pnas.93.17.9004; Dauwalder B, 1998, EMBO J, V17, P6049, DOI 10.1093/emboj/17.20.6049; DRESCHER W, 1964, J HERED, V55, P90; Dubendorfer A, 2002, INT J DEV BIOL, V46, P75; DZIERZON A, 1845, EICHSTADTER BIENENZE, V1, P109; GOODFELLOW PN, 1993, ANNU REV GENET, V27, P71, DOI 10.1146/annurev.ge.27.120193.000443; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Hasselmann M, 2001, INSECT MOL BIOL, V10, P605, DOI 10.1046/j.0962-1075.2001.00300.x; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; HILFIKERKLEINER D, 1993, GENETICS, V134, P1187; HOSHIJIMA K, 1991, SCIENCE, V252, P833, DOI 10.1126/science.1902987; Hunter CP, 1999, CURR BIOL, V9, pR440, DOI 10.1016/S0960-9822(99)80276-0; INOUE K, 1990, NATURE, V344, P461, DOI 10.1038/344461a0; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kennedy CF, 1998, MOL CELL BIOL, V18, P5425, DOI 10.1128/MCB.18.9.5425; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kristensen Niels P., 1995, Zoologische Beitraege, V36, P83; LAIDLAW HH, 1956, GENETICS, V41, P179; Laidlaw HH., 1997, QUEEN REARING BEE BR; Lasko P, 2000, J CELL BIOL, V150, pF51, DOI 10.1083/jcb.150.2.F51; MACKENSEN OTTO, 1955, JOUR HEREDITY, V46, P72; Maine EM, 2001, DEV BIOL, V239, P177, DOI 10.1006/dbio.2001.0394; MANCEBO R, 1990, MOL CELL BIOL, V10, P2492, DOI 10.1128/MCB.10.6.2492; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990; McAllister BF, 2000, GENETICS, V154, P1711; MCKEOWN M, 1987, CELL, V48, P489, DOI 10.1016/0092-8674(87)90199-1; MCKEOWN M, 1988, CELL, V53, P887, DOI 10.1016/S0092-8674(88)90369-8; Mount SM, 2000, J CELL BIOL, V150, pF37, DOI 10.1083/jcb.150.2.F37; OISHI K, 1993, GENETICA, V88, P119, DOI 10.1007/BF02424468; OMHOLT SW, 1995, APIDOLOGIE, V26, P297, DOI 10.1051/apido:19950404; Pane A, 2002, DEVELOPMENT, V129, P3715; PENG YSC, 1992, J INVERTEBR PATHOL, V60, P127, DOI 10.1016/0022-2011(92)90085-I; Sambrook J., 1989, MOL CLONING LAB MANU; Schutt C, 2000, DEVELOPMENT, V127, P667; Snodgrass R.E., 1956, ANATOMY HONEYBEE; SOSNOWSKI BA, 1989, CELL, V58, P449, DOI 10.1016/0092-8674(89)90426-1; Staden R, 2000, Methods Mol Biol, V132, P115; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TIAN M, 1993, CELL, V74, P105, DOI 10.1016/0092-8674(93)90298-5; WALLDORF U, 1990, FEBS LETT, V267, P245, DOI 10.1016/0014-5793(90)80936-D; Whiting PW, 1943, GENETICS, V28, P365; WILKINS AS, 1995, BIOESSAYS, V17, P71, DOI 10.1002/bies.950170113; Willhoeft U, 1996, GENETICS, V144, P737; Wilson EB, 1905, SCIENCE, V22, P500, DOI 10.1126/science.22.564.500	63	364	399	4	73	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 22	2003	114	4					419	429		10.1016/S0092-8674(03)00606-8	http://dx.doi.org/10.1016/S0092-8674(03)00606-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	714TD	12941271	Bronze			2022-12-01	WOS:000184928800006
J	Coull, JAM; Boudreau, D; Bachand, K; Prescott, SA; Nault, F; Sik, A; De Koninck, P; De Koninck, Y				Coull, JAM; Boudreau, D; Bachand, K; Prescott, SA; Nault, F; Sik, A; De Koninck, P; De Koninck, Y			Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain	NATURE			English	Article							CHRONIC CONSTRICTION INJURY; RAT SCIATIC-NERVE; DORSAL-HORN; SELECTIVE LOSS; GABA; MODEL; INHIBITION; EXCITATION; CORD; PHARMACOLOGY	Modern pain-control theory(1) predicts that a loss of inhibition (disinhibition) in the dorsal horn of the spinal cord is a crucial substrate for chronic pain syndromes(2). However, the nature of the mechanisms that underlie such disinhibition has remained controversial(3-6). Here we present evidence for a novel mechanism of disinhibition following peripheral nerve injury. It involves a trans-synaptic reduction in the expression of the potassium-chloride exporter KCC2, and the consequent disruption of anion homeostasis in neurons of lamina I of the superficial dorsal horn, one of the main spinal nociceptive output pathways(7). In our experiments, the resulting shift in the transmembrane anion gradient caused normally inhibitory anionic synaptic currents to be excitatory, substantially driving up the net excitability of lamina I neurons. Local blockade or knock-down of the spinal KCC2 exporter in intact rats markedly reduced the nociceptive threshold, confirming that the reported disruption of anion homeostasis in lamina I neurons was sufficient to cause neuropathic pain.	Univ Laval Robert Giffard, Ctr Rech, Quebec City, PQ G1J 2G3, Canada; McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada	Laval University; McGill University	De Koninck, Y (corresponding author), Univ Laval Robert Giffard, Ctr Rech, Quebec City, PQ G1J 2G3, Canada.		Boudreau, Dominic/I-8144-2012; De Koninck, Yves/C-2659-2008	De Koninck, Yves/0000-0002-5779-9330				BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Blomqvist A, 2000, J COMP NEUROL, V428, P1; CODERRE TJ, 1994, PAIN, V59, P345, DOI 10.1016/0304-3959(94)90020-5; CODERRE TJ, 1992, J NEUROSCI, V12, P3665; COOK AJ, 1987, NATURE, V325, P151, DOI 10.1038/325151a0; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; Farber NB, 2002, MOL PSYCHIATR, V7, P726, DOI 10.1038/sj.mp.4001087; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Hwang JH, 1997, PAIN, V70, P15, DOI 10.1016/S0304-3959(96)03249-6; Keller AF, 2001, J NEUROSCI, V21, P7871, DOI 10.1523/JNEUROSCI.21-20-07871.2001; Kontinen VK, 2001, ANESTHESIOLOGY, V94, P333, DOI 10.1097/00000542-200102000-00024; LIGHT AR, 1992, INITIAL PROCESSING P; Malan TP, 2002, ANESTHESIOLOGY, V96, P1161, DOI 10.1097/00000542-200205000-00020; Martin TJ, 2001, J PHARMACOL EXP THER, V299, P811; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Moore KA, 2002, J NEUROSCI, V22, P6724, DOI 10.1523/jneurosci.22-15-06724.2002; Mosconi T, 1996, PAIN, V64, P37, DOI 10.1016/0304-3959(95)00077-1; Nabekura J, 2002, J NEUROSCI, V22, P4412, DOI 10.1523/JNEUROSCI.22-11-04412.2002; Pitcher GM, 2000, EUR J NEUROSCI, V12, P2006, DOI 10.1046/j.1460-9568.2000.00087.x; Polgar E, 2003, PAIN, V104, P229, DOI 10.1016/S0304-3959(03)00011-3; Prescott SA, 2002, J PHYSIOL-LONDON, V539, P817, DOI 10.1113/jphysiol.2001.013437; Rabben T, 1999, J PHARMACOL EXP THER, V289, P1060; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Serpell MG, 2002, PAIN, V99, P557, DOI 10.1016/S0304-3959(02)00255-5; Somers DL, 2002, NEUROSCI LETT, V323, P171, DOI 10.1016/S0304-3940(02)00157-X; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; vandenPol AN, 1996, J NEUROSCI, V16, P4283; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765	30	769	808	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 21	2003	424	6951					938	942		10.1038/nature01868	http://dx.doi.org/10.1038/nature01868			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713EH	12931188				2022-12-01	WOS:000184843600041
J	Huber, C; Eisenreich, W; Hecht, S; Wachtershausher, G				Huber, C; Eisenreich, W; Hecht, S; Wachtershausher, G			A possible primordial peptide cycle	SCIENCE			English	Article							AMINO-ACIDS; ENZYMES; ORIGIN; LIFE	alpha-Amino acids can undergo peptide formation by activation with carbon monoxide (CO) under hot aqueous conditions in the presence of freshly coprecipitated colloidal (Fe,Ni)S. We now show that CO-driven peptide formation proceeds concomitantly with CO-driven, N-terminal peptide degradation by racemizing N-terminal hydantoin and urea derivatives to alpha-amino acids. This establishes a peptide cycle with closely related anabolic and catabolic segments. The hydantoin derivative is a purin-related heterocycle. The (Fe,Ni)S-dependent urea hydrolysis could have been the evolutionary precursor of the nickel-enzyme urease. The results support the theory of a chemoautotrophic origin of life with a CO-driven, (Fe,Ni)S-dependent primordial metabolism.	Tech Univ Munich, Inst Organ Chem & Biochem, D-85747 Garching, Germany	Technical University of Munich	Wachtershausher, G (corresponding author), Tech Univ Munich, Inst Organ Chem & Biochem, Lichtenbergstr 4, D-85747 Garching, Germany.		Eisenreich, Wolfgang/A-1258-2013	Eisenreich, Wolfgang/0000-0002-9832-8279				Huber C, 1998, SCIENCE, V281, P670, DOI 10.1126/science.281.5377.670; Huber C, 1997, SCIENCE, V276, P245, DOI 10.1126/science.276.5310.245; JABRI E, 1995, SCIENCE, V268, P998, DOI 10.1126/science.7754395; Kricheldorf H. R., 1987, ALPHA AMINOACID N CA; Syldatk C, 1999, APPL MICROBIOL BIOT, V51, P293, DOI 10.1007/s002530051395; Taillades J, 1998, ORIGINS LIFE EVOL B, V28, P61, DOI 10.1023/A:1006566810636; WACHTERSHAUSER G, 1988, MICROBIOL REV, V52, P452	7	181	187	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2003	301	5635					938	940		10.1126/science.1086501	http://dx.doi.org/10.1126/science.1086501			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711RY	12920291				2022-12-01	WOS:000184755900030
J	Pandolfi, JM; Bradbury, RH; Sala, E; Hughes, TP; Bjorndal, KA; Cooke, RG; McArdle, D; McClenachan, L; Newman, MJH; Paredes, G; Warner, RR; Jackson, JBC				Pandolfi, JM; Bradbury, RH; Sala, E; Hughes, TP; Bjorndal, KA; Cooke, RG; McArdle, D; McClenachan, L; Newman, MJH; Paredes, G; Warner, RR; Jackson, JBC			Global trajectories of the long-term decline of coral reef ecosystems	SCIENCE			English	Article							CLIMATE-CHANGE; BELIZE; DISEASES; ECOLOGY; FUTURE; SCALE	Degradation of coral reef ecosystems began centuries ago, but there is no global summary of the magnitude of change. We compiled records, extending back thousands of years, of the status and trends of seven major guilds of carnivores, herbivores, and architectural species from 14 regions. Large animals declined before small animals and architectural species, and Atlantic reefs declined before reefs in the Red Sea and Australia, but the trajectories of decline were markedly similar worldwide. All reefs were substantially degraded long before outbreaks of coral disease and bleaching. Regardless of these new threats, reefs will not survive without immediate protection from human exploitation over large spatial scales.	Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA; Australian Natl Univ, Ctr Resource & Environm Studies, Canberra, ACT 0200, Australia; Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; James Cook Univ, Ctr Coral Reef Biodivers, Sch Marine Biol, Townsville, Qld 4811, Australia; Univ Florida, Archie Carr Ctr Sea Turtle Res, Dept Zool, Gainesville, FL 32611 USA; Smithsonian Trop Res Inst, Ctr Trop Paleoecol & Archaeol, Balboa, Panama; Univ Calif Santa Barbara, Calif Sea Grant, Cooperat Extens, Santa Barbara, CA 93105 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Australian National University; University of California System; University of California San Diego; Scripps Institution of Oceanography; James Cook University; State University System of Florida; University of Florida; Smithsonian Institution; Smithsonian Tropical Research Institute; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Pandolfi, JM (corresponding author), Natl Museum Nat Hist, Dept Paleobiol, MRC-121,POB 37012, Washington, DC 20013 USA.	pandolfi.john@nmnh.si.edu	Pandolfi, John M/A-3121-2009; Hughes, Terry P/L-4721-2013; Warner, Robert R./M-5342-2013	Pandolfi, John M/0000-0003-3047-6694; Hughes, Terry P/0000-0002-5257-5063; Warner, Robert R./0000-0002-3299-5685; Bjorndal, Karen/0000-0002-6286-1901; Bradbury, Roger/0000-0002-0940-3493				Aronson RB, 1998, CORAL REEFS, V17, P223, DOI 10.1007/s003380050122; Aronson RB, 2000, NATURE, V405, P36, DOI 10.1038/35011132; Aronson RB, 2002, ECOL MONOGR, V72, P233, DOI 10.1890/0012-9615(2002)072[0233:TESOST]2.0.CO;2; Brown BE, 1997, ADV MAR BIOL, V31, P221, DOI DOI 10.1016/S0065-2881(08)60224-2; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; GOREAU TF, 1959, ECOLOGY, V40, P67, DOI 10.2307/1929924; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; LEWIS JB, 1984, CORAL REEFS, V3, P117, DOI 10.1007/BF00301955; McClanahan TR, 2002, SCOPE SER, V60, P111; Richardson LL, 1998, TRENDS ECOL EVOL, V13, P438, DOI 10.1016/S0169-5347(98)01460-8; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Wolanski E, 2003, AM SCI, V91, P44, DOI 10.1511/2003.11.843; [No title captured]	19	1369	1429	21	1006	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2003	301	5635					955	958		10.1126/science.1085706	http://dx.doi.org/10.1126/science.1085706			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711RY	12920296				2022-12-01	WOS:000184755900036
J	Brummelkamp, TR; Nijman, SMB; Dirac, AMG; Bernards, R				Brummelkamp, TR; Nijman, SMB; Dirac, AMG; Bernards, R			Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappa B	NATURE			English	Article							NECROSIS-FACTOR; DEUBIQUITINATING ENZYMES; TNF; MECHANISMS; KINASE; CANCER	Protein modification by the conjugation of ubiquitin moieties-ubiquitination- plays a major part in many biological processes, including cell cycle and apoptosis(1). The enzymes that mediate ubiquitin-conjugation have been well-studied, but much less is known about the ubiquitin-specific proteases that mediate deubiquitination of cellular substrates(2,3). To study this gene family, we designed a collection of RNA interference vectors to suppress 50 human de-ubiquitinating enzymes, and used these vectors to identify de-ubiquitinating enzymes in cancer-relevant pathways. We report here that inhibition of one of these enzymes, the familial cylindromatosis tumour suppressor gene (CYLD)(4), having no known function, enhances activation of the transcription factor NF-kappaB. We show that CYLD binds to the NEMO (also known as IKKgamma) component of the IkappaB kinase (IKK) complex, and appears to regulate its activity through de-ubiquitination of TRAF2, as TRAF2 ubiquitination can be modulated by CYLD. Inhibition of CYLD increases resistance to apoptosis, suggesting a mechanism through which loss of CYLD contributes to oncogenesis. We show that this effect can be relieved by aspirin derivatives that inhibit NF-kappaB activity(5), which suggests a therapeutic intervention strategy to restore growth control in patients suffering from familial cylindromatosis.	Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl		Bernards, Rene/0000-0001-8677-3423				Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Chung CH, 1999, BIOCHEM BIOPH RES CO, V266, P633, DOI 10.1006/bbrc.1999.1880; Chung JY, 2002, J CELL SCI, V115, P679; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; HOLTMANN H, 1988, IMMUNOBIOLOGY, V177, P7, DOI 10.1016/S0171-2985(88)80087-1; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; NAKAMURA T, 1988, ONCOGENE RES, V2, P357; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Schmidt-Ullrich R, 2001, DEVELOPMENT, V128, P3843; SchmidtUllrich R, 1996, DEVELOPMENT, V122, P2117; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; Smahi A, 2002, HUM MOL GENET, V11, P2371, DOI 10.1093/hmg/11.20.2371; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; VANBALKOM IDC, 1994, J MED GENET, V31, P321, DOI 10.1136/jmg.31.4.321; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948	27	784	819	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2003	424	6950					797	801		10.1038/nature01811	http://dx.doi.org/10.1038/nature01811			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12917690	Green Published			2022-12-01	WOS:000184733900045
J	Alonso, JM; Stepanova, AN; Leisse, TJ; Kim, CJ; Chen, HM; Shinn, P; Stevenson, DK; Zimmerman, J; Barajas, P; Cheuk, R; Gadrinab, C; Heller, C; Jeske, A; Koesema, E; Meyers, CC; Parker, H; Prednis, L; Ansari, Y; Choy, N; Deen, H; Geralt, M; Hazari, N; Hom, E; Karnes, M; Mulholland, C; Ndubaku, R; Schmidt, I; Guzman, P; Aguilar-Henonin, L; Schmid, M; Weigel, D; Carter, DE; Marchand, T; Risseeuw, E; Brogden, D; Zeko, A; Crosby, WL; Berry, CC; Ecker, JR				Alonso, JM; Stepanova, AN; Leisse, TJ; Kim, CJ; Chen, HM; Shinn, P; Stevenson, DK; Zimmerman, J; Barajas, P; Cheuk, R; Gadrinab, C; Heller, C; Jeske, A; Koesema, E; Meyers, CC; Parker, H; Prednis, L; Ansari, Y; Choy, N; Deen, H; Geralt, M; Hazari, N; Hom, E; Karnes, M; Mulholland, C; Ndubaku, R; Schmidt, I; Guzman, P; Aguilar-Henonin, L; Schmid, M; Weigel, D; Carter, DE; Marchand, T; Risseeuw, E; Brogden, D; Zeko, A; Crosby, WL; Berry, CC; Ecker, JR			Genome-wide Insertional mutagenesis of Arabidopsis thaliana	SCIENCE			English	Article							T-DNA; TRANSFORMATION; GENES; INTEGRATION; TARGET	Over 225,000 independent Agrobacterium transferred DNA (T-DNA) insertion events in the genome of the reference plant Arabidopsis thaliana have been created that represent near saturation of the gene space. The precise locations were determined for more than 88,000 T-DNA insertions, which resulted in the identification of mutations in more than 21,700 of the similar to29,454 predicted Arabidopsis genes. Genome-wide analysis of the distribution of integration events revealed the existence of a large integration site bias at both the chromosome and gene levels. Insertion mutations were identified in genes that are regulated in response to the plant hormone ethylene.	Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; Natl Res Council Canada, Inst Plant Biotechnol, Saskatoon, SK S7N 0W9, Canada; Univ Calif San Diego, Dept Family Prevent Med, San Diego, CA 92093 USA	Salk Institute; National Research Council Canada; University of California System; University of California San Diego	Ecker, JR (corresponding author), Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ecker@salk.edu	Alonso, Jose M/K-6826-2014; Weigel, Detlef/C-1418-2008; Schmid, Markus/I-4384-2015; Stepanova, Anna/P-9575-2019; Weigel, Detlef/AAR-3312-2021; Guzman, Plinio/A-3073-2012; Weigel, Detlef/GSJ-0799-2022; Ecker, Joseph R/B-9144-2008	Alonso, Jose M/0000-0001-7087-1571; Weigel, Detlef/0000-0002-2114-7963; Schmid, Markus/0000-0002-0068-2967; Stepanova, Anna/0000-0003-1018-4758; Weigel, Detlef/0000-0002-2114-7963; Ecker, Joseph R/0000-0001-5799-5895; Chen, Huaming/0000-0001-5289-7882; Koesema, Eric/0000-0002-7743-0127; Wu, Emily/0000-0001-8160-0654				ALONSO J, UNPUB; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Bargmann CI, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews1005; Bechtold N, 2000, GENETICS, V155, P1875; Chen H. M., UNPUB; Desfeux C, 2000, PLANT PHYSIOL, V123, P895, DOI 10.1104/pp.123.3.895; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gong M, 2003, CURR OPIN GENET DEV, V13, P215, DOI 10.1016/S0959-437X(03)00018-2; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Haupt W, 2001, PLANT J, V27, P285, DOI 10.1046/j.1365-313x.2001.01087.x; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; McElver J, 2001, GENETICS, V159, P1751; Parinov S, 2000, CURR OPIN BIOTECH, V11, P157, DOI 10.1016/S0958-1669(00)00075-6; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Tzfira T, 2002, TRENDS CELL BIOL, V12, P121, DOI 10.1016/S0962-8924(01)02229-2; Tzfira T, 2000, MOL PLANT PATHOL, V1, P201, DOI 10.1046/j.1364-3703.2000.00026.x; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	25	4003	4176	14	501	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2003	301	5633					653	657		10.1126/science.1086391	http://dx.doi.org/10.1126/science.1086391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893945				2022-12-01	WOS:000184473600042
J	Bergman, A; Siegal, ML				Bergman, A; Siegal, ML			Evolutionary capacitance as a general feature of complex gene networks	NATURE			English	Article							CANALIZATION; HSP90; ARCHITECTURE	An evolutionary capacitor buffers genotypic variation under normal conditions, thereby promoting the accumulation of hidden polymorphism. But it occasionally fails, thereby revealing this variation phenotypically(1).Theprincipal example of an evolutionary capacitor is Hsp90, a molecular chaperone that targets an important set of signal transduction proteins. Experiments in Drosophila and Arabidopsis have demonstrated three key properties of Hsp90: (1) it suppresses phenotypic variation under normal conditions and releases this variation when functionally compromised; (2) its function is overwhelmed by environmental stress; and (3) it exerts pleiotropic effects on key developmental processes(1,2). But whether these properties necessarily make Hsp90 a significant and unique facilitator of adaptation(1-10) is unclear. Here we use numerical simulations of complex gene networks, as well as genome-scale expression data from yeast single-gene deletion strains, to present a mechanism that extends the scope of evolutionary capacitance beyond the action of Hsp90 alone. We illustrate that most, and perhaps all, genes reveal phenotypic variation when functionally compromised, and that the availability of loss-of-function mutations accelerates adaptation to a new optimum phenotype. However, this effect does not require the mutations to be conditional on the environment. Thus, there might exist a large class of evolutionary capacitors whose effects on phenotypic variation complement the systemic, environment-induced effects of Hsp90.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Ctr Computat Genet & Biol Modeling, Stanford, CA 94305 USA	Stanford University; Stanford University	Siegal, ML (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	mlsiegal@stanford.edu		Siegal, Mark/0000-0001-6930-2988				Cossins A, 1998, NATURE, V396, P309, DOI 10.1038/24483; Dickinson WJ, 1999, NATURE, V399, P30, DOI 10.1038/19894; Edwards RJ, 2003, MOL BIOL EVOL, V20, P30, DOI 10.1093/molbev/msg001; Featherstone DE, 2002, BIOESSAYS, V24, P267, DOI 10.1002/bies.10054; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.3.CO;2-A; Hansen TF, 2001, THEOR POPUL BIOL, V59, P61, DOI 10.1006/tpbi.2000.1508; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; McLaren A, 1999, TRENDS GENET, V15, P169, DOI 10.1016/S0168-9525(99)01732-1; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Mitchell-Olds T, 2002, SCIENCE, V296, P2348, DOI 10.1126/science.1073846; Pigliucci M, 2002, NATURE, V417, P598, DOI 10.1038/417598a; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rice SH, 1998, EVOLUTION, V52, P647, DOI 10.1111/j.1558-5646.1998.tb03690.x; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; SCHARLOO W, 1991, ANNU REV ECOL SYST, V22, P65, DOI 10.1146/annurev.ecolsys.22.1.65; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; STEARNS SC, 1995, J EVOLUTION BIOL, V8, P539, DOI 10.1046/j.1420-9101.1995.8050539.x; Tautz D, 2000, TRENDS GENET, V16, P475, DOI 10.1016/S0168-9525(00)02118-1; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wagner A, 1996, EVOLUTION, V50, P1008, DOI 10.1111/j.1558-5646.1996.tb02342.x; Wagner GP, 1997, EVOLUTION, V51, P329, DOI 10.1111/j.1558-5646.1997.tb02420.x; Wagner GP, 2000, J THEOR BIOL, V203, P163, DOI 10.1006/jtbi.2000.1074; Wagner GP, 1999, J EXP ZOOL, V285, P116, DOI 10.1002/(SICI)1097-010X(19990815)285:2<116::AID-JEZ3>3.0.CO;2-P; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	27	364	370	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2003	424	6948					549	552		10.1038/nature01765	http://dx.doi.org/10.1038/nature01765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891357				2022-12-01	WOS:000184454700042
J	Agathon, A; Thisse, C; Thisse, B				Agathon, A; Thisse, C; Thisse, B			The molecular nature of the zebrafish tail organizer	NATURE			English	Article								Based on grafting experiments, Mangold and Spemann showed the dorsal blastopore lip of an amphibian gastrula to be able to induce a secondary body axis(1). The equivalent of this organizer region has been identified in different vertebrates including teleosts(2). However, whereas the graft can induce ectopic head and trunk, endogenous and ectopic axes fuse in the posterior part of the body(3,4), raising the question of whether a distinct organizer region is necessary for tail development. Here we reveal, by isochronic and heterochronic transplantation, the existence of a tail organizer deriving from the ventral margin of the zebrafish embryo, which is independent of the dorsal Spemann organizer. Loss-of-function experiments reveal that bone morphogenetic protein (BMP), Nodal and Wnt8 signalling pathways are required for tail development. Moreover, stimulation of naive cells by a combination of BMP, Nodal and Wnt8 mimics the tail-organizing activity of the ventral margin and induces surrounding tissues to become tail. In contrast to induction of the vertebrate head, known to result from the triple inhibition of BMP, Nodal and Wnt(5), here we show that induction of the tail results from the triple stimulation of BMP, Nodal and Wnt8 signalling pathways.	Inst Genet & Biol Mol & Cellulaire, CNRS, UMR 7104, INSERM,ULP, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Thisse, B (corresponding author), Inst Genet & Biol Mol & Cellulaire, CNRS, UMR 7104, INSERM,ULP, 1 Rue Laurent Fries,BP10142,CU Strasbourg, F-67404 Illkirch Graffenstaden, France.	thisse@igbmc.u-strasbg.fr		THISSE, Christine/0000-0002-8684-1681				Connors SA, 1999, DEVELOPMENT, V126, P3119; Furthauer M, 1999, DEV BIOL, V214, P181, DOI 10.1006/dbio.1999.9401; GONT LK, 1993, DEVELOPMENT, V119, P991; JOLY JS, 1993, DEVELOPMENT, V119, P1261; Kanki JP, 1997, DEVELOPMENT, V124, P881; KELLY GM, 1995, DEVELOPMENT, V121, P1787; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; Knezevic V, 1998, DEVELOPMENT, V125, P1791; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Mangold O, 1933, NATURWISSENSCHAFTEN, V21, P761, DOI 10.1007/BF01503740; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Muller F, 2000, DEVELOPMENT, V127, P3889; Mullins MC, 1996, DEVELOPMENT, V123, P81; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Nikaido M, 1999, DEVELOPMENT, V126, P181; Oppenheimer JM, 1936, J EXP ZOOL, V72, P409, DOI 10.1002/jez.1400720304; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; RENUCCI A, 1996, DEVELOPMENT, V122, P735; Saude L, 2000, DEVELOPMENT, V127, P3407; Schier AF, 2001, CURR OPIN GENET DEV, V11, P393, DOI 10.1016/S0959-437X(00)00209-4; Schmid B, 2000, DEVELOPMENT, V127, P957; Shih J, 1996, DEVELOPMENT, V122, P1313; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; Thisse B, 2000, NATURE, V403, P425, DOI 10.1038/35000200; TUCKER AS, 1995, CURR BIOL, V5, P807, DOI 10.1016/S0960-9822(95)00158-8; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Woo K, 1997, SCIENCE, V277, P254, DOI 10.1126/science.277.5323.254	28	164	168	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					448	452		10.1038/nature01822	http://dx.doi.org/10.1038/nature01822			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879074				2022-12-01	WOS:000184318400048
J	LaCroix, AZ; Cauley, JA; Pettinger, M; Hsia, J; Bauer, DC; McGowan, J; Chen, Z; Lewis, CE; McNeeley, SG; Passaro, MD; Jackson, RD				LaCroix, AZ; Cauley, JA; Pettinger, M; Hsia, J; Bauer, DC; McGowan, J; Chen, Z; Lewis, CE; McNeeley, SG; Passaro, MD; Jackson, RD			Statin use, clinical fracture, and bone density in postmenopausal women: Results from the women's health initiative observational study	ANNALS OF INTERNAL MEDICINE			English	Article							HMG-COA REDUCTASE; MINERAL DENSITY; RISK; INHIBITORS; PRAVASTATIN; LOVASTATIN; FREQUENCY; MASS	Background: 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) have been shown to stimulate bone formation in laboratory studies, both in vitro and in vivo. While early epidemiologic studies showed lower risk for hip fracture among statin users than nonusers, subsequent studies have produced mixed results. Objective: To examine the association of statin use with incidence of hip, lower arm or wrist, and other clinical fractures and with baseline levels of bone density. Design: Prospective study. Setting: women's Health Initiative Observational Study conducted in 40 clinical centers in the United States. Participants: 93 716 postmenopausal women ages 50 to 79 years. Measurements: Rates of hip, lower arm or wrist, and other clinical fractures were compared among 7846 statin users and 85 870 nonusers over a median follow-up of 3.9 years. In 6442 women enrolled at three clinical centers, baseline levels of total hip, posterior-anterior spine, and total-body bone density measured by using dual-energy x-ray absorptiometry were compared according to statin use. Results: Age-adjusted rates of hip, lower arm or wrist, and other clinical fractures were similar between statin users and nonusers regardless of duration of statin use. The multivadate-adjusted hazard ratios for current statin use were 1.22 (95% CI, 0.83 to 1.81) for hip fracture, 1.04 (CI, 0.85 to 1.27) for lower arm or wrist fracture, and 1.11 (CI, 1.00 to 1.22) for other clinical fracture. Bone density levels did not statistically differ between statin users and nonusers at any skeletal site after adjustment for age, ethnicity, body mass index, and other factors. Conclusion: Statin use did not improve fracture risk or bone density in the Women's Health Initiative Observational Study. The cumulative evidence does not warrant use of statins to prevent or treat osteoporosis.	Fred Hutchinson Canc Res Ctr, Womens Hlth Initiat Clin Coordinating Ctr, Seattle, WA 98109 USA; Univ Pittsburgh, Pittsburgh, PA USA; George Washington Univ, Washington, DC USA; Medlant Res Inst, Washington, DC USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Natl Inst Arthrit & Musculoskeletal Dis, NIH, Bethesda, MD USA; Univ Arizona, Tucson, AZ USA; Univ Alabama Birmingham, Birmingham, AL USA; Wayne State Univ, Detroit, MI USA; Ohio State Univ, Columbus, OH 43210 USA	Fred Hutchinson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; George Washington University; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Arizona; University of Alabama System; University of Alabama Birmingham; Wayne State University; University System of Ohio; Ohio State University	LaCroix, AZ (corresponding author), Fred Hutchinson Canc Res Ctr, Womens Hlth Initiat Clin Coordinating Ctr, 1100 Fairview Ave N,MP-1002,POB 19024, Seattle, WA 98109 USA.		Cauley, Jane A/N-4836-2015	Cauley, Jane A/0000-0003-0752-4408				Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Bauer DC, 1999, J BONE MINER RES, V14, pS179; Chan KA, 2000, LANCET, V355, P2185, DOI 10.1016/S0140-6736(00)02400-4; Chung YS, 2000, J CLIN ENDOCR METAB, V85, P1137, DOI 10.1210/jc.85.3.1137; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Edwards CJ, 2000, LANCET, V355, P2218, DOI 10.1016/S0140-6736(00)02408-9; Garrett IR, 2000, J BONE MINER RES, V15, pS225; Jones P, 1998, AM J CARDIOL, V81, P582, DOI 10.1016/S0002-9149(97)00965-X; Kristal AR, 1997, AM J EPIDEMIOL, V146, P856, DOI 10.1093/oxfordjournals.aje.a009203; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Meier CR, 2000, JAMA-J AM MED ASSOC, V283, P3205, DOI 10.1001/jama.283.24.3205; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; MUNDY GR, 2001, IBMS BONE KEY, P1; Pasco JA, 2002, ARCH INTERN MED, V162, P537, DOI 10.1001/archinte.162.5.537; PEDERSEN TR, 1994, LANCET, V344, P1383; Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899; Reid IR, 2001, LANCET, V357, P509, DOI 10.1016/S0140-6736(00)04042-3; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; van Staa TP, 2001, JAMA-J AM MED ASSOC, V285, P1850, DOI 10.1001/jama.285.14.1850; Wang PS, 2000, JAMA-J AM MED ASSOC, V283, P3211, DOI 10.1001/jama.283.24.3211; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Watanabe S, 2000, J BONE MINER RES, V15, pS194	22	133	142	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2003	139	2					97	104		10.7326/0003-4819-139-2-200307150-00009	http://dx.doi.org/10.7326/0003-4819-139-2-200307150-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701HX	12859159				2022-12-01	WOS:000184163100003
J	McGrath, J; Somlo, S; Makova, S; Tian, X; Brueckner, M				McGrath, J; Somlo, S; Makova, S; Tian, X; Brueckner, M			Two populations of node monocilia initiate left-right asymmetry in the mouse	CELL			English	Article							POLYCYSTIC KIDNEY-DISEASE; PRIMARY CILIARY DYSKINESIA; RIGHT AXIS DETERMINATION; SITUS-INVERSUS; PRIMARY CILIUM; KINESIN-II; GENE; MICE; MUTATIONS; EXPRESSION	The vertebrate body plan has conserved handed left-right (LR) asymmetry that is manifested in the heart, lungs, and gut. Leftward flow of extracellular fluid at the node (nodal flow) is critical for normal LR axis determination in the mouse. Nodal flow is generated by motile node cell monocilia and requires the axonemal dynein, left-right dynein (lrd). In the absence of lrd, LR determination becomes random. The cation channel polycystin-2 is also required to establish LR asymmetry. We show that lrd localizes to a centrally located subset of node monocilia, while polycystin-2 is found in all node monocilia. Asymmetric calcium signaling appears at the left margin of the node coincident with nodal flow. These observations suggest that LR asymmetry is established by an entirely ciliary mechanism: motile, lrd-containing monocilia generate nodal flow, and nonmotile polycystin-2 containing cilia sense nodal flow initiating an asymmetric calcium signal at the left border of the node.	Yale Univ, Sch Med, Dept Comparat Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pediat, Cardiol Sect, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Brueckner, M (corresponding author), Yale Univ, Sch Med, Dept Comparat Med, 333 Cedar St, New Haven, CT 06520 USA.	martina.brueckner@yale.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054053] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK54053] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Barr MM, 2001, CURR BIOL, V11, P1341, DOI 10.1016/S0960-9822(01)00423-7; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Bellomo D, 1996, DEV DYNAM, V205, P471, DOI 10.1002/(SICI)1097-0177(199604)205:4<471::AID-AJA10>3.0.CO;2-4; BROWN NA, 1990, DEVELOPMENT, V109, P1; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Guichard C, 2001, AM J HUM GENET, V68, P1030, DOI 10.1086/319511; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hummel K. P., 1959, Journal of Heredity, V50, P9; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Kramer KL, 2002, CELL, V111, P981, DOI 10.1016/S0092-8674(02)01200-X; LAYTON WM, 1976, J HERED, V67, P336, DOI 10.1093/oxfordjournals.jhered.a108749; Levin M, 1999, DEVELOPMENT, V126, P4703; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; Levin M, 1998, DEV BIOL, V203, P90, DOI 10.1006/dbio.1998.9024; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Lowe LA, 2001, DEVELOPMENT, V128, P1831; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Mochizuki T, 1998, NATURE, V395, P177, DOI 10.1038/26006; Morgan D, 1998, NAT GENET, V20, P149, DOI 10.1038/2450; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Poole CA, 1997, CELL BIOL INT, V21, P483, DOI 10.1006/cbir.1997.0177; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; SULIK K, 1994, DEV DYNAM, V201, P260, DOI 10.1002/aja.1002010309; Supp DM, 1999, DEVELOPMENT, V126, P5495; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407; Wilhelmi H, 1921, ARCH ENTWICKLUNG ORG, V48, P517, DOI 10.1007/BF02554577; Wu GQ, 2000, NAT GENET, V24, P75, DOI 10.1038/71724; Wu GQ, 2002, HUM MOL GENET, V11, P1845, DOI 10.1093/hmg/11.16.1845; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178	50	570	595	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2003	114	1					61	73		10.1016/S0092-8674(03)00511-7	http://dx.doi.org/10.1016/S0092-8674(03)00511-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	702JC	12859898	Bronze			2022-12-01	WOS:000184219900006
J	Miller, RF; Cloutier, R; Turner, S				Miller, RF; Cloutier, R; Turner, S			The oldest articulated chondrichthyan from the Early Devonian period	NATURE			English	Article							BRAINCASE; INTERRELATIONSHIPS; EVOLUTION; SHARKS	Chondrichthyans (including living sharks, skates, rays and chimaeras) have a fossil record of scales and dermal denticles perhaps dating back to the Late Ordovician period, about 455 million years ago(1,2). Their fossil tooth record extends to the earliest Devonian period, almost 418 million years ago(3), whereas the oldest known articulated shark remains date from the Early Devonian period(4), about 394 million years ago(5). Here we report the discovery of an articulated shark that is almost 409 million years old 5 from the Early Devonian (early Emsian) period of New Brunswick, Canada. The specimen, identified as Doliodus problematicus (Woodward)(6), sheds light on the earliest chondrichthyans and their interrelationships with basal jawed vertebrates. This species has been truly problematic(7). Previously known only from isolated teeth(2,6,8), it has been identified as an acanthodian and a chondrichthyan. This specimen is the oldest shark showing the tooth families in situ, and preserves one of the oldest chondrichthyan braincases. More notably, it shows the presence of paired pectoral fin-spines, previously unknown in cartilaginous fishes.	New Brunswick Museum, Steinhammer Palaeontol Lab, St John, NB E2K 1E5, Canada; Univ Quebec, Lab Biol Evolut, Rimouski, PQ G5L 3A1, Canada; Monash Univ, Sch Geosci, Clayton, Vic 3088, Australia; Queensland Museum, Brisbane, Qld 4101, Australia	University of Quebec; Monash University; Queensland Museum	Miller, RF (corresponding author), New Brunswick Museum, Steinhammer Palaeontol Lab, St John, NB E2K 1E5, Canada.		Turner, Susan/AAS-6992-2021	Turner, Susan/0000-0003-2308-158X; Cloutier, Richard/0000-0001-5780-3304				[Anonymous], 1988, SHARKS ORDER CARCHAR; Blieck Alain, 2000, Courier Forschungsinstitut Senckenberg, V223, P223; Coates MI, 2001, SYST ASSOC SPEC VOL, V61, P241; Coates MI, 1998, T ROY SOC EDIN-EARTH, V89, P63, DOI 10.1017/S026359330000701X; Denison R., 1979, Handbook of Paleoichthyology, V5, P1; DINELEY DL, 1968, CAN J EARTH SCI, V5, P945, DOI DOI 10.1139/E68-091; Forey P.L., 1992, Bulletin of the British Museum (Natural History) Geology, V48, P25; Gensel P.G., 1984, PLANT LIFE DEVONIAN; Heidtke Ulrich H.J., 2001, Mainzer Geowissenschaftliche Mitteilungen, V30, P105; Janvier P., 1986, Bulletin de l'Institut Francais d'Etudes Andines, V15, P73; JANVIER P., 1996, EARLY VERTEBRATES; KEPPIE JD, 1999, GEOLOGICAL SOC AM SP, V336, P267; Long John A., 1995, Records of the Western Australian Museum, V17, P287; Mader H., 1986, GOTTINGER ARB GEOL P, V28, P1; MAISEY J G, 1986, Cladistics, V2, P201, DOI 10.1111/j.1096-0031.1986.tb00462.x; Maisey JG, 2001, J VERTEBR PALEONTOL, V21, P702, DOI 10.1671/0272-4634(2001)021[0702:APCBFT]2.0.CO;2; Maisey JG, 2001, SYST ASSOC SPEC VOL, V61, P263; REIF WE, 1982, EVOL BIOL, V15, P287; Shear WA, 1996, NATURE, V384, P555, DOI 10.1038/384555a0; Smith MM, 2001, SYST ASSOC SPEC VOL, V61, P223; Traquair RH, 1893, GEOLOGICAL MAGAZINE, V10, P145; Tucker RD, 1998, EARTH PLANET SC LETT, V158, P175, DOI 10.1016/S0012-821X(98)00050-8; TURNER S, RECENT ADV ORIGIN EA; WHITEAVES JF, 1881, CANADIAN NATURALIST, V10, P93; Williams G. L., 1985, LEXICON CANADIAN STR, VVI; Woodward A.S., 1892, GEOL MAG, P1, DOI [10.1017/S0016756800188533, DOI 10.1017/S0016756800188533]; YOUNG GC, 1982, PALAEONTOLOGY, V25, P817; Zangerl R., 1981, Handbook of Paleoichthyology, V3, P1; Zhu M, 2001, SYST ASSOC SPEC VOL, V61, P289; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594	30	119	126	3	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2003	425	6957					501	504		10.1038/nature02001	http://dx.doi.org/10.1038/nature02001			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727FN	14523444				2022-12-01	WOS:000185648100042
J	Murray, CJL; Shengelia, B; Gupta, N; Moussavi, S; Tandon, A; Thieren, M				Murray, CJL; Shengelia, B; Gupta, N; Moussavi, S; Tandon, A; Thieren, M			Validity of reported vaccination coverage in 45 countries	LANCET			English	Article							SAMPLE SELECTION BIAS; CHILD VACCINATION; MOTHERS REPORTS; ACCURACY	Background Monitoring and assessment of coverage rates in national health programmes is becoming increasingly important, We aimed to assess the accuracy of officially reported coverage rates of vaccination with diphtheria-tetanus-pertussis vaccine (DTP3), which is commonly used to monitor child health interventions. Methods We compared officially reported national data for DTP3 coverage with those from the household Demographic and Health Surveys (DHS) in 45 countries between :1990 and 2000. We adjusted survey data to reflect the number of valid vaccinations (ie, those administered in accordance with the schedule recommended by WHO) using a probit model with sample selection. The model predicted the probability of valid vaccinations for children, including those without documented vaccinations, after correcting for bias from differences between the children with and without documented information on vaccination. We then assessed the extent of survey bias and differences between officially reported data and those from DHS estimates. Findings Our results suggest that officially reported DTP3 coverage is higher than that reported from household surveys. This size of the difference increases with the rate of reported coverage of DTP3. Results of time-trend analysis show that changes in reported coverage are not correlated with changes reported from household surveys. Interpretation Although reported data might be the most widely available information for assessment of vaccination coverage, their validity for measuring changes in coverage over time is highly questionable. Household surveys can be used to validate data collected by service providers. Strategies for measurement of the coverage of all health interventions should be grounded in careful assessments of the validity of data derived from various sources.	WHO, Dept Hlth Serv Provis Evidence & Informat Policy, CH-1211 Geneva 27, Switzerland	World Health Organization	Shengelia, B (corresponding author), WHO, Dept Hlth Serv Provis Evidence & Informat Policy, CH-1211 Geneva 27, Switzerland.	shengeliab@who.int		Gupta, Neeru/0000-0002-3806-4435				Angelillo IF, 1999, B WORLD HEALTH ORGAN, V77, P224; BENNETT P, 1992, HEALTH EDUC RES, V7, P341, DOI 10.1093/her/7.3.341; BERK RA, 1983, AM SOCIOL REV, V48, P386, DOI 10.2307/2095230; Bhattacharya N, 1990, Indian J Public Health, V34, P220; Boerma J, 1994, DHS METHODOLOGICAL R; BORGDORFF MW, 1988, J TROP MED HYG, V91, P35; BROWN J, 2002, MEASURE EVALUATION W; Brugha R, 2002, LANCET, V359, P435, DOI 10.1016/S0140-6736(02)07607-9; CUTTS FT, 1993, B WORLD HEALTH ORGAN, V71, P633; GAREABALLAH ET, 1989, B WORLD HEALTH ORGAN, V67, P669; George K, 1990, Indian J Pediatr, V57, P588, DOI 10.1007/BF02726779; Guerin N, 1998, VACCINE, V16, pS81, DOI 10.1016/S0264-410X(98)00304-1; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Langsten R, 1998, SOC SCI MED, V46, P1205, DOI 10.1016/S0277-9536(97)10049-1; *LATH CONS, 2001, IMM DAT QUAL AUD EV; LEWIS T, 1988, AM J DIS CHILD, V142, P283, DOI 10.1001/archpedi.1988.02150030053018; *MACR INT, 1996, SAMPL MAN DHS 3 BAS; *ORC MACR, 2001, MOD A QUEST MEASURE; Ramakrishnan R, 1999, Indian Pediatr, V36, P881; Singh R, 1976, Indian J Pediatr, V43, P118, DOI 10.1007/BF02749242; Suarez L, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e3; *UNICEF, ROUT IMM EST IMM COV; VALADEZ JJ, 1992, AM J PUBLIC HEALTH, V82, P120, DOI 10.2105/AJPH.82.1.120; VANDEVEN WPMM, 1981, J ECONOMETRICS, V17, P229, DOI 10.1016/0304-4076(81)90028-2; *WHO, 1999, WHOVB9906 DEP VACC B; *WHO, 1991, WHOEPIMLM9110 EXP PR; *WHO, 1996, WHOGPVGEN9503 GLOB P; *WHO, 2000, WHOVB0032 DEP VACC B; Wittet S, 2000, VACCINE, V19, P385, DOI 10.1016/S0264-410X(00)00196-1	29	154	161	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 27	2003	362	9389					1022	1027		10.1016/S0140-6736(03)14411-X	http://dx.doi.org/10.1016/S0140-6736(03)14411-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	725WD	14522532				2022-12-01	WOS:000185564600009
J	Allan, RS; Smith, CM; Belz, GT; van Lint, AL; Wakim, LM; Heath, WR; Carbone, FR				Allan, RS; Smith, CM; Belz, GT; van Lint, AL; Wakim, LM; Heath, WR; Carbone, FR			Epidermal viral immunity induced by CD8 alpha(+) dendritic cells but not by Langerhans cells	SCIENCE			English	Article							HERPES-SIMPLEX VIRUS-1; TUMOR-NECROSIS-FACTOR; DRAINING LYMPH-NODE; SURFACE PHENOTYPE; STEADY-STATE; MOUSE; SKIN; ANTIGEN; SPLEEN; INFECTION	The classical paradigm for dendritic cell function derives from the study of Langerhans cells, which predominate within skin epidermis. After an encounter with foreign agents, Langerhans cells are thought to migrate to draining lymph nodes, where they initiate T cell priming. Contrary to this, we show here that infection of murine epidermis by herpes simplex virus did not result in the priming of virus-specific cytotoxic T lymphocytes by Langerhans cells. Rather, the priming response required a distinct CD8alpha(+) dendritic cell subset. Thus, the traditional view of Langerhans cells in epidermal immunity needs to be revisited to accommodate a requirement for other dendritic cells in this response.	Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3050, Australia; Walter & Eliza Hall Inst Med Res, Cooperat Res Vaccine Technol, Melbourne, Vic 3050, Australia	University of Melbourne; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute	Heath, WR (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia.		Belz, Gabrielle T/C-9350-2013; Carbone, Francis/ABF-2141-2020	Belz, Gabrielle T/0000-0002-9660-9587; Heath, William/0000-0001-9670-259X; Allan, Rhys/0000-0003-0906-2980; Wakim, Linda/0000-0003-1752-9579				ALLAN RJ, UNPUB; Austyn JM, 1996, J EXP MED, V183, P1287, DOI 10.1084/jem.183.4.1287; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Coles RM, 2002, J IMMUNOL, V168, P834, DOI 10.4049/jimmunol.168.2.834; CUMBERBATCH M, 1995, IMMUNOLOGY, V84, P31; Hemmi H, 2001, INT IMMUNOL, V13, P695, DOI 10.1093/intimm/13.5.695; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; HOEFSMIT ECM, 1982, IMMUNOBIOLOGY, V161, P255, DOI 10.1016/S0171-2985(82)80081-8; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; MAURER D, 2001, DENDRITIC CELLS, V2, pCH5; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; MOLL H, 1993, EUR J IMMUNOL, V23, P1595, DOI 10.1002/eji.1830230730; Mueller SN, 2002, IMMUNOL CELL BIOL, V80, P156, DOI 10.1046/j.1440-1711.2002.01071.x; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; ROAKE JA, 1995, J EXP MED, V181, P2237, DOI 10.1084/jem.181.6.2237; ROMANI N, 1989, J EXP MED, V169, P1169, DOI 10.1084/jem.169.3.1169; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; SILBERBERGSINAKIN I, 1976, CELL IMMUNOL, V25, P137, DOI 10.1016/0008-8749(76)90105-2; Smith CM, 2003, J IMMUNOL, V170, P4437, DOI 10.4049/jimmunol.170.9.4437; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	24	464	474	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2003	301	5641					1925	1928		10.1126/science.1087576	http://dx.doi.org/10.1126/science.1087576			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725GW	14512632				2022-12-01	WOS:000185536700056
J	Tedford, RH; Harington, CR				Tedford, RH; Harington, CR			An Arctic mammal fauna from the Early Pliocene of North America	NATURE			English	Article								A peat deposit on Ellesmere Island(1), Nunavut, Canada, allows a unique glimpse of the Early Pliocene terrestrial biota north of the Arctic Circle. The peat accumulated in a beaver pond surrounded by boreal larch forest near regional tree line(2) in coastal hills close to the Arctic Ocean. The ecological affinities of the plant and beetle remains(3) contained in the peat indicate that winter temperatures on Ellesmere Island were nearly 15degreesC higher and summer temperatures 10degreesC higher than they are today. Here we show that the mammalian remains buried in the peat represent mainly taxa of Eurasiatic zoogeographic and phyletic affinities, including the first North American occurrence of a meline badger (Arctomeles). This deposit contains direct evidence of the composition of an Early Pliocene (4-5 million years ago) arctic mammalian fauna during an active period of interchange between Asia and North America.	Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; Canadian Museum Nat Paleobiol, Ottawa, ON K1P 6P4, Canada	American Museum of Natural History (AMNH)	Tedford, RH (corresponding author), Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA.	tedford@amnh.org						BJORK PR, 1970, T AM PHILOS SOC, V60, P3, DOI 10.2307/1006119; Dompierre H., 1997, Journal of Vertebrate Paleontology, V17, p43A; Dowsett H. J., 1999, 99535 US GEOL SURV; Elias SA, 2002, CAN J EARTH SCI, V39, P911, DOI 10.1139/E01-096; FYLES JG, 1989, CURR RES GEOL SURV C, V89, P101; Harington C.R., 2001, MERIDIAN         FAL, P11; Hulbert RC, 1999, PALAEONTOLOGY, V42, P1017; Hutchison JH, 2002, CAN J EARTH SCI, V39, P439, DOI 10.1139/E01-078; Lindsay E, 2002, J VERTEBR PALEONTOL, V22, P429, DOI 10.1671/0272-4634(2002)022[0429:ROTHBB]2.0.CO;2; MATTHEWS JV, 1990, ARCTIC, V43, P364; PETTER G, 1971, Mammalia, V35, P567, DOI 10.1515/mamm.1971.35.4.567; ROSHCHIN AD, 1949, T ODESKOGO GOSUD U, V60, P97; Rybczynski N., 1997, Journal of Vertebrate Paleontology, V17, p72A; SHER AV, 1986, PALAEONTOGRAPHICA IT, V74, P77; Shi N, 1994, STRIAE, V36, P1; Stach J., 1951, Acta Geologica Polonica, V2, P129; Tedford R.H., 1991, Journal of Vertebrate Paleontology, V11, P519; Teilhard de Chardin P., 1945, I GEOBIOL PEKING, V12, P1; VIRET J, 1934, TRAV LAB GEOL FS LYO, V2, P7; Zakrzewski R. J., 2001, Journal of Vertebrate Paleontology, V21, p116A	20	63	66	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2003	425	6956					388	390		10.1038/nature01892	http://dx.doi.org/10.1038/nature01892			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	724TG	14508486				2022-12-01	WOS:000185502300038
J	Buljevac, D; Hop, WCJ; Reedeker, W; Janssens, ACJW; van der Meche, FGA; van Doorn, PA; Hintzen, RQ				Buljevac, D; Hop, WCJ; Reedeker, W; Janssens, ACJW; van der Meche, FGA; van Doorn, PA; Hintzen, RQ			Self reported stressful life events and exacerbations in multiple sclerosis: prospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PSYCHOLOGICAL STRESS; EMOTIONAL-STRESS; DISEASE; MS; INFECTIONS; MODELS	Objective To study the relation between self reported stressful life events not related to multiple sclerosis and the occurrence of exacerbations in relapsing-remitting multiple sclerosis. Design Longitudinal, prospective cohort study. Setting Outpatient clinic of a department of neurology in the Netherlands. Participants Patients aged 18-55 with relapsing-remitting multiple sclerosis who could walk with a cane or better (score of 0-6.0 on the expanded disability status scale) and had had at least two exacerbations in 24 months before inclusion in the study. Patients with other serious conditions were excluded. Main outcome measure The risk of increased disease activity as measured by the occurrence of exacerbations after weeks with stressful events. Results Seventy out of 73 included patients (96%) reported at least one stressful event. In total, 457 stressful life events were reported that were not related to multiple sclerosis. Average follow up time was 1.4 years. Throughout the study, 134 exacerbations occurred in 56 patients and 136 infections occurred in 57 patients. Cox regression. analysis with time dependent variables showed that the occurrence of stress was associated with a doubling of the exacerbation rate (relative risk 2.2, 95% confidence interval 1.2 to 4.0, P = 0.014) during the subsequent four weeks. Infections were associated with a threefold increase in the risk of exacerbation, but this effect was found to be independent of experienced stress. Conclusion Stressful events were associated with increased exacerbations in relapsing-remitting multiple sclerosis. This association was independent of die triggering effect of infections on exacerbations of multiple sclerosis.	Erasmus MC, Dept Neurol, NL-3000 CA Rotterdam, Netherlands; Erasmus MC, Dept Epidemiol & Biostat, NL-3000 CA Rotterdam, Netherlands; Erasmus MC, Dept Med Psychol & Psychotherapy, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Hintzen, RQ (corresponding author), Erasmus MC, Dept Neurol, Postbox 2040, NL-3000 CA Rotterdam, Netherlands.	rhintzen@xs4all.nl	janssens, cecile c/L-1075-2015	Janssens, A Cecile/0000-0002-6153-4976				Antel JP, 1999, J NEUROIMMUNOL, V100, P181, DOI 10.1016/S0165-5728(99)00186-1; Buljevac D, 2002, BRAIN, V125, P952, DOI 10.1093/brain/awf098; Charnley J, 1979, LOW FRICTION ARTHROP, P157; CHELMICKASCHORR E, 1994, ANN NEUROL, V36, pS29, DOI 10.1002/ana.410360710; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; COX DR, 1972, J R STAT SOC B, V34, P187; Franklin GM, 1988, J NEUROL REHABIL, V2, P7; Goodin DS, 1999, NEUROLOGY, V52, P1737, DOI 10.1212/WNL.52.9.1737; GRANT I, 1989, J NEUROL NEUROSUR PS, V52, P8, DOI 10.1136/jnnp.52.1.8; Jafarian-Tehrani M, 1999, J NEUROIMMUNOL, V100, P13, DOI 10.1016/S0165-5728(99)00207-6; JANSSENS ACJ, 2003, IN PRESS ACTA NEUROL; Kroencke DC, 1999, MULT SCLER J, V5, P89, DOI 10.1177/135245859900500204; Mohr DC, 2000, NEUROLOGY, V55, P55, DOI 10.1212/WNL.55.1.55; NISIPEANU P, 1993, NEUROLOGY, V43, P1311, DOI 10.1212/WNL.43.7.1311; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; RABINS PV, 1986, BRAIN, V109, P585, DOI 10.1093/brain/109.4.585; SCHUMACHER GA, 1965, ANN NY ACAD SCI, V122, P552; Schwartz CE, 1999, BEHAV MED, V25, P110, DOI 10.1080/08964289909596740; SHERIDAN JF, 1994, CLIN MICROBIOL REV, V7, P200, DOI 10.1128/CMR.7.2.200-212.1994; SIBLEY WA, 1985, LANCET, V1, P1313; SIBLEY WA, 1997, MULTIPLE SCLEROSIS C, P141; Sternberg EM, 2001, J ENDOCRINOL, V169, P429, DOI 10.1677/joe.0.1690429; WARREN S, 1982, J CHRON DIS, V35, P821, DOI 10.1016/0021-9681(82)90047-9; WARREN S, 1991, J PSYCHOSOM RES, V35, P37, DOI 10.1016/0022-3999(91)90005-9	25	99	100	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2003	327	7416					646	+		10.1136/bmj.327.7416.646	http://dx.doi.org/10.1136/bmj.327.7416.646			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	724AC	14500435	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000185463100015
J	Wu, WJ; Tu, S; Cerione, RA				Wu, WJ; Tu, S; Cerione, RA			Activated Cdc42 sequesters c-Cbl and prevents EGF receptor degradation	CELL			English	Article							TYROSINE KINASE; BINDING PARTNERS; GROWTH; RHO; RAC; REGULATOR; GTPASES; FAMILY; ENDOCYTOSIS; PROTEINS	Cdc42 is a Ras-related protein that has been implicated in the control of normal cell growth, and when improperly regulated, in cellular transformation and invasiveness. A variety of extracellular stimuli, including epidermal growth factor (EGF), activate Cdc42. Here, we show that activation of Cdc42 protects the EGF receptor from the negative regulatory activity of the c-CbI ubiquitin ligase. Activated Cdc42 binds to p85Cool-1 (for cloned-out-of-library)/beta-Pix (for Pak-interactive exchange factor), a protein that directly associates with c-CbI. This inhibits the binding of CbI by the EGF receptor and thus prevents CbI from catalyzing receptor ubiquitination. The role played by Cdc42 in regulating the timing of EGIF receptor-CbI interactions is underscored by the fact that constitutively active Cdc42(F28L), by persistently blocking the binding of CbI to these receptors, leads to their aberrant accumulation and sustained EGF-stimulated ERK activation, thus resulting in cellular transformation.	Cornell Univ, Ctr Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; Cornell Univ, Baker Lab, Dept Chem & Biol Chem, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Ctr Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu		Tu, S. Sean/0000-0003-0391-8186	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040654, R01GM047458] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM47458, GM40654] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Bao J, 2003, P NATL ACAD SCI USA, V100, P2438, DOI 10.1073/pnas.0437945100; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Feng QY, 2002, J BIOL CHEM, V277, P5644, DOI 10.1074/jbc.M107704200; Flanders JA, 2003, FEBS LETT, V550, P119, DOI 10.1016/S0014-5793(03)00853-6; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Lin Q, 2002, J BIOL CHEM, V277, P10134, DOI 10.1074/jbc.M110329200; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; PAVELIC K, 1993, ANTICANCER RES, V13, P1133; Qiu RG, 1997, MOL CELL BIOL, V17, P3449, DOI 10.1128/MCB.17.6.3449; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Tu S, 2001, J BIOL CHEM, V276, P19656, DOI 10.1074/jbc.M009838200; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; WHITEHEAD IP, 1997, BIOCHIM BIOPHYS ACTA, V1332, P11; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Wu WJ, 1998, J BIOL CHEM, V273, P16655, DOI 10.1074/jbc.273.27.16655; Yang WN, 1997, J BIOL CHEM, V272, P24819, DOI 10.1074/jbc.272.40.24819; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556	34	156	159	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2003	114	6					715	725		10.1016/S0092-8674(03)00688-3	http://dx.doi.org/10.1016/S0092-8674(03)00688-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	724AL	14505571	Bronze			2022-12-01	WOS:000185464000009
J	Wellman, CH; Osterloff, PL; Mohiuddin, U				Wellman, CH; Osterloff, PL; Mohiuddin, U			Fragments of the earliest land plants	NATURE			English	Article							WELSH BORDERLAND; SPORE MASSES; MICROFOSSIL RECORD; VASCULAR PLANTS; SPORANGIA; ULTRASTRUCTURE; ORDOVICIAN; BRYOPHYTES; ECOSYSTEMS; TETRADS	The earliest fossil evidence for land plants comes from microscopic dispersed spores(1-3). These microfossils are abundant and widely distributed in sediments, and the earliest generally accepted reports are from rocks of mid-Ordovician age (Llanvirn, 475 million years ago)(4). Although distribution, morphology and ultrastructure of the spores indicate that they are derived from terrestrial plants, possibly early relatives of the bryophytes, this interpretation remains controversial 5 as there is little in the way of direct evidence for the parent plants. An additional complicating factor is that there is a significant hiatus between the appearance of the first dispersed spores and fossils of relatively complete land plants (megafossils)(6): spores predate the earliest megafossils (Late Silurian, 425 million year ago) by some 50 million years(7). Here we report the description of spore-containing plant fragments from Ordovician rocks of Oman. These fossils provide direct evidence for the nature of the spore-producing plants. They confirm that the earliest spores developed in large numbers within sporangia, providing strong evidence that they are the fossilized remains of bona fide land plants. Furthermore, analysis of spore wall ultrastructure supports liverwort affinities.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Petr Dev Oman LLC, Muscat 113, Oman	University of Sheffield	Wellman, CH (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Alfred Denny Bldg,Western Bank, Sheffield S10 2TN, S Yorkshire, England.							[Anonymous], 1993, ORIGIN LAND PLANTS; BANKS HP, 1975, REV PALAEOBOT PALYNO, V20, P13, DOI 10.1016/0034-6667(75)90004-4; Brown R.C., 1990, MICROSPORES EVOLUTIO, P55; Droste H.H., 1997, GEOARABIA, V2, P419; Edwards D, 1999, BOT J LINN SOC, V130, P111, DOI 10.1006/bojl.1998.0243; EDWARDS D, 1995, NATURE, V374, P635, DOI 10.1038/374635a0; Edwards D, 1996, REV PALAEOBOT PALYNO, V90, P159, DOI 10.1016/0034-6667(95)00081-X; EDWARDS D, 1980, NATURE, V287, P41, DOI 10.1038/287041a0; EDWARDS D, 1995, NATURE, V377, P329, DOI 10.1038/377329a0; Edwards D., 2001, PLANTS INVADE LAND E, P3; GRAY J, 1971, SCIENCE, V173, P918, DOI 10.1126/science.173.4000.918; GRAY J, 1985, PHILOS T ROY SOC B, V309, P167, DOI 10.1098/rstb.1985.0077; Kenrick P, 2000, PHILOS T R SOC B, V355, P847, DOI 10.1098/rstb.2000.0619; Kenrick P., 1997, ORIGIN EARLY DIVERSI; Kroken SB, 1996, AM J BOT, V83, P1241, DOI 10.2307/2446108; MOHIUDDIN U, THESIS U SHEFFIELD; Nickrent DL, 2000, MOL BIOL EVOL, V17, P1885, DOI 10.1093/oxfordjournals.molbev.a026290; Pacini E, 1990, MICROSPORES EVOLUTIO, P213, DOI DOI 10.1016/B978-0-12-103458-0.50014-6; Qiu YL, 2000, J PHYCOL, V36, P799, DOI 10.1046/j.1529-8817.2000.03653.x; Richardson J. B., 1988, SUBSURFACE PALYNOSTR, P89; Steemans P, 1999, GEOBIOS-LYON, V32, P341, DOI 10.1016/S0016-6995(99)80048-5; Strother PK, 1996, GEOLOGY, V24, P55, DOI 10.1130/0091-7613(1996)024<0055:NEFLPF>2.3.CO;2; Taylor WA, 2002, REV PALAEOBOT PALYNO, V119, P325, DOI 10.1016/S0034-6667(01)00136-1; TAYLOR WA, 1995, NATURE, V373, P391, DOI 10.1038/373391b0; Wellman CH, 2000, PHILOS T R SOC B, V355, P717, DOI 10.1098/rstb.2000.0612; Wellman CH, 1998, PHILOS T ROY SOC B, V353, P1983, DOI 10.1098/rstb.1998.0349; Wellman CH, 1998, BOT J LINN SOC, V127, P117, DOI 10.1111/j.1095-8339.1998.tb02092.x	27	384	412	1	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 18	2003	425	6955					282	285		10.1038/nature01884	http://dx.doi.org/10.1038/nature01884			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722JA	13679913	Green Accepted			2022-12-01	WOS:000185370900041
J	Hennessy, S; Bilker, WB; Zhou, L; Weber, AL; Brensinger, C; Wang, YL; Strom, BL				Hennessy, S; Bilker, WB; Zhou, L; Weber, AL; Brensinger, C; Wang, YL; Strom, BL			Retrospective drug utilization review, prescribing errors, and clinical outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICARE BENEFICIARIES; INTERVENTION; DATABASES; DISEASE	Context Retrospective drug utilization review is required of all state Medicaid programs and is performed by most private-sector prescription programs. However, it has not been shown to improve clinical outcomes or reduce the rate of potential prescribing errors, known as "exceptions." Objective To look for an effect of retrospective drug utilization review on the rate of exceptions and of clinical outcomes in patients with an exception. Design, Setting, and Participants Longitudinal ecologic study of the rate of exceptions, controlling for preintervention trends and calendar time; and a cohort study of all-cause and cause-specific hospitalizations in patients with an exception, controlling for potential individual-level confounders in 6 Medicaid programs using the same software in the mid-1990s. Main Outcome Measures The rate of exceptions was examined as a function of retrospective drug utilization review implementation. In addition, before-after comparisons were made of the incidence of all-cause and cause-specific hospitalization in patients with exceptions. Results We found no reduction in the rate of exceptions coincident with retrospective drug utilization review implementation (rate increase, 0.064 exceptions per 1000 prescriptions per month; 95% confidence interval [CI], -0.006 to 0.133). We also found no effect of retrospective drug utilization review on the incidence of all-cause hospitalization (odds ratio, 0.99; 95% Cl, 0.98-1.00) or cause-specific hospitalization. These results persisted in multiple subgroup analyses. Study states intervened using physician alerts in between 1% and 25% of exceptions. Conclusions We were unable to identify an effect of retrospective drug utilization review on the rate of exceptions or on clinical outcomes. Given the lack of evidence for effectiveness, and suggestions from previous research of possible harm, policy-makers should consider withdrawing the legislative mandate for retrospective drug utilization review.	Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Educ & Res Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Hennessy, S (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Dept Biostat & Epidemiol, 803 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.		Bilker, Warren/AAS-3515-2021		AHRQ HHS [U18-HS10399] Funding Source: Medline; NIA NIH HHS [1K23AG000987, 1R01 AG14601] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG000987, R01AG014601] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*ABT ASS INC, 1998, EV DRUG US REV DEM P; Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Carson JL, 2000, PHARMACOEPIDEM DR S, P307; CLARK DO, 1995, MED CARE, V33, P783, DOI 10.1097/00005650-199508000-00004; Coleman CI, 2003, AM J HEALTH-SYST PH, V60, P1142, DOI 10.1093/ajhp/60.11.1142; Hennessey S, 2000, PHARMACOEPIDEM DR S, P505; Hennessy S, 2003, PHARMACOEPIDEM DR S, V12, P103, DOI 10.1002/pds.765; JAY DE, 1991, MED CAL THERAPEUTIC; Kleinbaum D.G., 1988, APPL REGRESSION ANAL; Krumholz HM, 1998, J AM COLL CARDIOL, V31, P957, DOI 10.1016/S0735-1097(98)00106-5; KRUMHOLZ HM, 1995, CIRCULATION, V92, P2841, DOI 10.1161/01.CIR.92.10.2841; LIPTON HL, 1993, MED CARE, V31, P1069, DOI 10.1097/00005650-199312000-00001; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Raiford DS, 1996, EPIDEMIOLOGY, V7, P101, DOI 10.1097/00001648-199601000-00018; Ray WA, 1997, ANN INTERN MED, V127, P712, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00055; Smith DH, 1998, MED CARE, V36, P1013, DOI 10.1097/00005650-199807000-00008; SOUMERAI SB, 1995, NEW ENGL J MED, V332, P1641, DOI 10.1056/NEJM199506153322411; STROM BL, 1995, AM J MED, V99, P282, DOI 10.1016/S0002-9343(99)80161-2; STROM BL, 1990, EPIDEMIOL REV, V12, P87, DOI 10.1093/oxfordjournals.epirev.a036064; Strom BL, 1997, ARCH INTERN MED, V157, P2626, DOI 10.1001/archinte.157.22.2626; *US CTR MED MED SE, MED DUALL EL POP; *US CTR MED MED SE, MED ENR BEN SEL FISC; West SL, 2000, PHARMACOEPIDEMIOLOGY, V3rd edn, P661; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; ZIMMERMAN DR, 1994, INQUIRY-J HEALTH CAR, V31, P89; 1969, FINAL REPORT TASK FO	27	38	40	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2003	290	11					1494	1499		10.1001/jama.290.11.1494	http://dx.doi.org/10.1001/jama.290.11.1494			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721RE	13129990				2022-12-01	WOS:000185329000032
J	Huynen, L; Millar, CD; Scofield, RP; Lambert, DM				Huynen, L; Millar, CD; Scofield, RP; Lambert, DM			Nuclear DNA sequences detect species limits in ancient moa	NATURE			English	Article							MITOCHONDRIAL-DNA; GENOME SEQUENCES; SEX; BIRDS; GENE	Ancient DNA studies have typically used multi-copy mitochondrial DNA sequences(1,2). This is largely because single-locus nuclear genes have been difficult to recover from sub-fossil material(3), restricting the scope of ancient DNA research. Here, we have isolated single-locus nuclear DNA markers to assign the sex of 115 extinct moa and, in combination with a mitochondrial DNA phylogeny, tested competing hypotheses about the specific status of moa taxa. Moa were large ratite birds that showed extreme size variation both within and among species(4). For some taxa, this large variation was hypothesized to represent sexual dimorphism, while for others it was argued to reflect the existence of different species(5). Our results show that moa were characterized by extreme reverse sexual dimorphism and as a result we have been able to clarify the number of moa species. For example, we show that the three recognized 'species' of Dinornis comprised only two monophyletic groups and that two of these 'species' comprised individuals of one sex only. This study also illustrates that single-locus nuclear DNA sequences can be consistently recovered from ancient material.	Univ Auckland, Sch Biol Sci, Allan Wilson Ctr Mol Ecol & Evolut, Auckland 1, New Zealand; Canterbury Museum, Christchurch 8001, New Zealand	Massey University; University of Auckland	Lambert, DM (corresponding author), Massey Univ, Inst Mol Biosci, Allan Wilson Ctr Mol Ecol & Evolut, Private Bag 102 904, Palmerston North, New Zealand.	D.M.Lambert@massey.ac.nz	Scofield, R. Paul/A-4271-2011	Scofield, R. Paul/0000-0002-7510-6980; Lambert, David/0000-0002-5821-3637				ANDERSON AJ, 1989, PRODIGIIOUS BIRDS MO; ANSARI HA, 1988, CYTOGENET CELL GENET, V47, P185, DOI 10.1159/000132545; Asfaw B, 2002, NATURE, V416, P317, DOI 10.1038/416317a; Clinton M, 1999, CELL MOL LIFE SCI, V55, P876, DOI 10.1007/s000180050341; Cooper A, 1998, CURR OPIN BIOTECH, V9, P49, DOI 10.1016/S0958-1669(98)80083-9; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; Cooper Alan, 1997, P345, DOI 10.1016/B978-012498315-1/50019-4; Cracraft J., 1976, Smithsonian Contributions to Paleobiology, VNo. 27, P189; Ellegren H, 1996, P ROY SOC B-BIOL SCI, V263, P1635, DOI 10.1098/rspb.1996.0239; GRIFFITHS R, 1995, NATURE, V375, P454, DOI 10.1038/375454a0; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Haddrath O, 2001, P ROY SOC B-BIOL SCI, V268, P939, DOI 10.1098/rspb.2001.1587; HERMANN B, 1993, ANCIENNT DNA; HIGUCHI R, 1984, NATURE, V312, P282, DOI 10.1038/312282a0; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Holdaway RN, 2000, SCIENCE, V287, P2250, DOI 10.1126/science.287.5461.2250; Huynen L, 2002, MOL ECOL, V11, P851, DOI 10.1046/j.1365-294X.2002.01483.x; Lambert DM, 2002, SCIENCE, V295, P2270, DOI 10.1126/science.1068105; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; Owen R., 1839, P ZOOL SOC LOND, V7, P169; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; Polack J. S., 1838, NZ BEING NARRATIVE T, V1; PRANGE HD, 1979, AM NAT, V113, P103, DOI 10.1086/283367; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Swofford DL, 2002, PAUP PHYLOGENETIC AN, DOI DOI 10.1111/J.0014-3820.2002.TB00191.X; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Worthy T.H., 1988, NATL MUSEUM NZ MISCE, V17, P1; Worthy T.H., 2002, LOST WORLD MOA PREHI	30	96	100	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2003	425	6954					175	178		10.1038/nature01838	http://dx.doi.org/10.1038/nature01838			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719ZT	12968179				2022-12-01	WOS:000185236000041
J	Theise, ND; Wilmut, I				Theise, ND; Wilmut, I			Flexible arrangement	NATURE			English	Editorial Material									Beth Israel Med Ctr, Div Digest Dis, New York, NY 10003 USA; Roslin Inst, Roslin Bioctr, Roslin EH25 9PS, Midlothian, Scotland	Harvard University; Beth Israel Deaconess Medical Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute	Theise, ND (corresponding author), Beth Israel Med Ctr, Div Digest Dis, New York, NY 10003 USA.							Blau HM, 2002, NATURE, V419, P437, DOI 10.1038/419437a; Cavaleri F, 2003, CELL, V113, P551, DOI 10.1016/S0092-8674(03)00394-5; Theise ND, 2002, LEUKEMIA, V16, P542, DOI 10.1038/sj.leu.2402445; Wilmut I, 2002, NATURE, V419, P583, DOI 10.1038/nature01079	4	40	40	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 4	2003	425	6953					21	21		10.1038/425021a	http://dx.doi.org/10.1038/425021a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717LD	12955119	Bronze			2022-12-01	WOS:000185089200018
J	Chiovato, L; Latrofa, F; Braverman, LE; Pacini, F; Capezzone, M; Masserini, L; Grasso, L; Pinchera, A				Chiovato, L; Latrofa, F; Braverman, LE; Pacini, F; Capezzone, M; Masserini, L; Grasso, L; Pinchera, A			Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens	ANNALS OF INTERNAL MEDICINE			English	Article							GRAVES-DISEASE; ANTITHYROGLOBULIN ANTIBODIES; SURGICAL-TREATMENT; TSH RECEPTOR; AUTOANTIBODIES; THYROGLOBULIN; CARCINOMA; CANCER	Background: The development of antibodies to thyroid peroxidase, thyroglobulin, and thyroid-stimulating hormone (TSH) receptor is a main feature of autoimmune thyroid diseases. Objective: To investigate whether complete removal of thyroid antigens results in the abatement of humoral thyroid autoimmunity. Design: Retrospective chart review study of patients treated and monitored with a standard prospective protocol. Setting: University hospital in Pisa, Italy, between 1976 and 1994. Patients: 182 patients with differentiated thyroid carcinoma and serum antibodies to thyroid peroxidase, thyroglobulin, or TSH receptor due to coexistent clinical Hashimoto thyroiditis, Graves disease, or focal autoimmune thyroiditis. Intervention: Total thyroidectomy and radioiodine treatment to ablate residual or metastatic thyroid tissue. Regular follow-up with iodine-131 whole-body scanning and serum thyroglobulin measurement. Mean follow-up (+/-SD) was 10.1 +/- 4.1 years (range, 4 to 20 years). Measurements: Serum antibodies to thyroid peroxidase, thyroglobulin, and TSH receptor. Results: Thyroid peroxidase, thyroglobulin, and TSH-receptor antibodies progressively disappeared after the initial treatment. The median disappearance time was 6.3 years for thyroid peroxidase antibodies and 3.0 years for thyroglobulin antibodies. There was a statistically significant correlation between the disappearance of thyroid tissue and that of thyroid antibodies. The coexistence of Hashimoto thyroiditis or Graves disease with thyroid cancer did not modify the pattern of disappearance of thyroid antibody compared with patients with focal autoimmune thyroiditis. Conclusions: Complete ablation of thyroid tissue with its antigenic components results in the disappearance of antibodies to all major thyroid antigens, thus supporting the concept that continued antibody production depends on the persistence of autoantigen in the body.	Univ Pisa, Osped Cisanello, Dipartimento Endocrinol & Metab Ortopedia & Traum, I-56124 Pisa, Italy; Boston Univ, Sch Med, Boston, MA 02118 USA	University of Pisa; Boston University	Pinchera, A (corresponding author), Univ Pisa, Osped Cisanello, Dipartimento Endocrinol & Metab Ortopedia & Traum, Via Paradisa 2, I-56124 Pisa, Italy.	a.pinchera@endoc.med.unipi.it	Capezzone, Marco/AAA-3137-2022; Capezzone, Marco/AAD-1776-2022; Chiovato, Luca/K-6617-2016; Capezzone, Marco/AAL-2308-2020; chiovato, luca/AAC-9003-2019	Capezzone, Marco/0000-0001-8624-5831; Chiovato, Luca/0000-0001-7457-7353; MASSERINI, LUCIO/0000-0002-9661-9953; Braverman, Lewis/0000-0003-1263-1099; Latrofa, Francesco/0000-0003-0297-5904				DEBRUIN TWA, 1988, CLIN EXP IMMUNOL, V72, P481; Fatemi S., 2000, Endocrine Journal, V47, P108; HAYASHI Y, 1985, J CLIN ENDOCR METAB, V61, P1172, DOI 10.1210/jcem-61-6-1172; Larbre H, 2000, ANN ENDOCRINOL-PARIS, V61, P422; Marcocci C, 2000, THYROID, V8, P414; MARIOTTI S, 1984, J CLIN ENDOCR METAB, V58, P18, DOI 10.1210/jcem-58-1-18; MCLACHLAN SM, 1983, CLIN EXP IMMUNOL, V52, P620; Miccoli P, 1996, SURGERY, V120, P1020, DOI 10.1016/S0039-6060(96)80049-3; MORI Y, 1992, WORLD J SURG, V16, P647, DOI 10.1007/BF02067345; PACINI F, 1988, ACTA ENDOCRINOL-COP, V119, P373, DOI 10.1530/acta.0.1190373; Park Y. J., 2000, Endocrine Journal, V47, P108; PINCHERA A, 1969, J CLIN ENDOCR METAB, V29, P231, DOI 10.1210/jcem-29-2-231; Roeher HD, 1996, SURGERY, V120, P1024; RUBELLO D, 1992, J NUCL MED, V33, P1478; Spencer CA, 1998, J CLIN ENDOCR METAB, V83, P1121, DOI 10.1210/jc.83.4.1121; TENG CS, 1980, J CLIN ENDOCR METAB, V50, P1005, DOI 10.1210/jcem-50-6-1005; WEETMAN AP, 1994, ENDOCR REV, V15, P788, DOI 10.1210/er.15.6.788; WINSA B, 1995, EUR J ENDOCRINOL, V132, P406, DOI 10.1530/eje.0.1320406	18	225	240	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 2	2003	139	5	1				346	351		10.7326/0003-4819-139-5_Part_1-200309020-00010	http://dx.doi.org/10.7326/0003-4819-139-5_Part_1-200309020-00010			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	716PL	12965943				2022-12-01	WOS:000185037500005
J	Lerman, R				Lerman, R			Death rituals	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									William Beaumont Hosp, Imaging Ctr, Royal Oak, MI 48073 USA	Beaumont Health	Lerman, R (corresponding author), William Beaumont Hosp, Imaging Ctr, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA.	rlerman@beaumont.edu							0	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 2	2003	139	5	1				384	384		10.7326/0003-4819-139-5_Part_1-200309020-00016	http://dx.doi.org/10.7326/0003-4819-139-5_Part_1-200309020-00016			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	716PL	12965949				2022-12-01	WOS:000185037500011
J	Wang, CT; Lu, JC; Bai, JH; Chang, PY; Martin, TFJ; Chapman, ER; Jackson, MB				Wang, CT; Lu, JC; Bai, JH; Chang, PY; Martin, TFJ; Chapman, ER; Jackson, MB			Different domains of synaptotagmin control the choice between kiss-and-run and full fusion	NATURE			English	Article							ADRENAL CHROMAFFIN CELLS; CA2+ BINDING; HIPPOCAMPAL SYNAPSES; PC12 CELLS; EXOCYTOSIS; IV; KINETICS; MECHANISM; SECRETION; SENSOR	Exocytosis-the release of the contents of a vesicle-proceeds by two mechanisms(1-6). Full fusion occurs when the vesicle and plasma membranes merge. Alternatively, in what is termed kiss-and-run, vesicles can release transmitter during transient contacts with the plasma membrane. Little is known at the molecular level about how the choice between these two pathways is regulated. Here we report amperometric recordings of catecholamine efflux through individual fusion pores. Transfection with synaptotagmin (Syt) IV increased the frequency and duration of kiss-and-run events, but left their amplitude unchanged. Endogenous Syt IV, induced by forskolin treatment, had a similar effect. Full fusion was inhibited by mutation of a Ca2+ ligand in the C(2)A domain of Syt I; kiss-and-run was inhibited by mutation of a homologous Ca2+ ligand in the C2B domain of Syt IV. The Ca2+ sensitivity for full fusion was 5-fold higher with Syt I than Syt IV, but for kiss-and-run the Ca2+ sensitivities differed by a factor of only two. Syt thus regulates the choice between full fusion and kiss-and-run, with Ca2+ binding to the C(2)A and C2B domains playing an important role in this choice.	Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; Univ Wisconsin, Dept Comparat Biosci, Endocrinol Reprod Physiol Program, Madison, WI 53706 USA; Univ Wisconsin, Biophys Program, Madison, WI 53706 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Jackson, MB (corresponding author), Univ Wisconsin, Dept Physiol, 1300 Univ Ave, Madison, WI 53706 USA.		Lu, Juu-Chin/ABB-3198-2020; Wang, Chih-Tien/GRE-8232-2022	Lu, Juu-Chin/0000-0001-8523-6992; Wang, Chih-Tien/0000-0001-7639-7508; Chapman, Edwin/0000-0001-9787-8140				Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; ALVAREZ DT, 1993, NATURE, V363, P554, DOI DOI 10.1038/363554A0; Bai JH, 2002, P NATL ACAD SCI USA, V99, P1665, DOI 10.1073/pnas.032541099; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Chow Robert H., 1995, P245; COLQUHOUN D, 1982, PHILOS T ROY SOC B, V300, P1, DOI 10.1098/rstb.1982.0156; CORMACK B, 1994, CURRENT PROTOCOLS MO; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Eaton BA, 2000, J NEUROSCI, V20, P7334; Ferguson GD, 2001, MOL NEUROBIOL, V23, P173; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; JACKSON MB, 1992, METHOD ENZYMOL, V207, P729; Klenchin VA, 1998, METHODS, V16, P204, DOI 10.1006/meth.1998.0668; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Littleton JT, 1999, NATURE, V400, P757, DOI 10.1038/23462; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Schneider SW, 2001, J MEMBRANE BIOL, V181, P67; Schroeder TJ, 1996, BIOPHYS J, V70, P1061, DOI 10.1016/S0006-3495(96)79652-2; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; VICIAN L, 1995, P NATL ACAD SCI USA, V92, P2164, DOI 10.1073/pnas.92.6.2164; vonPoser C, 1997, J BIOL CHEM, V272, P14314, DOI 10.1074/jbc.272.22.14314; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002	28	170	174	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 21	2003	424	6951					943	947		10.1038/nature01857	http://dx.doi.org/10.1038/nature01857			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713EH	12931189				2022-12-01	WOS:000184843600042
J	Harmon, LJ; Schulte, JA; Larson, A; Losos, JB				Harmon, LJ; Schulte, JA; Larson, A; Losos, JB			Tempo and mode of evolutionary radiation in iguanian lizards	SCIENCE			English	Article							PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENIES; ANOLIS LIZARDS; DIVERSITY; PATTERNS; DIVERSIFICATION; DISPARITY; STATES	Identification of general properties of evolutionary radiations has been hindered by the lack of a general statistical and phylogenetic approach applicable across diverse taxa. We present a comparative analytical framework for examining phylogenetic patterns of diversification and morphological disparity with data from four iguanian-lizard taxa that exhibit substantially different patterns of evolution. Taxa whose diversification occurred disproportionately early in their evolutionary history partition more of their morphological disparity among, rather than within, subclades. This inverse relationship between timing of diversification and morphological disparity within subclades may be a general feature that transcends the historically contingent properties of different evolutionary radiations.	Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Harmon, LJ (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	harmon@biology.wustl.edu	Harmon, Luke/A-8225-2012	Harmon, Luke/0000-0002-4985-5750				Ciampaglio CN, 2001, PALEOBIOLOGY, V27, P695, DOI 10.1666/0094-8373(2001)027<0695:DCIMOP>2.0.CO;2; Conway-Morris S., 1998, CRUCIBLE CREATION; Cunningham CW, 1998, TRENDS ECOL EVOL, V13, P361, DOI 10.1016/S0169-5347(98)01382-2; Etheridge Richard, 1995, American Museum Novitates, V3142, P1; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; FOOTE M, 1993, PALEOBIOLOGY, V19, P185, DOI 10.1017/S0094837300015864; Fortey RA, 1996, BIOL J LINN SOC, V57, P13, DOI 10.1006/bijl.1995.0002; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; Givnish T.J., 1997, MOL EVOLUTION ADAPTI; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Jackman TR, 1999, SYST BIOL, V48, P254, DOI 10.1080/106351599260283; LOSOS JB, 1994, ANNU REV ECOL SYST, V25, P467, DOI 10.1146/annurev.es.25.110194.002343; Losos JB, 2002, AM NAT, V160, P147, DOI 10.1086/341557; Melville J, 2001, J EXP ZOOL, V291, P339, DOI 10.1002/jez.1133; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pianka E.R., 1986, ECOLOGY NATURAL HIST; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Ruber L, 2001, J EVOLUTION BIOL, V14, P325, DOI 10.1046/j.1420-9101.2001.00269.x; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schulte JA, 2000, BIOL J LINN SOC, V69, P75, DOI 10.1006/bijl.1999.0346; SCHULTE JA, 2001, THESIS WASHINGTON U; Simpson G.G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; SITES JW, 1992, B AM MUS NAT HIST, P1; SMITH DC, 1981, ECOLOGY, V62, P679, DOI 10.2307/1937736; Wagner PJ, 1995, PALEOBIOLOGY, V21, P410, DOI 10.1017/S0094837300013464; Wills M. A., 2001, FOSSILS PHYLOGENY FO, P55	28	505	519	2	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2003	301	5635					961	964		10.1126/science.1084786	http://dx.doi.org/10.1126/science.1084786			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711RY	12920297				2022-12-01	WOS:000184755900038
J	Opalka, N; Chlenov, M; Chacon, P; Rice, WJ; Wriggers, W; Darst, SA				Opalka, N; Chlenov, M; Chacon, P; Rice, WJ; Wriggers, W; Darst, SA			Structure and function of the transcription elongation factor GreB bound to bacterial RNA polymerase	CELL			English	Article							CLEAVAGE FACTORS GREA; CRYSTAL-STRUCTURE; FACTOR TFIIS; II ELONGATION; NASCENT TRANSCRIPT; IN-VIVO; SUBUNIT; BINDING; DOMAIN; MECHANISM	Bacterial GreA and GreB promote transcription elongation by stimulating an endogenous, endonucleolytic transcript cleavage activity of the RNA polymerase. The structure of Escherichia coli core RNA polymerase bound to GreB was determined by cryo-electron microscopy and image processing of helical crystals to a nominal resolution of 15 Angstrom, allowing fitting of high-resolution RNA polymerase and GreB structures. In the resulting model, the GreB N-terminal coiled-coil domain extends 45 Angstrom through a channel directly to the RNA polymerase active site. The model leads to detailed insights into the mechanism of Gre factor activity that explains a wide range of experimental observations and points to a key role for conserved acidic residues at the tip of the Gre factor coiled coil in modifying the RNA polymerase active site to catalyze the cleavage reaction. Mutational studies confirm that these positions are critical for Gre factor function.	Rockefeller Univ, New York, NY 10021 USA; Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92037 USA; NYU, Med Ctr, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Med Ctr, Dept Cell Biol, New York, NY 10016 USA	Rockefeller University; Scripps Research Institute; New York University; New York University	Darst, SA (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	darst@rockefeller.edu	Chacon, Pablo/B-4211-2014	Chacon, Pablo/0000-0002-3168-4826; Rice, William/0000-0002-5187-255X; Wriggers, Willy/0000-0001-5326-3152	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061898, R01GM062968, R01GM058020] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGARWAL K, 1991, BIOCHEMISTRY-US, V30, P7842, DOI 10.1021/bi00245a026; ARCHAMBAULT J, 1992, MOL CELL BIOL, V12, P4142, DOI 10.1128/MCB.12.9.4142; ARCHAMBAULT J, 1993, MICROBIOL REV, V57, P703, DOI 10.1128/MMBR.57.3.703-724.1993; Awrey DE, 1997, J BIOL CHEM, V272, P14747, DOI 10.1074/jbc.272.23.14747; Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; BORUKHOV S, 1991, J BIOL CHEM, V266, P23921; Borukhov S, 1996, METHOD ENZYMOL, V274, P315; BORUKHOV S, 1992, P NATL ACAD SCI USA, V89, P8899, DOI 10.1073/pnas.89.19.8899; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; BORUKHOV S, 1991, J BIOL CHEM, V266, P23932; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; CIPRESPALACIN G, 1995, BIOCHEMISTRY-US, V34, P15375, DOI 10.1021/bi00046a046; Cramer P, 2001, SCIENCE, V292, P1863, DOI 10.1126/science.1059493; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Darst SA, 2002, P NATL ACAD SCI USA, V99, P4296, DOI 10.1073/pnas.052054099; Darst SA, 2001, CURR OPIN STRUC BIOL, V11, P155; DeRosier D, 1999, J MOL BIOL, V289, P159, DOI 10.1006/jmbi.1999.2677; Epshtein V, 2002, MOL CELL, V10, P623, DOI 10.1016/S1097-2765(02)00640-8; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; FENG GH, 1994, J BIOL CHEM, V269, P22282; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Fu JH, 1999, CELL, V98, P799, DOI 10.1016/S0092-8674(00)81514-7; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Hogan BP, 2002, J BIOL CHEM, V277, P967, DOI 10.1074/jbc.M108737200; HSU LM, 1995, P NATL ACAD SCI USA, V92, P11588, DOI 10.1073/pnas.92.25.11588; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; JEON CJ, 1994, P NATL ACAD SCI USA, V91, P9106, DOI 10.1073/pnas.91.19.9106; Juo ZS, 2003, NATURE, V422, P534, DOI 10.1038/nature01534; Kamada K, 2001, P NATL ACAD SCI USA, V98, P3115, DOI 10.1073/pnas.051631098; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Kornberg Roger D., 1999, Trends in Cell Biology, V9, pM46, DOI 10.1016/S0962-8924(99)01679-7; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Koulich D, 1998, J MOL BIOL, V276, P379, DOI 10.1006/jmbi.1997.1545; Koulich D, 1997, J BIOL CHEM, V272, P7201, DOI 10.1074/jbc.272.11.7201; Kulish D, 2000, J BIOL CHEM, V275, P12789, DOI 10.1074/jbc.275.17.12789; Loizos N, 1999, J BIOL CHEM, V274, P23378, DOI 10.1074/jbc.274.33.23378; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; Marr MT, 2000, MOL CELL, V6, P1275, DOI 10.1016/S1097-2765(00)00126-X; Minakhin L, 2001, P NATL ACAD SCI USA, V98, P892, DOI 10.1073/pnas.98.3.892; Morin PE, 1996, P NATL ACAD SCI USA, V93, P10604, DOI 10.1073/pnas.93.20.10604; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Mustaev A, 1997, P NATL ACAD SCI USA, V94, P6641, DOI 10.1073/pnas.94.13.6641; NAKANISHI T, 1995, J BIOL CHEM, V270, P8991, DOI 10.1074/jbc.270.15.8991; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; NIKOLOV DB, 1992, NATURE, V360, P40, DOI 10.1038/360040a0; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Olmsted VK, 1998, J BIOL CHEM, V273, P22589, DOI 10.1074/jbc.273.35.22589; Opalka N, 2000, P NATL ACAD SCI USA, V97, P617, DOI 10.1073/pnas.97.2.617; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; POLYAKOV A, 1995, CELL, V83, P365, DOI 10.1016/0092-8674(95)90114-0; Polyakov A, 1998, J MOL BIOL, V281, P465, DOI 10.1006/jmbi.1998.1958; QIAN XQ, 1993, NATURE, V365, P277, DOI 10.1038/365277a0; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; REINES D, 1992, J BIOL CHEM, V267, P3795; REINES D, 1989, J BIOL CHEM, V264, P10799; Rice WJ, 2001, BIOPHYS J, V80, P2187, DOI 10.1016/S0006-3495(01)76191-7; RUDD MD, 1994, P NATL ACAD SCI USA, V91, P8057, DOI 10.1073/pnas.91.17.8057; SEVERINOV K, 1994, J BIOL CHEM, V269, P14254; SLUDER AE, 1989, J BIOL CHEM, V264, P8963; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; SURRATT CK, 1991, P NATL ACAD SCI USA, V88, P7983, DOI 10.1073/pnas.88.18.7983; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Toulme F, 2000, EMBO J, V19, P6853, DOI 10.1093/emboj/19.24.6853; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; WANG DG, 1993, P NATL ACAD SCI USA, V90, P843, DOI 10.1073/pnas.90.3.843; Wriggers W, 2001, STRUCTURE, V9, P779, DOI 10.1016/S0969-2126(01)00648-7; Wu JS, 1996, P NATL ACAD SCI USA, V93, P11552, DOI 10.1073/pnas.93.21.11552; YEE D, 1979, BIOCHEMISTRY-US, V18, P4116, DOI 10.1021/bi00586a009; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhang GY, 1998, SCIENCE, V281, P262, DOI 10.1126/science.281.5374.262	81	164	172	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2003	114	3					335	345		10.1016/S0092-8674(03)00600-7	http://dx.doi.org/10.1016/S0092-8674(03)00600-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914698	Bronze			2022-12-01	WOS:000184679200010
J	Stern, SA				Stern, SA			The evolution of comets in the Oort cloud and Kuiper belt	NATURE			English	Article							EROSION	Comets are remnants from the time when the outer planets formed, similar to4-4.5 billion years ago. They have been in storage since then in the Oort cloud and Kuiper belt-distant regions that are so cold and sparsely populated that it was long thought that comets approaching the Sun were pristine samples from the time of Solar System formation. It is now recognized, however, that a variety of subtle but important evolutionary mechanisms operate on comets during their long storage, so they can no longer be regarded as wholly pristine.	SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA		Stern, SA (corresponding author), SW Res Inst, Dept Space Studies, 1050 Walnut St,Suite 400, Boulder, CO 80302 USA.	astern@swri.edu						Asphaug E, 1996, ICARUS, V121, P225, DOI 10.1006/icar.1996.0083; BELTON M, 2002, NEW FRONTIERS SOLAR, P457; DELSEMME AH, 1977, COMETS ASTEROIDS MET, P3; DONES L, UNPUB ICARUS; DUNCAN M, 1988, ASTROPHYS J, V328, pL69, DOI 10.1086/185162; Durda DD, 2000, ICARUS, V145, P220, DOI 10.1006/icar.1999.6333; FARINELLA P, 2000, PROTOSTARS PLANETS, V4, P125; Gerakines PA, 2001, J GEOPHYS RES-PLANET, V106, P33381, DOI 10.1029/2000JE001320; GERAKINES PA, 2001, J GEOPHYS RES, V106, P33275; Greenberg J., 1982, COMETS, P131; JEWITT D, 1993, NATURE, V362, P730, DOI 10.1038/362730a0; Johnson R. E., 1990, ENERGETIC CHARGED PA, P232; KLINGER J, 1985, ICES SOLAR SYSTEM, P407; KOUCHI A, 1992, ASTROPHYS J, V388, pL73, DOI 10.1086/186333; Kuiper G.P., 1951, ASTROPHYSICS TOPICAL, P357; LEVISON HF, 1994, ICARUS, V108, P18, DOI 10.1006/icar.1994.1039; LISSAUER JJ, 1989, ASTROPHYS J, V340, P468, DOI 10.1086/167409; Mumma M. J., 1997, Astronomical Society of the Pacific Conference Series, V122, P369; MUMMA MJ, 1993, PROTOSTARS PLANETS, V3, P1177; ODELL CR, 1973, ICARUS, V19, P137; Oort J., 1950, BAIN, V11, P91; Prialnik D, 1999, SPACE SCI REV, V90, P169, DOI 10.1023/A:1005202215579; SAFRONOV VS, 1987, EVOLUTION SMALL BODI, P217; Schwadron NA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015829; STERN SA, 1988, ICARUS, V73, P499, DOI 10.1016/0019-1035(88)90059-0; STERN SA, 1990, ICARUS, V84, P447, DOI 10.1016/0019-1035(90)90048-E; STERN SA, 1986, ICARUS, V68, P276, DOI 10.1016/0019-1035(86)90024-2; Stern SA, 2001, NATURE, V409, P589, DOI 10.1038/35054508; STERN SA, 1988, NATURE, V332, P407, DOI 10.1038/332407a0; STRAZZULA G, 1999, COMPOSITION ORIGIN C, P269; THOMPSON WR, 1987, J GEOPHYS RES, V92, P14933, DOI 10.1029/JA092iA13p14933; THROOP HB, 2000, THESIS U COLORADO, P1; Weaver HA, 2002, ASTROPHYS J, V576, pL95, DOI 10.1086/343087; WEISSMAN PR, 1990, NATURE, V344, P825, DOI 10.1038/344825a0; Weissman PR, 1996, ASTR SOC P, V107, P265; WEISSMAN PR, IN PRESS COMETS, V2; WHIPPLE FL, 1950, ASTROPHYS J, V111, P375, DOI 10.1086/145272; WHIPPLE FL, 1964, P NATL ACAD SCI USA, V51, P711, DOI 10.1073/pnas.51.5.711; WHIPPLE FL, 1977, COMETS ASTEROIDS MET, P25; Wilkening L. L, 1982, IAU C 61 COMET DISCO, P85; [No title captured]	41	83	86	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2003	424	6949					639	642		10.1038/nature01725	http://dx.doi.org/10.1038/nature01725			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904784				2022-12-01	WOS:000184578800036
J	Winston, FK; Kassam-Adams, N; Garcia-Espana, F; Ittenbach, R; Cnaan, A				Winston, FK; Kassam-Adams, N; Garcia-Espana, F; Ittenbach, R; Cnaan, A			Screening for risk of persistent posttraumatic stress in injured children and their parents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL INJURY; SEVERITY SCORE; DISORDER; SYMPTOMS; EPIDEMIOLOGY; DISASTER; TRAUMA; IMPACT; ADOLESCENTS; PREDICTORS	Context Injury, a leading health threat to children, is also a common cause of posttraumatic stress disorder (PTSD) in childhood. Most injured children with PTSD are not diagnosed or treated. Objective To develop a stand-alone screening tool for use by clinicians during acute trauma care to identify injured children and their parents who are at risk of significant, persistent posttraumatic stress symptoms. Design The Screening Tool for Early Predictors of PTSD (STEPP) was derived from a 50-item risk factor survey administered within 1 month of injury as part of a prospective cohort study of posttraumatic stress in injured children and their parents. Symptoms of PTSD were assessed at least 3 months after injury. Setting Urban, pediatric level I trauma center. Participants A sample of 269 children aged 8 to 17 years admitted for treatment of traffic-related injuries between July 1999 and October 2001, and one parent per child, completed a risk factor survey assessing potential predictors of PTSD outcome. One hundred seventy-one families (63%) completed a follow-up assessment. Main Outcome Measures The Clinician-Administered PTSD Scale for Children and Adolescents and the PTSD Checklist served as criterion standards for child and parent outcomes, respectively. Positive cases were defined as those meeting criteria for at least subsyndromal PTSD with continuing impairment ("persistent traumatic stress"). Results The STEPP contains 4 dichotomous questions asked of the child, 4 asked of one parent, and 4 items obtained easily from the emergency medical record. STEPP sensitivity in predicting posttraumatic stress was 0.88 for children and 0.96 for parents, with negative predictive values of 0.95 for children and 0.99 for parents. The odds ratio for prediction of persistent traumatic stress was 6.5 (95% confidence interval [CI], 1.8-22.8) in children and 26.6 (95% CI, 3.5-202.1) in parents. Conclusions The STEPP represents a new method to guide clinicians in making evidence-based decisions for the allocation of scarce mental health resources for traumatic stress. Its brevity and simple scoring rule suggest that it can be easily administered in the acute care setting.	Childrens Hosp Philadelphia, Traumalink Pediat Interdisciplinary Injury Contro, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Div Gen Pediat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Ctr Pediat Traumat Stress, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Biostat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Winston, FK (corresponding author), Childrens Hosp Philadelphia, Traumalink Pediat Interdisciplinary Injury Contro, 34th St & Civic Ctr Blvd,3535 TraumaLink,10th Flo, Philadelphia, PA 19104 USA.	flaura@mail.med.upenn.edu	Ittenbach, Richard F/Q-1806-2015; Kassam-Adams, Nancy/C-4091-2009	Kassam-Adams, Nancy/0000-0001-7412-1428	PHS HHS [R40 MC 00138] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aaron J, 1999, J PEDIATR PSYCHOL, V24, P335, DOI 10.1093/jpepsy/24.4.335; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Athey JL, 1997, PROF PSYCHOL-RES PR, V28, P464, DOI 10.1037/0735-7028.28.5.464; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baker SP, 1992, THE INJURY FACT BOOK, V2nd; Breslau N, 2001, J CLIN PSYCHIAT, V62, P16; BRETON JJ, 1993, J AM ACAD CHILD PSY, V32, P438, DOI 10.1097/00004583-199303000-00028; BULL JP, 1975, ACCIDENT ANAL PREV, V7, P249, DOI 10.1016/0001-4575(75)90026-3; Daviss WB, 2000, J AM ACAD CHILD PSY, V39, P576, DOI 10.1097/00004583-200005000-00011; de Vries APJ, 1999, PEDIATRICS, V104, P1293, DOI 10.1542/peds.104.6.1293; DiGallo A, 1997, BRIT J PSYCHIAT, V170, P358, DOI 10.1192/bjp.170.4.358; Fletcher Kenneth E., 1996, P242; Foy D., 1994, J SCH PSYCHOL, V34, P133; Gavin LA, 1997, PEDIATR EMERG CARE, V13, P222, DOI 10.1097/00006565-199706000-00013; GREEN BL, 1991, J AM ACAD CHILD PSY, V30, P945, DOI 10.1097/00004583-199111000-00012; HAINES C, 1995, J ADV NURS, V21, P350, DOI 10.1111/j.1365-2648.1995.tb02533.x; *I MED, 1999, RED BURD INJ ADV PRE; KOCH WJ, 1995, COGN BEHAV PRACT, V2, P327, DOI 10.1016/S1077-7229(95)80016-6; KOOPMAN C, 1994, AM J PSYCHIAT, V151, P888; Kovacs M., 1992, CHILDRENS DEPRESSION; Kuch K, 1996, CAN J PSYCHIAT, V41, P429, DOI 10.1177/070674379604100707; Litz BT, 2002, CLIN PSYCHOL-SCI PR, V9, P112, DOI 10.1093/clipsy/9.2.112; March J.S., 2013, MULTIDIMENSIONAL ANX; March JS, 1998, J AM ACAD CHILD PSY, V37, P585, DOI 10.1097/00004583-199806000-00008; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; Mirza KAH, 1998, BRIT J PSYCHIAT, V172, P443, DOI 10.1192/bjp.172.5.443; National Institute of Mental Health, 1998, NIH PUBL, V98-4321; NEWMAN E, 1996, MEASUREMENT STRESS T, P108; NORRIS FH, 1992, J CONSULT CLIN PSYCH, V60, P409, DOI 10.1037/0022-006X.60.3.409; Pfefferbaum B, 2000, PSYCHIATRY, V63, P358, DOI 10.1080/00332747.2000.11024929; PTACEK JT, 1995, J PAIN SYMPTOM MANAG, V10, P446, DOI 10.1016/0885-3924(95)00083-B; PYNOOS RS, 1991, POSTTRAUMATIC STRESS, P65; Richmond TS, 1998, J TRAUMA, V44, P635, DOI 10.1097/00005373-199804000-00012; SAXE G, 1998, J BURN CARE REHABIL, V19, pS206; SCHREIBER S, 1993, PAIN, V54, P107, DOI 10.1016/0304-3959(93)90105-X; SHANNON MP, 1994, J AM ACAD CHILD PSY, V33, P80, DOI 10.1097/00004583-199401000-00012; Stallard P, 1998, BRIT MED J, V317, P1619, DOI 10.1136/bmj.317.7173.1619; Stuber J, 2002, PSYCHIAT SERV, V53, P815, DOI 10.1176/appi.ps.53.7.815; U.S. Public Health Service, 2000, SURG GEN C CHILDR ME; Vernberg EM, 1996, J ABNORM PSYCHOL, V105, P237, DOI 10.1037/0021-843X.105.2.237; Weathers F.W., 1996, MEASUREMENT STRESS T, P250; Winje D, 1996, J CONSULT CLIN PSYCH, V64, P1037, DOI 10.1037/0022-006X.64.5.1037; Winston FK, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e90; Yehuda R, 1998, BIOL PSYCHIAT, V44, P1305, DOI 10.1016/S0006-3223(98)00276-5; 1997, INT CLASSIFICATION D	48	128	130	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2003	290	5					643	649		10.1001/jama.290.5.643	http://dx.doi.org/10.1001/jama.290.5.643			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	708GH	12902368	Bronze			2022-12-01	WOS:000184558500019
J	Burrows, M				Burrows, M			Biomechanics: Froghopper insects leap to new heights - An innovative leaping action propels these bugs to the top of the insect athletic league.	NATURE			English	Editorial Material							JUMP; ENERGETICS; MECHANISM		Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Burrows, M (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.							ALEXANDER RM, 1995, PHILOS T R SOC B, V347, P235, DOI 10.1098/rstb.1995.0024; Bennet-Clark H.C., 1976, P467; BENNETCLARK HC, 1967, J EXP BIOL, V47, P59; BENNETCLARK HC, 1975, J EXP BIOL, V63, P53; Burrows M, 2003, J EXP BIOL, V206, P1035, DOI 10.1242/jeb.00214; DOWLING JJ, 1993, J APPL BIOMECH, V9, P95, DOI 10.1123/jab.9.2.95; EVANS MEG, 1973, J ZOOL, V169, P181; ROTHSCHILD M, 1975, PHILOS T ROY SOC B, V271, P499, DOI 10.1098/rstb.1975.0064; Sander K., 1956, Zoologische Jahrbuecher Jena Anatomie, V75, P383; WEISFOGH T, 1956, J EXP BIOL, V33, P668	10	168	175	11	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					509	509		10.1038/424509a	http://dx.doi.org/10.1038/424509a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891345	Bronze			2022-12-01	WOS:000184454700029
J	Matsushita, T; Mochizuki, N; Nagatani, A				Matsushita, T; Mochizuki, N; Nagatani, A			Dimers of the N-terminal domain of phytochrome B are functional in the nucleus	NATURE			English	Article							SIGNAL-TRANSDUCTION; LIGHT; PROTEIN; REVEALS; ENCODES; REGION; PIF3	A plant modulates its developmental processes in response to light by several informational photoreceptors such as phytochrome. Phytochrome is a dimeric chromoprotein which regulates various aspects of plant development from seed germination to flowering(1). Upon absorption of red light, phytochrome translocates from the cytoplasm to the nucleus(2-4), and regulates gene expression through interaction with transcription factors such as PIF3 (refs 5-7). The phytochrome polypeptide has two domains(1,8) : the amino-terminal photosensory domain with a chromophore and the carboxy-terminal domain which contains signalling motifs such as a kinase domain(9). The latter is widely believed to transduce the signal to downstream components(1,5,810). Here we show that the C-terminal domain of Arabidopsis phytochrome B (phyB), which is known as the most important member of the phytochrome family(1), is not directly involved in signal transduction. The N-terminal domain isolated from phyB, when dimerized and localized in the nucleus, triggered full phyB responses with much higher photosensitivity than the full-length phyB. These findings indicate that the C-terminal domain attenuates the activity of phyB rather than positively transducing the signal.	Kyoto Univ, Grad Sch Sci, Dept Bot, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Nagatani, A (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Bot, Sakyo Ku, Kyoto 6068502, Japan.	nagatani@physiol.bot.kyoto-u.ac.jp						CHERRY JR, 1993, PLANT CELL, V5, P565, DOI 10.1105/tpc.5.5.565; Clough RC, 1999, PLANT J, V17, P155, DOI 10.1046/j.1365-313X.1999.00360.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; Grebenok RJ, 1997, PLANT J, V11, P573, DOI 10.1046/j.1365-313X.1997.11030573.x; Jarillo JA, 2001, NATURE, V410, P487, DOI 10.1038/35068589; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kato A, 1999, PLANT CELL PHYSIOL, V40, P586, DOI 10.1093/oxfordjournals.pcp.a029581; Kircher S, 2002, PLANT CELL, V14, P1541, DOI 10.1105/tpc.001156; Liu XL, 2001, PLANT CELL, V13, P1293, DOI 10.1105/tpc.13.6.1293; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Nagy F, 2000, SEMIN CELL DEV BIOL, V11, P505, DOI 10.1006/scdb.2000.0202; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Park CM, 2000, SEMIN CELL DEV BIOL, V11, P449, DOI 10.1006/scdb.2000.0200; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; Sakamoto K, 1996, PLANT J, V10, P859, DOI 10.1046/j.1365-313X.1996.10050859.x; SHACKLOCK PS, 1992, NATURE, V358, P753, DOI 10.1038/358753a0; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Shinomura T, 1996, P NATL ACAD SCI USA, V93, P8129, DOI 10.1073/pnas.93.15.8129; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; STOCKHAUS J, 1992, GENE DEV, V6, P2364, DOI 10.1101/gad.6.12a.2364; Wagner D, 1996, P NATL ACAD SCI USA, V93, P4011, DOI 10.1073/pnas.93.9.4011; Wagner D, 1996, PLANT CELL, V8, P859, DOI 10.1105/tpc.8.5.859; WAGNER D, 1995, P NATL ACAD SCI USA, V92, P8596, DOI 10.1073/pnas.92.19.8596; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Yamaguchi R, 1999, J CELL BIOL, V145, P437, DOI 10.1083/jcb.145.3.437; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976	30	227	245	3	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2003	424	6948					571	574		10.1038/nature01837	http://dx.doi.org/10.1038/nature01837			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891362				2022-12-01	WOS:000184454700047
J	Mitchell, K; Owens, RG				Mitchell, K; Owens, RG			National survey of medical decisions at end of life made by New Zealand general practitioners	BRITISH MEDICAL JOURNAL			English	Article									Univ Auckland, Dept Psychol, Auckland, New Zealand; Univ Wales, Bangor LL57 2AS, Gwynedd, Wales	University of Auckland; Bangor University	Mitchell, K (corresponding author), Univ Auckland, Dept Psychol, Private Bag 92019, Auckland, New Zealand.							Deliens L, 2000, LANCET, V356, P1806, DOI 10.1016/S0140-6736(00)03233-5; GILLETT GR, 1991, NZ LAW J         APR; Kuhse H, 1997, MED J AUSTRALIA, V166, P191, DOI 10.5694/j.1326-5377.1997.tb140074.x; van der Maas PJ, 1992, HEALTH POLICY, V22, P1; Zylicz Z, 2000, PATIENT EDUC COUNS, V41, P47, DOI 10.1016/S0738-3991(00)00114-2	5	32	32	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2003	327	7408					202	203		10.1136/bmj.327.7408.202	http://dx.doi.org/10.1136/bmj.327.7408.202			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	706DL	12881263	Green Published, Bronze			2022-12-01	WOS:000184437300019
J	Limpens, E; Franken, C; Smit, P; Willemse, J; Bisseling, T; Geurts, R				Limpens, E; Franken, C; Smit, P; Willemse, J; Bisseling, T; Geurts, R			LysM domain receptor kinases regulating rhizobial Nod factor-induced infection	SCIENCE			English	Article							MEDICAGO-TRUNCATULA CONTROLS; FACTOR-PERCEPTION; NODULATION FACTOR; MELILOTI; SIGNAL; SPECIFICITY; RESISTANCE; GENOMES; GENES; ENTRY	The rhizobial infection of legumes has the most stringent demand toward Nod factor structure of all host responses, and therefore a specific Nod factor entry receptor has been proposed. The SYM2 gene identfied in certain ecotypes of pea (Pisum sativum) is a good candidate for such an entry receptor. We exploited the close phylogenetic relationship of pea and the model legume Medicago truncatula to identify genes specifically involved in rhizobial infection. The SYM2 orthologous region of M. truncatula contains 15 putative receptor-like genes, of which 7 are LysM domain-containing receptor-like kinases (LYKs). Using reverse genetics in M. truncatula, we show that two LYK genes are specifically involved in infection thread formation. This, as well as the properties of the LysM domains, strongly suggests that they are Nod factor entry receptors.	Univ Wageningen & Res Ctr, Dept Plant Sci, Mol Biol Lab, NL-6703 HA Wageningen, Netherlands	Wageningen University & Research	Bisseling, T (corresponding author), Univ Wageningen & Res Ctr, Dept Plant Sci, Mol Biol Lab, Dreijenlaan 3, NL-6703 HA Wageningen, Netherlands.		Willemse, Joost/B-1861-2008; poinssot, benoit/B-2569-2009; Bisseling, Ton/A-2421-2013	Willemse, Joost/0000-0001-9312-6021; poinssot, benoit/0000-0001-5890-4318; 				Amon P, 1998, PLANT CELL, V10, P781; ARDOUREL M, 1994, PLANT CELL, V6, P1357, DOI 10.1105/tpc.6.10.1357; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; Ben Amor B, 2003, PLANT J, V34, P495, DOI 10.1046/j.1365-313X.2003.01743.x; Boisson-Dernier A, 2001, MOL PLANT MICROBE IN, V14, P695, DOI 10.1094/MPMI.2001.14.6.695; Catoira R, 2001, DEVELOPMENT, V128, P1507; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; Cullimore JV, 2001, TRENDS PLANT SCI, V6, P24, DOI 10.1016/S1360-1385(00)01810-0; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; FIRMIN JL, 1993, MOL MICROBIOL, V10, P351, DOI 10.1111/j.1365-2958.1993.tb01961.x; Gage DJ, 2002, J BACTERIOL, V184, P7042, DOI 10.1128/JB.184.24.7042-7046.2002; Geurts R, 1997, PLANT PHYSIOL, V115, P351, DOI 10.1104/pp.115.2.351; Geurts R, 2002, PLANT CELL, V14, pS239, DOI 10.1105/tpc.002451; GEURTS R, UNPUB; Gualtieri G, 2002, PLANT MOL BIOL, V50, P225, DOI 10.1023/A:1016085523752; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; LIE TA, 1984, PLANT SOIL, V82, P415, DOI 10.1007/BF02184279; LIMPENS E, UNPUBLISHED; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; Oldroyd GED, 2001, PLANT J, V28, P191, DOI 10.1046/j.1365-313X.2001.01149.x; Walker SA, 2000, MOL PLANT MICROBE IN, V13, P754, DOI 10.1094/MPMI.2000.13.7.754; Young ND, 2003, CURR OPIN PLANT BIOL, V6, P199, DOI 10.1016/S1369-5266(03)00006-2	23	534	577	6	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2003	302	5645					630	633		10.1126/science.1090074	http://dx.doi.org/10.1126/science.1090074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735MV	12947035				2022-12-01	WOS:000186119900055
J	Thayer, SP; di Magliano, MP; Heiser, PW; Nielsen, CM; Roberts, DJ; Lauwers, GY; Qi, YP; Gysin, S; Fernandez-del Castillo, CF; Yajnik, V; Antoniu, B; McMahon, M; Warshaw, AL; Hebrok, M				Thayer, SP; di Magliano, MP; Heiser, PW; Nielsen, CM; Roberts, DJ; Lauwers, GY; Qi, YP; Gysin, S; Fernandez-del Castillo, CF; Yajnik, V; Antoniu, B; McMahon, M; Warshaw, AL; Hebrok, M			Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis	NATURE			English	Article							SONIC-HEDGEHOG; INTRAEPITHELIAL NEOPLASIA; SIGNALING PATHWAY; DUCT LESIONS; NEURAL-TUBE; EXPRESSION; GENE; ADENOCARCINOMA; INACTIVATION; CYCLOPAMINE	Hedgehog signalling-an essential pathway during embryonic pancreatic development, the misregulation of which has been implicated in several forms of cancer-may also be an important mediator in human pancreatic carcinoma(1-8). Here we report that sonic hedgehog, a secreted hedgehog ligand, is abnormally expressed in pancreatic adenocarcinoma and its precursor lesions: pancreatic intraepithelial neoplasia (PanIN). Pancreata of Pdx-Shh mice (in which Shh is misexpressed in the pancreatic endoderm) develop abnormal tubular structures, a phenocopy of human PanIN-1 and -2. Moreover, these PanIN-like lesions also contain mutations in K-ras and overexpress HER-2/neu, which are genetic mutations found early in the progression of human pancreatic cancer. Furthermore, hedgehog signalling remains active in cell lines established from primary and metastatic pancreatic adenocarcinomas. Notably, inhibition of hedgehog signalling by cyclopamine induced apoptosis and blocked proliferation in a subset of the pancreatic cancer cell lines both in vitro and in vivo. These data suggest that this pathway may have an early and critical role in the genesis of this cancer, and that maintenance of hedgehog signalling is important for aberrant proliferation and tumorigenesis.	Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Gastroenterol Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hebrok, M (corresponding author), Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA.		Roberts, Drucilla/AAB-6379-2022; Castillo, Carlos Fenandez-del/AAO-2602-2020	Heiser, Patrick/0000-0002-8831-4973; Pasca di Magliano, Marina/0000-0001-9632-9035	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD034448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060533] Funding Source: NIH RePORTER; NICHD NIH HHS [R29 HD034448-02] Funding Source: Medline; NIDDK NIH HHS [R01 DK060533] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; CAPDEVILA J, 1994, EMBO J, V13, P71, DOI 10.1002/j.1460-2075.1994.tb06236.x; Day JD, 1996, HUM PATHOL, V27, P119, DOI 10.1016/S0046-8177(96)90364-0; Hardcastle Z, 1998, DEVELOPMENT, V125, P2803; HASEGAWA Y, 1995, ONCOGENE, V10, P1441; Hebrok M, 2000, DEVELOPMENT, V127, P4905; Hebrok M, 2003, MECH DEVELOP, V120, P45, DOI 10.1016/S0925-4773(02)00331-3; Hebrok M, 1998, GENE DEV, V12, P1705, DOI 10.1101/gad.12.11.1705; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Ito Y, 2002, INT J ONCOL, V20, P1263; Jaffee EM, 1998, CANCER J SCI AM, V4, P194; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Lee J, 1997, DEVELOPMENT, V124, P2537; Lopez T, 2002, CANCER CELL, V1, P339, DOI 10.1016/S1535-6108(02)00055-7; Marigo V, 1996, P NATL ACAD SCI USA, V93, P9346, DOI 10.1073/pnas.93.18.9346; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Roberts DJ, 1998, DEVELOPMENT, V125, P2791; ROBERTS DJ, 2000, DEV GASTROINTESTINAL, P1; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Sasaki H, 1997, DEVELOPMENT, V124, P1313; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; van den Brink GR, 2001, GASTROENTEROLOGY, V121, P317, DOI 10.1053/gast.2001.26261; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Wicking C, 1999, ONCOGENE, V18, P7844, DOI 10.1038/sj.onc.1203282; Wilentz RE, 1998, CANCER RES, V58, P4740; Wilentz RE, 2000, CANCER RES, V60, P2002	30	1190	1318	2	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2003	425	6960					851	856		10.1038/nature02009	http://dx.doi.org/10.1038/nature02009			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735ME	14520413	Green Accepted			2022-12-01	WOS:000186118500048
J	Chan, SP; Kao, DI; Tsai, WY; Cheng, SC				Chan, SP; Kao, DI; Tsai, WY; Cheng, SC			The Prp19p-associated complex in spliceosome activation	SCIENCE			English	Article							PRE-MESSENGER-RNA; SM-LIKE PROTEINS; SMALL NUCLEAR RNAS; U6 SNRNA; REQUIRES ATP; YEAST; SITE; ASSOCIATION; COMPONENTS; PRP19	During spliceosome activation, a large structural rearrangement occurs that involves the release of two small nuclear RNAs, U1 and U4, and the addition of a protein complex associated with Prp19p. We show here that the Prp19p-associated complex is required for stable association of U5 and U6 with the spliceosome after U4 is dissociated. Ultraviolet crosslinking analysis revealed the existence of two modes of base pairing between U6 and the 5' splice site, as well as a switch of such base pairing from one to the other that required the Prp19p-associated complex during spliceosome activation. Moreover, a Prp19p-dependent structural change in U6 small nuclear ribonucleoprotein particles was detected that involves destabilization of Sm-like (Lsm) proteins to bring about interactions between the Lsm binding site of U6 and the intron sequence near the 5' splice site, indicating dynamic association of Lsm with U6 and a direct role of Lsm proteins in activation of the spliceosome.	Natl Yang Ming Univ, Inst Microbiol & Immunol, Shih Pai, Taiwan; Acad Sinica, Inst Mol Biol, Nankang, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Cheng, SC (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Shih Pai, Taiwan.	mbscc@ccvax.sinica.edu.tw	Cheng, Soo-Chen/AAZ-7956-2021	Cheng, Soo-Chen/0000-0002-7570-9415; Chan, Shih-Peng/0000-0001-6322-2821				Achsel T, 1999, EMBO J, V18, P5789, DOI 10.1093/emboj/18.20.5789; Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Burge C.B., 1999, RNA WORLD, V37, P525; Chen CH, 2002, NUCLEIC ACIDS RES, V30, P1029, DOI 10.1093/nar/30.4.1029; Chen CH, 2001, J BIOL CHEM, V276, P488, DOI 10.1074/jbc.M006958200; Chen HR, 1998, MOL CELL BIOL, V18, P2196, DOI 10.1128/MCB.18.4.2196; Chen JYF, 2001, MOL CELL, V7, P227, DOI 10.1016/S1097-2765(01)00170-8; CHENG SC, 1994, NUCLEIC ACIDS RES, V22, P1548, DOI 10.1093/nar/22.9.1548; Kim CH, 1996, RNA, V2, P995; LESSER CF, 1993, SCIENCE, V262, P1982, DOI 10.1126/science.8266093; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Mayes AE, 1999, EMBO J, V18, P4321, DOI 10.1093/emboj/18.15.4321; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; SAWA H, 1992, P NATL ACAD SCI USA, V89, P11269, DOI 10.1073/pnas.89.23.11269; SAWA H, 1992, GENE DEV, V6, P244, DOI 10.1101/gad.6.2.244; SERAPHIN B, 1995, EMBO J, V14, P2089, DOI 10.1002/j.1460-2075.1995.tb07200.x; SONTHEIMER EJ, 1993, SCIENCE, V262, P1989, DOI 10.1126/science.8266094; Staley JP, 1999, MOL CELL, V3, P55, DOI 10.1016/S1097-2765(00)80174-4; TARN WY, 1993, P NATL ACAD SCI USA, V90, P10821, DOI 10.1073/pnas.90.22.10821; TARN WY, 1993, MOL CELL BIOL, V13, P1883, DOI 10.1128/MCB.13.3.1883; TARN WY, 1994, EMBO J, V13, P2421, DOI 10.1002/j.1460-2075.1994.tb06527.x; Tsai WY, 1999, J BIOL CHEM, V274, P9455, DOI 10.1074/jbc.274.14.9455; VIJAYRAGHAVAN U, 1986, EMBO J, V5, P1683, DOI 10.1002/j.1460-2075.1986.tb04412.x; Wang Q, 2003, J BIOL CHEM, V278, P7875, DOI 10.1074/jbc.M210839200; Will CL, 1997, CURR OPIN CELL BIOL, V9, P320, DOI 10.1016/S0955-0674(97)80003-8; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	28	244	244	2	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2003	302	5643					279	282		10.1126/science.1086602	http://dx.doi.org/10.1126/science.1086602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HT	12970570				2022-12-01	WOS:000185825900040
J	Shi, Y; Evans, JE; Rock, KL				Shi, Y; Evans, JE; Rock, KL			Molecular identification of a danger signal that alerts the immune system to dying cells	NATURE			English	Article							URATE MONOHYDRATE CRYSTALS; MONOSODIUM URATE; PARTICULATE ANTIGENS; ENDOGENOUS ADJUVANTS; DENDRITIC CELLS; URIC-ACID; SOLUBILITY; MACROPHAGES; GOUT	In infections, microbial components provide signals that alert the immune system to danger and promote the generation of immunity(1,2). In the absence of such signals, there is often no immune response or tolerance may develop. This has led to the concept that the immune system responds only to antigens perceived to be associated with a dangerous situation such as infection(3,4). Danger signals are thought to act by stimulating dendritic cells to mature so that they can present foreign antigens and stimulate T lymphocytes(2,5-7). Dying mammalian cells have also been found to release danger signals of unknown identity(8-11). Here we show that uric acid is a principal endogenous danger signal released from injured cells. Uric acid stimulates dendritic cell maturation and, when co-injected with antigen in vivo, significantly enhances the generation of responses from CD8(+) T cells. Eliminating uric acid in vivo inhibits the immune response to antigens associated with injured cells, but not to antigens presented by activated dendritic cells. Our findings provide a molecular link between cell injury and immunity and have important implications for vaccines, autoimmunity and inflammation.	Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Proteom & Mass Spectrometry Facil, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Rock, KL (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA.	kenneth.rock@umassmed.edu	Shi, Yan/Y-6642-2019					Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; BOSMANSKY K, 1984, Z RHEUMATOL, V43, P59; Coligan JKA, 1991, CURRENT PROTOCOLS IM; Cox JC, 1997, VACCINE, V15, P248, DOI 10.1016/S0264-410X(96)00183-1; FIDDIS RW, 1983, ANN RHEUM DIS, V42, P12, DOI 10.1136/ard.42.Suppl_1.12; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Hunter RL, 2002, VACCINE, V20, pS7, DOI 10.1016/S0264-410X(02)00164-0; IWATA H, 1989, J UROLOGY, V142, P1095, DOI 10.1016/S0022-5347(17)39003-1; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jeha S, 2001, SEMIN HEMATOL, V38, P4, DOI 10.1053/shem.2001.29017; KIPPEN I, 1974, ANN RHEUM DIS, V33, P313, DOI 10.1136/ard.33.4.313; Koka RM, 2000, AM J PHYSIOL-RENAL, V278, pF989, DOI 10.1152/ajprenal.2000.278.6.F989; Landis RC, 2002, ARTHRITIS RHEUM, V46, P3026, DOI 10.1002/art.10614; LOEB JN, 1972, ARTHRITIS RHEUM-US, V15, P189, DOI 10.1002/art.1780150209; Majno G, 1996, CELLS TISSUES DIS PR; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Schijns VEJC, 2000, CURR OPIN IMMUNOL, V12, P456, DOI 10.1016/S0952-7915(00)00120-5; Shi Y, 2002, EUR J IMMUNOL, V32, P155, DOI 10.1002/1521-4141(200201)32:1<155::AID-IMMU155>3.0.CO;2-P; Shi Y, 2000, P NATL ACAD SCI USA, V97, P14590, DOI 10.1073/pnas.260497597; SMYTH CJ, 1998, GOUT HYPERURICEMIA O; TAK HK, 1980, ARTHRITIS RHEUM, V23, P574, DOI 10.1002/art.1780230509; TALBOTT JH, 1976, GOUT URIC ACID METAB; Vidard L, 1996, J IMMUNOL, V156, P2809; Yagnik DR, 2000, ARTHRITIS RHEUM, V43, P1779, DOI 10.1002/1529-0131(200008)43:8<1779::AID-ANR14>3.0.CO;2-2	26	1267	1345	2	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2003	425	6957					516	521		10.1038/nature01991	http://dx.doi.org/10.1038/nature01991			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	727FN	14520412				2022-12-01	WOS:000185648100046
J	Lee, Y; Ahn, C; Han, JJ; Choi, H; Kim, J; Yim, J; Lee, J; Provost, P; Radmark, O; Kim, S; Kim, VN				Lee, Y; Ahn, C; Han, JJ; Choi, H; Kim, J; Yim, J; Lee, J; Provost, P; Radmark, O; Kim, S; Kim, VN			The nuclear RNase III Drosha initiates microRNA processing	NATURE			English	Article							RIBONUCLEASE-III; INTERFERENCE; EXPRESSION; DICER; IDENTIFICATION; MATURATION; PROTEINS; ENCODES; GENES	Hundreds of small RNAs of similar to22 nucleotides, collectively named microRNAs (miRNAs), have been discovered recently in animals and plants(1-10). Although their functions are being unravelled(1,2,11-13), their mechanism of biogenesis remains poorly understood. miRNAs are transcribed as long primary transcripts (pri-miRNAs) whose maturation occurs through sequential processing events: the nuclear processing of the pri-miRNAs into stem-loop precursors of similar to70 nucleotides (pre-miRNAs), and the cytoplasmic processing of pre-miRNAs into mature miRNAs(14). Dicer, a member of the RNase III superfamily of bidentate nucleases, mediates the latter step(15-19), whereas the processing enzyme for the former step is unknown. Here we identify another RNase III, human Drosha, as the core nuclease that executes the initiation step of miRNA processing in the nucleus. Immunopurified Drosha cleaved pri-miRNA to release pre-miRNA in vitro. Furthermore, RNA interference of Drosha resulted in the strong accumulation of pri-miRNA and the reduction of pre-miRNA and mature miRNA in vivo. Thus, the two RNase III proteins, Drosha and Dicer, may collaborate in the stepwise processing of miRNAs, and have key roles in miRNA-mediated gene regulation in processes such as development and differentiation.	Seoul Natl Univ, Inst Mol Biol & Genet, Seoul 151742, South Korea; Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; Yonsei Univ, Dept Biol, Seoul 120749, South Korea; CHU Laval, Ctr Rech, Ctr Rech Rhumatol & Immunol, Quebec City, PQ G1V 4G2, Canada; Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Laval University; Karolinska Institutet	Lee, Y (corresponding author), Seoul Natl Univ, Inst Mol Biol & Genet, Seoul 151742, South Korea.		Provost, Patrick/G-2786-2010; Han, Jinju/D-9091-2017	Provost, Patrick/0000-0002-6099-6562; Kim, Jaekwang/0000-0002-7312-4077; HAN, Jinju/0000-0003-1844-2301				Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Filippov V, 2000, GENE, V245, P213, DOI 10.1016/S0378-1119(99)00571-5; Fortin KR, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-26; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Wu HJ, 2000, J BIOL CHEM, V275, P36957, DOI 10.1074/jbc.M005494200; Zamore PD, 2001, MOL CELL, V8, P1158, DOI 10.1016/S1097-2765(01)00418-X; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	30	3654	4056	10	516	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 25	2003	425	6956					415	419		10.1038/nature01957	http://dx.doi.org/10.1038/nature01957			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	724TG	14508493				2022-12-01	WOS:000185502300045
J	Mukherjee, JS				Mukherjee, JS			HIV-1 care in resource-poor settings: a view from Haiti	LANCET			English	Editorial Material							HAART		Harvard Univ, Sch Med, Div Social Med & Hlth Inequal, Partners Hlth, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Partners Healthcare System	Mukherjee, JS (corresponding author), Harvard Univ, Sch Med, Div Social Med & Hlth Inequal, Partners Hlth, Boston, MA 02115 USA.							[Anonymous], 1916, PYGMALION; Farmer P, 2001, B WORLD HEALTH ORGAN, V79, P1145; *FUND FUND, CURR FUND CRIS; Gilks C, 2001, B WORLD HEALTH ORGAN, V79, P1154; Marseille E, 2002, LANCET, V359, P1851, DOI 10.1016/S0140-6736(02)08705-6	5	16	16	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 20	2003	362	9388					994	995		10.1016/S0140-6736(03)14373-5	http://dx.doi.org/10.1016/S0140-6736(03)14373-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724LT	14513853				2022-12-01	WOS:000185489600026
J	Marler, JR; Goldstein, LB				Marler, JR; Goldstein, LB			Medicine - Stroke - tPA and the clinic	SCIENCE			English	Editorial Material							ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN-ACTIVATOR; PRACTICE GUIDELINES; RT-PA; STATEMENT		Natl Inst Neurol Disorders & Stroke, Clin Trials, Bethesda, MD 20817 USA; Duke Univ, Duke Ctr Cerebrovasc Dis, Dept Med Neurol, Durham, NC 27710 USA; Duke Univ, Ctr Clin Hlth Policy Res, Stroke Policy Program, Durham, NC 27710 USA; Vet Adm Med Ctr, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Marler, JR (corresponding author), Natl Inst Neurol Disorders & Stroke, Clin Trials, Bethesda, MD 20817 USA.	marlerj@ninds.nih.gov						Adams HP, 2003, STROKE, V34, P1056, DOI 10.1161/01.STR.0000064841.47697.22; Alberts MJ, 2000, JAMA-J AM MED ASSOC, V283, P3102, DOI 10.1001/jama.283.23.3102; Barber PA, 2001, NEUROLOGY, V56, P1015, DOI 10.1212/WNL.56.8.1015; Crocco T J, 1999, Prehosp Emerg Care, V3, P201, DOI 10.1080/10903129908958937; Fagan SC, 1998, NEUROLOGY, V50, P883, DOI 10.1212/WNL.50.4.883; Goldstein L B, 1999, J Stroke Cerebrovasc Dis, V8, P349, DOI 10.1016/S1052-3057(99)80010-X; Goldstein LB, 2000, STROKE, V31, P66, DOI 10.1161/01.STR.31.1.66; Katzan IL, 2003, STROKE, V34, P799, DOI 10.1161/01.STR.0000056944.42686.1E; Kidwell CS, 2000, STROKE, V31, P71, DOI 10.1161/01.STR.31.1.71; LaMonte MP, 2003, STROKE, V34, P725, DOI 10.1161/01.STR.0000056945.36583.37; LOMAS J, 1991, JAMA-J AM MED ASSOC, V265, P2202, DOI 10.1001/jama.265.17.2202; LOMAS J, 1989, NEW ENGL J MED, V321, P1306, DOI 10.1056/NEJM198911093211906; Lopez-Yunez AR, 2001, STROKE, V32, P12, DOI 10.1161/01.STR.32.1.12; Marler JR, 2000, NEUROLOGY, V55, P1649, DOI 10.1212/WNL.55.11.1649; *NIH, IN PRESS NIH PUBL; Villar-Cordova C, 1998, NEUROLOGY, V50, P1491, DOI 10.1212/WNL.50.5.1491; ZIVIN JA, 1985, SCIENCE, V230, P1289, DOI 10.1126/science.3934754	17	50	54	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2003	301	5640					1677	1677		10.1126/science.1090270	http://dx.doi.org/10.1126/science.1090270			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722QN	14500967				2022-12-01	WOS:000185387700028
J	Williams, BG; Dye, C				Williams, BG; Dye, C			Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS	SCIENCE			English	Article							HIV-INFECTION; CELL DECLINE; AIDS; SURVIVAL; THERAPY; PROGRESSION; EVOLUTION; PREDICT; AFRICA; TIME	Human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/ AIDS) has dramatically increased the incidence of tuberculosis (TB) in sub-Saharan Africa, where up to 60% of TB patients are coinfected with HIV and each year 200,000 TB deaths are attributable to HIV coinfection. Now HIV threatens control of TB in Asia, Eastern Europe, and Latin America. Antiretroviral ( ARV) drugs can prevent TB by preserving immunity, but cohort analysis shows that early therapy, plus high levels of coverage and compliance, will be needed to avert a significant fraction of TB cases. However, ARV drugs could enhance the treatment of TB, and TB programs provide an important entry point for the treatment of HIV/ AIDS.	WHO, Communicable Dis, CH-1211 Geneva 27, Switzerland	World Health Organization	Williams, BG (corresponding author), WHO, Communicable Dis, CH-1211 Geneva 27, Switzerland.	williamsbg@who.int	Dye, Christopher/AIC-4659-2022	Williams, Brian/0000-0002-3174-4876; Dye, Christopher/0000-0002-2957-1793				ANTONUCCI G, 1995, JAMA-J AM MED ASSOC, V274, P143, DOI 10.1001/jama.274.2.143; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Cohen J, 2002, SCIENCE, V296, P2320, DOI 10.1126/science.296.5577.2320; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; CURRIE CSM, IN PRESS AIDS; De Cock KM, 1999, INT J TUBERC LUNG D, V3, P457; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Dorrucci M, 1999, EUR J EPIDEMIOL, V15, P317, DOI 10.1023/A:1007503018729; DRABICK JJ, 1992, AIDS RES HUM RETROV, V8, P2039, DOI 10.1089/aid.1992.8.2039; EASTERBROOK PJ, 1993, AIDS, V7, P959, DOI 10.1097/00002030-199307000-00009; Gottlieb GS, 2002, J INFECT DIS, V185, P905, DOI 10.1086/339295; Harries AD, 2001, INT J TUBERC LUNG D, V5, P1109; LANG W, 1989, J ACQ IMMUN DEF SYND, V2, P63; Lepri AC, 1997, J INFECT DIS, V175, P775, DOI 10.1086/513970; Levi GC, 2002, AIDS, V16, P2373, DOI 10.1097/00002030-200212060-00001; Markowitz N, 1997, ANN INTERN MED, V126, P123, DOI 10.7326/0003-4819-126-2-199701150-00005; McNeil AJ, 1996, STAT MED, V15, P75, DOI 10.1002/(SICI)1097-0258(19960115)15:1&lt;75::AID-SIM142&gt;3.0.CO;2-8; Morgan D, 2002, AIDS, V16, P597, DOI 10.1097/00002030-200203080-00011; MSF, 2002, EQ ACC SCAL HIV AIDS; Pilheu JA, 1997, INT J TUBERC LUNG D, V1, P422; Raviglione MC, 2002, LANCET, V359, P775, DOI 10.1016/S0140-6736(02)07880-7; Salamon R, 2002, J ACQ IMMUN DEF SYND, V29, P149, DOI 10.1097/00042560-200202010-00007; SCHELLEKENS PTA, 1992, AIDS, V6, P665, DOI 10.1097/00002030-199207000-00008; Tan Darrell HS, 2003, BMC Int Health Hum Rights, V3, P2, DOI 10.1186/1472-698X-3-2; *UNAIDS, 2003, UNAIDS0226E UNAIDS; *WHO, 2003, WHOCDSTB2001287; WILLIAMS BG, UNPUB; World Health Organization, 2002, SCAL ANT THER RES LT; Yamashita TE, 2001, AIDS, V15, P735, DOI 10.1097/00002030-200104130-00009; Yazdanpanah Y, 2001, INT J EPIDEMIOL, V30, P864, DOI 10.1093/ije/30.4.864	31	181	191	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2003	301	5639					1535	1537		10.1126/science.1086845	http://dx.doi.org/10.1126/science.1086845			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	720HL	12920302				2022-12-01	WOS:000185255300050
J	Eaves, AA; Palmer, AR				Eaves, AA; Palmer, AR			Reproduction - Widespread cloning in echinoderm larvae	NATURE			English	Editorial Material							EVOLUTION		Univ Alberta, Dept Biol Sci, Physiol & Cell Biol Grp, Edmonton, AB T6G 2E9, Canada; Univ Alberta, Dept Biol Sci, Systemat & Evolut Grp, Edmonton, AB T6G 2E9, Canada; Bamfield Marine Sci Ctr, Bamfield, BC V0R 1B0, Canada	University of Alberta; University of Alberta; Simon Fraser University	Eaves, AA (corresponding author), Univ Alberta, Dept Biol Sci, Physiol & Cell Biol Grp, Edmonton, AB T6G 2E9, Canada.	aeaves@ualberta.ca	Palmer, A. Richard/A-3593-2010	Palmer, A. Richard/0000-0002-7579-3899				Balser EJ, 1998, BIOL BULL-US, V194, P187, DOI 10.2307/1543049; BOSCH I, 1989, NATURE, V337, P169, DOI 10.1038/337169a0; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Davidson EH, 1998, DEVELOPMENT, V125, P3269; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; JAECKLE WB, 1994, BIOL BULL, V186, P62, DOI 10.2307/1542036; Knott KE, 2003, BIOL BULL-US, V204, P246, DOI 10.2307/1543596; Lacalli TC, 2000, INVERTEBR BIOL, V119, P234; MacBride EW, 1921, NATURE, V106, P501; Mortensen TH., 1921, STUDIES DEV LARVAL F; Vickery MS, 2000, BIOL BULL, V199, P298, DOI 10.2307/1543186	11	61	62	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2003	425	6954					146	146		10.1038/425146a	http://dx.doi.org/10.1038/425146a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719ZT	12968170	Bronze			2022-12-01	WOS:000185236000032
J	Hupert, N; Bearman, GML; Mushlin, AI; Callahan, MA				Hupert, N; Bearman, GML; Mushlin, AI; Callahan, MA			Accuracy of screening for inhalational anthrax after a bioterrorist attack	ANNALS OF INTERNAL MEDICINE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; NEW-YORK-CITY; RESPIRATORY SYNCYTIAL VIRUS; CLINICAL-FEATURES; BIOLOGICAL WEAPON; INFLUENZA-A; MANAGEMENT; DIAGNOSIS; INFECTION; EPIDEMIC	Background: Bioterrorism using anthrax claimed five lives in the United States in 2001 and remains a potential public health threat. In the aftermath of a large-scale anthrax attack, mass screening to identify early inhalational anthrax may improve both the management of individual cases and the efficiency of health resource utilization. Purpose: To develop the evidence base for outpatient anthrax screening protocols by quantifying differences in clinical presentation between inhalational anthrax and common viral respiratory tract infections. Design: Review, compilation, and data extraction from English-language case reports of inhalational anthrax and epidemiologic studies of influenza and other viral respiratory infections. Data Sources: 13 reports of 28 cases of inhalational anthrax from 1920 to 2001 and 5 studies reporting on the clinical features of 2762 cases of influenza and 1932 cases of noninfluenza viral respiratory disease. Data Synthesis: Characterization of presenting clinical symptoms in anthrax and viral disease and calculation of likelihood ratios for the presence of selected clinical features. Results: Fever and cough do not reliably discriminate between inhalational anthrax and viral respiratory tract infection. Features suggestive of anthrax include the presence of nonheadache neurologic symptoms (positive likelihood ratio cannot be calculated), dyspnea (positive likelihood ratio, 5.3 [95% Cl, 3.7 to 7.4]), nausea or vomiting (positive likelihood ratio, 5.1 [Cl, 3.0 to 8.5]), and finding of any abnormality on lung auscultation (positive likelihood ratio, 8.1 [Cl, 5.3 to 12.5]). In contrast, rhinorrhea (positive likelihood ratio, 0.2 [Cl, 0.1 to 0.4]) and sore throat (positive likelihood ratio, 0.2 [Cl, 0.1 to 0.5]) are more suggestive of viral respiratory tract infection. Conclusion: Inhalational anthrax has characteristic clinical features that are distinct from those seen in common viral respiratory tract infections. Screening protocols based on these features may improve rapid identification of patients with presumptive inhalational anthrax in the setting of a large-scale anthrax attack.	Cornell Univ, Weill Med Coll, Dept Publ Hlth, New York, NY 10021 USA; New York Presbyterian Hosp, New York, NY USA	Cornell University; NewYork-Presbyterian Hospital	Hupert, N (corresponding author), Cornell Univ, Weill Med Coll, Dept Publ Hlth, 3rd Floor,411 E 69th St, New York, NY 10021 USA.	nah2005@med.cornell.edu	Bearman, Gonzalo/ABB-2443-2020		PHS HHS [290-00-0013] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Barakat LA, 2002, JAMA-J AM MED ASSOC, V287, P863, DOI 10.1001/jama.287.7.863; Bartlett JG, 2002, CLIN INFECT DIS, V35, P851, DOI 10.1086/341902; Bloem K, 2001, PUBLIC HEALTH REP, V116, P34; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Borio L, 2001, JAMA-J AM MED ASSOC, V286, P2554, DOI 10.1001/jama.286.20.2554; BRACHMAN PS, 1961, NEW ENGL J MED, V265, P203, DOI 10.1056/NEJM196108032650501; Brookmeyer R, 2002, SCIENCE, V295, P1861, DOI 10.1126/science.1068474; Brooksher WR, 1920, J AMER MED ASSOC, V74, P323, DOI 10.1001/jama.1920.26210050002012a; Carrat F, 1999, CLIN INFECT DIS, V28, P283, DOI 10.1086/515117; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P909; Church DL, 2002, CLIN INFECT DIS, V34, P790, DOI 10.1086/338960; COWDERY JS, 1947, ARCH PATHOL, V43, P396; Fine AD, 2001, CLIN INFECT DIS, V32, P1784, DOI 10.1086/320747; Gerberding JL, 2002, JAMA-J AM MED ASSOC, V287, P898, DOI 10.1001/jama.287.7.898; GOLD H, 1955, ARCH INTERN MED, V96, P387, DOI 10.1001/archinte.1955.00250140109012; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Govaert TME, 1998, FAM PRACT, V15, P16, DOI 10.1093/fampra/15.1.16; Grinberg LM, 2001, MODERN PATHOL, V14, P482, DOI 10.1038/modpathol.3880337; HAIGHT TH, 1952, AM J MED SCI, V224, P57, DOI 10.1097/00000441-195207000-00009; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Hall CB, 2001, CLIN INFECT DIS, V33, P792, DOI 10.1086/322657; Hupert N, 2002, MED DECIS MAKING, V22, pS17, DOI 10.1177/027298902237709; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Kaufmann AF, 1997, EMERG INFECT DIS, V3, P83, DOI 10.3201/eid0302.970201; Khan AS, 2000, LANCET, V356, P1179, DOI 10.1016/S0140-6736(00)02769-0; Kuehnert MJ, 2003, CLIN INFECT DIS, V36, P328, DOI 10.1086/346035; LAFORCE FM, 1969, ARCH ENVIRON HEALTH, V18, P798, DOI 10.1080/00039896.1969.10665490; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Marrie TJ, 1996, AM J MED, V101, P508, DOI 10.1016/S0002-9343(96)00255-0; Mayer TA, 2001, JAMA-J AM MED ASSOC, V286, P2549, DOI 10.1001/jama.286.20.2549; MESELSON M, 1994, SCIENCE, V266, P1202, DOI 10.1126/science.7973702; Metlay JP, 1997, ARCH INTERN MED, V157, P1453, DOI 10.1001/archinte.157.13.1453; Metlay JP, 2003, ANN INTERN MED, V138, P109, DOI 10.7326/0003-4819-138-2-200301210-00012; Mina B, 2002, JAMA-J AM MED ASSOC, V287, P858, DOI 10.1001/jama.287.7.858; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; MOOLENAAR RL, 1995, CLIN INFECT DIS, V21, P643, DOI 10.1093/clinids/21.3.643; *NIH OFF PUBL HLTH, 2001, OPT POST PREV INH AN; Oliveira EC, 2001, CHEST, V119, P1717, DOI 10.1378/chest.119.6.1717; Plotkin SA, 2002, AM J MED, V112, P4, DOI 10.1016/S0002-9343(01)01050-6; PLOTKIN SA, 2002, AM J MED, V112, P2, DOI DOI 10.1016/S0002-9343(01)01050-6; Sackett D. L, 2000, EVIDENCE BASED MED T; SEVERN M, 1976, BRIT MED J, V1, P748, DOI 10.1136/bmj.1.6012.748; Shafazand S, 1999, CHEST, V116, P1369, DOI 10.1378/chest.116.5.1369; SUFFIN SC, 1978, HUM PATHOL, V9, P594, DOI 10.1016/S0046-8177(78)80140-3; Swartz MN, 2001, NEW ENGL J MED, V345, P1621, DOI 10.1056/NEJMra012892; van Elden LJR, 2001, BRIT J GEN PRACT, V51, P630; VESSAL K, 1975, CLIN RADIOL, V26, P471, DOI 10.1016/S0009-9260(75)80100-0; Vlahov D, 2002, J URBAN HEALTH, V79, P2, DOI 10.1093/jurban/79.1.2; Yang Q K, 1979, Zhonghua Fang She Xue Za Zhi, V13, P242; Zambon M, 2001, ARCH INTERN MED, V161, P2116, DOI 10.1001/archinte.161.17.2116; 2001, MMWR MORB MORTAL WKL, V50, P1077; 2001, MMWR MORB MORTAL WKL, V50, P893; 2001, MMWR MORB MORTAL WKL, V50, P984; 1928, N ENGL J MED, V198, P148	56	33	33	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 2	2003	139	5	1				337	345		10.7326/0003-4819-139-5_Part_1-200309020-00009	http://dx.doi.org/10.7326/0003-4819-139-5_Part_1-200309020-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	716PL	12965942				2022-12-01	WOS:000185037500004
J	Katou, Y; Kanoh, Y; Bando, M; Noguchi, H; Tanaka, H; Ashikari, T; Sugimoto, K; Shirahige, K				Katou, Y; Kanoh, Y; Bando, M; Noguchi, H; Tanaka, H; Ashikari, T; Sugimoto, K; Shirahige, K			S-phase checkpoint proteins Tof1 and Mrc1 form a stable replication-pausing complex	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-DAMAGE; CHROMOSOME-VI; PROGRESSION; GENOME; YEAST; TRANSCRIPTION; LOCATION; ORIGINS; KINASE	The checkpoint regulatory mechanism has an important role in maintaining the integrity of the genome(1-5). This is particularly important in S phase of the cell cycle, when genomic DNA is most susceptible to various environmental hazards(3,6,7). When chemical agents damage DNA, activation of checkpoint signalling pathways results in a temporary cessation of DNA replication. A replication-pausing complex is believed to be created at the arrested forks to activate further checkpoint cascades, leading to repair of the damaged DNA. Thus, checkpoint factors are thought to act not only to arrest replication but also to maintain a stable replication complex at replication forks(6-9). However, the molecular mechanism coupling checkpoint regulation and replication arrest is unknown. Here we demonstrate that the checkpoint regulatory proteins Tof1 and Mrc1 interact directly with the DNA replication machinery in Saccharomyces cerevisiae. When hydroxyurea blocks chromosomal replication, this assembly forms a stable pausing structure that serves to anchor subsequent DNA repair events.	Yokohama City Univ, RIKEN, Genom Sci Ctr,Human Genome Res Grp, Genome Struct & Funct Team, Kanagawa 2300045, Japan; Yokohama City Univ, Grad Sch Integrated Sci, Tsurumi Ku, Kanagawa 2300045, Japan; Yokohama City Univ, Kihara Inst Biol Res, Div Biochem, Totsuka Ku, Kanagawa 2440813, Japan; Yokohama City Univ, Grad Sch Integrated Sci, Totsuka Ku, Kanagawa 2440813, Japan; Suntory Ltd, Inst Adv Technol, Shimamoto, Osaka 6188503, Japan; Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4640814, Japan	RIKEN; Yokohama City University; Yokohama City University; Yokohama City University; Yokohama City University; Suntory Holdings Ltd; Nagoya University	Shirahige, K (corresponding author), Yokohama City Univ, RIKEN, Genom Sci Ctr,Human Genome Res Grp, Genome Struct & Funct Team, 1-7-22 Suehiro Cho, Kanagawa 2300045, Japan.			Shirahige, Katsuhiko/0000-0002-7862-1144				Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Cimbora DM, 2000, MOL CELL BIOL, V20, P5581, DOI 10.1128/MCB.20.15.5581-5591.2000; De Antoni A, 2000, GENE, V246, P179, DOI 10.1016/S0378-1119(00)00083-4; Foss EJ, 2001, GENETICS, V157, P567; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Kondo T, 2001, SCIENCE, V294, P867, DOI 10.1126/science.1063827; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lengronne A, 2001, NUCLEIC ACIDS RES, V29, P1433, DOI 10.1093/nar/29.7.1433; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Melo JA, 2001, GENE DEV, V15, P2809; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Schubeler D, 2002, NAT GENET, V32, P438, DOI 10.1038/ng1005; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; SHIRAHIGE K, 1993, MOL CELL BIOL, V13, P5043, DOI 10.1128/MCB.13.8.5043; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Yamashita M, 1997, GENES CELLS, V2, P655, DOI 10.1046/j.1365-2443.1997.1530351.x; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	26	531	546	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2003	424	6952					1078	1083		10.1038/nature01900	http://dx.doi.org/10.1038/nature01900			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715QR	12944972				2022-12-01	WOS:000184984200049
J	Egan, ES; Waldor, MK				Egan, ES; Waldor, MK			Distinct replication requirements for the two vibrio cholerae chromosomes	CELL			English	Article							ESCHERICHIA-COLI CHROMOSOME; PLASMID DNA-REPLICATION; DAM METHYLTRANSFERASE; PROTEIN; ORIGIN; INITIATION; BACTERIAL; SEQUENCE; BINDING; GENOME	Studies of prokaryotic chromosome replication have focused almost exclusively on organisms with one chromosome. We defined and characterized the origins of replication of the two Vibrio cholerae chromosomes, oriCI(vc), and oriCII(vc). OriCII(vc) differs from the origin assigned by bioinformatic analysis and is unrelated to oriCI(vc). OriCII(vc)-based replication requires an internal 12 base pair repeat and two hypothetical genes that flank oriCII(vc). One of these genes is conserved among diverse genera of the family Vibrionaceae and encodes an origin binding protein. The other gene codes for an RNA and not a protein. OriCII(vc)- but not oriCI(vc)-based replication is negatively regulated by a DNA sequence adjacent to oriCII(vc). There is an unprecedented requirement for DNA adenine methyltransferase in both oriCI(vc)- and oriCII(vc)-based replication. Our studies of replication in V. cholerae indicate that microorganisms having multiple chromosomes may utilize unique mechanisms for the control of replication.	Tufts Univ, Sch Med, Dept Microbiol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Genet, Boston, MA 02111 USA; Howard Hughes Med Inst, Boston, MA 02111 USA	Tufts University; Tufts University; Tufts University; Howard Hughes Medical Institute	Waldor, MK (corresponding author), Tufts Univ, Sch Med, Dept Microbiol, 136 Harrison Ave, Boston, MA 02111 USA.			Waldor, Matthew/0000-0003-1843-7000	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042347, R37AI042347] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-42347] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABELES A, 1993, J BACTERIOL, V175, P7801, DOI 10.1128/JB.175.24.7801-7807.1993; BOYE E, 1990, CELL, V62, P981, DOI 10.1016/0092-8674(90)90272-G; Boye E, 2000, EMBO REP, V1, P479, DOI 10.1093/embo-reports/kvd116; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Cabezon E, 1997, MOL GEN GENET, V254, P400, DOI 10.1007/s004380050432; CAMPBELL JL, 1990, CELL, V62, P967, DOI 10.1016/0092-8674(90)90271-F; Chattoraj DK, 2000, MOL MICROBIOL, V37, P467, DOI 10.1046/j.1365-2958.2000.01986.x; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; DelVecchio VG, 2002, P NATL ACAD SCI USA, V99, P443, DOI 10.1073/pnas.221575398; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; Guo FB, 2003, NUCLEIC ACIDS RES, V31, P1780, DOI 10.1093/nar/gkg254; HANSEN EB, 1986, P NATL ACAD SCI USA, V83, P4423, DOI 10.1073/pnas.83.12.4423; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; JENSEN MR, 1990, J MOL BIOL, V215, P257, DOI 10.1016/S0022-2836(05)80344-4; Julio SM, 2001, INFECT IMMUN, V69, P7610, DOI 10.1128/IAI.69.12.7610-7615.2001; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; Kitagawa R, 1996, MOL MICROBIOL, V19, P1137, DOI 10.1046/j.1365-2958.1996.453983.x; KITATSUKAMOTO K, 1993, INT J SYST BACTERIOL, V43, P8, DOI 10.1099/00207713-43-1-8; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; LESSL M, 1992, J BACTERIOL, V174, P2493, DOI 10.1128/jb.174.8.2493-2500.1992; LobnerOlesen A, 1996, EMBO J, V15, P5999; LOBNEROLESEN A, 1992, MOL MICROBIOL, V6, P1841, DOI 10.1111/j.1365-2958.1992.tb01356.x; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; Marinus M.G., 1996, E COLI SALMONELLA CE, P782; MARSZALEK J, 1994, J BIOL CHEM, V269, P4883; Messer W., 1996, ESCHERICHIA COLI SAL, V2nd ed., P1579; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Moyer KE, 2001, MOL MICROBIOL, V41, P311, DOI 10.1046/j.1365-2958.2001.02517.x; NOVICK RP, 1987, MICROBIOL REV, V51, P381, DOI 10.1128/MMBR.51.4.381-395.1987; PAPP PP, 1994, J BIOL CHEM, V269, P23563; PEARSON GDN, 1993, P NATL ACAD SCI USA, V90, P3750, DOI 10.1073/pnas.90.8.3750; RUSSELL DW, 1987, CELL, V50, P1071, DOI 10.1016/0092-8674(87)90173-5; Slominska M, 2001, MOL MICROBIOL, V40, P1371, DOI 10.1046/j.1365-2958.2001.02480.x; Trucksis M, 1998, P NATL ACAD SCI USA, V95, P14464, DOI 10.1073/pnas.95.24.14464; Weitao T, 2000, EMBO REP, V1, P494; Yamaichi Y, 1999, MOL MICROBIOL, V31, P1513, DOI 10.1046/j.1365-2958.1999.01296.x; ZYSKIND JW, 1983, P NATL ACAD SCI-BIOL, V80, P1164, DOI 10.1073/pnas.80.5.1164	37	135	140	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 22	2003	114	4					521	530		10.1016/S0092-8674(03)00611-1	http://dx.doi.org/10.1016/S0092-8674(03)00611-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	714TD	12941279	Bronze			2022-12-01	WOS:000184928800014
J	Thibert, C; Teillet, MA; Lapointe, F; Mazelin, L; Le Douarin, NM; Mehlen, P				Thibert, C; Teillet, MA; Lapointe, F; Mazelin, L; Le Douarin, NM; Mehlen, P			Inhibition of neuroepithelial patched-induced apoptosis by Sonic hedgehog	SCIENCE			English	Article							RECEPTORS UNC5H; NEURAL-TUBE; MECHANISM; SURVIVAL; DCC; SPECIFICATION; DEPENDENCE; DEFINES; CHICK; ACTS	During early development in vertebrates, Sonic hedgehog (Shh) is produced by the notochord and the floor plate. A ventrodorsal gradient of Shh directs ventrodorsal patterning of the neural tube. However, Shh is also required for the survival of neuroepithelial cells. We show that Patched (Ptc) induces apoptotic cell death unless its ligand Shh is present to block the signal. Moreover, the blockade of Ptc-induced cell death partly rescues the chick spinal cord defect provoked by Shh deprivation. Thus, the proapoptotic activity of unbound Ptc and the positive effect of Shh-bound Ptc on cell differentiation probably cooperate to achieve the appropriate spinal cord development.	Univ Lyon 1, CNRS, UMR 5534,Mol & Cellular Genet Ctr, Apoptosis Differentiat Lab, F-69622 Villeurbanne, France; CNRS, UMR 7128, Lab Embryol Cellulaire & Mol, F-94736 Nogent Sur Marne, France; Int Agcy Res Canc, F-69008 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); World Health Organization; International Agency for Research on Cancer (IARC)	Mehlen, P (corresponding author), Univ Lyon 1, CNRS, UMR 5534,Mol & Cellular Genet Ctr, Apoptosis Differentiat Lab, F-69622 Villeurbanne, France.	mehlen@univ-lyon1.fr	Mazelin, Laetitia/AAD-9319-2020; THIBERT, Chantal/N-1828-2013; Thibert, Chantal/D-4367-2019	Mazelin, Laetitia/0000-0002-4001-2132; Thibert, Chantal/0000-0002-1516-5671				Aoto K, 2002, DEV BIOL, V251, P320, DOI 10.1006/dbio.2002.0811; Barnes EA, 2001, EMBO J, V20, P2214, DOI 10.1093/emboj/20.9.2214; Bordeaux MC, 2000, EMBO J, V19, P4056, DOI 10.1093/emboj/19.15.4056; Bredesen DE, 1998, CELL DEATH DIFFER, V5, P365, DOI 10.1038/sj.cdd.4400378; Britto J, 2002, NAT NEUROSCI, V5, P103, DOI 10.1038/nn797; Charrier JB, 1999, DEVELOPMENT, V126, P4771; Charrier JB, 2001, DEVELOPMENT, V128, P4011; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Forcet C, 2001, P NATL ACAD SCI USA, V98, P3416, DOI 10.1073/pnas.051378298; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Koike C, 2002, ONCOGENE, V21, P2670, DOI 10.1038/sj.onc.1205370; Le Douarin NM, 2000, CURR OPIN NEUROBIOL, V10, P23, DOI 10.1016/S0959-4388(99)00062-8; Le Douarin NM, 1998, INT J DEV BIOL, V42, P909; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Miao NN, 1997, J NEUROSCI, V17, P5891; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tanikawa C, 2003, NAT CELL BIOL, V5, P216, DOI 10.1038/ncb943; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thiebault K, 2003, P NATL ACAD SCI USA, V100, P4173, DOI 10.1073/pnas.0738063100; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Wicking C, 2001, CANCER LETT, V173, P1, DOI 10.1016/S0304-3835(01)00676-0; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916	29	250	260	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2003	301	5634					843	846		10.1126/science.1085405	http://dx.doi.org/10.1126/science.1085405			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907805				2022-12-01	WOS:000184615700048
J	Kuiken, T; Fouchier, RAM; Schutten, M; Rimmelzwaan, GF; van Amerongen, G; van Riel, D; Laman, JD; de Jong, T; van Doornum, G; Lim, W; Ling, AE; Chan, PKS; Tam, JS; Zambon, MC; Gopal, R; Drosten, C; van der Werf, S; Escriou, N; Manuguerra, JC; Stohr, K; Peiris, JSM; Osterhaus, ADME				Kuiken, T; Fouchier, RAM; Schutten, M; Rimmelzwaan, GF; van Amerongen, G; van Riel, D; Laman, JD; de Jong, T; van Doornum, G; Lim, W; Ling, AE; Chan, PKS; Tam, JS; Zambon, MC; Gopal, R; Drosten, C; van der Werf, S; Escriou, N; Manuguerra, JC; Stohr, K; Peiris, JSM; Osterhaus, ADME			Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome	LANCET			English	Article							POLYMERASE-CHAIN-REACTION; HONG-KONG; EXPERIMENTAL-INFECTION; IDENTIFICATION; PATHOGENICITY; CHILDREN; OUTBREAK; DISEASE; GENE; PCR	Background The worldwide outbreak. of severe acute respiratory syndrome (SARS) is associated with a newly discovered coronavirus, SARS-associated coronavirus (SARS-CoV). We did clinical and experimental studies to assess the role of this virus in the cause of SARS. Methods We tested clinical and postmortem samples from 436 SARS patients in six countries for infection with SARS-CoV, human metapneumovirus, and other respiratory pathogens. We infected four cynomolgus macaques (Macaca fascicularis) with SARS-CoV in an attempt to replicate SARS and did necropsies on day 6 after infection. Findings SARS-CoV infection was diagnosed in 329 (75%) of 436 patients fitting the case definition of SARS; human metapneumovirus was diagnosed in 41 (12%) of 335, and other respiratory pathogens were diagnosed only sporadically. SARS-CoV was, therefore, the most likely causal agent of SARS. The four SARS-CoV-infected macaques excreted SARS-CoV from nose, mouth, and pharynx from 2 days after infection. Three of four macaques developed diffuse alveolar damage, similar to that in SARS patients, and characterised by epithelial necrosis, serosanguineous exudate, formation of hyaline membranes, type 2 pneumocyte hyperplasia, and the presence of syncytia. SARS-CoV was detected in pneumonic areas by virus isolation and RT-PCR, and was localised to alveolar epithelial cells and syncytia by immunohistochemistry and transmission electron microscopy. Interpretation Replication in SARS-CoV-infected macaques of pneumonia similar to that in human beings with SARS, combined with the high prevalence of SARS-CoV infection in SARS patients, fulfill the criteria required to prove that SARS-CoV is the primary cause of SARS.	Erasmus Med Ctr, Dept Virol, NL-3000 DR Rotterdam, Netherlands; Erasmus Med Ctr, Dept Immunol, NL-3000 DR Rotterdam, Netherlands; Erasmus Med Ctr, Dept Pathol, NL-3000 DR Rotterdam, Netherlands; Publ Hlth Lab Ctr, Govt Virus Unit, Kowloon, Hong Kong, Peoples R China; Singapore Gen Hosp, Dept Pathol, Singapore 0316, Singapore; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Hlth Protect Agcy, Enter Resp & Neurol Virus Lab, London, England; Bernhard Nocht Inst Trop Med, Dept Virol, Hamburg, Germany; Inst Pasteur, Unite Genet Mol Virus Resp, Paris, France; WHO, SARS Aetiol Study Grp, CH-1211 Geneva, Switzerland; Univ Hong Kong, Queen Mary Hosp, Dept Microbiol & Med, Hong Kong, Hong Kong, Peoples R China	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Singapore General Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Health Protection Agency; Bernhard Nocht Institut fur Tropenmedizin; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; World Health Organization; University of Hong Kong	Kuiken, T (corresponding author), Erasmus Med Ctr, Dept Virol, POB 1738, NL-3000 DR Rotterdam, Netherlands.	t.kuiken@erasmusmc.nl	Escriou, Nicolas/A-2392-2016; Fouchier, Ron A/A-1911-2014; Chan, Paul KS/J-9360-2013	Escriou, Nicolas/0000-0002-1224-6839; Fouchier, Ron A/0000-0001-8095-2869; Chan, Paul KS/0000-0002-6360-4608; Osterhaus, Albert/0000-0002-6074-1172; van der WERF, Sylvie/0000-0002-1148-4456; van Riel, Debby/0000-0001-9753-3564				BHATT PN, 1977, ARCH VIROL, V54, P345, DOI 10.1007/BF01314779; CHAN PKS, IN PRESS EMERG INFEC; CLAAS HC, 1990, EUR J CLIN MICROBIOL, V9, P864, DOI 10.1007/BF01967500; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; DUNGWORTH DL, 1993, PATHOLOGY DOMESTIC A, V2, P539; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; JABRANE A, 1994, CAN VET J, V35, P86; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; LAI MMC, 1999, FIELDS VIROLOGY, P1163; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; MAHY BWJ, 1997, DICT VIROLOGY; Myers J.L., 1993, PULMONARY PATHOLOGY, P57; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; OTOOLE D, 1989, RES VET SCI, V47, P23, DOI 10.1016/S0034-5288(18)31226-8; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Peiris JSM, 2003, EMERG INFECT DIS, V9, P628; Peret TCT, 2002, J INFECT DIS, V185, P1660, DOI 10.1086/340518; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Reischl U, 2003, EUR J CLIN MICROBIOL, V22, P54, DOI 10.1007/s10096-002-0858-2; SCHNEIDERSCHAUL.S, 2002, EXPERT REV MOL MED; Stephensen CB, 1999, VIRUS RES, V60, P181, DOI 10.1016/S0168-1702(99)00017-9; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; *WHO, 2003, WKLY EPIDEMIOL REC, V78, P81; PCR PRIMERS SARS DEV; CUMULATIVE NUMBER RE; PNEUMONIA CHINA GUAN	29	755	818	9	121	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					263	270		10.1016/S0140-6736(03)13967-0	http://dx.doi.org/10.1016/S0140-6736(03)13967-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892955	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000184413400007
J	Howitz, KT; Bitterman, KJ; Cohen, HY; Lamming, DW; Lavu, S; Wood, JG; Zipkin, RE; Chung, P; Kisielewski, A; Zhang, LL; Scherer, B; Sinclair, DA				Howitz, KT; Bitterman, KJ; Cohen, HY; Lamming, DW; Lavu, S; Wood, JG; Zipkin, RE; Chung, P; Kisielewski, A; Zhang, LL; Scherer, B; Sinclair, DA			Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan	NATURE			English	Article							CALORIE RESTRICTION; TRANS-RESVERATROL; PROTEIN SIR2; YEAST SIR2; NAD; LONGEVITY; P53; DEACETYLASES; NICOTINAMIDE; INHIBITION	In diverse organisms, calorie restriction slows the pace of ageing and increases maximum lifespan. In the budding yeast Saccharomyces cerevisiae, calorie restriction extends lifespan by increasing the activity of Sir2 (ref. 1), a member of the conserved sirtuin family of NAD(+)-dependent protein deacetylases(2-6). Included in this family are SIR-2.1, a Caenorhabditis elegans enzyme that regulates lifespan(7), and SIRT1, a human deacetylase that promotes cell survival by negatively regulating the p53 tumour suppressor(8-10). Here we report the discovery of three classes of small molecules that activate sirtuins. We show that the potent activator resveratrol, a polyphenol found in red wine, lowers the Michaelis constant of SIRT1 for both the acetylated substrate and NAD(+), and increases cell survival by stimulating SIRT1-dependent deacetylation of p53. In yeast, resveratrol mimics calorie restriction by stimulating Sir2, increasing DNA stability and extending lifespan by 70%. We discuss possible evolutionary origins of this phenomenon and suggest new lines of research into the therapeutic use of sirtuin activators.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; BIOMOL Res Labs Inc, Plymouth Meeting, PA 19462 USA	Harvard University; Harvard Medical School	Sinclair, DA (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.		Lamming, Dudley/O-7191-2015	Lamming, Dudley/0000-0002-0079-4467; Cohen, Haim Y./0000-0002-6613-8710; Sinclair, David/0000-0002-9936-436X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG028730, R01AG028730, R01AG019719, R01AG019972, P01AG027916, R13AG033466] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG019972, R01 AG019719, P01 AG027916, R13 AG033466, R37 AG028730, R01 AG028730] Funding Source: Medline; NIGMS NIH HHS [R01 GM068072] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Dong ZG, 2003, MUTAT RES-FUND MOL M, V523, P145, DOI 10.1016/S0027-5107(02)00330-5; Ferguson LR, 2001, MUTAT RES-FUND MOL M, V475, P89, DOI 10.1016/S0027-5107(01)00073-2; GLOSSMANN H, 1981, N-S ARCH PHARMACOL, V317, P100, DOI 10.1007/BF00506266; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jazwinski SM, 2000, ANN NY ACAD SCI, V908, P21; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Middleton E, 2000, PHARMACOL REV, V52, P673; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nicolini G, 2001, NEUROSCI LETT, V302, P41, DOI 10.1016/S0304-3940(01)01654-8; OLIVER JM, 1994, J BIOL CHEM, V269, P29697; Pandey R, 2002, NUCLEIC ACIDS RES, V30, P5036, DOI 10.1093/nar/gkf660; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sinclair DA, 2002, MECH AGEING DEV, V123, P857, DOI 10.1016/S0047-6374(02)00023-4; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Soleas GJ, 1997, CLIN BIOCHEM, V30, P91, DOI 10.1016/S0009-9120(96)00155-5; Stojanovic S, 2001, ARCH BIOCHEM BIOPHYS, V391, P79, DOI 10.1006/abbi.2001.2388; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X	30	2888	3073	18	505	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 11	2003	425	6954					191	196		10.1038/nature01960	http://dx.doi.org/10.1038/nature01960			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719ZT	12939617				2022-12-01	WOS:000185236000046
J	Fujii, N; Graybiel, AM				Fujii, N; Graybiel, AM			Representation of action sequence boundaries by macaque prefrontal cortical neurons	SCIENCE			English	Article							BASAL GANGLIA; CORTEX; MOVEMENTS; SACCADES; MODEL	Complex biological systems such as human language and the genetic code are characterized by explicit markers at the beginning and end of functional sequences. We report here that macaque prefrontal cortical neurons exhibit phasic peaks of spike activity that occur at the beginning and endpoint of sequential oculomotor saccade performance and have the properties of dynamic start- and end-state encoders accompanying responses to sequential actions. Sequence bounding may thus reflect a general mechanism for encoding biological information.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Graybiel, AM (corresponding author), MIT, Dept Brain & Cognit Sci, 45 Carleton St,E25-618, Cambridge, MA 02139 USA.			Graybiel, Ann/0000-0002-4326-7720	NATIONAL EYE INSTITUTE [R01EY012848] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY012848, EY12848] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Averbeck BB, 2002, P NATL ACAD SCI USA, V99, P13172, DOI 10.1073/pnas.162485599; Bair W, 2002, J NEUROSCI, V22, P3189, DOI 10.1523/JNEUROSCI.22-08-03189.2002; Beiser DG, 1998, J NEUROPHYSIOL, V79, P3168, DOI 10.1152/jn.1998.79.6.3168; Bor D, 2003, NEURON, V37, P361, DOI 10.1016/S0896-6273(02)01171-6; Braitenberg V, 1997, BEHAV BRAIN SCI, V20, P229, DOI 10.1017/S0140525X9700143X; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Curran T., 1995, PSYCHE, V2, P12; Dehaene S, 1997, P NATL ACAD SCI USA, V94, P13293, DOI 10.1073/pnas.94.24.13293; Dreher JC, 2002, EUR J NEUROSCI, V16, P1609, DOI 10.1046/j.1460-9568.2002.02212.x; Duffy CJ, 1997, EXP BRAIN RES, V114, P472, DOI 10.1007/PL00005656; FUJII N, 2001, SOC NEUR ABSTR, V27; Fuster J. M., 1999, MEMORY CEREBRAL CORT; Grafton ST, 1998, J NEUROSCI, V18, P9420; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; KROGH A, 1994, NUCLEIC ACIDS RES, V22, P4768, DOI 10.1093/nar/22.22.4768; Lashley K. S., 1951, CEREBRAL MECH BEHAV; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; MAKHOUL J, 1995, P NATL ACAD SCI USA, V92, P9956, DOI 10.1073/pnas.92.22.9956; Miller EK, 2002, PHILOS T R SOC B, V357, P1123, DOI 10.1098/rstb.2002.1099; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/0033-295X.101.2.343; Schall JD, 2002, PHILOS T ROY SOC B, V357, P1073, DOI 10.1098/rstb.2002.1098; Sipser M., 2012, INTRO THEORY COMPUTA; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Toni I, 1998, NEUROIMAGE, V8, P50, DOI 10.1006/nimg.1998.0349; Ward G, 1997, Q J EXP PSYCHOL-A, V50, P49, DOI 10.1080/027249897392224; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Zacks JM, 2001, NAT NEUROSCI, V4, P651, DOI 10.1038/88486	27	133	135	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 29	2003	301	5637					1246	1249		10.1126/science.1086872	http://dx.doi.org/10.1126/science.1086872			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZC	12947203				2022-12-01	WOS:000185003500046
J	Saunders, A; Werner, J; Andrulis, ED; Nakayama, T; Hirose, S; Reinberg, D; Lis, JT				Saunders, A; Werner, J; Andrulis, ED; Nakayama, T; Hirose, S; Reinberg, D; Lis, JT			Tracking FACT and the RNA polymerase II elongation complex through chromatin in vivo	SCIENCE			English	Article							HEAT-SHOCK GENES; TRANSCRIPTION ELONGATION; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; REMODELING PROTEIN; DNASE-I; SPT5; NUCLEOSOME; PROMOTER; LOCALIZATION	RNA polymerase II (Pol II) transcription through nucleosomes is facilitated in vitro by the protein complex FACT (Facilitates Chromatin Transcription). Here we show that FACT is associated with actively transcribed Pol II genes on Drosophila polytene chromosomes. FACT displays kinetics of recruitment and of chromosome tracking in vivo similar to Pol II and elongation factors Spt5 and Spt6. Interestingly, FACT does not colocalize with Pol III-transcribed genes, which are known to undergo nucleosome transfer rather than disassembly in vitro. Our observations are consistent with FACT being restricted to transcription that involves nucleosome disassembly mechanisms.	Cornell Univ, Ithaca, NY 14850 USA; Natl Inst Genet, Dept Dev Genet, Mishima, Shizuoka 4118540, Japan; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Howard Hughes Med Inst, Piscataway, NJ 08854 USA	Cornell University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center	Lis, JT (corresponding author), Cornell Univ, Biotechnol Bldg, Ithaca, NY 14850 USA.	jtl10@cornell.edu	Hirose, Susumu/I-8865-2019	Reinberg, Danny/0000-0003-4288-2016	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025232, R37GM025232] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM25232] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adelman K, 2002, MOL CELL, V9, P451, DOI 10.1016/S1097-2765(02)00487-2; Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Armstrong JA, 2002, EMBO J, V21, P5245, DOI 10.1093/emboj/cdf517; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; BOEHM AK, IN PRESS MOL CELL BI; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; COSTLOW N, 1984, MOL CELL BIOL, V4, P1853, DOI 10.1128/MCB.4.9.1853; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Formosa T, 2003, CURR TOP MICROBIOL, V274, P171; Formosa T, 2002, GENETICS, V162, P1557; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; Kaplan CD, 2000, GENE DEV, V14, P2623, DOI 10.1101/gad.831900; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; LIS JT, 1983, CELL, V35, P403, DOI 10.1016/0092-8674(83)90173-3; OBRIEN T, 1993, MOL CELL BIOL, V13, P3456, DOI 10.1128/MCB.13.6.3456; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Pei Y, 2002, J BIOL CHEM, V277, P19639, DOI 10.1074/jbc.M200015200; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; SCHWARTZ BE, IN PRESS METHODS ENZ; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; SIMON JA, 1985, CHROMOSOMA, V93, P26, DOI 10.1007/BF01259442; Studitsky VM, 1997, SCIENCE, V278, P1960, DOI 10.1126/science.278.5345.1960; Takada S, 2000, CELL, V101, P459, DOI 10.1016/S0092-8674(00)80857-0; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; Wen YX, 1999, GENE DEV, V13, P1774, DOI 10.1101/gad.13.14.1774; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403	32	225	234	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2003	301	5636					1094	1096		10.1126/science.1085712	http://dx.doi.org/10.1126/science.1085712			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713RP	12934007				2022-12-01	WOS:000184872400039
J	Xie, ZG; Sanada, K; Samuels, BA; Shih, H; Tsai, LH				Xie, ZG; Sanada, K; Samuels, BA; Shih, H; Tsai, LH			Serine 732 phosphorylation of FAK by Cdk5 is important for microtubule organization, nuclear movement, and neuronal migration	CELL			English	Article							FOCAL ADHESION KINASE; CENTRAL-NERVOUS-SYSTEM; ASPERGILLUS-NIDULANS; CYTOPLASMIC DYNEIN; TYROSINE KINASE; GENE-TRANSFER; CEREBRAL-CORTEX; P35/CDK5 KINASE; MICE LACKING; BRAIN	The serine/threonine kinase Cdk5 plays an essential role in neuronal positioning during corticogenesis, but the underlying mechanisms are unknown. In nonneuronal cells, the tyrosine kinase FAK is a major regulator of cell motility through focal adhesions. It is unclear whether FAK plays a role in brain development. Here, we show that FAK phosphorylation by Cdk5 at S732 is important for microtubule organization, nuclear movement, and neuronal migration. In cultured neurons, S732-phosphorylated FAK is enriched along a centrosome-associated microtubule fork that abuts the nucleus. Overexpression of the nonphosphorylatable mutant FAK S732A results in disorganization of the microtubule fork and impairment of nuclear movement in vitro, and neuronal positioning defects in vivo. These observations are reminiscent of what is seen in the Cdk5-deficient mice. Taken together, these results suggest that Cdk5 phosphorylation of FAK is critical for neuronal migration through regulation of a microtubule fork important for nuclear translocation.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Program Neurosci, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Howard Hughes Medical Institute	Tsai, LH (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.		SANADA, YOSHIKADO/G-5014-2014	Sanada, Kamon/0000-0002-0280-8957; Xie, Zhigang/0000-0002-7190-992X	NINDS NIH HHS [NS37007] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037007] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams NC, 2002, DEVELOPMENT, V129, P965; ANDRE E, 1993, BIOCHEM BIOPH RES CO, V190, P140, DOI 10.1006/bbrc.1993.1022; Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Beckwith SM, 1998, J CELL BIOL, V143, P1239, DOI 10.1083/jcb.143.5.1239; Bornens M, 1999, METHOD CELL BIOL, V61, P13; BURGAYA F, 1995, EUR J NEUROSCI, V7, P1810, DOI 10.1111/j.1460-9568.1995.tb00700.x; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Contestabile A, 2003, INT J DEV NEUROSCI, V21, P83, DOI 10.1016/S0736-5748(02)00126-0; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; de Rouvroit CL, 2001, MECH DEVELOP, V105, P47, DOI 10.1016/S0925-4773(01)00396-3; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; GRANT SGN, 1995, GENE DEV, V9, P1909, DOI 10.1101/gad.9.15.1909; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Kesavapany S, 2001, EUR J NEUROSCI, V13, P241, DOI 10.1046/j.1460-9568.2001.01376.x; Keshvara L, 2002, J NEUROSCI, V22, P4869, DOI 10.1523/JNEUROSCI.22-12-04869.2002; Ko J, 2001, J NEUROSCI, V21, P6758; Kwon YT, 2000, CURR BIOL, V10, P363, DOI 10.1016/S0960-9822(00)00411-5; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Morris NR, 1998, TRENDS CELL BIOL, V8, P467, DOI 10.1016/S0962-8924(98)01389-0; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Patzke H, 2003, J NEUROSCI, V23, P2769; Rashid T, 2001, J BIOL CHEM, V276, P49043, DOI 10.1074/jbc.M105599200; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Reiner O, 1998, INT J MOL MED, V1, P849; Reinsch S, 1998, J CELL SCI, V111, P2283; Renaudin A, 1999, J NEUROSCI RES, V55, P458, DOI 10.1002/(SICI)1097-4547(19990215)55:4<458::AID-JNR6>3.0.CO;2-D; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sapir T, 1997, EMBO J, V16, P6977, DOI 10.1093/emboj/16.23.6977; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Stevens GR, 1996, J NEUROSCI RES, V46, P445, DOI 10.1002/(SICI)1097-4547(19961115)46:4<445::AID-JNR6>3.3.CO;2-D; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Walsh CA, 2000, CURR OPIN GENET DEV, V10, P270, DOI 10.1016/S0959-437X(00)00076-9; Xiang X, 1999, CURR GENET, V35, P626, DOI 10.1007/s002940050461; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297; XIANG X, 1994, P NATL ACAD SCI USA, V91, P2100, DOI 10.1073/pnas.91.6.2100; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417	62	241	251	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 22	2003	114	4					469	482		10.1016/S0092-8674(03)00605-6	http://dx.doi.org/10.1016/S0092-8674(03)00605-6			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	714TD	12941275	Bronze			2022-12-01	WOS:000184928800010
J	Choi, CH; Hiromura, M; Usheva, A				Choi, CH; Hiromura, M; Usheva, A			Transcription factor IIB acetylates itself to regulate transcription	NATURE			English	Article							RNA-POLYMERASE-II; PROTEIN; BINDING; AUTOACYLATION; ACYLATION; TFIIB	Acetylation is a well-known regulatory post-translational modification(1), but a biological function for acetylation in regulating basal transcription factors has not been reported. Here we show that the general transcription factor TFIIB, which is required for the initiation of eukaryotic polymerase II transcription(2), is acetylated. TFIIB is also an autoacetyltransferase, although it shares no sequence homology with any known acetyltransferases. In the absence of other enzymes, it binds acetyl-coenzyme A (acetyl-CoA), and catalyses the transfer of the acetyl group onto a specific lysine residue (K238). Both recombinant and cellular TFIIB can autoacetylate, markedly stabilizing the interaction between TFIIB and transcription factor TFIIF and activating transcription in vitro and in cells. A K238A mutant, which cannot be autoacetylated, does not show this activation of transcription. Our findings suggest that there is a regulatory pathway controlling acetylation of TFIIB, and they link acetyl-CoA with basal gene transcription.	Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Endocrinol Div, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Usheva, A (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Endocrinol Div, 99 Brookline Ave, Boston, MA 02215 USA.							BAGBY S, 1995, CELL, V82, P857, DOI 10.1016/0092-8674(95)90483-2; BIZZOZERO OA, 1987, J BIOL CHEM, V262, P13550; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Duncan JA, 1996, J BIOL CHEM, V271, P23594, DOI 10.1074/jbc.271.38.23594; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fang SM, 1996, J BIOL CHEM, V271, P11703, DOI 10.1074/jbc.271.20.11703; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Luger K, 1999, METHOD ENZYMOL, V304, P3; MAYER RT, 1974, J CHROMATOGR, V90, P390, DOI 10.1016/S0021-9673(00)92549-4; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Usheva A, 1996, P NATL ACAD SCI USA, V93, P13571, DOI 10.1073/pnas.93.24.13571; Veit M, 1998, BBA-LIPID LIPID MET, V1394, P90, DOI 10.1016/S0005-2760(98)00097-6; YAMASHITA A, 1995, BIOCHEM J, V312, P301, DOI 10.1042/bj3120301; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849	18	41	41	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 21	2003	424	6951					965	969		10.1038/nature01899	http://dx.doi.org/10.1038/nature01899			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713EH	12931194				2022-12-01	WOS:000184843600047
J	Nishimura, MT; Stein, M; Hou, BH; Vogel, JP; Edwards, H; Somerville, SC				Nishimura, MT; Stein, M; Hou, BH; Vogel, JP; Edwards, H; Somerville, SC			Loss of a callose synthase results in salicylic acid-dependent disease resistance	SCIENCE			English	Article							PERONOSPORA-PARASITICA; DEFENSE RESPONSES; ARABIDOPSIS; MUTANT	Plants attacked by pathogens rapidly deposit callose, a beta-1,3-glucan, at wound sites. Traditionally, this deposition is thought to reinforce the cell wall and is regarded as a defense response. Surprisingly, here we found that powdery mildew resistant 4 (pmr4), a mutant lacking pathogen-induced callose, became resistant to pathogens, rather than more susceptible. This resistance was due to mutation of a callose synthase, resulting in a loss of the induced callose response. Double-mutant analysis indicated that blocking the salicylic acid ( SA) defense signaling pathway was sufficient to restore susceptibility to pmr4 mutants. Thus, callose or callose synthase negatively regulates the SA pathway.	Carnegie Inst, Dept Plant Biol, Stanford, CA 94305 USA; Western Illinois Univ, Dept Biol Sci, Macomb, IL 61455 USA	Carnegie Institution for Science; Western Illinois University	Somerville, SC (corresponding author), Carnegie Inst, Dept Plant Biol, Stanford, CA 94305 USA.		Vogel, John P/B-3176-2009; Bruening, Stefan/B-8505-2011	Vogel, John/0000-0003-1786-2689; Nishimura, Marc Tad/0000-0003-4666-6900; Stein, Monica/0000-0002-1926-4212				Aist J. R., 1991, The fungal spore and disease initiation in plants and animals., P321; AIST JR, 1976, ANNU REV PHYTOPATHOL, V14, P145, DOI 10.1146/annurev.py.14.090176.001045; Aviv DH, 2002, PLANT J, V29, P381, DOI 10.1046/j.0960-7412.2001.01225.x; Cano-Delgado A, 2003, PLANT J, V34, P351, DOI 10.1046/j.1365-313X.2003.01729.x; Donofrio NM, 2001, MOL PLANT MICROBE IN, V14, P439, DOI 10.1094/MPMI.2001.14.4.439; Ellis C, 2002, PLANT CELL, V14, P1557, DOI 10.1105/tpc.002022; GASPAR Y, COMMUNICATION; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; Keen NT, 2000, ANNU REV PHYTOPATHOL, V38, P31, DOI 10.1146/annurev.phyto.38.1.31; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Nickle TC, 1998, PLANT J, V15, P321, DOI 10.1046/j.1365-313X.1998.00212.x; Ostergaard L, 2002, PLANT MOL BIOL, V49, P559, DOI 10.1023/A:1015558231400; RAAB TK, COMMUNICATION; Rairdan GJ, 2001, MOL PLANT MICROBE IN, V14, P1235, DOI 10.1094/MPMI.2001.14.10.1235; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; STEIN MA, UNPUB; Stone BA, 1992, CHEM BIOL 1 3 BETA G; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vogel J, 2000, P NATL ACAD SCI USA, V97, P1897, DOI 10.1073/pnas.030531997; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Zhu YM, 2003, PLANT PHYSIOL, V132, P494, DOI 10.1104/pp.103.020420	21	486	512	1	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2003	301	5635					969	972		10.1126/science.1086716	http://dx.doi.org/10.1126/science.1086716			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711RY	12920300				2022-12-01	WOS:000184755900041
J	Chiti, F; Stefani, M; Taddei, N; Ramponi, G; Dobson, CM				Chiti, F; Stefani, M; Taddei, N; Ramponi, G; Dobson, CM			Rationalization of the effects of mutations on peptide and protein aggregation rates	NATURE			English	Article							X-RAY-DIFFRACTION; TAU-PROTEIN; MISFOLDING DISEASES; ALZHEIMERS-DISEASE; INCLUSION-BODIES; ALPHA-SYNUCLEIN; FTDP-17 MUTANTS; AMYLOID FIBRILS; PRION PROTEIN; POLYMERIZATION	In order for any biological system to function effectively, it is essential to avoid the inherent tendency of proteins to aggregate and form potentially harmful deposits(1-4). In each of the various pathological conditions associated with protein deposition, such as Alzheimer's and Parkinson's diseases, a specific peptide or protein that is normally soluble is deposited as insoluble aggregates generally referred to as amyloid(2,3). It is clear that the aggregation process is generally initiated from partially or completely unfolded forms of the peptides and proteins associated with each disease. Here we show that the intrinsic effects of specific mutations on the rates of aggregation of unfolded polypeptide chains can be correlated to a remarkable extent with changes in simple physicochemical properties such as hydrophobicity, secondary structure propensity and charge. This approach allows the pathogenic effects of mutations associated with known familial forms of protein deposition diseases to be rationalized, and more generally enables prediction of the effects of mutations on the aggregation propensity of any polypeptide chain.	Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; Univ Florence, Dipartimento Sci Biochim, I-50134 Florence, Italy	University of Cambridge; University of Florence	Dobson, CM (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.			STEFANI, MASSIMO/0000-0002-4490-1922; Taddei, Niccolo/0000-0003-2513-1018				Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Carrio MM, 2002, J BIOTECHNOL, V96, P3, DOI 10.1016/S0168-1656(02)00032-9; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2002, NATURE, V418, P729, DOI 10.1038/418729a; Esler WP, 1996, BIOCHEMISTRY-US, V35, P13914, DOI 10.1021/bi961302+; Gamblin TC, 2000, BIOCHEMISTRY-US, V39, P6136, DOI 10.1021/bi000201f; Gamblin TC, 2003, BIOCHEMISTRY-US, V42, P2252, DOI 10.1021/bi0272510; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Li L, 2002, J BIOL CHEM, V277, P41390, DOI 10.1074/jbc.M206334200; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; Miravalle L, 2000, J BIOL CHEM, V275, P27110; Nacharaju P, 1999, FEBS LETT, V447, P195, DOI 10.1016/S0014-5793(99)00294-X; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Orpiszewski J, 1999, J MOL BIOL, V289, P413, DOI 10.1006/jmbi.1999.2768; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Sakagashira S, 2000, AM J PATHOL, V157, P2101, DOI 10.1016/S0002-9440(10)64848-1; Salmona M, 1999, BIOCHEM J, V342, P207, DOI 10.1042/0264-6021:3420207; Street AG, 1999, P NATL ACAD SCI USA, V96, P9074, DOI 10.1073/pnas.96.16.9074; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Symmons MF, 1997, FEBS LETT, V412, P397, DOI 10.1016/S0014-5793(97)00809-0; Thompson AJ, 2001, BBA-PROTEIN STRUCT M, V1544, P242, DOI 10.1016/S0167-4838(00)00225-9; Van Nostrand WE, 2001, J BIOL CHEM, V276, P32860, DOI 10.1074/jbc.M104135200	30	882	904	0	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 14	2003	424	6950					805	808		10.1038/nature01891	http://dx.doi.org/10.1038/nature01891			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12917692				2022-12-01	WOS:000184733900047
J	Spiro, D				Spiro, D			A little bit longer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2003	290	6					716	716		10.1001/jama.290.6.716	http://dx.doi.org/10.1001/jama.290.6.716			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	709VU	12915408				2022-12-01	WOS:000184647700001
J	MacQueen, KM; Karim, QA; Sugarman, J				MacQueen, KM; Karim, QA; Sugarman, J		Ethics Working Grp HIV Prevention	Ethics guidance for HIV prevention trials	BRITISH MEDICAL JOURNAL			English	Article									Family Hlth Int, Res Triangle Pk, NC 27709 USA; Univ Natal, Ctr AIDS Program Res S Africa, ZA-4001 Durban, South Africa; Duke Univ, Ctr Study Med Eth & Humanities, Durham, NC USA	University of Kwazulu Natal; Duke University	MacQueen, KM (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.		Abdool Karim, Quarraisha/GVS-1160-2022	Abdool Karim, Quarraisha/0000-0002-0985-477X; Sugarman, Jeremy/0000-0001-7022-8332	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068619] Funding Source: NIH RePORTER; NIAID NIH HHS [UM1 AI068619] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*HIV PREV TRIALS N, ETH GUID RES; MacQueen Kathleen M, 2003, IRB, V25, P11, DOI 10.2307/3563635	2	6	6	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2003	327	7410					340	340		10.1136/bmj.327.7410.340	http://dx.doi.org/10.1136/bmj.327.7410.340			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	710JE	12907494	Green Published			2022-12-01	WOS:000184676400030
J	Hu, DL; Chan, B; Bush, JWM				Hu, DL; Chan, B; Bush, JWM			The hydrodynamics of water strider locomotion	NATURE			English	Article							GERRIS-REMIGIS; SURFACE; FLIGHT	Water striders Gerridae are insects of characteristic length 1 cm and weight 10 dynes that reside on the surface of ponds, rivers, and the open ocean(1-4). Their weight is supported by the surface tension force generated by curvature of the free surface(5,6), and they propel themselves by driving their central pair of hydrophobic legs in a sculling motion(7,8). Previous investigators have assumed that the hydrodynamic propulsion of the water strider relies on momentum transfer by surface waves(1,9,10). This assumption leads to Denny's paradox(11): infant water striders, whose legs are too slow to generate waves, should be incapable of propelling themselves along the surface. We here resolve this paradox through reporting the results of high-speed video and particle-tracking studies. Experiments reveal that the strider transfers momentum to the underlying fluid not primarily through capillary waves, but rather through hemispherical vortices shed by its driving legs. This insight guided us in constructing a self-contained mechanical water strider whose means of propulsion is analogous to that of its natural counterpart.	MIT, Dept Math, Cambridge, MA 02139 USA; MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bush, JWM (corresponding author), MIT, Dept Math, Cambridge, MA 02139 USA.							Andersen N.M., 1976, Videnskabelige Meddr dansk naturh Foren, V139, P337; Andersen N.M, 1982, SEMIAQUATIC BUGS HEM; Baudoin R, 1955, B BIOL FR BELG, V89, P16; BOWDAN E, 1978, J COMP PHYSIOL, V123, P43, DOI 10.1007/BF00657342; Brinkhurst R. O., 1960, Proceedings of the Zoological Society of London, V133, P531; Childress S., 1981, MECH SWIMMING FLYING; COBBEN RH, 1960, STUD FAUNA CURACAO, V11, P1; Darnhofer-Demar, 1969, ZOOL ANZ S, V32, P430; DEGENNES PG, 2002, GOUTTES BOULES PERLE; DENNY MW, 1993, AIR WATER BIOL PHYSI; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; ELLINGTON CP, 1990, NATURE, V347, P472, DOI 10.1038/347472a0; Glasheen JW, 1996, NATURE, V380, P340, DOI 10.1038/380340a0; Henry T. J., 1998, CATALOG HETEROPTERA; HUNGERFORD HB, 1960, KANS U SCI B, V41; Keller JB, 1998, PHYS FLUIDS, V10, P3009, DOI 10.1063/1.869820; Lamb, 1993, HYDRODYNAMICS; MATSUDA K, 1985, APPL OPTICS, V24, P4443, DOI 10.1364/AO.24.004443; MURPHEY RK, 1971, Z VERGL PHYSIOL, V72, P150, DOI 10.1007/BF00297819; RAYNER JMV, 1986, NATURE, V321, P162, DOI 10.1038/321162a0; SCHOOLEY AH, 1958, J MAR RES, V16, P100; SCRIVEN LE, 1960, NATURE, V187, P186, DOI 10.1038/187186a0; STARR VP, 1947, J MAR RES, V6, P175; Sun SM, 2001, PHYS FLUIDS, V13, P2146, DOI 10.1063/1.1384889; Suter RB, 1997, J EXP BIOL, V200, P2523; Suter RB, 1999, J EXP BIOL, V202, P2771; Tseng M, 1999, CAN J ZOOL, V77, P923, DOI 10.1139/cjz-77-6-923; Vogel S., 1994, LIFE MOVING FLUIDS; VOGEL S, 1988, LIFES DEVICES; WILCOX RS, 1979, SCIENCE, V206, P1325, DOI 10.1126/science.206.4424.1325	30	507	533	21	346	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					663	666		10.1038/nature01793	http://dx.doi.org/10.1038/nature01793			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904790				2022-12-01	WOS:000184578800042
J	Walther, TC; Askjaer, P; Gentzel, M; Habermann, A; Griffiths, G; Wilm, M; Mattaj, IW; Hetzer, M				Walther, TC; Askjaer, P; Gentzel, M; Habermann, A; Griffiths, G; Wilm, M; Mattaj, IW; Hetzer, M			RanGTP mediates nuclear pore complex assembly	NATURE			English	Article							IMPORTIN-BETA; GTPASE CYCLE; CHROMATIN; SUBCOMPLEX; PROTEINS; YEAST	In metazoa, the nuclear envelope breaks down and reforms during each cell cycle. Nuclear pore complexes (NPCs), which serve as channels for transport between the nucleus and cytoplasm(1), assemble into the reforming nuclear envelope in a sequential process involving association of a subset of NPC proteins, nucleoporins, with chromatin followed by the formation of a closed nuclear envelope fenestrated by NPCs2-7. How chromatin recruitment of nucleoporins and NPC assembly are regulated is unknown. Here we demonstrate that RanGTP production is required to dissociate nucleoporins Nup107, Nup153 and Nup358 from Importin beta, to target them to chromatin and to induce association between separate NPC subcomplexes. Additionally, either an excess of RanGTP or removal of Importin beta induces formation of NPC-containing membrane structures-annulate lamellae-both in vitro in the absence of chromatin and in vivo. Annulate lamellae formation is strongly and specifically inhibited by an excess of Importin beta. The data demonstrate that RanGTP triggers distinct steps of NPC assembly, and suggest a mechanism for the spatial restriction of NPC assembly to the surface of chromatin.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Mattaj, IW (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Askjaer, Peter/I-3316-2012	Askjaer, Peter/0000-0003-3192-4428; Mattaj, Iain/0000-0002-5537-8284; Habermann, Anja/0000-0003-3686-9050; Gentzel, Marc/0000-0002-4482-6010; Wilm, Matthias/0000-0002-5461-6834; Walther, Tobias/0000-0003-1442-1327				Askjaer P, 2002, MOL BIOL CELL, V13, P4355, DOI 10.1091/mbc.E02-06-0346; Bamba C, 2002, CURR BIOL, V12, P503, DOI 10.1016/S0960-9822(02)00741-8; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Bodoor K, 1999, J CELL SCI, V112, P2253; DABAUVALLE MC, 1991, J CELL BIOL, V112, P1073, DOI 10.1083/jcb.112.6.1073; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; DEMETER J, 1995, P NATL ACAD SCI USA, V92, P1436, DOI 10.1073/pnas.92.5.1436; Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883; GRIFFITHS G, 1993, FINE STRUCTURE IMMUN, P137; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hinkle B, 2002, J CELL SCI, V115, P4685, DOI 10.1242/jcs.00136; KESSEL RG, 1992, INT REV CYTOL, V133, P43, DOI 10.1016/S0074-7696(08)61858-6; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Lusk CP, 2002, J CELL BIOL, V159, P267, DOI 10.1083/jcb.200203079; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; MURRAY AW, 1991, CELL CYCLE EXTRACTS, P581; Rout MP, 2001, J BIOL CHEM, V276, P16593, DOI 10.1074/jbc.R100015200; Ryan KJ, 2003, J CELL BIOL, V160, P1041, DOI 10.1083/jcb.200209116; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Vasu SK, 2001, CURR OPIN CELL BIOL, V13, P363, DOI 10.1016/S0955-0674(00)00221-0; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429; Zhang CM, 2002, EUR J CELL BIOL, V81, P623, DOI 10.1078/0171-9335-00288; Zhang CM, 2002, CURR BIOL, V12, P498, DOI 10.1016/S0960-9822(02)00714-5	30	166	173	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					689	694		10.1038/nature01898	http://dx.doi.org/10.1038/nature01898			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12894213				2022-12-01	WOS:000184578800049
J	Dowsett, M; Ashworth, A				Dowsett, M; Ashworth, A			New biology of the oestrogen receptor	LANCET			English	Editorial Material							BREAST-CANCER		Royal Marsden Hosp, Dept Biochem, London SW3 6JJ, England; Inst Canc Res, Breakthrough Breast Canc Ctr, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Dowsett, M (corresponding author), Royal Marsden Hosp, Dept Biochem, London SW3 6JJ, England.	mitch@icr.ac.uk						CLARK JH, 1979, FEMALE SEX STEROIDS, P70; Gruvberger S, 2001, CANCER RES, V61, P5979; McDonnell DP, 2002, RECENT PROG HORM RES, V57, P295, DOI 10.1210/rp.57.1.295; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Peto R, 2000, LANCET, V356, P593, DOI 10.1016/S0140-6736(05)73970-2; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Smith IE, 2003, NEW ENGL J MED, V348, P2431, DOI 10.1056/NEJMra023246; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998	10	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					260	262		10.1016/S0140-6736(03)14005-6	http://dx.doi.org/10.1016/S0140-6736(03)14005-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892953				2022-12-01	WOS:000184413400005
J	Stephan, KE; Marshall, JC; Friston, KJ; Rowe, JB; Ritzl, A; Zilles, K; Fink, GR				Stephan, KE; Marshall, JC; Friston, KJ; Rowe, JB; Ritzl, A; Zilles, K; Fink, GR			Lateralized cognitive processes and lateralized task control in the human brain	SCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; HEMISPHERIC-SPECIALIZATION; VISUAL-ATTENTION; WORKING-MEMORY; RHESUS-MONKEY; DISSOCIATION; CONNECTIONS; ASYMMETRY; CONFLICT; PATHWAYS	The principles underlying human hemispheric specialization are poorly understood. We used functional magnetic resonance imaging of letter and visuospatial decision tasks with identical word stimuli to address two unresolved problems. First, hemispheric specialization depended on the nature of the task rather than on the nature of the stimulus. Second, analysis of frontal candidate regions for cognitive control showed increased coupling between left anterior cingulate cortex (ACC) and left inferior frontal gyrus during letter decisions, whereas right ACC showed enhanced coupling with right parietal areas during visuospatial decisions. Cognitive control is thus localized in the same hemisphere as task execution.	Res Ctr Julich, Inst Med, D-52425 Julich, Germany; Univ Aachen, Dept Neurol, D-52074 Aachen, Germany; UCL, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; UCL, Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Neuropsychol Unit, Oxford OX2 6HE, England; Univ Dusseldorf, C&O Vogt Brain Res Inst, D-40225 Dusseldorf, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Radcliffe Infirmary; University of Oxford; Heinrich Heine University Dusseldorf	Fink, GR (corresponding author), Res Ctr Julich, Inst Med, D-52425 Julich, Germany.	g.fink@fz-juelich.de	Tick, Beata/ABA-1728-2020; Zilles, Karl/J-9704-2013; Zilles, Karl/Y-3784-2019; Friston, Karl/D-9230-2011; rowe, james B/C-3661-2013; Fink, Gereon R./AFW-9377-2022; Fink, Gereon R./E-1616-2012	Zilles, Karl/0000-0001-9296-9959; Zilles, Karl/0000-0002-4705-4175; Friston, Karl/0000-0001-7984-8909; rowe, james B/0000-0001-7216-8679; Fink, Gereon R./0000-0002-8230-1856; Fink, Gereon R./0000-0002-8230-1856; Stephan, Klaas Enno/0000-0002-8594-9092	Wellcome Trust [077029] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BRADSHAW JL, 1981, BEHAV BRAIN SCI, V4, P51, DOI 10.1017/S0140525X00007548; Buchel C, 1997, CEREB CORTEX, V7, P768, DOI 10.1093/cercor/7.8.768; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; CAVADA C, 1989, J COMP NEUROL, V287, P393, DOI 10.1002/cne.902870402; CHIARELLO C, 1986, NEUROPSYCHOLOGIA, V24, P521, DOI 10.1016/0028-3932(86)90096-5; Corballis PM, 1999, NEUROREPORT, V10, P2183, DOI 10.1097/00001756-199907130-00033; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; Fink GR, 1999, BRAIN, V122, P497, DOI 10.1093/brain/122.3.497; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; HELLIGE JB, 1990, ANNU REV PSYCHOL, V41, P55, DOI 10.1146/annurev.ps.41.020190.000415; HUGDAHL K, 2003, ASYMMETRICAL BRAIN; LEVY J, 1976, J EXP PSYCHOL HUMAN, V2, P299, DOI 10.1037/0096-1523.2.3.299; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MARSHALL JC, 1981, BEHAV BRAIN SCI, V4, P72, DOI 10.1017/S0140525X00007664; MCINTOSH AR, 1994, J NEUROSCI, V14, P655; Nystrom LE, 2000, NEUROIMAGE, V11, P424, DOI 10.1006/nimg.2000.0572; PANDYA DN, 1981, EXP BRAIN RES, V42, P319, DOI 10.1007/BF00237497; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; SERGENT J, 1983, PSYCHOL BULL, V93, P481, DOI 10.1037/0033-2909.93.3.481; Shallice T, 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45	27	223	229	3	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					384	386		10.1126/science.1086025	http://dx.doi.org/10.1126/science.1086025			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869765				2022-12-01	WOS:000184207300049
J	Agrawal, A; Lingappa, J; Leppla, SH; Agrawal, S; Jabbar, A; Quinn, C; Pulendran, B				Agrawal, A; Lingappa, J; Leppla, SH; Agrawal, S; Jabbar, A; Quinn, C; Pulendran, B			Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin	NATURE			English	Article								Anthrax poses a clear and present danger as an agent of biological terrorism(1-3). Infection with Bacillus anthracis, the causative agent of anthrax, if untreated can result in rampant bacteraemia, multisystem dysfunction and death(4-8). Anthrax lethal toxin (LT) is a critical virulence factor of B. anthracis, which occurs as a complex of protective antigen and lethal factor. Here we demonstrate that LT severely impairs the function of dendritic cells-which are pivotal to the establishment of immunity against pathogens- and host immune responses by disrupting the mitogen-activated protein (MAP) kinase intracellular signalling network. Dendritic cells exposed to LT and then stimulated with lipopolysaccharide do not upregulate co-stimulatory molecules, secrete greatly diminished amounts of proinflammatory cytokines, and do not effectively stimulate antigen-specific T cells in vivo. Furthermore, injections of LT induce a profound impairment of antigen-specific T- and B-cell immunity. These data suggest a role for LT in suppressing host immunity during B. anthracis infections, and represent an immune evasion strategy, where a microbe targets MAP kinases in dendritic cells to disarm the immune response.	Emory Vaccine Res Ctr, Atlanta, GA 30329 USA; CDCP, Meningitis & Special Pathogens Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; NIAID, Microbial Pathogenesis Sect, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pulendran, B (corresponding author), Emory Vaccine Res Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.		Lingappa, Jairam/N-7760-2017; Pulendran, Bali/AAW-9550-2021	Pulendran, Bali/0000-0001-6517-4333	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000929, ZIAAI000929] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Brossier F, 2001, TOXICON, V39, P1747, DOI 10.1016/S0041-0101(01)00161-1; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; HANNA PC, 1993, P NATL ACAD SCI USA, V90, P10198, DOI 10.1073/pnas.90.21.10198; Hanna PC, 1999, TRENDS MICROBIOL, V7, P180, DOI 10.1016/S0966-842X(99)01507-3; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Lane HC, 2001, NAT MED, V7, P1271, DOI 10.1038/nm1201-1271; Little SF, 1999, MICROBES INFECT, V1, P131, DOI 10.1016/S1286-4579(99)80004-5; Liu LZ, 2002, NAT MED, V8, P185, DOI 10.1038/nm0202-185; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Mourez M, 2002, TRENDS MICROBIOL, V10, P287, DOI 10.1016/S0966-842X(02)02369-7; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Pulendran B, 1997, J IMMUNOL, V159, P2222; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Sailaja G, 2003, J IMMUNOL, V170, P2496, DOI 10.4049/jimmunol.170.5.2496; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Smith H, 2000, TRENDS MICROBIOL, V8, P199, DOI 10.1016/S0966-842X(00)01755-8; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Yi AK, 2001, INT IMMUNOL, V13, P1391, DOI 10.1093/intimm/13.11.1391; Yi AK, 2002, J IMMUNOL, V168, P4711, DOI 10.4049/jimmunol.168.9.4711	30	238	250	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					329	334		10.1038/nature01794	http://dx.doi.org/10.1038/nature01794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867985				2022-12-01	WOS:000184183900046
J	Houde, M; Bertholet, S; Gagnon, E; Brunet, S; Goyette, G; Laplante, A; Princiotta, MF; Thibault, P; Sacks, D; Desjardins, M				Houde, M; Bertholet, S; Gagnon, E; Brunet, S; Goyette, G; Laplante, A; Princiotta, MF; Thibault, P; Sacks, D; Desjardins, M			Phagosomes are competent organelles for antigen cross-presentation	NATURE			English	Article							MHC CLASS-I; CD8(+) T-CELLS; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; COMPLEX; PHAGOCYTOSIS; ACTIVATION; PATHWAY; CYTOSOL; LOCALIZATION	The ability to process microbial antigens and present them at the surface of cells is an important aspect of our innate ability to clear infections. It is generally accepted that antigens in the cytoplasm are loaded in the endoplasmic reticulum and presented at the cell surface on major histocompatibility complex (MHC) class I molecules, whereas peptides present in endo/phagocytic compartments are presented on MHC class II molecules(1,2). Despite the apparent segregation of the class I and class II pathways, antigens from intracellular pathogens including mycobacteria, Escherichia coli, Salmonella typhimurium, Brucella abortus and Leishmania, have been shown to elicit an MHCclass-I-dependent CD8(+) T-cell response(3-7), a process referred to as cross-presentation(2). The cellular mechanisms allowing the cross-presentation pathway are poorly understood. Here we show that phagosomes display the elements and properties needed to be self-sufficient for the cross-presentation of exogenous antigens, a newly ascribed function linked to phagocytosis mediated by the endoplasmic reticulum.	Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada; NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; Caprion Pharmaceut Inc, Montreal, PQ H45 2C8, Canada	Universite de Montreal; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Desjardins, M (corresponding author), Univ Montreal, Dept Pathol & Biol Cellulaire, CP6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.			Goyette, Guillaume/0000-0003-3277-568X; Desjardins, Michel/0000-0002-5684-5980; Thibault, Pierre/0000-0001-5993-0331	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000494, ZIAAI000494, Z01AI000658, ZIAAI000658] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; Brooks P, 2000, BIOCHEM J, V352, P611, DOI 10.1042/0264-6021:3520611; Canaday DH, 1999, J IMMUNOL, V162, P372; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Lennon-Dumenil AM, 2002, J EXP MED, V196, P529, DOI 10.1084/jem.20020327; MacAry PA, 2001, P NATL ACAD SCI USA, V98, P3982, DOI 10.1073/pnas.071477498; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Muno D, 2000, FEBS LETT, V478, P178, DOI 10.1016/S0014-5793(00)01849-4; OLIVEIRA SC, 1995, EUR J IMMUNOL, V25, P2551, DOI 10.1002/eji.1830250922; PFEIFER JD, 1993, NATURE, V361, P359, DOI 10.1038/361359a0; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Ramachandra L, 1999, J IMMUNOL, V162, P3263; RIVETT AJ, 1992, J HISTOCHEM CYTOCHEM, V40, P1165, DOI 10.1177/40.8.1619280; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; Tirosh B, 2003, J BIOL CHEM, V278, P6664, DOI 10.1074/jbc.M210158200; Turner J, 1996, IMMUNOLOGY, V87, P339, DOI 10.1046/j.1365-2567.1996.512590.x; Watts C, 2001, SEMIN IMMUNOL, V13, P373; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0	27	564	582	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 25	2003	425	6956					402	406		10.1038/nature01912	http://dx.doi.org/10.1038/nature01912			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	724TG	14508490				2022-12-01	WOS:000185502300042
J	Berkley, S				Berkley, S			Thorny issues in the ethics of AIDS vaccine trials	LANCET			English	Editorial Material									IAVI, New York, NY 10013 USA	International AIDS Vaccine Initiative	Berkley, S (corresponding author), IAVI, New York, NY 10013 USA.							*IAVI, 2001, NEW ACC PAR PUBL SEC; Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916	2	23	24	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 20	2003	362	9388					992	992		10.1016/S0140-6736(03)14371-1	http://dx.doi.org/10.1016/S0140-6736(03)14371-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	724LT	14513850				2022-12-01	WOS:000185489600024
J	Chen, EH; Pryce, BA; Tzeng, JA; Gonzalez, GA; Olson, EN				Chen, EH; Pryce, BA; Tzeng, JA; Gonzalez, GA; Olson, EN			Control of myoblast fusion by a guanine nucleotide exchange factor, loner, and its effector ARF6	CELL			English	Article							ADP-RIBOSYLATION FACTOR; DROSOPHILA EMBRYOGENESIS; ACTIN CYTOSKELETON; TRANSCRIPTION FACTOR; MUSCLE DEVELOPMENT; GENETIC-ANALYSIS; ROLLING-PEBBLES; PROTEIN; MEMBRANE; MYOGENESIS	Myoblast fusion is essential for the formation and regeneration of skeletal muscle. In a genetic screen for regulators of muscle development in Drosophila, we discovered a gene encoding a guanine nucleotide exchange factor, called loner, which is required for myoblast fusion. Loner localizes to subcellular sites of fusion and acts downstream of cell surface fusion receptors by recruiting the small GTPase ARF6 and stimulating guanine nucleotide exchange. Accordingly, a dominant-negative ARF6 disrupts myoblast fusion in Drosophila embryos and in mammalian myoblasts in culture, mimicking the fusion defects caused by loss of Loner. Loner and ARF6, which also control the proper membrane localization of another small GTPase, Rac, are key components of a cellular apparatus required for myoblast fusion and muscle development. In muscle cells, this fusigenic mechanism is coupled to fusion receptors; in other fusion-competent cell types it may be triggered by different upstream signals.	Univ Texas, SW Med Ctr, Dept Biol Mol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Biol Mol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.							Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Artero RD, 2001, DEVELOPMENT, V128, P4251; Bate Michael, 1993, P1013; Baylies MK, 2001, CURR OPIN GENET DEV, V11, P431, DOI 10.1016/S0959-437X(00)00214-8; Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; Blau HM, 2002, NATURE, V419, P437, DOI 10.1038/419437a; Blumenthal R, 2003, CHEM REV, V103, P53, DOI 10.1021/cr000036+; Boshans RL, 2000, MOL CELL BIOL, V20, P3685, DOI 10.1128/MCB.20.10.3685-3694.2000; Bour BA, 2000, GENE DEV, V14, P1498; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Chen EH, 2001, DEV CELL, V1, P705, DOI 10.1016/S1534-5807(01)00084-3; CORBIN V, 1991, CELL, V67, P311, DOI 10.1016/0092-8674(91)90183-Y; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Doberstein SK, 1997, J CELL BIOL, V136, P1249, DOI 10.1083/jcb.136.6.1249; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Dworak HA, 2002, BIOESSAYS, V24, P591, DOI 10.1002/bies.10115; Dworak HA, 2001, DEVELOPMENT, V128, P4265; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Frasch M, 2000, CELL, V102, P127, DOI 10.1016/S0092-8674(00)00016-7; Frasch M, 1999, CURR OPIN GENET DEV, V9, P522, DOI 10.1016/S0959-437X(99)00014-3; Fuerstenberg S, 1998, DEV BIOL, V201, P66, DOI 10.1006/dbio.1998.8944; GAUL U, 1987, CELL, V50, P639, DOI 10.1016/0092-8674(87)90037-7; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Keller CA, 1997, DEV BIOL, V181, P197, DOI 10.1006/dbio.1996.8434; KIEHART DP, 1986, J CELL BIOL, V103, P1517, DOI 10.1083/jcb.103.4.1517; KNUDSEN KA, 1992, MEMBRANE FUSION, P601; Langille SE, 1999, J BIOL CHEM, V274, P27099, DOI 10.1074/jbc.274.38.27099; LILLY B, 1994, P NATL ACAD SCI USA, V91, P5662, DOI 10.1073/pnas.91.12.5662; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Menon SD, 2001, DEV CELL, V1, P691, DOI 10.1016/S1534-5807(01)00075-2; Morinaga N, 1997, P NATL ACAD SCI USA, V94, P12926, DOI 10.1073/pnas.94.24.12926; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; NGUYEN HT, 1994, P NATL ACAD SCI USA, V91, P7520, DOI 10.1073/pnas.91.16.7520; Paris S, 1997, J BIOL CHEM, V272, P22221, DOI 10.1074/jbc.272.35.22221; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Paululat A, 1999, MECH DEVELOP, V83, P17, DOI 10.1016/S0925-4773(99)00029-5; Radhakrishna H, 1999, J CELL SCI, V112, P855; Rau A, 2001, DEVELOPMENT, V128, P5061; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; RuizGomez M, 1997, DEVELOPMENT, V124, P3407; Rusconi JC, 1998, MECH DEVELOP, V79, P39, DOI 10.1016/S0925-4773(98)00170-1; SHEVELL DE, 1994, CELL, V77, P1051, DOI 10.1016/0092-8674(94)90444-8; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Taylor MV, 2002, CURR BIOL, V12, pR224, DOI 10.1016/S0960-9822(02)00757-1; WAKELAM MJO, 1985, BIOCHEM J, V228, P1	61	128	132	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 19	2003	114	6					751	762		10.1016/S0092-8674(03)00720-7	http://dx.doi.org/10.1016/S0092-8674(03)00720-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	724AL	14505574	Bronze			2022-12-01	WOS:000185464000012
J	Ouzounov, DG; Ahmad, FR; Muller, D; Venkataraman, N; Gallagher, MT; Thomas, MG; Silcox, J; Koch, KW; Gaeta, AL				Ouzounov, DG; Ahmad, FR; Muller, D; Venkataraman, N; Gallagher, MT; Thomas, MG; Silcox, J; Koch, KW; Gaeta, AL			Generation of megawatt optical solitons in hollow-core photonic band-gap fibers	SCIENCE			English	Article							FEMTOSECOND LASER-PULSES; SELF-FREQUENCY SHIFT; ANOMALOUS-DISPERSION; MICROSTRUCTURED FIBERS; CRYSTAL FIBERS; AIR; GUIDANCE; NM	The measured dispersion of a low-loss, hollow-core photonic band-gap fiber is anomalous throughout most of the transmission band, and its variation with wavelength is large compared with that of a conventional step-index fiber. For an air-filled fiber, femtosecond self-frequency-shifted fundamental solitons with peak powers greater than 2 megawatts can be supported. For Xe-filled fibers, nonfrequency-shifted temporal solitons with peak powers greater than 5.5 megawatts can be generated, representing an increase in the power that can be propagated in an optical fiber of two orders of magnitude. The results demonstrate a unique capability to deliver high-power pulses in a single spatial mode over distances exceeding 200 meters.	Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; Corning Inc, Corning, NY 14831 USA	Cornell University; Corning Inc; State University of New York (SUNY) System; SUNY Community College	Gaeta, AL (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.	a.gaeta@cornell.edu	Gaeta, Alexander/AAE-2095-2019; Muller, David/A-7745-2010	Muller, David/0000-0003-4129-0473	NCI NIH HHS [R44CA88391-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R44CA088391] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS MJ, 1981, INTRO OPTICAL WAVEGU, P245; AGRAWAL GP, 2001, NONLINEAR FIBER OPTI, P120; Allan DC, 2001, NATO SCI SER II-MATH, V563, P305; Atherton BW, 1998, P SOC PHOTO-OPT INS, V3269, P22, DOI 10.1117/12.580605; Benabid F, 2002, SCIENCE, V298, P399, DOI 10.1126/science.1076408; Cregan RF, 1999, SCIENCE, V285, P1537, DOI 10.1126/science.285.5433.1537; DIANOV EM, 1985, JETP LETT+, V41, P294; GORDON JP, 1986, OPT LETT, V11, P662, DOI 10.1364/OL.11.000662; HASEGAWA A, 1973, APPL PHYS LETT, V23, P142, DOI 10.1063/1.1654836; JACKSON JD, 1975, CLASSICAL ELECTRODYN, P343; Knight JC, 2000, IEEE PHOTONIC TECH L, V12, P807, DOI 10.1109/68.853507; Knight JC, 1998, SCIENCE, V282, P1476, DOI 10.1126/science.282.5393.1476; MITSCHKE FM, 1986, OPT LETT, V11, P659, DOI 10.1364/OL.11.000659; MOLLENAUER LF, 1980, PHYS REV LETT, V45, P1095, DOI 10.1103/PhysRevLett.45.1095; Nibbering ETJ, 1997, J OPT SOC AM B, V14, P650, DOI 10.1364/JOSAB.14.000650; Ouzounov D, 2002, OPT COMMUN, V205, P227, DOI 10.1016/S0030-4018(02)01359-7; Ouzounov D, 2001, OPT COMMUN, V192, P219, DOI 10.1016/S0030-4018(01)01185-3; Ouzounov DG, 2002, OPT LETT, V27, P1513, DOI 10.1364/OL.27.001513; Price JHV, 2002, J OPT SOC AM B, V19, P1286, DOI 10.1364/JOSAB.19.001286; Ranka JK, 2000, OPT LETT, V25, P796, DOI 10.1364/OL.25.000796; Ranka JK, 2000, OPT LETT, V25, P25, DOI 10.1364/OL.25.000025; RANKA JK, 1997, OPT LETT, V22, P1934; Smith CM, 2003, NATURE, V424, P657, DOI 10.1038/nature01849; VENKATARAMAN N, 2002, EUR C OPT COMM; Wadsworth WJ, 2000, ELECTRON LETT, V36, P53, DOI 10.1049/el:20000134; Washburn BR, 2001, ELECTRON LETT, V37, P1510, DOI 10.1049/el:20011047	26	415	439	1	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2003	301	5640					1702	1704		10.1126/science.1088387	http://dx.doi.org/10.1126/science.1088387			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722QN	14500976				2022-12-01	WOS:000185387700038
J	Miller, MW; Williams, ES				Miller, MW; Williams, ES			Horizontal prion transmission in mule deer	NATURE			English	Editorial Material							CHRONIC WASTING DISEASE; ODOCOILEUS-HEMIONUS; SCRAPIE; SHEEP; EPIDEMIOLOGY		Wildlife Res Ctr, Colorado Div, Ft Collins, CO 80526 USA; Univ Wyoming, Dept Vet Sci, Laramie, WY 82070 USA	University of Wyoming	Miller, MW (corresponding author), Wildlife Res Ctr, Colorado Div, Ft Collins, CO 80526 USA.							HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; Hoinville LJ, 1996, REV SCI TECH OIE, V15, P827, DOI 10.20506/rst.15.3.959; Hourrigan J., 1979, Slow transmissible diseases of the nervous system. Volume 1., P331; MCFADYEAN J, 1918, J COMP PATHOL THER, V31, P102; Miller MW, 2000, J WILDLIFE DIS, V36, P676, DOI 10.7589/0090-3558-36.4.676; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Redman CA, 2002, EPIDEMIOL INFECT, V128, P513, DOI 10.1017/S0950268802007008; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Spraker TR, 2002, VET PATHOL, V39, P110, DOI 10.1354/vp.39-1-110; Williams E.S., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P551; Williams ES, 2002, REV SCI TECH OIE, V21, P305, DOI 10.20506/rst.21.2.1340; Woolhouse MEJ, 1998, P ROY SOC B-BIOL SCI, V265, P1205, DOI 10.1098/rspb.1998.0421	12	221	225	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 4	2003	425	6953					35	36		10.1038/425035a	http://dx.doi.org/10.1038/425035a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717LD	12955129				2022-12-01	WOS:000185089200026
J	Gottfried, JA; O'Doherty, J; Dolan, RJ				Gottfried, JA; O'Doherty, J; Dolan, RJ			Encoding predictive reward value in human amygdala and orbitofrontal cortex	SCIENCE			English	Article							SENSORY-SPECIFIC SATIETY; PREFRONTAL CORTEX; ACTIVATION; LESIONS; REINFORCEMENT; MOTIVATION; RESPONSES; NEURONS; HUNGER; FMRI	Adaptive behavior is optimized in organisms that maintain flexible representations of the value of sensory-predictive cues. To identify central representations of predictive reward value in humans, we used reinforcer devaluation while measuring neural activity with functional magnetic resonance imaging. We presented two arbitrary visual stimuli, both before and after olfactory devaluation, in a paradigm of appetitive conditioning. In amygdala and orbitofrontal cortex, responses evoked by a predictive target stimulus were decreased after devaluation, whereas responses to the nondevalued stimulus were maintained. Thus, differential activity in amygdala and orbitofrontal cortex encodes the current value of reward representations accessible to predictive cues.	Wellcome Dept Imaging Neurosci, Funct Imaging Lab, London WC1N 3BG, England	University of London; University College London	Gottfried, JA (corresponding author), Wellcome Dept Imaging Neurosci, Funct Imaging Lab, 12 Queen Sq, London WC1N 3BG, England.		O'Doherty, John P/F-1204-2013	Dolan, Ray/0000-0001-9356-761X				Balleine BW, 2000, J NEUROSCI, V20, P8954; Baxter MG, 2000, J NEUROSCI, V20, P4311; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1673, DOI 10.1152/jn.1996.75.4.1673; Critchley HD, 2002, NEURON, V33, P653, DOI 10.1016/S0896-6273(02)00588-3; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Dickinson A., 2002, STEVENS HDB EXPT PSY, V3; Gallagher M, 1999, J NEUROSCI, V19, P6610; Gottfried JA, 2002, J NEUROSCI, V22, P10829; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Hatfield T, 1996, J NEUROSCI, V16, P5256; Ikeda M, 2002, J NEUROL NEUROSUR PS, V73, P371, DOI 10.1136/jnnp.73.4.371; LaBar KS, 2001, BEHAV NEUROSCI, V115, P493, DOI 10.1037//0735-7044.115.2.493; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Malkova L, 1997, J NEUROSCI, V17, P6011; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; O'Doherty J, 2000, NEUROREPORT, V11, P893, DOI 10.1097/00001756-200003200-00046; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; ROLLS BJ, 1981, PHYSIOL BEHAV, V27, P137, DOI 10.1016/0031-9384(81)90310-3; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1970, DOI 10.1152/jn.1996.75.5.1970; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Small DM, 1999, NEUROREPORT, V10, P7, DOI 10.1097/00001756-199901180-00002; TERZIAN H, 1955, NEUROLOGY, V5, P373, DOI 10.1212/WNL.5.6.373	28	838	845	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 22	2003	301	5636					1104	1107		10.1126/science.1087919	http://dx.doi.org/10.1126/science.1087919			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713RP	12934011	Green Submitted			2022-12-01	WOS:000184872400043
J	Harvey, KF; Pfleger, CM; Hariharan, IK				Harvey, KF; Pfleger, CM; Hariharan, IK			The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis	CELL			English	Article							PROTEIN-KINASE; REGULATING APOPTOSIS; TNF SUPERFAMILY; IMAGINAL DISC; JNK PATHWAY; DEGRADATION; REAPER; DIAP1; GENE; GRIM	Establishing and maintaining homeostasis is critical to the well-being of an organism and is determined by the balance of cell proliferation and death. Two genes that function together to regulate growth, proliferation, and apoptosis in Drosophila are warts (wts), encoding a serine/threonine kinase, and salvador (sav), encoding a WW domain containing Wts-interacting protein. However, the mechanisms by which sav and wts regulate growth and apoptosis are not well understood. Here, we describe mutations in hippo (hpo), which encodes a protein kinase most related to mammalian Mst1 and Mst2. Like wts and sav, hpo mutations result in increased tissue growth and impaired apoptosis characterized by elevated levels of the cell cycle regulator cyclin E and apoptosis inhibitor DIAP1. Hpo, Sav, and Wts interact physically and functionally, and regulate DIAP1 levels, likely by Hpo-mediated phosphorylation and subsequent degradation. Thus, Hpo links Sav and Wts to a key regulator of apoptosis.	Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Hariharan, IK (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Bldg 149,13th St, Charlestown, MA 02129 USA.		Harvey, Kieran/AAD-5268-2022	Harvey, Kieran/0000-0001-7845-369X	NCI NIH HHS [CA95281] Funding Source: Medline; NIGMS NIH HHS [GM61672] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA095281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061672] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Creasy CL, 1995, GENE, V167, P303, DOI 10.1016/0378-1119(95)00653-2; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hays R, 2002, NAT CELL BIOL, V4, P425, DOI 10.1038/ncb794; Holley CL, 2002, NAT CELL BIOL, V4, P439, DOI 10.1038/ncb798; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Lee KK, 1998, ONCOGENE, V16, P3029, DOI 10.1038/sj.onc.1201840; Lisi S, 2000, GENETICS, V154, P669; Marygold SJ, 2002, CURR BIOL, V12, pR785, DOI 10.1016/S0960-9822(02)01294-0; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Richardson H, 2002, J IMMUNOL METHODS, V265, P21, DOI 10.1016/S0022-1759(02)00068-6; RICHARDSON H, 1995, DEVELOPMENT, V121, P3371; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Suzanne M, 2001, DEV BIOL, V237, P282, DOI 10.1006/dbio.2001.0384; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; WHITE K, 1994, SCIENCE, V264, P668; Wilson R, 2002, NAT CELL BIOL, V4, P445, DOI 10.1038/ncb799; Wing JP, 2002, NAT CELL BIOL, V4, P451, DOI 10.1038/ncb800; XU TA, 1995, DEVELOPMENT, V121, P1053; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793	40	722	753	2	69	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 22	2003	114	4					457	467		10.1016/S0092-8674(03)00557-9	http://dx.doi.org/10.1016/S0092-8674(03)00557-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	714TD	12941274	Bronze			2022-12-01	WOS:000184928800009
J	Chien, P; DePace, AH; Collins, SR; Weissman, JS				Chien, P; DePace, AH; Collins, SR; Weissman, JS			Generation of prion transmission barriers by mutational control of amyloid conformations	NATURE			English	Article							STRUCTURAL BASIS; SUP35 PROTEIN; IN-VITRO; YEAST; PSI+; DIVERSITY; DISEASES; STRAINS; VARIANT; PSI(+)	Self-propagating beta-sheet-rich protein aggregates are implicated in a wide range of protein-misfolding phenomena, including amyloid diseases and prion-based inheritance(1). Two properties have emerged as common features of amyloids. Amyloid formation is ubiquitous: many unrelated proteins form such aggregates and even a single polypeptide can misfold into multiple forms(2-6) - a process that is thought to underlie prion strain variation(7). Despite this promiscuity, amyloid propagation can be highly sequence specific: amyloid fibres often fail to catalyse the aggregation of other amyloidogenic proteins(8,9). In prions, this specificity leads to barriers that limit transmission between species(7,8,10-12). Using the yeast prion [PSI+](13), we show in vitro that point mutations in Sup35p, the protein determinant of [PSI+], alter the range of 'infectious' conformations, which in turn changes amyloid seeding specificity. We generate a new transmission barrier in vivo by using these mutations to specifically disfavour subsets of prion strains. The ability of mutations to alter the conformations of amyloid states without preventing amyloid formation altogether provides a general mechanism for the generation of prion transmission barriers and may help to explain how mutations alter toxicity in conformational diseases.	Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA.	jsw1@itsa.ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X; Collins, Sean/0000-0002-4276-5840				Barron RM, 2001, EMBO J, V20, P5070, DOI 10.1093/emboj/20.18.5070; Bartz JC, 2000, J VIROL, V74, P5542, DOI 10.1128/JVI.74.12.5542-5547.2000; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baxa U, 2002, P NATL ACAD SCI USA, V99, P5253, DOI 10.1073/pnas.082097899; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; DePace AH, 2002, NAT STRUCT BIOL, V9, P389, DOI 10.1038/nsb786; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 1996, GENETICS, V144, P1375; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Hill AF, 1999, J GEN VIROL, V80, P11, DOI 10.1099/0022-1317-80-1-11; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; King CY, 2001, J MOL BIOL, V307, P1247, DOI 10.1006/jmbi.2001.4542; Kochneva-Pervukhova NV, 2001, YEAST, V18, P489, DOI 10.1002/yea.700; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; Kushnirov VV, 2000, CURR BIOL, V10, P1443, DOI 10.1016/S0960-9822(00)00802-2; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Mastrianni JA, 2001, NEUROLOGY, V57, P2198, DOI 10.1212/WNL.57.12.2198; Nakayashiki T, 2001, MOL CELL, V7, P1121, DOI 10.1016/S1097-2765(01)00259-3; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Post K, 2000, ARCH VIROL, P265; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Uptain SM, 2001, EMBO J, V20, P6236, DOI 10.1093/emboj/20.22.6236; Zhou P, 1999, EMBO J, V18, P1182, DOI 10.1093/emboj/18.5.1182	29	85	86	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2003	424	6951					948	951		10.1038/nature01894	http://dx.doi.org/10.1038/nature01894			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713EH	12931190				2022-12-01	WOS:000184843600043
J	Gompel, N; Carroll, SB				Gompel, N; Carroll, SB			Genetic mechanisms and constraints governing the evolution of correlated traits in drosophilid flies	NATURE			English	Article							CONVERGENT PHENOTYPES; ADULT ABDOMEN; MELANOGASTER; PHYLOGENY; PROTEINS; PATTERN; PANNIER	Some morphological traits differ greatly between related species, but it is not clear whether diversity evolves through changes in the same genes and whether similar, independent (that is, convergent) changes occur by the same mechanism(1,2). Pigmentation in fruitflies presents an attractive opportunity to explore these issues because pigmentation patterns are diverse, similar patterns have arisen in independent clades, and numerous genes governing their formation have been identified(3-5) in Drosophila melanogaster. Here we show that both evolutionary diversification and convergence can be due to evolution at the same locus, by comparing abdominal pigmentation and trichome patterns and the expression of Bric-a-brac2 (Bab2), which regulates both traits in D. melanogaster(3,6), in 13 species representing the major clades (7,8) of the subfamily Drosophilinae. Modifications of Bab2 expression are frequently correlated with diverse pigmentation and trichome patterns that evolved independently in multiple lineages. In a few species, Bab2 expression is not correlated with changes in pigmentation but is correlated with a conserved pattern of trichomes, indicating that this locus can be circumvented to evolve new patterns when a correlated trait is under different constraints.	Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1525 Linden Dr, Madison, WI 53706 USA.	sbcarrol@facstaff.wisc.edu		Gompel, Nicolas/0000-0003-3358-7963				Abzhanov A, 2000, DEVELOPMENT, V127, P2239; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; AYALA FJ, 1965, EVOLUTION, V19, P538, DOI 10.1111/j.1558-5646.1965.tb03329.x; BOCK IR, 1972, STUDIES GENETICS, P1, DOI DOI 10.1590/S0085-56262014000400004; Calleja M, 2000, DEVELOPMENT, V127, P3971; Couderc JL, 2002, DEVELOPMENT, V129, P2419; GRIMALDI DA, 1990, B AM MUS NAT HIST, P1; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Kopp A, 1999, DEVELOPMENT, V126, P3495; Kopp A, 2003, GENETICS, V163, P771; Kopp A, 1997, DEVELOPMENT, V124, P3715; Kwiatowski J, 1999, MOL PHYLOGENET EVOL, V13, P319, DOI 10.1006/mpev.1999.0657; Lachaise D, 2000, P ROY SOC B-BIOL SCI, V267, P1487, DOI 10.1098/rspb.2000.1169; Llopart A, 2002, EVOLUTION, V56, P2262; Maddison D.R., 2000, MACCLADE 4 ANAL PHYL; MADHAVAN MM, 1980, J EMBRYOL EXP MORPH, V60, P1; Majerus M.E.N., 1998, MELANISM EVOLUTION A; Majerus M. E. N, 1994, LADYBIRDS; Remsen J, 2002, MOL PHYLOGENET EVOL, V24, P249, DOI 10.1016/S1055-7903(02)00226-9; Schutt C, 2000, DEVELOPMENT, V127, P667; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Wittkopp PJ, 2003, P NATL ACAD SCI USA, V100, P1808, DOI 10.1073/pnas.0336368100; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849; Wray GA, 2002, BRAIN BEHAV EVOLUT, V59, P327, DOI 10.1159/000063566; Wulbeck C, 2002, DEVELOPMENT, V129, P3861	25	98	104	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2003	424	6951					931	935		10.1038/nature01787	http://dx.doi.org/10.1038/nature01787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713EH	12931186				2022-12-01	WOS:000184843600039
J	Gentner, TQ; Margoliash, D				Gentner, TQ; Margoliash, D			Neuronal populations and single cells representing learned auditory objects	NATURE			English	Article							INDIVIDUAL VOCAL RECOGNITION; WHITE-CROWNED SPARROW; EUROPEAN STARLINGS; PREFRONTAL CORTEX; SONG SYSTEM; DISCRIMINATION; PLASTICITY; MONKEYS; SOUNDS; ORGANIZATION	The neural representations associated with learned auditory behaviours, such as recognizing individuals based on their vocalizations, are not well described. Higher vertebrates learn to recognize complex conspecific vocalizations that comprise sequences of easily identified, naturally occurring auditory objects(1,2), which should facilitate the analysis of higher auditory pathways. Here we describe the first example of neurons selective for learned conspecific vocalizations in adult animals-in starlings that have been trained operantly to recognize conspecific songs. The neuronal population is found in a non-primary forebrain auditory region, exhibits increased responses to the set of learned songs compared with novel songs, and shows differential responses to categories of learned songs based on recognition training contingencies. Within the population, many cells respond highly selectively to a subset of specific motifs (acoustic objects) present only in the learned songs. Such neuronal selectivity may contribute to song-recognition behaviour, which in starlings is sensitive to motif identity(3,4). In this system, both top-down and bottom-up processes may modify the tuning properties of neurons during recognition learning, giving rise to plastic representations of behaviourally meaningful auditory objects.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago	Gentner, TQ (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1027 E 57th St, Chicago, IL 60637 USA.				NIDCD NIH HHS [F32 DC000389, F32 DC000389-03] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC000389] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BAKIN JS, 1990, BRAIN RES, V536, P271, DOI 10.1016/0006-8993(90)90035-A; EENS M, 1989, ARDEA, V77, P75; Gentner T. Q., 2002, ACOUSTIC COMMUNICATI, P324; Gentner TQ, 1998, ANIM BEHAV, V56, P579, DOI 10.1006/anbe.1998.0810; Gentner TQ, 2000, J NEUROBIOL, V42, P117, DOI 10.1002/(SICI)1097-4695(200001)42:1<117::AID-NEU11>3.0.CO;2-M; Gentner TQ, 2000, J ACOUST SOC AM, V107, P3369, DOI 10.1121/1.429408; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Kilgard MP, 2002, P NATL ACAD SCI USA, V99, P3205, DOI 10.1073/pnas.261705198; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Kroodsma D.E., 1996, ECOLOGY EVOLUTION AC; KROODSMA DE, 1999, DESIGN ANIMAL COMMUN; LEPPELSACK HJ, 1976, J COMP PHYSIOL, V107, P263, DOI 10.1007/BF00656737; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; MARGOLIASH D, 1986, J NEUROSCI, V6, P1643; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MULLER CM, 1985, EXP BRAIN RES, V59, P587; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rainer G, 2000, NEURON, V27, P179, DOI 10.1016/S0896-6273(00)00019-2; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; RECANZONE GH, 1993, J NEUROSCI, V13, P87; SCHEICH H, 1979, J COMP PHYSIOL, V132, P257, DOI 10.1007/BF00614497; Sen K, 2001, J NEUROPHYSIOL, V86, P1445, DOI 10.1152/jn.2001.86.3.1445; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Wang XQ, 2001, J NEUROPHYSIOL, V86, P2616, DOI 10.1152/jn.2001.86.5.2616	27	186	187	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					669	674		10.1038/nature01731	http://dx.doi.org/10.1038/nature01731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904792	Green Accepted			2022-12-01	WOS:000184578800044
J	Krekelberg, B; Dannenberg, S; Hoffmann, KP; Bremmer, F; Ross, J				Krekelberg, B; Dannenberg, S; Hoffmann, KP; Bremmer, F; Ross, J			Neural correlates of implied motion	NATURE			English	Article							VISUAL AREA MT; TRANSPARENT MOTION; MACAQUE MONKEY; DIRECTION; PERCEPTION; SIGNALS; NEURONS; SELECTIVITY; ORIENTATION; CORTEX	Current views of the visual system assume that the primate brain analyses form and motion along largely independent pathways(1); they provide no insight into why form is sometimes interpreted as motion. In a series of psychophysical and electrophysiological experiments in humans and macaques, here we show that some form information is processed in the prototypical motion areas of the superior temporal sulcus (STS). First, we show that STS cells respond to dynamic Glass patterns(2),which contain no coherent motion but suggest a path of motion(3). Second, we show that when motion signals conflict with form signals suggesting a different path of motion, both humans and monkeys perceive motion in a compromised direction. This compromise also has a correlate in the responses of STS cells, which alter their direction preferences in the presence of conflicting implied motion information. We conclude that cells in the prototypical motion areas in the dorsal visual cortex process form that implies motion. Estimating motion by combining motion cues with form cues may be a strategy to deal with the complexities of motion perception in our natural environment.	Salk Inst Biol Studies, Vis Ctr Lab, La Jolla, CA 92037 USA; Ruhr Univ Bochum, Dept Neurobiol, D-44780 Bochum, Germany; Univ Marburg, Dept Neurophys, Cognit Neurosci Lab, D-35032 Marburg, Germany; Univ Western Australia, Sch Psychol, Nedlands, WA 6907, Australia	Salk Institute; Ruhr University Bochum; Philipps University Marburg; University of Western Australia	Krekelberg, B (corresponding author), Salk Inst Biol Studies, Vis Ctr Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Bremmer, Frank/F-3268-2012; Krekelberg, Bart/N-7938-2019	Bremmer, Frank/0000-0003-1597-7407; Krekelberg, Bart/0000-0003-1083-6103				ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; BATSCHELET E., 1981, CIRCULAR STAT BIOL M; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; Burr DC, 2002, J NEUROSCI, V22, P8661; Geisler WS, 1999, NATURE, V400, P65, DOI 10.1038/21886; Geisler WS, 2001, VISUAL NEUROSCI, V18, P501, DOI 10.1017/S0952523801184014; GLASS L, 1969, NATURE, V223, P578, DOI 10.1038/223578a0; Jancke D, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-14-j0005.2000; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; QIAN N, 1994, J NEUROSCI, V14, P7367; Ross J, 2000, CURR BIOL, V10, P679, DOI 10.1016/S0960-9822(00)00524-8; Rudolph K, 1999, CEREB CORTEX, V9, P90, DOI 10.1093/cercor/9.1.90; SCHOPPMANN A, 1976, NEUROSCI LETT, V2, P177, DOI 10.1016/0304-3940(76)90011-2; Smith MA, 2002, J NEUROSCI, V22, P8334, DOI 10.1523/jneurosci.22-18-08334.2002; SNOWDEN RJ, 1991, J NEUROSCI, V11, P2768; Wilson HR, 1997, VISION RES, V37, P2325, DOI 10.1016/S0042-6989(97)00104-1	20	122	125	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					674	677		10.1038/nature01852	http://dx.doi.org/10.1038/nature01852			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904793				2022-12-01	WOS:000184578800045
J	Blackburn, C; Spencer, N; Bonas, S; Coe, C; Dolan, A; Moy, R				Blackburn, C; Spencer, N; Bonas, S; Coe, C; Dolan, A; Moy, R			Effect of strategies to reduce exposure of infants to environmental tobacco smoke in the home: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article							URINARY COTININE; PARENTAL SMOKING; CHILDREN; ASTHMA	Objective To examine parents' reported knowledge and use of harm reduction strategies to protect their infants from exposure to tobacco smoke in the home, and the relation between reported use of strategies and urinary cotinine to creatinine ratios in the infants. Design Cross sectional survey. Settings Coventry and Birmingham. Main outcome measures Parents' reported knowledge and use of harm reduction strategies and urinary cotinine to creatinine ratios in their infants. Participants 314 smoking households with infants. Results 86% of parents (264/307) believed that environmental tobacco smoke is harmful, 90% (281/314) believed that infants can be protected from it in the home, and 10% (32/314) were either unaware of measures or reported using none. 65% of parents (205/314) reported using two or more measures, but only 18% (58/314) reported not allowing smoking in the home. No difference was found in mean log e transformed urinary cotinine to creatinine ratio in infants from households that used no measures compared with households that used less strict measures. Mean log cotinine to creatinine ratios were significantly different in households banning smoking in the home compared with those using less strict or no measures. Banning smoking in the home was independently associated with a significant reduction in urinary cotinine to creatinine ratio by a factor of 2.6 (1.6 to 4.2) after adjustment for average household cigarette consumption, tenure, and overcrowding. Conclusions Less than a fifth of parents in smoking households ban smoking in the home. Banning smoking was associated with a small but significant reduction in urinary cotinine to creatinine ratio in infants, whereas less strict measures compared with no measures had no effect on the infants' exposure to environmental tobacco smoke.	Univ Warwick, Sch Hlth & Social Studies, Coventry CV4 7AL, W Midlands, England; Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England; Birmingham Childrens Hosp, Inst Child Hlth, Birmingham, W Midlands, England	University of Warwick; University of Leicester; University of Birmingham	Blackburn, C (corresponding author), Univ Warwick, Sch Hlth & Social Studies, Coventry CV4 7AL, W Midlands, England.							Bakoula CG, 1997, CANCER CAUSE CONTROL, V8, P73, DOI 10.1023/A:1018487222533; Cook DG, 1999, THORAX, V54, P357, DOI 10.1136/thx.54.4.357; GRAHAM H, 1993, WHEN LIFES DRAG WOME; Haufroid V, 1998, INT ARCH OCC ENV HEA, V71, P162, DOI 10.1007/s004200050266; Jarvis MJ, 2000, BRIT MED J, V321, P343, DOI 10.1136/bmj.321.7257.343; Mascola MA, 1998, AM J PUBLIC HEALTH, V88, P893, DOI 10.2105/AJPH.88.6.893; Peterson EL, 1997, J CLIN EPIDEMIOL, V50, P917, DOI 10.1016/S0895-4356(97)00095-4; Wakefield M, 2000, AM J PREV MED, V19, P188, DOI 10.1016/S0749-3797(00)00197-5; Winkelstein ML, 1997, ANN ALLERG ASTHMA IM, V78, P419, DOI 10.1016/S1081-1206(10)63206-1	9	85	90	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2003	327	7409					257	260		10.1136/bmj.327.7409.257	http://dx.doi.org/10.1136/bmj.327.7409.257			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708KP	12896936	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000184566300017
J	Sejvar, JJ; Haddad, MB; Tierney, BC; Campbell, GL; Marfin, AA; Van Gerpen, JA; Fleischauer, A; Leis, AA; Stokic, DS; Petersen, LR				Sejvar, JJ; Haddad, MB; Tierney, BC; Campbell, GL; Marfin, AA; Van Gerpen, JA; Fleischauer, A; Leis, AA; Stokic, DS; Petersen, LR			Neurologic manifestations and outcome of West Nile virus infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEW-YORK; JAPANESE ENCEPHALITIS; MOVEMENT-DISORDERS; CLINICAL-FEATURES; OUTBREAK; POLIOMYELITIS; EPIDEMIC	Context The neurologic manifestations, laboratory findings, and outcome of patients with West Nile virus (WNV) infection have not been prospectively characterized. Objective To describe prospectively the clinical and laboratory features and long-term outcome of patients with neurologic manifestations of WNV infection. Design, Setting, and Participants From August 1 to September 2, 2002, a community-based, prospective case series was conducted in St Tammany Parish, La. Standardized clinical data were collected on patients with suspected WNV infection. Confirmed WNV-seropositive patients were reassessed at 8 months. Main Outcome Measures Clinical, neurologic, and laboratory features at initial presentation, and long-term neurologic outcome. Results Sixteen (37%) of 39 suspected cases had antibodies against WNV; 5 had meningitis, 8 had encephalitis, and 3 had poliomyelitis-like acute flaccid paralysis. Movement disorders, including tremor (15 [94%]), myoclonus (5 [31%]) and parkinsonism (11 [69%]), were common among WNV-seropositive patients. One patient died. At 8-month followup, fatigue, headache, and myalgias were persistent symptoms; gait and movement disorders persisted in 6 patients. Patients with WNV meningitis or encephalitis had favorable outcomes, although patients with acute flaccid paralysis did not recover limb strength. Conclusions Movement disorders, including tremor, myoclonus, and parkinsonism, may be present during acute illness with WNV infection. Some patients with WNV infection and meningitis or encephalitis ultimately may have good long-term outcome, although an irreversible poliomyelitis-like syndrome may result.	CDCP, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDCP, Div Vector Borne Infect Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDCP, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA 30333 USA; Ochsner Clin & Alton Ochsner Med Fdn, Dept Neurol, New Orleans, LA USA; Methodist Rehabil Ctr, Ctr Neurosci & Neurol Recovery, Jackson, MS USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Ochsner Health System	Sejvar, JJ (corresponding author), CDCP, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, 1600 Clifton Rd,MS A-39, Atlanta, GA 30333 USA.	zea3@cdc.gov		Stokic, Dobrivoje/0000-0002-1891-5730				ALCOCK A, 1985, CMAJ, V130, P1305; Asnis DS, 2000, CLIN INFECT DIS, V30, P413, DOI 10.1086/313737; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P825; Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P708; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P37; Chowers MY, 2001, EMERG INFECT DIS, V7, P675; Glass JD, 2002, NEW ENGL J MED, V347, P1280, DOI 10.1056/NEJM200210173471616; Goh KJ, 2000, NEW ENGL J MED, V342, P1229, DOI 10.1056/NEJM200004273421701; GORDON B, 1990, ARCH NEUROL-CHICAGO, V47, P646, DOI 10.1001/archneur.1990.00530060054017; Han LL, 1999, J INFECT DIS, V179, P230, DOI 10.1086/314566; Hokkanen L, 2000, NEUROPSYCHOL REV, V10, P151, DOI 10.1023/A:1009079531196; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Leis AA, 2002, NEW ENGL J MED, V347, P1279, DOI 10.1056/NEJM2002c021587; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; Martin DA, 2002, CLIN DIAGN LAB IMMUN, V9, P544, DOI 10.1128/CDLI.9.3.544-549.2002; Misra UK, 2002, POSTGRAD MED J, V78, P238, DOI 10.1136/pmj.78.918.238; Misra UK, 1997, J NEUROL, V244, P299, DOI 10.1007/s004150050090; Modlin John F., 1997, P57; MONATH T, 1980, ST LOUIS ENCEPHALITI, P503; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Murgod UA, 2001, NEUROLOGY, V57, P2313, DOI 10.1212/WNL.57.12.2313; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; PETROV V, 2001, MOSCOW VOPROSY VIRUS, V45, P22; Platonov AE, 2001, EMERG INFECT DIS, V7, P128, DOI 10.3201/eid0701.010118; Pradhan S, 1999, NEUROLOGY, V53, P1781, DOI 10.1212/WNL.53.8.1781; Sejvar JJ, 2003, EMERG INFECT DIS, V9, P788, DOI 10.3201/eid0907.030129; Shieh WJ, 2000, EMERG INFECT DIS, V6, P370, DOI 10.3201/eid0604.000407; SHOJI H, 1993, J NEUROL, V240, P59, DOI 10.1007/BF00838449; Solomon T, 2002, CURR TOP MICROBIOL, V267, P171; SOUTHERN PM, 1969, ANN INTERN MED, V71, P681, DOI 10.7326/0003-4819-71-4-681; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; TZENG S, 1989, CHINESE MED J, V43, P208; Wasay M, 2000, ARCH NEUROL-CHICAGO, V57, P114, DOI 10.1001/archneur.57.1.114; Weiss D, 2001, EMERG INFECT DIS, V7, P654, DOI 10.3201/eid0704.010409	35	382	396	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2003	290	4					511	515		10.1001/jama.290.4.511	http://dx.doi.org/10.1001/jama.290.4.511			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703JB	12876094	Bronze			2022-12-01	WOS:000184275300023
J	Wrenger, E; Muller, R; Moesenthin, M; Welte, T; Frolich, JC; Neumann, KH				Wrenger, E; Muller, R; Moesenthin, M; Welte, T; Frolich, JC; Neumann, KH			Lesson of the week - Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases	BRITISH MEDICAL JOURNAL			English	Review							CONGESTIVE-HEART-FAILURE; LIFE-THREATENING HYPERKALEMIA; CONVERTING ENZYME-INHIBITORS; HYPORENINEMIC HYPOALDOSTERONISM; COMBINED THERAPY; RALES		Univ Magdeburg, Div Nephrol, Dept Internal Med, D-39120 Magdeburg, Germany; Univ Magdeburg, Div Cardiol Pulmonol & Angiol, Dept Internal Med, D-39120 Magdeburg, Germany; Hannover Med Sch, Inst Clin Pharmacol, Hannover, Germany	Otto von Guericke University; Otto von Guericke University; Hannover Medical School	Wrenger, E (corresponding author), Univ Magdeburg, Div Nephrol, Dept Internal Med, Leipziger Str 44, D-39120 Magdeburg, Germany.							Bauersachs J, 2000, CIRCULATION, V102, P2325, DOI 10.1161/01.CIR.102.19.2325; Berry C, 2001, Heart, V85, pE8, DOI 10.1136/heart.85.4.e8; Blaustein DA, 2002, AM J CARDIOL, V90, P662, DOI 10.1016/S0002-9149(02)02580-8; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; DEFRONZO RA, 1980, KIDNEY INT, V17, P118, DOI 10.1038/ki.1980.14; Evers S, 1998, J NEUROL NEUROSUR PS, V64, P249, DOI 10.1136/jnnp.64.2.249; Georges B, 2000, LANCET, V355, P1369, DOI 10.1016/S0140-6736(05)72606-4; Greenberg A, 2000, AM J MED SCI, V319, P10, DOI 10.1097/00000441-200001000-00002; Hu YW, 2002, ANESTH ANALG, V95, P39, DOI 10.1097/00000539-200207000-00006; JACKSON EK, 1996, GOODMAN GILMANS PHAR, P733; JOHNSTON RT, 1992, INT J CARDIOL, V34, P213, DOI 10.1016/0167-5273(92)90159-Z; LARGE DM, 1984, POSTGRAD MED J, V60, P370, DOI 10.1136/pgmj.60.703.370; Millane T, 2000, BRIT MED J, V320, P559, DOI 10.1136/bmj.320.7234.559; Obialo CI, 2002, AM J CARDIOL, V90, P663, DOI 10.1016/S0002-9149(02)02581-X; Pitt B, 1996, AM J CARDIOL, V78, P902; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Schepkens H, 2001, AM J MED, V110, P438, DOI 10.1016/S0002-9343(01)00642-8; Vanpee D, 2000, AGING-CLIN EXP RES, V12, P315, DOI 10.1007/BF03339853	18	82	87	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 19	2003	327	7407					147	149		10.1136/bmj.327.7407.147	http://dx.doi.org/10.1136/bmj.327.7407.147			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702WJ	12869459	Green Published			2022-12-01	WOS:000184247500022
